PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mathew, R; Seiler, MP; Scanlon, ST; Mao, AP; Constantinides, MG; Bertozzi-Villa, C; Singer, JD; Bendelac, A				Mathew, Rebecca; Seiler, Michael P.; Scanlon, Seth T.; Mao, Ai-ping; Constantinides, Michael G.; Bertozzi-Villa, Clara; Singer, Jeffrey D.; Bendelac, Albert			BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs	NATURE			English	Article							UBIQUITIN LIGASE; PROMYELOCYTIC LEUKEMIA; NUCLEAR LAMINA; CHROMATIN; PROTEINS; GENES; MECHANISMS; REPRESSION; ADAPTERS; COMPLEX	The differentiation of several T- and B-cell effector programs in the immune system is directed by signature transcription factors that induce rapid epigenetic remodelling. Here we report that promyelocytic leukaemia zinc finger (PLZF), the BTB-zinc finger (BTB-ZF) transcription factor directing the innate-like effector program of natural killer T-cell thymocytes(1,2), is prominently associated with cullin 3 (CUL3), an E3 ubiquitin ligase previously shown to use BTB domain-containing proteins as adaptors for substrate binding(3-7). PLZF transports CUL3 to the nucleus, where the two proteins are associated within a chromatin-modifying complex. Furthermore, PLZF expression results in selective ubiquitination changes of several components of this complex. CUL3 was also found associated with the BTB-ZF transcription factor BCL6, which directs the germinal-centre B cell and follicular T-helper cell programs. Conditional CUL3 deletion in mice demonstrated an essential role for CUL3 in the development of PLZF- and BCL6-dependent lineages. We conclude that distinct lineage-specific BTB-ZF transcription factors recruit CUL3 to alter the ubiquitination pattern of their associated chromatin-modifying complex. We propose that this new function is essential to direct the differentiation of several T- and B-cell effector programs, and may also be involved in the oncogenic role of PLZF and BCL6 in leukaemias and lymphomas(8,9).	[Mathew, Rebecca; Seiler, Michael P.; Scanlon, Seth T.; Mao, Ai-ping; Constantinides, Michael G.; Bertozzi-Villa, Clara; Bendelac, Albert] Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA; [Singer, Jeffrey D.] Portland State Univ, Dept Biol, Portland, OR 97207 USA	Howard Hughes Medical Institute; University of Chicago; Portland State University	Bendelac, A (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu	Mathew, Rebecca/H-7154-2013	Constantinides, Michael/0000-0003-4770-7751; Scanlon, Seth Thomas/0000-0002-1792-6382	National Institute of Health (NIH) [5RO1GM082940, RO1AI038339]; Irvington Institute postdoctoral fellowship from the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082940] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute postdoctoral fellowship from the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Dinner, J. Licht, G. Prive, A. Ruthenburg, R. Sciammas, H. Singh and P. Wilson for discussions, J. C. Silva and M. Stokes for UbiScan analysis, C. Labno and V. Bindokas for help with confocal microscopy, and K. Block, L. Roach, D. Zabner, F. Meng and L. Bai for help with experiments. This work was supported by National Institute of Health (NIH) grants 5RO1GM082940 (J.D.S.) and RO1AI038339 (A.B.), and an Irvington Institute postdoctoral fellowship from the Cancer Research Institute (R.M.). A.B. is a Howard Hughes Medical Institute Investigator.	Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Guidez F, 2007, P NATL ACAD SCI USA, V104, P18694, DOI 10.1073/pnas.0704433104; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hyjek E, 2001, BLOOD, V97, P270, DOI 10.1182/blood.V97.1.270; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; McConnell MJ, 2007, CURR TOP MICROBIOL, V313, P31; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; Ohnuki H, 2012, BLOOD, V119, P2688, DOI 10.1182/blood-2011-03-345306; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Savage AK, 2011, J IMMUNOL, V186, P5801, DOI 10.4049/jimmunol.1100119; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	33	77	83	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					619	+		10.1038/nature11548	http://dx.doi.org/10.1038/nature11548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23086144	Green Accepted			2022-12-24	WOS:000311339800057
J	Girotra, S; Nallamothu, BK; Spertus, JA; Li, Y; Krumholz, HM; Chan, PS				Girotra, Saket; Nallamothu, Brahmajee K.; Spertus, John A.; Li, Yan; Krumholz, Harlan M.; Chan, Paul S.		Amer Heart Assoc Get Guidelines	Trends in Survival after In-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; AUSTRALIAN-RESUSCITATION-COUNCIL; HEALTH-CARE-PROFESSIONALS; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; NATIONAL-REGISTRY; DELAYED TIME; GUIDELINES; OUTCOMES; DEFIBRILLATION	BACKGROUND Despite advances in resuscitation care in recent years, it is not clear whether survival and neurologic function after in-hospital cardiac arrest have improved over time. METHODS We identified all adults who had an in-hospital cardiac arrest at 374 hospitals in the Get with the Guidelines-Resuscitation registry between 2000 and 2009. Using multivariable regression, we examined temporal trends in risk-adjusted rates of survival to discharge. Additional analyses explored whether trends were due to improved survival during acute resuscitation or postresuscitation care and whether they occurred at the expense of greater neurologic disability in survivors. RESULTS Among 84,625 hospitalized patients with cardiac arrest, 79.3% had an initial rhythm of asystole or pulseless electrical activity, and 20.7% had ventricular fibrillation or pulseless ventricular tachycardia. The proportion of cardiac arrests due to asystole or pulseless electrical activity increased over time (P<0.001 for trend). Risk-adjusted rates of survival to discharge increased from 13.7% in 2000 to 22.3% in 2009 (adjusted rate ratio per year, 1.04; 95% confidence interval [CI], 1.03 to 1.06; P<0.001 for trend). Survival improvement was similar in the two rhythm groups and was due to improvement in both acute resuscitation survival and postresuscitation survival. Rates of clinically significant neurologic disability among survivors decreased over time, with a risk- adjusted rate of 32.9% in 2000 and 28.1% in 2009 (adjusted rate ratio per year, 0.98; 95% CI, 0.97 to 1.00; P = 0.02 for trend). CONCLUSIONS Both survival and neurologic outcomes after in-hospital cardiac arrest have improved during the past decade at hospitals participating in a large national qualityimprovement registry. (Funded by the American Heart Association.)	[Girotra, Saket] Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiovasc Dis, Iowa City, IA 52242 USA; [Nallamothu, Brahmajee K.] Res & Dev Ctr Excellence, Vet Affairs Ann Arbor Hlth Serv, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Spertus, John A.; Chan, Paul S.] Univ Missouri, Kansas City, MO USA; [Spertus, John A.; Li, Yan; Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, KS USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Missouri System; University of Missouri Kansas City; Saint Luke's Mid America Heart Institute; Yale University; Yale University; Yale University; Yale University	Girotra, S (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, Div Cardiovasc Dis, 200 Hawkins Dr,Suite 4430 RCP, Iowa City, IA 52242 USA.	saket-girotra@uiowa.edu	Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020	Girotra, Saket/0000-0002-4784-4513	American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the American Heart Association.	Abella BS, 2007, RESUSCITATION, V73, P54, DOI 10.1016/j.resuscitation.2006.10.027; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Aufderheide TP, 2010, HEART RHYTHM, V7, P1357, DOI 10.1016/j.hrthm.2010.04.022; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chan PS, 2010, JAMA-J AM MED ASSOC, V304, P2129, DOI 10.1001/jama.2010.1576; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Edelson DP, 2008, EMERG MED J, V168, P1063; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hinchey PR, 2010, ANN EMERG MED, V56, P348, DOI 10.1016/j.annemergmed.2010.01.036; Hunt EA, 2008, PEDIATRICS, V121, pE34, DOI 10.1542/peds.2007-0029; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Kayser RG, 2008, RESUSCITATION, V78, P151, DOI 10.1016/j.resuscitation.2008.03.007; Meaney PA, 2010, CRIT CARE MED, V38, P101, DOI 10.1097/CCM.0b013e3181b43282; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Mhyre JM, 2010, ANESTHESIOLOGY, V113, P782, DOI 10.1097/ALN.0b013e3181eaa74f; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Pell JP, 2006, EUR HEART J, V27, P406, DOI 10.1093/eurheartj/ehi604; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	25	554	575	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1912	1920		10.1056/NEJMoa1109148	http://dx.doi.org/10.1056/NEJMoa1109148			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150959	Green Accepted, Bronze			2022-12-24	WOS:000311029300007
J	Grantham, J				Grantham, Jeremy			Be persuasive. Be brave. Be arrested (if necessary)	NATURE			English	Editorial Material									[Grantham, Jeremy] GMO, Boston, MA USA; [Grantham, Jeremy] Grantham Fdn Protect Environm, Boston, MA USA		Grantham, J (corresponding author), GMO, Boston, MA USA.	jeremy@granthamfoundation.org							0	23	23	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					303	303		10.1038/491303a	http://dx.doi.org/10.1038/491303a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	036MY	23151541	Bronze			2022-12-24	WOS:000311031600004
J	Aoudjehane, HC; Avice, G; Barrat, JA; Boudouma, O; Chen, G; Duke, MJM; Franchi, IA; Gattacceca, J; Grady, MM; Greenwood, RC; Herd, CDK; Hewins, R; Jambon, A; Marty, B; Rochette, P; Smith, CL; Sautter, V; Verchovsky, A; Weber, P; Zanda, B				Aoudjehane, H. Chennaoui; Avice, G.; Barrat, J. -A.; Boudouma, O.; Chen, G.; Duke, M. J. M.; Franchi, I. A.; Gattacceca, J.; Grady, M. M.; Greenwood, R. C.; Herd, C. D. K.; Hewins, R.; Jambon, A.; Marty, B.; Rochette, P.; Smith, C. L.; Sautter, V.; Verchovsky, A.; Weber, P.; Zanda, B.			Tissint Martian Meteorite: A Fresh Look at the Interior, Surface, and Atmosphere of Mars	SCIENCE			English	Article							SHERGOTTITES; GEOCHEMISTRY; CHEMISTRY; DAR-AL-GANI-476; NITROGEN; SYSTEM; GASES; HF	Tissint (Morocco) is the fifth martian meteorite collected after it was witnessed falling to Earth. Our integrated mineralogical, petrological, and geochemical study shows that it is a depleted picritic shergottite similar to EETA79001A. Highly magnesian olivine and abundant glass containing martian atmosphere are present in Tissint. Refractory trace element, sulfur, and fluorine data for the matrix and glass veins in the meteorite indicate the presence of a martian surface component. Thus, the influence of in situ martian weathering can be unambiguously distinguished from terrestrial contamination in this meteorite. Martian weathering features in Tissint are compatible with the results of spacecraft observations of Mars. Tissint has a cosmic-ray exposure age of 0.7 +/- 0.3 million years, consistent with those of many other shergottites, notably EETA79001, suggesting that they were ejected from Mars during the same event.	[Aoudjehane, H. Chennaoui] Hassan II Univ Casablanca, GAIA Lab, Fac Sci, Casablanca, Morocco; [Aoudjehane, H. Chennaoui; Boudouma, O.; Jambon, A.] Univ Paris 06, Inst Terre Paris, UMR 7193, F-75005 Paris, France; [Avice, G.; Marty, B.] Univ Lorraine, Ctr Rech Petrograph & Geochim, F-54501 Vandoeuvre Les Nancy, France; [Barrat, J. -A.] Univ Bretagne Occidentale, Inst Univ Europeen Mer, UMR 6538, F-29280 Plouzane, France; [Chen, G.; Herd, C. D. K.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Duke, M. J. M.] Univ Alberta, SLOWPOKE Nucl Reactor Facil, Edmonton, AB T6G 2J9, Canada; [Grady, M. M.; Greenwood, R. C.; Verchovsky, A.] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Rochette, P.] Aix Marseille Univ, CNRS, Ctr Europeen Rech & Enseignement Geosci Environm, F-13545 Aix En Provence 4, France; [Grady, M. M.; Smith, C. L.] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Hewins, R.; Sautter, V.; Zanda, B.] Museum Natl Hist Nat, Lab Etud Mat Extraterrestre, F-75005 Paris, France; [Hewins, R.; Sautter, V.; Zanda, B.] CNRS, UMS2679, F-75005 Paris, France; [Smith, C. L.] ESA European Space Agcy, European Space Res & Technol Ctr, NL-2200 AG Noordwijk, Netherlands; [Smith, C. L.] UK Space Agcy, ESA Harwell Ctr, Didcot OX11 0QX, Oxon, England; [Weber, P.] Univ Bern, Albert Einstein Ctr Fundamental Phys, CH-3012 Bern, Switzerland	Hassan II University of Casablanca; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Alberta; University of Alberta; Open University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Natural History Museum London; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); European Space Agency; University of Bern	Aoudjehane, HC (corresponding author), Hassan II Univ Casablanca, GAIA Lab, Fac Sci, BP 5366 Maarif, Casablanca, Morocco.	chennaoui_h@yahoo.fr	Smith, Caroline/AAO-3652-2020; Rochette, Pierre/O-4612-2019; Gattacceca, Jerome/AAG-5651-2019; IMPMC, ROCKS @/U-8478-2017; Barrat, Jean-Alix/C-8416-2017; Zanda, Brigitte M/D-6787-2015	Smith, Caroline/0000-0001-7005-6470; Rochette, Pierre/0000-0002-7362-0660; Gattacceca, Jerome/0000-0002-1639-7140; Barrat, Jean-Alix/0000-0003-3158-3109; Zanda, Brigitte M/0000-0002-4210-7151; Grady, Monica/0000-0002-4055-533X; Chennaoui, Hasnaa/0000-0001-8792-246X; Avice, Guillaume/0000-0003-0962-0049; Herd, Christopher/0000-0001-5210-4002; Greenwood, Richard/0000-0002-5544-8027	Hassan II University Casablanca, Faculte des Sciences Ain Chock; Centre de Recherches Scientifiques et Techniques Morocco; CNRS France [01/10]; Comite Mixte Inter Universitaire Franco-Marocain Volubilis [MA/11/252]; CRPG Nancy, France; CNES; CNRS; European Research Council under the European Community's Seventh Framework Programme [267255]; Universite de Bretagne Occidentale-Institut Universitaire Europeen de la Mer, Plouzane, France; Programme National de Planetologie, Institut National des Sciences de l'Univers; Open University; Science and Technology Facilities Council; University of Alberta; Natural Sciences and Engineering Research Council of Canada [261740-03]; Science and Technology Facilities Council [ST/I002820/1, ST/I001964/1] Funding Source: researchfish; STFC [ST/I001964/1] Funding Source: UKRI	Hassan II University Casablanca, Faculte des Sciences Ain Chock; Centre de Recherches Scientifiques et Techniques Morocco; CNRS France(Centre National de la Recherche Scientifique (CNRS)); Comite Mixte Inter Universitaire Franco-Marocain Volubilis; CRPG Nancy, France; CNES(Centre National D'etudes Spatiales); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council under the European Community's Seventh Framework Programme(European Commission); Universite de Bretagne Occidentale-Institut Universitaire Europeen de la Mer, Plouzane, France; Programme National de Planetologie, Institut National des Sciences de l'Univers; Open University; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); University of Alberta(University of Alberta); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge D. N. Menegas and family for their generous donation enabling the acquisition of Tissint (BM.2012,M1), M. Aoudjehane for fieldwork, A. Aaranson for field information, J. Gibson for assistance with oxygen isotope analysis, L. Labenne for loan of a sample, and A. Irving for 400 mg of powdered sample. This study was funded at Hassan II University Casablanca, Faculte des Sciences Ain Chock, by Centre de Recherches Scientifiques et Techniques Morocco and CNRS France (Projet International de Cooperation Scientifique, Sciences de l'Univers 01/10), and by Comite Mixte Inter Universitaire Franco-Marocain Volubilis (MA/11/252); CRPG Nancy, France, by the CNES, CNRS, and European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013 no. 267255); Universite de Bretagne Occidentale-Institut Universitaire Europeen de la Mer, Plouzane, France, by the Programme National de Planetologie, Institut National des Sciences de l'Univers; Open University, by Science and Technology Facilities Council grant to the Planetary and Space Sciences Discipline; and University of Alberta, by the Natural Sciences and Engineering Research Council of Canada (grant 261740-03).	ARVIDSON RE, 1989, REV GEOPHYS, V27, P39, DOI 10.1029/RG027i001p00039; Barrat JA, 2012, GEOCHIM COSMOCHIM AC, V83, P79, DOI 10.1016/j.gca.2011.12.011; Barrat JA, 2002, GEOCHIM COSMOCHIM AC, V66, P3505, DOI 10.1016/S0016-7037(02)00934-1; Barrat JA, 2001, METEORIT PLANET SCI, V36, P23, DOI 10.1111/j.1945-5100.2001.tb01807.x; Beck P, 2006, GEOCHIM COSMOCHIM AC, V70, P2127, DOI 10.1016/j.gca.2006.01.016; BECKER RH, 1984, EARTH PLANET SC LETT, V69, P225, DOI 10.1016/0012-821X(84)90183-3; Blichert-Toft J, 1999, EARTH PLANET SC LETT, V173, P25, DOI 10.1016/S0012-821X(99)00222-8; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; Crozaz G, 2001, GEOCHIM COSMOCHIM AC, V65, P971, DOI 10.1016/S0016-7037(00)00586-X; Dreibus G, 2000, METEORIT PLANET SCI, V35, pA49; Franchi IA, 1999, METEORIT PLANET SCI, V34, P657, DOI 10.1111/j.1945-5100.1999.tb01371.x; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; MARTI K, 1995, SCIENCE, V267, P1981, DOI 10.1126/science.7701319; Marty B, 2003, SPACE SCI REV, V106, P175, DOI 10.1023/A:1024689721371; Mittlefehldt DW, 2003, GEOCHIM COSMOCHIM AC, V67, P1911, DOI 10.1016/S0016-7037(02)01411-4; Neal C. R., 2001, LUNAR PLANET SCI, V32, P1671; Nier A. O., 1977, Journal of Geophysical Research, V82, P4341, DOI 10.1126/science.194.4271.1298; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; Rao MN, 1999, GEOPHYS RES LETT, V26, P3265, DOI 10.1029/1999GL005388; Rochette P, 2005, METEORIT PLANET SCI, V40, P529, DOI 10.1111/j.1945-5100.2005.tb00961.x; Sautter V, 2002, EARTH PLANET SC LETT, V195, P223, DOI 10.1016/S0012-821X(01)00591-X; Treiman AH, 2000, PLANET SPACE SCI, V48, P1213, DOI 10.1016/S0032-0633(00)00105-7; Walton EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4829, DOI 10.1016/j.gca.2010.04.065	24	104	104	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					785	788		10.1126/science.1224514	http://dx.doi.org/10.1126/science.1224514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23065902				2022-12-24	WOS:000310839500040
J	Trivedi, TK; DeSalvo, T; Lee, L; Palumbo, A; Moll, M; Curns, A; Hall, AJ; Patel, M; Parashar, UD; Lopman, BA				Trivedi, Tarak K.; DeSalvo, Traci; Lee, Lore; Palumbo, Aimee; Moll, Maria; Curns, Aaron; Hall, Aron J.; Patel, Manish; Parashar, Umesh D.; Lopman, Benjamin A.			Hospitalizations and Mortality Associated With Norovirus Outbreaks in Nursing Homes, 2009-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERM-CARE FACILITIES; MINIMUM DATA SET; GASTROENTERITIS OUTBREAKS; RESIDENT ASSESSMENT; NORWALK VIRUS; UNITED-STATES; ENGLAND; SURVEILLANCE; OUTCOMES; DEATHS	Context Norovirus outbreaks are common among vulnerable, elderly populations in US nursing homes. Objectives To assess whether all-cause hospitalization and mortality rates are increased during norovirus outbreak vs nonoutbreak periods in nursing homes, and to identify factors associated with increased risk. Design, Setting, and Participants A retrospective cohort study of Medicare-certified nursing homes in Oregon, Wisconsin, and Pennsylvania that reported at least 1 confirmed or suspected norovirus outbreak to the Centers for Disease Control and Prevention's National Outbreak Reporting System (NORS), January 2009 to December 2010. Deaths and hospitalizations occurring among residents of these nursing homes were identified through the Medicare Minimum Data Set (MDS). Main Outcome Measures Rates of all-cause hospitalization and mortality during outbreak compared with nonoutbreak periods were estimated using a random-effects Poisson regression model controlling for background seasonality in both outcomes. Results The cohort consisted of 308 nursing homes that reported 407 norovirus outbreaks to NORS. Per MDS, 67 730 hospitalizations and 26 055 deaths occurred in these homes during the 2-year study. Hospitalization rates were 124.0 (95% CI, 119.4-129.1) vs 109.5 (95% CI, 108.6-110.3) hospitalizations per nursing home-year during outbreak vs nonoutbreak periods, yielding a seasonally adjusted rate ratio (RR) of 1.09 (95% CI, 1.05-1.14). Similarly, mortality rates were 53.7 (95% CI, 50.6-57.0) vs 41.9 (95% CI, 41.4-42.4) deaths per nursing home-year in outbreak vs nonoutbreak periods (seasonally adjusted RR, 1.11; 95% CI, 1.05-1.18). The increases in hospitalizations and mortality were concentrated in the first 2 weeks (week 0 and 1) and the initial week (week 0) of the outbreak, respectively. Homes with lower daily registered nurse (RN) hours per resident (<0.75) had increased mortality rates during norovirus outbreaks compared with baseline (RR, 1.26; 95% CI, 1.14-1.40), while no increased risk (RR, 1.03; 95% CI, 0.96-1.12) was observed in homes with higher daily RN hours per resident (P=.007 by likelihood ratio test); the increase in hospitalization rates did not show a similar pattern. Conclusion Norovirus outbreaks were associated with significant concurrent increases in all-cause hospitalization and mortality in nursing homes. JAMA. 2012;308(16):1668-1675 Published online October 18, 2012. doi:10.1001/jama.2012.14023 www.jama.com	[Trivedi, Tarak K.] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Curns, Aaron; Hall, Aron J.; Patel, Manish; Parashar, Umesh D.; Lopman, Benjamin A.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA; [DeSalvo, Traci] Wisconsin Dept Hlth Serv, Div Publ Hlth, Madison, WI USA; [Lee, Lore] Oregon Publ Hlth Div, Portland, OR USA; [Palumbo, Aimee; Moll, Maria] Div Infect Dis Epidemiol, Harrisburg, PA USA; [Palumbo, Aimee; Moll, Maria] Penn Dept Hlth, Harrisburg, PA 17108 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Trivedi, TK (corresponding author), Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, 1600 Clifton Rd NE,MS A34, Atlanta, GA 30333 USA.	ttrivedi@uchicago.edu	Trivedi, Tarak/S-9107-2019; Palumbo, Aimee/AAE-1762-2022	Trivedi, Tarak/0000-0003-3357-9525; Palumbo, Aimee/0000-0003-0769-6015	Centers for Disease Control and Prevention (CDC); Pfizer Inc.; CDC	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pfizer Inc.(Pfizer); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Mr Trivedi reports being a fellow of The CDC Experience, a 1-year fellowship for medical students in applied epidemiology at the Centers for Disease Control and Prevention (CDC) and made possible by a public/private partnership supported by a grant to the CDC Foundation from external medical affairs, Pfizer Inc. Ms DeSalvo reports receipt of a grant to the institution and travel support to the institution from the CDC; and travel/accommodations/meeting expenses unrelated to activities listed from the Association of Public Health Laboratories and the Council of State and Territorial Epidemiologists. The other authors report no disclosures.	Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Blaney DD, 2011, AM J INFECT CONTROL, V39, P296, DOI 10.1016/j.ajic.2010.10.010; Centers for Disease Control and Prevention, FLUV WEEKL INFL SURV; Centers for Medicare and Medicaid Services, NURS HOM DAT COMP; Centers for Medicare and Medicaid Services, NURS HOM COMP; Centers for Medicare & Medicaid Services, IMPR NURS HOM COMP C; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; Gustavsson L, 2011, J HOSP INFECT, V79, P27, DOI 10.1016/j.jhin.2011.05.018; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Harrington C, 2000, J GERONTOL B-PSYCHOL, V55, pS278, DOI 10.1093/geronb/55.5.S278; Harrington C, 2000, GERONTOLOGIST, V40, P5; Harris JP, 2010, J HOSP INFECT, V74, P1, DOI 10.1016/j.jhin.2009.07.025; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Horn SD, 2005, AM J NURS, V105, P58, DOI 10.1097/00000446-200511000-00028; KAPLAN JE, 1982, ANN INTERN MED, V96, P756, DOI 10.7326/0003-4819-96-6-756; Kirk MD, 2010, CLIN INFECT DIS, V51, P907, DOI 10.1086/656406; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; MacCannell T, 2011, INFECT CONT HOSP EP, V32, P939, DOI 10.1086/662025; Mor V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-78; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; Rosenthal NA, 2011, EPIDEMIOL INFECT, V139, P286, DOI 10.1017/S095026881000083X; Turcios RM, 2006, CLIN INFECT DIS, V42, P964, DOI 10.1086/500940; US Social Security Administration, COMP SOC SEC LAWS RE; van Asten L, 2011, EPIDEMIOLOGY, V22, P336, DOI 10.1097/EDE.0b013e31821179af; Wikswo M, 2012, INT C EM INF DIS ICE; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478	31	68	69	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1668	1675		10.1001/jama.2012.14023	http://dx.doi.org/10.1001/jama.2012.14023			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028PI	23079758	Bronze			2022-12-24	WOS:000310434100021
J	Wootton, DM; Alevriadou, BR				Wootton, David M.; Alevriadou, B. Rita			The Shear Stress of Busting Blood Clots	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FLOW		[Wootton, David M.] Cooper Union Adv Sci & Art, Dept Mech Engn, New York, NY 10003 USA; [Wootton, David M.] Cooper Union Adv Sci & Art, Maurice Kanbar Ctr Biomed Engn, New York, NY 10003 USA; [Alevriadou, B. Rita] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Alevriadou, B. Rita] Ohio State Univ, Dept Internal Med Cardiovasc Med, Columbus, OH USA; [Alevriadou, B. Rita] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH USA	Ohio State University; Ohio State University; Ohio State University	Wootton, DM (corresponding author), Cooper Union Adv Sci & Art, Dept Mech Engn, New York, NY 10003 USA.		Alevriadou, Barbara R/E-2628-2011	Alevriadou, Barbara/0000-0003-1897-755X				Korin N, 2012, SCIENCE, V337, P738, DOI 10.1126/science.1217815; Ruggeri ZM, 2009, MICROCIRCULATION, V16, P58, DOI 10.1080/10739680802651477; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; TILLES AW, 1987, MICROVASC RES, V33, P211, DOI 10.1016/0026-2862(87)90018-5; Wootton DM, 2002, BIOTECHNOL BIOENG, V77, P405, DOI 10.1002/bit.10127	5	10	10	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1361	1363		10.1056/NEJMcibr1207994	http://dx.doi.org/10.1056/NEJMcibr1207994			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034026				2022-12-24	WOS:000309406100017
J	Arshad, A; Powell, C; Tighe, MP				Arshad, A.; Powell, C.; Tighe, M. P.			Hirschsprung's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTORS; 1ST STOOL; DIAGNOSIS; ENTEROCOLITIS; CONSTIPATION; BIOPSY; JAPAN		[Arshad, A.; Tighe, M. P.] Poole Hosp NHS Trust, Dept Paediat, Poole BH15 2JB, Dorset, England; [Powell, C.] Upton Surg, Poole BH16 5PW, Dorset, England		Tighe, MP (corresponding author), Poole Hosp NHS Fdn Trust, Poole Hosp, Longfleet Rd, Poole BH21 2HJ, Dorset, England.	mpt195@hotmail.com						Afzal NA, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-28; Aslam A, 1997, J PEDIATR SURG, V32, P1206, DOI 10.1016/S0022-3468(97)90683-7; Beaudet A.R., 2001, METABOLIC MOL BASES, V8th; Blake NS, 2010, HIRSCHSPRUNGS DIS AL, P223; CLARK DA, 1977, PEDIATRICS, V60, P457; de Lorijn F, 2005, J PEDIATR-US, V146, P787, DOI 10.1016/j.jpeds.2005.01.044; Doodnath R, 2010, PEDIATR SURG INT, V26, P1107, DOI 10.1007/s00383-010-2694-2; Ghosh A, 1998, ARCH DIS CHILD, V79, P266, DOI 10.1136/adc.79.3.266; Hackam DJ, 1998, J PEDIATR SURG, V33, P830, DOI 10.1016/S0022-3468(98)90652-2; Haricharan RN, 2008, J PEDIATR SURG, V43, P1115, DOI 10.1016/j.jpedsurg.2008.02.039; IKEDA K, 1984, ANN SURG, V199, P400, DOI 10.1097/00000658-198404000-00005; KLEINHAUS S, 1979, J PEDIATR SURG, V14, P588, DOI 10.1016/S0022-3468(79)80145-1; Liem NT, 2008, ASIAN J SURG, V31, P216, DOI 10.1016/S1015-9584(08)60090-1; National Institute for Health and Clinical Excellence, 2010, DIAGN MAN ID CHILDH; Nofech-Mozes Y, 2004, J PAEDIATR CHILD H, V40, P716, DOI 10.1111/j.1440-1754.2004.00519.x; Pini-Prato A, 2007, PEDIATR SURG INT, V23, P117, DOI 10.1007/s00383-006-1845-y; RESCORLA FJ, 1992, ARCH SURG-CHICAGO, V127, P934; SHERRY SN, 1955, J PEDIATR-US, V46, P158, DOI 10.1016/S0022-3476(55)80205-3; Singh SJ, 2003, PEDIATR SURG INT, V19, P247, DOI 10.1007/s00383-002-0842-z; Suita S, 2005, J PEDIATR SURG, V40, P197, DOI 10.1016/j.jpedsurg.2004.09.052; SWENSON O, 1973, J PEDIATR SURG, V8, P587, DOI 10.1016/0022-3468(73)90395-3; TEITELBAUM DH, 1988, ANN SURG, V207, P240, DOI 10.1097/00000658-198803000-00003; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; Ziad F, 2006, ANN SAUDI MED, V26, P200, DOI 10.5144/0256-4947.2006.200	24	21	23	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2012	345								e5521	10.1136/bmj.e5521	http://dx.doi.org/10.1136/bmj.e5521			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KB	23028095				2022-12-24	WOS:000309657900005
J	Leppik, IE; Walczak, TS; Birnbaum, AK				Leppik, Ilo E.; Walczak, Thaddeus S.; Birnbaum, Angela K.			Challenges of epilepsy in elderly people	LANCET			English	Editorial Material							NURSING-HOME RESIDENTS; ANTIEPILEPTIC DRUG-USE; VARIABILITY; THERAPY		[Leppik, Ilo E.; Birnbaum, Angela K.] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Leppik, Ilo E.; Walczak, Thaddeus S.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Leppik, Ilo E.; Walczak, Thaddeus S.] MINCEP Epilepsy Care, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Leppik, IE (corresponding author), Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	leppi001@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026390] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG026390] Funding Source: Medline; NINDS NIH HHS [P50 NS016308] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn JE, 2008, NEUROLOGY, V71, P38, DOI 10.1212/01.wnl.0000316392.55784.57; Birnbaum A, 2003, NEUROLOGY, V60, P555, DOI 10.1212/01.WNL.0000052997.43492.E0; Birnbaum AK, 2012, EPILEPSY RES, V101, P22, DOI 10.1016/j.eplepsyres.2012.02.014; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; COLD JA, 1990, DICP ANN PHARMAC, V24, P601, DOI 10.1177/106002809002400610; Eberly LE, 2010, NEUROLOGY, V74, pA42; Ensrud KE, 2008, NEUROLOGY, V71, P723, DOI 10.1212/01.wnl.0000324919.86696.a9; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Fisher RS, 2008, EPILEPSIA, V49, P7, DOI 10.1111/j.1528-1167.2008.01921.x; Garrard J, 2000, J GERONTOL A-BIOL, V55, pM384, DOI 10.1093/gerona/55.7.M384; Garrard J, 2007, INT REV NEUROBIOL, V81, P165, DOI 10.1016/S0074-7742(06)81010-X; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Leppik IE, 2006, EPILEPSY RES, V68, pS1; LEPPIK IE, 1979, THER DRUG MONIT, V1, P475, DOI 10.1097/00007691-197910000-00004	14	10	10	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1128	1130		10.1016/S0140-6736(12)61517-7	http://dx.doi.org/10.1016/S0140-6736(12)61517-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021270				2022-12-24	WOS:000309255900007
J	Blakemore, SJ				Blakemore, Sarah-Jayne			Teenage kicks: cannabis and the adolescent brain	LANCET			English	Editorial Material									UCL Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London	Blakemore, SJ (corresponding author), UCL Inst Cognit Neurosci, London WC1N 3AR, England.	s.blakemore@ucl.ac.uk	Blakemore, Sarah-Jayne/A-1792-2010	Blakemore, Sarah-Jayne/0000-0002-1690-2805				Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Steinberg L, 2010, ADOLESCENCE; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136	11	13	13	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					888	889		10.1016/S0140-6736(12)61578-5	http://dx.doi.org/10.1016/S0140-6736(12)61578-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105LB	23117180				2022-12-24	WOS:000316069700010
J	Acquaviva, L; Szekvolgyi, L; Dichtl, B; Dichtl, BS; Saint Andre, CD; Nicolas, A; Geli, V				Acquaviva, Laurent; Szekvoelgyi, Lorant; Dichtl, Bernhard; Dichtl, Beatriz Solange; Saint Andre, Christophe de La Roche; Nicolas, Alain; Geli, Vincent			The COMPASS Subunit Spp1 Links Histone Methylation to Initiation of Meiotic Recombination	SCIENCE			English	Article							STRAND BREAK FORMATION; H3 TRIMETHYLATION; GENE-EXPRESSION; SITES; PROMOTER; FEATURES; HOTSPOTS; COMPLEX; PRDM9; ONSET	During meiosis, combinatorial associations of genetic traits arise from homologous recombination between parental chromosomes. Histone H3 lysine 4 trimethylation marks meiotic recombination hotspots in yeast and mammals, but how this ubiquitous chromatin modification relates to the initiation of double-strand breaks (DSBs) dependent on Spo11 remains unknown. Here, we show that the tethering of a PHD-containing protein, Spp1 (a component of the COMPASS complex), to recombinationally cold regions is sufficient to induce DSB formation. Furthermore, we found that Spp1 physically interacts with Mer2, a key protein of the differentiated chromosomal axis required for DSB formation. Thus, by interacting with H3K4me3 and Mer2, Spp1 promotes recruitment of potential meiotic DSB sites to the chromosomal axis, allowing Spo11 cleavage at nearby nucleosome-depleted regions.	[Acquaviva, Laurent; Saint Andre, Christophe de La Roche; Geli, Vincent] Aix Marseille Univ, Inst Paoli Calmettes, Marseille Canc Res Ctr CRCM, INSERM,CNRS,U1068,UMR7258, F-13009 Marseille, France; [Szekvoelgyi, Lorant; Nicolas, Alain] Univ Paris 06, CNRS, Inst Curie, Ctr Rech,UMR3244, F-75248 Paris, France; [Dichtl, Bernhard; Dichtl, Beatriz Solange] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Melbourne, Vic 3125, Australia; [Szekvoelgyi, Lorant] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Deakin University; University of Debrecen	Dichtl, B (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Melbourne, Vic 3125, Australia.	b.dichtl@deakin.edu.au; laroche@ifr88.cnrs-mrs.fr; alain.nicolas@curie.fr; geli@ifr88.cnrs-mrs.fr	Székvölgyi, Lóránt/AAC-1600-2021	Székvölgyi, Lóránt/0000-0002-7529-0319; Dichtl, Bernhard/0000-0001-5514-4982; Acquaviva, Laurent/0000-0001-5080-3619	"Ligue contre le Cancer" (Equipe Labelisees); Swiss National Science Foundation; Fondation ARC; European Union; Hungarian Research Fund	"Ligue contre le Cancer" (Equipe Labelisees); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation ARC; European Union(European Commission); Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We thank F. Klein and V. Borde for materials, J. B. Boule for his help, and S. Kowalczykowski for reading of the manuscript. Work in the V. G. and A.N. laboratories is supported by the "Ligue contre le Cancer" (Equipe Labelisees). Work in the laboratory of B. D. was supported by the Swiss National Science Foundation. L. A. was supported by grants from the Fondation ARC and L.Sz. by the European Union and the Hungarian Research Fund.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Li J, 2006, GENETICS, V173, P1969, DOI 10.1534/genetics.106.058768; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Murakami H, 2009, MOL CELL BIOL, V29, P3500, DOI 10.1128/MCB.00088-09; Murton BL, 2010, J MOL BIOL, V398, P481, DOI 10.1016/j.jmb.2010.03.036; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Pecina A, 2002, CELL, V111, P173, DOI 10.1016/S0092-8674(02)01002-4; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Tischfield SE, 2012, CELL CYCLE, V11, P1496, DOI 10.4161/cc.19733; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	24	132	134	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					215	218		10.1126/science.1225739	http://dx.doi.org/10.1126/science.1225739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23160953				2022-12-24	WOS:000313328200047
J	Zhu, WQ; London, NR; Gibson, CC; Davis, CT; Tong, ZZ; Sorensen, LK; Shi, DS; Guo, JP; Smith, MCP; Grossmann, AH; Thomas, KR; Li, DY				Zhu, Weiquan; London, Nyall R.; Gibson, Christopher C.; Davis, Chadwick T.; Tong, Zongzhong; Sorensen, Lise K.; Shi, Dallas S.; Guo, Jinping; Smith, Matthew C. P.; Grossmann, Allie H.; Thomas, Kirk R.; Li, Dean Y.			Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability	NATURE			English	Article							NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; ANTI-TNF-ALPHA; ENDOTHELIAL PERMEABILITY; INFLAMMATION; MECHANISMS; PROTEIN; GENE; MICE	The innate immune response is essential for combating infectious disease. Macrophages and other cells respond to infection by releasing cytokines, such as interleukin-1 beta (IL-1 beta), which in turn activate a well-described, myeloid-differentiation factor 88 (MYD88)-mediated, nuclear factor-kappa B (NF-kappa B)-dependent transcriptional pathway that results in inflammatory-cell activation and recruitment(1-4). Endothelial cells, which usually serve as a barrier to the movement of inflammatory cells out of the blood and into tissue, are also critical mediators of the inflammatory response(5,6). Paradoxically, the cytokines vital to a successful immune defence also have disruptive effects on endothelial cell-cell interactions and can trigger degradation of barrier function and dissociation of tissue architecture(7-9). The mechanism of this barrier dissolution and its relationship to the canonical NF-kappa B pathway remain poorly defined. Here we show that the direct, immediate and disruptive effects of IL-1 beta on endothelial stability in a human in vitro cell model are NF-kappa B independent and are instead the result of signalling through the small GTPase ADP-ribosylation factor 6 (ARF6) and its activator ARF nucleotide binding site opener (ARNO; also known as CYTH2). Moreover, we show that ARNO binds directly to the adaptor protein MYD88, and thus propose MYD88-ARNO-ARF6 as a proximal IL-1 beta signalling pathway distinct from that mediated by NF-kappa B. Finally, we show that SecinH3, an inhibitor of ARF guanine nucleotide-exchange factors such as ARNO, enhances vascular stability and significantly improves outcomes in animal models of inflammatory arthritis and acute inflammation.	[Zhu, Weiquan; London, Nyall R.; Guo, Jinping; Smith, Matthew C. P.; Thomas, Kirk R.; Li, Dean Y.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Zhu, Weiquan; London, Nyall R.; Gibson, Christopher C.; Davis, Chadwick T.; Sorensen, Lise K.; Shi, Dallas S.; Guo, Jinping; Smith, Matthew C. P.; Grossmann, Allie H.; Thomas, Kirk R.; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA; [London, Nyall R.; Smith, Matthew C. P.; Li, Dean Y.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Gibson, Christopher C.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Davis, Chadwick T.; Shi, Dallas S.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Tong, Zongzhong] Navigen Inc, Salt Lake City, UT 84112 USA; [Guo, Jinping] Second Mil Med Univ, Dept Anat, Shanghai 200433, Peoples R China; [Grossmann, Allie H.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Li, Dean Y.] VA Salt Lake City Hlth Care Syst, Cardiol Sect, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Sichuan Acad Med Sci, Inst Lab Med, Key Lab Human Dis Gene Study Sichuan Prov, Chengdu 610072, Sichuan, Peoples R China; [Li, Dean Y.] Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Naval Medical University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Li, DY (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	dean.li@u2m2.utah.edu		Sorensen, Lise K./0000-0003-3250-4564	National Heart, Lung, and Blood Institute; Burroughs Wellcome Fund; Juvenile Diabetes Research Foundation; NIAID Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease; American Asthma Foundation; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA163970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112311, R01HL084516, R01HL065648] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIAID Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease; American Asthma Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Lim and T. Mleynek for graphical assistance, G. Zimmerman and J. Kaplan for reading the manuscript, S. Odelberg for reading the manuscript and statistical analysis, J. Ling for help with immunostaining, R. Campbell and A. Weyrich for providing primary human blood cells, C. Rodesch and the University of Utah Cell Imaging/Fluorescence Facility as well as the University of Utah Flow Cytometry Facility, and M. P. Revelo for help with pathology. D.Y.L. and his laboratory were funded by grants from the National Heart, Lung, and Blood Institute; Burroughs Wellcome Fund; Juvenile Diabetes Research Foundation; NIAID Rocky Mountain Regional Center of Excellence in Biodefense and Emerging Infectious Disease; the American Asthma Foundation; and the Department of Defense. D.Y.L. is the HA and Edna Benning Endowed Professor of Medicine and Cardiology.	Arend WP, 2001, SEMIN ARTHRITIS RHEU, V30, P1, DOI 10.1053/sarh.2001.23693; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; London NR, 2009, ANGIOGENESIS, V12, P149, DOI 10.1007/s10456-009-9130-z; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matthews JS, 1999, CYTOKINE, V11, P643, DOI 10.1006/cyto.1998.0478; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Riley KN, 2003, MOL BIOL CELL, V14, P4155, DOI 10.1091/mbc.e02-11-0726; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; ROYALL JA, 1989, AM J PHYSIOL, V257, pL399, DOI 10.1152/ajplung.1989.257.6.L399; Silva LCR, 2010, IMMUNOTHERAPY-UK, V2, P817, DOI [10.2217/imt.10.67, 10.2217/IMT.10.67]; Szekanecz Z, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2515; VANDENBERG WB, 1994, CLIN EXP IMMUNOL, V95, P237; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; WOOLEY PH, 1993, J IMMUNOL, V151, P6602; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235	30	113	121	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					252	255		10.1038/nature11603	http://dx.doi.org/10.1038/nature11603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23143332	Green Accepted			2022-12-24	WOS:000312259300042
J	Weinstock, JV				Weinstock, Joel V.			The worm returns	NATURE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; TRICHURIS-SUIS THERAPY; CROHNS-DISEASE; COLITIS		[Weinstock, Joel V.] Tufts Univ, Boston, MA 02111 USA; [Weinstock, Joel V.] Tufts Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02111 USA	Tufts University; Tufts Medical Center	Weinstock, JV (corresponding author), Tufts Univ, Boston, MA 02111 USA.	jweinstock2@tuftsmedicalcenter.org			NIDDK NIH HHS [R01 DK091987] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091987] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEER RJS, 1976, RES VET SCI, V20, P47, DOI 10.1016/S0034-5288(18)33478-7; Blum AM, 2012, J IMMUNOL, V189, P2512, DOI 10.4049/jimmunol.1102892; Elliott DE, 2003, AM J PHYSIOL-GASTR L, V284, pG385, DOI 10.1152/ajpgi.00049.2002; Elliott DE, 2000, FASEB J, V14, P1848, DOI 10.1096/fj.99-0885hyp; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143, DOI 10.1016/0016-5085(91)90594-B; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Weinstock JV, 2004, GUT, V53, P7, DOI 10.1136/gut.53.1.7; World Health Organization, 2007, ACT WORMS	10	60	69	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					183	185		10.1038/491183a	http://dx.doi.org/10.1038/491183a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135449	Green Accepted, Bronze			2022-12-24	WOS:000310774300014
J	de Wijn, AG				de Wijn, Alfred G.			Measuring Solar Magnetism	SCIENCE			English	Editorial Material							DYNAMICS-OBSERVATORY SDO; FIELD; MISSION		Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	de Wijn, AG (corresponding author), Natl Ctr Atmospher Res, High Altitude Observ, Pob 3000, Boulder, CO 80307 USA.	dwijn@ucar.edu		de Wijn, Alfred/0000-0002-5084-4661				AUER LH, 1977, SOL PHYS, V55, P47, DOI 10.1007/BF00150873; Borrero JM, 2011, SOL PHYS, V273, P267, DOI 10.1007/s11207-010-9515-6; Casini R, 2003, ASTROPHYS J, V598, pL67, DOI 10.1086/380496; DeRosa ML, 2009, ASTROPHYS J, V696, P1780, DOI 10.1088/0004-637X/696/2/1780; Hale GE, 1908, ASTROPHYS J, V28, P315, DOI 10.1086/141602; Hathaway DH, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-1; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Kuckein C, 2009, ASTRON ASTROPHYS, V501, P1113, DOI 10.1051/0004-6361/200911800; LITES BW, 1982, ASTROPHYS J SUPPL S, V49, P293, DOI 10.1086/190800; Pesnell WD, 2012, SOL PHYS, V275, P3, DOI 10.1007/s11207-011-9841-3; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; SKUMANICH A, 1987, ASTROPHYS J, V322, P473, DOI 10.1086/165743; STENFLO JO, 1973, SOL PHYS, V32, P41, DOI 10.1007/BF00152728; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Zeeman P., 1896, VERSL GEW VERG AFD N, P181	15	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					476	477		10.1126/science.1226336	http://dx.doi.org/10.1126/science.1226336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112318				2022-12-24	WOS:000310195800040
J	Sasson, C; Magid, DJ; Chan, P; Root, ED; McNally, BF; Kellermann, AL; Haukoos, JS				Sasson, Comilla; Magid, David J.; Chan, Paul; Root, Elisabeth D.; McNally, Bryan F.; Kellermann, Arthur L.; Haukoos, Jason S.		CARES Surveillance Grp	Association of Neighborhood Characteristics with Bystander-Initiated CPR	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL CARDIAC-ARREST; AMERICAN-HEART-ASSOCIATION; EUROPEAN-RESUSCITATION-COUNCIL; CARDIOPULMONARY-RESUSCITATION; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS; RACIAL-DIFFERENCES; STROKE-FOUNDATION; TASK-FORCE; SURVIVAL	BACKGROUND For persons who have an out-of-hospital cardiac arrest, the probability of receiving bystander-initiated cardiopulmonary resuscitation (CPR) may be influenced by neighborhood characteristics. METHODS We analyzed surveillance data prospectively submitted from 29 U. S. sites to the Cardiac Arrest Registry to Enhance Survival between October 1, 2005, and December 31, 2009. The neighborhood in which each cardiac arrest occurred was determined from census-tract data. We classified neighborhoods as high-income or low-income on the basis of a median household income threshold of $40,000 and as white or black if more than 80% of the census tract was predominantly of one race. Neighborhoods without a predominant racial composition were classified as integrated. We analyzed the relationship between the median income and racial composition of a neighborhood and the performance of bystander-initiated CPR. RESULTS Among 14,225 patients with cardiac arrest, bystander-initiated CPR was provided to 4068 (28.6%). As compared with patients who had a cardiac arrest in high-income white neighborhoods, those in low-income black neighborhoods were less likely to receive bystander-initiated CPR (odds ratio, 0.49; 95% confidence interval [CI], 0.41 to 0.58). The same was true of patients with cardiac arrest in neighborhoods characterized as low-income white (odds ratio, 0.65; 95% CI, 0.51 to 0.82), low-income integrated (odds ratio, 0.62; 95% CI, 0.56 to 0.70), and high-income black (odds ratio, 0.77; 95% CI, 0.68 to 0.86). The odds ratio for bystander-initiated CPR in high-income integrated neighborhoods (1.03; 95% CI, 0.64 to 1.65) was similar to that for high-income white neighborhoods. CONCLUSIONS In a large cohort study, we found that patients who had an out-of-hospital cardiac arrest in low-income black neighborhoods were less likely to receive bystander-initiated CPR than those in high-income white neighborhoods. (Funded by the Centers for Disease Control and Prevention and others.)	[Sasson, Comilla; Haukoos, Jason S.] Univ Colorado, Sch Med, Dept Emergency Med, Leprino Off Bldg,12401 E 17th Ave,B215, Aurora, CO 80045 USA; [Magid, David J.] Kaiser Permanente, Inst Healthcare Res, Denver, CO USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Denver, CO USA; [Chan, Paul] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Root, Elisabeth D.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [McNally, Bryan F.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Kellermann, Arthur L.] RAND Corp, Washington, DC USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Colorado School of Public Health; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Colorado System; University of Colorado Boulder; Emory University; RAND Corporation	Sasson, C (corresponding author), Univ Colorado, Sch Med, Dept Emergency Med, Leprino Off Bldg,12401 E 17th Ave,B215, Aurora, CO 80045 USA.	comilla.sasson@ucdenver.edu	McNally, Bryan/AAE-9332-2020; Root, Elisabeth/A-7429-2016	Root, Elisabeth/0000-0002-9566-4031; McMullan, Jason/0000-0002-7656-7447	Cardiac Arrest Registry to Enhance Survival [U18 PS000314]; Centers for Disease Control and Prevention [U18 PS000314]; Emergency Medicine Foundation; American Heart Association; Agency for Healthcare Research and Quality [K02 HS017526]; National Heart, Lung, and Blood Institute [K23HL102224]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017526] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U18PS000314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	Cardiac Arrest Registry to Enhance Survival; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Emergency Medicine Foundation; American Heart Association(American Heart Association); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a cooperative agreement between the Cardiac Arrest Registry to Enhance Survival and the Centers for Disease Control and Prevention (U18 PS000314); grants from the Emergency Medicine Foundation and the American Heart Association (to Dr. Sasson); an Independent Scientist Award from the Agency for Healthcare Research and Quality (K02 HS017526, to Dr. Haukoos); and a grant from the National Heart, Lung, and Blood Institute (K23HL102224, to Dr. Chan).	Abella BS, 2008, CIRCULATION, V117, P704, DOI 10.1161/CIRCULATIONAHA.107.188486; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; BROOKOFF D, 1994, ANN EMERG MED, V24, P1147, DOI 10.1016/S0196-0644(94)70246-2; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1993, ANNU REV PUBL HEALTH, V14, P313; Diez-Roux AV, 2000, SOC SCI MED, V50, P673, DOI 10.1016/S0277-9536(99)00320-2; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Ding JZ, 2003, AM HEART J, V146, P459, DOI 10.1016/S0002-8703(03)00228-X; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; Govindarajan P, 2012, RESUSCITATION, V83, P76, DOI 10.1016/j.resuscitation.2011.06.026; Grenvik ASP., 1981, BRAIN FAILURE RESUSC, P155; Iwashyna TJ, 1999, ANN EMERG MED, V34, P459, DOI 10.1016/S0196-0644(99)80047-X; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Lisabeth LD, 2007, AM J EPIDEMIOL, V165, P279, DOI 10.1093/aje/kwk005; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; McNally B, 2009, ANN EMERG MED, V54, P674, DOI 10.1016/j.annemergmed.2009.03.018; Mitchell MJ, 2009, PREHOSP EMERG CARE, V13, P478, DOI 10.1080/10903120903144833; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Petersen LA, 2002, MED CARE, V40, P86; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sasson C, 2008, JAMA-J AM MED ASSOC, V300, P1432, DOI 10.1001/jama.300.12.1432; Sasson C, 2011, RESUSCITATION, V82, P674, DOI 10.1016/j.resuscitation.2011.02.002; Sasson C, 2010, ANN INTERN MED, V153, P19, DOI 10.7326/0003-4819-153-1-201007060-00255; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; U.S. Census Bureau, TOP INT GEOGR ENC RE; Vadeboncoeur TF, 2008, AM J EMERG MED, V26, P655, DOI 10.1016/j.ajem.2007.10.002; Vaillancourt C, 2008, RESUSCITATION, V79, P417, DOI 10.1016/j.resuscitation.2008.07.012	32	183	189	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1607	1615		10.1056/NEJMoa1110700	http://dx.doi.org/10.1056/NEJMoa1110700			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094722	Green Accepted			2022-12-24	WOS:000310131700007
J	Chopra, V; Flanders, SA; Saint, S				Chopra, Vineet; Flanders, Scott A.; Saint, Sanjay			The Problem With Peripherally Inserted Central Catheters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; CENTRAL VENOUS CATHETER; CENTERS		[Chopra, Vineet; Flanders, Scott A.; Saint, Sanjay] Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48109 USA; [Chopra, Vineet; Saint, Sanjay] Ann Arbor VA Med Ctr, Hosp Outcomes Program Excellence, Patient Safety Enhancement Program, Ann Arbor, MI USA; [Chopra, Vineet; Saint, Sanjay] Ann Arbor VA Med Ctr, VA Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Chopra, V (corresponding author), 2800 Plymouth Rd,Bldg 16,Room 430W, Ann Arbor, MI 48109 USA.	vineetc@med.umich.edu	Kokot, Antonio/O-3111-2019; Saint, Sanjay/AAF-5126-2019; Kokot, Antonio/B-3276-2017	Kokot, Antonio/0000-0002-4836-7536; Chopra, Vineet/0000-0001-8670-9376				Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010; Climo M, 2003, INFECT CONT HOSP EP, V24, P942, DOI 10.1086/502163; Ajenjo MC, 2011, INFECT CONT HOSP EP, V32, P125, DOI 10.1086/657942; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; El Ters M, 2012, AM J KIDNEY DIS, V60, P601, DOI 10.1053/j.ajkd.2012.05.007; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243; Tejedor SC, 2012, INFECT CONT HOSP EP, V33, P50, DOI 10.1086/663645; Tsan L, 2010, AM J INFECT CONTROL, V38, P461, DOI 10.1016/j.ajic.2009.12.009; Woller SC, 2011, AM J MED, V124, P947, DOI 10.1016/j.amjmed.2011.06.004	9	75	77	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1527	1528		10.1001/jama.2012.12704	http://dx.doi.org/10.1001/jama.2012.12704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073947				2022-12-24	WOS:000309858100016
J	Spence, D				Spence, Des			Bad medicine: clinical breast examination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						American Cancer Society, BREAST CANC EARL DET; [Anonymous], 2012, BBC NEWS; Fenton Joshua J, 2005, J Natl Cancer Inst Monogr, P67, DOI 10.1093/jncimonographs/lgi040; Kosters J P, 2003, Cochrane Database Syst Rev, pCD003373, DOI 10.1002/14651858.CD003373; National Institute for Health and Clinical Excellence, 2005, REF GUID SUSP CANC C; U.S. Preventive Services Task Force, 2009, SCREEN BREAST CANC	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2012	345								e6789	10.1136/bmj.e6789	http://dx.doi.org/10.1136/bmj.e6789			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TI	23060657				2022-12-24	WOS:000309907900006
J	Jack, A				Jack, Andrew			Faking it	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				[Anonymous], IPHARMACIST ME; Bate R, 2012, RES REP TROP MED, V3, P57, DOI 10.2147/RRTM.S33108; Bate R, 2012, RES REP TROP MED, V3, P63, DOI 10.2147/RRTM.S33690; Efpia, 2012, EUR STAK MOD; European Commission, 2011, REP EU CUST ENF INT; Gathigah M, 2011, KEN CIV SOC DEF ACC; Jack A., 2012, FINANCIAL TIMES; Jack Andrew, 2011, FINANC TIMES; Jack Andrew., 2008, FINANCIAL TIMES; Organization W. H., 2012, MED SPUR FALS LAB FA; Pharmaceutical Security Institute, COUNT SIT; Tanne JH, 2008, BRIT MED J, V336, P412, DOI 10.1136/bmj.39496.419248.DB; WHO, 2006, COUNT MED FACTSH REV	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 20	2012	345								e7836	10.1136/bmj.e7836	http://dx.doi.org/10.1136/bmj.e7836			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GT	23169809				2022-12-24	WOS:000311608200012
J	Ortega, FB; Silventoinen, K; Tynelius, P; Rasmussen, F				Ortega, Francisco B.; Silventoinen, Karri; Tynelius, Per; Rasmussen, Finn			Muscular strength in male adolescents and premature death: cohort study of one million participants	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; ATTEMPTED-SUICIDE COHORT; CARDIORESPIRATORY FITNESS; MUSCLE STRENGTH; SELF-ESTEEM; DEPRESSIVE SYMPTOMS; PHYSICAL-ACTIVITY; EARLY ADULTHOOD; GRIP STRENGTH	Objectives To explore the extent to which muscular strength in adolescence is associated with all cause and cause specific premature mortality (<55 years). Design Prospective cohort study. Setting Sweden. Participants 1 142 599 Swedish male adolescents aged 16-19 years were followed over a period of 24 years. Main outcome measures Baseline examinations included knee extension, handgrip, and elbow flexion strength tests, as well as measures of diastolic and systolic blood pressure and body mass index. Cox regression was used to estimate hazard ratios for mortality according to muscular strength categories (tenths). Results During a median follow-up period of 24 years, 26 145 participants died. Suicide was a more frequent cause of death in young adulthood (22.3%) than was cardiovascular diseases (7.8%) or cancer (14.9%). High muscular strength in adolescence, as assessed by knee extension and handgrip tests, was associated with a 20-35% lower risk of premature mortality due to any cause or cardiovascular disease, independently of body mass index or blood pressure; no association was observed with mortality due to cancer. Stronger adolescents had a 20-30% lower risk of death from suicide and were 15-65% less likely to have any psychiatric diagnosis (such as schizophrenia and mood disorders). Adolescents in the lowest tenth of muscular strength showed by far the highest risk of mortality for different causes. All cause mortality rates (per 100 000 person years) ranged between 122.3 and 86.9 for the weakest and strongest adolescents; corresponding figures were 9.5 and 5.6 for mortality due to cardiovascular diseases and 24.6 and 16.9 for mortality due to suicide. Conclusions Low muscular strength in adolescents is an emerging risk factor for major causes of death in young adulthood, such as suicide and cardiovascular diseases. The effect size observed for all cause mortality was equivalent to that for well established risk factors such as elevated body mass index or blood pressure.	[Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, Stockholm, Sweden; [Ortega, Francisco B.] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Ortega, Francisco B.] Karolinska Inst, Novum, Dept Biosci & Nutr, Stockholm, Sweden; [Ortega, Francisco B.] Univ Granada, Sch Med, Dept Med Physiol, E-18071 Granada, Spain; [Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland	Karolinska Institutet; University of Granada; Karolinska Institutet; University of Granada; University of Helsinki	Rasmussen, F (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Child & Adolescent Publ Hlth Epidemiol Grp, Stockholm, Sweden.	Finn.Rasmussen@ki.se	Ortega, Francisco B/B-4002-2010; Ortega, Francisco B./AAG-5195-2021	Ortega, Francisco B/0000-0003-2001-1121; Ortega, Francisco B./0000-0003-2001-1121; Tynelius, Per/0000-0001-8155-7406; Silventoinen, Karri/0000-0003-1759-3079; Rasmussen, Finn/0000-0001-7915-7809	Swedish Research Council [2007-5942]; Spanish Ministry of Science and Innovation [RYC-2011-09011]; Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by a grant to FR from the Swedish Research Council (grant 2007-5942). FBO was supported by grants from the Spanish Ministry of Science and Innovation (RYC-2011-09011). The funding bodies had no role in the preparation of this manuscript.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: the study was supported by a grant to FR from the Swedish Research Council, and FBO was supported by grants from the Spanish Ministry of Science and Innovation; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021; Artero EG, 2011, J AM COLL CARDIOL, V57, P1831, DOI 10.1016/j.jacc.2010.12.025; Au ACY, 2009, ADOLESCENCE, V44, P851; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Batty GD, 2010, AM J EPIDEMIOL, V172, P890, DOI 10.1093/aje/kwq274; Batty GD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2506; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Beary M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1152; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P685; De Leo D, 2004, INT SUICIDE RATES PR; Dishman RK, 2006, HEALTH PSYCHOL, V25, P396, DOI 10.1037/0278-6133.25.3.396; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; FUJITA Y, 1995, J CLIN EPIDEMIOL, V48, P1349, DOI 10.1016/0895-4356(95)00533-1; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gale CR, 2012, ARCH GEN PSYCHIAT, V69, P823, DOI 10.1001/archgenpsychiatry.2011.2000; Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28; Garaigordobil M, 2008, PSICOTHEMA, V20, P114; Greenleaf CA, 2010, RES Q EXERCISE SPORT, V81, pS65, DOI 10.1080/02701367.2010.10599695; Katzmarzyk PT, 2002, MED SCI SPORT EXER, V34, P740, DOI 10.1097/00005768-200205000-00002; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Koivukangas J, 2010, SCHIZOPHR RES, V116, P152, DOI 10.1016/j.schres.2009.10.022; Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; National Board of Health and Welfare, 2010, CAUS DEATH HIST BACK; Neovius M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b496; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Ortega FB, 2005, REV ESP CARDIOL, V58, P898, DOI 10.1016/S1885-5857(06)60372-1; Ortega FB, 2010, AM J PREV MED, V39, P440, DOI 10.1016/j.amepre.2010.07.015; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y; Roberts JE, 1999, BRIT J CLIN PSYCHOL, V38, P425, DOI 10.1348/014466599162917; Romm KL, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-136; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Sato M, 2009, EPIDEMIOLOGY, V20, P463, DOI 10.1097/EDE.0b013e31819ed09f; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Statistics Sweden. Multi-generation register, 2011, MULT REG 2010 DESCR; Sui XM, 2009, J PSYCHIATR RES, V43, P546, DOI 10.1016/j.jpsychires.2008.08.002; Sundstrom J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d643; VIITASALO JT, 1985, ERGONOMICS, V28, P1563, DOI 10.1080/00140138508963288; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P37, DOI 10.1177/1359786810384639	46	328	336	5	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2012	345								e7279	10.1136/bmj.e7279	http://dx.doi.org/10.1136/bmj.e7279			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044GT	23169869	Green Published, hybrid			2022-12-24	WOS:000311608200003
J	Bernards, R				Bernards, Rene			A Missing Link in Genotype-Directed Cancer Therapy	CELL			English	Editorial Material							INHIBITION; VEMURAFENIB; EGFR	Genotype-directed therapy holds great promise for the treatment of cancer, but crosstalk between signaling pathways often confounds simple genotype-drug response relationships. To deliver on the promise of precision medicine, a coordinated effort is needed to make a comprehensive inventory of the many signaling feedback circuits that exist in cancer cells.	[Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423				Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	9	76	79	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					465	468		10.1016/j.cell.2012.10.014	http://dx.doi.org/10.1016/j.cell.2012.10.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101617	Bronze			2022-12-24	WOS:000310529300002
J	Chalmers, M				Chalmers, Matthew			COSMOLOGY Out of the darkness	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					S2	S4		10.1038/490S2a	http://dx.doi.org/10.1038/490S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019IY	23051769	Bronze			2022-12-24	WOS:000309733300002
J	Roehr, B				Roehr, Bob			Why the NFL is investing in health research	BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Lehman EJ, 2012, NEUROLOGY; NFL, WE CAN MAK GAM SAF; NFL. Mangini Lt. Co, 2012, KYL DISC HEAD INJ NF; Roehr B, AAAS BRIEFING RES DE; US Army, TBI MIL GRID PAN DIS	5	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 5	2012	345								e6626	10.1136/bmj.e6626	http://dx.doi.org/10.1136/bmj.e6626			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018LO	23043091				2022-12-24	WOS:000309662300010
J	Armstrong, K				Armstrong, Katrina			Genomics and Health Care Disparities The Role of Statistical Discrimination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Ctr Comparat Effectiveness Genom Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Armstrong, K (corresponding author), Univ Penn, Ctr Comparat Effectiveness Genom Med, Perelman Sch Med, 1220 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	karmstro@mail.med.upenn.edu			NCI NIH HHS [UC2CA148310] Funding Source: Medline; NATIONAL CANCER INSTITUTE [UC2CA148310] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agency for Healthcare Research and Quality, 2010 NAT HEALTHC QUA; Bickell NA, 2006, J CLIN ONCOL, V24, P1357, DOI 10.1200/JCO.2005.04.5799; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; Harman JS, 2004, PSYCHIAT SERV, V55, P1379, DOI 10.1176/appi.ps.55.12.1379; *I MED, 2002, UN TREATM CONFR RAC; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lo SS, 2010, J CLIN ONCOL, V28, P1671, DOI 10.1200/JCO.2008.20.2119; Lohmueller KE, 2006, AM J HUM GENET, V78, P130, DOI 10.1086/499287; Valenzuela JM, 2011, PEDIATR DIABETES, V12, P696, DOI 10.1111/j.1399-5448.2011.00766.x	10	5	5	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1979	1980		10.1001/2012.jama.10820	http://dx.doi.org/10.1001/2012.jama.10820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23138130				2022-12-24	WOS:000311291400019
J	Gruen, RL; Reade, MC				Gruen, Russell L.; Reade, Michael C.			Administer tranexamic acid early to injured patients at risk of substantial bleeding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRAUMA PATIENTS; HEMORRHAGE; CRASH-2; MORTALITY		[Gruen, Russell L.] Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Gruen, Russell L.] Monash Univ, Melbourne, Vic 3004, Australia; [Reade, Michael C.] Univ Queensland, Royal Brisbane & Womens Hosp, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld 4129, Australia; [Reade, Michael C.] Australian Def Force Joint Hlth Command, Canberra, ACT 2600, Australia; [Reade, Michael C.] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld 4129, Australia; [Gruen, Russell L.] The Alfred, Melbourne, Vic 3004, Australia	Monash University; Royal Brisbane & Women's Hospital; University of Queensland; Royal Brisbane & Women's Hospital	Gruen, RL (corresponding author), Natl Trauma Res Inst, Level 4,89 Commercial Rd, Melbourne, Vic 3004, Australia.	r.gruen@alfred.org.au	Reade, Michael/G-7035-2012	Reade, Michael/0000-0003-1570-0707				Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Roberts I, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5839; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roberts I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub3; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	14	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 19	2012	345								e7133	10.1136/bmj.e7133	http://dx.doi.org/10.1136/bmj.e7133			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044GQ	23165649				2022-12-24	WOS:000311607800001
J	Tidow, H; Poulsen, LR; Andreeva, A; Knudsen, M; Hein, KL; Wiuf, C; Palmgren, MG; Nissen, P				Tidow, Henning; Poulsen, Lisbeth R.; Andreeva, Antonina; Knudsen, Michael; Hein, Kim L.; Wiuf, Carsten; Palmgren, Michael G.; Nissen, Poul			A bimodular mechanism of calcium control in eukaryotes	NATURE			English	Article							MEMBRANE CA2+ PUMP; STRUCTURE VALIDATION; REGULATORY DOMAIN; BINDING DOMAIN; CALMODULIN; PLANT; CA2+-ATPASE; ACTIVATION; DIVERSITY; PROTEINS	Calcium ions (Ca2+) have an important role as secondary messengers in numerous signal transduction processes(1-4), and cells invest much energy in controlling and maintaining a steep gradient between intracellular (similar to 0.1-micromolar) and extracellular (similar to 2-millimolar) Ca2+ concentrations(1). Calmodulin-stimulated calcium pumps, which include the plasma-membrane Ca2+-ATPases (PMCAs), are key regulators of intracellular Ca2+ in eukaryotes(5-8). They contain a unique amino- or carboxy-terminal regulatory domain responsible for autoinhibition, and binding of calcium-loaded calmodulin to this domain releases autoinhibition and activates the pump. However, the structural basis for the activation mechanism is unknown and a key remaining question is how calmodulin-mediated PMCA regulation can cover both basal Ca2+ levels in the nanomolar range as well as micromolar-range Ca2+ transients generated by cell stimulation(7). Here we present an integrated study combining the determination of the high-resolution crystal structure of a PMCA regulatory-domain/calmodulin complex with in vivo characterization and biochemical, biophysical and bioinformatics data that provide mechanistic insights into a two-step PMCA activation mechanism mediated by calcium-loaded calmodulin. The structure shows the entire PMCA regulatory domain and reveals an unexpected 2: 1 stoichiometry with two calcium-loaded calmodulin molecules binding to different sites on a long helix. A multifaceted characterization of the role of both sites leads to a general structural-model for calmodulin-mediated regulation of PMCAs that allows stringent, highly responsive control of intracellular calcium in eukaryotes, making it possible to maintain a stable, basal level at a threshold Ca2+ concentration, where steep activation occurs.	[Tidow, Henning; Poulsen, Lisbeth R.; Knudsen, Michael; Hein, Kim L.; Palmgren, Michael G.; Nissen, Poul] Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; [Tidow, Henning; Hein, Kim L.; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Poulsen, Lisbeth R.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Andreeva, Antonina] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Knudsen, Michael] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Wiuf, Carsten] Univ Copenhagen, Dept Math Sci, DK-2100 Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; MRC Laboratory Molecular Biology; Aarhus University; University of Copenhagen	Palmgren, MG (corresponding author), Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	palmgren@life.ku.dk; pn@mb.au.dk	Poulsen, Lisbeth R/I-1843-2014; Palmgren, Michael/A-9808-2013; Wiuf, Carsten/H-6320-2011; Poulsen, Lisbeth Rosager/AAP-1301-2020; Nissen, Poul/D-5774-2014; Tidow, Henning/K-3420-2015	Poulsen, Lisbeth R/0000-0002-9133-3358; Palmgren, Michael/0000-0002-9982-6114; Wiuf, Carsten/0000-0002-1302-4445; Nissen, Poul/0000-0003-0948-6628; Knudsen, Michael/0000-0002-6294-2517; Tidow, Henning/0000-0002-4702-9332; Andreeva, Antonina/0000-0002-0450-0091	EMBO Long-Term Fellowship; Marie-Curie Intra-European Fellowship; HFSP Long-Term Fellowship; ERC advanced grant (BIOMEMOS); MRC [MC_U105192716] Funding Source: UKRI; Medical Research Council [MC_U105192716] Funding Source: researchfish	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie Intra-European Fellowship(European Commission); HFSP Long-Term Fellowship; ERC advanced grant (BIOMEMOS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Nissen and Palmgren labs for discussions, and P. Gourdon for help with data collection. We thank the staff at beamlines ID23-2 at the European Radiation Synchrotron Facility, France; PX3 at the Swiss Light Source, Paul Scherrer Institute, Switzerland; and X33 at EMBL/DESY, Germany. We are grateful to K. Nagai for a plasmid expressing mammalian CaM. Support from the European Community-Research Infrastructure Action under the FP7 is acknowledged for access to EMBL/DESY. H. T. is a Junior Research Fellow at Trinity College, Cambridge, and was supported by an EMBO Long-Term Fellowship, a Marie-Curie Intra-European Fellowship and an HFSP Long-Term Fellowship. P.N. was supported by an ERC advanced grant (BIOMEMOS).	Afonine PV, 2005, CCP4 NEWSL, V42; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bonza MC, 2010, FEBS LETT, V584, P4783, DOI 10.1016/j.febslet.2010.11.008; Brini M, 2011, COLD SPRING HARB PER, V3, DOI [DOI 10.1101/CSHPERSPECT.A004168, 10.1101/cshperspect.a004168]; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENYEDI A, 1994, J BIOL CHEM, V269, P41; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Fusca T, 2009, J BIOL CHEM, V284, P30881, DOI 10.1074/jbc.M109.006148; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2010, J BIOL CHEM, V285, P38502, DOI 10.1074/jbc.M110.131201; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Malmstrom S, 1997, FEBS LETT, V400, P324, DOI 10.1016/S0014-5793(96)01448-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meneghelli S, 2008, MOL MEMBR BIOL, V25, P539, DOI 10.1080/09687680802508747; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tidow H, 2010, ACTA CRYSTALLOGR F, V66, P361, DOI 10.1107/S1744309110003805	48	83	84	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					468	+		10.1038/nature11539	http://dx.doi.org/10.1038/nature11539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23086147				2022-12-24	WOS:000311031600051
J	Joiner, MLA; Koval, OM; Li, JD; He, BJ; Allamargot, C; Gao, Z; Luczak, ED; Hall, DD; Fink, BD; Chen, BY; Yang, JY; Moore, SA; Scholz, TD; Strack, S; Mohler, PJ; Sivitz, WI; Song, LS; Anderson, ME				Joiner, Mei-ling A.; Koval, Olha M.; Li, Jingdong; He, B. Julie; Allamargot, Chantal; Gao, Zhan; Luczak, Elizabeth D.; Hall, Duane D.; Fink, Brian D.; Chen, Biyi; Yang, Jinying; Moore, Steven A.; Scholz, Thomas D.; Strack, Stefan; Mohler, Peter J.; Sivitz, William I.; Song, Long-Sheng; Anderson, Mark E.			CaMKII determines mitochondrial stress responses in heart	NATURE			English	Article							II INHIBITION PROTECTS; KINASE-II; CALMODULIN KINASE; CALCIUM UNIPORTER; IN-VIVO; INNER MEMBRANE; FAILURE; HYPERTROPHY; APOPTOSIS; OXIDATION	Myocardial cell death is initiated by excessive mitochondrial Ca2+ entry causing Ca2+ overload, mitochondrial permeability transition pore (mPTP) opening and dissipation of the mitochondrial inner membrane potential (Delta Psi m)(1,2). However, the signalling pathways that control mitochondrial Ca2+ entry through the inner membrane mitochondrial Ca2+ uniporter (MCU)(3-5) are not known. The multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated in ischaemia reperfusion, myocardial infarction and neurohumoral injury, common causes of myocardial death and heart failure; these findings suggest that CaMKII could couple disease stress to mitochondrial injury. Here we show that CaMKII promotes mPTP opening and myocardial death by increasing MCU current (I-MCU). Mitochondrial-targeted CaMKII inhibitory protein or cyclosporin A, an mPTP antagonist with clinical efficacy in ischaemia reperfusion injury(6), equivalently prevent mPTP opening, Delta Psi m deterioration and diminish mitochondrial disruption and programmed cell death in response to ischaemia reperfusion injury. Mice with myocardial and mitochondrial-targeted CaMKII inhibition have reduced I-MCU and are resistant to ischaemia reperfusion injury, myocardial infarction and neurohumoral injury, suggesting that pathological actions of CaMKII are substantially mediated by increasing I-MCU. Our findings identify CaMKII activity as a central mechanism for mitochondrial Ca2+ entry in myocardial cell death, and indicate that mitochondrial-targeted CaMKII inhibition could prevent or reduce myocardial death and heart failure in response to common experimental forms of pathophysiological stress.	[Joiner, Mei-ling A.; Koval, Olha M.; Li, Jingdong; He, B. Julie; Gao, Zhan; Luczak, Elizabeth D.; Hall, Duane D.; Chen, Biyi; Yang, Jinying; Mohler, Peter J.; Sivitz, William I.; Song, Long-Sheng; Anderson, Mark E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Joiner, Mei-ling A.; Koval, Olha M.; Li, Jingdong; He, B. Julie; Gao, Zhan; Luczak, Elizabeth D.; Hall, Duane D.; Chen, Biyi; Yang, Jinying; Mohler, Peter J.; Sivitz, William I.; Song, Long-Sheng; Anderson, Mark E.] Univ Iowa, Ctr Cardiovasc, Carver Coll Med, Iowa City, IA 52242 USA; [He, B. Julie; Moore, Steven A.; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Allamargot, Chantal] Univ Iowa, Carver Coll Med, Cent Microscopy Res Facil, Iowa City, IA 52242 USA; [Fink, Brian D.; Sivitz, William I.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Moore, Steven A.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Scholz, Thomas D.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Strack, Stefan] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa	Joiner, MLA (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	mei-ling-joiner@uiowa.edu; mark-e-anderson@uiowa.edu	Hall, Duane/ACD-6815-2022; Chen, Biyi/AAF-3077-2021	Hall, Duane/0000-0003-2228-0966; Strack, Stefan/0000-0002-6175-7280; Koval, Olha/0000-0003-1644-0046; Sivitz, William/0000-0002-7829-0189; Joiner, Mei-ling/0000-0002-7775-7349; Song, Long-Sheng/0000-0002-6035-8106; Moore, Steven/0000-0002-6353-7900; Fink, Brian/0000-0002-1149-7935; Scholz, Thomas/0000-0003-0759-2486	AHA [0635357N]; NIH [R01 HL090905, R01 HL079031, R01 HL62494, R01 HL70250, R01 HL113001, R01 HL084583, R01 HL083422]; Fondation Leducq for the Alliance for CaMKII Signaling; Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079031, R01HL062494, R01HL083422, R01HL070250, R01HL090905, R01HL084583, R01HL113001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq for the Alliance for CaMKII Signaling; Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to acknowledge discussions with A. Lee, B. Davidson, K. Campbell and C. Sigmund. This work was funded by: AHA 0635357N (M.A.J.); (NIH R01 HL090905 (L.-S.S.); NIH R01 HL079031, R01 HL62494, R01 HL70250 and R01 HL113001 and supported by a grant from the Fondation Leducq for the Alliance for CaMKII Signaling (M. E. A.); NIH R01 HL084583, R01 HL083422 and Pew Scholars Trust (P.J.M.).	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Garcia-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Feldman DS, 2005, NAT CLIN PRACT CARD, V2, P475, DOI 10.1038/ncpcardio0309; FONG YL, 1989, J BIOL CHEM, V264, P16759; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; Herlein JA, 2009, ENDOCRINOLOGY, V150, P46, DOI 10.1210/en.2008-0404; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Odagiri K, 2009, J MOL CELL CARDIOL, V46, P989, DOI 10.1016/j.yjmcc.2008.12.022; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Saotome M, 2005, AM J PHYSIOL-HEART C, V288, pH1820, DOI 10.1152/ajpheart.00589.2004; Sharma V, 2010, MOL CELL BIOCHEM, V337, P223, DOI 10.1007/s11010-009-0303-2; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wu YJ, 2001, P NATL ACAD SCI USA, V98, P2877, DOI 10.1073/pnas.051449198; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	31	292	308	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					269	+		10.1038/nature11444	http://dx.doi.org/10.1038/nature11444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23051746	Green Accepted			2022-12-24	WOS:000310774300047
J	Cohen, JM; Woolsey, AM; Sabot, OJ; Gething, PW; Tatem, AJ; Moonen, B				Cohen, Justin M.; Woolsey, Aaron M.; Sabot, Oliver J.; Gething, Peter W.; Tatem, Andrew J.; Moonen, Bruno			Optimizing Investments in Malaria Treatment and Diagnosis	SCIENCE			English	Editorial Material							SUB-SAHARAN AFRICA; COUNTRIES; FEVERS; POLICY		[Cohen, Justin M.; Woolsey, Aaron M.; Sabot, Oliver J.; Moonen, Bruno] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Gething, Peter W.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32610 USA	University of Oxford; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cohen, JM (corresponding author), Clinton Hlth Access Initiat, Boston, MA 02127 USA.	jcohen@clinton-healthaccess.org	Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022	Gething, Peter/0000-0001-6759-5449; Cohen, Justin/0000-0003-4481-6784; Tatem, Andrew/0000-0002-7270-941X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arnold F., 2012, PRELIMINARY REP IND; Bastiaens GJH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-76; Clinton Health Access Initiative, 2011, MAINT GAINS GLOB MAL; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fairhurst RM, 2012, AM J TROP MED HYG, V87, P231, DOI 10.4269/ajtmh.2012.12-0025; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Johnston G., 1996, REPEATED MEASURES AN; Kunene S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-313; Larson BA, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-314; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-99; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GUID TREATM MAL, V2nd; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	24	38	38	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					612	614		10.1126/science.1229045	http://dx.doi.org/10.1126/science.1229045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118172				2022-12-24	WOS:000310516000033
J	Camm, AJ				Camm, A. John			Cardiac arrhythmias-trials and tribulations	LANCET			English	Editorial Material							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ATRIAL-FIBRILLATION; ANTIARRHYTHMIC-DRUGS; PROPHYLACTIC IMPLANTATION; VENTRICULAR-ARRHYTHMIAS; CATHETER ABLATION; RHYTHM CONTROL; HIGH-RISK; PREVENTION; THERAPY		St Georges Univ London, Dept Clin Sci, London SW17 0RE, England	St Georges University London	Camm, AJ (corresponding author), St Georges Univ London, Dept Clin Sci, London SW17 0RE, England.	jcamm@sgul.ac.uk						[Anonymous], 1989, NEW ENGL J MED, V321, P406; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Brignole M, 2012, CIRCULATION, V125, P2566, DOI 10.1161/CIRCULATIONAHA.111.082313; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Camm AJ, 2007, EUROPACE, V9, P1110, DOI 10.1093/europace/eum253; Camm A J, 2012, J R Coll Physicians Edinb, V42 Suppl 18, P23, DOI 10.4997/JRCPE.2012.S03; Camm AJ, 2010, EUROPACE, V12, P1356, DOI 10.1093/europace/euq183; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Einthoven W., 1906, ARCH INT PHYSIOL, V4, P132; Gold MR, 2009, HEART RHYTHM, V6, P295, DOI 10.1016/j.hrthm.2008.11.033; Grace AA, 2012, LANCET, V380, P1498, DOI 10.1016/S0140-6736(12)61462-7; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Healey JS, 2006, CIRCULATION, V114, P11, DOI 10.1161/CIRCULATIONAHA.105.610303; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; John RM, 2012, LANCET, V380, P1520, DOI 10.1016/S0140-6736(12)61413-5; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Morillo C, 2012, LAT BREAK TRIALS HEA, P9; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Piccini JP, 2009, CIRC-ARRHYTHMIA ELEC, V2, P626, DOI 10.1161/CIRCEP.109.856633; Romme JJ, 2011, COCHRANE DB SYST REV, V10; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Savelieva I, 2008, EUROPACE, V10, P647, DOI 10.1093/europace/eun130; Savelieva I, 2011, EUROPACE, V13, P1063, DOI 10.1093/europace/eur181; Theuns DAMJ, 2010, EUROPACE, V12, P1564, DOI 10.1093/europace/euq329; Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061; Wells G, 2011, CAN MED ASSOC J, V183, P421, DOI 10.1503/cmaj.101685; Wokhlu A, 2010, J CARDIOVASC ELECTR, V21, P1071, DOI 10.1111/j.1540-8167.2010.01786.x; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	32	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1448	1451		10.1016/S0140-6736(12)61773-5	http://dx.doi.org/10.1016/S0140-6736(12)61773-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101702				2022-12-24	WOS:000310272000005
J	Grace, AA; Roden, DM				Grace, Andrew A.; Roden, Dan M.			Systems biology and cardiac arrhythmias	LANCET			English	Article							GENOME-WIDE ASSOCIATION; LONG-QT SYNDROME; ATRIAL-FIBRILLATION; COMMON VARIANTS; ION-CHANNEL; VENTRICULAR-ARRHYTHMIAS; SUDDEN-DEATH; RISK-FACTORS; PR INTERVAL; CELL MODEL	During the past few years, the development of effective, empirical technologies for treatment of cardiac arrhythmias has exceeded the pace at which detailed knowledge of the underlying biology has accumulated. As a result, although some clinical arrhythmias can be cured with techniques such as catheter ablation, drug treatment and prediction of the risk of sudden death remain fairly primitive. The identification of key candidate genes for monogenic arrhythmia syndromes shows that to bring basic biology to the clinic is a powerful approach. Increasingly sophisticated experimental models and methods of measurement, including stem cell-based models of human cardiac arrhythmias, are being deployed to study how perturbations in several biologic pathways can result in an arrhythmia-prone heart. The biology of arrhythmia is largely quantifiable, which allows for systematic analysis that could transform treatment strategies that are often still empirical into management based on molecular evidence.	[Grace, Andrew A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Grace, Andrew A.] Papworth Hosp, Cambridge CB3 8RE, England; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	University of Cambridge; Papworth Hospital; Vanderbilt University	Grace, AA (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	aag1000@cam.ac.uk	Roden, Dan/ABD-5412-2021		Clinical Data (Forest Laboratories); British Heart Foundation; UK Medical Research Council; Wellcome Trust; UK Biotechnology and Biological Sciences Research Council; US Public Health Service [HL49989, HL65962]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049989, U19HL065962, U01HL065962] Funding Source: NIH RePORTER	Clinical Data (Forest Laboratories); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	AAG is a consultant for Xention. DMR has received patent royalties from Clinical Data (Forest Laboratories).; AAG is supported by the British Heart Foundation, the UK Medical Research Council, the Wellcome Trust, and the UK Biotechnology and Biological Sciences Research Council. DMR is supported by grants from the US Public Health Service, including grant numbers HL49989 and HL65962.	Ackerman MJ, 2010, CIRC RES, V107, P457, DOI 10.1161/CIRCRESAHA.110.224592; Albert CM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P222, DOI 10.1161/CIRCEP.110.944934; Atienza F, 2006, CIRCULATION, V114, P2434, DOI 10.1161/CIRCULATIONAHA.106.633735; Barsheshet A, 2012, CIRCULATION, V125, P1988, DOI 10.1161/CIRCULATIONAHA.111.048041; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Brink PA, 2005, CIRCULATION, V112, P2602, DOI 10.1161/CIRCULATIONAHA.105.572453; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Cerrone M, 2009, HEART RHYTHM, V6, P1652, DOI 10.1016/j.hrthm.2009.06.033; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Chugh SS, 2010, NAT REV CARDIOL, V7, P318, DOI 10.1038/nrcardio.2010.52; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Darbar D, 2008, CIRCULATION, V117, P1927, DOI 10.1161/CIRCULATIONAHA.107.757955; Delacretaz E, 2006, NEW ENGL J MED, V354, P1039, DOI 10.1056/NEJMcp051145; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Dewey FE, 2012, CIRCULATION, V125, P931, DOI 10.1161/CIRCULATIONAHA.110.972828; Dobrev D, 2012, NAT REV DRUG DISCOV, V11, P275, DOI 10.1038/nrd3682; Dow LE, 2012, CELL, V148, P1099, DOI 10.1016/j.cell.2012.02.023; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Golbus JR, 2012, CIRC-CARDIOVASC GENE, V5, P391, DOI 10.1161/CIRCGENETICS.112.962928; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; John RM, 2012, LANCET, V380, P1520, DOI 10.1016/S0140-6736(12)61413-5; Jons C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001551; Jouven X, 2005, EUR HEART J, V26, P2142, DOI 10.1093/eurheartj/ehi376; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Kaab S, 2012, CIRC-CARDIOVASC GENE, V5, P91, DOI 10.1161/CIRCGENETICS.111.960930; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kong MH, 2011, J AM COLL CARDIOL, V57, P794, DOI 10.1016/j.jacc.2010.09.064; Lalani GG, 2012, J AM COLL CARDIOL, V59, P595, DOI 10.1016/j.jacc.2011.10.879; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Magnani JW, 2011, CIRCULATION, V124, P1982, DOI 10.1161/CIRCULATIONAHA.111.039677; Mann SA, 2012, J AM COLL CARDIOL, V59, P1017, DOI 10.1016/j.jacc.2011.11.039; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Moreno JD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002588; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Murray SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025387; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2011, CIRCULATION, V123, P2922, DOI 10.1161/CIRCULATIONAHA.110.977827; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; Noseworthy PA, 2008, CIRCULATION, V118, P1854, DOI 10.1161/CIRCULATIONAHA.108.783654; Noseworthy PA, 2011, CIRC-CARDIOVASC GENE, V4, P305, DOI 10.1161/CIRCGENETICS.110.959049; Nurse P, 2011, CELL, V144, P850, DOI 10.1016/j.cell.2011.02.045; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Rentschler S, 2011, J CLIN INVEST, V121, P525, DOI 10.1172/JCI44470; Rienstra M, 2012, CIRCULATION, V125, P2933, DOI 10.1161/CIRCULATIONAHA.111.069450; Ritchie MD, 2012, J AM COLL CARDIOL, V60, P1173, DOI 10.1016/j.jacc.2012.04.030; Rudy Y, 2008, CIRCULATION, V118, P1202, DOI 10.1161/CIRCULATIONAHA.108.772715; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Thomsen PEB, 2010, CIRCULATION, V122, P1258, DOI 10.1161/CIRCULATIONAHA.109.902148; Thul R, 2012, P NATL ACAD SCI USA, V109, P2150, DOI 10.1073/pnas.1115855109; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Voigt N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P472, DOI 10.1161/CIRCEP.110.954636; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Watanabe H, 2011, CIRCULATION, V124, P1001, DOI 10.1161/CIRCULATIONAHA.110.987248; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Weiss JN, 2011, CIRC RES, V108, P98, DOI 10.1161/CIRCRESAHA.110.223586; Westaway SK, 2011, CIRC-CARDIOVASC GENE, V4, P397, DOI 10.1161/CIRCGENETICS.111.959916; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	100	23	25	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2012	380	9852					1498	1508		10.1016/S0140-6736(12)61462-7	http://dx.doi.org/10.1016/S0140-6736(12)61462-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026JJ	23101717	Green Accepted			2022-12-24	WOS:000310272000030
J	Handley, SA; Thackray, LB; Zhao, G; Presti, R; Miller, AD; Droit, L; Abbink, P; Maxfield, LF; Kambal, A; Duan, E; Stanley, K; Kramer, J; Macri, SC; Permar, SR; Schmitz, JE; Mansfield, K; Brenchley, JM; Veazey, RS; Stappenbeck, TS; Wang, D; Barouch, DH; Virgin, HW				Handley, Scott A.; Thackray, Larissa B.; Zhao, Guoyan; Presti, Rachel; Miller, Andrew D.; Droit, Lindsay; Abbink, Peter; Maxfield, Lori F.; Kambal, Amal; Duan, Erning; Stanley, Kelly; Kramer, Joshua; Macri, Sheila C.; Permar, Sallie R.; Schmitz, Joern E.; Mansfield, Keith; Brenchley, Jason M.; Veazey, Ronald S.; Stappenbeck, Thaddeus S.; Wang, David; Barouch, Dan H.; Virgin, Herbert W.			Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric Virome	CELL			English	Article							GUT MICROBIOME; IMMUNE ACTIVATION; HIV-INFECTION; GENE ATG16L1; METAGENOMICS; DISEASE; MOUSE; TRANSLOCATION; SEQUENCES; COLITIS	Pathogenic simian immunodeficiency virus (SIV) infection is associated with enteropathy, which likely contributes to AIDS progression. To identify candidate etiologies for AIDS enteropathy, we used next-generation sequencing to define the enteric virome during SIV infection in nonhuman primates. Pathogenic, but not nonpathogenic, SIV infection was associated with significant expansion of the enteric virome. We identified at least 32 previously undescribed enteric viruses during pathogenic SIV infection and confirmed their presence by using viral culture and PCR testing. We detected unsuspected mucosal adenovirus infection associated with enteritis as well as parvovirus viremia in animals with advanced AIDS, indicating the pathogenic potential of SIV-associated expansion of the enteric virome. No association between pathogenic SIV infection and the family-level taxonomy of enteric bacteria was detected. Thus, enteric viral infections may contribute to AIDS enteropathy and disease progression. These findings underline the importance of metagenomic analysis of the virome for understanding AIDS pathogenesis.	[Abbink, Peter; Maxfield, Lori F.; Stanley, Kelly; Schmitz, Joern E.; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Handley, Scott A.; Thackray, Larissa B.; Zhao, Guoyan; Droit, Lindsay; Kambal, Amal; Duan, Erning; Stappenbeck, Thaddeus S.; Wang, David; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Zhao, Guoyan; Droit, Lindsay; Wang, David; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Presti, Rachel] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Miller, Andrew D.; Kramer, Joshua; Macri, Sheila C.; Mansfield, Keith] Harvard Univ, Sch Med, Dept Comparat Pathol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Miller, Andrew D.; Kramer, Joshua; Macri, Sheila C.; Mansfield, Keith] Harvard Univ, Sch Med, Dept Vet Resources, New England Primate Res Ctr, Southborough, MA 01772 USA; [Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA; [Brenchley, Jason M.] NIAID, Program Barrier Immun, NIH, Bethesda, MD 20892 USA; [Brenchley, Jason M.] NIAID, Repair & Immunopathogenesis Unit, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Veazey, Ronald S.] Tulane Univ, Tulane Natl Primate Res Ctr, Sch Med, Covington, LA 70433 USA; [Barouch, Dan H.] Massachusetts Gen Hosp, Ragon Inst, MIT, Boston, MA 02114 USA; [Barouch, Dan H.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tulane University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu; virgin@wustl.edu	Duan, Erning/H-4608-2014; Brenchley, Jason/AAC-5085-2019; Schmitz, Joern/A-4929-2018; Barouch, Dan/Y-3918-2019	Schmitz, Joern/0000-0001-8803-0922; Presti, Rachel/0000-0002-5469-0727; Brenchley, Jason/0000-0001-8357-2984; Virgin, Herbert/0000-0001-8580-7628	Project 10 [U54 AI057160-08]; National Center for Research Resources [1R01 RR032309]; Office of Research Infrastructure Programs [OD11170-02]; Crohn's and Colitis Foundation [3132];  [AI066305];  [AI066924];  [AI078526];  [AI095985];  [AI65335];  [8P51OD011103-5]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR032309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066924, R01AI065335, U19AI078526, U19AI066305, P30AI060354, K08AI087992, ZIAAI001029, U54AI057160, U19AI095985] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011170, P51OD011103] Funding Source: NIH RePORTER	Project 10; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; Crohn's and Colitis Foundation; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Project 10 of U54 AI057160-08 to D. W. for development of VirusHunter software, was initially funded by the National Center for Research Resources 1R01 RR032309, and is currently supported by the Office of Research Infrastructure Programs OD11170-02 to H. W. V. and D. H. B.; Crohn's and Colitis Foundation Grant 3132 to H. W. V. and T. S. S.; grants AI066305, AI066924, AI078526, and AI095985 to D. H. B.; AI65335 to J.E.S.; and grant 8P51OD011103-5 to A. D. M. and J.K. We would like to thank Angela Carville, Elizabeth Curran, and Vanessa Hirsch for assistance with these experiments.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey C, 2010, VET PATHOL, V47, P462, DOI 10.1177/0300985810363719; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loh J, 2011, J VIROL, V85, P2642, DOI 10.1128/JVI.01661-10; Loh J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Oberste MS, 2007, J GEN VIROL, V88, P3360, DOI 10.1099/vir.0.83124-0; Oberste MS, 2002, J VIROL, V76, P1244, DOI 10.1128/JVI.76.3.1244-1251.2002; Pandrea I, 2008, J IMMUNOL, V181, P6687, DOI 10.4049/jimmunol.181.10.6687; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Presti RM, 2009, J VIROL, V83, P11599, DOI 10.1128/JVI.00677-09; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sasseville VG, 2010, J IMMUNOTOXICOL, V7, P79, DOI 10.3109/15476910903213521; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao GY, 2011, J VIROL, V85, P10230, DOI 10.1128/JVI.00637-11	38	210	218	0	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					253	266		10.1016/j.cell.2012.09.024	http://dx.doi.org/10.1016/j.cell.2012.09.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063120	Green Accepted, Bronze			2022-12-24	WOS:000309981000006
J	Broderick, CR; Herbert, RD; Latimer, J; Barnes, C; Curtin, JA; Mathieu, E; Monagle, P; Brown, SA				Broderick, Carolyn R.; Herbert, Robert D.; Latimer, Jane; Barnes, Chris; Curtin, Julie A.; Mathieu, Erin; Monagle, Paul; Brown, Simon A.			Association Between Physical Activity and Risk of Bleeding in Children With Hemophilia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECOMBINANT FACTOR-VIII; FACTOR-IX; PROPHYLACTIC TREATMENT; PHARMACOKINETICS; PARTICIPATION; OUTCOMES; PATIENT; DISEASE; SAFETY	Context Vigorous physical activity is thought to increase risk of bleeds in children with hemophilia, but the magnitude of the risk is unknown. Objective To quantify the transient increase in risk of bleeds associated with physical activity in children with hemophilia. Design, Setting, and Participants A case-crossover study nested within a prospective cohort study was conducted at 3 pediatric hemophilia centers in Australia between July 2008 and October 2010. A total of 104 children and adolescent boys aged 4 through 18 years with moderate or severe hemophilia A or B were monitored for bleeds for up to 1 year. Following each bleed, the child or parent was interviewed to ascertain exposures to physical activity preceding the bleed. Physical activity was categorized according to expected frequency and severity of collisions. The risk of bleeds associated with physical activity was estimated by contrasting exposure to physical activity in the 8 hours before the bleed with exposures in two 8-hour control windows, controlling for levels of clotting factor in the blood. Main Outcome Measures Association of physical activity and factor level with risk of bleeding. Results The participants were observed for 4839 person-weeks during which time 436 bleeds occurred. Of these, 336 bleeds occurred more than 2 weeks after the preceding bleed and were used in the primary analysis of risk. Compared with inactivity and category 1 activities (eg, swimming), category 2 activities (eg, basketball) were associated with a transient increase in the risk of bleeding (30.6% of bleed windows vs 24.8% of first control windows; odds ratio, 2.7; 95% CI, 1.7-4.8, P < .001). Category 3 activities (eg, wrestling) were associated with a greater transient increase in risk (7.0% of bleed windows vs 3.4% of first control windows; odds ratio, 3.7; 95% CI, 2.3-7.3, P < .001). To illustrate absolute risk increase, for a child who bleeds 5 times annually and is exposed on average to category 2 activities twice weekly and to category 3 activities once weekly, exposure to these activities was associated with only 1 of the 5 annual bleeds. For every 1% increase in clotting factor level, bleeding incidence was lower by 2% (95% CI, 1%-3%; P=.004). Conclusions In children and adolescents with hemophilia, vigorous physical activity was transiently associated with a moderate relative increase in risk of bleeding. Because the increased relative risk is transient, the absolute increase in risk of bleeds associated with physical activity is likely to be small. JAMA. 2012;308(14):1452-1459 www.jama.com	[Broderick, Carolyn R.] Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW 2052, Australia; [Broderick, Carolyn R.; Latimer, Jane; Mathieu, Erin] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Broderick, Carolyn R.] Childrens Hosp Westmead, Childrens Hosp Inst Sports Med, Westmead, NSW, Australia; [Curtin, Julie A.] Childrens Hosp Westmead, Dept Haematol, Westmead, NSW, Australia; [Broderick, Carolyn R.; Herbert, Robert D.; Latimer, Jane] George Inst Global Hlth, Musculoskeletal Div, Sydney, NSW, Australia; [Herbert, Robert D.] Neurosci Res Australia, Randwick, NSW, Australia; [Barnes, Chris; Monagle, Paul] Royal Childrens Hosp, Dept Haematol, Melbourne, Vic, Australia; [Monagle, Paul] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [Brown, Simon A.] Royal Childrens Hosp, Dept Haematol & Oncol, Herston, Qld, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; George Institute for Global Health; University of Sydney; Neuroscience Research Australia; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Brisbane	Broderick, CR (corresponding author), Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW 2052, Australia.	c.broderick@unsw.edu.au	Herbert, Rob/E-9442-2012	Herbert, Rob/0000-0003-4188-9195; Mathieu, Erin/0000-0002-5209-7989; Monagle, Paul/0000-0002-3970-8984; Broderick, Carolyn/0000-0003-0096-796X	Bayer Hemophilia Awards Program; NovoNordisk; Bayer; Baxter Health Care; CSL-Behring; BaxterHealthCare; CSL; Baxter; Pfizer; National Health and Medical Research Council (NHMRC); Australian NHMRC; Australian Research Council	Bayer Hemophilia Awards Program; NovoNordisk(Novo Nordisk); Bayer(Bayer AG); Baxter Health Care; CSL-Behring; BaxterHealthCare; CSL; Baxter; Pfizer(Pfizer); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Broderick, Herbert, Latimer, and Curtin reported that they have previously received a competitive research grant from the Bayer Hemophilia Awards Program. Dr Barnes reported receiving speaker fees from NovoNordisk, Bayer, Baxter Health Care, and CSL-Behring. He has also received consultant fees from NovoNordisk and BaxterHealthCare. Dr Curtin reported that she is a paid consultant of the Novo Nordisk Hemophilia Advisory Board and has received research support from CSL. She has also received conference travel support from Baxter and Pfizer. Dr Brown has previously received an honorarium from Novo Nordisk.; This study was supported by a project grant from the National Health and Medical Research Council (NHMRC). Dr Herbert is supported by a research fellowship from the Australian NHMRC, and Dr Latimer is supported by a Future Fellowship from the Australian Research Council.	ALEDORT LM, 1994, J INTERN MED, V236, P391, DOI 10.1111/j.1365-2796.1994.tb00815.x; Anderson A, 2005, PLAYING IT SAFE BLEE; Barnes C, 2006, HAEMOPHILIA, V12, P40, DOI 10.1111/j.1365-2516.2006.01333.x; Bjorkman S, 1997, HAEMOPHILIA, V3, P1, DOI 10.1046/j.1365-2516.1997.00074.x; Bjorkman S, 2001, HAEMOPHILIA, V7, P133, DOI 10.1046/j.1365-2516.2001.00465.x; Blanchette VS, 2008, J THROMB HAEMOST, V6, P1319, DOI 10.1111/j.1538-7836.2008.03032.x; Broderick CR, 2013, HAEMOPHILIA, V19, P59, DOI 10.1111/j.1365-2516.2012.02904.x; Broderick Carolyn R, 2008, BMC Blood Disord, V8, P2, DOI 10.1186/1471-2326-8-2; CARLSSON N, 1993, EUR J HAEMATOL, V51, P247; Collins PW, 2009, J THROMB HAEMOST, V7, P413, DOI 10.1111/j.1538-7836.2008.03270.x; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Fischer K, 2002, HAEMOPHILIA, V8, P753, DOI 10.1046/j.1365-2516.2002.00694.x; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Karafoulidou A, 2009, EUR J CLIN PHARMACOL, V65, P1121, DOI 10.1007/s00228-009-0699-3; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Poon MC, 2002, THROMB HAEMOSTASIS, V87, P431; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Ross C, 2009, PEDIATRICS, V124, P1267, DOI 10.1542/peds.2009-0072; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Srivastava A, 2003, HAEMOPHILIA, V9, P391, DOI 10.1046/j.1365-2516.2003.00766.x; Tiktinsky R, 2009, HAEMOPHILIA, V15, P695, DOI 10.1111/j.1365-2516.2009.01990.x; Twisk JWR, 2003, APPL LONGITUDINAL DA; Van den Berg HM, 2007, J THROMB HAEMOST, V5, P151, DOI 10.1111/j.1538-7836.2007.02503.x; Weigel N, 1975, Am Correct Ther J, V29, P197	25	92	94	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1452	1459		10.1001/jama.2012.12727	http://dx.doi.org/10.1001/jama.2012.12727			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047359	Bronze			2022-12-24	WOS:000309579300024
J	Huang, GN; Thatcher, JE; McAnally, J; Kong, YL; Qi, XX; Tan, W; DiMaio, JM; Amatruda, JF; Gerard, RD; Hill, JA; Bassel-Duby, R; Olson, EN				Huang, Guo N.; Thatcher, Jeffrey E.; McAnally, John; Kong, Yongli; Qi, Xiaoxia; Tan, Wei; DiMaio, J. Michael; Amatruda, James F.; Gerard, Robert D.; Hill, Joseph A.; Bassel-Duby, Rhonda; Olson, Eric N.			C/EBP Transcription Factors Mediate Epicardial Activation During Heart Development and Injury	SCIENCE			English	Article							RETINOIC ACID; BINDING PROTEIN; GRAINY-HEAD; MOUSE HEART; REGENERATION; ZEBRAFISH; CELLS; DROSOPHILA; INTEGRITY; IMMUNITY	The epicardium encapsulates the heart and functions as a source of multipotent progenitor cells and paracrine factors essential for cardiac development and repair. Injury of the adult heart results in reactivation of a developmental gene program in the epicardium, but the transcriptional basis of epicardial gene expression has not been delineated. We established a mouse embryonic heart organ culture and gene expression system that facilitated the identification of epicardial enhancers activated during heart development and injury. Epicardial activation of these enhancers depends on a combinatorial transcriptional code centered on CCAAT/enhancer binding protein (C/EBP) transcription factors. Disruption of C/EBP signaling in the adult epicardium reduced injury-induced neutrophil infiltration and improved cardiac function. These findings reveal a transcriptional basis for epicardial activation and heart injury, providing a platform for enhancing cardiac regeneration.	[Huang, Guo N.; McAnally, John; Qi, Xiaoxia; Amatruda, James F.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Thatcher, Jeffrey E.; DiMaio, J. Michael] Univ Texas SW Med Ctr Dallas, Dept Cardiovasc & Thorac Surg, Dallas, TX 75390 USA; [Kong, Yongli; Tan, Wei; Amatruda, James F.; Gerard, Robert D.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Tan, Weihong/A-5412-2008; Tan, Weihong/AAA-4536-2020	Tan, Weihong/0000-0002-8066-1524; Huang, Guo/0000-0002-4335-9123	O'Donnell Foundation Fellow of the Life Sciences Research Foundation; NIH Pathway [1K99HL114738]; NIH [HL100401-01]; Donald W. Reynolds Center for Clinical Cardiovascular Research; American Heart Association; Jon Holden DeHaan Foundation; Leducq Foundation; Robert A. Welch Foundation [1-0025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111665, K99HL114738, R01HL093039, U01HL100401, R00HL114738, R01HL077439] Funding Source: NIH RePORTER	O'Donnell Foundation Fellow of the Life Sciences Research Foundation; NIH Pathway; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; American Heart Association(American Heart Association); Jon Holden DeHaan Foundation; Leducq Foundation(Leducq Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Cabrera for graphical assistance; J. Shelton and J. A. Richardson for histology; A. Mobley for assistance with fluorescence-activated cell sorting; the UT Southwestern microarray core facility; and K. Kangasniemi, K. Sagiyama, and M. Takahashi for cardiac magnetic resonance imaging. We are grateful to G. Begemann, S. Jane, P. Johnson, C. Lagman, R. MacDonald, R. Roeder, J. Rosen, G. Stark, C. Vinson, M. Wolfgang, and C. Zahnow for plasmids and reagents. We thank J. Chen, N. Munshi, P. Yi, and members of the Olson laboratory for scientific discussion and critical reading of the manuscript. G. N. H. is an O'Donnell Foundation Fellow of the Life Sciences Research Foundation and a recipient of the NIH Pathway to Independence Award (1K99HL114738). Supported by NIH grant HL100401-01, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the American Heart Association, the Jon Holden DeHaan Foundation, the Leducq Foundation, and the Robert A. Welch Foundation (grant 1-0025) (E.N.O.). Microarray data have been deposited in Gene Expession Omnibus (accession no. GSE41959).	Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Didon L, 2011, AM J RESP CRIT CARE, V184, P233, DOI 10.1164/rccm.201007-1113OC; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kim CH, 2011, VITAM HORM, V86, P83, DOI 10.1016/B978-0-12-386960-9.00004-6; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Osada S, 1996, J BIOL CHEM, V271, P3891; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Serluca FC, 2008, DEV BIOL, V315, P18, DOI 10.1016/j.ydbio.2007.10.007; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Sucov HM, 2009, PEDIATR CARDIOL, V30, P617, DOI 10.1007/s00246-009-9391-8; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	28	149	155	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1599	1603		10.1126/science.1229765	http://dx.doi.org/10.1126/science.1229765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23160954	Green Accepted			2022-12-24	WOS:000312533100047
J	Abitua, PB; Wagner, E; Navarrete, IA; Levine, M				Abitua, Philip Barron; Wagner, Eileen; Navarrete, Ignacio A.; Levine, Michael			Identification of a rudimentary neural crest in a non-vertebrate chordate	NATURE			English	Article							MESODERMAL TISSUES; CELL FATE; LINEAGE; GENE; PLASTICITY; INDUCTION; EVOLUTION; INSIGHTS; ORIGIN; GENOME	Neural crest arises at the neural plate border, expresses a core set of regulatory genes and produces a diverse array of cell types, including ectomesenchyme derivatives that elaborate the vertebrate head(1,2). The evolution of neural crest has been proposed to be a key event leading to the appearance of new cell types that fostered the transition from filter feeding to active predation in ancestral vertebrates(3). However, the origin of neural crest remains controversial, as homologous cell types have not been unambiguously identified in non-vertebrate chordates(1,4). Here we show that the tunicate Ciona intestinalis possesses a cephalic melanocyte lineage (a9.49) similar to neural crest that can be reprogrammed into migrating 'ectomesenchyme' by the targeted misexpression of Twist (also known as twist-like 2). Our results suggest that the neural crest melanocyte regulatory network pre-dated the divergence of tunicates and vertebrates. We propose that the co-option of mesenchyme determinants, such as Twist, into the neural plate ectoderm was crucial to the emergence of the vertebrate 'new head'(3).	[Abitua, Philip Barron; Wagner, Eileen; Navarrete, Ignacio A.; Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Div Genet Genom & Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Div Genet Genom & Dev, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu		Levine, Michael/0000-0001-7629-0081; Abitua, Philip/0000-0002-8264-0807; Navarrete, Ignacio/0000-0001-6644-1616	US National Science Foundation; US National Institutes of Health [NS 076542]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Stolfi for his continued support and guidance, Y. Satou for isolating the Twist enhancer, N. Ellis for cloning Dmbx > Twist and B. Gainous for critical reading of the manuscript. P. B. A is supported by a graduate fellowship from the US National Science Foundation. This work was supported by a grant from the US National Institutes of Health (NS 076542).	Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Horie T, 2011, NATURE, V469, P525, DOI 10.1038/nature09631; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Imai KS, 2002, DEVELOPMENT, V129, P3441; Jeffery WR, 2006, J EXP ZOOL PART B, V306B, P470, DOI 10.1002/jez.b.21109; Jeffery WR, 2008, DEV BIOL, V324, P152, DOI 10.1016/j.ydbio.2008.08.022; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; NISHIDA H, 1989, DEV BIOL, V132, P355, DOI 10.1016/0012-1606(89)90232-7; Russo MT, 2004, DEV BIOL, V267, P517, DOI 10.1016/j.ydbio.2003.11.005; Shi W, 2008, DEVELOPMENT, V135, P931, DOI 10.1242/dev.011940; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Squarzoni P, 2011, DEVELOPMENT, V138, P1421, DOI 10.1242/dev.057323; Stolfi A, 2011, DEVELOPMENT, V138, P995, DOI 10.1242/dev.061507; Tassy O, 2010, GENOME RES, V20, P1459, DOI 10.1101/gr.108175.110; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Tokuoka M, 2005, DEV BIOL, V288, P387, DOI 10.1016/j.ydbio.2005.09.018; Vincentz JW, 2008, DEV BIOL, V320, P131, DOI 10.1016/j.ydbio.2008.04.037; Vlaeminck-Guillem V, 2000, MECH DEVELOP, V91, P331, DOI 10.1016/S0925-4773(99)00272-5; Wada H, 2006, INT J BIOL SCI, V2, P133; Yajima I, 2003, MECH DEVELOP, V120, P1489, DOI 10.1016/j.mod.2003.08.009; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108	30	147	148	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					104	+		10.1038/nature11589	http://dx.doi.org/10.1038/nature11589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23135395	Green Accepted			2022-12-24	WOS:000311893400054
J	Young, GR; Eksmond, U; Salcedo, R; Alexopoulou, L; Stoye, JP; Kassiotis, G				Young, George R.; Eksmond, Urszula; Salcedo, Rosalba; Alexopoulou, Lena; Stoye, Jonathan P.; Kassiotis, George			Resurrection of endogenous retroviruses in antibody-deficient mice	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; B-CELL RESPONSES; TARGETED DISRUPTION; RECEPTOR; LYMPHOCYTES; MOUSE; RETROELEMENTS; EXPRESSION; INDUCTION; LIPOPOLYSACCHARIDE	The mammalian host has developed a long-standing symbiotic relationship with a considerable number of microbial species. These include the microbiota on environmental surfaces, such as the respiratory and gastrointestinal tracts(1), and also endogenous retroviruses (ERVs), comprising a substantial fraction of the mammalian genome(2,3). The long-term consequences for the host of interactions with these microbial species can range from mutualism to parasitism and are not always completely understood. The potential effect of one microbial symbiont on another is even less clear. Here we study the control of ERVs in the commonly used C57BL/6 (B6) mouse strain, which lacks endogenous murine leukaemia viruses (MLVs) able to replicate in murine cells. We demonstrate the spontaneous emergence of fully infectious ecotropic(4) MLV in B6 mice with a range of distinct immune deficiencies affecting antibody production. These recombinant retroviruses establish infection of immunodeficient mouse colonies, and ultimately result in retrovirus-induced lymphomas. Notably, ERV activation in immunodeficient mice is prevented in husbandry conditions associated with reduced or absent intestinal microbiota. Our results shed light onto a previously unappreciated role for immunity in the control of ERVs and provide a potential mechanistic link between immune activation by microbial triggers and a range of pathologies associated with ERVs, including cancer.	[Young, George R.; Eksmond, Urszula; Kassiotis, George] MRC Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England; [Salcedo, Rosalba] SAIC Frederick Inc, Basic Sci Program, NIH, Frederick, MD 21701 USA; [Salcedo, Rosalba] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Alexopoulou, Lena] Aix Marseille Univ, UM2, Ctr Immunol Marseille Luminy CIML,INSERM, U1104,CNRS UMR7280, Marseille, France; [Stoye, Jonathan P.] MRC Natl Inst Med Res, Div Virol, London NW7 1AA, England	MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; MRC National Institute for Medical Research	Kassiotis, G (corresponding author), MRC Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England.	gkassio@nimr.mrc.ac.uk	Young, George/C-6733-2009; Alexopoulou, Lena/A-5041-2017	Young, George/0000-0002-1203-588X; Alexopoulou, Lena/0000-0003-4619-697X; Stoye, Jonathan/0000-0003-3377-323X; Kassiotis, George/0000-0002-8457-2633	UK Medical Research Council [U117581330, U117512710]; Medical Research Council [MC_U117581330, MC_U117512710] Funding Source: researchfish; MRC [MC_U117512710, MC_U117581330] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank W.-D. Hardt for mouse samples and discussion, L. Selles Vidal for technical assistance, and colleagues for critical reading of the manuscript. We also wish to thank the staff of the Unit for Laboratory Animal Medicine, University of Michigan, for the provision of germ-free mice. We are grateful for assistance from the Division of Biological Services, the Flow Cytometry, Electron Microscopy and Microarray facilities at NIMR. This work was supported by the UK Medical Research Council (U117581330 and U117512710).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Bock M, 2000, J VIROL, V74, P7422, DOI 10.1128/JVI.74.16.7422-7430.2000; Bromham L, 2001, J VIROL, V75, P3053, DOI 10.1128/JVI.75.6.3053-3057.2001; Browne EP, 2012, IMMUNOLOGY, V136, P370, DOI 10.1111/j.1365-2567.2012.03587.x; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DeFranco AL, 2012, IMMUNOL REV, V247, P64, DOI 10.1111/j.1600-065X.2012.01115.x; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GREENBERGER JS, 1975, J IMMUNOL, V115, P317; Harriman GR, 1999, J IMMUNOL, V162, P2521; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KING SR, 1988, VIROLOGY, V162, P1, DOI 10.1016/0042-6822(88)90388-1; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOZAK CA, 1980, J EXP MED, V152, P219, DOI 10.1084/jem.152.1.219; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Li MF, 1999, J VIROL, V73, P9178, DOI 10.1128/JVI.73.11.9178-9186.1999; Lim A, 2011, AIDS, V25, P1379, DOI 10.1097/QAD.0b013e328348a789; Lotscher M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001158; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; MCCUBREY J, 1982, CELL, V28, P881, DOI 10.1016/0092-8674(82)90067-8; MELAMEDOFF M, 1983, J EXP MED, V158, P506, DOI 10.1084/jem.158.2.506; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORONI C, 1975, NATURE, V254, P60, DOI 10.1038/254060a0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Pothlichet J, 2006, INT J CANCER, V119, P1869, DOI 10.1002/ijc.22066; Reid RR, 1997, J IMMUNOL, V159, P970; Romanish MT, 2010, SEMIN CANCER BIOL, V20, P246, DOI 10.1016/j.semcancer.2010.05.005; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; STOYE JP, 1983, J EXP MED, V157, P1660, DOI 10.1084/jem.157.5.1660; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; STOYE JP, 1991, J VIROL, V65, P1273, DOI 10.1128/JVI.65.3.1273-1285.1991; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Uren TK, 2003, J IMMUNOL, V170, P2531, DOI 10.4049/jimmunol.170.5.2531; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wu Licheng, 2006, Current Issues in Intestinal Microbiology, V7, P19; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoshinobu K, 2009, J IMMUNOL, V182, P8094, DOI 10.4049/jimmunol.0900263; Young GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002709	59	152	158	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					774	+		10.1038/nature11599	http://dx.doi.org/10.1038/nature11599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103862	Green Accepted			2022-12-24	WOS:000311606000049
J	Mancusso, R; Gregorio, GG; Liu, Q; Wang, DN				Mancusso, Romina; Gregorio, G. Glenn; Liu, Qun; Wang, Da-Neng			Structure and mechanism of a bacterial sodium-dependent dicarboxylate transporter	NATURE			English	Article							COUPLED CITRATE TRANSPORTER; CRYSTAL-STRUCTURE; NA+/DICARBOXYLATE COTRANSPORTER; ANOMALOUS DIFFRACTION; CARRIER PROTEIN; MEMBRANE; EXPRESSION; SYSTEM; RESIDUES; INSIGHTS	In human cells, cytosolic citrate is a chief precursor for the synthesis of fatty acids, triacylglycerols, cholesterol and low-density lipoprotein. Cytosolic citrate further regulates the energy balance of the cell by activating the fatty-acid-synthesis pathway while downregulating both the glycolysis and fatty-acid beta-oxidation pathways(1-4). The rate of fatty-acid synthesis in liver and adipose cells, the two main tissue types for such synthesis, correlates directly with the concentration of citrate in the cytosol(2-5), with the cytosolic citrate concentration partially depending on direct import across the plasma membrane through the Na+-dependent citrate transporter (NaCT)(6,7). Mutations of the homologous fly gene (Indy; I'm not dead yet) result in reduced fat storage through calorie restriction(8). More recently, Nact (also known as Slc13a5)-knockout mice have been found to have increased hepatic mitochondrial biogenesis, higher lipid oxidation and energy expenditure, and reduced lipogenesis, which taken together protect the mice from obesity and insulin resistance(9). To understand the transport mechanism of NaCT and INDY proteins, here we report the 3.2 angstrom crystal structure of a bacterial INDY homologue. One citrate molecule and one sodium ion are bound per protein, and their binding sites are defined by conserved amino acid motifs, forming the structural basis for understanding the specificity of the transporter. Comparison of the structures of the two symmetrical halves of the transporter suggests conformational changes that propel substrate translocation.	[Mancusso, Romina; Gregorio, G. Glenn; Wang, Da-Neng] NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Mancusso, Romina] NYU, Sch Med, Mol Biophys Grad Program, New York, NY 10016 USA; [Liu, Qun] Brookhaven Natl Lab, NSLS X4, New York Struct Biol Ctr, Upton, NY 11973 USA; [Wang, Da-Neng] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; United States Department of Energy (DOE); Brookhaven National Laboratory; New York University	Wang, DN (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, 540 1st Ave, New York, NY 10016 USA.	wang@saturn.med.nyu.edu	Liu, Qun/A-8757-2011	Liu, Qun/0000-0002-1179-290X; Gregorio, Gabriel Glenn/0000-0001-8677-133X; Wang, Da-Neng/0000-0002-6496-4699	National Institutes of Health [U54-GM075026, R01-DK073973, R01-GM093825, R01-MH083840]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073973, R01DK053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093825, U54GM075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to M. Punta and B. Rost for bioinformatics analysis of membrane transporters, to J. Love and B. Kloss for assistance in cloning, and to the staff at beamlines X4, X25 and X29 of the National Synchrotron Light Source in the Brookhaven National Laboratory and at the 23ID at the Advanced Photon Source at the Argonne National Laboratory for assistance in X-ray diffraction experiments, and to J. Llodra for help with artwork. We thank B. K. Czyzewski, W. A. Hendrickson, N. K. Karpowich, F. Mancia and J. J. Marden for discussions and for participating in synchrotron trips. This work was financially supported by National Institutes of Health grants U54-GM075026, R01-DK073973, R01-GM093825 and R01-MH083840.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; BLOCH K, 1977, ANNU REV BIOCHEM, V46, P263, DOI 10.1146/annurev.bi.46.070177.001403; Boulter JM, 2001, PROTEIN EXPRES PURIF, V22, P337, DOI 10.1006/prep.2001.1440; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006; Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b; Hall JA, 2005, J BACTERIOL, V187, P5189, DOI 10.1128/JB.187.15.5189-5194.2005; Hall JA, 2007, J BACTERIOL, V189, P880, DOI 10.1128/JB.01452-06; HIRATO T, 1984, J BACTERIOL, V160, P421, DOI 10.1128/JB.160.1.421-426.1984; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Inoue K, 2003, BIOCHEM J, V374, P21, DOI 10.1042/BJ20030827; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Joshi A. D., 1945, BIOCHEMISTRY-US, V45, P4231; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Li XD, 2001, FEBS LETT, V494, P165, DOI 10.1016/S0014-5793(01)02334-1; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Liu Q, 2011, ACTA CRYSTALLOGR D, V67, P45, DOI 10.1107/S0907444910046573; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Markovich D, 2004, PFLUG ARCH EUR J PHY, V447, P594, DOI 10.1007/s00424-003-1128-6; NISHIKOR.K, 1973, FEBS LETT, V32, P19, DOI 10.1016/0014-5793(73)80725-2; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Pajor AM, 2001, J BIOL CHEM, V276, P29961, DOI 10.1074/jbc.M011387200; Pajor AM, 2010, AM J PHYSIOL-RENAL, V299, pF704, DOI 10.1152/ajprenal.00213.2010; Prakash S, 2003, BBA-BIOMEMBRANES, V1618, P79, DOI 10.1016/j.bbamem.2003.10.010; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Safferling M, 2003, BIOCHEMISTRY-US, V42, P13969, DOI 10.1021/bi035173q; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SPENCER AF, 1962, J BIOL CHEM, V237, P3640; Strickler MA, 2009, BBA-BIOMEMBRANES, V1788, P2489, DOI 10.1016/j.bbamem.2009.10.008; Sul HS, 2008, N COMP BIOC, P155, DOI 10.1016/B978-044453219-0.50008-8; Wang DN, 2003, BBA-BIOMEMBRANES, V1610, P23, DOI 10.1016/S0005-2736(02)00709-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WRIGHT SH, 1983, J BIOL CHEM, V258, P5456; WRIGHT SH, 1980, J MEMBRANE BIOL, V57, P73, DOI 10.1007/BF01868987; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao XZ, 2000, AM J PHYSIOL-RENAL, V279, pF54, DOI 10.1152/ajprenal.2000.279.1.F54; Youn JW, 2008, J BACTERIOL, V190, P6458, DOI 10.1128/JB.00780-08; Zhang FF, 2001, BBA-BIOMEMBRANES, V1511, P80, DOI 10.1016/S0005-2736(00)00385-0	49	124	125	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					622	+		10.1038/nature11542	http://dx.doi.org/10.1038/nature11542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23086149	Green Accepted			2022-12-24	WOS:000311339800058
J	Weinberg, DS; Schoen, RE				Weinberg, David S.; Schoen, Robert E.			Colorectal Cancer Screening: America's Next Top Model?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TASK-FORCE; COLONOSCOPY; POLYPS		[Weinberg, David S.] Fox Chase Canc Ctr, Dept Med, Philadelphia, PA 19111 USA; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weinberg, DS (corresponding author), Fox Chase Canc Ctr, Dept Med, 333 Cottman Ave, Philadelphia, PA 19111 USA.	david.weinberg@fccc.edu						Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Knudsen AB, 2012, ANN INTERN MED, V157, P611, DOI 10.7326/0003-4819-157-9-201211060-00005; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Penn E, 2010, ARCH INTERN MED, V170, P1127, DOI 10.1001/archinternmed.2010.152; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245	9	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					673	+		10.7326/0003-4819-157-9-201211060-00017	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00017			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128867				2022-12-24	WOS:000310783300012
J	Lorang, J; Kidarsa, T; Bradford, CS; Gilbert, B; Curtis, M; Tzeng, SC; Maier, CS; Wolpert, TJ				Lorang, J.; Kidarsa, T.; Bradford, C. S.; Gilbert, B.; Curtis, M.; Tzeng, S. -C.; Maier, C. S.; Wolpert, T. J.			Tricking the Guard: Exploiting Plant Defense for Disease Susceptibility	SCIENCE			English	Article							HOST-SELECTIVE TOXINS; VICTORIN SENSITIVITY; RESISTANCE GENE; THIOREDOXIN H5; LRR GENE; ARABIDOPSIS; PROTEINS; FEATURES	Typically, pathogens deploy virulence effectors to disable defense. Plants defeat effectors with resistance proteins that guard effector targets. We found that a pathogen exploits a resistance protein by activating it to confer susceptibility in Arabidopsis. The guard mechanism of plant defense is recapitulated by interactions among victorin (an effector produced by the necrotrophic fungus Cochliobolus victoriae), TRX-h5 (a defense-associated thioredoxin), and LOV1 (an Arabidopsis susceptibility protein). In LOV1's absence, victorin inhibits TRX-h5, resulting in compromised defense but not disease by C. victoriae. In LOV1's presence, victorin binding to TRX-h5 activates LOV1 and elicits a resistance-like response that confers disease susceptibility. We propose that victorin is, or mimics, a conventional pathogen virulence effector that was defeated by LOV1 and confers virulence to C. victoriae solely because it incites defense.	[Lorang, J.; Kidarsa, T.; Bradford, C. S.; Gilbert, B.; Curtis, M.; Wolpert, T. J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Lorang, J.; Kidarsa, T.; Bradford, C. S.; Gilbert, B.; Curtis, M.; Wolpert, T. J.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Tzeng, S. -C.; Maier, C. S.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Wolpert, TJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	wolpertt@science.oregonstate.edu		Maier, Claudia S./0000-0003-0743-8956	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D016541/1, BB/H008039/1]; Royal Society; BBSRC [BB/D016541/1, BB/H008039/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008039/1, BB/D016541/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank M. Rashbrooke for assistance with initial phenotype analyses and rough mapping of sp1; U. Ranganathan for her contribution to the analysis of SPL1; R. Patel and R. Berkeley for excellent technical assistance; N. Allcock and S. Hyman for electron microscopy (EM) carried out within the EM Laboratory, University of Leicester; C. Dean and R. Trosch for helpful comments on the manuscript; U. Flores-Perez for antigen preparation (atToc132 and atToc34); M. Boutry (PMA2), N. E. Hoffman (LHCP), K. Inoue (OEP80), F. Kessler (atToc159), and G. Thorlby (SFR2) for antibodies; C. E. Stebbins for the AtUBC8 clone; and the Salk Institute Genomic Analysis Laboratory (SIGnAL) and the Nottingham Arabidopsis Stock Centre (NASC) for the sp1-2 and sp1-3 alleles. This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC; BB/D016541/1 and BB/H008039/1) to P.J., by the Royal Society Rosenheim Research Fellowship to P.J., and by a Royal Society International Incoming Fellowship to W. H. This work is the subject of patent application number GB 1216090.9, which covers the role of the ubiquitin-proteasome system in the control of plastid development. The data are presented in the manuscript and in the supplementary materials.	CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Lorang J, 2010, MOL BREEDING, V26, P545, DOI 10.1007/s11032-010-9458-5; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Mundt CC, 2009, PHYTOPATHOLOGY, V99, P1116, DOI 10.1094/PHYTO-99-10-1116; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Sweat TA, 2008, MOL PLANT MICROBE IN, V21, P7, DOI 10.1094/MPMI-21-1-0007; Sweat TA, 2007, PLANT CELL, V19, P673, DOI 10.1105/tpc.106.047563; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; WOLPERT TJ, 1988, PLANT PHYSIOL, V88, P37, DOI 10.1104/pp.88.1.37; Wroblewski T, 2009, PLANT PHYSIOL, V150, P1733, DOI 10.1104/pp.109.140251	16	129	130	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					659	662		10.1126/science.1226743	http://dx.doi.org/10.1126/science.1226743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23087001	Green Accepted			2022-12-24	WOS:000310516000051
J	Spence, D				Spence, Des			How the Liverpool care pathway has transformed end of life care	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Bowater D., 2012, TELEGRAPH; Doughty, 2012, DAILY MAIL	2	4	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 31	2012	345								e7308	10.1136/bmj.e7308	http://dx.doi.org/10.1136/bmj.e7308			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FF	23114070				2022-12-24	WOS:000310778900012
J	Payne, D				Payne, David			Tamiflu: the battle for secret drug data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; INFLUENZA					dpayne@bmj.com						Centers for Disease Control and Prevention, REC INFL ANT MED REM; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3513; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7168; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374	7	12	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2012	345								e7303	10.1136/bmj.e7303	http://dx.doi.org/10.1136/bmj.e7303			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109482	Bronze			2022-12-24	WOS:000310778000010
J	Chojnacki, J; Staudt, T; Glass, B; Bingen, P; Engelhardt, J; Anders, M; Schneider, J; Muller, B; Hell, SW; Krausslich, HG				Chojnacki, Jakub; Staudt, Thorsten; Glass, Baerbel; Bingen, Pit; Engelhardt, Johann; Anders, Maria; Schneider, Jale; Mueller, Barbara; Hell, Stefan W.; Kraeusslich, Hans-Georg			Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN INCORPORATION; GP41 CYTOPLASMIC TAIL; INFLUENZA-VIRUS; TYPE-1; VIRIONS; FUSION; ENV; ORGANIZATION; TOMOGRAPHY	Human immunodeficiency virus type 1 (HIV-1) buds from the cell as an immature particle requiring subsequent proteolysis of the main structural polyprotein Gag for morphological maturation and infectivity. Visualization of the viral envelope (Env) glycoprotein distribution on the surface of individual HIV-1 particles with stimulated emission depletion (STED) superresolution fluorescence microscopy revealed maturation-induced clustering of Env proteins that depended on the Gag-interacting Env tail. Correlation of Env surface clustering with the viral entry efficiency revealed coupling between the viral interior and exterior: Rearrangements of the inner protein lattice facilitated the alteration of the virus surface in preparation for productive entry. We propose that Gag proteolysis-dependent clustering of the sparse Env trimers on the viral surface may be an essential aspect of HIV-1 maturation.	[Chojnacki, Jakub; Glass, Baerbel; Anders, Maria; Mueller, Barbara; Kraeusslich, Hans-Georg] Univ Heidelberg, Dept Infect Dis, D-69120 Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Schneider, Jale; Hell, Stefan W.] German Canc Res Ctr, Opt Nanoscopy Div, D-69120 Heidelberg, Germany; [Staudt, Thorsten; Bingen, Pit; Engelhardt, Johann; Schneider, Jale; Hell, Stefan W.] BIOQUANT, D-69120 Heidelberg, Germany; [Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Krausslich, HG (corresponding author), Univ Heidelberg, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	hans-georg.kraeusslich@med.uni-heidelberg.de	Chojnacki, Jakub/AAL-8170-2021; Muller, Barbara/AAC-4483-2020	Krausslich, Hans-Georg/0000-0002-8756-329X; Chojnacki, Jakub/0000-0002-4457-8096; Muller, Barbara/0000-0001-5726-5585	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	We are grateful to J. Mak (Burnet Institute, Melbourne) for purified recombinant HIV-1 Gag and to P. Guardado-Calves (Institut Pasteur, Paris) for monomeric and trimeric Env gp140. We thank L. Castillo for purified recombinant HIV-1 CA, V. Bosch (DKFZ Heidelberg) for HIV-1 gp120 and CD4 antisera as well as HIV-1 Env expression plasmids, R. Doms (University of Pennsylvania) for SupT1R5 cells, C. Aiken (Vanderbilt University Medical Center) for infectious HIV-1 variant plasmids, and T. Hope (Northwestern University Chicago) for the eGFP. Vpr construct. H.-G.K. is an investigator of the Excellence Cluster CellNetworks funded by the German Research Foundation (DFG). S.W.H. holds a patent on STED microscopy in several European countries and the United States, which has been licensed to Leica, a microscope manufacturer.	Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CHENG RH, 1995, CELL, V80, P621; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Endress T, 2008, EUR BIOPHYS J BIOPHY, V37, P1291, DOI 10.1007/s00249-008-0322-z; Forster MJ, 2000, J MOL BIOL, V298, P841, DOI 10.1006/jmbi.2000.3715; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Holtkotte D, 2006, AIDS RES HUM RETROV, V22, P57, DOI 10.1089/aid.2006.22.57; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Lee SF, 2000, J BIOL CHEM, V275, P15809, DOI 10.1074/jbc.M000601200; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; WILK T, 1992, VIROLOGY, V189, P167, DOI 10.1016/0042-6822(92)90692-I; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	26	189	193	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					524	528		10.1126/science.1226359	http://dx.doi.org/10.1126/science.1226359			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112332				2022-12-24	WOS:000310195800057
J	Teperino, R; Amann, S; Bayer, M; Mcgee, SL; Loipetzberger, A; Connor, T; Jaeger, C; Kammerer, B; Winter, L; Wiche, G; Dalgaard, K; Selvaraj, M; Gaster, M; Lee-Young, RS; Febbraio, MA; Knauf, C; Cani, PD; Aberger, F; Penninger, JM; Pospisilik, JA; Esterbauer, H				Teperino, Raffaele; Amann, Sabine; Bayer, Martina; Mcgee, Sean L.; Loipetzberger, Andrea; Connor, Timothy; Jaeger, Carsten; Kammerer, Bernd; Winter, Lilli; Wiche, Gerhard; Dalgaard, Kevin; Selvaraj, Madhan; Gaster, Michael; Lee-Young, Robert S.; Febbraio, Mark A.; Knauf, Claude; Cani, Patrice D.; Aberger, Fritz; Penninger, Josef M.; Pospisilik, J. Andrew; Esterbauer, Harald			Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat	CELL			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; PRIMARY CILIA; PATHWAY; PROMOTE; OBESITY; REQUIREMENT; INHIBITION; OXYSTEROLS; MECHANISMS	Diabetes, obesity, and cancer affect upward of 15% of the world's population. Interestingly, all three diseases juxtapose dysregulated intracellular signaling with altered metabolic state. Exactly which genetic factors define stable metabolic set points in vivo remains poorly understood. Here, we show that hedgehog signaling rewires cellular metabolism. We identify a cilium-dependent Smo-Ca2+-Ampk axis that triggers rapid Warburg-like metabolic reprogramming within minutes of activation and is required for proper metabolic selectivity and flexibility. We show that Smo modulators can uncouple the Smo-Ampk axis from canonical signaling and identify cyclopamine as one of a new class of "selective partial agonists," capable of concomitant inhibition of canonical and activation of noncanonical hedgehog signaling. Intriguingly, activation of the Smo-Ampk axis in vivo drives robust insulin-independent glucose uptake in muscle and brown adipose tissue. These data identify multiple noncanonical endpoints that are pivotal for rational design of hedgehog modulators and provide a new therapeutic avenue for obesity and diabetes.	[Teperino, Raffaele; Pospisilik, J. Andrew] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Amann, Sabine; Bayer, Martina; Dalgaard, Kevin; Selvaraj, Madhan; Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Mcgee, Sean L.; Connor, Timothy] Deakin Univ, Metabol Remodeling Lab, Metab Res Unit, Sch Med, Geelong, Vic 3220, Australia; [Loipetzberger, Andrea; Aberger, Fritz] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Jaeger, Carsten; Kammerer, Bernd] Ctr Biol Syst Anal ZBSA, Metabol Core, D-79104 Freiburg, Germany; [Winter, Lilli; Wiche, Gerhard] Max F Perutz Labs, Dept Biochem & Cell Biol, A-1030 Vienna, Austria; [Gaster, Michael] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Gaster, Michael] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Lee-Young, Robert S.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic 3004, Australia; [Knauf, Claude] Univ Toulouse 3, Inst Med Mol Rangueil, Team 3, CHU Rangueil,INSERM,U1048, F-31432 Toulouse 4, France; [Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Max Planck Society; Medical University of Vienna; Deakin University; Salzburg University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Baker Heart and Diabetes Institute; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Catholique Louvain; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Pospisilik, JA (corresponding author), Max Planck Inst Immunobiol & Epigenet, Stuebeweg 51, D-79108 Freiburg, Germany.	pospisilik@ie-freiburg.mpg.de; harald.esterbauer@meduniwien.ac.at	Febbraio, Mark/AAE-9632-2019; WICHE, Gerhard/AAA-3227-2021; Aberger, Fritz/B-6357-2012; Penninger, Josef M/I-6860-2013; Winter, Lilli/ABB-3043-2021; Winter, Lilli/R-5949-2017; D., Cani Patrice/M-8055-2016	Aberger, Fritz/0000-0003-2009-6305; Penninger, Josef M/0000-0002-8194-3777; Winter, Lilli/0000-0002-6368-1160; Winter, Lilli/0000-0002-6368-1160; D., Cani Patrice/0000-0003-2040-2448; Esterbauer, Harald/0000-0001-7343-7455; McGee, Sean/0000-0001-6953-106X; Wiche, Gerhard/0000-0001-9550-5463; Febbraio, Mark/0000-0002-9296-4418; Jaeger, Carsten/0000-0003-2192-1792; Lee, Robert/0000-0002-8166-142X; Knauf, Claude/0000-0001-5213-5378; Teperino, Raffaele/0000-0001-8815-1409	DART; AIRC; Marie-Curie; JDRF; WWTF; MPG; FWF; FFG; OeAW; Austrian Science Fund (FWF) [I 413, I 1207, P 23729] Funding Source: researchfish	DART; AIRC(Fondazione AIRC per la ricerca sul cancro); Marie-Curie(European Commission); JDRF(Juvenile Diabetes Research Foundation); WWTF; MPG(Max Planck Society); FWF(Austrian Science Fund (FWF)); FFG; OeAW; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors are indebted to the DART, AIRC, Marie-Curie, and JDRF for fellowships and WWTF, MPG, FWF, FFG (GenAU-program), and OeAW for funding. S. L. M. is a Career Development Fellow and M. A. F. a Senior Research Fellow of the National Health and Medical Research Council of Australia. The authors are grateful to E. Hobeika, M. Bilban, E. Einwallner, A. Jais, I. Lynfort, and B. Vind for critical technical and theoretical help. The authors are also grateful to M. Scott for providing Smoothened expression constructs, to J. Reiter for Smo-CLD and providing Kif3a<SUP>-/-</SUP> and Ift88<SUP>-/-</SUP> cells, to J. Taipale for providing Smo<SUP>-/-</SUP> cells, and to L. Cantley for the AMPKAR vector.	Belgacem YH, 2011, P NATL ACAD SCI USA, V108, P4482, DOI 10.1073/pnas.1018217108; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Li YW, 2012, EXPERT OPIN THER TAR, V16, P49, DOI 10.1517/14728222.2011.617367; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Roudaut H, 2011, MOL PHARMACOL, V79, P453, DOI 10.1124/mol.110.069708; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Whittle AJ, 2011, TRENDS MOL MED, V17, P405, DOI 10.1016/j.molmed.2011.04.001; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	56	191	193	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					414	426		10.1016/j.cell.2012.09.021	http://dx.doi.org/10.1016/j.cell.2012.09.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063129	Bronze, Green Published			2022-12-24	WOS:000309981000018
J	Banerjee, S; Narayanan, M; Gould, K				Banerjee, Suryabrata; Narayanan, Manjusha; Gould, Kate			Monitoring aminoglycoside level	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; ADULTS		[Banerjee, Suryabrata] Queen Elizabeth Hosp, Gateshead NE9 6SX, England; [Narayanan, Manjusha] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Gould, Kate] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK	Banerjee, S (corresponding author), Queen Elizabeth Hosp, Gateshead NE9 6SX, England.	drsuryabrata@yahoo.co.uk	Banerjee, Suryabrata/AAY-7602-2021	Banerjee, Suryabrata/0000-0001-8200-4432				American Speech-Language-Hearing Association, 1994, AUD MAN IND REC COCH; Anaizi N, 1997, INT J CLIN PHARM TH, V35, P223; Begg EJ, 1999, BRIT J CLIN PHARMACO, V47, P23, DOI 10.1046/j.1365-2125.1999.00850.x; Chabner B., 2010, GOODMAN GILLMAN PHAR, V12th; Edson RS, 1999, MAYO CLIN PROC, V74, P519, DOI 10.4065/74.5.519; Gilbert DN, 2010, MANDELL DOUGLAS BENN; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Naughton CA, 2008, AM FAM PHYSICIAN, V78, P743; NICOLAU DP, 1995, ANTIMICROB AGENTS CH, V39, P650, DOI 10.1128/AAC.39.3.650; Ramakrishnan K, 2005, AM FAM PHYSICIAN, V71, P933; Scottish Medicines Consortium Scottish Antimicrobial Prescribing Group, 2009, GUID US GENT VANC AD; Turnidge J, 2003, INFECT DIS CLIN N AM, V17, P503, DOI 10.1016/S0891-5520(03)00057-6; Urban A W, 1997, Curr Clin Top Infect Dis, V17, P236	13	7	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 27	2012	345								e6354	10.1136/bmj.e6354	http://dx.doi.org/10.1136/bmj.e6354			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OZ	23044986				2022-12-24	WOS:000309386700009
J	Jangi, S				Jangi, Sushrut			Facing Uncertainty - Dispatch from Beth Israel Medical Center, Manhattan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Jangi, S (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2267	2269		10.1056/NEJMp1213844	http://dx.doi.org/10.1056/NEJMp1213844			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23151280				2022-12-24	WOS:000312187700015
J	Palm-Meinders, IH; Koppen, H; Terwindt, GM; Launer, LJ; Konishi, J; Moonen, JME; Bakkers, JTN; Hofman, PAM; van Lew, B; Middelkoop, HAM; van Buchem, MA; Ferrari, MD; Kruit, MC				Palm-Meinders, Inge H.; Koppen, Hille; Terwindt, Gisela M.; Launer, Lenore J.; Konishi, Junya; Moonen, Juliette M. E.; Bakkers, Jacobus T. N.; Hofman, Paul A. M.; van Lew, Baldur; Middelkoop, Huub A. M.; van Buchem, Mark A.; Ferrari, Michel D.; Kruit, Mark C.			Structural Brain Changes in Migraine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WHITE-MATTER HYPERINTENSITIES; SMALL-VESSEL DISEASE; CARDIOVASCULAR-DISEASE; COGNITIVE FUNCTION; VERBAL FLUENCY; POPULATION; LESIONS; RISK; HEADACHE; INFARCTS	Context A previous cross-sectional study showed an association of migraine with a higher prevalence of magnetic resonance imaging (MRI)-measured ischemic lesions in the brain. Objective To determine whether women or men with migraine (with and without aura) have a higher incidence of brain lesions 9 years after initial MRI, whether migraine frequency was associated with progression of brain lesions, and whether progression of brain lesions was associated with cognitive decline. Design, Setting, and Participants In a follow-up of the 2000 Cerebral Abnormalities in Migraine, an Epidemiological Risk Analysis cohort, a prospective population-based observational study of Dutch participants with migraine and an age-and sex-matched control group, 203 of the 295 baseline participants in the migraine group and 83 of 140 in the control group underwent MRI scan in 2009 to identify progression of MRI-measured brain lesions. Comparisons were adjusted for age, sex, hypertension, diabetes, and educational level. The participants in the migraine group were a mean 57 years (range, 43-72 years), and 71% were women. Those in the control group were a mean 55 years (range, 44-71 years), and 69% were women. Main Outcome Measures Progression of MRI-measured cerebral deep white matter hyperintensities, infratentorial hyperintensities, and posterior circulation territory infarctlike lesions. Change in cognition was also measured. Results Of the 145 women in the migraine group, 112 (77%) vs 33 of 55 women (60%) in the control group had progression of deep white matter hyperintensities (adjusted odds ratio [OR], 2.1; 95% CI, 1.0-4.1; P = .04). There were no significant associations of migraine with progression of infratentorial hyperintensities: 21 participants (15%) in the migraine group and 1 of 57 participants (2%) in the control group showed progression (adjusted OR, 7.7; 95% CI, 1.0-59.5; P = .05) or new posterior circulation territory infarctlike lesions: 10 of 203 participants (5%) in the migraine group but none of 83 in the control group (P = .07). There was no association of number or frequency of migraine headaches with progression of lesions. There was no significant association of high vs nonhigh deep white matter hyperintensity load with change in cognitive scores (-3.7 in the migraine group vs 1.4 in the control group; 95% CI, -4.4 to 0.2; adjusted P = .07). Conclusions In a community-based cohort followed up after 9 years, women with migraine had a higher incidence of deep white matter hyperintensities but did not have significantly higher progression of other MRI-measured brain changes. There was no association of migraine with progression of any MRI-measured brain lesions in men. JAMA. 2012;308(18):1889-1897 www.jama.com	[Palm-Meinders, Inge H.; Konishi, Junya; Moonen, Juliette M. E.; van Buchem, Mark A.; Kruit, Mark C.] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands; [van Lew, Baldur] Leiden Univ, Med Ctr, Div Image Proc, NL-2300 RC Leiden, Netherlands; [Koppen, Hille; Terwindt, Gisela M.; Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; [Middelkoop, Huub A. M.] Leiden Univ, Med Ctr, Dept Neuropsychol, NL-2300 RC Leiden, Netherlands; [Koppen, Hille] Haga Hosp, Dept Neurol, The Hague, Netherlands; [Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Bakkers, Jacobus T. N.] Slingeland Hosp, Dept Radiol, Doetinchem, Netherlands; [Hofman, Paul A. M.] Acad Hosp Maastricht, Dept Radiol, Maastricht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Maastricht University; Maastricht University Medical Centre (MUMC)	Kruit, MC (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, POB 9600, NL-2300 RC Leiden, Netherlands.	m.c.kruit@lumc.nl	van Buchem, Mark/AAC-9843-2022; Ferrari, Michel D./ABE-3758-2021; Kruit, Mark C/K-2431-2012	van Buchem, Mark/0000-0003-1881-1998; Ferrari, Michel D./0000-0001-9691-9449; Kruit, Mark C/0000-0002-4319-834X; Dichgans, Martin/0000-0002-0654-387X	Almirall; Coherex; Colucid; Eisai; GlaxoSmithKline; Linde; MAP; Medtronic; Menarini; Merck; Minster; Pfizer; St Jude; National Institutes of Health [1R01NS061382-01]; Netherlands Heart Foundation [2007B016]; Netherlands Organisation for Scientific Research [903-52-291, VICI 918-56-602]; National Institute on Aging [907-00-217, Vidi 917-11-319]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061382] Funding Source: NIH RePORTER	Almirall(Almirall); Coherex; Colucid; Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Linde; MAP; Medtronic(Medtronic); Menarini(Menarini Group); Merck(Merck & Company); Minster; Pfizer(Pfizer); St Jude(St. Jude Medical); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Ferrari reported receiving grants and consultancy or industry support from Almirall, Coherex, Colucid, Eisai, GlaxoSmithKline, Linde, MAP, Medtronic, Menarini, Merck, Minster, Pfizer, and St Jude, and independent support from the Netherlands Organisation for Scientific Research (NOW). Dr Terwindt reported receiving consultancy support from Merck, Janssen-Cilag, Almirall, and Menarini. Dr Koppen reported consultancy or industry support from Allergan, Benecke congres, Pfizer, and In circulation website. The other authors reported no financial disclosures.; This work was supported by grants 1R01NS061382-01 from the National Institutes of Health, 2007B016 from the Netherlands Heart Foundation, and 903-52-291, VICI 918-56-602, and Spinoza 2009 from the Netherlands Organisation for Scientific Research, and 907-00-217 and Vidi 917-11-319 from the Intramural Research Program at the National Institute on Aging.	Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Buyck JF, 2009, STROKE, V40, P2327, DOI 10.1161/STROKEAHA.109.548222; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; Kruit MC, 2006, STROKE, V37, P1109, DOI 10.1161/01.STR.0000206446.26702.e9; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7357; Kurth Tobias, 2006, Curr Pain Headache Rep, V10, P214, DOI 10.1007/s11916-006-0048-5; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Le Pira F, 2004, FUNCT NEUROL, V19, P101; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; Mulder EJCM, 1999, CEPHALALGIA, V19, P557, DOI 10.1046/j.1468-2982.1999.019006557.x; O'Bryant SE, 2006, HEADACHE, V46, P1364, DOI 10.1111/j.1526-4610.2006.00579.x; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rey A, 1985, EXAMIN CLIN PSYCHOL; Scher AI, 2006, ANN NEUROL, V59, P372, DOI 10.1002/ana.20755; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2010, HEADACHE, V50, P588, DOI 10.1111/j.1526-4610.2009.01570.x; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Schwedt TJ, 2008, CEPHALALGIA, V28, P531, DOI 10.1111/j.1468-2982.2008.01554.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tietjen GE, 2009, STROKE, V40, P2977, DOI 10.1161/STROKEAHA.109.547901; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van der Flier WM, 2005, STROKE, V36, P2116, DOI 10.1161/01.STR.0000179092.59909.42; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Waldie KE, 2002, NEUROLOGY, V59, P904, DOI 10.1212/WNL.59.6.904; Wechsler D., 1981, WECHSLER ADULT INTEL; Wolf ME, 2011, NEUROLOGY, V76, P1911, DOI 10.1212/WNL.0b013e31821d74d5	35	137	144	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1889	1897		10.1001/jama.2012.14276	http://dx.doi.org/10.1001/jama.2012.14276			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150008	Green Accepted			2022-12-24	WOS:000310952700025
J	Buesseler, KO				Buesseler, Ken O.			Fishing for Answers off Fukushima	SCIENCE			English	Editorial Material							RADIONUCLIDES; RADIOCESIUM; JAPAN		Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu						Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Doi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029295; International Atomic Energy Agency, 2004, TECHN REP SER, V422; Japan Ministry of Agriculture, 2012, RES INSP RAD MAT FIS; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Ministry of Education, 2012, READ MAR SOIL MON SE; Rowan DJ, 1995, J APPL ECOL, V32, P739, DOI 10.2307/2404813; ROWAN DJ, 1994, CAN J FISH AQUAT SCI, V51, P2388, DOI 10.1139/f94-240; Tokyo Electric Power Company, 2012, NUCL AN RES FISH SHE; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493	11	88	96	7	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					480	482		10.1126/science.1228250	http://dx.doi.org/10.1126/science.1228250			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112321	Green Submitted			2022-12-24	WOS:000310195800043
J	LaRue, CC; Padilla, PA				LaRue, Candace C.; Padilla, Pamela A.			A Mutant Search-Caenorhabditis elegans and Gene Discovery	SCIENCE			English	Editorial Material									[LaRue, Candace C.; Padilla, Pamela A.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Padilla, PA (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	pamela.padilla@unt.edu			Division Of Integrative Organismal Systems [0747391] Funding Source: National Science Foundation	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		BRENNER S, 1974, GENETICS, V77, P71; Girard LR, 2007, NUCLEIC ACIDS RES, V35, pD472, DOI 10.1093/nar/gkl894; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954	4	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					487	488		10.1126/science.1215229	http://dx.doi.org/10.1126/science.1215229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112325				2022-12-24	WOS:000310195800047
J	McFarland, E				McFarland, Eric			Unconventional Chemistry for Unconventional Natural Gas	SCIENCE			English	Editorial Material							CATALYSTS; METHANE; CHLOROMETHANE; OXIDATION		Univ Calif Santa Barbara, Dept Chem Engn, Santa Barabara, CA 93106 USA	University of California System; University of California Santa Barbara	McFarland, E (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barabara, CA 93106 USA.	ewmcfar@engineering.ucsb.edu	McFarland, Eric/G-1763-2014					Chesnokov VV, 2003, J CATAL, V218, P438, DOI 10.1016/S0021-9517(03)00085-X; Ding KL, 2012, ACS CATAL, V2, P479, DOI 10.1021/cs2006058; I.A.U. Energy, 2012, ANN ENERGY OUTLOOK 2; Lange JP, 1996, CHEM ENG SCI, V51, P2379, DOI 10.1016/0009-2509(96)00094-2; LERSCH P, 1991, APPL CATAL, V75, P133, DOI 10.1016/S0166-9834(00)83129-2; Lorkovic IM, 2004, CATAL TODAY, V98, P317, DOI 10.1016/j.cattod.2004.07.058; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; Podkolzin SG, 2007, J AM CHEM SOC, V129, P2569, DOI 10.1021/ja066913w; Sousa-Aguiar EF, 2011, CATAL SCI TECHNOL, V1, P698, DOI 10.1039/c1cy00116g; Statistical B. P., 2012, REV WORLD EN 2012; Tullo AH, 2008, CHEM ENG NEWS, V86, P15, DOI 10.1021/cen-v086n011.p015; Ueda W, 2000, APPL CATAL A-GEN, V200, P135, DOI 10.1016/S0926-860X(00)00627-X; WHITE CM, 1992, ENERG FUEL, V6, P76, DOI 10.1021/ef00031a012; Zhang AH, 2011, PHYS CHEM CHEM PHYS, V13, P2550, DOI 10.1039/c0cp01985b	14	313	317	12	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					340	342		10.1126/science.1226840	http://dx.doi.org/10.1126/science.1226840			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087239				2022-12-24	WOS:000309955800030
J	Talbert, J; Blumenschein, K; Burke, A; Stromberg, A; Freeman, P				Talbert, Jeffery; Blumenschein, Karen; Burke, Amy; Stromberg, Arnold; Freeman, Patricia			Pseudoephedrine Sales and Seizures of Clandestine Methamphetamine Laboratories in Kentucky	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Talbert, Jeffery; Blumenschein, Karen; Burke, Amy; Stromberg, Arnold; Freeman, Patricia] Univ Kentucky, Coll Pharm, Inst Pharmaceut Outcomes & Policy, Lexington, KY 40506 USA	University of Kentucky	Talbert, J (corresponding author), Univ Kentucky, Coll Pharm, Inst Pharmaceut Outcomes & Policy, Lexington, KY 40506 USA.	jtalb1@uky.edu	Talbert, Jeffery C/F-3929-2011; Freeman, Patricia/W-2473-2019; Freeman, Patricia R./L-3752-2019	Talbert, Jeffery C/0000-0002-4304-5167; Freeman, Patricia/0000-0002-4749-6563	NCATS NIH HHS [UL1 TR000117, UL1TR000117, UL1 TR001998] Funding Source: Medline; NCRR NIH HHS [UL1RR033173, UL1 RR033173] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Kentucky State Police, 2010, METH MAN KENT; McKetin R, 2011, ADDICTION, V106, P1911, DOI 10.1111/j.1360-0443.2011.03582.x; Nonnemaker J, 2011, HEALTH ECON, V20, P519, DOI 10.1002/hec.1610; Prah PM, 2005, CQ RES, P589; US Department of Justice National Drug Intelligence Center, 2011, NAT DRUG THREAT ASS	5	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1524	1526		10.1001/jama.2012.12992	http://dx.doi.org/10.1001/jama.2012.12992			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073945	Bronze, Green Accepted			2022-12-24	WOS:000309858100014
J	Maher, J				Maher, Julie			Lack of Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Tufts Med Ctr, Boston, MA USA	Tufts Medical Center	Maher, J (corresponding author), Tufts Med Ctr, Boston, MA USA.							Cohen JG, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.019	1	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1331	1332		10.1001/2012.jama.12096	http://dx.doi.org/10.1001/2012.jama.12096			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032548				2022-12-24	WOS:000309369300026
J	Williams, SN				Williams, Simon Nicholas			A tax on indoor tanning would reduce demand in Europe	BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS MALIGNANT-MELANOMA		Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Williams, SN (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	simonwilliams@northwestern.edu		Williams, Simon/0000-0003-2854-9946				Autier P, 2011, LANCET, V377, P1299, DOI 10.1016/S0140-6736(10)61966-6; Committee on medical aspects of radiation in the environment (COMARE), 2009, THIRTEENTH REPORT; European Cancer Observatory, 2008, CANCER MELANOMA OF S; Gallus S, 2006, TOB CONTROL, V15, P114, DOI 10.1136/tc.2005.012468; Green A, 2007, INT J CANCER, V120, P1116, DOI 10.1002/ijc.22453; Health Wellbeing and Local Government Committee National Assembly for Wales, INQUIRY INTO THE USE; Jain N, 2012, ARCH DERMATOL, V148, P122, DOI 10.1001/archderm.148.1.122; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Robinson JK, 2008, ARCH DERMATOL, V144, P484, DOI 10.1001/archderm.144.4.484; The Sunbed Association UK, 1996, CONSUMER RESEARCH ON	11	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 2	2012	345								e6550	10.1136/bmj.e6550	http://dx.doi.org/10.1136/bmj.e6550			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KN	23033417				2022-12-24	WOS:000309659300005
J	Shoham, S; Marr, KA				Shoham, Shmuel; Marr, Kieren A.			Treatment of Iatrogenic Fungal Infections: A Black Mold Defines a New Gray Zone in Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VORICONAZOLE		[Shoham, Shmuel; Marr, Kieren A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21212 USA	Johns Hopkins University	Marr, KA (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 720 Rutland Ave,Ross 1064, Baltimore, MD 21212 USA.	Kmarr4@jhmi.edu			NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006973] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Centers for Disease Control and Prevention, MULTISTATE FUNGAL ME; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P842; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kauffman CA, 2012, N ENGL J MED; Klont RR, 2004, CLIN INFECT DIS, V39, P1467, DOI 10.1086/425317; Lyons JL, 2012, ANN INTERN MED, V157, P835, DOI 10.7326/0003-4819-158-1-201212040-00557; Marr KA, 2012, PRESENTED AT 22ND EU; Pascual A, 2008, CLIN INFECT DIS, V46, P201, DOI 10.1086/524669; U.S. Food and Drug Administration, MULTISTATE OUTBREAK; U.S. Food and Drug Administration Antiviral Drugs Advisory Committee, 2001, BRIEFING DOCUMENT FO	11	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					208	+		10.7326/0003-4819-158-3-201302050-00572	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00572			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23147215	Green Accepted			2022-12-24	WOS:000314757900008
J	Friedmann-Morvinski, D; Bushong, EA; Ke, E; Soda, Y; Marumoto, T; Singer, O; Ellisman, MH; Verma, IM				Friedmann-Morvinski, Dinorah; Bushong, Eric A.; Ke, Eugene; Soda, Yasushi; Marumoto, Tomotoshi; Singer, Oded; Ellisman, Mark H.; Verma, Inder M.			Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice	SCIENCE			English	Article							NEURAL STEM-CELLS; MOUSE MODELS; BRAIN; GLIOBLASTOMA; ORIGIN; NF1; NEUROGENESIS; PROGRESSION; EXPRESSION; DISEASE	Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumor in humans. Here we show that gliomas can originate from differentiated cells in the central nervous system (CNS), including cortical neurons. Transduction by oncogenic lentiviral vectors of neural stem cells (NSCs), astrocytes, or even mature neurons in the brains of mice can give rise to malignant gliomas. All the tumors, irrespective of the site of lentiviral vector injection (the initiating population), shared common features of high expression of stem or progenitor markers and low expression of differentiation markers. Microarray analysis revealed that tumors of astrocytic and neuronal origin match the mesenchymal GBM subtype. We propose that most differentiated cells in the CNS upon defined genetic alterations undergo dedifferentiation to generate a NSC or progenitor state to initiate and maintain the tumor progression, as well as to give rise to the heterogeneous populations observed in malignant gliomas.	[Friedmann-Morvinski, Dinorah; Ke, Eugene; Soda, Yasushi; Marumoto, Tomotoshi; Singer, Oded; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ke, Eugene] Univ Calif San Diego, Grad Program Bioinformat, La Jolla, CA 92093 USA; [Marumoto, Tomotoshi] Kyushu Univ, Dept Mol Genet, Div Mol & Clin Genet, Med Inst Bioregulat,Higashi Ku, Fukuoka 8128582, Japan	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Kyushu University	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu		Friedmann-Morvinski, Dinorah/0000-0002-6394-9876	American Cancer Society Professor of Molecular Biology; National Institutes of Health (NIH) [HL053670]; Cancer Center Core Grant [P30 CA014195-38]; Ipsen/Biomeasure; Sanofi Aventis; H. N. and Frances C. Berger Foundation; National Center for Research Resources [5P41RR004050]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053670] Funding Source: NIH RePORTER	American Cancer Society Professor of Molecular Biology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Core Grant; Ipsen/Biomeasure; Sanofi Aventis(Sanofi-Aventis); H. N. and Frances C. Berger Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Estepa for her technical help, F. H. Gage and S. Subramaniam for useful discussions, and N. Varki and S. Kesari for pathological analysis. I. M. V. is an American Cancer Society Professor of Molecular Biology and holds the Irwin and Joan Jacobs Chair in Exemplary Life Sciences. D. F.-M. was supported by a fellowship from the European Molecular Biology Organization. This work was supported in part by grants from the National Institutes of Health (NIH) (HL053670), a Cancer Center Core Grant (P30 CA014195-38), Ipsen/Biomeasure, Sanofi Aventis, the H. N. and Frances C. Berger Foundation, and National Center for Research Resources grant 5P41RR004050 to M. H. E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or NIH. Microarray data have been deposited in the Gene Expression Omnibus (GEO) database (accession no. GSE35917). The authors (T. M., I. M. V., and Y.S.) and the Salk Institute have filed a patent application relating to mouse tumor models created with lentiviral vectors.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hide T, 2011, STEM CELLS, V29, P590, DOI 10.1002/stem.618; Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Price DL, 2006, NEUROINFORMATICS, V4, P65, DOI 10.1385/NI:4:1:65; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	23	368	381	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1080	1084		10.1126/science.1226929	http://dx.doi.org/10.1126/science.1226929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23087000	Green Accepted			2022-12-24	WOS:000311390600044
J	Kirste, M; Wang, XA; Schewe, HC; Meijer, G; Liu, KP; van der Avoird, A; Janssen, LMC; Gubbels, KB; Groenenboom, GC; van de Meerakker, SYT				Kirste, Moritz; Wang, Xingan; Schewe, H. Christian; Meijer, Gerard; Liu, Kopin; van der Avoird, Ad; Janssen, Liesbeth M. C.; Gubbels, Koos B.; Groenenboom, Gerrit C.; van de Meerakker, Sebastiaan Y. T.			Quantum-State Resolved Bimolecular Collisions of Velocity-Controlled OH with NO Radicals	SCIENCE			English	Article							DIFFERENTIAL CROSS-SECTIONS; INELASTIC-SCATTERING; MOLECULAR-BEAMS; ENERGY SURFACE; AR	Whereas atom-molecule collisions have been studied with complete quantum-state resolution, interactions between two state-selected molecules have proven much harder to probe. Here, we report the measurement of state-resolved inelastic scattering cross sections for collisions between two open-shell molecules that are both prepared in a single quantum state. Stark-decelerated hydroxyl (OH) radicals were scattered with hexapole-focused nitric oxide (NO) radicals in a crossed-beam configuration. Rotationally and spin-orbit inelastic scattering cross sections were measured on an absolute scale for collision energies between 70 and 300 cm(-1). These cross sections show fair agreement with quantum coupled-channels calculations using a set of coupled model potential energy surfaces based on ab initio calculations for the long-range nonadiabatic interactions and a simplistic short-range interaction. This comparison reveals the crucial role of electrostatic forces in complex molecular collision processes.	[van der Avoird, Ad; Janssen, Liesbeth M. C.; Gubbels, Koos B.; Groenenboom, Gerrit C.; van de Meerakker, Sebastiaan Y. T.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Kirste, Moritz; Wang, Xingan; Schewe, H. Christian; Meijer, Gerard; van de Meerakker, Sebastiaan Y. T.] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; [Liu, Kopin] Acad Sinica, IAMS, Taipei 10617, Taiwan	Radboud University Nijmegen; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Academia Sinica - Taiwan	Groenenboom, GC (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Heijendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	gerritg@theochem.ru.nl; basvdm@science.ru.nl	van de Meerakker, Sebastiaan Y.T./D-4581-2012; Meijer, Gerard/D-2141-2009; Groenenboom, Gerrit C/F-9692-2015; Groenenboom, Gerrit/S-8138-2019; Liu, Kopin/F-7929-2012	Meijer, Gerard/0000-0001-9669-8340; Groenenboom, Gerrit/0000-0002-0920-3707; Liu, Kopin/0000-0001-7499-2397; Janssen, Liesbeth/0000-0001-5283-1330	Alexander von Humboldt Foundation (AvHF); AvHF; Netherlands Organisation for Scientific Research (NWO);  [ERC-2009-AdG];  [247142-MolChip]	Alexander von Humboldt Foundation (AvHF); AvHF; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; 	S.Y.T.v.d.M. acknowledges support from the Netherlands Organisation for Scientific Research (NWO) via a VIDI grant. G. M. and K. B. G. acknowledge support from the ERC-2009-AdG under grant agreement 247142-MolChip. K. L. and A.v.d.A. acknowledge the Alexander von Humboldt Foundation (AvHF) for a Humboldt Research Award. X. W. acknowledges the AvHF for a research fellowship. We thank J. Blokland for her help setting up the narrowband laser system. We thank the referees for valuable and stimulating comments. The authors declare no competing financial interests.	BERNSTEIN RB, 1964, SCIENCE, V144, P141, DOI 10.1126/science.144.3615.141; Berteloite C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.203201; Chandler D. W., 2010, TUTORIALS MOL REACTI; CLARY DC, 1990, ANNU REV PHYS CHEM, V41, P61; Dagdigian PJ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078386; Eyles CJ, 2011, NAT CHEM, V3, P597, DOI [10.1038/nchem.1071, 10.1038/NCHEM.1071]; Gilijamse JJ, 2006, SCIENCE, V313, P1617, DOI 10.1126/science.1131867; Hartogh P, 2011, NATURE, V478, P218, DOI 10.1038/nature10519; Kohguchi H, 2002, ANN RP CH C, V98, P421, DOI 10.1039/B111167C; Kohguchi H, 2001, SCIENCE, V294, P832, DOI 10.1126/science.1063774; LEVINE RD, 1987, MOL REACTION DYNAMIC; Lorenz KT, 2001, SCIENCE, V293, P2063, DOI 10.1126/science.1062754; Nguyen MT, 1998, CHEM PHYS, V230, P1, DOI 10.1016/S0301-0104(97)00383-2; Paterson G, 2012, INT REV PHYS CHEM, V31, P69, DOI 10.1080/0144235X.2012.659046; Sawyer BC, 2011, PHYS CHEM CHEM PHYS, V13, P19059, DOI 10.1039/c1cp21203f; Scharfenberg L, 2011, EUR PHYS J D, V65, P189, DOI 10.1140/epjd/e2011-20009-4; Scharfenberg L, 2010, PHYS CHEM CHEM PHYS, V12, P10660, DOI 10.1039/c004422a; Scharfenberg L, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023410; SCHIFFMAN A, 1995, INT REV PHYS CHEM, V14, P371, DOI 10.1080/01442359509353315; Schreel K, 1996, J CHEM PHYS, V105, P4522, DOI 10.1063/1.472328; SHARKEY P, 1994, J CHEM SOC FARADAY T, V90, P3609, DOI 10.1039/ft9949003609; Smith IWM, 2011, ANNU REV ASTRON ASTR, V49, P29, DOI 10.1146/annurev-astro-081710-102533; STOLTE S, 1991, NATURE, V353, P391, DOI 10.1038/353391a0; Van De Meerakker SYT, 2008, NAT PHYS, V4, P595, DOI 10.1038/nphys1031; van de Meerakker SYT, 2012, CHEM REV, V112, P4828, DOI 10.1021/cr200349r; Vonk MT, 1997, J CHEM PHYS, V106, P1353, DOI 10.1063/1.473972; Watanabe D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.043201; WEINREB S, 1963, NATURE, V200, P829, DOI 10.1038/200829a0	28	105	105	5	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1060	1063		10.1126/science.1229549	http://dx.doi.org/10.1126/science.1229549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180857	Green Submitted			2022-12-24	WOS:000311390600038
J	Cook-Deegan, R				Cook-Deegan, Robert			Law and Science Collide Over Human Gene Patents	SCIENCE			English	Editorial Material							CANCER SUSCEPTIBILITY; ASCO STATEMENT		Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	bob.cd@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	NHGRI NIH HHS [P50 HG003391] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Collins FS, 1996, J CLIN ONCOL, V14, P1738; Conley J., 2012, GENOMIC LAW REP 0817; Holman CM, 2008, SCIENCE, V322, P198, DOI 10.1126/science.1160687; Holman Christopher M., 2009, KAN JL PUB POLY, V18, P215; Rai Arti K., 2011, YALE LAW J ONLINE, V121, P335; Skolnick M, 1996, J CLIN ONCOL, V14, P1737; Visco FM, 1996, J CLIN ONCOL, V14, P1737, DOI 10.1200/JCO.1996.14.5.1737	7	13	13	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					745	747		10.1126/science.1229854	http://dx.doi.org/10.1126/science.1229854			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	033ZI	23139317				2022-12-24	WOS:000310839500026
J	Messerli, FH				Messerli, Franz H.			Chocolate Consumption, Cognitive Function, and Nobel Laureates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COCOA		[Messerli, Franz H.] St Lukes Roosevelt Hosp, New York, NY 10025 USA; [Messerli, Franz H.] Columbia Univ, New York, NY USA	Mount Sinai St. Luke's; Mount Sinai West; Columbia University	Messerli, FH (corresponding author), St Lukes Roosevelt Hosp, New York, NY 10025 USA.		Messerli, Franz/AAR-4783-2021					Bisson JF, 2008, BRIT J NUTR, V100, P94, DOI 10.1017/S0007114507886375; Corti R, 2009, CIRCULATION, V119, P1433, DOI 10.1161/CIRCULATIONAHA.108.827022; Desideri G, 2012, HYPERTENSION, V60, P794, DOI 10.1161/HYPERTENSIONAHA.112.193060; Nurk E, 2009, J NUTR, V139, P120, DOI 10.3945/jn.108.095182; Sorond Farzaneh A, 2008, Neuropsychiatr Dis Treat, V4, P433	5	95	96	34	273	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1562	1564		10.1056/NEJMon1211064	http://dx.doi.org/10.1056/NEJMon1211064			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23050509				2022-12-24	WOS:000309904500016
J	Guthrie, B; Payne, K; Alderson, P; McMurdo, MET; Mercer, SW				Guthrie, Bruce; Payne, Katherine; Alderson, Phil; McMurdo, Marion E. T.; Mercer, Stewart W.			Adapting clinical guidelines to take account of multimorbidity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; QUALITY; TRIALS		[Guthrie, Bruce; McMurdo, Marion E. T.] Univ Dundee, Med Res Inst, Populat Hlth Sci Div, Dundee DD2 4BF, Scotland; [Payne, Katherine] Univ Manchester, Sch Community Based Med, Manchester, Lancs, England; [Alderson, Phil] Natl Inst Hlth & Clin Excellence, Ctr Clin Practice, Manchester, Lancs, England; [Mercer, Stewart W.] Univ Glasgow, Glasgow, Lanark, Scotland	University of Dundee; University of Manchester; National Institute for Health & Care Excellence; University of Glasgow	Guthrie, B (corresponding author), Univ Dundee, Med Res Inst, Populat Hlth Sci Div, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Guthrie, Bruce/HHM-9696-2022; Payne, Katherine/AAJ-3728-2020	Payne, Katherine/0000-0002-3938-4350; Mercer, Stewart William/0000-0002-1703-3664; Guthrie, Bruce/0000-0003-4191-4880	National Institute for Health Research [11/2003/27] Funding Source: researchfish; Chief Scientist Office [ARPG/07/01] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office		Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Braithwaite RS, 2011, MED DECIS MAKING, V31, P582, DOI 10.1177/0272989X10386117; Braithwaite R Scott, 2009, Med Care, V47, P610, DOI 10.1097/MLR.0b013e31819748d5; Claxton K, 2008, PHARMACOECONOMICS, V26, P781, DOI 10.2165/00019053-200826090-00008; Grimshaw J M, 2004, Health Technol Assess, V8, piii; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; McMurdo MET, 2005, BMJ-BRIT MED J, V331, P1036, DOI 10.1136/bmj.331.7524.1036; National Institute for Health and Clinical Excellence, 2009, DEPR AD CHRON PHYS H; National Institute for Health and Clinical Excellence, 2006, ATR FIBR NAT CLIN GU; National Institute for Health and Clinical Excellence, 2008, OST CAR MAN OST AD; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; O'Brien R, 2011, CHRONIC ILLN, V7, P45, DOI 10.1177/1742395310382461; O'Hagan A., 2006, UNCERTAIN JUDGMENTS; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	22	287	291	3	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2012	345								e6341	10.1136/bmj.e6341	http://dx.doi.org/10.1136/bmj.e6341			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018LH	23036829	Green Accepted			2022-12-24	WOS:000309661500009
J	Spencer, FA; Iorio, A; You, J; Murad, MH; Schunemann, HJ; Vandvik, PO; Crowther, MA; Pottie, K; Lang, ES; Meerpohl, JJ; Falck-Ytter, Y; Alonso-Coello, P; Guyatt, GH				Spencer, Frederick A.; Iorio, Alfonso; You, John; Murad, M. Hassad; Schuenemann, Holger J.; Vandvik, Per O.; Crowther, Mark A.; Pottie, Kevin; Lang, Eddy S.; Meerpohl, Joerg J.; Falck-Ytter, Yngve; Alonso-Coello, Pablo; Guyatt, Gordon H.			Uncertainties in baseline risk estimates and confidence in treatment effects	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATRIAL-FIBRILLATION; GRADE; QUALITY; RECOMMENDATIONS; ANTICOAGULATION; PUBLICATION		[Spencer, Frederick A.; Iorio, Alfonso; You, John; Schuenemann, Holger J.; Crowther, Mark A.] McMaster Univ, Dept Med, Hamilton, ON L8N 4A6, Canada; [Iorio, Alfonso; You, John; Schuenemann, Holger J.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 4A6, Canada; [Murad, M. Hassad] Mayo Clin, Div Prevent Med, Rochester, MN USA; [Vandvik, Per O.] Inlandet Hosp Trust, Dept Med, Gjovik, Norway; [Vandvik, Per O.] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Crowther, Mark A.] McMaster Univ, Dept Mol Med, Hamilton, ON L8N 4A6, Canada; [Pottie, Kevin] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Pottie, Kevin] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Lang, Eddy S.] Univ Calgary, Div Emergency Med, Calgary, AB, Canada; [Meerpohl, Joerg J.] Univ Med Ctr, Inst Med Biometry & Med Informat, German Cochrane Ctr, Freiburg, Germany; [Falck-Ytter, Yngve] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Alonso-Coello, Pablo] CIBERESP IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain	McMaster University; McMaster University; Mayo Clinic; Innlandet Hospital Trust; Norwegian Knowledge Centre for Health Services; McMaster University; University of Ottawa; University of Ottawa; University of Calgary; University of Freiburg; Case Western Reserve University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Spencer, FA (corresponding author), McMaster Univ, Dept Med, Hamilton, ON L8N 4A6, Canada.	fspence@mcmaster.ca	Lang, Eddy/AAS-2080-2020; Murad, M. Hassan/AAW-4367-2020; Iorio, Alfonso/B-9478-2013; Falck-Ytter, Yngve/GZH-0993-2022; Meerpohl, Joerg J/J-4224-2013; Yngve Falck-Ytter, AGAF/AAC-5362-2019; Pottie, Kevin/ABC-4385-2020; Lang, Eddy/I-4759-2014	Iorio, Alfonso/0000-0002-3331-8766; Meerpohl, Joerg J/0000-0002-1333-5403; Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; Schunemann, Holger/0000-0003-3211-8479; Crowther, Mark/0000-0003-4986-4873; Murad, Mohammad Hassan/0000-0001-5502-5975; Lang, Eddy/0000-0003-0850-4337; Alonso-Coello, Pablo/0000-0002-8001-8504				Bates SM, 2012, CHEST, V141, pE691S, DOI 10.1378/chest.11-2300; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; Danish SF, 2005, NEUROSURGERY, V56, P92; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Mara M, 2004, Ceska Gynekol, V69, P312; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	20	36	40	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 14	2012	345								e7401	10.1136/bmj.e7401	http://dx.doi.org/10.1136/bmj.e7401			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040PZ	23152569	Green Submitted, Bronze			2022-12-24	WOS:000311336400019
J	Attaran, A; Barry, D; Basheer, S; Bate, R; Benton, D; Chauvin, J; Garrett, L; Kickbusch, I; Kohler, JC; Midha, K; Newton, PN; Nishtar, S; Orhii, P; McKee, M				Attaran, Amir; Barry, Donna; Basheer, Shamnad; Bate, Roger; Benton, David; Chauvin, James; Garrett, Laurie; Kickbusch, Ilona; Kohler, Jillian Clare; Midha, Kamal; Newton, Paul N.; Nishtar, Sania; Orhii, Paul; McKee, Martin			How to achieve international action on falsified and substandard medicines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRUG QUALITY		[Attaran, Amir] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Barry, Donna] Partners Hlth, Boston, MA USA; [Basheer, Shamnad] Natl Univ Jurid Sci, Kolkata, India; [Bate, Roger] Amer Enterprise Inst Publ Policy Res, Washington, DC USA; [Benton, David] Int Council Nurses, Geneva, Switzerland; [Chauvin, James] World Federat Publ Hlth Assoc, Geneva, Switzerland; [Garrett, Laurie] Council Foreign Relat, New York, NY USA; [Kickbusch, Ilona] Grad Inst, Global Hlth Programme, Geneva, Switzerland; [Kohler, Jillian Clare] Univ Toronto, Toronto, ON, Canada; [Midha, Kamal] Int Pharmaceut Federat, The Hague, Netherlands; [Newton, Paul N.] Univ Oxford, Oxford, England; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Orhii, Paul] Natl Agcy Food & Drug Adm & Control, Abuja, Nigeria; [McKee, Martin] London Sch Hyg & Trop Med, London WC1, England	University of Ottawa; Partners Healthcare System; American Enterprise Institute for Public Policy Research; University of Toronto; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Attaran, A (corresponding author), Univ Ottawa, 1 Stewart St, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca	benton, david/AAC-5298-2020; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	benton, david/0000-0001-8418-8618; McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Benton, David/0000-0002-4068-8124; Newton, Paul/0000-0002-4608-6431	Wellcome Trust [089275] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmad K, 2004, LANCET, V363, P713, DOI 10.1016/S0140-6736(04)15670-5; [Anonymous], 2011, LANCET, V377, P1626, DOI 10.1016/S0140-6736(11)60656-9; [Anonymous], 2010, BERKELEY DECLARATION; [Anonymous], 2011, HIV AIDS KENYA MAJOR; Attaran A, 2011, J INT CRIM JUSTICE, V9, P325, DOI 10.1093/jicj/mqr005; Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; Bate R, 2010, LANCET, V376, P1446, DOI 10.1016/S0140-6736(10)61416-X; Beni S, 2011, ANAL BIOANAL CHEM, V399, P527, DOI 10.1007/s00216-010-4121-x; Callard C, 2010, TOB CONTROL, V19, P285, DOI 10.1136/tc.2009.035071; China State Council, 2012, NAT 12 5 YEAR PLAN D; Choudary A., 2012, POLICE BODY RECOMMEN; Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100; Council of Europe, 2011, CONV COUNT MED PROD; Erhun WO., 2001, J HLTH POPULATION DE, V4, P23; European Commission, 2011, REP EU CUST ENF INT; Fitz-Maurice E, 1932, AM J INT LAW, V26, P533, DOI 10.2307/2190203; Garrett L, ENSURING SAFETY INTE; India Parliamentary Standing Committee on Health and Family Welfare, 2012, 59 IND PARL STAND CO; Kubic TT, 2010, J BIOLAW BUS, V13, P38; Molzon JA, 2011, CLIN PHARMACOL THER, V89, P503, DOI 10.1038/clpt.2011.10; Mullard A, 2010, LANCET, V375, P1335, DOI 10.1016/S0140-6736(10)60560-0; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Newton PN, 2002, BRIT MED J, V324, P800, DOI 10.1136/bmj.324.7341.800; Nordt SP, 2010, AM J CARDIOVASC DRUG, V10, P261, DOI 10.2165/11537640-000000000-00000; Okie S, 2009, NEW ENGL J MED, V361, P737, DOI 10.1056/NEJMp0903870; Oxfam, 2011, EYE BALL MED REG NOT; People's Health Movement, 2011, IT CONS 64 WHA; Pew Charitable Trusts, 2011, HEP PROT CONS RISKS; Schep LJ, 2009, CLIN TOXICOL, V47, P525, DOI 10.1080/15563650903086444; Third World Network, 2010, WHOS COUNT PROGR LEG; United Nations Office on Drugs and Crime, 2010, GLOBALIZATION CRIME; Von Braun J, 2010, AFR J INT COMP LAW, V18, P238, DOI 10.3366/ajicl.2010.0007; Weaver CM, 2012, WALL STREET J; WHO, 2011, WHOS ROL PREV CONTR; WHO, 2011, WHO PREQ MED PROGR F; WHO, 2011, FALS LAM ZID NEV TAB; WHO and IMPACT, 2006, COUNT MED UPD EST; World Health Organization, 2010, COUNT MED PROD REP S; World Health Organization, 2011, REP WORK GROUP MEMB; World Health Organization, INT PHARM; World Trade Organization, 1994, TRAD REL ASP INT PRO; [No title captured]	43	65	65	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2012	345								e7381	10.1136/bmj.e7381	http://dx.doi.org/10.1136/bmj.e7381			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PU	23149211	Bronze, Green Submitted			2022-12-24	WOS:000311335800015
J	Shaughnessy, AF				Shaughnessy, Allen F.			Meningitis outbreak shines light on compounding pharmacies	BRITISH MEDICAL JOURNAL			English	Editorial Material									Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Shaughnessy, AF (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	Allen.Shaughnessy@Tufts.edu						Ballentine Carol, 1981, FDA CONSUMER MAG JUN; Centers for Disease Control and Prevention, MULT FUNG MEN OUTBR; EMLab P& K, 2011, USP 797 STAND GUID U; Lam Carol, PHARM COMPOUNDING RE; Lamb E, EARN PHARM COMPOUNDI; Pharmaceutical Commerce, 2012, DRUG SHORT 2012 WORS; Silverman E., 2012, PHARMALOT       1005; US Food and Drug Administration, 2012, QUEST ANSW FUNG MEN	8	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 5	2012	345								e7432	10.1136/bmj.e7432	http://dx.doi.org/10.1136/bmj.e7432			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036KY	23129491				2022-12-24	WOS:000311026000005
J	Colman, E; Golden, J; Roberts, M; Egan, A; Weaver, J; Rosebraugh, C				Colman, Eric; Golden, Julie; Roberts, Mary; Egan, Amy; Weaver, Joyce; Rosebraugh, Curtis			The FDA's Assessment of Two Drugs for Chronic Weight Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Colman, Eric; Golden, Julie; Roberts, Mary; Egan, Amy; Weaver, Joyce; Rosebraugh, Curtis] US FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Colman, E (corresponding author), US FDA, Silver Spring, MD USA.							[Anonymous], 2012, M END MET DRUGS ADV; Center for Drug Evaluation and Research Food and Drug Administration US Department of Health and Human Services, 2007, GUID IND DEV PROD WE; Margulis AV, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.008; Rothman RB, 2009, EXPERT OPIN DRUG SAF, V8, P317, DOI 10.1517/14740330902931524	4	121	128	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1577	1579		10.1056/NEJMp1211277	http://dx.doi.org/10.1056/NEJMp1211277			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23050510				2022-12-24	WOS:000310131700001
J	Marx, V				Marx, Vivien			TECHNOLOGY FEATURE CHARTING THE BRAIN'S NETWORKS	NATURE			English	Editorial Material							NERVOUS-SYSTEM											Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	8	13	13	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					293	298		10.1038/490293a	http://dx.doi.org/10.1038/490293a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060196	Bronze			2022-12-24	WOS:000309733300059
J	Holmqvist, ME; Neovius, M; Eriksson, J; Mantel, A; Wallberg-Jonsson, S; Jacobsson, LTH; Askling, J				Holmqvist, Marie E.; Neovius, Martin; Eriksson, Jonas; Mantel, Angla; Wallberg-Jonsson, Solveig; Jacobsson, Lennart T. H.; Askling, Johan			Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION	Context Recent reports suggest that rheumatoid arthritis (RA) may be a risk factor for venous thromboembolism (VTE), particularly in conjunction with hospitalization. Using hospitalization data to identify RA and VTE may identify patients when they are at elevated risk for other reasons, obscuring the incompletely understood underlying association between RA and VTE and leading to inappropriate institution or timing of interventions. Objective To estimate risks for VTE in patients with RA, including the relation of these risks to disease duration and hospitalization. Design, Setting, and Patients Prospective, population-based cohort study of 1 prevalent RA cohort (n = 37 856), 1 incident RA cohort (n = 7904), and matched general population comparison cohorts, all from Sweden, with follow-up from 1997 through 2010. Main Outcome Measure First-time VTE. Results Patients with prevalent RA were at greater risk of VTE than the general population (rate, 5.9 [95% CI, 5.1-6.6] vs 2.8 [95% CI, 2.6-3.1] per 1000 person-years (adjusted hazard ratio [HR], 2.0 [95% CI, 1.9-2.2]; P < .001). By the time of RA symptom onset, there was no statistically significant association between a history of VTE and RA (odds ratio, 1.2 [95% CI, 1.0-1.4]; P = .08; 150 events in the RA cohort vs 587 in the comparison cohort). Counting from RA diagnosis, an increased rate in the RA cohort vs the comparison cohort (3.8 [95% CI, 2.5-5.2] vs 2.4 [95% CI, 1.9-2.9] per 1000 person-years; HR, 1.6 [95% CI, 1.1-2.5]; P = .02) was detected within the first year and did not increase further during the first decade. Although rates for VTE following hospitalization were higher, the 1-year rate of VTE per 1000 person-years was not higher in the RA cohort than in the comparison cohort after hospital discharge (11.8 [95% CI, 8.6-15.1] vs 13.1 [11.3-14.8]; HR, 1.0 [95% CI, 0.7-1.4]; P = .90). The rates of VTE increased with age but were largely similar across sex and rheumatoid factor status, as were the HRs for VTE across age, sex, and rheumatoid factor status. Conclusions Compared with the general population, Swedish patients with RA had an elevated risk for VTE that was stable over the first 10 years after diagnosis. Although hospitalization was a risk factor for VTE the first year after discharge, the excess risk was not greater in patients with RA than in the general population. JAMA. 2012;308(13):1350-1356	[Holmqvist, Marie E.; Neovius, Martin; Eriksson, Jonas; Mantel, Angla; Askling, Johan] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Askling, Johan] Karolinska Inst, Dept Med Solna, Rheumatol Unit, SE-17176 Stockholm, Sweden; [Wallberg-Jonsson, Solveig] Univ Hosp, Inst Publ Hlth & Clin Med Rheumatol, Umea, Sweden; [Jacobsson, Lennart T. H.] Malmo Univ Hosp, Rheumatol Unit, Dept Med, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Umea University; Lund University; Skane University Hospital	Holmqvist, ME (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, T2 01, SE-17176 Stockholm, Sweden.	marie.holmqvist@ki.se		Neovius, Martin/0000-0003-2300-3055; Holmqvist, Marie/0000-0001-8996-5260	Schering-Plough; AstraZeneca; Novo Nordisk; Pfizer; Roche; Swedish Research Council; Swedish program on Chronic inflammation (Combine); Swedish Foundation for Strategic Research	Schering-Plough(Merck & CompanySchering Plough Corporation); AstraZeneca(AstraZeneca); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Roche(Roche Holding); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish program on Chronic inflammation (Combine); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Neovius reported participating in advisory boards for Pfizer (rheumatology) and Abbott (nonrheumatology) (unrelated to the current work); participating in research projects fully or partly funded by Schering-Plough, AstraZeneca, Novo Nordisk, Pfizer, and Roche (unrelated to the current work); and serving as a consultant (unrelated to rheumatology since 2008) to Pfizer, sanofi-aventis, and Abbott. Dr Wallberg-Jonsson reported serving as an invited speaker at a seminar organized by Roche (unrelated to the current work); contributing to patient information days organized by the Swedish Rheumatism Association (unrelated to the current work); receiving royalties for writing book chapters meant for education in rheumatology and cardiology; and receiving funding from Roche to travel to a conference in 2012. Dr Askling reported receiving grants within a public-private research consortium partly financed by Pfizer and AstraZeneca (unrelated to the current work); serving as an invited speaker at meeting organized by Merck on an unrelated topic; and serving as a member of a safety advisory committee at AstraZeneca.; This research was funded by the Swedish Research Council, Swedish program on Chronic inflammation (Combine), and Swedish Foundation for Strategic Research.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bacani AK, 2012, ARTHRITIS RHEUM-US, V64, P53, DOI 10.1002/art.33322; Bremell T, 2009, SRF REUMA B J SWEDIS, V732, P19; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mameli A, 2009, CLIN EXP RHEUMATOL, V27, P846; Matta F, 2009, THROMB HAEMOSTASIS, V101, P134, DOI 10.1160/TH08-08-0551; McEntegart A, 2001, RHEUMATOLOGY, V40, P640, DOI 10.1093/rheumatology/40.6.640; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Ramagopalan SV, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-1; Sanjeevi CB, 2012, LANCET, V379, P200, DOI 10.1016/S0140-6736(11)61510-9; Seriolo B, 1999, RHEUMATOLOGY, V38, P675, DOI 10.1093/rheumatology/38.7.675; Swedish National Board of Health and Wellfare (Social Styrelsen), NAT PAT REG SOC STYR; WALLBERGJONSSON S, 1993, CLIN RHEUMATOL, V12, P318, DOI 10.1007/BF02231572; World Health Organization (WHO), INT CLASS DIS IDC; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5; Zoller B, 2012, LANCET, V379, P244, DOI 10.1016/S0140-6736(11)61306-8	16	97	98	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1350	1356		10.1001/2012.jama.11741	http://dx.doi.org/10.1001/2012.jama.11741			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032551				2022-12-24	WOS:000309369300029
J	Sneddon, JB; Borowiak, M; Melton, DA				Sneddon, Julie B.; Borowiak, Malgorzata; Melton, Douglas A.			Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme	NATURE			English	Article							DIFFERENTIATION; MOUSE; EXPRESSION; DERIVATION; ENDODERM	One goal of regenerative medicine, to use stem cells to replace cells lost by injury or disease, depends on producing an excess of the relevant cell for study or transplantation. To this end, the stepwise differentiation of stem cells into specialized derivatives has been successful for some cell types(1-3), but a major problem remains the inefficient conversion of cells from one stage of differentiation to the next. If specialized cells are to be produced in large numbers it will be necessary to expand progenitor cells, without differentiation, at some steps of the process. Using the pancreatic lineage as a model for embryonic-stem-cell differentiation, we demonstrate that this is a solvable problem. Co-culture with organ-matched mesenchyme permits proliferation and self-renewal of progenitors, without differentiation, and enables an expansion of more than a million-fold for human endodermal cells with full retention of their developmental potential. This effect is specific both to the mesenchymal cell and to the progenitor being amplified. Progenitors that have been serially expanded on mesenchyme give rise to glucose-sensing, insulin-secreting cells when transplanted in vivo. Theoretically, the identification of stage-specific renewal signals can be incorporated into any scheme for the efficient production of large numbers of differentiated cells from stem cells and may therefore have wide application in regenerative biology.	[Sneddon, Julie B.; Borowiak, Malgorzata; Melton, Douglas A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University	Melton, DA (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Borowiak, Malgorzata/0000-0002-5829-1213	National Institutes of Health [5 U42 RR006042-20, K08 DK084206]; Howard Hughes Medical Institute; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Morrison for providing the Sox17-GFP reporter mouse ESC line and K. Kaestner for the Ngn3-GFP knock-in mouse ESCs. We also thank J. LaVecchio, G. Buruzula and B. Tilton for support for cell sorting, A. Kweudjeu for help with gene-expression experiments and human ESC culture, and C. Xie, C. Balatbat and K. Koszka for technical assistance. We are grateful to A. Tward and D. Cohen for critical reading of the manuscript. We thank J. Annes for assistance in obtaining human tissue samples and acknowledge the use of human tissues provided by the National Disease Research Interchange (NDRI), with support from National Institutes of Health grants 5 U42 RR006042-20 and K08 DK084206. J.B.S. is supported by the Howard Hughes Medical Institute. M.B. was supported by a grant from The Leona M. and Harry B. Helmsley Charitable Trust. D.A.M. is an investigator of the Howard Hughes Medical Institute.	Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; JAMES R, 1991, J BIOL CHEM, V266, P3246; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Thompson D.W, 1917, GROWTH FORM; WESSELLS NK, 1967, DEV BIOL, V15, P237, DOI 10.1016/0012-1606(67)90042-5; Yamashita YM, 2005, INT J HEMATOL, V82, P377, DOI 10.1532/IJH97.05097	25	102	145	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					765	+		10.1038/nature11463	http://dx.doi.org/10.1038/nature11463			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23041930	Green Accepted			2022-12-24	WOS:000311606000047
J	Moynihan, R				Moynihan, Ray			Too much medicine, not enough mirth	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDER		Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					[Anonymous], ONION; [Anonymous], 2002, BMJ, V324; Gotzsche PC, 2002, BRIT MED J, V324, P890; Lenzer J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6230; Morrow RL, 2012, CAN MED ASSOC J, V184, P755, DOI 10.1503/cmaj.111619; Moynihan R, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745-a; Moynihan R, 2002, BMJ-BRIT MED J, V324, P859, DOI 10.1136/bmj.324.7342.859; Payer L, 2006, DIS MONGERS DOCTORS; Schwarz A., 2012, NY TIMES	9	4	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 31	2012	345								e7116	10.1136/bmj.e7116	http://dx.doi.org/10.1136/bmj.e7116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FF	23114064				2022-12-24	WOS:000310778900009
J	Kratz, JR; Van den Eeden, SK; He, JX; Jablons, DM; Mann, MJ				Kratz, Johannes R.; Van den Eeden, Stephen K.; He, Jianxing; Jablons, David M.; Mann, Michael J.			A Prognostic Assay to Identify Patients at High Risk of Mortality Despite Small, Node-Negative Lung Tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CANCER		[Kratz, Johannes R.; Jablons, David M.; Mann, Michael J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Van den Eeden, Stephen K.] No Calif Kaiser Permanente, Dept Res, Oakland, CA USA; [He, Jianxing] Guangzhou Med Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	University of California System; University of California San Francisco; Kaiser Permanente; Guangzhou Medical University	Kratz, JR (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	michael.mann@ucsfmedctr.org		Kratz, Johannes R/0000-0003-0696-4073; He, Jianxing/0000-0003-1737-8192				Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	6	23	26	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1629	1631		10.1001/jama.2012.13551	http://dx.doi.org/10.1001/jama.2012.13551			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093159	Bronze			2022-12-24	WOS:000310434100013
J	Carroll, MD; Kit, BK; Lacher, DA; Shero, ST; Mussolino, ME				Carroll, Margaret D.; Kit, Brian K.; Lacher, David A.; Shero, Susan T.; Mussolino, Michael E.			Trends in Lipids and Lipoproteins in US Adults, 1988-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES ADULTS; CHOLESTEROL LEVELS; SERUM-CHOLESTEROL; NATIONAL-HEALTH; PREVALENCE; PLASMA; RISK; OBESITY	Context Serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) contribute to atherosclerosis and its clinical consequences. Between the periods 1988-1994 and 1999-2002, mean TC and mean LDL-C declined in adults. During this time, there was an increase in the percentage of adults receiving lipid-lowering medications. Geometric mean triglyceride levels increased but mean high-density lipoprotein cholesterol (HDL-C) remained unchanged. Objective To examine trends in serum lipids in adults between 1988 and 2010. Design, Setting, and Participants Three distinct US cross-sectional National Health and Nutrition Examination Surveys, 1988-1994 (n=16 573), 1999-2002 (n=9471), and 2007-2010 (n=11 766). Main Outcome Measures Mean TC, LDL-C, HDL-C, non-HDL-C, and geometric mean triglyceride levels and the prevalence of lipid-lowering medication use. Results Mean TC declined from 206 (95% CI, 205-207) mg/dL in 1988-1994 to 196 (95% CI, 195-198) mg/dL in 2007-2010 (P<.001 for linear trend); mean LDL-C declined from 129 (95% CI, 127-130) mg/dL to 116 (95% CI, 114-117) mg/dL (P<.001 for linear trend). Mean non-HDL-C declined from 155 (95% CI, 153-157) mg/dL in 1988-1994 to 144 (95% CI, 143-145) mg/dL in 2007-2010 (P<.001 for linear trend). Mean HDL-C increased from 50.7 (95% CI, 50.0-51.0) mg/dL during 1988-1994 to 52.5 (95% CI, 51.8-53.2) mg/dL in 2007-2010 (P=.001 for linear trend). Geometric mean serum triglyceride levels increased from 118 (95% CI, 114-121) mg/dL in 1988-1994 to 123 (95% CI, 119-127) mg/dL in 1999-2002 and decreased to 110 (95% CI, 107-113) mg/dL in 2007-2010 (P<.001 for quadratic trend). The prevalence of lipid-lowering medication use increased from 3.4% (95% CI, 2.9%-3.9%) in 1988-1994 to 15.5% (95% CI, 14.7%-16.3%) in 2007-2010 (P<.001 for linear trend). Among adults not receiving lipid-lowering medications, trends in lipids were similar to those reported for adults overall. Among obese adults, mean TC, non-HDL-C, LDL-C, and geometric mean triglycerides declined between 1988 and 2010. Conclusion Between 1988 and 2010, favorable trends in lipid levels have occurred among adults in the United States. JAMA. 2012;308(15):1545-1554 www.jama.com	[Carroll, Margaret D.; Kit, Brian K.; Lacher, David A.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth & Nutr Examinat Surveys, Hyattsville, MD 20782 USA; [Shero, Susan T.] NHLBI, Div Applicat Res Discoveries, NIH, Bethesda, MD USA; [Mussolino, Michael E.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Carroll, MD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth & Nutr Examinat Surveys, 3311 Toledo Rd,Room 4311, Hyattsville, MD 20782 USA.	mdc3@cdc.gov			National Heart, Lung, and Blood Institute, National Institutes of Health [Y1-HC-8039]	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The laboratory analysis of lipids was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (intra-agency agreement Y1-HC-8039).	ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], EARL REL SEL EST BAS; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Assmann G, 1998, EUR HEART J, V19, pA2; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; BACHORIK PS, 1984, CLIN CHEM, V30, P839; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Centers for Disease Control and Prevention/Lipid Standardization Program, 2012, LAB QUAL ASS STAND P; Centers for Disease Control and Prevention/National Center for Health Statistic, 2010, LAB PROC MAN TRIGL; Centers for Disease Control and Prevention/National Center for Health Statistics, 2010, LAB PROC MAN TOT CHO; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Ferrieres J, 2009, ARCH CARDIOVASC DIS, V102, P293, DOI 10.1016/j.acvd.2009.02.002; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fleiss JL, 2013, STAT METHODS RATES P; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FULWOOD R, 1987, JAMA-J AM MED ASSOC, V257, P937; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Klein RJ, 2010, AGE ADJUSTMENT USING; National Center for Health Statistics, NAT HLTH NUTR EX SUR; National Heart Lung and Blood Institute Division of blood diseases and resources, 2002, NIH PUBL; Physical Activity Guidelines Advisory Committee, 2008, 12009 PHYS ACT GUID; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; U. S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; United States Department of Health and Human Services, 2000, HLTH PEOPL 2010, V2; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; Wiefeld A, 1974, METHODS ENZYMATIC AN; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Winer B.J., 1962, STAT PRINCIPLES EXPT; Wolters KM, 1985, INTRO VARIANCE ESTIM; Wright Jacqueline D, 2010, NCHS Data Brief, P1	38	181	191	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1545	1554		10.1001/jama.2012.13260	http://dx.doi.org/10.1001/jama.2012.13260			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073951				2022-12-24	WOS:000309858100021
J	Greenwood, B; Owusu-Agyei, S				Greenwood, Brian; Owusu-Agyei, Seth			Malaria in the Post-Genome Era	SCIENCE			English	Editorial Material							RESISTANCE; SEQUENCE		[Greenwood, Brian] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London NW3 5AB, England; [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo 200, Ghana	University of London; London School of Hygiene & Tropical Medicine; Kintampo Health Research Centre	Greenwood, B (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London NW3 5AB, England.	brian.greenwood@lshtm.ac.uk; seth.owusu-agyei@kintamp-hrc.org		Owusu-Agyei, Seth/0000-0002-0807-1781				Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; D'Souza BJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-28; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; WHO, 2011, WORLD MALARIA REPORT 2011, P1	13	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					49	50		10.1126/science.1229177	http://dx.doi.org/10.1126/science.1229177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042872				2022-12-24	WOS:000309457400041
J	Schaeffner, ES; Ebert, N; Delanaye, P; Frei, U; Gaedeke, J; Jakob, O; Kuhlmann, MK; Schuchardt, M; Tolle, M; Ziebig, R; van der Giet, M; Martus, P				Schaeffner, Elke S.; Ebert, Natalie; Delanaye, Pierre; Frei, Ulrich; Gaedeke, Jens; Jakob, Olga; Kuhlmann, Martin K.; Schuchardt, Mirjam; Toelle, Markus; Ziebig, Reinhard; van der Giet, Markus; Martus, Peter			Two Novel Equations to Estimate Kidney Function in Persons Aged 70 Years or Older	ANNALS OF INTERNAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CYSTATIN-C; CREATININE-BASED FORMULAS; CKD-EPI; IOHEXOL CLEARANCE; PLASMA-CLEARANCE; ESTIMATING GFR; RENAL-DISEASE; POPULATION; PREVALENCE	Background: In older adults, current equations to estimate glomerular filtration rate (GFR) are not validated and may misclassify elderly persons in terms of their stage of chronic kidney disease. Objective: To derive the Berlin Initiative Study (BIS) equation, a novel estimator of GFR in elderly participants. Design: Cross-sectional. Data were split for analysis into 2 sets for equation development and internal validation. Setting: Random community-based population of a large insurance company. Participants: 610 participants aged 70 years or older (mean age, 78.5 years). Intervention: Iohexol plasma clearance measurement as gold standard. Measurements: GFR, measured as the plasma clearance of the endogenous marker iohexol, to compare performance of existing equations of estimated GFR with measured GFR of the gold standard; estimation of measured GFR from standardized creatinine and cystatin C levels, sex, and age in the learning sample; and comparison of the BIS equations (BIS1: creatinine-based; BIS2: creatinine- and cystatin C-based) with other estimating equations and determination of bias, precision, and accuracy in the validation sample. Results: The new BIS2 equation yielded the smallest bias followed by the creatinine- based BIS1 and Cockcroft-Gault equations. All other equations considerably overestimated GFR. The BIS equations confirmed a high prevalence of persons older than 70 years with a GFR less than 60 mL/min per 1.73 m(2) (BIS1, 50.4%; BIS2, 47.4%; measured GFR, 47.9%). The total misclassification rate for this criterion was smallest for the BIS2 equation (11.6%), followed by the cystatin C equation 2 (15.1%) proposed by the Chronic Kidney Disease Epidemiology Collaboration. Among the creatinine- based equations, BIS1 had the smallest misclassification rate (17.2%), followed by the Chronic Kidney Disease Epidemiology Collaboration equation (20.4%). Limitation: There was no validation by an external data set. Conclusion: The BIS2 equation should be used to estimate GFR in persons aged 70 years or older with normal or mild to moderately reduced kidney function. If cystatin C is not available, the BIS1 equation is an acceptable alternative.	Charite, Vivantes Klinikum Friedrichshain, Inst Biostat & Clin Epidemiol,Lab Berlin, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany; Univ Liege, CHU Sart Tilman, Liege, Belgium; Univ Tubingen, UKT Tubingen, Inst Med Biostat, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Liege; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schaeffner, ES (corresponding author), Charite Hosp, Campus Virchow Klinikum, Div Nephrol & Intens Care Med, Augustenburger Pl 1, D-13353 Berlin, Germany.	elke.schaeffner@charite.de	Tölle, Markus/GPP-7157-2022; Delanaye, Pierre/T-4225-2019; Schuchardt, Mirjam/AAS-3704-2021	Delanaye, Pierre/0000-0002-1480-5761; Ebert, Natalie/0000-0002-4463-3315; Schuchardt, Mirjam/0000-0001-7388-9611; Schaeffner, Elke/0000-0002-7925-4577; van der Giet, Markus/0000-0003-3590-5451	Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine; Dr. Werner Jackstadt Foundation	Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine; Dr. Werner Jackstadt Foundation	Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine.; By the Kuratorium fur Dialyse und Nierentransplatation (KfH) Foundation of Preventive Medicine and the Dr. Werner Jackstadt Foundation.	Agarwal R, 2003, AM J KIDNEY DIS, V41, P752, DOI 10.1016/S0272-6386(03)00022-2; ARVIDSSON A, 1990, SCAND J CLIN LAB INV, V50, P757, DOI 10.3109/00365519009091069; Botev R, 2011, CLIN J AM SOC NEPHRO, V6, P937, DOI 10.2215/CJN.09241010; Brandstrom E, 1998, NEPHROL DIAL TRANSPL, V13, P1176, DOI 10.1093/ndt/13.5.1176; BROCHNER.J, 1972, SCAND J CLIN LAB INV, V30, P271, DOI 10.3109/00365517209084290; BROWN SCW, 1991, J UROLOGY, V146, P675, DOI 10.1016/S0022-5347(17)37891-6; Campbell KH, 2008, CURR OPIN NEPHROL HY, V17, P298, DOI 10.1097/MNH.0b013e3282f5dd90; Cavalier E, 2008, CLIN CHIM ACTA, V396, P80, DOI 10.1016/j.cca.2008.07.011; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Delanaye P, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-8; Delanaye P, 2008, CLIN CHIM ACTA, V398, P118, DOI 10.1016/j.cca.2008.09.001; Finney H, 1999, ARCH GERONTOL GERIAT, V29, P75, DOI 10.1016/S0167-4943(99)00025-4; Fliser D, 2001, AM J KIDNEY DIS, V37, P79, DOI 10.1053/ajkd.2001.20591; FRENNBY B, 1994, INVEST RADIOL, V29, pS234, DOI 10.1097/00004424-199406001-00079; Garg AX, 2004, KIDNEY INT, V65, P649, DOI 10.1111/j.1523-1755.2004.00412.x; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P1151, DOI 10.1001/jama.2010.303; Inker LA, 2011, AM J KIDNEY DIS, V58, P682, DOI 10.1053/j.ajkd.2011.05.019; Johnson D, 2005, NEPHROLOGY CARLTO S4, V10, pS157; KRUTZEN E, 1984, J LAB CLIN MED, V104, P955; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Newman DJ, 2002, ANN CLIN BIOCHEM, V39, P89, DOI 10.1258/0004563021901847; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; OLSSON B, 1983, INVEST RADIOL, V18, P177, DOI 10.1097/00004424-198303000-00015; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rule AD, 2010, CLIN J AM SOC NEPHRO, V5, P951, DOI 10.2215/CJN.03110410; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Schaeffner ES, 2010, EUR J EPIDEMIOL, V25, P203, DOI 10.1007/s10654-010-9424-x; Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385; Segarra A, 2011, CLIN J AM SOC NEPHRO, V6, P2411, DOI 10.2215/CJN.01150211; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Shastri S, 2011, CLIN J AM SOC NEPHRO, V6, P1410, DOI 10.2215/CJN.08801010; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Smith HW., 1951, KIDNEY STRUCTURE FUN, P552; Spinler SA, 1998, ANN PHARMACOTHER, V32, P1275, DOI 10.1345/aph.18122; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Stolz A, 2010, TRANSPLANTATION, V89, P440, DOI 10.1097/TP.0b013e3181ca7d1b; van den Brand JAJG, 2011, NEPHROL DIAL TRANSPL, V26, P3176, DOI 10.1093/ndt/gfr003; Van Pottelbergh C, 2011, Adv Gerontol, V24, P108; Van Pottelbergh G, 2011, AGE AGEING, V40, P401, DOI 10.1093/ageing/afr033; Wasen E, 2004, J INTERN MED, V256, P70, DOI 10.1111/j.1365-2796.2004.01340.x; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	55	381	399	2	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					471	U54		10.7326/0003-4819-157-7-201210020-00003	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	016MQ	23027318	Green Submitted			2022-12-24	WOS:000309523200002
J	Dixson, DL; Hay, ME				Dixson, Danielle L.; Hay, Mark E.			Corals Chemically Cue Mutualistic Fishes to Remove Competing Seaweeds	SCIENCE			English	Article							REGION-WIDE DECLINES; OCEAN ACIDIFICATION; DWELLING GOBIES; GENUS GOBIODON; CLIMATE-CHANGE; BENTHIC ALGAE; REEFS; SPECIALIZATION; BIODIVERSITY; HERBIVORES	Corals in the genus Acropora generate much of the structural complexity upon which coral reefs depend, but they are susceptible to damage from toxic seaweeds. Acropora nasuta minimizes this damage by chemically cuing symbiotic goby fishes (Gobidon histrio or Paragobidon enchinocephalus) to remove the toxic seaweed Chlorodesmis fastigiata. Within minutes of seaweed contact, or contact from only seaweed chemical extract, the coral releases an odor that recruits gobies to trim the seaweed and dramatically reduce coral damage that would otherwise occur. In turn, chemically defended gobies become more toxic after consumption of this noxious alga. Mutualistic gobies and corals appear to represent a marine parallel to terrestrial ant-plants, in that the host provides shelter and food in return for protection from natural enemies.	[Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Aquat Chem Ecol Ctr, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Hay, ME (corresponding author), Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011; Dixson, Danielle L/B-9253-2018	Hay, Mark E/0000-0002-6130-9349; Dixson, Danielle L/0000-0003-1493-1482	NSF [OCE-0929119]; NIH [U01-TW007401]; Teasley Endowment; Division Of Ocean Sciences [0929119] Funding Source: National Science Foundation; FOGARTY INTERNATIONAL CENTER [U19TW007401, U01TW007401] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Support provided by NSF grant OCE-0929119, NIH grant U01-TW007401, and the Teasley Endowment to the Georgia Institute of Technology. We thank the Fijian government and the Korolevu-i-wai district elders for collection and research permissions; B. Devine, J. White, G. Longo, R. Bonaldo, and D. Rasher for field, lab, or statistical assistance; J. Kubanek, D. Rasher, P. Munday, J. P. Hobbs, and anonymous reviewers for comments on the manuscript; and V. Bonito for assisting scientifically and culturally. The data reported in this manuscript are presented in the main paper and supplementary materials.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Brooker RM, 2010, J FISH BIOL, V76, P2578, DOI 10.1111/j.1095-8649.2010.02644.x; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; HASHIMOTO Y, 1974, TOXICON, V12, P523, DOI 10.1016/0041-0101(74)90043-9; HAY ME, 1989, OECOLOGIA, V81, P418, DOI 10.1007/BF00377093; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; MEYER KD, 1994, CORAL REEFS, V13, P105, DOI 10.1007/BF00300770; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Riedlecker E, 2009, J ZOOL SYST EVOL RES, V47, P160, DOI 10.1111/j.1439-0469.2008.00497.x; Schubert M, 2003, ENVIRON BIOL FISH, V67, P359, DOI 10.1023/A:1025826829548; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Williams DE, 2012, CORAL REEFS, V31, P369, DOI 10.1007/s00338-011-0847-y	29	48	49	4	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					804	807		10.1126/science.1225748	http://dx.doi.org/10.1126/science.1225748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139333	Green Accepted			2022-12-24	WOS:000310839500046
J	Cardemil, CV; Cortese, MM; Medina-Marino, A; Jasuja, S; Desai, R; Leung, J; Rodriguez-Hart, C; Villarruel, G; Howland, J; Quaye, O; Tam, KI; Bowen, MD; Parashar, UD; Gerber, SI				Cardemil, Cristina V.; Cortese, Margaret M.; Medina-Marino, Andrew; Jasuja, Supriya; Desai, Rishi; Leung, Jessica; Rodriguez-Hart, Cristina; Villarruel, Gissela; Howland, Julia; Quaye, Osbourne; Tam, Ka Ian; Bowen, Michael D.; Parashar, Umesh D.; Gerber, Susan I.		Rotavirus Invest Team	Two Rotavirus Outbreaks Caused by Genotype G2P[4] at Large Retirement Communities Cohort Studies	ANNALS OF INTERNAL MEDICINE			English	Article							NURSING-HOME; GASTROENTERITIS; INFECTION; VACCINE; SEVERITY; CHILDREN; DIARRHEA; ADULTS; EPIDEMIOLOGY; SURVEILLANCE	Background: Outbreaks of rotavirus gastroenteritis in elderly adults are reported infrequently but are often caused by G2P[4] strains. In 2011, outbreaks were reported in 2 Illinois retirement facilities. Objective: To implement control measures, determine the extent and severity of illness, and assess risk factors for disease among residents and employees. Design: Cohort studies using surveys and medical chart abstraction. Setting: Two large retirement facilities in Cook County, Illinois. Patients: Residents and employees at both facilities and community residents with rotavirus disease. Measurements: Attack rates, hospitalization rates, and rotavirus genotype. Results: At facility A, 84 of 324 residents (26%) were identified with clinical or laboratory-confirmed rotavirus gastroenteritis (median age, 84 years) and 11 (13%) were hospitalized. The outbreak lasted 7 weeks. At facility B, 90 case patients among 855 residents (11%) were identified (median age, 88 years) and 19 (21%) were hospitalized. The facility B outbreak lasted 9.3 weeks. Ill employees were identified at both locations. In each facility, attack rates seemed to differ by residential setting, with the lowest rates among those in more separated settings or with high baseline level of infection control measures. The causative genotype for both outbreaks was G2P[4]. Some individuals shed virus detected by enzyme immunoassay or genotyping reverse transcription polymerase chain reaction for at least 35 days. G2P[4] was also identified in 17 of 19 (89%) samples from the older adult community but only 15 of 40 (38%) pediatric samples. Limitation: Medical or cognitive impairment among residents limited the success of some interviews. Conclusion: Rotavirus outbreaks can occur among elderly adults in residential facilities and can result in considerable morbidity. Among older adults, G2P[4] may be of unique importance. Health professionals should consider rotavirus as a cause of acute gastroenteritis in adults.	[Cortese, Margaret M.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Cook Cty Dept Publ Hlth, Oak Forest, IL USA; Illinois Dept Publ Hlth, Chicago, IL USA	Centers for Disease Control & Prevention - USA	Cortese, MM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA.	mcortese@cdc.gov	Desai, Rishi/AAH-8988-2021	Quaye, Osbourne/0000-0002-0621-876X; , Andrew/0000-0002-0095-4141				ABBAS AMA, 1987, J HOSP INFECT, V9, P76, DOI 10.1016/0195-6701(87)90099-5; Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; Anderson EJ, 2012, J INFECTION, V64, P89, DOI 10.1016/j.jinf.2011.09.003; Banyai Krisztian, 2002, Orv Hetil, V143, P1347; Barnes GL, 2003, J PEDIATR-US, V142, P722, DOI 10.1067/mpd.2003.240; BARNES GL, 1992, J PAEDIATR CHILD H, V28, P54, DOI 10.1111/j.1440-1754.1992.tb02618.x; BERN C, 1992, J CLIN MICROBIOL, V30, P3234, DOI 10.1128/JCM.30.12.3234-3238.1992; Bishop RF, 1996, ARCH VIROL, P119; Sanz JC, 2009, ENFERM INFEC MICR CL, V27, P219, DOI 10.1016/j.eimc.2008.06.005; Cascio A, 2001, CLIN INFECT DIS, V32, P1126, DOI 10.1086/319744; Chimura Yuri, 2002, Kansenshogaku Zasshi, V76, P450; Clark HF, 2011, HUM VACCINES, V7, P1118, DOI 10.4161/hv.7.11.17820; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; CUBITT WD, 1980, J CLIN PATHOL, V33, P306, DOI 10.1136/jcp.33.3.306; de Rougemont A, 2011, PEDIATR INFECT DIS J, V30, P118, DOI 10.1097/INF.0b013e3181ef034e; Edmonson L M, 2000, J Am Med Dir Assoc, V1, P175; Fauvel M, 1980, CAN DIS WEEKLY REP, V6, P205; Feeney SA, 2006, J MED VIROL, V78, P1119, DOI 10.1002/jmv.20671; Fletcher M., 2000, Morbidity and Mortality Weekly Report, V49, P1131; Freeman MM, 2008, J MED VIROL, V80, P1489, DOI 10.1002/jmv.21228; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; GOUVEA V, 1990, J INFECT DIS, V162, P362, DOI 10.1093/infdis/162.2.362; GREEN KY, 1990, J INFECT DIS, V161, P667, DOI 10.1093/infdis/161.4.667; Griffin DD, 2002, J INFECT DIS, V185, P1502, DOI 10.1086/340218; HALVORSRUD J, 1980, SCAND J INFECT DIS, V12, P161, DOI 10.3109/inf.1980.12.issue-3.01; HOLZEL H, 1980, J INFECTION, V2, P33, DOI 10.1016/S0163-4453(80)91750-8; Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78; Iijima Y, 2006, SCAND J INFECT DIS, V38, P490, DOI 10.1080/00365540500532134; Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2; Kapikian A.Z., 1996, FIELDS VIROLOGY, P1657; Kirk MD, 2010, CLIN INFECT DIS, V51, P907, DOI 10.1086/656406; LAMBERT M, 1991, CAN J PUBLIC HEALTH, V82, P351; Lederer P, 1995, Gesundheitswesen, V57, P326; LEWIS DC, 1989, J HOSP INFECT, V14, P9, DOI 10.1016/0195-6701(89)90128-X; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; MARRIE TJ, 1982, ARCH INTERN MED, V142, P313, DOI 10.1001/archinte.142.2.313; Marshall J, 2003, J CLIN VIROL, V28, P331, DOI 10.1016/S1386-6532(03)00081-7; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Mori I, 2002, J MED VIROL, V67, P613, DOI 10.1002/jmv.10147; National Institute of Infectious Diseases, 2000, OUTBR GROUP A ROT GA; Piednoir E, 2010, J HOSP INFECT, V75, P295, DOI 10.1016/j.jhin.2010.03.024; RAO GG, 1995, J HOSP INFECT, V30, P1, DOI 10.1016/0195-6701(95)90244-9; Ryan MJ, 1997, J INFECTION, V34, P49, DOI 10.1016/S0163-4453(97)80009-6; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Skaza A Trop, 2011, EURO SURVEILL, V16; SPRINGTHORPE VS, 1986, J HYG-CAMBRIDGE, V97, P139, DOI 10.1017/S0022172400064433; STEEL HM, 1992, J MED VIROL, V37, P132, DOI 10.1002/jmv.1890370211; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; WANDLESS I, 1981, AGE AGEING, V10, P36, DOI 10.1093/ageing/10.1.36; Yamagami Takaya, 2007, Kansenshogaku Zasshi, V81, P256; YOLKEN RH, 1978, NEW ENGL J MED, V299, P1156, DOI 10.1056/NEJM197811232992103	53	24	25	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					621	+		10.7326/0003-4819-157-9-201211060-00006	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00006			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128862				2022-12-24	WOS:000310783300003
J	Okaz, E; Arguello-Miranda, O; Bogdanova, A; Vinod, PK; Lipp, JJ; Markova, Z; Zagoriy, I; Novak, B; Zachariae, W				Okaz, Elwy; Argueello-Miranda, Orlando; Bogdanova, Aliona; Vinod, P. K.; Lipp, Jesse J.; Markova, Zuzana; Zagoriy, Ievgeniia; Novak, Bela; Zachariae, Wolfgang			Meiotic Prophase Requires Proteolysis of M Phase Regulators Mediated by the Meiosis-Specific APC/C-Ama1	CELL			English	Article							ANAPHASE PROMOTING COMPLEX/CYCLOSOME; SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; MOLECULAR-BIOLOGY; YEAST MEIOSIS; BUDDING YEAST; FHA DOMAIN; PROTEIN; KINASE	Whereas proliferating cells enter M phase shortly after DNA replication, the first M phase of meiosis is preceded by an extended prophase in which homologous chromosomes undergo recombination. Exit from prophase I is controlled by the recombination checkpoint (RC), which, in yeast, represses the meiosis-specific transcription factor Ndt80 required for the expression of B-type cyclins and other M phase regulators. We show that an extended prophase I additionally requires the suppression of latent, mitotic cell-cycle controls by the anaphase-promoting complex (APC/C) and its meiosis-specific activator Ama1, which trigger the degradation of M phase regulators and Ndd1, a subunit of a mitotic transcription factor. ama1 Delta mutants exit from prophase I prematurely and independently of the RC, which results in recombination defects and chromosome missegregation. Thus, control of prophase I by meiotic mechanisms depends on the suppression of the alternative, mitotic mechanisms by a meiosis-specific form of the APC/C.	[Argueello-Miranda, Orlando; Bogdanova, Aliona; Markova, Zuzana; Zagoriy, Ievgeniia; Zachariae, Wolfgang] Max Planck Inst Biochem, Lab Chromosome Biol, D-82152 Martinsried, Germany; [Okaz, Elwy; Argueello-Miranda, Orlando; Bogdanova, Aliona; Lipp, Jesse J.; Markova, Zuzana; Zagoriy, Ievgeniia; Zachariae, Wolfgang] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Okaz, Elwy; Vinod, P. K.; Novak, Bela] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	Max Planck Society; Max Planck Society; University of Oxford	Zachariae, W (corresponding author), Max Planck Inst Biochem, Lab Chromosome Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	zachar@biochem.mpg.de	Novak, Bela/D-5365-2009; Argüello-Miranda, Orlando/AAU-6814-2020; Arguello, Orlando/AAC-3445-2021; Arguello-Miranda, Orlando/R-8552-2019	Novak, Bela/0000-0002-6961-1366; Argüello-Miranda, Orlando/0000-0002-0579-4650; Zagoriy, Ievgeniia/0000-0003-2523-5132; Vinod, P K/0000-0003-2968-498X	Max Planck Society; Deutsche Forschungsgemeinschaft [SPP1384, ZA519/1-1]; Boehringer Ingelheim Fonds scholarship; European Commission FP7 (UniCellSys, MitoSys); OCISB grants	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds scholarship; European Commission FP7 (UniCellSys, MitoSys); OCISB grants	We thank Angelika Amon, Kirsten Benjamin, Rita Cha, Franz Klein, Michael Knop, Shirleen Roeder, Karin Schmekel, and Wolfgang Seufert for strains and reagents. This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (SPP1384 grant ZA519/1-1 to W. Z.), a Boehringer Ingelheim Fonds scholarship to J. J. L., and European Commission FP7 (UniCellSys, MitoSys) and OCISB grants to B.N.	Andrews B, 1998, TRENDS GENET, V14, P66, DOI 10.1016/S0168-9525(97)01322-X; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Breeden LL, 2000, CURR BIOL, V10, pR586, DOI 10.1016/S0960-9822(00)00634-5; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Dayani Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002083; He E, 2011, P NATL ACAD SCI USA, V108, P10016, DOI 10.1073/pnas.1102106108; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Johnson R, 2007, PLOS GENET, V3, P2338, DOI 10.1371/journal.pgen.0030223; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Montano SP, 2002, P NATL ACAD SCI USA, V99, P14041, DOI 10.1073/pnas.222312199; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shin ME, 2010, MOL CELL BIOL, V30, P2996, DOI 10.1128/MCB.01682-09; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597; Vershon AK, 2000, CURR OPIN CELL BIOL, V12, P334, DOI 10.1016/S0955-0674(00)00104-6	46	62	62	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					603	618		10.1016/j.cell.2012.08.044	http://dx.doi.org/10.1016/j.cell.2012.08.044			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101628	Bronze			2022-12-24	WOS:000310529300016
J	Blackburn, EH; Epel, ES				Blackburn, Elizabeth H.; Epel, Elissa S.			Too toxic to ignore	NATURE			English	Editorial Material							TELOMERE LENGTH; LIFE STRESS; CANCER		[Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	elizabeth.blackburn@ucsf.edu						Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Commission on Social Determinants of Health, 2008, CLOS GAP GEN; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Honig LS, 2012, ARCH NEUROL; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Shalev I, 2012, MOL PSYCHIAT; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Willeit P, 2011, JAMA-J AM MED ASSOC, V306, P42, DOI 10.1001/jama.2011.901	10	101	102	1	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					169	171		10.1038/490169a	http://dx.doi.org/10.1038/490169a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060172	Bronze			2022-12-24	WOS:000309733300023
J	Mets, OM; de Jong, PA; Prokop, M				Mets, Onno M.; de Jong, Pim A.; Prokop, Mathias			Computed Tomographic Screening for Lung Cancer An Opportunity to Evaluate Other Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-ARTERY CALCIUM; POPULATION; MORTALITY; TRIAL		[Mets, Onno M.; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands; [Prokop, Mathias] Radboud Univ Nijmegen, Dept Radiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	de Jong, PA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Heidelberglaan 100,Postbus 85500, NL-3508 GA Utrecht, Netherlands.	pimdejong@gmail.com	de Jong, Pim A/G-7220-2014; Prokop, W.M./H-8081-2014	de Jong, Pim A/0000-0003-4840-6854; Prokop, Mathias/0000-0001-8157-8055				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Budoff MJ, 2010, RADIOLOGY, V257, P434, DOI 10.1148/radiol.10100132; Jacobs PC, 2010, ATHEROSCLEROSIS, V209, P455, DOI 10.1016/j.atherosclerosis.2009.09.031; Mets OM, 2011, JAMA-J AM MED ASSOC, V306, P1775, DOI 10.1001/jama.2011.1531; Sverzellati N, 2012, RADIOLOGY, V262, P460, DOI 10.1148/radiol.11110364; van Ginneken B, 2011, RADIOLOGY, V261, P719, DOI 10.1148/radiol.11091710; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	8	60	60	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1433	1434		10.1001/jama.2012.12656	http://dx.doi.org/10.1001/jama.2012.12656			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047354				2022-12-24	WOS:000309579300018
J	Costentin, C; Drouet, S; Robert, M; Saveant, JM				Costentin, Cyrille; Drouet, Samuel; Robert, Marc; Saveant, Jean-Michel			A Local Proton Source Enhances CO2 Electroreduction to CO by a Molecular Fe Catalyst	SCIENCE			English	Article							ELECTROCHEMICAL REDUCTION; CARBON-DIOXIDE; ELECTROCATALYTIC REDUCTION; PALLADIUM COMPLEX; PORPHYRINS; CONVERSION	Electrochemical conversion of carbon dioxide (CO2) to carbon monoxide (CO) is a potentially useful step in the desirable transformation of the greenhouse gas to fuels and commodity chemicals. We have found that modification of iron tetraphenylporphyrin through the introduction of phenolic groups in all ortho and ortho' positions of the phenyl groups considerably speeds up catalysis of this reaction by the electrogenerated iron(0) complex. The catalyst, which uses one of the most earth-abundant metals, manifests a CO faradaic yield above 90% through 50 million turnovers over 4 hours of electrolysis at low overpotential (0.465 volt), with no observed degradation. The basis for the enhanced activity appears to be the high local concentration of protons associated with the phenolic hydroxyl substituents.	[Costentin, Cyrille; Drouet, Samuel; Robert, Marc; Saveant, Jean-Michel] Univ Paris Diderot, Lab Electrochim Mol, Unite Mixte Rech Univ CNRS 7591, F-75205 Paris 13, France	UDICE-French Research Universities; Universite Paris Cite	Costentin, C (corresponding author), Univ Paris Diderot, Lab Electrochim Mol, Unite Mixte Rech Univ CNRS 7591, Batiment Lavoisier,15 Rue Jean de Baif, F-75205 Paris 13, France.	cyrille.costentin@univ-paris-diderot.fr; saveant@univ-paris-diderot.fr			Agence Nationale de la Recherche [ANR 2010 BLAN 0808]	Agence Nationale de la Recherche(French National Research Agency (ANR))	Partial financial support from the Agence Nationale de la Recherche (ANR 2010 BLAN 0808) is gratefully acknowledged.	Bard A. J., 1995, STANDARD POTENTIALS; BELEY M, 1986, J AM CHEM SOC, V108, P7461, DOI 10.1021/ja00284a003; Benson EE, 2009, CHEM SOC REV, V38, P89, DOI 10.1039/b804323j; Bhugun I, 1996, J PHYS CHEM-US, V100, P19981, DOI 10.1021/jp9618486; BHUGUN I, 1994, J AM CHEM SOC, V116, P5015, DOI 10.1021/ja00090a068; Bhugun I, 1996, J AM CHEM SOC, V118, P1769, DOI 10.1021/ja9534462; Bourrez M, 2011, ANGEW CHEM INT EDIT, V50, P9903, DOI 10.1002/anie.201103616; Carver CT, 2012, J AM CHEM SOC, V134, P5444, DOI 10.1021/ja211987f; Chen ZF, 2011, CHEM COMMUN, V47, P12607, DOI 10.1039/c1cc15071e; Cole EB, 2010, J AM CHEM SOC, V132, P11539, DOI 10.1021/ja1023496; Costentin C, 2012, J AM CHEM SOC, V134, P11235, DOI 10.1021/ja303560c; Costentin C, 2011, P NATL ACAD SCI USA, V108, P8559, DOI 10.1073/pnas.1104952108; DuBois DL, 2011, EUR J INORG CHEM, P1017, DOI 10.1002/ejic.201001081; Dubois MR, 2009, ACCOUNTS CHEM RES, V42, P1974, DOI 10.1021/ar900110c; Froehlich JD, 2012, INORG CHEM, V51, P3932, DOI 10.1021/ic3001619; HAMMOUCHE M, 1988, J ELECTROANAL CHEM, V249, P347, DOI 10.1016/0022-0728(88)80372-3; HAWECKER J, 1984, J CHEM SOC CHEM COMM, P328, DOI 10.1039/c39840000328; LAMY E, 1977, J ELECTROANAL CHEM, V78, P403, DOI 10.1016/0368-1874(77)80196-2; Raebiger JW, 2006, ORGANOMETALLICS, V25, P3345, DOI 10.1021/om060228g; Rosen BA, 2011, SCIENCE, V334, P643, DOI 10.1126/science.1209786; Saveant JM, 2008, CHEM REV, V108, P2348, DOI 10.1021/cr068079z; STEFFEY BD, 1995, ORGANOMETALLICS, V14, P4937, DOI 10.1021/om00010a066	22	862	873	38	1201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					90	94		10.1126/science.1224581	http://dx.doi.org/10.1126/science.1224581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042890				2022-12-24	WOS:000309457400059
J	McCartney, M				McCartney, Margaret			Taking ecstasy on television: a show trial	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Channel 4, DRUGS LIV ECST TRIAL; Laughland O., 2012, GUARDIAN	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 1	2012	345								e6621	10.1136/bmj.e6621	http://dx.doi.org/10.1136/bmj.e6621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018KB	23028102				2022-12-24	WOS:000309657900003
J	Montealegre-Z, F; Jonsson, T; Robson-Brown, KA; Postles, M; Robert, D				Montealegre-Z, Fernando; Jonsson, Thorin; Robson-Brown, Kate A.; Postles, Matthew; Robert, Daniel			Convergent Evolution Between Insect and Mammalian Audition	SCIENCE			English	Article							AUDITORY RECEPTOR ORGANS; BUSH-CRICKETS; MORPHOLOGY; PHYSIOLOGY; EAR	In mammals, hearing is dependent on three canonical processing stages: (i) an eardrum collecting sound, (ii) a middle ear impedance converter, and (iii) a cochlear frequency analyzer. Here, we show that some insects, such as rainforest katydids, possess equivalent biophysical mechanisms for auditory processing. Although katydid ears are among the smallest in all organisms, these ears perform the crucial stage of air-to-liquid impedance conversion and signal amplification, with the use of a distinct tympanal lever system. Further along the chain of hearing, spectral sound analysis is achieved through dispersive wave propagation across a fluid substrate, as in the mammalian cochlea. Thus, two phylogenetically remote organisms, katydids and mammals, have evolved a series of convergent solutions to common biophysical problems, despite their reliance on very different morphological substrates.	[Montealegre-Z, Fernando; Jonsson, Thorin; Postles, Matthew; Robert, Daniel] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Robson-Brown, Kate A.] Univ Bristol, Dept Archaeol & Anthropol, Imaging Lab, Bristol BS8 1UG, Avon, England	University of Bristol; University of Bristol	Montealegre-Z, F (corresponding author), Lincoln Univ, Sch Life Sci, Riseholme Campus, Lincoln LN2 2LG, England.	fmontealegrez@lincoln.ac.uk; d.robert@bristol.ac.uk	Jonsson, Thorin/AAH-3490-2019	Jonsson, Thorin/0000-0002-5049-7612	Human Frontier Science Program (Cross Disciplinary Fellowship) [LT00024/2008-C]; Royal Society of London; UK-India Education and Research Initiative [SA06-169E]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I009671/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C518522/1, BB/I009671/1] Funding Source: researchfish	Human Frontier Science Program (Cross Disciplinary Fellowship)(Human Frontier Science Program); Royal Society of London(Royal Society of London); UK-India Education and Research Initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was sponsored by the Human Frontier Science Program (Cross Disciplinary Fellowship LT00024/2008-C to F.M.-Z.). D. R. is supported by the Royal Society of London. This research was also partially supported by the UK-India Education and Research Initiative (grant no. SA06-169E) and the Biotechnology and Biological Sciences Research Council. We declare no conflict of interest. The Colombian Ministry of Environment granted a permit for fieldwork at Gorgona National Park (decree DTS0-G-31 11/07). All additional information regarding data generation is given in the text and the supplementary materials.	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bangert M, 1998, HEARING RES, V115, P27, DOI 10.1016/S0378-5955(97)00177-9; BELWOOD JJ, 1987, SCIENCE, V238, P64, DOI 10.1126/science.238.4823.64; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; Boistel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022080; Hoy RR, 1996, ANNU REV ENTOMOL, V41, P433, DOI 10.1146/annurev.en.41.010196.002245; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KALMRING K, 1993, ZOOL JAHRB ALLG ZOOL, V97, P75; LEWIS DB, 1974, J EXP BIOL, V60, P839; Montealegre-Z Fernando, 2010, Journal of Orthoptera Research, V19, P347, DOI 10.1665/034.019.0223; Muller J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000889; Nowotny M, 2010, J COMP PHYSIOL A, V196, P939, DOI 10.1007/s00359-010-0577-6; OLDFIELD BP, 1982, J COMP PHYSIOL, V147, P461, DOI 10.1007/BF00612011; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Thomassen HA, 2007, HEARING RES, V225, P25, DOI 10.1016/j.heares.2006.11.013; Udayashankar AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031008; von Bekesy G, 1960, EXPT HEARING; Windmill JFC, 2005, J EXP BIOL, V208, P157, DOI 10.1242/jeb.01332; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	19	57	59	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					968	971		10.1126/science.1225271	http://dx.doi.org/10.1126/science.1225271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162003				2022-12-24	WOS:000311083600049
J	Montano, SP; Pigli, YZ; Rice, PA				Montano, Sherwin P.; Pigli, Ying Z.; Rice, Phoebe A.			The Mu transpososome structure sheds light on DDE recombinase evolution	NATURE			English	Article							IN-VITRO TRANSPOSITION; DNA-BINDING DOMAIN; BACTERIOPHAGE-MU; PHAGE-MU; STRAND TRANSFER; CRYSTAL-STRUCTURE; COMPLEX; PROTEIN; CLPX; INTEGRATION	Studies of bacteriophage Mu transposition paved the way for understanding retroviral integration and V(D)J recombination as well as many other DNA transposition reactions. Here we report the structure of the Mu transpososome-Mu transposase (MuA) in complex with bacteriophage DNA ends and target DNA-determined from data that extend anisotropically to 5.2 angstrom, 5.2 angstrom and 3.7 angstrom resolution, in conjunction with previously determined structures of individual domains. The highly intertwined structure illustrates why chemical activity depends on formation of the synaptic complex, and reveals that individual domains have different roles when bound to different sites. The structure also provides explanations for the increased stability of the final product complex and for its preferential recognition by the ATP-dependent unfoldase ClpX. Although MuA and many other recombinases share a structurally conserved 'DDE' catalytic domain, comparisons among the limited set of available complex structures indicate that some conserved features, such as catalysis in trans and target DNA bending, arose through convergent evolution because they are important for function.	[Montano, Sherwin P.; Pigli, Ying Z.; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Rice, PA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	PRice@uchicago.edu			NIH [GM086826]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086826] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Mizuuchi for initiating this project, K. K. Swinger and B. Vertessy for early crystallization efforts, and X. Yang and the staff of APS beamlines 14, 19 and 21 for assistance with data collection. This work was funded in part by NIH grant GM086826 (to P.A.R.).	Abdelhakim AH, 2008, MOL CELL, V30, P39, DOI 10.1016/j.molcel.2008.02.013; Abdelhakim AH, 2010, P NATL ACAD SCI USA, V107, P2437, DOI 10.1073/pnas.0910905106; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aldaz H, 1996, CELL, V85, P257, DOI 10.1016/S0092-8674(00)81102-2; ALLISON RG, 1992, J BIOL CHEM, V267, P19963; Au TK, 2004, EMBO J, V23, P3408, DOI 10.1038/sj.emboj.7600344; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burton BM, 2003, CHEM BIOL, V10, P463, DOI 10.1016/S1074-5521(03)00102-9; CHACONAS G, 1983, VIROLOGY, V128, P48, DOI 10.1016/0042-6822(83)90317-3; Choi W, 2010, P NATL ACAD SCI USA, V107, P10014, DOI 10.1073/pnas.0912615107; Clubb RT, 1997, J MOL BIOL, V273, P19, DOI 10.1006/jmbi.1997.1312; CRAIG NL, 2002, MOBILE DNA, V2; CRAIGIE R, 1986, CELL, V45, P793, DOI 10.1016/0092-8674(86)90554-4; CRAIGIE R, 1984, CELL, V39, P387, DOI 10.1016/0092-8674(84)90017-5; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Ducruix A., 1992, PREPARATION SELENOME; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Haapa S, 1999, NUCLEIC ACIDS RES, V27, P2777, DOI 10.1093/nar/27.13.2777; Harshey RM, 2006, CRIT REV BIOCHEM MOL, V41, P387, DOI 10.1080/10409230600946015; Jiang H, 1999, EMBO J, V18, P3845, DOI 10.1093/emboj/18.13.3845; Krementsova E, 1998, J BIOL CHEM, V273, P31358, DOI 10.1074/jbc.273.47.31358; Kruklitis R, 1996, EMBO J, V15, P935, DOI 10.1002/j.1460-2075.1996.tb00428.x; KUO CF, 1991, EMBO J, V10, P1585, DOI 10.1002/j.1460-2075.1991.tb07679.x; LAVOIE BD, 1993, GENE DEV, V7, P2510, DOI 10.1101/gad.7.12b.2510; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; MIZUUCHI K, 1983, CELL, V35, P785, DOI 10.1016/0092-8674(83)90111-3; Mizuuchi M, 2001, EMBO J, V20, P6927, DOI 10.1093/emboj/20.23.6927; MIZUUCHI M, 1991, P NATL ACAD SCI USA, V88, P9031, DOI 10.1073/pnas.88.20.9031; Mizuuchi M, 2007, P NATL ACAD SCI USA, V104, P14622, DOI 10.1073/pnas.0706556104; Montano SP, 2011, CURR OPIN STRUC BIOL, V21, P370, DOI 10.1016/j.sbi.2011.03.004; Naigamwalla DZ, 1998, J MOL BIOL, V282, P265, DOI 10.1006/jmbi.1998.2011; Namgoong SY, 1998, NUCLEIC ACIDS RES, V26, P3521, DOI 10.1093/nar/26.15.3521; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schumacher S, 1997, EMBO J, V16, P7532, DOI 10.1093/emboj/16.24.7532; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; SURETTE MG, 1989, J BIOL CHEM, V264, P3028; SURETTE MG, 1992, CELL, V68, P1101, DOI 10.1016/0092-8674(92)90081-M; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Tanaka Y, 2001, EMBO J, V20, P6612, DOI 10.1093/emboj/20.23.6612; Watkins S, 2004, NUCLEIC ACIDS RES, V32, P4306, DOI 10.1093/nar/gkh770; WU ZG, 1995, EMBO J, V14, P3835, DOI 10.1002/j.1460-2075.1995.tb00053.x; Yanagihara K, 2002, P NATL ACAD SCI USA, V99, P11317, DOI 10.1073/pnas.132403399; YANG JY, 1995, EMBO J, V14, P2374, DOI 10.1002/j.1460-2075.1995.tb07232.x; Yuan JF, 2005, GENE DEV, V19, P840, DOI 10.1101/gad.1291405; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358; ZOU A, 1991, J BIOL CHEM, V266, P20476	63	83	86	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					413	+		10.1038/nature11602	http://dx.doi.org/10.1038/nature11602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23135398	Green Accepted			2022-12-24	WOS:000311031600039
J	Wu, CY; Chen, YJ; Ho, HJ; Hsu, YC; Kuo, KN; Wu, MS; Lin, JT				Wu, Chun-Ying; Chen, Yi-Ju; Ho, Hsiu J.; Hsu, Yao-Chun; Kuo, Ken N.; Wu, Ming-Shiang; Lin, Jaw-Town			Association Between Nucleoside Analogues and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Following Liver Resection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMORTAL TIME BIAS; ANTIVIRAL THERAPY; VIRAL LOAD; LAMIVUDINE; SURVIVAL; REPLICATION; APOPTOSIS; IMPACT	Context Tumor recurrence is a major issue for patients with hepatocellular carcinoma (HCC) following curative liver resection. Objective To investigate the association between nucleoside analogue use and risk of tumor recurrence in patients with hepatitis B virus (HBV)-related HCC after curative surgery. Design, Setting, and Participants A nationwide cohort study between October 2003 and September 2010. Data from the Taiwan National Health Insurance Research Database. Among 100 938 newly diagnosed HCC patients, we identified 4569 HBV-related HCC patients who received curative liver resection for HCC between October 2003 and September 2010. Main Outcome Measures The risk of first tumor recurrence was compared between patients not taking nucleoside analogues (untreated cohort, n=4051) and patients taking nucleoside analogues (treated cohort, n=518). Cumulative incidences and hazard ratios (HRs) were calculated after adjusting for competing mortality. Results The treated cohort had a higher prevalence of liver cirrhosis when compared with the untreated cohort (48.6% vs 38.7%; P<.001), but lower risk of HCC recurrence (n=106 [20.5%] vs n=1765 [43.6%]; P<.001), and lower overall death (n=55 [10.6%] vs n=1145 [28.3%]; P<.001). After adjusting for competing mortality, the treated cohort had a significantly lower 6-year HCC recurrence rate (45.6%; 95% CI, 36.5%-54.6% vs untreated, 54.6%; 95% CI, 52.5%-56.6%; P<.001). Six-year overall mortalities for treated cohorts were 29.0% (95% CI, 20.0%-38.0%) and for untreated 42.4% (95% CI, 40.0%-44.7%; P<.001). On modified Cox regression analysis, nucleoside analogue use (HR, 0.67; 95% CI, 0.55-0.81; P<.001), statin use (HR, 0.68; 95% CI, 0.53-0.87; P=.002), and nonsteroidal anti-inflammatory drugs or aspirin use (HR, 0.80; 95% CI, 0.73-0.88; P<.001) were independently associated with a reduced risk of HCC recurrence. Multivariable stratified analyses verified the association in all subgroups of patients, including those who were noncirrhotic (HR, 0.56; 95% CI, 0.42-0.76) and diabetic (HR, 0.52; 95% CI, 0.31-0.89). Conclusion Nucleoside analogue use was associated with a lower risk of HCC recurrence among patients with HBV-related HCC after liver resection. JAMA. 2012; 308(18): 1906-1913 Published online November 12, 2012. doi: 10.1001/2012.jama.11975 www.jama.com	[Wu, Chun-Ying; Chen, Yi-Ju] Natl Yang Ming Univ, Sch Med, Taipei 11221, Taiwan; [Wu, Chun-Ying] Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan; [Chen, Yi-Ju] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan; [Wu, Chun-Ying; Hsu, Yao-Chun] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wu, Chun-Ying; Hsu, Yao-Chun] China Med Univ, Grad Inst Clin Med, Taichung, Taiwan; [Wu, Chun-Ying] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Ho, Hsiu J.; Wu, Ming-Shiang; Lin, Jaw-Town] Natl Taiwan Univ Hosp, Div Gastroenterol, Taipei, Taiwan; [Hsu, Yao-Chun; Lin, Jaw-Town] I Shou Univ, Dept Internal Med, E Da Hosp, Kaohsiung, Taiwan; [Kuo, Ken N.] Taipei Med Coll, Coll Med, Taipei, Taiwan; [Kuo, Ken N.; Lin, Jaw-Town] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; E-Da Hospital; I Shou University; Taipei Medical University; National Health Research Institutes - Taiwan; Fu Jen Catholic University	Wu, CY (corresponding author), Natl Yang Ming Univ, Sch Med, 155,Sect 2,Linong St, Taipei 11221, Taiwan.	chun@vghtc.gov.tw	Wu, Chun-Ying/AAX-5077-2021	Wu, Chun-Ying/0000-0001-5053-1801; Wu, Ming-Shiang/0000-0002-1940-6428	National Health Research Institutes; Taiwan's National Health Research Institute [PH-101-PP-23]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); Taiwan's National Health Research Institute	The National Health Research Institutes provided access to the National Health Insurance Research Database (NHIRD) and financial support for the hiring of a research assistant. This work was supported by Taiwan's National Health Research Institute (PH-101-PP-23). This study is based on data from the NHIRD provided by the Bureau of National Health Insurance, Department of Health, and managed by the NHIRD, Taiwan.	Chan ACY, 2011, ARCH SURG-CHICAGO, V146, P675, DOI 10.1001/archsurg.2011.125; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cho YK, 2011, J GASTROEN HEPATOL, V26, P1354, DOI 10.1111/j.1440-1746.2011.06812.x; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Grazi GL, 2003, ALIMENT PHARM THER, V17, P119, DOI 10.1046/j.1365-2036.17.s2.9.x; Hossain MA, 2012, INT J ONCOL, V40, P1298, DOI 10.3892/ijo.2011.1304; Hung IFN, 2008, AM J GASTROENTEROL, V103, P1663, DOI 10.1111/j.1572-0241.2008.01872.x; Jang JW, 2007, CANCER, V110, P1760, DOI 10.1002/cncr.22984; Kim BK, 2008, LIVER INT, V28, P393, DOI 10.1111/j.1478-3231.2007.01625.x; Kubo S, 2000, CANCER-AM CANCER SOC, V88, P1016, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V; Kubo S, 2007, HEPATOL RES, V37, P94, DOI 10.1111/j.1872-034X.2007.00013.x; Kuzuya T, 2007, J GASTROEN HEPATOL, V22, P1929, DOI 10.1111/j.1440-1746.2006.04707.x; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Li N, 2010, ANN SURG ONCOL, V17, P179, DOI 10.1245/s10434-009-0694-z; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2009, J HEPATOL, V51, P403, DOI 10.1016/j.jhep.2009.04.003; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Poon RTP, 2000, J CLIN ONCOL, V18, P1094, DOI 10.1200/JCO.2000.18.5.1094; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; TONG MJ, 1971, ANN INTERN MED, V75, P687, DOI 10.7326/0003-4819-75-5-687; Tsan YT, 2012, J CLIN ONCOL, V30, P623, DOI 10.1200/JCO.2011.36.0917; Wu CY, 2011, GUT, V60, P1038, DOI 10.1136/gut.2010.224329; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Yang PM, 2010, CANCER RES, V70, P7699, DOI 10.1158/0008-5472.CAN-10-1626; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x	35	670	694	5	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1906	1913		10.1001/2012.jama.11975	http://dx.doi.org/10.1001/2012.jama.11975			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23162861	Green Submitted, Bronze			2022-12-24	WOS:000310952700027
J	Nishimasu, H; Ishizu, H; Saito, K; Fukuhara, S; Kamatani, MK; Bonnefond, L; Matsumoto, N; Nishizawa, T; Nakanaga, K; Aoki, J; Ishitani, R; Siomi, H; Siomi, MC; Nureki, O				Nishimasu, Hiroshi; Ishizu, Hirotsugu; Saito, Kuniaki; Fukuhara, Satoshi; Kamatani, Miharu K.; Bonnefond, Luc; Matsumoto, Naoki; Nishizawa, Tomohiro; Nakanaga, Keita; Aoki, Junken; Ishitani, Ryuichiro; Siomi, Haruhiko; Siomi, Mikiko C.; Nureki, Osamu			Structure and function of Zucchini endoribonuclease in piRNA biogenesis	NATURE			English	Article							PHOSPHOLIPASE-D FAMILY; CRYSTAL-STRUCTURE; NUAGE FORMATION; SMALL RNAS; DROSOPHILA; GERMLINE; GENOME; PIWI; REPLACEMENT; MECHANISM	PIWI-interacting RNAs (piRNAs) silence transposons to maintain genome integrity in animal germ lines(1-4). piRNAs are classified as primary and secondary piRNAs, depending on their biogenesis machinery(5-10). Primary piRNAs are processed from long non-coding RNA precursors transcribed from piRNA clusters in the genome through the primary processing pathway(5,8-10). Although the existence of a ribonuclease participating in this pathway has been predicted, its molecular identity remained unknown. Here we show that Zucchini (Zuc), a mitochondrial phospholipase D (PLD) superfamily member(11), is an endoribonuclease essential for primary piRNA biogenesis. We solved the crystal structure of Drosophila melanogaster Zuc (DmZuc) at 1.75 angstrom resolution. The structure revealed that DmZuc has a positively charged, narrow catalytic groove at the dimer interface, which could accommodate a single-stranded, but not a double-stranded, RNA. DmZuc and the mouse homologue MmZuc (also known as Pld6 and MitoPLD)(12-14) showed endoribonuclease activity for single-stranded RNAs in vitro. The RNA cleavage products bear a 5'-monophosphate group, a hallmark of mature piRNAs. Mutational analyses revealed that the conserved active-site residues of DmZuc are critical for the ribonuclease activity in vitro, and for piRNA maturation and transposon silencing in vivo. We propose a model for piRNA biogenesis in animal germ lines, in which the Zuc endoribonuclease has a key role in primary piRNA maturation.	[Nishimasu, Hiroshi; Ishizu, Hirotsugu; Fukuhara, Satoshi; Bonnefond, Luc; Matsumoto, Naoki; Nishizawa, Tomohiro; Ishitani, Ryuichiro; Siomi, Mikiko C.; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Ishizu, Hirotsugu; Saito, Kuniaki; Kamatani, Miharu K.; Siomi, Haruhiko; Siomi, Mikiko C.] Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; [Nakanaga, Keita; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Siomi, Mikiko C.; Nureki, Osamu] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan	University of Tokyo; Keio University; Tohoku University; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	siomim@biochem.s.u-tokyo.ac.jp; nureki@biochem.s.u-tokyo.ac.jp	Saito, Kuniaki/A-6967-2015; Siomi, Haruhiko/A-7020-2015; ISHIZU, HIROTSUGU/G-4991-2014; Bonnefond, Luc/P-3926-2016; NUREKI, OSAMU/G-4960-2014	Saito, Kuniaki/0000-0001-8233-9283; Siomi, Haruhiko/0000-0001-8690-3822; Bonnefond, Luc/0000-0002-1164-742X; Aoki, Junken/0000-0001-9435-1896	Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [11J05211] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Kurabayashi, H. Kotani and Y. Tamaki for technical assistance; other members of the Siomi laboratory for discussions and comments on the manuscript; the beamline staff at BL32XU of SPring-8 for assistance in data collection; and T. Suzuki and H. Suga for technical suggestions and comments. This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) program' to O.N., by the Core Research for Evolutional Science and Technology (CREST) program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of the Japan Science and Technology Agency (JST) to O.N. and M. C. S., and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to H.N., H. I., H. S., M. C. S. and O.N.. K.S. is supported by the JSPS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuhara S, ACTA CRYS F IN PRESS; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pillai RS, 2012, DEV GROWTH DIFFER, V54, P78, DOI 10.1111/j.1440-169X.2011.01320.x; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; Ponting CP, 1996, PROTEIN SCI, V5, P914; RAAE AJ, 1975, EUR J BIOCHEM, V60, P437, DOI 10.1111/j.1432-1033.1975.tb21021.x; Rotondo G, 1996, NUCLEIC ACIDS RES, V24, P2377, DOI 10.1093/nar/24.12.2377; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Zhao Y, 1997, PROTEIN SCI, V6, P2655	33	229	243	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					284	U157		10.1038/nature11509	http://dx.doi.org/10.1038/nature11509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064230				2022-12-24	WOS:000310774300050
J	Raiten, JM; Neuman, MD				Raiten, Jesse M.; Neuman, Mark D.			"If I Had Only Known" - On Choice and Uncertainty in the ICU	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Raiten, Jesse M.; Neuman, Mark D.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neuman, Mark D.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Raiten, JM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA.							Mol A, 2009, LANCET, V373, P1756, DOI 10.1016/S0140-6736(09)60971-5; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Neuman MD, 2012, MILBANK Q, V90, P135, DOI 10.1111/j.1468-0009.2011.00657.x; Schwarze ML, 2010, CRIT CARE MED, V38, P843, DOI 10.1097/CCM.0b013e3181cc466b	5	10	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1779	1781		10.1056/NEJMp1209698	http://dx.doi.org/10.1056/NEJMp1209698			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23134380				2022-12-24	WOS:000310773200004
J	Vaidya, N; Manapat, ML; Chen, IA; Xulvi-Brunet, R; Hayden, EJ; Lehman, N				Vaidya, Nilesh; Manapat, Michael L.; Chen, Irene A.; Xulvi-Brunet, Ramon; Hayden, Eric J.; Lehman, Niles			Spontaneous network formation among cooperative RNA replicators	NATURE			English	Article							NATURAL SELF-ORGANIZATION; EVOLUTION; RIBOZYME; ORIGIN; HYPERCYCLE; PRINCIPLE; LIFE; EMERGENCE; SELECTION; SYSTEMS	The origins of life on Earth required the establishment of self-replicating chemical systems capable of maintaining and evolving biological information. In an RNA world, single self-replicating RNAs would have faced the extreme challenge of possessing a mutation rate low enough both to sustain their own information and to compete successfully against molecular parasites with limited evolvability. Thus theoretical analyses suggest that networks of interacting molecules were more likely to develop and sustain life-like behaviour. Here we show that mixtures of RNA fragments that self-assemble into self-replicating ribozymes spontaneously form cooperative catalytic cycles and networks. We find that a specific three-membered network has highly cooperative growth dynamics. When such cooperative networks are competed directly against selfish autocatalytic cycles, the former grow faster, indicating an intrinsic ability of RNA populations to evolve greater complexity through cooperation. We can observe the evolvability of networks through in vitro selection. Our experiments highlight the advantages of cooperative behaviour even at the molecular stages of nascent life.	[Vaidya, Nilesh; Lehman, Niles] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Manapat, Michael L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manapat, Michael L.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Chen, Irene A.; Xulvi-Brunet, Ramon] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Hayden, Eric J.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Portland State University; Harvard University; Harvard University; Harvard University; Stanford University	Lehman, N (corresponding author), Portland State Univ, Dept Chem, POB 751, Portland, OR 97207 USA.	niles@pdx.edu	Lehman, Niles/ABF-7609-2021	Lehman, Niles/0000-0002-9056-6600; Chen, Irene/0000-0001-6040-7927; Xulvi-Brunet, Ramon/0000-0002-6013-4831	NASA [NNX10AR15G]; Center for Life in Extreme Environments at Portland State University; Human Frontier Science Program Organization; Direct For Biological Sciences [0963548] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Center for Life in Extreme Environments at Portland State University; Human Frontier Science Program Organization(Human Frontier Science Program); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to thank A. Burton, R. Ghadiri, P. Higgs, B. Larson, K. Chacon and A. Lopez Garcia de Lomana for help during preparation of this manuscript. This work was supported by NASA grant NNX10AR15G to N.L., the Center for Life in Extreme Environments at Portland State University, and a fellowship from the Human Frontier Science Program Organization to R.X.-B.	BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; Draper WE, 2008, NUCLEIC ACIDS RES, V36, P520, DOI 10.1093/nar/gkm1055; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P341, DOI 10.1007/BF00439699; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P7, DOI 10.1007/BF00420631; Hayden EJ, 2008, ANGEW CHEM INT EDIT, V47, P8424, DOI 10.1002/anie.200802177; Hayden EJ, 2006, CHEM BIOL, V13, P909, DOI 10.1016/j.chembiol.2006.06.014; Hordijk W, 2004, J THEOR BIOL, V227, P451, DOI 10.1016/j.jtbi.2003.11.020; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; Kauffman S.A., 1993, ORIGINS ORDER; Kim DE, 2004, CHEM BIOL, V11, P1505, DOI 10.1016/j.chembiol.2004.08.021; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Lee DH, 1997, NATURE, V390, P591, DOI 10.1038/37569; Lee DH, 1997, CURR OPIN CHEM BIOL, V1, P491, DOI 10.1016/S1367-5931(97)80043-9; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; Levy M, 2001, NAT STRUCT BIOL, V8, P580, DOI 10.1038/89601; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2008, P NATL ACAD SCI USA, V105, P14924, DOI 10.1073/pnas.0806714105; REINHOLDHUREK B, 1992, NATURE, V357, P173, DOI 10.1038/357173a0; SIEVERS D, 1994, NATURE, V369, P221, DOI 10.1038/369221a0; SMITH JM, 1979, NATURE, V280, P445, DOI 10.1038/280445a0; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Voytek SB, 2009, P NATL ACAD SCI USA, V106, P7780, DOI 10.1073/pnas.0903397106; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	32	232	235	6	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					72	77		10.1038/nature11549	http://dx.doi.org/10.1038/nature11549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23075853				2022-12-24	WOS:000310434500032
J	Wang, YF; Wang, Y; Breed, DR; Manoharan, VN; Feng, L; Hollingsworth, AD; Weck, M; Pine, DJ				Wang, Yufeng; Wang, Yu; Breed, Dana R.; Manoharan, Vinothan N.; Feng, Lang; Hollingsworth, Andrew D.; Weck, Marcus; Pine, David J.			Colloids with valence and specific directional bonding	NATURE			English	Article							ASYMMETRIC FUNCTIONALIZATION; CLUSTERS; NANOPARTICLES; PARTICLES; ANISOTROPY	The ability to design and assemble three-dimensional structures from colloidal particles is limited by the absence of specific directional bonds. As a result, complex or low-coordination structures, common in atomic and molecular systems, are rare in the colloidal domain. Here we demonstrate a general method for creating the colloidal analogues of atoms with valence: colloidal particles with chemically distinct surface patches that imitate hybridized atomic orbitals, including sp, sp(2), sp(3), sp(3)d, sp(3)d(2) and sp(3)d(3). Functionalized with DNA with single-stranded sticky ends, patches on different particles can form highly directional bonds through programmable, specific and reversible DNA hybridization. These features allow the particles to self-assemble into 'colloidal molecules' with triangular, tetrahedral and other bonding symmetries, and should also give access to a rich variety of new microstructured colloidal materials.	[Feng, Lang; Hollingsworth, Andrew D.; Pine, David J.] NYU, Ctr Soft Matter Res, New York, NY 10003 USA; [Feng, Lang; Hollingsworth, Andrew D.; Pine, David J.] NYU, Dept Phys, New York, NY 10003 USA; [Wang, Yufeng; Wang, Yu; Weck, Marcus] NYU, Inst Mol Design, New York, NY 10003 USA; [Wang, Yufeng; Wang, Yu; Weck, Marcus] NYU, Dept Chem, New York, NY 10003 USA; [Breed, Dana R.] Dow Chem Co USA, Freeport, TX 77541 USA; [Manoharan, Vinothan N.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manoharan, Vinothan N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	New York University; New York University; New York University; New York University; Dow Chemical Company; Harvard University; Harvard University	Pine, DJ (corresponding author), NYU, Ctr Soft Matter Res, New York, NY 10003 USA.	marcus.weck@nyu.edu; pine@nyu.edu	Manoharan, Vinothan N/C-1292-2008; Wang, Yu/E-7358-2015; Pine, David J/B-7740-2016; Feng, Lang/P-7891-2014	Manoharan, Vinothan N/0000-0003-0370-6095; Wang, Yu/0000-0003-1286-2401; Pine, David J/0000-0002-3304-6684; Wang, Yufeng/0000-0001-9409-7250; Weck, Marcus/0000-0002-6486-4268	MRSEC Program of the National Science Foundation [DMR-0820341]; National Science Foundation [ChE-0911460]; MRI programme of the National Science Foundation [DMR-0923251]	MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); National Science Foundation(National Science Foundation (NSF)); MRI programme of the National Science Foundation	We thank M. T. Elsesser, D. Kraft, and G.-R. Yi for discussions. This work was supported partially by the MRSEC Program of the National Science Foundation under award number DMR-0820341. Additional financial support was provided by the National Science Foundation (ChE-0911460). We acknowledge support from the MRI programme of the National Science Foundation under award number DMR-0923251 for the purchase of a Zeiss field emission scanning electron microscope.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Bianchi E, 2011, PHYS CHEM CHEM PHYS, V13, P6397, DOI 10.1039/c0cp02296a; Breed D. R., 2007, THESIS U CALIFORNIA; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Cho YS, 2007, CHEM MATER, V19, P3183, DOI 10.1021/cm070051w; Dreyfus R, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041404; Frenkel D, 2002, SCIENCE, V296, P65, DOI 10.1126/science.1070865; Glotzer SC, 2004, SCIENCE, V306, P419, DOI 10.1126/science.1099988; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; HO KM, 1990, PHYS REV LETT, V65, P3152, DOI 10.1103/PhysRevLett.65.3152; Hong L, 2008, LANGMUIR, V24, P621, DOI 10.1021/la7030818; Huo FW, 2006, ADV MATER, V18, P2304, DOI 10.1002/adma.200601178; Johnson PM, 2005, LANGMUIR, V21, P11510, DOI 10.1021/la0518750; Jones MR, 2011, J AM CHEM SOC, V133, P18865, DOI 10.1021/ja206777k; Khan A., 1985, MAKROMOL CHEM, V10, P215; Kraft DJ, 2009, SOFT MATTER, V5, P3823, DOI 10.1039/b910593j; Kraft DJ, 2009, J AM CHEM SOC, V131, P1182, DOI 10.1021/ja8079803; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Leunissen ME, 2009, NAT MATER, V8, P590, DOI [10.1038/nmat2471, 10.1038/NMAT2471]; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Manoharan V. N., 2004, THESIS U CALIFORNIA; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Meng GN, 2010, SCIENCE, V327, P560, DOI 10.1126/science.1181263; Miller MA, 2005, J PHYS CHEM B, V109, P23109, DOI 10.1021/jp0549632; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nelson DR, 2002, NANO LETT, V2, P1125, DOI 10.1021/n10202096; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; OTTEWILL RH, 1967, KOLLOID Z Z POLYM, V215, P161, DOI 10.1007/BF01520398; Pawar AB, 2010, MACROMOL RAPID COMM, V31, P150, DOI 10.1002/marc.200900614; Pawar AB, 2009, LANGMUIR, V25, P9057, DOI 10.1021/la900809b; Perro A, 2009, ANGEW CHEM INT EDIT, V48, P361, DOI 10.1002/anie.200802562; Romano F, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3578182; Rossi L, 2011, SOFT MATTER, V7, P4139, DOI 10.1039/c0sm01246g; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Sacanna S, 2011, CURR OPIN COLLOID IN, V16, P96, DOI 10.1016/j.cocis.2011.01.003; UGELSTAD J, 1979, MAKROMOL CHEM, V180, P737; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P292; Velikov KP, 2002, SCIENCE, V296, P106, DOI 10.1126/science.1067141; Walther A, 2008, SOFT MATTER, V4, P663, DOI 10.1039/b718131k; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b; Zerrouki D, 2006, LANGMUIR, V22, P57, DOI 10.1021/la051765t; Zhang G, 2005, NANO LETT, V5, P143, DOI 10.1012/nl048121a; Zhang ZL, 2005, LANGMUIR, V21, P11547, DOI 10.1021/la0513611; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zoldesi CI, 2006, LANGMUIR, V22, P4343, DOI 10.1021/la060101w	47	785	794	15	676	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					51	U61		10.1038/nature11564	http://dx.doi.org/10.1038/nature11564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128225	Green Submitted			2022-12-24	WOS:000310434500029
J	Orozco, LD; Bennett, BJ; Farber, CR; Ghazalpour, A; Pan, C; Che, N; Wen, PZ; Qi, HX; Mutukulu, A; Siemers, N; Neuhaus, I; Yordanova, R; Gargalovic, P; Pellegrini, M; Kirchgessner, T; Lusis, AJ				Orozco, Luz D.; Bennett, Brian J.; Farber, Charles R.; Ghazalpour, Anatole; Pan, Calvin; Che, Nam; Wen, Pingzi; Qi, Hong Xiu; Mutukulu, Adonisa; Siemers, Nathan; Neuhaus, Isaac; Yordanova, Roumyana; Gargalovic, Peter; Pellegrini, Matteo; Kirchgessner, Todd; Lusis, Aldons J.			Unraveling Inflammatory Responses using Systems Genetics and Gene-Environment Interactions in Macrophages	CELL			English	Article							PPAR-GAMMA; LIPOPOLYSACCHARIDE; ATHEROSCLEROSIS; CHOLESTEROL; EXPRESSION; RECEPTORS; IMMUNITY; ABCA1; ALPHA	Many common diseases have an important inflammatory component mediated in part by macrophages. Here we used a systems genetics strategy to examine the role of common genetic variation in macrophage responses to inflammatory stimuli. We examined genome-wide transcript levels in macrophages from 92 strains of the Hybrid Mouse Diversity Panel. We exposed macrophages to control media, bacterial lipopolysaccharide (LPS), or oxidized phospholipids. We performed association mapping under each condition and identified several thousand expression quantitative trait loci (eQTL), gene-by-environment interactions, and eQTL "hot spots" that specifically control LPS responses. We used siRNA knockdown of candidate genes to validate an eQTL hot spot in chromosome 8 and identified the gene 2310061C15Rik as a regulator of inflammatory responses in macrophages. We have created a public database where the data presented here can be used as a resource for understanding many common inflammatory traits that are modeled in the mouse and for the dissection of regulatory relationships between genes.	[Orozco, Luz D.; Pan, Calvin; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Bennett, Brian J.; Ghazalpour, Anatole; Che, Nam; Wen, Pingzi; Qi, Hong Xiu; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mutukulu, Adonisa] Univ Calif Los Angeles, Dept Biochem, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Farber, Charles R.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Siemers, Nathan; Neuhaus, Isaac] Bristol Myers Squibb Co, Dept Bioinformat & Proteom, Pennington, NJ 08534 USA; [Yordanova, Roumyana] Bristol Myers Squibb Co, Dept Appl Genom, Pennington, NJ 08534 USA; [Gargalovic, Peter; Kirchgessner, Todd] Bristol Myers Squibb Co, Dept Atherosclerosis Drug Discovery, Pennington, NJ 08534 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Virginia; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Orozco, LD (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	ldorozco@mednet.ucla.edu	Yordanova, Roumyana/AAR-2275-2021	Pellegrini, Matteo/0000-0001-9355-9564; Farber, Charles/0000-0002-6748-4711; bennett, brian/0000-0002-0766-3195	NIH [HL30568, HL28481, D094311, K99 HL102223]; Ruth L. Kirschstein NIH F32 Fellowship [5F32DK074317]; USPHS National Research Service Award [GM07104, T32-HG002536]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL102223, P01HL030568, R00HL102223, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK074317, DP3DK094311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095656, T32GM007104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NIH F32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS National Research Service Award(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.J.L. and this work were supported by the NIH grants HL30568, HL28481, and D094311. B. J. B. was supported by the NIH grant K99 HL102223. C. R. F. was supported by the Ruth L. Kirschstein NIH F32 Fellowship 5F32DK074317. L. D. O. was supported by USPHS National Research Service Award GM07104 and USPHS National Research Service Award T32-HG002536. N. S., I. N., R. Y., P. G., and T. K. are employees of Bristol-Myers Squibb.	Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; Chen YY, 2007, CELL METAB, V6, P164, DOI 10.1016/j.cmet.2007.07.001; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Edgel KA, 2010, ATHEROSCLEROSIS, V209, P387, DOI 10.1016/j.atherosclerosis.2009.10.019; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Rojo L, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/73976; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	21	92	95	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					658	670		10.1016/j.cell.2012.08.043	http://dx.doi.org/10.1016/j.cell.2012.08.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101632	Green Accepted, Bronze			2022-12-24	WOS:000310529300020
J	Ou, HD; Kwiatkowski, W; Deerinck, TJ; Noske, A; Blain, KY; Land, HS; Soria, C; Powers, CJ; May, AP; Shu, XK; Tsien, RY; Fitzpatrick, JAJ; Long, JA; Ellisman, MH; Choe, S; O'Shea, CC				Ou, Horng D.; Kwiatkowski, Witek; Deerinck, Thomas J.; Noske, Andrew; Blain, Katie Y.; Land, Hannah S.; Soria, Conrado; Powers, Colin J.; May, Andrew P.; Shu, Xiaokun; Tsien, Roger Y.; Fitzpatrick, James A. J.; Long, Jeff A.; Ellisman, Mark H.; Choe, Senyon; O'Shea, Clodagh C.			A Structural Basis for the Assembly and Functions of a Viral Polymer that Inactivates Multiple Tumor Suppressors	CELL			English	Article							E4 ORF3 PROTEIN; DNA-BINDING DOMAIN; ADENOVIRUS INFECTION; INTRINSIC DISORDER; CRYSTAL-STRUCTURE; MRE11 COMPLEX; REPLICATION; E1A; 3D; MICROSCOPY	Evolution of minimal DNA tumor virus' genomes has selected for small viral oncoproteins that hijack critical cellular protein interaction networks. The structural basis for the multiple and dominant functions of adenovirus oncoproteins has remained elusive. E4-ORF3 forms a nuclear polymer and simultaneously inactivates p53, PML, TRIM24, and MRE11/RAD50/NBS1 (MRN) tumor suppressors. We identify oligomerization mutants and solve the crystal structure of E4-ORF3. E4-ORF3 forms a dimer with a central beta core, and its structure is unrelated to known polymers or oncogenes. E4-ORF3 dimer units coassemble through reciprocal and nonreciprocal exchanges of their C-terminal tails. This results in linear and branched oligomer chains that further assemble in variable arrangements to form a polymer network that partitions the nuclear volume. E4-ORF3 assembly creates avidity-driven interactions with PML and an emergent MRN binding interface. This reveals an elegant structural solution whereby a small protein forms a multivalent matrix that traps disparate tumor suppressors.	[Ou, Horng D.; Soria, Conrado; Powers, Colin J.; O'Shea, Clodagh C.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Kwiatkowski, Witek; Blain, Katie Y.; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Land, Hannah S.; Long, Jeff A.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Fitzpatrick, James A. J.] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Deerinck, Thomas J.; Noske, Andrew; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Shu, Xiaokun; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Shu, Xiaokun; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA; [May, Andrew P.] Fluidigm Corp, San Francisco, CA 94080 USA; [Shu, Xiaokun] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Shu, Xiaokun] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	Salk Institute; Salk Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco	O'Shea, CC (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	oshea@salk.edu	Fitzpatrick, James/C-2268-2009	Fitzpatrick, James/0000-0002-7907-3602; Lipton, Stuart/0000-0002-3490-1259; shu, Xiaokun/0000-0001-9248-7095	NIH [CA137094, CA009370, P30CA014195, P30NS057096, 5P41RR004050, P41GM103412-24, RO1GM086197]; William Scandling Developmental Chair; American Cancer Society; Sontag Foundation; Arnold and Mabel Beckman Foundation; Anna Fuller Fund; NATIONAL CANCER INSTITUTE [R01CA137094, T32CA009370, P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086197, P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Scandling Developmental Chair; American Cancer Society(American Cancer Society); Sontag Foundation; Arnold and Mabel Beckman Foundation; Anna Fuller Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. McCormick, T. Hunter, J. Chory, V. Lundblad, J. Young, I. Verma, and members of the C.C.O. laboratory for all of their support, insights, and helpful comments. We thank S. Phan and M. Terada for help with EM tomography. This work was supported by the following NIH grants awarded to the Salk Institute: CA137094 to C.C.O., a T32 fellowship (CA009370) to H.D.O., P30CA014195 provides support for the Salk Cancer Center, P30NS057096 supports in part the Salk X-ray equipment. The National Center for Microscopy contributions were supported by NIH awards 5P41RR004050 and P41GM103412-24 to M. H. E. The MiniSOG probe development was supported under RO1GM086197 (to R.Y.T. and M. H. E.). C.C.O. is also supported by the William Scandling Developmental Chair and young investigator awards from the American Cancer Society, the Sontag Foundation, the Arnold and Mabel Beckman Foundation, and the Anna Fuller Fund.	AEBI U, 1986, ANN NY ACAD SCI, V483, P100, DOI 10.1111/j.1749-6632.1986.tb34502.x; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Berk AJ, 2007, FIELDS VIROLOGY, P2355; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; BRENDEL V, 1989, P NATL ACAD SCI USA, V86, P5698, DOI 10.1073/pnas.86.15.5698; Carson CT, 2009, EMBO J, V28, P652, DOI 10.1038/emboj.2009.15; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Evans JD, 2003, J VIROL, V77, P5295, DOI 10.1128/JVI.77.9.5295-5304.2003; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hoppe A, 2006, J VIROL, V80, P3042, DOI 10.1128/JVI.80.6.3042-3049.2006; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Martos V, 2008, CURR OPIN CHEM BIOL, V12, P698, DOI 10.1016/j.cbpa.2008.08.024; MORGAN C, 1960, J EXP MED, V112, P373, DOI 10.1084/jem.112.2.373; NORDQVIST K, 1994, MOL CELL BIOL, V14, P437, DOI 10.1128/MCB.14.1.437; O'Shea CC, 2005, ONCOGENE, V24, P7640, DOI 10.1038/sj.onc.1209047; Ou HD, 2011, WIRES SYST BIOL MED, V3, P48, DOI 10.1002/wsbm.88; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Ponstingl H, 2000, PROTEINS, V41, P47; PUVIONDUTILLEUL F, 1995, EXP CELL RES, V218, P9, DOI 10.1006/excr.1995.1125; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seeliger MA, 2005, J BIOL CHEM, V280, P30448, DOI 10.1074/jbc.M501450200; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stracker TH, 2005, J VIROL, V79, P6664, DOI 10.1128/JVI.79.11.6664-6673.2005; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Ullman AJ, 2007, J VIROL, V81, P4744, DOI 10.1128/JVI.02385-06; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Weitzman MD, 2005, ONCOGENE, V24, P7686, DOI 10.1038/sj.onc.1209063; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Yondola MA, 2007, J VIROL, V81, P4264, DOI 10.1128/JVI.02629-06	55	61	64	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					304	319		10.1016/j.cell.2012.08.035	http://dx.doi.org/10.1016/j.cell.2012.08.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063122	Green Accepted, Bronze			2022-12-24	WOS:000309981000010
J	Cohen, MR				Cohen, Marlene R.			When Attention Wanders	SCIENCE			English	Editorial Material							VISUAL-CORTEX; NEURONAL RESPONSES; AREA V4; PERFORMANCE; MECHANISMS; MOTION; SPACE; MIND		Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cohen, MR (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	cohenm@pitt.edu			NATIONAL EYE INSTITUTE [R01EY005911, R00EY020844, K99EY020844] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01EY005911, 5R00EY020844-04, K99EY020844-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Assad JA, 2003, CURR OPIN NEUROBIOL, V13, P194, DOI 10.1016/S0959-4388(03)00045-X; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cohen MR, 2011, J NEUROSCI, V31, P15802, DOI 10.1523/JNEUROSCI.3063-11.2011; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hayden BY, 2009, VISION RES, V49, P1182, DOI 10.1016/j.visres.2008.06.011; Khayat PS, 2010, J NEUROSCI, V30, P2188, DOI 10.1523/JNEUROSCI.5314-09.2010; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	22	3	3	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					58	59		10.1126/science.1229552	http://dx.doi.org/10.1126/science.1229552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042879				2022-12-24	WOS:000309457400048
J	Reed, M; Huang, J; Graetz, I; Brand, R; Hsu, J; Fireman, B; Jaffe, M				Reed, Mary; Huang, Jie; Graetz, Ilana; Brand, Richard; Hsu, John; Fireman, Bruce; Jaffe, Marc			Outpatient Electronic Health Records and the Clinical Care and Outcomes of Patients With Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; INFORMATION-TECHNOLOGY; AMBULATORY-CARE; IMPACT	Background: Physicians can receive federal payments for meaningful use of complete certified electronic health records (EHRs). Evidence is limited on how EHR use affects clinical care and outcomes. Objective: To examine the association between use of a commercially available certified EHR and clinical care processes and disease control in patients with diabetes. Design: Quasi-experimental design with outpatient EHR implementation sequentially across 17 medical centers. Multivariate analyses adjusted for patient characteristics, medical center, time trends, and facility-level clustering. Setting: Kaiser Permanente Northern California, an integrated delivery system. Patients: 169 711 patients with diabetes mellitus. Intervention: Use of a commercially available certified EHR. Measurements: Drug treatment intensification and hemoglobin A(1c) (HbA(1c)) and low-density lipoprotein cholesterol (LDL-C) testing and values. Results: Use of an EHR was associated with statistically significant improvements in treatment intensification after HbA(1c) values of 9% or greater (odds ratio, 1.10 [95% CI, 1.05 to 1.15]) or LDL-C values of 2.6 to 3.3 mmol/L (100 to 129 mg/dL) (odds ratio, 1.06 [CI, 1.00 to 1.12]); increases in 1-year retesting for HbA(1c) and LDL-C levels among all patients, with the most dramatic change among patients with the worst disease control (HbA(1c) levels >= 9% or LDL-C levels >= 3.4 mmol/ L [>= 130 mg/dL]); and decreased 90-day retesting among patients with HbA(1c) levels less than 7% or LDL-C levels less than 2.6 mmol/ L (<100 mg/dL). The EHR was also associated with statistically significant reductions in HbA(1c) and LDL-C levels, with the largest reductions among patients with the worst control (0.06-mmol/ L [2.19-mg/dL] reduction among patients with baseline LDL-C levels >= 3.4 mmol/ L [>= 130 mg/dL]; P < 0.001). Limitation: The EHR was implemented in a setting with strong baseline performance on cardiovascular care quality measures. Conclusion: Use of a commercially available certified EHR was associated with improved drug treatment intensification, monitoring, and physiologic control among patients with diabetes, with greater improvements among patients with worse control and less testing in patients already meeting guideline-recommended glycemic and lipid targets.	[Reed, Mary] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Permanente Med Grp Inc, San Francisco, CA USA	Kaiser Permanente; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Permanente Medical Groups	Reed, M (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	mary.e.reed@kp.org	Graetz, Ilana/N-1189-2016	Graetz, Ilana/0000-0003-3664-5815; Jaffe, Marc/0000-0002-5049-7815	National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK R01DK085070]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085070] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases.; By the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK R01DK085070).	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Brailer DJ, 2010, HEALTH AFFAIR, V29, P586, DOI 10.1377/hlthaff.2010.0274; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Cameron A., 2010, HDB EMPIRICAL EC FIN, V3666, P1, DOI [10.1201/b10440-2, DOI 10.1201/B10440-2]; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Costa BM, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-72; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Herrin J, 2012, HEALTH SERV RES, V47, P1522, DOI 10.1111/j.1475-6773.2011.01370.x; Jha AK, 2010, JAMA-J AM MED ASSOC, V304, P1709, DOI 10.1001/jama.2010.1497; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Mangione CM, 2006, ANN INTERN MED, V145, P107, DOI 10.7326/0003-4819-145-2-200607180-00008; O'Connor PJ, 2005, ANN FAM MED, V3, P300, DOI 10.1370/afm.327; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sequist TD, 2005, J AM MED INFORM ASSN, V12, P431, DOI 10.1197/jamia.M1788; Sharma M, 2009, ANN INTERN MED, V151, P622, DOI 10.7326/0003-4819-151-9-200911030-00144; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; StataCorp, 2007, STAT BAS REF MAN REL; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Zhou L, 2009, J AM MED INFORM ASSN, V16, P457, DOI 10.1197/jamia.M3128	21	79	79	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2012	157	7					482	U66		10.7326/0003-4819-157-7-201210020-00004	http://dx.doi.org/10.7326/0003-4819-157-7-201210020-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	016MQ	23027319	Green Accepted			2022-12-24	WOS:000309523200003
J	McAleenan, A; Clemente-Blanco, A; Cordon-Preciado, V; Sen, N; Esteras, M; Jarmuz, A; Aragon, L				McAleenan, Alexandra; Clemente-Blanco, Andres; Cordon-Preciado, Violeta; Sen, Nicholas; Esteras, Miguel; Jarmuz, Adam; Aragon, Luis			Post-replicative repair involves separase-dependent removal of the kleisin subunit of cohesin	NATURE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; CLEAVAGE; PATHWAY; DAMAGE; EXO1; HELICASE	DNA double-strand break repair is critical for cell viability and involves highly coordinated pathways to restore DNA integrity at the lesion. An early event during homology-dependent repair is resection of the break to generate progressively longer 3' single-strand tails that are used to identify suitable templates for repair(1). Sister chromatids provide near-perfect sequence homology and are therefore the preferred templates during homologous recombination(2,3). To provide a bias for the use of sisters as donors, cohesin-the complex that tethers sister chromatids together(4)-is recruited to the break(5,6) to enforce physical proximity. Here we show that DNA breaks promote dissociation of cohesin loaded during the previous S phase in budding yeast, and that damage-induced dissociation of cohesin requires separase, the protease that dissolves cohesion in anaphase(7). Moreover, a separase-resistant allele of the gene coding for the alpha-kleisin subunit of cohesin, Mcd1 (also known as Scc1), reduces double-strand break resection and compromises the efficiency of repair even when loaded during DNA damage. We conclude that post-replicative DNA repair involves cohesin dissociation by separase to promote accessibility to repair factors during the coordinated cellular response to restore DNA integrity.	[McAleenan, Alexandra; Clemente-Blanco, Andres; Cordon-Preciado, Violeta; Sen, Nicholas; Esteras, Miguel; Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Cycle Grp, London W12 0NN, England	Imperial College London	Aragon, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Cycle Grp, Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Blanco, Andrés Clemente/D-4255-2014	Blanco, Andrés Clemente/0000-0002-3674-0671; Esteras Bejar, Miguel/0000-0001-6697-3890	Intramural Research Program of the Medical Research Council UK; MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328] Funding Source: researchfish	Intramural Research Program of the Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank D. Koshland, E. Unal, J. Haber, G. Ira and K. Nasmyth for providing valuable strains. We thank members of the Aragon laboratory, P. Ullal, S. Farmer, K. Pegram, J. Torres-Rosell and M. Merkenschlager for discussions and reading of the manuscript. This work was funded by the Intramural Research Program of the Medical Research Council UK.	Baskerville C, 2008, GENETICS, V178, P2361, DOI 10.1534/genetics.107.085308; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Jain S, 2009, GENE DEV, V23, P291, DOI 10.1101/gad.1751209; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	19	38	38	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					250	U270		10.1038/nature11630	http://dx.doi.org/10.1038/nature11630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23178808				2022-12-24	WOS:000313259600045
J	Lee, GS; Subramanian, N; Kim, AI; Aksentijevich, I; Goldbach-Mansky, R; Sacks, DB; Germain, RN; Kastner, DL; Chae, JJ				Lee, Geun-Shik; Subramanian, Naeha; Kim, Andrew I.; Aksentijevich, Ivona; Goldbach-Mansky, Raphaela; Sacks, David B.; Germain, Ronald N.; Kastner, Daniel L.; Chae, Jae Jin			The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP	NATURE			English	Article							NALP3 INFLAMMASOME; ACTIVATION; ATP; LIPOPOLYSACCHARIDE; SECRETION; CRYSTALS	Mutations in the gene encoding NLRP3 cause a spectrum of auto-inflammatory diseases known as cryopyrin-associated periodic syndromes (CAPS)(1). NLRP3 is a key component of one of several distinct cytoplasmic multiprotein complexes (inflammasomes) that mediate the maturation of the proinflammatory cytokine interleukin-1 beta (IL-1 beta) by activating caspase-1. Although several models for inflammasome activation, such as K+ efflux(2), generation of reactive oxygen species(3) and lysosomal destabilization(4), have been proposed, the precise molecular mechanism of NLRP3 inflammasome activation, as well as the mechanism by which CAPS-associated mutations activate NLRP3, remain to be elucidated. Here we show that the murine calcium-sensing receptor (CASR) activates the NLRP3 inflammasome, mediated by increased intracellular Ca2+ and decreased cellular cyclic AMP(cAMP). Ca2+ or other CASR agonists activate the NLRP3 inflammasome in the absence of exogenous ATP, whereas knockdown of CASR reduces inflammasome activation in response to known NLRP3 activators. CASR activates the NLRP3 inflammasome through phospholipase C, which catalyses inositol-1,4,5-trisphosphate production and thereby induces release of Ca2+ from endoplasmic reticulum stores. The increased cytoplasmic Ca2+ promotes the assembly of inflammasome components, and intracellular Ca2+ is required for spontaneous inflammasome activity in cells from patients with CAPS. CASR stimulation also results in reduced intracellular cAMP, which independently activates the NLRP3 inflammasome. cAMP binds to NLRP3 directly to inhibit inflammasome assembly, and downregulation of cAMP relieves this inhibition. The binding affinity of cAMP for CAPS-associated mutant NLRP3 is substantially lower than for wild-type NLRP3, and the uncontrolled mature IL-1 beta production from CAPS patients' peripheral blood mononuclear cells is attenuated by increasing cAMP. Taken together, these findings indicate that Ca2+ and cAMP are two key molecular regulators of the NLRP3 inflammasome that have critical roles in the molecular pathogenesis of CAPS.	[Lee, Geun-Shik; Kim, Andrew I.; Aksentijevich, Ivona; Kastner, Daniel L.; Chae, Jae Jin] NHGRI, Inflammatory Dis Sect, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Lee, Geun-Shik] Kangwon Natl Univ, Coll Vet Med, Chunchon 200701, Gangwon, South Korea; [Subramanian, Naeha; Germain, Ronald N.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Goldbach-Mansky, Raphaela] NIAMSD, Translat Autoinflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Sacks, David B.] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kastner, DL (corresponding author), NHGRI, Inflammatory Dis Sect, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	kastnerd@mail.nih.gov; chaej@mail.nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019; Goldbach-Mansky, Raphaela/N-5917-2017; Aksentijevich, Ivona/AAF-1335-2019	Subramanian, Naeha/0000-0003-3754-0521; Chae, Jae Jin/0000-0003-0719-4349; Sacks, David/0000-0003-3100-0735	NIAMS; NHGRI; NIAID, NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200372, ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIEAR041176, ZIAAR041138] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CLINICAL CENTER	This work was supported by the Intramural Research Programs of the NIAMS, NHGRI, and NIAID, NIH. We thank E. Remmers for discussion and a thorough review of this manuscript.	Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; COCKCROFT S, 1979, J PHYSIOL-LONDON, V296, P229, DOI 10.1113/jphysiol.1979.sp013002; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Menkin V., 1981, BIOCH MECH INFLAMMAT; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Osawa Y, 2006, AM J PHYSIOL-CELL PH, V290, pC143, DOI 10.1152/ajpcell.00171.2005; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Ross PE, 1997, J CELL BIOL, V138, P987, DOI 10.1083/jcb.138.5.987; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Xi YH, 2010, MOL CELL BIOCHEM, V342, P233, DOI 10.1007/s11010-010-0489-3; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	24	614	641	11	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					123	+		10.1038/nature11588	http://dx.doi.org/10.1038/nature11588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23143333	Green Accepted			2022-12-24	WOS:000311893400058
J	Sotomayor, M; Weihofen, WA; Gaudet, R; Corey, DP				Sotomayor, Marcos; Weihofen, Wilhelm A.; Gaudet, Rachelle; Corey, David P.			Structure of a force-conveying cadherin bond essential for inner-ear mechanotransduction	NATURE			English	Article							USHER-SYNDROME; HAIR-CELLS; MOLECULAR-DYNAMICS; SENSORY TRANSDUCTION; HEARING-LOSS; ADHESION; MUTATIONS; PCDH15; CDH23; STEREOCILIA	Hearing and balance use hair cells in the inner ear to transform mechanical stimuli into electrical signals(1). Mechanical force from sound waves or head movements is conveyed to hair-cell transduction channels by tip links(2,3), fine filaments formed by two atypical cadherins known as protocadherin 15 and cadherin 23 (refs 4, 5). These two proteins are involved in inherited deafness(6-10) and feature long extracellular domains that interact tip-to-tip(5,11) in a Ca2+-dependent manner. However, the molecular architecture of this complex is unknown. Here we combine crystallography, molecular dynamics simulations and binding experiments to characterize the protocadherin 15-cadherin 23 bond. We find a unique cadherin interaction mechanism, in which the two most amino-terminal cadherin repeats (extracellular cadherin repeats 1 and 2) of each protein interact to form an overlapped, antiparallel heterodimer. Simulations predict that this tip-link bond is mechanically strong enough to resist forces in hair cells. In addition, the complex is shown to become unstable in response to Ca2+ removal owing to increased flexure of Ca2+-free cadherin repeats. Finally, we use structures and biochemical measurements to study the molecular mechanisms by which deafness mutations disrupt tip-link function. Overall, our results shed light on the molecular mechanics of hair-cell sensory transduction and on new interaction mechanisms for cadherins, a large protein family implicated in tissue and organ morphogenesis(12,13), neural connectivity(14) and cancer(15).	[Sotomayor, Marcos; Corey, David P.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Sotomayor, Marcos; Corey, David P.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Weihofen, Wilhelm A.; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University	Corey, DP (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	gaudet@mcb.harvard.edu; dcorey@hms.harvard.edu	Gaudet, Rachelle/I-4133-2014; Sotomayor, Marcos/J-4898-2012; Sotomayor, Marcos/T-2411-2019; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Sotomayor, Marcos/0000-0002-3333-1805; Sotomayor, Marcos/0000-0002-3333-1805; Gaudet, Rachelle/0000-0002-9177-054X; Corey, David/0000-0003-4497-6016	NIH [R01 DC02281, RC2GM093307, RR-15301]; National Science Foundation through TeraGrid/XSEDE [TRAC MCB080015]; Department of Energy (DOE) [DE-AC02-06CH11357]; DOE [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation through TeraGrid/XSEDE; Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Derfler for assistance with mutagenesis, V. D'Souza and her laboratory for advice on calorimetry, and the Corey and Gaudet laboratories for discussions. Full-length complementary DNAs of Cdh23 and Pcdh15 used as template for some of our constructs were provided by U. Muller (The Scripps Research Institute) and T. B. Friedman (National Institutes of Health (NIH)). This work was supported by the NIH (R01 DC02281 to D. P. C.; RC2GM093307 to National Resource for Biomedical Supercomputing/Pittsburgh Supercomputing Center) and the National Science Foundation through TeraGrid/XSEDE (TRAC MCB080015). Simulations were performed at the NCSA-Abe, NICS-Kraken, TACC-Ranger and PSC-Anton supercomputers. Use of Advanced Photon Source beamlines was supported by NIH award RR-15301 and Department of Energy (DOE) contract no. DE-AC02-06CH11357. Use of Advanced Light Source beamline 4.2.2 was supported by DOE contract no. DE-AC02-05CH11231. M. S. was a Howard Hughes Medical Institute (HHMI) Fellow of the Helen Hay Whitney Foundation and D. P. C. is an HHMI Investigator.	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Ahmed ZM, 2008, HUM GENET, V124, P215, DOI 10.1007/s00439-008-0543-3; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; de Brouwer APM, 2003, HUM GENET, V112, P156, DOI 10.1007/s00439-002-0833-0; Deans MR, 2011, NEURON, V71, P820, DOI 10.1016/j.neuron.2011.06.026; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Han F, 2012, PHARMACOGENOMICS J, V12, P30, DOI 10.1038/tpj.2010.60; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lelli A, 2010, J NEUROSCI, V30, P11259, DOI 10.1523/JNEUROSCI.1949-10.2010; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marchand S, 1998, PROTEINS, V33, P265, DOI 10.1002/(SICI)1097-0134(19981101)33:2<265::AID-PROT10>3.3.CO;2-G; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Rouget-Quermalet V, 2006, ONCOGENE, V25, P2807, DOI 10.1038/sj.onc.1209301; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Stauffer EA, 2007, J NEUROPHYSIOL, V98, P3360, DOI 10.1152/jn.00914.2007; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thomson J.A., 2004, BIOCALORIMETRY, P37; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6	46	102	108	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					128	+		10.1038/nature11590	http://dx.doi.org/10.1038/nature11590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23135401	Green Accepted, Green Submitted			2022-12-24	WOS:000311893400059
J	Tokinaga, H; Xie, SP; Deser, C; Kosaka, Y; Okumura, YM				Tokinaga, Hiroki; Xie, Shang-Ping; Deser, Clara; Kosaka, Yu; Okumura, Yuko M.			Slowdown of the Walker circulation driven by tropical Indo-Pacific warming	NATURE			English	Article							ASIAN CLIMATE; PRECIPITATION; SENSITIVITY; SIMULATION; SHIFT	Global mean sea surface temperature (SST) has risen steadily over the past century(1,2), but the overall pattern contains extensive and often uncertain spatial variations, with potentially important effects on regional precipitation(3,4). Observations suggest a slowdown of the zonal atmospheric overturning circulation above the tropical Pacific Ocean (the Walker circulation) over the twentieth century(1,5). Although this change has been attributed to a muted hydrological cycle forced by global warming(5,6), the effect of SST warming patterns has not been explored and quantified(1,7,8). Here we perform experiments using an atmospheric model, and find that SST warming patterns are the main cause of the weakened Walker circulation over the past six decades (1950-2009). The SST trend reconstructed from bucket-sampled SST and night-time marine surface air temperature features a reduced zonal gradient in the tropical Indo-Pacific Ocean, a change consistent with subsurface temperature observations(8). Model experiments with this trend pattern robustly simulate the observed changes, including the Walker circulation slowdown and the eastward shift of atmospheric convection from the Indonesian maritime continent to the central tropical Pacific. Our results cannot establish whether the observed changes are due to natural variability or anthropogenic global warming, but they do show that the observed slowdown in the Walker circulation is presumably driven by oceanic rather than atmospheric processes.	[Tokinaga, Hiroki; Xie, Shang-Ping] Univ Hawaii Manoa, SOEST, Dept Meteorol, Int Pacific Res Ctr, 1680 EW Rd, Honolulu, HI 96822 USA; [Xie, Shang-Ping] Ocean Univ China, Phys Oceanog Lab, Qingdao 266003, Peoples R China; [Deser, Clara] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Okumura, Yuko M.] Univ Texas Austin, Inst Geophys, Austin, TX 78758 USA	University of Hawaii System; University of Hawaii Manoa; Ocean University of China; National Center Atmospheric Research (NCAR) - USA; University of Texas System; University of Texas Austin	Tokinaga, H (corresponding author), Univ Hawaii Manoa, SOEST, Dept Meteorol, Int Pacific Res Ctr, 1680 EW Rd, Honolulu, HI 96822 USA.	tokinaga@hawaii.edu; xie@hawaii.edu	Okumura, Yuko/A-9742-2012; Kosaka, Yu/C-2792-2009; Xie, Shang-Ping/C-1254-2009; Tokinaga, Hiroki/K-6813-2012	Kosaka, Yu/0000-0001-5575-4668; Xie, Shang-Ping/0000-0002-3676-1325; Tokinaga, Hiroki/0000-0002-2734-1820; Okumura, Yuko/0000-0002-1874-3465	JAMSTEC; National Basic Research Program of China [2012CB955600]; NASA; NSF; NOAA	JAMSTEC; National Basic Research Program of China(National Basic Research Program of China); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	We thank A. Timmermann for discussions, and X. T. Zheng and J. Ma for data processing. The work was supported by JAMSTEC, the National Basic Research Program of China (2012CB955600), NASA, NSF and NOAA. NCAR is sponsored by NSF.	Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Anderson JL, 2004, J CLIMATE, V17, P4641, DOI 10.1175/JCLI-3223.1; Bunge L, 2009, J CLIMATE, V22, P3979, DOI 10.1175/2009JCLI2724.1; Chen MY, 2002, J HYDROMETEOROL, V3, P249, DOI 10.1175/1525-7541(2002)003<0249:GLPAYM>2.0.CO;2; Clement A, 2011, J CLIMATE, V24, P4056, DOI 10.1175/2011JCLI3973.1; Collins WD, 2006, J CLIMATE, V19, P2144, DOI 10.1175/JCLI3760.1; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Deser C, 2006, J CLIMATE, V19, P6170, DOI 10.1175/JCLI3963.1; Deser C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043321; DiNezio P. N., 2010, EOS T AM GEOPHYS UN, V91, P141, DOI DOI 10.1029/2010EO160001; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Hulme M, 1998, GEOPHYS RES LETT, V25, P3379, DOI 10.1029/98GL02562; Johnson NC, 2010, NAT GEOSCI, V3, P842, DOI 10.1038/NGEO1008; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kendall M. G., 1975, RANK CORRELATION MET; Kennedy JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015218; KENNEDY JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI DOI 10.1029/2010JD015220; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meehl GA, 2009, J CLIMATE, V22, P780, DOI 10.1175/2008JCLI2552.1; Meng QJ, 2012, CLIM DYNAM, V38, P1757, DOI 10.1007/s00382-011-1047-8; Neale R. B., J CLIM UNPUB; Power SB, 2011, J CLIMATE, V24, P6501, DOI 10.1175/2011JCLI4101.1; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Roeckner E., 2003, 349 MPI; Schneider U., 2008, GLOBAL PRECIPITATION; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shin SI, 2011, CLIM DYNAM, V36, P1577, DOI 10.1007/s00382-009-0732-3; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Tokinaga H, 2012, J CLIMATE, V25, P1689, DOI 10.1175/JCLI-D-11-00263.1; Tokinaga H, 2011, J CLIMATE, V24, P267, DOI 10.1175/2010JCLI3789.1; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; WILLMOTT CJ, 1995, INT J CLIMATOL, V15, P221, DOI 10.1002/joc.3370150207; Woodruff SD, 2011, INT J CLIMATOL, V31, P951, DOI 10.1002/joc.2103; Xie SP, 2010, J CLIMATE, V23, P3352, DOI 10.1175/2010JCLI3429.1; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1	38	246	261	4	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					439	443		10.1038/nature11576	http://dx.doi.org/10.1038/nature11576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151588				2022-12-24	WOS:000311031600045
J	Antman, EM; Harrington, RA				Antman, Elliott M.; Harrington, Robert A.			Transforming Clinical Trials in Cardiovascular Disease Mission Critical for Health and Economic Well-being	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DESIGN		[Antman, Elliott M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Harrington, Robert A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Harvard University; Brigham & Women's Hospital; Stanford University	Antman, EM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu						Antman E, 2012, WIRES SYST BIOL MED, V4, P367, DOI 10.1002/wsbm.1173; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Iglehart JK, 2009, NEW ENGL J MED, V361, P325, DOI 10.1056/NEJMp0904133; Mehta C, 2009, CIRCULATION, V119, P597, DOI 10.1161/CIRCULATIONAHA.108.809707; Meurer WJ, 2012, JAMA-J AM MED ASSOC, V307, P2377, DOI 10.1001/jama.2012.4174; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; US Food and Drug Administration Center for Drug Evaluation and Research, 2011, CDER SCI PRIOR REV C	8	33	33	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1743	1744		10.1001/jama.2012.14841	http://dx.doi.org/10.1001/jama.2012.14841			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117771				2022-12-24	WOS:000310726500017
J	Arnett, DK; Claas, SA				Arnett, Donna K.; Claas, Steven A.			Preventing and Controlling Hypertension in the Era of Genomic Innovation and Environmental Transformation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Arnett, Donna K.; Claas, Steven A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Arnett, DK (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, RPHB 220E,1530 3rd Ave S, Birmingham, AL USA.	arnett@ms.soph.uab.edu		Claas, Steven/0000-0001-9789-8395				Bloom DE, 2011, GLOBAL EC BURDEN NON; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Konner M, 2010, NUTR CLIN PRACT, V25, P594, DOI 10.1177/0884533610385702; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; World Health Organization, 2012, CARD DIS CVDS FACT S	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1745	1746		10.1001/jama.2012.28747	http://dx.doi.org/10.1001/jama.2012.28747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117772				2022-12-24	WOS:000310726500018
J	Califf, RM; Sanderson, I; Miranda, ML				Califf, Robert M.; Sanderson, Iain; Miranda, Marie Lynn			The Future of Cardiovascular Clinical Research Informatics, Clinical Investigators, and Community Engagement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Califf, Robert M.] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA; [Miranda, Marie Lynn] Univ Michigan, Dept Pediat, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Califf, Robert M.] Duke Translat Med Inst, Durham, England; [Sanderson, Iain] Duke Hlth Technol Solut, Durham, England	Duke University; University of Michigan System; University of Michigan	Califf, RM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, 200 Trent Dr,1117 Davison Bldg, Durham, NC 27710 USA.	robert.califf@duke.edu		Miranda, Marie Lynn/0000-0002-5670-0837				CALIFF RM, 1981, WESTERN J MED, V135, P321; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Grossman C, 2011, I MED NAT AC ENG WOR; Health Care Systems (HCS) Research Collaboratory, NIH COMM FUND OFF ST; Jha AK, 2010, HEALTH AFFAIR, V29, P1951, DOI 10.1377/hlthaff.2010.0502; Miranda Marie Lynn, 2011, N C Med J, V72, P132; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	9	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1747	1748		10.1001/jama.2012.28745	http://dx.doi.org/10.1001/jama.2012.28745			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117773				2022-12-24	WOS:000310726500019
J	Stevenson, DG				Stevenson, David G.			Growing Pains for the Medicare Hospice Benefit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PALLIATIVE CARE		Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Stevenson, DG (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.							Byock I, 1998, J Palliat Med, V1, P165, DOI 10.1089/jpm.1998.1.165; Groninger H, 2012, HEALTH AFFAIR, V31, P452, DOI [10.1377/hlthaff.2011.0473, 10.1377/HLTHAFF.2011.0473]; Meier DE, 2011, MILBANK Q, V89, P343, DOI 10.1111/j.1468-0009.2011.00632.x; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Waldman P, 2011, WASHINGTON POST	5	17	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1683	1685		10.1056/NEJMp1208465	http://dx.doi.org/10.1056/NEJMp1208465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113479				2022-12-24	WOS:000310440800004
J	Hawkes, N				Hawkes, Nigel			Bright lights and big city health problems	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2012	345								e7226	10.1136/bmj.e7226	http://dx.doi.org/10.1136/bmj.e7226			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109328				2022-12-24	WOS:000310778000003
J	Jia, JL; Zheng, XB; Hu, GQ; Cui, KR; Zhang, JQ; Zhang, AY; Jiang, H; Lu, BW; Yates, J; Liu, CY; Zhao, KJ; Zheng, YX				Jia, Junling; Zheng, Xiaobin; Hu, Gangqing; Cui, Kairong; Zhang, Junqi; Zhang, Anying; Jiang, Hao; Lu, Bingwen; Yates, John, III; Liu, Chengyu; Zhao, Keji; Zheng, Yixian			Regulation of Pluripotency and Self-Renewal of ESCs through Epigenetic-Threshold Modulation and mRNA Pruning	CELL			English	Article							EMBRYONIC STEM-CELLS; CORE TRANSCRIPTIONAL NETWORK; DEVELOPMENTAL REGULATORS; TROPHECTODERM DIFFERENTIATION; GENE-EXPRESSION; POLYMERASE-II; TARGET GENES; CHROMATIN; POLYCOMB; PROTEIN	Embryonic stem cell (ESC) pluripotency requires bivalent epigenetic modifications of key developmental genes regulated by various transcription factors and chromatin-modifying enzymes. How these factors coordinate with one another to maintain the bivalent chromatin state so that ESCs can undergo rapid self-renewal while retaining pluripotency is poorly understood. We report that Utf1, a target of Oct4 and Sox2, is a bivalent chromatin component that buffers poised states of bivalent genes. By limiting PRC2 loading and histone 3 lysine-27 trimethylation, Utf1 sets proper activation thresholds for bivalent genes. It also promotes nuclear tagging of messenger RNAs (mRNAs) transcribed from insufficiently silenced bivalent genes for cytoplasmic degradation through mRNA decapping. These opposing functions of Utf1 promote coordinated differentiation. The mRNA degradation function also ensures rapid cell proliferation by blocking the Myc-Arf feedback control. Thus, Utf1 couples the core pluripotency factors with Myc and PRC2 networks to promote the pluripotency and proliferation of ESCs.	[Jia, Junling; Zheng, Xiaobin; Zhang, Junqi; Zhang, Anying; Jiang, Hao; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Jia, Junling; Zheng, Yixian] NHLBI, Howard Hughes Med Inst, NIH, Bethesda, MD 20892 USA; [Hu, Gangqing; Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core Facil, NIH, Bethesda, MD 20892 USA; [Lu, Bingwen; Yates, John, III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Scripps Research Institute	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	zheng@ciwemb.edu	Zhang, An/GRS-5852-2022; Hu, Gangqing/ABA-3507-2020; HU, GANGQING/K-5849-2012; Zheng, Xiaobin/AAD-7564-2019	HU, GANGQING/0000-0001-5453-6888; 	NIH [GM56312, MH067880, P41 RR011823]; NHLBI; HHMI [P41 RR011823, R01 HL079442-08]; Cystic Fibrosis Foundation Therapeutics, Inc. [BALCH05X5];  [R01 GM056312]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005907, ZICHL006058, ZIAHL005801, R01HL079442, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); HHMI(Howard Hughes Medical Institute); Cystic Fibrosis Foundation Therapeutics, Inc.; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Allison Pinder for deep-seq; Nick Ingolia for advice on data analyses; and Chen-ming Fan, Nick Ingolia, Xin Chen, Haiqing Zhao, Dong Yang, Ma Wan, Max Guo, and members of the Zheng lab for comments. This work was supported by NIH (GM56312 to Y. Z.; MH067880 and P41 RR011823 to J. R. Y.) and by NHLBI intramural research (G. H., K. C., C. L., and K. Z.). This work was also supported by R01 GM056312 (Y. Z., J. Z., A. Z.), HHMI (J. J., Y. Z.), P41 RR011823 and R01 HL079442-08 (J. Y.), and Cystic Fibrosis Foundation Therapeutics, Inc. BALCH05X5 (B.L.).	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cleveland JL, 2004, CANCER CELL, V6, P309, DOI 10.1016/j.ccr.2004.09.020; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fukushima A, 1998, J BIOL CHEM, V273, P25840, DOI 10.1074/jbc.273.40.25840; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Ling SHM, 2011, WIRES RNA, V2, P193, DOI 10.1002/wrna.44; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Tritschler F, 2009, P NATL ACAD SCI USA, V106, P21591, DOI 10.1073/pnas.0909871106; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Vong QP, 2010, STEM CELLS, V28, P1030, DOI 10.1002/stem.428; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	54	57	57	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					576	589		10.1016/j.cell.2012.09.023	http://dx.doi.org/10.1016/j.cell.2012.09.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101626	Green Accepted, Bronze			2022-12-24	WOS:000310529300014
J	Weeks, JC; Catalano, PJ; Cronin, A; Finkelman, MD; Mack, JW; Keating, NL; Schrag, D				Weeks, Jane C.; Catalano, Paul J.; Cronin, Angel; Finkelman, Matthew D.; Mack, Jennifer W.; Keating, Nancy L.; Schrag, Deborah			Patients' Expectations about Effects of Chemotherapy for Advanced Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL LUNG-CANCER; ADVANCED COLORECTAL-CANCER; CARE OUTCOMES RESEARCH; QUALITY-OF-LIFE; SURVEILLANCE CONSORTIUM; MULTIPLE IMPUTATION; RANDOMIZED-TRIAL; PALLIATIVE CARE; SUPPORTIVE CARE; TREATMENT GOALS	Background Chemotherapy for metastatic lung or colorectal cancer can prolong life by weeks or months and may provide palliation, but it is not curative. Methods We studied 1193 patients participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) study (a national, prospective, observational cohort study) who were alive 4 months after diagnosis and received chemotherapy for newly diagnosed metastatic (stage IV) lung or colorectal cancer. We sought to characterize the prevalence of the expectation that chemotherapy might be curative and to identify the clinical, sociodemographic, and health-system factors associated with this expectation. Data were obtained from a patient survey by professional interviewers in addition to a comprehensive review of medical records. Results Overall, 69% of patients with lung cancer and 81% of those with colorectal cancer did not report understanding that chemotherapy was not at all likely to cure their cancer. In multivariable logistic regression, the risk of reporting inaccurate beliefs about chemotherapy was higher among patients with colorectal cancer, as compared with those with lung cancer (odds ratio, 1.75; 95% confidence interval [CI], 1.29 to 2.37); among nonwhite and Hispanic patients, as compared with non-Hispanic white patients (odds ratio for Hispanic patients, 2.82; 95% CI, 1.51 to 5.27; odds ratio for black patients, 2.93; 95% CI, 1.80 to 4.78); and among patients who rated their communication with their physician very favorably, as compared with less favorably (odds ratio for highest third vs. lowest third, 1.90; 95% CI, 1.33 to 2.72). Educational level, functional status, and the patient's role in decision making were not associated with such inaccurate beliefs about chemotherapy. Conclusions Many patients receiving chemotherapy for incurable cancers may not understand that chemotherapy is unlikely to be curative, which could compromise their ability to make informed treatment decisions that are consonant with their preferences. Physicians may be able to improve patients' understanding, but this may come at the cost of patients' satisfaction with them. (Funded by the National Cancer Institute and others.)	[Weeks, Jane C.; Cronin, Angel; Schrag, Deborah] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Catalano, Paul J.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Mack, Jennifer W.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Finkelman, Matthew D.] Tufts Univ, Sch Dent Med, Dept Publ Hlth & Community Serv, Boston, MA 02111 USA; [Keating, Nancy L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Keating, Nancy L.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Tufts University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Weeks, JC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	jane_weeks@dfci.harvard.edu	Maslov, Victor Pavlovich/M-9068-2015; Keating, Nancy L/I-9968-2019	Maslov, Victor Pavlovich/0000-0003-2599-5086; Keating, Nancy L/0000-0002-8274-4681	National Cancer Institute (NCI) [U01 CA093344]; NCI; Dana-Farber Cancer Institute/Cancer Research Network [U01 CA093332]; Harvard Medical School/Northern California Cancer Center [U01 CA093324, RAND/UCLA U01 CA093348]; University of Alabama at Birmingham [U01 CA093329]; University of Iowa [U01 CA093339]; University of North Carolina [U01 CA093326]; Department of Veterans Affairs [CRS 02-164]; NATIONAL CANCER INSTITUTE [U01CA093326, U01CA093344, U01CA093324, U01CA093332, U01CA093348, U01CA093329, U01CA093339] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana-Farber Cancer Institute/Cancer Research Network; Harvard Medical School/Northern California Cancer Center; University of Alabama at Birmingham; University of Iowa; University of North Carolina; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Cancer Institute (NCI) to the Statistical Coordinating Center (U01 CA093344) and the NCI-supported Primary Data Collection and Research Centers, Dana-Farber Cancer Institute/Cancer Research Network (U01 CA093332), Harvard Medical School/Northern California Cancer Center (U01 CA093324, RAND/UCLA U01 CA093348), University of Alabama at Birmingham (U01 CA093329), University of Iowa (U01 CA093339), and University of North Carolina (U01 CA093326); and by a Department of Veterans Affairs grant to the Durham Veterans Affairs Medical Center (CRS 02-164).	[Anonymous], 2004, J PALLIAT MED, V7, P637; Ayanian JZ, 2010, J CLIN ONCOL, V28, P4154, DOI 10.1200/JCO.2009.27.3268; Ayanian JZ, 2004, J CLIN ONCOL, V22, P2992, DOI 10.1200/JCO.2004.06.020; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Burns CM, 2007, SUPPORT CARE CANCER, V15, P187, DOI 10.1007/s00520-006-0116-8; Catalano P, 2012, MED CARE APPL M 0307; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Chen JY, 2008, MED CARE, V46, P1157, DOI 10.1097/MLR.0b013e31817924bc; Chow E, 2001, CLIN ONCOL-UK, V13, P204, DOI 10.1053/clon.2001.9255; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; Gabrijel S, 2008, J CLIN ONCOL, V26, P297, DOI 10.1200/JCO.2007.13.0609; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; GLIMELIUS B, 1994, CANCER, V73, P556, DOI 10.1002/1097-0142(19940201)73:3<556::AID-CNCR2820730310>3.0.CO;2-8; Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66; Hays RD, 1999, MED CARE, V37, pMS22, DOI 10.1097/00005650-199903001-00003; He Y, 2010, STAT METHODS MED RES, V19, P653, DOI 10.1177/0962280208101273; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Helsing M, 1998, EUR J CANCER, V34, P1036, DOI 10.1016/S0959-8049(97)10122-8; Keating NL, 2010, J CLIN ONCOL, V28, P4364, DOI 10.1200/JCO.2009.26.8870; Leighl NB, 2011, J CLIN ONCOL, V29, P2077, DOI 10.1200/JCO.2010.32.0754; LIDZ CW, 1988, ARCH INTERN MED, V148, P1385, DOI 10.1001/archinte.148.6.1385; Mack JW, 2007, J CLIN ONCOL, V25, P1357, DOI 10.1200/JCO.2006.08.3170; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; Malin JL, 2006, SUPPORT CARE CANCER, V14, P837, DOI 10.1007/s00520-005-0902-8; MCQUELLON RP, 1995, J CLIN ONCOL, V13, P858, DOI 10.1200/JCO.1995.13.4.858; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; PRONZATO P, 1994, SUPPORT CARE CANCER, V2, P242, DOI 10.1007/BF00365729; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Smith Thomas J, 2011, J Support Oncol, V9, P79; Smith TJ, 2010, CLIN CANCER RES, V16, P5981, DOI 10.1158/1078-0432.CCR-10-1278; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Tourangeau R., 2000, PSYCHOL SURVEY RESPO; von Gunten Charles F, 2004, J Palliat Med, V7, P209, DOI 10.1089/109662104773709332; von Roenn JH, 2003, J CLIN ONCOL, V21, P570, DOI 10.1200/JCO.2003.10.161; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469	39	769	774	3	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1616	1625		10.1056/NEJMoa1204410	http://dx.doi.org/10.1056/NEJMoa1204410			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23094723	Green Accepted			2022-12-24	WOS:000310131700008
J	Nestler, EJ				Nestler, Eric J.			Stress makes its molecular mark	NATURE			English	Editorial Material							MOUSE NUCLEUS-ACCUMBENS; HISTONE METHYLATION; DEPRESSION		[Nestler, Eric J.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu			NIMH NIH HHS [R01 MH051399, P50 MH096890] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH051399] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Caldji C, 2011, FEBS LETT, V585, P2049, DOI 10.1016/j.febslet.2011.03.032; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Sun H, 2012, NEUROPSYCHOPHARMACOL; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009	10	53	53	1	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					171	172		10.1038/490171a	http://dx.doi.org/10.1038/490171a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060173	Green Accepted			2022-12-24	WOS:000309733300024
J	Shukla, S				Shukla, Shubhlakshmi			Africa's changing mosquito dynamics	LANCET			English	Editorial Material							HIGHLANDS		The Lancet, London NW1 7BY, England		Shukla, S (corresponding author), The Lancet, London NW1 7BY, England.	shubhs82@gmail.com						[Anonymous], KEN MAL FACT SHEET; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; London School of Hygiene and Tropical Medicine, NEW MAL TRANSM MOSQ; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Stevenson J, 2012, EMERG INFECT DIS, V18, P1547, DOI 10.3201/eid1809.120283; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2012, MAL FACT SHEET	8	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2012	380	9848					1130	1131		10.1016/S0140-6736(12)61617-1	http://dx.doi.org/10.1016/S0140-6736(12)61617-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	23021271				2022-12-24	WOS:000309255900008
J	Kerkering, TM; Grifasi, ML; Baffoe-Bonnie, AW; Bansal, E; Garner, DC; Smith, JA; Demicco, DD; Schleupner, CJ; Aldoghaither, RA; Savaliya, VA				Kerkering, Thomas M.; Grifasi, Marissa L.; Baffoe-Bonnie, Anthony W.; Bansal, Ekta; Garner, Dorothy C.; Smith, Jean A.; Demicco, Deborah D.; Schleupner, Charles J.; Aldoghaither, Rabia A.; Savaliya, Vipul A.			Early Clinical Observations in Prospectively Followed Patients With Fungal Meningitis Related to Contaminated Epidural Steroid Injections	ANNALS OF INTERNAL MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBRAL PHEOHYPHOMYCOSIS; MELANIZED FUNGI; AMPHOTERICIN-B; EXSEROHILUM	Background: Administration of epidural steroid injections (ESIs) with contaminated methylprednisolone resulted in an outbreak of fungal meningitis in many locations in the United States. Objective: To characterize early clinical findings and initial response to treatment. Design: Case series with standardized observation studied from 4 October to 31 October 2012. Setting: An 800-bed hospital in Virginia. Patients: 172 patients who presented to the hospital with exposure to contaminated ESI. Intervention: Standardized approach to screening, case definition, treatment, and data collection. Measurements: Clinical findings, cerebrospinal fluid (CSF) values, magnetic resonance imaging (MRI), serum and CSF voriconazole concentrations, and clinician assessment of response to therapy. Results: Of 172 patients presenting to the hospital who had had ESI, 131 had lumbar puncture because of symptoms or signs consistent with central nervous system disease. Twenty-five (19%) had neutrophilic meningitis. All were started on voriconazole therapy alone. Three patients developed stroke during treatment. Ten patients had arachnoiditis, another had an epidural abscess, and 9 had urine retention. Fifteen continued to receive voriconazole, and 10 were switched to amphotericin B. Cerebrospinal fluid leukocyte counts began to decrease by day 13 of treatment. Findings on MRI included ventriculitis, leptomeningeal enhancement, infarction, hemorrhage, and arachnoiditis. Serum voriconazole levels varied, and CSF concentrations of voriconazole were approximately 50% those of serum. Exserohilum rostratum and Cladosporium species have been cultured. Limitations: This is an observational study of an evolving outbreak. Not all exposed patients presented for evaluation. Follow-up is too short to determine final outcomes. Conclusion: Meningitis after receipt of contaminated ESI has been diagnosed in many exposed patients presenting to 1 hospital. Most patients have improved on receipt of empirical voriconazole therapy. The full natural history and long-term sequelae of this infection are currently unknown. Primary Funding Source: None. Ann Intern Med. 2013;158:154-161.	[Kerkering, Thomas M.; Grifasi, Marissa L.; Baffoe-Bonnie, Anthony W.; Bansal, Ekta; Garner, Dorothy C.; Smith, Jean A.; Demicco, Deborah D.; Schleupner, Charles J.; Aldoghaither, Rabia A.; Savaliya, Vipul A.] Virginia Tech Caril Sch Med, Roanoke, VA 24014 USA		Kerkering, TM (corresponding author), Virginia Tech Caril Sch Med, 1906 Belleview Ave, Roanoke, VA 24014 USA.			SAVALIYA, Vipul/0000-0002-3221-4500				ADAM RD, 1986, MEDICINE, V65, P203, DOI 10.1097/00005792-198607000-00001; Adler A, 2006, EUR J CLIN MICROBIOL, V25, P247, DOI 10.1007/s10096-006-0093-3; BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Carter E, 2004, J CLIN MICROBIOL, V42, P5419, DOI 10.1128/JCM.42.11.5419-5423.2004; Centers for Disease Control and Prevention Health Alert Network, 2012, MEN STROK ASS POT CO; da Cunha KC, 2012, ANTIMICROB AGENTS CH, V56, P4951, DOI 10.1128/AAC.00488-12; Doshi SM, 2012, AM J KIDNEY DIS, V59, P222, DOI 10.1053/j.ajkd.2011.08.029; Filizzola Marcelo J., 2003, International Journal of Infectious Diseases, V7, P282, DOI 10.1016/S1201-9712(03)90108-1; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kantarcioglu AS, 2004, MYCOSES, V47, P4, DOI 10.1046/j.1439-0507.2003.00956.x; Li DM, 2009, LANCET INFECT DIS, V9, P376, DOI 10.1016/S1473-3099(09)70131-8; Lyons JL, 2012, ANN INTERN MED, V157, P835, DOI 10.7326/0003-4819-158-1-201212040-00557; Moja M, 2000, NEURORADIOLOGY, V42, P261, DOI 10.1007/s002340050882; Pai MP, 2011, ANTIMICROB AGENTS CH, V55, P2601, DOI 10.1128/AAC.01765-10; Pettit AC, 2012, N ENGL J MED; Revankar SG, 2010, CLIN MICROBIOL REV, V23, P884, DOI 10.1128/CMR.00019-10; Revankar SG, 2004, CLIN INFECT DIS, V38, P206, DOI 10.1086/380635; SAAG MS, 1992, NEW ENGL J MED, V326, P83, DOI 10.1056/NEJM199201093260202; Theuretzbacher U, 2006, CLIN PHARMACOKINET, V45, P649, DOI 10.2165/00003088-200645070-00002; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Virginia Department of Health, 2012, EP UPD FUNG INF ASS	21	41	41	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					154	+		10.7326/0003-4819-158-3-201302050-00568	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00568			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23183583				2022-12-24	WOS:000314757900002
J	Baudisch, A; Vaupel, JW				Baudisch, Annette; Vaupel, James W.			Getting to the Root of Aging	SCIENCE			English	Editorial Material							SENESCENCE		[Baudisch, Annette] Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany; [Baudisch, Annette; Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany; [Vaupel, James W.] Univ So Denmark, Odense, Denmark; [Vaupel, James W.] Duke Univ, Durham, NC 27705 USA	Max Planck Society; University of Southern Denmark; Duke University	Baudisch, A (corresponding author), Max Planck Res Grp Modeling Evolut Aging, Rostock, Germany.	baudisch@demogr.mpg.de	Baudisch, Annette/ABA-2290-2020	Baudisch, Annette/0000-0002-4202-089X; Vaupel, James/0000-0003-0783-3905	NATIONAL INSTITUTE ON AGING [P01AG031719] Funding Source: NIH RePORTER; NIA NIH HHS [AG-031719, P01 AG031719] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baudisch A, 2008, INEVITABLE SENESCENC; Baudisch A, 2012, GERONTOLOGY, V58, P481, DOI 10.1159/000341861; Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109; Colchero F, 2012, METHODS ECOL EVOL, V3, P466, DOI 10.1111/j.2041-210X.2012.00186.x; Danko MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034146; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; Medawar P. B., 1952, UNIQUENESS INDIVIDUA, P44; PARTRIDGE L, 1991, PHILOS T R SOC B, V332, P3, DOI 10.1098/rstb.1991.0027; Salguero-Gomez R, 2010, J ECOL, V98, P312, DOI 10.1111/j.1365-2745.2009.01616.x; Stearns S.C., 1992, pi; Turner F.B., 1987, 87RD81 SO CAL ED CO; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	18	66	66	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					618	619		10.1126/science.1226467	http://dx.doi.org/10.1126/science.1226467			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118175	Green Accepted			2022-12-24	WOS:000310516000036
J	Marx, V				Marx, Vivien			READING THE SECOND GENOMIC CODE	NATURE			English	Editorial Material							CHROMATIN; CANCER; DNA											Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; Cipriany BR, 2012, P NATL ACAD SCI USA, V109, P8477, DOI 10.1073/pnas.1117549109; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232	9	17	19	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					143	146		10.1038/491143a	http://dx.doi.org/10.1038/491143a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	028PM	23128234	Bronze			2022-12-24	WOS:000310434500047
J	Farrell, L				Farrell, Liam			Breaking good news	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 31	2012	345								e7355	10.1136/bmj.e7355	http://dx.doi.org/10.1136/bmj.e7355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033FF	23114076				2022-12-24	WOS:000310778900019
J	Allotey, P; Amazigo, U; Adjei, S; Seddoh, A; Lusamba-Dikassa, PS				Allotey, Pascale; Amazigo, Uche; Adjei, Sam; Seddoh, Anthony; Lusamba-Dikassa, Paul-Samson			15 years of APOC-a lifetime of public health evidence	LANCET			English	Editorial Material							ONCHOCERCIASIS CONTROL; ELIMINATION; AFRICA; DISEASES; LOIASIS; REALITY; IMPACT; CARE		[Allotey, Pascale] Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway 46150, Selangor DE, Malaysia; [Amazigo, Uche; Lusamba-Dikassa, Paul-Samson] APOC, Ouagadougou, Burkina Faso; [Adjei, Sam; Seddoh, Anthony] Ctr Hlth & Social Serv, Accra, Ghana	Monash University; Monash University Sunway	Allotey, P (corresponding author), Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Sunway Campus, Bandar Sunway 46150, Selangor DE, Malaysia.	pascale.allotey@monash.edu		Allotey, Pascale/0000-0002-6942-5774				Adjei S, 2010, REPORT EXTERNAL MIDT; Allen T, 2011, THIRD WORLD Q, V32, P91, DOI 10.1080/01436597.2011.543816; Boatin B, 1997, J HELMINTHOL, V71, P91, DOI 10.1017/S0022149X00015741; DFID, BRIT PROT MOR 140 MI; Heymann DL, NEGLECTED INFECT DIS; Mackenzie CD, 2012, TRENDS PARASITOL, V28, P16, DOI 10.1016/j.pt.2011.10.003; Molyneux DH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-234; Molyneux DH, 2005, TRENDS PARASITOL, V21, P525, DOI 10.1016/j.pt.2005.08.027; RIFKIN SB, 1986, SOC SCI MED, V23, P559, DOI 10.1016/0277-9536(86)90149-8; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Tekle AH, 2011, ACTA TROP, V120, pS81, DOI 10.1016/j.actatropica.2010.05.008; WALSH JA, 1980, SOC SCI MED-MED ECON, V14, P145, DOI 10.1016/0160-7995(80)90034-9; Waters HR, 2004, TROP MED INT HEALTH, V9, pA16, DOI 10.1111/j.1365-3156.2004.01210.x; WHO APOC, 2011, WHO YEAR 2011 PROGR; Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210	15	2	2	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 20	2012	380	9851					1361	1363		10.1016/S0140-6736(12)60723-5	http://dx.doi.org/10.1016/S0140-6736(12)60723-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025NM	23084441				2022-12-24	WOS:000310196500005
J	Tachibana, M; Amato, P; Sparman, M; Woodward, J; Sanchis, DM; Ma, H; Gutierrez, NM; Tippner-Hedges, R; Kang, E; Lee, HS; Ramsey, C; Masterson, K; Battaglia, D; Lee, D; Wu, D; Jensen, J; Patton, P; Gokhale, S; Stouffer, R; Mitalipov, S				Tachibana, Masahito; Amato, Paula; Sparman, Michelle; Woodward, Joy; Sanchis, Dario Melguizo; Ma, Hong; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Kang, Eunju; Lee, Hyo-Sang; Ramsey, Cathy; Masterson, Keith; Battaglia, David; Lee, David; Wu, Diana; Jensen, Jeffrey; Patton, Phillip; Gokhale, Sumita; Stouffer, Richard; Mitalipov, Shoukhrat			Towards germline gene therapy of inherited mitochondrial diseases	NATURE			English	Article							OOCYTE VITRIFICATION; ACTIVATION; COMMON	Mutations in mitochondrial DNA (mtDNA) are associated with severe human diseases and are maternally inherited through the egg's cytoplasm. Here we investigated the feasibility of mtDNA replacement in human oocytes by spindle transfer (ST; also called spindle-chromosomal complex transfer). Of 106 human oocytes donated for research, 65 were subjected to reciprocal ST and 33 served as controls. Fertilization rate in ST oocytes (73%) was similar to controls (75%); however, a significant portion of ST zygotes (52%) showed abnormal fertilization as determined by an irregular number of pronuclei. Among normally fertilized ST zygotes, blastocyst development (62%) and embryonic stem cell isolation (38%) rates were comparable to controls. All embryonic stem cell lines derived from ST zygotes had normal euploid karyotypes and contained exclusively donor mtDNA. The mtDNA can be efficiently replaced in human oocytes. Although some ST oocytes displayed abnormal fertilization, remaining embryos were capable of developing to blastocysts and producing embryonic stem cells similar to controls.	[Tachibana, Masahito; Sparman, Michelle; Woodward, Joy; Sanchis, Dario Melguizo; Ma, Hong; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Kang, Eunju; Lee, Hyo-Sang; Ramsey, Cathy; Jensen, Jeffrey; Stouffer, Richard; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Amato, Paula; Masterson, Keith; Battaglia, David; Lee, David; Wu, Diana; Patton, Phillip; Stouffer, Richard; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod Endocrinol, Dept Obstet & Gynecol, Portland, OR 97239 USA; [Jensen, Jeffrey] Oregon Hlth & Sci Univ, Ctr Womens Hlth, Portland, OR 97239 USA; [Gokhale, Sumita] Boston Univ, Sch Med, Univ Pathologists LLC, Providence, RI 02908 USA; [Gokhale, Sumita] Roger Williams Med Ctr, Providence, RI 02908 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Boston University; Roger Williams Medical Center	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu	Jensen, Jeffrey T/C-7421-2014	Jensen, Jeffrey T/0000-0002-4733-1224; Melguizo Sanchis, Dario/0000-0002-5728-4345	OHSU Center for Women's Health Circle of Giving; OHSU; Leducq Foundation; National Institutes of Health [HD063276, HD057121, HD059946, EY021214, 8P51OD011092]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD063276, R01HD057121, R01HD059946] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	OHSU Center for Women's Health Circle of Giving; OHSU; Leducq Foundation(Leducq Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the Oregon Health & Science University (OHSU) Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for providing oversight and guidance. We thank oocyte and sperm donors and staff at the Women's Health Research Unit at the Center for Women's Health, University Fertility Consultants and Reproductive Endocrinology & Infertility Division at the Department of Obstetrics & Gynecology of Oregon Health & Science University for their support and procurement of human gametes. The Division of Animal Resources, Surgery Team, Assisted Reproductive Technology & Embryonic Stem Cell Core, Endocrine Technology Core, Imaging & Morphology Core, Flow Cytometry Core and Molecular & Cellular Biology Core at the Oregon National Primate Research Center provided expertise and services for the nonhuman primate research. Hamilton Thorne Inc., donated an XYClone laser system for this study. We are grateful to W. Sanger and D. Zaleski for karyotyping services, C. Penedo for microsatellite analysis and J. Hennebold for consulting on metabolic assays. We are also indebted to A. Steele, R. Cervera Juanes and E. Wolff for their technical support. The human oocyte/embryo research was supported by grants from the OHSU Center for Women's Health Circle of Giving and other OHSU institutional funds, as well as the Leducq Foundation. The nonhuman primate study was supported by grants from the National Institutes of Health HD063276, HD057121, HD059946, EY021214 and 8P51OD011092.	Burgstaller JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-141; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484; Donnez J, 2011, ANN MED, V43, P437, DOI 10.3109/07853890.2010.546807; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Fisher DL, 1999, DEVELOPMENT, V126, P4537; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Gao SR, 2005, TRENDS BIOTECHNOL, V23, P66, DOI 10.1016/j.tibtech.2004.12.007; Gropman A L, 2001, Curr Neurol Neurosci Rep, V1, P185; Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Lee DM, 2004, NATURE, V428, P137, DOI 10.1038/428137a; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Mandelbaum J, 2004, EUR J OBSTET GYN R B, V113, pS17, DOI 10.1016/j.ejogrb.2003.11.005; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Rienzi L, 2012, HUM REPROD, V27, P1606, DOI 10.1093/humrep/des088; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Smith DG, 2005, COMPARATIVE MED, V55, P227; SUSKOPARRISH JL, 1994, DEV BIOL, V166, P729, DOI 10.1006/dbio.1994.1351; Tachibana M, 2010, NAT PROTOC, V5, P1138, DOI 10.1038/nprot.2010.75; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Wakayama T, 1998, BIOL REPROD, V59, P100, DOI 10.1095/biolreprod59.1.100	24	266	284	4	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					627	631		10.1038/nature11647	http://dx.doi.org/10.1038/nature11647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23103867	Green Accepted			2022-12-24	WOS:000314219600047
J	Chakraborty, S; Gruber, T; Barry, CE; Boshoff, HI; Rhee, KY				Chakraborty, Sumit; Gruber, Todd; Barry, Clifton E., III; Boshoff, Helena I.; Rhee, Kyu Y.			Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis	SCIENCE			English	Article							DIHYDROPTEROATE SYNTHASE; THYMIDYLATE SYNTHASE; ESCHERICHIA-COLI; LIGAND-BINDING; RESISTANCE; METHOTREXATE; INHIBITION; DEPLETION; THYX	Folate biosynthesis is an established anti-infective target, and the antifolate para-aminosalicylic acid (PAS) was one of the first anti-infectives introduced into clinical practice on the basis of target-based drug discovery. Fifty years later, PAS continues to be used to treat tuberculosis. PAS is assumed to inhibit dihydropteroate synthase (DHPS) in Mycobacterium tuberculosis by mimicking the substrate p-aminobenzoate (PABA). However, we found that sulfonamide inhibitors of DHPS inhibited growth of M. tuberculosis only weakly because of their intracellular metabolism. In contrast, PAS served as a replacement substrate for DHPS. Products of PAS metabolism at this and subsequent steps in folate metabolism inhibited those enzymes, competing with their substrates. PAS is thus a prodrug that blocks growth of M. tuberculosis when its active forms are generated by enzymes in the pathway they poison.	[Chakraborty, Sumit; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Chakraborty, Sumit; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Gruber, Todd; Barry, Clifton E., III; Boshoff, Helena I.] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rhee, KY (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	kyr9001@med.cornell.edu	Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X	Burroughs Wellcome Career Award in the Biomedical Sciences; William Randolph Hearst Foundation; Bill and Melinda Gates TB Drug Accelerator Program [OPP1024050]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); William Randolph Hearst Foundation; Bill and Melinda Gates TB Drug Accelerator Program; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Nathan for critical discussions and reading of the manuscript, D. Garboczi for assistance in preparing purified FolP1 and FolC, R. Lee and M. Serono for the generous gifts of pure folate intermediates and pteroate analogs, S. Fischer for expert mass spectrometric support, a Burroughs Wellcome Career Award in the Biomedical Sciences to K.Y.R., the William Randolph Hearst Foundation, and the Bill and Melinda Gates TB Drug Accelerator Program (OPP1024050) for support. This work was supported in part by the Intramural Research Program of NIAID, NIH. Primary data are deposited in Dryad; the provisional doi is 10.5061/dryad.vh36n.	ALLEGRA CJ, 1985, P NATL ACAD SCI USA, V82, P4881, DOI 10.1073/pnas.82.15.4881; ALLEGRA CJ, 1986, J BIOL CHEM, V261, P6478; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; ELION GERTRUDE B., 1965, ADVANCE CHEMOTHERAP, V2, P91; Fivian-Hughes AS, 2012, MICROBIOL-SGM, V158, P308, DOI 10.1099/mic.0.053983-0; Gengenbacher M, 2008, FEMS MICROBIOL LETT, V287, P128, DOI 10.1111/j.1574-6968.2008.01302.x; Huang TS, 2012, J ANTIMICROB CHEMOTH, V67, P633, DOI 10.1093/jac/dkr501; Hunter JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002237; Kwon YK, 2010, ACS CHEM BIOL, V5, P787, DOI 10.1021/cb100096f; Long E. R, 1958, CHEM CHEMOTHERAPY TU, P347; Lu WY, 2007, J AM SOC MASS SPECTR, V18, P898, DOI 10.1016/j.jasms.2007.01.017; Mathys V, 2009, ANTIMICROB AGENTS CH, V53, P2100, DOI 10.1128/AAC.01197-08; Nathan C, 2009, CELL HOST MICROBE, V5, P220, DOI 10.1016/j.chom.2009.02.004; Nopponpunth V, 1999, J BACTERIOL, V181, P6814, DOI 10.1128/JB.181.21.6814-6821.1999; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; ROSDAHL K. -G, 1948, SVENSK KEMISK TIDSKR, V60, P12; Schuessler DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034471; Spencer HT, 1997, BIOCHEMISTRY-US, V36, P4212, DOI 10.1021/bi961794q; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108	22	138	141	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					88	91		10.1126/science.1228980	http://dx.doi.org/10.1126/science.1228980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23118010	Green Accepted			2022-12-24	WOS:000312985800058
J	Neria, Y; Shultz, JM				Neria, Yuval; Shultz, James M.			Mental Health Effects of Hurricane Sandy Characteristics, Potential Aftermath, and Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; TERRORIST ATTACKS		[Neria, Yuval] New York State Psychiat Inst & Hosp, Unit 69, New York, NY 10032 USA; [Neria, Yuval] Columbia Univ, Dept Psychiat, New York, NY USA; [Neria, Yuval] Columbia Univ, Dept Epidemiol, New York, NY USA; [Shultz, James M.] Univ Miami, Miller Sch Med, Ctr Disaster & Extreme Event Preparedness DEEP Ct, Miami, FL 33136 USA	New York State Psychiatry Institute; Columbia University; Columbia University; University of Miami	Neria, Y (corresponding author), New York State Psychiat Inst & Hosp, Unit 69, 1051 Riverside Dr, New York, NY 10032 USA.	ny126@columbia.edu			NIMH NIH HHS [R01 MH072833] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072833] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; [Anonymous], NY TIMES; Foa EB, 2005, NEUROPSYCHOPHARMACOL, V30, P1806, DOI 10.1038/sj.npp.1300815; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Sandy Hurricane, 2012, HURR SAND; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Walsh MW, NY TIMES	9	98	99	0	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2571	2572		10.1001/jama.2012.110700	http://dx.doi.org/10.1001/jama.2012.110700			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23160987	Green Accepted			2022-12-24	WOS:000312916600020
J	Alexander, GC; Kruszewski, SP; Webster, DW				Alexander, G. Caleb; Kruszewski, Stefan P.; Webster, Daniel W.			Rethinking Opioid Prescribing to Protect Patient Safety and Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION; PAIN		[Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Webster, Daniel W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Webster, Daniel W.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Gun Policy & Res, Baltimore, MD 21205 USA; [Alexander, G. Caleb] Johns Hopkins Med, Dept Med, Sect Gen Internal Med, Baltimore, MD USA; [Alexander, G. Caleb] Univ Illinois, Sch Pharm, Dept Pharm Practice, Chicago, IL USA; [Kruszewski, Stefan P.] Stefan P Kruszewski MD & Associates, Harrisburg, PA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alexander, GC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St,W6035, Baltimore, MD 21205 USA.	galexand@jhsph.edu			AHRQ HHS [R01 HS0189960] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		American College of Emergency Physicians Opioid Guideline Writing Panel, CLIN POL CRIT ISS PR; Baucus, 2012, GRASSLEY SEEK ANSWER; Centers for Disease Control and Prevention (CDC), 2011, CDC VIT SIGNS PRESCR; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; National Center for Injury Prevention and Control Division of Unintentional Injury Centers for Disease Control and Prevention, 2011, POL IMP PRESCR PAIN; University of Wisconsin Pain and Policy Group, CENTR PRINC BAL	8	70	70	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1865	1866		10.1001/jama.2012.14282	http://dx.doi.org/10.1001/jama.2012.14282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150006				2022-12-24	WOS:000310952700020
J	Bolker, J				Bolker, Jessica			There's more to life than rats and flies	NATURE			English	Editorial Material							MODEL; MICE; BIOLOGY		Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Bolker, J (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	jessica.bolker@unh.edu						Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; BOLKER JA, 1995, BIOESSAYS, V17, P451, DOI 10.1002/bies.950170513; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Kohler R.E., 1994, LORDS FLY DROSOPHILA; Maher B, 2009, NATURE, V458, P695, DOI 10.1038/458695a; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Schnabel J, 2008, NATURE, V454, P682, DOI 10.1038/454682a; von Herrath MG, 2005, J EXP MED, V202, P1159, DOI 10.1084/jem.20051224	10	114	117	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					31	33		10.1038/491031a	http://dx.doi.org/10.1038/491031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23128209	Bronze			2022-12-24	WOS:000310434500013
J	Phrampus, BJ; Hornbach, MJ				Phrampus, Benjamin J.; Hornbach, Matthew J.			Recent changes to the Gulf Stream causing widespread gas hydrate destabilization	NATURE			English	Article							OCEAN; FLOW	The Gulf Stream is an ocean current that modulates climate in the Northern Hemisphere by transporting warm waters from the Gulf of Mexico into the North Atlantic and Arctic oceans(1,2). A changing Gulf Stream has the potential to thaw and convert hundreds of gigatonnes of frozen methane hydrate trapped below the sea floor into methane gas, increasing the risk of slope failure and methane release(3-9). How the Gulf Stream changes with time and what effect these changes have on methane hydrate stability is unclear. Here, using seismic data combined with thermal models, we show that recent changes in intermediate-depth ocean temperature associated with the Gulf Stream are rapidly destabilizing methane hydrate along a broad swathe of the North American margin. The area of active hydrate destabilization covers at least 10,000 square kilometres of the United States eastern margin, and occurs in a region prone to kilometre-scale slope failures. Previous hypothetical studies(3,5) postulated that an increase of five degrees Celsius in intermediate-depth ocean temperatures could release enough methane to explain extreme global warming events like the Palaeocene-Eocene thermal maximum (PETM) and trigger widespread ocean acidification(7). Our analysis suggests that changes in Gulf Stream flow or temperature within the past 5,000 years or so are warming the western North Atlantic margin by up to eight degrees Celsius and are now triggering the destabilization of 2.5 gigatonnes of methane hydrate (about 0.2 per cent of that required to cause the PETM). This destabilization extends along hundreds of kilometres of the margin and may continue for centuries. It is unlikely that the western North Atlantic margin is the only area experiencing changing ocean currents(10-12); our estimate of 2.5 gigatonnes of destabilizing methane hydrate may therefore represent only a fraction of the methane hydrate currently destabilizing globally. The transport from ocean to atmosphere of any methane released-and thus its impact on climate-remains uncertain.	[Phrampus, Benjamin J.; Hornbach, Matthew J.] So Methodist Univ, Huffington Dept Earth Sci, Dallas, TX 75275 USA	Southern Methodist University	Phrampus, BJ (corresponding author), So Methodist Univ, Huffington Dept Earth Sci, Dallas, TX 75275 USA.	bphrampus@mail.smu.edu		Phrampus, Benjamin/0000-0002-6405-3625				Archer D, 2004, EARTH PLANET SC LETT, V222, P333, DOI 10.1016/j.epsl.2004.03.011; Biastoch A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047222; BRYAN GM, 1980, MAR GEOL, V35, P43, DOI 10.1016/0025-3227(80)90021-3; Carpenter G., 1981, GEO-MAR LETT, V1, P29, DOI [10.1007/BF02463298, DOI 10.1007/BF02463298]; DESER C, 1993, J CLIMATE, V6, P1743, DOI 10.1175/1520-0442(1993)006<1743:SCVOTN>2.0.CO;2; Dickens GR, 2001, ORG GEOCHEM, V32, P1179, DOI 10.1016/S0146-6380(01)00086-9; Dillon W. P., 1993, US GEOL SURV PROF PA, V1570, P313; Dugan B, 2000, SCIENCE, V289, P288, DOI 10.1126/science.289.5477.288; Evans HK, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001409; Flemings PB, 2003, GEOLOGY, V31, P1057, DOI 10.1130/G19863.1; Holbrook WS, 1996, SCIENCE, V273, P1840, DOI 10.1126/science.273.5283.1840; Hornbach MJ, 2004, NATURE, V427, P142, DOI 10.1038/nature02172; HUTCHISON I, 1985, GEOPHYS J ROY ASTR S, V82, P439, DOI 10.1111/j.1365-246X.1985.tb05145.x; Kennett JP, 2003, SPEC PUBL SER, V54; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Lund DC, 2006, NATURE, V444, P601, DOI 10.1038/nature05277; Lynch-Stieglitz J, 1999, NATURE, V402, P644, DOI 10.1038/45204; Lynch-Stieglitz J, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002032; MACKENZIE KV, 1981, J ACOUST SOC AM, V70, P801, DOI 10.1121/1.386919; Milton D. J., 1976, FUTURE SUPPLY NATURE, P927; Paull C. K., 1996, P OCEAN DRILLING PRO, V164, P5; Rajan A, 2012, MAR PETROL GEOL, V32, P36, DOI 10.1016/j.marpetgeo.2011.12.008; Ruppel C, 1997, GEOLOGY, V25, P699, DOI 10.1130/0091-7613(1997)025<0699:ACTOAT>2.3.CO;2; RUPPEL C, 1995, J GEOPHYS RES-SOL EA, V100, P20037, DOI 10.1029/95JB01860; SHIPLEY TH, 1979, AAPG BULL, V63, P2204; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Westbrook CD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038186; Winguth A, 2010, J CLIMATE, V23, P2562, DOI 10.1175/2009JCLI3113.1; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; YAMANO M, 1982, GEOLOGY, V10, P339, DOI 10.1130/0091-7613(1982)10<339:EOHFDF>2.0.CO;2	30	111	115	6	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					527	+		10.1038/nature11528	http://dx.doi.org/10.1038/nature11528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23099408				2022-12-24	WOS:000310196200039
J	Sutton, M; Nikolova, S; Boaden, R; Lester, H; McDonald, R; Roland, M				Sutton, Matt; Nikolova, Silviya; Boaden, Ruth; Lester, Helen; McDonald, Ruth; Roland, Martin			Reduced Mortality with Hospital Pay for Performance in England	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; FOR-PERFORMANCE; IMPROVEMENT	BACKGROUND Pay-for-performance programs are being adopted internationally despite little evidence that they improve patient outcomes. In 2008, a program called Advancing Quality, based on the Hospital Quality Incentive Demonstration in the United States, was introduced in all National Health Service (NHS) hospitals in the northwest region of England (population, 6.8 million). METHODS We analyzed 30-day in-hospital mortality among 134,435 patients admitted for pneumonia, heart failure, or acute myocardial infarction to 24 hospitals covered by the pay-for-performance program. We used difference-in-differences regression analysis to compare mortality 18 months before and 18 months after the introduction of the program with mortality in two comparators: 722,139 patients admitted for the same three conditions to the 132 other hospitals in England and 241,009 patients admitted for six other conditions to both groups of hospitals. RESULTS Risk-adjusted, absolute mortality for the conditions included in the pay-for-performance program decreased significantly, with an absolute reduction of 1.3 percentage points (95% confidence interval [CI], 0.4 to 2.1; P = 0.006) and a relative reduction of 6%, equivalent to 890 fewer deaths (95% CI, 260 to 1500) during the 18-month period. The largest reduction, for pneumonia, was significant (1.9 percentage points; 95% CI, 0.9 to 3.0; P<0.001), with nonsignificant reductions for acute myocardial infarction (0.6 percentage points; 95% CI, -0.4 to 1.7; P = 0.23) and heart failure (0.6 percentage points; 95% CI, -0.6 to 1.8; P = 0.30). CONCLUSIONS The introduction of pay for performance in all NHS hospitals in one region of England was associated with a clinically significant reduction in mortality. As compared with a similar U. S. program, the U. K. program had larger bonuses and a greater investment by hospitals in quality-improvement activities. Further research is needed on how implementation of pay-for-performance programs influences their effects. (Funded by the NHS National Institute for Health Research.)	[Sutton, Matt; Nikolova, Silviya] Univ Manchester, Ctr Hlth Econ, Inst Populat Hlth, Manchester M13 9PL, Lancs, England; [Boaden, Ruth] Univ Manchester, Manchester Business Sch, Manchester M13 9PL, Lancs, England; [Lester, Helen] Univ Birmingham, Birmingham, W Midlands, England; [McDonald, Ruth] Univ Nottingham, Sch Business, Nottingham NG7 2RD, England; [Roland, Martin] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge, England	University of Manchester; University of Manchester; University of Birmingham; University of Nottingham; University of Cambridge	Sutton, M (corresponding author), Univ Manchester, Ctr Hlth Econ, Inst Populat Hlth, Rm 1-304,Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	matt.sutton@manchester.ac.uk	McDonald, Ruth/C-3547-2013; Boaden, Ruth/L-3443-2016	Boaden, Ruth/0000-0003-1927-6405; Sutton, Matt/0000-0002-6635-2127; Nikolova, Silviya/0000-0002-6922-5115; Roland, Martin/0000-0002-8533-3060; McDonald, Ruth/0000-0002-3488-4209	NHS National Institute for Health Research; National Health Service National Institute for Health Research; National Institute for Health Research [08/1809/250] Funding Source: researchfish	NHS National Institute for Health Research(National Institute for Health Research (NIHR)); National Health Service National Institute for Health Research; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the NHS National Institute for Health Research.; Supported by the National Health Service National Institute for Health Research.	Bhattacharyya T, 2009, HEALTH AFFAIR, V28, P526, DOI 10.1377/hlthaff.28.2.526; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P26490; Damberg CL, 2009, HEALTH AFFAIR, V28, P517, DOI 10.1377/hlthaff.28.2.517; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Grossbart SR, 2006, MED CARE RES REV, V63, p29S, DOI 10.1177/1077558705283643; Healthcare Commission, ANN HLTH CHECK 2007; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Marini G, 2008, HEALTH ECON, V17, P751, DOI 10.1002/hec.1292; Mehrotra A, 2009, AM J MED QUAL, V24, P19, DOI 10.1177/1062860608326634; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ryan AM, 2011, HEALTH SERV RES, V46, P712, DOI 10.1111/j.1475-6773.2010.01224.x; Ryan AM, 2009, INQUIRY-J HEALTH CAR, V46, P274, DOI 10.5034/inquiryjrnl_46.03.274; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277; Werner RM, 2007, JAMA-J AM MED ASSOC, V297, P700	19	146	151	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1821	1828		10.1056/NEJMsa1114951	http://dx.doi.org/10.1056/NEJMsa1114951			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033DG	23134382	Green Published			2022-12-24	WOS:000310773200009
J	Lembke, A				Lembke, Anna			Why Doctors Prescribe Opioids to Known Opioid Abusers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA	Stanford University	Lembke, A (corresponding author), Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA.							[Anonymous], 2011, PUBL SMA; FASSIN D., 2009, EMPIRE TRAUMA INQUIR; Meldrum ML, 2003, JAMA-J AM MED ASSOC, V290, P2470, DOI 10.1001/jama.290.18.2470; Pizzo PA, 2012, NEW ENGL J MED, V366, P197, DOI 10.1056/NEJMp1109084	4	82	82	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1580	1581		10.1056/NEJMp1208498	http://dx.doi.org/10.1056/NEJMp1208498			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024TO	23094719				2022-12-24	WOS:000310131700002
J	Astrow, AB				Astrow, Alan B.			Cancer Survivorship and Beyond	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Maimonides Hosp, Brooklyn, NY 11219 USA	Maimonides Medical Center	Astrow, AB (corresponding author), Maimonides Hosp, Brooklyn, NY 11219 USA.	aastrow@maimonidesmed.org						[Anonymous], 2006, PION SURV 20 YEARS A, P7; Hoffman B, 2006, J CLIN ONCOL, V24, P5154, DOI 10.1200/JCO.2006.06.5300; Institute of Medicine, 2005, CANC PAT CANC SURV L; MULLAN F, 1985, NEW ENGL J MED, V313, P270, DOI 10.1056/NEJM198507253130421; Mullan F, 1982, VITAL SIGNS YOUNG DO	5	9	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1639	1640		10.1001/jama.2012.13258	http://dx.doi.org/10.1001/jama.2012.13258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093162				2022-12-24	WOS:000310434100017
J	Hagberg, CE; Mehlem, A; Falkevall, A; Muhl, L; Fam, BC; Ortsater, H; Scotney, P; Nyqvist, D; Samen, E; Lu, L; Stone-Elander, S; Proietto, J; Andrikopoulos, S; Sjoholm, A; Nash, A; Eriksson, U				Hagberg, Carolina E.; Mehlem, Annika; Falkevall, Annelie; Muhl, Lars; Fam, Barbara C.; Ortsater, Henrik; Scotney, Pierre; Nyqvist, Daniel; Samen, Erik; Lu, Li; Stone-Elander, Sharon; Proietto, Joseph; Andrikopoulos, Sofianos; Sjoholm, Ake; Nash, Andrew; Eriksson, Ulf			Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes	NATURE			English	Article							GROWTH-FACTOR-B; OXIDATIVE-PHOSPHORYLATION; GLUCOSE-PRODUCTION; SKELETAL-MUSCLE; METABOLISM; TOLERANCE; ISOFORMS	The prevalence of type 2 diabetes is rapidly increasing, with severe socioeconomic impacts(1,2). Excess lipid deposition in peripheral tissues impairs insulin sensitivity and glucose uptake, and has been proposed to contribute to the pathology of type 2 diabetes(3-5). However, few treatment options exist that directly target ectopic lipid accumulation(6). Recently it was found that vascular endothelial growth factor B (VEGF-B) controls endothelial uptake and transport of fatty acids in heart and skeletal muscle(7). Here we show that decreased VEGF-B signalling in rodent models of type 2 diabetes restores insulin sensitivity and improves glucose tolerance. Genetic deletion of Vegfb in diabetic db/db mice prevented ectopic lipid deposition, increased-muscle glucose uptake and maintained normoglycaemia. Pharmacological inhibition of VEGF-B signalling by antibody administration to db/db mice enhanced glucose tolerance, preserved pancreatic islet architecture, improved beta-cell function and ameliorated dyslipidaemia, key elements of type 2 diabetes and the metabolic syndrome. The potential use of VEGF-B neutralization in type 2 diabetes was further elucidated in rats fed a high-fat diet, in which it normalized insulin sensitivity and increased glucose uptake in skeletal muscle and heart. Our results demonstrate that the vascular endothelium can function as an efficient barrier to excess muscle lipid uptake even under conditions of severe obesity and type 2 diabetes, and that this barrier can be maintained by inhibition of VEGF-B signalling. We propose VEGF-B antagonism as a novel pharmacological approach for type 2 diabetes, targeting the lipid-transport properties of the endothelium to improve muscle insulin sensitivity and glucose disposal.	[Hagberg, Carolina E.; Mehlem, Annika; Falkevall, Annelie; Muhl, Lars; Nyqvist, Daniel; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Tissue Biol Grp, SE-17177 Stockholm, Sweden; [Hagberg, Carolina E.; Falkevall, Annelie; Muhl, Lars] Karolinska Inst, Stockholm Branch, Ludwig Inst Canc Res Ltd, SE-17177 Stockholm, Sweden; [Fam, Barbara C.; Proietto, Joseph; Andrikopoulos, Sofianos] Univ Melbourne, Dept Med AH, Heidelberg, Vic 3091, Australia; [Ortsater, Henrik; Sjoholm, Ake] Karolinska Inst, Dept Clin Sci & Educ, Diabet Res Unit, SE-11883 Stockholm, Sweden; [Scotney, Pierre; Nash, Andrew] CSL Ltd, Parkville, Vic 3052, Australia; [Samen, Erik; Lu, Li; Stone-Elander, Sharon] Karolinska Univ Hosp, Dept Neuroradiol, SE-17176 Stockholm, Sweden; [Samen, Erik; Lu, Li; Stone-Elander, Sharon] Karolinska Univ Hosp, Karolinska Expt Res & Imaging Ctr, SE-17176 Stockholm, Sweden; [Samen, Erik; Stone-Elander, Sharon] Karolinska Inst, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research; University of Melbourne; Karolinska Institutet; CSL; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Eriksson, U (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Tissue Biol Grp, SE-17177 Stockholm, Sweden.	ulf.pe.eriksson@ki.se	Mehlem, Annika/AAB-4883-2022	Nyqvist, Daniel/0000-0002-6527-6716; Hagberg, Carolina/0000-0002-5497-2855	Frans Wilhelm och Waldemar von Frenckells Fond; Wilhelm och Else Stockmanns Stiftelse; Swedish Society for Medical Research; Ludwig Institute for Cancer Research; Novo Nordisk Foundation; Swedish Cancer Foundation; Swedish Research Council; Torsten och Ragnar Soderbergs Stiftelser; Dr Peter Wallenbergs Foundation for Economics and Technology; Swedish Heart and Lung Foundation; Diabetes Foundation; Karolinska Institutet	Frans Wilhelm och Waldemar von Frenckells Fond; Wilhelm och Else Stockmanns Stiftelse; Swedish Society for Medical Research; Ludwig Institute for Cancer Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten och Ragnar Soderbergs Stiftelser; Dr Peter Wallenbergs Foundation for Economics and Technology; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Diabetes Foundation; Karolinska Institutet(Karolinska Institutet)	We thank S. Wittgren and A. Gustafsson for technical assistance, and G. Christofori for the RIP VEGF-B mice. C.E.H. was supported by the Frans Wilhelm och Waldemar von Frenckells Fond and Wilhelm och Else Stockmanns Stiftelse. D.N. was supported by the Swedish Society for Medical Research. This study was supported by the Ludwig Institute for Cancer Research, the Novo Nordisk Foundation, the Swedish Cancer Foundation, the Swedish Research Council, Torsten och Ragnar Soderbergs Stiftelser, Dr Peter Wallenbergs Foundation for Economics and Technology, the Swedish Heart and Lung Foundation, the Diabetes Foundation and Karolinska Institutet.	Aase K, 2001, CIRCULATION, V104, P358, DOI 10.1161/01.CIR.104.3.358; Albrecht I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014109; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bostrom P, 2010, DIABETES, V59, P1870, DOI 10.2337/db09-1503; Chaggar PS, 2009, DIABETES VASC DIS RE, V6, P146, DOI 10.1177/1479164109338772; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fujimoto WY., 2000, AM J MED S6A, V108, p9S, DOI DOI 10.1016/S0002-9343(00)00337-5; GENUTH SM, 1971, ENDOCRINOLOGY, V88, P1230, DOI 10.1210/endo-88-5-1230; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Kawasaki F, 2005, AM J PHYSIOL-ENDOC M, V288, pE510, DOI 10.1152/ajpendo.00128.2004; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Lamont BJ, 2003, DIABETOLOGIA, V46, P1338, DOI 10.1007/s00125-003-1180-y; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Mangiafico SP, 2011, J ENDOCRINOL, V210, P335, DOI 10.1530/JOE-11-0126; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muoio DM, 2010, NEW ENGL J MED, V363, P291, DOI 10.1056/NEJMcibr1005397; NOLAN CJ, 1994, DIABETOLOGIA, V37, P976, DOI 10.1007/s001250050207; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schmitz-Peiffer C, 2010, DIABETES, V59, P2351, DOI 10.2337/db10-0912; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Scotney PD, 2002, CLIN EXP PHARMACOL P, V29, P1024, DOI 10.1046/j.1440-1681.2002.03769.x; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Visinoni S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1132, DOI 10.1152/ajpendo.90552.2008; Wong N, 2011, ENDOCRINOLOGY, V152, P3690, DOI 10.1210/en.2011-0288; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	38	201	218	4	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					426	+		10.1038/nature11464	http://dx.doi.org/10.1038/nature11464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23023133				2022-12-24	WOS:000309918500051
J	Lotti, F; Imlach, WL; Saieva, L; Beck, ES; Hao, LT; Li, DK; Jiao, W; Mentis, GZ; Beattie, CE; McCabe, BD; Pellizzoni, L				Lotti, Francesco; Imlach, Wendy L.; Saieva, Luciano; Beck, Erin S.; Hao, Le T.; Li, Darrick K.; Jiao, Wei; Mentis, George Z.; Beattie, Christine E.; McCabe, Brian D.; Pellizzoni, Livio			An SMN-Dependent U12 Splicing Event Essential for Motor Circuit Function	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL; NEURON; DEFECTS; PROTEIN; GENE; ZEBRAFISH; MODEL; BIOGENESIS; DEFICIENCY	Spinal muscular atrophy (SMA) is a motor neuron disease caused by deficiency of the ubiquitous survival motor neuron (SMN) protein. To define the mechanisms of selective neuronal dysfunction in SMA, we investigated the role of SMN-dependent U12 splicing events in the regulation of motor circuit activity. We show that SMN deficiency perturbs splicing and decreases the expression of a subset of U12 intron-containing genes in mammalian cells and Drosophila larvae. Analysis of these SMN target genes identifies Stasimon as a protein required for motor circuit function. Restoration of Stasimon expression in the motor circuit corrects defects in neuromuscular junction transmission and muscle growth in Drosophila SMN mutants and aberrant motor neuron development in SMN-deficient zebrafish. These findings directly link defective splicing of critical neuronal genes induced by SMN deficiency to motor circuit dysfunction, establishing a molecular framework for the selective pathology of SMA.	[Lotti, Francesco; Saieva, Luciano; Li, Darrick K.; Jiao, Wei; Mentis, George Z.; McCabe, Brian D.; Pellizzoni, Livio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Imlach, Wendy L.; Beck, Erin S.; Jiao, Wei; McCabe, Brian D.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Lotti, Francesco; Imlach, Wendy L.; Saieva, Luciano; Beck, Erin S.; Li, Darrick K.; Jiao, Wei; Mentis, George Z.; McCabe, Brian D.; Pellizzoni, Livio] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Hao, Le T.; Beattie, Christine E.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	Columbia University; Columbia University; Columbia University; University System of Ohio; Ohio State University	McCabe, BD (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	brian@mccabelab.org; lp2284@columbia.edu	Imlach, Wendy/G-7609-2011; Lotti, Francesco/AAC-3186-2019; Beck, Erin/AAA-8399-2022	Imlach, Wendy/0000-0002-7521-9969; McCabe, Brian/0000-0003-1620-0501; Pellizzoni, Livio/0000-0002-9168-5628	NIH-NINDS [R01NS069601, R21NS077038, R01NS078375, R01NS050414]; DoD [W81XWH-08-1-0009, W81XWH-11-1-0753, W81XWH-11-1-0689]; SMA Foundation; MDA USA; FSMA A. Lewis Young Investigator Award; Columbia University Motor Neuron Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078375, R01NS069601, R21NS077038, R01NS050414] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DoD(United States Department of Defense); SMA Foundation; MDA USA(Muscular Dystrophy Association); FSMA A. Lewis Young Investigator Award; Columbia University Motor Neuron Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank Chris Henderson for invaluable comments. We are grateful to Spyros Artavanis-Tsakonas and Greg Matera for Drosophila stocks and reagents. This work was supported by grants from NIH-NINDS R01NS069601 and R21NS077038 (L. P.), R01NS078375 (G.Z.M.), and R01NS050414 (C. E. B.); DoD W81XWH-08-1-0009 and W81XWH-11-1-0753 (B. D. M.) and W81XWH-11-1-0689 (G.Z.M.); SMA Foundation (L. P. and C. E. B.); MDA USA (L. P.); FSMA A. Lewis Young Investigator Award (G.Z.M.); and Columbia University Motor Neuron Center (L. P. and B. D. M.).	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Beattie CE, 2007, J CHILD NEUROL, V22, P995, DOI 10.1177/0883073807305671; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dalgin G, 2011, DEVELOPMENT, V138, P4597, DOI 10.1242/dev.067736; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Jodelka FM, 2010, HUM MOL GENET, V19, P4906, DOI 10.1093/hmg/ddq425; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin CF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-47; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Praveen K, 2012, CELL REPORTS, V1, P624, DOI 10.1016/j.celrep.2012.05.014; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	33	226	235	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					440	454		10.1016/j.cell.2012.09.012	http://dx.doi.org/10.1016/j.cell.2012.09.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063131	Bronze, Green Accepted			2022-12-24	WOS:000309981000020
J	Sharpley, MS; Marciniak, C; Eckel-Mahan, K; McManus, M; Crimi, M; Waymire, K; Lin, CS; Masubuchi, S; Friend, N; Koike, M; Chalkia, D; MacGregor, G; Sassone-Corsi, P; Wallace, DC				Sharpley, Mark S.; Marciniak, Christine; Eckel-Mahan, Kristin; McManus, Meagan; Crimi, Marco; Waymire, Katrina; Lin, Chun Shi; Masubuchi, Satoru; Friend, Nicole; Koike, Maya; Chalkia, Dimitra; MacGregor, Grant; Sassone-Corsi, Paolo; Wallace, Douglas C.			Heteroplasmy of Mouse mtDNA Is Genetically Unstable and Results in Altered Behavior and Cognition	CELL			English	Article							MAMMALIAN MITOCHONDRIAL-DNA; EVOLUTIONARY MEDICINE; SPERM MITOCHONDRIA; RAPID SEGREGATION; SELECTION; TRANSMISSION; BOTTLENECK; MODEL; MICE; REPLICATION	Maternal inheritance of mtDNA is the rule in most animals, but the reasons for this pattern remain unclear. To investigate the consequence of overriding uniparental inheritance, we generated mice containing an admixture (heteroplasmy) of NZB and 129S6 mtDNAs in the presence of a congenic C57BL/6J nuclear background. Analysis of the segregation of the two mtDNAs across subsequent maternal generations revealed that proportion of NZB mtDNA was preferentially reduced. Ultimately, this segregation process produced NZB-129 heteroplasmic mice and their NZB or 129 mtDNA homoplasmic counterparts. Phenotypic comparison of these three mtDNA lines demonstrated that the NZB-129 heteroplasmic mice, but neither homoplasmic counterpart, had reduced activity, food intake, respiratory exchange ratio; accentuated stress response; and cognitive impairment. Therefore, admixture of two normal but different mouse mtDNAs can be genetically unstable and can produce adverse physiological effects, factors that may explain the advantage of uniparental inheritance of mtDNA.	[Sharpley, Mark S.; McManus, Meagan; Lin, Chun Shi; Friend, Nicole; Koike, Maya; Chalkia, Dimitra; Wallace, Douglas C.] Univ Penn, Ctr Mitochondrial & Epigen Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Sharpley, Mark S.; McManus, Meagan; Lin, Chun Shi; Friend, Nicole; Koike, Maya; Chalkia, Dimitra; Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Sharpley, Mark S.; Marciniak, Christine; Crimi, Marco; Waymire, Katrina; Lin, Chun Shi; Friend, Nicole; Chalkia, Dimitra; MacGregor, Grant; Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; [Sharpley, Mark S.; Marciniak, Christine; Eckel-Mahan, Kristin; Crimi, Marco; Waymire, Katrina; Lin, Chun Shi; Friend, Nicole; Chalkia, Dimitra; Sassone-Corsi, Paolo; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Eckel-Mahan, Kristin; Masubuchi, Satoru; Sassone-Corsi, Paolo] Univ Calif Irvine, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Waymire, Katrina; MacGregor, Grant] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wallace, DC (corresponding author), Univ Penn, Ctr Mitochondrial & Epigen Med, Childrens Hosp Philadelphia, Colket Translat Res Bldg, Philadelphia, PA 19104 USA.	wallaced1@email.chop.edu	Chalkia, Dimitra/J-3793-2016; Crimi, Marco/A-4032-2008; McManus, Meagan J/F-7932-2018	Chalkia, Dimitra/0000-0003-4780-544X; Crimi, Marco/0000-0001-6903-9163; McManus, Meagan J/0000-0001-6064-0665; Eckel-Mahan, Kristin/0000-0001-8201-1675	NIH [HD36437, HD45913, NS21328, NS070298, AG24373, DK73691]; California Institute of Regenerative Medicine [RC1-00353]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036437, U01HD045913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070298, R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We express our special appreciation for the technical contributions of Prasanth Potluri, PhD, Marie Lott, Christopher deSolis, Kierstin Keller, Stefanie Navarro, and Paulette Allard. This work was supported by NIH grants HD36437 and HD45913 to G. R. M. and NS21328, NS070298, AG24373, and DK73691, and California Institute of Regenerative Medicine grant RC1-00353 awarded to D. C. W.	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; ALONSO SJ, 1991, PHYSIOL BEHAV, V49, P69, DOI 10.1016/0031-9384(91)90232-D; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Etain B, 2011, EUR NEUROPSYCHOPHARM, V21, pS676, DOI 10.1016/j.euroneuro.2011.07.007; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Flaisher-Grinberg S, 2010, J PSYCHOPHARMACOL, V24, P437, DOI 10.1177/0269881108097905; Gindre C, 2010, ENCEPHALE, V36, pD92, DOI 10.1016/j.encep.2008.09.006; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Hadjivasiliou Z, 2012, P ROY SOC B-BIOL SCI, V279, P1865, DOI 10.1098/rspb.2011.1871; Hogan B, 1994, MANIPULATING MOUSE E; Isobe Y, 2011, J NEUROSCI RES, V89, P929, DOI 10.1002/jnr.22609; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Jokinen R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001161; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051; Lane N, 2011, SCIENCE, V334, P184, DOI 10.1126/science.1214012; Minassian A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024185; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; Phillips D, 2012, AM J PHYSIOL-REG I, V302, pR1034, DOI 10.1152/ajpregu.00596.2011; Poole JC, 2010, BIOL CHEM, V391, P1115, DOI 10.1515/BC.2010.125; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sartori SB, 2012, NEUROPHARMACOLOGY, V62, P304, DOI 10.1016/j.neuropharm.2011.07.027; Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597; SOLIGNAC M, 1987, GENETICS, V117, P687; Sportiche N, 2010, NEUROSCIENCE, V170, P247, DOI 10.1016/j.neuroscience.2010.06.038; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Sutovsky P, 2003, BIOL REPROD, V68, P1793, DOI 10.1095/biolreprod.102.012799; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808	47	243	249	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					333	343		10.1016/j.cell.2012.09.004	http://dx.doi.org/10.1016/j.cell.2012.09.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063123	Bronze, Green Accepted			2022-12-24	WOS:000309981000012
J	Chang, HH; Larson, J; Blencowe, H; Spong, CY; Howson, CP; Cairns-Smith, S; Lackritz, EM; Lee, SK; Mason, E; Serazin, AC; Walani, S; Simpson, JL; Lawn, JE				Chang, Hannah H.; Larson, Jim; Blencowe, Hannah; Spong, Catherine Y.; Howson, Christopher P.; Cairns-Smith, Sarah; Lackritz, Eve M.; Lee, Shoo K.; Mason, Elizabeth; Serazin, Andrew C.; Walani, Salimah; Simpson, Joe Leigh; Lawn, Joy E.		Born Too Soon Preterm Prevention A	Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index	LANCET			English	Article							PREGNANT-WOMEN; SYSTEMATIC ANALYSIS; CERVICAL PESSARY; TIME TRENDS; SMOKING; RATES; RISK; PROGESTERONE; OUTCOMES; METAANALYSIS	Background Every year, 1.1 million babies die from prematurity, and many survivors are disabled. Worldwide, 15 million babies are born preterm (<37 weeks' gestation), with two decades of increasing rates in almost all countries with reliable data. The understanding of drivers and potential benefit of preventive interventions for preterm births is poor. We examined trends and estimate the potential reduction in preterm births for countries with very high human development index (VHHDI) if present evidence-based interventions were widely implemented. This analysis is to inform a rate reduction target for Born Too Soon. Methods Countries were assessed for inclusion based on availability and quality of preterm prevalence data (2000-10), and trend analyses with projections undertaken. We analysed drivers of rate increases in the USA, 1989-2004. For 39 countries with VHHDI with more than 10 000 births, we did country-by-country analyses based on target population, incremental coverage increase, and intervention efficacy. We estimated cost savings on the basis of reported costs for preterm care in the USA adjusted using World Bank purchasing power parity. Findings From 2010, even if all countries with VHHDI achieved annual preterm birth rate reductions of the best performers for 1990-2010 (Estonia and Croatia), 2000-10 (Sweden and Netherlands), or 2005-10 (Lithuania, Estonia), rates would experience a relative reduction of less than 5% by 2015 on average across the 39 countries. Our analysis of preterm birth rise 1989-2004 in USA suggests half the change is unexplained, but important drivers include non-medically indicated labour induction and caesarean delivery and assisted reproductive technologies. For all 39 countries with VHHDI, five interventions modelling at high coverage predicted a 5% relative reduction of preterm birth rate from 9.59% to 9.07% of livebirths: smoking cessation (0.01 rate reduction), decreasing multiple embryo transfers during assisted reproductive technologies (0.06), cervical cerclage (0.15), progesterone supplementation (0.01), and reduction of non-medically indicated labour induction or caesarean delivery (0.29). These findings translate to roughly 58 000 preterm births averted and total annual economic cost savings of about US$3 billion. Interpretation We recommend a conservative target of a relative reduction in preterm birth rates of 5% by 2015. Our findings highlight the urgent need for research into underlying mechanisms of preterm births, and development of innovative interventions. Furthermore, the highest preterm birth rates occur in low-income settings where the causes of prematurity might differ and have simpler solutions such as birth spacing and treatment of infections in pregnancy than in high-income countries. Urgent focus on these settings is also crucial to reduce preterm births worldwide.	[Chang, Hannah H.; Larson, Jim; Cairns-Smith, Sarah] Boston Consulting Grp Inc, Boston, MA USA; [Blencowe, Hannah] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Howson, Christopher P.; Walani, Salimah; Simpson, Joe Leigh] March Dimes Fdn, White Plains, NY USA; [Lackritz, Eve M.] Alliance Prevent Prematur & Stillbirth, Seattle, WA USA; [Lee, Shoo K.] Canadian Inst Hlth Res, Inst Human Dev Child & Youth Hlth, Toronto, ON, Canada; [Mason, Elizabeth] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Serazin, Andrew C.] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA USA; [Lawn, Joy E.] Save Children, Saving Newborn Lives, London, England	Boston Consulting Group (BCG); University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Institute for Work & Health; World Health Organization; Bill & Melinda Gates Foundation; Save the Children	Lawn, JE (corresponding author), Save Children, Saving Newborn Lives, London, England.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020; Lee, Shoo K/P-3016-2015	Lawn, Joy/0000-0002-4573-1443; Lackritz, Eve/0000-0002-5397-7291; Blencowe, Hannah/0000-0003-1556-3159	March of Dimes, USA; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health, USA; March of Dimes; Bill & Melinda Gates Foundation	March of Dimes, USA(March of Dimes); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	March of Dimes, USA, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Institutes of Health, USA.; The time of HHC, JL, and SC-S was funded by the March of Dimes and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. JEL's time was funded by a grant from the Bill & Melinda Gates Foundation to Save the Children's Saving Newborn Lives programme. HB's time was funded by a grant from the Bill & Melinda Gates Foundation to the Child Health Epidemiology Reference Group. We thank Simon Cousens of the London School of Hygiene and Tropical Medicine and Craig Rubens of the Global Alliance to Prevent Prematurity and Stillbirth for technical review. We are grateful to Lori McDougall of the Partnership for Maternal Newborn and Child Health, Lily Kak of USAID, Tola Ladejobi of Boston Consulting Group, Judith Palais, and Rachel Diamond of the March of Dimes for support.	Aly H, 2010, J PERINATOL, V30, P447, DOI 10.1038/jp.2009.117; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Behrman RE, 2007, PRETERM BIRTH CAUSES, V6; Berghella V, 2012, AM J OBSTET GYNECOL, V206, P376, DOI 10.1016/j.ajog.2012.03.010; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Bhattacharya S, 2010, OBSTET GYNECOL, V115, P1125, DOI 10.1097/AOG.0b013e3181dffcdb; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brose LS, 2011, THORAX, V66, P924, DOI 10.1136/thoraxjnl-2011-200251; Centers for Disease Control and Prevention American Society for Reproductive Medicine and Society for Assisted Reproductive Technology, 2009, 2009 ASS REPR TECHN; Centers for Disease Control and Prevention ASfRM Society for Assisted Reproductive Technology, 2011, 2009 ASS REPR TECHN; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cobb NK, 2005, NICOTINE TOB RES, V7, P207, DOI 10.1080/14622200500055319; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Declercq E, 2006, AM J PUBLIC HEALTH, V96, P867, DOI 10.2105/AJPH.2004.052381; Dodd JM, 2006, COCHRANE DB SYST REV, V1; Dodd JM, 2008, OBSTET GYNECOL, V112, P127, DOI 10.1097/AOG.0b013e31817d0262; Donovan EF, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.044; Ferraretti AP, 2012, HUM REPROD, V27, P2571, DOI 10.1093/humrep/des255; Filion KB, 2011, BJOG-INT J OBSTET GY, V118, P1422, DOI 10.1111/j.1471-0528.2011.03065.x; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Fritz MA, 2009, FERTIL STERIL, V92, P1518, DOI 10.1016/j.fertnstert.2009.08.059; Gibbons L, 2010, WORLD HEALTH REPORT; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Houda M, 2012, LANCET, V380, P886, DOI 10.1016/S0140-6736(12)61503-7; Howson CP, 2012, MARCH DIMES PMNCH SA; Hui ASY, 2012, LANCET, V380, P887, DOI 10.1016/S0140-6736(12)61504-9; Kim SY, 2009, AM J PUBLIC HEALTH, V99, P893, DOI 10.2105/AJPH.2008.144485; Kramer MS, 2012, AM J OBSTET GYNECOL, V206, P108, DOI 10.1016/j.ajog.2011.10.864; Lanting CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008363; Laughon SK, 2010, OBSTET GYNECOL, V116, P1047, DOI 10.1097/AOG.0b013e3181f73f97; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Martin JA., 2009, NATL VITAL STAT REP, V57, P1; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Melendez J, 2012, LANCET, V380, P886, DOI 10.1016/S0140-6736(12)61502-5; Mugo M, 2005, CURR HYPERTENS REP, V7, P348, DOI 10.1007/s11906-005-0068-2; Murphy HR, 2011, DIABETIC MED, V28, P1060, DOI 10.1111/j.1464-5491.2011.03333.x; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Norman JE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-79; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Osterman Michelle J K, 2011, Natl Vital Stat Rep, V59, P1; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; Reddy UM, 2009, PEDIATRICS, V124, P234, DOI 10.1542/peds.2008-3232; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; TESTART J, 1992, HUM REPROD, V7, P362, DOI 10.1093/oxfordjournals.humrep.a137651; U.S. Census Bureau, 2011, STAT ABSTR US 2012; van der Klis KAM, 2002, AUST NZ J PUBL HEAL, V26, P125, DOI 10.1111/j.1467-842X.2002.tb00904.x; VanderWeele TJ, 2012, SOC SCI MED, V74, P196, DOI 10.1016/j.socscimed.2011.10.031; Zhang X, 2012, BJOG-INT J OBSTET GY, V119, P1309, DOI 10.1111/j.1471-0528.2012.03453.x	54	352	375	3	116	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2013	381	9862					223	234		10.1016/S0140-6736(12)61856-X	http://dx.doi.org/10.1016/S0140-6736(12)61856-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075LL	23158883	Green Accepted			2022-12-24	WOS:000313887600034
J	Okuda, S; Freinkman, E; Kahne, D				Okuda, Suguru; Freinkman, Elizaveta; Kahne, Daniel			Cytoplasmic ATP Hydrolysis Powers Transport of Lipopolysaccharide Across the Periplasm in E-coli	SCIENCE			English	Article							OUTER-MEMBRANE; INNER-MEMBRANE; GENETIC-CODE; FUNCTIONAL-ANALYSIS; PROTEIN COMPLEX; CELL-ENVELOPE; IDENTIFICATION; MECHANISM; SURFACE; EXPORT	Millions of molecules of lipopolysaccharide (LPS) must be assembled on the Escherichia coli cell surface each time the cell divides. The biogenesis of LPS requires seven essential lipopolysaccharide transport (Lpt) proteins to move LPS from the inner membrane through the periplasm to the cell surface. However, no intermediate transport states have been observed. We developed methods to observe intermediate LPS molecules bound to Lpt proteins in the process of being transported in vivo. Movement of individual LPS molecules along these binding sites required multiple rounds of adenosine triphosphate (ATP) hydrolysis in vitro, which suggests that ATP is used to push a continuous stream of LPS through a transenvelope bridge in discrete steps against a concentration gradient.	[Okuda, Suguru; Freinkman, Elizaveta; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kahne, Daniel] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kahne@chemistry.harvard.edu	Okuda, Suguru/K-6571-2017	Okuda, Suguru/0000-0002-9184-5601	NIH [AI081059, GM066174]; Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The plasmid pSup-BpaRS-6TRN was a gift from P. G. Schultz (Scripps Research Institute). We thank C. Hagan for valuable discussion. Supported by NIH grants AI081059 and GM066174 (D.K.) and a Fannie and John Hertz Foundation graduate fellowship (E.F.).	Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; KABACK HR, 1966, P NATL ACAD SCI USA, V55, P920, DOI 10.1073/pnas.55.4.920; KIM YJ, 1994, CELL, V78, P845; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yakushi T, 1998, J BIOL CHEM, V273, P32576, DOI 10.1074/jbc.273.49.32576	27	139	141	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1214	1217		10.1126/science.1228984	http://dx.doi.org/10.1126/science.1228984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23138981	Green Accepted			2022-12-24	WOS:000311666200047
J	Hernandez, AF; Mi, XJ; Hammill, BG; Hammill, SC; Heidenreich, PA; Masoudi, FA; Qualls, LG; Peterson, ED; Fonarow, GC; Curtis, LH				Hernandez, Adrian F.; Mi, Xiaojuan; Hammill, Bradley G.; Hammill, Stephen C.; Heidenreich, Paul A.; Masoudi, Frederick A.; Qualls, Laura G.; Peterson, Eric D.; Fonarow, Gregg C.; Curtis, Lesley H.			Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CLINICAL-TRIALS; OLDER PATIENTS; SPIRONOLACTONE; HYPERKALEMIA; STATES; RATES; CARE	Context Aldosterone antagonist therapy for heart failure and reduced ejection fraction has been highly efficacious in randomized trials. However, questions remain regarding the effectiveness and safety of the therapy in clinical practice. Objective To examine the clinical effectiveness of newly initiated aldosterone antagonist therapy among older patients hospitalized with heart failure and reduced ejection fraction. Design, Setting, and Participants Using clinical registry data linked to Medicare claims from 2005 through 2010, we examined outcomes of eligible patients hospitalized with heart failure and reduced ejection fraction. We used Cox proportional hazards models and inverse-weighted estimates of the probability of treatment to adjust for treatment selection bias. Main Outcome Measures All-cause mortality, cardiovascular readmission, and heart failure readmission at 3 years, and hyperkalemia readmission at 30 days and 1 year. Results Among 5887 patients who met the inclusion criteria, the mean age was 77.6 years; of those 1070 (18.2%) started aldosterone antagonist therapy at discharge. Cumulative incidence rates among treated and untreated patients were 49.9% vs 51.2% (P=.62) for mortality; 63.8% vs 63.9% (P=.65) for cardiovascular readmission; and 38.7% vs 44.9% (P<.001) for heart failure readmission at 3 years; and 2.9% vs 1.2% (P<.001) for hyperkalemia readmission within 30 days and 8.9% vs 6.3% (P=.002) within 1 year. After inverse weighting for the probability of treatment, there were no significant differences in mortality (hazard ratio [HR], 1.04; 95% CI, 0.96-1.14; P=.32) and cardiovascular readmission (HR, 1.00; 95% CI, 0.91-1.09; P=.94). Heart failure readmission was lower among treated patients at 3 years (HR, 0.87; 95% CI, 0.77-0.98; P=.02). Readmission associated with hyperkalemia was higher with aldosterone antagonist therapy at 30 days (HR, 2.54; 95% CI, 1.51-4.29; P<.001) and 1 year (HR, 1.50; 95% CI, 1.23-1.84; P<.001). Conclusions Initiation of aldosterone antagonist therapy at hospital discharge was not independently associated with improved mortality or cardiovascular readmission but was associated with improved heart failure readmission among eligible older patients with heart failure and reduced ejection fraction. There was a significant increase in the risk of readmission with hyperkalemia, predominantly within 30 days after discharge. JAMA. 2012;308(20):2097-2107 www.jama.com	[Hernandez, Adrian F.; Mi, Xiaojuan; Qualls, Laura G.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Hernandez, Adrian F.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Heidenreich, Paul A.] VA Palo Alto Healthcare Syst, Palo Alto, CA USA; [Masoudi, Frederick A.] Univ Colorado Anschutz Med Campus, Aurora, CO USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA	Duke University; Duke University; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Peterson, Eric David/ABF-5033-2021; Masoudi, Frederick/Q-7467-2019; Fonarow, Gregg C/D-5988-2014; Heidenreich, Paul/AAU-6864-2021; Hernandez, Adrian F/A-7818-2016	Fonarow, Gregg C/0000-0002-3192-8093; Heidenreich, Paul/0000-0001-7730-8490; Hernandez, Adrian F/0000-0003-3387-9616	Amylin Pharmaceutical; Johnson Johnson; American College of Cardiology; Oklahoma Foundation for Medical Quality; American Heart Association; Massachusetts Medical Society; Eli Lilly Co; GlaxoSmithKline; Ahmanson Foundation; National Heart, Lung, and Blood Institute; (Duke University DEcIDE Center) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services [HHSA29020050032I]; Agency for Healthcare Research and Quality [U19HS021092]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021092] Funding Source: NIH RePORTER	Amylin Pharmaceutical(Bristol-Myers Squibb); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); American College of Cardiology(General Electric); Oklahoma Foundation for Medical Quality; American Heart Association(American Heart Association); Massachusetts Medical Society; Eli Lilly Co(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Ahmanson Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); (Duke University DEcIDE Center) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hernandez reported receiving grant funding from Amylin Pharmaceutical and Johnson & Johnson; and receiving honoraria from AstraZeneca, Corthera, and sanofi-aventis. Dr Masoudi reported receiving salary support through his institution from the American College of Cardiology and the Oklahoma Foundation for Medical Quality; and receiving payment for editorial board service from the American Heart Association and the Massachusetts Medical Society. Dr Peterson reported receiving grant funding from Eli Lilly& Co and Johnson & Johnson. Dr Fonarow reported receiving grant funding and other research support from GlaxoSmithKline; receiving honoraria from Boston Scientific/Guidant, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, and St Jude Medical; and serving as a consultant for Amgen, Gambro, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Relypsa, Scios, and St Jude Medical. Dr Fonarow holds the Eliot Corday Chair of Cardiovascular Medicine at UCLA and is also supported by the Ahmanson Foundation. Dr Curtis reported receiving grant funding from GlaxoSmithKline, Johnson & Johnson, and the National Heart, Lung, and Blood Institute. Drs Hernandez, Setoguchi, Peterson, and Curtis have made available online detailed listings of financial disclosures (https://www.dcri.org/about-us/conflict-of-interest).; This study was funded under contract number HHSA29020050032I (Duke University DEcIDE Center) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. Dr Peterson was supported in part by grant number U19HS021092 from the Agency for Healthcare Research and Quality. Get With the Guidelines-Heart Failure is provided by the American Heart Association; is currently supported in part by Medtronic, Ortho-McNeil, and the American Heart Association Pharmaceutical Roundtable; and had been funded through support from GlaxoSmithKline.	Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Cherubini A, 2011, ARCH INTERN MED, V171, P550, DOI 10.1001/archinternmed.2011.31; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Curtis LH, 2012, AM HEART J, V163, P946, DOI 10.1016/j.ahj.2012.03.007; Dreyer NA, 2010, AM J MANAG CARE, V16, P467; Ezekowitz JA, 2009, EUR HEART J, V30, P469, DOI 10.1093/eurheartj/ehn543; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Fonarow GC, 2012, J AM HEART ASSOC, V1, P16, DOI 10.1161/JAHA.111.000018; Fonarow GC, 2011, AM HEART J, V161, P1024, DOI 10.1016/j.ahj.2011.01.027; Fonarow GC, 2011, CIRCULATION, V123, P1601, DOI 10.1161/CIRCULATIONAHA.110.989632; Ghali JK, 2010, J AM COLL CARDIOL, V56, P2077, DOI 10.1016/j.jacc.2010.07.013; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hamaguchi S, 2010, AM HEART J, V160, P1156, DOI 10.1016/j.ahj.2010.08.036; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Hernandez AF, 2010, AM HEART J, V159, P406, DOI 10.1016/j.ahj.2009.12.024; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jessup M, 2009, J AM COLL CARDIOL, V53, P1343, DOI 10.1016/j.jacc.2008.11.009; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Levine M, 2008, USERS GUIDES MED LIT, P363; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; MANTEL N, 1974, J AM STAT ASSOC, V69, P81, DOI 10.2307/2285503; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Tamirisa KP, 2004, AM HEART J, V148, P971, DOI 10.1016/j.ahj.2004.10.005; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	32	99	101	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2097	2107		10.1001/jama.2012.14795	http://dx.doi.org/10.1001/jama.2012.14795			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188026	Bronze			2022-12-24	WOS:000311537200024
J	Byers, J; Dunn, S				Byers, John; Dunn, Stacey			Bateman in Nature: Predation on Offspring Reduces the Potential for Sexual Selection	SCIENCE			English	Article							MATE CHOICE; MATING SUCCESS; VARIANCE	Sexual selection is driven by competition for mates, and the advantage of a competitor is determined by the number of offspring it produces. Early experiments by Angus Bateman characterized this interaction, and the quantitative relationship between a male's number of mates and number of offspring is known as the Bateman slope. Sexual dimorphism, one of the most obvious results of sexual selection, largely requires a positive Bateman relationship, and the slope provides an estimate of the potential for sexual selection. However, natural selection from the environment can also influence male success, as can random effects, and some have argued for inclusion of the latter in calculations of mate success. Data from pronghorn (Antilocapra americana) reveal the presence of a positive Bateman slope in each year of a 10-year study. We found no evidence that random effects skewed male mating success; however, substantial yearly variation in the Bateman slope due to predation on fawns was evident. These results support the validity of the Bateman relationship, yet they also demonstrate that environmental or extrinsic influences can limit the potential for sexual selection.	[Byers, John; Dunn, Stacey] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	Idaho; University of Idaho	Byers, J (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.	jbyers@uidaho.edu			U.S. Fish and Wildlife Service; NSF [9808377, 0097115, 0738012]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); NSF(National Science Foundation (NSF))	We thank the dozens of field volunteers who helped build our data set, L. Waits for laboratory guidance, S. Nuismer for statistical consultation, and the U.S. Fish and Wildlife Service for access permits and support. Supported by NSF grants 9808377, 0097115, and 0738012 to J.B. Data location: Dryad Digital Repository (http://datadryad.org/handle/10255/dryad.34974).	ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; Barnowe-Meyer KK, 2010, J MAMMAL, V91, P712, DOI 10.1644/09-MAMM-A-057.1; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Byers J.A., 1997, AM PRONGHORN SOCIAL; Byers J. A., 2006, P 22 BIENN PRONGH WO, V22, P27; Byers JA, 1997, J MAMMAL, V78, P894, DOI 10.2307/1382948; BYERS JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P147, DOI 10.1007/BF00293804; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; HUBBELL SP, 1987, AM NAT, V130, P91, DOI 10.1086/284700; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; Jones AG, 2009, EVOLUTION, V63, P1673, DOI 10.1111/j.1558-5646.2009.00664.x; SUTHERLAND WJ, 1985, ANIM BEHAV, V33, P1349, DOI 10.1016/S0003-3472(85)80197-4; Wade MJ, 2010, HEREDITY, V105, P507, DOI 10.1038/hdy.2010.8	14	23	23	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					802	804		10.1126/science.1224660	http://dx.doi.org/10.1126/science.1224660			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139332				2022-12-24	WOS:000310839500045
J	Knudsen, AB; Hur, C; Gazelle, GS; Schrag, D; McFarland, EG; Kuntz, KM				Knudsen, Amy B.; Hur, Chin; Gazelle, G. Scott; Schrag, Deborah; McFarland, Elizabeth G.; Kuntz, Karen M.			Rescreening of Persons With a Negative Colonoscopy Result: Results From a Microsimulation Model	ANNALS OF INTERNAL MEDICINE			English	Article							FECAL OCCULT-BLOOD; AMERICAN-CANCER-SOCIETY; RANDOMIZED CONTROLLED-TRIAL; ON-COLORECTAL-CANCER; SERVICES TASK-FORCE; CT COLONOGRAPHY; SCREENING COLONOSCOPY; MEDICARE POPULATION; LARGE-INTESTINE; LARGE-BOWEL	Background: Persons with a negative result on screening colonoscopy are recommended to repeat the procedure in 10 years. Objective: To assess the effectiveness and costs of colonoscopy versus other rescreening strategies after an initial negative colonoscopy result. Design: Microsimulation model. Data Sources: Literature and data from the Surveillance, Epidemiology, and End Results program. Target Population: Persons aged 50 years who had no adenomas or cancer detected on screening colonoscopy. Time Horizon: Lifetime. Perspective: Societal. Intervention: No further screening or rescreening starting at age 60 years with colonoscopy every 10 years, annual highly sensitive guaiac fecal occult blood testing (HSFOBT), annual fecal immuno-chemical testing (FIT), or computed tomographic colonography (CTC) every 5 years. Outcome Measures: Lifetime cases of colorectal cancer, life expectancy, and lifetime costs per 1000 persons, assuming either perfect or imperfect adherence. Results of Base-Case Analysis: Rescreening with any method substantially reduced the risk for colorectal cancer compared with no further screening (range, 7.7 to 12.6 lifetime cases per 1000 persons [perfect adherence] and 17.7 to 20.9 lifetime cases per 1000 persons [imperfect adherence] vs. 31.3 lifetime cases per 1000 persons with no further screening). In both adherence scenarios, the differences in life-years across rescreening strategies were small (range, 30 893 to 30 902 life-years per 1000 persons [perfect adherence] vs. 30 865 to 30 869 life-years per 1000 persons [imperfect adherence]). Rescreening with HSFOBT, FIT, or CTC had fewer complications and was less costly than continuing colonoscopy. Results of Sensitivity Analysis: Results were sensitive to test-specific adherence rates. Limitation: Data on adherence to rescreening were limited. Conclusion: Compared with the currently recommended strategy of continuing colonoscopy every 10 years after an initial negative examination, rescreening at age 60 years with annual HSFOBT, annual FIT, or CTC every 5 years provides approximately the same benefit in life-years with fewer complications at a lower cost. Therefore, it is reasonable to use other methods to rescreen persons with negative colonoscopy results.	[Knudsen, Amy B.] Harvard Univ, Massachusetts Gen Hosp, Sch Publ Hlth, Inst Technol Assessment, Boston, MA 02114 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; SSM St Joseph Hosp, St Charles, MO USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; University of Minnesota System; University of Minnesota Twin Cities	Knudsen, AB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Publ Hlth, Inst Technol Assessment, 101 Merrimac St,10th Floor, Boston, MA 02114 USA.	aknudsen@mgh-ita.org		Hur, Chin/0000-0002-2819-7576	National Cancer Institute, National Institutes of Health [RC1CA147256, U01CA088204, U01CA152959]; National Cancer Institute; NATIONAL CANCER INSTITUTE [U01CA088204, RC1CA147256, U01CA152959] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By award RC1CA147256 and grants U01CA088204 and U01CA152959 from the National Cancer Institute, National Institutes of Health.; Primary Funding Source: National Cancer Institute.	Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Centers for Medicare & Medicaid Services (CMS) HHS, 2006, FED REG, V71, P69623; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; de Gonzalez AB, 2011, AM J ROENTGENOL, V196, P816, DOI 10.2214/AJR.10.4907; Ding A, 2011, RADIOL CLIN N AM, V49, P257, DOI 10.1016/j.rcl.2010.11.004; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Gellad ZF, 2011, AM J GASTROENTEROL, V106, P1125, DOI 10.1038/ajg.2011.11; Ho W, 2010, AM J ROENTGENOL, V195, P393, DOI 10.2214/AJR.09.3500; Hol L, 2009, BRIT J CANCER, V100, P1103, DOI 10.1038/sj.bjc.6604961; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Jonas DE, 2007, AM J GASTROENTEROL, V102, P2401, DOI 10.1111/j.1572-0241.2007.01387.x; Klabunde CN, 2011, CANCER EPIDEM BIOMAR, V20, P1611, DOI 10.1158/1055-9965.EPI-11-0220; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Kuntz KM, 2011, MED DECIS MAKING, V31, P530, DOI 10.1177/0272989X11408730; Lansdorp-Vogelaar I, 2010, ANN INTERN MED, V153, P368, DOI 10.7326/0003-4819-153-6-201009210-00004; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Moawad FJ, 2010, AM J ROENTGENOL, V195, P1118, DOI 10.2214/AJR.10.4921; National Center for Health Statistics, 2009, 2008 NAT HLTH INT SU; Pickhardt PJ, 2011, RADIOLOGY, V259, P393, DOI 10.1148/radiol.11101887; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Population Division U.S. Census Bureau, 2009, NCEST200801 US CENS; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Scholefield JH, 2002, GUT, V50, P840, DOI 10.1136/gut.50.6.840; Schwartz DC, 2008, AM J GASTROENTEROL, V103, P346, DOI 10.1111/j.1572-0241.2007.01586.x; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Thomson PDR, 2010, RED BOOK PHARM FUNDA; U.S. Bureau of Labor Statistics, 2011, NAT COMP SURV OCC EA; U.S. Census Bureau, 2011, STAT ABSTR US 2012; van Ballegooijen M, 2011, MED DECIS MAKING, V31, P540, DOI 10.1177/0272989X11408915; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yabroff KR, 2005, MED CARE, V43, P640, DOI 10.1097/01.mlr.0000167177.45020.4a; Zauber AG, 2007, COST EFFECTIVENESS D; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	64	23	23	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					611	+		10.7326/0003-4819-157-9-201211060-00005	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128861	Green Accepted			2022-12-24	WOS:000310783300002
J	McCartney, M				McCartney, Margaret			The assault on the Liverpool care pathway	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2010, DAILY MAIL; [Anonymous], 2004, DAILY MAIL; [Anonymous], 2012, DAILY MAIL; Boggan S., 2009, DAILY MAIL; Catholic Herald, 2010, CATHOLIC HERALD 0423; Christian Medical Comment, 2012, LIVERPOOL CARE PATHW; Clarke N., DIS NHS KILL MY MOTH; Doughty, 2012, DAILY MAIL; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6654; Maes N., 2011, DAILY MAIL; Marie Curie Palliative Care Institute Liverpool, 2010, WHAT IS LIV CAR PATH; Phillips M., 2012, DAILY MAIL; Preston M, 2007, END LIFE CARE, V1, P1	13	14	14	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 30	2012	345								e7316	10.1136/bmj.e7316	http://dx.doi.org/10.1136/bmj.e7316			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EY	23112122				2022-12-24	WOS:000310778200019
J	Kaufman, F				Kaufman, Frederick			Wall Street's thirst for water	NATURE			English	Editorial Material									CUNY, Grad Sch Journalism, New York, NY 10018 USA	City University of New York (CUNY) System	Kaufman, F (corresponding author), CUNY, Grad Sch Journalism, New York, NY 10018 USA.							Brookshire D. S., 2011, RFF PRESS WATER POLI; Ghosh N, 2010, COMMODITY VISION, V4, P8; Global Water Partnership and International Network of Basin Organizations, 2009, HDB INT WAT RES MAN; Kaufman F., 2011, FOREIGN POLICY; Keim B., 2012, WIRED SCI       0306; Lagi M, 2011, PREPRINT; Moya E., 2010, GUARDIAN; Nguyen A., 2011, BLOOMBERG       1214	8	9	9	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					469	471		10.1038/490469a	http://dx.doi.org/10.1038/490469a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NK	23099383	Bronze			2022-12-24	WOS:000310196200012
J	Newman, SA				Newman, Stuart A.			Physico-Genetic Determinants in the Evolution of Development	SCIENCE			English	Editorial Material							BIOLOGICAL PATTERN-FORMATION; AMPHIMEDON-QUEENSLANDICA; SEGMENTATION CLOCK; GENOME; ORIGIN; COMPLEXITY; DROSOPHILA; EXPLOSION; MODEL; WNT	Animal bodies and the embryos that generate them exhibit an assortment of stereotypic morphological motifs that first appeared more than half a billion years ago. During development, cells arrange themselves into tissues with interior cavities and multiple layers with immiscible boundaries, containing patterned arrangements of cell types. These tissues go on to elongate, fold, segment, and form appendages. Their motifs are similar to the outcomes of physical processes generic to condensed, chemically excitable, viscoelastic materials, although the embryonic mechanisms that generate them are typically much more complex. I propose that the origins of animal development lay in the mobilization of physical organizational effects that resulted when certain gene products of single-celled ancestors came to operate on the spatial scale of multicellular aggregates.	New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	New York Medical College	Newman, SA (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	newman@nymc.edu	Newman, Stuart/W-1617-2019					Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; AKAM M, 1989, NATURE, V341, P282, DOI 10.1038/341282a0; Amack JD, 2012, SCIENCE, V338, P212, DOI 10.1126/science.1223953; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Harrington MJ, 2009, MOL REPROD DEV, V76, P954, DOI 10.1002/mrd.21085; Kicheva A, 2012, SCIENCE, V338, P210, DOI 10.1126/science.1225182; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Morris SC, 2006, PHILOS T R SOC B, V361, P1069, DOI 10.1098/rstb.2006.1846; Newman SA, 2006, INT J DEV BIOL, V50, P289, DOI 10.1387/ijdb.052049sn; Newman SA, 2011, J EXP ZOOL PART B, V316B, P467, DOI 10.1002/jez.b.21417; Newman SA, 2009, INT J DEV BIOL, V53, P693, DOI 10.1387/ijdb.072481sn; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Reinke H, 2006, TRENDS BIOCHEM SCI, V31, P189, DOI 10.1016/j.tibs.2006.02.001; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shen B, 2008, SCIENCE, V319, P81, DOI 10.1126/science.1150279; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Strogatz S., 2003, SYNC THE EMERGING SC; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Tyson JJ, 2011, CURR BIOL, V21, pR185, DOI 10.1016/j.cub.2011.01.042; Wilkins A., 2002, THE EVOLUTION OF DEV	30	61	66	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					217	219		10.1126/science.1222003	http://dx.doi.org/10.1126/science.1222003			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066074	Green Submitted			2022-12-24	WOS:000309712300035
J	Steinbrook, R; Sharfstein, JM				Steinbrook, Robert; Sharfstein, Joshua M.			The FDA Safety and Innovation Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Steinbrook, Robert] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	Yale University; Maryland Department of Health & Mental Hygiene	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA.	rsteinbrook@attglobal.net						Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Institute of Medicine, 2011, MED DEV PUBL HLTH FD	2	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1437	1438		10.1001/jama.2012.12829	http://dx.doi.org/10.1001/jama.2012.12829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047356				2022-12-24	WOS:000309579300020
J	Soerjomataram, I; Lortet-Tieulent, J; Parkin, DM; Ferlay, J; Mathers, C; Forman, D; Bray, F				Soerjomataram, Isabelle; Lortet-Tieulent, Joannie; Parkin, D. Maxwell; Ferlay, Jacques; Mathers, Colin; Forman, David; Bray, Freddie			Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions	LANCET			English	Article							MORTALITY; SURVIVAL; OVERDIAGNOSIS; OUTCOMES; DISEASE; EUROPE; TRENDS	Background Country comparisons that consider the effect of fatal and non-fatal disease outcomes are needed for health-care planning. We calculated disability-adjusted life-years (DALYs) to estimate the global burden of cancer in 2008. Methods We used population-based data, mostly from cancer registries, for incidence, mortality, life expectancy, disease duration, and age at onset and death, alongside proportions of patients who were treated and living with sequelae or regarded as cured, to calculate years of life lost (YLLs) and years lived with disability (YLDs). We used YLLs and YLDs to derive DALYs for 27 sites of cancers in 184 countries in 12 world regions. Estimates were grouped into four categories based on a country's human development index (HDI). We applied zero discounting and uniform age weighting, and age-standardised rates to enable cross-country and regional comparisons. Findings Worldwide, an estimated 169.3 million years of healthy life were lost because of cancer in 2008. Colorectal, lung, breast, and prostate cancers were the main contributors to total DALYs in most world regions and caused 18-50% of the total cancer burden. We estimated an additional burden of 25% from infection-related cancers (liver, stomach, and cervical) in sub-Saharan Africa, and 27% in eastern Asia. We noted substantial global differences in the cancer profile of DALYs by country and region; however, YLLs were the most important component of DALYs in all countries and for all cancers, and contributed to more than 90% of the total burden. Nonetheless, low-resource settings had consistently higher YLLs (as a proportion of total DALYs) than did high-resource settings. Interpretation Age-adjusted DALYs lost from cancer are substantial, irrespective of world region. The consistently larger proportions of YLLs in low HDI than in high HDI countries indicate substantial inequalities in prognosis after diagnosis, related to degree of human development. Therefore, radical improvement in cancer care is needed in low-resource countries.	[Soerjomataram, Isabelle; Lortet-Tieulent, Joannie; Ferlay, Jacques; Forman, David; Bray, Freddie] Int Agcy Res Canc, Sect Canc Informat, F-69372 Lyon, France; [Parkin, D. Maxwell] Univ Oxford, Dept Med, Clin Trial Serv Unit, Oxford, England; [Mathers, Colin] WHO, Dept Evidence & Policy Cluster, CH-1211 Geneva, Switzerland	World Health Organization; International Agency for Research on Cancer (IARC); University of Oxford; World Health Organization	Soerjomataram, I (corresponding author), Int Agcy Res Canc, Sect Canc Informat, 150 Cours Albert Thomas, F-69372 Lyon, France.	soerjomatarami@iarc.fr	Lortet-Tieulent, Joannie/AAE-9099-2019; Ferlay, Jacques/ABD-5058-2021	Lortet-Tieulent, Joannie/0000-0002-8816-7475; Bray, Freddie/0000-0002-3248-7787; Mathers, Colin/0000-0002-0617-6731	Dutch Scientific Society; Erasmus University Rotterdam; International Agency for research on Cancer	Dutch Scientific Society; Erasmus University Rotterdam; International Agency for research on Cancer	Dutch Scientific Society, Erasmus University Rotterdam, and International Agency for research on Cancer.	Albreht T, 2008, EUR J CANCER, V44, P1451, DOI 10.1016/j.ejca.2008.02.015; [Anonymous], 2004, LANCET, V364, P2153; [Anonymous], 1966, CANC INCIDENCE 5 CON, DOI DOI 10.1001/jamaoncol.2019.2996; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Cvancarova M, 2012, INT J CANC, DOI 10.1002/ijc.27802; de Larrea-Baz NF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-42; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Francisci S, 2009, EUR J CANCER, V45, P1067, DOI 10.1016/j.ejca.2008.11.034; International Agency for Research on Cancer WHO, 2010, GLOBOCAN 2008 CANC I; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kerr DJ, 2010, NEW ENGL J MED, V363, P801, DOI 10.1056/NEJMp1002812; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murthy NS, 2010, ASIAN PAC J CANCER P, V11, P633; National Cancer Institute, SURV EP END RES; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Parkin DM, 2010, INT J CANCER, V126, P1187, DOI 10.1002/ijc.24838; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Public Health Group of the Department of Human Services, 2005, VICT BURD DIS STUD M; Sankaranarayanan R, 2011, IARC Sci Publ, P257; Sankaranarayanan R, 2011, IARC Sci Publ, P1; Sankaranarayanan R, 2010, ANN ONCOL, V21, P1935, DOI 10.1093/annonc/mdq049; Sankaranarayanan R, 1998, IARC SCI PUBL, V145, P1; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Soerjomataram I, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-125; Stouthard MEA, 1997, DISABILITY WEIGHTS D; United Nations, 2009, WORLD POP PROSP 2008; United Nations Development Programme, 2007, HUMAN DEV REPORT; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P2188, DOI 10.1016/j.ejca.2011.04.034; Verhoeven RHA, 2007, EUR J CANCER, V43, P2553, DOI 10.1016/j.ejca.2007.08.022; Vostakolaei FA, 2011, EUR J PUBLIC HEALTH, V21, P573, DOI 10.1093/eurpub/ckq120; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; World Health Organization, 2008, GLOB BURD DIS 2004 U	44	409	447	5	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2012	380	9856					1840	1850		10.1016/S0140-6736(12)60919-2	http://dx.doi.org/10.1016/S0140-6736(12)60919-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23079588				2022-12-24	WOS:000311435000029
J	Adashi, EY; Lee, E				Adashi, Eli Y.; Lee, Eric			The President's Global Health Initiative at Midterm Progress in the Balance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.; Lee, Eric] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	Eli_Adashi@brown.edu		Lee, Eric/0000-0002-1347-2635				Marrero SL, 2012, JAMA-J AM MED ASSOC, V307, P2037, DOI 10.1001/jama.2012.3546; Romney M., 2011, MY PROL PLEDG; The Henry J. Kaiser Family Foundation Kaiser Family Foundation, 2012, BUDG TRACK STAT US F; The United States government Global Health Initiative: strategy document, 2011, STRAT DOC PRES EM PL; The US Global Health Initiative (GHI), 2012, FACT SHEET; US Department of State, 2010, 1 QUADR DIPL DEV QDD; US Global Health Initiative, 2011, LEADERSHIP; US Global Health Initiative, 2012, GLOB HLTH IN NEXT ST; *WHIT HOUS, 2009, STAT PRES GLOB HLTH	9	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2012	308	19					1977	1978		10.1001/jama.2012.14287	http://dx.doi.org/10.1001/jama.2012.14287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040AQ	23060258				2022-12-24	WOS:000311291400018
J	Ipsaro, JJ; Haase, AD; Knott, SR; Joshua-Tor, L; Hannon, GJ				Ipsaro, Jonathan J.; Haase, Astrid D.; Knott, Simon R.; Joshua-Tor, Leemor; Hannon, Gregory J.			The structural biochemistry of Zucchini implicates it as a nuclease in piRNA biogenesis	NATURE			English	Article							SMALL RNAS; NUAGE FORMATION; MESSENGER-RNA; PROTEIN; RECOGNITION; MECHANISM; ELEMENTS; MITOPLD; PATHWAY	PIWI-family proteins and their associated small RNAs (piRNAs) act in an evolutionarily conserved innate immune mechanism to provide essential protection for germ-cell genomes against the activity of mobile genetic elements(1). piRNA populations comprise a molecular definition of transposons, which permits them to distinguish transposons from host genes and selectively silence them. piRNAs can be generated in two distinct ways, forming either primary or secondary piRNAs. Primary piRNAs come from discrete genomic loci, termed piRNA clusters, and seem to be derived from long, single-stranded precursors(2). The biogenesis of primary piRNAs involves at least two nucleolytic steps. An unknown enzyme cleaves piRNA cluster transcripts to generate monophosphorylated piRNA 5' ends. piRNA 3' ends are probably formed by exonucleolytic trimming, after a piRNA precursor is loaded into its PIWI partner(1,3). Secondary piRNAs arise during the adaptive 'ping-pong' cycle, with their 5' termini being formed by the activity of PIWIs themselves(2,4). A number of proteins have been implicated genetically in primary piRNA biogenesis. One of these, Drosophila melanogaster Zucchini, is a member of the phospholipase-D family of phosphodiesterases, which includes both phospholipases and nucleases(5-7). Here we produced a dimeric, soluble fragment of the mouse Zucchini homologue (mZuc; also known as PLD6) and show that it possesses single-strand-specific nuclease activity. A crystal structure of mZuc at 1.75 angstrom resolution indicates greater architectural similarity to phospholipase-D family nucleases than to phospholipases. Together, our data suggest that the Zucchini proteins act in primary piRNA biogenesis as nucleases, perhaps generating the 5' ends of primary piRNAs.	[Ipsaro, Jonathan J.; Haase, Astrid D.; Knott, Simon R.; Joshua-Tor, Leemor; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Ipsaro, Jonathan J.; Joshua-Tor, Leemor] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu; hannon@cshl.edu	Hannon, Gregory/AAB-3568-2019; @haase_astrid, Astrid D/HHS-1635-2022	@haase_astrid, Astrid D/0000-0003-1120-9013; Ipsaro, Jonathan/0000-0002-2743-3776; Joshua-Tor, Leemor/0000-0001-8185-8049	National Cancer Institute Cancer Center Support Grant [CA045508]; Department of Energy, Office of Basic Energy Sciences; Harvey L. Karp award; Ruth L. Kirschstein National Research Service Awards National Institutes of Health (NIH) [F32GM97888]; NIH [R01GM062534]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097888, R01GM062534] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Harvey L. Karp award; Ruth L. Kirschstein National Research Service Awards National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Filipowicz, R. MacDonald and members of the G.J.H. and L.J. laboratories for discussions; G. Bencze, K. Rivera and D. Pappin of the Cold Spring Harbor Laboratory proteomics facility, which is funded in part by an National Cancer Institute Cancer Center Support Grant (CA045508), for support with mass spectrometry; and H. Robinson for help at the National Synchrotron Light Source, which is supported by the Department of Energy, Office of Basic Energy Sciences. J.J.I. was supported by the Harvey L. Karp award and by a Ruth L. Kirschstein National Research Service Awards National Institutes of Health (NIH) fellowship F32GM97888. This work was supported by NIH grant R01GM062534. G.J.H. and L.J. are Howard Hughes Medical Institute Investigators.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LACKEY D, 1977, J BACTERIOL, V131, P583, DOI 10.1128/JB.131.2.583-588.1977; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; Pozharski EV, 2001, ANAL BIOCHEM, V291, P158, DOI 10.1006/abio.2001.5012; SCHUPBACH T, 1991, GENETICS, V129, P1119; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005	44	216	227	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					279	U151		10.1038/nature11502	http://dx.doi.org/10.1038/nature11502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064227	Green Accepted			2022-12-24	WOS:000310774300049
J	Lederle, FA; Bloomfield, HE				Lederle, Frank A.; Bloomfield, Hanna E.			Drug Treatment of Asymptomatic Hypertriglyceridemia to Prevent Pancreatitis: Where Is the Evidence?	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; TRIGLYCERIDES; CHOLESTEROL; THERAPY		[Lederle, Frank A.; Bloomfield, Hanna E.] Vet Affairs Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Lederle, FA (corresponding author), Vet Affairs Med Ctr 111O, Minneapolis, MN 55417 USA.	frank.lederle@va.gov		bloomfield, hanna/0000-0002-0756-7064				[Anonymous], 1984, JAMA, V251, P1196; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; CHAIT A, 1992, ADV INTERNAL MED, V37, P249; Christian JB, 2011, AM J CARDIOL, V107, P891, DOI 10.1016/j.amjcard.2010.11.008; DOMINGUEZMUNOZ JE, 1995, INT J PANCREATOL, V18, P101; FORTSON MR, 1995, AM J GASTROENTEROL, V90, P2134; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hall M F, 2010, NATL HLTH STAT REPOR, V29; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Linares CL, 2008, PANCREAS, V37, P13, DOI 10.1097/MPA.0b013e31816074a1; MILLER A, 1979, ANN SURG, V190, P401, DOI 10.1097/00000658-197909000-00016; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Nichols GA, 2011, AM J CARDIOL, V107, P225, DOI 10.1016/j.amjcard.2010.09.010; Sandhu S, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-157; Veterans Health Administration Pharmacy Benefits Management Services Medical Advisory Panel Center for Medication Safety, 2009, NAT PBM B SAF HIGH D	18	14	16	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					662	+		10.7326/0003-4819-157-9-201211060-00011	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128864				2022-12-24	WOS:000310783300007
J	Kressler, D; Bange, G; Ogawa, Y; Stjepanovic, G; Bradatsch, B; Pratte, D; Amlacher, S; Strauss, D; Yoneda, Y; Katahira, J; Sinning, I; Hurt, E				Kressler, Dieter; Bange, Gert; Ogawa, Yutaka; Stjepanovic, Goran; Bradatsch, Bettina; Pratte, Dagmar; Amlacher, Stefan; Strauss, Daniela; Yoneda, Yoshihiro; Katahira, Jun; Sinning, Irmgard; Hurt, Ed			Synchronizing Nuclear Import of Ribosomal Proteins with Ribosome Assembly	SCIENCE			English	Article							EUKARYOTIC RIBOSOME; TRANSPORT; COMPLEX; RNA; BIOGENESIS; RESOLUTION; NUCLEOLUS; CYTOPLASM; SUBUNIT; PATHWAY	Ribosomal proteins are synthesized in the cytoplasm, before nuclear import and assembly with ribosomal RNA (rRNA). Little is known about coordination of nucleocytoplasmic transport with ribosome assembly. Here, we identify a transport adaptor, symportin 1 (Syo1), that facilitates synchronized coimport of the two 5S-rRNA binding proteins Rpl5 and Rpl11. In vitro studies revealed that Syo1 concomitantly binds Rpl5-Rpl11 and furthermore recruits the import receptor Kap104. The Syo1-Rpl5-Rpl11 import complex is released from Kap104 by RanGTP and can be directly transferred onto the 5S rRNA. Syo1 can shuttle back to the cytoplasm by interaction with phenylalanine-glycine nucleoporins. X-ray crystallography uncovered how the a-solenoid symportin accommodates the Rpl5 amino terminus, normally bound to 5S rRNA, in an extended groove. Symportin-mediated coimport of Rpl5-Rpl11 could ensure coordinated and stoichiometric incorporation of these proteins into pre-60S ribosomes.	[Kressler, Dieter; Bange, Gert; Stjepanovic, Goran; Bradatsch, Bettina; Amlacher, Stefan; Strauss, Daniela; Sinning, Irmgard; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Kressler, Dieter; Pratte, Dagmar] Univ Fribourg, Dept Biol, Unit Biochem, CH-1700 Fribourg, Switzerland; [Ogawa, Yutaka; Yoneda, Yoshihiro; Katahira, Jun] Osaka Univ, Grad Sch Frontier Biosci, Biomol Networks Labs, Suita, Osaka 5650871, Japan	Ruprecht Karls University Heidelberg; University of Fribourg; Osaka University	Kressler, D (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	dieter.kressler@unifr.ch; irmi.sinning@bzh.uni-heidelberg.de; ed.hurt@bzh.uni-heidelberg.de	Stjepanovic, Goran/A-7902-2010; Bange, Gert/AAB-3734-2021; Ed Hurt, Dr./AAE-8874-2019; Kressler, Dieter/C-2218-2012	Stjepanovic, Goran/0000-0002-4841-9949; Ed Hurt, Dr./0000-0002-4535-8255; Bange, Gert/0000-0002-7826-0932; Kressler, Dieter/0000-0003-4855-3563; Katahira, Jun/0000-0001-5188-0368	German Research Council [Hu363/9-4, SFB 638]; Swiss National Science Foundation [PP00P3_123341]; Japan Society for the Promotion of Science [21570195, 21247032]	German Research Council(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank A. Hendricks and C. Deforel for technical assistance, J. Kopp and C. Siegmann from the BZH Cluster of Excellence:CellNetworks crystallization platform, J. Lechner and his team for mass spectrometry, T. Ruppert and M. Mayer (Zentrum fur Molekulare Biologie Heidelberg) for access to the core facility for mass spectrometry for the HX-MS experiments, J. Woolford for sharing published rpl5 mutant plasmids, and L. Dimitrova (Hurt laboratory) for providing the full-length ctKAP104 clone. Data collection was performed at the European Synchrotron Radiation Facility, Grenoble. This work was funded by the German Research Council (Hu363/9-4 to E. H. and SFB 638 to I. S.), the Swiss National Science Foundation (PP00P3_123341 to D. K.), and the Japan Society for the Promotion of Science (no. 21570195 and no. 21247032 to J.K. and Y.Y., respectively). I. S. and E. H. are investigators of the Cluster of Excellence:CellNetworks, and G. B. is a fellow of the Peter and Traudl Engelhorn Foundation. D. K., G. B., I. S., and E. H. conceived the experiments. D. K., G. B., J.K., I. S., and E. H. analyzed the data. D. K., G. B., I. S., and E. H. wrote the paper. D. K. and D. S. constructed yeast strains and carried out all yeast genetic experiments. D. K., G. B., and S. A. constructed plasmids. D. K. carried out tandem-affinity purifications of yeast proteins. G. B. and D. K. performed binding assays. G. B. determined crystal structures. G. S. carried out the HX-MS experiments. D. P. and D. S. performed fluorescence microscopy of live yeast cells. B. B. performed in vitro FG-repeat binding assays. Y.O. performed in vitro import assays with permeabilized HeLa cells under the supervision of J.K. in the laboratory of Y.Y. J.K. measured binding constants by BIAcore. D. K. and G. B. contributed equally to this study. All authors commented on the manuscript. Atomic coordinates and structure factors for the reported crystal structures have been deposited with the Protein Data Bank (PDB) under accession codes 4GMNO (ctSyo1) and 4GMN (ctSyo1/ctL5-N). The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to D. K. (dieter. kressler@unifr.ch), I.S. (irmi.sinning@bzh.uni-heidelberg.de), or E.H. (ed.hurt@bzh.uni-heidelberg.de).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Claussen M, 1999, J BIOL CHEM, V274, P33951, DOI 10.1074/jbc.274.48.33951; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	31	77	82	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					666	671		10.1126/science.1226960	http://dx.doi.org/10.1126/science.1226960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118189	Green Submitted			2022-12-24	WOS:000310516000053
J	Ryan, A; O'Toole, L				Ryan, Andrea; O'Toole, Louise			Ochronosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ryan, Andrea; O'Toole, Louise] Mater Private Hosp, Dublin, Ireland	Mater Private Hospital	Ryan, A (corresponding author), Mater Private Hosp, Dublin, Ireland.	andrearyan11@gmail.com							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					E26	E26		10.1056/NEJMicm1111515	http://dx.doi.org/10.1056/NEJMicm1111515			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028RS	23113505				2022-12-24	WOS:000310440800012
J	Roskar, R; Debattista, VP				Roskar, Rok; Debattista, Victor P.			Galactic Archaeology	SCIENCE			English	Editorial Material									[Roskar, Rok] Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland; [Debattista, Victor P.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England	University of Zurich; University of Central Lancashire	Roskar, R (corresponding author), Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland.	roskar@physik.uzh.ch; vpdebattista@uclan.ac.uk		Roskar, Rok/0000-0001-9962-0389	STFC [ST/J001341/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001341/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		[Anonymous], 2012, STARS BORDERS RADIAL; Bland-Hawthorn J, 2010, ASTROPHYS J, V713, P166, DOI 10.1088/0004-637X/713/1/166; Gilmore G, 2012, MESSENGER, V147, P25; Meidt SE, 2009, ASTROPHYS J, V702, P277, DOI 10.1088/0004-637X/702/1/277; Sanchez SF, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117353; Sellwood JA, 2011, MON NOT R ASTRON SOC, V410, P1637, DOI 10.1111/j.1365-2966.2010.17545.x; Sellwood JA, 2002, MON NOT R ASTRON SOC, V336, P785, DOI 10.1046/j.1365-8711.2002.05806.x; Wielen R, 1996, ASTRON ASTROPHYS, V314, P438	8	0	0	3	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					333	334		10.1126/science.1227302	http://dx.doi.org/10.1126/science.1227302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087234				2022-12-24	WOS:000309955800025
J	Moreira, L; Balaguer, F; Lindor, N; de la Chapelle, A; Hampel, H; Aaltonen, LA; Hopper, JL; Le Marchand, L; Gallinger, S; Newcomb, PA; Haile, R; Thibodeau, SN; Gunawardena, S; Jenkins, MA; Buchanan, DD; Potter, JD; Baron, JA; Ahnen, DJ; Moreno, V; Andreu, M; de Leon, MP; Rustgi, AK; Castells, A				Moreira, Leticia; Balaguer, Francesc; Lindor, Noralane; de la Chapelle, Albert; Hampel, Heather; Aaltonen, Lauri A.; Hopper, John L.; Le Marchand, Loic; Gallinger, Steven; Newcomb, Polly A.; Haile, Robert; Thibodeau, Stephen N.; Gunawardena, Shanaka; Jenkins, Mark A.; Buchanan, Daniel D.; Potter, John D.; Baron, John A.; Ahnen, Dennis J.; Moreno, Victor; Andreu, Montserrat; de Leon, Maurizio Ponz; Rustgi, Anil K.; Castells, Antoni		EPICOLON Consortium	Identification of Lynch Syndrome Among Patients With Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REVISED BETHESDA GUIDELINES; POPULATION-BASED COHORT; MICROSATELLITE INSTABILITY; GERMLINE MUTATIONS; COST-EFFECTIVENESS; CLINICAL-CRITERIA; COLON-CANCER; RISK; MLH1; PREDICTION	Context Lynch syndrome is the most common form of hereditary colorectal cancer (CRC) and is caused by germline mutations in DNA mismatch repair (MMR) genes. Identification of gene carriers currently relies on germline analysis in patients with MMR-deficient tumors, but criteria to select individuals in whom tumor MMR testing should be performed are unclear. Objective To establish a highly sensitive and efficient strategy for the identification of MMR gene mutation carriers among CRC probands. Design, Setting, and Patients Pooled-data analysis of 4 large cohorts of newly diagnosed CRC probands recruited between 1994 and 2010 (n=10 206) from the Colon Cancer Family Registry, the EPICOLON project, the Ohio State University, and the University of Helsinki examining personal, tumor-related, and family characteristics, as well as microsatellite instability, tumor MMR immunostaining, and germline MMR mutational status data. Main Outcome Measures Performance characteristics of selected strategies (Bethesda guidelines, Jerusalem recommendations, and those derived from a bivariate/multivariate analysis of variables associated with Lynch syndrome) were compared with tumor MMR testing of all CRC patients (universal screening). Results Of 10 206 informative, unrelated CRC probands, 312 (3.1%) were MMR gene mutation carriers. In the population-based cohorts (n=3671 probands), the universal screening approach (sensitivity, 100%; 95% CI, 99.3%-100%; specificity, 93.0%; 95% CI, 92.0%-93.7%; diagnostic yield, 2.2%; 95% CI, 1.7%-2.7%) was superior to the use of Bethesda guidelines (sensitivity, 87.8%; 95% CI, 78.9%-93.2%; specificity, 97.5%; 95% CI, 96.9%-98.0%; diagnostic yield, 2.0%; 95% CI, 1.5%-2.4%; P<.001), Jerusalem recommendations (sensitivity, 85.4%; 95% CI, 77.1%-93.6%; specificity, 96.7%; 95% CI, 96.0%-97.2%; diagnostic yield, 1.9%; 95% CI, 1.4%-2.3%; P<.001), and a selective strategy based on tumor MMR testing of cases with CRC diagnosed at age 70 years or younger and in older patients fulfilling the Bethesda guidelines (sensitivity, 95.1%; 95% CI, 89.8%-99.0%; specificity, 95.5%; 95% CI, 94.7%-96.1%; diagnostic yield, 2.1%; 95% CI, 1.6%-2.6%; P<.001). This selective strategy missed 4.9% of Lynch syndrome cases but resulted in 34.8% fewer cases requiring tumor MMR testing and 28.6% fewer cases undergoing germline mutational analysis than the universal approach. Conclusion Universal tumor MMR testing among CRC probands had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the increase in the diagnostic yield was modest. JAMA. 2012;308(15):1555-1565 www.jama.com	[Moreira, Leticia; Balaguer, Francesc; Castells, Antoni] Univ Barcelona, IDIBAPS Inst Invest Biomed August Pi & Sunyer, CIBEREHD, Dept Gastroenterol,Hosp Clin, E-08036 Barcelona, Catalonia, Spain; [Lindor, Noralane; Thibodeau, Stephen N.; Gunawardena, Shanaka] Mayo Clin, Mayo Colorectal Canc Family Registry, Rochester, MN USA; [de la Chapelle, Albert; Hampel, Heather] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Aaltonen, Lauri A.] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic, Australia; [Le Marchand, Loic] Univ Hawaii, Hawaii Family Registry Colon Canc, Honolulu, HI 96822 USA; [Gallinger, Steven] Canc Care Ontario, Ontario Familial Colorectal Canc Registry, Toronto, ON, Canada; [Newcomb, Polly A.; Potter, John D.] Fred Hutchinson Canc Res Ctr, Seattle Familial Colorectal Canc Registry, Seattle, WA 98104 USA; [Haile, Robert] Univ So Calif Consortium, Los Angeles, CA USA; [Buchanan, Daniel D.] Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4006, Australia; [Baron, John A.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Ahnen, Dennis J.] Vet Affairs Med Ctr, Denver Dept, Dept Med, Denver, CO USA; [Ahnen, Dennis J.] Univ Colorado, Sch Med, Denver, CO 80202 USA; [Moreno, Victor] Univ Barcelona, IDIBAPS Inst Invest Biomed August Pi & Sunyer, CIBEREHD, Unit Biomarkers & Susceptibil,Catalan Inst Oncol, E-08036 Barcelona, Catalonia, Spain; [Andreu, Montserrat] Pompeu Fabra Univ, IMIM, Hosp del Mar, Dept Gastroenterol, Barcelona, Spain; [de Leon, Maurizio Ponz] Univ Modena, Dept Med Genet, I-41100 Modena, Italy; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Dept Genet, Philadelphia, PA 19104 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Mayo Clinic; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Helsinki; University of Helsinki; University of Melbourne; University of Hawaii System; Cancer Care Ontario; Fred Hutchinson Cancer Center; QIMR Berghofer Medical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Universita di Modena e Reggio Emilia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Castells, A (corresponding author), Univ Barcelona, IDIBAPS Inst Invest Biomed August Pi & Sunyer, CIBEREHD, Dept Gastroenterol,Hosp Clin, Villarroel 170, E-08036 Barcelona, Catalonia, Spain.	castells@clinic.ub.es	de Leon, Maurizio Ponz/A-9356-2015; Jenkins, Mark/P-7803-2015; BALAGUER, FRANCESC/G-2389-2016; Balaguer, Francesc/GPX-7801-2022; Aaltonen, Lauri/A-5375-2010; Hampel, Heather/AAV-4041-2020; Moreno, Victor/A-1697-2010; Gallinger, Steven/E-4575-2013; Andreu, Montserrat/D-9911-2015; Moreira, Leticia/AAN-9863-2021; Castells, Antoni/ABC-1002-2021	de Leon, Maurizio Ponz/0000-0003-4465-1043; Jenkins, Mark/0000-0002-8964-6160; Aaltonen, Lauri/0000-0001-6839-4286; Hampel, Heather/0000-0001-7558-9794; Moreno, Victor/0000-0002-2818-5487; Andreu, Montserrat/0000-0003-4286-1098; Moreira, Leticia/0000-0002-4518-8591; Castells, Antoni/0000-0001-8431-2033; Buchanan, Daniel/0000-0003-2225-6675; Potter, John/0000-0001-5439-1500; Balaguer, Francesc/0000-0002-0206-0539	Ministerio de Economia y Competividad [SAF2010-19273]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009 SGR 849]; Asociacion Espanola contra el Cancer (Fundacion Cientifica); Asociacion Espanola contra el Cancer (Junta de Barcelona); Hospital Clinic of Barcelona; Instituto de Salud Carlos III [PI10/00384]; National Cancer Institute [CA67941, CA16058]; National Institutes of Health [5R01DK056645, RFA CA-95-011]; National Colon Cancer Research Alliance; Hansen Foundation; NATIONAL CANCER INSTITUTE [U01CA097735, P30CA016058, U01CA074799, U01CA074806, U01CA074783, K22CA095011, R01CA067941, U01CA074794, U01CA074800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056645] Funding Source: NIH RePORTER	Ministerio de Economia y Competividad(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Asociacion Espanola contra el Cancer (Fundacion Cientifica); Asociacion Espanola contra el Cancer (Junta de Barcelona); Hospital Clinic of Barcelona; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Colon Cancer Research Alliance; Hansen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Ministerio de Economia y Competividad (SAF2010-19273), Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009 SGR 849), Asociacion Espanola contra el Cancer (Fundacion Cientifica and Junta de Barcelona), Hospital Clinic of Barcelona (Josep Font grant), and Instituto de Salud Carlos III (PI10/00384). CIBEREHD and CIBERESP are funded by the Instituto de Salud Carlos III. The research at the Ohio State University Comprehensive Cancer Center was supported by National Cancer Institute grants CA67941 and CA16058. The research at the University of Pennsylvania was supported by the National Institutes of Health under 5R01DK056645, the National Colon Cancer Research Alliance, and the Hansen Foundation. This work was also supported by the National Cancer Institute, by the National Institutes of Health under RFA CA-95-011, and through cooperative agreements with members of the Colon Cancer Family Registry and Principal Investigators. Collaborating centers include Australasian Colorectal Cancer Family Registry (U01 CA097735), Familial Colorectal Neoplasia Collaborative Group (U01 CA074799) (University of Southern California), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01 CA074800), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), Seattle Colorectal Cancer Family Registry (U01 CA074794), and University of Hawaii Colorectal Cancer Family Registry (U01 CA074806). The work was carried out in part at the Esther Koplowitz Center, Barcelona.	Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; [Anonymous], 2008, CLIN GASTROENTEROL H, V6, P206, DOI 10.1016/j.cgh.2007.10.011; [Anonymous], BREAST COL CANC FAM; Balaguer F, 2008, GASTROENTEROLOGY, V134, P39, DOI 10.1053/j.gastro.2007.10.042; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Balmana J, 2008, J MED GENET, V45, P557, DOI 10.1136/jmg.2008.059311; Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Boland CR, 1998, CANCER RES, V58, P5248; Boland CR, 2010, GASTROENTEROLOGY, V138, P2197, DOI [10.1053/j.gastro.2010.04.024, DOI 10.1053/J.GASTRO.2010.04.024]; Boland CR, 2010, GASTROENTEROLOGY, V138, pe1; Chen SN, 2006, JAMA-J AM MED ASSOC, V296, P1479, DOI 10.1001/jama.296.12.1479; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Cicek MS, 2011, J MOL DIAGN, V13, P271, DOI 10.1016/j.jmoldx.2010.12.004; Domingo E, 2005, ONCOGENE, V24, P3995, DOI 10.1038/sj.onc.1208569; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kastrinos F, 2011, CANCER J, V17, P405, DOI 10.1097/PPO.0b013e318237e408; Kastrinos F, 2011, GASTROENTEROLOGY, V140, P73, DOI 10.1053/j.gastro.2010.08.021; Ladabaum U, 2011, ANN INTERN MED, V155, P69, DOI 10.7326/0003-4819-155-2-201107190-00002; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Loughrey MB, 2007, FAM CANCER, V6, P301, DOI 10.1007/s10689-007-9124-1; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Paya A, 2009, CLIN CANCER RES, V15, P3156, DOI 10.1158/1078-0432.CCR-08-3116; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Ramsey SD, 2001, ANN INTERN MED, V135, P577, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00008; Rodriguez-Moranta F, 2006, AM J GASTROENTEROL, V101, P1104, DOI 10.1111/j.1572-0241.2006.00522.x; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Stoffel EM, 2010, GASTROENTEROLOGY, V139, P1436, DOI 10.1053/j.gastro.2010.09.018; Therneau TM, R PORT; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2005, JAMA-J AM MED ASSOC, V293, P2028, DOI 10.1001/jama.293.16.2028; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	40	349	364	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2012	308	15					1555	1565		10.1001/jama.2012.13088	http://dx.doi.org/10.1001/jama.2012.13088			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021AQ	23073952	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000309858100022
J	Grosse-Sundrup, M; Henneman, JP; Sandberg, WS; Bateman, BT; Uribe, JV; Nguyen, NT; Ehrenfeld, JM; Martinez, EA; Kurth, T; Eikermann, M				Grosse-Sundrup, Martina; Henneman, Justin P.; Sandberg, Warren S.; Bateman, Brian T.; Uribe, Jose Villa; Nicole Thuy Nguyen; Ehrenfeld, Jesse M.; Martinez, Elizabeth A.; Kurth, Tobias; Eikermann, Matthias			Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRACHEAL INTUBATION; MUSCLE-ACTIVITY; CARE-UNIT; ANESTHESIA; MORBIDITY; BLOCKADE; REVERSAL; NEOSTIGMINE; PREDICTORS; SURGERY	Objective To determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the incidence of postoperative respiratory complications. Design Prospective, propensity score matched cohort study. Setting General teaching hospital in Boston, Massachusetts, United States, 2006-10. Participants 18 579 surgical patients who received intermediate acting neuromuscular blocking agents during surgery were matched by propensity score to 18 579 reference patients who did not receive such agents. Main outcome measures The main outcome measures were oxygen desaturation after extubation (hemoglobin oxygen saturation <90% with a decrease in oxygen saturation after extubation of >3%) and reintubations requiring unplanned admission to an intensive care unit within seven days of surgery. We also evaluated effects on these outcome variables of qualitative monitoring of neuromuscular transmission (train-of-four ratio) and reversal of neuromuscular blockade with neostigmine to prevent residual postoperative neuromuscular blockade. Results The use of intermediate acting neuromuscular blocking agents was associated with an increased risk of postoperative desaturation less than 90% after extubation (odds ratio 1.36, 95% confidence interval 1.23 to 1.51) and reintubation requiring unplanned admission to an intensive care unit (1.40, 1.09 to 1.80). Qualitative monitoring of neuromuscular transmission did not decrease this risk and neostigmine reversal increased the risk of postoperative desaturation less than 90% (1.32, 1.20 to 1.46) and reintubation (1.76, 1.38 to 2.26). Conclusion The use of intermediate acting neuromuscular blocking agents during anesthesia was associated with an increased risk of clinically meaningful respiratory complications. Our data suggest that the strategies used in our trial to prevent residual postoperative neuromuscular blockade should be revisited.	[Grosse-Sundrup, Martina; Henneman, Justin P.; Bateman, Brian T.; Uribe, Jose Villa; Nicole Thuy Nguyen; Martinez, Elizabeth A.; Eikermann, Matthias] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Sandberg, Warren S.; Ehrenfeld, Jesse M.] Vanderbilt Univ, Sch Med, Dept Anaesthesiol, Nashville, TN 37212 USA; [Bateman, Brian T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02114 USA; [Kurth, Tobias] INSERM, Unit Neuroepidemio 708, Bordeaux, France; [Kurth, Tobias] Univ Bordeaux, Bordeaux, France; [Kurth, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02114 USA; [Eikermann, Matthias] Univ Klinikum Essen, Klin Anaesthesie & Intens Med, Essen, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Duisburg Essen	Eikermann, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	meikermann@partners.org	Ehrenfeld, Jesse/AAI-2951-2020; Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620; Ehrenfeld, Jesse/0000-0003-3427-0140	Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, United States; French National Research Agency; US National Institutes of Health; Migraine Research Foundation; Parkinson's Disease Foundation; Merck; Pfizer; ResMed Foundation; Department of Anesthesia; Critical Care and Pain Medicine of the Massachusetts General Hospital	Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, United States; French National Research Agency(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Migraine Research Foundation; Parkinson's Disease Foundation; Merck(Merck & Company); Pfizer(Pfizer); ResMed Foundation; Department of Anesthesia; Critical Care and Pain Medicine of the Massachusetts General Hospital	This study was funded by the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, United States.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: that this study has been funded only by academic research funds; TK has received investigator initiated research funding from the French National Research Agency, the US National Institutes of Health, the Migraine Research Foundation, and the Parkinson's Disease Foundation. He has received honorariums from Allergan, the American Academy of Neurology, and Merck for educational lectures, from the BMJ for editorial services, and from MAP Pharmaceutical for contributing to a scientific advisory panel. ME has received investigator initiated research funding from Merck, Pfizer, and the ResMed Foundation, as well as the Department of Anesthesia and Critical Care and Pain Medicine of the Massachusetts General Hospital. He has received honorariums from Hill-Rom for giving advise, and from the American Thoracic Society, Brown University, Michigan University, and Vanderbilt University for educational lectures, and from the Journal Anesthesiology for editorial services; the authors have no financial relationships with any organisation or company that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	ABAJIAN J, 1955, ANN SURG, V142, P138; Alfille PH, 2009, CURR OPIN ANESTHESIO, V22, P730, DOI 10.1097/ACO.0b013e328331d545; Arbous MS, 2005, ANESTHESIOLOGY, V102, P257, DOI 10.1097/00000542-200502000-00005; BEECHER HK, 1954, ANN SURG, V140, P2, DOI 10.1097/00000658-195407000-00001; BEEMER GH, 1991, BRIT J ANAESTH, V66, P469, DOI 10.1093/bja/66.4.469; Berg H, 1997, ACTA ANAESTH SCAND, V41, P1095, DOI 10.1111/j.1399-6576.1997.tb04851.x; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Butterly A, 2010, BRIT J ANAESTH, V105, P304, DOI 10.1093/bja/aeq157; CALDWELL JE, 1995, ANESTH ANALG, V80, P1168, DOI 10.1097/00000539-199506000-00018; Chan KS, 2009, SURG TODAY, V39, P295, DOI 10.1007/s00595-008-3876-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claudius C, 2008, ANESTHESIOLOGY, V108, P1117, DOI 10.1097/ALN.0b013e318173f62f; Debaene B, 2003, ANESTHESIOLOGY, V98, P1042, DOI 10.1097/00000542-200305000-00004; Eikermann M, 2008, BRIT J ANAESTH, V101, P344, DOI 10.1093/bja/aen176; Eikermann M, 2005, CHEST, V127, P1703, DOI 10.1378/chest.127.5.1703; Eikermann M, 2002, BRIT J ANAESTH, V89, P277, DOI 10.1093/bja/aef177; Eikermann M, 2007, ANESTHESIOLOGY, V107, P621, DOI 10.1097/01.anes.0000281928.88997.95; Eikermann M, 2007, AM J RESP CRIT CARE, V175, P9, DOI 10.1164/rccm.200512-1862OC; Evers AS, 2005, CLIN ANESTH, P111; HARRISON GG, 1978, BRIT J ANAESTH, V50, P1041, DOI 10.1093/bja/50.10.1041; Hayes AH, 2001, ANAESTHESIA, V56, P312, DOI 10.1046/j.1365-2044.2001.01921.x; Herbstreit F, 2010, ANESTHESIOLOGY, V113, P1280, DOI 10.1097/ALN.0b013e3181f70f3d; Johnson RG, 2007, J AM COLL SURGEONS, V204, P1188, DOI 10.1016/j.jamcollsurg.2007.02.070; Kopman AF, 2009, ANAESTHESIA, V64, P22, DOI 10.1111/j.1365-2044.2008.05867.x; Krodel DJ, 2010, ANESTHESIOLOGY, V113, P200, DOI 10.1097/ALN.0b013e3181e32e68; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; LUNN JN, 1983, ANAESTHESIA, V38, P1090, DOI 10.1111/j.1365-2044.1983.tb12486.x; Mencke T, 2003, ANESTHESIOLOGY, V98, P1049, DOI 10.1097/00000542-200305000-00005; Mencke T, 2006, ANESTH ANALG, V102, P306, DOI 10.1213/01.ANE.0000181290.37527.CE; Murphy GS, 2006, MINERVA ANESTESIOL, V72, P97; Murphy GS, 2008, ANESTHESIOLOGY, V109, P389, DOI 10.1097/ALN.0b013e318182af3b; Murphy GS, 2008, ANESTH ANALG, V107, P130, DOI 10.1213/ane.0b013e31816d1268; Murphy GS, 2010, ANESTH ANALG, V111, P120, DOI 10.1213/ANE.0b013e3181da832d; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Parsons L., SAS I P 26 ANN SAS U; Paton F, 2010, BRIT J ANAESTH, V105, P558, DOI 10.1093/bja/aeq269; PAYNE JP, 1980, BRIT J ANAESTH, V52, P69, DOI 10.1093/bja/52.1.69; PEDERSEN T, 1992, ACTA ANAESTH SCAND, V36, P812, DOI 10.1111/j.1399-6576.1992.tb03570.x; Ramachandran SK, 2011, ANESTHESIOLOGY, V115, P44, DOI 10.1097/ALN.0b013e31821cf6de; ROSE DK, 1994, ANESTHESIOLOGY, V81, P410, DOI 10.1097/00000542-199408000-00020; SEGREDO V, 1992, NEW ENGL J MED, V327, P524, DOI 10.1056/NEJM199208203270804; Sprung J, 2003, ANESTHESIOLOGY, V99, P259, DOI 10.1097/00000542-200308000-00006; Srivastava A, 2009, BRIT J ANAESTH, V103, P115, DOI 10.1093/bja/aep093; Sundman E, 2000, ANESTHESIOLOGY, V92, P977, DOI 10.1097/00000542-200004000-00014; Wilcox SR, 2012, CRIT CARE MED, V40, P1808, DOI 10.1097/CCM.0b013e31824e0e67; Williams MT, 2003, ANAESTHESIA, V58, P574, DOI 10.1046/j.1365-2044.2003.03150.x	46	164	169	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2012	345								e6329	10.1136/bmj.e6329	http://dx.doi.org/10.1136/bmj.e6329			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024WG	23077290	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000310140600001
J	Imlach, WL; Beck, ES; Choi, BJ; Lotti, F; Pellizzoni, L; McCabe, BD				Imlach, Wendy L.; Beck, Erin S.; Choi, Ben Jiwon; Lotti, Francesco; Pellizzoni, Livio; McCabe, Brian D.			SMN Is Required for Sensory-Motor Circuit Function in Drosophila	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; NEUROMUSCULAR-JUNCTIONS; ELECTRICAL-PROPERTIES; SINGLE NUCLEOTIDE; NEURON PROTEIN; MOUSE MODEL; GENE; SURVIVAL; MICE; MUSCLE	Spinal muscular atrophy (SMA) is a lethal human disease characterized by motor neuron dysfunction and muscle deterioration due to depletion of the ubiquitous survival motor neuron (SMN) protein. Drosophila SMN mutants have reduced muscle size and defective locomotion, motor rhythm, and motor neuron neurotransmission. Unexpectedly, restoration of SMN in either muscles or motor neurons did not alter these phenotypes. Instead, SMN must be expressed in proprioceptive neurons and interneurons in the motor circuit to nonautonomously correct defects in motor neurons and muscles. SMN depletion disrupts the motor system subsequent to circuit development and can be mimicked by the inhibition of motor network function. Furthermore, increasing motor circuit excitability by genetic or pharmacological inhibition of K+ channels can correct SMN-dependent phenotypes. These results establish sensory-motor circuit dysfunction as the origin of motor system deficits in this SMA model and suggest that enhancement of motor neural network activity could ameliorate the disease.	[Imlach, Wendy L.; Beck, Erin S.; Choi, Ben Jiwon; Lotti, Francesco; Pellizzoni, Livio; McCabe, Brian D.] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, 630 W 168th St, New York, NY 10032 USA; [Imlach, Wendy L.; Choi, Ben Jiwon; Lotti, Francesco; Pellizzoni, Livio; McCabe, Brian D.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Beck, Erin S.; McCabe, Brian D.] Columbia Univ, Med Ctr, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	McCabe, BD (corresponding author), Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, 630 W 168th St, New York, NY 10032 USA.	brian@mccabelab.org	Imlach, Wendy/G-7609-2011; Lotti, Francesco/AAC-3186-2019; Beck, Erin/AAA-8399-2022	Imlach, Wendy/0000-0002-7521-9969; Choi, Ben Jiwon/0000-0001-9155-8445; Pellizzoni, Livio/0000-0002-9168-5628; McCabe, Brian/0000-0003-1620-0501	NIH-NINDS [R01NS069601]; Columbia University Motor Neuron Center; Gatsby Initiative in Brain Circuitry;  [DoD-W81XWH-08-1-0009];  [DoD-W81XWH-11-1-0753]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075572, R01NS069601] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Columbia University Motor Neuron Center; Gatsby Initiative in Brain Circuitry; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are very grateful to Spyros Artavanis-Tsakonas and Greg Matera for smn stocks and reagents. We also thank Haig Keshishian, James Hodge, Cynthia Hughes, John Thomas, Michael Nitabach, Andrea Pizzo, Jonathan Javitch, Graeme Davis, Julie Simpson, and Wesley Grueber for additional stocks and advice. We thank George Mentis and especially Chris Henderson for critical reading of this manuscript. L. P. was supported by NIH-NINDS R01NS069601 and with B. D. M. by the Columbia University Motor Neuron Center. B. D. M. was supported by DoD-W81XWH-08-1-0009, DoD-W81XWH-11-1-0753, and the Gatsby Initiative in Brain Circuitry.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Baines RA, 2006, INT REV NEUROBIOL, V75, P91, DOI 10.1016/S0074-7742(06)75005-X; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Cattaert D, 2001, J NEUROBIOL, V48, P58, DOI 10.1002/neu.1042; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Chwieduk CM, 2010, CNS DRUGS, V24, P883, DOI 10.2165/11205910-000000000-00000; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Crisp S, 2008, DEVELOPMENT, V135, P3707, DOI 10.1242/dev.026773; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Hayes Keith C, 2007, Expert Rev Neurother, V7, P453, DOI 10.1586/14737175.7.5.453; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Imlach Wendy, 2009, J Vis Exp, DOI 10.3791/1109; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kitamoto T, 2000, J NEUROBIOL, V42, P161, DOI 10.1002/(SICI)1097-4695(20000205)42:2<161::AID-NEU1>3.0.CO;2-P; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Marder E, 2005, CURR OPIN NEUROBIOL, V15, P86, DOI 10.1016/j.conb.2005.01.011; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pinter MJ, 1997, J NEUROSCI, V17, P4500; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Renault F, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P301, DOI 10.1016/S0370-4475(83)80042-2; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Salvaterra P M, 2001, Brain Res Gene Expr Patterns, V1, P73; Schmid A, 2007, J CHILD NEUROL, V22, P1004, DOI 10.1177/0883073807305667; Simic G, 2008, ACTA NEUROPATHOL, V116, P223, DOI 10.1007/s00401-008-0411-1; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Wu Y, 2008, PLOS BIOL, V6, P2512, DOI 10.1371/journal.pbio.0060273; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	57	139	140	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					427	439		10.1016/j.cell.2012.09.011	http://dx.doi.org/10.1016/j.cell.2012.09.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063130	Green Accepted, Bronze			2022-12-24	WOS:000309981000019
J	Zaratiegui, M; Martienssen, RA				Zaratiegui, Mikel; Martienssen, Robert A.			SnapShot: Small RNA-Mediated Epigenetic Modifications	CELL			English	Editorial Material							GERMLINE; PIRNAS; MEMORY		[Zaratiegui, Mikel] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Rutgers State University New Brunswick; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Zaratiegui, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.			Zaratiegui, Mikel/0000-0002-0342-0268	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM076396-05, R01 GM076396] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501	10	4	4	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					456	+		10.1016/j.cell.2012.10.001	http://dx.doi.org/10.1016/j.cell.2012.10.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063132	Green Accepted, Bronze			2022-12-24	WOS:000309981000022
J	Emmerich, J; Dumarcet, N; Lorence, A				Emmerich, Joseph; Dumarcet, Nathalie; Lorence, Annie			France's New Framework for Regulating Off-Label Drug Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Emmerich, Joseph; Dumarcet, Nathalie; Lorence, Annie] Agence Natl Securite Med & Prod Sante, St Denis, France		Emmerich, J (corresponding author), Agence Natl Securite Med & Prod Sante, St Denis, France.							Eichler HG, 2008, NAT REV DRUG DISCOV, V7, P818, DOI 10.1038/nrd2664; FERNER RE, 1996, PRESCRIBERS J, V36, P73; Mello MM, 2009, NEW ENGL J MED, V360, P1557, DOI 10.1056/NEJMhle0807695; Mullard A, 2011, LANCET, V377, P890, DOI 10.1016/S0140-6736(11)60334-6; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107	5	43	49	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1279	1281		10.1056/NEJMp1208347	http://dx.doi.org/10.1056/NEJMp1208347			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014WJ	23034018				2022-12-24	WOS:000309406100002
J	Gayathri, P; Fujii, T; Moller-Jensen, J; van den Ent, F; Namba, K; Lowe, J				Gayathri, P.; Fujii, T.; Moller-Jensen, J.; van den Ent, F.; Namba, K.; Loewe, J.			A Bipolar Spindle of Antiparallel ParM Filaments Drives Bacterial Plasmid Segregation	SCIENCE			English	Article							DYNAMIC INSTABILITY; STRUCTURAL BASIS; DNA SEGREGATION; F-ACTIN; VISUALIZATION; MECHANISM	To ensure their stable inheritance by daughter cells during cell division, bacterial low-copy-number plasmids make simple DNA segregating machines that use an elongating protein filament between sister plasmids. In the ParMRC system of the Escherichia coli R1 plasmid, ParM, an actinlike protein, forms the spindle between ParRC complexes on sister plasmids. By using a combination of structural work and total internal reflection fluorescence microscopy, we show that ParRC bound and could accelerate growth at only one end of polar ParM filaments, mechanistically resembling eukaryotic formins. The architecture of ParM filaments enabled two ParRC-bound filaments to associate in an antiparallel orientation, forming a bipolar spindle. The spindle elongated as a bundle of at least two antiparallel filaments, thereby pushing two plasmid clusters toward the poles.	[Gayathri, P.; Moller-Jensen, J.; van den Ent, F.; Loewe, J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Fujii, T.; Namba, K.] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Namba, K.] Riken Quantitat Biol Ctr, Suita, Osaka 5650871, Japan	MRC Laboratory Molecular Biology; Osaka University; RIKEN	Lowe, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	jyl@mrc-lmb.cam.ac.uk	Namba, Keiichi/A-9406-2016; Møller-Jensen, Jakob/AAO-8480-2020; Löwe, Jan/X-6998-2019	Møller-Jensen, Jakob/0000-0002-6008-3771; Lowe, Jan/0000-0002-5218-6615; Gayathri, Pananghat/0000-0002-2242-4619	MRC [U105184326]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21227006]; FP7-IIF-2008 fellowship; MRC [MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184326] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); FP7-IIF-2008 fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge N. Barry and C. Johnson (MRC-LMB, help with TIRF microscopy and isothermal titration calorimetry); T. Kato (Osaka University, technical support with cryo-EM); beamline support at ID29, ID14-2 (European Synchrotron Radiation Facility, France), and I02 (Diamond Light Source, UK); L. Amos, S. Bullock, A. Carter, and R. Gasper-Schonenbrucher (MRC-LMB, critical reading of the manuscript); and K. Gerdes (Newcastle University) and A. Toste Rego (MRC-LMB) (provision of reagents). Support by the MRC (U105184326 to J.L.), Grants-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (21227006 to K. N.), and FP7-IIF-2008 fellowship (P. G.) is acknowledged. Protein Data Bank (PDB) accession codes: ParM-AMPPNP, 4A61; ParM-AMPPNP-ParR<INF>pept</INF>, 4A62. The EM reconstruction has been deposited in the Electron Microscopy Data Bank (EMD-1980), fitted coordinates in the PDB (4A6J).	Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Choi CL, 2008, J BIOL CHEM, V283, P28081, DOI 10.1074/jbc.M803833200; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Sun SX, 2010, CURR BIOL, V20, pR649, DOI 10.1016/j.cub.2010.07.004; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672	22	63	65	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1334	1337		10.1126/science.1229091	http://dx.doi.org/10.1126/science.1229091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23112295	Green Accepted			2022-12-24	WOS:000311991200064
J	Fuglie, K; Heisey, P; King, J; Pray, CE; Schimmelpfennig, D				Fuglie, Keith; Heisey, Paul; King, John; Pray, Carl E.; Schimmelpfennig, David			The Contribution of Private Industry to Agricultural Innovation	SCIENCE			English	Editorial Material							PRODUCTIVITY; WILL		[Fuglie, Keith; Heisey, Paul; Schimmelpfennig, David] Econ Res Serv, USDA, Washington, DC 20472 USA; [King, John] USDA, Off Chief Scientist, Washington, DC 20250 USA; [Pray, Carl E.] Rutgers State Univ, New Brunswick, NJ 08901 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Rutgers State University New Brunswick	Schimmelpfennig, D (corresponding author), Econ Res Serv, USDA, Washington, DC 20472 USA.	des@ers.usda.gov		Fuglie, Keith/0000-0002-7601-0542; King, John/0000-0003-4947-0241				Alston J. M., 2004, California Agriculture, V58, P80, DOI 10.3733/ca.v058n02p80; Alston JM, 2010, NAT RES MANAG POLICY, V34, P1, DOI 10.1007/978-1-4419-0658-8; Alston JM, 2009, SCIENCE, V325, P1209, DOI 10.1126/science.1170451; [Anonymous], 2011, COST TIME INVOLVED D; Cohen JI, 2005, NAT BIOTECHNOL, V23, P27, DOI 10.1038/nbt0105-27; DASGUPTA P, 1980, ECON J, V90, P266, DOI 10.2307/2231788; Fuglie K., 2011, EC RES REP USDA; Fuglie K.O., 2001, J AGR APPL EC, V33, P459; Huffman W.E., 2006, SCI AGR LONG TERM PE, V2nd ed.; Klotz C., 1995, AGES9525 USDA EC RES; McDougall P., 2010, COST NEW AGROCHEMICA; Pardey P. G., 2006, Agricultural research: a growing global divide?; Piesse J, 2010, PHILOS T R SOC B, V365, P3035, DOI 10.1098/rstb.2010.0140; Pingali PL, 2002, FOOD POLICY, V27, P223, DOI 10.1016/S0306-9192(02)00012-X; Pray C. E, 2007, HDB AGR EC, V3; Pray CE, 1998, WORLD DEV, V26, P1127, DOI 10.1016/S0305-750X(98)00040-0; Rubenstein KD, 2006, CROP SCI, V46, P1021, DOI 10.2135/cropsci2005.0129; SCHILDOW DV, 2004, CLIN RESP MED, P19; Wang CG, 2009, AM J AGR ECON, V91, P374, DOI 10.1111/j.1467-8276.2008.01246.x; *WORLD BANK, 2007, WORLD DEV REP 2008 A	20	29	29	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1031	1032		10.1126/science.1226294	http://dx.doi.org/10.1126/science.1226294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041HJ	23180847				2022-12-24	WOS:000311390600026
J	Sprunck, S; Rademacher, S; Vogler, F; Gheyselinck, J; Grossniklaus, U; Dresselhaus, T				Sprunck, Stefanie; Rademacher, Svenja; Vogler, Frank; Gheyselinck, Jacqueline; Grossniklaus, Ueli; Dresselhaus, Thomas			Egg Cell-Secreted EC1 Triggers Sperm Cell Activation During Double Fertilization	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; ARABIDOPSIS; PLANTS; FUSION	Double fertilization is the defining characteristic of flowering plants. However, the molecular mechanisms regulating the fusion of one sperm with the egg and the second sperm with the central cell are largely unknown. We show that gamete interactions in Arabidopsis depend on small cysteine-rich EC1 (EGG CELL 1) proteins accumulating in storage vesicles of the egg cell. Upon sperm arrival, EC1-containing vesicles are exocytosed. The sperm endomembrane system responds to exogenously applied EC1 peptides by redistributing the potential gamete fusogen HAP2/GCS1 (HAPLESS 2/GENERATIVE CELL SPECIFIC 1) to the cell surface. Furthermore, fertilization studies with ec1 quintuple mutants show that successful male-female gamete interactions are necessary to prevent multiple-sperm cell delivery. Our findings provide evidence that mutual gamete activation, regulated exocytosis, and sperm plasma membrane modifications govern flowering plant gamete interactions.	[Sprunck, Stefanie; Rademacher, Svenja; Vogler, Frank; Dresselhaus, Thomas] Univ Regensburg, Biochem Zentrum Regensburg, D-93053 Regensburg, Germany; [Gheyselinck, Jacqueline; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Gheyselinck, Jacqueline; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	University of Regensburg; University of Zurich; University of Zurich	Sprunck, S (corresponding author), Univ Regensburg, Biochem Zentrum Regensburg, Univ Str 31, D-93053 Regensburg, Germany.	stefanie.sprunck@biologie.uni-regensburg.de	Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974	Deutsche Forschungsgemeinschaft [SP 686/1-2, SFB924, DR 334/5]; Universitat Bayern e.V.; Australian Grains Research Development Corporation; Swiss National Science Foundation [3100AO-112489]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Universitat Bayern e.V.; Australian Grains Research Development Corporation(Grains R&D Corp); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Seeds were kindly provided by M. Johnson (HAP2p:HAP2-YFP) and F. Berger (HTR10p:HTR10-mRFP1). We thank M. Gebert for her help in in situ hybridization, M. Gahrtz for providing plasmids, M. Kammerer and B. Bellmann for technical assistance, and F. Sprenger for his support in spinning disc microscopy. This work was supported by the Deutsche Forschungsgemeinschaft (grants SP 686/1-2 and SFB924 to S. S. and DR 334/5 to T. D.), by a graduate scholarship of Universitat Bayern e.V. (to S. R.), and, in part, by the Australian Grains Research Development Corporation (to T. D.) and the Swiss National Science Foundation (grant 3100AO-112489 to U. G.). S. S. and T. D. are inventors on a patent (WO 2007/092992) related to the EC1 promoter sequences. Accession numbers and author contributions are listed in the supplementary materials.	Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Faure JE, 2002, PLANT J, V30, P481, DOI 10.1046/j.1365-313X.2002.01305.x; Gebert M, 2008, PLANT CELL, V20, P2798, DOI 10.1105/tpc.108.061028; Grote E, 2010, J CELL SCI, V123, P1902, DOI 10.1242/jcs.066662; Guignard M.L., 1899, REV G N BOT, V11, P129; Hamamura Y, 2011, CURR BIOL, V21, P497, DOI 10.1016/j.cub.2011.02.013; Hirohashi N, 2008, DEV GROWTH DIFFER, V50, pS221, DOI 10.1111/j.1440-169X.2008.01017.x; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Inoue N, 2011, ASIAN J ANDROL, V13, P81, DOI 10.1038/aja.2010.70; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Liu Y, 2008, ACTA METEOROL SIN, V22, P22; McCue AD, 2011, J EXP BOT, V62, P1621, DOI 10.1093/jxb/err032; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Nawaschin S., 1898, B IMP ACAD SCI, V9, P377; Neill AT, 2004, REPRODUCTION, V127, P141, DOI 10.1530/rep.1.00085; Pan JM, 2000, CURR OPIN MICROBIOL, V3, P596, DOI 10.1016/S1369-5274(00)00146-6; Parrington J, 2007, DEV DYNAM, V236, P2027, DOI 10.1002/dvdy.21255; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Sprunck S, 2005, PLANT J, V41, P660, DOI 10.1111/j.1365-313X.2005.02332.x; Sprunck S, 2010, BIOCHEM SOC T, V38, P635, DOI 10.1042/BST0380635; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	23	204	221	9	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1093	1097		10.1126/science.1223944	http://dx.doi.org/10.1126/science.1223944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180860				2022-12-24	WOS:000311390600047
J	Davis, JG; Gierszal, KP; Wang, P; Ben-Amotz, D				Davis, Joel G.; Gierszal, Kamil P.; Wang, Ping; Ben-Amotz, Dor			Water structural transformation at molecular hydrophobic interfaces	NATURE			English	Article							HYDRATION; METHANE	Hydrophobic hydration is considered to have a key role in biological processes ranging from membrane formation to protein folding and ligand binding(1). Historically, hydrophobic hydration shells were thought to resemble solid clathrate hydrates(2-4), with solutes surrounded by polyhedral cages composed of tetrahedrally hydrogen-bonded water molecules. But more recent experimental(5-8) and theoretical(9-16) studies have challenged this view and emphasized the importance of the length scales involved. Here we report combined polarized, isotopic and temperature-dependent Raman scattering measurements with multivariate curve resolution (Raman-MCR)(17-19) that explore hydrophobic hydration by mapping the vibrational spectroscopic features arising from the hydrophobic hydration shells of linear alcohols ranging from methanol to heptanol. Our data, covering the entire 0-100 degrees C temperature range, show clear evidence that at low temperatures the hydration shells have a hydrophobically enhanced water structure with greater tetrahedral order and fewer weak hydrogen bonds than the surrounding bulk water. This structure disappears with increasing temperature and is then, for hydrophobic chains longer than similar to 1 nm, replaced by a more disordered structure with weaker hydrogen bonds than bulk water. These observations support our current understanding of hydrophobic hydration, including the thermally induced water structural transformation that is suggestive of the hydrophobic crossover predicted to occur at lengths of similar to 1 nm (refs 5, 9, 10, 14).	[Davis, Joel G.; Gierszal, Kamil P.; Wang, Ping; Ben-Amotz, Dor] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ben-Amotz, D (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	bendor@purdue.edu			National Science Foundation [CHE-0847928]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (CHE-0847928). We thank B. Widom, D. Chandler, M. Fayer and S. Granick for comments and suggestions; D. Wilcox for writing the SMCR code used in this work; B. Rankin for performing molecular dynamics simulations to determine the number of water molecules in the first hydration shells of n-alcohols (as further described in Supplementary Methods); and D. L. McCaffrey, S. Zukowski and C. DeShaw (undergraduate research students) for assistance in collecting experimental results relevant to this work.	Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Ben-Amotz D, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121648; Buchanan P, 2005, CHEM PHYS LETT, V415, P89, DOI 10.1016/j.cplett.2005.08.064; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; FRANK HS, 1945, J CHEM PHYS, V13, P507, DOI 10.1063/1.1723985; Friesen AD, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3633478; Garde S, 1996, PHYS REV LETT, V77, P4966, DOI 10.1103/PhysRevLett.77.4966; Garde S, 2011, P NATL ACAD SCI USA, V108, P16491, DOI 10.1073/pnas.1113256108; Gierszal KP, 2011, J PHYS CHEM LETT, V2, P2930, DOI 10.1021/jz201373e; GILL SJ, 1985, J PHYS CHEM-US, V89, P3758, DOI 10.1021/j100263a034; GLEW DN, 1962, J PHYS CHEM-US, V66, P605, DOI 10.1021/j100810a008; Laage D, 2009, J PHYS CHEM B, V113, P2428, DOI 10.1021/jp809521t; LAWTON WH, 1971, TECHNOMETRICS, V13, P617, DOI 10.2307/1267173; Li F, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3516460; Li ITS, 2011, P NATL ACAD SCI USA, V108, P16527, DOI 10.1073/pnas.1105450108; Liu CL, 2011, SPECTROSC SPECT ANAL, V31, P1524, DOI 10.3964/j.issn.1000-0593(2011)06-1524-05; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Matysiak S, 2011, J PHYS CHEM B, V115, P14859, DOI 10.1021/jp2079633; Perera PN, 2009, P NATL ACAD SCI USA, V106, P12230, DOI 10.1073/pnas.0903675106; Perera P, 2008, J AM CHEM SOC, V130, P4576, DOI 10.1021/ja077333h; Petersen C, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3142861; Raschke TM, 2005, P NATL ACAD SCI USA, V102, P6777, DOI 10.1073/pnas.0500225102; ROSSKY PJ, 1982, FARADAY SYMP CHEM S, P69, DOI 10.1039/fs9821700069; Smith JD, 2005, P NATL ACAD SCI USA, V102, P14171, DOI 10.1073/pnas.0506899102; Stiopkin IV, 2011, NATURE, V474, P192, DOI 10.1038/nature10173; Tomlinson-Phillips J, 2011, J PHYS CHEM A, V115, P6177, DOI 10.1021/jp111346s; Torii H, 2006, J PHYS CHEM A, V110, P9469, DOI 10.1021/jp062033s; Yang M, 2010, PHYS CHEM CHEM PHYS, V12, P982, DOI 10.1039/b918314k; Zhang XY, 2002, SCIENCE, V295, P663, DOI 10.1126/science.1066854	30	379	380	21	657	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					582	585		10.1038/nature11570	http://dx.doi.org/10.1038/nature11570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23172216				2022-12-24	WOS:000311339800049
J	Berman, AJ; Cech, TR				Berman, Andrea J.; Cech, Thomas R.			SnapShot: Telomeres and Telomerase	CELL			English	Editorial Material									[Berman, Andrea J.; Cech, Thomas R.] Univ Colorado, HHMI, BioFrontiers Inst, Boulder, CO 80309 USA; [Berman, Andrea J.; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, BioFrontiers Inst, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Berman, AJ (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.							Du H.-Y., 2008, TELOMERES TELOMERASE; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700	3	6	6	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5								10.1016/j.cell.2012.11.008	http://dx.doi.org/10.1016/j.cell.2012.11.008			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178129	Bronze			2022-12-24	WOS:000311423500024
J	Nadelman, RB; Hanincova, K; Mukherjee, P; Liveris, D; Nowakowski, J; McKenna, D; Brisson, D; Cooper, D; Bittker, S; Madison, G; Holmgren, D; Schwartz, I; Wormser, GP				Nadelman, Robert B.; Hanincova, Klara; Mukherjee, Priyanka; Liveris, Dionysios; Nowakowski, John; McKenna, Donna; Brisson, Dustin; Cooper, Denise; Bittker, Susan; Madison, Gul; Holmgren, Diane; Schwartz, Ira; Wormser, Gary P.			Differentiation of Reinfection from Relapse in Recurrent Lyme Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BURGDORFERI SENSU-STRICTO; BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; IXODES-SCAPULARIS; HEMATOGENOUS DISSEMINATION; GENETIC DIVERSITY; CULTURE; INFECTION; FAILURE; OSPC	BACKGROUND Erythema migrans is the most common manifestation of Lyme disease. Recurrences are not uncommon, and although they are usually attributed to reinfection rather than relapse of the original infection, this remains somewhat controversial. We used molecular typing of Borrelia burgdorferi isolates obtained from patients with culture-confirmed episodes of erythema migrans to distinguish between relapse and reinfection. Methods We determined the genotype of the gene encoding outer-surface protein C (ospC) of B. burgdorferi strains detected in cultures of skin or blood specimens obtained from patients with consecutive episodes of erythema migrans. After polymerase-chain-reaction amplification, ospC genotyping was performed by means of reverse line-blot analysis or DNA sequencing of the nearly full-length gene. Most strains were further analyzed by determining the genotype according to the 16S-23S ribosomal RNA intergenic spacer type, multilocus sequence typing, or both. Patients received standard courses of antibiotics for erythema migrans. RESULTS B. burgdorferi isolates obtained from 17 patients who received a diagnosis of erythema migrans between 1991 and 2011 and who had 22 paired episodes of this lesion (initial and second episodes) were available for testing. The ospC genotype was found to be different at each initial and second episode. Apparently identical genotypes were identified on more than one occasion in only one patient, at the first and third episodes, 5 years apart, but different genotypes were identified at the second and fourth episodes. CONCLUSIONS None of the 22 paired consecutive episodes of erythema migrans were associated with the same strain of B. burgdorferi on culture. Our data show that repeat episodes of erythema migrans in appropriately treated patients were due to reinfection and not relapse. (Funded by the National Institutes of Health and the William and Sylvia Silberstein Foundation.)	[Nadelman, Robert B.; Nowakowski, John; McKenna, Donna; Cooper, Denise; Bittker, Susan; Madison, Gul; Holmgren, Diane; Wormser, Gary P.] New York Med Coll, Div Infect Dis, Dept Med, Valhalla, NY 10595 USA; [Hanincova, Klara; Mukherjee, Priyanka; Liveris, Dionysios; Schwartz, Ira] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Brisson, Dustin] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	New York Medical College; New York Medical College; University of Pennsylvania	Nadelman, RB (corresponding author), New York Med Coll, Div Infect Dis, Dept Med, Rm 245, Valhalla, NY 10595 USA.	robert_nadelman@nymc.edu	Brisson, Dustin/B-2428-2008	Brisson, Dustin/0000-0002-9493-7579; Madison, Guy/0000-0001-5366-1169	National Institutes of Health; William and Sylvia Silberstein Foundation; Guide-point Global and Decision Resources; Baxter; Bio-Rad; DiaSorin; Immunetics; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William and Sylvia Silberstein Foundation; Guide-point Global and Decision Resources; Baxter; Bio-Rad; DiaSorin; Immunetics; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by the National Institutes of Health and the William and Sylvia Silberstein Foundation.; Supported in part by grants from the National Institutes of Health (AR41511 and AI45801) and the William and Sylvia Silberstein Foundation, to Dr. Schwartz.; Dr. Nadelman reports receiving consulting fees from Guide-point Global and Decision Resources and serving as an expert witness in medical malpractice cases regarding Lyme disease. Dr. Wormser reports receiving consulting fees from Baxter, serving as an expert witness in medical malpractice cases regarding Lyme disease, holding stock in Abbott, and receiving grant support to his institution from Bio-Rad, DiaSorin, Immunetics, and bioMerieux. No other potential conflict of interest relevant to this article was reported.	BERGER BW, 1992, J AM ACAD DERMATOL, V27, P34, DOI 10.1016/0190-9622(92)70152-6; Brisson D, 2006, AM J TROP MED HYG, V74, P615, DOI 10.4269/ajtmh.2006.74.615; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2010, EMERG INFECT DIS, V16, P911, DOI 10.3201/eid1606.090329; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Dandache P, 2008, INFECT DIS CLIN N AM, V22, P235, DOI 10.1016/j.idc.2007.12.012; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; Golde WT, 1998, J CLIN MICROBIOL, V36, P1015, DOI 10.1128/JCM.36.4.1015-1019.1998; Guttman DS, 1996, J CLIN MICROBIOL, V34, P652, DOI 10.1128/JCM.34.3.652-656.1996; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P5008, DOI 10.1128/AEM.00479-08; Jones KL, 2006, J CLIN MICROBIOL, V44, P4407, DOI 10.1128/JCM.01077-06; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; MALANE MS, 1991, ANN INTERN MED, V114, P490, DOI 10.7326/0003-4819-114-6-490; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; MELSKI JW, 1993, ARCH DERMATOL, V129, P709, DOI 10.1001/archderm.129.6.709; NADELMAN RB, 1993, AM J MED, V94, P583, DOI 10.1016/0002-9343(93)90208-7; Nadelman RB, 2008, CLIN INFECT DIS, V46, P950, DOI 10.1086/528872; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Nowakowski J, 1997, ANN INTERN MED, V127, P130, DOI 10.7326/0003-4819-127-2-199707150-00006; Nowakowski J, 2000, ARCH FAM MED, V9, P563, DOI 10.1001/archfami.9.6.563; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Nowakowski J, 2001, CLIN INFECT DIS, V33, P2023, DOI 10.1086/324490; Probert WS, 1997, J INFECT DIS, V175, P400, DOI 10.1093/infdis/175.2.400; Qiu WG, 2002, GENETICS, V160, P833; SCHWARTZ I, 1992, J CLIN MICROBIOL, V30, P3082, DOI 10.1128/JCM.30.12.3082-3088.1992; Seinost G, 1999, ARCH DERMATOL, V135, P1329, DOI 10.1001/archderm.135.11.1329; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; Vaz A, 2001, INFECT IMMUN, V69, P7437, DOI 10.1128/IAI.69.12.7437-7444.2001; Wang GQ, 1999, J CLIN MICROBIOL, V37, P3025, DOI 10.1128/JCM.37.9.3025-3028.1999; Wang IN, 1999, GENETICS, V151, P15; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2009, CLIN MICROBIOL REV, V22, P387, DOI 10.1128/CMR.00004-09; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922	38	63	64	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1883	1890		10.1056/NEJMoa1114362	http://dx.doi.org/10.1056/NEJMoa1114362			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23150958	Green Accepted, Bronze			2022-12-24	WOS:000311029300004
J	Drucker, E				Drucker, Ernest			Drugs: the third rail of US politics	LANCET			English	Editorial Material									[Drucker, Ernest] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Drucker, Ernest] CUNY, John Jay Coll Criminal Justice, New York, NY 10021 USA	Columbia University; City University of New York (CUNY) System	Drucker, E (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.	emdrucker@earthlink.net						[Anonymous], 2010, BARS 2 SUBST AB AM P; Baker P., 2012, NY TIMES; Drucker E., 2011, PLAGUE PRISONS EPIDE; Drucker E, 2012, J PUBLIC HEALTH POL, V33, P309, DOI 10.1057/jphp.2012.16; Drug Policy Alliance, 2012, REF MAR LAWS; European Commission Eurostat, 1998, EU27 EUR COMM EUR; Guillermoprieto A., 2012, NEW YORK REV BOOKS; Kain E., 2012, FORBES; OECD, 2012, HLTH GLANC EUR 2010; Onishi N, 2012, NY TIMES; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; The Disaster Center, 2011, 2011 US CRIM RAT 196; Thoumi FE, 2005, J DRUG ISSUES, V35, P185, DOI 10.1177/002204260503500109; UN Office on Drugs and Crime, 2011, GLOB STUD HOM 2011; US Centers for Disease Control and Prevention, 2012, HOM RECR SAF UN POIS	15	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1626	1628		10.1016/S0140-6736(12)61889-3	http://dx.doi.org/10.1016/S0140-6736(12)61889-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	035MN	23138110				2022-12-24	WOS:000310951400006
J	Bascom-Slack, CA; Arnold, AE; Strobel, SA				Bascom-Slack, Carol A.; Arnold, A. Elizabeth; Strobel, Scott A.			Student-Directed Discovery of the Plant Microbiome and Its Products	SCIENCE			English	Editorial Material							ENDOPHYTES; DIVERSITY		[Bascom-Slack, Carol A.; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA	Yale University; University of Arizona	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	scott.strobel@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Stone JK, 2000, BOOK SOIL P, P3; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel SA, 2007, NAT CHEM BIOL, V3, P356, DOI 10.1038/nchembio0707-356	8	44	46	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					485	486		10.1126/science.1215227	http://dx.doi.org/10.1126/science.1215227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112324				2022-12-24	WOS:000310195800046
J	Cals, JWL; de Bont, EGPM				Cals, Jochen W. L.; de Bont, Eefje G. P. M.			10-MINUTE CONSULTATION Minor incised traumatic laceration	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cals, Jochen W. L.; de Bont, Eefje G. P. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands	Maastricht University	Cals, JWL (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, POB 616, NL-6200 MD Maastricht, Netherlands.	j.cals@maastrichtuniversity.nl	Cals, Jochen WL/A-1262-2007	Cals, Jochen WL/0000-0001-9550-5674; de Bont, Eefje/0000-0002-2700-4752					0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 23	2012	345								e6824	10.1136/bmj.e6824	http://dx.doi.org/10.1136/bmj.e6824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MT	23092899				2022-12-24	WOS:000310427100017
J	Clevers, H				Clevers, Hans			The Paneth Cell, Caloric Restriction, and Intestinal Integrity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Hubrecht Inst, Utrecht, Netherlands.							CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Ouellette AJ, 2010, CURR OPIN GASTROEN, V26, P547, DOI 10.1097/MOG.0b013e32833dccde; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	4	5	5	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2012	367	16					1560	1561		10.1056/NEJMcibr1208353	http://dx.doi.org/10.1056/NEJMcibr1208353			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021SA	23075184				2022-12-24	WOS:000309904500015
J	Milstein, A; Shortell, S				Milstein, Arnold; Shortell, Stephen			Innovations in Care Delivery to Slow Growth of US Health Spending	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROLLED-TRIAL		[Milstein, Arnold] Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA; [Shortell, Stephen] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Stanford University; University of California System; University of California Berkeley	Milstein, A (corresponding author), Stanford Univ, Sch Med, Clin Excellence Res Ctr, 366 Galvez St,334, Stanford, CA 94305 USA.	amilstein@stanford.edu						[Anonymous], IMPR PAT FLOW THROUG; [Anonymous], HLTH AFFAIRS; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Milstein A, 2009, HEALTH AFFAIR, V28, P1317, DOI 10.1377/hlthaff.28.5.1317; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Orszag P, FOREIGN AFFAIRS; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Zuvekas SH, 2007, HEALTH AFFAIR, V26, P249, DOI 10.1377/hlthaff.26.1.249	10	14	14	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1439	1440		10.1001/jama.2012.12659	http://dx.doi.org/10.1001/jama.2012.12659			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	017GY	23047357				2022-12-24	WOS:000309579300021
J	Tren, R; Nchabi, R; Attaran, A				Tren, Richard; Nchabi, Richard; Attaran, Amir			The UN is premature in trying to ban DDT for malaria control	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [Attaran, Amir] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [Tren, Richard] Africa Fighting Malaria, Washington, DC USA	University of Ottawa; University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca						African Leaders Malaria Alliance, 2010, 2010 REP ALMA HEADS; Attaran A, 2000, BRIT MED J, V321, P1403, DOI 10.1136/bmj.321.7273.1403; Mckay B, 2006, WALL STREET J; Office of Senator Tom Coburn US Senate, 2012, OV ACT MULT BIL MAL; PATH Malaria Vaccine Initiative, 2011, STAY COURS MAL RES D; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; Roberts DR, 1997, EMERG INFECT DIS, V3, P295, DOI 10.3201/eid0303.970305; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Southern African Development Community Secretariat, NOT SADC COUNTR RESP; Stockholm Convention on Persistent Organic Pollutants, 2010, 2 M INT STEER COMM; Stockholm Convention on Persistent Organic Pollutants, 2010, 3 EXP GROUP M DDT; Stockholm Convention on Persistent Organic Pollutants, PRINC ORG; Stockholm Convention on Persistent Organic Pollutants, 2009, CONV TEXT; Stockholm Convention on Persistent Organic Pollutants, 2011, 1 ASS GLOB ALL ALT D; Stockholm Convention on Persistent Organic Pollutants, 2007, FUT PLANS WORK DDT E; WHO, 2010, WORLD MALARIA REPORT 2010, P1; [WHO World Health Organization (WHO)], 2011, US DDT MAL VECT CONT; WHO, 2011, DDT IND RES SPRAY HU	18	1	1	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2012	345								e6801	10.1136/bmj.e6801	http://dx.doi.org/10.1136/bmj.e6801			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054354				2022-12-24	WOS:000309907400009
J	Gittis, A				Gittis, Aryn			Striatal Interneurons: Causes of or Cures for Movement Disorders?	SCIENCE			English	Editorial Material							BASAL GANGLIA; INHIBITION; DOPAMINE		[Gittis, Aryn] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Gittis, Aryn] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gittis, A (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.		Gittis, Aryn/I-6128-2016	Gittis, Aryn/0000-0002-3591-5775	NINDS NIH HHS [R00 NS076524] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gittis AH, 2011, J NEUROSCI, V31, P15727, DOI 10.1523/JNEUROSCI.3875-11.2011; Gittis AH, 2011, NEURON, V71, P858, DOI 10.1016/j.neuron.2011.06.035; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Magazanik LG, 1997, J PHYSIOL-LONDON, V505, P655, DOI 10.1111/j.1469-7793.1997.655ba.x; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365	10	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103								10.1126/science.1229852	http://dx.doi.org/10.1126/science.1229852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042880				2022-12-24	WOS:000309457400049
J	Ohouo, PY; de Oliveira, FMB; Liu, Y; Ma, CJ; Smolka, MB				Ohouo, Patrice Y.; de Oliveira, Francisco M. Bastos; Liu, Yi; Ma, Chu Jian; Smolka, Marcus B.			DNA-repair scaffolds dampen checkpoint signalling by counteracting the adaptor Rad9	NATURE			English	Article							HOLLIDAY JUNCTION RESOLVASE; DAMAGE CHECKPOINT; PROTEIN-INTERACTION; REPLICATION STRESS; PHOSPHORYLATION; DPB11; SLX4; ACTIVATION; KINASE; DOMAIN	In response to genotoxic stress, a transient arrest in cell-cycle progression enforced by the DNA-damage checkpoint (DDC) signalling pathway positively contributes to genome maintenance(1). Because hyperactivated DDC signalling can lead to a persistent and detrimental cell-cycle arrest(2,3), cells must tightly regulate the activity of the kinases involved in this pathway. Despite their importance, the mechanisms for monitoring and modulating DDC signalling are not fully understood. Here we show that the DNA-repair scaffolding proteins Slx4 and Rtt107 prevent the aberrant hyperactivation of DDC signalling by lesions that are generated during DNA replication in Saccharomyces cerevisiae. On replication stress, cells lacking Slx4 or Rtt107 show hyperactivation of the downstream DDC kinase Rad53, whereas activation of the upstream DDC kinase Mec1 remains normal. An Slx4-Rtt107 complex counteracts the checkpoint adaptor Rad9 by physically interacting with Dpb11 and phosphorylated histone H2A, two positive regulators of Rad9-dependent Rad53 activation. A decrease in DDC signalling results from hypomorphic mutations in RAD53 and H2A and rescues the hypersensitivity to replication stress of cells lacking Slx4 or Rtt107. We propose that the Slx4-Rtt107 complex modulates Rad53 activation by a competition-based mechanism that balances the engagement of Rad9 at replication-induced lesions. Our findings show that DDC signalling is monitored and modulated through the direct action of DNA-repair factors.	[Ohouo, Patrice Y.; de Oliveira, Francisco M. Bastos; Liu, Yi; Ma, Chu Jian; Smolka, Marcus B.] Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University	Smolka, MB (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	mbs266@cornell.edu	Bastos de Oliveira, Francisco/C-2349-2008; de Oliveira, Francisco Bastos/I-3540-2013	de Oliveira, Francisco Bastos/0000-0003-3314-3940	National Institutes of Health [RO1-GM097272, F31-GM093588]; Cornell Fleming Research Fellowship; HHMI Institutional Undergraduate Education Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097272, F31GM093588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Fleming Research Fellowship; HHMI Institutional Undergraduate Education Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (RO1-GM097272 to M. B. S. and F31-GM093588 to P.Y.O.). F.M.B.O. was supported by a Cornell Fleming Research Fellowship. C.J.M. was supported by an HHMI Institutional Undergraduate Education Grant to Cornell. The authors thank B. Almeida for technical assistance and R. Weiss, S. Emr, A. Bretscher, G. Balmus and P. Russell for comments on the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Clerici M, 2001, EMBO J, V20, P6485, DOI 10.1093/emboj/20.22.6485; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Granata M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001047; Javaheri A, 2006, P NATL ACAD SCI USA, V103, P13771, DOI 10.1073/pnas.0511192103; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Li XX, 2012, J BIOL CHEM, V287, P9137, DOI 10.1074/jbc.M111.311860; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Ohouo PY, 2010, MOL CELL, V39, P300, DOI 10.1016/j.molcel.2010.06.019; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Pfander B, 2011, EMBO J, V30, P4897, DOI 10.1038/emboj.2011.345; Puddu F, 2008, MOL CELL BIOL, V28, P4782, DOI 10.1128/MCB.00330-08; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	30	73	73	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					120	+		10.1038/nature11658	http://dx.doi.org/10.1038/nature11658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23160493	Green Accepted			2022-12-24	WOS:000312933800043
J	O'Dowd, A				O'Dowd, Adrian			Liverpool care pathway: doctors speak out	BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@aol.com						[Anonymous], 2012, DAILY TELEGRAPH; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7511; McCartney M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7316	3	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 14	2012	345								e7644	10.1136/bmj.e7644	http://dx.doi.org/10.1136/bmj.e7644			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PZ	23152572				2022-12-24	WOS:000311336400012
J	Anbarasan, P; Baer, ZC; Sreekumar, S; Gross, E; Binder, JB; Blanch, HW; Clark, DS; Toste, FD				Anbarasan, Pazhamalai; Baer, Zachary C.; Sreekumar, Sanil; Gross, Elad; Binder, Joseph B.; Blanch, Harvey W.; Clark, Douglas S.; Toste, F. Dean			Integration of chemical catalysis with extractive fermentation to produce fuels	NATURE			English	Article							MICROBIAL-PRODUCTION; BUTANOL; RECOVERY; BIOMASS; HYDROCARBONS; CONVERSION; SUBSTRATE; BIOFUELS; ALKANES; ACETONE	Nearly one hundred years ago, the fermentative production of acetone by Clostridium acetobutylicum provided a crucial alternative source of this solvent for manufacture of the explosive cordite. Today there is a resurgence of interest in solventogenic Clostridium species to produce n-butanol and ethanol for use as renewable alternative transportation fuels(1-3). Acetone, a product of acetone-n-butanol-ethanol (ABE) fermentation, harbours a nucleophilic alpha-carbon, which is amenable to C-C bond formation with the electrophilic alcohols produced in ABE fermentation. This functionality can be used to form higher-molecular-mass hydrocarbons similar to those found in current jet and diesel fuels. Here we describe the integration of biological and chemocatalytic routes to convert ABE fermentation products efficiently into ketones by a palladium-catalysed alkylation. Tuning of the reaction conditions permits the production of either petrol or jet and diesel precursors. Glyceryl tributyrate was used for the in situ selective extraction of both acetone and alcohols to enable the simple integration of ABE fermentation and chemical catalysis, while reducing the energy demand of the overall process. This process provides a means to selectively produce petrol, jet and diesel blend stocks from lignocellulosic and cane sugars at yields near their theoretical maxima.	[Anbarasan, Pazhamalai; Sreekumar, Sanil; Gross, Elad; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Anbarasan, Pazhamalai; Baer, Zachary C.; Sreekumar, Sanil; Binder, Joseph B.; Blanch, Harvey W.; Clark, Douglas S.; Toste, F. Dean] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Baer, Zachary C.; Blanch, Harvey W.; Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Gross, Elad; Toste, F. Dean] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019; Anbarasan, Pazhamalai/E-7054-2011	Toste, F. Dean/0000-0001-8018-2198; Anbarasan, Pazhamalai/0000-0001-6049-5023	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Energy Biosciences Institute	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Energy Biosciences Institute	We are grateful to H.-J. Song for performing initial experiments on the catalytic alkylation of acetone, and V. Mitchell for analysing acid pretreatment hydrolysate inhibitors present in Miscanthus giganteus. F. D. T. and E. G. acknowledge funding from the Director, Office of Science of the US Department of Energy, under contract no. DE-AC02-05CH11231. This work was funded by the Energy Biosciences Institute.	Alsaker KV, 2010, BIOTECHNOL BIOENG, V105, P1131, DOI 10.1002/bit.22628; Blommel PG, 2008, INT SUGAR J, V110, P672; Carlini C, 2004, J MOL CATAL A-CHEM, V212, P65, DOI 10.1016/j.molcata.2003.10.045; Corma A, 2011, ANGEW CHEM INT EDIT, V50, P2375, DOI 10.1002/anie.201007508; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Green EM, 2011, CURR OPIN BIOTECH, V22, P337, DOI 10.1016/j.copbio.2011.02.004; Guillena G, 2007, ANGEW CHEM INT EDIT, V46, P2358, DOI 10.1002/anie.200603794; Guillena G, 2010, CHEM REV, V110, P1611, DOI 10.1021/cr9002159; Gurbuz EI, 2010, GREEN CHEM, V12, P223, DOI 10.1039/b920369a; Hamid MHSA, 2007, ADV SYNTH CATAL, V349, P1555, DOI 10.1002/adsc.200600638; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; JEON YJ, 1987, ANN NY ACAD SCI, V506, P536, DOI 10.1111/j.1749-6632.1987.tb23848.x; Kraemer K, 2011, COMPUT CHEM ENG, V35, P949, DOI 10.1016/j.compchemeng.2011.01.028; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Kwon MS, 2005, ANGEW CHEM INT EDIT, V44, P6913, DOI 10.1002/anie.200502422; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Ren C, 2010, METAB ENG, V12, P446, DOI 10.1016/j.ymben.2010.05.002; ROFFLER SR, 1987, BIOPROCESS ENG, V2, P181, DOI 10.1007/BF00387326; ROFFLER SR, 1988, BIOTECHNOL BIOENG, V31, P135, DOI 10.1002/bit.260310207; SALVAPATI GS, 1989, J MOL CATAL, V54, P9, DOI 10.1016/0304-5102(89)80134-8; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Tracy BP, 2012, CURR OPIN BIOTECH, V23, P364, DOI 10.1016/j.copbio.2011.10.008; Vane LM, 2008, BIOFUEL BIOPROD BIOR, V2, P553, DOI 10.1002/bbb.108; Wang C, 2011, METAB ENG, V13, P648, DOI 10.1016/j.ymben.2011.08.001; WAYMAN M, 1987, J FERMENT BIOENG, V65, P295, DOI 10.1016/0385-6380(87)90091-4; Xing R, 2010, GREEN CHEM, V12, P1933, DOI 10.1039/c0gc00263a	27	282	289	10	391	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					235	239		10.1038/nature11594	http://dx.doi.org/10.1038/nature11594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23135469				2022-12-24	WOS:000310774300040
J	Yoshizaki, A; Miyagaki, T; DiLillo, DJ; Matsushita, T; Horikawa, M; Kountikov, EI; Spolski, R; Poe, JC; Leonard, WJ; Tedder, TF				Yoshizaki, Ayumi; Miyagaki, Tomomitsu; DiLillo, David J.; Matsushita, Takashi; Horikawa, Mayuka; Kountikov, Evgueni I.; Spolski, Rosanne; Poe, Jonathan C.; Leonard, Warren J.; Tedder, Thomas F.			Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions	NATURE			English	Article							B10 CELLS; TRANSGENIC MICE; LYMPHOCYTE DEVELOPMENT; CUTTING EDGE; PLASMA-CELLS; HUMAN CD19; MEMORY B; IN-VIVO; IL-21; IL-10	B cells regulate immune responses by producing antigen-specific antibodies(1). However, specific B-cell subsets can also negatively regulate T-cell immune responses, and have been termed regulatory B cells(2-4). Human and mouse regulatory B cells (B10 cells) with the ability to express the inhibitory cytokine interleukin-10 (IL-10) have been identified(2-5). Although rare, B10 cells are potent negative regulators of antigen-specific inflammation and T-cell-dependent autoimmune diseases in mice(5-7). How B10-cell IL-10 production and regulation of antigen-specific immune responses are controlled in vivo without inducing systemic immunosuppression is unknown. Using a mouse model for multiple sclerosis, here we show that B10-cell maturation into functional IL-10-secreting effector cells that inhibit in vivo autoimmune disease requires IL-21 and CD40-dependent cognate interactions with T cells. Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease. The ex vivo expansion and reinfusion of autologous B10 cells may provide a novel and effective in vivo treatment for severe autoimmune diseases that are resistant to current therapies.	[Yoshizaki, Ayumi; Miyagaki, Tomomitsu; DiLillo, David J.; Matsushita, Takashi; Horikawa, Mayuka; Kountikov, Evgueni I.; Poe, Jonathan C.; Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Spolski, Rosanne; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	thomas.tedder@duke.edu	Matsushita, Takashi/C-4750-2015; Leonard, Warren/AAA-1397-2022; Yoshizaki, Ayumi/AAN-1548-2021; Miyagaki, Tomomitsu/AFP-0003-2022	Matsushita, Takashi/0000-0002-1617-086X; Yoshizaki, Ayumi/0000-0002-8194-9140; Poe, Jonathan/0000-0002-7789-1564	National Institutes of Health (NIH) [AI56363, AI057157]; Lymphoma Research Foundation; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, U19AI056363] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Maseda, E. Weimer, J. Bryant, K. Candando and G. Venturi for help and comments. These studies were supported by grants from the National Institutes of Health (NIH; AI56363 and AI057157), the Lymphoma Research Foundation, and the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH.	Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2011, IMMUNOL REV, V240, P52, DOI 10.1111/j.1600-065X.2010.00991.x; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Hoehlig K, 2012, EUR J IMMUNOL, V42, P1164, DOI 10.1002/eji.201142242; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Linterman MA, 2010, PROG MOL BIOL TRANSL, V92, P207, DOI 10.1016/S1877-1173(10)92009-7; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2011, METHODS MOL BIOL, V677, P99, DOI 10.1007/978-1-60761-869-0_7; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2010, CURR OPIN IMMUNOL, V22, P761, DOI 10.1016/j.coi.2010.10.009; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Poe JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022464; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Sato S, 1997, J IMMUNOL, V158, P4662; Sato S, 1996, J IMMUNOL, V157, P4371; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Tedder T. F., 1995, LEUCOCYTE TYPING 5, V1, P483; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884	37	463	491	5	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					264	+		10.1038/nature11501	http://dx.doi.org/10.1038/nature11501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064231	Green Accepted			2022-12-24	WOS:000310774300046
J	Chen, CE; Dhruva, SS; Redberg, RF				Chen, Connie E.; Dhruva, Sanket S.; Redberg, Rita F.			Inclusion of Comparative Effectiveness Data in High-Risk Cardiovascular Device Studies at the Time of Premarket Approval	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chen, Connie E.] Stanford Hosp & Clin, Dept Med, Palo Alto, CA USA; [Dhruva, Sanket S.] Univ Calif Davis, Div Cardiovasc Med, Davis, CA 95616 USA; [Redberg, Rita F.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA	Stanford University; University of California System; University of California Davis; University of California System; University of California San Francisco	Chen, CE (corresponding author), Stanford Hosp & Clin, Dept Med, Palo Alto, CA USA.	redberg@medicine.ucsf.edu						Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Food and Drug Administration, DET SAF EFF 860 7 VA; Food and Drug Administration, FDA SUMM SAF EFF DAT; Goldberg NH, 2011, JAMA-J AM MED ASSOC, V305, P1786, DOI 10.1001/jama.2011.539	4	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1740	1742		10.1001/jama.2012.14491	http://dx.doi.org/10.1001/jama.2012.14491			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117769	Bronze			2022-12-24	WOS:000310726500015
J	Safford, MM; Brown, TM; Muntner, PM; Durant, RW; Glasser, S; Halanych, JH; Shikany, JM; Prineas, RJ; Samdarshi, T; Bittner, VA; Lewis, CE; Gamboa, C; Cushman, M; Howard, V; Howard, G				Safford, Monika M.; Brown, Todd M.; Muntner, Paul M.; Durant, Raegan W.; Glasser, Stephen; Halanych, Jewell H.; Shikany, James M.; Prineas, Ronald J.; Samdarshi, Tandaw; Bittner, Vera A.; Lewis, Cora E.; Gamboa, Christopher; Cushman, Mary; Howard, Virginia; Howard, George		REGARDS Investigators	Association of Race and Sex With Risk of Incident Acute Coronary Heart Disease Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; UNIVERSAL DEFINITION; UNITED-STATES; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; MULTIPLE IMPUTATION; TRENDS; REVASCULARIZATION; STROKE; HEALTH	Context It is unknown whether long-standing disparities in incidence of coronary heart disease (CHD) among US blacks and whites persist. Objective To examine incident CHD by black and white race and by sex. Design, Setting, and Participants Prospective cohort study of 24 443 participants without CHD at baseline from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, who resided in the continental United States and were enrolled between 2003 and 2007 with follow-up through December 31, 2009. Main Outcome Measure Expert-adjudicated total (fatal and nonfatal) CHD, fatal CHD, and nonfatal CHD (definite or probable myocardial infarction [MI]; very small non-ST-elevation MI [NSTEMI] had peak troponin level <0.5 mu g/L). Results Over a mean (SD) of 4.2 (1.5) years of follow-up, 659 incident CHD events occurred (153 in black men, 138 in black women, 254 in white men, and 114 in white women). Among men, the age-standardized incidence rate per 1000 person-years for total CHD was 9.0 (95% CI, 7.5-10.8) for blacks vs 8.1 (95% CI, 6.9-9.4) for whites; fatal CHD: 4.0 (95% CI, 2.9-5.3) vs 1.9 (95% CI, 1.4-2.6), respectively; and nonfatal CHD: 4.9 (95% CI, 3.8-6.2) vs 6.2 (95% CI, 5.2-7.4). Among women, the age-standardized incidence rate per 1000 person-years for total CHD was 5.0 (95% CI, 4.2-6.1) for blacks vs 3.4 (95% CI, 2.8-4.2) for whites; fatal CHD: 2.0 (95% CI, 1.5-2.7) vs 1.0 (95% CI, 0.7-1.5), respectively; and nonfatal CHD: 2.8 (95% CI, 2.2-3.7) vs 2.2 (95% CI, 1.7-2.9). Age-and region-adjusted hazard ratios for fatal CHD among blacks vs whites was near 2.0 for both men and women and became statistically nonsignificant after multivariable adjustment. The multivariable-adjusted hazard ratio for incident nonfatal CHD for blacks vs whites was 0.68 (95% CI, 0.51-0.91) for men and 0.81 (95% CI, 0.58-1.15) for women. Of the 444 nonfatal CHD events, 139 participants (31.3%) had very small NSTEMIs. Conclusions The higher risk of fatal CHD among blacks compared with whites was associated with cardiovascular disease risk factor burden. These relationships may differ by sex.	[Safford, Monika M.; Brown, Todd M.; Durant, Raegan W.; Glasser, Stephen; Halanych, Jewell H.; Shikany, James M.; Bittner, Vera A.; Lewis, Cora E.] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA; [Muntner, Paul M.; Gamboa, Christopher; Howard, Virginia; Howard, George] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Prineas, Ronald J.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Samdarshi, Tandaw] Univ Mississippi, Sch Med, Oxford, MS USA; [Cushman, Mary] Univ Vermont, Sch Med, Burlington, VT 05405 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Wake Forest Baptist Medical Center; University of Mississippi; University of Vermont	Safford, MM (corresponding author), Univ Alabama Birmingham, Sch Med, 1717 11th Ave S,MT643, Birmingham, AL 35294 USA.	msafford@uab.edu	Cushman, Mary/K-1157-2019	Cushman, Mary/0000-0002-7871-6143; Howard, George/0000-0002-3068-5720; Brown, Todd/0000-0002-9820-5738; Bittner, Vera/0000-0001-9456-850X	National Heart, Lung, and Blood Institute [R01 HL080477]; National Center for Research Resources [KL2 RR025776-04]; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services [U01 NS041588]; Amgen Corporation; Amgen; NovoNordisk; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025776] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL111154, R01HL080477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amgen Corporation(Amgen); Amgen(Amgen); NovoNordisk(Novo Nordisk); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Brown reported receiving grants from Amgen Pharmaceuticals not related to this article. Dr Muntner reported serving on an Amgen advisory board in 2011; serving as a consultant to Amgen; and receiving grants from Amgen. Dr Lewis reported receiving a grant from NovoNordisk for an obesity study. No other authors reported any disclosures.; This research project was supported by grant R01 HL080477 from the National Heart, Lung, and Blood Institute (Dr Safford); grant KL2 RR025776-04 from the National Center for Research Resources (Dr Brown); and cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services (Dr G Howard). Additional funding was provided by an investigator-initiated grant-in-aid from Amgen Corporation (Dr Safford).	Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Centers for Disease Control and Prevention, CDC WOND COMPR MORT; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Halim SA, 2009, CIRC-CARDIOVASC QUAL, V2, P199, DOI 10.1161/CIRCOUTCOMES.108.810127; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hochholzer W, 2008, AM J MED, V121, P399, DOI 10.1016/j.amjmed.2008.01.033; Howard VJ, 2010, J AM SOC HYPERTENS, V4, P32, DOI 10.1016/j.jash.2010.02.001; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Jones DW, 2002, ARCH INTERN MED, V162, P2565, DOI 10.1001/archinte.162.22.2565; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; Prineas R., 1982, MINNESOTA CODE MANUA; Prineas RJ, 2010, MINNESOTA CODE MANUA; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Ross JS, 2007, CIRCULATION, V115, P1012, DOI 10.1161/CIRCULATIONAHA.106.658377; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Soliman EZ, 2011, HEART, V97, P1597, DOI 10.1136/hrt.2010.215871; Spertus JA, 2004, CIRCULATION, V110, P3789, DOI 10.1161/01.CIR.0000150392.70749.C7; Tate J, ANAL CHARACTERISTICS; Thygesen K, 2012, EUR HEART J; Thygesen K, 2008, CURR OPIN CRIT CARE, V14, P543, DOI 10.1097/MCC.0b013e32830d34b9; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Urban P, 2008, AM J MED, V121, P1065, DOI 10.1016/j.amjmed.2008.08.020; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	40	226	228	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2012	308	17					1768	1774		10.1001/jama.2012.14306	http://dx.doi.org/10.1001/jama.2012.14306			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032NR	23117777	Green Accepted, Bronze			2022-12-24	WOS:000310726500023
J	Aronin, N; Moore, M				Aronin, Neil; Moore, Melissa			Hunting Down Huntingtin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Aronin, Neil; Moore, Melissa] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Aronin, Neil; Moore, Melissa] Univ Massachusetts, Sch Med, Neurotherapeut Inst, Worcester, MA USA; [Moore, Melissa] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Aronin, N (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA.				HHMI Funding Source: Medline	HHMI(Howard Hughes Medical Institute)		Bhide PG, 1996, J NEUROSCI, V16, P5523; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lu XH, 2012, NEURON, V74, P964, DOI 10.1016/j.neuron.2012.06.001; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	5	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1753	1754		10.1056/NEJMcibr1209595	http://dx.doi.org/10.1056/NEJMcibr1209595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113488				2022-12-24	WOS:000310440800015
J	Green, DJ; Alemseged, Z				Green, David J.; Alemseged, Zeresenay			Australopithecus afarensis Scapular Ontogeny, Function, and the Role of Climbing in Human Evolution	SCIENCE			English	Article							HOMININ SHOULDER; CHIMPANZEE; LOCOMOTION; PRIMATE; EMG; ETHIOPIA; BEHAVIOR; MUSCLES; WALKING; ANGLE	Scapular morphology is predictive of locomotor adaptations among primates, but this skeletal element is scarce in the hominin fossil record. Notably, both scapulae of the juvenile Australopithecus afarensis skeleton from Dikika, Ethiopia, have been recovered. These scapulae display several traits characteristic of suspensory apes, as do the few known fragmentary adult australopith representatives. Many of these traits change significantly throughout modern human ontogeny, but remain stable in apes. Thus, the similarity of juvenile and adult fossil morphologies implies that A. afarensis development was apelike. Additionally, changes in other scapular traits throughout African ape development are associated with shifts in locomotor behavior. This affirms the functional relevance of those characteristics, and their presence in australopith fossils supports the hypothesis that their locomotor repertoire included a substantial amount of climbing.	[Green, David J.] Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA; [Alemseged, Zeresenay] Calif Acad Sci, Dept Anthropol, San Francisco, CA 94118 USA	Midwestern University; California Academy of Sciences	Green, DJ (corresponding author), Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA.	dgreen1@midwestern.edu			NSF IGERT grant [9987590]; NSF [BCS-0824552, BCS-0914687]; Leakey Foundation; Wenner-Gren Foundation; George Washington University; Midwestern University; California Academy of Sciences	NSF IGERT grant; NSF(National Science Foundation (NSF)); Leakey Foundation; Wenner-Gren Foundation; George Washington University; Midwestern University; California Academy of Sciences	We thank C. Kiarie and the staff at the National Museum of Ethiopia for help during the preparation of these fragile fossils. We greatly appreciate critical comments offered by B. Richmond, B. Wood, R. Bernstein, M. Hamrick, L.P. Hernandez, and three anonymous reviewers on this manuscript and A. Gordon for analytical assistance. We thank D. Hunt, L. Gordon, E. Westwig, I. Tattersall, G. Garcia, J. Chupasko, M. Omura, Y. Haile-Selassie, L. Jellema, M. Harman, A. Gill, E. Mbua, S. Muteti, M. Yilma, P.V. Tobias, B. Zipfel, S. Potze, and T. Perregil for coordinating museum visits. We also acknowledge the NSF IGERT grant (9987590), NSF Doctoral Dissertation Improvement Grant (BCS-0824552), NSF (BCS-0914687), The Leakey Foundation, the Wenner-Gren Foundation, The George Washington University, Midwestern University, and the California Academy of Sciences for funding support. This paper was written by D.J.G. and Z.A. Fossil data were collected and described by D.J.G. and Z.A. Extant primate data were collected and analyzed by D.J.G. The data reported in this paper are summarized in the supplementary materials; raw data are available on request to D.J.G.	Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; ASHTON E. H., 1964, PROC ZOOL SOC LONDON, V142, P49; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; DORAN DM, 1992, J HUM EVOL, V23, P139, DOI 10.1016/0047-2484(92)90104-H; Green D. J., 2012, J EXP ZOOL B; Green D. J., 2010, THESIS G WASHINGTON; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; HUNT KD, 1991, AM J PHYS ANTHROPOL, V86, P521, DOI 10.1002/ajpa.1330860408; Inman VT, 1944, J BONE JOINT SURG, V26, P1; Inouye SE, 1997, INT J PRIMATOL, V18, P629, DOI 10.1023/A:1026319424308; LARSON SG, 1986, AM J ANAT, V176, P171, DOI 10.1002/aja.1001760207; LARSON SG, 1995, AM J PHYS ANTHROPOL, V98, P13, DOI 10.1002/ajpa.1330980103; LARSON SG, 1991, AM J PHYS ANTHROPOL, V85, P71, DOI 10.1002/ajpa.1330850109; LARSON SG, 1987, J ZOOL, V212, P629, DOI 10.1111/j.1469-7998.1987.tb05961.x; Larson SG, 2007, J HUM EVOL, V53, P718, DOI 10.1016/j.jhevol.2007.06.003; Larson SG, 2007, EVOL ANTHROPOL, V16, P172, DOI 10.1002/evan.20149; Latimer B., 1991, P169; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; MENSFORTH RP, 1990, AM J PHYS ANTHROPOL, V81, P267; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; OXNARD CE, 1967, AM J PHYS ANTHROPOL, V26, P219, DOI 10.1002/ajpa.1330260209; Roberts D., 1974, P171; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; Susman R.L., 1991, P121; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Young NM, 2008, AM J PHYS ANTHROPOL, V136, P247, DOI 10.1002/ajpa.20799; Young NM, 2002, THESIS HARVARD U	30	88	91	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					514	517		10.1126/science.1227123	http://dx.doi.org/10.1126/science.1227123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	025NH	23112331				2022-12-24	WOS:000310195800054
J	Patel, K				Patel, Kinesh			Tax calories to end the buffet syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 3	2012	345								e6674	10.1136/bmj.e6674	http://dx.doi.org/10.1136/bmj.e6674			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KZ	23034861				2022-12-24	WOS:000309660600002
J	Wilson, LE; Blythe, D; Sharfstein, JM				Wilson, Lucy E.; Blythe, David; Sharfstein, Joshua M.			Fungal Meningitis From Injection of Contaminated Steroids A Compounding Problem	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wilson, Lucy E.; Blythe, David; Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD 21202 USA	Maryland Department of Health & Mental Hygiene	Sharfstein, JM (corresponding author), Maryland Dept Hlth & Mental Hyg, 201 W Preston St, Baltimore, MD 21202 USA.	joshua.sharfstein@maryland.gov						[Anonymous], 2002, KANSAS CITY STA 1006; Centers for Disease Control and Prevention (CDC), MULT FUNG MEN OUTBR; Centers for Disease Control and Prevention (CDC), CAS DEF MEN SEPT ART; Food and Drug Administration (FDA), FUNG MEN OUTBR ARCH; Hallissy E, 2002, SAN FRANCISCO CHRONI; Kliff S, 2012, WASHINGTON POST; Professional Compounding Centers of America (PCCA), COMP PHARM PHARM AR	7	15	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2461	2462		10.1001/jama.2012.47932	http://dx.doi.org/10.1001/jama.2012.47932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23104261				2022-12-24	WOS:000312441400019
J	Lee, GM; Kleinman, K; Soumerai, SB; Tse, A; Cole, D; Fridkin, SK; Horan, T; Platt, R; Gay, C; Kassler, W; Goldmann, DA; Jernigan, J; Jha, AK				Lee, Grace M.; Kleinman, Ken; Soumerai, Stephen B.; Tse, Alison; Cole, David; Fridkin, Scott K.; Horan, Teresa; Platt, Richard; Gay, Charlene; Kassler, William; Goldmann, Donald A.; Jernigan, John; Jha, Ashish K.			Effect of Nonpayment for Preventable Infections in US Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE-ASSOCIATED INFECTIONS; PAY-FOR-PERFORMANCE; URINARY-TRACT-INFECTIONS; QUALITY-OF-CARE; SAFETY-NET HOSPITALS; HEALTH-CARE; MEDICARE POLICY; PAYMENT POLICY; UNINTENDED CONSEQUENCES; ACQUIRED CONDITIONS	Background In October 2008, the Centers for Medicare and Medicaid Services (CMS) discontinued additional payments for certain hospital-acquired conditions that were deemed preventable. The effect of this policy on rates of health care-associated infections is unknown. Methods Using a quasi-experimental design with interrupted time series with comparison series, we examined changes in trends of two health care-associated infections that were targeted by the CMS policy (central catheter-associated bloodstream infections and catheter-associated urinary tract infections) as compared with an outcome that was not targeted by the policy (ventilator-associated pneumonia). Hospitals participating in the National Healthcare Safety Network and reporting data on at least one health care-associated infection before the onset of the policy were eligible to participate. Data from January 2006 through March 2011 were included. We used regression models to measure the effect of the policy on changes in infection rates, adjusting for base-line trends. Results A total of 398 hospitals or health systems contributed 14,817 to 28,339 hospital unit-months, depending on the type of infection. We observed decreasing secular trends for both targeted and nontargeted infections long before the policy was implemented. There were no significant changes in quarterly rates of central catheter-associated bloodstream infections (incidence-rate ratio in the postimplementation vs. preimplementation period, 1.00; P = 0.97), catheter-associated urinary tract infections (incidence-rate ratio, 1.03; P = 0.08), or ventilator-associated pneumonia (incidence-rate ratio, 0.99; P = 0.52) after the policy implementation. Our findings did not differ for hospitals in states without mandatory reporting, nor did it differ according to the quartile of percentage of Medicare admissions or hospital size, type of ownership, or teaching status. Conclusions We found no evidence that the 2008 CMS policy to reduce payments for central catheter-associated bloodstream infections and catheter-associated urinary tract infections had any measurable effect on infection rates in U.S. hospitals. (Funded by the Agency for Healthcare Research and Quality.)	[Lee, Grace M.] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Ctr Child Hlth Care Studies, Boston, MA 02215 USA; [Lee, Grace M.] Harvard Univ, Sch Med, Div Infect Dis, Boston, MA USA; [Lee, Grace M.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Kassler, William] Harvard Univ, Sch Publ Hlth, Ctr Medicare Serv, Boston, MA 02115 USA; [Kassler, William] Harvard Univ, Sch Publ Hlth, Ctr Medicaid Serv, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Inst Healthcare Improvement, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Fridkin, Scott K.; Horan, Teresa; Jernigan, John] Ctr Dis Control & Prevent, Div Healthcare Qual & Promot, Atlanta, GA USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Centers for Medicare & Medicaid Services; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Medicare & Medicaid Services; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA	Lee, GM (corresponding author), Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Ctr Child Hlth Care Studies, 133 Brookline Ave,6th Fl, Boston, MA 02215 USA.	grace.lee@childrens.harvard.edu		Kawai, Alison/0000-0002-2923-2169; Kleinman, Ken/0000-0002-5600-5834; Jernigan, John/0000-0001-8163-925X	Agency for Healthcare Research and Quality [5R01HS018414-03]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018414] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a grant from the Agency for Healthcare Research and Quality (5R01HS018414-03, to Dr. Lee).	Agency for Healthcare Research and Quality, HEALTHC ASS INF; American Hospital Association, 2011, MED NONP HEALTHC ASS; [Anonymous], STAT BAS HAI PREV; [Anonymous], RED HEALTHC INF; [Anonymous], 2011, HOSP ACQ COND PRES A; Burton DC, 2011, INFECT CONT HOSP EP, V32, P748, DOI 10.1086/660872; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P32816; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Department of Health and Human Services, 2011, COMMUNICATION    071; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; Emmert M, 2011, EUR J HLTH EC; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Hartmann CW, 2012, MED CARE RES REV, V69, P45, DOI 10.1177/1077558711413606; Health Forum LLC, 2010, AM HOSP ASS ANN SURV; Healthcare-associated infections (HAI), HEALTHC ASS INF HAI; Hoff T, 2011, J HEALTHC MANAG, V56, P319, DOI 10.1097/00115514-201109000-00007; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Karve AM, 2008, AM HEART J, V155, P571, DOI 10.1016/j.ahj.2007.10.043; Krein SL, 2012, J GEN INTERN MED, V27, P773, DOI 10.1007/s11606-011-1935-y; Lee GM, 2012, AM J INFECT CONTROL, V40, P314, DOI 10.1016/j.ajic.2011.11.003; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; McClellan M., 2009, MOVING ACCOUNT ABLE; McHugh M, 2011, MED CARE RES REV, V68, P667, DOI 10.1177/1077558711408326; McNair PD, 2009, HEALTH AFFAIR, V28, P1485, DOI 10.1377/hlthaff.28.5.1485; McNutt Robert, 2010, Qual Manag Health Care, V19, P17, DOI 10.1097/QMH.0b013e3181ccbd07; Meddings J, 2010, INFECT CONT HOSP EP, V31, P627, DOI 10.1086/652523; Methicillin-resistant Staphylococcus aureus (MRSA) and other healthcare-associated infections, METH RES STAPH AURC; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Ryan AM, 2011, HEALTH SERV RES, V46, P712, DOI 10.1111/j.1475-6773.2010.01224.x; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Serumaga B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d108; Sherman ER, 2006, INFECT CONT HOSP EP, V27, P332, DOI 10.1086/502684; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Stone Patricia W, 2011, Policy Polit Nurs Pract, V12, P73, DOI 10.1177/1527154411416129; Stone PW, 2010, MED CARE, V48, P433, DOI 10.1097/MLR.0b013e3181d5fb3f; Teufack SG, 2010, J NEUROSURG, V112, P249, DOI 10.3171/2009.7.JNS09753; The Joint Commission, INF CONTR; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; Werner RM, 2007, JAMA-J AM MED ASSOC, V297, P700; Zhan CL, 2009, MED CARE, V47, P364, DOI 10.1097/MLR.0b013e31818af83d; Zrelak Patricia A, 2011, J Healthc Qual, V33, P29, DOI 10.1111/j.1945-1474.2010.00114.x	53	161	166	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1428	1437		10.1056/NEJMsa1202419	http://dx.doi.org/10.1056/NEJMsa1202419			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	23050526	Green Published, Green Submitted			2022-12-24	WOS:000309652700009
J	Vohra, P				Vohra, Pankaj			Why this love for antibiotics in India?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Max Healthcare, New Delhi, India		Vohra, P (corresponding author), Max Healthcare, New Delhi, India.	pankajvohramd@yahoo.com						Bate R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006003; Dutta S, 2006, DIAGN MICR INFEC DIS, V56, P359, DOI 10.1016/j.diagmicrobio.2006.06.024; Ganguly NK, 2011, INDIAN J MED RES, V134, P281; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 2	2012	345								e6209	10.1136/bmj.e6209	http://dx.doi.org/10.1136/bmj.e6209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018KN	23033364				2022-12-24	WOS:000309659300006
J	Tulloch, J; David, B; Newman, RD; Meek, S				Tulloch, Jim; David, Benedict; Newman, Robert D.; Meek, Sylvia			Artemisinin-resistant malaria in the Asia-Pacific region	LANCET			English	Editorial Material									[Tulloch, Jim] Artemisinin Resistance Assessment Team, Adelaide, SA, Australia; [David, Benedict] Australian Agcy Int Dev, Canberra, ACT 2601, Australia; [Newman, Robert D.] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Meek, Sylvia] Malaria Consortium, London, England	World Health Organization	David, B (corresponding author), Australian Agcy Int Dev, Canberra, ACT 2601, Australia.	benedict.david@ausaid.gov.au						[Anonymous], 2011, GLOB PLAN ART RES CO; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008; Malaria Consortium National Malaria Centre Ministry of Health Cambodia WHO, 2011, MOV MAL EL TOOLS STR; Meek S, 2011, JOINT ASSESSMENT RES; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Roll Back Malaria, 2011, PROGR IMP SER, V7; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO - World Health Organization, 2012, UPD ART RES APR 2012; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601	11	14	14	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					E16	E17		10.1016/S0140-6736(12)61820-0	http://dx.doi.org/10.1016/S0140-6736(12)61820-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23122219				2022-12-24	WOS:000320319500001
J	Vahedi, G; Takahashi, H; Nakayamada, S; Sun, HW; Sartorelli, V; Kanno, Y; O'Shea, JJ				Vahedi, Golnaz; Takahashi, Hayato; Nakayamada, Shingo; Sun, Hong-wei; Sartorelli, Vittorio; Kanno, Yuka; O'Shea, John J.			STATs Shape the Active Enhancer Landscape of T Cell Populations	CELL			English	Article							CHIP-SEQ DATA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; REGULATORY ELEMENTS; LINEAGE COMMITMENT; RNA-SEQ; BET; DIFFERENTIATION; IDENTIFICATION; ACCESSIBILITY	Signaling pathways are intimately involved in cellular differentiation, allowing cells to respond to their environment by regulating gene expression. Although enhancers are recognized as key elements that regulate selective gene expression, the interplay between signaling pathways and actively used enhancer elements is not clear. Here, we use CD4(+) T cells as a model of differentiation, mapping the activity of cell-type-specific enhancer elements in T helper 1 (Th1) and Th2 cells. Our data establish that STAT proteins have a major impact on the activation of lineage-specific enhancers and the suppression of enhancers associated with alternative cell fates. Transcriptome analysis further supports a functional role for enhancers regulated by STATs. Importantly, expression of lineage-defining master regulators in STAT-deficient cells fails to fully recover the chromatin signature of STAT-dependent enhancers. Thus, these findings point to a critical role of STATs as environmental sensors in dynamically molding the specialized enhancer architecture of differentiating cells.	[Vahedi, Golnaz; Takahashi, Hayato; Nakayamada, Shingo; Kanno, Yuka; O'Shea, John J.] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sun, Hong-wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Sartorelli, Vittorio] NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kanno, Y (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	kannoy@mail.nih.gov	Takahashi, Hayato/AAV-7707-2021; Kanno, Yuka/B-5802-2013	Takahashi, Hayato/0000-0001-6768-8821; Kanno, Yuka/0000-0001-5668-9319; Sartorelli, Vittorio/0000-0002-9284-3675	Intramural Research Programs of NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041164, ZIAAR041159, ZIHAR041173, Z01AR041159] Funding Source: NIH RePORTER	Intramural Research Programs of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Drs. K. Zhao, A. Poholek, and K. Ghoreschi for critically reading this manuscript. We also thank G. Gutierrez-Cruz (Biodata Mining Core Facility, NIAMS), J. Simone, and J. Lay (Flow Cytometry Section, NIAMS) for their excellent technical support. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. This work was supported by the Intramural Research Programs of NIAMS.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chong MMW, 2010, GENE DEV, V24, P659, DOI 10.1101/gad.1901610; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smale ST, 2010, IMMUNITY, V32, P296, DOI 10.1016/j.immuni.2010.03.011; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Watson CJ, 2008, SEMIN CELL DEV BIOL, V19, P401, DOI 10.1016/j.semcdb.2008.07.021; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	41	251	254	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					981	993		10.1016/j.cell.2012.09.044	http://dx.doi.org/10.1016/j.cell.2012.09.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178119	Bronze, Green Accepted			2022-12-24	WOS:000311423500012
J	Kalager, M; Tamimi, RM; Bretthauer, M; Adami, HO				Kalager, Mette; Tamimi, Rulla M.; Bretthauer, Michael; Adami, Hans-Olov			Prognosis in women with interval breast cancer: population based observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SCREENING-PROGRAM; TRUE INTERVAL; SURVIVAL; MAMMOGRAPHY; COMPLETENESS; FEATURES; REGISTRY; 10-YEAR; NORWAY; TIME	Objective To compare the prognosis in women with interval breast cancer (cancer detected after a normal screening mammogram and before the next scheduled mammogram) with breast cancer detected among women not yet invited to mammography screening (non-screened). Design Population based observational study. Setting Norwegian breast cancer screening programme, implemented in different counties from 1996 to 2005. Participants 7116 women with a diagnosis of breast cancer at age 50 to 72 years; 1816 had interval breast cancer and 5300 had a diagnosis of breast cancer but had not yet been invited to screening. Main outcome measures Characteristics of the breast tumours, and survival of the women using Kaplan Meier curves and multivariable Cox proportional hazard models. Results Although interval cancers on average were slightly larger than the cancers in women not invited to screening, the histological type or status of axilliary lymph nodes did not differ noticeably between the two groups. Among interval cancers, there were no appreciable trends in size, nodal status, grade, or hormone receptor positivity associated with time since the last normal mammogram as a marker of growth rate. After 10 years of follow-up, the survival rates were 79.1% (95% confidence interval 75.4% to 82.3%) among women with interval cancers and 76.8% (75.3% to 78.2%) among women in the non-screened cancer group (hazard ratio 0.98, 95% confidence interval 0.84 to 1.15; P=0.53). Analyses stratified by time since last normal mammogram, age at diagnosis, or screening round showed similar results. Conclusion The prognosis of women with interval breast cancers was the same as that of women with breast cancers diagnosed without mammography screening.	[Kalager, Mette; Tamimi, Rulla M.; Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kalager, Mette; Bretthauer, Michael] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Kalager, Mette] Telemark Hosp, Dept Clin Res, Skien, Norway; [Tamimi, Rulla M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA; [Bretthauer, Michael] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Organ Transplantat, N-0027 Oslo, Norway; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; Telemark Hospital Trust; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; National Hospital Norway; Karolinska Institutet	Kalager, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mkalager@hsph.harvard.edu			Norwegian Research Council and Frontier Science	Norwegian Research Council and Frontier Science	This study was funded by research grants from the Norwegian Research Council and Frontier Science. The funders had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, or approval of the manuscript.	ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Bordas P, 2007, BREAST, V16, P47, DOI 10.1016/j.breast.2006.05.006; BREKELMANS CT, 1995, EUR J CANCER, V31A, P1830, DOI 10.1016/0959-8049(95)00324-C; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Collins S, 1998, BRIT MED J, V316, P832, DOI 10.1136/bmj.316.7134.832; Cowan WK, 2000, J CLIN PATHOL, V53, P140, DOI 10.1136/jcp.53.2.140; DEGROOTE R, 1983, SURGERY, V94, P543; Domingo L, 2010, CANCER CAUSE CONTROL, V21, P1155, DOI 10.1007/s10552-010-9541-6; Edge SB, 2010, AJCC CANC STAGING MA; ERZAAS A, 2003, QUALITY ASSURANCE MA; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; FRISELL J, 1992, BREAST CANCER RES TR, V24, P11, DOI 10.1007/BF01832353; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Hofvind S, 2008, ACTA RADIOL, V49, P975, DOI 10.1080/02841850802403730; Hofvind S, 2005, RADIOLOGY, V237, P437, DOI 10.1148/radiol.2372041174; HOLMBERG LH, 1986, LANCET, V2, P27; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kalager M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2331; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lawrence G, 2009, J MED SCREEN, V16, P186, DOI 10.1258/jms.2009.009040; PERRY NM, 1996, EUROPEAN GUIDELINES; Porter GJR, 2006, J MED SCREEN, V13, P115, DOI 10.1258/096914106778440572; Rayson D, 2011, CLIN BREAST CANCER, V11, P27, DOI 10.3816/CBC.2011.n.005; Schroen AA, 1996, J SURG ONCOL, V63, P141, DOI 10.1002/(SICI)1096-9098(199611)63:3<141::AID-JSO2>3.0.CO;2-D; SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349; Sihto H, 2008, CLIN CANCER RES, V14, P4103, DOI 10.1158/1078-0432.CCR-07-5003; Tingulstad S, 2002, INT J CANCER, V98, P907, DOI 10.1002/ijc.10254; Vitak B, 1999, EUR RADIOL, V9, P460, DOI 10.1007/s003300050693; Vitak B, 1997, EUR J CANCER, V33, P1453, DOI 10.1016/S0959-8049(97)00185-8; Vitak B, 1998, EUR RADIOL, V8, P639, DOI 10.1007/s003300050452; Wang H, 2001, CANCER CAUSE CONTROL, V12, P39, DOI 10.1023/A:1008999403069; Wang HG, 2001, INT J CANCER, V94, P594, DOI 10.1002/ijc.1511; Zackrisson S, 2007, J MED SCREEN, V14, P138, DOI 10.1258/096914107782066239	34	27	28	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 16	2012	345								e7536	10.1136/bmj.e7536	http://dx.doi.org/10.1136/bmj.e7536			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040QI	23160783	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000311337500001
J	Nielsen, SF; Nordestgaard, BG; Bojesen, SE				Nielsen, Sune F.; Nordestgaard, Borge G.; Bojesen, Stig E.			Statin Use and Reduced Cancer-Related Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HMG-COA REDUCTASE; BREAST-CANCER; MEVALONATE PATHWAY; PROSPECTIVE COHORT; CELL-GROWTH; RISK; CHOLESTEROL; RECURRENCE; INHIBITORS; DRUGS	BACKGROUND A reduction in the availability of cholesterol may limit the cellular proliferation required for cancer growth and metastasis. We tested the hypothesis that statin use begun before a cancer diagnosis is associated with reduced cancer-related mortality. METHODS We assessed mortality among patients from the entire Danish population who had received a diagnosis of cancer between 1995 and 2007, with follow-up until December 31, 2009. Among patients 40 years of age or older, 18,721 had used statins regularly before the cancer diagnosis and 277,204 had never used statins. RESULTS Multivariable-adjusted hazard ratios for statin users, as compared with patients who had never used statins, were 0.85 (95% confidence interval [CI], 0.83 to 0.87) for death from any cause and 0.85 (95% CI, 0.82 to 0.87) for death from cancer. Adjusted hazard ratios for death from any cause according to the defined daily statin dose (the assumed average maintenance dose per day) were 0.82 (95% CI, 0.81 to 0.85) for a dose of 0.01 to 0.75 defined daily dose per day, 0.87 (95% CI, 0.83 to 0.89) for 0.76 to 1.50 defined daily dose per day, and 0.87 (95% CI, 0.81 to 0.91) for higher than 1.50 defined daily dose per day; the corresponding hazard ratios for death from cancer were 0.83 (95% CI, 0.81 to 0.86), 0.87 (95% CI, 0.83 to 0.91), and 0.87 (95% CI, 0.81 to 0.92). The reduced cancer-related mortality among statin users as compared with those who had never used statins was observed for each of 13 cancer types. CONCLUSIONS Statin use in patients with cancer is associated with reduced cancer-related mortality. This suggests a need for trials of statins in patients with cancer.	[Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Bojesen, SE (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, 54M1,Herlev Ringvej 75, DK-2730 Herlev, Denmark.	stig.egil.bojesen@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020	Nordestgaard, Borge/0000-0002-1954-7220; Bojesen, Stig/0000-0002-4061-4133				Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Andersen TF, 1999, DAN MED BULL, V46, P263; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; BASERGA R, 1986, INT J RADIAT BIOL, V49, P219, DOI 10.1080/09553008514552511; Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Boudreau DM, 2010, EXPERT OPIN DRUG SAF, V9, P603, DOI 10.1517/14740331003662620; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Cholesterol Treatment Trialists' (CTT) Collaborators, 2012, LANCET; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Denoyelle C, 2001, CARCINOGENESIS, V22, P1139, DOI 10.1093/carcin/22.8.1139; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; FENTON RG, 1992, J CELL BIOL, V117, P347, DOI 10.1083/jcb.117.2.347; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fiorenza AM, 2000, INT J CLIN LAB RES, V30, P141, DOI 10.1007/s005990070013; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Fritz G, 2005, INT J ONCOL, V27, P1401; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Garcia MJ, 2003, METHOD FIND EXP CLIN, V25, P457; Gauthaman K, 2009, J CELL BIOCHEM, V106, P975, DOI 10.1002/jcb.22092; Hamilton RJ, 2010, CANCER-AM CANCER SOC, V116, P3389, DOI 10.1002/cncr.25308; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; HEROLD G, 1995, DIGESTION, V56, P57, DOI 10.1159/000201223; Jakobisiak M, 2003, INT J ONCOL, V23, P1055; Kawata S, 2001, BRIT J CANCER, V84, P886, DOI 10.1054/bjoc.2000.1716; Kusama T, 2001, CANCER RES, V61, P4885; Kwan ML, 2008, BREAST CANCER RES TR, V109, P573, DOI 10.1007/s10549-007-9683-8; LAMB E, 2009, PHARM TIMES     0515; Lamond AI, 2002, NATURE, V417, P383, DOI 10.1038/417383a; Mannello F, 2009, CANCER INVEST, V27, P466, DOI 10.1080/07357900802491444; Nielsen SF, 2012, CAN MED ASSOC J, V184, pE57, DOI 10.1503/cmaj.110167; Nielsen SF, 2011, BLOOD, V118, P4062, DOI 10.1182/blood-2011-02-337170; Pedersen CB, 2006, DAN MED BULL, V53, P441; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Sobin L, 2009, TNM CLASSIFICATION M; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Storm HH, 1997, DAN MED BULL, V44, P535; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476	40	681	694	1	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2012	367	19					1792	1802		10.1056/NEJMoa1201735	http://dx.doi.org/10.1056/NEJMoa1201735			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033DG	23134381				2022-12-24	WOS:000310773200006
J	Brayne, C; Davis, D				Brayne, Carol; Davis, Daniel			Making Alzheimer's and dementia research fit for populations	LANCET			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; RISK-FACTORS; DISEASE; PREVALENCE; DIAGNOSIS; CRITERIA		[Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England	University of Cambridge	Brayne, C (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Robinson Way, Cambridge CB2 0SR, England.	cb105@medschl.cam.ac.uk	Davis, Daniel/F-9995-2012; Brayne, Carol/AAA-4285-2020	Davis, Daniel/0000-0002-1560-1955; Brayne, Carol/0000-0001-5307-663X	Wellcome Trust [090661] Funding Source: Medline; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Ablin R, 2010, NY TIMES; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bhamra S, 2008, QUAL AGEING OLDER AD, V9, P27, DOI 10.1108/14717794200800025; BRAYNE C, 1993, PSYCHOL MED, V23, P287, DOI 10.1017/S003329170002835X; BRAYNE C, 1993, BRIT J PSYCHIAT, V162, P439, DOI 10.1192/bjp.162.4.439; BRAYNE C, 1988, LANCET, V2, P514, DOI 10.1016/S0140-6736(88)90166-3; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Matthews FE, 2008, J AM GERIATR SOC, V56, P1424, DOI 10.1111/j.1532-5415.2008.01820.x; Matthews FE, 2007, PLOS MED, V4, P1615, DOI 10.1371/journal.pmed.0040304; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Muniz-Terrera G, 2011, INT J GERIATR PSYCH, V26, P584, DOI 10.1002/gps.2566; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Schoenmaker N, 2004, LANCET NEUROL, V3, P627, DOI 10.1016/S1474-4422(04)00884-1; Yip AG, 2006, AGE AGEING, V35, P154, DOI 10.1093/ageing/afj030; Zimmern RL, 2009, CLIN MED, V9, P68, DOI 10.7861/clinmedicine.9-1-68	22	68	68	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2012	380	9851					1441	1443		10.1016/S0140-6736(12)61803-0	http://dx.doi.org/10.1016/S0140-6736(12)61803-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025NM	23084456	Green Accepted			2022-12-24	WOS:000310196500034
J	Arie, S				Arie, Sophie			Ending the French love affair with drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@sophiearie.com						Benkimoun P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6882; Debre B, 2012, GUIDE 4000 MED UTILE; OECD, 2012, HLTH KEY TABL PHARM; OECD, 2011, HLTH GLANC 2011 PHAR	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 17	2012	345								e6996	10.1136/bmj.e6996	http://dx.doi.org/10.1136/bmj.e6996			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	024WR	23077372				2022-12-24	WOS:000310141900016
J	Hinrichs, KU; Inagaki, F				Hinrichs, Kai-Uwe; Inagaki, Fumio			Downsizing the Deep Biosphere	SCIENCE			English	Editorial Material							SUBSURFACE SEDIMENTS		[Hinrichs, Kai-Uwe] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Hinrichs, Kai-Uwe] Univ Bremen, Dept Geosci, D-28359 Bremen, Germany; [Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Kochi 7838502, Japan	University of Bremen; University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Hinrichs, KU (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany.	khinrichs@uni-bremen.de; inagaki@jamstec.go.jp	Hinrichs, Kai-Uwe/C-7675-2009; Inagaki, Fumio/AAI-1156-2019	Hinrichs, Kai-Uwe/0000-0002-0739-9291; Inagaki, Fumio/0000-0003-2887-6525				D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Hoehler TM, 2004, GEOBIOLOGY, V2, P205, DOI 10.1111/j.1472-4677.2004.00033.x; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Kallmeyer J, 2008, LIMNOL OCEANOGR-METH, V6, P236, DOI 10.4319/lom.2008.6.236; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lipp JS, 2009, GEOCHIM COSMOCHIM AC, V73, P6816, DOI 10.1016/j.gca.2009.08.003; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Rebata-Landa V, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001355; Schouten S, 2010, GEOCHIM COSMOCHIM AC, V74, P3806, DOI 10.1016/j.gca.2010.03.029; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	12	28	29	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					204	205		10.1126/science.1229296	http://dx.doi.org/10.1126/science.1229296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066067				2022-12-24	WOS:000309712300028
J	Erickson, GM; Krick, BA; Hamilton, M; Bourne, GR; Norell, MA; Lilleodden, E; Sawyer, WG				Erickson, Gregory M.; Krick, Brandon A.; Hamilton, Matthew; Bourne, Gerald R.; Norell, Mark A.; Lilleodden, Erica; Sawyer, W. Gregory			Complex Dental Structure and Wear Biomechanics in Hadrosaurid Dinosaurs	SCIENCE			English	Article							CONTACT; SURFACE	Mammalian grinding dentitions are composed of four major tissues that wear differentially, creating coarse surfaces for pulverizing tough plants and liberating nutrients. Although such dentition evolved repeatedly in mammals (such as horses, bison, and elephants), a similar innovation occurred much earlier (similar to 85 million years ago) within the duck-billed dinosaur group Hadrosauridae, fueling their 35-million-year occupation of Laurasian megaherbivorous niches. How this complexity was achieved is unknown, as reptilian teeth are generally two-tissue structures presumably lacking biomechanical attributes for grinding. Here we show that hadrosaurids broke from the primitive reptilian archetype and evolved a six-tissue dental composition that is among the most sophisticated known. Three-dimensional wear models incorporating fossilized wear properties reveal how these tissues interacted for grinding and ecological specialization.	[Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Krick, Brandon A.; Hamilton, Matthew; Sawyer, W. Gregory] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Bourne, Gerald R.] Colorado Sch Mines, Dept Met & Mat Engn, Golden, CO 80401 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Lilleodden, Erica] Helmholtz Zentrum Geesthacht, Inst Mat Res, Geesthacht, Germany	State University System of Florida; Florida State University; State University System of Florida; University of Florida; Colorado School of Mines; American Museum of Natural History (AMNH); Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	gerickson@bio.fsu.edu	Bourne, Gerald/B-7219-2008; Sawyer, W Gregory/A-7983-2008	Bourne, Gerald/0000-0001-6977-2138; Lilleodden, Erica/0000-0002-4014-0986; Sawyer, W Gregory/0000-0002-4461-7227; Krick, Brandon/0000-0003-3191-5433	NSF [EAR 0959029]; Directorate For Geosciences [1226730] Funding Source: National Science Foundation; Division Of Earth Sciences [1226704] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank W. Nix, A. Prieto-Marquez, P. Lee, P. Druckenmiller, C. Taylor, and E. McCumiskey for their assistance and NSF (grant EAR 0959029 to G.M.E. and M.A.N.) for research funding. Data described in the paper are archived by the Computer Support Group of the Department of Biological Science at Florida State University as databases S1 to S19.	ARCHARD JF, 1953, J APPL PHYS, V24, P981, DOI 10.1063/1.1721448; ARCHARD JF, 1956, PROC R SOC LON SER-A, V236, P397, DOI 10.1098/rspa.1956.0144; Butler RJ, 2010, P ROY SOC B-BIOL SCI, V277, P375, DOI 10.1098/rspb.2009.1494; Currey JD, 2003, ARCH ORAL BIOL, V48, P439, DOI 10.1016/S0003-9969(03)00037-2; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Evans DC, 2005, LIFE O PAST, P349; Hillson S., 1986, TEETH; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; Johnson WM, 2007, J MATER SCI-MATER M, V18, P591, DOI 10.1007/s10856-007-2306-4; KHRUSCHOV MM, 1974, WEAR, V28, P69, DOI 10.1016/0043-1648(74)90102-1; Leidy J., 1865, SMITHSONIAN CONTRIBU, V14, P1; Lucas P., 2004, DENT FUNCTIONAL MORP; Lull R.S., 1942, SPEC PAP GEOL SOC AM, V40; Norman DB., 1991, BIOMECHANICS EVOLUTI, P161; Ostrom JH., 1961, B AM MUS NAT HIST, V122, P1; Peyer B, 1968, COMP ODONTOLOGY; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Reisz Robert R., 2000, P9, DOI 10.1017/CBO9780511549717.003; Sawyer WG, 2004, TRIBOL LETT, V17, P139, DOI 10.1023/B:TRIL.0000032438.56992.be; Schmidt W.J., 1971, POLARIZING MICROSCOP; Schwenk K., 2000, FEEDING FUNCTION EVO; Tweet JS, 2008, PALAIOS, V23, P624, DOI 10.2110/palo.2007.p07-044r; WEISHAMPEL D B, 1983, Acta Palaeontologica Polonica, V28, P271; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106	24	85	85	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					98	101		10.1126/science.1224495	http://dx.doi.org/10.1126/science.1224495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042891	Green Submitted			2022-12-24	WOS:000309457400061
J	Baker, CR; Booth, LN; Sorrells, TR; Johnson, AD				Baker, Christopher R.; Booth, Lauren N.; Sorrells, Trevor R.; Johnson, Alexander D.			Protein Modularity, Cooperative Binding, and Hybrid Regulatory States Underlie Transcriptional Network Diversification	CELL			English	Article							HOMEO DOMAIN PROTEIN; CELL-TYPE; SACCHAROMYCES-CEREVISIAE; REPRESSOR ALPHA-2; YEAST ALPHA-2; EVOLUTION; HOMEODOMAIN; CIRCUIT; LOCUS; GENE	We examine how different transcriptional network structures can evolve from an ancestral network. By characterizing how the ancestral mode of gene regulation for genes specific to a-type cells in yeast species evolved from an activating paradigm to a repressing one, we show that regulatory protein modularity, conversion of one cis-regulatory sequence to another, distribution of binding energy among protein-protein and protein-DNA interactions, and exploitation of ancestral network features all contribute to the evolution of a novel regulatory mode. The formation of this derived mode of regulation did not disrupt the ancestral mode and thereby created a hybrid regulatory state where both means of transcription regulation (ancestral and derived) contribute to the conserved expression pattern of the network. Finally, we show how this hybrid regulatory state has resolved in different ways in different lineages to generate the diversity of regulatory network structures observed in modern species.	[Baker, Christopher R.; Booth, Lauren N.; Sorrells, Trevor R.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94102 USA; [Baker, Christopher R.; Booth, Lauren N.; Sorrells, Trevor R.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94102 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94102 USA.	ajohnson@cgl.ucsf.edu		Sorrells, Trevor/0000-0002-3527-8622	National Institute of Health [RO1 GM057049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM057049] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Chiraj Dalal, Clarissa Nobile, and Brian Tuch for critically reading the manuscript and Jennifer Garcia, Victor Hanson-Smith, Oliver Homann, Quinn Mitrovich, and Brian Tuch for their generous and helpful advice concerning experimental and computational procedures. We thank Peter Philippsen for kindly sharing genomic DNA and sequences from Ashbya gossypii. This work was supported by RO1 GM057049 from the National Institute of Health. The authors declare no conflict of interest. C.R.B. performed reporter assays and the Mcm1 ancestral gene reconstruction. L.N.B. performed experiments in L. kluyveri and K. wickerhamii. L.N.B. and T.R.S. performed K. lactis experiments. Data were analyzed and computation experiments performed by C.R.B., L.N.B., and T.R.S. All authors contributed to the design of the study and wrote the article.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Booth LN, 2010, NATURE, V468, P959, DOI 10.1038/nature09560; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; HALL MN, 1987, SCIENCE, V237, P1007, DOI 10.1126/science.2887035; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; MADHANI HD, 2007, A ALPHA YEAST MODEL; MAK A, 1993, GENE DEV, V7, P1862, DOI 10.1101/gad.7.10.1862; Mead J, 1996, MOL CELL BIOL, V16, P2135; SMITH DL, 1994, EMBO J, V13, P2378, DOI 10.1002/j.1460-2075.1994.tb06521.x; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; VERSHON AK, 1993, CELL, V72, P105, DOI 10.1016/0092-8674(93)90054-T; Wohlbach DJ, 2009, CURR OPIN GENET DEV, V19, P571, DOI 10.1016/j.gde.2009.09.007; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	38	70	70	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					80	95		10.1016/j.cell.2012.08.018	http://dx.doi.org/10.1016/j.cell.2012.08.018			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021217	Green Accepted, Bronze			2022-12-24	WOS:000309544200012
J	de Gage, SB; Begaud, B; Bazin, F; Verdoux, H; Dartigues, JF; Peres, K; Kurth, T; Pariente, A				de Gage, Sophie Billioti; Begaud, Bernard; Bazin, Fabienne; Verdoux, Helene; Dartigues, Jean-Francois; Peres, Karine; Kurth, Tobias; Pariente, Antoine			Benzodiazepine use and risk of dementia: prospective population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NESTED CASE-CONTROL; MINI-MENTAL-STATE; COGNITIVE DECLINE; ALZHEIMER-DISEASE; ELDERLY-PEOPLE; PSYCHOTROPIC MEDICATION; HUMAN-MEMORY; COMMUNITY; EPIDEMIOLOGY; IMPAIRMENT	Objective To evaluate the association between use of benzodiazepines and incident dementia. Design Prospective, population based study. Setting PAQUID study, France. Participants 1063 men and women (mean age 78.2 years) who were free of dementia and did not start taking benzodiazepines until at least the third year of follow-up. Main outcome measures Incident dementia, confirmed by a neurologist. Results During a 15 year follow-up, 253 incident cases of dementia were confirmed. New use of benzodiazepines was associated with an increased risk of dementia (multivariable adjusted hazard ratio 1.60, 95% confidence interval 1.08 to 2.38). Sensitivity analysis considering the existence of depressive symptoms showed a similar association (hazard ratio 1.62, 1.08 to 2.43). A secondary analysis pooled cohorts of participants who started benzodiazepines during follow-up and evaluated the association with incident dementia. The pooled hazard ratio across the five cohorts of new benzodiazepine users was 1.46 (1.10 to 1.94). Results of a complementary nested case-control study showed that ever use of benzodiazepines was associated with an approximately 50% increase in the risk of dementia (adjusted odds ratio 1.55, 1.24 to 1.95) compared with never users. The results were similar in past users (odds ratio 1.56, 1.23 to 1.98) and recent users (1.48, 0.83 to 2.63) but reached significance only for past users. Conclusions In this prospective population based study, new use of benzodiazepines was associated with increased risk of dementia. The result was robust in pooled analyses across cohorts of new users of benzodiazepines throughout the study and in a complementary case-control study. Considering the extent to which benzodiazepines are prescribed and the number of potential adverse effects of this drug class in the general population, indiscriminate widespread use should be cautioned against.	[de Gage, Sophie Billioti; Begaud, Bernard; Bazin, Fabienne; Verdoux, Helene; Dartigues, Jean-Francois; Peres, Karine; Kurth, Tobias; Pariente, Antoine] Univ Bordeaux Segalen, F-33000 Bordeaux, France; [de Gage, Sophie Billioti; Begaud, Bernard; Bazin, Fabienne; Verdoux, Helene; Pariente, Antoine] INSERM, U657, F-33000 Bordeaux, France; [Begaud, Bernard; Dartigues, Jean-Francois; Pariente, Antoine] CHU Bordeaux, F-33000 Bordeaux, France; [Verdoux, Helene] Ctr Hosp Charles Perrens, F-33000 Bordeaux, France; [Dartigues, Jean-Francois; Peres, Karine] INSERM, U897, F-33000 Bordeaux, France; [Kurth, Tobias] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Kurth, Tobias] INSERM, Neuroepidemiol U708, F-33000 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm)	de Gage, SB (corresponding author), Univ Bordeaux Segalen, INSERM, U657, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	sophie.billiotidegage@u-bordeaux2.fr; bernard.begaud@u-bordeaux2.fr	Verdoux, Helene/T-1996-2019; Kurth, Tobias/A-9243-2012; DARTIGUES, Jean François/T-4513-2019; PERES, Karine/T-4128-2019; Pariente, Antoine/S-9231-2019	Verdoux, Helene/0000-0003-2948-3782; Kurth, Tobias/0000-0001-7169-2620; PERES, Karine/0000-0002-0720-0684; Pariente, Antoine/0000-0002-7873-5483	INSERM (Institut National de la Sante et de la Recherche Medicale); Universite Bordeaux Segalen; IRESP (Institut de Recherche en Sante Publique) acting on behalf of the French Ministry of Health (Direction Generale de la Sante, Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques); French Ministry of Health (Direction Generale de la Sante); Caisse Nationale des Travailleurs Salaries, Regime Social des Independants, Caisse Nationale de Solidarite pour l'Autonomie; Institut National de Prevention et d'Education pour la Sante	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Bordeaux Segalen; IRESP (Institut de Recherche en Sante Publique) acting on behalf of the French Ministry of Health (Direction Generale de la Sante, Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques); French Ministry of Health (Direction Generale de la Sante); Caisse Nationale des Travailleurs Salaries, Regime Social des Independants, Caisse Nationale de Solidarite pour l'Autonomie; Institut National de Prevention et d'Education pour la Sante	This research was conducted by the INSERM U657 research team co-funded by INSERM (Institut National de la Sante et de la Recherche Medicale) and Universite Bordeaux Segalen. Additional support was provided by a 2010 grant from IRESP (Institut de Recherche en Sante Publique) acting on behalf of the French Ministry of Health (Direction Generale de la Sante, Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques); by a 2011 grant from the French Ministry of Health (Direction Generale de la Sante); and by Caisse Nationale des Travailleurs Salaries, Regime Social des Independants, Caisse Nationale de Solidarite pour l'Autonomie, and Institut National de Prevention et d'Education pour la Sante.	Allard J, 2003, INT J GERIATR PSYCH, V18, P874, DOI 10.1002/gps.891; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BENTON AL, 1972, J PSYCHOL, V80, P189, DOI 10.1080/00223980.1972.9924794; Boeuf-Cazou O, 2011, EUR J CLIN PHARMACOL, V67, P1045, DOI 10.1007/s00228-011-1047-y; Briot M, 2006, BON USAGE MEDICAMENT; Buffett-Jerrott SE, 2002, CURR PHARM DESIGN, V8, P45, DOI 10.2174/1381612023396654; Carrasco-Garrido P, 2007, PHARMACOEPIDEM DR S, V16, P449, DOI 10.1002/pds.1344; CURRAN HV, 1986, BIOL PSYCHOL, V23, P179, DOI 10.1016/0301-0511(86)90081-5; DARTIGUES JF, 1992, NEUROEPIDEMIOLOGY, V11, P14, DOI 10.1159/000110955; Dealberto MJ, 1997, INT J GERIATR PSYCH, V12, P567, DOI 10.1002/(SICI)1099-1166(199705)12:5<567::AID-GPS552>3.0.CO;2-V; Dell'osso B, 2012, EUR PSYCHIAT; Egan M, 2000, J AM GERIATR SOC, V48, P811, DOI 10.1111/j.1532-5415.2000.tb04758.x; European Medicines Agency, 2012, SUMM PROD CHAR BENZ; Fastbom J, 1998, ALZ DIS ASSOC DIS, V12, P14, DOI 10.1097/00002093-199803000-00002; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fourrier A, 2001, EUR J CLIN PHARMACOL, V57, P419, DOI 10.1007/s002280100326; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1; GHONEIM MM, 1990, ANESTHESIOLOGY, V72, P926; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Hanlon JT, 1998, CLIN PHARMACOL THER, V64, P684, DOI 10.1016/S0009-9236(98)90059-5; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hogan David B, 2003, Can J Clin Pharmacol, V10, P72; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Johansson L, 2010, BRAIN, V133, P2217, DOI 10.1093/brain/awq116; Jorm AF, 2000, AUST NZ J PUBL HEAL, V24, P7, DOI 10.1111/j.1467-842X.2000.tb00715.x; Lagnaoui R, 2004, EUR J CLIN PHARMACOL, V60, P523, DOI 10.1007/s00228-004-0808-2; Lagnaoui R, 2002, J CLIN EPIDEMIOL, V55, P314, DOI 10.1016/S0895-4356(01)00453-X; Lagnaoui R, 2009, AGE AGEING, V38, P226, DOI 10.1093/ageing/afn277; Li G, 2011, ARCH GEN PSYCHIAT, V68, P970, DOI 10.1001/archgenpsychiatry.2011.86; Li J, 2011, NEUROLOGY, V76, P1485, DOI 10.1212/WNL.0b013e318217e7a4; LISTER RG, 1985, NEUROSCI BIOBEHAV R, V9, P87, DOI 10.1016/0149-7634(85)90034-X; Muliyala KP, 2010, ANN INDIAN ACAD NEUR, V13, P69, DOI 10.4103/0972-2327.74248; Neutel CI, 2005, INT REV PSYCHIATR, V17, P189, DOI 10.1080/09540260500071863; Pariente A, 2008, DRUG AGING, V25, P61, DOI 10.2165/00002512-200825010-00007; Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Pierfitte C, 2001, BMJ-BRIT MED J, V322, P704, DOI 10.1136/bmj.322.7288.704; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sonnenberg CM, 2012, SOC PSYCH PSYCH EPID, V47, P293, DOI 10.1007/s00127-011-0344-1; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Verdoux H, 2005, PSYCHOL MED, V35, P307, DOI 10.1017/S0033291704003897; Vinkers CH, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/416864; Windle A, 2007, AUST NZ J PUBL HEAL, V31, P379, DOI 10.1111/j.1753-6405.2007.00091.x; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210	50	181	187	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2012	345								e6231	10.1136/bmj.e6231	http://dx.doi.org/10.1136/bmj.e6231			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OZ	23045258	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000309386700007
J	Hou, XW; Pedi, L; Diver, MM; Long, SB				Hou, Xiaowei; Pedi, Leanne; Diver, Melinda M.; Long, Stephen B.			Crystal Structure of the Calcium Release-Activated Calcium Channel Orai	SCIENCE			English	Article							CRAC CHANNEL; PLASMA-MEMBRANE; SUBUNIT STOICHIOMETRY; ION SELECTIVITY; MOLECULAR-BASIS; CA2+ SENSOR; I-CRAC; STIM1; STORE; CELLS	The plasma membrane protein Orai forms the pore of the calcium release-activated calcium (CRAC) channel and generates sustained cytosolic calcium signals when triggered by depletion of calcium from the endoplasmic reticulum. The crystal structure of Orai from Drosophila melanogaster, determined at 3.35 angstrom resolution, reveals that the calcium channel is composed of a hexameric assembly of Orai subunits arranged around a central ion pore. The pore traverses the membrane and extends into the cytosol. A ring of glutamate residues on its extracellular side forms the selectivity filter. A basic region near the intracellular side can bind anions that may stabilize the closed state. The architecture of the channel differs markedly from other ion channels and gives insight into the principles of selective calcium permeation and gating.	[Hou, Xiaowei; Pedi, Leanne; Diver, Melinda M.; Long, Stephen B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Long, SB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	longs@mskcc.org		Long, Stephen/0000-0002-8144-1398; Hou, Xiaowei/0000-0002-6668-1115; Diver, Melinda/0000-0001-5037-7322	NIH [GM094273]; Burroughs Wellcome Career Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Goldberg, M. B. Long, R. MacKinnon, and N. P. Pavletich for discussions and comments on the manuscript; C. D. Lima and members of the laboratory for discussions; E. Gouaux for green fluorescent protein fusion vectors; the staff of beamlines X25 and X29 (National Synchrotron Light Source, Brookhaven National Laboratory); the staff of the monoclonal antibody and proteomics and microchemistry facilities at MSKCC; the Keck Biophysics Resource at Yale University; and the Center for Applied Isotope Studies at the University of Georgia for protein analysis. This work was supported by the NIH (grant GM094273) and by a Burroughs Wellcome Career Award (to S. B. L). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 4HKR (wild type) and 4HKS (K163W mutant).	Aussel C, 1996, BIOCHEM J, V313, P909, DOI 10.1042/bj3130909; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HILLE B, 1992, IONIC CHANNELS EXCIT, pR13; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1995, PFLUG ARCH EUR J PHY, V430, P315, DOI 10.1007/BF00373905; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; James BD, 1996, INORG CHIM ACTA, V247, P169, DOI 10.1016/0020-1693(95)04955-X; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; KAWASAKI H, 1995, PROTEIN PROFILE, V2, P297; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	43	422	430	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1308	1313		10.1126/science.1228757	http://dx.doi.org/10.1126/science.1228757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23180775	Green Accepted			2022-12-24	WOS:000311991200057
J	Shin, HN; Iwasaki, A				Shin, Haina; Iwasaki, Akiko			A vaccine strategy that protects against genital herpes by establishing local memory T cells	NATURE			English	Article							REPLICATION-DEFECTIVE MUTANT; SIMPLEX-VIRUS TYPE-2; IMMUNE-RESPONSES; DENDRITIC CELLS; VIRAL-INFECTION; RESIDENT MEMORY; RM CELLS; MIGRATION; MUCOSAL; HSV-2	Most successful existing vaccines rely on neutralizing antibodies, which may not require specific anatomical localization of B cells. However, efficacious vaccines that rely on T cells for protection have been difficult to develop, as robust systemic memory T-cell responses do not necessarily correlate with host protection(1). In peripheral sites, tissue-resident memory T cells provide superior protection compared to circulating memory T cells(2,3). Here we describe a simple and non-inflammatory vaccine strategy that enables the establishment of a protective memory T-cell pool within peripheral tissue. The female genital tract, which is a portal of entry for sexually transmitted infections, is an immunologically restrictive tissue that prevents entry of activated T cells in the absence of inflammation or infection(4). To overcome this obstacle, we developed a vaccine strategy that we term 'prime and pull' to establish local tissue-resident memory T cells at a site of potential viral exposure. This approach relies on two steps: conventional parenteral vaccination to elicit systemic T-cell responses (prime), followed by recruitment of activated T cells by means of topical chemokine application to the restrictive genital tract (pull), where such T cells establish a long-term niche and mediate protective immunity. In mice, prime and pull protocol reduces the spread of infectious herpes simplex virus 2 into the sensory neurons and prevents development of clinical disease. These results reveal a promising vaccination strategy against herpes simplex virus 2, and potentially against other sexually transmitted infections such as human immunodeficiency virus.	[Shin, Haina; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Shin, Haina/0000-0002-1014-1451	NIAID [F32AI091024]; NIH [AI054359, AI062428]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI091024, R56AI062428, R01AI062428, R01AI054359] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Foxman and R. Medzhitov for critical reading of the manuscript, and N. Iijima, H. Dong and B. Yordy for technical support. H. S. is supported by NIAID grant F32AI091024. This work is supported by NIH grants AI054359 and AI062428 to A.I.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Gajewski TF, 2011, CURR OPIN IMMUNOL, V23, P286, DOI 10.1016/j.coi.2010.11.013; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gill N, 2008, AM J REPROD IMMUNOL, V59, P35, DOI 10.1111/j.1600-0897.2007.00558.x; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Khanna KM, 2004, TRENDS IMMUNOL, V25, P230, DOI 10.1016/j.it.2004.02.010; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Parr MB, 2003, J NEUROVIROL, V9, P594, DOI 10.1080/714044481; PARR MB, 1994, LAB INVEST, V70, P369; Perkins N, 2011, SEX TRANSM INFECT, V87, P292, DOI 10.1136/sti.2010.047431; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Soderberg KA, 2004, J IMMUNOL, V173, P1908, DOI 10.4049/jimmunol.173.3.1908; SPANG AE, 1983, J VIROL, V45, P332, DOI 10.1128/JVI.45.1.332-342.1983; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	30	414	427	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					463	+		10.1038/nature11522	http://dx.doi.org/10.1038/nature11522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23075848	Green Accepted			2022-12-24	WOS:000311031600050
J	Wodak, A				Wodak, Alex			Drug law reform: when bad policy is good politics	LANCET			English	Editorial Material									St Vincents Hosp, Darlinghurst, NSW 2010, Australia	St Vincents Hospital Sydney	Wodak, A (corresponding author), St Vincents Hosp, Darlinghurst, NSW 2010, Australia.	alex.wodak@gmail.com						Bewley-Taylor D. R., 1999, US INT DRUG CONTROL; Cave D., 2012, NY TIMES; Commission on Narcotic Drugs, 2008, ECN72008CRP17 COMM N; Douglas B., 2012, ALTERNATIVES PROHIBI; Global Commission on Drug Policy, 2012, WAR DRUGS HIV AIDS C; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Rau B, 2006, INT AFF, V82, P285, DOI 10.1111/j.1468-2346.2006.00531.x; Rolles Stephen, 2010, BMJ, V341, pc3360, DOI 10.1136/bmj.c3360; The Global Commission on Drug Policy, 2011, WAR DRUGS; UNODC, 2008, 51 SESS COMM NARC DR; Youngers C., 2012, DRUG LAW REFORM GENI	12	3	3	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2012	380	9854					1624	1626		10.1016/S0140-6736(12)61847-9	http://dx.doi.org/10.1016/S0140-6736(12)61847-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	035MN	23134835				2022-12-24	WOS:000310951400005
J	Marcia, M; Pyle, AM				Marcia, Marco; Pyle, Anna Marie			Visualizing Group II Intron Catalysis through the Stages of Splicing	CELL			English	Article							SMALL NUCLEAR-RNA; METAL-ION COORDINATION; STRUCTURE VALIDATION; TERTIARY STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; 2ND STEP; IN-VIVO; SPLICEOSOME; NUCLEOTIDES	Group II introns are self-splicing ribozymes that share a reaction mechanism and a common ancestor with the eukaryotic spliceosome, thereby providing a model system for understanding the chemistry of pre-mRNA splicing. Here we report 14 crystal structures of a group II intron at different stages of catalysis. We provide a detailed mechanism for the first step of splicing, we describe a reversible conformational change between the first and the second steps of splicing, and we present the ligand-free intron structure after splicing in an active state that corresponds to the retrotransposable form of the intron. During each reaction, the reactants are aligned and activated by a heteronuclear four-metal-ion center that contains a metal cluster and obligate monovalent cations, and they adopt a structural arrangement similar to that of protein endonucleases. Based on our data, we propose a model for the splicing cycle and show that it is applicable to the eukaryotic spliceosome.	[Marcia, Marco; Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, New Haven, CT 06511 USA; [Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	anna.pyle@yale.edu	Marcia, Marco/M-2887-2014	Marcia, Marco/0000-0003-2430-0713	National Institute of Health [RO1GM50313]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050313] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline scientists at 24-ID-C and E, NE-CAT, APS, Argonne (IL), USA for their thorough support during data collection. We acknowledge all members of the Pyle lab, and in particular Dr. Olga Fedorova for synthesizing the oligonucleotide fragment, Dr. Maximilian Bailor for cloning the OiD1-5 construct, Gabriele Drews for cloning the Oi5eD1-5 construct, Dr. Kevin Keating for the analysis of the backbone kink at the 50 splice junction (Table S2), Dr. Srinivas Somarowthu for calculating the model of intron domain 6 in the silent conformation (Figure S4), Dr. Laura Murray for sharing preliminary unpublished results, Dr. Dahai Luo and Dr. Patrick Lombardi for valuable discussion, and Dr. Isabel Chillon Gazquez for constructive criticism and help preparing the figures. Additionally, we acknowledge Dr. John Abelson, Dr. John Stahley, Dr. Magda Konarska, Dr. Patrick Cramer, Dr. Giovanni Capranico, Dr. Ulrich Ermler, and Tanja Hedderich for insightful discussion. This project was supported by the National Institute of Health (RO1GM50313). Prof. Pyle is a Howard Hughes Medical Institute Investigator.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AGARWAL RC, 1978, ACTA CRYSTALLOGR A, V34, P791, DOI 10.1107/S0567739478001618; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; BOULANGER SC, 1995, MOL CELL BIOL, V15, P4479; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burke JE, 2012, RNA, V18, P673, DOI 10.1261/rna.031138.111; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Chan RT, 2012, NAT STRUCT MOL BIOL, V19, P555, DOI 10.1038/nsmb.2270; CHANFREAU G, 1993, EMBO J, V12, P5173, DOI 10.1002/j.1460-2075.1993.tb06212.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conn GL, 2002, J MOL BIOL, V318, P963, DOI 10.1016/S0022-2836(02)00147-X; Cotton AF, 1980, ADV ORGANIC CHEM COM, P58; Dai LX, 2002, RNA, V8, P1294, DOI 10.1017/S1355838202023014; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Lencastre A, 2005, NAT STRUCT MOL BIOL, V12, P626, DOI 10.1038/nsmb957; De Lencastre A, 2008, RNA, V14, P11, DOI 10.1261/rna.774008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erat MC, 2008, J BIOL INORG CHEM, V13, P1025, DOI 10.1007/s00775-008-0390-7; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; Fedorova O, 2003, J MOL BIOL, V330, P197, DOI 10.1016/S0022-2836(03)00594-1; Garcia-Rodriguez FM, 2011, APPL ENVIRON MICROB, V77, P854, DOI 10.1128/AEM.02319-10; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; HARDY SF, 1984, NATURE, V308, P375, DOI 10.1038/308375a0; Ho Faix P., 1998, THESIS U PITTSBURGH; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Lambert D, 2009, J MOL BIOL, V390, P791, DOI 10.1016/j.jmb.2009.04.083; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; McConnell TS, 1997, BIOCHEMISTRY-US, V36, P8293, DOI 10.1021/bi9700678; Messerschmidt A., 2001, HDB METALLOPROTEINS; Mikheeva S, 2000, RNA, V6, P1509, DOI 10.1017/S1355838200000972; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PADGETT RA, 1994, SCIENCE, V266, P1685, DOI 10.1126/science.7527587; Pingoud V, 2009, J MOL BIOL, V393, P140, DOI 10.1016/j.jmb.2009.08.011; Podar M, 1998, RNA, V4, P890, DOI 10.1017/S1355838298971643; PODAR M, 1995, MOL CELL BIOL, V15, P4466; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Schmidt U, 1996, RNA, V2, P1161; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toor N, 2010, RNA, V16, P57, DOI 10.1261/rna.1844010; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; WOLFF T, 1994, P NATL ACAD SCI USA, V91, P903, DOI 10.1073/pnas.91.3.903; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617	57	123	123	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					497	507		10.1016/j.cell.2012.09.033	http://dx.doi.org/10.1016/j.cell.2012.09.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101623	Bronze, Green Accepted			2022-12-24	WOS:000310529300008
J	Joosten, MM; Pai, JK; Bertoia, ML; Rimm, EB; Spiegelman, D; Mittleman, MA; Mukamal, KJ				Joosten, Michel M.; Pai, Jennifer K.; Bertoia, Monica L.; Rimm, Eric B.; Spiegelman, Donna; Mittleman, Murray A.; Mukamal, Kenneth J.			Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANKLE-BRACHIAL INDEX; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; INTERMITTENT CLAUDICATION; NUTRITION EXAMINATION; ALCOHOL-CONSUMPTION; FUNCTIONAL DECLINE; SMOKING-CESSATION; PHYSICAL-ACTIVITY; NATIONAL-HEALTH	Context Previous studies have examined the associations of individual clinical risk factors with risk of peripheral artery disease (PAD), but the combined effects of these risk factors are largely unknown. Objective To estimate the degree to which the 4 conventional cardiovascular risk factors of smoking, hypertension, hypercholesterolemia, and type 2 diabetes are associated with the risk of PAD among men. Design, Setting, and Participants Prospective study of 44 985 men in the United States without a history of cardiovascular disease at baseline in 1986; participants in the Health Professionals Follow-up Study were followed up for 25 years until January 2011. The presence of risk factors was updated biennially during follow-up. Main Outcome Measure Clinically significant PAD defined as limb amputation or revascularization, angiogram reporting vascular obstruction of 50% or greater, ankle-brachial index of less than 0.90, or physician-diagnosed PAD. Results During a median follow-up of 24.2 years (interquartile range, 20.8-24.7 years), there were 537 cases of incident PAD. Each risk factor was significantly and independently associated with a higher risk of PAD after adjustment for the other 3 risk factors and confounders. The age-adjusted incidence rates were 9 (95% CI, 6-14) cases/100 000 person-years (n=19 incident cases) for 0 risk factors, 23 (95% CI, 18-28) cases/100 000 person-years (n=99 incident cases) for 1 risk factor, 47 (95% CI, 39-56) cases/100 000 person-years (n=176 incident cases) for 2 risk factors, 92(95% CI, 76-111) cases/100 000 person-years (n=180 incident cases) for 3 risk factors, and 186(95% CI, 141-246) cases/100 000 person-years (n=63 incident cases) for 4 risk factors. The multivariable-adjusted hazard ratio for each additional risk factor was 2.06 (95% CI, 1.88-2.26). Men without any of the 4 risk factors had a hazard ratio of PAD of 0.23 (95% CI, 0.14-0.36) compared with all other men in the cohort. In 96% of PAD cases (95% CI, 94%-98%), at least 1 of the 4 risk factors was present at the time of PAD diagnosis. The population-attributable risk associated with these 4 risk factors was 75% (95% CI, 64%-87%). The absolute incidence of PAD among men with all 4 risk factors was 3.5/1000 person-years. Conclusion Among men in this cohort, smoking, hypertension, hypercholesterolemia, and type 2 diabetes account for the majority of risk associated with development of clinically significant PAD. JAMA. 2012;308(16):1660-1667 www.jama.com	[Joosten, Michel M.; Bertoia, Monica L.; Mukamal, Kenneth J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Sch Med, Boston, MA 02215 USA; [Mittleman, Murray A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Cardiovasc Epidemiol Res Unit, Sch Med,Dept Med, Boston, MA 02215 USA; [Joosten, Michel M.; Bertoia, Monica L.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Pai, Jennifer K.; Rimm, Eric B.; Spiegelman, Donna; Mittleman, Murray A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Joosten, Michel M.] Top Inst Food & Nutr, Wageningen, Netherlands; [Joosten, Michel M.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Pai, Jennifer K.; Rimm, Eric B.; Spiegelman, Donna] Harvard Univ, Channing Div Network Med, Brigham & Womens Hosp, Sch Med,Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Top Institute Food & Nutrition; University of Groningen; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Joosten, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave,Bldg 2, Boston, MA 02115 USA.	hpmmj@channing.harvard.edu	Mukamal, Kenneth/GVR-7978-2022	Mittleman, Murray/0000-0001-9788-7274; Joosten, Michel Marinus/0000-0002-0039-6629	National Institutes of Health [R01 HL091874, HL35464, CA55075]; National Heart, Lung, and Blood Institute; Environmental Protection Agency; Health Effects Institute; NATIONAL CANCER INSTITUTE [P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091874, R01HL035464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Environmental Protection Agency(United States Environmental Protection Agency); Health Effects Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Mittleman reported institutional grant support from the National Heart, Lung, and Blood Institute; and receiving or having institutional grants pending from the National Institutes of Health, the Environmental Protection Agency, and Health Effects Institute. Dr Mukamal reported institutional grant support from the National Heart, Lung, and Blood Institute and the National Institutes of Health; and institutional support in the form of active and placebo capsules provided from the Martek Corporation to Harvard Medical School for a trial of docosahexaenoic acid for periodontitis. No other author reported disclosures.; This work was supported by National Institutes of Health grants R01 HL091874, HL35464, and CA55075.	Adler AI, 2002, DIABETES CARE, V25, P894, DOI 10.2337/diacare.25.5.894; Al-Delaimy WK, 2004, AM J MED, V116, P236, DOI 10.1016/j.amjmed.2003.09.038; Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Bonow RO, 2011, BRAUNWALDS HEART DIS, P1338; Cacoub Patrice P, 2009, Atherosclerosis, V204, pe86, DOI 10.1016/j.atherosclerosis.2008.10.023; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Dhaliwal G, 2007, INT J ANGIOL, V16, P36, DOI 10.1055/s-0031-1278244; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gentil A, 2009, J NEUROL NEUROSUR PS, V80, P1006, DOI 10.1136/jnnp.2009.172551; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Ho DY, 2011, CIRCULATION, V124, P2303, DOI 10.1161/CIRCULATIONAHA.111.045187; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Hussein AA, 2011, J AM COLL CARDIOL, V57, P1220, DOI 10.1016/j.jacc.2010.10.034; JONASON T, 1987, ACTA MED SCAND, V221, P253; Joosten MM, 2011, DIABETES, V60, P74, DOI 10.2337/db10-1052; KANNEL WB, 1985, J AM GERIATR SOC, V33, P13, DOI 10.1111/j.1532-5415.1985.tb02853.x; KAWACHI I, 1994, ARCH INTERN MED, V154, P169, DOI 10.1001/archinte.154.2.169; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; Kennedy M, 2005, ARCH INTERN MED, V165, P1896, DOI 10.1001/archinte.165.16.1896; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; McDermott MM, 2009, J AM COLL CARDIOL, V53, P1056, DOI 10.1016/j.jacc.2008.09.063; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Mehler PS, 2003, CIRCULATION, V107, P753, DOI 10.1161/01.CIR.0000049640.46039.52; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; Psaty BM, 2001, ARCH INTERN MED, V161, P1183, DOI 10.1001/archinte.161.9.1183; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Sakkinen PA, 2000, AM J EPIDEMIOL, V152, P897, DOI 10.1093/aje/152.10.897; Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Therneau TM, 2000, MODELING SURVIVAL DA; West AM, 2011, J AM COLL CARDIOL, V58, P1068, DOI 10.1016/j.jacc.2011.04.034	46	177	187	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2012	308	16					1660	1667		10.1001/jama.2012.13415	http://dx.doi.org/10.1001/jama.2012.13415			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028PI	23093164	Green Accepted			2022-12-24	WOS:000310434100020
J	Cohen, DA; Babey, SH				Cohen, Deborah A.; Babey, Susan H.			Candy at the Cash Register - A Risk Factor for Obesity and Chronic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, Deborah A.] RAND Hlth, Santa Clara, CA USA; [Babey, Susan H.] UCLA Ctr Hlth Policy Res, Los Angeles, CA USA	RAND Corporation; University of California System; University of California Los Angeles	Cohen, DA (corresponding author), RAND Hlth, Santa Clara, CA USA.			Babey, Susan/0000-0001-8113-1739				CURHAN RC, 1974, J MARKETING RES, V11, P286, DOI 10.2307/3151144; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; Sorenson H, 2009, INSIDE MIND SHOPPER; Thomas M, 2011, J CONSUM RES, V38, P126, DOI 10.1086/657331; Wedel M, 2008, VISUAL MARKETING ATT	5	37	36	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1381	1383		10.1056/NEJMp1209443	http://dx.doi.org/10.1056/NEJMp1209443			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	23050524				2022-12-24	WOS:000309652700003
J	Mather, J; Mao, M				Mather, John; Mao, Minnie			ASTRONOMY A conversation about observation	NATURE			English	Editorial Material									[Mao, Minnie] Natl Radio Astron Observ, Socorro, NM 87801 USA	National Radio Astronomy Observatory (NRAO)	Mather, J (corresponding author), NASA, Washington, DC 20546 USA.								0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					S5	S7		10.1038/490S5a	http://dx.doi.org/10.1038/490S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019IY	23051770	Bronze			2022-12-24	WOS:000309733300003
J	Grynbaum, MM				Grynbaum, Michael M.			Will soda restrictions help New York win the war on obesity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									New York Times Co, New York, NY 10036 USA	New York Times	Grynbaum, MM (corresponding author), New York Times Co, New York, NY 10036 USA.	grynbaum@nytimes.com						City of New York, 2012, REV EP NEW YORK CIT; de Ruyter JC, 2012, N ENGL J MED; Ebbeling CB, 2012, N ENGL J MED; KATAN M, NEW ENG J MEDI; Nestle M, FIGHTING FOOD GIANTS; Rabin Roni Caryn, 2012, NY TIMES; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12	7	10	10	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2012	345								e6768	10.1136/bmj.e6768	http://dx.doi.org/10.1136/bmj.e6768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021TD	23054050				2022-12-24	WOS:000309907400019
J	Ye, L; Kleiner, S; Wu, J; Sah, R; Gupta, RK; Banks, AS; Cohen, P; Khandekar, MJ; Bostrom, P; Mepani, RJ; Laznik, D; Kamenecka, TM; Song, XY; Liedtke, W; Mootha, VK; Puigserver, P; Griffin, PR; Clapham, DE; Spiegelman, BM				Ye, Li; Kleiner, Sandra; Wu, Jun; Sah, Rajan; Gupta, Rana K.; Banks, Alexander S.; Cohen, Paul; Khandekar, Melin J.; Bostroem, Pontus; Mepani, Rina J.; Laznik, Dina; Kamenecka, Theodore M.; Song, Xinyi; Liedtke, Wolfgang; Mootha, Vamsi K.; Puigserver, Pere; Griffin, Patrick R.; Clapham, David E.; Spiegelman, Bruce M.			TRPV4 Is a Regulator of Adipose Oxidative Metabolism, Inflammation, and Energy Homeostasis	CELL			English	Article							DIET-INDUCED OBESITY; WHITE FAT DEPOTS; BROWN ADIPOCYTES; INSULIN-RESISTANCE; CATION CHANNEL; GENE-EXPRESSION; PROTEIN-KINASE; TISSUE; ACTIVATION; MICE	PGC1 alpha is a key transcriptional coregulator of oxidative metabolism and thermogenesis. Through a high-throughput chemical screen, we found that molecules antagonizing the TRPVs (transient receptor potential vanilloid), a family of ion channels, induced PGC1 alpha expression in adipocytes. In particular, TRPV4 negatively regulated the expression of PGC1 alpha, UCP1, and cellular respiration. Additionally, it potently controlled the expression of multiple proinflammatory genes involved in the development of insulin resistance. Mice with a null mutation for TRPV4 or wild-type mice treated with a TRPV4 antagonist showed elevated thermogenesis in adipose tissues and were protected from diet-induced obesity, adipose inflammation, and insulin resistance. This role of TRPV4 as a cell-autonomous mediator for both the thermogenic and proinflammatory programs in adipocytes could offer a target for treating obesity and related metabolic diseases.	[Ye, Li; Kleiner, Sandra; Wu, Jun; Gupta, Rana K.; Banks, Alexander S.; Cohen, Paul; Khandekar, Melin J.; Bostroem, Pontus; Mepani, Rina J.; Laznik, Dina; Puigserver, Pere; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ye, Li; Kleiner, Sandra; Wu, Jun; Gupta, Rana K.; Banks, Alexander S.; Cohen, Paul; Khandekar, Melin J.; Bostroem, Pontus; Mepani, Rina J.; Laznik, Dina; Puigserver, Pere; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Sah, Rajan; Clapham, David E.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cardiol,Boston Childrens Hosp, Boston, MA 02115 USA; [Sah, Rajan; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kamenecka, Theodore M.; Song, Xinyi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Liedtke, Wolfgang] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Scripps Research Institute; Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Gupta, Rana/R-3051-2019; Banks, Alexander/B-4832-2012; Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Liedtke, Wolfgang/GNH-1878-2022	Banks, Alexander/0000-0003-1787-6925; Clapham, David/0000-0002-4459-9428; Gupta, Rana/0000-0002-9001-4531	NIH [DK031405, DK080261];  [5R90DK071507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071507, R24DK080261, R01DK031405, K01DK094824, R37DK031405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Zoltan Arany (Beth Israel Deaconess Medical Center) and Bridget Wagner (The Broad Institute) for help with screen setup and Dr. Kai Cui (Duke University) for assistance with statistical analysis. We are grateful to Drs. Patrick Seale and Chih-Hao Lee for useful discussion. We also thank Yingying Zhang, Diti Bhowmick, and Lingling Dai for technical assistance. L.Y. was supported by the Interdisciplinary Training grant 5R90DK071507. This work was supported by NIH grants DK031405 and DK080261 (B.M.S.). B.M.S., V.K.M., and P.R.G. are consultants and shareholders in Ember Therapeutics, Inc.	Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Petrocellis L, 2001, J NEUROCHEM, V77, P1660, DOI 10.1046/j.1471-4159.2001.00406.x; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Jia L, 2010, J LIPID RES, V51, P3024, DOI 10.1194/jlr.M008599; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Li JJ, 2009, ENVIRON HEALTH PERSP, V117, P400, DOI 10.1289/ehp.0800311; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sell H, 2009, P NUTR SOC, V68, P378, DOI 10.1017/S0029665109990218; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	56	239	248	13	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					96	110		10.1016/j.cell.2012.08.034	http://dx.doi.org/10.1016/j.cell.2012.08.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021218	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000309544200013
J	Sando, R; Gounko, N; Pieraut, S; Liao, LJ; Yates, J; Maximov, A				Sando, Richard, III; Gounko, Natalia; Pieraut, Simon; Liao, Lujian; Yates, John, III; Maximov, Anton			HDAC4 Governs a Transcriptional Program Essential for Synaptic Plasticity and Memory	CELL			English	Article							II HISTONE DEACETYLASES; NEURONAL-ACTIVITY; GENE-EXPRESSION; MECP2 PHOSPHORYLATION; NERVOUS-SYSTEM; NUCLEAR EXPORT; NMDA RECEPTOR; CELL-DEATH; CORTEX; GROWTH	Neuronal activity influences genes involved in circuit development and information processing. However, the molecular basis of this process remains poorly understood. We found that HDAC4, a histone deacetylase that shuttles between the nucleus and cytoplasm, controls a transcriptional program essential for synaptic plasticity and memory. The nuclear import of HDAC4 and its association with chromatin is negatively regulated by NMDA receptors. In the nucleus, HDAC4 represses genes encoding constituents of central synapses, thereby affecting synaptic architecture and strength. Furthermore, we show that a truncated form of HDAC4 encoded by an allele associated with mental retardation is a gain-of-function nuclear repressor that abolishes transcription and synaptic transmission despite the loss of the deacetylase domain. Accordingly, mice carrying a mutant that mimics this allele exhibit deficits in neurotransmission, spatial learning, and memory. These studies elucidate a mechanism of experience-dependent plasticity and define the biological role of HDAC4 in the brain.	[Sando, Richard, III; Gounko, Natalia; Pieraut, Simon; Maximov, Anton] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Liao, Lujian; Yates, John, III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Sando, Richard, III; Gounko, Natalia; Pieraut, Simon; Maximov, Anton] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Sando, Richard, III] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Maximov, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	amaximov@scripps.edu	Karakhanov, Edward/P-1660-2015; Gounko, Natalia/N-4102-2019	Gounko, Natalia/0000-0003-0791-9477	NIH [MH085776, MH067880-09, RR011823, NS057096]; Novartis Advanced Discovery Institute; Baxter Foundation; Helen Dorris Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880, R01MH085776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Advanced Discovery Institute; Baxter Foundation; Helen Dorris Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Hollis Cline, Ulrich Mueller, Ardem Patapoutian, Franck Polleux, Mark Mayford, and Kristin Baldwin for advice and critical comments; Drs. Thomas Sudhof and Martyn Goulding for mouse strains and antibodies; members of the Cline, Mueller, Polleux, Baldwin, Feeney, and McHeyzer-Williams labs for help with experiments; and Nina Torabi-Rander, TSRI DNA array, mouse transgenic, and behavioral cores for expert technical assistance. This study was supported, in part, by the NIH grants MH085776 (A. M.), MH067880-09 (J.Y.), RR011823 (J.Y.), and NS057096 (J.Y.); Novartis Advanced Discovery Institute (A. M.); The Baxter Foundation (A. M.); and Helen Dorris Postdoctoral Fellowship (S.P.).	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Cao P, 2011, CELL, V145, P300, DOI 10.1016/j.cell.2011.03.034; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chao HT, 2009, P NATL ACAD SCI USA, V106, P4577, DOI 10.1073/pnas.0901518106; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Mandel G, 2011, P NATL ACAD SCI USA, V108, P16789, DOI 10.1073/pnas.1113486108; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Seabrooke S, 2008, DEV NEUROBIOL, V68, P379, DOI 10.1002/dneu.20595; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	57	184	191	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					821	834		10.1016/j.cell.2012.09.037	http://dx.doi.org/10.1016/j.cell.2012.09.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141539	Green Accepted, Bronze			2022-12-24	WOS:000310921200013
J	Taylor, JR; Stocker, R				Taylor, John R.; Stocker, Roman			Trade-Offs of Chemotactic Foraging in Turbulent Water	SCIENCE			English	Article							MICROSCALE NUTRIENT PATCHES; MICROBIAL FOOD-WEB; MARINE-BACTERIA; SIMULATION; MOTILITY; BEHAVIOR; FLUID; SEA	Bacteria play an indispensable role in marine biogeochemistry by recycling dissolved organic matter. Motile species can exploit small, ephemeral solute patches through chemotaxis and thereby gain a fitness advantage over nonmotile competitors. This competition occurs in a turbulent environment, yet turbulence is generally considered inconsequential for bacterial uptake. In contrast, we show that turbulence affects uptake by stirring nutrient patches into networks of thin filaments that motile bacteria can readily exploit. We find that chemotactic motility is subject to a trade-off between the uptake benefit due to chemotaxis and the cost of locomotion, resulting in an optimal swimming speed. A second trade-off results from the competing effects of stirring and mixing and leads to the prediction that chemotaxis is optimally favored at intermediate turbulence intensities.	[Stocker, Roman] MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, Cambridge, MA 02139 USA; [Taylor, John R.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Massachusetts Institute of Technology (MIT); University of Cambridge	Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Stocker, Roman/N-8987-2019; Stocker, Roman/T-9456-2017	Stocker, Roman/0000-0002-3199-0508	NSF Mathematical Sciences Postdoctoral Research Fellowship; NSF [OCE-0744641-CAREER, CBET-1066566]	NSF Mathematical Sciences Postdoctoral Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	We thank W. M. Durham, R. Ferrari, M. Follows, M. Garren, F. Menolascina, S. Merrifield, T. Pedley, S. Smriga, and R. Watteaux for helpful comments and suggestions. The calculation of the resistive force coefficient for a bacterium was performed by Marcos. J.R.T. was supported by an NSF Mathematical Sciences Postdoctoral Research Fellowship. R. S. acknowledges NSF grants OCE-0744641-CAREER and CBET-1066566.	Ahmed T, 2008, BIOPHYS J, V95, P4481, DOI 10.1529/biophysj.108.134510; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Donzis DA, 2010, FLOW TURBUL COMBUST, V85, P549, DOI 10.1007/s10494-010-9271-6; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Durham WM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238102; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; Gregg MC, 1996, DYNAM ATMOS OCEANS, V24, P1, DOI 10.1016/0377-0265(95)00406-8; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; Grunbaum D, 2002, HYDROBIOLOGIA, V480, P175, DOI 10.1023/A:1021296103358; Hutz A, 2011, APPL ENVIRON MICROB, V77, P4412, DOI 10.1128/AEM.00490-11; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; LAZIER JRN, 1989, DEEP-SEA RES, V36, P1721, DOI 10.1016/0198-0149(89)90068-X; Marshall JS, 2010, CHEM ENG SCI, V65, P3865, DOI 10.1016/j.ces.2010.03.036; Matz C, 2005, APPL ENVIRON MICROB, V71, P921, DOI 10.1128/AEM.71.2.921-929.2005; Mitchell JG, 1996, APPL ENVIRON MICROB, V62, P3716, DOI 10.1128/AEM.62.10.3716-3721.1996; Moin P, 1998, ANNU REV FLUID MECH, V30, P539, DOI 10.1146/annurev.fluid.30.1.539; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Munoz-Garcia J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103043; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Seymour JR, 2009, AM NAT, V173, pE15, DOI 10.1086/593004; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Williams P.J.I.B., 2000, MICROBIAL ECOLOGY OC, P153; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108	28	111	115	3	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					675	679		10.1126/science.1219417	http://dx.doi.org/10.1126/science.1219417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118190				2022-12-24	WOS:000310516000055
J	Dodwell, E; Snyder, B; Wright, J				Dodwell, Emily; Snyder, Brian; Wright, James			Off-Label Use of Bone Morphogenetic Proteins in Pediatric Spinal Arthrodesis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Dodwell, Emily] Hosp Special Surg, New York, NY 10021 USA; [Snyder, Brian] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wright, James] Childrens Hosp, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital	Dodwell, E (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	dodwelle@hss.edu		Dodwell, Emily/0000-0001-8424-4341				Agency for Healthcare Research and Quality, 2009, HEALTHC COST UT PROJ; Cahill ME, 2009, P NATL ACAD SCI USA, V106, P13058, DOI 10.1073/pnas.0904636106; Dewald R, 2003, SPINAL DEFORMITIES C, P644; HCUP central distributor SID California file composition, 2006, HEALTHC COST UT PROJ; Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2; US Food and Drug Administration, OP 1 H010002; US Food and Drug Administration, F INFUSE BON GRAFT L	7	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1429	1432		10.1001/jama.2012.12929	http://dx.doi.org/10.1001/jama.2012.12929			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047351	Bronze			2022-12-24	WOS:000309579300015
J	Bangalore, S; Steg, PG; Deedwania, P; Crowley, K; Eagle, KA; Goto, S; Ohman, EM; Cannon, CP; Smith, SC; Zeymer, U; Hoffman, EB; Messerli, FH; Bhatt, DL				Bangalore, Sripal; Steg, Ph Gabriel; Deedwania, Prakash; Crowley, Kevin; Eagle, Kim A.; Goto, Shinya; Ohman, E. Magnus; Cannon, Christopher P.; Smith, Sidney C., Jr.; Zeymer, Uwe; Hoffman, Elaine B.; Messerli, Franz H.; Bhatt, Deepak L.		REACH Registry Investigators	beta-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENT RATES; BLOOD-PRESSURE; PROPENSITY SCORE; HEART-FAILURE; HYPERTENSION; RISK; THERAPY; ASSOCIATION; CARVEDILOL	Context beta-Blockers remain the standard of care after a myocardial infarction (MI). However, the benefit of beta-blocker use in patients with coronary artery disease (CAD) but no history of MI, those with a remote history of MI, and those with only risk factors for CAD is unclear. Objective To assess the association of beta-blocker use with cardiovascular events in stable patients with a prior history of MI, in those with CAD but no history of MI, and in those with only risk factors for CAD. Design, Setting, and Patients Longitudinal, observational study of patients in the Reduction of Atherothrombosis for Continued Health (REACH) registry who were divided into 3 cohorts: known prior MI (n = 14 043), known CAD without MI (n = 12 012), or those with CAD risk factors only (n = 18 653). Propensity score matching was used for the primary analyses. The last follow-up data collection was April 2009. Main Outcome Measures The primary outcome was a composite of cardiovascular death, nonfatal MI, or nonfatal stroke. The secondary outcome was the primary outcome plus hospitalization for atherothrombotic events or a revascularization procedure. Results Among the 44 708 patients, 21 860 were included in the propensity score-matched analysis. With a median follow-up of 44 months (interquartile range, 35-45 months), event rates were not significantly different in patients with beta-blocker use compared with those without beta-blocker use for any of the outcomes tested, even in the prior MI cohort (489 [16.93%] vs 532 [18.60%], respectively; hazard ratio [HR], 0.90 [95% CI, 0.79-1.03]; P = .14). In the CAD without MI cohort, the associated event rates were not significantly different in those with beta-blocker use for the primary outcome (391 [12.94%]) vs without beta-blocker use (405 [13.55%]) (HR, 0.92[95% CI, 0.79-1.08]; P = .31), with higher rates for the secondary outcome (1101 [30.59%] vs 1002 [27.84%]; odds ratio [OR], 1.14 [95% CI, 1.03-1.27]; P = .01) and for the tertiary outcome of hospitalization (870 [24.17%] vs 773 [21.48%]; OR, 1.17 [95% CI, 1.04-1.30]; P = .01). In the cohort with CAD risk factors only, the event rates were higher for the primary outcome with beta-blocker use (467 [14.22%]) vs without beta-blocker use (403 [12.11%]) (HR, 1.18 [95% CI, 1.02-1.36]; P = .02), for the secondary outcome (870 [22.01%] vs 797 [20.17%]; OR, 1.12 [95% CI, 1.00-1.24]; P = .04) but not for the tertiary outcomes of MI (89 [2.82%] vs 68 [2.00%]; HR, 1.36 [95% CI, 0.97-1.90]; P = .08) and stroke (210 [6.55%] vs 168 [5.12%]; HR, 1.22 [95% CI, 0.99-1.52]; P = .06). However, in those with recent MI (<= 1 year), beta-blocker use was associated with a lower incidence of the secondary outcome (OR, 0.77 [95% CI, 0.64-0.92]). Conclusion In this observational study of patients with either CAD risk factors only, known prior MI, or known CAD without MI, the use of beta-blockers was not associated with a lower risk of composite cardiovascular events. JAMA. 2012;308(13):1340-1349	[Bangalore, Sripal] NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY 10016 USA; [Steg, Ph Gabriel] Univ Paris Diderot, Hosp Bichat, AP HP, INSERM,U698, Paris, France; [Deedwania, Prakash] Univ Calif San Francisco, Dept Internal Med Cardiol, Sch Med, Fresno, CA USA; [Crowley, Kevin; Cannon, Christopher P.; Hoffman, Elaine B.; Bhatt, Deepak L.] TIMI Study Grp, Boston, MA USA; [Eagle, Kim A.] Univ Michigan Hlth Syst, Cardiovasc Ctr, Ann Arbor, MI USA; [Goto, Shinya] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Ohman, E. Magnus] Duke Univ, Med Ctr, Durham, NC USA; [Cannon, Christopher P.; Bhatt, Deepak L.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Cannon, Christopher P.; Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Sidney C., Jr.] Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC USA; [Zeymer, Uwe] Herzzentrum Ludwigshafen, Ludwigshafen, Germany; [Zeymer, Uwe] Inst Herzinfarktforsch Ludwigshafen, Ludwigshafen, Germany; [Messerli, Franz H.] St Lukes Roosevelt Hosp, New York, NY 10025 USA; [Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA USA	New York University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; Tokai University; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Institute Heart Attack Research; Mount Sinai St. Luke's; Mount Sinai West; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Bangalore, S (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, 550 1st Ave, New York, NY 10016 USA.	sripalbangalore@gmail.com	Messerli, Franz/AAR-4783-2021; Bangalore, Sripal/B-6246-2013; Cannon, Christopher P/AAY-7644-2020; STEG, Philippe Gabriel/Z-1567-2019; Goto, Shinya/AAU-6045-2020; Statsenko, Mikhail E./N-7573-2015	Cannon, Christopher P/0000-0003-4596-2791; Goto, Shinya/0000-0002-6821-1504; Statsenko, Mikhail E./0000-0002-3306-0312; Bangalore, Sripal/0000-0001-9485-0652; STEG, Philippe Gabriel/0000-0001-6896-2941	sanofi-aventis; Servier [U-698]; New York University School of Medicine; Ablynx; Amarin; Amgen; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Meyers Squibb; Daiichi Sankyo; Eisai; GlaxoSmithKline; Lilly; Medtronic; Merck Sharp Dohme; Novartis; Otsuka; Pfizer; Roche; Medicines Company; Forest Pharmaceuticals; Daichii Sankyo; Asteras; Medtronics Japan; Mitsubishi Tanabe; Takeda; Mochida; Eli Lilly Company; Maquet; Accumetrics; Essentials; Merck; Regeneron; Ethicon; Waksman Foundation (Tokyo, Japan)	sanofi-aventis(Sanofi-Aventis); Servier(Servier); New York University School of Medicine; Ablynx(Ablynx); Amarin; Amgen(Amgen); Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Meyers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Medtronic(Medtronic); Merck Sharp Dohme(Merck & Company); Novartis(Novartis); Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Roche(Roche Holding); Medicines Company; Forest Pharmaceuticals; Daichii Sankyo(Daiichi Sankyo Company Limited); Asteras; Medtronics Japan; Mitsubishi Tanabe(Mitsubishi Tanabe Pharma Corporation); Takeda(Takeda Pharmaceutical Company Ltd); Mochida; Eli Lilly Company(Eli Lilly); Maquet; Accumetrics; Essentials; Merck(Merck & Company); Regeneron(Regeneron); Ethicon; Waksman Foundation (Tokyo, Japan)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Steg reported receiving a research grant from sanofi-aventis and Servier awarded to INSERM U-698 and the New York University School of Medicine; serving as a consultant or receiving speakers fees from Ablynx, Amarin, Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Meyers Squibb, Daiichi Sankyo, Eisai, GlaxoSmithKline, Lilly, Medtronic, Merck Sharp & Dohme, Novartis, Otsuka, Pfizer, Roche, sanofi-aventis, Servier, the Medicines Company; and holding stock in Aterovax. Dr Deedwania reported serving as a consultant or receiving speakers fees from Forest Pharmaceuticals, Novartis, Daichii Sankyo, Servier, and Pfizer. Dr Goto reported receiving consulting fees and honoraria from Eisai, sanofi-aventis, Otsuka, Bayer, Novartis, AstraZeneca, Asteras, Pfizer, Medtronics Japan, Mitsubishi Tanabe, Takeda, Daiichi Sankyo, Mochida, Merck Sharp & Dohme; and receiving research grants from sanofi-aventis, Eisai, Boehringer Ingelheim, Otsuka, and Daiichi Sankyo. Dr Ohman reported receiving research grants from Daiichi Sankyo, Eli Lilly & Company, Maquet; serving as a consultant to AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, LipoScience, Merck, Pozen, Roche, sanofi-aventis, the Medicines Company, and WebMD; and serving on the speakers bureau for Boehringer Ingelheim, Gilead Sciences, and the Medicines Company. Dr Cannon reported receiving research grants or support from Accumetrics, AstraZeneca, Essentials, GlaxoSmithKline, Merck, Regeneron, sanofi-aventis, and Takeda; serving on advisory boards (but funds donated to charity) for Bristol-Myers Squibb, Alnylam, Pfizer, and CSL; receiving honoraria for the development of independent educational symposia for Pfizer and AstraZeneca; and serving as a clinical advisor for and owning equity in Automedics Medical Systems. Dr Bhatt reported serving on an advisory board for Medscape Cardiology; serving on the boards of directors for Boston VA Research Institute and the Society of Chest Pain Centers; serving as chair for the American Heart Association Get With The Guidelines Science Subcommittee; receiving honoraria from the American College of Cardiology for serving as editor of Clinical Trials, Cardiosource, Duke Clinical Research Institute for serving on clinical trial steering committees, Slack Publications for serving as chief medical editor of Cardiology Today Intervention, and WebMD for serving on continuing medical education steering committees; serving as senior associate editor for the Journal of Invasive Cardiology; receiving research grants from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, sanofi-aventis, and the Medicines Company; and unfunded research from FlowCo, PLx Pharma, and Takeda. Drs Bangalore, Eagle, Smith Jr, Zeymer, Hoffman, and Messerli and Mr Crowley did not report any disclosures.; The REACH Registry is sponsored by sanofi-aventis, Bristol-Myers Squibb, and the Waksman Foundation (Tokyo, Japan) and is endorsed by the World Heart Federation. Statistical analyses of the REACH database by TIMI Study Group statisticians were funded by sanofi-aventis.	Ahmed A, 2006, EUR HEART J, V27, P1431, DOI 10.1093/eurheartj/ehi890; Bangalore S, 2008, INT J CLIN PRACT, V62, P1643, DOI 10.1111/j.1742-1241.2008.01916.x; Bangalore S, 2007, J HUM HYPERTENS, V21, P259, DOI 10.1038/sj.jhh.1002144; Bangalore S, 2008, J AM COLL CARDIOL, V52, P1482, DOI 10.1016/j.jacc.2008.06.048; Bangalore S, 2008, J AM COLL CARDIOL, V52, P1062, DOI 10.1016/j.jacc.2008.05.057; Bangalore S, 2008, AM HEART J, V156, P241, DOI 10.1016/j.ahj.2008.02.023; Bangalore S, 2007, AM J CARDIOL, V100, P1254, DOI 10.1016/j.amjcard.2007.05.057; Bangalore S, 2007, J AM COLL CARDIOL, V50, P563, DOI 10.1016/j.jacc.2007.04.060; Bangalore S, 2006, J AM COLL CARDIOL, V48, P1284, DOI 10.1016/j.jacc.2006.06.038; Bangalore Sripal, 2007, Curr Cardiol Rep, V9, P441, DOI 10.1007/BF02938387; Bangalore Sripal, 2006, Anadolu Kardiyol Derg, V6, P358; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bradley HA, 2006, J HYPERTENS, V24, P2131, DOI 10.1097/01.hjh.0000249685.58370.28; Chen J, 2000, ARCH INTERN MED, V160, P947, DOI 10.1001/archinte.160.7.947; Chen ZM, 2005, LANCET, V366, P1622; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hirata K, 2005, J HYPERTENS, V23, P551, DOI 10.1097/01.hjh.0000160211.56103.48; Jonsson G, 2005, CARDIOLOGY, V103, P148, DOI 10.1158/000084584; Kramer JM, 2006, AM HEART J, V152, P454, DOI 10.1016/j.ahj.2006.02.030; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Meine TJ, 2005, AM HEART J, V149, P1043, DOI 10.1016/j.ahj.2005.02.010; Messerli FH, 2002, JAMA-J AM MED ASSOC, V288, P1845; Messerli FH, 2008, J AM COLL CARDIOL, V51, P330, DOI 10.1016/j.jacc.2007.09.040; Morgan T, 2004, AM J HYPERTENS, V17, P118, DOI 10.1016/j.amjhyper.2003.09.012; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Rubin DB, 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; SNOW PJD, 1965, LANCET, V2, P551; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Weir MR, 2000, AM HEART J, V139, P174, DOI 10.1016/S0002-8703(00)90325-9; Wiysonge CS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002003.pub2; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; [No title captured]	46	318	332	0	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1340	1349		10.1001/jama.2012.12559	http://dx.doi.org/10.1001/jama.2012.12559			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	23032550	Bronze			2022-12-24	WOS:000309369300028
J	Lariviere, L; Plaschka, C; Seizl, M; Wenzeck, L; Kurth, F; Cramer, P				Lariviere, Laurent; Plaschka, Clemens; Seizl, Martin; Wenzeck, Larissa; Kurth, Fabian; Cramer, Patrick			Structure of the Mediator head module	NATURE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION INITIATION; PREINITIATION COMPLEX; MAXIMUM-LIKELIHOOD; YEAST; RECRUITMENT; PROTEIN; CTD; ARCHITECTURE; HOLOENZYME	Gene transcription by RNA polymerase (Pol) II requires the coactivator complex Mediator. Mediator connects transcriptional regulators and Pol II, and is linked to human disease(1-4). Mediator from the yeast Saccharomyces cerevisiae has a molecular mass of 1.4 megadaltons and comprises 25 subunits that form the head, middle, tail and kinase modules(5-7). The head module constitutes one-half of the essential Mediator core(8), and comprises the conserved(9) subunits Med6, Med8, Med11, Med17, Med18, Med20 and Med22. Recent X-ray analysis of the S. cerevisiae head module at 4.3 angstrom resolution led to a partial architectural model with three submodules called neck, fixed jaw and moveable jaw(10). Here we determine de novo the crystal structure of the head module from the fission yeast Schizosaccharomyces pombe at 3.4 angstrom resolution. Structure solution was enabled by new structures of Med6 and the fixed jaw, and previous structures of the moveable jaw(11) and part of the neck(12), and required deletion of Med20. The S. pombe head module resembles the head of a crocodile with eight distinct elements, of which at least four are mobile. The fixed jaw comprises tooth and nose domains, whereas the neck submodule contains a helical spine and one limb, with shoulder, arm and finger elements. The arm and the essential shoulder contact other parts of Mediator. The jaws and a central joint are implicated in interactions with Pol II and its carboxy-terminal domain, and the joint is required for transcription in vitro. The S. pombe head module structure leads to a revised model of the S. cerevisiae module, reveals a high conservation and flexibility, explains knownmutations, and provides the basis for unravelling a central mechanism of gene regulation.	[Lariviere, Laurent; Plaschka, Clemens; Seizl, Martin; Wenzeck, Larissa; Kurth, Fabian; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Lariviere, Laurent; Plaschka, Clemens; Seizl, Martin; Wenzeck, Larissa; Kurth, Fabian; Cramer, Patrick] Univ Munich, CIPSM, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Lariviere, L (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	larivier@genzentrum.lmu.de; cramer@genzentrum.lmu.de		Plaschka, Clemens/0000-0002-6020-9514	Boehringer Ingelheim fellowship; Elite Network of Bavaria; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960]; CIPSM; NIM; European Research Council; LMU innovativ project Bioimaging Network; Vallee Foundation; Jung-Stiftung	Boehringer Ingelheim fellowship(Boehringer Ingelheim); Elite Network of Bavaria; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; NIM; European Research Council(European Research Council (ERC)European Commission); LMU innovativ project Bioimaging Network; Vallee Foundation; Jung-Stiftung	We thank S. Baumli, A. C. Cheung, A. Imhof and C. Schmidt for help. We acknowledge the crystallization facility at the Max Planck Institute of Biochemistry, Martinsried. Diffraction data were collected at the Swiss Light Source, Villigen, Switzerland. M.S. was supported by a Boehringer Ingelheim fellowship and the Elite Network of Bavaria. P.C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM, an Advanced Grant of the European Research Council, the LMU innovativ project Bioimaging Network, the Vallee Foundation, and the Jung-Stiftung.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W., 2011, SEMIN CELL DEV BIOL; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Girard E, 2003, ACTA CRYSTALLOGR D, V59, P1914, DOI 10.1107/S0907444903020511; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kaufmann R, 2010, AM J HUM GENET, V87, P667, DOI 10.1016/j.ajhg.2010.09.016; Knablein J, 1997, J MOL BIOL, V270, P1, DOI 10.1006/jmbi.1997.1074; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Lariviere L., 2012, CURR OPIN CELL BIOL; Lariviere L, 2008, GENE DEV, V22, P872, DOI 10.1101/gad.465108; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lee YC, 1998, MOL CELL BIOL, V18, P5364, DOI 10.1128/MCB.18.9.5364; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; NONET ML, 1989, GENETICS, V123, P715; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; SCHNEIDER G, 1994, ACTA CRYSTALLOGR D, V50, P186, DOI 10.1107/S0907444993009679; Seizl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027595; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tan Q, 2000, GENE DEV, V14, P339; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	48	76	78	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					448	+		10.1038/nature11670	http://dx.doi.org/10.1038/nature11670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23123849	Green Published			2022-12-24	WOS:000312488200060
J	Bleyer, A; Welch, HG				Bleyer, Archie; Welch, H. Gilbert			Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY; THERAPY	Background To reduce mortality, screening must detect life-threatening disease at an earlier, more curable stage. Effective cancer-screening programs therefore both increase the incidence of cancer detected at an early stage and decrease the incidence of cancer presenting at a late stage. Methods We used Surveillance, Epidemiology, and End Results data to examine trends from 1976 through 2008 in the incidence of early-stage breast cancer (ductal carcinoma in situ and localized disease) and late-stage breast cancer (regional and distant disease) among women 40 years of age or older. Results The introduction of screening mammography in the United States has been associated with a doubling in the number of cases of early-stage breast cancer that are detected each year, from 112 to 234 cases per 100,000 women - an absolute increase of 122 cases per 100,000 women. Concomitantly, the rate at which women present with late-stage cancer has decreased by 8%, from 102 to 94 cases per 100,000 women - an absolute decrease of 8 cases per 100,000 women. With the assumption of a constant underlying disease burden, only 8 of the 122 additional early-stage cancers diagnosed were expected to progress to advanced disease. After excluding the transient excess incidence associated with hormone-replacement therapy and adjusting for trends in the incidence of breast cancer among women younger than 40 years of age, we estimated that breast cancer was overdiagnosed (i.e., tumors were detected on screening that would never have led to clinical symptoms) in 1.3 million U.S. women in the past 30 years. We estimated that in 2008, breast cancer was overdiagnosed in more than 70,000 women; this accounted for 31% of all breast cancers diagnosed. Conclusions Despite substantial increases in the number of cases of early-stage breast cancer detected, screening mammography has only marginally reduced the rate at which women present with advanced cancer. Although it is not certain which women have been affected, the imbalance suggests that there is substantial overdiagnosis, accounting for nearly a third of all newly diagnosed breast cancers, and that screening is having, at best, only a small effect on the rate of death from breast cancer.	[Bleyer, Archie] St Charles Hlth Syst, Qual Dept, Cent Oregon, OR USA; [Bleyer, Archie] Oregon Hlth & Sci Univ, Dept Radiat Med, Portland, OR 97201 USA; [Bleyer, Archie] Univ Texas Med Sch Houston, Houston, TX USA; [Welch, H. Gilbert] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	Oregon Health & Science University; University of Texas System; University of Texas Health Science Center Houston; Dartmouth College	Bleyer, A (corresponding author), 2500 NE Neff Rd, Bend, OR 97701 USA.	ableyer@gmail.com	wang, edwin/G-5372-2010	Welch, H. Gilbert/0000-0002-3448-1207				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; [Anonymous], 2005, SEER DAT 1973 2009 I; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Breen N, 2007, CANCER DETECT PREV, V31, P220, DOI 10.1016/j.cdp.2007.04.006; CHU KC, 1991, JNCI-J NATL CANCER I, V83, P1636, DOI 10.1093/jnci/83.22.1636; De P, 2010, JNCI-J NATL CANCER I, V102, P1489, DOI 10.1093/jnci/djq345; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gager J.G., 1992, BATTLEFIELDS KNOWLED, P3; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kopans DB, 2011, RADIOLOGY, V260, P616, DOI 10.1148/radiol.11110716; Ries LAG, 2007, SEER SURVIVAL MONOGR, P105; Surveillance Epidemiology and End Results (SEER) Program, 2010, SEER STAT DAT BAS IN; United States Census Bureau, POP EST; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 2006, BRIT MED J, V332, P727, DOI 10.1136/bmj.332.7543.727; Welch HG, 1997, J GEN INTERN MED, V12, P118, DOI 10.1046/j.1525-1497.1997.00017.x; Welch HG, 2011, OVERDIAGNOSED MAKING, P84; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	21	892	912	0	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1998	2005		10.1056/NEJMoa1206809	http://dx.doi.org/10.1056/NEJMoa1206809			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171096	Bronze			2022-12-24	WOS:000311340200007
J	Firth, P; Ttendo, S				Firth, Paul; Ttendo, Stephen			Intensive Care in Low-Income Countries - A Critical Need	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AFRICA		[Firth, Paul] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Ttendo, Stephen] Mbarara Reg Referral Hosp, Dept Anaesthesia & Crit Care, Mbarara, Uganda	Harvard University; Massachusetts General Hospital	Firth, P (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.			Firth, Paul/0000-0003-1909-5225				[Anonymous], 2011, BMJ-BRIT MED J, DOI DOI 10.1136/bmj.d7031; Central Intelligence Agency, WORLD FACTB; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Riviello ED, 2011, CRIT CARE MED, V39, P860, DOI 10.1097/CCM.0b013e318206d6d5; Towey RM, 2008, AFR HEALTH SCI, V8, P61	5	47	47	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1974	1976		10.1056/NEJMp1204957	http://dx.doi.org/10.1056/NEJMp1204957			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040RI	23171093				2022-12-24	WOS:000311340200003
J	Sedrakyan, A				Sedrakyan, Art			Hip resurfacing: a complex challenge for device regulation	LANCET			English	Editorial Material							NATIONAL JOINT REGISTRY; METAL; IMPLANTS; ENGLAND; WALES; RATES		[Sedrakyan, Art] Weill Cornell Med Coll, Patient Centered Comparat Effectiveness Program, New York, NY 10065 USA; [Sedrakyan, Art] Weill Cornell Med Coll, Med Device Epidemiol Sci & Infrastruct Ctr, New York, NY 10065 USA	Cornell University; Cornell University	Sedrakyan, A (corresponding author), Weill Cornell Med Coll, Patient Centered Comparat Effectiveness Program, New York, NY 10065 USA.	ars2013@med.cornell.edu						Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Food and Drug Administration, PREM APPR PMA; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Makela T, 2012, BRIT MED J, V345, pe4646; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; McMinn DJW, 2011, INT ORTHOP, V35, P231, DOI 10.1007/s00264-010-1148-8; Meier B, 2012, NY TIMES; MHRA, 2012, MDA2012036 MHRA; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Sedrakyan A, 2010, MED CARE, V48, pS121, DOI 10.1097/MLR.0b013e3181d991c4; Smith AJ, 2012, LANCET; Smith AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2383; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Tower SS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e430	15	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 17	2012	380	9855					1720	1722		10.1016/S0140-6736(12)61270-7	http://dx.doi.org/10.1016/S0140-6736(12)61270-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038CV	23036898				2022-12-24	WOS:000311153700008
J	Schubeler, D				Schuebeler, Dirk			Epigenetic Islands in a Genetic Ocean	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; DNA METHYLATION; BASE-RESOLUTION; IN-VIVO; TRANSCRIPTION; 5-HYDROXYMETHYLCYTOSINE; REGIONS; BINDING; STATES		Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	dirk@fmi.ch						Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Satterlee JS, 2010, NAT BIOTECHNOL, V28, P1039, DOI 10.1038/nbt1010-1039; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	25	38	40	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					756	757		10.1126/science.1227243	http://dx.doi.org/10.1126/science.1227243			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139324				2022-12-24	WOS:000310839500033
J	Ohsawa, S; Sato, Y; Enomoto, M; Nakamura, M; Betsumiya, A; Igaki, T				Ohsawa, Shizue; Sato, Yoshitaka; Enomoto, Masato; Nakamura, Mai; Betsumiya, Aya; Igaki, Tatsushi			Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila	NATURE			English	Article							STEM-CELL PROLIFERATION; TISSUE OVERGROWTH; OXIDATIVE STRESS; PATHWAY; CANCER; REGENERATION; GROWTH; COOPERATION; INVASION; MIDGUT	Mitochondrial respiratory function is frequently impaired in human cancers(1-4). However, the mechanisms by which mitochondrial dysfunction contributes to tumour progression remain elusive. Here we show in Drosophila imaginal epithelium that defects in mitochondrial function potently induce tumour progression of surrounding tissue in conjunction with oncogenic Ras. Our data show that Ras activation and mitochondrial dysfunction cooperatively stimulate production of reactive oxygen species, which causes activation of c-Jun amino (N)-terminal kinase (JNK) signalling. JNK cooperates with oncogenic Ras to inactivate the Hippo pathway, leading to upregulation of its targets Unpaired (an interleukin-6 homologue) and Wingless (a Wnt homologue). Mitochondrial dysfunction in Ras-activated cells further cooperates with Ras signalling in neighbouring cells with normal mitochondrial function, causing benign tumours to exhibit metastatic behaviour. Our findings provide a mechanistic basis for interclonal tumour progression driven by mitochondrial dysfunction and oncogenic Ras.	[Ohsawa, Shizue; Sato, Yoshitaka; Enomoto, Masato; Nakamura, Mai; Betsumiya, Aya; Igaki, Tatsushi] Kobe Univ, Grad Sch Med, Div Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Igaki, Tatsushi] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kobe University; Japan Science & Technology Agency (JST)	Igaki, T (corresponding author), Kobe Univ, Grad Sch Med, Div Genet, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	igaki@med.kobe-u.ac.jp	Sato, Yoshitaka/P-9728-2015	Sato, Yoshitaka/0000-0002-8541-6413; Igaki, Tatsushi/0000-0001-5839-9526	Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Japan Society for the Promotion of Science for Young Scientists; Japan Science and Technology Agency; G-COE program for Global Center for Education and Research in Integrative Membrane Biology; Fumi Yamamura Memorial Foundation for Female Natural Scientists; Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Human Frontier Science Program Career Development Award	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); G-COE program for Global Center for Education and Research in Integrative Membrane Biology; Fumi Yamamura Memorial Foundation for Female Natural Scientists; Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Human Frontier Science Program Career Development Award	We thank J. Pastor-Pareja and M. Miura for comments on the manuscript; T. Sawada and K. Takino for technical support; D. Harrison, T. Orr-Weaver and H. Richardson for antibodies; T. Adachi-Yamada, U. Banerjee, D. Bohmann, F. Missirlis, M. Miura, H. Sun, T. Xu, Y. Hiromi, the Bloomington Stock Center, the Vienna Drosophila RNAi Center, the National Institute of Genetics Stock Center and the Drosophila Genetic Resource Center for fly stocks. We also thank T. Xu for encouragement. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to S.O., M.E. and T.I, a Grant-in-Aid for Scientific Research on Innovative Areas from the MEXT to S.O. and T.I., the Japan Society for the Promotion of Science for Young Scientists to S.O. and M. E., the Japan Science and Technology Agency to T.I., the G-COE program for Global Center for Education and Research in Integrative Membrane Biology to S.O. and T.I., the Fumi Yamamura Memorial Foundation for Female Natural Scientists to S.O, the Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientists to S.O., the Takeda Science Foundation to S.O. and T.I., the Astellas Foundation for Research on Metabolic Disorders to T.I., the Kanae Foundation for the Promotion of Medical Science to T.I., the Senri Life Science Foundation to T.I. and a Human Frontier Science Program Career Development Award to T.I.	Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frei C, 2005, EMBO J, V24, P623, DOI 10.1038/sj.emboj.7600523; Giebel B, 2006, CURR BIOL, V16, pR91, DOI 10.1016/j.cub.2006.01.022; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Morata G, 2011, DEV GROWTH DIFFER, V53, P168, DOI 10.1111/j.1440-169X.2010.01225.x; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702	29	142	143	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					547	+		10.1038/nature11452	http://dx.doi.org/10.1038/nature11452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23023132				2022-12-24	WOS:000310196200044
J	Zust, T; Heichinger, C; Grossniklaus, U; Harrington, R; Kliebenstein, DJ; Turnbull, LA				Zuest, Tobias; Heichinger, Christian; Grossniklaus, Ueli; Harrington, Richard; Kliebenstein, Daniel J.; Turnbull, Lindsay A.			Natural Enemies Drive Geographic Variation in Plant Defenses	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; EVOLUTIONARY DYNAMICS; GENETIC DIVERSITY; LOCAL ADAPTATION; GREEN PEACH; GLUCOSINOLATE; POPULATIONS; POLYMORPHISM; RESISTANCE; HERBIVORY	Plants defend themselves against attack by natural enemies, and these defenses vary widely across populations. However, whether communities of natural enemies are a sufficiently potent force to maintain polymorphisms in defensive traits is largely unknown. Here, we exploit the genetic resources of Arabidopsis thaliana, coupled with 39 years of field data on aphid abundance, to (i) demonstrate that geographic patterns in a polymorphic defense locus (GS-ELONG) are strongly correlated with changes in the relative abundance of two specialist aphids; and (ii) demonstrate differential selection by the two aphids on GS-ELONG, using a multigeneration selection experiment. We thereby show a causal link between variation in abundance of the two specialist aphids and the geographic pattern at GS-ELONG, which highlights the potency of natural enemies as selective forces.	[Zuest, Tobias; Turnbull, Lindsay A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Zuest, Tobias; Turnbull, Lindsay A.] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8057 Zurich, Switzerland; [Heichinger, Christian; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Heichinger, Christian; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Harrington, Richard] Rothamsted Res, Rothamsted Insect Survey, AgroEcol Dept, Harpenden AL5 2JQ, Herts, England; [Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kliebenstein, Daniel J.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DynaMo Ctr Excellence, DK-1871 Copenhagen, Denmark	University of Zurich; University of Zurich; University of Zurich; University of Zurich; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of California System; University of California Davis; University of Copenhagen	Zust, T (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	tobias.zuest@cornell.edu	Grossniklaus, Ueli/E-9995-2016; Turnbull, Lindsay A./A-2680-2012	Grossniklaus, Ueli/0000-0002-0522-8974; Kliebenstein, Daniel/0000-0001-5759-3175; Zust, Tobias/0000-0001-7142-8731	Forschungskredit of the University of Zurich; Swiss National Science Foundation [31-107531]; U.S. NSF [DBI0820580]; European Research Council; University of Zurich; Biotechnology and Biological Sciences Research Council; Lawes Agricultural Trust; EU EXAMINE Project [EVK2-1999-00151]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00006003, BBS/E/C/00004957, BBS/E/C/00005191] Funding Source: researchfish; BBSRC [BBS/E/C/00005191, BBS/E/C/00004957] Funding Source: UKRI	Forschungskredit of the University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); University of Zurich; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lawes Agricultural Trust; EU EXAMINE Project; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Forschungskredit of the University of Zurich (T.Z.) and by Swiss National Science Foundation grant 31-107531 (L.A.T.), by U.S. NSF grant DBI0820580 (D.J.K.), an Advanced Grant of the European Research Council (U.G.), and a special grant of the University of Zurich in commemoration of Prof. Christine B. Muller. The Rothamsted Insect Survey is supported by a Biotechnology and Biological Sciences Research Council National Capability Grant and the Lawes Agricultural Trust. We thank members of the EU EXAMINE Project (EVK2-1999-00151) for use of data and A. A. Agrawal, S. West, J. Levine, and two anonymous reviewers for comments that improved the manuscript. All data presented in this paper and R code of all analyses are provided in the supplementary materials.	Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bidart-Bouzat MG, 2008, J CHEM ECOL, V34, P1026, DOI 10.1007/s10886-008-9498-z; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; DELOACH CJ, 1974, ANN ENTOMOL SOC AM, V67, P332, DOI 10.1093/aesa/67.3.332; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kliebenstein DJ, 2004, PLANT CELL ENVIRON, V27, P675, DOI 10.1111/j.1365-3040.2004.01180.x; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Newton EL, 2009, OECOLOGIA, V160, P63, DOI 10.1007/s00442-009-1281-5; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7	24	197	198	7	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					116	119		10.1126/science.1226397	http://dx.doi.org/10.1126/science.1226397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042895	Green Accepted			2022-12-24	WOS:000309457400066
J	Galvez, T; Gilleron, J; Zerial, M; O'Sullivan, GA				Galvez, Thierry; Gilleron, Jerome; Zerial, Marino; O'Sullivan, Gregory A.			SnapShot: Mammalian Rab Proteins in Endocytic Trafficking	CELL			English	Editorial Material									[Galvez, Thierry; Gilleron, Jerome; Zerial, Marino; O'Sullivan, Gregory A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Galvez, T (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Gilleron, Jerome/GRX-8574-2022; O'Sullivan, Gregory A/F-8355-2011	Gilleron, Jerome/0000-0002-6389-8685; O'Sullivan, Gregory A/0000-0003-0428-041X; galvez, thierry/0000-0003-2800-3732				Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Pfeffer SR, 2011, COLD SPRING HARB PER, V3; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	4	46	47	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					234	U244	234.e2	10.1016/j.cell.2012.09.013	http://dx.doi.org/10.1016/j.cell.2012.09.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021225	Bronze			2022-12-24	WOS:000309544200023
J	Qaseem, A; Fihn, SD; Dallas, P; Williams, S; Owens, DK; Shekelle, P				Qaseem, Amir; Fihn, Stephan D.; Dallas, Paul; Williams, Sankey; Owens, Douglas K.; Shekelle, Paul		Amer Coll Phys	Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL; OPTIMAL MEDICAL THERAPY; IN-HOSPITAL MORTALITY; INDIVIDUAL ANTIRETROVIRAL DRUGS; CONVERTING-ENZYME-INHIBITORS; SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST	Description: The American College of Physicians (ACP) developed this guideline with the American College of Cardiology Foundation (ACCF), American Heart Association (AHA), American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, and Society of Thoracic Surgeons to present the available evidence on the management of stable known or suspected ischemic heart disease. Methods: Literature on this topic published before November 2011 was identified by using MEDLINE, Embase, Cochrane CENTRAL, PsychINFO, AMED, and SCOPUS. Searches were limited to human studies published in English. This guideline grades the evidence and recommendations according to a translation of the ACCF/AHA grading system into ACP's clinical practice guidelines grading system. Recommendations: The guideline includes 48 specific recommendations that address the following issues: patient education, management of proven risk factors (dyslipidemia, hypertension, diabetes, physical activity body weight, and smoking), risk factor reduction strategies of unproven benefit, medical therapy to prevent myocardial infarction and death and to relieve symptoms, alternative therapy, revascularization to improve survival and symptoms, and patient follow-up. Ann Intern Med. 2012;157:735-743.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Dept Vet Affairs, Seattle, WA USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA; Stanford Univ, Stanford, CA 94305 USA; Virginia Tech Caril Sch Med, Roanoke, VA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Fihn, Stephan/ABA-1040-2020		ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Abrams J, 2003, ORGANIC NITRATES NIT; ALDERMAN EL, 1983, CIRCULATION, V68, P785, DOI 10.1161/01.CIR.68.4.785; ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141, DOI 10.1016/0735-1097(93)90429-5; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; American Academy of Family Physicians (AAFP), 2000, AM FAM PHYSICIAN, V62, P1712; Anand SS, 2003, J AM COLL CARDIOL, V41, p62S, DOI 10.1016/S0735-1097(02)02776-6; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 2004, N S W Public Health Bull, V15, P107; [Anonymous], 1982, NEW ENGL J MED, V307, P976; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P277; [Anonymous], 1984, HYPERTENSION, V6, pI198; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Aubry MC, 2007, J RHEUMATOL, V34, P937; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BALL SG, 1993, LANCET, V342, P821; BALSANO F, 1990, CIRCULATION, V82, P17, DOI 10.1161/01.CIR.82.1.17; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Berman DS, 2006, J NUCL CARDIOL, V13, P191, DOI 10.1016/j.nuclcard.2006.01.020; Bernheim AM, 2011, AM HEART J, V161, P740, DOI 10.1016/j.ahj.2010.12.017; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boekholdt SM, 2001, CIRCULATION, V104, P3063, DOI 10.1161/hc5001.100793; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; BOMAN K, 1995, EUR J CLIN PHARMACOL, V49, P27; Bosworth HB, 2007, CONTEMP CLIN TRIALS, V28, P33, DOI 10.1016/j.cct.2006.08.006; Bottcher M, 2002, AM J CARDIOL, V89, P1019, DOI 10.1016/S0002-9149(02)02268-3; Bouzas-Mosquera A, 2010, EUR J CLIN INVEST, V40, P1122, DOI 10.1111/j.1365-2362.2010.02365.x; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brogden RN, 1996, DRUGS, V51, P792, DOI 10.2165/00003495-199651050-00007; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cecil WT, 2008, AM J MANAG CARE, V14, P521; Centers for Medicare & Medicaid Services, 2008, MED MED STAT SUPPL; Chae C, 1999, BETABLOCKERS; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Clayton TC, 2005, BMJ-BRIT MED J, V331, P869, DOI 10.1136/bmj.38603.656076.63; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Collins R, 1994, ANTIHYPERTENSIVE DRU; Critchley J, 2003, COCHRANE DB SYST REV; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Daly C, 2003, EUR HEART J, V24, P534, DOI 10.1016/S0195-668X(02)00820-5; Daly CA, 2006, BMJ-BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; Davis AM, 2007, MED CARE RES REV, V64, p29S, DOI 10.1177/1077558707305416; Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; DICARLI MF, 1995, CIRCULATION, V92, P3436, DOI 10.1161/01.CIR.92.12.3436; DIGENIO AG, 1991, S AFR MED J, V79, P188; Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544; Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Duvall WL, 2006, J NUCL CARDIOL, V13, P202, DOI 10.1016/j.nuclcard.2006.01.003; Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072; Edwards FH, 1998, ANN THORAC SURG, V66, P125, DOI 10.1016/S0003-4975(98)00358-0; Emanuelsson H, 1999, AM HEART J, V137, P854, DOI 10.1016/S0002-8703(99)70409-6; EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435, DOI 10.1016/0735-1097(92)90599-I; EZEKOWITZ MD, 1995, AM HEART J, V129, P527, DOI 10.1016/0002-8703(95)90281-3; FARNETT L, 1991, JAMA-J AM MED ASSOC, V265, P489, DOI 10.1001/jama.265.4.489; Feit F, 2000, CIRCULATION, V101, P2795, DOI 10.1161/01.CIR.101.24.2795; Feldman DN, 2006, AM J CARDIOL, V98, P1334, DOI 10.1016/j.amjcard.2006.06.026; Fihn SD, 2012, J AM COLL C IN PRESS; Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913; Food and Drug Administration, 2008, INF HEALTHC PROF VAR; Food and Drug Administration, 2008, IMP INF CHANT VAR; Fox KM, 2003, LANCET, V362, P782; Franklin BA, 1998, CHEST, V114, P902, DOI 10.1378/chest.114.3.902; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; FRISHMAN WH, 1991, AM J CARDIOL, V67, P665, DOI 10.1016/0002-9149(91)90518-P; FROELICHER V, 1984, JAMA-J AM MED ASSOC, V252, P1291, DOI 10.1001/jama.252.10.1291; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Ginsberg HN, 1998, ARTERIOSCL THROM VAS, V18, P441, DOI 10.1161/01.ATV.18.3.441; Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gorin SS, 2004, CANCER EPIDEM BIOMAR, V13, P2012; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Goyal D, 2009, CARDIOVASC THER, V27, P10, DOI 10.1111/j.1755-5922.2008.00067.x; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hachamovitch R, 2003, J AM COLL CARDIOL, V41, P1329, DOI 10.1016/S0735-1097(03)00125-6; Haffner SM, 2000, NEW ENGL J MED, V342, P1040, DOI 10.1056/NEJM200004063421408; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Hambrecht R, 1993, J AM COLL CARDIOL, V22, P468, DOI 10.1016/0735-1097(93)90051-2; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; HASKELL WL, 1994, CIRCULATION, V89, P975, DOI 10.1161/01.CIR.89.3.975; HaufZachariou U, 1997, EUR J CLIN PHARMACOL, V52, P95, DOI 10.1007/s002280050256; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; HEBERT PR, 1993, ARCH INTERN MED, V153, P578, DOI 10.1001/archinte.153.5.578; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; HIRSH J, 1995, CHEST, V108, pS247, DOI 10.1378/chest.108.4_Supplement.247S; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; HOLMES DR, 1989, J AM COLL CARDIOL, V13, P524, DOI 10.1016/0735-1097(89)90587-1; Holubkov R, 2002, AM HEART J, V144, P826, DOI 10.1067/mhj.2002.125505; HSIEH SD, 1995, INT J OBESITY, V19, P585; Hughes J., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB2; Hughes JR, 2003, J GEN INTERN MED, V18, P1053, DOI 10.1111/j.1525-1497.2003.20640.x; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hypertension Detection and Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.242.23.2562; Innocenti F, 2011, INT J CARDIOVAS IMAG, V27, P65, DOI 10.1007/s10554-010-9655-7; Jagathesan R, 2006, J CARDIOVASC PHARM, V48, P110, DOI 10.1097/01.fjc.0000245404.20922.9f; Jeger RV, 2004, CHEST, V125, P1124, DOI 10.1378/chest.125.3.1124; Joint Commission, 2007, Jt Comm Perspect, V27, P9; Joint Commission on Accreditation of Healthcare Organizations, 2007, Jt Comm Perspect, V27, P9; Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Julius S, 2006, HYPERTENSION, V48, P385, DOI 10.1161/01.HYP.0000236119.96301.f2; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; Kardas P, 2007, VASC HEALTH RISK MAN, V3, P235, DOI 10.2147/vhrm.2007.3.2.235; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; KERN MJ, 1995, J AM COLL CARDIOL, V25, P178, DOI 10.1016/0735-1097(94)00328-N; Kernis SJ, 2004, J AM COLL CARDIOL, V43, P1773, DOI 10.1016/j.jacc.2003.09.071; Khunnawat C, 2008, AM J CARDIOL, V102, P635, DOI 10.1016/j.amjcard.2008.04.035; King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; KREPP HP, 1991, CARDIOLOGY, V79, P14, DOI 10.1159/000174919; KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1; Kwok JMF, 2002, J AM COLL CARDIOL, V39, P1475, DOI 10.1016/S0735-1097(02)01769-2; LACOSTE LL, 1994, AM J CARDIOL, V73, P1058; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; LANCASTER T, 2005, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001292.PUB3, 10.1002/14651858.CD001292.pub3]; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lavi S, 2007, CATHETER CARDIO INTE, V70, P525, DOI 10.1002/ccd.21154; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Leizorovicz A, 2002, AM HEART J, V143, P301, DOI 10.1067/mhj.2002.120768; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mannucci PM, 2003, CIRCULATION, V107, P1117, DOI 10.1161/01.CIR.0000051465.94572.D0; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Martini CH, 2005, J THROMB HAEMOST, V3, P177, DOI 10.1111/j.1538-7836.2004.01080.x; Matetzky S, 2003, ARCH INTERN MED, V163, P457, DOI 10.1001/archinte.163.4.457; Matzkies FK, 2001, NEPHRON, V89, P10, DOI 10.1159/000046036; MAY GA, 1984, PHYS THER, V64, P1361, DOI 10.1093/ptj/64.9.1361; McGillion M, 2007, CAN J NURS RES, V39, P48; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McNulty PH, 2002, CATHETER CARDIO INTE, V56, P174, DOI 10.1002/ccd.10186; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Mehta NJ, 2003, ANGIOLOGY, V54, P269, DOI 10.1177/000331970305400302; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Miller NH, 1995, MONOGRAPH HUMAN KINE, V2; Morrow D, 2005, CHRONIC CORONARY ART; Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Moscucci M, 2001, CIRCULATION, V104, P263, DOI 10.1161/01.CIR.104.3.263; Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462; Munzel T, 2002, CIRCULATION, V106, P170, DOI 10.1161/01.CIR.0000021663.39699.30; Muszbek N, 2008, INT J CLIN PRACT, V62, P338, DOI 10.1111/j.1742-1241.2007.01683.x; MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487; NARAHARA KA, 1990, AM J CARDIOL, V65, P577, DOI 10.1016/0002-9149(90)91033-3; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; National Heart Lung and Blood Institute, 2008, CLIN GUID ID EV TREA; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3; Oka R, 2008, DIABETES RES CLIN PR, V79, P474, DOI 10.1016/j.diabres.2007.10.016; Okin PM, 2003, CIRCULATION, V108, P684, DOI 10.1161/01.CIR.0000083724.28630.C3; OLDRIDGE NB, 1989, MED SCI SPORT EXER, V21, P308; ORNISH D, 1983, JAMA-J AM MED ASSOC, V249, P54, DOI 10.1001/jama.249.1.54; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Parker JD, 1998, NEW ENGL J MED, V338, P520, DOI 10.1056/NEJM199802193380807; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pazhenkottil AP, 2011, J NUCL MED, V52, P196, DOI 10.2967/jnumed.110.080580; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; PEPINE CJ, 1994, CIRCULATION, V90, P762, DOI 10.1161/01.CIR.90.2.762; Pepine CJ, 2004, HOPE PEACE UPDATE RO; Perrone-Filardi P, 2010, J NUCL CARDIOL, V17, P310, DOI 10.1007/s12350-009-9182-x; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Phillips HR, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.026; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Pitt B, 2001, AM J CARDIOL, V87, P1058, DOI 10.1016/S0002-9149(01)01461-8; Poole-Wilson PA, 2007, EUR HEART J, V28, P1928, DOI 10.1093/eurheartj/ehm198; Qaseem A, 2012, ANN INTERN MED, V157, P729, DOI 10.7326/0003-4819-157-10-201211200-00010; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Qureshi MA, 2003, J AM COLL CARDIOL, V42, P1890, DOI 10.1016/j.jacc.2003.06.014; Raftery EB, 1996, EUR HEART J, V17, P30, DOI 10.1093/eurheartj/17.suppl_B.30; Rao SV, 2004, ARCH INTERN MED, V164, P1128, DOI 10.1001/archinte.164.10.1128; Rehnqvist N, 1995, Cardiologia, V40, P301; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; Resnic FS, 2001, AM J CARDIOL, V88, P5, DOI 10.1016/S0002-9149(01)01576-4; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; ROSSOUW JE, 1990, NEW ENGL J MED, V323, P1112, DOI 10.1056/NEJM199010183231606; Ruggenenti P, 1997, LANCET, V349, P1857; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Savonitto S, 1996, J AM COLL CARDIOL, V27, P311, DOI 10.1016/0735-1097(95)00489-0; Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026; SCHAEFER EJ, 1995, ARTERIOSCL THROM VAS, V15, P1079, DOI 10.1161/01.ATV.15.8.1079; Schaefer EJ, 1997, AM J CLIN NUTR, V65, P823, DOI 10.1093/ajcn/65.3.823; SCHULER G, 1992, CIRCULATION, V86, P1, DOI 10.1161/01.CIR.86.1.1; SEBRECHTS CP, 1986, AM HEART J, V112, P1217, DOI 10.1016/0002-8703(86)90351-0; Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw RE, 2002, J AM COLL CARDIOL, V39, P1104, DOI 10.1016/S0735-1097(02)01731-X; Shaw Richard E, 2003, J Invasive Cardiol, V15, P578; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Silagy C., 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000146.PUB2; Singh M, 2005, AM J CARDIOL, V96, P907, DOI 10.1016/j.amjcard.2005.05.045; Singh M, 2002, J AM COLL CARDIOL, V40, P387, DOI 10.1016/S0735-1097(02)01980-0; Singh M, 2008, J AM COLL CARDIOL, V51, P2313, DOI 10.1016/j.jacc.2008.01.066; Slomka PJ, 2007, J NUCL CARDIOL, V14, P44, DOI 10.1016/j.nuclcard.2006.10.021; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Stead LF, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001007.PUB2; Stead LF, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002850; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; STEVENS VJ, 1993, ARCH INTERN MED, V153, P849, DOI 10.1001/archinte.153.7.849; Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044; SULLIVAN AK, 1994, BRIT MED J, V308, P883, DOI 10.1136/bmj.308.6933.883; Tabib A, 2000, CORONARY ARTERY DIS, V11, P41, DOI 10.1097/00019501-200002000-00008; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Tepper David, 1999, Congest Heart Fail, V5, P184; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; TODD IC, 1992, BRIT HEART J, V68, P560; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; TRESCH DD, 1985, AM HEART J, V110, P1139, DOI 10.1016/0002-8703(85)90003-1; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; TSUYA T, 1990, AM J CARDIOL, V66, P275, DOI 10.1016/0002-9149(90)90835-O; Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108; Turnbull F, 2003, LANCET, V362, P1527; Turnbull F., 2007, J HYPERTENS, V25, P951, DOI [DOI 10.1097/HJH.0B013E3280BAD9B4, 10.1097/HJH.0b013-3280bad9b4]; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ussher M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub2; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; VANCAMP SP, 1986, JAMA-J AM MED ASSOC, V256, P1160, DOI 10.1001/jama.256.9.1160; VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Verma S, 2007, J AM SOC HYPERTENS, V1, P286, DOI 10.1016/j.jash.2007.05.003; VONARNIM T, 1995, J AM COLL CARDIOL, V25, P231, DOI 10.1016/0735-1097(94)00345-Q; Vongvanich P, 1996, AM J CARDIOL, V77, P1383, DOI 10.1016/S0002-9149(96)00215-9; WAYSBORT J, 1991, CARDIOLOGY, V79, P19, DOI 10.1159/000174920; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Whelton SP, 2004, AM J CARDIOL, V93, P1119, DOI 10.1016/j.amjcard.2004.01.038; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; WONG ND, 1991, ANN INTERN MED, V115, P687, DOI 10.7326/0003-4819-115-9-687; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Wright JT, 2002, ARCH INTERN MED, V162, P1636, DOI 10.1001/archinte.162.14.1636; Wu CT, 2006, J AM COLL CARDIOL, V47, P654, DOI 10.1016/j.jacc.2005.09.071; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	317	46	51	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					735	+		10.7326/0003-4819-157-10-201211200-00011	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00011			31	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23165665				2022-12-24	WOS:000311580000019
J	Mudd, PA; Martins, MA; Ericsen, AJ; Tully, DC; Power, KA; Bean, AT; Piaskowski, SM; Duan, LJ; Seese, A; Gladden, AD; Weisgrau, KL; Furlott, JR; Kim, YI; de Santana, MGV; Rakasz, E; Capuano, S; Wilson, NA; Bonaldo, MC; Galler, R; Allison, DB; Piatak, M; Haase, AT; Lifson, JD; Allen, TM; Watkins, DI				Mudd, Philip A.; Martins, Mauricio A.; Ericsen, Adam J.; Tully, Damien C.; Power, Karen A.; Bean, Alex T.; Piaskowski, Shari M.; Duan, Lijie; Seese, Aaron; Gladden, Adrianne D.; Weisgrau, Kim L.; Furlott, Jessica R.; Kim, Young-il; Veloso de Santana, Marlon G.; Rakasz, Eva; Capuano, Saverio, III; Wilson, Nancy A.; Bonaldo, Myrna C.; Galler, Ricardo; Allison, David B.; Piatak, Michael, Jr.; Haase, Ashley T.; Lifson, Jeffrey D.; Allen, Todd M.; Watkins, David I.			Vaccine-induced CD8(+) T cells control AIDS virus replication	NATURE			English	Article							MAMU-B-ASTERISK-08-POSITIVE MACAQUES; IMMUNODEFICIENCY; SIV; RESPONSES; HIV; INFECTION; DISEASE; ESCAPE; HOST	Developing a vaccine for human immunodeficiency virus(HIV) may be aided by a complete understanding of those rare cases in which some HIV-infected individuals control replication of the virus(1-3). Most of these elite controllers express the histocompatibility alleles HLA-B*57 or HLA-B*27 (ref. 3). These alleles remain by far the most robust associations with low concentrations of plasma virus(4,5), yet the mechanism of control in these individuals is not entirely clear. Here we vaccinate Indian rhesus macaques that express Mamu-B*08, an animal model for HLA-B*27-mediated elite control(6), with three Mamu-B*08-restricted CD8(+) T-cell epitopes, and demonstrate that these vaccinated animals control replication of the highly pathogenic clonal simian immunodeficiency virus (SIV) mac239 virus. High frequencies of CD8(+) T cells against these Vif and Nef epitopes in the blood, lymph nodes and colon were associated with viral control. Moreover, the frequency of the CD8(+) T-cell response against the Nef RL10 epitope (Nef amino acids 137-146) correlated significantly with reduced acute phase viraemia. Finally, two of the eight vaccinees lost control of viral replication in the chronic phase, concomitant with escape in all three targeted epitopes, further implicating these three CD8(+) T-cell responses in the control of viral replication. Our findings indicate that narrowly targeted vaccine-induced virus-specific CD8(+) T-cell responses can control replication of the AIDS virus.	[Martins, Mauricio A.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Mudd, Philip A.; Ericsen, Adam J.; Bean, Alex T.; Piaskowski, Shari M.; Weisgrau, Kim L.; Furlott, Jessica R.; Wilson, Nancy A.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53711 USA; [Mudd, Philip A.] Univ Wisconsin Madison, Med Scientist Training Program, Madison, WI 53705 USA; [Tully, Damien C.; Power, Karen A.; Seese, Aaron; Gladden, Adrianne D.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA; [Duan, Lijie; Haase, Ashley T.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Kim, Young-il] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Veloso de Santana, Marlon G.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil; [Rakasz, Eva; Capuano, Saverio, III; Wilson, Nancy A.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53711 USA; [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil; [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA	University of Miami; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Fundacao Oswaldo Cruz; University of Wisconsin System; University of Wisconsin Madison; Fundacao Oswaldo Cruz; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Watkins, DI (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	dwatkins@med.miami.edu	Ericsen, Adam/AAW-1187-2020; Galler, Ricardo/B-3280-2014; Martins, Mauricio/AAU-9226-2020; Bonaldo, Myrna C/D-9494-2013; Bonaldo, Myrna/AAE-2799-2021; Allen, Todd/F-5473-2011; Rakasz, Eva G/H-9197-2019; Veloso de Santana, Marlon Gilsepp/H-8146-2017	Ericsen, Adam/0000-0003-4176-8270; Martins, Mauricio/0000-0001-8336-216X; Allen, Todd/0000-0002-6609-1318; Allison, David/0000-0003-3566-9399; Mudd, Philip/0000-0002-3860-5473; Tully, Damien/0000-0002-7620-9340; Veloso de Santana, Marlon Gilsepp/0000-0002-3427-841X; Wilson, Nancy/0000-0002-9472-6026	National Institutes of Health (NIH) [R37 AI052056, RO1 AI076114, RR015371, HHSN261200800001E]; FAPERJ; INCTV; CNPq; MCT; FIOCRUZ; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015371, P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078985, R37AI052056, R01AI076114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INCTV; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCT; FIOCRUZ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank M. Stevenson, M. Reynolds, N. Maness and J. Sacha for discussions and suggestions. We also thank D. Evans, L. Heyer and Z. R. Bergman for facilitating the experiments. This work was funded in part by National Institutes of Health (NIH) grants R37 AI052056, RO1 AI076114, RR015371, contract number HHSN261200800001E and FAPERJ, INCTV, CNPq, MCT and FIOCRUZ.	Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115; Cline AN, 2005, J MED PRIMATOL, V34, P303; Dang Q, 2008, ADV PHARMACOL, V56, P369, DOI 10.1016/S1054-3589(07)56012-6; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Mudd PA, 2012, J IMMUNOL, V188, P3364, DOI 10.4049/jimmunol.1102470; Mudd PA, 2011, CURR OPIN HIV AIDS, V6, P197, DOI 10.1097/COH.0b013e3283453e16; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Tsukamoto T, 2009, J VIROL, V83, P9339, DOI 10.1128/JVI.01120-09; Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09	24	143	149	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					129	U152		10.1038/nature11443	http://dx.doi.org/10.1038/nature11443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23023123	Green Accepted			2022-12-24	WOS:000310434500044
J	Zelenitsky, DK; Therrien, F; Erickson, GM; DeBuhr, CL; Kobayashi, Y; Eberth, DA; Hadfield, F				Zelenitsky, Darla K.; Therrien, Francois; Erickson, Gregory M.; DeBuhr, Christopher L.; Kobayashi, Yoshitsugu; Eberth, David A.; Hadfield, Frank			Feathered Non-Avian Dinosaurs from North America Provide Insight into Wing Origins	SCIENCE			English	Article							THEROPOD DINOSAUR; EVOLUTIONARY ORIGIN; SOFT-TISSUE; ARCHAEOPTERYX	Previously described feathered dinosaurs reveal a fascinating record of feather evolution, although substantial phylogenetic gaps remain. Here we report the occurrence of feathers in ornithomimosaurs, a clade of non-maniraptoran theropods for which fossilized feathers were previously unknown. The Ornithomimus specimens, recovered from Upper Cretaceous deposits of Alberta, Canada, provide new insights into dinosaur plumage and the origin of the avian wing. Individuals from different growth stages reveal the presence of a filamentous feather covering throughout life and winglike structures on the forelimbs of adults. The appearance of winglike structures in older animals indicates that they may have evolved in association with reproductive behaviors. These specimens show that primordial wings originated earlier than previously thought, among non-maniraptoran theropods.	[Zelenitsky, Darla K.; DeBuhr, Christopher L.] Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada; [Therrien, Francois; Eberth, David A.] Royal Tyrrell Museum Palaeontol, Drumheller, AB TOJ OYO, Canada; [Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Kobayashi, Yoshitsugu] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido 0600810, Japan; [Hadfield, Frank] Palcoprep, Drumheller, AB TOJ OYO, Canada	University of Calgary; State University System of Florida; Florida State University; Hokkaido University	Zelenitsky, DK (corresponding author), Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada.	dkzeleni@ucalgary.ca; francois.therrien@gov.ab.ca			Royal Tyrrell Museum of Palaeontology; Natural Sciences and Engineering Research Council of Canada; University of Calgary; NSF Division of Earth Sciences [EAR 0959029]	Royal Tyrrell Museum of Palaeontology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary; NSF Division of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank P. Andrew (landowner), D. Brinkman (logistical support), J. Csotonyi (artwork), D. MacLeod (specimen preparation), M. Newbrey (discussions), D. Sloan (technical illustrations), and K. Womble (graphics). Research was funded by the Royal Tyrrell Museum of Palaeontology, a Natural Sciences and Engineering Research Council of Canada Discovery grant (D.K.Z.), the University of Calgary Start-up Fund (D.K.Z.), and an NSF Division of Earth Sciences grant (EAR 0959029) (G.M.E.). TMP 1995.110.1, TMP 2008.70.1, and TMP 2009.110.1 are permanently deposited at the Royal Tyrrell Museum, Drumheller, Alberta, Canada.	BOCK WALTER J., 1965, SYST ZOOL, V14, P272, DOI 10.2307/2411681; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Cho P., 1984, Zoo Biology, V3, P133, DOI 10.1002/zoo.1430030205; Dal Sasso C, 1998, NATURE, V392, P383; Davies S.J.J.F., 2002, RATITES TINAMOUS; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Duerden J. E., 1911, AGR J UNION S AFRICA, V1, P29; Fastovsky D. E., 1989, AGE DINOSAURS, V2, P22; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; GILL FB, 2007, ORNITHOLOGY; Heers AM, 2012, TRENDS ECOL EVOL, V27, P296, DOI 10.1016/j.tree.2011.12.003; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kellner Alexander W.A., 2002, P389; Kellner AWA, 1996, NATURE, V379, P32, DOI 10.1038/379032a0; Lucas A.M., 1972, AVIAN ANATOMY INTE 1; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; WRAY R. S., 1887, P ZOOL SOC LONDON, V1887, P343; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	36	66	69	0	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					510	514		10.1126/science.1225376	http://dx.doi.org/10.1126/science.1225376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112330				2022-12-24	WOS:000310195800053
J	Johnson, JE; Reyes, FE; Polaski, JT; Batey, RT				Johnson, James E., Jr.; Reyes, Francis E.; Polaski, Jacob T.; Batey, Robert T.			B-12 cofactors directly stabilize an mRNA regulatory switch	NATURE			English	Article							VITAMIN-B-12 METABOLISM; COMPARATIVE GENOMICS; GENETIC-CONTROL; FOLDING MOTIF; RIBOSWITCHES; RECOGNITION; MECHANISMS; EXPRESSION; BACTERIA; ELEMENTS	Structures of riboswitch receptor domains bound to their effector have shown how messenger RNAs recognize diverse small molecules, but mechanistic details linking the structures to the regulation of gene expression remain elusive(1,2). To address this, here we solve crystal structures of two different classes of cobalamin (vitamin B-12)-binding riboswitches that include the structural switch of the downstream regulatory domain. These classes share a common cobalamin-binding core, but use distinct peripheral extensions to recognize different B12 derivatives. In each case, recognition is accomplished through shape complementarity between the RNA and cobalamin, with relatively few hydrogen bonding interactions that typically govern RNA-small molecule recognition. We show that a composite cobalamin-RNA scaffold stabilizes an unusual long-range intramolecular kissing-loop interaction that controls mRNA expression. This is the first, to our knowledge, riboswitch crystal structure detailing how the receptor and regulatory domains communicate in a ligand-dependent fashion to regulate mRNA expression.	[Johnson, James E., Jr.; Reyes, Francis E.; Polaski, Jacob T.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 596, Boulder, CO 80309 USA.	francis.reyes@colorado.edu; robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625; Polaski, Jacob/0000-0001-6570-1789	National Institutes of Health [GM073850, 1S10RR026516]; Colorado Diversity Initiative Fellowship; NIH Ruth L. Kirschstein fellowship [F32GM095121]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073850, F32GM095121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Diversity Initiative Fellowship; NIH Ruth L. Kirschstein fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM073850 and 1S10RR026516) to R. T. B. and by a Colorado Diversity Initiative Fellowship and NIH Ruth L. Kirschstein fellowship (F32GM095121) to J.E.J. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; Edwards Andrea L., 2009, V535, P135, DOI 10.1007/978-1-59745-557-2_9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferre-D'Amare AR, 2010, METHODS, V52, P159, DOI 10.1016/j.ymeth.2010.06.008; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Franklund CV, 1997, J BACTERIOL, V179, P4039, DOI 10.1128/jb.179.12.4039-4042.1997; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Gilbert Sunny D., 2009, V540, P97, DOI 10.1007/978-1-59745-558-9_8; GREGORIAN RS, 1995, J MOL BIOL, V248, P968, DOI 10.1006/jmbi.1995.0275; Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; LUNDRIGAN MD, 1991, P NATL ACAD SCI USA, V88, P1479, DOI 10.1073/pnas.88.4.1479; LUNDRIGAN MD, 1989, J BACTERIOL, V171, P154, DOI 10.1128/jb.171.1.154-161.1989; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Pyle AM, 2002, J BIOL INORG CHEM, V7, P679, DOI 10.1007/s00775-002-0387-6; Reyes FE, 2009, METHOD ENZYMOL, V469, P119, DOI 10.1016/S0076-6879(09)69006-6; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Sussman D, 2000, NAT STRUCT BIOL, V7, P53, DOI 10.1038/71253; TAYLOR RT, 1973, ARCH BIOCHEM BIOPHYS, V156, P521, DOI 10.1016/0003-9861(73)90301-9; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xin YR, 2008, RNA, V14, P2465, DOI 10.1261/rna.1249208	40	115	115	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					133	+		10.1038/nature11607	http://dx.doi.org/10.1038/nature11607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23064232	Green Accepted			2022-12-24	WOS:000311893400060
J	Sohi, SP				Sohi, Saran P.			Carbon Storage with Benefits	SCIENCE			English	Editorial Material							BIOCHAR; SOIL; CHARCOAL; UK		Univ Edinburgh, Sch Geosci, UK Biochar Res Ctr, Edinburgh EH9 3JN, Midlothian, Scotland	University of Edinburgh	Sohi, SP (corresponding author), Univ Edinburgh, Sch Geosci, UK Biochar Res Ctr, Edinburgh EH9 3JN, Midlothian, Scotland.	saran.sohi@ed.ac.uk	Sohi, Saran/K-1220-2019	Sohi, Saran/0000-0003-3207-8665				Bird MI, 2008, J ARCHAEOL SCI, V35, P2698, DOI 10.1016/j.jas.2008.04.018; Brewer CE, 2011, BIOENERG RES, V4, P312, DOI 10.1007/s12155-011-9133-7; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Dias BO, 2010, BIORESOURCE TECHNOL, V101, P1239, DOI 10.1016/j.biortech.2009.09.024; Elad Y, 2011, PHYTOPATHOL MEDITERR, V50, P335; Hale SE, 2011, ENVIRON SCI TECHNOL, V45, P10445, DOI 10.1021/es202970x; Hammond J, 2011, ENERG POLICY, V39, P2646, DOI 10.1016/j.enpol.2011.02.033; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Prendergast-Miller MT, 2011, SOIL BIOL BIOCHEM, V43, P2243, DOI 10.1016/j.soilbio.2011.07.019; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P1, DOI 10.1016/j.palaeo.2010.03.044; Shackley S, 2011, CARBON MANAG, V2, P335, DOI 10.4155/CMT.11.22; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Spokas KA, 2010, CARBON MANAG, V1, P289, DOI 10.4155/CMT.10.32; Spokas KA, 2010, PLANT SOIL, V333, P443, DOI 10.1007/s11104-010-0359-5; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053	19	284	309	21	452	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1034	1035		10.1126/science.1225987	http://dx.doi.org/10.1126/science.1225987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041HJ	23180849				2022-12-24	WOS:000311390600028
J	Feng, Y; Li, WF; Li, J; Wang, JW; Ge, JP; Xu, D; Liu, YJ; Wu, KQ; Zeng, QY; Wu, JW; Tian, CL; Zhou, B; Yang, MJ				Feng, Yue; Li, Wenfei; Li, Jian; Wang, Jiawei; Ge, Jingpeng; Xu, Duo; Liu, Yanjing; Wu, Kaiqi; Zeng, Qingyin; Wu, Jia-Wei; Tian, Changlin; Zhou, Bing; Yang, Maojun			Structural insight into the type-II mitochondrial NADH dehydrogenases	NATURE			English	Article							QUINONE OXIDOREDUCTASE; COMPLEX-I; SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; PROTON; NDI1; IDENTIFICATION; SOFTWARE; OXIDASE	The single-component type-II NADH dehydrogenases (NDH-2s) serve as alternatives to the multisubunit respiratory complex I (type-I NADH dehydrogenase (NDH-1), also called NADH: ubiquinone oxidoreductase; EC 1.6.5.3) in catalysing electron transfer from NADH to ubiquinone in the mitochondrial respiratory chain(1). The yeast NDH-2 (Ndi1) oxidizes NADH on the matrix side and reduces ubiquinone to maintain mitochondrial NADH/NAD(+) homeostasis. Ndi1 is a potential therapeutic agent for human diseases caused by complex I defects(2-9), particularly Parkinson's disease, because its expression restores the mitochondrial activity in animals with complex I deficiency. NDH-2s in pathogenic microorganisms are viable targets for new antibiotics(10,11). Here we solve the crystal structures of Ndi1 in its substrate-free, NADH-, ubiquinone-and NADH-ubiquinone-bound states, to help understand the catalytic mechanism of NDH-2s. We find that Ndi1 homodimerization through its carboxy-terminal domain is critical for its catalytic activity and membrane targeting. The structures reveal two ubiquinone-binding sites (UQ(I) and UQ(II)) in Ndi1. NADH and UQ(I) can bind to Ndi1 simultaneously to form a substrate-protein complex. We propose that UQ(I) interacts with FAD to act as an intermediate for electron transfer, and that NADH transfers electrons through this FAD-UQ(I) complex to UQ(II). Together our data reveal the regulatory and catalytic mechanisms of Ndi1 and may facilitate the development or targeting of NDH-2s for potential therapeutic applications.	[Feng, Yue; Li, Wenfei; Li, Jian; Wang, Jiawei; Ge, Jingpeng; Xu, Duo; Wu, Jia-Wei; Zhou, Bing; Yang, Maojun] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Liu, Yanjing; Zeng, Qingyin] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Wu, Kaiqi; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Tian, Changlin] Chinese Acad Sci, High Magnet Field Lab, Hefei 230031, Anhui, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Yang, MJ (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	maojunyang@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Xu, Duo/M-9378-2019; 刘, 妍婧/HCI-6701-2022; Tian, Changlin/P-1469-2014; Ge, Jingpeng/AGG-3471-2022; Gai, Jingpeng/AAT-9369-2021; Feng, Yue/HGE-4589-2022	Wang, Jiawei/0000-0001-9893-8539; Xu, Duo/0000-0003-0483-8719; Gai, Jingpeng/0000-0001-6164-1221; Feng, Yue/0000-0002-1576-1385; Zeng, Qing-Yin/0000-0002-5730-3016; Yang, Maojun/0000-0002-6798-3094	Ministry of Science and Technology of China [2011CB910502, 2011CB910900, 2012CB911101]; National Natural Science Foundation of China [31030020, 31170679]; Chinese Key Research Plan-Protein Sciences [2011CB911104]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Research Plan-Protein Sciences	We would like to thank the staff at beamline BL17U of the Shanghai Synchrotron Radiation Facility for their assistance with data collection. We thank W. Tong for maintenance and support of the EPR facility at the High Magnetic Field Laboratory, Chinese Academy of Sciences. This work was supported by the Ministry of Science and Technology of China (2011CB910502, 2011CB910900 and 2012CB911101), the National Natural Science Foundation of China (31030020 and 31170679) and Chinese Key Research Plan-Protein Sciences (2011CB911104).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adelroth P, 2000, P NATL ACAD SCI USA, V97, P13086, DOI 10.1073/pnas.230439597; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barber-Singh J, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/438370; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Biagini GA, 2012, P NATL ACAD SCI USA, V109, P8298, DOI 10.1073/pnas.1205651109; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; INGLEDEW WJ, 1995, EUR J BIOCHEM, V227, P903, DOI 10.1111/j.1432-1033.1995.tb20217.x; Kerscher SJ, 2000, BBA-BIOENERGETICS, V1459, P274, DOI 10.1016/S0005-2728(00)00162-6; Kerscher Stefan, 2008, V45, P185, DOI 10.1007/400_2007_028; Maas MFPM, 2010, J MOL BIOL, V399, P31, DOI 10.1016/j.jmb.2010.04.015; Marella M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025910; Marella M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011472; Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Murai M, 2010, BIOCHEMISTRY-US, V49, P2973, DOI 10.1021/bi100005j; OHNISHI T, 1966, B SOC CHIM BIOL, V48, P1189; OHNISHI T, 1966, J BIOL CHEM, V241, P1797; Ohnishi T, 2012, BBA-BIOENERGETICS, V1817, P1803, DOI 10.1016/j.bbabio.2012.03.032; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perales-Clemente E, 2008, P NATL ACAD SCI USA, V105, P18735, DOI 10.1073/pnas.0810518105; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/BSE0470001, 10.1042/bse0470001]; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Sevrioukova IF, 2010, J BIOL CHEM, V285, P13616, DOI 10.1074/jbc.M110.104968; Teh J. S., 2007, Infectious Disorders - Drug Targets, V7, P169; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P2213, DOI 10.1107/S0907444902016384; Villegas JM, 2011, ARCH BIOCHEM BIOPHYS, V505, P155, DOI 10.1016/j.abb.2010.10.001; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yang Y, 2011, J BIOL CHEM, V286, P9287, DOI 10.1074/jbc.M110.175547	42	83	85	5	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					478	+		10.1038/nature11541	http://dx.doi.org/10.1038/nature11541			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23086143				2022-12-24	WOS:000311031600053
J	Beletsky, L; Rich, JD; Walley, AY				Beletsky, Leo; Rich, Josiah D.; Walley, Alexander Y.			Prevention of Fatal Opioid Overdose	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NALOXONE		[Beletsky, Leo] Northeastern Univ, Sch Law, Boston, MA 02115 USA; [Beletsky, Leo] Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Beletsky, Leo] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Rich, Josiah D.] Brown Med Sch, Providence, RI USA; [Rich, Josiah D.] Miriam Hosp, Providence, RI 02906 USA; [Walley, Alexander Y.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Walley, Alexander Y.] Boston Med Ctr, Boston, MA USA	Northeastern University; Northeastern University; University of California System; University of California San Diego; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Boston University; Boston Medical Center	Beletsky, L (corresponding author), Northeastern Univ, Sch Law, 400 Huntington Ave, Boston, MA 02115 USA.	l.beletsky@neu.edu		Walley, Alexander/0000-0002-8158-4882; Beletsky, Leo/0000-0003-0726-0676	NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029201, R37DA019829, K24DA022112, R01DA032082, R25DA013582] Funding Source: NIH RePORTER; NIAAA NIH HHS [U01AA11003] Funding Source: Medline; NIAID NIH HHS [P30 AI042853] Funding Source: Medline; NIDA NIH HHS [1R21DA029201, R25-DA13582, R25 DA013582, R01DA032082, R01 DA032082, R21 DA029201, 5K24DA022112, R37DA019829, R37 DA019829, K24 DA022112] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; American Medical Association, AMA AD NEW POL ANN M; Beletsky L, 2007, J URBAN HEALTH, V84, P126, DOI 10.1007/s11524-006-9120-z; Burris S., 2009, DREXEL LAW REV, V1, P273; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Wheeler Eliza, 2012, Morbidity and Mortality Weekly Report, V61, P101	7	75	76	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1863	1864		10.1001/jama.2012.14205	http://dx.doi.org/10.1001/jama.2012.14205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150005	Green Accepted			2022-12-24	WOS:000310952700019
J	Alzu, A; Bermejo, R; Begnis, M; Lucca, C; Piccini, D; Carotenuto, W; Saponaro, M; Brambati, A; Cocito, A; Foiani, M; Liberi, G				Alzu, Amaya; Bermejo, Rodrigo; Begnis, Martina; Lucca, Chiara; Piccini, Daniele; Carotenuto, Walter; Saponaro, Marco; Brambati, Alessandra; Cocito, Andrea; Foiani, Marco; Liberi, Giordano			Senataxin Associates with Replication Forks to Protect Fork Integrity across RNA-Polymerase-II-Transcribed Genes	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; OCULOMOTOR APRAXIA TYPE-2; SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; GENOMIC INSTABILITY; MESSENGER-RNA; YEAST SEN1; HOMOLOGOUS RECOMBINATION; RESOLVING CONFLICTS	Transcription hinders replication fork progression and stability. The ATR checkpoint and specialized DNA helicases assist DNA synthesis across transcription units to protect genome integrity. Combining genomic and genetic approaches together with the analysis of replication intermediates, we searched for factors coordinating replication with transcription. We show that the Sen1/Senataxin DNA/RNA helicase associates with forks, promoting their progression across RNA polymerase II (RNAPII)-transcribed genes. sen1 mutants accumulate aberrant DNA structures and DNA-RNA hybrids while forks clash head-on with RNAPII transcription units. These replication defects correlate with hyper-recombination and checkpoint activation in sen1 mutants. The Sen1 function at the forks is separable from its role in RNA processing. Our data, besides unmasking a key role for Senataxin in coordinating replication with transcription, provide a framework for understanding the pathological mechanisms caused by Senataxin deficiencies and leading to the severe neurodegenerative diseases ataxia with oculomotor apraxia type 2 and amyotrophic lateral sclerosis 4.	[Alzu, Amaya; Bermejo, Rodrigo; Begnis, Martina; Lucca, Chiara; Piccini, Daniele; Carotenuto, Walter; Saponaro, Marco; Brambati, Alessandra; Cocito, Andrea; Foiani, Marco; Liberi, Giordano] FIRC Inst Mol Oncol IFOM Fdn, I-20139 Milan, Italy; [Brambati, Alessandra; Liberi, Giordano] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Milan	Liberi, G (corresponding author), FIRC Inst Mol Oncol IFOM Fdn, Via Adamello 16, I-20139 Milan, Italy.	giordano.liberi@igm.cnr.it	BRAMBATI, Alessandra/AAY-8195-2020; Bermejo, Rodrigo/S-2445-2019; BRAMBATI, Alessandra/Q-1213-2018; Foiani, Marco/M-8234-2014; LIBERI, GIORDANO/AAY-7273-2020; Saponaro, Marco/M-1854-2015; Bermejo, Rodrigo/AAG-7830-2019; Bermejo, Rodrigo/K-6613-2014	BRAMBATI, Alessandra/0000-0002-3816-425X; BRAMBATI, Alessandra/0000-0002-3816-425X; Foiani, Marco/0000-0003-4795-834X; LIBERI, GIORDANO/0000-0003-3160-2242; Saponaro, Marco/0000-0002-9302-2553; Bermejo, Rodrigo/0000-0002-2692-7045	Spanish Ministry of Science and Innovation [RYC-2010-07131, BFU2011-24909]; European Community [293770]; Associazione Italiana per la Ricerca sul Cancro (AIRC); Telethon-Italy [GGP08057]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon)	We thank Yuki Katou and Katsuhiko Shirahige for assistance with ChIP-chip map construction; Massimo Lopes, Ted Weinert, Michele Giannattasio, and all members of our labs for discussion; and Victor Gonzalez-Huici, Cheng-Fu Kao, Aurora Cerutti, Michael Culbertson, Rosella Visintin, Philip Hieter, and Hannah Klein for reagents, advice, and technical support. We also thank the Microarray Facility at the IFOM-IEO campus. A. B. is a student of the PhD program in Genetics, Molecular, and Cellular Biology of the University of Pavia. R. B. is supported by the Spanish Ministry of Science and Innovation (RYC-2010-07131 and BFU2011-24909) and the European Community's FP7 (under grant agreement 293770). This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) and Telethon-Italy (GGP08057) to G.L.	Aguilera A, 2005, NAT STRUCT MOL BIOL, V12, P737, DOI 10.1038/nsmb0905-737; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Bermejo R, 2009, CELL, V138, P870, DOI 10.1016/j.cell.2009.06.022; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Clelland BW, 2010, TRANSCR-AUSTIN, V1, P115, DOI 10.4161/trns.1.3.13735; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conrad NK, 2000, GENETICS, V154, P557; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; DEMARINI DJ, 1992, MOL CELL BIOL, V12, P2154, DOI 10.1128/MCB.12.5.2154; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Hu ZL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl142; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Jamonnak N, 2011, RNA, V17, P2011, DOI 10.1261/rna.2840711; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Koster DA, 2010, CELL, V142, P519, DOI 10.1016/j.cell.2010.08.001; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Olavarrieta L, 2002, MOL MICROBIOL, V46, P699, DOI 10.1046/j.1365-2958.2002.03217.x; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; SPENCER F, 1990, GENETICS, V124, P237; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Stirling PC, 2012, GENE DEV, V26, P163, DOI 10.1101/gad.179721.111; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004; Yurov YB, 2011, THESCIENTIFICWORLDJO, V11, P2602, DOI 10.1100/2011/625690	79	153	157	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					835	846		10.1016/j.cell.2012.09.041	http://dx.doi.org/10.1016/j.cell.2012.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141540	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000310921200014
J	Acuna, GP; Moller, FM; Holzmeister, P; Beater, S; Lalkens, B; Tinnefeld, P				Acuna, G. P.; Moeller, F. M.; Holzmeister, P.; Beater, S.; Lalkens, B.; Tinnefeld, P.			Fluorescence Enhancement at Docking Sites of DNA-Directed Self-Assembled Nanoantennas	SCIENCE			English	Article							SINGLE-MOLECULE; NANOSCALE; EMISSION; ORIGAMI; LIGHT; MICROSCOPY; RESOLUTION; ANTENNAS; BIOLOGY; SURFACE	We introduce self-assembled nanoantennas to enhance the fluorescence intensity in a plasmonic hotspot of zeptoliter volume. The nanoantennas are prepared by attaching one or two gold nanoparticles (NPs) to DNA origami structures, which also incorporated docking sites for a single fluorescent dye next to one NP or in the gap between two NPs. We measured the dependence of the fluorescence enhancement on NP size and number and compare it to numerical simulations. A maximum of 117-fold fluorescence enhancement was obtained for a dye molecule positioned in the 23-nanometer gap between 100-nanometer gold NPs. Direct visualization of the binding and unbinding of short DNA strands, as well as the conformational dynamics of a DNA Holliday junction in the hotspot of the nanoantenna, show the compatibility with single-molecule assays.	[Acuna, G. P.; Moeller, F. M.; Holzmeister, P.; Beater, S.; Lalkens, B.; Tinnefeld, P.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, NanoBioSci Grp, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Acuna, GP (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, NanoBioSci Grp, Hans Sommer Str 10, D-38106 Braunschweig, Germany.	g.acuna@tu-bs.de; p.tinnefeld@tu-bs.de	Acuna, Guillermo/L-8169-2016	Acuna, Guillermo/0000-0001-8066-2677; Zumsande, Friederike/0000-0002-0902-7619	starting grant (SiMBA) of the European Research Council; Volkswagen Foundation; Center for NanoScience	starting grant (SiMBA) of the European Research Council; Volkswagen Foundation(Volkswagen); Center for NanoScience	We thank A. Gietl, J. J. Schmied, D. Grohmann, T. Liedl, and F. Stefani for fruitful discussion; A. Tiefnig for sample preparation; F. Demming for assistance with the numerical simulations; and S. Carregal Romero for the transmission electron microscopy images. This work was carried out at the NanoBioScience group, Braunschweig University of Technology, and was supported by a starting grant (SiMBA) of the European Research Council, the Volkswagen Foundation, and the Center for NanoScience. Technische Universitat Braunschweig, G.P.A., and P.T. have filed a provisional patent application, EP1260316.1., on the described method of creating hotspots using self-assembled DNA origami.	Acuna GP, 2012, ACS NANO, V6, P3189, DOI 10.1021/nn2050483; Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; Bek A, 2008, NANO LETT, V8, P485, DOI 10.1021/nl072602n; Busson MP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1964; Cang H, 2011, NATURE, V469, P385, DOI 10.1038/nature09698; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Coronado EA, 2011, NANOSCALE, V3, P4042, DOI 10.1039/c1nr10788g; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; Di Fiori N, 2010, BIOPHYS J, V98, P2265, DOI 10.1016/j.bpj.2010.02.008; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Gietl A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks326; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Kuhn S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.017402; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lin HZ, 2012, CHEMPHYSCHEM, V13, P973, DOI 10.1002/cphc.201100743; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI 10.1038/NPHOTON.2010.237; Ringler M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.203002; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Taminiau TH, 2008, NAT PHOTONICS, V2, P234, DOI 10.1038/nphoton.2008.32; Tinnefeld P, 2005, ANGEW CHEM INT EDIT, V44, P2642, DOI 10.1002/anie.200300647; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518	28	507	519	24	566	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					506	510		10.1126/science.1228638	http://dx.doi.org/10.1126/science.1228638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112329				2022-12-24	WOS:000310195800052
J	Tougher, S; Ye, Y; Amuasi, JH; Kourgueni, IA; Thomson, R; Goodman, C; Mann, AG; Ren, RL; Willey, BA; Adegoke, CA; Amin, A; Ansong, D; Bruxvoort, K; Diallo, DA; Diap, G; Festo, C; Johanes, B; Juma, E; Kalolella, A; Malam, O; Mberu, B; Ndiaye, S; Nguah, SB; Seydou, M; Taylor, M; Rueda, ST; Wamukoya, M; Arnold, F; Hanson, K				Tougher, Sarah; Ye, Yazoume; Amuasi, John H.; Kourgueni, Idrissa A.; Thomson, Rebecca; Goodman, Catherine; Mann, Andrea G.; Ren, Ruilin; Willey, Barbara A.; Adegoke, Catherine A.; Amin, Abdinasir; Ansong, Daniel; Bruxvoort, Katia; Diallo, Diadier A.; Diap, Graciela; Festo, Charles; Johanes, Boniface; Juma, Elizabeth; Kalolella, Admirabilis; Malam, Oumarou; Mberu, Blessing; Ndiaye, Salif; Nguah, Samuel B.; Seydou, Moctar; Taylor, Mark; Rueda, Sergio Torres; Wamukoya, Marilyn; Arnold, Fred; Hanson, Kara		ACTwatch Grp	Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data	LANCET			English	Article							GLOBAL SUBSIDY; TANZANIA; ACT	Background Malaria is one of the greatest causes of mortality worldwide. Use of the most effective treatments for malaria remains inadequate for those in need, and there is concern over the emergence of resistance to these treatments. In 2010, the Global Fund launched the Affordable Medicines Facility-malaria (AMFm), a series of national-scale pilot programmes designed to increase the access and use of quality-assured artemisinin based combination therapies (QAACTs) and reduce that of artemisinin monotherapies for treatment of malaria. AMFm involves manufacturer price negotiations, subsidies on the manufacturer price of each treatment purchased, and supporting interventions such as communications campaigns. We present findings on the effect of AMFm on QAACT price, availability, and market share, 6-15 months after the delivery of subsidised ACTs in Ghana, Kenya, Madagascar, Niger, Nigeria, Uganda, and Tanzania (including Zanzibar). Methods We did nationally representative baseline and endpoint surveys of public and private sector outlets that stock antimalarial treatments. QAACTs were identified on the basis of the Global Fund's quality assurance policy. Changes in availability, price, and market share were assessed against specified success benchmarks for 1 year of AMFm implementation. Key informant interviews and document reviews recorded contextual factors and the implementation process. Findings In all pilots except Niger and Madagascar, there were large increases in QAACT availability (25.8-51.9 percentage points), and market share (15.9-40.3 percentage points), driven mainly by changes in the private for-profit sector. Large falls in median price for QAACTs per adult equivalent dose were seen in the private for-profit sector in six pilots, ranging from US$1.28 to $4.82. The market share of oral artemisinin monotherapies decreased in Nigeria and Zanzibar, the two pilots where it was more than 5% at baseline. Interpretation Subsidies combined with supporting interventions can be effective in rapidly improving avail ability, price, and market share of QAACTs, particularly in the private for-profit sector. Decisions about the future of AMFm should also consider the effect on use in vulnerable populations, access to malaria diagnostics, and cost-effectiveness.	[Tougher, Sarah; Thomson, Rebecca; Goodman, Catherine; Mann, Andrea G.; Willey, Barbara A.; Bruxvoort, Katia; Diallo, Diadier A.; Taylor, Mark; Rueda, Sergio Torres; Hanson, Kara] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Amuasi, John H.] Univ Minnesota, Sch Publ Hlth, PhD Program, Div Hlth Policy & Management, Minneapolis, MN USA; [Amuasi, John H.; Ansong, Daniel; Nguah, Samuel B.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Kourgueni, Idrissa A.] Ctr Int Etud & Rech Populat Africaines, Niamey, Niger; [Kourgueni, Idrissa A.; Malam, Oumarou; Seydou, Moctar] Inst Natl Stat, Niamey, Niger; [Diap, Graciela] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Thomson, Rebecca; Bruxvoort, Katia; Festo, Charles; Johanes, Boniface; Kalolella, Admirabilis; Taylor, Mark] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Ansong, Daniel] Kwame Nkrumah Univ Sci & Technol, Dept Child Hlth, Sch Med Sci, Kumasi, Ghana; [Mberu, Blessing] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Ndiaye, Salif] Ctr Rech Dev Humain, Dakar, Senegal; [Juma, Elizabeth] Ctr Global Hlth Res, Kenya Med Res Inst, Nairobi, Kenya; [Taylor, Mark] Univ Exeter, European Ctr Environm & Human Hlth, Sch Med, Exeter EX4 4QJ, Devon, England	University of London; London School of Hygiene & Tropical Medicine; University of Minnesota System; University of Minnesota Twin Cities; Kwame Nkrumah University Science & Technology; Ifakara Health Institute; Kwame Nkrumah University Science & Technology; African Population & Health Research Centre; Kenya Medical Research Institute; University of Exeter	Tougher, S (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	sarah.tougher@lshtm.ac.uk	Nguah, Samuel/AAQ-9725-2020	Wamukoya, Marylene/0000-0002-2900-9178; Amuasi, John/0000-0002-8640-2662; Taylor, Mark/0000-0002-7646-7905; Bruxvoort, Katia/0000-0001-8277-2431; Thomson, Rebecca/0000-0001-9683-9457; Tougher, Sarah/0000-0001-7990-4368; ANSONG, Daniel/0000-0003-1328-9117; Goodman, Catherine/0000-0002-2241-3485	Global Fund; Tuberculosis and Malaria; Bill & Melinda Gates Foundation; Tuberculosis; Malaria; Bill & Melinda Gates Foundation for ACTwatch Central; ACTwatch surveys [058992]; Bill and Melinda Gates Foundation; European Regional Development Fund; European Social Fund Convergence Programme for Cornwall; Isles of Scilly	Global Fund; Tuberculosis and Malaria; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Tuberculosis; Malaria; Bill & Melinda Gates Foundation for ACTwatch Central; ACTwatch surveys; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Regional Development Fund(European Commission); European Social Fund Convergence Programme for Cornwall; Isles of Scilly	The Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Bill & Melinda Gates Foundation.; We thank the large number of people from many different organisations who assisted with data analysis, data processing, and primary data collection. We acknowledge the contributions of Noureddine Abderrahim, Mwenda Gitonga, and David Muturi with data entry programmes; Ronnette Nolasco with project arrangements; Adrienne Keen with support to data analysis and processing, and Barry Dewitt, Dan Hamilton, Zhuzhi Moore, Falgunee Parekh, Yuan Cheng, and Ashley Garley with outlet survey table preparation. We also thank Immo Kleinschmidt, Milly Marston, Neal Alexander, Karim Anaya-Izquierdo and John Bradley for statistical advice; Meghna Ranganathan, Olivia Nuccio, Angela Camilleri, Edna Ogada, Emily Carter, Emily Harris, Tsione Solomon, Yohannes Kinfu, and Iarimalanto Rabary for research assistance; and Ohene Buabeng, Isaac Boakye, Raymond Atiemo Danso and other staff of the Research and Development Unit at Komfo Ankye Teaching Hospital who assisted technically and logistically with the field surveys in Ghana. We thank the following members of the AMFm Secretariat for their advice and support: Melisse Murray, Silas Holland, Fabienne Jourberton, Lloyd Matowe, and Orion Yeandel. Finally, we acknowledge the contribution of all the respondents who participated in the surveys and interviews. The evaluation was funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria, with support from the Bill & Melinda Gates Foundation for ACTwatch Central and ACTwatch surveys in three countries (#058992). Sarah Tougher, Rebecca Thomson, Catherine Goodman, Andrea G Mann, Barbara Willey, Katia Bruxvoort, Sergio Torres Rueda, Kara Hanson, and Benjamin Palafox are members of the LSHTM Malaria Centre. Catherine Goodman, Rebecca Thomson, Katia Bruxvoort, Charles Festo, Boniface Johanes, Admirabilis Kalolella, and Mark Taylor work with the IMPACT2 project, part of the ACT Consortium (http://www.actconsortium.org/) which is funded by the Bill and Melinda Gates Foundation. Mark Taylor now works with the European Centre for Environment and Human Health (part of the University of Exeter Medical School) which is supported by investment from the European Regional Development Fund and the European Social Fund Convergence Programme for Cornwall and the Isles of Scilly.	ACTwatch Group, 2012, ACTWATCH HOUS SURV; ACTwatch Group and Association Beninoise pour le Marketing Social (ABMS)/Benin, 2011, OUTL SURV REP BEN 20; ACTwatch Group and Association Beninoise pour le Marketing Social (ABMS)/Benin, 2009, OUTL SURV REP BEN 20; ACTwatch Group and Population Services International (PSI)/Madagascar, 2009, MAD OUTL SURV 2008 R; ACTwatch Group and Society for Family Health (SFH)/Zambia, 2009, OUTL SURV REP ZAMB 2; ACTwatch Group and Society for Family Health (SFH)/Zambia, 2011, OUTL SURV REP ZAM 20; ACTwatch Group and the Program for Accessible Health CEPU, 2009, UG OUTL SURV 2009 RE; Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; [Anonymous], AFF MED FAC MAL; [Anonymous], 2012, IND EV PHAS 1 AFF ME; [Anonymous], GLOB FUND QUAL ASS P; Craig P., 2008, DEV EVALUATING COMPL; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Government of India Department of Customs, 2009, IND CHEM IMP EXP DAT; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Kamal-Yanni M, 2010, LANCET, V375, P121, DOI 10.1016/S0140-6736(10)60048-7; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Laxminarayan R, 2009, HEALTH AFFAIR, V28, P949, DOI 10.1377/hlthaff.28.4.949; Measure DHS, 2012, DEM HLTH SURV MAL RW; Measure DHS, 2012, MAL IND SURV ANG KEN; Moon S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000106; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Roll Back Malaria, 2011, UPD ACT PRIC AFF MED; Sabot O, 2009, DISTRIBUTION ARTEMIS; Sabot O, 2011, HEALTH POLICY PLANN, V26, P441, DOI 10.1093/heapol/czr067; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Schaferhoff M, 2010, ESTIMATING BENCHMARK; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yadav P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-299; Yamey G, 2012, B WORLD HEALTH ORGAN, V90, P452, DOI 10.2471/BLT.11.091199; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	33	114	115	1	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2012	380	9857					1916	1926		10.1016/S0140-6736(12)61732-2	http://dx.doi.org/10.1016/S0140-6736(12)61732-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23122217				2022-12-24	WOS:000311758500028
J	King, MA; Bingham, RJ; Moore, P; Whitehouse, PL; Bentley, MJ; Milne, GA				King, Matt A.; Bingham, Rory J.; Moore, Phil; Whitehouse, Pippa L.; Bentley, Michael J.; Milne, Glenn A.			Lower satellite-gravimetry estimates of Antarctic sea-level contribution	NATURE			English	Article							GLACIAL ISOSTATIC-ADJUSTMENT; ICE-SHEET; GRACE; RETREAT; DRIVEN; SIGNAL; MODEL	Recent estimates of Antarctica's present-day rate of ice-mass contribution to changes in sea level range from 31 gigatonnes a year (Gt yr(-1); ref. 1) to 246 Gt yr(-1) (ref. 2), a range that cannot be reconciled within formal errors(3). Time-varying rates of mass loss(2,4-6) contribute to this, but substantial technique-specific systematic errors also exist(3). In particular, estimates of secular ice-mass change derived from Gravity Recovery and Climate Experiment (GRACE) satellite data are dominated by significant uncertainty in the accuracy of models of mass change due to glacial isostatic adjustment(7,8) (GIA). Here we adopt a new model of GIA, developed from geological constraints, which produces GIA rates systematically lower than those of previous models, and an improved fit to independent uplift data(9). After applying the model to 99 months (from August 2002 to December 2010) of GRACE data, we estimate a continent-wide ice-mass change of -69 +/- 18 Gt yr(-1) (+0.19 +/- 0.05 mm yr(-1) sea-level equivalent). This is about a third to a half of the most recently published GRACE estimates(2,5), which cover a similar time period but are based on older GIA models. Plausible GIA model uncertainties, and errors relating to removing longitudinal GRACE artefacts ('destriping'), confine our estimate to the range -126 Gt yr(-1) to -29 Gt yr(-1) (0.08-0.35 mm yr(-1) sea-level equivalent). We resolve 26 independent drainage basins and find that Antarctic mass loss, and its acceleration, is concentrated in basins along the Amundsen Sea coast. Outside this region, we find that West Antarctica is nearly in balance and that East Antarctica is gaining substantial mass.	[King, Matt A.; Bingham, Rory J.; Moore, Phil] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [King, Matt A.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Whitehouse, Pippa L.; Bentley, Michael J.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Milne, Glenn A.] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada	Newcastle University - UK; University of Tasmania; Durham University; University of Ottawa	King, MA (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.a.king@newcastle.ac.uk	King, Matt/B-4622-2008; Bentley, Michael J/F-7386-2011	King, Matt/0000-0001-5611-9498; Bentley, Michael J/0000-0002-2048-0019; Whitehouse, Pippa/0000-0002-9092-3444	NERC; RCUK Academic Fellowship; COST Action [ES0701]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs programme; NERC [NE/E007023/1, NE/F014260/1, NE/F01466X/1, NE/E004806/1, NE/F01452X/1] Funding Source: UKRI; Natural Environment Research Council [NE/E004806/1, NE/E007023/1, NE/F01452X/1, NE/F014260/1, NE/F01466X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); RCUK Academic Fellowship(UK Research & Innovation (UKRI)); COST Action(European Cooperation in Science and Technology (COST)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs programme(Canada Research Chairs); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC, and an RCUK Academic Fellowship to M. A. K., and partially supported by COST Action ES0701. G.A.M. acknowledges support from the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chairs programme. We thank E. Ivins for discussions.	Barletta VR, 2008, GEOPHYS J INT, V172, P18, DOI 10.1111/j.1365-246X.2007.03630.x; Bentley MJ, 2010, GEOLOGY, V38, P411, DOI 10.1130/G30754.1; Bevis M, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002642; Chen JL, 2009, NAT GEOSCI, V2, P859, DOI 10.1038/ngeo694; Cheng MK, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003028; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; Gladstone RM, 2012, EARTH PLANET SC LETT, V333, P191, DOI 10.1016/j.epsl.2012.04.022; Gunter B, 2009, J GEODESY, V83, P1051, DOI 10.1007/s00190-009-0323-4; Horwath M, 2009, GEOPHYS J INT, V177, P849, DOI 10.1111/j.1365-246X.2009.04139.x; Ivins ER, 2005, ANTARCT SCI, V17, P541, DOI 10.1017/S0954102005002968; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Mackintosh A, 2011, NAT GEOSCI, V4, P195, DOI 10.1038/NGEO1061; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Purcell A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048624; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Shepherd A, 2007, SCIENCE, V315, P1529, DOI 10.1126/science.1136776; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stammer D, 2011, SURV GEOPHYS, V32, P621, DOI 10.1007/s10712-011-9142-2; Swenson S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025285; Swenson S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005338; Tamisiea ME, 2011, GEOPHYS J INT, V186, P1036, DOI 10.1111/j.1365-246X.2011.05116.x; Tamisiea ME, 2001, J GEOPHYS RES-SOL EA, V106, P30849, DOI 10.1029/2000JB000011; Thomas ID, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049277; Tregoning P, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006161; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Wahr J, 1998, J GEOPHYS RES-SOL EA, V103, P30205, DOI 10.1029/98JB02844; Whitehouse PL, 2012, GEOPHYS J INT, V190, P1464, DOI 10.1111/j.1365-246X.2012.05557.x; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zwally HJ, 2011, SURV GEOPHYS, V32, P351, DOI 10.1007/s10712-011-9123-5	37	138	147	1	102	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					586	+		10.1038/nature11621	http://dx.doi.org/10.1038/nature11621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23086145				2022-12-24	WOS:000311339800050
J	Osmundson, J; Montero-Diez, C; Westblade, LF; Hochschild, A; Darst, SA				Osmundson, Joseph; Montero-Diez, Cristina; Westblade, Lars F.; Hochschild, Ann; Darst, Seth A.			Promoter-Specific Transcription Inhibition in Staphylococcus aureus by a Phage Protein	CELL			English	Article							RNA-POLYMERASE HOLOENZYME; PRIMARY SIGMA-FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ALPHA-SUBUNIT; BACTERIOPHAGE-T7 DNA; RIBOSOME SYNTHESIS; BACTERIAL; RECOGNITION; INITIATION	Phage G1 gp67 is a 23 kDa protein that binds to the Staphylococcus aureus (Sau) RNA polymerase (RNAP) sigma(A) subunit and blocks cell growth by inhibiting transcription. We show that gp67 has little to no effect on transcription from most promoters but is a potent inhibitor of ribosomal RNA transcription. A 2.0-angstrom-resolution crystal structure of the complex between gp67 and Sau sigma(A) domain 4 (sigma(A)(4)) explains how gp67 joins the RNAP promoter complex through sigma(A)(4) without significantly affecting sigma(A)(4) function. Our results indicate that gp67 forms a complex with RNAP at most, if not all, sigma(A)-dependent promoters, but selectively inhibits promoters that depend on an interaction between upstream DNA and the RNAP alpha-subunit C-terminal domain (alpha CTD). Thus, we reveal a promoter-specific transcription inhibition mechanism by which gp67 interacts with the RNAP promoter complex through one subunit (sigma(A)), and selectively affects the function of another subunit (alpha CTD) depending on promoter usage.	[Osmundson, Joseph; Westblade, Lars F.; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA; [Montero-Diez, Cristina; Hochschild, Ann] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Rockefeller University; Harvard University; Harvard Medical School	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	darst@rockefeller.edu			Office of Basic Energy Sciences, U.S. Department of Energy; National Center for Research Resources, National Institutes of Health (NIH) [RR-15301]; NIH [RO1 GM044025, RO1 GM053759]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025, R01GM053759] Funding Source: NIH RePORTER	Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E.A. Campbell, R. Gourse, W. Ross, and P. Deighan for helpful discussions; K.R. Rajashankar and F. Murphy at APS NE-CAT beamline 24ID, and W. Shi at NSLS beamline X3A for support with synchrotron data collection; S. Wigneshweraraj for gifts of plasmids and helpful advice; and C. Zhao and S. Dewell of The Rockefeller University Genomics Resource Center for assistance with RNA-seq. We also thank all members of the Darst and Hochschild laboratories for helpful discussions. This work was based in part on research conducted at the APS and NSLS, supported by the Office of Basic Energy Sciences, U.S. Department of Energy. The NE-CAT beamlines at the APS are supported by award RR-15301 from the National Center for Research Resources, National Institutes of Health (NIH). This work was supported by NIH grants RO1 GM044025 to A. H. and RO1 GM053759 to S. A. D.	Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Datta I, 2005, J BIOCHEM MOL BIOL, V38, P97; Dehbi M, 2009, J BACTERIOL, V191, P3763, DOI 10.1128/JB.00241-09; Deora R, 1996, J BIOL CHEM, V271, P21828, DOI 10.1074/jbc.271.36.21828; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Dove Simon L, 2004, Methods Mol Biol, V261, P231; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Fox K R, 1997, Methods Mol Biol, V90, P1; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Hinton DM, 2005, MICROBIOL-SGM, V151, P1729, DOI 10.1099/mic.0.27972-0; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jain D, 2005, MOL CELL, V19, P259, DOI 10.1016/j.molcel.2005.06.006; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; KADESCH TR, 1982, J MOL BIOL, V155, P1, DOI 10.1016/0022-2836(82)90489-2; KEILTY S, 1987, J BIOL CHEM, V262, P6389; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lambert LJ, 2004, EMBO J, V23, P2952, DOI 10.1038/sj.emboj.7600312; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nechaev S, 2003, ANNU REV MICROBIOL, V57, P301, DOI 10.1146/annurev.micro.57.030502.090942; Nordmann P, 2007, CURR OPIN MICROBIOL, V10, P436, DOI 10.1016/j.mib.2007.07.004; OZOLINE ON, 1995, NUCLEIC ACIDS RES, V23, P4533, DOI 10.1093/nar/23.22.4533; Patikoglou GA, 2007, J MOL BIOL, V372, P649, DOI 10.1016/j.jmb.2007.06.081; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Ptashne M, 1992, GENETIC SWITCH PHAGE; RAO L, 1995, J BACTERIOL, V177, P2609, DOI 10.1128/jb.177.10.2609-2614.1995; Reyes D, 2011, J BACTERIOL, V193, P6020, DOI 10.1128/JB.05436-11; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROSENBERG S, 1982, J MOL BIOL, V155, P31, DOI 10.1016/0022-2836(82)90490-9; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; STEVENS A, 1977, NUCLEIC ACIDS RES, V4, P877, DOI 10.1093/nar/4.4.877; Tiemann B, 2004, J BACTERIOL, V186, P7262, DOI 10.1128/JB.186.21.7262-7272.2004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRAVERS AA, 1984, NUCLEIC ACIDS RES, V12, P2605, DOI 10.1093/nar/12.6.2605; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WADE HE, 1964, BIOCHEM J, V93, P121, DOI 10.1042/bj0930121; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10; Yano ST, 2011, MOL MICROBIOL, V79, P1325, DOI 10.1111/j.1365-2958.2010.07526.x	64	17	19	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1005	1016		10.1016/j.cell.2012.10.034	http://dx.doi.org/10.1016/j.cell.2012.10.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178120	Green Accepted, Bronze			2022-12-24	WOS:000311423500014
J	McCarthy, DP; Donald, PF; Scharlemann, JPW; Buchanan, GM; Balmford, A; Green, JMH; Bennun, LA; Burgess, ND; Fishpool, LDC; Garnett, ST; Leonard, DL; Maloney, RF; Morling, P; Schaefer, HM; Symes, A; Wiedenfeld, DA; Butchart, SHM				McCarthy, Donal P.; Donald, Paul F.; Scharlemann, Joern P. W.; Buchanan, Graeme M.; Balmford, Andrew; Green, Jonathan M. H.; Bennun, Leon A.; Burgess, Neil D.; Fishpool, Lincoln D. C.; Garnett, Stephen T.; Leonard, David L.; Maloney, Richard F.; Morling, Paul; Schaefer, H. Martin; Symes, Andy; Wiedenfeld, David A.; Butchart, Stuart H. M.			Financial Costs of Meeting Global Biodiversity Conservation Targets: Current Spending and Unmet Needs	SCIENCE			English	Article							PROTECTED-AREA; ALLOCATION; RESOURCES; BENEFITS; PROGRESS	World governments have committed to halting human-induced extinctions and safeguarding important sites for biodiversity by 2020, but the financial costs of meeting these targets are largely unknown. We estimate the cost of reducing the extinction risk of all globally threatened bird species (by >= 1 International Union for Conservation of Nature Red List category) to be U. S. $0.875 to $1.23 billion annually over the next decade, of which 12% is currently funded. Incorporating threatened nonavian species increases this total to U. S. $3.41 to $4.76 billion annually. We estimate that protecting and effectively managing all terrestrial sites of global avian conservation significance (11,731 Important Bird Areas) would cost U. S. $65.1 billion annually. Adding sites for other taxa increases this to U. S. $76.1 billion annually. Meeting these targets will require conservation funding to increase by at least an order of magnitude.	[McCarthy, Donal P.; Bennun, Leon A.; Fishpool, Lincoln D. C.; Symes, Andy; Butchart, Stuart H. M.] BirdLife Int, Wellbrook Court, Cambridge CB3 0NA, England; [McCarthy, Donal P.; Donald, Paul F.; Buchanan, Graeme M.; Morling, Paul] RSPB, Sandy SG19 2DL, Beds, England; [Scharlemann, Joern P. W.] United Nations Environm Programme World Conservat, Cambridge CB3 0DL, England; [Scharlemann, Joern P. W.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Balmford, Andrew; Green, Jonathan M. H.; Burgess, Neil D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Green, Jonathan M. H.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Burgess, Neil D.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-1165 Copenhagen, Denmark; [Burgess, Neil D.] World Wildlife Fund, Conservat Sci Program, Washington, DC 20090 USA; [Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Leonard, David L.] Univ Hawaii Manoa, Hawaii Div Forestry & Wildlife, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA; [Maloney, Richard F.] Dept Conservat, Sci & Tech Grp, Christchurch, New Zealand; [Schaefer, H. Martin] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Wiedenfeld, David A.] 12 Fishback Court, Warrenton, VA 20186 USA	BirdLife International; Royal Society for Protection of Birds; University of Sussex; University of Cambridge; Princeton University; University of Copenhagen; World Wildlife Fund; Charles Darwin University; University of Hawaii System; University of Hawaii Manoa; University of Freiburg	Butchart, SHM (corresponding author), BirdLife Int, Wellbrook Court, Cambridge CB3 0NA, England.	stuart.butchart@birdlife.org	Green, Jonathan M H/D-7081-2017; Garnett, Stephen/M-3877-2013; Scharlemann, Jorn/A-4737-2008; Butchart, Stuart/AAJ-1852-2021; Butchart, Stuart HM/Y-2711-2018	Garnett, Stephen/0000-0002-0724-7060; Scharlemann, Jorn/0000-0002-2834-6367; Butchart, Stuart/0000-0002-1140-4049; Donald, Paul F./0000-0003-0023-6200; Green, Jonathan/0000-0002-5003-0203; Balmford, Andrew/0000-0002-0144-3589	Cambridge Conservation Initiative Collaborative Fund for Conservation; Arcadia	Cambridge Conservation Initiative Collaborative Fund for Conservation; Arcadia	This work was supported by the Cambridge Conservation Initiative Collaborative Fund for Conservation and by Arcadia. For helpful comments and assistance, we thank A. Bruner, R. Naidoo, M. Ausden, L. Donaldson, and many other individuals who kindly provided estimates of costs of species conservation or site management; a full list is given in the supplementary materials. All data sources are listed in the supplementary materials.	[Anonymous], 2009, EC ECOSYSTEMS BIODIV; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; BirdLife International, 2004, STAT WORLDS BIRDS 20; BirdLife International, 2011, IUCN RED LIST BIRDS; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Convention on Biological Diversity (CBD), 2011, C PART DEC 10 2 STRA; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Donald P. F., 2010, FACING EXTINCTION WO; Drechsler M, 2011, BIODIVERS CONSERV, V20, P1045, DOI 10.1007/s10531-011-0013-4; Dudley N., 2008, GUIDELINES APPPL PRO; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Foster Matthew N., 2012, Journal of Threatened Taxa, V4, P2733; Gibbs KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035730; IUCN, 2022, IUCN RED LIST THREAT; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Laycock HF, 2011, ECOL ECON, V70, P1789, DOI 10.1016/j.ecolecon.2011.05.002; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Leonard DL, 2008, BIOL CONSERV, V141, P2054, DOI 10.1016/j.biocon.2008.06.001; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; Martin TG, 2012, CONSERV LETT, V5, P274, DOI 10.1111/j.1755-263X.2012.00239.x; McCarthy MA, 2008, J APPL ECOL, V45, P1428, DOI 10.1111/j.1365-2664.2008.01521.x; McKinney ML, 2002, CONSERV BIOL, V16, P539, DOI 10.1046/j.1523-1739.2002.00442.x; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; RTS Resource Ltd, 2012, SOFT DRINKS FACT SHE; UN Environment Programme-Financial Initiative and Principles for Responsible Investment, 2010, UN OWN WHY ENV EXT M; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x	33	393	401	9	326	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					946	949		10.1126/science.1229803	http://dx.doi.org/10.1126/science.1229803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23065904				2022-12-24	WOS:000311083600043
J	Koerte, IK; Ertl-Wagner, B; Reiser, M; Zafonte, R; Shenton, ME				Koerte, Inga K.; Ertl-Wagner, Birgit; Reiser, Maximilian; Zafonte, Ross; Shenton, Martha E.			White Matter Integrity in the Brains of Professional Soccer Players Without a Symptomatic Concussion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Koerte, Inga K.] Harvard Univ, Sch Med, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Ertl-Wagner, Birgit; Reiser, Maximilian] Univ Munich, Inst Clin Radiol, Munich, Germany; [Shenton, Martha E.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Munich; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Koerte, IK (corresponding author), Harvard Univ, Sch Med, Psychiat Neuroimaging Lab, Boston, MA 02115 USA.	ikoerte@bwh.harvard.edu	Ertl-Wagner, Birgit/AAD-5708-2020; Koerte, Inga Katharina/AAW-3031-2021	Ertl-Wagner, Birgit/0000-0002-7896-7049	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078337] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS078337] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024	5	163	164	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1859	1861		10.1001/jama.2012.13735	http://dx.doi.org/10.1001/jama.2012.13735			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150002	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000310952700016
J	Nissen, SE				Nissen, Steven E.			Cardiovascular Effects of Diabetes Drugs: Emerging From the Dark Ages	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MYOCARDIAL-INFARCTION; DEATH; ROSIGLITAZONE; MELLITUS; RISK		Cleveland Clin, Dept Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin, Dept Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org						Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GOLDNER MG, 1971, J AMER MED ASSOC, V218, P1400, DOI 10.1001/jama.218.9.1400; Meier JJ, 2004, HEART, V90, P9, DOI 10.1136/heart.90.1.9; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Schwartz TB, 2004, PERSPECT BIOL MED, V47, P564, DOI 10.1353/pbm.2004.0071; US Food and Drug Administration, 2008, GUID IND DIAB MELL E	11	20	20	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2012	157	9					671	672		10.7326/0003-4819-157-9-201211060-00016	http://dx.doi.org/10.7326/0003-4819-157-9-201211060-00016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033GX	23128866				2022-12-24	WOS:000310783300011
J	Elli, L				Elli, Luca			Where's the evidence for gluten sensitivity?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Osped Maggiore Policlin, Ctr Prevent & Diag Coeliac Dis, Fdn IRCCS Ca Granda, I-20122 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico	Elli, L (corresponding author), Osped Maggiore Policlin, Ctr Prevent & Diag Coeliac Dis, Fdn IRCCS Ca Granda, Via Francesco Sforza 35, I-20122 Milan, Italy.	lucelli@yahoo.com	Elli, Luca/K-6084-2016	Elli, Luca/0000-0002-0873-0759				Elli L, 2003, TOXICOL LETT, V146, P1, DOI 10.1016/j.toxlet.2003.09.004; Enck P, 2010, EUR J GASTROEN HEPAT, V22, P1402, DOI 10.1097/MEG.0b013e3283405a17; Painter K, 2008, US TODAY; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Volta U, 2012, NAT REV GASTRO HEPAT, V9, P295, DOI 10.1038/nrgastro.2012.15	7	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 2	2012	345								e7360	10.1136/bmj.e7360	http://dx.doi.org/10.1136/bmj.e7360			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033FL	23125126				2022-12-24	WOS:000310779500001
J	Godlee, F				Godlee, Fiona			Open letter to Roche about oseltamivir trial data	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; NEURAMINIDASE INHIBITORS; ACUTE INFLUENZA; COMPLICATIONS; EFFICACY; SAFETY					fgodlee@bmj.com						Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016	7	25	25	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2012	345								e7305	10.1136/bmj.e7305	http://dx.doi.org/10.1136/bmj.e7305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033EW	23109484	Bronze			2022-12-24	WOS:000310778000012
J	Park, HY; Man, SFP; Sin, DD				Park, Hye Yun; Man, S. F. Paul; Sin, Don D.			Inhaled corticosteroids for chronic obstructive pulmonary disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; METERED-DOSE INHALER; SHORT-TERM RESPONSE; OF-THE-LITERATURE; SALMETEROL/FLUTICASONE PROPIONATE; SPUTUM-EOSINOPHILIA; FLUTICASONE PROPIONATE; TIOTROPIUM BROMIDE; CLINICAL-TRIAL; DOUBLE-BLIND		[Sin, Don D.] St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart & Lung Hlth, Vancouver, BC V6Z 1Y6, Canada; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Sungkyunkwan University (SKKU); Samsung Medical Center; University of British Columbia	Sin, DD (corresponding author), St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart & Lung Hlth, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	don.sin@hli.ubc.ca	park, hy/O-5934-2014; Sin, Don/AAC-2219-2021					Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Altose MD, 2000, NEW ENGL J MED, V343, P1902; Barnes PJ, 2010, PHARMACEUTICALS, V3, P514, DOI 10.3390/ph3030514; Briggs AH, 2010, EUR RESPIR J, V35, P532, DOI 10.1183/09031936.00153108; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2005, THORAX, V60, P193, DOI 10.1136/thx.2004.032516; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Dal Negro Roberto, 2007, Int J Chron Obstruct Pulmon Dis, V2, P169; Ferguson GT, 2009, CHEST, V136, P1456, DOI 10.1378/chest.08-3016; Foisy MM, 2008, HIV MED, V9, P389, DOI 10.1111/j.1468-1293.2008.00579.x; Johnell O, 2002, EUR RESPIR J, V19, P1058, DOI 10.1183/09031936.02.00276602; Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.200602-244OC; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; National Institute for Health and Clinical Excellence, 2010, CHRON OBSTR PULM DIS; Pizzichini E, 1998, AM J RESP CRIT CARE, V158, P1511, DOI 10.1164/ajrccm.158.5.9804028; Rennard SI, 2009, DRUGS, V69, P549, DOI 10.2165/00003495-200969050-00004; Roland NJ, 2004, CHEST, V126, P213, DOI 10.1378/chest.126.1.213; Sharafkhaneh A, 2012, RESP MED, V106, P257, DOI 10.1016/j.rmed.2011.07.020; Sin DD, 2009, LANCET, V374, P712, DOI 10.1016/S0140-6736(09)61250-2; Singh D, 2008, THORAX, V63, P592, DOI 10.1136/thx.2007.087213; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; Sobieraj DM, 2008, CLIN THER, V30, P1416, DOI 10.1016/j.clinthera.2008.08.004; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin DP, 2008, DRUGS, V68, P1975, DOI 10.2165/00003495-200868140-00004; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC	31	9	10	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2012	345								e6843	10.1136/bmj.e6843	http://dx.doi.org/10.1136/bmj.e6843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028MZ	23100329				2022-12-24	WOS:000310427800008
J	Ramsey, CB; Staff, RA; Bryant, CL; Brock, F; Kitagawa, H; van der Plicht, J; Schlolaut, G; Marshall, MH; Brauer, A; Lamb, HF; Payne, RL; Tarasov, PE; Haraguchi, T; Gotanda, K; Yonenobu, H; Yokoyama, Y; Tada, R; Nakagawa, T				Ramsey, Christopher Bronk; Staff, Richard A.; Bryant, Charlotte L.; Brock, Fiona; Kitagawa, Hiroyuki; van der Plicht, Johannes; Schlolaut, Gordon; Marshall, Michael H.; Brauer, Achim; Lamb, Henry F.; Payne, Rebecca L.; Tarasov, Pavel E.; Haraguchi, Tsuyoshi; Gotanda, Katsuya; Yonenobu, Hitoshi; Yokoyama, Yusuke; Tada, Ryuji; Nakagawa, Takeshi			A Complete Terrestrial Radiocarbon Record for 11.2 to 52.8 kyr BP	SCIENCE			English	Article							C-14 CALIBRATION; ICE CORES; CAL BP; YR BP; CHRONOLOGY	Radiocarbon (C-14) provides a way to date material that contains carbon with an age up to similar to 50,000 years and is also an important tracer of the global carbon cycle. However, the lack of a comprehensive record reflecting atmospheric C-14 prior to 12.5 thousand years before the present (kyr B. P.) has limited the application of radiocarbon dating of samples from the Last Glacial period. Here, we report C-14 results from Lake Suigetsu, Japan (35 degrees 35'N, 135 degrees 53'E), which provide a comprehensive record of terrestrial radiocarbon to the present limit of the C-14 method. The time scale we present in this work allows direct comparison of Lake Suigetsu paleoclimatic data with other terrestrial climatic records and gives information on the connection between global atmospheric and regional marine radiocarbon levels.	[Ramsey, Christopher Bronk; Staff, Richard A.; Brock, Fiona] Univ Oxford, Oxford, England; [Bryant, Charlotte L.] Scottish Univ Environm Res Ctr, Nat Environm Res Council, Radiocarbon Facil, E Kilbride, Lanark, Scotland; [Kitagawa, Hiroyuki] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [van der Plicht, Johannes] Univ Groningen, Groningen, Netherlands; [van der Plicht, Johannes] Leiden Univ, Leiden, Netherlands; [Schlolaut, Gordon; Brauer, Achim] German Res Ctr Geosci, GeoForschungsZentrum, Potsdam, Germany; [Payne, Rebecca L.; Nakagawa, Takeshi] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Marshall, Michael H.; Lamb, Henry F.] Aberystwyth Univ, Aberystwyth, Dyfed, Wales; [Tarasov, Pavel E.] Free Univ Berlin, Berlin, Germany; [Haraguchi, Tsuyoshi] Osaka City Univ, Osaka 558, Japan; [Gotanda, Katsuya] Chiba Univ Commerce, Chiba, Japan; [Yonenobu, Hitoshi] Naruto Univ Educ, Naruto 772, Japan; [Yokoyama, Yusuke; Tada, Ryuji] Univ Tokyo, Tokyo, Japan	University of Oxford; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Nagoya University; University of Groningen; Leiden University; Leiden University - Excl LUMC; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Newcastle University - UK; Aberystwyth University; Free University of Berlin; Osaka Metropolitan University; Naruto University of Education; University of Tokyo	Ramsey, CB (corresponding author), Univ Oxford, Oxford, England.	christopher.ramsey@rlaha.ox.ac.uk	Tarasov, Pavel/ABG-3993-2020; van der Plicht, Johannes/B-9994-2013; Ramsey, Christopher Bronk/A-3277-2012; Yonenobu, Hitoshi/AAB-1500-2021; Ramsey, Christopher Bronk/AAQ-2227-2021; Yokoyama, Yusuke/N-9623-2013; Brock, Fiona/I-4970-2016	Tarasov, Pavel/0000-0002-7219-5009; Ramsey, Christopher Bronk/0000-0002-8641-9309; Yonenobu, Hitoshi/0000-0002-1596-7543; Ramsey, Christopher Bronk/0000-0002-8641-9309; Brock, Fiona/0000-0003-0728-6091; Brauer, Achim/0000-0002-6655-9451; Lamb, Henry Francis/0000-0003-0025-0766; Nakagawa, Takeshi/0000-0003-0831-6803; Staff, Richard/0000-0002-8634-014X; Marshall, Dr Michael/0000-0001-8279-7532	UK Natural Environment Research Council [NE/D000289/1, NE/F003048/1]; Deutsche Forschungsgemeinschaft [BR 2208/7-1, TA 540/3-1]; Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI [21101002]; John Fell Oxford University Press Research Fund; NERC [NRCF010001, NE/F004400/1, NRCF010002, NE/F003056/1, NE/G011001/1, NE/F003048/1] Funding Source: UKRI; Natural Environment Research Council [NE/G011001/1, NRCF010002, NE/F004400/1, NE/F003048/1, NE/F003056/1, NRCF010001] Funding Source: researchfish; Grants-in-Aid for Scientific Research [22500974, 23221002, 23240116] Funding Source: KAKEN	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); John Fell Oxford University Press Research Fund; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project was funded by the UK Natural Environment Research Council (NE/D000289/1 and NE/F003048/1, as well as Radiocarbon Facility support); the Deutsche Forschungsgemeinschaft (BR 2208/7-1 and TA 540/3-1); Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI (21101002); and the John Fell Oxford University Press Research Fund.	Bard E, 2004, QUATERNARY RES, V61, P204, DOI 10.1016/j.yqres.2003.11.006; Brauer A, 1999, QUATERN INT, V61, P17, DOI 10.1016/S1040-6182(99)00014-2; HAJDAS I, 1993, CLIM DYNAM, V9, P107, DOI 10.1007/BF00209748; Hoffmann DL, 2010, EARTH PLANET SC LETT, V289, P1, DOI 10.1016/j.epsl.2009.10.004; Hua Q, 2009, QUATERNARY SCI REV, V28, P2982, DOI 10.1016/j.quascirev.2009.08.013; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Kitagawa H, 1998, SCIENCE, V279, P1187, DOI 10.1126/science.279.5354.1187; Kromer B, 2004, RADIOCARBON, V46, P1203, DOI 10.1017/S0033822200033099; Marshall M., 2012, QUAT GEOCHRONOL; Muscheler R, 2008, NAT GEOSCI, V1, P263, DOI 10.1038/ngeo128; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; Muscheler R., COMMUNICATION; Nakagawa T, 2012, QUATERNARY SCI REV, V36, P164, DOI 10.1016/j.quascirev.2010.12.013; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schlolaut G., 2012, QUAT GEOCHRONOL; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Staff RA, 2010, NUCL INSTRUM METH B, V268, P960, DOI 10.1016/j.nimb.2009.10.074; Staff RA, 2011, RADIOCARBON, V53, P511, DOI 10.1017/S0033822200034627; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; van der Plicht J, 2004, RADIOCARBON, V46, P1225, DOI 10.1017/S0033822200033117	21	178	184	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					370	374		10.1126/science.1226660	http://dx.doi.org/10.1126/science.1226660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087245	Green Published			2022-12-24	WOS:000309955800038
J	Paik, JM; Curhan, GC; Taylor, EN				Paik, Julie M.; Curhan, Gary C.; Taylor, Eric N.			Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARATHYROID CELL-PROLIFERATION; CHRONIC-RENAL-FAILURE; SEX-RELATED INCIDENCE; SERUM-CALCIUM; HORMONE; REPRODUCIBILITY; ROCHESTER; VALIDITY; AGE; QUESTIONNAIRE	Objective To examine the association between calcium intake and risk of primary hyperparathyroidism in women. Design Prospective cohort study. Setting Nurses' Health Study I, which originally recruited participants from the 11 most populous states in the United States. Participants 58 354 female registered nurses enrolled in the Nurses' Health Study I aged 39-66 years in 1986 and with no history of primary hyperparathyroidism. Calcium intake was assessed every four years using semiquantitative questionnaires on food frequency. Main outcome measure Incident primary hyperparathyroidism, confirmed by medical record review. Results During 22 years of follow-up, we recorded 277 incident cases of primary hyperparathyroidism. Women were divided into five equal groups, according to intake of dietary calcium. After adjusting for age, body mass index, race, and other factors, the relative risk of primary hyperparathyroidism for women in the group with the highest intake of dietary calcium was 0.56 (95% confidence interval 0.37 to 0.86, P=0.009 for trend), compared with the group with the lowest intake. The multivariable relative risk of primary hyperparathyroidism for women taking more than 500 mg/day of calcium supplements compared with no calcium supplements was 0.41 (95% confidence interval 0.29 to 0.60, P<0.001 for trend). Analyses restricted to participants with regular physical exams did not significantly change the association between calcium intake and risk of primary hyperparathyroidism. Conclusion Increased calcium intake is independently associated with a reduced risk of primary hyperparathyroidism in women.	[Paik, Julie M.; Curhan, Gary C.; Taylor, Eric N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA 02115 USA; [Paik, Julie M.; Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Curhan, Gary C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Taylor, Eric N.] Maine Med Ctr, Div Nephrol & Transplantat, Portland, ME 04102 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Maine Medical Center	Paik, JM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA 02115 USA.	jmpaik@partners.org			US National Institutes of Health [DK084707, HL092947, DK91417, CA087969]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK091417, F32DK084707] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the US National Institutes of Health grants DK084707, HL092947, DK91417, and CA087969.	ARNOLD A, 1988, NEW ENGL J MED, V318, P658, DOI 10.1056/NEJM198803173181102; ARNOLD A, 1989, J CLIN INVEST, V83, P2034, DOI 10.1172/JCI114114; ARNOLD A, 1995, J CLIN INVEST, V95, P2047, DOI 10.1172/JCI117890; BEARD CM, 1989, ARCH INTERN MED, V149, P1887, DOI 10.1001/archinte.149.8.1887; Bilezikian J P, 2000, Rev Endocr Metab Disord, V1, P237, DOI 10.1023/A:1026508829397; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; DENT CE, 1961, LANCET, V2, P336; INSOGNA KL, 1985, NEW ENGL J MED, V313, P1126, DOI 10.1056/NEJM198510313131805; Jorde R, 2000, J CLIN EPIDEMIOL, V53, P1164, DOI 10.1016/S0895-4356(00)00239-0; Jorde R, 2002, EUR J NUTR, V41, P258, DOI 10.1007/s00394-002-0383-1; Kanesaka Y, 2001, ENDOCRINOLOGY, V142, P407, DOI 10.1210/en.142.1.407; KAO PC, 1992, MAYO CLIN PROC, V67, P637, DOI 10.1016/S0025-6196(12)60717-4; Karp HJ, 2009, BRIT J NUTR, V102, P1341, DOI 10.1017/S0007114509990195; LJUNGHALL S, 1991, SURGERY, V110, P47; Locker FG, 1997, AM J MED, V102, P543, DOI 10.1016/S0002-9343(97)00053-3; Lundgren E, 1997, SURGERY, V121, P287, DOI 10.1016/S0039-6060(97)90357-3; Lundgren E, 2002, WORLD J SURG, V26, P931, DOI 10.1007/s00268-002-6621-0; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Marcocci C, 2011, NEW ENGL J MED, V365, P2389, DOI 10.1056/NEJMcp1106636; McKane WR, 1996, J CLIN ENDOCR METAB, V81, P1699, DOI 10.1210/jc.81.5.1699; Melton LJ, 2002, J BONE MINER RES, V17, pN12; Miedlich S, 2003, CLIN ENDOCRINOL, V59, P539, DOI 10.1046/j.1365-2265.2003.t01-1-01755.x; Miedlich S, 2000, EUR J ENDOCRINOL, V143, P47, DOI 10.1530/eje.0.1430047; Miller BS, 2008, WORLD J SURG, V32, P795, DOI 10.1007/s00268-007-9427-2; NAVEHMANY T, 1989, ENDOCRINOLOGY, V125, P275, DOI 10.1210/endo-125-1-275; NAVEHMANY T, 1995, J CLIN INVEST, V96, P1786, DOI 10.1172/JCI118224; Norman J, 2011, ENDOCR PRACT, V17, P384, DOI 10.4158/EP09346.OR; POTTS JT, 1991, ANN INTERN MED, V114, P593, DOI 10.7326/0003-4819-114-7-593; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Ruda JM, 2005, OTOLARYNG HEAD NECK, V132, P359, DOI 10.1016/j.otohns.2004.10.005; RUTLEDGE R, 1985, SURGERY, V98, P1107; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Shan L, 1997, VIRCHOWS ARCH, V430, P247, DOI 10.1007/BF01324809; Shelby H, 2008, WORLD J SURG, V32, P800, DOI 10.1007/s00268-007-9422-7; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Tordoff MG, 1998, AM J PHYSIOL-REG I, V274, pR214, DOI 10.1152/ajpregu.1998.274.1.R214; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359/JBMR.050910; Wermers RA, 1997, ANN INTERN MED, V126, P433, DOI 10.7326/0003-4819-126-6-199703150-00003; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	42	23	24	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2012	345								e6390	10.1136/bmj.e6390	http://dx.doi.org/10.1136/bmj.e6390			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024WU	23080543	hybrid, Green Submitted, Green Published			2022-12-24	WOS:000310142300001
J	Coste, B				Coste, Bertrand			The Cellular Feeling of Pressure	SCIENCE			English	Editorial Material							CHANNELS; CURRENTS; PIEZO		Res Ctr Neurobiol Neurophysiol Marseilles, Marseille, France		Coste, B (corresponding author), Res Ctr Neurobiol Neurophysiol Marseilles, Marseille, France.							Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253	9	1	1	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103								10.1126/science.1229853	http://dx.doi.org/10.1126/science.1229853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042881				2022-12-24	WOS:000309457400050
J	Keller, KE; Tan, IS; Lee, YS				Keller, Kirstie E.; Tan, Irene S.; Lee, Young-Sam			SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited Conditions	SCIENCE			English	Article							TUMOR; METABOLISM; INHIBITION	Pyruvate kinase isoform M2 (PKM2) plays an important role in the growth and metabolic reprogramming of cancer cells in stress conditions. Here, we report that SAICAR (succinylaminoimidazolecarboxamide ribose-5'-phosphate, an intermediate of the de novo purine nucleotide synthesis pathway) specifically stimulates PKM2. Upon glucose starvation, cellular SAICAR concentration increased in an oscillatory manner and stimulated PKM2 activity in cancer cells. Changes in SAICAR amounts in cancer cells altered cellular energy level, glucose uptake, and lactate production. The SAICAR-PKM2 interaction also promoted cancer cell survival in glucose-limited conditions. SAICAR accumulation was not observed in normal adult epithelial cells or lung fibroblasts, regardless of glucose conditions. This allosteric regulation may explain how cancer cells coordinate different metabolic pathways to optimize their growth in the nutrient-limited conditions commonly observed in the tumor microenvironment.	[Keller, Kirstie E.; Lee, Young-Sam] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Tan, Irene S.] Natl Inst Hlth Johns Hopkins Univ Grad Partnershi, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA	Lee, YS (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.	ylee99@jhu.edu	Lee, Young-Sam/A-2499-2013		Johns Hopkins University Krieger School of Arts and Sciences startup fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231] Funding Source: NIH RePORTER	Johns Hopkins University Krieger School of Arts and Sciences startup fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Coupet, D. Meyer, and E. Pryce for technical assistance; R. Coleman, Y. Wang, C. Arrowsmith, and members of our department for sharing their equipment and materials; and A. Le, E. O'Shea, and members of our department for comments on the manuscript. Supported by Johns Hopkins University Krieger School of Arts and Sciences startup fund to Y.-S.L. The authors declare no conflict of interest.	Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lee P, 2007, PROTEIN EXPRES PURIF, V51, P227, DOI 10.1016/j.pep.2006.07.023; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Macintyre AN, 2011, MOL CELL, V42, P713, DOI 10.1016/j.molcel.2011.06.003; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; SANT ME, 1992, J BIOL CHEM, V267, P11038; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470	17	145	155	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1069	1072		10.1126/science.1224409	http://dx.doi.org/10.1126/science.1224409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23086999	Green Accepted			2022-12-24	WOS:000311390600041
J	Kim, B; Eggel, A; Tarchevskaya, SS; Vogel, M; Prinz, H; Jardetzky, TS				Kim, Beomkyu; Eggel, Alexander; Tarchevskaya, Svetlana S.; Vogel, Monique; Prinz, Heino; Jardetzky, Theodore S.			Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor	NATURE			English	Article							CONFORMATIONAL FLEXIBILITY; DISSOCIATION RATE; CRYSTAL-STRUCTURE; FC; REVEALS; LIGANDS; BINDING; SITE	IgE antibodies bind the high-affinity IgE Fc receptor (Fc epsilon RI), found primarily on mast cells and basophils, and trigger inflammatory cascades of the allergic response(1,2). Inhibitors of IgE-Fc epsilon RI binding have been identified and an anti-IgE therapeutic antibody (omalizumab) is used to treat severe allergic asthma(3,4). However, preformed IgE-Fc epsilon RI complexes that prime cells before allergen exposure dissociate extremely slowly(5) and cannot be disrupted by strictly competitive inhibitors. IgE-Fc conformational flexibility indicated that inhibition could be mediated by allosteric or other non-classical mechanisms(6-8). Here we demonstrate that an engineered protein inhibitor, DARPin E2_79 (refs 9-11), acts through a non-classical inhibition mechanism, not only blocking IgE-Fc epsilon RI interactions, but actively stimulating the dissociation of preformed ligand-receptor complexes. The structure of the E2_79-IgE-Fc(3-4) complex predicts the presence of two non-equivalent E2_79 sites in the asymmetric IgE-Fc epsilon RI complex, with site 1 distant from the receptor and site 2 exhibiting partial steric overlap. Although the structure is indicative of an allosteric inhibition mechanism, mutational studies and quantitative kinetic modelling indicate that E2_79 acts through a facilitated dissociation mechanism at site 2 alone. These results demonstrate that high-affinity IgE-Fc epsilon RI complexes can be actively dissociated to block the allergic response and suggest that protein-protein complexes may be more generally amenable to active disruption by macromolecular inhibitors.	[Kim, Beomkyu; Tarchevskaya, Svetlana S.; Jardetzky, Theodore S.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Eggel, Alexander; Vogel, Monique] Univ Bern, Inst Immunol, CH-3010 Bern, Switzerland; [Prinz, Heino] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Stanford University; University of Bern; Max Planck Society	Jardetzky, TS (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	tjardetz@stanford.edu	Kim, Beomkyu/AAM-7220-2020; Eggel, Alexander/J-8177-2019	Eggel, Alexander/0000-0001-8746-3339	NIH [AI-18939]; American Asthma Foundation; Swiss National Science Foundation [310030_127350]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018939, R37AI038972, R37AI018939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Wurzburg and other past and present members of the Jardetzky Laboratory. This research was supported in part by an NIH research grant (AI-18939) and an American Asthma Foundation Senior Investigator Award as well as the Swiss National Science Foundation grant number 310030_127350 to T.S.J. We also thank C. A. Dahinden and B. M. Stadler and members of their groups for valuable discussions. Furthermore, we thank M. J. Baumann for technical support and Molecular Partners AG, especially P. Amstutz, M. T. Stumpp, P. Forrer and D. Steiner, for placing DARPin libraries at our disposal and providing scientific support.	BASU M, 1993, J BIOL CHEM, V268, P13118; Baumann MJ, 2010, IMMUNOL LETT, V133, P78, DOI 10.1016/j.imlet.2010.07.005; BOULAIN JC, 1982, SCIENCE, V217, P732, DOI 10.1126/science.7100919; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Amato Gennaro, 2006, Treat Respir Med, V5, P393, DOI 10.2165/00151829-200605060-00004; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; Eggel A, 2011, ALLERGY, V66, P961, DOI 10.1111/j.1398-9995.2011.02546.x; Eggel A, 2009, J MOL BIOL, V393, P598, DOI 10.1016/j.jmb.2009.08.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gutfreund H., 1995, KINETICS LIFE SCI RE; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendonsa SD, 2004, ANAL CHEM, V76, P5387, DOI 10.1021/ac049857v; Mirkina I, 2007, IMMUNOL LETT, V109, P120, DOI 10.1016/j.imlet.2007.02.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRINZ H, 1993, J BIOL CHEM, V268, P18580; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; WANG CC, 1988, P NATL ACAD SCI USA, V85, P8400, DOI 10.1073/pnas.85.22.8400; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wiegand TW, 1996, J IMMUNOL, V157, P221; Wright JD, 1998, PROTEIN ENG, V11, P421, DOI 10.1093/protein/11.6.421; Wuezburg B.A., J BIOL CHEM; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Wurzburg BA, 2009, J MOL BIOL, V393, P176, DOI 10.1016/j.jmb.2009.08.012; Zheng L, 2008, BIOCHEM BIOPH RES CO, V375, P619, DOI 10.1016/j.bbrc.2008.08.055	34	78	79	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					613	+		10.1038/nature11546	http://dx.doi.org/10.1038/nature11546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23103871	Green Accepted			2022-12-24	WOS:000311339800056
J	Houllier, F				Houllier, Francois			Bring more rigour to GM research	NATURE			English	Editorial Material							BT COTTON		INRA, Paris, France	INRAE	Houllier, F (corresponding author), INRA, Paris, France.	francois.houllier@paris.inra.fr						[Anonymous], FRANC OGM; Arnich N, 2011, INT J HYG ENVIR HEAL, V214, P271, DOI 10.1016/j.ijheh.2010.12.002; Joly PB, 2007, NATURE, V450, P174, DOI 10.1038/450174a; Lemaire O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000551; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Seralini GE, 2012, FOOD CHEM TOXICOL, V50, P4221, DOI 10.1016/j.fct.2012.08.005; Snell C, 2012, FOOD CHEM TOXICOL, V50, P1134, DOI 10.1016/j.fct.2011.11.048; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050	9	5	9	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					327	327		10.1038/491327a	http://dx.doi.org/10.1038/491327a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	036MY	23151562	Bronze			2022-12-24	WOS:000311031600014
J	Laxminarayan, R; Arrow, K; Jamison, D; Bloom, BR				Laxminarayan, Ramanan; Arrow, Kenneth; Jamison, Dean; Bloom, Barry R.			From Financing to Fevers: Lessons of an Antimalarial Subsidy Program	SCIENCE			English	Editorial Material							MALARIA		[Bloom, Barry R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Laxminarayan, Ramanan] Princeton Univ, Washington, DC 20036 USA; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA; [Arrow, Kenneth] Stanford Univ, Stanford, CA 94305 USA; [Jamison, Dean] Univ Washington, Seattle, WA 98195 USA	Harvard University; Harvard T.H. Chan School of Public Health; Princeton University; Stanford University; University of Washington; University of Washington Seattle	Bloom, BR (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	bbloom@hsph.harvard.edu	Laxminarayan, Ramanan/ABD-5050-2021					Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; AMFm Expert Advisory Group, AMFM GLOB FUND AIDS; [Anonymous], IMCI HDB; [Anonymous], 2001, ANT DRUG COMB THER; [Anonymous], 2012, IND EV PHAS 1 AFF ME; Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Frost LJ, 2008, ACCESS DO GOOD HLTH; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; WHO, WHO URG REG MEAS STO; Yamey G, 2012, B WORLD HEALTH ORGAN, V90, P452, DOI 10.2471/BLT.11.091199; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340	14	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					615	616		10.1126/science.1231010	http://dx.doi.org/10.1126/science.1231010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SM	23118173				2022-12-24	WOS:000310516000034
J	Liao, XY; Lochhead, P; Nishihara, R; Morikawa, T; Kuchiba, A; Yamauchi, M; Imamura, Y; Qian, ZR; Baba, Y; Shima, K; Sun, RF; Nosho, K; Meyerhardt, JA; Giovannucci, E; Fuchs, CS; Chan, AT; Ogino, S				Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Morikawa, Teppei; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Baba, Yoshifumi; Shima, Kaori; Sun, Ruifang; Nosho, Katsuhiko; Meyerhardt, Jeffrey A.; Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.; Ogino, Shuji			Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISLAND METHYLATOR PHENOTYPE; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; MICROSATELLITE INSTABILITY; COLON-CANCER; PERSONALIZED MEDICINE; RANDOMIZED-TRIALS; BRAF MUTATION; RISK; METASTASIS; INHIBITION	BACKGROUND Regular use of aspirin after a diagnosis of colon cancer has been associated with a superior clinical outcome. Experimental evidence suggests that inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2) (also known as cyclooxygenase-2) by aspirin down-regulates phosphatidylinositol 3-kinase (PI3K) signaling activity. We hypothesized that the effect of aspirin on survival and prognosis in patients with cancers characterized by mutated PIK3CA (the phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene) might differ from the effect among those with wild-type PIK3CA cancers. METHODS We obtained data on 964 patients with rectal or colon cancer from the Nurses' Health Study and the Health Professionals Follow-up Study, including data on aspirin use after diagnosis and the presence or absence of PIK3CA mutation. We used a Cox proportional-hazards model to compute the multivariate hazard ratio for death. We examined tumor markers, including PTGS2, phosphorylated AKT, KRAS, BRAF, microsatellite instability, CpG island methylator phenotype, and methylation of long interspersed nucleotide element 1. RESULTS Among patients with mutated-PIK3CA colorectal cancers, regular use of aspirin after diagnosis was associated with superior colorectal cancer-specific survival (multivariate hazard ratio for cancer-related death, 0.18; 95% confidence interval [CI], 0.06 to 0.61; P<0.001 by the log-rank test) and overall survival (multivariate hazard ratio for death from any cause, 0.54; 95% CI, 0.31 to 0.94; P = 0.01 by the log-rank test). In contrast, among patients with wild-type PIK3CA, regular use of aspirin after diagnosis was not associated with colorectal cancer-specific survival (multivariate hazard ratio, 0.96; 95% CI, 0.69 to 1.32; P = 0.76 by the log-rank test; P = 0.009 for interaction between aspirin and PIK3CA variables) or overall survival (multivariate hazard ratio, 0.94; 95% CI, 0.75 to 1.17; P = 0.96 by the log-rank test; P = 0.07 for interaction). CONCLUSIONS Regular use of aspirin after diagnosis was associated with longer survival among patients with mutated-PIK3CA colorectal cancer, but not among patients with wild-type PIK3CA cancer. The findings from this molecular pathological epidemiology study suggest that the PIK3CA mutation in colorectal cancer may serve as a predictive molecular biomarker for adjuvant aspirin therapy. (Funded by The National Institutes of Health and others.)	[Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Sun, Ruifang; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liao, Xiaoyun; Lochhead, Paul; Nishihara, Reiko; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Qian, Zhi Rong; Sun, Ruifang; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Chan, Andrew T.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Giovannucci, Edward; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Baba, Yoshifumi] Kumamoto Univ, Dept Surg Gastroenterol, Kumamoto, Japan; [Shima, Kaori] Kagoshima Univ, Dept Oral Pathol, Kagoshima 890, Japan; [Nosho, Katsuhiko] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Tokyo; Kumamoto University; Kagoshima University; Sapporo Medical University	Chan, AT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St, Boston, MA 02115 USA.	achan@partners.org; shuji_ogino@dfci.harvard.edu	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323; Qian, Zhi rong/0000-0003-1633-4120	National Institutes of Health [P01 CA87969, P01 CA55075, P50 CA127003, R01 CA149222, R01 CA137178, R01 CA151993]; Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Frank Knox Memorial Fellowship at Harvard University; Chief Scientist Office, Scotland; Damon Runyon Clinical Investigator Award; NATIONAL CANCER INSTITUTE [P50CA127003, P01CA087969, R01CA137178, R01CA151993, R01CA149222, P01CA055075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; Chief Scientist Office [CAF/10/15] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Frank Knox Memorial Fellowship at Harvard University; Chief Scientist Office, Scotland; Damon Runyon Clinical Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chief Scientist Office	Supported by grants from the National Institutes of Health (P01 CA87969 and P01 CA55075; P50 CA127003, to Dr. Fuchs; R01 CA149222, to Dr. Meyerhardt; R01 CA137178, to Dr. Chan; and R01 CA151993, to Dr. Ogino), the Bennett Family Fund for Targeted Therapies Research, and the Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; by the Frank Knox Memorial Fellowship at Harvard University and a fellowship from the Chief Scientist Office, Scotland (to Dr. Lochhead); and by a Damon Runyon Clinical Investigator Award (to Dr. Chan).	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dikshit P, 2006, J BIOL CHEM, V281, P29228, DOI 10.1074/jbc.M602629200; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; He YJ, 2009, CLIN CANCER RES, V15, P6956, DOI 10.1158/1078-0432.CCR-09-1165; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Kaur J, 2010, TUMOR BIOL, V31, P623, DOI 10.1007/s13277-010-0078-9; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Lu ML, 2008, CLIN CANCER RES, V14, P3168, DOI 10.1158/1078-0432.CCR-07-4362; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]; Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Uddin S, 2010, INT J CANCER, V126, P382, DOI 10.1002/ijc.24757; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865	40	621	646	6	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2012	367	17					1596	1606		10.1056/NEJMoa1207756	http://dx.doi.org/10.1056/NEJMoa1207756			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	024TO	23094721	Green Accepted, Bronze			2022-12-24	WOS:000310131700006
J	Sainsbury, S; Niesser, J; Cramer, P				Sainsbury, Sarah; Niesser, Juergen; Cramer, Patrick			Structure and function of the initially transcribing RNA polymerase II-TFIIB complex	NATURE			English	Article							TRANSCRIPTION FACTOR IIB; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; PROMOTER CLEARANCE; IN-VIVO; INITIATION; MECHANISM; DNA; ARCHITECTURE	The general transcription factor (TF) IIB is required for RNA polymerase (Pol) II initiation and extends with its B-reader element into the Pol II active centre cleft. Low-resolution structures of the Pol II-TFIIB complex(1,2) indicated how TFIIB functions in DNA recruitment, but they lacked nucleic acids and half of the B-reader, leaving other TFIIB functions(3,4) enigmatic. Here we report crystal structures of the Pol II-TFIIB complex from the yeast Saccharomyces cerevisiae at 3.4 angstrom resolution and of an initially transcribing complex that additionally contains the DNA template and a 6-nucleotide RNA product. The structures reveal the entire B-reader and protein-nucleic acid interactions, and together with functional data lead to a more complete understanding of transcription initiation. TFIIB partially closes the polymerase cleft to position DNA and assist in its opening. The B-reader does not reach the active site but binds the DNA template strand upstream to assist in the recognition of the initiator sequence and in positioning the transcription start site. TFIIB rearranges active-site residues, induces binding of the catalytic metal ion B, and stimulates initial RNA synthesis allosterically. TFIIB then prevents the emerging DNA-RNA hybrid duplex from tilting, which would impair RNA synthesis. When the RNA grows beyond 6 nucleotides, it is separated from DNA and is directed to its exit tunnel by the B-reader loop. Once the RNA grows to 12-13 nucleotides, it clashes with TFIIB, triggering TFIIB displacement and elongation complex formation. Similar mechanisms may underlie all cellular transcription because all eukaryotic and archaeal RNA polymerases use TFIIB-like factors(5), and the bacterial initiation factor sigma has TFIIB-like topology(1,2) and contains the loop region 3.2 that resembles the B-reader loop in location, charge and function(6-8). TFIIB and its counterparts may thus account for the two fundamental properties that distinguish RNA from DNA polymerases: primer-independent chain initiation and product separation from the template.	[Sainsbury, Sarah; Niesser, Juergen; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Sainsbury, Sarah; Niesser, Juergen; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de			Alexander-von-Humboldt Foundation; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960]; CIPSM; NIM; European Research Council; LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; NIM; European Research Council(European Research Council (ERC)European Commission); LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation	We thank C. Bajen, A. Cheung, S. Etzold, F. Hog, D. Kostrewa, N. Pirkl and other members of the Cramer laboratory. Part of this work was performed at the Swiss Light Source (SLS) at the Paul Scherrer Institut, Villigen, Switzerland. S. S. was supported by a postdoctoral fellowship from the Alexander-von-Humboldt Foundation. P. C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM, an Advanced Grant of the European Research Council, the LMUinnovativ project Bioimaging Network, the Jung-Stiftung, and the Vallee Foundation.	Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Fishburn J, 2012, MOL CELL BIOL, V32, P12, DOI 10.1128/MCB.06242-11; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hawkes NA, 1999, J BIOL CHEM, V274, P14337, DOI 10.1074/jbc.274.20.14337; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Naji S, 2008, NUCLEIC ACIDS RES, V36, P676, DOI 10.1093/nar/gkm1086; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; SIKORSKI RS, 1989, GENETICS, V122, P19; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Yang C, 2012, NUCLEIC ACIDS RES, V40, P6495, DOI 10.1093/nar/gks323; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	34	130	132	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					437	U191		10.1038/nature11715	http://dx.doi.org/10.1038/nature11715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23151482	Green Published			2022-12-24	WOS:000313615900059
J	Taniguchi, H; Lu, JT; Huang, ZJ				Taniguchi, Hiroki; Lu, Jiangteng; Huang, Z. Josh			The Spatial and Temporal Origin of Chandelier Cells in Mouse Neocortex	SCIENCE			English	Article							CEREBRAL-CORTEX; NEURONS; INTERNEURON; SPECIFICATION; GENERATION	Diverse gamma-aminobutyric acid-releasing interneurons regulate the functional organization of cortical circuits and derive from multiple embryonic sources. It remains unclear to what extent embryonic origin influences interneuron specification and cortical integration because of difficulties in tracking defined cell types. Here, we followed the developmental trajectory of chandelier cells (ChCs), the most distinct interneurons that innervate the axon initial segment of pyramidal neurons and control action potential initiation. ChCs mainly derive from the ventral germinal zone of the lateral ventricle during late gestation and require the homeodomain protein Nkx2.1 for their specification. They migrate with stereotyped routes and schedule and achieve specific laminar distribution in the cortex. The developmental specification of this bona fide interneuron type likely contributes to the assembly of a cortical circuit motif.	[Taniguchi, Hiroki; Lu, Jiangteng; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu		Huang, Z. Josh/0000-0003-0592-028X	NIH [R01 MH094705]; Japan Science and Technology Agency; Brain and Behavior Research Foundation (NARSAD); Patterson Foundation; Simons Foundation; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094705] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Brain and Behavior Research Foundation (NARSAD)(NARSAD); Patterson Foundation; Simons Foundation; NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank G. Miyoshi for technical advice of fate-mapping experiments and helpful discussion. Support by NIH R01 MH094705. H.T. is a Precursory Research for Embryonic Science and Technology investigator supported by Japan Science and Technology Agency and was supported by a Brain and Behavior Research Foundation (NARSAD) Postdoctoral Fellowship. J.L. is in part supported by a Patterson Foundation Postdoctoral Fellowship. Z.J.H. is supported by the Simons Foundation and a NARSAD Distinguished Investigator award.	ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Inan M, 2012, CEREB CORTEX, V22, P820, DOI 10.1093/cercor/bhr148; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lewis DA, 2011, DEV NEUROBIOL, V71, P118, DOI 10.1002/dneu.20825; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Sussel L, 1999, DEVELOPMENT, V126, P3359; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Szentagothai J, 1974, Neurosci Res Program Bull, V12, P305; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009	20	172	174	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					70	74		10.1126/science.1227622	http://dx.doi.org/10.1126/science.1227622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23180771	Green Accepted			2022-12-24	WOS:000312985800053
J	Savage, PE				Savage, Phillip E.			Algae Under Pressure and in Hot Water	SCIENCE			English	Editorial Material							BIO-OIL; EXTRACTION; BIOMASS		Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Savage, PE (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	psavage@umich.edu	Savage, Phillip/ABC-8765-2021	Savage, Phillip/0000-0002-7902-3744				Akiya N, 2002, CHEM REV, V102, P2725, DOI 10.1021/cr000668w; Berl E, 1944, SCIENCE, V99, P309, DOI 10.1126/science.99.2573.309; Biller P, 2012, BIOFUELS-UK, V3, P603, DOI 10.4155/BFS.12.42; Chakraborty M, 2012, FUEL, V95, P63, DOI 10.1016/j.fuel.2011.10.055; Duan PG, 2011, BIORESOURCE TECHNOL, V102, P1899, DOI 10.1016/j.biortech.2010.08.013; Guan QQ, 2012, ENERG FUEL, V26, P4575, DOI 10.1021/ef3007992; Heilmann SM, 2010, BIOMASS BIOENERG, V34, P875, DOI 10.1016/j.biombioe.2010.01.032; Khan MY, 2012, ENERG FUEL, V26, P6137, DOI 10.1021/ef300935z; Levine RB, 2010, ENERG FUEL, V24, P5235, DOI 10.1021/ef1008314; Patil PD, 2011, BIORESOURCE TECHNOL, V102, P118, DOI 10.1016/j.biortech.2010.06.031; Roussis SG, 2012, ENERG FUEL, V26, P5294, DOI 10.1021/ef300798b; Savage PE, 2010, RSC ENERGY ENVIRON S, P192; Soh L, 2011, GREEN CHEM, V13, P1422, DOI 10.1039/c1gc15068e; Stucki S, 2009, ENERG ENVIRON SCI, V2, P535, DOI 10.1039/b819874h; U.S. Department of Energy, 2010, NAT ALG BIOF TECHN R; Valdez PJ, 2012, BIOMASS BIOENERG, V46, P317, DOI 10.1016/j.biombioe.2012.08.009	16	77	78	1	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1039	1040		10.1126/science.1224310	http://dx.doi.org/10.1126/science.1224310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180853				2022-12-24	WOS:000311390600032
J	Cheng, JK				Cheng, Jennifer K.			Confronting the Social Determinants of Health - Obesity, Neglect, and Inequity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital	Cheng, JK (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA.							Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Murtagh L, 2011, JAMA-J AM MED ASSOC, V306, P206, DOI 10.1001/jama.2011.903; Waldfogel J, 1998, ARCH PEDIAT ADOLESC, V8, P104; Wilkinson RG, 2003, SOCIAL DETERMINANTS	4	21	21	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					1976	1977		10.1056/NEJMp1209420	http://dx.doi.org/10.1056/NEJMp1209420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040RI	23171094	Bronze			2022-12-24	WOS:000311340200004
J	Fukunaga, R; Han, BW; Hung, JH; Xu, J; Weng, ZP; Zamore, PD				Fukunaga, Ryuya; Han, Bo W.; Hung, Jui-Hung; Xu, Jia; Weng, Zhiping; Zamore, Phillip D.			Dicer Partner Proteins Tune the Length of Mature miRNAs in Flies and Mammals	CELL			English	Article							DOUBLE-STRANDED-RNA; SMALL-INTERFERING RNA; SMALL SILENCING RNAS; ENDOGENOUS SIRNAS; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; MICRORNA MATURATION; SOMATIC-CELLS; MOUSE OOCYTES; DROSOPHILA	Drosophila Dicer-1 produces microRNAs (miRNAs) from pre-miRNA, whereas Dicer-2 generates small interfering RNAs (siRNAs) from long dsRNA. Alternative splicing of the loquacious (loqs) mRNA generates three distinct Dicer partner proteins. To understand the function of each, we constructed flies expressing Loqs-PA, Loqs-PB, or Loqs-PD. Loqs-PD promotes both endo-and exo-siRNA production by Dicer-2. Loqs-PA or Loqs-PB is required for viability, but the proteins are not fully redundant: a specific subset of miRNAs requires Loqs-PB. Surprisingly, Loqs-PB tunes where Dicer-1 cleaves pre-miR-307a, generating a longer miRNA isoform with a distinct seed sequence and target specificity. The longer form of miR-307a represses glycerol kinase and taranis mRNA expression. The mammalian Dicer-partner TRBP, a Loqs-PB homolog, similarly tunes where Dicer cleaves pre-miR-132. Thus, Dicer-binding partner proteins change the choice of cleavage site by Dicer, producing miRNAs with target specificities different from those made by Dicer alone or Dicer bound to alternative protein partners.	[Fukunaga, Ryuya; Han, Bo W.; Zamore, Phillip D.] Univ Massachusetts, Howard Hughes Med Inst, Sch Med, Worcester, MA 01605 USA; [Fukunaga, Ryuya; Han, Bo W.; Zamore, Phillip D.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA; [Hung, Jui-Hung; Xu, Jia; Weng, Zhiping] Univ Massachusetts, Program Bioinformat & Integrat Biol, Sch Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Howard Hughes Med Inst, Sch Med, 364 Plantat St, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Fukunaga, Ryuya/AAK-8609-2020; Zamore, Phillip D/A-8941-2013; Hung, Jui-Hung/G-2673-2012; Xu, Jia/F-7750-2012	Fukunaga, Ryuya/0000-0002-5814-8206; Hung, Jui-Hung/0000-0003-2208-9213; Xu, Jia/0000-0003-3921-018X; Zamore, Phillip/0000-0002-4505-9618; Han, Bo/0000-0001-9501-8702	National Institutes of Health [GM62862, GM65236]; JSPS; Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R37GM062862, R01GM062862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Haruhiko and Mikiko Siomi for strains and antibodies; Richard Carthew, Qinghua Liu, and the Bloomington Stock Center for strains; Ganes Sen and Robert Braun for MEF cells; Ian MacRae for human Dicer plasmid; Lin Wang and Lauren Dedow for RNA-Seq library protocols; Chengjian Li for help with small RNA libraries; Wei Wang for bioinformatics help; Alicia Boucher, Cindy Tipping, and Shengmei Ma for fly husbandry; and Traci Hall, Gang Lu, and members of the Zamore laboratory for discussion, advice, and comments on the manuscript. This work was supported in part by the National Institutes of Health (GM62862 and GM65236) and a JSPS Research Fellowship for Research Abroad and a Charles A. King Trust Postdoctoral Fellowship to R. F. P. D. Z. is a member of the scientific advisory board of Regulus Therapeutics.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Miyoshi K, 2010, RNA, V16, P506, DOI 10.1261/rna.1952110; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Ye XC, 2007, J BIOL CHEM, V282, P28373, DOI 10.1074/jbc.M705208200; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684; Zhou R, 2009, RNA, V15, P1886, DOI 10.1261/rna.1611309	62	139	141	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					533	546		10.1016/j.cell.2012.09.027	http://dx.doi.org/10.1016/j.cell.2012.09.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23063653	Green Accepted, Bronze			2022-12-24	WOS:000310529300011
J	Kannan, K; Vazquez-Laslop, N; Mankin, AS				Kannan, Krishna; Vazquez-Laslop, Nora; Mankin, Alexander S.			Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI RIBOSOMES; ERYTHROMYCIN RESISTANCE; NASCENT PEPTIDE; TRANSFER-RNA; TRANSLATION ELONGATION; MOLECULAR-MECHANISM; STRUCTURAL INSIGHT; HMR 3647; ANTIBIOTICS	The polypeptide exit tunnel is an important functional compartment of the ribosome where the newly synthesized proteins are surveyed. The tunnel is the target of clinically important macrolide antibiotics. Macrolides plug the tunnel and are believed to stop production of all proteins. Contrary to this view, we show that drug-bound ribosomes can synthesize a distinct subset of cellular polypeptides. The structure of a protein defines its ability to thread through the antibiotic-obstructed tunnel. Synthesis of certain polypeptides that initially bypass translational arrest can be stopped at later stages of elongation while translation of some proteins goes to completion. Our findings reveal that small-molecule effectors can accentuate the discriminatory properties of the ribosomal exit tunnel and that macrolide antibiotics reshape the cellular proteome rather than block global protein synthesis.	[Kannan, Krishna; Vazquez-Laslop, Nora; Mankin, Alexander S.] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mankin, AS (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol, 900 S Ashland Ave, Chicago, IL 60607 USA.	shura@uic.edu		Kannan, Krishna/0000-0002-2301-7900	National Science Foundation [MCB-0824739]; Div Of Molecular and Cellular Bioscience [0824739] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Anusha Rethi Paul Raj, Dorota Klepacki, Anna Ochabowicz, and Jacqueline M. LaMarre for help with experiments, Teymur Kazakov for advice, Prabha Fernandez for providing solithromycin and CEM-112, and Kirk Hevener for advice on using Chimera software. We are grateful to Peter Moore, Harry Noller, and Ada Yonath for their comments on the manuscript. This work was supported by grant MCB-0824739 from the National Science Foundation.	Ackermann G, 2003, J ANTIMICROB CHEMOTH, V51, P497, DOI 10.1093/jac/dkg123; ANDERSSON S, 1987, BIOCHIMIE, V69, P901, DOI 10.1016/0300-9084(87)90218-5; APIRION D, 1967, J MOL BIOL, V30, P255; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; BROCK TD, 1959, BIOCHIM BIOPHYS ACTA, V33, P274, DOI 10.1016/0006-3002(59)90535-9; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; DOUTHWAITE S, 1989, J MOL BIOL, V209, P655, DOI 10.1016/0022-2836(89)93000-3; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; ENNIS HL, 1972, ANTIMICROB AGENTS CH, V1, P197, DOI 10.1128/AAC.1.3.197; ETTAYEBI M, 1985, J BACTERIOL, V162, P551, DOI 10.1128/JB.162.2.551-557.1985; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Fulle S, 2009, J MOL BIOL, V387, P502, DOI 10.1016/j.jmb.2009.01.037; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; GRAHAM MY, 1979, J BACTERIOL, V137, P1464, DOI 10.1128/JB.137.3.1464-1467.1979; Hamilton-Miller JMT, 1998, J ANTIMICROB CHEMOTH, V41, P649, DOI 10.1093/jac/41.6.649; HARDESTY B, 1990, BIOCHIM BIOPHYS ACTA, V1050, P197, DOI 10.1016/0167-4781(90)90166-Y; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; HORINOUCHI S, 1980, P NATL ACAD SCI-BIOL, V77, P7079, DOI 10.1073/pnas.77.12.7079; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lovmar M, 2006, J BIOL CHEM, V281, P6742, DOI 10.1074/jbc.M511918200; Lovmar M, 2009, EMBO J, V28, P736, DOI 10.1038/emboj.2009.17; Mankin AS, 2008, CURR OPIN MICROBIOL, V11, P414, DOI 10.1016/j.mib.2008.08.003; MAYFORD M, 1989, J MOL BIOL, V206, P69, DOI 10.1016/0022-2836(89)90524-X; MENNINGER JR, 1994, MOL GEN GENET, V243, P225, DOI 10.1007/BF00280320; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Moore SD, 2008, P NATL ACAD SCI USA, V105, P18261, DOI 10.1073/pnas.0810357105; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; ODOM OW, 1991, EUR J BIOCHEM, V198, P713, DOI 10.1111/j.1432-1033.1991.tb16071.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oleinick N.L., 1975, ANTIBIOTICS, P397; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; OTAKA T, 1975, P NATL ACAD SCI USA, V72, P2649, DOI 10.1073/pnas.72.7.2649; Peltz SW, 2009, RNA BIOL, V6, P329, DOI 10.4161/rna.6.3.8953; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Ramu H, 2009, MOL MICROBIOL, V71, P811, DOI 10.1111/j.1365-2958.2008.06576.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Starosta AL, 2010, CHEM BIOL, V17, P504, DOI 10.1016/j.chembiol.2010.04.008; TAI PC, 1974, BIOCHEMISTRY-US, V13, P4653, DOI 10.1021/bi00719a029; TAUBMAN S B, 1963, Antimicrob Agents Chemother (Bethesda), V161, P395; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Tenson T, 1997, J BIOL CHEM, V272, P17425, DOI 10.1074/jbc.272.28.17425; Tenson T, 1996, P NATL ACAD SCI USA, V93, P5641, DOI 10.1073/pnas.93.11.5641; Tenson T, 2001, PEPTIDES, V22, P1661, DOI 10.1016/S0196-9781(01)00501-0; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; VAZQUEZ D, 1966, BIOCHIM BIOPHYS ACTA, V114, P289, DOI 10.1016/0005-2787(66)90310-8; Vazquez D., 1979, INHIBITORS PROTEIN B; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Vazquez-Laslop N, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P377; Vazquez-Laslop N, 2011, P NATL ACAD SCI USA, V108, P10496, DOI 10.1073/pnas.1103474108; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797; Yao S, 2008, MOL MICROBIOL, V69, P1439, DOI 10.1111/j.1365-2958.2008.06370.x; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Zaporojets D, 2003, J BACTERIOL, V185, P6921, DOI 10.1128/JB.185.23.6921-6927.2003; Zhanel George G, 2002, Expert Opin Pharmacother, V3, P277	70	105	106	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					508	520		10.1016/j.cell.2012.09.018	http://dx.doi.org/10.1016/j.cell.2012.09.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101624	Bronze			2022-12-24	WOS:000310529300009
J	Ferriman, A				Ferriman, Annabel			Finding the smoking gun: a speech by Richard Peto	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 24	2012	345								e7119	10.1136/bmj.e7119	http://dx.doi.org/10.1136/bmj.e7119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028MY	23097544				2022-12-24	WOS:000310427600016
J	Vo, TT; Ryan, J; Carrasco, R; Neuberg, D; Rossi, DJ; Stone, RM; DeAngelo, DJ; Frattini, MG; Letai, A				Thanh-Trang Vo; Ryan, Jeremy; Carrasco, Ruben; Neuberg, Donna; Rossi, Derrick J.; Stone, Richard M.; DeAngelo, Daniel J.; Frattini, Mark G.; Letai, Anthony			Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; BH3 MIMETIC ABT-737; BCL-2 FAMILY; BH3-ONLY PROTEINS; CYTOCHROME-C; APOPTOSIS; DEATH; MCL-1; BAX; INHIBITOR	Despite decades of successful use of cytotoxic chemotherapy in acute myelogenous leukemia (AML), the biological basis for its differential success among individuals and for the existence of a therapeutic index has remained obscure. Rather than taking a genetic approach favored by many, we took a functional approach to ask how differential mitochondrial readiness for apoptosis ("priming") might explain individual variation in clinical behavior. We found that mitochondrial priming measured by BH3 profiling was a determinant of initial response to induction chemotherapy, relapse after remission, and requirement for allogeneic bone marrow transplantation. Differential priming between malignant myeloblasts and normal hematopoietic stem cells supports a mitochondrial basis to the therapeutic index for chemotherapy. BH3 profiling identified BCL-2 inhibition as a targeted strategy likely to have a useful therapeutic index. BH3 profiling refines predictive information provided by conventional biomarkers currently in use and thus may itself have utility as a clinical predictive biomarker.	[Thanh-Trang Vo; Letai, Anthony] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Thanh-Trang Vo; Ryan, Jeremy; Carrasco, Ruben; Neuberg, Donna; Stone, Richard M.; DeAngelo, Daniel J.; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA; [Frattini, Mark G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Letai, A (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	anthony_letai@dfci.harvard.edu		Ryan, Jeremy/0000-0002-3327-1283	NIH [F31 CA150562, P01 CA139980, R01CA129974]; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [F31CA150562, P01CA139980, R01CA129974] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge support from the following sources: NIH grants F31 CA150562, P01 CA139980, and R01CA129974, Gabrielle's Angel Foundation for Cancer Research. A. L. is a Leukemia and Lymphoma Society Scholar. We thank Abbott Laboratories for providing ABT-737. We thank Martha Wadleigh, MD, and Ilene Galinsky, RN, and the Pasquarello Tissue Bank for help with clinical data and samples. A. L. was a cofounder and formerly served on the scientific advisory board of Eutropics Pharmaceuticals, which has a license for BH3 profiling.	Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Brunelle JK, 2009, J CELL BIOL, V187, P429, DOI 10.1083/jcb.200904049; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lacombe F, 1997, LEUKEMIA, V11, P1878, DOI 10.1038/sj.leu.2400847; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Sekeres Mikkael A, 2002, Curr Oncol Rep, V4, P403, DOI 10.1007/s11912-002-0034-y; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	37	251	272	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					344	355		10.1016/j.cell.2012.08.038	http://dx.doi.org/10.1016/j.cell.2012.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063124	Green Accepted, Bronze			2022-12-24	WOS:000309981000013
J	Joynt, KE; Blumenthal, DM; Orav, EJ; Resnic, FS; Jha, AK				Joynt, Karen E.; Blumenthal, Daniel M.; Orav, E. John; Resnic, Frederic S.; Jha, Ashish K.			Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR DATA REGISTRY; MORTALITY RISK PREDICTION; UNINTENDED CONSEQUENCES; HEART-ASSOCIATION; BYPASS-SURGERY; MANAGEMENT; UPDATE	Context Public reporting of patient outcomes is an important tool to improve quality of care, but some observers worry that such efforts will lead clinicians to avoid high-risk patients. Objective To determine whether public reporting for percutaneous coronary intervention (PCI) is associated with lower rates of PCI for patients with acute myocardial infarction (MI) or with higher mortality rates in this population. Design, Setting, and Patients Retrospective observational study conducted using data from fee-for-service Medicare patients (49 660 from reporting states and 48 142 from nonreporting states) admitted with acute MI to US acute care hospitals between 2002 and 2010. Logistic regression was used to compare PCI and mortality rates between reporting states (New York, Massachusetts, and Pennsylvania) and regional nonreporting states (Maine, Vermont, New Hampshire, Connecticut, Rhode Island, Maryland, and Delaware). Changes in PCI rates over time in Massachusetts compared with nonreporting states were also examined. Main Outcome Measures Risk-adjusted PCI and mortality rates. Results In 2010, patients with acute MI were less likely to receive PCI in public reporting states than in nonreporting states (unadjusted rates, 37.7% vs 42.7%, respectively; risk-adjusted odds ratio [OR], 0.82 [95% CI, 0.71-0.93]; P=.003). Differences were greatest among the 6708 patients with ST-segment elevation MI (61.8% vs 68.0%; OR, 0.73 [95% CI, 0.59-0.89]; P=.002) and the 2194 patients with cardiogenic shock or cardiac arrest (41.5% vs 46.7%; OR, 0.79 [95% CI, 0.64-0.98]; P=.03). There were no differences in overall mortality among patients with acute MI in reporting vs nonreporting states. In Massachusetts, odds of PCI for acute MI were comparable with odds in nonreporting states prior to public reporting (40.6% vs 41.8%; OR, 1.00 [95% CI, 0.71-1.41]). However, after implementation of public reporting, odds of undergoing PCI in Massachusetts decreased compared with nonreporting states (41.1% vs 45.6%; OR, 0.81 [95% CI, 0.47-1.38]; P=.03 for difference in differences). Differences were most pronounced for the 6081 patients with cardiogenic shock or cardiac arrest (prereporting: 44.2% vs 36.6%; OR, 1.40 [95% CI, 0.85-2.32]; postreporting: 43.9% vs 44.8%; OR, 0.92 [95% CI, 0.38-2.22]; P=.03 for difference in differences). Conclusions Among Medicare beneficiaries with acute MI, the use of PCI was lower for patients treated in 3 states with public reporting of PCI outcomes compared with patients treated in 7 regional control states without public reporting. However, there was no difference in overall acute MI mortality between states with and without public reporting. JAMA. 2012;308(14):1460-1468 www.jama.com	[Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Joynt, Karen E.; Resnic, Frederic S.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA; [Blumenthal, Daniel M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Massachusetts General Hospital	Joynt, KE (corresponding author), 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			National Heart, Lung, and Blood Institute [1K23HL109177-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this study was provided by grant 1K23HL109177-01 from the National Heart, Lung, and Blood Institute.	Apolito RA, 2008, AM HEART J, V155, P267, DOI 10.1016/j.ahj.2007.10.013; Burack JH, 1999, ANN THORAC SURG, V68, P1195, DOI 10.1016/S0003-4975(99)00907-8; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Moscucci M, 2005, J AM COLL CARDIOL, V45, P1759, DOI 10.1016/j.jacc.2005.01.055; Narins CR, 2005, ARCH INTERN MED, V165, P83, DOI 10.1001/archinte.165.1.83; Omoigui NA, 1996, CIRCULATION, V93, P27, DOI 10.1161/01.CIR.93.1.27; Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Resnic FS, 2011, J AM COLL CARDIOL, V57, P904, DOI 10.1016/j.jacc.2010.09.057; Resnic FS, 2009, J AM COLL CARDIOL, V53, P825, DOI 10.1016/j.jacc.2008.11.034; Ritley D, 2011, STATE CARDIAC REVASC; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wright RS, 2011, CIRCULATION, V123, P2022, DOI 10.1161/CIR.0b013e31820f2f3e	16	153	155	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1460	1468		10.1001/jama.2012.12922	http://dx.doi.org/10.1001/jama.2012.12922			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047360	Green Accepted			2022-12-24	WOS:000309579300025
J	Walden, AP; Bonten, MJ; Wise, MP				Walden, Andrew P.; Bonten, Marc J.; Wise, Matt P.			Should selective digestive decontamination be used in critically ill patients?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE UNITS; TRACT; OROPHARYNX		[Walden, Andrew P.] Royal Berkshire Hosp, Wantage OX12 8HG, England; [Bonten, Marc J.] Univ Med Ctr, Utrecht, Netherlands; [Wise, Matt P.] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales	Royal Berkshire Hospital; Utrecht University; Utrecht University Medical Center; Cardiff University	Walden, AP (corresponding author), Royal Berkshire Hosp, Wantage OX12 8HG, England.	apwalden@hotmail.com		Wise, Matt/0000-0002-2763-4316				Bastin AJ, 2009, ANAESTHESIA, V64, P46, DOI 10.1111/j.1365-2044.2008.05676.x; Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; Cuthbertson BH, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-117; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; de Smet AMGA, 2011, LANCET INFECT DIS, V11, P372, DOI 10.1016/S1473-3099(11)70035-4; de Smet AMGA, 2009, INTENS CARE MED, V35, P1609, DOI 10.1007/s00134-009-1554-9; GASTINNE H, 1992, NEW ENGL J MED, V326, P594, DOI 10.1056/NEJM199202273260903; Health Protection Agency, 2012, ENGL NAT POINT PREV; Julius Center, UMC UTR R GNOSIS; Liberati A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000022.pub3; Lingnau W, 1998, J HOSP INFECT, V39, P195, DOI 10.1016/S0195-6701(98)90258-4; Melsen WG, 2011, CRIT CARE MED, V39, P2736, DOI 10.1097/CCM.0b013e3182281f33; Muscedere JG, 2008, J CRIT CARE, V23, P5, DOI 10.1016/j.jcrc.2007.11.012; Oostdijk EAN, 2010, AM J RESP CRIT CARE, V181, P452, DOI 10.1164/rccm.200908-1210OC; Rello J, 2010, INTENS CARE MED, V36, P773, DOI 10.1007/s00134-010-1841-5	15	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2012	345								e6697	10.1136/bmj.e6697	http://dx.doi.org/10.1136/bmj.e6697			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TA	23047967				2022-12-24	WOS:000309907100011
J	Chang, JC; Lockner, DA; Reches, Z				Chang, J. C.; Lockner, D. A.; Reches, Z.			Rapid Acceleration Leads to Rapid Weakening in Earthquake-Like Laboratory Experiments	SCIENCE			English	Article							RUPTURE; SLIP; GOUGE; LUBRICATION; FRACTURE; POWDER; ZONE	After nucleation, a large earthquake propagates as an expanding rupture front along a fault. This front activates countless fault patches that slip by consuming energy stored in Earth's crust. We simulated the slip of a fault patch by rapidly loading an experimental fault with energy stored in a spinning flywheel. The spontaneous evolution of strength, acceleration, and velocity indicates that our experiments are proxies of fault-patch behavior during earthquakes of moment magnitude (M-w) = 4 to 8. We show that seismically determined earthquake parameters (e.g., displacement, velocity, magnitude, or fracture energy) can be used to estimate the intensity of the energy release during an earthquake. Our experiments further indicate that high acceleration imposed by the earthquake's rupture front quickens dynamic weakening by intense wear of the fault zone.	[Chang, J. C.; Reches, Z.] Univ Oklahoma, Norman, OK 73019 USA; [Lockner, D. A.] US Geol Survey, Menlo Pk, CA 94022 USA	University of Oklahoma System; University of Oklahoma - Norman; United States Department of the Interior; United States Geological Survey	Reches, Z (corresponding author), Univ Oklahoma, 100 E Boyd St, Norman, OK 73019 USA.	reches@ou.edu		Chang, Jefferson/0000-0002-1258-589X	NSF [0732715, 1045414, NEHRP2011, G11AP20008]	NSF(National Science Foundation (NSF))	We thank J. Young, J. Fineberg, and E. Aharonov, and T. Shimamoto and two anonymous reviewers for their thoughtful reviews. This work was supported by NSF Geosciences awards 0732715 and 1045414 and NEHRP2011 award G11AP20008.	Andrews DJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003191; Fukuyama E, 2010, INT J FRACTURE, V163, P15, DOI 10.1007/s10704-009-9417-5; Goldsby DL, 2011, SCIENCE, V334, P216, DOI 10.1126/science.1207902; GRADY DE, 1985, J APPL PHYS, V58, P1210, DOI 10.1063/1.336139; Han R, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006136; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; Kanamori H, 2006, GEOPHYS MONOGR SER, V170, P3, DOI 10.1029/170GM03; LOCKNER DA, 1983, J GEOPHYS RES, V88, P4313, DOI 10.1029/JB088iB05p04313; Niemeijer A, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008181; Ohnaka M, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2000JB000123; OHNAKA M, 1989, J GEOPHYS RES-SOLID, V94, P4089, DOI 10.1029/JB094iB04p04089; OKUBO PG, 1981, GEOPHYS RES LETT, V8, P887, DOI 10.1029/GL008i008p00887; OLGAARD DL, 1983, INT J ROCK MECH MIN, V20, P11, DOI 10.1016/0148-9062(83)91610-8; Reches Z, 2005, EARTH PLANET SC LETT, V235, P361, DOI 10.1016/j.epsl.2005.04.009; Reches Z, 2010, NATURE, V467, P452, DOI 10.1038/nature09348; Sone H, 2009, NAT GEOSCI, V2, P705, DOI 10.1038/NGEO637; Tinti E, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003644; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Wilson B, 2005, NATURE, V434, P749, DOI 10.1038/nature03433; Wornyoh EYA, 2007, J TRIBOL-T ASME, V129, P438, DOI 10.1115/1.2647859	20	47	49	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					101	105		10.1126/science.1221195	http://dx.doi.org/10.1126/science.1221195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042892				2022-12-24	WOS:000309457400062
J	Yamaguchi, S; Hong, K; Liu, R; Shen, L; Inoue, A; Diep, D; Zhang, K; Zhang, Y				Yamaguchi, Shinpei; Hong, Kwonho; Liu, Rui; Shen, Li; Inoue, Azusa; Diep, Dinh; Zhang, Kun; Zhang, Yi			Tet1 controls meiosis by regulating meiotic gene expression	NATURE			English	Article							PRIMORDIAL GERM-CELLS; DNA METHYLATION; EPIGENETIC EVENTS; MAMMALIAN DNA; MOUSE; MICE; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; SPECIFICATION; PLURIPOTENCY	Meiosis is a germ-cell-specific cell division process through which haploid gametes are produced for sexual reproduction(1). Before the initiation of meiosis, mouse primordial germ cells undergo a series of epigenetic reprogramming steps(2,3), including the global erasure of DNA methylation at the 5-position of cytosine (5mC) in CpG-rich DNA(4,5). Although several epigenetic regulators, such as Dnmt3l and the histone methyltransferases G9a and Prdm9, have been reported to be crucial for meiosis(6), little is known about how the expression of meiotic genes is regulated and how their expression contributes to normal meiosis. Using a loss-of-function approach in mice, here we show that the 5mC-specific dioxygenase Tet1 has an important role in regulating meiosis in mouse oocytes. Tet1 deficiency significantly reduces female germ-cell numbers and fertility. Univalent chromosomes and unresolved DNA double-strand breaks are also observed in Tet1-deficient oocytes. Tet1 deficiency does not greatly affect the genome-wide demethylation that takes place in primordial germ cells, but leads to defective DNA demethylation and decreased expression of a subset of meiotic genes. Our study thus establishes a function for Tet1 in meiosis and meiotic gene activation in female germ cells.	[Liu, Rui; Diep, Dinh; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Yamaguchi, Shinpei; Hong, Kwonho; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Hong, Kwonho; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Hong, Kwonho; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, K (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	kzhang@bioeng.ucsd.edu; yzhang@genetics.med.harvard.edu	Yamaguchi, Shinpei/HCH-5553-2022; Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; Zhang, Yi/0000-0002-2789-0811; Hong, Kwonho/0000-0001-7479-4091; Yamaguchi, Shinpei/0000-0002-9377-4835	National Institutes of Health [U01DK089565]; CIRM [BRB3-05083];  [R01GM097253]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wang and W. Jiang for FACS sorting, A. Adey and J. Shendure for sharing reagents and protocols for Tn5mC-seq, and H.-L. Fung for Illumina sequencing. This work was partially supported by U01DK089565 (National Institutes of Health) (to Y.Z.), R01GM097253 and CIRM BRB3-05083 (to K.Z.). Y.Z. is an Investigator of the Howard Hughes Medical Institute. D.D. is a CIRM-UCSD pre-doctoral fellow.	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/nmeth.1871, 10.1038/NMETH.1871]; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Kouznetsova A, 2005, J CELL SCI, V118, P2271, DOI 10.1242/jcs.02362; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takada Y, 2011, DEVELOPMENT, V138, P4207, DOI 10.1242/dev.064444; Wang H, 2006, J CELL BIOL, V173, P485, DOI 10.1083/jcb.200512077; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934	29	196	207	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					443	+		10.1038/nature11709	http://dx.doi.org/10.1038/nature11709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23151479	Green Submitted, Green Accepted			2022-12-24	WOS:000312488200059
J	Murray, B				Murray, Barbara			Liverpool care pathway: doctors have always aimed to ease distress in dying	BRITISH MEDICAL JOURNAL			English	Editorial Material									Manor Med Practice, Stockport SK1 3PZ, Lancs, England		Murray, B (corresponding author), Manor Med Practice, Stockport SK1 3PZ, Lancs, England.	barby@doctors.org.uk						European Federation of National Associations of Orthopaedics and Traumatology, 2012, CONSENSUS STATEMENT; General Medical Council, 2010, TREATM CAR END LIFE; Marie Curie Palliative Care Institute Liverpool, 2010, WHAT IS LIV CAR PATH; Morrow A., 2009, WHAT IS HOSPICE COMF; National Institute for Health and Clinical Excellence, 2010, PALL CAR NEEDS	5	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 14	2012	345								e7606	10.1136/bmj.e7606	http://dx.doi.org/10.1136/bmj.e7606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040PZ	23152571				2022-12-24	WOS:000311336400008
J	Zhang, F; Wang, J; Xu, J; Zhang, Z; Koppetsch, BS; Schultz, N; Vreven, T; Meignin, C; Davis, I; Zamore, PD; Weng, ZP; Theurkauf, WE				Zhang, Fan; Wang, Jie; Xu, Jia; Zhang, Zhao; Koppetsch, Birgit S.; Schultz, Nadine; Vreven, Thom; Meignin, Carine; Davis, Ilan; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			UAP56 Couples piRNA Clusters to the Perinuclear Transposon Silencing Machinery	CELL			English	Article							MESSENGER-RNA EXPORT; DROSOPHILA-MELANOGASTER; MAGO NASHI; AXIS SPECIFICATION; CRYSTAL-STRUCTURE; NUCLEAR EXPORT; VASA PROTEIN; GERM PLASM; LOCALIZATION; HELICASE	piRNAs silence transposons during germline development. In Drosophila, transcripts from heterochromatic clusters are processed into primary piRNAs in the perinuclear nuage. The nuclear DEAD box protein UAP56 has been previously implicated in mRNA splicing and export, whereas the DEAD box protein Vasa has an established role in piRNA production and localizes to nuage with the piRNA binding PIWI proteins Ago3 and Aub. We show that UAP56 colocalizes with the cluster-associated HP1 variant Rhino, that nuage granules containing Vasa localize directly across the nuclear envelope from cluster foci containing UAP56 and Rhino, and that cluster transcripts immunoprecipitate with both Vasa and UAP56. Significantly, a charge-substitution mutation that alters a conserved surface residue in UAP56 disrupts colocalization with Rhino, germline piRNA production, transposon silencing, and perinuclear localization of Vasa. We therefore propose that UAP56 and Vasa function in a piRNA-processing compartment that spans the nuclear envelope.	[Wang, Jie; Xu, Jia; Vreven, Thom; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Zhang, Fan; Zhang, Zhao; Koppetsch, Birgit S.; Schultz, Nadine; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Cell & Dev Dynam, Worcester, MA 01655 USA; [Zhang, Fan; Zhang, Zhao; Koppetsch, Birgit S.; Schultz, Nadine; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Meignin, Carine] Univ Strasbourg, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, CNRS, F-67084 Strasbourg, France; [Davis, Ilan] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Zamore, Phillip D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA.	zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Xu, Jia/F-7750-2012; Zamore, Phillip D/A-8941-2013	Xu, Jia/0000-0003-3921-018X; Theurkauf, William/0000-0001-7342-1912; Meignin, Carine/0000-0002-6588-9045; Davis, Ilan/0000-0002-5385-3053; Zamore, Phillip/0000-0002-4505-9618	NIH [HD049116]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Thanks to members of the Theurkauf and Weng labs for critical discussions and constructive criticisms, to Dr. Paul Lasko for antibodies, and to the Bloomington Drosophila Stock Center for strains. Special thanks to Melissa Moore for sharing her insights into DEAD box proteins. This work was supported by NIH grant HD049116.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Britten RJ, 2010, P NATL ACAD SCI USA, V107, P19945, DOI 10.1073/pnas.1014330107; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Eberl DF, 1997, GENETICS, V146, P951; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; EDDY EM, 1975, INT REV CYTOL, V43, P229; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAY B, 1990, DEVELOPMENT, V109, P425; Hedges DJ, 2011, ADV GENET, V73, P219, DOI 10.1016/B978-0-12-380860-8.00006-9; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jang JK, 2003, J CELL SCI, V116, P3069, DOI 10.1242/jcs.00614; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Ma HH, 2012, MOL CELL PROTEOMICS, V11, P501, DOI 10.1074/mcp.O111.016246; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meignin C, 2008, DEV BIOL, V315, P89, DOI 10.1016/j.ydbio.2007.12.004; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Mohr SE, 2001, GENE DEV, V15, P2886; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Newmark PA, 1997, DEVELOPMENT, V124, P3197; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Shen HH, 2009, BMB REP, V42, P185, DOI 10.5483/BMBRep.2009.42.4.185; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Siomi MC, 2010, SEMIN CELL DEV BIOL, V21, P754, DOI 10.1016/j.semcdb.2010.01.011; Updike DL, 2011, J CELL BIOL, V192, P939, DOI 10.1083/jcb.201010104; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006	49	158	165	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					871	884		10.1016/j.cell.2012.09.040	http://dx.doi.org/10.1016/j.cell.2012.09.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141543	Bronze, Green Accepted			2022-12-24	WOS:000310921200017
J	Farago, M; Rosenbluh, C; Tevlin, M; Fraenkel, S; Schlesinger, S; Masika, H; Gouzman, M; Teng, G; Schatz, D; Rais, Y; Hanna, JH; Mildner, A; Jung, S; Mostoslavsky, G; Cedar, H; Bergman, Y				Farago, Marganit; Rosenbluh, Chaggai; Tevlin, Maya; Fraenkel, Shira; Schlesinger, Sharon; Masika, Hagit; Gouzman, Masha; Teng, Grace; Schatz, David; Rais, Yoach; Hanna, Jacob H.; Mildner, Alexander; Jung, Steffen; Mostoslavsky, Gustavo; Cedar, Howard; Bergman, Yehudit			Clonal allelic predetermination of immunoglobulin-kappa rearrangement	NATURE			English	Article							B-CELL DEVELOPMENT; ASYNCHRONOUS REPLICATION; IN-VITRO; MATURE B; GENES; EXPRESSION; TRANSCRIPTION; INACTIVATION; LYSINE-4; MICE	Although most genes are expressed biallelically, a number of key genomic sites-including immune and olfactory receptor regions-are controlled monoallelically in a stochastic manner, with some cells expressing the maternal allele and others the paternal allele in the target tissue(1,2). Very little is known about how this phenomenon is regulated and programmed during development. Here, using mouse immunoglobulin-kappa (Ig kappa) as a model system, we demonstrate that although individual haematopoietic stem cells are characterized by allelic plasticity, early lymphoid lineage cells become committed to the choice of a single allele, and this decision is then stably maintained in a clonal manner that predetermines monoallelic rearrangement in B cells. This is accompanied at the molecular level by underlying allelic changes in asynchronous replication timing patterns at the kappa locus. These experiments may serve to define a new concept of stem cell plasticity.	[Farago, Marganit; Rosenbluh, Chaggai; Tevlin, Maya; Fraenkel, Shira; Schlesinger, Sharon; Masika, Hagit; Gouzman, Masha; Cedar, Howard; Bergman, Yehudit] Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Teng, Grace; Schatz, David] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Schatz, David] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Rais, Yoach; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Mildner, Alexander; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Dept Med, Boston, MA 02118 USA	Hebrew University of Jerusalem; Yale University; Howard Hughes Medical Institute; Yale University; Weizmann Institute of Science; Weizmann Institute of Science; Boston University	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, POB 12272, IL-91120 Jerusalem, Israel.	cedar@mail.huji.ac.il; Yehudit.Bergman@huji.ac.il	mildner, alexander/AFK-2161-2022; Hanna, Jacob/K-1339-2012; Mildner, Alexander/ABG-6122-2020; mildner, alexander/GQA-3761-2022; mildner, alexander/AAF-9451-2022; Schatz, David/A-6748-2013; Jung, Steffen/K-1409-2012; Schlesinger, Sharon/A-5283-2016	mildner, alexander/0000-0002-2019-8427; Hanna, Jacob/0000-0003-2042-9974; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Schatz, David/0000-0002-5669-1176; Jung, Steffen/0000-0003-4290-5716; Schlesinger, Sharon/0000-0001-9549-2383; Mostoslavsky, Gustavo/0000-0002-0784-2169	Israel Academy of Sciences; National Institutes of Health; Israel Cancer Research Foundation; European Community	Israel Academy of Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Cancer Research Foundation; European Community(European Commission)	We thank M. Nussenzweig for providing the Ig kappa<SUP>m/h</SUP> mice, A. Waisman for providing the IiMOG-marked ES cells, A. G. Fisher and V. Azuara for guiding us through the replication timing analysis by S-phase fractionation assay, M. Inlay for coaching us on the purification and culturing of MPPs and CLPs, A. Wutz for providing some of the single-cell clones, Y. Smith for image analysis and L. Dempsey for sharing ideas. This work was supported by research grants from the Israel Academy of Sciences (H.C., Y.B.), National Institutes of Health (Y.B.), the Israel Cancer Research Foundation (H.C., Y.B.), the European Community 5th Framework Quality of Life Program (Y.B.), Lew Sanders (H.C.) and Norton Herrick (H.C.).	Alexander MK, 2007, J CELL BIOL, V179, P269, DOI 10.1083/jcb.200706053; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Fitzsimmons SP, 2007, J IMMUNOL, V179, P5264, DOI 10.4049/jimmunol.179.8.5264; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Goren A, 2003, NAT REV MOL CELL BIO, V4, P25, DOI 10.1038/nrm1008; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gribnau J, 2005, J CELL BIOL, V168, P365, DOI 10.1083/jcb.200405117; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Ikawa M, 1999, CURR TOP DEV BIOL, V44, P1; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Lande-Diner L, 2005, NAT REV GENET, V6, P648, DOI 10.1038/nrg1639; Lande-Diner L, 2009, MOL CELL, V34, P767, DOI 10.1016/j.molcel.2009.05.027; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Liu XD, 1999, MOL IMMUNOL, V36, P461, DOI 10.1016/S0161-5890(99)00065-6; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; Ramirez J, 2010, CURR OPIN IMMUNOL, V22, P177, DOI 10.1016/j.coi.2010.02.003; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150	36	34	34	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					561	+		10.1038/nature11496	http://dx.doi.org/10.1038/nature11496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23023124				2022-12-24	WOS:000310196200047
J	Beaglehole, R; Bonita, R; Horton, R; Ezzati, M; Bhala, N; Amuyunzu-Nyamongo, M; Mwatsama, M; Reddy, KS				Beaglehole, Robert; Bonita, Ruth; Horton, Richard; Ezzati, Majid; Bhala, Neeraj; Amuyunzu-Nyamongo, Mary; Mwatsama, Modi; Reddy, K. Srinath			Measuring progress on NCDs: one goal and five targets	LANCET			English	Editorial Material							CHRONIC DISEASES; CARDIOVASCULAR-DISEASE; INCOME COUNTRIES; MIDDLE-INCOME; PREVENTION; HEALTH; PROGRAMS; POLICIES; ALCOHOL; REDUCE		[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1142, New Zealand; [Horton, Richard] The Lancet, London NW1 7BY, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Bhala, Neeraj] Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Amuyunzu-Nyamongo, Mary] Consortium NCD Prevent & Control Sub Saharan Afri, Nairobi, Kenya; [Mwatsama, Modi] Natl Heart Forum, London, England; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	University of Auckland; Imperial College London; University of Birmingham; Public Health Foundation of India	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1142, New Zealand.			Reddy, K Srinath/0000-0003-3416-3548; Bhala, Neeraj/0000-0003-2502-1177	Medical Research Council [G0801056B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abascal W, 2012, LANCET; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], SMOKEFREE 2025; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Joint WHO/FAO Expert Consultation on Diet Nutrition and the Prevention of Chronic Diseases, 2002, DIET NUTRITION AND T; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; MacMahon S, 2005, LANCET, V365, P1108; Malta DC, 2012, LANCET, V380, P195, DOI 10.1016/S0140-6736(12)61041-1; Mehta S, 2014, EUR J PREV CARDIOL, V21, P192, DOI 10.1177/2047487312462150; Mendez D, 2012, TOB CONTROL, DOI [10.1136/tobaccocontrol-2011-050147, DOI 10.1136/T0BACCOCONTROL-2011-050147]; Sadler K, 2011, NATIONAL DIET AND NU; UN General Assembly, 2011, UNITED NATIONS A 66; WHO, 2012, 65TH WORLD HEALTH AS; WHO, 2012, MONITORING FRAMEWORK; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	20	65	70	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2012	380	9850					1283	1285		10.1016/S0140-6736(12)61692-4	http://dx.doi.org/10.1016/S0140-6736(12)61692-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	23063272				2022-12-24	WOS:000309931400004
J	Tornqvist, B; Stromberg, C; Persson, G; Nilsson, M				Tornqvist, Bjorn; Stromberg, Cecilia; Persson, Gunnar; Nilsson, Magnus			Effect of intended intraoperative cholangiography and early detection of bile duct injury on survival after cholecystectomy: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							HEPATIC-ARTERY INJURY; LAPAROSCOPIC CHOLECYSTECTOMY; VOLUME; STRICTURES; LESIONS; LEAKS; RISK	Objectives To determine whether the routine use of intraoperative cholangiography can improve survival from complications related to bile duct injuries. Design Population based cohort study. Setting Prospectively collected data from the Swedish national registry of gallstone surgery and endoscopic retrograde cholangiopancreatography, GallRiks. Multivariate analysis done by Cox regression. Population All cholecystectomies recorded in GallRiks between 1 May 2005 and 31 December 2010. Main outcome measures Evidence of bile duct injury, rate of intended use of intraoperative cholangiography, and rate of survival after cholecytectomy. Results During the study, 51 041 cholecystectomies were registered in GallRiks and 747 (1.5%) iatrogenic bile duct injuries identified. Patients with bile duct injuries had an impaired survival compared with those without injury (mortality at one year 3.9% v 1.1%). Kaplan-Meier analysis showed that early detection of a bile duct injury, during the primary operation, improved survival. The intention to use intraoperative cholangiography reduced the risk of death after cholecystectomy by 62% (hazard ratio 0.38 (95% confidence interval 0.31 to 0.46)). Conclusions The high incidence of bile duct injury recorded is probably from GallRiks' ability to detect the entire range of injury severities, from minor ductal lesions to complete transections of major ducts. Patients with bile duct injury during cholecystectomy had impaired survival, and early detection of the injury improved survival. The intention to perform an intraoperative cholangiography reduced the risk of death after cholecystectomy.	[Tornqvist, Bjorn; Stromberg, Cecilia; Nilsson, Magnus] Karolinska Univ Hosp, Dept Surg Gastroenterol, SE-14186 Stockholm, Sweden; [Tornqvist, Bjorn; Stromberg, Cecilia; Nilsson, Magnus] Karolinska Univ Hosp, Karolinska Inst, CLINTEC, Div Surg, SE-14186 Stockholm, Sweden; [Persson, Gunnar] Ryhov Hosp, Dept Surg, Jonkoping, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Tornqvist, B (corresponding author), Karolinska Univ Hosp, Dept Surg Gastroenterol, SE-14186 Stockholm, Sweden.	bjorn.tornqvist@karolinska.se		Nilsson, Magnus/0000-0002-6215-8132; Stromberg, Cecilia/0000-0003-0843-7920				Alves A, 2003, ANN SURG, V238, P93, DOI 10.1097/01.sla.0000074983.39297.c5; Archer SB, 2001, ANN SURG, V234, P549, DOI 10.1097/00000658-200110000-00014; Bektas H, 2007, BRIT J SURG, V94, P1119, DOI 10.1002/bjs.5752; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741; Bismuth H, 2001, WORLD J SURG, V25, P1241, DOI 10.1007/s00268-001-0102-8; Connor S, 2006, BRIT J SURG, V93, P158, DOI 10.1002/bjs.5266; Dolan JP, 2005, SURG ENDOSC, V19, P967, DOI 10.1007/s00464-004-8942-6; Eisenstein S, 2008, ARCH SURG-CHICAGO, V143, P1178, DOI 10.1001/archsurg.143.12.1178; Flum DR, 2003, JAMA-J AM MED ASSOC, V290, P2168, DOI 10.1001/jama.290.16.2168; Flum DR, 2003, JAMA-J AM MED ASSOC, V289, P1639, DOI 10.1001/jama.289.13.1639; Flum DR, 2001, ARCH SURG-CHICAGO, V136, P1287, DOI 10.1001/archsurg.136.11.1287; Giger UF, 2006, J AM COLL SURGEONS, V203, P723, DOI 10.1016/j.jamcollsurg.2006.07.018; GOUMA DJ, 1994, J AM COLL SURGEONS, V178, P229; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Lillemoe KD, 1997, ANN SURG, V225, P459, DOI 10.1097/00000658-199705000-00003; Murphy MM, 2010, J AM COLL SURGEONS, V211, P73, DOI 10.1016/j.jamcollsurg.2010.02.050; Patti M G, 1998, J Gastrointest Surg, V2, P186, DOI 10.1016/S1091-255X(98)80011-5; Persson G, 2011, GALLRIKS ANN REPORT; Persson G, 2010, GALLRIKS ANN REPORT; Pinkas H, 2008, HEPATOB PANCREAT DIS, V7, P628; Richardson MC, 1996, BRIT J SURG, V83, P1356, DOI 10.1002/bjs.1800831009; Savader SJ, 1997, ANN SURG, V225, P268, DOI 10.1097/00000658-199703000-00005; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SIEWERT JR, 1994, CHIRURG, V65, P748; Stewart L, 2004, J GASTROINTEST SURG, V8, P523, DOI 10.1016/j.gassur.2004.02.010; STRASBERG SM, 1995, J AM COLL SURGEONS, V180, P101; Tornqvist B, 2009, CLIN GASTROENTEROL H, V7, P1013, DOI 10.1016/j.cgh.2009.05.014; Tzovaras G, 2001, HPB (Oxford), V3, P165, DOI 10.1080/136518201317077189; Waage A, 2006, ARCH SURG-CHICAGO, V141, P1207, DOI 10.1001/archsurg.141.12.1207	29	132	135	3	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 11	2012	345								e6457	10.1136/bmj.e6457	http://dx.doi.org/10.1136/bmj.e6457			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021TI	23060654	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000309907900001
J	Pacheco, AR; Curtis, MM; Ritchie, JM; Munera, D; Waldor, MK; Moreira, CG; Sperandio, V				Pacheco, Alline R.; Curtis, Meredith M.; Ritchie, Jennifer M.; Munera, Diana; Waldor, Matthew K.; Moreira, Cristiano G.; Sperandio, Vanessa			Fucose sensing regulates bacterial intestinal colonization	NATURE			English	Article							PHOSPHATE-TRANSPORT SYSTEM; ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; CARBON NUTRITION; MEMBRANE-PROTEIN; UHP GENES; GROWTH; INDUCTION; MG1655; MUCIN	The mammalian gastrointestinal tract provides a complex and competitive environment for the microbiota(1). Successful colonization by pathogens requires scavenging nutrients, sensing chemical signals, competing with the resident bacteria and precisely regulating the expression of virulence genes(2). The gastrointestinal pathogen enterohaemorrhagic Escherichia coli (EHEC) relies on inter-kingdom chemical sensing systems to regulate virulence gene expression(3,4). Here we show that these systems control the expression of a novel two-component signal transduction system, named FusKR, where FusK is the histidine sensor kinase and FusR the response regulator. FusK senses fucose and controls expression of virulence and metabolic genes. This fucose-sensing system is required for robust EHEC colonization of the mammalian intestine. Fucose is highly abundant in the intestine(5). Bacteroides theta-iotaomicron produces multiple fucosidases that cleave fucose from host glycans, resulting in high fucose availability in the gut lumen(6). During growth in mucin, B. thetaiotaomicron contributes to EHEC virulence by cleaving fucose from mucin, thereby activating the FusKR signalling cascade, modulating the virulence gene expression of EHEC. Our findings suggest that EHEC uses fucose, a host-derived signal made available by the microbiota, to modulate EHEC pathogenicity and metabolism.	[Pacheco, Alline R.; Curtis, Meredith M.; Moreira, Cristiano G.; Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Pacheco, Alline R.; Curtis, Meredith M.; Moreira, Cristiano G.; Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Ritchie, Jennifer M.; Munera, Diana; Waldor, Matthew K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sperandio, V (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	vanessa.sperandio@utsouthwestern.edu	Moreira, Cristiano/D-8694-2014; Moreira, Cristiano Gallina/AHB-1469-2022	Moreira, Cristiano/0000-0002-0689-4119; Moreira, Cristiano Gallina/0000-0002-0689-4119; Ritchie, Jennifer/0000-0002-1244-3082	National Institutes of Health (NIH) [AI053067, AI77853, AI077613]; Burroughs Wellcome Fund; NIH [AI42347, 5 T32 AI7520-14]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053067, R01AI077613, R37AI042347, T32AI007520, R01AI042347, U01AI077853] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Kendall for comments. We thank the microarray core facility. This work was supported by the National Institutes of Health (NIH) Grants AI053067, AI77853 and AI077613, and the Burroughs Wellcome Fund (to V. S.) and NIH Grant AI42347 and HHMI (to M. K. W.). M. M. C. was supported through NIH Training Grant 5 T32 AI7520-14. The contents are solely the responsibility of the authors and do not represent the official views of the NIH NIAID.	Autieri SM, 2007, INFECT IMMUN, V75, P5465, DOI 10.1128/IAI.00822-07; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CHEN YM, 1987, J BACTERIOL, V169, P3712, DOI 10.1128/jb.169.8.3712-3719.1987; CHEN YM, 1987, MOL GEN GENET, V210, P331, DOI 10.1007/BF00325702; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Fox JT, 2009, J ANIM SCI, V87, P1304, DOI 10.2527/jas.2008-1166; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; ISLAND MD, 1992, J BACTERIOL, V174, P2754, DOI 10.1128/JB.174.9.2754-2762.1992; Janausch IG, 2004, MICROBIOL-SGM, V150, P877, DOI 10.1099/mic.0.26900-0; JASWAL VMS, 1988, BIOCHEM MED METAB B, V39, P105, DOI 10.1016/0885-4505(88)90064-3; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Reading NC, 2010, MICROBIOL-SGM, V156, P1167, DOI 10.1099/mic.0.033027-0; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Ritchie K. M., 1989, INFECT IMMUN, V71, P7129; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sharp FC, 2007, INFECT IMMUN, V75, P2432, DOI 10.1128/IAI.02003-06; Snider TA, 2009, VET MICROBIOL, V136, P150, DOI 10.1016/j.vetmic.2008.10.033; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2000, TRENDS MICROBIOL, V8, P544, DOI 10.1016/S0966-842X(00)01896-5; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; WESTON LA, 1987, J BACTERIOL, V169, P3546, DOI 10.1128/jb.169.8.3546-3555.1987; WESTON LA, 1988, J BACTERIOL, V170, P3375, DOI 10.1128/jb.170.8.3375-3383.1988; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; ZHU Y, 1986, J MOL EVOL, V23, P259, DOI 10.1007/BF02115582	38	316	327	8	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					113	+		10.1038/nature11623	http://dx.doi.org/10.1038/nature11623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23160491	Green Accepted, Green Submitted			2022-12-24	WOS:000311893400056
J	Kjer-Nielsen, L; Patel, O; Corbett, AJ; Le Nours, J; Meehan, B; Liu, LG; Bhati, M; Chen, ZJ; Kostenko, L; Reantragoon, R; Williamson, NA; Purcell, AW; Dudek, NL; McConville, MJ; O'Hair, RAJ; Khairallah, GN; Godfrey, DI; Fairlie, DP; Rossjohn, J; McCluskey, J				Kjer-Nielsen, Lars; Patel, Onisha; Corbett, Alexandra J.; Le Nours, Jerome; Meehan, Bronwyn; Liu, Ligong; Bhati, Mugdha; Chen, Zhenjun; Kostenko, Lyudmila; Reantragoon, Rangsima; Williamson, Nicholas A.; Purcell, Anthony W.; Dudek, Nadine L.; McConville, Malcolm J.; O'Hair, Richard A. J.; Khairallah, George N.; Godfrey, Dale I.; Fairlie, David P.; Rossjohn, Jamie; McCluskey, James			MR1 presents microbial vitamin B metabolites to MAIT cells	NATURE			English	Article							INVARIANT T-CELLS; CRYSTAL-STRUCTURE; ANTIGEN PRESENTATION; SELECTION	Antigen-presenting molecules, encoded by the major histocompatibility complex (MHC) and CD1 family, bind peptide- and lipid-based antigens, respectively, for recognition by T cells. Mucosal-associated invariant T (MAIT) cells are an abundant population of innate-like T cells in humans that are activated by an antigen(s) bound to the MHC class I-like molecule MR1. Although the identity of MR1-restricted antigen(s) is unknown, it is present in numerous bacteria and yeast. Here we show that the structure and chemistry within the antigen-binding cleft of MR1 is distinct from the MHC and CD1 families. MR1 is ideally suited to bind ligands originating from vitamin metabolites. The structure of MR1 in complex with 6-formyl pterin, a folic acid (vitamin B9) metabolite, shows the pterin ring sequestered within MR1. Furthermore, we characterize related MR1-restricted vitamin derivatives, originating from the bacterial riboflavin (vitamin B2) biosynthetic pathway, which specifically and potently activate MAIT cells. Accordingly, we show that metabolites of vitamin B represent a class of antigen that are presented by MR1 for MAIT-cell immunosurveillance. As many vitamin biosynthetic pathways are unique to bacteria and yeast, our data suggest that MAIT cells use these metabolites to detect microbial infection.	[Kjer-Nielsen, Lars; Corbett, Alexandra J.; Meehan, Bronwyn; Chen, Zhenjun; Kostenko, Lyudmila; Reantragoon, Rangsima; Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Patel, Onisha; Le Nours, Jerome; Bhati, Mugdha; Purcell, Anthony W.; Dudek, Nadine L.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Liu, Ligong; Fairlie, David P.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Williamson, Nicholas A.; Purcell, Anthony W.; Dudek, Nadine L.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Metabol Australia, Parkville, Vic 3010, Australia; [Williamson, Nicholas A.; Purcell, Anthony W.; Dudek, Nadine L.; McConville, Malcolm J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Metabol Australia, Parkville, Vic 3010, Australia; [O'Hair, Richard A. J.; Khairallah, George N.] Univ Melbourne, Sch Chem, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [O'Hair, Richard A. J.; Khairallah, George N.] Univ Melbourne, ARC Ctr Excellence Free Radical Chem & Biotechnol, Melbourne, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; Monash University; Monash University; University of Queensland; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Cardiff University	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	jamie.rossjohn@monash.edu; jamesm1@unimelb.edu.au	Purcell, Anthony/AAH-1942-2019; liu, ligong/B-1690-2010; Rossjohn, Jamie/F-9032-2013; Corbett, Alexandra/A-1225-2019; Fairlie, David P/F-8865-2014; McCluskey, James/A-1291-2007; Williamson, Nicholas A/O-9812-2016	Purcell, Anthony/0000-0003-0532-8331; liu, ligong/0000-0002-2693-1896; Rossjohn, Jamie/0000-0002-2020-7522; Corbett, Alexandra/0000-0003-1618-4337; Fairlie, David P/0000-0002-7856-8566; McCluskey, James/0000-0002-8597-815X; Williamson, Nicholas A/0000-0002-2173-3452; Patel, Onisha/0000-0001-6701-7139; O'Hair, Richard/0000-0002-8044-0502; Kostenko, Lyudmila/0000-0002-8466-7966; Le Nours, Jerome/0000-0002-2221-7636; Khairallah, George/0000-0002-3359-8358; Meehan, Bronwyn/0000-0001-7368-2979; Godfrey, Dale/0000-0002-3009-5472	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank R. Strugnell, T. Stinear, T. Mulhern, P. O'Donnell, J. Pyke, T. Rupasinghe, D. L. Tull, J. Ralton, L. Foster, S. H. Ramarathinam, M. Bharadwaj, D. Pellicci and K. Wun for discussions and technical advice, T. Hansen for the anti-MR1 monoclonal antibody and the staff of the Australian Synchrotron for assistance with data collection. This research was supported by the National Health and Medical Research Council of Australia (NHMRC) and the Australian Research Council. O.P. was supported by an ARC Future Fellowship; A.W.P. by an NHMRC Senior Research Fellowship; M.J.M. by a NHMRC Principal Research Fellowship; D.I.G. and D.P.F. were supported by NHMRC Senior Principal Research Fellowships; J. R. was supported by an NHMRC Australia Fellowship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bricogne G., 2011, AUTOBUSTER V 1 6 0; Chua WJ, 2011, J IMMUNOL, V186, P4744, DOI 10.4049/jimmunol.1003254; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gapin L, 2009, PLOS BIOL, V7, P435, DOI 10.1371/journal.pbio.1000070; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2010, NAT IMMUNOL, V11, P693, DOI 10.1038/ni0810-693; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Goldfinch N, 2010, VET RES, V41, DOI 10.1051/vetres/2010034; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Hee CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000557; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang SX, 2008, J EXP MED, V205, P1201, DOI 10.1084/jem.20072579; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Off MK, 2005, J PHOTOCH PHOTOBIO B, V80, P47, DOI 10.1016/j.jphotobiol.2005.03.001; PLAUT GWE, 1974, ANNU REV BIOCHEM, V43, P899, DOI 10.1146/annurev.bi.43.070174.004343; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Shimamura M, 2007, EUR J IMMUNOL, V37, P1836, DOI 10.1002/eji.200636689; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432	42	831	868	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					717	+		10.1038/nature11605	http://dx.doi.org/10.1038/nature11605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23051753				2022-12-24	WOS:000311606000036
J	Brandman, O; Stewart-Ornstein, J; Wong, D; Larson, A; Williams, CC; Li, GW; Zhou, S; King, D; Shen, PS; Weibezahn, J; Dunn, JG; Rouskin, S; Inada, T; Frost, A; Weissman, JS				Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Larson, Adam; Williams, Christopher C.; Li, Gene-Wei; Zhou, Sharleen; King, David; Shen, Peter S.; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Inada, Toshifumi; Frost, Adam; Weissman, Jonathan S.			A Ribosome-Bound Quality Control Complex Triggers Degradation of Nascent Peptides and Signals Translation Stress	CELL			English	Article							HEAT-SHOCK FACTOR-1; GENOME-WIDE ANALYSIS; PROTEIN-DEGRADATION; TRANSCRIPTION FACTOR; IN-VIVO; YEAST; KINASE; SYSTEM; SURVEILLANCE; ELONGATION	The conserved transcriptional regulator heat shock factor 1 (Hsf1) is a key sensor of proteotoxic and other stress in the eukaryotic cytosol. We surveyed Hsf1 activity in a genome-wide loss-of-function library in Saccaromyces cerevisiae as well as similar to 78,000 double mutants and found Hsf1 activity to be modulated by highly diverse stresses. These included disruption of a ribosome-bound complex we named the Ribosome Quality Control Complex (RQC) comprising the Ltn1 E3 ubiquitin ligase, two highly conserved but poorly characterized proteins (Tae2 and Rqc1), and Cdc48 and its cofactors. Electron microscopy and biochemical analyses revealed that the RQC forms a stable complex with 60S ribosomal subunits containing stalled polypeptides and triggers their degradation. A negative feedback loop regulates the RQC, and Hsf1 senses an RQC-mediated translation-stress signal distinctly from other stresses. Our work reveals the range of stresses Hsf1 monitors and elucidates a conserved cotranslational protein quality control mechanism.	[Shen, Peter S.; Frost, Adam] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Shen, Peter S.; Frost, Adam] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Inada, Toshifumi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Zhou, Sharleen; King, David] Univ Calif Berkeley, HHMI Mass Spectrometry Lab, Berkeley, CA 94720 USA; [Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Williams, Christopher C.; Li, Gene-Wei; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Williams, Christopher C.; Li, Gene-Wei; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Larson, Adam] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Brandman, Onn; Stewart-Ornstein, Jacob; Wong, Daisy; Williams, Christopher C.; Li, Gene-Wei; Weibezahn, Jimena; Dunn, Joshua G.; Rouskin, Silvi; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Tohoku University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Frost, A (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	frost@biochem.utah.edu; weissman@cmp.ucsf.edu	Inada, Toshifumi/AAE-1517-2019	Frost, Adam/0000-0003-2231-2577; Shen, Peter/0000-0002-6256-6910; Dunn, Joshua/0000-0003-4476-7257; Li, Gene-Wei/0000-0001-7036-8511; Weissman, Jonathan/0000-0003-2445-670X; Rouskin, Silvi/0000-0003-2042-6642	Helen Hay Whitney postdoctoral fellowship; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM105913, T32GM064337] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20112006] Funding Source: KAKEN	Helen Hay Whitney postdoctoral fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of the Weissman lab, M. Bassik, E. Boydston, L. Gilbert, A. Grenninger, C. Jan, M. Jonikas, M. Kampmann, Y. Liu, W. Luddington, M. McKeon, E. Oh, C. Reiger, M. Smith, N. Stern-Ginossar, and P. Walter for their valuable help with the manuscript and input on the project; T. Becker and R. Beckmann for help with EM; M. Larson and B. Toyama for help with graphic design; and M. Szeto for help in creating the fluorescent reporters. O.B. was supported by a Helen Hay Whitney postdoctoral fellowship. This work was funded by the Howard Hughes Medical Institute (to J.S.W.).	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Christians ES, 2006, HANDB EXP PHARM, V172, P139; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Fritah S, 2009, MOL BIOL CELL, V20, P4976, DOI 10.1091/mbc.E09-04-0295; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005	45	372	384	2	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					1042	1054		10.1016/j.cell.2012.10.044	http://dx.doi.org/10.1016/j.cell.2012.10.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178123	Bronze, Green Accepted			2022-12-24	WOS:000311423500017
J	Jakobsen, L; Ratcliffe, JM; Surlykke, A				Jakobsen, Lasse; Ratcliffe, John M.; Surlykke, Annemarie			Convergent acoustic field of view in echolocating bats	NATURE			English	Article							SOUND BEAM; BROWN BAT; PREY; VESPERTILIONIDAE; PURSUIT; SIZE	Most echolocating bats exhibit a strong correlation between body size and the frequency of maximum energy in their echolocation calls (peak frequency), with smaller species using signals of higher frequency than larger ones(1,2). Size-signal allometry or acoustic detection constraints imposed on wavelength by preferred prey size have been used to explain this relationship(1,3). Here we propose the hypothesis that smaller bats emit higher frequencies to achieve directional sonar beams, and that variable beam width is critical for bats. Shorter wavelengths relative to the size of the emitter translate into more directional sound beams(4). Therefore, bats that emit their calls through their mouths should show a relationship between mouth size and wavelength, driving smaller bats to signals of higher frequency. We found that in a flight room mimicking a closed habitat, six aerial hawking vespertilionid species (ranging in size from 4 to 21 g, ref. 5) produced sonar beams of extraordinarily similar shape and volume. Each species had a directivity index of 11 +/- 1 dB (a half-amplitude angle of approximately 37 degrees) and an on-axis sound level of 108 +/- 4 dB sound pressure level referenced to 20 mu Pa root mean square at 10 cm. Thus all bats adapted their calls to achieve similar acoustic fields of view. We propose that the necessity for high directionality has been a key constraint on the evolution of echolocation, which explains the relationship between bat size and echolocation call frequency. Our results suggest that echolocation is a dynamic system that allows different species, regardless of their body size, to converge on optimal fields of view in response to habitat and task.	[Jakobsen, Lasse; Ratcliffe, John M.; Surlykke, Annemarie] Univ So Denmark, Sound Commun Grp, Inst Biol, DK-5230 Odense M, Denmark	University of Southern Denmark	Surlykke, A (corresponding author), Univ So Denmark, Sound Commun Grp, Inst Biol, DK-5230 Odense M, Denmark.	ams@biology.sdu.dk		Jakobsen, Lasse/0000-0002-8496-5576	Danish Council for Natural Sciences (FNU), Carlsberg, Oticon; European Commission via the Seventh Framework Programme project ChiRoPing, Information Society Technologies [215370]	Danish Council for Natural Sciences (FNU), Carlsberg, Oticon; European Commission via the Seventh Framework Programme project ChiRoPing, Information Society Technologies	We thank H. Baagoe and B. Fenton for access to the bat collections at the Natural History Museum of Denmark and the Royal Ontario Museum, respectively, and R. Fisher and J. Hallam for providing gape heights of bats in flight. S. Brinklov, C. Elemans, B. Falk, B. Fenton, J. Galef, P. Madsen, C. Moss, H.-U. Schnitzler and M. Wahlberg provided detailed comments that improved the manuscript. This study was funded by the Danish Council for Natural Sciences (FNU), Carlsberg, Oticon and the European Commission via the Seventh Framework Programme project ChiRoPing, Information Society Technologies Contract 215370. Animal capture and experimentation was approved by Skov-og Naturstyrelsen (Denmark).	ANSI standard S1, 1995, S1261995ASA1131995 A; BAAGOE HJ, 1987, RECENT ADV STUDY BAT, P57; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Bruel & Kj&AELIG;r, 1982, DAT HDB; Dietz C., 2007, HDB FLEDERMAUSE EURO; Ghose K, 2006, J NEUROSCI, V26, P1704, DOI 10.1523/JNEUROSCI.4315-05.2006; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; Houston R. D., 2004, ECHOLOCATION BATS DO, P339, DOI DOI 10.1016/0370-1573(95)00083-6; Hulva P, 2004, MOL PHYLOGENET EVOL, V32, P1023, DOI 10.1016/j.ympev.2004.04.007; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 1999, J EXP BIOL, V202, P3359; KALLEN FC, 1972, J MORPHOL, V136, P385, DOI 10.1002/jmor.1051360402; Land MF, 2012, OXF ANIMAL BIOL SER, P1; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; MOGENSEN F, 1979, J COMP PHYSIOL, V134, P165, DOI 10.1007/BF00610475; Moss CF, 2011, CURR OPIN NEUROBIOL, V21, P645, DOI 10.1016/j.conb.2011.05.028; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Pye J. David, 1993, Bioacoustics, V4, P271; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; Surlykke A, 2009, P ROY SOC B-BIOL SCI, V276, P853, DOI 10.1098/rspb.2008.1505; Suthers RA, 2004, AN ACAD BRAS CIENC, V76, P247, DOI 10.1590/S0001-37652004000200009; WATERS DA, 1995, BEHAV ECOL SOCIOBIOL, V37, P321, DOI 10.1007/BF00174136; Wotton JM, 1997, J ACOUST SOC AM, V101, P1723, DOI 10.1121/1.418271	29	82	85	2	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					93	96		10.1038/nature11664	http://dx.doi.org/10.1038/nature11664			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23172147				2022-12-24	WOS:000312933800037
J	Abyzov, A; Mariani, J; Palejev, D; Zhang, Y; Haney, MS; Tomasini, L; Ferrandino, AF; Belmaker, LAR; Szekely, A; Wilson, M; Kocabas, A; Calixto, NE; Grigorenko, EL; Huttner, A; Chawarska, K; Weissman, S; Urban, AE; Gerstein, M; Vaccarino, FM				Abyzov, Alexej; Mariani, Jessica; Palejev, Dean; Zhang, Ying; Haney, Michael Seamus; Tomasini, Livia; Ferrandino, Anthony F.; Belmaker, Lior A. Rosenberg; Szekely, Anna; Wilson, Michael; Kocabas, Arif; Calixto, Nathaniel E.; Grigorenko, Elena L.; Huttner, Anita; Chawarska, Katarzyna; Weissman, Sherman; Urban, Alexander Eckehart; Gerstein, Mark; Vaccarino, Flora M.			Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells	NATURE			English	Article							GENOMIC STRUCTURAL VARIANTS; NUCLEOTIDE-RESOLUTION; RETROTRANSPOSITION; FIBROBLASTS; FRAMEWORK; REGIONS; BRAIN; NANOG	Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) has been suspected of causing de novo copy number variation(1-4). To explore this issue, here we performa whole-genome and transcriptome analysis of 20 human iPSC lines derived from the primary skin fibroblasts of seven individuals using next-generation sequencing. We find that, on average, an iPSC line manifests two copy number variants (CNVs) not apparent in the fibroblasts from which the iPSC was derived. Using PCR and digital droplet PCR, we show that at least 50% of those CNVs are present as low-frequency somatic genomic variants in parental fibroblasts (that is, the fibroblasts from which each corresponding human iPSC line is derived), and are manifested in iPSC lines owing to their clonal origin. Hence, reprogramming does not necessarily lead to de novo CNVs in iPSCs, because most of the line-manifested CNVs reflect somatic mosaicism in the human skin. Moreover, our findings demonstrate that clonal expansion, and iPSC lines in particular, can be used as a discovery tool to reliably detect low-frequency CNVs in the tissue of origin. Overall, we estimate that approximately 30% of the fibroblast cells have somatic CNVs in their genomes, suggesting widespread somatic mosaicism in the human body. Our study paves the way to understanding the fundamental question of the extent to which cells of the human body normally acquire structural alterations in their DNA post-zygotically.	[Abyzov, Alexej; Mariani, Jessica; Palejev, Dean; Zhang, Ying; Tomasini, Livia; Ferrandino, Anthony F.; Belmaker, Lior A. Rosenberg; Szekely, Anna; Wilson, Michael; Kocabas, Arif; Calixto, Nathaniel E.; Grigorenko, Elena L.; Huttner, Anita; Chawarska, Katarzyna; Weissman, Sherman; Urban, Alexander Eckehart; Gerstein, Mark; Vaccarino, Flora M.] Yale Univ, Program Neurodev & Regenerat, New Haven, CT 06520 USA; [Abyzov, Alexej; Wilson, Michael; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Abyzov, Alexej; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Mariani, Jessica; Palejev, Dean; Tomasini, Livia; Ferrandino, Anthony F.; Belmaker, Lior A. Rosenberg; Wilson, Michael; Kocabas, Arif; Calixto, Nathaniel E.; Grigorenko, Elena L.; Chawarska, Katarzyna; Vaccarino, Flora M.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Zhang, Ying; Szekely, Anna; Weissman, Sherman] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Haney, Michael Seamus; Urban, Alexander Eckehart] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Haney, Michael Seamus; Urban, Alexander Eckehart] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Szekely, Anna] Yale Univ, Dept Neurol, New Haven, CT 06520 USA; [Grigorenko, Elena L.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Grigorenko, Elena L.] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Huttner, Anita] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Vaccarino, Flora M.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Stanford University; Stanford University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Vaccarino, FM (corresponding author), Yale Univ, Program Neurodev & Regenerat, New Haven, CT 06520 USA.	aeurban@stanford.edu; mark.gerstein@yale.edu; flora.vaccarino@yale.edu	Abyzov, Alexej/AAT-4615-2020; Abyzov, Alexej/M-4284-2013	Palejev, Dean/0000-0002-0563-6636; Vaccarino, Flora/0000-0003-2167-981X; Calixto, Nathaniel/0000-0002-0948-7607; Wilson, Michael/0000-0001-5892-6074; Abyzov, Alexej/0000-0001-5405-6729	National Institutes of Health (NIH); AL Williams Professorship fund; Harris Professorship fund; NIMH [MH089176, MH087879]; Simons Foundation [SFARI 137055]; State of Connecticut; NIH [RR19895]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089176, R33MH087879, P50MH081756, R21MH087879] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AL Williams Professorship fund; Harris Professorship fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; State of Connecticut; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge support from the National Institutes of Health (NIH) and from the AL Williams Professorship fund and the Harris Professorship fund. We also acknowledge the Yale University Biomedical High Performance Computing Center and its support team(in particular, R. Bjornson and N. Carriero). We thank A. Klin for help with family recruitment. We thank M. V. Simonini for technical help, I.-H. Park for advice in the characterization of iPSC lines and the gift of the iPSC PGP1-1, and S. A. Duncan for the gift of the K3 iPSC line. We acknowledge the following grant support: NIMH MH089176 and MH087879, the Simons Foundation (SFARI 137055 F. V.) and the State of Connecticut, which funded the hiPSC generation and characterization; and NIH grant RR19895, which funded the instrumentation. We acknowledge the Yale Center for Clinical Investigation for clinical support in obtaining the biopsy specimens. We thank J. Overton for advice in carrying out DNA and RNA sequencing. Finally, we thank M. O'Huallachain and J. Li-Pook-Than for their advice on planning, carrying out and analysing the ddPCR experiments.	Abyzov A, 2011, BIOINFORMATICS, V27, P595, DOI 10.1093/bioinformatics/btq713; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Arlt MF, 2011, P NATL ACAD SCI USA, V108, P17360, DOI 10.1073/pnas.1109272108; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Brennand KJ, 2011, STEM CELLS, V29, P1915, DOI 10.1002/stem.762; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Elliott AM, 2010, MOL BIOTECHNOL, V46, P234, DOI 10.1007/s12033-010-9294-1; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Habegger L, 2011, BIOINFORMATICS, V27, P281, DOI 10.1093/bioinformatics/btq643; Haraksingh RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027859; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mkrtchyan H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009591; O'Huallachain M., 2012, P NATL ACAD SCI US; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaccarino FM, 2011, J CHILD PSYCHOL PSYC, V52, P504, DOI 10.1111/j.1469-7610.2010.02348.x; Wang LY, 2009, GENOME RES, V19, P106, DOI 10.1101/gr.080069.108; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	48	272	286	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					438	+		10.1038/nature11629	http://dx.doi.org/10.1038/nature11629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23160490	Green Accepted			2022-12-24	WOS:000312488200058
J	Brown, MTC; Tan, KR; O'Connor, EC; Nikonenko, I; Muller, D; Luscher, C				Brown, Matthew T. C.; Tan, Kelly R.; O'Connor, Eoin C.; Nikonenko, Irina; Muller, Dominique; Luescher, Christian			Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning	NATURE			English	Article							TONICALLY ACTIVE NEURONS; DOPAMINERGIC-NEURONS; NUCLEUS-ACCUMBENS; REWARD; ACTIVATION; STRIATUM; RELEASE; COCAINE	The ventral tegmental area (VTA) and nucleus accumbens (NAc) are essential for learning about environmental stimuli associated with motivationally relevant outcomes. The task of signalling such events, both rewarding and aversive, from the VTA to the NAc has largely been ascribed to dopamine neurons(1-3). The VTA also contains GABA (gamma-aminobutyric acid)-releasing neurons, which provide local inhibition(4,5) and also project to the NAc6,7. However, the cellular targets and functional importance of this long-range inhibitory projection have not been ascertained. Here we show that GABA-releasing neurons of the VTA that project to the NAc (VTA GABA projection neurons) inhibit accumbal cholinergic interneurons (CINs) to enhance stimulus-outcome learning. Combining optogenetics with structural imaging and electrophysiology, we found that VTA GABA projection neurons selectively target NAc CINs, forming multiple symmetrical synaptic contacts that generated inhibitory postsynaptic currents. This is remarkable considering that CINs represent a very small population of all accumbal neurons, and provide the primary source of cholinergic tone in the NAc. Brief activation of this projection was sufficient to halt the spontaneous activity of NAc CINs, resembling the pause recorded in animals learning stimulus-outcome associations(8-12). Indeed, we found that forcing CINs to pause in behaving mice enhanced discrimination of a motivationally important stimulus that had been associated with an aversive outcome. Our results demonstrate that VTA GABA projection neurons, through their selective targeting of accumbal CINs, provide a novel route through which the VTA communicates saliency to the NAc. VTA GABA projection neurons thus emerge as orchestrators of dopaminergic and cholinergic modulation in the NAc.	[Brown, Matthew T. C.; Tan, Kelly R.; O'Connor, Eoin C.; Nikonenko, Irina; Muller, Dominique; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Brown, Matthew/0000-0001-6983-962X; O'Connor, Eoin/0000-0002-7810-1915	Swiss National Science Foundation; National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation	We thank the members of the Luscher laboratory for discussion and comments on the manuscript. This work was funded by a grant of the Swiss National Science Foundation to C.L. and the National Center of Competence in Research (NCCR) 'SYNAPSY - The Synaptic Bases of Mental Diseases' of the Swiss National Science Foundation. fTom<SUP>PVALBcre</SUP> mice were provided by A. Holtmaat.	AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Apicella P, 2011, J NEUROSCI, V31, P1507, DOI 10.1523/JNEUROSCI.4880-10.2011; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Inokawa H, 2010, NEUROSCIENCE, V168, P395, DOI 10.1016/j.neuroscience.2010.03.062; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; KIMURA M, 1984, P NATL ACAD SCI-BIOL, V81, P4998, DOI 10.1073/pnas.81.15.4998; Ligorio M, 2009, J CHEM NEUROANAT, V37, P33, DOI 10.1016/j.jchemneu.2008.08.003; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Padgett CL, 2012, NEURON, V73, P978, DOI 10.1016/j.neuron.2011.12.031; Pratt WE, 2007, BEHAV NEUROSCI, V121, P1215, DOI 10.1037/0735-7044.121.6.1215; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Schulz JM, 2011, J NEUROSCI, V31, P11133, DOI 10.1523/JNEUROSCI.0661-11.2011; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771	30	224	225	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					452	456		10.1038/nature11657	http://dx.doi.org/10.1038/nature11657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23178810				2022-12-24	WOS:000312488200061
J	Xu, NL; Harnett, MT; Williams, SR; Huber, D; O'Connor, DH; Svoboda, K; Magee, JC				Xu, Ning-long; Harnett, Mark T.; Williams, Stephen R.; Huber, Daniel; O'Connor, Daniel H.; Svoboda, Karel; Magee, Jeffrey C.			Nonlinear dendritic integration of sensory and motor input during an active sensing task	NATURE			English	Article							PRIMARY SOMATOSENSORY CORTEX; CORTICAL-NEURONS; OBJECT LOCALIZATION; PYRAMIDAL NEURONS; NEURAL ACTIVITY; CIRCUITS; ORGANIZATION; DYNAMICS; WHISKING; MOTION	Active dendrites provide neurons with powerful processing capabilities. However, little is known about the role of neuronal dendrites in behaviourally related circuit computations. Here we report that a novel global dendritic nonlinearity is involved in the integration of sensory and motor information within layer 5 pyramidal neurons during an active sensing behaviour. Layer 5 pyramidal neurons possess elaborate dendritic arborizations that receive functionally distinct inputs, each targeted to spatially separate regions(1,2). At the cellular level, coincident input from these segregated pathways initiates regenerative dendritic electrical events that produce bursts of action potential output(3,4) and circuits featuring this powerful dendritic nonlinearity can implement computations based on input correlation(5). To examine this in vivo we recorded dendritic activity in layer 5 pyramidal neurons in the barrel cortex using two-photon calcium imagingin mice performing an object-localization task. Large-amplitude, global calcium signals were observed throughout the apical tuft dendrites when active touch occurred at particular object locations or whisker angles. Such global calcium signals are produced by dendritic plateau potentials that require both vibrissal sensory input and primary motor cortex activity. These data provide direct evidence of nonlinear dendritic processing of correlated sensory and motor information in the mammalian neocortex during active sensation.	[Xu, Ning-long; Harnett, Mark T.; Huber, Daniel; O'Connor, Daniel H.; Svoboda, Karel; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Williams, Stephen R.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia	Howard Hughes Medical Institute; University of Queensland	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	mageej@janelia.hhmi.org	Xu, Ning-long/U-8665-2019; Huber, Daniel/C-2932-2013	Xu, Ning-long/0000-0002-1651-401X; Williams, Stephen/0000-0001-5352-7947; Huber, Daniel/0000-0002-0744-7679	Australian research council [FT100100502]; Australian National Health and Medical Research Council [APP1004575]	Australian research council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank L. Tian and L. Looger for GCaMP3 constructs; J. Chandrashekar, N. Ryba and C. Zuker for GCaMP3 transgenic mice; W. Denk for comments on the manuscript; N. Clack, G. Myers, T. Zhao, V. Iyer, S. Peron and S. Drukmann for help with software and analysis; and L. Petreanu for help with experimental apparatus. S.R.W. is supported by the Australian research council (FT100100502) and Australian National Health and Medical Research Council (APP1004575).	Cauller LJ, 1998, J COMP NEUROL, V390, P297; Chen X., 2011, NATURE; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Iyer V., 2009, 2009 NEUR M PLANN SO; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Petreanu L., 2012, NATURE; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zhao T, 2011, NEUROINFORMATICS, V9, P247, DOI 10.1007/s12021-011-9120-3	38	308	311	6	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					247	+		10.1038/nature11601	http://dx.doi.org/10.1038/nature11601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23143335				2022-12-24	WOS:000312259300041
J	Jetz, W; Thomas, GH; Joy, JB; Hartmann, K; Mooers, AO				Jetz, W.; Thomas, G. H.; Joy, J. B.; Hartmann, K.; Mooers, A. O.			The global diversity of birds in space and time	NATURE			English	Article							MOLECULAR PHYLOGENIES; DIVERSIFICATION RATES; NORTH-AMERICAN; FOSSIL RECORD; EVOLUTION; RADIATIONS; PATTERNS; HISTORY; BIOGEOGRAPHY; EXTINCTION	Current global patterns of biodiversity result from processes that operate over both space and time and thus require an integrated macroecological and macroevolutionary perspective(1-4). Molecular time trees have advanced our understanding of the tempo and mode of diversification(5-7) and have identified remarkable adaptive radiations across the tree of life(8-10). However, incomplete joint phylogenetic and geographic sampling has limited broad-scale inference. Thus, the relative prevalence of rapid radiations and the importance of their geographic settings in shaping global biodiversity patterns remain unclear. Here we present, analyse and map the first complete dated phylogeny of all 9,993 extant species of birds, a widely studied group showing many unique adaptations. We find that birds have undergone a strong increase in diversification rate from about 50 million years ago to the near present. This acceleration is due to a number of significant rate increases, both within songbirds and within other young and mostly temperate radiations including the waterfowl, gulls and woodpeckers. Importantly, species characterized with very high past diversification rates are interspersed throughout the avian tree and across geographic space. Geographically, the major differences in diversification rates are hemispheric rather than latitudinal, with bird assemblages in Asia, North America and southern South America containing a disproportionate number of species from recent rapid radiations. The contribution of rapidly radiating lineages to both temporal diversification dynamics and spatial distributions of species diversity illustrates the benefits of an inclusive geographical and taxonomical perspective. Overall, whereas constituent clades may exhibit slowdowns(10,11), the adaptive zone into which modern birds have diversified since the Cretaceous may still offer opportunities for diversification.	[Jetz, W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Thomas, G. H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Joy, J. B.; Mooers, A. O.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Hartmann, K.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia	Yale University; University of Sheffield; Simon Fraser University; University of Tasmania	Jetz, W (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06520 USA.	walter.jetz@yale.edu; amooers@sfu.ca	Jetz, Walter/ABF-1517-2020; Thomas, Gavin/AAE-8959-2019	Joy, Jeffrey/0000-0002-7013-1482; Thomas, Gavin/0000-0002-1982-6051; Jetz, Walter/0000-0002-1971-7277	NSF [DBI 0960550, DEB 1026764]; NASA [NNX11AP72G]; Natural Environment Research Council [NE/G012938/1]; NERC (Centre for Population Biology); NSERC Canada; Wissenschaftskolleg zu Berlin; Yale Institute for Biospheric Sciences; Simon Fraser University; NERC [NE/G012938/2, NE/G012938/1] Funding Source: UKRI; Natural Environment Research Council [NE/G012938/2] Funding Source: researchfish; Division Of Environmental Biology [1026764] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC (Centre for Population Biology)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); Yale Institute for Biospheric Sciences; Simon Fraser University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank D. Redding for critical input in the early stages of this project; A. Mimoto, F. Ronqvist and M. Teslenko for help modifying MrBayes; I. Martyn for coding; R. Bowie, J. McGuire, A. Cooper, K. Burns and M. Sorenson among others, for unpublished phylogenetic material or information; M. Benton, T. Ezard, T. Price, M. Donoghue, J. Beaulieu, J. Belmaker, P. M. Hull, D. Field, N. Longrich, V. Saranathan, M. Steel, H. Morlon, J. Brown, A. Phillimore, R. Fitzjohn, R. Etienne, W. Stein and especially T. Stadler for data, important input and/or discussion; G. Smith, C. Schank, D. Thiele, T. M. Lee, F. La Sorte, C. Edwards, K. Ashton and J. Hazelhurst for help with spatial and phylogenetic data collection and management; C. Schank for help preparing the tree visualizations. This work was carried out using the BlueFern Supercomputing Facilities (http://www.bluefern.canterbury.ac.nz), University of Canterbury, the Advanced Computing Research Centre, University of Bristol (http://www.bris.ac.uk/acrc/) and the Interdisciplinary Research in Mathematics and Computer Sciences Centre, Simon Fraser University (http://www.irmacs.sfu.ca). This work was partly supported by NSF grants DBI 0960550 and DEB 1026764 and NASA Biodiversity Grant NNX11AP72G (W. J.); the Natural Environment Research Council (Postdoctoral Fellowship grant number NE/G012938/1 and the NERC Centre for Population Biology) (G.H.T.); and NSERC Canada, the Wissenschaftskolleg zu Berlin, the Yale Institute for Biospheric Sciences and Simon Fraser University (A.O.M.). Most importantly, we thank the many avian systematists and phylogeneticists who have contributed their data to public databases and so made our study possible.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Derryberry EP, 2011, EVOLUTION, V65, P2973, DOI 10.1111/j.1558-5646.2011.01374.x; Ericson PGP, 2012, J BIOGEOGR, V39, P813, DOI 10.1111/j.1365-2699.2011.02650.x; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Grant PR, 2011, WHY SPECIES MULTIPLY; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Jetz W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001292; Linder HP, 2008, PHILOS T R SOC B, V363, P3097, DOI 10.1098/rstb.2008.0075; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Price T, 2000, AM NAT, V156, P354, DOI 10.1086/303397; Price T, 2008, SPECIATION BIRDS; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Sibley CG, 1990, PHYLOGENY CLASSIFICA; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842	30	1993	2034	33	1102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					444	448		10.1038/nature11631	http://dx.doi.org/10.1038/nature11631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23123857				2022-12-24	WOS:000311031600046
J	Manavella, PA; Hagmann, J; Ott, F; Laubinger, S; Franz, M; Macek, B; Weigel, D				Manavella, Pablo A.; Hagmann, Joerg; Ott, Felix; Laubinger, Sascha; Franz, Mirita; Macek, Boris; Weigel, Detlef			Fast-Forward Genetics Identifies Plant CPL Phosphatases as Regulators of miRNA Processing Factor HYL1	CELL			English	Article							RNA-POLYMERASE-II; SMALL INTERFERING RNA; CAP-BINDING COMPLEX; C-TERMINAL DOMAIN; ARABIDOPSIS-THALIANA; MICRORNA BIOGENESIS; ABSCISIC-ACID; POSTTRANSCRIPTIONAL REGULATION; PROTEIN-PHOSPHORYLATION; PRI-MIRNA	MicroRNAs (miRNAs) are processed from primary transcripts that contain partially self-complementary foldbacks. As in animals, the core microprocessor in plants is a Dicer protein, DICER-LIKE1 (DCL1). Processing accuracy and strand selection is greatly enhanced through the RNA binding protein HYPONASTIC LEAVES 1 (HYL1) and the zinc finger protein SERRATE (SE). We have combined a luciferase-based genetic screen with whole-genome sequencing for rapid identification of new regulators of miRNA biogenesis and action. Among the first six mutants analyzed were three alleles of C-TERMINAL DOMAIN PHOSPHATASE-LIKE 1 (CPL1)/FIERY2 (FRY2). In the miRNA processing complex, SE functions as a scaffold to mediate CPL1 interaction with HYL1, which needs to be dephosphorylated for optimal activity. In the absence of CPL1, HYL1 dephosphorylation and hence accurate processing and strand selection from miRNA duplexes are compromised. Our findings thus define a new regulatory step in plant miRNA biogenesis.	[Manavella, Pablo A.; Hagmann, Joerg; Ott, Felix; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Laubinger, Sascha] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Franz, Mirita; Macek, Boris] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Macek, Boris/N-1442-2015; Weigel, Detlef/GSJ-0799-2022	Weigel, Detlef/0000-0002-2114-7963; Macek, Boris/0000-0002-1206-2458; Weigel, Detlef/0000-0002-2114-7963; Manavella, Pablo/0000-0003-3589-4414; Laubinger, Sascha/0000-0002-6682-0728	European Community IP SIROCCO [LSHG-CT-2006-037900]; Deutsche Forschungsgemeinschaft; Max Planck Society	European Community IP SIROCCO; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We thank S. Grant and J. Dangl for cpl2 seeds, M. Christie, E. Izaurralde, I. Rubio-Somoza and R. Schwab for comments, C. Becker for help with RNA-seq analyses, and N. Camomilli for technical assistance. We are grateful to an anonymous reviewer for pointing out the miRNA* effects. Supported by a Human Frontier Science Program Long-Term Fellowship (P. A. M.), by European Community IP SIROCCO (contract LSHG-CT-2006-037900), a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft and the Max Planck Society.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bezerra IC, 2004, PLANT J, V40, P112, DOI 10.1111/j.1365-313X.2004.02194.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; de Felippes FF, 2010, METHODS MOL BIOL, V592, P255, DOI 10.1007/978-1-60327-005-2_17; de Felippes FF, 2011, NUCLEIC ACIDS RES, V39, P2880, DOI 10.1093/nar/gkq1240; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fujioka Y, 2007, PLANT CELL PHYSIOL, V48, P1243, DOI 10.1093/pcp/pcm099; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Isono E, 2010, METHODS MOL BIOL, V655, P377, DOI 10.1007/978-1-60761-765-5_25; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim S, 2008, PLANT CELL PHYSIOL, V49, P1634, DOI 10.1093/pcp/pcn146; Kinoshita E, 2004, DALTON T, P1189, DOI 10.1039/b400269e; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Koiwa H, 2004, P NATL ACAD SCI USA, V101, P14539, DOI 10.1073/pnas.0403174101; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lesicka-Gorecka J, 2008, ACTA BIOCHIM POL, V55, P517; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu CG, 2012, PLANT PHYSIOL, V159, P748, DOI 10.1104/pp.112.193508; Liu FQ, 2012, SCIENCE, V335, P1621, DOI 10.1126/science.1214402; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matsuda O, 2009, PLANT J, V57, P96, DOI 10.1111/j.1365-313X.2008.03663.x; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nogueira FTS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000320; Olsen Jesper V., 2009, V492, P131, DOI 10.1007/978-1-59745-493-3_7; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tagami Y, 2009, RNA, V15, P450, DOI 10.1261/rna.1297109; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Ueda A, 2008, PLANT MOL BIOL, V67, P683, DOI 10.1007/s11103-008-9348-y; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang W, 2011, PLANT CELL, V23, P3565, DOI 10.1105/tpc.111.091058; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Zhang JF, 2008, PLANT CELL ENVIRON, V31, P562, DOI 10.1111/j.1365-3040.2008.01786.x	70	153	159	2	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					859	870		10.1016/j.cell.2012.09.039	http://dx.doi.org/10.1016/j.cell.2012.09.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141542	Bronze			2022-12-24	WOS:000310921200016
J	McLaughlin, RN; Poelwijk, FJ; Raman, A; Gosal, WS; Ranganathan, R				McLaughlin, Richard N., Jr.; Poelwijk, Frank J.; Raman, Arjun; Gosal, Walraj S.; Ranganathan, Rama			The spatial architecture of protein function and adaptation	NATURE			English	Article							PDZ DOMAIN; ACTIVATION; TRANSCRIPTION; DETERMINANTS; INFORMATION; ROBUSTNESS; MECHANISM; NETWORK; FITNESS; UNITS	Statistical analysis of protein evolution suggests a design for natural proteins in which sparse networks of coevolving amino acids (termed sectors) comprise the essence of three-dimensional structure and function(1-5). However, proteins are also subject to pressures deriving from the dynamics of the evolutionary process itself-the ability to tolerate mutation and to be adaptive to changing selection pressures(6-10). To understand the relationship of the sector architecture to these properties, we developed a high-throughput quantitative method for a comprehensive single-mutation study in which every position is substituted individually to every other amino acid. Using a PDZ domain (PSD95(pdz3)) model system, we show that sector positions are functionally sensitive to mutation, whereas non-sector positions are more tolerant to substitution. In addition, we find that adaptation to a new binding specificity initiates exclusively through variation within sector residues. A combination of just two sector mutations located near and away from the ligand-binding site suffices to switch the binding specificity of PSD95(pdz3) quantitatively towards a class-switching ligand. The localization of functional constraint and adaptive variation within the sector has important implications for understanding and engineering proteins.	[McLaughlin, Richard N., Jr.; Poelwijk, Frank J.; Raman, Arjun; Gosal, Walraj S.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [McLaughlin, Richard N., Jr.; Poelwijk, Frank J.; Raman, Arjun; Gosal, Walraj S.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	Gosal, Walraj/J-5260-2012	Gosal, Walraj/0000-0003-3396-1505; Poelwijk, Frank/0000-0002-5696-4357; McLaughlin, Richard/0000-0003-0950-2253	University of Texas Southwestern Graduate School and Pharmacology Training Grant; Helen Hay Whitney Fellowship program; National Institutes of Health [R01EY018720-05]; Robert A. Welch Foundation [I-1366]; Green Center for Systems Biology; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	University of Texas Southwestern Graduate School and Pharmacology Training Grant; Helen Hay Whitney Fellowship program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Green Center for Systems Biology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank W. Russ, P. Mishra and other members of the Ranganathan laboratory for contributions to this work, W. Wakeland and C. Liang for assistance with Solexa sequencing, E. Curry and A. Mobley for assistance with flow cytometry, and M. Elowitz for providing the pZ plasmids. We acknowledge support from the University of Texas Southwestern Graduate School and Pharmacology Training Grant (R. N. M.), the Helen Hay Whitney Fellowship program (F.J.P.) and support from the National Institutes of Health (R01EY018720-05, R. R.), The Robert A. Welch Foundation (I-1366, R. R.) and the Green Center for Systems Biology (R.R.).	Adkar BV, 2012, STRUCTURE, V20, P371, DOI 10.1016/j.str.2011.11.021; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BUSHMAN FD, 1989, CELL, V58, P1163, DOI 10.1016/0092-8674(89)90514-X; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tiana G, 2004, P NATL ACAD SCI USA, V101, P2846, DOI 10.1073/pnas.0306638101; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Whipple FW, 1997, J MOL BIOL, V265, P261, DOI 10.1006/jmbi.1996.0735	35	297	298	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					138	U163		10.1038/nature11500	http://dx.doi.org/10.1038/nature11500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23041932	Green Accepted			2022-12-24	WOS:000310434500046
J	Marguerat, S; Schmidt, A; Codlin, S; Chen, W; Aebersold, R; Bahler, J				Marguerat, Samuel; Schmidt, Alexander; Codlin, Sandra; Chen, Wei; Aebersold, Ruedi; Baehler, Juerg			Quantitative Analysis of Fission Yeast Transcriptomes and Proteomes in Proliferating and Quiescent Cells	CELL			English	Article							GENE-EXPRESSION; SCHIZOSACCHAROMYCES-POMBE; MESSENGER-RNA; ABSOLUTE QUANTIFICATION; SEXUAL-DIFFERENTIATION; PROTEIN; HETEROCHROMATIN; RESOLUTION; RESPONSES; DIVISION	Data on absolute molecule numbers will empower the modeling, understanding, and comparison of cellular functions and biological systems. We quantified transcriptomes and proteomes in fission yeast during cellular proliferation and quiescence. This rich resource provides the first comprehensive reference for all RNA and most protein concentrations in a eukaryote under two key physiological conditions. The integrated data set supports quantitative biology and affords unique insights into cell regulation. Although mRNAs are typically expressed in a narrow range above 1 copy/cell, most long, noncoding RNAs, except for a distinct subset, are tightly repressed below 1 copy/cell. Cell-cycle-regulated transcription tunes mRNA numbers to phase-specific requirements but can also bring about more switch-like expression. Proteins greatly exceed mRNAs in abundance and dynamic range, and concentrations are regulated to functional demands. Upon transition to quiescence, the proteome changes substantially, but, in stark contrast to mRNAs, proteins do not uniformly decrease but scale with cell volume.	[Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Marguerat, Samuel; Codlin, Sandra; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Marguerat, Samuel; Codlin, Sandra; Baehler, Juerg] UCL Canc Inst, London WC1E 6BT, England; [Schmidt, Alexander] Univ Basel, Proteom Core Facil, Biozentrum, CH-4056 Basel, Switzerland; [Chen, Wei] Max Delbruck Ctr Mol Med MDC, Berlin Inst Med Syst Biol, D-13092 Berlin, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of London; University College London; University of London; University College London; University of Basel; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch; j.bahler@ucl.ac.uk	Marguerat, Samuel/AAY-3792-2020; Chen, Wei/C-1273-2011; Bahler, Jurg/B-4572-2009	Marguerat, Samuel/0000-0002-2402-3165; Bahler, Jurg/0000-0003-4036-1532; Chen, Wei/0000-0003-3263-1627	PhenOxiGEn (an EU FP7 research project); BBSRC [BB/I012451/1]; Wellcome Trust; SystemsX.ch; ERC; Biotechnology and Biological Sciences Research Council [BB/I012451/1] Funding Source: researchfish; Wellcome Trust [095598/Z/11/Z] Funding Source: researchfish	PhenOxiGEn (an EU FP7 research project); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); SystemsX.ch; ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank F. Bachand, D. Bitton, L. Foukas, A. Lock, D. Lovell, J. Mata, and V. Wood for comments on the manuscript, P. Gardner for advice on lncRNA sequences, and P. Oliveri for help with nCounter. This research was funded by PhenOxiGEn (an EU FP7 research project), a BBSRC Research Grant BB/I012451/1, and a Wellcome Trust Senior Investigator Award to J. B., and by SystemsX.ch and an ERC Advanced Grant to R.A.	Atkinson SR, 2012, SEMIN CELL DEV BIOL, V23, P200, DOI 10.1016/j.semcdb.2011.12.003; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002; Bhavsar Rital B., 2010, Human Genomics, V4, P327; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Coller HA, 2011, SCIENCE, V334, P1074, DOI 10.1126/science.1216242; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; de Almeida SF, 2012, TRENDS BIOCHEM SCI, V37, P248, DOI 10.1016/j.tibs.2012.02.002; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Dobryn HC, 2004, RNA, V10, P308, DOI 10.1261/rna.5970404; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lovell D, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P193; MACLEAN N, 1965, NATURE, V207, P322, DOI 10.1038/207322a0; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Marguerat S, 2006, YEAST, V23, P261, DOI 10.1002/yea.1351; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ng SS, 2001, FEBS LETT, V503, P131, DOI 10.1016/S0014-5793(01)02720-X; Pancaldi V, 2010, MOL BIOSYST, V6, P543, DOI 10.1039/b913876p; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shimanuki M, 2007, GENES CELLS, V12, P677, DOI 10.1111/j.1365-2443.2007.01079.x; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhurinsky J, 2010, CURR BIOL, V20, P2010, DOI 10.1016/j.cub.2010.10.002; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	52	360	364	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					671	683		10.1016/j.cell.2012.09.019	http://dx.doi.org/10.1016/j.cell.2012.09.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101633	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000310529300021
J	Sylwestrak, EL; Ghosh, A				Sylwestrak, Emily L.; Ghosh, Anirvan			Elfn1 Regulates Target-Specific Release Probability at CA1-Interneuron Synapses	SCIENCE			English	Article							DUAL INTRACELLULAR-RECORDINGS; SCHAFFER COLLATERAL SYNAPSES; EXCITATORY SYNAPSES; HIPPOCAMPAL SLICES; PYRAMIDAL CELLS; INTERNEURONS; FACILITATION; EXPRESSION; CIRCUITS; RAT	Although synaptic transmission may be unidirectional, the establishment of synaptic connections with specific properties can involve bidirectional signaling. Pyramidal neurons in the hippocampus form functionally distinct synapses onto two types of interneurons. Excitatory synapses onto oriens-lacunosum moleculare (O-LM) interneurons are facilitating and have a low release probability, whereas synapses onto parvalbumin interneurons are depressing and have a high release probability. Here, we show that the extracellular leucine-rich repeat fibronectin containing 1 (Elfn1) protein is selectively expressed by O-LM interneurons and regulates presynaptic release probability to direct the formation of highly facilitating pyramidal-O-LM synapses. Thus, postsynaptic expression of Elfn1 in O-LM interneurons regulates presynaptic release probability, which confers target-specific synaptic properties to pyramidal cell axons.	[Sylwestrak, Emily L.; Ghosh, Anirvan] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Sylwestrak, Emily L.; Ghosh, Anirvan] F Hoffmann La Roche, CNS Discovery, CH-4070 Basel, Switzerland; [Sylwestrak, Emily L.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of California System; University of California San Diego; Roche Holding; University of Basel	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	anirvan.ghosh@roche.com	Sylwestrak, Emily/GSE-3871-2022	Sylwestrak, Emily/0000-0002-1172-6523	NIH [R01NS067216]; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Scanziani, P. Scheiffele, and members of the Ghosh lab for suggestions and comments on the manuscript; J. de Wit for generating the Elfn1-GFP construct; and M. Macias, C. Sanchez, and E. Kang for help with virus and protein production. This work was supported by NIH grant R01NS067216 and the Gatsby Charitable Foundation.	Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Buchanan KA, 2012, NEURON, V75, P451, DOI 10.1016/j.neuron.2012.06.017; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sun HY, 2009, J NEUROPHYSIOL, V101, P1043, DOI 10.1152/jn.90286.2008; Sun HY, 2006, J NEUROSCI, V26, P10796, DOI 10.1523/JNEUROSCI.2746-06.2006; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	30	91	94	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					536	540		10.1126/science.1222482	http://dx.doi.org/10.1126/science.1222482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23042292	Green Accepted			2022-12-24	WOS:000310195800060
J	Jonsson, T; Stefansson, H; Steinberg, S; Jonsdottir, I; Jonsson, PV; Snaedal, J; Bjornsson, S; Huttenlocher, J; Levey, AI; Lah, JJ; Rujescu, D; Hampel, H; Giegling, I; Andreassen, OA; Engedal, K; Ulstein, I; Djurovic, S; Ibrahim-Verbaas, C; Hofman, A; Ikram, MA; van Duijn, CM; Thorsteinsdottir, U; Kong, A; Stefansson, K				Jonsson, Thorlakur; Stefansson, Hreinn; Steinberg, Stacy; Jonsdottir, Ingileif; Jonsson, Palmi V.; Snaedal, Jon; Bjornsson, Sigurbjorn; Huttenlocher, Johanna; Levey, Allan I.; Lah, James J.; Rujescu, Dan; Hampel, Harald; Giegling, Ina; Andreassen, Ole A.; Engedal, Knut; Ulstein, Ingun; Djurovic, Srdjan; Ibrahim-Verbaas, Carla; Hofman, Albert; Ikram, M. Arfan; van Duijn, Cornelia M.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Variant of TREM2 Associated with the Risk of Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; CUTTING EDGE; MUTATIONS; RESPONSES; INFLAMMATION; EXPRESSION; FREQUENCY; DEMENTIA; SYSTEM	BACKGROUND Sequence variants, including the epsilon 4 allele of apolipoprotein E, have been associated with the risk of the common late-onset form of Alzheimer's disease. Few rare variants affecting the risk of late-onset Alzheimer's disease have been found. METHODS We obtained the genome sequences of 2261 Icelanders and identified sequence variants that were likely to affect protein function. We imputed these variants into the genomes of patients with Alzheimer's disease and control participants and then tested for an association with Alzheimer's disease. We performed replication tests using case-control series from the United States, Norway, the Netherlands, and Germany. We also tested for a genetic association with cognitive function in a population of unaffected elderly persons. RESULTS A rare missense mutation (rs75932628-T) in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2), which was predicted to result in an R47H substitution, was found to confer a significant risk of Alzheimer's disease in Iceland (odds ratio, 2.92; 95% confidence interval [CI], 2.09 to 4.09; P=3.42x10(-10)). The mutation had a frequency of 0.46% in controls 85 years of age or older. We observed the association in additional sample sets (odds ratio, 2.90; 95% CI, 2.16 to 3.91; P=2.1x10(-12) in combined discovery and replication samples). We also found that carriers of rs75932628-T between the ages of 80 and 100 years without Alzheimer's disease had poorer cognitive function than noncarriers (P=0.003). CONCLUSIONS Our findings strongly implicate variant TREM2 in the pathogenesis of Alzheimer's disease. Given the reported antiinflammatory role of TREM2 in the brain, the R47H substitution may lead to an increased predisposition to Alzheimer's disease through impaired containment of inflammatory processes. (Funded by the National Institute on Aging and others.)	[Jonsson, Thorlakur; Stefansson, Hreinn; Steinberg, Stacy; Jonsdottir, Ingileif; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Jonsdottir, Ingileif; Jonsson, Palmi V.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonsson, Palmi V.; Snaedal, Jon; Bjornsson, Sigurbjorn] Landspitali Univ Hosp, Reykjavik, Iceland; [Huttenlocher, Johanna] Inst Human Genet, Dept Med Genet, Tubingen, Germany; Univ Munich, Dept Psychiat, Div Mol & Clin Neurobiol, D-80539 Munich, Germany; [Rujescu, Dan; Giegling, Ina] Univ Halle Wittenberg, D-06108 Halle, Germany; [Hampel, Harald] Univ Frankfurt Main, Dept Psychiat, Frankfurt, Germany; [Levey, Allan I.; Lah, James J.] Emory Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr, Atlanta, GA 30322 USA; [Andreassen, Ole A.; Djurovic, Srdjan] Univ Oslo, Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, Oslo, Norway; [Engedal, Knut; Ulstein, Ingun] Univ Oslo, Oslo Univ Hosp, Norwegian Ctr Aging & Hlth, Dept Geriatr, Oslo, Norway; [Andreassen, Ole A.; Engedal, Knut; Djurovic, Srdjan] Univ Oslo, Inst Clin Med, Oslo, Norway; [Ibrahim-Verbaas, Carla; Hofman, Albert; Ikram, M. Arfan; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	University of Iceland; Landspitali National University Hospital; Eberhard Karls University of Tubingen; University of Munich; Martin Luther University Halle Wittenberg; Goethe University Frankfurt; Emory University; University of Oslo; University of Oslo; University of Oslo; Erasmus University Rotterdam; Erasmus MC	Stefansson, K (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Ikram, M. Arfan/AAM-5225-2021; Levey, Allan/F-2104-2011; Andreassen, Ole A./AAY-7531-2020; Rujescu, Dan/GRS-3875-2022; Giegling, Ina/ABA-3677-2021; Stefansson, Kari/AAE-7187-2019; Alexandrov, Boian/D-8815-2016; Babu, Sudarsanam/D-1694-2010	Levey, Allan/0000-0002-3153-502X; Ibrahim-verbaas, Carla/0000-0002-4325-0857; Stefansson, Hreinn/0000-0002-9331-6666; Van Duijn, Cornelia/0000-0002-2374-9204; Andreassen, Ole A./0000-0002-4461-3568; Hampel, Harald/0000-0003-0894-8982; Djurovic, Srdjan/0000-0002-8140-8061; Ikram, Mohammad Arfan/0000-0003-0372-8585; Babu, Sudarsanam/0000-0002-3531-2579; Kong, Augustine/0000-0001-8193-5438	National Institute on Aging [P50-AG025688, U01AG006781]; Research Council of Norway; South-Eastern Norway Health Authority; National Institutes of Health [U01HG004438]; National Human Genome Research Institute [U01HG004610]; eMERGE Administrative Coordinating Center [U01HG004603]; National Center for Biotechnology Information; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development; Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; Research Institute for Diseases in the Elderly [014-93-015]; Stichting Alzheimer Onder-zoek; Hersenstichting Nederland; Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging); Seventh Framework Program; ENGAGE project [HEALTH-F4-2007-201413]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375, U01HG004438, U01HG004603, U01HG004610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P50AG025688, U01AG006781] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Council of Norway(Research Council of Norway); South-Eastern Norway Health Authority; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); eMERGE Administrative Coordinating Center; National Center for Biotechnology Information; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Research Institute for Diseases in the Elderly; Stichting Alzheimer Onder-zoek; Hersenstichting Nederland; Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging); Seventh Framework Program(European Commission); ENGAGE project(General Electric); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institute on Aging (P50-AG025688, to Dr. Levey, for samples from the Alzheimer's Disease Center at Emory University; U01AG006781 for the Alzheimer's Disease Patient Registry and Adult Changes in Thought study; and the Division of Neuroscience for the NIA-LOAD study); a grant from the Research Council of Norway and South-Eastern Norway Health Authority for samples from Norway; a gift from 3M to expand the Adult Changes in Thought cohort; a grant from the National Institutes of Health (U01HG004438) for genotyping at Johns Hopkins University; cooperative agreements with the National Human Genome Research Institute (U01HG004610 for genomewide association analyses); by the eMERGE Administrative Coordinating Center (U01HG004603) for assistance with phenotype harmonization and genotype data cleaning; and by the National Center for Biotechnology Information. The Rotterdam Study was funded by Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Health Research and Development; the Research Institute for Diseases in the Elderly; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission; and the Municipality of Rotterdam; by a grant (014-93-015; RIDE2) from the Research Institute for Diseases in the Elderly, Stichting Alzheimer Onder-zoek, Hersenstichting Nederland, the Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging), the Seventh Framework Program (FP7/2007-2013), and the ENGAGE project (grant agreement HEALTH-F4-2007-201413).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Brakhus Anne, 2011, Tidsskr Nor Laegeforen, V131, P2254, DOI 10.4045/tidsskr.11.0786; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Guerreiro RJ, 2012, ARCH NEUROL; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; ISHII T, 1984, ACTA NEUROPATHOL, V63, P296, DOI 10.1007/BF00687336; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Madry H, 2007, CLIN ORTHOP RELAT R, P262, DOI 10.1097/01.blo.0000229364.57985.df; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Montalbetti L, 2005, FUNCT NEUROL, V20, P71; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Paloneva, 2003, AM J HUM GENET, V72, P225; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; ROZEMULLER JM, 1986, VIRCHOWS ARCH B, V51, P247, DOI 10.1007/BF02899034; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stefano L, 2009, J NEUROCHEM, V110, P284, DOI 10.1111/j.1471-4159.2009.06130.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Wunderlich P, 2010, GAMMA SECRETASE MEDI	51	1539	1574	6	205	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					107	116		10.1056/NEJMoa1211103	http://dx.doi.org/10.1056/NEJMoa1211103			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23150908	Green Accepted			2022-12-24	WOS:000313238100001
J	Sur, IK; Hallikas, O; Vaharautio, A; Yan, J; Turunen, M; Enge, M; Taipale, M; Karhu, A; Aaltonen, LA; Taipale, J				Sur, Inderpreet Kaur; Hallikas, Outi; Vaharautio, Anna; Yan, Jian; Turunen, Mikko; Enge, Martin; Taipale, Minna; Karhu, Auli; Aaltonen, Lauri A.; Taipale, Jussi			Mice Lacking a Myc Enhancer That Includes Human SNP rs6983267 Are Resistant to Intestinal Tumors	SCIENCE			English	Article							LONG-RANGE INTERACTION; C-MYC; PROSTATE-CANCER; 8Q24 PROSTATE; BETA-CATENIN; COLON-CANCER; VARIANT; TARGET; SUSCEPTIBILITY; INHIBITION	Multiple cancer-associated single-nucleotide polymorphisms (SNPs) have been mapped to conserved sequences within a 500-kilobase region upstream of the MYC oncogene on human chromosome 8q24. These SNPs may affect cancer development through altered regulation of MYC expression, but this hypothesis has been difficult to confirm. We generated mice deficient in Myc-335, a putative MYC regulatory element that contains rs6983267, a SNP accounting for more human cancer-related morbidity than any other genetic variant or mutation. In Myc-335 null mice, Myc transcripts were expressed in the intestinal crypts in a pattern similar to that in wild-type mice but at modestly reduced levels. The mutant mice displayed no overt phenotype but were markedly resistant to intestinal tumorigenesis induced by the APCmin mutation. These results establish that a cancer-associated SNP identified in human genome-wide association studies has a functional effect in vivo.	[Sur, Inderpreet Kaur; Vaharautio, Anna; Yan, Jian; Enge, Martin; Taipale, Minna; Taipale, Jussi] Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, Stockholm, Sweden; [Sur, Inderpreet Kaur] Karolinska Univ Hosp, Clin Res Ctr, Stockholm, Sweden; [Hallikas, Outi; Vaharautio, Anna; Turunen, Mikko; Taipale, Minna; Taipale, Jussi] Univ Helsinki, Biomedicum, Inst Biomed, Genome Scale Biol Program, FI-00014 Helsinki, Finland; [Karhu, Auli; Aaltonen, Lauri A.] Univ Helsinki, Biomedicum, Dept Med Genet, Genome Scale Biol Program, FI-00014 Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; University of Helsinki	Taipale, J (corresponding author), Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, Stockholm, Sweden.	jussi.taipale@ki.se	Aaltonen, Lauri/A-5375-2010; Vähärautio, Anna/K-4279-2015; Yan, Jian/B-2631-2018; Enge, Martin/GYQ-5073-2022	Aaltonen, Lauri/0000-0001-6839-4286; Vähärautio, Anna/0000-0003-4721-3954; Yan, Jian/0000-0002-1267-2870; Sur, Inderpreet Kaur/0000-0001-5787-1040; Turunen, Mikko/0000-0001-5134-1559; Karhu, Auli/0000-0002-7927-0796; Enge, Martin/0000-0001-8748-8931; Taipale, Minna/0000-0002-1905-2551	Academy of Finland [140753]; Finnish Center of Excellence in Cancer Genetics Research [250345]; European Union Framework Program 7 project SYSCOL; European Research Council project GROWTHCONTROL; Sigrid Juselius Foundation; Finnish Cancer Society; Swedish Cancer Society; Center for Biosciences at Karolinska Institutet; Vetenskapsradet;  [134073]	Academy of Finland(Academy of Finland); Finnish Center of Excellence in Cancer Genetics Research; European Union Framework Program 7 project SYSCOL; European Research Council project GROWTHCONTROL; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Society; Swedish Cancer Society(Swedish Cancer Society); Center for Biosciences at Karolinska Institutet(Karolinska Institutet); Vetenskapsradet(Swedish Research Council); 	We thank S. Miettinen and A. Zetterlund for technical assistance. This work was supported by the Academy of Finland grant 140753, postdoctoral researcher's project 134073, Finnish Center of Excellence in Cancer Genetics Research 250345, European Union Framework Program 7 project SYSCOL, European Research Council project GROWTHCONTROL, the Sigrid Juselius Foundation, the Finnish Cancer Society, the Swedish Cancer Society, the Center for Biosciences at Karolinska Institutet, and Vetenskapsradet.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Athineos D, 2010, ONCOGENE, V29, P2585, DOI 10.1038/onc.2010.5; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen J Craig, 2004, BMC Dev Biol, V4, P4; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Evan G, 2012, SCIENCE, V335, P293, DOI 10.1126/science.1217819; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ignatenko NA, 2006, CANCER BIOL THER, V5, P1658, DOI 10.4161/cbt.5.12.3376; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	28	163	166	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1360	1363		10.1126/science.1228606	http://dx.doi.org/10.1126/science.1228606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23118011				2022-12-24	WOS:000311991200072
J	Groenen, MAM; Archibald, AL; Uenishi, H; Tuggle, CK; Takeuchi, Y; Rothschild, MF; Rogel-Gaillard, C; Park, C; Milan, D; Megens, HJ; Li, ST; Larkin, DM; Kim, H; Frantz, LAF; Caccamo, M; Ahn, H; Aken, BL; Anselmo, A; Anthon, C; Auvil, L; Badaoui, B; Beattie, CW; Bendixen, C; Berman, D; Blecha, F; Blomberg, J; Bolund, L; Bosse, M; Botti, S; Zhan, BJ; Bystrom, M; Capitanu, B; Carvalho-Silva, D; Chardon, P; Chen, C; Cheng, R; Choi, SH; Chow, W; Clark, RC; Clee, C; Crooijmans, RPMA; Dawson, HD; Dehais, P; De Sapio, F; Dibbits, B; Drou, N; Du, ZQ; Eversole, K; Fadista, J; Fairley, S; Faraut, T; Faulkner, GJ; Fowler, KE; Fredholm, M; Fritz, E; Gilbert, JGR; Giuffra, E; Gorodkin, J; Griffin, DK; Harrow, JL; Hayward, A; Howe, K; Hu, ZL; Humphray, SJ; Hunt, T; Hornshoj, H; Jeon, JT; Jern, P; Jones, M; Jurka, J; Kanamori, H; Kapetanovic, R; Kim, J; Kim, JH; Kim, KW; Kim, TH; Larson, G; Lee, K; Lee, KT; Leggett, R; Lewin, HA; Li, YR; Liu, WS; Loveland, JE; Lu, Y; Lunney, JK; Ma, J; Madsen, O; Mann, K; Matthews, L; McLaren, S; Morozumi, T; Murtaugh, MP; Narayan, J; Nguyen, DT; Ni, PX; Oh, SJ; Onteru, S; Panitz, F; Park, EW; Park, HS; Pascal, G; Paudel, Y; Perez-Enciso, M; Ramirez-Gonzalez, R; Reecy, JM; Rodriguez-Zas, S; Rohrer, GA; Rund, L; Sang, YM; Schachtschneider, K; Schraiber, JG; Schwartz, J; Scobie, L; Scott, C; Searle, S; Servin, B; Southey, BR; Sperber, G; Stadler, P; Sweedler, JV; Tafer, H; Thomsen, B; Wali, R; Wang, J; Wang, J; White, S; Xu, X; Yerle, M; Zhang, GJ; Zhang, JG; Zhang, J; Zhao, SH; Rogers, J; Churcher, C; Schook, LB				Groenen, Martien A. M.; Archibald, Alan L.; Uenishi, Hirohide; Tuggle, Christopher K.; Takeuchi, Yasuhiro; Rothschild, Max F.; Rogel-Gaillard, Claire; Park, Chankyu; Milan, Denis; Megens, Hendrik-Jan; Li, Shengting; Larkin, Denis M.; Kim, Heebal; Frantz, Laurent A. F.; Caccamo, Mario; Ahn, Hyeonju; Aken, Bronwen L.; Anselmo, Anna; Anthon, Christian; Auvil, Loretta; Badaoui, Bouabid; Beattie, Craig W.; Bendixen, Christian; Berman, Daniel; Blecha, Frank; Blomberg, Jonas; Bolund, Lars; Bosse, Mirte; Botti, Sara; Zhan Bujie; Bystrom, Megan; Capitanu, Boris; Carvalho-Silva, Denise; Chardon, Patrick; Chen, Celine; Cheng, Ryan; Choi, Sang-Haeng; Chow, William; Clark, Richard C.; Clee, Christopher; Crooijmans, Richard P. M. A.; Dawson, Harry D.; Dehais, Patrice; De Sapio, Fioravante; Dibbits, Bert; Drou, Nizar; Du, Zhi-Qiang; Eversole, Kellye; Fadista, Joao; Fairley, Susan; Faraut, Thomas; Faulkner, Geoffrey J.; Fowler, Katie E.; Fredholm, Merete; Fritz, Eric; Gilbert, James G. R.; Giuffra, Elisabetta; Gorodkin, Jan; Griffin, Darren K.; Harrow, Jennifer L.; Hayward, Alexander; Howe, Kerstin; Hu, Zhi-Liang; Humphray, Sean J.; Hunt, Toby; Hornshoj, Henrik; Jeon, Jin-Tae; Jern, Patric; Jones, Matthew; Jurka, Jerzy; Kanamori, Hiroyuki; Kapetanovic, Ronan; Kim, Jaebum; Kim, Jae-Hwan; Kim, Kyu-Won; Kim, Tae-Hun; Larson, Greger; Lee, Kyooyeol; Lee, Kyung-Tai; Leggett, Richard; Lewin, Harris A.; Li, Yingrui; Liu, Wansheng; Loveland, Jane E.; Lu, Yao; Lunney, Joan K.; Ma, Jian; Madsen, Ole; Mann, Katherine; Matthews, Lucy; McLaren, Stuart; Morozumi, Takeya; Murtaugh, Michael P.; Narayan, Jitendra; Dinh Truong Nguyen; Ni, Peixiang; Oh, Song-Jung; Onteru, Suneel; Panitz, Frank; Park, Eung-Woo; Park, Hong-Seog; Pascal, Geraldine; Paudel, Yogesh; Perez-Enciso, Miguel; Ramirez-Gonzalez, Ricardo; Reecy, James M.; Rodriguez-Zas, Sandra; Rohrer, Gary A.; Rund, Lauretta; Sang, Yongming; Schachtschneider, Kyle; Schraiber, Joshua G.; Schwartz, John; Scobie, Linda; Scott, Carol; Searle, Stephen; Servin, Bertrand; Southey, Bruce R.; Sperber, Goran; Stadler, Peter; Sweedler, Jonathan V.; Tafer, Hakim; Thomsen, Bo; Wali, Rashmi; Wang, Jian; Wang, Jun; White, Simon; Xu, Xun; Yerle, Martine; Zhang, Guojie; Zhang, Jianguo; Zhang, Jie; Zhao, Shuhong; Rogers, Jane; Churcher, Carol; Schook, Lawrence B.			Analyses of pig genomes provide insight into porcine demography and evolution	NATURE			English	Article							SEQUENCE; GENE; RECEPTOR; TASTE	For 10,000 years pigs and humans have shared a close and complex relationship. From domestication to modern breeding practices, humans have shaped the genomes of domestic pigs. Here we present the assembly and analysis of the genome sequence of a female domestic Duroc pig (Sus scrofa) and a comparison with the genomes of wild and domestic pigs from Europe and Asia. Wild pigs emerged in South East Asia and subsequently spread across Eurasia. Our results reveal a deep phylogenetic split between European and Asian wild boars similar to 1 million years ago, and a selective sweep analysis indicates selection on genes involved in RNA processing and regulation. Genes associated with immune response and olfaction exhibit fast evolution. Pigs have the largest repertoire of functional olfactory receptor genes, reflecting the importance of smell in this scavenging animal. The pig genome sequence provides an important resource for further improvements of this important livestock species, and our identification of many putative disease-causing variants extends the potential of the pig as a biomedical model.	[Groenen, Martien A. M.; Megens, Hendrik-Jan; Frantz, Laurent A. F.; Bosse, Mirte; Crooijmans, Richard P. M. A.; Dibbits, Bert; Madsen, Ole; Paudel, Yogesh] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6708 WD Wageningen, Netherlands; [Archibald, Alan L.; De Sapio, Fioravante; Faulkner, Geoffrey J.; Kapetanovic, Ronan] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Archibald, Alan L.; De Sapio, Fioravante; Faulkner, Geoffrey J.; Kapetanovic, Ronan] Univ Edinburgh, R D SVS, Easter Bush EH25 9RG, Midlothian, Scotland; [Uenishi, Hirohide; Kanamori, Hiroyuki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Tuggle, Christopher K.; Rothschild, Max F.; Bystrom, Megan; Cheng, Ryan; Du, Zhi-Qiang; Fritz, Eric; Hu, Zhi-Liang; Onteru, Suneel; Reecy, James M.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Tuggle, Christopher K.; Rothschild, Max F.; Bystrom, Megan; Cheng, Ryan; Du, Zhi-Qiang; Fritz, Eric; Hu, Zhi-Liang; Onteru, Suneel; Reecy, James M.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA 50011 USA; [Takeuchi, Yasuhiro] UCL, Div Infect & Immun, MRC, UCL Ctr Med Mol Virol, London WC1E 6BT, England; [Takeuchi, Yasuhiro] UCL, Div Infect & Immun, Wohl Vir Ctr, London WC1E 6BT, England; [Rogel-Gaillard, Claire; Chardon, Patrick; Giuffra, Elisabetta] INRA, Lab Anim Genet & Integrat Biol, Lab Radiobiol & Etud Genome, AgroParisTech,CEA,DSV,IRCM, F-78350 Jouy En Josas, France; [Park, Chankyu; Kim, Jaebum; Lee, Kyooyeol; Dinh Truong Nguyen] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea; [Milan, Denis; Dehais, Patrice; Faraut, Thomas; Servin, Bertrand; Yerle, Martine] INRA, Lab Genet Cellulaire, F-31320 Castanet Tolosan, France; [Li, Shengting; Bolund, Lars; Li, Yingrui; Lu, Yao; Ni, Peixiang; Wang, Jian; Wang, Jun; Xu, Xun; Zhang, Guojie; Zhang, Jianguo] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Shengting; Bolund, Lars] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Larkin, Denis M.; Narayan, Jitendra] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DA, Ceredigion, Wales; [Kim, Heebal; Ahn, Hyeonju] Seoul Natl Univ, Dept Agr Biotechnol & C&K Genom, Seoul 151742, South Korea; [Caccamo, Mario; Drou, Nizar; Leggett, Richard; Ramirez-Gonzalez, Ricardo; Rogers, Jane] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Aken, Bronwen L.; Chow, William; Clark, Richard C.; Clee, Christopher; Fairley, Susan; Gilbert, James G. R.; Harrow, Jennifer L.; Howe, Kerstin; Humphray, Sean J.; Hunt, Toby; Jones, Matthew; Loveland, Jane E.; Matthews, Lucy; McLaren, Stuart; Scott, Carol; Searle, Stephen; White, Simon; Churcher, Carol] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Anselmo, Anna; Badaoui, Bouabid; Botti, Sara; Giuffra, Elisabetta] Parco Tecnol Padano, I-26900 Lodi, Italy; [Anthon, Christian; Fredholm, Merete; Gorodkin, Jan] IBHV Univ Copenhagen, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark; [Auvil, Loretta; Capitanu, Boris] Univ Illinois, Illinois Informat Inst, Urbana, IL 61801 USA; [Beattie, Craig W.] Univ Illinois, Dept Surg, Chicago, IL 60612 USA; [Bendixen, Christian; Zhan Bujie; Fadista, Joao; Hornshoj, Henrik; Panitz, Frank; Thomsen, Bo] Aarhus Univ, Dept Mol Biol & Genet, DK-8830 Tjele, Denmark; [Berman, Daniel; Lunney, Joan K.; Mann, Katherine] USDA ARS, BARC Anim Parasit Dis Lab, Beltsville, MD 20705 USA; [Blecha, Frank; Sang, Yongming] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Acad Hosp, S-75185 Uppsala, Sweden; [Carvalho-Silva, Denise] European Bioinformat Inst, Hinxton CB10 1SD, Cambs, England; [Chen, Celine; Dawson, Harry D.] USDA, Immunol Lab, Beltsville Human Nutr Res Ctr, BARC E, Beltsville, MD 20705 USA; [Choi, Sang-Haeng; Park, Hong-Seog] Korean Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Eversole, Kellye] Eversole Associates, Bethesda, MD 20816 USA; [Eversole, Kellye] Alliance Anim Genome Res, Bethesda, MD 20816 USA; [Fowler, Katie E.; Griffin, Darren K.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Hayward, Alexander; Jern, Patric] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, BMC, SE-75123 Uppsala, Sweden; [Jeon, Jin-Tae] Gyeongsang Natl Univ, Coll Agr & Life Sci, Dept Anim Sci, Jinju 660701, South Korea; [Jurka, Jerzy] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Kanamori, Hiroyuki; Morozumi, Takeya] Inst Japan Assoc Technoinnovat Agr Forestry & Fis, Tsukuba, Ibaraki 3050854, Japan; [Kim, Jaebum] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Kim, Jae-Hwan] Natl Inst Anim Sci, Anim Genet Resources Stn, RDA, Namwon 590832, South Korea; [Kim, Kyu-Won] C&K Genom, Seoul 151742, South Korea; [Kim, Tae-Hun; Lee, Kyung-Tai; Park, Eung-Woo] Natl Inst Anim Sci, Anim Genom & Bioinformat Div, RDA, Suwon 441706, South Korea; [Larson, Greger] Univ Durham, Dept Archaeol, Durham DH1 3LE, England; [Lewin, Harris A.] Univ Calif Davis, UC Davis Genome Ctr, Dept Ecol & Evolut, Davis, CA 95618 USA; [Liu, Wansheng] Penn State Univ, Coll Agr Sci, CRBH, Dept Dairy & Anim Sci, University Pk, PA 16802 USA; [Ma, Jian] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Ma, Jian] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Murtaugh, Michael P.; Schwartz, John] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Oh, Song-Jung] Jeju Natl Univ, Cheju 690756, South Korea; [Pascal, Geraldine] INRA, CNRS, UMR85, IFCE,Physiol Reprod & Comportements UMR7247, F-37380 Nouzilly, France; [Pascal, Geraldine] Univ Tours, F-37041 Tours, France; [Perez-Enciso, Miguel] CRAG, ICREA, E-08193 Bellaterra, Spain; [Perez-Enciso, Miguel] UAB, Fac Vet, E-08193 Bellaterra, Spain; [Rodriguez-Zas, Sandra; Rund, Lauretta; Schachtschneider, Kyle; Southey, Bruce R.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Rohrer, Gary A.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; [Schraiber, Joshua G.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Scobie, Linda; Wali, Rashmi] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Sperber, Goran] Uppsala Univ, Biomed Ctr, Dept Neurosci, S-75124 Uppsala, Sweden; [Stadler, Peter; Tafer, Hakim] Univ Leipzig, Dept Comp Sci, Interdisciplinary Ctr Bioinformat, Bioinformat Grp, Leipzig, Germany; [Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Zhang, Guojie] BGI Europe, DK-2200 Copenhagen N, Denmark; [Zhang, Jie; Zhao, Shuhong] Huazhong Agr Univ, Minist Educ, Key Lab Anim Genet Breeding & Reprod, Wuhan 430070, Peoples R China; [Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Schook, Lawrence B.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Wageningen University & Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; National Institute of Agrobiological Sciences - Japan; Iowa State University; Iowa State University; University of London; University College London; University of London; University College London; AgroParisTech; CEA; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Konkuk University; INRAE; Beijing Genomics Institute (BGI); Aarhus University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Seoul National University (SNU); The Genome Analysis Centre (TGAC); Wellcome Trust Sanger Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Aarhus University; United States Department of Agriculture (USDA); Kansas State University; Uppsala University; European Molecular Biology Laboratory (EMBL); United States Department of Agriculture (USDA); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Kent; Uppsala University; Gyeongsang National University; University of Illinois System; University of Illinois Urbana-Champaign; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Durham University; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; Jeju National University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); ICREA; Autonomous University of Barcelona; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Glasgow Caledonian University; Uppsala University; Leipzig University; University of Illinois System; University of Illinois Urbana-Champaign; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Huazhong Agricultural University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Groenen, MAM (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, Elst 1, NL-6708 WD Wageningen, Netherlands.	martien.groenen@wur.nl; alan.archibald@roslin.ed.ac.uk	Pascal, Geraldine/P-8125-2019; Megens, Hendrik-Jan/M-5300-2019; Zhang, Guojie/B-6188-2014; Madsen, Ole/E-3730-2012; Faulkner, Geoffrey J/M-3168-2014; Ma, Jian/A-9838-2008; PASCAL, Géraldine/L-4519-2013; Sweedler, Jonathan V/A-9405-2009; Perez-Enciso, Miguel/H-6057-2015; kapetanovic, ronan/G-8322-2012; Jensen, Betina W/J-2207-2015; Eversole, Kellye/AAN-6141-2020; Stadler, Peter F. F/L-7857-2015; Larkin, Denis/AAB-2249-2022; Servin, Bertrand/B-2206-2008; Giuffra, Elisabetta/I-3201-2013; Xu, Xun/AAI-6763-2020; Park, Chankyu/D-8775-2011; Schwartz, John/I-3002-2019; Kim, Heebal/A-8889-2016; Jern, Patric/AAR-2133-2021; Larkin, Denis/AAB-1633-2022; Groenen, Martien/D-8408-2012; PASCAL, Géraldine/A-7041-2008; Ramírez, Ricardo/H-4808-2019; Badaoui, Bouabid/AAV-8968-2021; Zhang, Guojie/J-7273-2019; Dawson, Harry/ABG-2734-2021; Nguyen, Dinh-Truong/AAI-5062-2021; Li, Yingrui/K-1064-2015; LEWIN, HARRIS/HGC-6543-2022; Giuffra, Elisabetta/J-8080-2014; Kapetanovic, Ronan/GRO-1748-2022; Dawson, Harry/H-8242-2013; Panitz, Frank/A-3281-2017; Megens, Hendrik-Jan/E-9676-2010; Wang, Jun/A-7261-2013; Crooijmans, Richard PMA/E-2492-2012; Kim, Kyu Won/AAJ-7213-2020; Fadista, Joao/AAM-4870-2020; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Pascal, Geraldine/0000-0002-5250-6594; Megens, Hendrik-Jan/0000-0002-3619-7533; Zhang, Guojie/0000-0001-6860-1521; Madsen, Ole/0000-0001-8082-7881; Faulkner, Geoffrey J/0000-0001-5769-4494; Ma, Jian/0000-0002-4202-5834; PASCAL, Géraldine/0000-0002-5250-6594; Sweedler, Jonathan V/0000-0003-3107-9922; Perez-Enciso, Miguel/0000-0003-3524-995X; kapetanovic, ronan/0000-0002-2908-1014; Eversole, Kellye/0000-0002-8784-4913; Stadler, Peter F. F/0000-0002-5016-5191; Servin, Bertrand/0000-0001-5141-0913; Xu, Xun/0000-0002-5338-5173; Schwartz, John/0000-0003-2057-1831; Kim, Heebal/0000-0003-3064-1303; Jern, Patric/0000-0003-3393-5825; Larkin, Denis/0000-0001-7859-6201; Groenen, Martien/0000-0003-0484-4545; Ramírez, Ricardo/0000-0001-5745-7085; Zhang, Guojie/0000-0001-6860-1521; Dawson, Harry/0000-0002-7648-9952; Nguyen, Dinh-Truong/0000-0002-6452-5573; LEWIN, HARRIS/0000-0002-1043-7287; Kapetanovic, Ronan/0000-0002-2908-1014; Panitz, Frank/0000-0002-6909-5162; Megens, Hendrik-Jan/0000-0002-3619-7533; Fadista, Joao/0000-0003-2539-634X; Harrow, Jennifer/0000-0003-0338-3070; Giuffra, Elisabetta/0000-0001-9568-2056; Frantz, Laurent/0000-0001-8030-3885; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Rohrer, Gary/0000-0002-8252-9308; ROGEL-GAILLARD, Claire/0000-0002-2174-1962; Southey, Bruce/0000-0002-8959-7709; Hunt, Toby/0000-0001-8377-0841; Reecy, James/0000-0003-4602-0990; Thomsen, Bo/0000-0001-9622-0929; Gilbert, James/0000-0001-8079-3159; Aken, Bronwen/0000-0002-3032-4095; Leggett, Richard/0000-0003-3044-4297; Ahn, Hyeonju/0000-0002-8922-972X; Mann, Katherine/0000-0001-8144-8170; Chow, William/0000-0002-9056-201X; Hayward, Alexander/0000-0001-7413-718X; Wang, Jun/0000-0002-2113-5874; Gorodkin, Jan/0000-0001-5823-4000; Carvalho-Silva, Dr D/0000-0001-5662-1840; Wang, Jun/0000-0002-8540-8931; fadista, joao/0000-0001-7558-7043; Anselmo, Anna/0000-0002-5279-8670; Howe, Kerstin/0000-0003-2237-513X; Harvey, Katie/0000-0003-0359-2390; rund, laurie/0000-0003-0761-7196; Schook, Lawrence/0000-0002-6580-8364; Blomberg, Jonas/0000-0001-6492-2491; Schachtschneider, Kyle/0000-0002-7293-8642; Park, Chankyu/0000-0003-4855-2210; Bosse, Mirte/0000-0003-2433-2483; Fairley, Susan/0000-0001-9425-0788; Zhang, Jianguo/0000-0003-0723-1701; Archibald, Alan/0000-0001-9213-1830; Loveland, Jane/0000-0002-7669-2934; Anthon, Christian/0000-0002-4336-1688; CHENG, RYAN PEI YEN/0000-0002-2119-6431; Tafer, Hakim/0000-0002-6252-9802; Fredholm, Merete/0000-0002-3563-7648; Narayan, Jitendra/0000-0002-2065-2861; White, Simon/0000-0001-6375-2363	USDA CSREES/NIFA Swine Genome Coordination Program; College of Agricultural, Consumer and Environmental Sciences, University of Illinois; College of Agriculture and Life Sciences, Iowa State University; North Carolina Agricultural Research Service; USA National Pork Board; Iowa Pork Producers Association; North Carolina Pork Council; Danish government; TOPIGS Research Center IPG The Netherlands; INRA Genescope, France; Wellcome Trust Sanger Institute and BGI.; BBSRC [BB/E010520/1, BB/E010520/2, BB/I025328/1, BB/H005935/1, BB/G004013/1]; EC FP6 'Cutting edge genomics for sustainable animal breeding (SABRE)'; EC FP7 'Quantomics'; Australian NHMRC [575585]; Next-Generation BioGreen 21 Program [PJ009019, PJ0081162012, PJ0080892011]; RDA, Republic of Korea; Ministry of Research (Spain); NIH [R13 RR020283A, NIH R13 RR032267A, ILLU 535-314, ILLU 538-379, ILLU-538-312, ILLU-538-34, 5 P41LM006252, P20-RR017686, 5 P41 LM006252]; CSREES; NIFA; MAFF [IRPPIAUGT-AG 1101/1201]; USDA-NRSP8 Bioinformatics Coordination and Pig Genome Coordination funds; US-UK Fulbright Commission; USDA-ARS Project Plan [1235-51000-055-00D, 1265-32000-098-00D]; USDA AFRI NIFA/DHS [2010-39559-21860]; USDA ARS; USDA-NRSP8 Bioinformatics; NSFC [31025026]; Swedish Research Council FORMAS; Swedish Wenner-Gren Foundations; European Commission [LSHB-CT-2006-037377]; BioGreen21; RDA [PJ00622901, PJ00622902, PJ00622903, 20040301034467]; European Research Council under the European Community [249894]; NIH NIDA [P30 DA018310, R21 DA027548]; ANR [ANR07-GANI-001]; FTP/DFF [09-066598]; DSF/Strategic Growth Technologies [09-067036]; Lundbeck foundation [374/06]; DCSC (Scientific Computing); Funds for International Cooperation from the Ministry of Science and Technology of China [2002AA229061]; PL-Grid project: [POIG.02.03.00-00-007/08-00]; USDA-NIFA-CREES [AG 2006-35216-16668, AG 2002-34480-11828, AG 2003-34480-13172, AG 2004-34480-14417, AG 2005-34480-15939, AG 2006-34480-17150, AG 2008-34480-19328, AG 2009-34480-19875, AG 2002-35205-12712, AG 2008-35205-18769, AG 2009-65205-05642, AG 2004-3881-02193];  [USDA-NRI-2009-35205-05192];  [USDA-NRI-2006-35204-17337]; BBSRC [BB/E011640/1, BB/I025506/1, BBS/E/T/000PR5885, BBS/E/D/20211550, BB/I025360/1, BB/E010768/1, BBS/E/D/05191130] Funding Source: UKRI; MRC [G0900950] Funding Source: UKRI; NERC [NE/F003382/2, NE/F003382/1, NE/H005552/1, NE/H005269/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E010520/1, BB/E010768/1, BB/G004013/1, BBS/E/D/05191130, BB/I025360/1, BB/I025328/1, BB/H005935/1, BB/E010520/2, BB/I025506/1, BB/E011640/1, BBS/E/D/20211550] Funding Source: researchfish; Medical Research Council [G0900950, G0900950B] Funding Source: researchfish; Natural Environment Research Council [NE/F003382/1, NE/H005552/1, NE/F003382/2, NE/H005269/1] Funding Source: researchfish; Chief Scientist Office [ETM/32] Funding Source: researchfish; ICREA Funding Source: Custom; NATIONAL CENTER FOR RESEARCH RESOURCES [R13RR032267, P20RR017686, R13RR020283] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548, P30DA018310] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [P41LM006252] Funding Source: NIH RePORTER	USDA CSREES/NIFA Swine Genome Coordination Program; College of Agricultural, Consumer and Environmental Sciences, University of Illinois; College of Agriculture and Life Sciences, Iowa State University; North Carolina Agricultural Research Service; USA National Pork Board; Iowa Pork Producers Association; North Carolina Pork Council; Danish government; TOPIGS Research Center IPG The Netherlands; INRA Genescope, France; Wellcome Trust Sanger Institute and BGI.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC FP6 'Cutting edge genomics for sustainable animal breeding (SABRE)'; EC FP7 'Quantomics'; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); RDA, Republic of Korea; Ministry of Research (Spain); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); MAFF(Ministry of Agriculture Forestry & Fisheries - Japan); USDA-NRSP8 Bioinformatics Coordination and Pig Genome Coordination funds; US-UK Fulbright Commission; USDA-ARS Project Plan; USDA AFRI NIFA/DHS; USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-NRSP8 Bioinformatics; NSFC(National Natural Science Foundation of China (NSFC)); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Wenner-Gren Foundations; European Commission(European CommissionEuropean Commission Joint Research Centre); BioGreen21(Rural Development Administration (RDA), Republic of Korea); RDA(Rural Development Administration (RDA), Republic of Korea); European Research Council under the European Community(European Research Council (ERC)); NIH NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ANR(French National Research Agency (ANR)); FTP/DFF; DSF/Strategic Growth Technologies; Lundbeck foundation(Lundbeckfonden); DCSC (Scientific Computing); Funds for International Cooperation from the Ministry of Science and Technology of China; PL-Grid project:; USDA-NIFA-CREES; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Chief Scientist Office; ICREA(ICREA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors recognize the contributions of the following individuals towards the establishment of the Swine Genome Sequencing Consortium and their leadership in realizing this effort: J. Jen, P. J. Burfening, D. Hamernik, R. A. Easter, N. Merchen, R. D. Green, J. Cassady, B. Harlizius, M. Boggess and M. Stratton. Also the authors acknowledge A. Hernandez, C. Wright at the University of Illinois Keck Center for Comparative and Functional Genomics; N. Bruneau and Prof. Ning Li for their contribution to PERV studies; D. Goodband and D. Berman for their efforts in genome annotation; D. Grafham of the Welcome Trust Sanger Institute for his efforts in the genome assembly and J. Hedegaard, M. Nielsen and R. O. Nielsen for their contribution on the miRNA analysis. We also recognize contributions from the National Institute of Agrobiological Sciences and the Institute of Japan Association for Techno-innovation in Agriculture, Forestry and Fisheries, Tsukuba, Japan, H. Shinkai, T. Eguchi-Ogawa, K. Suzuki, D. Toki, T. Matsumoto, N. Fujishima-Kanaya, A. Mikawa, N. Okumura, M. Tanaka-Matsuda, K. Kurita, H. Sasaki, K. Kamiya, A. Kikuta, T. Bito and N. Fujitsuka. We acknowledge support from the USDA CSREES/NIFA Swine Genome Coordination Program, College of Agricultural, Consumer and Environmental Sciences, University of Illinois; College of Agriculture and Life Sciences, Iowa State University; North Carolina Agricultural Research Service; USA National Pork Board; Iowa Pork Producers Association; North Carolina Pork Council; Danish government; TOPIGS Research Center IPG The Netherlands; INRA Genescope, France; Wellcome Trust Sanger Institute and BGI. We are grateful to the genome team at NCBI for their assistance in checking the Sscrofa 10.2 assembly and for their independent annotation of the sequence. This project was also partially supported by grants: BBSRC grants (Ensembl): BB/E010520/1, BB/E010520/2, BB/I025328/1; EC FP6 'Cutting edge genomics for sustainable animal breeding (SABRE)'; EC FP7 'Quantomics'; C. J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC (575585); BBSRC (BB/H005935/1); Next-Generation BioGreen 21 Program (PJ009019, PJ0081162012), RDA, Republic of Korea; Consolider programme from Ministry of Research (Spain); NIH R13 RR020283A; NIH R13 RR032267A; ILLU 535-314; ILLU 538-379; ILLU-538-312; ILLU-538-34; CSREES, NIFA for funding genome coordination activities; NIH grant 5 P41LM006252; MAFF grants (IRPPIAUGT-AG 1101/1201); USDA-NRI-2009-35205-05192; USDA-NRSP8 Bioinformatics Coordination and Pig Genome Coordination funds; US-UK Fulbright Commission; Next-Generation BioGreen 21 (no. PJ0080892011) Program, RDA, Republic of Korea; USDA-ARS Project Plan 1235-51000-055-00D; USDA-ARS Project Plan 1265-32000-098-00D; USDA-NRI-2006-35204-17337 USDA AFRI NIFA/DHS 2010-39559-21860; NIH P20-RR017686; USDA ARS; USDA-NRSP8 Bioinformatics; USDA ARS Beltsville Area Summer Undergraduate Fellowships; BBSRC grant BB/G004013/1; NSFC Outstanding Youth grant (31025026); The Swedish Research Council FORMAS; The Swedish Wenner-Gren Foundations; European Commission FP6 funded project LSHB-CT-2006-037377; BioGreen21, RDA grant PJ00622901; BioGreen21, RDA grant PJ00622902; BioGreen21, RDA grant PJ00622903; BioGreen21, RDA grant PJ00622903. The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no.; 249894 (SelSweep); NIH P20-RR017686; NIH NIDA P30 DA018310; NIH NIDA R21 DA027548; NIAS, RDA grant PJ001758; BioGreen21, RDA grant PJ006229; NIAS, RDA grant 20040301034467; ANR grant ANR07-GANI-001 DeliSus; Danish funding agencies: FTP/DFF (09-066598); DSF/Strategic Growth Technologies (09-067036); the Lundbeck foundation (374/06); DCSC (Scientific Computing); The Funds for International Cooperation from the Ministry of Science and Technology of China 2002AA229061; PL-Grid project: POIG.02.03.00-00-007/08-00 'Genome Assembly'; USDA-NIFA-CREES AG 2006-35216-16668; AG 2002-34480-11828; AG 2003-34480-13172; AG 2004-34480-14417; AG 2005-34480-15939; AG 2006-34480-17150; AG 2008-34480-19328; AG 2009-34480-19875; AG 2002-35205-12712; somatic cell genomics: Integrating QTL Discovery and Validation; AG 2008-35205-18769; AG 2009-65205-05642; AG 2004-3881-02193; AG 2011-67015-30229; AG 58-5438-2-313; AG 58-5438-7-317; and AG 58-0208-7-149; NIH grant 5 P41 LM006252.	Archibald AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-438; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Eguchi-Ogawa T, 2009, DEV COMP IMMUNOL, V33, P1111, DOI 10.1016/j.dci.2009.06.006; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fang X., GIGASCIENCE IN PRESS; Fischer A, 2005, MOL BIOL EVOL, V22, P432, DOI 10.1093/molbev/msi027; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hellekant G, 1999, J ANIM PHYSIOL AN N, V82, P8, DOI 10.1046/j.1439-0396.1999.00206.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humphray SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r139; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kupsco JM, 2006, RNA, V12, P2103, DOI 10.1261/rna.186706; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Murgiano L., BMC GENOMIC IN PRESS; Nelson SL, 1997, CHEM SENSES, V22, P129, DOI 10.1093/chemse/22.2.129; Nguyen D. T., BMC GENOMIC IN PRESS; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Renard C, 2006, GENOMICS, V88, P96, DOI 10.1016/j.ygeno.2006.01.004; Rubin C. J., P NATL ACAD IN PRESS; Sambrook JG, 2006, IMMUNOGENETICS, V58, P481, DOI 10.1007/s00251-006-0110-9; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Schwartz JC, 2012, IMMUNOGENETICS, V64, P399, DOI 10.1007/s00251-011-0594-9; Schwartz JC, 2012, IMMUNOGENETICS, V64, P303, DOI 10.1007/s00251-011-0589-6; Shimamura M, 1999, MOL BIOL EVOL, V16, P1046, DOI 10.1093/oxfordjournals.molbev.a026194; Tanaka-Matsuda M, 2009, GENOMICS, V93, P261, DOI 10.1016/j.ygeno.2008.10.004; Tortereau F., BMC GENOMIC IN PRESS; Uenishi H, 2003, IMMUNOLOGY, V109, P515, DOI 10.1046/j.1365-2567.2003.01695.x; Uenishi H, 2009, MOL IMMUNOL, V46, P1212, DOI 10.1016/j.molimm.2008.11.010; VANDENBROECK K, 1993, EUR J BIOCHEM, V217, P45, DOI 10.1111/j.1432-1033.1993.tb18216.x; Walters E. M., BMC MED GEN IN PRESS; White S, 2011, ENVIRON HIST-US, V16, P94, DOI 10.1093/envhis/emq143; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	45	919	959	17	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					393	398		10.1038/nature11622	http://dx.doi.org/10.1038/nature11622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151582	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000311031600036
J	DeSantis, ME; Leung, EH; Sweeny, EA; Jackrel, ME; Cushman-Nick, M; Neuhaus-Follini, A; Vashist, S; Sochor, MA; Knight, MN; Shorter, J				DeSantis, Morgan E.; Leung, Eunice H.; Sweeny, Elizabeth A.; Jackrel, Meredith E.; Cushman-Nick, Mimi; Neuhaus-Follini, Alexandra; Vashist, Shilpa; Sochor, Matthew A.; Knight, M. Noelle; Shorter, James			Operational Plasticity Enables Hsp104 to Disaggregate Diverse Amyloid and Nonamyloid Clients	CELL			English	Article							PLUS CHAPERONE CLPB; PROTEIN DISAGGREGATION; AGGREGATED PROTEINS; COMMON MECHANISM; YEAST PRIONS; CENTRAL PORE; THERMOTOLERANCE; PROPAGATION; INHERITANCE; DISORDERS	It is not understood how Hsp104, a hexameric AAA+ ATPase from yeast, disaggregates diverse structures, including stress-induced aggregates, prions, and a-synuclein conformers connected to Parkinson disease. Here, we establish that Hsp104 hexamers adapt different mechanisms of intersubunit collaboration to disaggregate stress-induced aggregates versus amyloid. To resolve disordered aggregates, Hsp104 subunits collaborate noncooperatively via probabilistic substrate binding and ATP hydrolysis. To disaggregate amyloid, several subunits cooperatively engage substrate and hydrolyze ATP. Importantly, Hsp104 variants with impaired intersubunit communication dissolve disordered aggregates, but not amyloid. Unexpectedly, prokaryotic ClpB subunits collaborate differently than Hsp104 and couple probabilistic substrate binding to cooperative ATP hydrolysis, which enhances disordered aggregate dissolution but sensitizes ClpB to inhibition and diminishes amyloid disaggregation. Finally, we establish that Hsp104 hexamers deploy more subunits to disaggregate Sup35 prion strains with more stable "cross-beta" cores. Thus, operational plasticity enables Hsp104 to robustly dissolve amyloid and nonamyloid clients, which impose distinct mechanical demands.	[DeSantis, Morgan E.; Leung, Eunice H.; Sweeny, Elizabeth A.; Jackrel, Meredith E.; Cushman-Nick, Mimi; Neuhaus-Follini, Alexandra; Vashist, Shilpa; Sochor, Matthew A.; Knight, M. Noelle; Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [DeSantis, Morgan E.; Sweeny, Elizabeth A.; Sochor, Matthew A.; Knight, M. Noelle; Shorter, James] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA; [Cushman-Nick, Mimi; Neuhaus-Follini, Alexandra; Shorter, James] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Shorter, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Jackrel, Meredith/0000-0003-4406-9504; Sweeny, Elizabeth/0000-0001-7818-9112	NIH [T32GM071339, T32GM008275, T32AG000255, DP2OD002177]; NRSA [F31NS079009, F31NS067890]; AHA; Ellison Medical Foundation New Scholar in Aging Award; Penn Institute of Aging; Alzheimer Disease Core Center; Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071339, T32GM008275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS079009, F31NS067890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Ellison Medical Foundation New Scholar in Aging Award(Lawrence Ellison Foundation); Penn Institute of Aging; Alzheimer Disease Core Center; Diabetes Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Sue Lindquist, Sabine Kedzierska-Mieszkowska, and Virginia Lee for reagents. We thank Sandra Maday, Mark Lemmon, Aaron Gitler, Walter Englander, and Nancy Bonini for critiques and Lili Guo for artwork. Our work was funded by NIH training grant T32GM071339 and NRSA predoctoral fellowship F31NS079009 (M. E. D.); NIH training grant T32GM008275 (E. A. S. and M. A. S.); AHA predoctoral (E. A. S.) and postdoctoral fellowships (M.E.J.); NIH training grant T32AG000255 and NRSA predoctoral fellowship F31NS067890 (M.C.-N.); NIH Director's New Innovator Award (DP2OD002177), Ellison Medical Foundation New Scholar in Aging Award, Penn Institute of Aging, Alzheimer Disease Core Center, and Diabetes Research Center Awards (J.S.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dandoy-Dron F, 2006, NEUROSCI LETT, V405, P181, DOI 10.1016/j.neulet.2006.05.066; Doyle SM, 2007, P NATL ACAD SCI USA, V104, P11138, DOI 10.1073/pnas.0703980104; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Duennwald ML, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001346; Garrity SJ, 2010, P NATL ACAD SCI USA, V107, P10596, DOI 10.1073/pnas.0913280107; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lindquist S, 1996, P NATL ACAD SCI USA, V93, P5301, DOI 10.1073/pnas.93.11.5301; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Wang L, 2010, ANGEW CHEM INT EDIT, V49, P3904, DOI 10.1002/anie.201000068; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]	45	128	129	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					778	793		10.1016/j.cell.2012.09.038	http://dx.doi.org/10.1016/j.cell.2012.09.038			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141537	Green Accepted, Bronze			2022-12-24	WOS:000310921200010
J	Moon, TS; Lou, CB; Tamsir, A; Stanton, BC; Voigt, CA				Moon, Tae Seok; Lou, Chunbo; Tamsir, Alvin; Stanton, Brynne C.; Voigt, Christopher A.			Genetic programs constructed from layered logic gates in single cells	NATURE			English	Article							III SECRETION SYSTEM; SYNTHETIC BIOLOGY; ACTIVATION	Genetic programs function to integrate environmental sensors, implement signal processing algorithms and control expression dynamics(1). These programs consist of integrated genetic circuits that individually implement operations ranging from digital logic to dynamic circuits(2-6), and they have been used in various cellular engineering applications, including the implementation of process control in metabolic networks and the coordination of spatial differentiation in artificial tissues. A key limitation is that the circuits are based on biochemical interactions occurring in the confined volume of the cell, so the size of programs has been limited to a few circuits(1,7). Here we apply part mining and directed evolution to build a set of transcriptional AND gates in Escherichia coli. Each AND gate integrates two promoter inputs and controls one promoter output. This allows the gates to be layered by having the output promoter of an upstream circuit serve as the input promoter for a downstream circuit. Each gate consists of a transcription factor that requires a second chaperone protein to activate the output promoter. Multiple activator-chaperone pairs are identified from type III secretion pathways in different strains of bacteria. Directed evolution is applied to increase the dynamic range and orthogonality of the circuits. These gates are connected in different permutations to form programs, the largest of which is a 4-input AND gate that consists of 3 circuits that integrate 4 inducible systems, thus requiring 11 regulatory proteins. Measuring the performance of individual gates is sufficient to capture the behaviour of the complete program. Errors in the output due to delays (faults), a common problem for layered circuits, are not observed. This work demonstrates the successful layering of orthogonal logic gates, a design strategy that could enable the construction of large, integrated circuits in single cells.	[Moon, Tae Seok; Lou, Chunbo; Stanton, Brynne C.; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Tamsir, Alvin] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com		Lou, Chunbo/0000-0002-7941-6038; hong, xizhi/0000-0001-6029-6761; Moon, Tae Seok/0000-0001-8373-9051	Life Technologies; Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA) [CLIO N66001-12-C-4018]; Office of Naval Research [N00014-10-1-0245]; National Science Foundation (NSF) [CCF-0943385]; National Institutes of Health [AI067699]; NSF Synthetic Biology Engineering Research Center (SynBERC) [SA5284-11210]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067699, R01AI067699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095765] Funding Source: NIH RePORTER	Life Technologies; Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Synthetic Biology Engineering Research Center (SynBERC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.A.V. is supported by Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA; CLIO N66001-12-C-4018), the Office of Naval Research (N00014-10-1-0245), the National Science Foundation (NSF; CCF-0943385), the National Institutes of Health (AI067699) and the NSF Synthetic Biology Engineering Research Center (SynBERC; SA5284-11210). The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred.	Abelson H, 2000, COMMUN ACM, V43, P74, DOI 10.1145/332833.332842; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Clancy K, 2010, CURR OPIN BIOTECH, V21, P572, DOI 10.1016/j.copbio.2010.07.005; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Katz R. H., 1994, CONT LOGIC DESIGN; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mavris M, 2002, J BACTERIOL, V184, P6751, DOI 10.1128/JB.184.24.6751-6759.2002; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Temme K, 2008, J MOL BIOL, V377, P47, DOI 10.1016/j.jmb.2007.12.044; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Thibault J, 2009, J BIOL CHEM, V284, P15762, DOI 10.1074/jbc.M109.003533; Walker KA, 2004, J BACTERIOL, V186, P4056, DOI 10.1128/JB.186.13.4056-4066.2004; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516	28	362	379	2	296	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					249	253		10.1038/nature11516	http://dx.doi.org/10.1038/nature11516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23041931	Green Submitted, Green Accepted			2022-12-24	WOS:000310774300043
J	Frieda, KL; Block, SM				Frieda, Kirsten L.; Block, Steven M.			Direct Observation of Cotranscriptional Folding in an Adenine Riboswitch	SCIENCE			English	Article							RNA-POLYMERASE; NASCENT RNA; TRANSCRIPTION; ELONGATION; KINETICS; BINDING; RIBOZYME	Growing RNA chains fold cotranscriptionally as they are synthesized by RNA polymerase. Riboswitches, which regulate gene expression by adopting alternative RNA folds, are sensitive to cotranscriptional events. We developed an optical-trapping assay to follow the cotranscriptional folding of a nascent RNA and used it to monitor individual transcripts of the pbuE adenine riboswitch, visualizing distinct folding transitions. We report a particular folding signature for the riboswitch aptamer whose presence directs the gene-regulatory transcription outcome, and we measured the termination frequency as a function of adenine level and tension applied to the RNA. Our results demonstrate that the outcome is kinetically controlled. These experiments furnish a means to observe conformational switching in real time and enable the precise mapping of events during cotranscriptional folding.	[Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Block, Steven M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Frieda, Kirsten L.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	sblock@stanford.edu			National Institute of General Medical Services, NIH; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057035] Funding Source: NIH RePORTER	National Institute of General Medical Services, NIH; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Landick for providing purified RNAP and C. Garcia-Garcia, V. Schweikhard, W. Greenleaf, P. Anthony, and other members of the Block lab for useful discussions. The data described in this manuscript are tabulated in the main paper and in the supplementary materials. This research was supported by a grant from the National Institute of General Medical Services, NIH (S. M. B.), and an NSF Graduate Research Fellowship and Stanford Graduate Fellowship (K.L.F.).	Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Dalal RV, 2006, MOL CELL, V23, P231, DOI 10.1016/j.molcel.2006.06.023; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; MONFORTE JA, 1990, BIOCHEMISTRY-US, V29, P7882, DOI 10.1021/bi00486a015; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; Pan T, 1999, J MOL BIOL, V286, P721, DOI 10.1006/jmbi.1998.2516; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Perdrizet GA, 2012, P NATL ACAD SCI USA, V109, P3323, DOI 10.1073/pnas.1113086109; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Xayaphoummine A, 2007, NUCLEIC ACIDS RES, V35, P614, DOI 10.1093/nar/gkl1036	26	127	130	0	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					397	400		10.1126/science.1225722	http://dx.doi.org/10.1126/science.1225722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087247	Green Accepted			2022-12-24	WOS:000309955800045
J	Keller, R				Keller, Ray			Physical Biology Returns to Morphogenesis	SCIENCE			English	Editorial Material							GASTRULATION; MECHANICS; SHAPE; ADHESION; CELLS		Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Keller, R (corresponding author), Univ Virginia, Dept Biol, Gilmer Hall, Charlottesville, VA 22903 USA.	rek3k@virginia.edu						Bellairs R., 1982, CELL BEHAV; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; GUSTAFSON T, 1963, INT REV CYTOL, V15, P139, DOI 10.1016/S0074-7696(08)61117-1; HARDIN JD, 1986, DEV BIOL, V115, P490, DOI 10.1016/0012-1606(86)90269-1; Holtfreter J, 1944, J EXP ZOOL, V95, P171, DOI 10.1002/jez.1400950203; Holtfreter J, 1943, J EXP ZOOL, V94, P261, DOI 10.1002/jez.1400940302; Holtfreter J, 1943, J EXP ZOOL, V93, P251, DOI 10.1002/jez.1400930205; Holtreter J, 1939, ARCH EXP ZELLFORSCH, V23, P169; JACOBSON AG, 1976, J EXP ZOOL, V197, P191, DOI 10.1002/jez.1401970205; Koehl M.A.R., 1990, Seminars in Developmental Biology, V1, P367; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; STEINBERG M S, 1978, P25; STEINBERG MS, 1970, J EXP ZOOL, V173, P395, DOI 10.1002/jez.1401730406; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Trinkaus J. P., 1984, CELLS ORGANS FORCES; Vogt Walther, 1929, Wilhelm Roux Arch Entwickl Mech Org, V120, P384, DOI 10.1007/BF02109667	18	59	60	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					201	203		10.1126/science.1230718	http://dx.doi.org/10.1126/science.1230718			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066066				2022-12-24	WOS:000309712300026
J	Warden, MR; Selimbeyoglu, A; Mirzabekov, JJ; Lo, M; Thompson, KR; Kim, SY; Adhikari, A; Tye, KM; Frank, LM; Deisseroth, K				Warden, Melissa R.; Selimbeyoglu, Aslihan; Mirzabekov, Julie J.; Lo, Maisie; Thompson, Kimberly R.; Kim, Sung-Yon; Adhikari, Avishek; Tye, Kay M.; Frank, Loren M.; Deisseroth, Karl			A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge	NATURE			English	Article							COGNITIVE CONTROL; LATERAL HABENULA; DEPRESSION; RAT; DISORDERS; STIMULATION; MOOD	The prefrontal cortex (PFC) is thought to participate in high-level control of the generation of behaviours (including the decision to execute actions(1)); indeed, imaging and lesion studies in human beings have revealed that PFC dysfunction can lead to either impulsive states with increased tendency to initiate action(2), or to amotivational states characterized by symptoms such as reduced activity, hopelessness and depressed mood(3). Considering the opposite valence of these two phenotypes as well as the broad complexity of other tasks attributed to PFC, we sought to elucidate the PFC circuitry that favours effortful behavioural responses to challenging situations. Here we develop and use a quantitative method for the continuous assessment and control of active response to a behavioural challenge, synchronized with single-unit electrophysiology and optogenetics in freely moving rats. In recording from the medial PFC (mPFC), we observed that many neurons were not simply movement-related in their spike-firing patterns but instead were selectively modulated from moment to moment, according to the animal's decision to act in a challenging situation. Surprisingly, we next found that direct activation of principal neurons in the mPFC had no detectable causal effect on this behaviour. We tested whether this behaviour could be causally mediated by only a subclass of mPFC cells defined by specific downstream wiring. Indeed, by leveraging optogenetic projection-targeting to control cells with specific efferent wiring patterns, we found that selective activation of those mPFC cells projecting to the brainstem dorsal raphe nucleus (DRN), a serotonergic nucleus implicated in major depressive disorder(4), induced a profound, rapid and reversible effect on selection of the active behavioural state. These results may be of importance in understanding the neural circuitry underlying normal and pathological patterns of action selection and motivation in behaviour.	[Warden, Melissa R.; Selimbeyoglu, Aslihan; Mirzabekov, Julie J.; Thompson, Kimberly R.; Kim, Sung-Yon; Adhikari, Avishek; Tye, Kay M.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Selimbeyoglu, Aslihan; Kim, Sung-Yon; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Lo, Maisie] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Frank, Loren M.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Northwell Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Warden, MR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mwarden@stanford.edu; deissero@stanford.edu	Tye, Kay/J-6158-2013; Adhikari, Avishek/A-3339-2012; Warden, Melissa R/M-9300-2016; Adhikari, Avishek/AAF-4444-2021; Kim, Sung-Yon/AAO-8405-2020; Adhikari, Avishek/N-1284-2015	Tye, Kay/0000-0002-2435-0182; Adhikari, Avishek/0000-0002-9187-9211; Warden, Melissa R/0000-0003-2240-3997; Adhikari, Avishek/0000-0002-9187-9211; Kim, Sung-Yon/0000-0003-0791-7308; Adhikari, Avishek/0000-0002-9187-9211; Frank, Loren/0000-0002-1752-5677	Wiegers Family Fund; NARSAD; Stanford Graduate Fellowship; Samsung Scholarship; Berry Foundation Fellowship; NIMH [1F32MH088010-01]; NIMH; NIDA; DARPA REPAIR Program; Keck Foundation; McKnight Foundation; Yu Foundation; Snyder Foundation; Tarlton Foundation; Alice Woo Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, F32MH088010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER	Wiegers Family Fund; NARSAD(NARSAD); Stanford Graduate Fellowship(Stanford University); Samsung Scholarship(Samsung); Berry Foundation Fellowship; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR Program; Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Yu Foundation; Snyder Foundation; Tarlton Foundation; Alice Woo Foundation; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank H. Mayberg, R. Malenka, L. Gunaydin, J. Mattis, I. Ellwood and I. Witten for helpful comments on the manuscript; I. Ellwood, I. Witten, R. Airan, L. Meltzer, M. Roy, V. Gradinaru, A. Andalman, T. Davidson, R. Durand, M. Bower and M. Carr for useful discussions; and all members of the K. D. laboratory for their support. We are grateful to S. Pak, C. Ramakrishnan and C. Perry for technical assistance. This work was supported by the Wiegers Family Fund (K.D.), NARSAD (M.R.W. and K.R.T.), Stanford Graduate Fellowship (A.S.), Samsung Scholarship (S.-Y.K.), Berry Foundation Fellowship (A.A.), NIMH (1F32MH088010-01, K.M.T.), and NIMH, NIDA, the DARPA REPAIR Program, the Keck Foundation, the McKnight Foundation, the Yu, Snyder, Tarlton and Alice Woo Foundations, and the Gatsby Charitable Foundation (K.D.).	Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; DALGLEISH T, 1990, CLIN PSYCHOL REV, V10, P589, DOI 10.1016/0272-7358(90)90098-U; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Elliott R, 1997, PSYCHOL MED, V27, P931, DOI 10.1017/S0033291797005187; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Goncalves L, 2009, BRAIN RES BULL, V78, P240, DOI 10.1016/j.brainresbull.2008.11.012; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; INGRAM RE, 1994, COGNITIVE THER RES, V18, P317, DOI 10.1007/BF02357508; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kim U, 2012, EUR J NEUROSCI, V35, P1253, DOI 10.1111/j.1460-9568.2012.08030.x; Maes Michael, 1995, P933; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097	27	400	409	4	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					428	432		10.1038/nature11617	http://dx.doi.org/10.1038/nature11617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23160494	Green Accepted			2022-12-24	WOS:000312488200056
J	Ofri, D				Ofri, Danielle			The Storm and the Aftermath	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ofri, Danielle] NYU, Sch Med, New York, NY 10003 USA; [Ofri, Danielle] Bellevue Hosp, New York, NY USA	New York University; Bellevue Hospital Center	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10003 USA.			Ofri, Danielle/0000-0001-9865-7104					0	16	17	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2265	2267		10.1056/NEJMp1213843	http://dx.doi.org/10.1056/NEJMp1213843			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23151281				2022-12-24	WOS:000312187700014
J	Han, ZJ; Qiu, F; Eisenberg, R; Holland, PL; Krauss, TD				Han, Zhiji; Qiu, Fen; Eisenberg, Richard; Holland, Patrick L.; Krauss, Todd D.			Robust Photogeneration of H-2 in Water Using Semiconductor Nanocrystals and a Nickel Catalyst	SCIENCE			English	Article							PHOTOCATALYTIC HYDROGEN-PRODUCTION; ARTIFICIAL PHOTOSYNTHESIS; REDUCTION; COMPLEX; LIGHT; LIGANDS	Homogeneous systems for light-driven reduction of protons to H-2 typically suffer from short lifetimes because of decomposition of the light-absorbing molecule. We report a robust and highly active system for solar hydrogen generation in water that uses CdSe nanocrystals capped with dihydrolipoic acid (DHLA) as the light absorber and a soluble Ni2+-DHLA catalyst for proton reduction with ascorbic acid as an electron donor at pH = 4.5, which gives >600,000 turnovers. Under appropriate conditions, the precious-metal-free system has undiminished activity for at least 360 hours under illumination at 520 nanometers and achieves quantum yields in water of over 36%.	[Han, Zhiji; Qiu, Fen; Eisenberg, Richard; Holland, Patrick L.; Krauss, Todd D.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA	University of Rochester	Eisenberg, R (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	eisenberg@chem.rochester.edu; holland@chem.rochester.edu; krauss@chem.rochester.edu	Eisenberg, Robert/P-6070-2019; Qiu, Fen/H-9479-2016; Krauss, Todd/GQA-6399-2022	Krauss, Todd/0000-0002-4860-874X; Eisenberg, Richard/0000-0003-1762-535X	Office of Basic Energy Sciences, U.S. Department of Energy [DE-FG02-09ER16121, DE-SC0002106]	Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	Z.H. led the effort for hydrogen generation and catalysis, and F. Q. for nanocrystal synthesis and characterization. This work was supported by the Office of Basic Energy Sciences, U.S. Department of Energy, grant DE-FG02-09ER16121 and DE-SC0002106. The authors acknowledge the University of Rochester Medical Center and the Department of Environmental Medicine for the analytical support and R. M. Gelein for the cadmium and nickel AAS measurements.	Alstrum-Acevedo JH, 2005, INORG CHEM, V44, P6802, DOI 10.1021/ic050904r; Amirav L, 2010, J PHYS CHEM LETT, V1, P1051, DOI 10.1021/jz100075c; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; BONOMI F, 1992, INORG CHIM ACTA, V192, P237, DOI 10.1016/S0020-1693(00)80765-3; BROWN GM, 1979, J AM CHEM SOC, V101, P1298, DOI 10.1021/ja00499a051; Brown KA, 2012, J AM CHEM SOC, V134, P5627, DOI 10.1021/ja2116348; Brown KA, 2010, J AM CHEM SOC, V132, P9672, DOI 10.1021/ja101031r; DiSalle BF, 2011, J AM CHEM SOC, V133, P11819, DOI 10.1021/ja201514e; Eckenhoff WT, 2012, DALTON T, V41, P13004, DOI 10.1039/c2dt30823a; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Fihri A, 2008, ANGEW CHEM INT EDIT, V47, P564, DOI 10.1002/anie.200702953; Han ZJ, 2012, ANGEW CHEM INT EDIT, V51, P1667, DOI 10.1002/anie.201107329; Jasieniak J, 2011, ACS NANO, V5, P5888, DOI 10.1021/nn201681s; Kockerling M, 2000, INORG CHEM COMMUN, V3, P117; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; McCormick TM, 2010, J AM CHEM SOC, V132, P15480, DOI 10.1021/ja1057357; McNamara WR, 2012, P NATL ACAD SCI USA, V109, P15594, DOI 10.1073/pnas.1120757109; Probst B, 2011, INORG CHEM, V50, P3404, DOI 10.1021/ic102317u; Shemesh Y, 2011, ANGEW CHEM INT EDIT, V50, P1185, DOI 10.1002/anie.201006407; SLETTEN J, 1994, ACTA CHEM SCAND, V48, P929, DOI 10.3891/acta.chem.scand.48-0929; Streich D, 2010, CHEM-EUR J, V16, P60, DOI 10.1002/chem.200902489; Talapin DV, 2004, J PHYS CHEM B, V108, P18826, DOI 10.1021/jp046481g; TREMEL W, 1988, INORG CHEM, V27, P3886, DOI 10.1021/ic00295a004; Wang F, 2011, ANGEW CHEM INT EDIT, V50, P3193, DOI 10.1002/anie.201006352; White TA, 2011, J AM CHEM SOC, V133, P15332, DOI 10.1021/ja206782k	27	632	643	32	928	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1321	1324		10.1126/science.1227775	http://dx.doi.org/10.1126/science.1227775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23138979				2022-12-24	WOS:000311991200060
J	McCabe, MT; Ott, HM; Ganji, G; Korenchuk, S; Thompson, C; Van Aller, GS; Liu, Y; Graves, AP; Della Pietra, A; Diaz, E; LaFrance, LV; Mellinger, M; Duquenne, C; Tian, XR; Kruger, RG; McHugh, CF; Brandt, M; Miller, WH; Dhanak, D; Verma, SK; Tummino, PJ; Creasy, CL				McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath; Korenchuk, Susan; Thompson, Christine; Van Aller, Glenn S.; Liu, Yan; Graves, Alan P.; Della Pietra, Anthony, III; Diaz, Elsie; LaFrance, Louis V.; Mellinger, Mark; Duquenne, Celine; Tian, Xinrong; Kruger, Ryan G.; McHugh, Charles F.; Brandt, Martin; Miller, William H.; Dhanak, Dashyant; Verma, Sharad K.; Tummino, Peter J.; Creasy, Caretha L.			EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations	NATURE			English	Article							HISTONE METHYLTRANSFERASE EZH2; LYSINE 27; SOMATIC MUTATIONS; GENES; H3; HYPERTRIMETHYLATION; METHYLATION; SUBSTRATE; CANCER; H3K27	In eukaryotes, post-translational modification of histones is critical for regulation of chromatin structure and gene expression. EZH2 is the catalytic subunit of the polycomb repressive complex 2 (PRC2) and is involved in repressing gene expression through methylation of histone H3 on lysine 27 (H3K27). EZH2 overexpression is implicated in tumorigenesis and correlates with poor prognosis in several tumour types(1-5). Additionally, somatic heterozygous mutations of Y641 and A677 residues within the catalytic SET domain of EZH2 occur in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma(6-10). The Y641 residue is the most frequently mutated residue, with up to 22% of germinal centre B-cell DLBCL and follicular lymphoma harbouring mutations at this site. These lymphomas have increased H3K27 tri-methylation (H3K27me3) owing to altered substrate preferences of the mutant enzymes(9,11-13). However, it is unknown whether specific, direct inhibition of EZH2 methyltransferase activity will be effective in treating EZH2 mutant lymphomas. Here we demonstrate that GSK126, a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity, decreases global H3K27me3 levels and reactivates silenced PRC2 target genes. GSK126 effectively inhibits the proliferation of EZH2 mutant DLBCL cell lines and markedly inhibits the growth of EZH2 mutant DLBCL xenografts in mice. Together, these data demonstrate that pharmacological inhibition of EZH2 activity may provide a promising treatment for EZH2 mutant lymphoma.	[McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath; Korenchuk, Susan; Thompson, Christine; Van Aller, Glenn S.; Liu, Yan; Della Pietra, Anthony, III; LaFrance, Louis V.; Mellinger, Mark; Duquenne, Celine; Tian, Xinrong; Kruger, Ryan G.; McHugh, Charles F.; Miller, William H.; Dhanak, Dashyant; Verma, Sharad K.; Tummino, Peter J.; Creasy, Caretha L.] GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Canc Res, Oncol R&D, Collegeville, PA 19426 USA; [Graves, Alan P.; Diaz, Elsie; Brandt, Martin] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline	Creasy, CL (corresponding author), GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Canc Res, Oncol R&D, 1250 S Collegeville Rd, Collegeville, PA 19426 USA.	caretha.l.creasy@gsk.com	Thompson, Christine/GWV-6539-2022	Graves, Alan/0000-0002-8949-4961				Al-Katib AM, 1998, CLIN CANCER RES, V4, P1305; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chou RH, 2011, AM J TRANSL RES, V3, P243; Diaz E., 2012, J BIOMOL SCREEN; DYER MJS, 1990, BLOOD, V75, P709; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Ryan RJH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028585; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; TORNHEIM K, 1994, ANAL BIOCHEM, V221, P53, DOI 10.1006/abio.1994.1377; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	30	1274	1346	7	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					108	+		10.1038/nature11606	http://dx.doi.org/10.1038/nature11606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23051747				2022-12-24	WOS:000311893400055
J	Kong, D; Tong, QC; Ye, CP; Koda, S; Fuller, PM; Krashes, MJ; Vong, L; Ray, RS; Olson, DP; Lowell, BB				Kong, Dong; Tong, Qingchun; Ye, Chianping; Koda, Shuichi; Fuller, Patrick M.; Krashes, Michael J.; Vong, Linh; Ray, Russell S.; Olson, David P.; Lowell, Bradford B.			GABAergic RIP-Cre Neurons in the Arcuate Nucleus Selectively Regulate Energy Expenditure	CELL			English	Article							BROWN ADIPOSE-TISSUE; INSULIN-RECEPTOR SUBSTRATE-2; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PANCREATIC BETA-CELL; GLUCOSE-HOMEOSTASIS; AGRP NEURONS; VENTROLATERAL MEDULLA; SYMPATHETIC OUTFLOW; TRACTUS-SOLITARIUS; LEPTIN RESISTANCE	Neural regulation of energy expenditure is incompletely understood. By genetically disrupting GABAergic transmission in a cell-specific fashion, and by combining this with selective pharmacogenetic activation and optogenetic mapping techniques, we have uncovered an arcuate-based circuit that selectively drives energy expenditure. Specifically, mice lacking synaptic GABA release from RIP-Cre neurons have reduced energy expenditure, become obese and are extremely sensitive to high-fat diet-induced obesity, the latter due to defective diet-induced thermogenesis. Leptin's ability to stimulate thermogenesis, but not to reduce feeding, is markedly attenuated. Acute, selective activation of arcuate GABAergic RIP-Cre neurons, which monosynaptically innervate PVH neurons projecting to the NTS, rapidly stimulates brown fat and increases energy expenditure but does not affect feeding. Importantly, this response is dependent upon GABA release from RIP-Cre neurons. Thus, GABAergic RIP-Cre neurons in the arcuate selectively drive energy expenditure, contribute to leptin's stimulatory effect on thermogenesis, and protect against diet-induced obesity.	[Kong, Dong; Tong, Qingchun; Ye, Chianping; Koda, Shuichi; Krashes, Michael J.; Vong, Linh; Olson, David P.; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA; [Fuller, Patrick M.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Ray, Russell S.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; [Tong, Qingchun] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Houston, TX 77030 USA; [Koda, Shuichi] Asubio Pharma, Kobe, Hyogo 6500047, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston; Asubio Pharma Co., Ltd.	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA.	blowell@bidmc.harvard.edu	Krashes, Michael/P-7677-2019	Tong, Qingchun/0000-0002-4561-2540; Olson, David/0000-0001-9249-7760	BNORC & BADERC Transgenic Core Grant [P30DK046200, P30DK057521]; P&F from BADERC BNORC Grant [P30DK057521, P30DK0460200, R01 DK092605, AHA SDG3280017, NS0736313];  [R01 DK089044];  [R01 DK071051];  [R01 DK075632];  [R37 DK053477]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071051, R01DK075632, R01DK096010, R01DK089044, P30DK020572, R37DK053477, P30DK046200, P30DK057521, R01DK092605, K08DK071561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073613] Funding Source: NIH RePORTER	BNORC & BADERC Transgenic Core Grant; P&F from BADERC BNORC Grant; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge J. Lu, J. B. Ding, and members of the B. B. L. lab for helpful discussion; Z. Yang, J. Yu, B. Choi, X. Hu, S. Ma, and D. Cusher for technical support; C. B. Saper for insightful suggestions and reading the manuscript; K. Deisseroth for AAV-Flex-ChR2(H134R)-mCherry; and B. L. Roth for AAV-FLEX-hM3Dq-mCherry. This work was supported by Grants R01 DK089044, R01 DK071051, R01 DK075632, R37 DK053477, and BNORC & BADERC Transgenic Core Grants P30DK046200 and P30DK057521 (to B. B. L.), P&F from BADERC & BNORC Grants P30DK057521 and P30DK0460200 (to D. K.), R01 DK092605 and AHA SDG3280017 (to Q. T.), and NS0736313 (to P. M. F.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; ANDRESEN MC, 1994, ANNU REV PHYSIOL, V56, P93, DOI 10.1146/annurev.physiol.56.1.93; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Cano G, 2003, J COMP NEUROL, V460, P303, DOI 10.1002/cne.10643; Cao WH, 2010, AM J PHYSIOL-REG I, V299, pR277, DOI 10.1152/ajpregu.00039.2010; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Fuller PM, 2002, P NATL ACAD SCI USA, V99, P15723, DOI 10.1073/pnas.242251499; Geerling JC, 2006, J COMP NEUROL, V497, P646, DOI 10.1002/cne.21019; Geerling JC, 2010, J COMP NEUROL, V518, P1460, DOI 10.1002/cne.22283; GOLD RM, 1977, PHYSIOL BEHAV, V18, P1111, DOI 10.1016/0031-9384(77)90019-1; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hermann DM, 1997, J CHEM NEUROANAT, V13, P1, DOI 10.1016/S0891-0618(97)00019-7; Higley MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019155; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; LEIBOWITZ SF, 1978, PHARMACOL BIOCHEM BE, V8, P163, DOI 10.1016/0091-3057(78)90333-7; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; Madden CJ, 2012, AM J PHYSIOL-REG I, V302, pR224, DOI 10.1152/ajpregu.00449.2011; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; MERCHENTHALER I, 1991, NEUROSCIENCE, V44, P655, DOI 10.1016/0306-4522(91)90085-3; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	59	154	156	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					645	657		10.1016/j.cell.2012.09.020	http://dx.doi.org/10.1016/j.cell.2012.09.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101631	Bronze, Green Accepted			2022-12-24	WOS:000310529300019
J	Nasvall, J; Sun, L; Roth, JR; Andersson, DI				Nasvall, Joakim; Sun, Lei; Roth, John R.; Andersson, Dan I.			Real-Time Evolution of New Genes by Innovation, Amplification, and Divergence	SCIENCE			English	Article							DUPLICATION	Gene duplications allow evolution of genes with new functions. Here, we describe the innovation-amplification-divergence (IAD) model in which the new function appears before duplication and functionally distinct new genes evolve under continuous selection. One example fitting this model is a preexisting parental gene in Salmonella enterica that has low levels of two distinct activities. This gene is amplified to a high copy number, and the amplified gene copies accumulate mutations that provide enzymatic specialization of different copies and faster growth. Selection maintains the initial amplification and beneficial mutant alleles but is relaxed for other less improved gene copies, allowing their loss. This rapid process, completed in fewer than 3000 generations, shows the efficacy of the IAD model and allows the study of gene evolution in real time.	[Nasvall, Joakim; Sun, Lei; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Roth, John R.] Univ Calif Davis, Dept Biol, Davis, CA 95616 USA	Uppsala University; University of California System; University of California Davis	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	dan.andersson@imbim.uu.se	zhou, hua/A-6862-2017; Näsvall, Joakim/F-8750-2018; Sun, Lei/C-3687-2014	Näsvall, Joakim/0000-0002-6831-3105; Sun, Lei/0000-0002-7222-3137; Andersson, Dan/0000-0001-6640-2174	Swedish Research Council; NIH [GM27068]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027068] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Swedish Research Council to D. I. A. and from the NIH (grant GM27068) to J.R.R. The raw Illumina sequencing data sets have been deposited in the National Center for Biotechnology Information Sequence Read Archive (www.ncbi.nlm.nih.gov/Traces/sra/) with accession numbers SRX180378, SRX180382, SRX180383, SRX180384, SRX180385, SRX180387, SRX180388, SRX180390, SRX180391, and SRX180392.	ANDERSON P, 1981, P NATL ACAD SCI-BIOL, V78, P3113, DOI 10.1073/pnas.78.5.3113; Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Barona-Gomez F, 2003, EMBO REP, V4, P296, DOI 10.1038/sj.embor.embor771; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; FRAME R, 1971, BIOCHEM J, V121, P93, DOI 10.1042/bj1210093; Henn-Sax M, 2001, BIOL CHEM, V382, P1315, DOI 10.1515/BC.2001.163; Hoffmann M, 2007, P ROY SOC B-BIOL SCI, V274, P33, DOI 10.1098/rspb.2006.3707; Hooper SD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r48; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, EVOLUTION GENE DUPLI; Pettersson ME, 2009, GENETICA, V135, P309, DOI 10.1007/s10709-008-9289-z; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Wagner GP, 2003, P NATL ACAD SCI USA, V100, P14603, DOI 10.1073/pnas.2536656100	20	148	150	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					384	387		10.1126/science.1226521	http://dx.doi.org/10.1126/science.1226521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087246	Green Accepted			2022-12-24	WOS:000309955800041
J	Hardie, RC; Franze, K				Hardie, Roger C.; Franze, Kristian			Photomechanical Responses in Drosophila Photoreceptors	SCIENCE			English	Article							LIGHT-SENSITIVE CHANNELS; MEMBRANE-PROTEIN FUNCTION; PHOSPHOLIPASE-C; ION CHANNELS; TRP; ACTIVATION	Phototransduction in Drosophila microvillar photoreceptor cells is mediated by a G protein-activated phospholipase C (PLC). PLC hydrolyzes the minor membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2), leading by an unknown mechanism to activation of the prototypical transient receptor potential (TRP) and TRP-like (TRPL) channels. We found that light exposure evoked rapid PLC-mediated contractions of the photoreceptor cells and modulated the activity of mechanosensitive channels introduced into photoreceptor cells. Furthermore, photoreceptor light responses were facilitated by membrane stretch and were inhibited by amphipaths, which alter lipid bilayer properties. These results indicate that, by cleaving PIP2, PLC generates rapid physical changes in the lipid bilayer that lead to contractions of the microvilli, and suggest that the resultant mechanical forces contribute to gating the light-sensitive channels.	[Hardie, Roger C.; Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of Cambridge	Hardie, RC (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	rch14@cam.ac.uk		Franze, Kristian/0000-0002-8425-7297; Hardie, Roger/0000-0001-5531-3264	UK Biotechnology and Biological Sciences Research Council [BB/G0068651]; UK Medical Research Council Career Development Award; BBSRC [BB/J009253/1] Funding Source: UKRI; MRC [G1100312] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009253/1] Funding Source: researchfish; Medical Research Council [G1100312] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. G. Stavenga, S. B. Laughlin, and M. Postma for comments on the manuscript; O. Andersen for advice on the use of gramicidin; and J. Grosche (Effigos AG) for artwork for Fig. 1A. Supported by UK Biotechnology and Biological Sciences Research Council grant BB/G0068651 (R. C. H.) and a UK Medical Research Council Career Development Award (K. F.). Author contributions: project initiation, R. C. H.; whole-cell electrophysiology experiments, R. C. H.; AFM measurements, K. F., R. C. H.; paper written by R. C. H. with contribution from K.F.	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Ahyayauch H, 2005, BIOCHEMISTRY-US, V44, P11592, DOI 10.1021/bi050715k; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Franze K, 2011, CURR OPIN GENET DEV, V21, P530, DOI 10.1016/j.gde.2011.07.001; Hardie RC, 2004, J BIOL CHEM, V279, P47773, DOI 10.1074/jbc.M407525200; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2012, WILEY INTERDISCIPLIN, V1, P162, DOI [10.1002/wmts.20, DOI 10.1002/WMTS.20]; Holopainen JM, 2002, BIOPHYS J, V83, P932, DOI 10.1016/S0006-3495(02)75219-3; HUANG JH, 2010, FASD, V20, P189, DOI DOI 10.1016/J.CUB.2009.12.019; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; Lev S, 2012, J BIOL CHEM, V287, P1436, DOI 10.1074/jbc.M111.266585; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Parnas M, 2009, J NEUROSCI, V29, P2371, DOI 10.1523/JNEUROSCI.4280-08.2009; Patel A., 2010, FADS, V460, P571; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3	21	136	137	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					260	263		10.1126/science.1222376	http://dx.doi.org/10.1126/science.1222376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066080				2022-12-24	WOS:000309712300047
J	Qin, JJ; Li, YR; Cai, ZM; Li, SH; Zhu, JF; Zhang, F; Liang, SS; Zhang, WW; Guan, YL; Shen, DQ; Peng, YQ; Zhang, DY; Jie, ZY; Wu, WX; Qin, YW; Xue, WB; Li, JH; Han, LC; Lu, DH; Wu, PX; Dai, YL; Sun, XJ; Li, ZS; Tang, AF; Zhong, SL; Li, XP; Chen, WN; Xu, R; Wang, MB; Feng, Q; Gong, MH; Yu, J; Zhang, YY; Zhang, M; Hansen, T; Sanchez, G; Raes, J; Falony, G; Okuda, S; Almeida, M; LeChatelier, E; Renault, P; Pons, N; Batto, JM; Zhang, ZX; Chen, H; Yang, RF; Zheng, WM; Li, SG; Yang, HM; Wang, J; Ehrlich, SD; Nielsen, R; Pedersen, O; Kristiansen, K; Wang, J				Qin, Junjie; Li, Yingrui; Cai, Zhiming; Li, Shenghui; Zhu, Jianfeng; Zhang, Fan; Liang, Suisha; Zhang, Wenwei; Guan, Yuanlin; Shen, Dongqian; Peng, Yangqing; Zhang, Dongya; Jie, Zhuye; Wu, Wenxian; Qin, Youwen; Xue, Wenbin; Li, Junhua; Han, Lingchuan; Lu, Donghui; Wu, Peixian; Dai, Yali; Sun, Xiaojuan; Li, Zesong; Tang, Aifa; Zhong, Shilong; Li, Xiaoping; Chen, Weineng; Xu, Ran; Wang, Mingbang; Feng, Qiang; Gong, Meihua; Yu, Jing; Zhang, Yanyan; Zhang, Ming; Hansen, Torben; Sanchez, Gaston; Raes, Jeroen; Falony, Gwen; Okuda, Shujiro; Almeida, Mathieu; LeChatelier, Emmanuelle; Renault, Pierre; Pons, Nicolas; Batto, Jean-Michel; Zhang, Zhaoxi; Chen, Hua; Yang, Ruifu; Zheng, Weimou; Li, Songgang; Yang, Huanming; Wang, Jian; Ehrlich, S. Dusko; Nielsen, Rasmus; Pedersen, Oluf; Kristiansen, Karsten; Wang, Jun			A metagenome-wide association study of gut microbiota in type 2 diabetes	NATURE			English	Article							OBESITY; DIVERSITY; BACTEREMIA; INFECTION; STRESS	Assessment and characterization of gut microbiota has become a major research area in human disease, including type 2 diabetes, the most prevalent endocrine disease worldwide. To carry out analysis on gut microbial content in patients with type 2 diabetes, we developed a protocol for a metagenome-wide association study (MGWAS) and undertook a two-stage MGWAS based on deep shotgun sequencing of the gut microbial DNA from 345 Chinese individuals. We identified and validated approximately 60,000 type-2-diabetes-associated markers and established the concept of a metagenomic linkage group, enabling taxonomic species-level analyses. MGWAS analysis showed that patients with type 2 diabetes were characterized by a moderate degree of gut microbial dysbiosis, a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens, as well as an enrichment of other microbial functions conferring sulphate reduction and oxidative stress resistance. An analysis of 23 additional individuals demonstrated that these gut microbial markers might be useful for classifying type 2 diabetes.	[Qin, Junjie; Li, Yingrui; Li, Shenghui; Zhu, Jianfeng; Liang, Suisha; Zhang, Wenwei; Guan, Yuanlin; Shen, Dongqian; Peng, Yangqing; Zhang, Dongya; Jie, Zhuye; Wu, Wenxian; Qin, Youwen; Xue, Wenbin; Li, Junhua; Chen, Weineng; Xu, Ran; Wang, Mingbang; Feng, Qiang; Gong, Meihua; Yu, Jing; Zhang, Yanyan; Zhang, Ming; Zhang, Zhaoxi; Chen, Hua; Yang, Ruifu; Zheng, Weimou; Li, Songgang; Yang, Huanming; Wang, Jian; Kristiansen, Karsten; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Cai, Zhiming; Li, Zesong; Tang, Aifa; Zhong, Shilong] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen 518035, Peoples R China; [Zhang, Fan; Han, Lingchuan; Lu, Donghui; Wu, Peixian; Dai, Yali; Sun, Xiaojuan] Peking Univ, Shenzhen Hosp, Shenzhen 518036, Peoples R China; [Li, Xiaoping] Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangzhou 510080, Peoples R China; [Hansen, Torben; Pedersen, Oluf; Wang, Jun] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2100 Copenhagen, Denmark; [Sanchez, Gaston; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94820 USA; [Sanchez, Gaston; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94820 USA; [Raes, Jeroen; Falony, Gwen; Okuda, Shujiro] VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Raes, Jeroen; Falony, Gwen; Okuda, Shujiro] Vrije Univ Brussel, Dept Appl Biol Sci DBIT, B-1050 Brussels, Belgium; [Almeida, Mathieu; LeChatelier, Emmanuelle; Renault, Pierre; Pons, Nicolas; Batto, Jean-Michel; Ehrlich, S. Dusko] INRA, F-78350 Jouy En Josas, France; [Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, DK-8000 Aarhus, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Beijing Genomics Institute (BGI); Shenzhen University; Peking University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Novo Nordisk Foundation; University of Copenhagen; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Beijing Institute of Microbiology & Epidemiology; University of Copenhagen; Aarhus University; Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn	Pedersen, Oluf/Z-1731-2019; LE CHATELIER, Emmanuelle/O-1243-2017; Yang, Ruifu/A-2273-2011; Ehrlich, S./Y-2423-2019; Kristiansen, Karsten/J-5148-2014; Nielsen, Rasmus/D-4405-2009; Okuda, Shujiro/D-1700-2016; raes, jeroen/D-7835-2018; Li, Junhua/AAG-3919-2019; Pedersen, Oluf/AAG-8015-2020; Li, Yingrui/K-1064-2015; Qin, Youwen/AAY-1194-2021; Wang, Jun/A-7261-2013; Falony, Gwen/AAN-5011-2020; Wang, Mingbang/F-4457-2018; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Pedersen, Oluf/0000-0002-3321-3972; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Yang, Ruifu/0000-0003-3219-7269; Ehrlich, S./0000-0002-7563-4046; Kristiansen, Karsten/0000-0002-6024-0917; Nielsen, Rasmus/0000-0003-0513-6591; Okuda, Shujiro/0000-0002-7704-8104; raes, jeroen/0000-0002-1337-041X; Li, Junhua/0000-0001-6784-1873; Falony, Gwen/0000-0003-2450-0782; Wang, Mingbang/0000-0002-5989-5377; Li, Shenghui/0000-0003-1071-8510; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; guan, yuanlin/0000-0002-4839-0146; Liang, Suisha/0000-0003-0426-9827; Qin, Youwen/0000-0003-3956-4711; Hansen, Torben/0000-0001-8748-3831	Ministry of Science and Technology of China [2012AA02A201]; National Natural Science Foundation of China [30890032, 30725008, 30811130531, 31161130357]; Shenzhen Municipal Government of China [ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A]; Danish Strategic Research Council [2106-07-0021]; Danish Natural Science Research Council; Solexa project [272-07-0196]; European Commission [HEALTH-F4-2007-201052]; Novo Nordisk Foundation; Ministry of Science and Technology of China [2012AA02A201]; National Natural Science Foundation of China [30890032, 30725008, 30811130531, 31161130357]; Shenzhen Municipal Government of China [ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A]; Danish Strategic Research Council [2106-07-0021]; Danish Natural Science Research Council; Solexa project [272-07-0196]; European Commission [HEALTH-F4-2007-201052]; Novo Nordisk Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank L. Goodman for editing the manuscript and providing comments. This research was supported by the Ministry of Science and Technology of China, 863 program (2012AA02A201), the National Natural Science Foundation of China (30890032, 30725008, 30811130531, 31161130357), the Shenzhen Municipal Government of China (ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A), the Danish Strategic Research Council grant (2106-07-0021), the Ole Romer grant from Danish Natural Science Research Council, the Solexa project (272-07-0196), and the European Commission FP7 grant HEALTH-F4-2007-201052. The Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCamp, www.lucamp.org). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk). We are also indebted to many additional faculty and staff of BGI-Shenzhen who contributed to this work.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; BROOK I, 1995, J MED MICROBIOL, V42, P78, DOI 10.1099/00222615-42-2-78; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elsayed S, 2004, J CLIN MICROBIOL, V42, P4390, DOI 10.1128/JCM.42.9.4390-4392.2004; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kashyap P, 2011, NEUROGASTROENT MOTIL, V23, P111, DOI 10.1111/j.1365-2982.2010.01659.x; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li S., 2012, GIGASCIENCE; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MCCLEAN KL, 1994, CLIN INFECT DIS, V19, P100, DOI 10.1093/clinids/19.1.100; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Woo PCY, 2004, J CLIN MICROBIOL, V42, P5947, DOI 10.1128/JCM.42.12.5947-5949.2004; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S5; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	36	3752	4150	91	1494	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					55	60		10.1038/nature11450	http://dx.doi.org/10.1038/nature11450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23023125				2022-12-24	WOS:000309446800031
J	Gkogkas, CG; Khoutorsky, A; Ran, I; Rampakakis, E; Nevarko, T; Weatherill, DB; Vasuta, C; Yee, S; Truitt, M; Dallaire, P; Major, F; Lasko, P; Ruggero, D; Nader, K; Lacaille, JC; Sonenberg, N				Gkogkas, Christos G.; Khoutorsky, Arkady; Ran, Israeli; Rampakakis, Emmanouil; Nevarko, Tatiana; Weatherill, Daniel B.; Vasuta, Cristina; Yee, Stephanie; Truitt, Morgan; Dallaire, Paul; Major, Francois; Lasko, Paul; Ruggero, Davide; Nader, Karim; Lacaille, Jean-Claude; Sonenberg, Nahum			Autism-related deficits via dysregulated eIF4E-dependent translational control	NATURE			English	Article							FRAGILE-X-SYNDROME; COPY-NUMBER VARIATION; TUBEROUS-SCLEROSIS; ULTRASONIC VOCALIZATIONS; INHIBITORY SYNAPSES; SYNAPTIC PLASTICITY; SPECTRUM DISORDERS; LEARNING-DEFICITS; REPRESSOR 4E-BP2; MOUSE MODELS	Hyperconnectivity of neuronal circuits due to increased synaptic protein synthesis is thought to cause autism spectrum disorders (ASDs). The mammalian target of rapamycin (mTOR) is strongly implicated in ASDs by means of upstream signalling; however, downstream regulatory mechanisms are ill-defined. Here we show that knockout of the eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2)-an eIF4E repressor downstream of mTOR-or eIF4E overexpression leads to increased translation of neuroligins, which are postsynaptic proteins that are causally linked to ASDs. Mice that have the gene encoding 4E-BP2 (Eif4ebp2) knocked out exhibit an increased ratio of excitatory to inhibitory synaptic inputs and autistic-like behaviours (that is, social interaction deficits, altered communication and repetitive/stereotyped behaviours). Pharmacological inhibition of eIF4E activity or normalization of neuroligin 1, but not neuroligin 2, protein levels restores the normal excitation/inhibition ratio and rectifies the social behaviour deficits. Thus, translational control by eIF4E regulates the synthesis of neuroligins, maintaining the excitation-to-inhibition balance, and its dysregulation engenders ASD-like phenotypes.	[Gkogkas, Christos G.; Khoutorsky, Arkady; Rampakakis, Emmanouil; Nevarko, Tatiana; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Gkogkas, Christos G.; Khoutorsky, Arkady; Rampakakis, Emmanouil; Nevarko, Tatiana; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Ran, Israeli; Weatherill, Daniel B.; Vasuta, Cristina; Lacaille, Jean-Claude] Univ Montreal, GRSNC, Montreal, PQ H3C 3J7, Canada; [Ran, Israeli; Weatherill, Daniel B.; Vasuta, Cristina; Lacaille, Jean-Claude] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Rampakakis, Emmanouil] JSS Med Res Inc, Montreal, PQ H4S 1N8, Canada; [Yee, Stephanie; Lasko, Paul] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Truitt, Morgan; Ruggero, Davide] Univ Calif San Francisco, Sch Med, San Francisco, CA 94158 USA; [Truitt, Morgan; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Dallaire, Paul; Major, Francois] Univ Montreal, Dept Comp Sci, Montreal, PQ H3C 3J7, Canada; [Dallaire, Paul; Major, Francois] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; McGill University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Universite de Montreal; Universite de Montreal; McGill University	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	jean-claude.lacaille@umontreal.ca; nahum.sonenberg@mcgill.ca	Gkogkas, Christos/GQH-2659-2022; Gkogkas, Christos/GLR-5348-2022; Lasko, Paul/C-6761-2014; Ran, Israeli/B-2432-2009	Gkogkas, Christos/0000-0001-6281-3419; Lasko, Paul/0000-0002-4037-3501; Ran, Israeli/0000-0003-4824-6416; Rampakakis, Emmanouil/0000-0002-7427-8246; Khoutorsky, Arkady/0000-0003-3846-8728	Canadian Institutes of Health Research [MOP-114994, MOP-10848, MOP-93679, MOP-44050]; Autism Speaks [7109]; Fonds de la Recherche en Sante du Quebec (FRSQ; Groupe de Recherche sur le Systeme Nerveux Central); National Institutes of Health [NIH RO1 CA154916, NIH RO1 CA140456]; Canada Research Chair in Cellular and Molecular Neurophysiology; Savoy Foundation; NATIONAL CANCER INSTITUTE [R01CA154916, R01CA140456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088813] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Autism Speaks; Fonds de la Recherche en Sante du Quebec (FRSQ; Groupe de Recherche sur le Systeme Nerveux Central); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair in Cellular and Molecular Neurophysiology(Canada Research Chairs); Savoy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Institutes of Health Research (N.S., MOP-114994; J.-C.L., MOP-10848; P.D. and F.M., MOP-93679; and P.L. and N.S., MOP-44050), Autism Speaks (Grant 7109 to N.S.), and the Fonds de la Recherche en Sante du Quebec (J.-C.L. FRSQ; Groupe de Recherche sur le Systeme Nerveux Central), and the National Institutes of Health (D.R.; NIH RO1 CA154916 and NIH RO1 CA140456). D.R. is a Leukemia & Lymphoma Society Scholar. J.-C.L. is the recipient of the Canada Research Chair in Cellular and Molecular Neurophysiology. I.R. was supported by a Fellowship of the Savoy Foundation. We thank Y. Svitkin, A. Parsyan, E. Petroulakis, R. Karni and V. Polunovski for advice; K. Gamache, A. Sylvestre, S. Perreault, C. Lister and I. Harvey for technical assistance; T. Alain for assistance with lentiviral titration; S. Hamdani for assistance with USVs; and W. Sossin and P. Skehel for critical reading of the manuscript.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cornew L, 2012, J AUTISM DEV DISORD, V42, P1884, DOI 10.1007/s10803-011-1431-6; Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeffer CA, 2011, P NATL ACAD SCI USA, V108, P3383, DOI 10.1073/pnas.1013063108; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Jeste SS, 2008, J CHILD NEUROL, V23, P520, DOI 10.1177/0883073807309788; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parada LF, 2012, CURR OPIN NEUROBIOL; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	46	348	355	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					371	U113		10.1038/nature11628	http://dx.doi.org/10.1038/nature11628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23172145	Green Accepted, Green Published			2022-12-24	WOS:000313615900044
J	Haider, B; Hausser, M; Carandini, M				Haider, Bilal; Haeusser, Michael; Carandini, Matteo			Inhibition dominates sensory responses in the awake cortex	NATURE			English	Article							LOCAL CORTICAL NETWORKS; PRIMARY VISUAL-CORTEX; NEURONS IN-VIVO; ORIENTATION SELECTIVITY; NEOCORTICAL NEURONS; HZ OSCILLATION; BARREL CORTEX; MECHANISMS; INTERNEURONS; SPARSE	The activity of the cerebral cortex is thought to depend on the precise relationship between synaptic excitation and inhibition(1-4). In the visual cortex, in particular, intracellular measurements have related response selectivity to coordinated increases in excitation and inhibition(5-9). These measurements, however, have all been made during anaesthesia, which strongly influences cortical state(10) and therefore sensory processing(7,11-15). The synaptic activity that is evoked by visual stimulation during wakefulness is unknown. Here we measured visually evoked responses-and the underlying synaptic conductances-in the visual cortex of anaesthetized and awake mice. Under anaesthesia, responses could be elicited from a large region of visual space(16) and were prolonged. During wakefulness, responses were more spatially selective and much briefer. Whole-cell patch-clamp recordings of synaptic conductances(5,17) showed a difference in synaptic inhibition between the two conditions. Under anaesthesia, inhibition tracked excitation in amplitude and spatial selectivity. By contrast, during wakefulness, inhibition was much stronger than excitation and had extremely broad spatial selectivity. We conclude that during wakefulness, cortical responses to visual stimulation are dominated by synaptic inhibition, restricting the spatial spread and temporal persistence of neural activity. These results provide a direct glimpse of synaptic mechanisms that control sensory responses in the awake cortex.	[Haider, Bilal; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Haider, B (corresponding author), UCL, UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	b.haider@ucl.ac.uk	Carandini, Matteo/ABD-8296-2021; Hausser, Michael/AAW-6827-2020	Carandini, Matteo/0000-0003-4880-7682; Hausser, Michael/0000-0002-2673-8957; Haider, Bilal/0000-0002-6382-1426	National Science Foundation; European Research Council; Wellcome Trust; Medical Research Council; Gatsby Charitable Foundation; MRC [G0800791] Funding Source: UKRI; Medical Research Council [G0800791] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gatsby Charitable Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Sato, A. Saleem and A. Ayaz for help with procedures; S. L. Smith, C. Schmidt-Hieber and K. Powell for advice on recordings, and A. Roth, M. Scanziani and D. McCormick for comments. We are grateful to the National Science Foundation, the European Research Council, the Wellcome Trust, the Medical Research Council and the Gatsby Charitable Foundation for financial support. M. C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Arroyo S, 2012, J NEUROSCI, V32, P3859, DOI 10.1523/JNEUROSCI.0115-12.2012; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Cardin JA, 2010, J NEUROSCI, V30, P3652, DOI 10.1523/JNEUROSCI.5279-09.2010; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157	36	346	348	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					97	+		10.1038/nature11665	http://dx.doi.org/10.1038/nature11665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23172139	Green Accepted			2022-12-24	WOS:000312933800038
J	Park, SH; Das, BB; Casagrande, F; Tian, Y; Nothnagel, HJ; Chu, MN; Kiefer, H; Maier, K; De Angelis, AA; Marassi, FM; Opella, SJ				Park, Sang Ho; Das, Bibhuti B.; Casagrande, Fabio; Tian, Ye; Nothnagel, Henry J.; Chu, Mignon; Kiefer, Hans; Maier, Klaus; De Angelis, Anna A.; Marassi, Francesca M.; Opella, Stanley J.			Structure of the chemokine receptor CXCR1 in phospholipid bilayers	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; HUMAN INTERLEUKIN-8 RECEPTOR; NMR CHEMICAL-SHIFTS; SOLID-STATE NMR; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; SPECTROSCOPY; GPCR; PROTEOLIPOSOMES; REFINEMENT	CXCR1 is one of two high-affinity receptors for the CXC chemokine interleukin-8 (IL-8), a major mediator of immune and inflammatory responses implicated in many disorders, including tumour growth(1-3). IL-8, released in response to inflammatory stimuli, binds to the extracellular side of CXCR1. The ligand-activated intracellular signalling pathways result in neutrophil migration to the site of inflammation(2). CXCR1 is a class A, rhodopsin-like G-protein-coupled receptor (GPCR), the largest class of integral membrane proteins responsible for cellular signal transduction and targeted as drug receptors(4-7). Despite its importance, the molecular mechanism of CXCR1 signal transduction is poorly understood owing to the limited structural information available. Recent structural determination of GPCRs has advanced by modifying the receptors with stabilizing mutations, insertion of the protein T4 lysozyme and truncations of their amino acid sequences(8), as well as addition of stabilizing antibodies and small molecules(9) that facilitate crystallization in cubic phase monoolein mixtures(10). The intracellular loops of GPCRs are crucial for G-protein interactions(11), and activation of CXCR1 involves both amino-terminal residues and extracellular loops(2,12,13). Our previous nuclear magnetic resonance studies indicate that IL-8 binding to the N-terminal residues is mediated by the membrane, underscoring the importance of the phospholipid bilayer for physiological activity(14). Here we report the three-dimensional structure of human CXCR1 determined by NMR spectroscopy. The receptor is in liquid crystalline phospholipid bilayers, without modification of its amino acid sequence and under physiological conditions. Features important for intracellular G-protein activation and signal transduction are revealed. The structure of human CXCR1 in a lipid bilayer should help to facilitate the discovery of new compounds that interact with GPCRs and combat diseases such as breast cancer.	[Park, Sang Ho; Das, Bibhuti B.; Casagrande, Fabio; Tian, Ye; Nothnagel, Henry J.; Chu, Mignon; Opella, Stanley J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Tian, Ye; Marassi, Francesca M.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Kiefer, Hans] HBC Hsch Biberach, D-88400 Biberach, Germany; [Maier, Klaus; De Angelis, Anna A.] Membrane Receptor Technol, San Diego, CA 92121 USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Opella, SJ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sopella@ucsd.edu	Das, Bibhuti B./ABC-9067-2021; Park, Sang Ho/AAK-3432-2020	Das, Bibhuti B./0000-0001-9530-8785; Kiefer, Hans/0000-0002-8574-9867	National Institutes of Health (NIH) [R01EB005161, R01GM075877, R21GM94727, R21GM075917, P01AI074805, P41EB002031]; Swiss National Science Foundation [PBBSP3-123151]; Novartis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002031, R01EB005161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM094727, R21GM075917, R01GM075877, R01GM099986] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants R01EB005161, R01GM075877, R21GM94727, R21GM075917, P01AI074805 and P41EB002031 from the National Institutes of Health (NIH). Further support came from Cambridge Isotope Laboratories. F.C. was supported by fellowships from the Swiss National Science Foundation (PBBSP3-123151) and the Novartis Foundation.	Casagrande F, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P297; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Das BB, 2012, J AM CHEM SOC, V134, P2047, DOI 10.1021/ja209464f; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLano WL, 2005, PYMOL; Denny JK, 2001, J MAGN RESON, V152, P217, DOI 10.1006/jmre.2001.2405; EDIDIN M, 1974, ANNU REV BIOPHYS BIO, V3, P179, DOI 10.1146/annurev.bb.03.060174.001143; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Goncalves JA, 2010, PROG NUCL MAG RES SP, V57, P159, DOI 10.1016/j.pnmrs.2010.04.004; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McDermott A, 2009, ANNU REV BIOPHYS, V38, P385, DOI 10.1146/annurev.biophys.050708.133719; Mesleh MF, 2003, J AM CHEM SOC, V125, P8928, DOI 10.1021/ja034211q; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park SH, 2006, J AM CHEM SOC, V128, P7402, DOI 10.1021/ja0606632; Park SH, 2012, BBA-BIOMEMBRANES, V1818, P584, DOI 10.1016/j.bbamem.2011.10.008; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Park SH, 2011, BIOCHEMISTRY-US, V50, P2371, DOI 10.1021/bi101568j; Park SH, 2010, J PHYS CHEM B, V114, P13995, DOI 10.1021/jp106043w; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817	46	357	361	6	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					779	+		10.1038/nature11580	http://dx.doi.org/10.1038/nature11580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23086146	Green Accepted, Green Submitted			2022-12-24	WOS:000311606000050
J	Harnett, MT; Makara, JK; Spruston, N; Kath, WL; Magee, JC				Harnett, Mark T.; Makara, Judit K.; Spruston, Nelson; Kath, William L.; Magee, Jeffrey C.			Synaptic amplification by dendritic spines enhances input cooperativity	NATURE			English	Article							PYRAMIDAL NEURON DENDRITES; ELECTRICAL COMPARTMENTALIZATION; LEARNING RULES; PLASTICITY; COMPUTATION; INTEGRATION; MEMBRANE; SIGNALS; MODEL; NECK	Dendritic spines are the nearly ubiquitous site of excitatory synaptic input onto neurons(1,2) and as such are critically positioned to influence diverse aspects of neuronal signalling. Decades of theoretical studies have proposed that spines may function as highly effective and modifiable chemical and electrical compartments that regulate synaptic efficacy, integration and plasticity(3-8). Experimental studies have confirmed activity-dependent structural dynamics and biochemical compartmentalization by spines(9-12). However, there is a longstanding debate over the influence of spines on the electrical aspects of synaptic transmission and dendritic operation(3-8,13-18). Here we measure the amplitude ratio of spine head to parent dendrite voltage across a range of dendritic compartments and calculate the associated spine neck resistance (R-neck) for spines at apical trunk dendrites in rat hippocampal CA1 pyramidal neurons. We find that R-neck is large enough (similar to 500M Omega) to amplify substantially the spine head depolarization associated with a unitary synaptic input by similar to 1.5- to similar to 45-fold, depending on parent dendritic impedance. A morphologically realistic compartmental model capable of reproducing the observed spatial profile of the amplitude ratio indicates that spines provide a consistently high-impedance input structure throughout the dendritic arborization. Finally, we demonstrate that the amplification produced by spines encourages electrical interaction among coactive inputs through an R-neck-dependent increase in spine head voltage-gated conductance activation. We conclude that the electrical properties of spines promote nonlinear dendritic processing and associated forms of plasticity and storage, thus fundamentally enhancing the computational capabilities of neurons(19-21).	[Harnett, Mark T.; Makara, Judit K.; Spruston, Nelson; Magee, Jeffrey C.] HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Makara, Judit K.] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; [Kath, William L.] Northwestern Univ, Dept Appl Math, Evanston, IL 60208 USA; [Kath, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Northwestern University; Northwestern University	Magee, JC (corresponding author), HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA.	mageej@janelia.hhmi.org	Kath, William/B-6771-2009	Spruston, Nelson/0000-0003-3118-1636; Kath, William/0000-0003-3867-4783	Howard Hughes Medical Institute; National Institutes of Health [NS-046064, NS-077601]; Wellcome Trust [090915]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046064, R01NS077601] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Milstein, S. Gale and R. Chitwood for help in creating analysis tools and G. Murphy, S. Williams and D. Johnston for comments on the manuscript. This work was supported by the Howard Hughes Medical Institute, the National Institutes of Health (NS-046064, NS-077601) and the Wellcome Trust (International Senior Research Fellowship to J.K.M., grant number 090915).	Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Chen Y, 2012, CURR OPIN NEUROBIOL, V22, P389, DOI 10.1016/j.conb.2012.03.003; Dowell M., 1971, BIT (Nordisk Tidskrift for Informationsbehandling), V11, P168, DOI 10.1007/BF01934364; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gulledge AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036007; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Hao J, 2012, CURR OPIN NEUROBIOL, V22, P509, DOI 10.1016/j.conb.2011.10.004; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Johnston D., 1995, FDN CELLULAR NEUROPH, P400; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; KOCH C, 1993, J NEUROSCI, V13, P413; Legenstein R, 2011, J NEUROSCI, V31, P10787, DOI 10.1523/JNEUROSCI.5684-10.2011; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Makara JK, 2009, NAT NEUROSCI, V12, P1485, DOI 10.1038/nn.2428; MILLER JP, 1985, BRAIN RES, V325, P325, DOI 10.1016/0006-8993(85)90333-6; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; Rall W., 1974, CELLULAR MECH SUBSER; Ramon y Cajal S S, 1888, REV TRIM HISTOL NORM, V1, P1; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; Wu XE, 2009, NEURON, V62, P31, DOI 10.1016/j.neuron.2009.02.021; Yasuda R, 2011, CURR OPIN NEUROBIOL, V21, P313, DOI 10.1016/j.conb.2011.02.008; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	39	173	175	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					599	+		10.1038/nature11554	http://dx.doi.org/10.1038/nature11554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23103868	Green Accepted			2022-12-24	WOS:000311339800053
J	Spano, S; Galan, JE				Spano, Stefania; Galan, Jorge E.			A Rab32-Dependent Pathway Contributes to Salmonella Typhi Host Restriction	SCIENCE			English	Article							LYSOSOME-RELATED ORGANELLES; HERMANSKY-PUDLAK-SYNDROME; SECRETORY LYSOSOMES; BACTERIAL SURVIVAL; PUDIAK-SYNDROME; SYNDROME GENES; III SECRETION; MURINE; PATHOGENESIS; TYPHIMURIUM	Unlike other Salmonellae, the intracellular bacterial human pathogen Salmonella Typhi exhibits strict host specificity. The molecular bases for this restriction are unknown. Here we found that the expression of a single type III secretion system effector protein from broad-host Salmonella Typhimurium allowed Salmonella Typhi to survive and replicate within macrophages and tissues from mice, a nonpermissive host. This effector proteolytically targeted Rab32, which controls traffic to lysosome-related organelles in conjunction with components of the biogenesis of lysosome-related organelle complexes (BLOCs). RNA interference-mediated depletion of Rab32 or of an essential component of a BLOC complex was sufficient to allow S. Typhi to survive within mouse macrophages. Furthermore, S. Typhi was able to survive in macrophages from mice defective in BLOC components.	[Spano, Stefania; Galan, Jorge E.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Spanò, Stefania/F-4951-2011	Spanò, Stefania/0000-0001-9154-7463	National Institute of Allergy and Infectious Diseases [AI079022, AI055472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079022, R01AI055472, R56AI079022] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Mothes for providing primary bone-marrow-derived macrophages from pa/co/le mice, which had been provided to him by R. Swank. We also thank C. Roy's laboratory for providing various Rab GTPase constructs and members of the Galan laboratory for critical reading of the manuscript. This work was supported by National Institute of Allergy and Infectious Diseases grants AI079022 and AI055472 (to J.E.G.).	Aspengren S, 2009, INT REV CEL MOL BIO, V272, P245, DOI 10.1016/S1937-6448(08)01606-7; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Chan WT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002713; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; EDSALL G, 1960, J EXP MED, V112, P143, DOI 10.1084/jem.112.1.143; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Raffatellu M, 2008, J INFECT DEV COUNTR, V2, P260; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; VLADOIANU IR, 1990, MICROB PATHOGENESIS, V8, P83, DOI 10.1016/0882-4010(90)90072-X; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	36	100	100	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					960	963		10.1126/science.1229224	http://dx.doi.org/10.1126/science.1229224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162001	Green Accepted			2022-12-24	WOS:000311083600047
J	Lee, J; Sayed, N; Hunter, A; Au, KF; Wong, WH; Mocarski, ES; Pera, RR; Yakubov, E; Cooke, JP				Lee, Jieun; Sayed, Nazish; Hunter, Arwen; Au, Kin Fai; Wong, Wing H.; Mocarski, Edward S.; Pera, Renee Reijo; Yakubov, Eduard; Cooke, John P.			Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming	CELL			English	Article							PLURIPOTENT STEM-CELLS; NF-KAPPA-B; MURINE LEUKEMIA-VIRUS; TOLL-LIKE RECEPTOR-3; HISTONE H3; GENE-EXPRESSION; SOMATIC-CELLS; BINDING-SITE; LYSINE 9; FIBROBLASTS	Retroviral overexpression of reprogramming factors (Oct4, Sox2, Klf4, c-Myc) generates induced pluripotent stem cells (iPSCs). However, the integration of foreign DNA could induce genomic dysregulation. Cell-permeant proteins (CPPs) could overcome this limitation. To date, this approach has proved exceedingly inefficient. We discovered a striking difference in the pattern of gene expression induced by viral versus CPP-based delivery of the reprogramming factors, suggesting that a signaling pathway required for efficient nuclear reprogramming was activated by the retroviral, but not CPP approach. In gain-and loss-of-function studies, we find that the toll-like receptor 3 (TLR3) pathway enables efficient induction of pluripotency by viral or mmRNA approaches. Stimulation of TLR3 causes rapid and global changes in the expression of epigenetic modifiers to enhance chromatin remodeling and nuclear reprogramming. Activation of inflammatory pathways are required for efficient nuclear reprogramming in the induction of pluripotency.	[Lee, Jieun; Sayed, Nazish; Hunter, Arwen; Yakubov, Eduard; Cooke, John P.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Au, Kin Fai; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Pera, Renee Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Mocarski, Edward S.] Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA	Stanford University; Stanford University; Stanford University; Emory University	Cooke, JP (corresponding author), Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.	john.cooke@stanford.edu	Mocarski, Edward/ABC-2893-2020	Cooke, John/0000-0003-0033-9138; Sayed, Nazish/0000-0002-8229-721X; Reijo Pera, Renee/0000-0002-6487-1329	National Institutes of Health [U01HL100397, RC2HL103400]; University of California; NRSA grant [HL098049-01A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, T32HL098049, RC2HL103400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NRSA grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Drs. Joanna Wysocka, Karla Kirkegaard, and Vittorio Sebastiano for their guidance; Mr. Liqun Zhu for technical assistance; and Dr. Yaso Natkunam for histological studies. This work was supported by grants to J. P. C from National Institutes of Health (U01HL100397 and RC2HL103400). J. L. was supported by grant from the Tobacco Related Disease Research Program of the University of California. N. S was supported by NRSA grant (HL098049-01A1). J. P. C., N. S., and J. L. are inventors of the intellectual property, assigned to Stanford University, which was generated by this research.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; HAGINOYAMAGISHI K, 1987, J VIROL, V61, P1964, DOI 10.1128/JVI.61.6.1964-1971.1987; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang WC, 2009, BIOTECHNOL BIOENG, V104, P1047, DOI 10.1002/bit.22517; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	42	241	261	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					547	558		10.1016/j.cell.2012.09.034	http://dx.doi.org/10.1016/j.cell.2012.09.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101625	Green Accepted, Bronze			2022-12-24	WOS:000310529300012
J	White, JF; Noinaj, N; Shibata, Y; Love, J; Kloss, B; Xu, F; Gvozdenovic-Jeremic, J; Shah, P; Shiloach, J; Tate, CG; Grisshammer, R				White, Jim F.; Noinaj, Nicholas; Shibata, Yoko; Love, James; Kloss, Brian; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Shiloach, Joseph; Tate, Christopher G.; Grisshammer, Reinhard			Structure of the agonist-bound neurotensin receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; OPIOID RECEPTOR; BINDING-SITE; ACTIVE STATE; PEPTIDE; GPCR; ACTIVATION; INSIGHTS	Neurotensin (NTS) is a 13-amino-acid peptide that functions as both a neurotransmitter and a hormone through the activation of the neurotensin receptor NTSR1, a G-protein-coupled receptor (GPCR). In the brain, NTS modulates the activity of dopaminergic systems, opioid-independent analgesia, and the inhibition of food intake; in the gut, NTS regulates a range of digestive processes. Here we present the structure at 2.8 angstrom resolution of Rattus norvegicus NTSR1 in an active-like state, bound to NTS8-13, the carboxy-terminal portion of NTS responsible for agonist-induced activation of the receptor. The peptide agonist binds to NTSR1 in an extended conformation nearly perpendicular to the membrane plane, with the C terminus oriented towards the receptor core. Our findings provide, to our knowledge, the first insight into the binding mode of a peptide agonist to a GPCR and may support the development of non-peptide ligands that could be useful in the treatment of neurological disorders, cancer and obesity.	[White, Jim F.; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Grisshammer, Reinhard] Natl Inst Neurol Disorders & Stroke, Membrane Prot Struct Funct Unit, NIH, US Dept HHS, Rockville, MD 20852 USA; [Noinaj, Nicholas] NIDDKD, Mol Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Shibata, Yoko; Tate, Christopher G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Love, James; Kloss, Brian] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, Prot Prod Facil, New York, NY 10027 USA; [Shiloach, Joseph] NIDDKD, Biotechnol Core Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Grisshammer, R (corresponding author), Natl Inst Neurol Disorders & Stroke, Membrane Prot Struct Funct Unit, NIH, US Dept HHS, Rockville, MD 20852 USA.	rkgriss@helix.nih.gov	Grisshammer, Reinhard/C-3089-2015	Tate, Christopher/0000-0002-2008-9183; Kloss, Brian/0000-0003-0130-8739	National Institutes of Health (National Institute of Neurological Disorders and Stroke); National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases); Pfizer Global Research and Development; MRCT Development Gap Fund; UK Medical Research Council [MRC U105197215]; National Institutes of Health [U54GM075026]; NIH Roadmap grant [P50 GM073197]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; MRC [MC_U105197215] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, P50GM073197] Funding Source: NIH RePORTER; Medical Research Council [MC_U105197215] Funding Source: researchfish	National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pfizer Global Research and Development(Pfizer); MRCT Development Gap Fund(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Program of the National Institutes of Health (J.F.W., J.G.-J., P.S. and R.G.: National Institute of Neurological Disorders and Stroke; N.N. and J.S.: National Institute of Diabetes and Digestive and Kidney Diseases) and a joint grant from Pfizer Global Research and Development and the MRCT Development Gap Fund in addition to core funding from the UK Medical Research Council MRC U105197215 (Y.S., C.G.T.). The Protein Production Facility of the New York Consortium on Membrane Protein Structure was supported by the National Institutes of Health grant U54GM075026 (J.L., B.K.). We acknowledge the NIH Roadmap grant P50 GM073197 for technology development (to R. C. Stevens) for visitor support at The Scripps Research Institute. We thank the staff at the General Medicine and Cancer Institute's Collaborative Access Team (GM/CA-CAT) beamline at the Advanced Photon Source, Argonne National Laboratory for their assistance during data collection. Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barroso S, 2002, BRIT J PHARMACOL, V135, P997, DOI 10.1038/sj.bjp.0704546; Barroso S, 2000, J BIOL CHEM, V275, P328, DOI 10.1074/jbc.275.1.328; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; Harterich S, 2008, BIOORGAN MED CHEM, V16, P9359, DOI 10.1016/j.bmc.2008.08.051; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; HENRY JA, 1993, BIOORG MED CHEM LETT, V3, P949, DOI 10.1016/S0960-894X(00)80698-8; Hilgart MC, 2011, J SYNCHROTRON RADIAT, V18, P717, DOI 10.1107/S0909049511029918; Inagaki S, 2012, J MOL BIOL, V417, P95, DOI 10.1016/j.jmb.2012.01.023; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kitabgi P, 2002, CURR OPIN DRUG DI DE, V5, P764; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lebon G., 2012, CURR OPIN STRUC BIOL, V22, P1; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Luca S, 2003, P NATL ACAD SCI USA, V100, P10706, DOI 10.1073/pnas.1834523100; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Pang YP, 1996, J BIOL CHEM, V271, P15060, DOI 10.1074/jbc.271.25.15060; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schimpff RM, 2001, J NEUROL NEUROSUR PS, V70, P784, DOI 10.1136/jnnp.70.6.784; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; VITA N, 1993, FEBS LETT, V317, P139, DOI 10.1016/0014-5793(93)81509-X; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	59	373	383	7	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					508	+		10.1038/nature11558	http://dx.doi.org/10.1038/nature11558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23051748	Green Accepted			2022-12-24	WOS:000310196200035
J	Yang, HH; Kim, A; David, T; Palmer, D; Jin, TH; Tien, J; Huang, F; Cheng, T; Coughlin, SR; Jan, YN; Jan, LY				Yang, Huanghe; Kim, Andrew; David, Tovo; Palmer, Daniel; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Coughlin, Shaun R.; Jan, Yuh Nung; Jan, Lily Yeh			TMEM16F Forms a Ca2+-Activated Cation Channel Required for Lipid Scrambling in Platelets during Blood Coagulation	CELL			English	Article							ACTIVATED CHLORIDE CHANNELS; SCOTT-SYNDROME; EXPRESSION; TRPM5; MEMBRANES; CELLS	Collapse of membrane lipid asymmetry is a hallmark of blood coagulation. TMEM16F of the TMEM16 family that includes TMEM16A/B Ca2+-activated Cl- channels (CaCCs) is linked to Scott syndrome with deficient Ca2+-dependent lipid scrambling. We generated TMEM16F knockout mice that exhibit bleeding defects and protection in an arterial thrombosis model associated with platelet deficiency in Ca2+-dependent phosphatidylserine exposure and procoagulant activity and lack a Ca2+-activated cation current in the platelet precursor megakaryocytes. Heterologous expression of TMEM16F generates a small-conductance Ca2+-activated nonselective cation (SCAN) current with subpicosiemens single-channel conductance rather than a CaCC. TMEM16F-SCAN channels permeate both monovalent and divalent cations, including Ca2+, and exhibit synergistic gating by Ca2+ and voltage. We further pinpointed a residue in the putative pore region important for the cation versus anion selectivity of TMEM16F-SCAN and TMEM16A-CaCC channels. This study thus identifies a Ca2+-activated channel permeable to Ca2+ and critical for Ca2+-dependent scramblase activity during blood coagulation.	[Yang, Huanghe; Kim, Andrew; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; [Yang, Huanghe; Kim, Andrew; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; [Yang, Huanghe; Kim, Andrew; Jin, Taihao; Tien, Jason; Huang, Fen; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94143 USA; [David, Tovo; Palmer, Daniel; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu	Palmer, Daniel/J-2967-2014; DAVID, Tovo/B-5573-2013; Palmer, Daniel/Q-7595-2016	Palmer, Daniel/0000-0002-7954-9332; Palmer, Daniel/0000-0002-7954-9332; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299; Yang, Huanghe/0000-0001-9521-9328; Tien, Jason/0000-0003-3853-0827	NIH [HL65185, MH65334]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065334, R37MH065334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank David Gorczyca for help with confocal imaging; Xiuming Wong for help with cell culture; and Jianmin Cui, Ehud Isacoff, Min Li, Shi-Bing Yang, James Berg, and Christian Peters for suggestions and comments on the manuscript. We also thank Kevin Shannon and Ethan Weiss for sharing their CBC machine, Thrombinoscope, and other equipment. This study was supported by the NIH grant HL65185 to S.R.C. and MH65334 to L.Y.J. Y.N.J. and L.Y.J. are Howard Hughes Medical Institute investigators.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gurtovenko AA, 2010, CHEM REV, V110, P6077, DOI 10.1021/cr1000783; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Mahaut-Smith Martyn P, 2004, Methods Mol Biol, V273, P277; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Pena F, 2008, MINI-REV MED CHEM, V8, P812, DOI 10.2174/138955708784912166; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; ROSING J, 1985, BLOOD, V65, P319; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Teulon J, 2000, HANDB EXP PHARM, V147, P625; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; van Meer G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004671; Varga-Szabo D, 2011, CELL CALCIUM, V50, P270, DOI 10.1016/j.ceca.2011.04.002; WEISS HJ, 1979, AM J MED, V67, P206, DOI 10.1016/0002-9343(79)90392-9; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	38	285	289	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					111	122		10.1016/j.cell.2012.07.036	http://dx.doi.org/10.1016/j.cell.2012.07.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021219	Green Accepted, Bronze			2022-12-24	WOS:000309544200014
J	Hughes, AL; Gottschling, DE				Hughes, Adam L.; Gottschling, Daniel E.			An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; H+-ATPASE; PROTEINS; MECHANISMS; MEMBRANE; INHERITANCE; MORPHOLOGY; EXCHANGER; INSIGHTS	Mitochondria have a central role in ageing. They are considered to be both a target of the ageing process and a contributor to it(1). Alterations in mitochondrial structure and function are evident during ageing in most eukaryotes(2), but how this occurs is poorly understood. Here we identify a functional link between the lysosome-like vacuole and mitochondria in Saccharomyces cerevisiae, and show that mitochondrial dysfunction in replicatively aged yeast arises from altered vacuolar pH. We found that vacuolar acidity declines during the early asymmetric divisions of a mother cell, and that preventing this decline suppresses mitochondrial dysfunction and extends lifespan. Surprisingly, changes in vacuolar pH do not limit mitochondrial function by disrupting vacuolar protein degradation, but rather by reducing pH-dependent amino acid storage in the vacuolar lumen. We also found that calorie restriction promotes lifespan extension at least in part by increasing vacuolar acidity via conserved nutrient-sensing pathways(3). Interestingly, although vacuolar acidity is reduced in aged mother cells, acidic vacuoles are regenerated in newborn daughters, coinciding with daughter cells having a renewed lifespan potential(4). Overall, our results identify vacuolar pH as a critical regulator of ageing and mitochondrial function, and outline a potentially conserved mechanism by which calorie restriction delays the ageing process. Because the functions of the vacuole are highly conserved throughout evolution(5), we propose that lysosomal pH may modulate mitochondrial function and lifespan in other eukaryotic cells.	[Hughes, Adam L.; Gottschling, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Gottschling, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	dgottsch@fhcrc.org		Hughes, Adam/0000-0002-7095-3793	National Institutes of Health [AG037512, AG023779]; Glenn Award for Research in Biological Mechanisms of Aging; Helen Hay Whitney Foundation; Genetic Approaches to Aging Training Grant [T32 AG000057]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, R01AG037512, R01AG023779, R37AG023779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Award for Research in Biological Mechanisms of Aging; Helen Hay Whitney Foundation; Genetic Approaches to Aging Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Pallanck and members of the Gottschling laboratory for reviewing the manuscript; K. Henderson for helpful discussions; G. Miesenbock, D. Lindstromand J. Hsu for reagents; and L. Dimitrov for technical assistance. This work was supported by National Institutes of Health grants AG037512 and AG023779, and a Glenn Award for Research in Biological Mechanisms of Aging to D.E.G., and by fellowships from the Helen Hay Whitney Foundation and Genetic Approaches to Aging Training Grant (T32 AG000057) to A.L.H.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; Baker B, 1998, INTERNET WORLD, V9, P14; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Lam YT, 2011, FREE RADICAL BIO MED, V50, P963, DOI 10.1016/j.freeradbiomed.2011.01.013; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lindstrom DL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002015; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; MORANO KA, 1994, J CELL SCI, V107, P2813; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shimazu M, 2005, J BIOL CHEM, V280, P4851, DOI 10.1074/jbc.M412617200; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539	41	329	333	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					261	+		10.1038/nature11654	http://dx.doi.org/10.1038/nature11654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23172144	Green Accepted			2022-12-24	WOS:000312259300044
J	Hernandez, AR; Klein, AM; Kirschner, MW				Hernandez, Ana R.; Klein, Allon M.; Kirschner, Marc W.			Kinetic Responses of beta-Catenin Specify the Sites of Wnt Control	SCIENCE			English	Article							AXIN; PHOSPHORYLATION	Despite more than 30 years of work on the Wnt signaling pathway, the basic mechanism of how the extracellular Wnt signal increases the intracellular concentration of beta-catenin is still contentious. Circumventing much of the detailed biochemistry, we used basic principles of chemical kinetics coupled with quantitative measurements to define the reactions on beta-catenin directly affected by the Wnt signal. We conclude that the core signal transduction mechanism is relatively simple, with only two regulated phosphorylation steps. Their partial inhibition gives rise to the full dynamics of the response and subsequently maintains a steady state in which the concentration of beta-catenin is increased.	[Hernandez, Ana R.; Klein, Allon M.; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu			Novartis Institutes for Biomedical Research; Career Award at the Scientific Interface from the Burroughs Welcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125603] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; Career Award at the Scientific Interface from the Burroughs Welcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Gerhart, M. Springer, X. He, W. Fontana, J. Gunawardena, J. Gray, F. Cong, and R. Deibler for discussions and comments on the manuscript; Y. Ben-Neriah for plasmids; and the Novartis Institutes for Biomedical Research for support of this work. A. M. K. holds a Career Award at the Scientific Interface from the Burroughs Welcome Fund. M. W. K. serves as a paid consultant on the scientific review board of Novartis.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; CHANCE B, 1958, NATURE, V182, P1190, DOI 10.1038/1821190a0; HEINRICH R, 1974, EUR J BIOCHEM, V42, P97, DOI 10.1111/j.1432-1033.1974.tb03319.x; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; Peacocke AR, 1996, J THEOR BIOL, V182, P219, DOI 10.1006/jtbi.1996.0158; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P296, DOI 10.1021/bp990048k; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200	16	89	89	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1337	1340		10.1126/science.1228734	http://dx.doi.org/10.1126/science.1228734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23138978				2022-12-24	WOS:000311991200065
J	Salazar, RF; Dotson, NM; Bressler, SL; Gray, CM				Salazar, R. F.; Dotson, N. M.; Bressler, S. L.; Gray, C. M.			Content-Specific Fronto-Parietal Synchronization During Visual Working Memory	SCIENCE			English	Article							SHORT-TERM-MEMORY; PRIMATE PREFRONTAL CORTEX; POSTERIOR PARIETAL CORTICES; NEURAL MECHANISMS; RHESUS-MONKEY; TOP-DOWN; OSCILLATIONS; ATTENTION; NEURONS; NETWORKS	Lateral prefrontal and posterior parietal cortical areas exhibit task-dependent activation during working memory tasks in humans and monkeys. Neurons in these regions become synchronized during attention-demanding tasks, but the contribution of these interactions to working memory is largely unknown. Using simultaneous recordings of neural activity from multiple areas in both regions, we find widespread, task-dependent, and content-specific synchronization of activity across the fronto-parietal network during visual working memory. The patterns of synchronization are prevalent among stimulus-selective neurons and are governed by influences arising in parietal cortex. These results indicate that short-term memories are represented by large-scale patterns of synchronized activity across the fronto-parietal network.	[Salazar, R. F.; Dotson, N. M.; Gray, C. M.] Montana State Univ, Bozeman, MT 59717 USA; [Bressler, S. L.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA	Montana State University System; Montana State University Bozeman; State University System of Florida; Florida Atlantic University	Gray, CM (corresponding author), Montana State Univ, Bozeman, MT 59717 USA.	cmgray@cns.montana.edu		Salazar, Rodrigo/0000-0003-3530-666X; Dotson, Nicholas/0000-0002-0885-2182	National Institute of Mental Health [MH069374, MH081162]; National Institute of Neurological Disorders and Stroke [NS059312]; Swiss National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069374, R01MH081162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059312] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Mental Health (MH069374, MH081162), the National Institute of Neurological Disorders and Stroke (NS059312), and the Swiss National Science Foundation. We thank B. Goodell for the design and development of the microdrive systems used in this study and U. Koster for technical support in the computational procedures. We also thank two anonymous reviewers for helpful comments on an earlier version of the manuscript.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hebb Donald O., 1949, ORG BEHAV; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Liebe S, 2012, NAT NEUROSCI, V15, P456, DOI 10.1038/nn.3038; Miller EK, 1996, J NEUROSCI, V16, P5154; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; QUINTANA J, 1989, BRAIN RES, V503, P100, DOI 10.1016/0006-8993(89)91709-5; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Verhoef BE, 2011, J NEUROPHYSIOL, V105, P2030, DOI 10.1152/jn.00924.2010; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	31	236	239	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1097	1100		10.1126/science.1224000	http://dx.doi.org/10.1126/science.1224000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23118014	Green Accepted			2022-12-24	WOS:000311390600048
J	de Ligt, J; Willemsen, MH; van Bon, BWM; Kleefstra, T; Yntema, HG; Kroes, T; Vulto-van Silfhout, AT; Koolen, DA; de Vries, P; Gilissen, C; del Rosario, M; Hoischen, A; Scheffer, H; de Vries, BBA; Brunner, HG; Veltman, JA; Vissers, LELM				de Ligt, Joep; Willemsen, Marjolein H.; van Bon, Bregje W. M.; Kleefstra, Tjitske; Yntema, Helger G.; Kroes, Thessa; Vulto-van Silfhout, Anneke T.; Koolen, David A.; de Vries, Petra; Gilissen, Christian; del Rosario, Marisol; Hoischen, Alexander; Scheffer, Hans; de Vries, Bert B. A.; Brunner, Han G.; Veltman, Joris A.; Vissers, Lisenka E. L. M.			Diagnostic Exome Sequencing in Persons with Severe Intellectual Disability	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DE-NOVO MUTATIONS; MENTAL-RETARDATION; GENETICS	Background The causes of intellectual disability remain largely unknown because of extensive clinical and genetic heterogeneity. Methods We evaluated patients with intellectual disability to exclude known causes of the disorder. We then sequenced the coding regions of more than 21,000 genes obtained from 100 patients with an IQ below 50 and their unaffected parents. A data-analysis procedure was developed to identify and classify de novo, autosomal recessive, and X-linked mutations. In addition, we used high-throughput resequencing to confirm new candidate genes in 765 persons with intellectual disability (a confirmation series). All mutations were evaluated by molecular geneticists and clinicians in the context of the patients' clinical presentation. Results We identified 79 de novo mutations in 53 of 100 patients. A total of 10 de novo mutations and 3 X-linked (maternally inherited) mutations that had been previously predicted to compromise the function of known intellectual-disability genes were found in 13 patients. Potentially causative de novo mutations in novel candidate genes were detected in 22 patients. Additional de novo mutations in 3 of these candidate genes were identified in patients with similar phenotypes in the confirmation series, providing support for mutations in these genes as the cause of intellectual disability. We detected no causative autosomal recessive inherited mutations in the discovery series. Thus, the total diagnostic yield was 16%, mostly involving de novo mutations. Conclusions De novo mutations represent an important cause of intellectual disability; exome sequencing was used as an effective diagnostic strategy for their detection. (Funded by the European Union and others.)	[de Ligt, Joep; Willemsen, Marjolein H.; van Bon, Bregje W. M.; Kleefstra, Tjitske; Yntema, Helger G.; Kroes, Thessa; Vulto-van Silfhout, Anneke T.; Koolen, David A.; de Vries, Petra; Gilissen, Christian; del Rosario, Marisol; Hoischen, Alexander; Scheffer, Hans; de Vries, Bert B. A.; Brunner, Han G.; Veltman, Joris A.; Vissers, Lisenka E. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci,Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Veltman, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci,Inst Genet & Metab Dis, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.veltman@gen.umcn.nl	Brunner, Han/C-9928-2013; Scheffer, Hans/E-4644-2012; Willemsen, Marjolein/G-9491-2013; van Bon, Bregje/D-3720-2013; Gilissen, Christian/E-5246-2012; Vissers, Lisenka ELM/A-2598-2015; Hoischen, Alexander/AGF-7293-2022; Koolen, D.A./L-4448-2015; Willemsen, Marjolein/R-5958-2019; Yntema, H.G./L-4771-2015; Kleefstra, Tjitske/G-2619-2012; Hoischen, Alexander/D-1282-2013; Veltman, Joris A/F-5128-2010; van Bon, Bregje/Q-2445-2015; AT, Vulto-van Silfhout/H-4199-2015	Scheffer, Hans/0000-0002-2986-0915; Gilissen, Christian/0000-0003-1693-9699; Vissers, Lisenka ELM/0000-0001-6470-5497; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Veltman, Joris A/0000-0002-3218-8250; van Bon, Bregje/0000-0003-2234-0105; Kroes, Thessa/0000-0003-1416-5407; de Ligt, Joep/0000-0002-0348-419X	European Union; consortium Stronger on Your Own Feet; Netherlands Organization for Health Research and Development [ZonMW 907-00-365, 917-86-319, 916-12-095, 917-66-363, 916-86-016]; European Union-funded TECHGENE project [Health-F5-2009-223143]; GEUVADIS project [Health-F7-2010-261123]; European Research Council [DENOVO 281964];  [EU-7th-2010-241995]	European Union(European Commission); consortium Stronger on Your Own Feet; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Union-funded TECHGENE project; GEUVADIS project; European Research Council(European Research Council (ERC)European Commission); 	Funded by the European Union and others.; Supported by grants from the consortium Stronger on Your Own Feet (to Drs. Willemsen and Kleefstra), the Netherlands Organization for Health Research and Development (ZonMW 907-00-365, to Dr. Kleefstra; 917-86-319, to Ms. de Vries; 916-12-095, to Dr. Hoischen; 917-66-363, to Dr. Veltman; and 916-86-016, to Dr. Vissers), the GENCODYS project (EU-7th-2010-241995, to Drs. Vulto-van Silfout and Kleefstra), the European Union-funded TECHGENE project (Health-F5-2009-223143, to Mr. de Ligt and Drs. Brunner, Scheffer, and Veltman), the GEUVADIS project (Health-F7-2010-261123, to Dr. Veltman), and the European Research Council (DENOVO 281964, to Dr. Veltman).	Battaglia A, 2003, AM J MED GENET C, V117C, P3, DOI 10.1002/ajmg.c.10015; Bell J, 2007, PRACTICE GUIDELINES; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Catarino CB, 2011, BRAIN, V134, P2982, DOI 10.1093/brain/awr129; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Hamdan FF, 2011, AM J HUM GENET, V88, P516, DOI 10.1016/j.ajhg.2011.03.011; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hochstenbach R, 2009, EUR J MED GENET, V52, P161, DOI 10.1016/j.ejmg.2009.03.015; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MATSUNAGA E, 1981, AM J MED GENET, V8, P375, DOI 10.1002/ajmg.1320080403; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Moeschler JB, 2006, PEDIATRICS, V117, P2304, DOI 10.1542/peds.2006-1006; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Prasad C, 2011, BRAIN DEV-JPN, V33, P856, DOI 10.1016/j.braindev.2011.08.003; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Romano C, 2010, MONOGR HUM GENET, V18, P57; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shea Sarah E, 2006, Semin Pediatr Neurol, V13, P262, DOI 10.1016/j.spen.2006.09.010; Topper S, 2011, CLIN GENET, V80, P117, DOI 10.1111/j.1399-0004.2011.01720.x; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542	30	1068	1146	4	99	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2012	367	20					1921	1929		10.1056/NEJMoa1206524	http://dx.doi.org/10.1056/NEJMoa1206524			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036MB	23033978	Bronze			2022-12-24	WOS:000311029300008
J	Garrison, JL; Macosko, EZ; Bernstein, S; Pokala, N; Albrecht, DR; Bargmann, CI				Garrison, Jennifer L.; Macosko, Evan Z.; Bernstein, Samantha; Pokala, Navin; Albrecht, Dirk R.; Bargmann, Cornelia I.			Oxytocin/Vasopressin-Related Peptides Have an Ancient Role in Reproductive Behavior	SCIENCE			English	Article							MALE MATING-BEHAVIOR; CAENORHABDITIS-ELEGANS; C-ELEGANS; OXYTOCIN	Many biological functions are conserved, but the extent to which conservation applies to integrative behaviors is unknown. Vasopressin and oxytocin neuropeptides are strongly implicated in mammalian reproductive and social behaviors, yet rodent loss-of-function mutants have relatively subtle behavioral defects. Here we identify an oxytocin/vasopressin-like signaling system in Caenorhabditis elegans, consisting of a peptide and two receptors that are expressed in sexually dimorphic patterns. Males lacking the peptide or its receptors perform poorly in reproductive behaviors, including mate search, mate recognition, and mating, but other sensorimotor behaviors are intact. Quantitative analysis indicates that mating motor patterns are fragmented and inefficient in mutants, suggesting that oxytocin/vasopressin peptides increase the coherence of mating behaviors. These results indicate that conserved molecules coordinate diverse behavioral motifs in reproductive behavior.	[Garrison, Jennifer L.; Macosko, Evan Z.; Bernstein, Samantha; Pokala, Navin; Albrecht, Dirk R.; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Garrison, JL (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA.		Pokala, Navin/AAH-5719-2019; Macosko, Evan/X-4664-2019	Pokala, Navin/0000-0003-2323-6190; Bargmann, Cornelia/0000-0002-8484-0618	G. Harold and Leila Y. Mathers Foundation; Harvey Karp and Helen Hay Whitney Fellowships; NIH [K99GM092859, GM07739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM092859, T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; Harvey Karp and Helen Hay Whitney Fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Strains bearing ntc-1, ntr-1, and ntr-2 mutations are available through the C. elegans National BioResource Project (NBRP), subject to a materials transfer agreement. Sequence accession numbers are as follows: NM_001038459.1 (ntc-1), NM_060792 (ntr-1), NM_078076 (ntr-2). We thank S. Emmons for sharing the male wiring diagram before publication; D. Anderson, S. Emmons, S. Flavell, A. Gordus, W. Kristan, T. Maniar, P. McGrath, L. Vosshall, and Y. Xu for discussions; S. Chalasani for plasmids; S. Mitani and the National Bioresource Project for ntc-1, ntr-1, and ntr-2 mutants; and the Rockefeller Proteomics Facility, the Rockefeller Bioimaging Facility, and the Rockefeller High Throughput Screening Facility for technical support. This work was supported by a grant from the G. Harold and Leila Y. Mathers Foundation, by Harvey Karp and Helen Hay Whitney Fellowships to J.L.G., by NIH grant K99GM092859 to J.L.G., and by NIH grant GM07739 to E.Z.M. C.I.B. is an Investigator of the Howard Hughes Medical Institute.	Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; HODGKIN J, 1987, ANNU REV GENET, V21, P133, DOI 10.1146/annurev.ge.21.120187.001025; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Neumann ID, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00012; Wagenaar DA, 2010, CURR BIOL, V20, P487, DOI 10.1016/j.cub.2010.02.027; Winslow JT, 2002, NEUROPEPTIDES, V36, P221, DOI 10.1054/npep.2002.0909	16	163	166	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					540	543		10.1126/science.1226201	http://dx.doi.org/10.1126/science.1226201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112335	Green Accepted			2022-12-24	WOS:000310195800061
J	Dandekar, AA; Chugani, S; Greenberg, EP				Dandekar, Ajai A.; Chugani, Sudha; Greenberg, E. Peter			Bacterial Quorum Sensing and Metabolic Incentives to Cooperate	SCIENCE			English	Article							LUXR-LUXI FAMILY; PSEUDOMONAS-AERUGINOSA; POPULATIONS; CONFLICT; REGULATORS; MECHANISM	The opportunistic pathogen Pseudomonas aeruginosa uses a cell-cell communication system termed "quorum sensing" to control production of public goods, extracellular products that can be used by any community member. Not all individuals respond to quorum-sensing signals and synthesize public goods. Such social cheaters enjoy the benefits of the products secreted by cooperators. There are some P. aeruginosa cellular enzymes controlled by quorum sensing, and we show that quorum sensing-controlled expression of such private goods can put a metabolic constraint on social cheating and prevent a tragedy of the commons. Metabolic constraint of social cheating provides an explanation for private-goods regulation by a cooperative system and has general implications for population biology, infection control, and stabilization of quorum-sensing circuits in synthetic biology.	[Chugani, Sudha; Greenberg, E. Peter] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Dandekar, Ajai A.] Univ Washington, Sch Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Greenberg, EP (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	epgreen@u.washington.edu		Dandekar, Ajai/0000-0002-2992-6523; Greenberg, Everett/0000-0001-9474-8041	U.S. Public Health Service [GM-59026, P30 DK 89507]; Cystic Fibrosis Foundation Leroy Matthews Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059026] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Cystic Fibrosis Foundation Leroy Matthews Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Public Health Service grants GM-59026 and P30 DK 89507 to E. P. G. A. A. D. is supported by a Cystic Fibrosis Foundation Leroy Matthews Fellowship. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/DRYAD.122SV.	BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Chugani S, 2012, P NATL ACAD SCI USA, V109, pE2823, DOI 10.1073/pnas.1214128109; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; Kurachi M., 1958, B I CHEM RES, V36, P163; Kuzdzal-Fick JJ, 2011, SCIENCE, V334, P1548, DOI 10.1126/science.1213272; Mellbye B, 2011, MBIO, V2, DOI 10.1128/mBio.00131-11; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x	19	208	220	5	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					264	266		10.1126/science.1227289	http://dx.doi.org/10.1126/science.1227289			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066081	Green Accepted			2022-12-24	WOS:000309712300048
J	Fedorenko, A; Lishko, PV; Kirichok, Y				Fedorenko, Andriy; Lishko, Polina V.; Kirichok, Yuriy			Mechanism of Fatty-Acid-Dependent UCP1 Uncoupling in Brown Fat Mitochondria	CELL			English	Article							ADIPOSE-TISSUE MITOCHONDRIA; PHYSIOLOGICAL REGULATION; TRANSPORT ACTIVITY; INNER MEMBRANE; PROTEIN; SEQUENCE; BINDING; PHOSPHOLIPIDS; NUCLEOTIDE; VALUES	Mitochondrial uncoupling protein 1 (UCP1) is responsible for nonshivering thermogenesis in brown adipose tissue (BAT). Upon activation by long-chain fatty acids (LCFAs), UCP1 increases the conductance of the inner mitochondrial membrane (IMM) to make BAT mitochondria generate heat rather than ATP. Despite being a member of the family of mitochondrial anion carriers (SLC25), UCP1 is believed to transport H+ by an unusual mechanism that has long remained unresolved. Here, we achieved direct patch-clamp measurements of UCP1 currents from the IMM of BAT mitochondria. We show that UCP1 is an LCFA anion/H+ symporter. However, the LCFA anions cannot dissociate from UCP1 due to hydrophobic interactions established by their hydrophobic tails, and UCP1 effectively operates as an H+ carrier activated by LCFA. A similar LCFA-dependent mechanism of transmembrane H+ transport may be employed by other SLC25 members and be responsible for mitochondrial uncoupling and regulation of metabolic efficiency in various tissues.	[Fedorenko, Andriy; Lishko, Polina V.; Kirichok, Yuriy] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kirichok, Y (corresponding author), Univ Calif San Francisco, Dept Physiol, UCSF Mail Code 2140,Genentech Hall,Room N272F,600, San Francisco, CA 94158 USA.	yuriy.kirichok@ucsf.edu	Lishko, Polina/GQH-9569-2022; Lishko, Polina/L-1191-2017		NIH [DP2OD004656]; UCSF Program for Breakthrough Biomedical Research; Larry L. Hillblom Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research; Larry L. Hillblom Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are grateful to Drs. David Nicholls, Eduardo Rial, Robert Farese, Frederick Sachs, and Francesca Fieni for advice and to Dr. Leslie Kozak for the UCP1<SUP>-/-</SUP> mice. This work was funded by the NIH Director's New Innovator Award DP2OD004656, the UCSF Program for Breakthrough Biomedical Research, and a Larry L. Hillblom Foundation Start-up Award. A. F. and Y.K. conceived the project and designed the experiments. A. F. performed most of the experiments. Y. K. and P. V. L. helped with pilot experiments for the project. All authors discussed the results and commented on the manuscript.	ANEL A, 1993, BIOCHEMISTRY-US, V32, P530, DOI 10.1021/bi00053a018; Annunziata O, 1999, J COLLOID INTERF SCI, V216, P16, DOI 10.1006/jcis.1999.6269; AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BHAMIDIPATI SP, 1995, BIOCHEMISTRY-US, V34, P5666, DOI 10.1021/bi00016a043; Borecky J, 1997, J BIOL CHEM, V272, P19282; BOUILLAUD F, 1986, J BIOL CHEM, V261, P1487; Bruce P.Y, 2001, ORGANIC CHEM; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CANNON B, 1977, FEBS LETT, V74, P43, DOI 10.1016/0014-5793(77)80748-5; DECKER GL, 1977, J ULTRA MOL STRUCT R, V59, P44, DOI 10.1016/S0022-5320(77)80027-0; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Garlid KD, 1998, FEBS LETT, V438, P10, DOI 10.1016/S0014-5793(98)01246-0; Ghomashchi F, 2010, J BIOL CHEM, V285, P36100, DOI 10.1074/jbc.M110.165647; Goss KU, 2008, ENVIRON SCI TECHNOL, V42, P456, DOI 10.1021/es702192c; GUTHRIE JP, 1978, CAN J CHEM, V56, P2342, DOI 10.1139/v78-385; Hamilton JA, 1998, J LIPID RES, V39, P467; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Huang SG, 2003, ARCH BIOCHEM BIOPHYS, V412, P142, DOI 10.1016/S0003-9861(03)00031-6; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; JEZEK P, 1990, J BIOL CHEM, V265, P19303; JEZEK P, 1989, AM J PHYSIOL, V257, pC1142, DOI 10.1152/ajpcell.1989.257.6.C1142; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Klingenberg M, 2010, BBA-BIOENERGETICS, V1797, P579, DOI 10.1016/j.bbabio.2010.02.012; Lester HA, 1996, NEURON, V17, P807, DOI 10.1016/S0896-6273(00)80213-5; Lide D., 1998, HDB CHEM PHYS; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Peres A, 2004, NEWS PHYSIOL SCI, V19, P80, DOI 10.1152/nips.01504.2003; Rial E, 2004, BBA-BIOENERGETICS, V1608, P122, DOI 10.1016/j.bbabio.2003.11.001; Rial E, 2001, BBA-BIOENERGETICS, V1504, P70, DOI 10.1016/S0005-2728(00)00240-1; RIAL E, 1983, EUR J BIOCHEM, V137, P197, DOI 10.1111/j.1432-1033.1983.tb07815.x; RIDLEY RG, 1986, NUCLEIC ACIDS RES, V14, P4025, DOI 10.1093/nar/14.10.4025; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200; Stewart A, 2002, J BIOL CHEM, V277, P29526, DOI 10.1074/jbc.M204856200; WINKLER E, 1994, J BIOL CHEM, V269, P2508; ZURINI M, 1981, EUR J BIOCHEM, V119, P517, DOI 10.1111/j.1432-1033.1981.tb05638.x	48	542	562	10	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					400	413		10.1016/j.cell.2012.09.010	http://dx.doi.org/10.1016/j.cell.2012.09.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063128	Green Accepted, Bronze			2022-12-24	WOS:000309981000017
J	Melander, O; Maisel, AS; Almgren, P; Manjer, J; Belting, M; Hedblad, B; Engstrom, G; Kilger, U; Nilsson, P; Bergmann, A; Orho-Melander, M				Melander, Olle; Maisel, Alan S.; Almgren, Peter; Manjer, Jonas; Belting, Mattias; Hedblad, Bo; Engstrom, Gunnar; Kilger, Ute; Nilsson, Peter; Bergmann, Andreas; Orho-Melander, Marju			Plasma Proneurotensin and Incidence of Diabetes, Cardiovascular Disease, Breast Cancer, and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SWEDISH OBESE SUBJECTS; BARIATRIC SURGERY; REGULATORY PEPTIDES; GASTRIC BYPASS; NEUROMEDIN-N; NEUROTENSIN; PROGRESSION; EVENTS; INTERVENTION; EXPRESSION	Context Neurotensin regulates both satiety and breast cancer growth in the experimental setting, but little is known about its role in the development of breast cancer or cardiometabolic disease in humans. Objective To test if fasting plasma concentration of a stable 117-amino acid fragment from the neurotensin precursor hormone proneurotensin is associated with development of diabetes mellitus, cardiovascular disease, breast cancer, and mortality. Design, Setting, and Participants Proneurotensin was measured in plasma from 4632 fasting participants of the population-based Malmo Diet and Cancer Study baseline examination 1991-1994. Multivariate Cox proportional hazards models were used to relate baseline proneurotensin to first events and death during long-term follow-up until January 2009, with median follow-up ranging from 13.2 to 15.7 years depending on the disease. Main Outcome Measures Incident diabetes mellitus, cardiovascular disease, breast cancer, and mortality. Results Overall, proneurotensin (hazard ratio [HR] per SD increment of log-transformed proneurotensin) was related to risk of incident diabetes (142 events; HR, 1.28; 95% CI, 1.09-1.50; P=.003), cardiovascular disease (519 events; HR, 1.17; 95% CI, 1.07-1.27; P<.001), and cardiovascular mortality (174 events; HR, 1.29; 95% CI, 1.12-1.49; P=.001) with a significant interaction between proneurotensin and sex (P<.001) on risk of cardiovascular disease. Exclusively in women, proneurotensin was related to incident diabetes (74 events; HR, 1.41; 95% CI, 1.12-1.77; P=.003), cardiovascular disease (224 events; HR, 1.33; 95% CI, 1.17-1.51; P<.001), breast cancer (123 events; HR, 1.44; 95% CI, 1.21-1.71; P<.001), total mortality (285 events; HR, 1.13; 95% CI, 1.01-1.27; P=.03), and cardiovascular mortality (75 events; HR, 1.50; 95% CI, 1.20-1.87; P<.001). Conclusion Fasting proneurotensin was significantly associated with the development of diabetes, cardiovascular disease, breast cancer, and with total and cardiovascular mortality. JAMA. 2012;308(14):1469-1475 www.jama.com	[Belting, Mattias] Sect Oncol, Lund, Sweden; [Melander, Olle; Hedblad, Bo; Nilsson, Peter] Skane Univ Hosp, Ctr Emergency Med, Lund, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Surg, Lund, Sweden; [Belting, Mattias] Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Surg, SE-20502 Malmo, Sweden; [Belting, Mattias] Skane Univ Hosp, Dept Oncol, SE-20502 Malmo, Sweden; [Maisel, Alan S.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Kilger, Ute; Bergmann, Andreas] SphingoTec GmbH, Hohen Neuendorf, Germany; [Bergmann, Andreas] Waltraut Bergmann Fdn, Hohen Neuendorf, Germany; [Melander, Olle] Skane Univ Hosp, Dept Clin Sci, CRC, Ctr Emergency Med, SE-20502 Malmo, Sweden; [Melander, Olle; Almgren, Peter; Manjer, Jonas; Hedblad, Bo; Engstrom, Gunnar; Nilsson, Peter; Orho-Melander, Marju] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Lund University; Skane University Hospital; Lund University	Melander, O (corresponding author), Skane Univ Hosp, Dept Clin Sci, CRC, Ctr Emergency Med, Ent 72,Bldg 91,Level 12, SE-20502 Malmo, Sweden.	olle.melander@med.lu.se		Belting, Mattias/0000-0003-1585-5434; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Melander, Olle/0000-0002-2581-484X; Engstrom, Gunnar/0000-0002-8618-9152	European Research Council [StG-282255]; Swedish Heart and Lung Foundation; Swedish Research Council; Skane University Hospital donation funds; Medical Faculty, Lund University; Albert Pahlsson Research Foundation, Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	European Research Council(European Research Council (ERC)European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Skane University Hospital donation funds; Medical Faculty, Lund University; Albert Pahlsson Research Foundation, Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	Funding was obtained from the European Research Council (StG-282255) (Dr Melander); the Swedish Heart and Lung Foundation, and the Swedish Research Council (Drs Melander and Orho-Melander); the Skane University Hospital donation funds; the Medical Faculty, Lund University (Dr Melander); the governmental funding of clinical research within the national health services (Drs Melander and Orho-Melander); and the Albert Pahlsson Research Foundation, Region Skane, the King Gustaf V and Queen Victoria Foundation, and the Marianne and Marcus Wallenberg Foundation (Dr Melander).	ALEXANDER MJ, 1993, ENDOCRINOLOGY, V133, P1809, DOI 10.1210/en.133.4.1809; [Anonymous], 1993, J INTERN MED, V233, P39; Belting M, 2012, CANCER EPIDEM BIOMAR, V21, P513, DOI 10.1158/1055-9965.EPI-11-0840; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Christ-Crain M, 2006, J CLIN ENDOCR METAB, V91, P3544, DOI 10.1210/jc.2006-0256; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Dupouy S, 2011, BIOCHIMIE, V93, P1369, DOI 10.1016/j.biochi.2011.04.024; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663; Ernst A, 2006, PEPTIDES, V27, P1787, DOI 10.1016/j.peptides.2006.01.021; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Friry C, 2002, BIOCHEM BIOPH RES CO, V290, P1161, DOI 10.1006/bbrc.2001.6308; Holdstock C, 2008, INT J OBESITY, V32, P1640, DOI 10.1038/ijo.2008.157; Kalafatakis K, 2011, REGUL PEPTIDES, V170, P7, DOI 10.1016/j.regpep.2011.04.005; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kim ER, 2010, NEUROSCI LETT, V468, P64, DOI 10.1016/j.neulet.2009.10.064; KITABGI P, 1976, J BIOL CHEM, V251, P7053; Kitabgi P, 2006, J MOL MED, V84, P628, DOI 10.1007/s00109-006-0044-6; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; MINAMINO N, 1984, BIOCHEM BIOPH RES CO, V122, P542, DOI 10.1016/S0006-291X(84)80067-4; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Persson M, 2008, ATHEROSCLEROSIS, V200, P191, DOI 10.1016/j.atherosclerosis.2007.12.001; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; Sjostrom CD, 1999, OBES RES, V7, P477; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; Watters JJ, 1998, J NEUROSCI, V18, P6672; WISEN O, 1992, REGUL PEPTIDES, V39, P43, DOI 10.1016/0167-0115(92)90007-H	33	99	108	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2012	308	14					1469	1475		10.1001/jama.2012.12998	http://dx.doi.org/10.1001/jama.2012.12998			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	017GY	23047361	Bronze			2022-12-24	WOS:000309579300026
J	Spann, NJ; Garmire, LX; McDonald, JG; Myers, DS; Milne, SB; Shibata, N; Reichart, D; Fox, JN; Shaked, I; Heudobler, D; Raetz, CRH; Wang, EW; Kelly, SL; Sullards, MC; Murphy, RC; Merrill, AH; Brown, HA; Dennis, EA; Li, AC; Ley, K; Tsimikas, S; Fahy, E; Subramaniam, S; Quehenberger, O; Russell, DW; Glass, CK				Spann, Nathanael J.; Garmire, Lana X.; McDonald, Jeffrey G.; Myers, David S.; Milne, Stephen B.; Shibata, Norihito; Reichart, Donna; Fox, Jesse N.; Shaked, Iftach; Heudobler, Daniel; Raetz, Christian R. H.; Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Murphy, Robert C.; Merrill, Alfred H., Jr.; Brown, H. Alex; Dennis, Edward A.; Li, Andrew C.; Ley, Klaus; Tsimikas, Sotirios; Fahy, Eoin; Subramaniam, Shankar; Quehenberger, Oswald; Russell, David W.; Glass, Christopher K.			Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR LXR-ALPHA; ATHEROSCLEROTIC PLAQUES; LDL RECEPTOR; CHOLESTEROL; PROTEIN; GENE; MICE; IDENTIFICATION; PATHOGENESIS	Inflammation and macrophage foam cells are characteristic features of atherosclerotic lesions, but the mechanisms linking cholesterol accumulation to inflammation and LXR-dependent response pathways are poorly understood. To investigate this relationship, we utilized lipidomic and transcriptomic methods to evaluate the effect of diet and LDL receptor genotype on macrophage foam cell formation within the peritoneal cavities of mice. Foam cell formation was associated with significant changes in hundreds of lipid species and unexpected suppression, rather than activation, of inflammatory gene expression. We provide evidence that regulated accumulation of desmosterol underlies many of the homeostatic responses, including activation of LXR target genes, inhibition of SREBP target genes, selective reprogramming of fatty acid metabolism, and suppression of inflammatory-response genes, observed in macrophage foam cells. These observations suggest that macrophage activation in atherosclerotic lesions results from extrinsic, proinflammatory signals generated within the artery wall that suppress homeostatic and anti-inflammatory functions of desmosterol.	[Spann, Nathanael J.; Shibata, Norihito; Reichart, Donna; Fox, Jesse N.; Heudobler, Daniel; Subramaniam, Shankar; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Garmire, Lana X.; Fahy, Eoin; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dennis, Edward A.; Subramaniam, Shankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Li, Andrew C.; Tsimikas, Sotirios; Quehenberger, Oswald; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [McDonald, Jeffrey G.; Russell, David W.] UT SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; [Myers, David S.; Milne, Stephen B.; Brown, H. Alex] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Dept Pharmacol, Nashville, TN 37232 USA; [Raetz, Christian R. H.] Duke Univ, Dept Biochem, Sch Med, DUMC, Durham, NC 27710 USA; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Chem, Atlanta, GA 30332 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biochem, Atlanta, GA 30332 USA; [Wang, Elaine W.; Kelly, Samuel L.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Shaked, Iftach; Ley, Klaus] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; La Jolla Institute for Immunology	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Shaked, Iftach/AAS-9961-2020; Murphy, Robert/AAO-5349-2020; Shaked, Iftach/GNM-9959-2022; Glass, Christopher/AAI-3933-2021; Dennis, Edward A./M-5554-2019	Murphy, Robert/0000-0002-9430-6515; Glass, Christopher/0000-0003-4344-3592; Dennis, Edward A./0000-0003-3738-3140; SHIBATA, NORIHITO/0000-0001-5792-8510; Merrill, Alfred/0000-0002-6673-968X; Russell, David/0000-0002-0277-403X	NIH [GM U54 069338, PO1 HC088093, P01 DK074868]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115232, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were primarily supported by NIH grant GM U54 069338 to the LIPID MAPS Consortium. Additional support was provided by NIH grants PO1 HC088093 and P01 DK074868. N.J.S. was supported by an NIH training grant. We thank Hanna Lesch for critical comments, L. Bautista for assistance with preparation of the manuscript, and Dr. Peter Tontonoz for providing LXR DKO mice for macrophage isolation.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; AVIGAN J, 1960, BIOCHEM BIOPH RES CO, V2, P63, DOI 10.1016/0006-291X(60)90266-7; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Blake GJ, 2003, J AM COLL CARDIOL, V41, p37S, DOI 10.1016/S0735-1097(02)02953-4; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	41	375	391	0	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					138	152		10.1016/j.cell.2012.06.054	http://dx.doi.org/10.1016/j.cell.2012.06.054			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021221	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000309544200016
J	Redlener, I; Reilly, MJ				Redlener, Irwin; Reilly, Michael J.			Lessons from Sandy - Preparing Health Systems for Future Disasters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Redlener, Irwin; Reilly, Michael J.] Columbia Univ, Mailman Sch Publ Hlth, Natl Ctr Disaster Preparedness, New York, NY 10027 USA	Columbia University	Redlener, I (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Natl Ctr Disaster Preparedness, New York, NY 10027 USA.							Clements BW, 2009, DISASTERS AND PUBLIC HEALTH: PLANNING AND RESPONSE, P1; Hartocollis A, 2012, NY TIMES, pA1; Hupert N, 2011, HLTH CARE EMERGENCY, P223; Redlener I, 2006, AM RISK; U.S. Environmental Protection Agency, 2012, GOW CAN HURR SAND SA	5	66	67	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2269	2271		10.1056/NEJMp1213486	http://dx.doi.org/10.1056/NEJMp1213486			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23171063	Green Published			2022-12-24	WOS:000312187700016
J	Logothetis, NK; Eschenko, O; Murayama, Y; Augath, M; Steudel, T; Evrard, HC; Besserve, M; Oeltermann, A				Logothetis, N. K.; Eschenko, O.; Murayama, Y.; Augath, M.; Steudel, T.; Evrard, H. C.; Besserve, M.; Oeltermann, A.			Hippocampal-cortical interaction during periods of subcortical silence	NATURE			English	Article							SLOW-WAVE SLEEP; TRAINING REVERSIBLE INACTIVATION; MEMORY-SYSTEMS; DECLARATIVE MEMORY; SHARP WAVES; RIPPLES; OSCILLATION; CONSOLIDATION; REACTIVATION; STATE	Hippocampal ripples, episodic high-frequency field-potential oscillations primarily occurring during sleep and calmness, have been described in mice, rats, rabbits, monkeys and humans, and so far they have been associated with retention of previously acquired awake experience. Although hippocampal ripples have been studied in detail using neurophysiological methods, the global effects of ripples on the entire brain remain elusive, primarily owing to a lack of methodologies permitting concurrent hippocampal recordings and whole-brain activity mapping. By combining electrophysiological recordings in hippocampus with ripple-triggered functional magnetic resonance imaging, here we show that most of the cerebral cortex is selectively activated during the ripples, whereas most diencephalic, midbrain and brainstem regions are strongly and consistently inhibited. Analysis of regional temporal response patterns indicates that thalamic activity suppression precedes the hippocampal population burst, which itself is temporally bounded by massive activations of association and primary cortical areas. These findings suggest that during off-line memory consolidation, synergistic thalamocortical activity may be orchestrating a privileged interaction state between hippocampus and cortex by silencing the output of subcortical centres involved in sensory processing or potentially mediating procedural learning. Such a mechanism would cause minimal interference, enabling consolidation of hippocampus-dependent memory.	[Logothetis, N. K.; Eschenko, O.; Murayama, Y.; Augath, M.; Steudel, T.; Evrard, H. C.; Besserve, M.; Oeltermann, A.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Logothetis, N. K.] Univ Manchester, Biomed Imaging Inst, Ctr Imaging Sci, Manchester M13 9PT, Lancs, England; [Besserve, M.] Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany	Max Planck Society; University of Manchester; Max Planck Society	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	Nikos.Logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Eschenko, Oxana/N-7335-2013	Eschenko, Oxana/0000-0001-7482-5628; Evrard, Henry/0000-0001-8429-4699	Max Planck Society	Max Planck Society(Max Planck Society)	We thank D. Omer and M. Munk for reading the manuscript and for useful suggestions, D. Blaurock for English language corrections and editing, and P. Douay for help with the alert monkey experiments. This research was supported by the Max Planck Society. We apologize to those whose work we have not been able to cite for reasons of space.	Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Axmacher N, 2008, BRAIN, V131, P1806, DOI 10.1093/brain/awn103; Axmacher N, 2008, BEHAV BRAIN RES, V189, P1, DOI 10.1016/j.bbr.2007.12.018; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Born J, 2010, WORLD J BIOL PSYCHIA, V11, P16, DOI 10.3109/15622971003637637; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1997, ANNU REV PSYCHOL, V48, P547, DOI 10.1146/annurev.psych.48.1.547; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hasselmo M E, 1999, Prog Brain Res, V121, P3; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Molle M, 2002, J NEUROSCI, V22, P10941; MOURET J, 1963, J PHYSIOLOGY PARIS, V55, P305; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nadel L, 2011, NEUROPSYCHOPHARMACOL, V36, P251, DOI 10.1038/npp.2010.169; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV, P114; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310; Paxinos G., 2008, RHESUS MONKEY BRAIN, V2nd ed; Pennartz CMA, 2002, PROG BRAIN RES, V138, P143, DOI 10.1016/S0079-6123(02)38076-2; Poldrack RA, 2004, NEUROBIOL LEARN MEM, V82, P324, DOI 10.1016/j.nlm.2004.05.003; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Ramadan W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006697; Schroeder JP, 2002, HIPPOCAMPUS, V12, P280, DOI 10.1002/hipo.10024; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 2007, J NEUROPHYSIOL, V98, P898, DOI 10.1152/jn.00401.2007; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30	50	238	239	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					547	553		10.1038/nature11618	http://dx.doi.org/10.1038/nature11618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23172213				2022-12-24	WOS:000311339800042
J	Woodworth, MB; Greig, LC; Kriegstein, AR; Macklis, JD				Woodworth, Mollie B.; Greig, Luciano Custo; Kriegstein, Arnold R.; Macklis, Jeffrey D.			SnapShot: Cortical Development	CELL			English	Editorial Material							CEREBRAL-CORTEX; SPECIFICATION; NEURONS		[Woodworth, Mollie B.; Greig, Luciano Custo; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Woodworth, Mollie B.; Greig, Luciano Custo; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Woodworth, Mollie B.; Greig, Luciano Custo; Macklis, Jeffrey D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Woodworth, MB (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.			Greig, Luciano/0000-0002-0020-9379; Woodworth, Mollie/0000-0003-2130-2289	NIA NIH HHS [T32 AG000222] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NINDS NIH HHS [R01 NS072630, R01 NS049553, R37 NS041590, F31 NS064730, F31 NS080343, R01 NS045523, R01 NS075672, R01 NS041590, R01 NS075998, R37 NS035710] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035710, R01NS072630, F31NS064730, R01NS049553, R37NS041590, R01NS075672, R01NS075998, R01NS041590, R01NS045523, F31NS080343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; MACDONALD JL, 2012, DEV NEUROSCIENCE COM, V1; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Shoemaker LD, 2010, BIOESSAYS, V32, P197, DOI 10.1002/bies.200900114	6	44	44	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					918	+		10.1016/j.cell.2012.10.004	http://dx.doi.org/10.1016/j.cell.2012.10.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141546	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000310921200023
J	Arranz, R; Coloma, R; Chichon, FJ; Conesa, JJ; Carrascosa, JL; Valpuesta, JM; Ortin, J; Martin-Benito, J				Arranz, Rocio; Coloma, Rocio; Javier Chichon, Francisco; Javier Conesa, Jose; Carrascosa, Jose L.; Valpuesta, Jose M.; Ortin, Juan; Martin-Benito, Jaime			The Structure of Native Influenza Virion Ribonucleoproteins	SCIENCE			English	Article							A VIRUS NUCLEOPROTEIN; RNA; LOCALIZATION; NUCLEAR; REPLICATION; COMPLEXES; OLIGOMERIZATION; RECONSTRUCTION; POLYMERASE; PARTICLES	The influenza viruses cause annual epidemics of respiratory disease and occasional pandemics, which constitute a major public-health issue. The segmented negative-stranded RNAs are associated with the polymerase complex and nucleoprotein (NP), forming ribonucleoproteins (RNPs), which are responsible for virus transcription and replication. We describe the structure of native RNPs derived from virions. They show a double-helical conformation in which two NP strands of opposite polarity are associated with each other along the helix. Both strands are connected by a short loop at one end of the particle and interact with the polymerase complex at the other end. This structure will be relevant for unraveling the mechanisms of nuclear import of parental virus RNPs, their transcription and replication, and the encapsidation of progeny RNPs into virions.	[Coloma, Rocio; Ortin, Juan] Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid, Spain; [Arranz, Rocio; Javier Chichon, Francisco; Javier Conesa, Jose; Carrascosa, Jose L.; Valpuesta, Jose M.; Martin-Benito, Jaime] CSIC, Dept Macromol Struct, Ctr Nacl Biotecnol, Madrid, Spain; [Coloma, Rocio; Ortin, Juan] Inst Natl Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain; [Valpuesta, Jose M.] Inst Madrileno Estudios Avanzados Nanociencia IMD, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ortin, J (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid, Spain.	jortin@cnb.csic.es; jmartinb@cnb.csic.es	Conesa, Jose Javier/J-5878-2017; García, Francisco Javier Chichón/R-2167-2019; Ortin, Juan/L-3622-2013; Valpuesta, Jose M/AAA-6002-2019; Chichón García, Francisco Javier/B-6029-2011; Valpuesta, José M/T-1977-2017; Chichón García, Francisco Javier/K-5117-2012	Conesa, Jose Javier/0000-0002-8440-5691; García, Francisco Javier Chichón/0000-0003-2766-0327; Chichón García, Francisco Javier/0000-0003-2766-0327; Valpuesta, José M/0000-0001-7468-8053; Chichón García, Francisco Javier/0000-0003-2766-0327; Arranz, Rocio/0000-0001-5321-0915; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Ortin, Juan/0000-0002-6200-4678	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2010-17540/BMC, BFU2011-25090/BMC]; FLUPHARM strep project [FP7-259751]; Fundacion Marcelino Botin	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FLUPHARM strep project; Fundacion Marcelino Botin	The technical assistance of Y. Fernandez and N. Zamarreno is gratefully acknowledged. We thank D. Luque for help with the generation of movies. This work was supported by the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) grants BFU2010-17540/BMC (J.O.) and BFU2011-25090/BMC (J.M.-B.), by the FLUPHARM strep project (FP7-259751) (J.O.), and by Fundacion Marcelino Botin (J.O.). J.M.-B. and J.O. designed the experiments. R.A., J.M-B, R.C. F.J.C. and J.J.C. carried out the experiments. J.O. and J.M.-B. wrote the paper with contributions from R.A., R.C., F.J.C., and J.J.C. and discussions with J.L.C. and J.M.V. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. EM maps have been deposited in the EM Data Bank (www.ebi.ac.uk/pdbe/emdb/), accession numbers EMD-2205, 2206, 2207, and 2208. The atomic coordinates of the docking have been deposited in the Protein Data Bank (www.rcsb.org/), accession code 4bbl.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Bullido R, 2000, J GEN VIROL, V81, P135, DOI 10.1099/0022-1317-81-1-135; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Cros JF, 2005, TRAFFIC, V6, P205, DOI 10.1111/j.1600-0854.2005.00263.x; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; JENNINGS PA, 1983, CELL, V34, P619, DOI 10.1016/0092-8674(83)90394-X; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Noda T, 2012, P NATL ACAD SCI USA, V109, P8797, DOI 10.1073/pnas.1206736109; Noda T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1647; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; RUIGROK RWH, 1995, J GEN VIROL, V76, P1009, DOI 10.1099/0022-1317-76-4-1009; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Wu WWH, 2007, J MOL BIOL, V374, P910, DOI 10.1016/j.jmb.2007.10.022; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	29	214	219	4	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1634	1637		10.1126/science.1228172	http://dx.doi.org/10.1126/science.1228172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23180776				2022-12-24	WOS:000312533100057
J	Carrieri, C; Cimatti, L; Biagioli, M; Beugnet, A; Zucchelli, S; Fedele, S; Pesce, E; Ferrer, I; Collavin, L; Santoro, C; Forrest, ARR; Carninci, P; Biffo, S; Stupka, E; Gustincich, S				Carrieri, Claudia; Cimatti, Laura; Biagioli, Marta; Beugnet, Anne; Zucchelli, Silvia; Fedele, Stefania; Pesce, Elisa; Ferrer, Isidre; Collavin, Licio; Santoro, Claudio; Forrest, Alistair R. R.; Carninci, Piero; Biffo, Stefano; Stupka, Elia; Gustincich, Stefano			Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat	NATURE			English	Article							PARKINSONS-DISEASE; MAMMALIAN GENOME; GENE-EXPRESSION; LEWY BODIES; TRANSCRIPTION; SEQUENCES; DEMENTIA; UCH-L1	Most of the mammalian genome is transcribed(1-3). This generates a vast repertoire of transcripts that includes protein-coding messenger RNAs, long non-coding RNAs (lncRNAs) and repetitive sequences, such as SINEs (short interspersed nuclear elements). A large percentage of ncRNAs are nuclear-enriched with unknown function(4). Antisense lncRNAs may form sense-antisense pairs by pairing with a protein-coding gene on the opposite strand to regulate epigenetic silencing, transcription and mRNA stability(5-10). Here we identify a nuclear-enriched lncRNA antisense to mouse ubiquitin carboxyterminal hydrolase L1 (Uchl1), a gene involved in brain function and neurodegenerative diseases(11). Antisense Uchl1 increases UCHL1 protein synthesis at a post-transcriptional level, hereby identifying a new functional class of lncRNAs. Antisense Uchl1 activity depends on the presence of a 59 overlapping sequence and an embedded inverted SINEB2 element. These features are shared by other natural antisense transcripts and can confer regulatory activity to an artificial antisense to green fluorescent protein. Antisense Uchl1 function is under the control of stress signalling pathways, as mTORC1 inhibition by rapamycin causes an increase in UCHL1 protein that is associated to the shuttling of antisense Uchl1 RNA from the nucleus to the cytoplasm. Antisense Uchl1 RNA is then required for the association of the overlapping sense protein-coding mRNA to active polysomes for translation. These data reveal another layer of gene expression control at the post-transcriptional level.	[Carrieri, Claudia; Cimatti, Laura; Biagioli, Marta; Zucchelli, Silvia; Fedele, Stefania; Gustincich, Stefano] Int Sch Adv Studies SISSA, Area Neurosci, I-34136 Trieste, Italy; [Biagioli, Marta; Zucchelli, Silvia; Gustincich, Stefano] Giovanni Armenise Harvard Fdn Lab, I-34136 Trieste, Italy; [Beugnet, Anne; Pesce, Elisa; Biffo, Stefano] Ist Sci San Raffaele, DIBIT, Lab Mol Histol & Cell Growth, I-20132 Milan, Italy; [Ferrer, Isidre] Univ Hosp Bellvitge, IDIBELL, Inst Neuropathol, Lhospitalet De Llobregat 08907, Spain; [Collavin, Licio] LNCIB, I-34149 Trieste, Italy; [Collavin, Licio] Univ Trieste, Dept Life Sci DSV, I-34129 Trieste, Italy; [Santoro, Claudio] Univ Piemonte Orientale, Dept Hlth Sci, I-28100 Novara, Italy; [Forrest, Alistair R. R.; Carninci, Piero] RIKEN Yokohama Inst, Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Biffo, Stefano] Univ Piemonte Orientale, Dept Environm & Life Sci, I-15121 Alessandria, Italy; [Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy	International School for Advanced Studies (SISSA); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Trieste; University of Eastern Piedmont Amedeo Avogadro; RIKEN; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Gustincich, S (corresponding author), Int Sch Adv Studies SISSA, Area Neurosci, Via Bonomea 265, I-34136 Trieste, Italy.	gustinci@sissa.it	Collavin, Licio/A-5312-2010; Pesce, Elisa/GXH-1752-2022; Carninci, Piero/K-1568-2014	Collavin, Licio/0000-0001-6815-5381; Carninci, Piero/0000-0001-7202-7243; Pesce, Elisa/0000-0003-4214-1904; Carrieri, Claudia/0000-0002-9454-1021; Forrest, Alistair/0000-0003-4543-1675; Biagioli, Marta/0000-0001-8295-8025; biffo, stefano/0000-0002-3780-1050; Gustincich, Stefano/0000-0002-2749-2514; Zucchelli, Silvia/0000-0003-4556-2990; Stupka, Elia/0000-0003-3154-4011	FP7 Dopaminet; Giovanni Armenise-Harvard Foundation; Compagnia di San Paolo	FP7 Dopaminet; Giovanni Armenise-Harvard Foundation; Compagnia di San Paolo(Compagnia di San Paolo)	We thank S. G. laboratory members for thought-provoking discussions and C. Leonesi for technical help. We thank F. Persichetti, A. Mallamaci, E. Calautti, S. Saoncella, A. Lunardi, D. De Pietri Tonelli, R. Sanges, M. E. MacDonald and T. Perlmann for support and discussions; and M. J. Zigmond and B. Joseph for sharing the MN9D cell line. This work was supported by the FP7 Dopaminet to S.G., E.S. and P.C., by The Giovanni Armenise-Harvard Foundation to S.G. and by the Compagnia di San Paolo to S.B.	Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Barrachina M, 2006, NEUROBIOL DIS, V22, P265, DOI 10.1016/j.nbd.2005.11.005; Barrachina M, 2005, NEUROCHEM INT, V46, P253, DOI 10.1016/j.neuint.2004.08.006; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nordstrom KJV, 2009, GENOMICS, V94, P169, DOI 10.1016/j.ygeno.2009.05.012; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; QUENTIN Y, 1992, NUCLEIC ACIDS RES, V20, P487, DOI 10.1093/nar/20.3.487; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Spigoni G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008658; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	32	673	705	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					454	+		10.1038/nature11508	http://dx.doi.org/10.1038/nature11508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23064229	Green Published			2022-12-24	WOS:000311031600048
J	Gu, S; Jin, L; Zhang, Y; Huang, Y; Zhang, FJ; Valdmanis, PN; Kay, MA				Gu, Shuo; Jin, Lan; Zhang, Yue; Huang, Yong; Zhang, Feijie; Valdmanis, Paul N.; Kay, Mark A.			The Loop Position of shRNAs and Pre-miRNAs Is Critical for the Accuracy of Dicer Processing In Vivo	CELL			English	Article							RNA-INTERFERENCE; STRUCTURAL BASIS; HELICASE DOMAIN; MESSENGER-RNAS; RECOGNITION; EXPRESSION; MICRORNAS; BIOGENESIS; EFFICIENT; TERMINI	Short hairpin RNA (shRNA)-induced RNAi is used for biological discovery and therapeutics. Dicer, whose normal role is to liberate endogenous miRNAs from their precursors, processes shRNAs into different biologically active siRNAs, affecting their efficacy and potential for off-targeting. We found that, in cells, Dicer induced imprecise cleavage events around the expected sites based on the previously described 50/30 counting rules. These promiscuous noncanonical cleavages were abrogated when the cleavage site was positioned 2 nt from a bulge or loop. Interestingly, we observed that the similar to 1/3 of mammalian endogenous pre-miRNAs that contained such structures were more precisely processed by Dicer. Implementing a "loop-counting rule," we designed potent anti-HCV shRNAs with substantially reduced off-target effects. Our results suggest that Dicer recognizes the loop/bulge structure in addition to the ends of shRNAs/pre-miRNAs for accurate processing. This has important implications for both miRNA processing and future design of shRNAs for RNAi-based genetic screens and therapies.	[Gu, Shuo; Jin, Lan; Zhang, Yue; Huang, Yong; Zhang, Feijie; Valdmanis, Paul N.; Kay, Mark A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Gu, Shuo; Jin, Lan; Zhang, Yue; Huang, Yong; Zhang, Feijie; Valdmanis, Paul N.; Kay, Mark A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Kay, MA (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	markay@stanford.edu	Gu, Shuo/K-5404-2016	Gu, Shuo/0000-0002-7924-5363; Kay, Mark/0000-0002-2799-2615; Valdmanis, Paul/0000-0001-8840-6969	NIH [DK 078424, AI071068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078424] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH DK 078424 (M. A. K.) and NIH AI071068 (M. A. K.). We thank Dr. Grace Zheng for the Dicer KO ES cells and Dr. George Mias for helpful discussions on statistical methods.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gu S, 2011, P NATL ACAD SCI USA, V108, P9208, DOI 10.1073/pnas.1018023108; Gurtan AM, 2012, RNA, V18, P1116, DOI 10.1261/rna.032680.112; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Mcintyre GJ, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-34; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pan QW, 2012, TRENDS BIOTECHNOL, V30, P206, DOI 10.1016/j.tibtech.2012.01.002; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Sawh AN, 2012, NAT STRUCT MOL BIOL, V19, P365, DOI 10.1038/nsmb.2275; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Soifer HS, 2008, NUCLEIC ACIDS RES, V36, P6511, DOI 10.1093/nar/gkn687; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	48	194	206	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					900	911		10.1016/j.cell.2012.09.042	http://dx.doi.org/10.1016/j.cell.2012.09.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141545	Green Accepted, Bronze			2022-12-24	WOS:000310921200019
J	Zhou, XX; Chung, HK; Lam, AJ; Lin, MZ				Zhou, Xin X.; Chung, Hokyung K.; Lam, Amy J.; Lin, Michael Z.			Optical Control of Protein Activity by Fluorescent Protein Domains	SCIENCE			English	Article							SPATIOTEMPORAL CONTROL; LIGHT; ACTIVATION; INDUCTION; GTPASES; CELLS	Fluorescent proteins (FPs) are widely used as optical sensors, whereas other light-absorbing domains have been used for optical control of protein localization or activity. Here, we describe light-dependent dissociation and association in a mutant of the photochromic FP Dronpa, and we used it to control protein activities with light. We created a fluorescent light-inducible protein design in which Dronpa domains are fused to both termini of an enzyme domain. In the dark, the Dronpa domains associate and cage the protein, but light induces Dronpa dissociation and activates the protein. This method enabled optical control over guanine nucleotide exchange factor and protease domains without extensive screening. Our findings extend the applications of FPs from exclusively sensing functions to also encompass optogenetic control.	[Zhou, Xin X.; Chung, Hokyung K.; Lam, Amy J.; Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Lin, Michael Z.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University	Lin, MZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mzlin@stanford.edu		Lin, Michael/0000-0002-0492-1961; Zhou, Xin/0000-0002-8198-2856; Chung, H. Kay/0000-0002-7028-2432	Stanford School of Engineering; Stanford Graduate Fellowship; Siebel Foundation Scholarship; Lucille Packard Children's Health Initiative; Burroughs Wellcome Career Award for Medical Scientists; NIH [R01NS076860]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076860] Funding Source: NIH RePORTER	Stanford School of Engineering; Stanford Graduate Fellowship(Stanford University); Siebel Foundation Scholarship; Lucille Packard Children's Health Initiative; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Davidson (Florida State University) for pcDNA3-mNeptune-Fascin, N. Shaner and R. Tsien (University of California San Diego) for pBAD-tdTomato, M. Yazawa and R. Dolmetsch (Stanford University) for cell lines and advice, Y. Geng in the Lin laboratory for assistance with plasmid design, and other members of the Lin laboratory. This work was funded by the Stanford School of Engineering and a Stanford Graduate Fellowship (X.X.Z.); a Siebel Foundation Scholarship (A.J.L.); and the Lucille Packard Children's Health Initiative, a Burroughs Wellcome Career Award for Medical Scientists, and NIH grant R01NS076860 (M.Z.L.). M.Z.L. is a Rita Allen Foundation Scholar. X.X.Z. and M.Z.L. are inventors on a patent application filed by Stanford University covering the construct design described in the paper. X.X.Z. designed, executed, and analyzed experiments and cowrote the manuscript. H.K.C. designed, executed, and analyzed experiments. A.J.L. assisted with experimental design. M.Z.L. conceived of the study, directed the project, provided advice, analyzed experiments, and cowrote the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; Fan HY, 2011, BIOCHEMISTRY-US, V50, P1226, DOI 10.1021/bi101432p; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Krauss U, 2011, CHEM-EUR J, V17, P2552, DOI 10.1002/chem.201002716; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Leonard TA, 2007, CELL, V129, P1037, DOI 10.1016/j.cell.2007.06.001; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Mizuno H, 2008, P NATL ACAD SCI USA, V105, P9227, DOI 10.1073/pnas.0709599105; Mizuno H, 2010, PHOTOCH PHOTOBIO SCI, V9, P239, DOI 10.1039/b9pp00124g; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Muller J, 2008, CHEMBIOCHEM, V9, P2029, DOI 10.1002/cbic.200800190; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Powers Hilary J, 2012, Subcell Biochem, V56, P229, DOI 10.1007/978-94-007-2199-9_12; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Riggsbee CW, 2010, TRENDS BIOTECHNOL, V28, P468, DOI 10.1016/j.tibtech.2010.06.001; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Wu YI, 2011, METHOD ENZYMOL, V497, P393, DOI 10.1016/B978-0-12-385075-1.00016-0; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033	31	204	210	2	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					810	814		10.1126/science.1226854	http://dx.doi.org/10.1126/science.1226854			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139335	Green Accepted			2022-12-24	WOS:000310839500048
J	Ling, QH; Huang, WH; Baldwin, A; Jarvis, P				Ling, Qihua; Huang, Weihua; Baldwin, Amy; Jarvis, Paul			Chloroplast Biogenesis Is Regulated by Direct Action of the Ubiquitin-Proteasome System	SCIENCE			English	Article							MITOCHONDRIAL E3; IMPORT RECEPTOR; ARABIDOPSIS; LIGASE; PROTEINS; PLASTIDS; DEGRADATION; PATHWAYS; DYNAMICS; NUCLEUS	Development of chloroplasts and other plastids depends on the import of thousands of nucleus-encoded proteins from the cytosol. Import is initiated by TOC (translocon at the outer envelope of chloroplasts) complexes in the plastid outer membrane that incorporate multiple, client-specific receptors. Modulation of import is thought to control the plastid's proteome, developmental fate, and functions. Using forward genetics, we identified Arabidopsis SP1, which encodes a RING-type ubiquitin E3 ligase of the chloroplast outer membrane. The SP1 protein associated with TOC complexes and mediated ubiquitination of TOC components, promoting their degradation. Mutant sp1 plants performed developmental transitions that involve plastid proteome changes inefficiently, indicating a requirement for reorganization of the TOC machinery. Thus, the ubiquitin-proteasome system acts on plastids to control their development.	[Ling, Qihua; Huang, Weihua; Baldwin, Amy; Jarvis, Paul] Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Jarvis, P (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	rpj3@le.ac.uk	Huang, Weihua/GVS-4853-2022	Ling, Qihua/0000-0002-6984-9921; Baldwin, Amy/0000-0002-2162-3771; Jarvis, Paul/0000-0003-2127-5671	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D016541/1, BB/H008039/1]; Royal Society Rosenheim Research Fellowship; Royal Society International Incoming Fellowship; Biotechnology and Biological Sciences Research Council [BB/H008039/1, BB/D016541/1] Funding Source: researchfish; BBSRC [BB/H008039/1, BB/D016541/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Rosenheim Research Fellowship; Royal Society International Incoming Fellowship(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Rashbrooke for assistance with initial phenotype analyses and rough mapping of sp1; U. Ranganathan for her contribution to the analysis of SPL1; R. Patel and R. Berkeley for excellent technical assistance; N. Allcock and S. Hyman for electron microscopy (EM) carried out within the EM Laboratory, University of Leicester; C. Dean and R. Trosch for helpful comments on the manuscript; U. Flores-Perez for antigen preparation (atToc132 and atToc34); M. Boutry (PMA2), N. E. Hoffman (LHCP), K. Inoue (OEP80), F. Kessler (atToc159), and G. Thorlby (SFR2) for antibodies; C. E. Stebbins for the AtUBC8 clone; and the Salk Institute Genomic Analysis Laboratory (SIGnAL) and the Nottingham Arabidopsis Stock Centre (NASC) for the sp1-2 and sp1-3 alleles. This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC; BB/D016541/1 and BB/H008039/1) to P.J., by the Royal Society Rosenheim Research Fellowship to P.J., and by a Royal Society International Incoming Fellowship to W. H. This work is the subject of patent application number GB 1216090.9, which covers the role of the ubiquitin-proteasome system in the control of plastid development. The data are presented in the manuscript and in the supplementary materials.	Barsan C, 2010, J EXP BOT, V61, P2413, DOI 10.1093/jxb/erq070; Basnayake BMVS, 2011, PLANT CELL REP, V30, P37, DOI 10.1007/s00299-010-0941-6; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Huang WH, 2006, PLANT CELL, V18, P2479, DOI 10.1105/tpc.106.045013; Huang WH, 2011, PLANT PHYSIOL, V157, P147, DOI 10.1104/pp.111.181891; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kleffmann T, 2007, PLANT PHYSIOL, V143, P912, DOI 10.1104/pp.106.090738; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Lee S, 2009, PLANT CELL, V21, P3984, DOI 10.1105/tpc.109.071548; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Mochizuki N, 1996, PLANT PHYSIOL, V112, P1465, DOI 10.1104/pp.112.4.1465; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Shen GX, 2007, PLANT J, V52, P309, DOI 10.1111/j.1365-313X.2007.03239.x; Stanga JP, 2009, PLANT PHYSIOL, V149, P1896, DOI 10.1104/pp.109.135301; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Zhang BC, 2008, CELL RES, V18, P900, DOI 10.1038/cr.2008.75	29	165	177	10	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2012	338	6107					655	659		10.1126/science.1225053	http://dx.doi.org/10.1126/science.1225053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118188				2022-12-24	WOS:000310516000050
J	Killian, NJ; Jutras, MJ; Buffalo, EA				Killian, Nathaniel J.; Jutras, Michael J.; Buffalo, Elizabeth A.			A map of visual space in the primate entorhinal cortex	NATURE			English	Article							SPATIAL REPRESENTATION SYSTEM; MONKEY HIPPOCAMPAL-NEURONS; GRID CELLS; THETA OSCILLATIONS; MACAQUE HIPPOCAMPUS; MEMORY; PLACE; ORGANIZATION; PERIODICITY; NAVIGATION	Place-modulated activity among neurons in the hippocampal formation presents a means to organize contextual information in the service of memory formation and recall(1,2). One particular spatial representation, that of grid cells, has been observed in the entorhinal cortex (EC) of rats and bats(3-5), but has yet to be described in single units in primates. Here we examined spatial representations in the EC of head-fixed monkeys performing a free-viewing visual memory task(6,7). Individual neurons were identified in the primate EC that emitted action potentials when the monkey fixated multiple discrete locations in the visual field in each of many sequentially presented complex images. These firing fields possessed spatial periodicity similar to a triangular tiling with a corresponding well-defined hexagonal structure in the spatial auto-correlation. Further, these neurons showed theta-band oscillatory activity and changing spatial scale as a function of distance from the rhinal sulcus, which is consistent with previous findings in rodents(4,8-10). These spatial representations may provide a framework to anchor the encoding of stimulus content in a complex visual scene. Together, our results provide a direct demonstration of grid cells in the primate and suggest that EC neurons encode space during visual exploration, even without locomotion.	[Killian, Nathaniel J.; Jutras, Michael J.; Buffalo, Elizabeth A.] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Killian, Nathaniel J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Buffalo, Elizabeth A.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Buffalo, EA (corresponding author), Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	elizabeth.buffalo@emory.edu	Killian, Nathaniel/B-1914-2013	Killian, Nathaniel/0000-0002-4546-0516	National Institute of Mental Health [R01MH093807, R01MH080007, MH082559]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs/OD [P51OD11132]; NSF IGERT program [DGE-0333411]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080007, R01MH093807, F31MH082559] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NSF IGERT program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Potter, C. Erickson, J. Manns, M. Meister and K. Dunne for comments on the manuscript, and M. Tompkins and D. Solyst for assistance with experiments. This project was funded by the National Institute of Mental Health, R01MH093807 (E.A.B.), R01MH080007 (E.A.B.), MH082559 (M.J.J.), the National Center for Research Resources P51RR165, and is currently supported by the Office of Research Infrastructure Programs/OD P51OD11132. N.J.K. was supported by the NSF IGERT program (DGE-0333411).	Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Insausti R, 2008, J COMP NEUROL, V509, P608, DOI 10.1002/cne.21753; Jutras MJ, 2010, P NATL ACAD SCI USA, V107, P401, DOI 10.1073/pnas.0908378107; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; Robertson RG, 1999, HIPPOCAMPUS, V9, P206, DOI 10.1002/(SICI)1098-1063(1999)9:3<206::AID-HIPO2>3.0.CO;2-H; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; STEWART M, 1991, BRAIN RES, V538, P59, DOI 10.1016/0006-8993(91)90376-7; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; TAMURA R, 1992, HIPPOCAMPUS, V2, P307, DOI 10.1002/hipo.450020309; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	30	242	248	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					761	764		10.1038/nature11587	http://dx.doi.org/10.1038/nature11587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103863	Green Accepted			2022-12-24	WOS:000311606000046
J	Jones, JL; Esber, GR; McDannald, MA; Gruber, AJ; Hernandez, A; Mirenzi, A; Schoenbaum, G				Jones, Joshua L.; Esber, Guillem R.; McDannald, Michael A.; Gruber, Aaron J.; Hernandez, Alex; Mirenzi, Aaron; Schoenbaum, Geoffrey			Orbitofrontal Cortex Supports Behavior and Learning Using Inferred But Not Cached Values	SCIENCE			English	Article							PREFRONTAL CORTEX; VENTRAL STRIATUM; REWARD VALUE; LESIONS; AMYGDALA; INACTIVATION; DEVALUATION; RESPONSES; REVERSAL; NEURONS	Computational and learning theory models propose that behavioral control reflects value that is both cached (computed and stored during previous experience) and inferred (estimated on the fly on the basis of knowledge of the causal structure of the environment). The latter is thought to depend on the orbitofrontal cortex. Yet some accounts propose that the orbitofrontal cortex contributes to behavior by signaling "economic" value, regardless of the associative basis of the information. We found that the orbitofrontal cortex is critical for both value-based behavior and learning when value must be inferred but not when a cached value is sufficient. The orbitofrontal cortex is thus fundamental for accessing model-based representations of the environment to compute value rather than for signaling value per se.	[Jones, Joshua L.; Hernandez, Alex; Schoenbaum, Geoffrey] Univ Maryland, Dept Anat & Neurobiol, Sch Med, Baltimore, MD 21201 USA; [Esber, Guillem R.; McDannald, Michael A.; Mirenzi, Aaron; Schoenbaum, Geoffrey] NIDA, Behav Neurophysiol Res Sect, Cellular Neurobiol Res Branch, Intramural Res Program, Baltimore, MD 21201 USA; [Gruber, Aaron J.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Lethbridge	Jones, JL (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Sch Med, 20 Penn St, Baltimore, MD 21201 USA.	josh.jones@nih.gov; geoffrey.schoenbaum@nih.gov	Esber, Guillem/AAL-9246-2020	Esber, Guillem/0000-0001-8874-4255; Gruber, Aaron/0000-0003-2700-5429; Hernandez, Alex/0000-0002-2267-4781	National Institute on Drug Abuse (NIDA), NIH [F32-031517]; NIDA [R01-DA015718]; Natural Sciences and Engineering Research Council of Canada; Intramural Research Program at NIDA; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587, F32DA031517, R01DA015718] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Intramural Research Program at NIDA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse (NIDA), NIH, F32-031517 to J.L.J., NIDA R01-DA015718 to G. S., funding from Natural Sciences and Engineering Research Council of Canada to A.J.G., and by the Intramural Research Program at NIDA. The opinions expressed in this article are the authors' own and do not reflect the view of the NIH or U.S. Department of Health and Human Services. The authors declare that they have no conflicts of interest related to the data presented in this manuscript.	Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Brogden WJ, 1939, J EXP PSYCHOL, V25, P323, DOI 10.1037/h0058944; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Burke KA, 2009, EUR J NEUROSCI, V30, P1941, DOI 10.1111/j.1460-9568.2009.06992.x; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hall, 1982, QUANTITATIVE ANAL BE, V3, P241; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kamin LJ, 1969, PUNISHMENT AVERSIVE, P242; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Machado CJ, 2007, EUR J NEUROSCI, V25, P2885, DOI 10.1111/j.1460-9568.2007.05525.x; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pickens CL, 2005, BEHAV NEUROSCI, V119, P317, DOI 10.1037/0735-7044.119.1.317; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; West EA, 2011, J NEUROSCI, V31, P15128, DOI 10.1523/JNEUROSCI.3295-11.2011	30	185	186	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					953	956		10.1126/science.1227489	http://dx.doi.org/10.1126/science.1227489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162000	Green Accepted			2022-12-24	WOS:000311083600045
J	Connerth, M; Tatsuta, T; Haag, M; Klecker, T; Westermann, B; Langer, T				Connerth, Melanie; Tatsuta, Takashi; Haag, Mathias; Klecker, Till; Westermann, Benedikt; Langer, Thomas			Intramitochondrial Transport of Phosphatidic Acid in Yeast by a Lipid Transfer Protein	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CARDIOLIPIN BIOSYNTHESIS; MITOCHONDRIA; PHOSPHOLIPIDS; TRAFFICKING; UPS1P; SYNTHASE; BIOLOGY; TAM41	Mitochondria are dynamic organelles whose function depends on intramitochondrial phospholipid synthesis and the supply of membrane lipids from the endoplasmic reticulum. How phospholipids are transported to and in-between mitochondrial membranes remained unclear. We identified Ups1, a yeast member of a conserved family of intermembrane space proteins, as a lipid transfer protein that can shuttle phosphatidic acid between mitochondrial membranes. Lipid transfer required the dynamic assembly of Ups1 with Mdm35 and allowed conversion of phosphatidic acid to cardiolipin in the inner membrane. High cardiolipin concentrations prevented membrane dissociation of Ups1, leading to its proteolysis and inhibiting transport of phosphatidic acid and cardiolipin synthesis. Thus, intramitochondrial lipid trafficking may involve a regulatory feedback mechanism that limits the accumulation of cardiolipin in mitochondria.	[Connerth, Melanie; Tatsuta, Takashi; Haag, Mathias; Langer, Thomas] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Klecker, Till; Westermann, Benedikt] Univ Bayreuth, Inst Cell Biol, D-95440 Bayreuth, Germany; [Klecker, Till; Westermann, Benedikt] Univ Bayreuth, Electron Microscopy Lab, D-95440 Bayreuth, Germany; [Langer, Thomas] Max Planck Inst Biol Aging, D-50931 Cologne, Germany	University of Cologne; University of Bayreuth; University of Bayreuth; Max Planck Society	Langer, T (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany.	thomas.langer@uni-koeln.de	Westermann, Benedikt/H-7766-2013; Klecker, Till/L-6637-2017	Westermann, Benedikt/0000-0002-2991-1604; Klecker, Till/0000-0003-0149-042X; Langer, Thomas/0000-0003-1250-1462	Deutsche Forschungsgemeinschaft [SFB635, FOR885]; European Research Council [233078]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank G. Zimmer for technical assistance, S. Geimer for advice on electron microscopy, T. Endo for sharing unpublished results, and J. Nunnari for yeast strains. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB635, FOR885) and the European Research Council (AdG No. 233078) to T.L.	Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Harada Y, 2010, BIOCHEM BIOPH RES CO, V392, P228, DOI 10.1016/j.bbrc.2010.01.024; Janitor M, 1996, FEMS MICROBIOL LETT, V140, P43; KASPER AM, 1981, BIOCHIM BIOPHYS ACTA, V664, P22, DOI 10.1016/0005-2760(81)90025-4; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	21	170	174	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					815	818		10.1126/science.1225625	http://dx.doi.org/10.1126/science.1225625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23042293				2022-12-24	WOS:000310839500049
J	Grivennikov, SI; Wang, KP; Mucida, D; Stewart, CA; Schnabl, B; Jauch, D; Taniguchi, K; Yu, GY; Osterreicher, CH; Hung, KE; Datz, C; Feng, Y; Fearon, ER; Oukka, M; Tessarollo, L; Coppola, V; Yarovinsky, F; Cheroutre, H; Eckmann, L; Trinchieri, G; Karin, M				Grivennikov, Sergei I.; Wang, Kepeng; Mucida, Daniel; Stewart, C. Andrew; Schnabl, Bernd; Jauch, Dominik; Taniguchi, Koji; Yu, Guann-Yi; Oesterreicher, Christoph H.; Hung, Kenneth E.; Datz, Christian; Feng, Ying; Fearon, Eric R.; Oukka, Mohamed; Tessarollo, Lino; Coppola, Vincenzo; Yarovinsky, Felix; Cheroutre, Hilde; Eckmann, Lars; Trinchieri, Giorgio; Karin, Michael			Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth	NATURE			English	Article							PROMOTES COLON TUMORIGENESIS; COLORECTAL-CANCER; HELPER-CELLS; CUTTING EDGE; MOUSE MODEL; MICE; INFLAMMATION; COLITIS; DIFFERENTIATION; CARCINOGENESIS	Approximately 2% of colorectal cancer is linked to pre-existing inflammation known as colitis-associated cancer, but most develops in patients without underlying inflammatory bowel disease. Colorectal cancer often follows a genetic pathway whereby loss of the adenomatous polyposis coli (APC) tumour suppressor and activation of beta-catenin are followed by mutations in K-Ras, PIK3CA and TP53, as the tumour emerges and progresses(1,2). Curiously, however, 'inflammatory signature' genes characteristic of colitis-associated cancer are also upregulated in colorectal cancer(3,4). Further, like most solid tumours, colorectal cancer exhibits immune/inflammatory infiltrates(5), referred to as 'tumour-elicited inflammation'(6). Although infiltrating CD4(+) T(H)1 cells and CD8(+) cytotoxic T cells constitute a positive prognostic sign in colorectal cancer(7,8), myeloid cells and T-helper interleukin (IL)-17-producing (T(H)17) cells promote tumorigenesis(5,6), and a 'T(H)17 expression signature' in stage I/II colorectal cancer is associated with a drastic decrease in disease-free survival(9). Despite its pathogenic importance, the mechanisms responsible for the appearance of tumour-elicited inflammation are poorly understood. Many epithelial cancers develop proximally to microbial communities, which are physically separated from immune cells by an epithelial barrier(10). We investigated mechanisms responsible for tumour-elicited inflammation in a mouse model of colorectal tumorigenesis, which, like human colorectal cancer, exhibits upregulation of IL-23 and IL-17. Here we show that IL-23 signalling promotes tumour growth and progression, and development of a tumoural IL-17 response. IL-23 is mainly produced by tumour-associated myeloid cells that are likely to be activated by microbial products, which penetrate the tumours but not adjacent tissue. Both early and late colorectal neoplasms exhibit defective expression of several barrier proteins. We propose that barrier deterioration induced by colorectal-cancer-initiating genetic lesions results in adenoma invasion by microbial products that trigger tumour-elicited inflammation, which in turn drives tumour growth.	[Grivennikov, Sergei I.; Wang, Kepeng; Jauch, Dominik; Taniguchi, Koji; Yu, Guann-Yi; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Grivennikov, Sergei I.; Wang, Kepeng; Jauch, Dominik; Taniguchi, Koji; Yu, Guann-Yi; Karin, Michael] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA; [Wang, Kepeng] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China; [Mucida, Daniel; Cheroutre, Hilde] La Jolla Inst Allergy & Immunol, La Jolla, CA 92093 USA; [Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Stewart, C. Andrew; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Expt Immunol Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Schnabl, Bernd; Oesterreicher, Christoph H.; Eckmann, Lars] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Taniguchi, Koji] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Oesterreicher, Christoph H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Hung, Kenneth E.] Tufts Med Ctr, Dept Med, Boston, MA 02111 USA; [Datz, Christian] Paracelsus Med Univ, Oberndorf Hosp, Dept Internal Med, Salzburg, Austria; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Feng, Ying; Fearon, Eric R.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Oukka, Mohamed] Seattle Childrens Res Inst, Seattle, WA 98105 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA; [Coppola, Vincenzo] Ohio State Univ, Ctr Comprehens Canc, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Yarovinsky, Felix] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; La Jolla Institute for Immunology; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego; Keio University; Medical University of Vienna; Tufts Medical Center; Paracelsus Private Medical University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019; Trinchieri, Giorgio/F-9369-2015; Wang, Kepeng/F-8363-2014; Coppola, Vincenzo/E-2917-2011; Stewart, Charles/G-2470-2012; Yu, Guann-Yi/O-5139-2019; Coppola, Vincenzo/D-5352-2014	Grivennikov, Sergei/0000-0003-2987-0555; Trinchieri, Giorgio/0000-0001-5892-7464; Wang, Kepeng/0000-0001-6428-4709; Coppola, Vincenzo/0000-0001-6163-1779; Yu, Guann-Yi/0000-0002-0580-8282; Coppola, Vincenzo/0000-0001-6163-1779; Yarovinsky, Felix/0000-0001-5825-8002; Mucida, Daniel/0000-0002-0000-0452	Crohn's and Colitis Foundation of America [2693]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [K99-DK088589]; University of California, San Diego, Digestive Disease Research Development Center Pilot Grant [DK080506]; Croucher Foundation; China Postdoctoral Science Foundation [20110490919]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; SPAR Austria; NIH [R01CA082223, AI043477, DK035108]; American Association for Cancer Research [07-60-21-KARI]; NATIONAL CANCER INSTITUTE [ZIABC010793, R01CA082223, ZICBC011265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI050265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK088589, R24DK080506, K08DK081830, P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020703] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of California, San Diego, Digestive Disease Research Development Center Pilot Grant; Croucher Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; SPAR Austria; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank eBioscience, GeneTex, Santa Cruz, BioLegend and Cell Signaling for antibodies; Genentech and Amgen for Il23<SUP>-/-</SUP> and Il17ra<SUP>-/-</SUP> mice, respectively, and S. Reid and E. Southon for the help in generating Il23r<SUP>F/F</SUP> mice. This work was supported by Crohn's and Colitis Foundation of America (Career Development Award number 2693), NIH/National Institute of Diabetes and Digestive and Kidney Diseases (K99-DK088589) and a University of California, San Diego, Digestive Disease Research Development Center Pilot Grant (DK080506) to S. I. G.; Croucher Foundation and China Postdoctoral Science Foundation (20110490919) to K. W.; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation to K. T.; SPAR Austria to C. D.; NIH (R01CA082223) to E. R. F.; and NIH (AI043477; DK035108) and American Association for Cancer Research (07-60-21-KARI) grants to M. K., who is an American Cancer Society Research Professor. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; Dove WF, 1997, CANCER RES, V57, P812; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hoshino K, 1999, J IMMUNOL, V162, P5041; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Reichling T, 2005, CANCER RES, V65, P166; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Tanaka T, 2006, INT J CANCER, V118, P25, DOI 10.1002/ijc.21282; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang XX, 2011, THESCIENTIFICWORLDJO, V11, P826, DOI 10.1100/tsw.2011.86; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	44	857	888	6	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2012	491	7423					254	+		10.1038/nature11465	http://dx.doi.org/10.1038/nature11465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23034650	Green Accepted			2022-12-24	WOS:000310774300044
J	Huber, S; Gagliani, N; Zenewicz, LA; Huber, FJ; Bosurgi, L; Hu, B; Hedl, M; Zhang, W; O'Connor, W; Murphy, AJ; Valenzuela, DM; Yancopoulos, GD; Booth, CJ; Cho, JH; Ouyang, WJ; Abraham, C; Flavell, RA				Huber, Samuel; Gagliani, Nicola; Zenewicz, Lauren A.; Huber, Francis J.; Bosurgi, Lidia; Hu, Bo; Hedl, Matija; Zhang, Wei; O'Connor, William, Jr.; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.; Booth, Carmen J.; Cho, Judy H.; Ouyang, Wenjun; Abraham, Clara; Flavell, Richard A.			IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine	NATURE			English	Article							SODIUM-INDUCED COLITIS; BINDING-PROTEIN; ULCERATIVE-COLITIS; CROHNS-DISEASE; INTERLEUKIN 22; T-CELLS; IMMUNITY; SULFATE; CLONING; INNATE	Chronic mucosal inflammation and tissue damage predisposes patients to the development of colorectal cancer(1). This association could be explained by the hypothesis that the same factors and pathways important for wound healing also promote tumorigenesis. A sensor of tissue damage should induce these factors to promote tissue repair and regulate their action to prevent development of cancer. Interleukin 22 (IL-22), a cytokine of the IL-10 superfamily, has an important role in colonic epithelial cell repair, and its levels are increased in the blood and intestine of inflammatory bowel disease patients(2,3). This cytokine can be neutralized by the soluble IL-22 receptor, known as the IL-22 binding protein (IL-22BP, also known as IL22RA2); however, the significance of endogenous IL-22BP in vivo and the pathways that regulate this receptor are unknown(4,5). Here we describe that IL-22BP has a crucial role in controlling tumorigenesis and epithelial cell proliferation in the colon. IL-22BP is highly expressed by dendritic cells in the colon in steady-state conditions. Sensing of intestinal tissue damage via the NLRP3 or NLRP6 inflammasomes led to an IL-18-dependent downregulation of IL-22BP, thereby increasing the ratio of IL-22/IL-22BP. IL-22, which is induced during intestinal tissue damage, exerted protective properties during the peak of damage, but promoted tumour development if uncontrolled during the recovery phase. Thus, the IL-22-IL-22BP axis critically regulates intestinal tissue repair and tumorigenesis in the colon.	[Huber, Samuel; Gagliani, Nicola; Zenewicz, Lauren A.; Bosurgi, Lidia; Hu, Bo; O'Connor, William, Jr.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Huber, Samuel; Huber, Francis J.] Univ Klinikum Hamburg Eppendorf, Med Klin 1, D-20246 Hamburg, Germany; [Hedl, Matija; Abraham, Clara] Yale Univ, Sect Digest Dis, Dept Internal Med, New Haven, CT 06520 USA; [Zhang, Wei; Cho, Judy H.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Zhang, Wei; Cho, Judy H.] Yale Univ, Sch Med, Dept Genet, Sect Digest Dis, New Haven, CT 06520 USA; [Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Sect Comparat Med, New Haven, CT 06520 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Yale University; Yale University; Yale University; Regeneron; Yale University; Roche Holding; Genentech; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	shuber@uke.de; richard.flavell@yale.edu	Ouyang, Wenjun/ABA-8763-2020	Gagliani, Nicola/0000-0001-8514-1395; Ouyang, Wenjun/0000-0002-1811-5864; Bosurgi, Lidia/0000-0002-8775-4950; Zenewicz, Lauren/0000-0002-8787-5955; Murphy, Andrew/0000-0003-4152-4081; Huber, Samuel/0000-0001-9325-8227	Crohn's and Colitis Foundation of America; Stiftung experimentelle Biomedizin; Ernst Jung Foundation; EMBO; American Cancer Society; DFG [SFB841];  [R01DK077905];  [DK-P30-34989];  [U19-AI082713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077905, P30DK034989] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Stiftung experimentelle Biomedizin; Ernst Jung Foundation; EMBO(European Molecular Biology Organization (EMBO)); American Cancer Society(American Cancer Society); DFG(German Research Foundation (DFG)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank F. Manzo for expert administrative assistance, E. Eynon and J. Alderman for managing the mouse program. We also thank T. Taylor and G. Tokmoulina for expert help with the FACS sorting. R. A. F. is an Investigator of the Howard Hughes Medical Institute. S. H. was supported by a post-doctoral fellowship from the Crohn's and Colitis Foundation of America, the 'Stiftung experimentelle Biomedizin' and the Ernst Jung Foundation. N.G. was supported by an EMBO post-doctoral fellowship. L.A.Z. was supported by a post-doctoral fellowship from the American Cancer Society. A. J. M., D. M. V. and G.D.Y. were employees of Regeneron Pharmaceuticals at the time this work was performed. W.O. is an employee of Genentech Inc. This work was supported by R01DK077905, DK-P30-34989 and U19-AI082713 (to C. A. and R. A. F.) and by the DFG, SFB841 (to S.H.).	Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dumoutier L, 2001, J IMMUNOL, V166, P7090, DOI 10.4049/jimmunol.166.12.7090; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Jones BC, 2008, STRUCTURE, V16, P1333, DOI 10.1016/j.str.2008.06.005; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Li YH, 2012, CARCINOGENESIS, V33, P1231, DOI 10.1093/carcin/bgs137; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wei CC, 2003, GENES IMMUN, V4, P204, DOI 10.1038/sj.gene.6363947; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	35	508	534	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					259	+		10.1038/nature11535	http://dx.doi.org/10.1038/nature11535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23075849	Green Accepted			2022-12-24	WOS:000310774300045
J	Beets, I; Janssen, T; Meelkop, E; Temmerman, L; Suetens, N; Rademakers, S; Jansen, G; Schoofs, L				Beets, Isabel; Janssen, Tom; Meelkop, Ellen; Temmerman, Liesbet; Suetens, Nick; Rademakers, Suzanne; Jansen, Gert; Schoofs, Liliane			Vasopressin/Oxytocin-Related Signaling Regulates Gustatory Associative Learning in C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; OXYTOCIN RECEPTORS; IDENTIFICATION; PLASTICITY; MOTIVATION; SEROTONIN; DOPAMINE; CUES	Vasopressin- and oxytocin-related neuropeptides are key regulators of animal physiology, including water balance and reproduction. Although these neuropeptides also modulate social behavior and cognition in mammals, the mechanism for influencing behavioral plasticity and the evolutionary origin of these effects are not well understood. Here, we present a functional vasopressin- and oxytocin-like signaling system in the nematode Caenorhabditis elegans. Through activation of its receptor NTR-1, a vasopressin/oxytocin-related neuropeptide, designated nematocin, facilitates the experience-driven modulation of salt chemotaxis, a type of gustatory associative learning in C. elegans. Our study suggests that vasopressin and oxytocin neuropeptides have ancient roles in modulating sensory processing in neural circuits that underlie behavioral plasticity.	[Beets, Isabel; Janssen, Tom; Meelkop, Ellen; Temmerman, Liesbet; Suetens, Nick; Schoofs, Liliane] Katholieke Univ Leuven, Dept Biol, Funct Genom & Prote Unit, B-3000 Louvain, Belgium; [Rademakers, Suzanne; Jansen, Gert] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands	KU Leuven; Erasmus University Rotterdam; Erasmus MC	Schoofs, L (corresponding author), Katholieke Univ Leuven, Dept Biol, Funct Genom & Prote Unit, B-3000 Louvain, Belgium.	liliane.schoofs@bio.kuleuven.be	Meelkop, Ellen/G-3052-2012; Beets, Isabel/I-6386-2012; Janssen, Tom/AAC-1849-2020; schoofs, liliane/ABD-2943-2020; Jansen, Gert/HCI-8852-2022; Schoofs, Liliane/F-2815-2010	Beets, Isabel/0000-0002-0968-4360; Schoofs, Liliane/0000-0002-1673-432X; Jansen, Gert/0000-0002-7524-171X; Temmerman, Liesbet/0000-0002-1249-3995	Fund for Scientific Research-Flanders (FWO); KU Leuven Faculty Research Fund; KU Leuven [GOA/11/002]; FWO [G.0767.09, G.0601.11]	Fund for Scientific Research-Flanders (FWO)(FWO); KU Leuven Faculty Research Fund; KU Leuven(KU Leuven); FWO(FWO)	We thank the Caenorhabditis Genetics Center, S. Mitani, C. Bargmann, and M. Alkema for strains and reagents; L. Vanden Bosch, M. Vanhove, and W. De Haes for technical assistance. I.B., T.J., and L.T. benefit from the Fund for Scientific Research-Flanders (FWO) and E.M. from the KU Leuven Faculty Research Fund. This work was supported by the KU Leuven concerted research grant GOA/11/002 and FWO grants G.0767.09 and G.0601.11. GenBank accession numbers of ntc-1, ntr-1, and ntr-2 sequences are JQ277480, JQ277731, and JQ277479. Strains carrying the tm2385, tm2765, and tm2243 alleles are available through the C. elegans National BioResource Project (NBRP), subject to a materials transfer agreement.	Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; CULOTTI JG, 1978, GENETICS, V90, P243; DEWIED D, 1993, FRONT NEUROENDOCRIN, V14, P251, DOI 10.1006/frne.1993.1009; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Izquierdo A, 2012, BEHAV BRAIN RES, V233, P494, DOI 10.1016/j.bbr.2012.05.032; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Janssen T, 2010, ANN NY ACAD SCI, V1200, P1, DOI 10.1111/j.1749-6632.2010.05506.x; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Orcel H, 2009, MOL PHARMACOL, V75, P637, DOI 10.1124/mol.108.049031; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; SCHUMACHER M, 1990, SCIENCE, V250, P691, DOI 10.1126/science.2173139; SOLOFF MS, 1979, SCIENCE, V204, P1313, DOI 10.1126/science.221972; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; VANKESTEREN RE, 1995, NEURON, V15, P897, DOI 10.1016/0896-6273(95)90180-9; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	20	114	117	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					543	545		10.1126/science.1226860	http://dx.doi.org/10.1126/science.1226860			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112336	Green Accepted			2022-12-24	WOS:000310195800062
J	Chakkalakal, JV; Jones, KM; Basson, MA; Brack, AS				Chakkalakal, Joe V.; Jones, Kieran M.; Basson, M. Albert; Brack, Andrew S.			The aged niche disrupts muscle stem cell quiescence	NATURE			English	Article							FIBROBLAST-GROWTH-FACTOR; SATELLITE CELLS; SELF-RENEWAL; PROGENITOR CELLS; PROGRESSION; MYOGENESIS; SPROUTY; DIFFERENTIATION; HETEROGENEITY; CONTRIBUTES	The niche is a conserved regulator of stem cell quiescence and function. During ageing, stem cell function declines. To what extent and by what means age-related changes within the niche contribute to this phenomenon are unknown. Here we demonstrate that the aged muscle stem cell niche, the muscle fibre, expresses Fgf2 under homeostatic conditions, driving a subset of satellite cells to break quiescence and lose their self-renewing capacity. We show in mice that relatively dormant aged satellite cells robustly express sprouty 1 (Spry1), an inhibitor of fibroblast growth factor (FGF) signalling. Increasing FGF signalling in aged satellite cells under homeostatic conditions by removing Spry1 results in the loss of quiescence, satellite cell depletion and diminished regenerative capacity. Conversely, reducing niche-derived FGF activity through inhibition of Fgfr1 signalling or overexpression of Spry1 in satellite cells prevents their depletion. These experiments identify an age-dependent change in the stem cell niche that directly influences stem cell quiescence and function.	[Chakkalakal, Joe V.; Brack, Andrew S.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Jones, Kieran M.; Basson, M. Albert] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London SE1 9RT, England; [Brack, Andrew S.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Brack, Andrew S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; University of London; King's College London; Harvard University; Harvard University; Harvard Medical School	Brack, AS (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	Brack.Andrew@mgh.harvard.edu	Chakkalakal, Joe/ABD-2865-2020	Chakkalakal, Joe/0000-0002-8440-7312; Basson, M. Albert/0000-0001-9834-7528	MGH; Harvard Stem Cell Institute; NIH [R01 AR060868, R01 AR061002]; Wellcome Trust [WT091475]; MGH ECOR Postdoctoral Fellow Award; BBSRC Doctoral Training Award [BB/F017626/1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060868, R01AR061002] Funding Source: NIH RePORTER	MGH; Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MGH ECOR Postdoctoral Fellow Award; BBSRC Doctoral Training Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Hock, K. Hochedlinger and R. Friesel for the generous provision of reagents, and G. Estrada for technical assistance. We are also grateful to L. Prickett-Rice, K. Folz-Donahue and M. Weglarz for cell sorting. This work was supported by MGH start-up funds, Harvard Stem Cell Institute grants and NIH grants (R01 AR060868, R01 AR061002) (A. S. B.); a Wellcome Trust grant (WT091475) (M. A. B.); and an MGH ECOR Postdoctoral Fellow Award (J.V.C.) and a BBSRC Doctoral Training Award (BB/F017626/1) (K.M.J.).	Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; BISCHOFF R, 1990, DEVELOPMENT, V109, P943; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Buono M, 2010, J EXP MED, V207, P1647, DOI 10.1084/jem.20091022; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Flanagan-Steet H, 2000, DEV BIOL, V218, P21, DOI 10.1006/dbio.1999.9535; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kudla AJ, 1998, J CELL BIOL, V142, P241, DOI 10.1083/jcb.142.1.241; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; LEFAUCHEUR JP, 1995, J NEUROIMMUNOL, V57, P85, DOI 10.1016/0165-5728(94)00166-L; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Ono Y, 2012, J CELL SCI, V125, P1309, DOI 10.1242/jcs.096198; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xu XL, 2002, GENESIS, V32, P85, DOI 10.1002/gene.10028; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yang XH, 2008, DEV BIOL, V321, P64, DOI 10.1016/j.ydbio.2008.05.555; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	55	506	527	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					355	+		10.1038/nature11438	http://dx.doi.org/10.1038/nature11438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23023126	Green Submitted, Green Accepted			2022-12-24	WOS:000309918500036
J	Rajan, A; Perrimon, N				Rajan, Akhila; Perrimon, Norbert			Drosophila Cytokine Unpaired 2 Regulates Physiological Homeostasis by Remotely Controlling Insulin Secretion	CELL			English	Article							JAK/STAT PATHWAY; IMAGINAL DISKS; LIFE-SPAN; IN-VIVO; CELLS; GROWTH; MELANOGASTER; METABOLISM; PEPTIDES; NEURONS	In Drosophila, the fat body (FB), a functional analog of the vertebrate adipose tissue, is the nutrient sensor that conveys the nutrient status to the insulin-producing cells (IPCs) in the fly brain to release Drosophila insulin-like peptides (Dilps). Dilp secretion in turn regulates energy balance and promotes systemic growth. We identify Unpaired 2 (Upd2), a protein with similarities to type I cytokines, as a secreted factor produced by the FB in the fed state. When upd2 function is perturbed specifically in the FB, it results in a systemic reduction in growth and alters energy metabolism. Upd2 activates JAK/STAT signaling in a population of GABAergic neurons that project onto the IPCs. This activation relieves the inhibitory tone of the GABAergic neurons on the IPCs, resulting in the secretion of Dilps. Strikingly, we find that human Leptin can rescue the upd2 mutant phenotypes, suggesting that Upd2 is the functional homolog of Leptin.	[Rajan, Akhila; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Rajan, A (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	akhila@genetics.med.harvard.edu; perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X	National Institutes of Health [5P01CA120964, 5R01DK088718]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Zeidler, E. Bach, B. Hassan, B. White, B. Al-Anzi, M. Pankratz, P. Shen, J. Wang, D. Krantz, J. Simpson, A. Gould, E. Hafen, H. Stocker, P. Leopold, G. Technau, and E. Olson for reagents. We thank the Transgenic RNAi Resource Project, NIG-Fly Stock Center (Japan), and the Bloomington Stock Center for flies, the Developmental Studies Hybridoma Bank for monoclonal antibodies, and the Drosophila RNAi Screening Center (Harvard Medical School) for dsRNA reagents and plate-reader equipment. We also thank C. Villalta for performing embryonic microinjections to create the human Leptin transgenic flies, F. Demontis and C. Pitsouli for critical comments on the manuscript, Y. Kwon for advice on the STAT luciferase assay, I. Droujinine for discussions and help with the diet experiments, and P. Raghavan and F. Wirtz-Peitz for insightful comments and discussions during the course of this work. This work was supported by the National Institutes of Health (5P01CA120964 and 5R01DK088718). N.P. is a Howard Hughes Medical Institute investigator.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Caton PW, 2011, DIABETOLOGIA, V54, P3083, DOI 10.1007/s00125-011-2288-0; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; DasGupta R., 2005, SCI STKE, pcm5; DAVIS KT, 1977, SCIENCE, V196, P438, DOI 10.1126/science.403606; de Haas Y, 2011, J DAIRY SCI, V94, P6122, DOI 10.3168/jds.2011-4439; DINARELLO CA, 1986, ANNU REV MED, V37, P173; Enell LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015780; Fei H, 2010, J EXP BIOL, V213, P1717, DOI 10.1242/jeb.036053; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kahn CR, 2005, JOSLINS DIABETES MEL; Karsten P, 2006, CELL SIGNAL, V18, P819, DOI 10.1016/j.cellsig.2005.07.006; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; RODGERS ME, 1977, CELL, V12, P915, DOI 10.1016/0092-8674(77)90155-6; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Wright VM, 2011, CELL SIGNAL, V23, P920, DOI 10.1016/j.cellsig.2011.01.020; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou XB, 2005, LECT NOTES COMPUT SC, V3749, P885	47	312	320	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					123	137		10.1016/j.cell.2012.08.019	http://dx.doi.org/10.1016/j.cell.2012.08.019			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021220	Green Accepted, Bronze			2022-12-24	WOS:000309544200015
J	Lefaucheur, C; Loupy, A; Vernerey, D; Duong-Van-Huyen, JP; Suberbielle, C; Anglicheau, D; Verine, J; Beuscart, T; Nochy, D; Bruneval, P; Charron, D; Delahousse, M; Empana, JP; Hill, GS; Glotz, D; Legendre, C; Jouven, X				Lefaucheur, Carmen; Loupy, Alexandre; Vernerey, Dewi; Duong-Van-Huyen, Jean-Paul; Suberbielle, Caroline; Anglicheau, Dany; Verine, Jerome; Beuscart, Thibaut; Nochy, Dominique; Bruneval, Patrick; Charron, Dominique; Delahousse, Michel; Empana, Jean-Philippe; Hill, Gary S.; Glotz, Denis; Legendre, Christophe; Jouven, Xavier			Antibody-mediated vascular rejection of kidney allografts: a population-based study	LANCET			English	Article							ACUTE HUMORAL REJECTION; C4D DEPOSITION; TRANSPLANT RECIPIENTS; CLASSIFICATION; SURVIVAL; THERAPY; INJURY; PLASMAPHERESIS; VASCULOPATHY; PATHOLOGY	Background Rejection of allografts has always been the major obstacle to transplantation success. We aimed to improve characterisation of different kidney-allograft rejection phenotypes, identify how each one is associated with anti-HLA antibodies, and investigate their distinct prognoses. Methods Patients who underwent ABO-compatible kidney transplantations in Necker Hospital and Saint-Louis Hospital (Paris, France) between Jan 1, 1998, and Dec 31, 2008, were included in our population-based study. We assessed patients who provided biopsy samples for acute allograft rejection, which was defined as the association of deterioration in function and histopathological lesions. The main outcome was kidney allograft loss-ie, return to dialysis. To investigate distinct rejection patterns, we retrospectively assessed rejection episodes with review of graft histology, C4d in allograft biopsies, and donor-specific anti-HLA antibodies. Findings 2079 patients were included in the main analyses, of whom 302 (15%) had acute biopsy-proven rejection. We identified four distinct patterns of kidney allograft rejection: T cell-mediated vascular rejection (26 patients [9%]), antibody-mediated vascular rejection (64 [21%]), T cell-mediated rejection without vasculitis (139 [46%]), and antibody-mediated rejection without vasculitis (73 [24%]). Risk of graft loss was 9.07 times (95 CI 3.62-19.7) higher in antibody-mediated vascular rejection than in T cell-mediated rejection without vasculitis (p<0.0001), compared with an increase of 2.93 times (1.1-7.9; P=0.0237) in antibody-mediated rejection without vasculitis and no significant rise in T cell-mediated vascular rejection (hazard ratio [HR] 1.5, 95% CI 0.33-7.6; p=0.60). Interpretation We have identified a type of kidney rejection not presently included in classifications: antibody-mediated vascular rejection. Recognition of this distinct phenotype could lead to the development of new treatment strategies that could salvage many kidney allografts.	[Lefaucheur, Carmen; Charron, Dominique] Hop St Louis, AP HP, INSERM, Dept Immunol & Histocompatibil,U940, Paris, France; [Verine, Jerome] Hop St Louis, AP HP, INSERM, Dept Pathol,U940, Paris, France; [Loupy, Alexandre; Anglicheau, Dany; Legendre, Christophe] Hop Necker Enfants Malad, AP HP, Dept Kidney Transplantat, F-75015 Paris, France; [Loupy, Alexandre; Vernerey, Dewi; Beuscart, Thibaut; Empana, Jean-Philippe; Jouven, Xavier] Univ Paris 05, Paris Cardiovasc Res Ctr, Biostat Unit, UMR S970, Paris, France; [Duong-Van-Huyen, Jean-Paul; Beuscart, Thibaut; Nochy, Dominique; Bruneval, Patrick; Hill, Gary S.] Georges Pompidou European Hosp, Dept Pathol, Paris, France; [Jouven, Xavier] Georges Pompidou European Hosp, Dept Cardiol, Paris, France; [Duong-Van-Huyen, Jean-Paul] Hop Foch, Dept Pathol, Suresnes, France; [Delahousse, Michel] Hop Foch, Dept Nephrol & Kidney Transplantat, Suresnes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Hospital Foch	Loupy, A (corresponding author), Hop Necker Enfants Malad, AP HP, Dept Kidney Transplantat, 149 Rue Sevres, F-75015 Paris, France.	alexandreloupy@gmail.com	lefaucheur, carmen/AAS-7494-2020; Empana, Jean-Philippe/AAF-6923-2021; Loupy, Alexandre/K-8512-2019; lefaucheur, carmen/F-3502-2013	Empana, Jean-Philippe/0000-0002-1469-7772; Glotz, Denis/0000-0001-5258-4237				Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Bohmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091; de Serrea NPM, 2008, AM J TRANSPLANT, V8, P1290, DOI 10.1111/j.1600-6143.2008.02221.x; Einecke G, 2009, AM J TRANSPLANT, V9, P2520, DOI 10.1111/j.1600-6143.2009.02799.x; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Everly MJ, 2008, TRANSPLANTATION, V86, P1754, DOI 10.1097/TP.0b013e318190af83; Faguer S, 2007, TRANSPLANTATION, V83, P1277, DOI 10.1097/01.tp.0000261113.30757.d1; Garcia GG, 2012, LANCET, V379, pE36, DOI 10.1016/S0140-6736(12)60202-5; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Herzenberg AM, 2002, J AM SOC NEPHROL, V13, P234, DOI 10.1681/ASN.V131234; Hill GS, 2011, J AM SOC NEPHROL, V22, P975, DOI 10.1681/ASN.2010070777; Hirohashi T, 2010, AM J TRANSPLANT, V10, P510, DOI 10.1111/j.1600-6143.2009.02958.x; Kaufman CL, 2012, AM J TRANSPLANT, V12, P1004, DOI 10.1111/j.1600-6143.2011.03915.x; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lefaucheur C, 2007, AM J TRANSPLANT, V7, P832, DOI 10.1111/j.1600-6143.2006.01686.x; Lefaucheur C, 2009, AM J TRANSPLANT, V9, P1099, DOI 10.1111/j.1600-6143.2009.02591.x; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Loucaidou M, 2003, TRANSPLANTATION, V76, P1120, DOI 10.1097/01.TP.0000076474.76480.A4; Loupy A, 2011, AM J TRANSPLANT, V11, P1478, DOI 10.1111/j.1600-6143.2011.03563.x; Loupy A, 2011, AM J TRANSPLANT, V11, P56, DOI 10.1111/j.1600-6143.2010.03364.x; Loupy A, 2010, TRANSPLANTATION, V89, P1403, DOI 10.1097/TP.0b013e3181da1cc3; Mauiyyedi S, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133779; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rocha PN, 2003, TRANSPLANTATION, V75, P1490, DOI 10.1097/01.TP.0000060252.57111.AC; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shimizu T, 2010, CLIN TRANSPLANT, V24, P22, DOI 10.1111/j.1399-0012.2010.01277.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Sis B, 2010, AM J TRANSPLANT, V10, P421, DOI 10.1111/j.1600-6143.2009.02938.x; Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Takemoto SK, 2004, AM J TRANSPLANT, V4, P1033, DOI 10.1111/j.1600-6143.2004.00500.x; Trpkov K, 1996, TRANSPLANTATION, V61, P1586, DOI 10.1097/00007890-199606150-00007	36	240	247	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					313	319		10.1016/S0140-6736(12)61265-3	http://dx.doi.org/10.1016/S0140-6736(12)61265-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23182298				2022-12-24	WOS:000314021800028
J	Nandakumar, J; Bell, CF; Weidenfeld, I; Zaug, AJ; Leinwand, LA; Cech, TR				Nandakumar, Jayakrishnan; Bell, Caitlin F.; Weidenfeld, Ina; Zaug, Arthur J.; Leinwand, Leslie A.; Cech, Thomas R.			The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity	NATURE			English	Article							SINGLE-STRANDED-DNA; FISSION YEAST; LENGTH REGULATOR; POT1; PROTECTION; GENE; LOCALIZATION; TEL1(ATM); INTERACTS; REQUIRES	Human chromosome ends are capped by shelterin, a protein complex that protects the natural ends from being recognized as sites of DNA damage and also regulates the telomere-replicating enzyme, telomerase(1-3). Shelterin includes the heterodimeric POT1-TPP1 protein, which binds the telomeric single-stranded DNA tail(4-9). TPP1 has been implicated both in recruiting telomerase to telomeres and in stimulating telomerase processivity (the addition of multiple DNA repeats after a single primer-binding event)(9-14). Determining the mechanisms of these activities has been difficult, especially because genetic perturbations also tend to affect the essential chromosome end-protection function of TPP1 (refs 15-17). Here we identify separation-of-function mutants of human TPP1 that retain full telomere-capping function in vitro and in vivo, yet are defective in binding human telomerase. The seven separation-of-function mutations map to a patch of amino acids on the surface of TPP1, the TEL patch, that both recruits telomerase to telomeres and promotes high-processivity DNA synthesis, indicating that these two activities are manifestations of the same molecular interaction. Given that the interaction between telomerase and TPP1 is required for telomerase function in vivo, the TEL patch of TPP1 provides a new target for anticancer drug development.	[Nandakumar, Jayakrishnan; Bell, Caitlin F.; Weidenfeld, Ina; Zaug, Arthur J.; Leinwand, Leslie A.; Cech, Thomas R.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Nandakumar, Jayakrishnan; Bell, Caitlin F.; Zaug, Arthur J.; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Nandakumar, Jayakrishnan; Bell, Caitlin F.; Zaug, Arthur J.; Cech, Thomas R.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Weidenfeld, Ina; Leinwand, Leslie A.; Cech, Thomas R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.	thomas.cech@colorado.edu		Bell, Caitlin/0000-0001-7352-142X; LEINWAND, LESLIE/0000-0003-1470-4810; Nandakumar, Jayakrishnan/0000-0001-9146-2785	National Cancer Institute of the National Institutes of Health [K99CA167644]; US National Institutes of Health [R01GM29090, R01GM099705]; NATIONAL CANCER INSTITUTE [K99CA167644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099705, R01GM029090] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. de Lange, M. Terns and S. Langer for suggestions and sharing protocols; T. Nahreini for maintenance of the departmental tissue culture facility; J. Friedman and G. Voeltz for help with confocal microscopy; and A. Berman, S. Borah and M. Nakashima for critical reading of the manuscript. T.R.C. is an investigator of the Howard Hughes Medical Institute (HHMI). J.N. was an HHMI fellow of the Helen Hay Whitney Foundation during a major part of this study and is supported by the National Cancer Institute of the National Institutes of Health under award number K99CA167644. This work was supported in part by US National Institutes of Health grant R01GM29090 to L.A.L. and R01GM099705 to T.R.C.	Abell AN, 2004, J CELL SCI, V117, P243, DOI 10.1242/jcs.00853; Abreu E, 2011, METHODS MOL BIOL, V735, P125, DOI 10.1007/978-1-61779-092-8_12; Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Berger SM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq616; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Lue NF, 2004, BIOESSAYS, V26, P955, DOI 10.1002/bies.20093; Majerska J, 2011, MOL BIOSYST, V7, P1013, DOI 10.1039/c0mb00268b; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Moser BA, 2011, NAT STRUCT MOL BIOL, V18, P1408, DOI 10.1038/nsmb.2187; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nandakumar J, 2010, P NATL ACAD SCI USA, V107, P651, DOI 10.1073/pnas.0911099107; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Sexton A. N, 2012, J BIOL CHEM; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Weidenfeld I, 2012, METHODS MOL BIOL, V815, P289, DOI 10.1007/978-1-61779-424-7_22; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Yamazaki H, 2012, GENE DEV, V26, P241, DOI 10.1101/gad.177873.111; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	33	231	237	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					285	+		10.1038/nature11648	http://dx.doi.org/10.1038/nature11648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23103865	Green Accepted			2022-12-24	WOS:000312259300049
J	Kainer, MA; Reagan, DR; Nguyen, DB; Wiese, AD; Wise, ME; Ward, J; Park, BJ; Kanago, ML; Baumblatt, J; Schaefer, MK; Berger, BE; Marder, EP; Min, JY; Dunn, JR; Smith, RM; Dreyzehner, J; Jones, TF				Kainer, Marion A.; Reagan, David R.; Nguyen, Duc B.; Wiese, Andrew D.; Wise, Matthew E.; Ward, Jennifer; Park, Benjamin J.; Kanago, Meredith L.; Baumblatt, Jane; Schaefer, Melissa K.; Berger, Brynn E.; Marder, Ellyn P.; Min, Jea-Young; Dunn, John R.; Smith, Rachel M.; Dreyzehner, John; Jones, Timothy F.		Tennessee Fungal Meningitis Invest	Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASPERGILLUS MENINGITIS; EPIDURAL ABSCESS; SRI-LANKA; OUTBREAK; EXSEROHILUM; PHEOHYPHOMYCOSIS; VORICONAZOLE; MANAGEMENT; INJECTION	Background We investigated an outbreak of fungal infections of the central nervous system that occurred among patients who received epidural or paraspinal glucocorticoid injections of preservative-free methylprednisolone acetate prepared by a single compounding pharmacy. Methods Case patients were defined as patients with fungal meningitis, posterior circulation stroke, spinal osteomyelitis, or epidural abscess that developed after epidural or paraspinal glucocorticoid injections. Clinical and procedure data were abstracted. A cohort analysis was performed. Results The median age of the 66 case patients was 69 years (range, 23 to 91). The median time from the last epidural glucocorticoid injection to symptom onset was 18 days (range, 0 to 56). Patients presented with meningitis alone (73%), the cauda equina syndrome or focal infection (15%), or posterior circulation stroke with or without meningitis (12%). Symptoms and signs included headache (in 73% of the patients), new or worsening back pain (in 50%), neurologic symptoms (in 48%), nausea (in 39%), and stiff neck (in 29%). The median cerebrospinal fluid white-cell count on the first lumbar puncture among patients who presented with meningitis, with or without stroke or focal infection, was 648 per cubic millimeter (range, 6 to 10,140), with 78% granulocytes (range, 0 to 97); the protein level was 114 mg per deciliter (range, 29 to 440); and the glucose concentration was 44 mg per deciliter (range, 12 to 121) (2.5 mmol per liter [range, 0.7 to 6.7]). A total of 22 patients had laboratory confirmation of Exserohilum rostratum infection (21 patients) or Aspergillus fumigatus infection (1 patient). The risk of infection increased with exposure to lot 06292012@26, older vials, higher doses, multiple procedures, and translaminar approach to epidural glucocorticoid injection. Voriconazole was used to treat 61 patients (92%); 35 patients (53%) were also treated with liposomal amphotericin B. Eight patients (12%) died, seven of whom had stroke. Conclusions We describe an outbreak of fungal meningitis after epidural or paraspinal glucocorticoid injection with methylprednisolone from a single compounding pharmacy. Rapid recognition of illness and prompt initiation of therapy are important to prevent complications. (Funded by the Tennessee Department of Health and the Centers for Disease Control and Prevention.)	[Kainer, Marion A.] Tennessee Dept Hlth, Div Communicable & Environm Dis & Emergency Prepa, Nashville, TN 37243 USA; [Nguyen, Duc B.; Wise, Matthew E.; Schaefer, Melissa K.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Nguyen, Duc B.; Baumblatt, Jane; Smith, Rachel M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA USA; [Park, Benjamin J.; Smith, Rachel M.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Tennessee Department Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kainer, MA (corresponding author), Tennessee Dept Hlth, Div Communicable & Environm Dis & Emergency Prepa, 1st Fl,Cordell Hull Bldg,425 5th Ave N, Nashville, TN 37243 USA.	marion.kainer@tn.gov	Wiese, Andrew D/U-9745-2017; Wiese, Andrew/D-2200-2019	Wiese, Andrew D/0000-0002-0699-4224; Wiese, Andrew/0000-0002-0699-4224; Kainer, Marion/0000-0001-7678-8744; Marder, Ellyn/0000-0003-3331-7920; Pepe, Dana/0000-0002-5519-4506	Tennessee Department of Health; Centers for Disease Control and Prevention [5U38HM000414-5]; Prevention and Public Health Fund: Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Building and Strengthening Epidemiology; Laboratory and Health Information Systems Capacity in State and Local Health Departments [3U5OCI000929-02S5]; Epidemiology and Laboratory Capacity for Infectious Diseases-Program Components [1U5OCK000211-01]; Emerging Infections Program [1U5OCK000198-01]; National Center for Preparedness, Detection, and Control of Infectious Diseases [U50CI000929] Funding Source: NIH RePORTER	Tennessee Department of Health; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Prevention and Public Health Fund: Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Building and Strengthening Epidemiology; Laboratory and Health Information Systems Capacity in State and Local Health Departments; Epidemiology and Laboratory Capacity for Infectious Diseases-Program Components; Emerging Infections Program; National Center for Preparedness, Detection, and Control of Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Tennessee Department of Health, by an appointment to the Applied Epidemiology Fellowship Program administered by the Council of State and Territorial Epidemiologists and funded by the Centers for Disease Control and Prevention Cooperative Agreement 5U38HM000414-5, and by the Prevention and Public Health Fund 2012: Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity in State and Local Health Departments Cooperative Agreement 3U5OCI000929-02S5; the Epidemiology and Laboratory Capacity for Infectious Diseases-Program Components Cooperative Agreement 1U5OCK000211-01; and the Emerging Infections Program Cooperative Agreement 1U5OCK000198-01 (all, Centers for Disease Control and Prevention).	Adler A, 2006, EUR J CLIN MICROBIOL, V25, P247, DOI 10.1007/s10096-006-0093-3; AGARWAL A, 1995, MYCOPATHOLOGIA, V131, P9, DOI 10.1007/BF01103898; Anderson Shoana, 2012, Morbidity and Mortality Weekly Report, V61, P501; Carrino JA, 2002, RADIOLOGY, V225, P723, DOI 10.1148/radiol.2253011401; Centers for Disease Control and Prevention, INT TREATM GUID CENT; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1109; Civen R, 2006, CLIN INFECT DIS, V43, P831, DOI 10.1086/507336; CLSI, 2008, MM18A CLSI; Food and Drug Administration, 2012, FDA FUNG MEN UPD 10; Frost BA, 2011, NEW ENGL J MED, V365, P2238, DOI 10.1056/NEJMc1105759; Gunaratne P. S., 2006, Ceylon Medical Journal, V51, P137; Gunaratne PS, 2007, NEW ENGL J MED, V356, P754, DOI 10.1056/NEJMc062547; Hooten WM, 2004, MAYO CLIN PROC, V79, P682, DOI 10.4065/79.5.682; Huang RC, 2004, SPINE, V29, pE7, DOI 10.1097/01.BRS.0000106764.40001.84; Jacobs F, 2012, EUR J CLIN MICROBIOL, V31, P1173, DOI 10.1007/s10096-011-1425-5; Jones TF, 2002, AM J MED, V112, P31, DOI 10.1016/S0002-9343(01)01032-4; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kolbe ABL, 2007, ACTA RADIOL, V48, P687, DOI 10.1080/02841850701342153; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; LaSala PR, 2005, PEDIATR INFECT DIS J, V24, P939, DOI 10.1097/01.inf.0000180988.96528.5c; MCGINNIS MR, 1986, J CLIN MICROBIOL, V24, P250, DOI 10.1128/JCM.24.2.250-259.1986; McPherson TB, 2006, J AM PHARM ASSOC, V46, P568, DOI 10.1331/1544-3191.46.5.568.McPherson; Muijsers RBR, 2002, DRUGS, V62, P2655, DOI 10.2165/00003495-200262180-00010; NG TTC, 1994, MICROBIOL-UK, V140, P2475, DOI 10.1099/13500872-140-9-2475; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Scott LJ, 2007, DRUGS, V67, P269, DOI 10.2165/00003495-200767020-00009; Sunenshine RH, 2007, CLIN INFECT DIS, V45, P527, DOI 10.1086/520664	28	119	120	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2194	2203		10.1056/NEJMoa1212972	http://dx.doi.org/10.1056/NEJMoa1212972			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23131029	Green Accepted			2022-12-24	WOS:000311890600006
J	Choat, B; Jansen, S; Brodribb, TJ; Cochard, H; Delzon, S; Bhaskar, R; Bucci, SJ; Feild, TS; Gleason, SM; Hacke, UG; Jacobsen, AL; Lens, F; Maherali, H; Martinez-Vilalta, J; Mayr, S; Mencuccini, M; Mitchell, PJ; Nardini, A; Pittermann, J; Pratt, RB; Sperry, JS; Westoby, M; Wright, IJ; Zanne, AE				Choat, Brendan; Jansen, Steven; Brodribb, Tim J.; Cochard, Herve; Delzon, Sylvain; Bhaskar, Radika; Bucci, Sandra J.; Feild, Taylor S.; Gleason, Sean M.; Hacke, Uwe G.; Jacobsen, Anna L.; Lens, Frederic; Maherali, Hafiz; Martinez-Vilalta, Jordi; Mayr, Stefan; Mencuccini, Maurizio; Mitchell, Patrick J.; Nardini, Andrea; Pittermann, Jarmila; Pratt, R. Brandon; Sperry, John S.; Westoby, Mark; Wright, Ian J.; Zanne, Amy E.			Global convergence in the vulnerability of forests to drought	NATURE			English	Article							HYDRAULIC ARCHITECTURE; TROPICAL FORESTS; XYLEM CAVITATION; WOODY-PLANTS; RAIN-FOREST; DIE-OFF; WATER; VEGETATION; MORTALITY; EMBOLISM	Shifts in rainfall patterns and increasing temperatures associated with climate change are likely to cause widespread forest decline in regions where droughts are predicted to increase in duration and severity(1). One primary cause of productivity loss and plant mortality during drought is hydraulic failure(2-4). Drought stress creates trapped gas emboli in the water transport system, which reduces the ability of plants to supply water to leaves for photosynthetic gas exchange and can ultimately result in desiccation and mortality. At present we lack a clear picture of how thresholds to hydraulic failure vary across a broad range of species and environments, despite many individual experiments. Here we draw together published and unpublished data on the vulnerability of the transport system to drought-induced embolism for a large number of woody species, with a view to examining the likely consequences of climate change for forest biomes. We show that 70% of 226 forest species from 81 sites worldwide operate with narrow (<1 megapascal) hydraulic safety margins against injurious levels of drought stress and therefore potentially face long-term reductions in productivity and survival if temperature and aridity increase as predicted for many regions across the globe(5,6). Safety margins are largely independent of mean annual precipitation, showing that there is global convergence in the vulnerability of forests to drought, with all forest biomes equally vulnerable to hydraulic failure regardless of their current rainfall environment. These findings provide insight into why drought-induced forest decline is occurring not only in arid regions but also in wet forests not normally considered at drought risk(7,8).	[Jansen, Steven] Ulm Univ, Inst Systemat Bot & Ecol, D-89081 Ulm, Germany; [Choat, Brendan] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW 2753, Australia; [Brodribb, Tim J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [Cochard, Herve] INRA, PIAF UMR547, F-63100 Clermont Ferrand, France; [Delzon, Sylvain] Univ Bordeaux, INRA, UMR BIOGECO, F-33450 Talence, France; [Bhaskar, Radika] Brown Univ, Environm Change Initiat, Providence, RI 02912 USA; [Bucci, Sandra J.] Univ Nacl Patagonia San Juan Bosco, Dept Biol, Fac Ciencias Nat, RA-9000 Comodoro Rivadavia, Argentina; [Feild, Taylor S.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Gleason, Sean M.; Westoby, Mark; Wright, Ian J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Hacke, Uwe G.] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2E3, Canada; [Jacobsen, Anna L.; Pratt, R. Brandon] Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA; [Lens, Frederic] Leiden Univ, Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Maherali, Hafiz] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Martinez-Vilalta, Jordi] CREAF, Cerdanyola Del Valles 08193, Spain; [Mencuccini, Maurizio] Univ Autonoma Barcelona, ICREA, CREAF, Cerdanyola Del Valles 08193, Spain; [Mayr, Stefan] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria; [Mencuccini, Maurizio] Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3JN, Midlothian, Scotland; [Mitchell, Patrick J.] CSIRO, Sandy Bay, Tas 7005, Australia; [Nardini, Andrea] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy; [Pittermann, Jarmila] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Sperry, John S.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Zanne, Amy E.] Ctr Conservat & Sustainable Dev, Missouri Bot Garden, St Louis, MO 63166 USA; [Zanne, Amy E.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	Ulm University; Western Sydney University; University of Tasmania; INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Brown University; Universidad Nacional de la Patagonia San Juan Bosco; James Cook University; Macquarie University; University of Alberta; California State University System; California State University Bakersfield; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; University of Guelph; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); ICREA; University of Innsbruck; University of Edinburgh; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Trieste; University of California System; University of California Santa Cruz; Utah System of Higher Education; University of Utah; Missouri Botanical Gardens; George Washington University	Jansen, S (corresponding author), Ulm Univ, Inst Systemat Bot & Ecol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	steven.jansen@uni-ulm.de	Gleason, Sean M/AAZ-7685-2020; Mencuccini, Maurizio/B-9052-2011; Jansen, Steven/A-9868-2012; Martínez-Vilalta, Jordi/D-3385-2014; Hacke, Uwe/M-7719-2015; Lens, Frederic/B-8482-2011; Cochard, Hervé/P-7406-2015; Camarero, J. Julio/A-8602-2013; Nardini, Andrea/C-6525-2009; Choat, Brendan/C-8445-2009; Delzon, Sylvain/R-9538-2018; Brodribb, Timothy John/C-6797-2013; Wright, Ian J/G-4979-2012; Dorman, Michael/F-7389-2010; Mitchell, Patrick/D-7454-2011	Mencuccini, Maurizio/0000-0003-0840-1477; Jansen, Steven/0000-0002-4476-5334; Martínez-Vilalta, Jordi/0000-0002-2332-7298; Hacke, Uwe/0000-0001-5983-3582; Lens, Frederic/0000-0002-5001-0149; Cochard, Hervé/0000-0002-2727-7072; Camarero, J. Julio/0000-0003-2436-2922; Choat, Brendan/0000-0002-9105-640X; Delzon, Sylvain/0000-0003-3442-1711; Brodribb, Timothy John/0000-0002-4964-6107; Wright, Ian J/0000-0001-8338-9143; Mitchell, Patrick/0000-0002-5016-7031; Bhaskar, Radika/0000-0002-9191-3555; Gleason, Sean/0000-0002-5607-4741; Mayr, Stefan/0000-0002-3319-4396; Jacobsen, Anna/0000-0001-7830-5590; Westoby, Mark/0000-0001-7690-4530; Bucci, Sandra Janet/0000-0003-1079-9277	Alexander von Humboldt Foundation; NERC [NE/I011749/1] Funding Source: UKRI; ICREA Funding Source: Custom; Austrian Science Fund (FWF) [P 20852] Funding Source: researchfish; Natural Environment Research Council [NE/I011749/1] Funding Source: researchfish	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ICREA(ICREA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the ARC-NZ Vegetation Function Network for hosting the original working group from which the data set was compiled. We are grateful to the Alexander von Humboldt Foundation for supporting B.C. during preparation of the manuscript.	Alder NN, 1996, OECOLOGIA, V105, P293, DOI 10.1007/BF00328731; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allison I, 2009, COPENHAGEN DIAGNOSIS; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Brodribb TJ, 2010, NEW PHYTOL, V188, P533, DOI 10.1111/j.1469-8137.2010.03393.x; Brodribb TJ, 2009, PLANT PHYSIOL, V149, P575, DOI 10.1104/pp.108.129783; Choat B, 2005, TREES-STRUCT FUNCT, V19, P305, DOI 10.1007/s00468-004-0392-1; Delzon S, 2010, PLANT CELL ENVIRON, V33, P2101, DOI 10.1111/j.1365-3040.2010.02208.x; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Lamy JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023476; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Martinez-Vilalta J, 2004, PLANT ECOL, V171, P3, DOI 10.1023/B:VEGE.0000029378.87169.b1; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Meinzer FC, 2009, FUNCT ECOL, V23, P922, DOI 10.1111/j.1365-2435.2009.01577.x; Meir P, 2010, NEW PHYTOL, V187, P553, DOI 10.1111/j.1469-8137.2010.03390.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pockman WT, 2000, AM J BOT, V87, P1287, DOI 10.2307/2656722; POCKMAN WT, 1995, NATURE, V378, P715, DOI 10.1038/378715a0; Scholz FG, 2011, TREE PHYSIOL-NETH, V4, P341, DOI 10.1007/978-94-007-1242-3_13; Sperry JS, 2006, AM J BOT, V93, P1490, DOI 10.3732/ajb.93.10.1490; Sperry JS, 1998, PLANT CELL ENVIRON, V21, P347, DOI 10.1046/j.1365-3040.1998.00287.x; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Wortemann R, 2011, TREE PHYSIOL, V31, P1175, DOI 10.1093/treephys/tpr101; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	30	1501	1588	77	1637	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					752	+		10.1038/nature11688	http://dx.doi.org/10.1038/nature11688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23172141	Green Published			2022-12-24	WOS:000311606000044
J	Rucklin, M; Donoghue, PCJ; Johanson, Z; Trinajstic, K; Marone, F; Stampanoni, M				Ruecklin, Martin; Donoghue, Philip C. J.; Johanson, Zerina; Trinajstic, Kate; Marone, Federica; Stampanoni, Marco			Development of teeth and jaws in the earliest jawed vertebrates	NATURE			English	Article							EVOLUTIONARY ORIGINS; PHARYNGEAL DENTICLES; PLACODERMS; DENTITION; SKELETON; GROWTH; FISH	Teeth and jaws constitute a model of the evolutionary developmental biology concept of modularity(1) and they have been considered the key innovations underpinning a classic example of adaptive radiation(2). However, their evolutionary origins are much debated. Placoderms comprise an extinct sister clade(3) or grade(4,5) to the clade containing chondrichthyans and osteichthyans, and although they clearly possess jaws, previous studies have suggested that they lack teeth(6-8), that they possess convergently evolved tooth-like structures(9-11) or that they possess true teeth(12). Here we use synchrotron radiation X-ray tomographic microscopy (SRXTM)(13) of a developmental series of Compagopiscis croucheri (Arthrodira) to show that placoderm jaws are composed of distinct cartilages and gnathal ossifications in both jaws, and a dermal element in the lower jaw. The gnathal ossification is a composite of distinct teeth that developed in succession, polarized along three distinct vectors, comparable to tooth families. The teeth are composed of dentine and bone, and show a distinct pulp cavity that is infilled centripetally as development proceeds. This pattern is repeated in other placoderms, but differs from the structure and development of tooth-like structures in the postbranchial lamina and dermal skeleton of Compagopiscis and other placoderms. We interpret this evidence to indicate that Compagopiscis and other arthrodires possessed teeth, but that tooth and jaw development was not developmentally or structurally integrated in placoderms. Teeth did not evolve convergently among the extant and extinct classes of early jawed vertebrates but, rather, successional teeth evolved within the gnathostome stem-lineage soon after the origin of jaws. The chimaeric developmental origin of this model of modularity reflects the distinct evolutionary origins of teeth and of component elements of the jaws.	[Ruecklin, Martin; Donoghue, Philip C. J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Johanson, Zerina] Nat Hist Museum, London SW7 5BD, England; [Trinajstic, Kate] Curtin Univ Technol, Dept Chem, Bentley, WA 6102, Australia; [Trinajstic, Kate] Western Australian Museum, Dept Earth & Planetary Sci, Welshpool 6106, Australia; [Marone, Federica; Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Stampanoni, Marco] ETH, CH-8092 Zurich, Switzerland	University of Bristol; Natural History Museum London; Curtin University; Western Australian Museum; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rucklin, M (corresponding author), Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	m.ruecklin@bristol.ac.uk; phil.donoghue@bristol.ac.uk	Donoghue, Philip/A-3873-2008; Marone, Federica/J-4420-2013; Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/GRR-9695-2022; Rücklin, Martin/D-7948-2018; Stampanoni, Marco/J-4099-2013	Donoghue, Philip/0000-0003-3116-7463; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Rücklin, Martin/0000-0002-7254-837X; Stampanoni, Marco/0000-0001-7486-6681; Trinajstic, Kate/0000-0002-6519-6396; Johanson, Zerina/0000-0002-8444-6776	EU; Australian Research Council [DP 110101127]; Natural Environment Research Council [NE/G016623/1]; Paul Scherrer Institut; NERC [NE/G020264/1, NE/G016623/1] Funding Source: UKRI; Natural Environment Research Council [NE/G020264/1] Funding Source: researchfish	EU(European Commission); Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Paul Scherrer Institut; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Bengtson, J. Cunningham, D. Murdock, S. Giles and A. Hetherington for help at the TOMCAT beamline; K. Robson-Brown for help at the Micro-CT, and H. Lelievre and G. Clement for loan of specimens. The study was funded by EU grant FP7 MC-IEF (to M.R. and P.C.J.D.), Australian Research Council Grant DP 110101127 (to Z.J. and K.T.), Natural Environment Research Council grant NE/G016623/1 (to P.C.J.D.) and the Paul Scherrer Institut (P.C.J.D.).	ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow CJ, 2003, SCIENCE, V300; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; Downs JP, 2009, J MORPHOL, V270, P1364, DOI 10.1002/jmor.10765; Finarelli JA, 2012, P ROY SOC B-BIOL SCI, V279, P775, DOI 10.1098/rspb.2011.1107; Fraser GJ, 2006, J EXP ZOOL PART B, V306B, P183, DOI 10.1002/jez.b.21097; Fraser GJ, 2010, BIOESSAYS, V32, P808, DOI 10.1002/bies.200900151; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; Huysseune A, 2008, DEV GENES EVOL, V218, P427, DOI 10.1007/s00427-008-0237-9; Huysseune A, 2009, J ANAT, V214, P465, DOI 10.1111/j.1469-7580.2009.01053.x; Johanson Z, 2005, BIOL REV, V80, P303, DOI 10.1017/S1464793104006682; Johanson Z, 2003, J MORPHOL, V257, P289, DOI 10.1002/jmor.10124; Lelievre Herve, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P163; Marone F, 2012, J SYNCHROTRON RADIAT, V19, P1029, DOI 10.1107/S0909049512032864; ORVIG T, 1980, ZOOL SCR, V9, P141, DOI 10.1111/j.1463-6409.1980.tb00660.x; Orvig T., 1973, Palaeontographica Abt A, V143, P119; REIF WE, 1982, EVOL BIOL, V15, P287; Rucklin M, 2011, EVOL DEV, V13, P523, DOI 10.1111/j.1525-142X.2011.00508.x; Smith MM, 2003, SCIENCE, V299, P1235, DOI 10.1126/science.1079623; SMITH MM, 1985, J ANAT, V140, P627; Soukup V, 2008, NATURE, V455, P795, DOI 10.1038/nature07304; Stampanoni M, 2007, AIP CONF PROC, V879, P848; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; Young GC, 2003, J VERTEBR PALEONTOL, V23, P987, DOI 10.1671/31; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x	29	77	82	4	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					748	+		10.1038/nature11555	http://dx.doi.org/10.1038/nature11555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23075852				2022-12-24	WOS:000311606000043
J	Elsasser, SJ; Huang, HD; Lewis, PW; Chin, JW; Allis, CD; Patel, DJ				Elsaesser, Simon J.; Huang, Hongda; Lewis, Peter W.; Chin, Jason W.; Allis, C. David; Patel, Dinshaw J.			DAXX envelops a histone H3.3-H4 dimer for H3.3-specific recognition	NATURE			English	Article							STRUCTURAL BASIS; CHAPERONE; ATRX; H3; GENES	Histone chaperones represent a structurally and functionally diverse family of histone-binding proteins that prevent promiscuous interactions of histones before their assembly into chromatin. DAXX is a metazoan histone chaperone specific to the evolutionarily conserved histone variant H3.3. Here we report the crystal structures of the DAXX histone-binding domain with a histone H3.3-H4 dimer, including mutants within DAXX and H3.3, together with in vitro and in vivo functional studies that elucidate the principles underlying H3.3 recognition specificity. Occupying 40% of the histone surface-accessible area, DAXX wraps around the H3.3-H4 dimer, with complex formation accompanied by structural transitions in the H3.3-H4 histone fold. DAXX uses an extended a-helical conformation to compete with major inter-histone, DNA and ASF1 interaction sites. Our structural studies identify recognition elements that read out H3.3-specific residues, and functional studies address the contributions of Gly 90 in H3.3 and Glu 225 in DAXX to chaperone-mediated H3.3 variant recognition specificity.	[Elsaesser, Simon J.; Lewis, Peter W.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Elsaesser, Simon J.; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Huang, Hongda; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Rockefeller University; MRC Laboratory Molecular Biology; Memorial Sloan Kettering Cancer Center	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@mail.rockefeller.edu; pated@mskcc.org	Elsässer, Simon/AAM-3986-2020; Elsässer, Simon/B-8911-2014; Huang, Hongda/G-8962-2015	Elsässer, Simon/0000-0001-8724-4849; Elsässer, Simon/0000-0001-8724-4849; Lewis, Peter/0000-0002-9816-7823	Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) [P30-EB-009998]; National Center for Research Resources of the NIH [1S10RR022321-01, 1S10RR027037-01]; Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; Rockefeller University; UK Medical Research Council (MRC) [U105181009, UD99999908]; Boehringer Ingelheim Funds fellowship; David Rockefeller Graduate Program; MRC [MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027037, S10RR022321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; Rockefeller University; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim Funds fellowship(Boehringer Ingelheim); David Rockefeller Graduate Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the personnel of synchrotron beam lines 24-I/D-C/E at the Advanced Photon Source (Argonne National Laboratory) and beam line X29 at the Brookhaven National Laboratory for their assistance, and the Center for Synchrotron Biosciences grant, P30-EB-009998, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) for funding. The use of the Rigaku/MSC microMax 007HF and Formulator in the Rockefeller University Structural Biology Resource Center was made possible by grant numbers 1S10RR022321-01 and 1S10RR027037-01 from the National Center for Research Resources of the NIH. We thank B. Black for sharing data before publication, A. Ruthenburg, J. Song and Z. Cheng for advice and discussions, and E. Datan for help in expressing DAXX protein. D. J. P. was supported by funds from the Abby Rockefeller Mauze Trust, and the Maloris and STARR Foundations. C. D. A. also acknowledges support from the STARR Foundation and The Rockefeller University. J. W. C. acknowledges support from UK Medical Research Council (MRC) (grants U105181009 and UD99999908). S. J. E. was supported by a Boehringer Ingelheim Funds fellowship and the David Rockefeller Graduate Program and holds an EMBO ALTF 1232-2011.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Elsasser SJ, 2012, BBA-GENE REGUL MECH, V1819, P211, DOI 10.1016/j.bbagrm.2011.07.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hamiche A, 2012, BBA-GENE REGUL MECH, V1819, P230, DOI 10.1016/j.bbagrm.2011.08.009; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854	29	166	169	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					560	+		10.1038/nature11608	http://dx.doi.org/10.1038/nature11608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23075851	Green Accepted			2022-12-24	WOS:000311339800044
J	Calabrese, JM; Sun, W; Song, LY; Mugford, JW; Williams, L; Yee, D; Starmer, J; Mieczkowski, P; Crawford, GE; Magnuson, T				Calabrese, J. Mauro; Sun, Wei; Song, Lingyun; Mugford, Joshua W.; Williams, Lucy; Yee, Della; Starmer, Joshua; Mieczkowski, Piotr; Crawford, Gregory E.; Magnuson, Terry			Site-Specific Silencing of Regulatory Elements as a Mechanism of X Inactivation	CELL			English	Article							TROPHOBLAST STEM-CELLS; CHROMOSOME INACTIVATION; XIST RNA; MOUSE; METHYLATION; SEQUENCES; GENOME; GENE; RECRUITMENT; INITIATION	The inactive X chromosome's (Xi) physical territory is microscopically devoid of transcriptional hallmarks and enriched in silencing-associated modifications. How these microscopic signatures relate to specific Xi sequences is unknown. Therefore, we profiled Xi gene expression and chromatin states at high resolution via allele-specific sequencing in mouse trophoblast stem cells. Most notably, X-inactivated transcription start sites harbored distinct epigenetic signatures relative to surrounding Xi DNA. These sites displayed H3-lysine27-trimethylation enrichment and DNaseI hypersensitivity, similar to autosomal Polycomb targets, yet excluded Pol II and other transcriptional hallmarks, similar to nontranscribed genes. CTCF bound X-inactivated and escaping genes, irrespective of measured chromatin boundaries. Escape from X inactivation occurred within, and X inactivation was maintained exterior to, the area encompassed by Xist in cells subject to imprinted and random X inactivation. The data support a model whereby inactivation of specific regulatory elements, rather than a simple chromosome-wide separation from transcription machinery, governs gene silencing over the Xi.	[Calabrese, J. Mauro; Sun, Wei; Mugford, Joshua W.; Williams, Lucy; Yee, Della; Starmer, Joshua; Mieczkowski, Piotr; Magnuson, Terry] Univ N Carolina, Carolina Ctr Genome Sci, Dept Genet, Chapel Hill, NC 27599 USA; [Calabrese, J. Mauro; Sun, Wei; Mugford, Joshua W.; Williams, Lucy; Yee, Della; Starmer, Joshua; Mieczkowski, Piotr; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sun, Wei] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27708 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University	Magnuson, T (corresponding author), Univ N Carolina, Carolina Ctr Genome Sci, Dept Genet, Chapel Hill, NC 27599 USA.	trm4@med.unc.edu		Mieczkowski, Piotr/0000-0003-2418-0096	NIH [R01-GM101974]; UNC Cancer Research Fund; American Cancer Society postdoctoral fellowship [117571-PF-09-124-01-DDC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101974, R01GM074175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Cancer Research Fund; American Cancer Society postdoctoral fellowship(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to Magnuson lab members for critical comments, to Terry Furey and Darin London for DNase-Seq help, and to Victor Lobanenkov for kindly providing the CTCF antibody mixture. This work was supported by the NIH grant R01-GM101974 and UNC Cancer Research Fund. JMC was supported by the American Cancer Society postdoctoral fellowship 117571-PF-09-124-01-DDC.	Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chadwick BP, 2007, CHROMOSOMA, V116, P147, DOI 10.1007/s00412-006-0085-1; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Ciavatta D, 2006, P NATL ACAD SCI USA, V103, P9958, DOI 10.1073/pnas.0603754103; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Quinn J, 2006, METH MOLEC MED, V121, P125; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Song L, 2010, COLD SPRING HARB PRO, V2; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tattermusch A, 2011, HUM GENET, V130, P247, DOI 10.1007/s00439-011-1027-4; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Williams LH, 2011, DEVELOPMENT, V138, P2049, DOI 10.1242/dev.061176; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109	35	135	140	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					951	963		10.1016/j.cell.2012.10.037	http://dx.doi.org/10.1016/j.cell.2012.10.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178118	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000311423500010
J	Pencheva, N; Tran, H; Buss, C; Huh, D; Drobnjak, M; Busam, K; Tavazoie, SF				Pencheva, Nora; Tran, Hien; Buss, Colin; Huh, Doowon; Drobnjak, Marija; Busam, Klaus; Tavazoie, Sohail F.			Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis	CELL			English	Article							CANCER METASTASIS; TUMOR INVASION; MICRORNAS; GENE; SIGNATURES; SURVIVAL	Through in vivo selection of human cancer cell populations, we uncover a convergent and cooperative miRNA network that drives melanoma metastasis. We identify miR-1908, miR-199a-5p, and miR-199a-3p as endogenous promoters of metastatic invasion, angiogenesis, and colonization in melanoma. These miRNAs convergently target apolipoprotein E (ApoE) and the heat shock factor DNAJA4. Cancer-secreted ApoE suppresses invasion and metastatic endothelial recruitment (MER) by engaging melanoma cell LRP1 and endothelial cell LRP8 receptors, respectively, while DNAJA4 promotes ApoE expression. Expression levels of these miRNAs and ApoE correlate with human metastatic progression outcomes. Treatment of cells with locked nucleic acids (LNAs) targeting these miRNAs inhibits metastasis to multiple organs, and therapeutic delivery of these LNAs strongly suppresses melanoma metastasis. We thus identify miRNAs with dual cell-intrinsic/cell-extrinsic roles in cancer, reveal convergent cooperativity in a metastatic miRNA network, identify ApoE as an anti-angiogenic and metastasis-suppressive factor, and uncover multiple prognostic miRNAs with synergistic combinatorial therapeutic potential in melanoma.	[Pencheva, Nora; Tran, Hien; Buss, Colin; Huh, Doowon; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Drobnjak, Marija; Busam, Klaus] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu	Buss, Colin/I-5326-2014	Buss, Colin/0000-0001-7771-1685; Huh, Doowon/0000-0003-2722-0217; Drobnjak, Marija/0000-0003-0676-4709	Rita Allen foundation; Elizabeth foundation; Vincent Mayer foundation; DOD Era of Hope Scholar award; CTSA [5KL2 RR024142-04]; Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024142] Funding Source: NIH RePORTER	Rita Allen foundation; Elizabeth foundation; Vincent Mayer foundation; DOD Era of Hope Scholar award; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the members of our laboratory for thoughtful comments on previous versions of this manuscript and Masoud Tavazoie for insightful discussions regarding melanoma. ApoE null mice were generously provided by Jan Breslow. We thank Jordana Ray-Kirton for tremendous help with clinical sample procurement and Yves Marcel for kindly providing ApoE neutralization antibody. S.F.T. was supported by the Rita Allen and the Elizabeth and Vincent Mayer foundations and a DOD Era of Hope Scholar award. H.T. was partially supported by an NIH/NCRR clinical scholar and CTSA awards 5KL2 RR024142-04. This work was also generously supported by the Melanoma Research Alliance and the Melanoma Research Foundation. S.F.T. is a cofounder and shareholder of Rgenix and a member of its scientific advisory board.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Lucas R., 2006, ENV BURDEN DIS SERIE, V13; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; POLLACK VA, 1982, J NATL CANCER I, V69, P137; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6	28	259	277	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1068	1082		10.1016/j.cell.2012.10.028	http://dx.doi.org/10.1016/j.cell.2012.10.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23142051	Green Accepted, Bronze			2022-12-24	WOS:000311423500019
J	Paltiel, AD; Walensky, RP				Paltiel, A. David; Walensky, Rochelle P.			Home HIV Testing: Good News but Not a Game Changer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Management, New Haven, CT 06520 USA; Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA	Yale University; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Paltiel, AD (corresponding author), Yale Univ, Sch Publ Hlth, 60 Coll St,Room 305, New Haven, CT 06520 USA.	david.paltiel@yale.edu		Walensky, Rochelle P./0000-0002-8795-379X	NIAID NIH HHS [P30 AI060354, R37 AI042006, R37 AI42006] Funding Source: Medline; NIDA NIH HHS [R01 DA015612] Funding Source: Medline; NIMH NIH HHS [R01 MH065869, R01 MH65869] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042006, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Branson BM, 1998, JAMA-J AM MED ASSOC, V280, P1699, DOI 10.1001/jama.280.19.1699; McNeil DG, 2012, NY TIMES, pA1; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Paltiel AD, 2010, MED DECIS MAKING, V30, P217, DOI 10.1177/0272989X09334420; Sax PE, J WATCH BLOGS HIV ID; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; U.S. Food and Drug Administration, VACC BLOOD BIOL INF; Walensky RP, 2006, ANN INTERN MED, V145, P459, DOI 10.7326/0003-4819-145-6-200609190-00010	10	19	21	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					744	+		10.7326/0003-4819-157-10-201211200-00545	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00545			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043VZ	23044643	Green Accepted			2022-12-24	WOS:000311580000020
J	Elias, M; Wellner, A; Goldin-Azulay, K; Chabriere, E; Vorholt, JA; Erb, TJ; Tawfik, DS				Elias, Mikael; Wellner, Alon; Goldin-Azulay, Korina; Chabriere, Eric; Vorholt, Julia A.; Erb, Tobias J.; Tawfik, Dan S.			The molecular basis of phosphate discrimination in arsenate-rich environments	NATURE			English	Article							BETA-SEMIALDEHYDE DEHYDROGENASE; HYDROGEN-BONDS; ESCHERICHIA-COLI; TRANSPORT-SYSTEMS; ACTIVE-TRANSPORT; PROTEIN; SPECIFICITY; BACTERIA; RECEPTOR; GFAJ-1	Arsenate and phosphate are abundant on Earth and have striking similarities: nearly identical pK(a) values(1,2), similarly charged oxygen atoms, and thermochemical radii that differ by only 4% (ref. 3). Phosphate is indispensable and arsenate is toxic, but this extensive similarity raises the question whether arsenate may substitute for phosphate in certain niches(4,5). However, whether it is used or excluded, discriminating phosphate from arsenate is a paramount challenge. Enzymes that utilize phosphate, for example, have the same binding mode and kinetic parameters as arsenate, and the latter's presence therefore decouples metabolism(6,7). Can proteins discriminate between these two anions, and how would they do so? In particular, cellular phosphate uptake systems face a challenge in arsenate-rich environments. Here we describe a molecular mechanism for this process. We examined the periplasmic phosphate-binding proteins (PBPs) of the ABC-type transport system that mediates phosphate uptake into bacterial cells, including two PBPs from the arsenate-rich Mono Lake Halomonas strain GFAJ-1. All PBPs tested are capable of discriminating phosphate over arsenate at least 500-fold. The exception is one of the PBPs of GFAJ-1 that shows roughly 4,500-fold discrimination and its gene is highly expressed under phosphate-limiting conditions. Sub-angstrom-resolution structures of Pseudomonas fluorescens PBP with both arsenate and phosphate show a unique mode of binding that mediates discrimination. An extensive network of dipole-anion interactions(8,9), and of repulsive interactions, results in the 4% larger arsenate distorting a unique low-barrier hydrogen bond. These features enable the phosphate transport system to bind phosphate selectively over arsenate (at least 10(3) excess) even in highly arsenate-rich environments.	[Elias, Mikael; Wellner, Alon; Goldin-Azulay, Korina; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Chabriere, Eric] Univ Aix Marseille 2, CNRS, Fac Med & Pharm, Unite Rech Malad Infect & Trop Emergentes, F-13385 Marseille, France; [Vorholt, Julia A.; Erb, Tobias J.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Weizmann Institute of Science; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Swiss Federal Institutes of Technology Domain; ETH Zurich	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	mikael.elias@weizmann.ac.il; tawfik@weizmann.ac.il	Elias, Mikael/C-8484-2011; Erb, Tobias/J-5214-2013; Vorholt, Julia/K-3514-2016; Elias, Mikael/AAH-9385-2021	Elias, Mikael/0000-0003-0406-7539; Erb, Tobias/0000-0003-3685-0894; Vorholt, Julia/0000-0002-6011-4910; Elias, Mikael/0000-0003-0406-7539; WELLNER, ALON/0000-0001-5247-189X	Israel Science Foundation; Intra-European Fellowships Marie Curie program [252836]; Eidgenossische Technische Hochschule fellowship	Israel Science Foundation(Israel Science Foundation); Intra-European Fellowships Marie Curie program; Eidgenossische Technische Hochschule fellowship	We thank G. Gotthard for valuable inputs, C. Jelsch for help with the software Mopro, and A. Toth-Petroczy for help with the phylogenetic analysis. Financial support by the Israel Science Foundation is gratefully acknowledged. M. E. is a fellow supported by the Intra-European Fellowships Marie Curie program (grant No. 252836). D. S. T. is the Nella and Leon Benoziyo Professor of Biochemistry. T.J.E. was supported by an Eidgenossische Technische Hochschule fellowship.	Ahn S, 2007, FEBS LETT, V581, P3455, DOI 10.1016/j.febslet.2007.06.050; Butt AS, 2011, WORLD J MICROB BIOT, V27, P2435, DOI 10.1007/s11274-011-0716-4; Cleland WW, 2000, ARCH BIOCHEM BIOPHYS, V382, P1, DOI 10.1006/abbi.2000.2011; Dixon HBF, 1997, ADV INORG CHEM, V44, P191; Erb TJ, 2012, SCIENCE, V337, P467, DOI 10.1126/science.1218455; Faehnle CR, 2004, ACTA CRYSTALLOGR D, V60, P2320, DOI 10.1107/S0907444904026411; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim EE, 2012, CURR MED IMAGING REV, V8, P1; Kish MM, 1999, INORG CHEM, V38, P818, DOI 10.1021/ic981082j; KLINE PC, 1993, BIOCHEMISTRY-US, V32, P13212, DOI 10.1021/bi00211a033; Kohn RA, 1998, J ANIM SCI, V76, P1702; LARSEN EH, 1992, MIKROCHIM ACTA, V109, P47, DOI 10.1007/BF01243209; Ledvina PS, 1996, P NATL ACAD SCI USA, V93, P6786, DOI 10.1073/pnas.93.13.6786; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Liebschner D, 2009, J AM CHEM SOC, V131, P7879, DOI 10.1021/ja901900y; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Reaves ML, 2012, SCIENCE, V337, P470, DOI 10.1126/science.1219861; STEINER T, 1994, ACTA CRYSTALLOGR B, V50, P348, DOI 10.1107/S0108768193011966; Tanabe M, 2007, ACTA CRYSTALLOGR D, V63, P1185, DOI 10.1107/S0907444907048299; Tawfik DS, 2011, BIOCHEMISTRY-US, V50, P1128, DOI 10.1021/bi200002a; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; Wang ZM, 1997, NAT STRUCT BIOL, V4, P519, DOI 10.1038/nsb0797-519; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; WILLSKY GR, 1980, J BACTERIOL, V144, P366, DOI 10.1128/JB.144.1.366-374.1980; WILLSKY GR, 1980, J BACTERIOL, V144, P356, DOI 10.1128/JB.144.1.356-365.1980; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258	30	144	149	4	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					134	137		10.1038/nature11517	http://dx.doi.org/10.1038/nature11517			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23034649				2022-12-24	WOS:000310434500045
J	Mizuno, K; Miyabe, I; Schalbetter, SA; Carr, AM; Murray, JM				Mizuno, Ken'Ichi; Miyabe, Izumi; Schalbetter, Stephanie A.; Carr, Antony M.; Murray, Johanne M.			Recombination-restarted replication makes inverted chromosome fusions at inverted repeats	NATURE			English	Article							BREAK-INDUCED REPLICATION; GENOMIC REARRANGEMENTS; TEMPLATE EXCHANGE; RIBOSOMAL DNA; FRAGILE SITE; MECHANISMS; DISORDERS; REPAIR	Impediments to DNA replication are known to induce gross chromosomal rearrangements (GCRs) and copy-number variations (CNVs). GCRs and CNVs underlie human genomic disorders(1) and are a feature of cancer(2). During cancer development, environmental factors and oncogene-driven proliferation promote replication stress. Resulting GCRs and CNVs are proposed to contribute to cancer development and therapy resistance(3). When stress arrests replication, the replisome remains associated with the fork DNA(stalled fork) and is protected by the inter-S-phase checkpoint. Stalled forks efficiently resume when the stress is relieved. However, if the polymerases dissociate from the fork (fork collapse) or the fork structure breaks (broken fork), replication restart can proceed either by homologous recombination or microhomology-primed re-initiation(4,5). Here we ascertain the consequences of replication with a fork restarted by homologous recombination in fission yeast. We identify a new mechanism of chromosomal rearrangement through the observation that recombination-restarted forks have a considerably high propensity to execute a U-turn at small inverted repeats (up to 1 in 40 replication events). We propose that the error-prone nature of restarted forks contributes to the generation of GCRs and gene amplification in cancer, and to non-recurrent CNVs in genomic disorders.	[Mizuno, Ken'Ichi; Miyabe, Izumi; Schalbetter, Stephanie A.; Carr, Antony M.; Murray, Johanne M.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Carr, AM (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	a.m.carr@sussex.ac.uk	Miyabe, Izumi/K-7536-2017; Mizuno, Ken'Ichi/P-7350-2015	Miyabe, Izumi/0000-0002-4546-2837; Carr, Antony Michael/0000-0002-2028-2389; Mizuno, Ken'Ichi/0000-0001-8115-7808	Cancer Research UK (CRUK) [C9601/A9484]; Medical Research Council (MRC) [G0600233]; Biotechnology and Biological Sciences Research Council [BB/C510291/1] Funding Source: researchfish; Medical Research Council [G1100074, G0600233, G0500308] Funding Source: researchfish; Worldwide Cancer Research [10-0273] Funding Source: researchfish; MRC [G0600233, G1100074, G0500308] Funding Source: UKRI	Cancer Research UK (CRUK)(Cancer Research UK); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank E. Hoffman, J. Baxter, M. Neale and members of the Carr and Murray laboratories for discussions. J. M. M. acknowledges Cancer Research UK (CRUK) grant C9601/A9484: A. M. C. acknowledges Medical Research Council (MRC) grant G0600233.	Arlt MF, 2012, CURR OPIN GENET DEV, V22, P204, DOI 10.1016/j.gde.2012.01.009; Blow JJ, 2011, TRENDS BIOCHEM SCI, V36, P405, DOI 10.1016/j.tibs.2011.05.002; Blumrich A, 2011, HUM MOL GENET, V20, P1488, DOI 10.1093/hmg/ddr027; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Iraqui I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002976; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Ozeri-Galai E, 2011, MOL CELL, V43, P122, DOI 10.1016/j.molcel.2011.05.019; Pelliccia F, 2010, CANCER LETT, V299, P37, DOI 10.1016/j.canlet.2010.08.001; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; WILLIAMS WL, 1987, J MOL BIOL, V196, P743; Zuffardi O, 2009, CLIN GENET, V75, P505, DOI 10.1111/j.1399-0004.2009.01187.x	30	109	110	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					246	249		10.1038/nature11676	http://dx.doi.org/10.1038/nature11676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23178809	Green Accepted			2022-12-24	WOS:000313259600044
J	Shah, DI; Takahashi-Makise, N; Cooney, JD; Li, LT; Schultz, IJ; Pierce, EL; Narla, A; Seguin, A; Hattangadi, SM; Medlock, AE; Langer, NB; Dailey, TA; Hurst, SN; Faccenda, D; Wiwczar, JM; Heggers, SK; Vogin, G; Chen, W; Chen, CY; Campagna, DR; Brugnara, C; Zhou, Y; Ebert, BL; Danial, NN; Fleming, MD; Ward, DM; Campanella, M; Dailey, HA; Kaplan, J; Paw, BH				Shah, Dhvanit I.; Takahashi-Makise, Naoko; Cooney, Jeffrey D.; Li, Liangtao; Schultz, Iman J.; Pierce, Eric L.; Narla, Anupama; Seguin, Alexandra; Hattangadi, Shilpa M.; Medlock, Amy E.; Langer, Nathaniel B.; Dailey, Tamara A.; Hurst, Slater N.; Faccenda, Danilo; Wiwczar, Jessica M.; Heggers, Spencer K.; Vogin, Guillaume; Chen, Wen; Chen, Caiyong; Campagna, Dean R.; Brugnara, Carlo; Zhou, Yi; Ebert, Benjamin L.; Danial, Nika N.; Fleming, Mark D.; Ward, Diane M.; Campanella, Michelangelo; Dailey, Harry A.; Kaplan, Jerry; Paw, Barry H.			Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts	NATURE			English	Article							IRON-METABOLISM; ZEBRAFISH; YEAST; FERROCHELATASE; INHIBITOR; TRANSPORT; DEFECTS; PROTEIN; CYTOSOL; ANEMIA	Defects in the availability of haem substrates or the catalytic activity of the terminal enzyme in haem biosynthesis, ferrochelatase (Fech), impair haem synthesis and thus cause human congenital anaemias(1,2). The interdependent functions of regulators of mitochondrial homeostasis and enzymes responsible for haem synthesis are largely unknown. To investigate this we used zebrafish genetic screens and cloned mitochondrial ATPase inhibitory factor 1 (atpif1) from a zebrafish mutant with profound anaemia, pinotage (pnt (tq209)). Here we describe a direct mechanism establishing that Atpif1 regulates the catalytic efficiency of vertebrate Fech to synthesize haem. The loss of Atpif1 impairs haemoglobin synthesis in zebrafish, mouse and human haematopoietic models as a consequence of diminished Fech activity and elevated mitochondrial pH. To understand the relationship between mitochondrial pH, redox potential, [2Fe-2S] clusters and Fech activity, we used genetic complementation studies of Fech constructs with or without [2Fe-2S] clusters in pnt, as well as pharmacological agents modulating mitochondrial pH and redox potential. The presence of [2Fe-2S] cluster renders vertebrate Fech vulnerable to perturbations in Atpif1-regulated mitochondrial pH and redox potential. Therefore, Atpif1 deficiency reduces the efficiency of vertebrate Fech to synthesize haem, resulting in anaemia. The identification of mitochondrial Atpif1 as a regulator of haem synthesis advances our understanding of the mechanisms regulating mitochondrial haem homeostasis and red blood cell development. An ATPIF1 deficiency may contribute to important human diseases, such as congenital sideroblastic anaemias and mitochondriopathies.	[Shah, Dhvanit I.; Cooney, Jeffrey D.; Schultz, Iman J.; Pierce, Eric L.; Narla, Anupama; Langer, Nathaniel B.; Hurst, Slater N.; Heggers, Spencer K.; Vogin, Guillaume; Chen, Wen; Chen, Caiyong; Ebert, Benjamin L.; Paw, Barry H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA; [Takahashi-Makise, Naoko; Li, Liangtao; Seguin, Alexandra; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84312 USA; [Narla, Anupama; Hattangadi, Shilpa M.; Paw, Barry H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Med,Div Hematol Oncol, Boston, MA 02115 USA; [Hattangadi, Shilpa M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hattangadi, Shilpa M.] MIT, Cambridge, MA 02142 USA; [Medlock, Amy E.; Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Microbiol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Medlock, Amy E.; Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Biochem, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Medlock, Amy E.; Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Mol Biol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Faccenda, Danilo; Campanella, Michelangelo] Univ London Royal Vet Coll, London NW1 0TU, England; [Faccenda, Danilo; Campanella, Michelangelo] UCL, Consortium Mitochondrial Res, London NW1 0TU, England; [Wiwczar, Jessica M.; Danial, Nika N.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Campagna, Dean R.; Fleming, Mark D.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Brugnara, Carlo] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of London; University of London Royal Veterinary College; University of London; University College London; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Paw, BH (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA.	hdailey@uga.edu; jerry.kaplan@path.utah.edu; bpaw@rics.bwh.harvard.edu	; Campanella, Michelangelo/K-8172-2016	Fleming, Mark/0000-0003-0948-4024; Vogin, Guillaume/0000-0002-8114-5900; Faccenda, Danilo/0000-0003-2827-2529; Campanella, Michelangelo/0000-0002-6948-4184; Shah, Dhvanit/0000-0002-3173-2402; Paw, Barry/0000-0002-0492-1419; Medlock, Amy/0000-0001-9402-3593	Cooley's Anemia Foundation; March of Dimes Foundation; American Heart Association; Dutch National Science Fund; Fondation Soldati pour la Recherche en Cancerologie; Burroughs Welcome Fund; NIDDK; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072437, R01DK070838, R01DK052380, R01DK096051, R01DK087992, R56DK032303, K01DK085217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I013695/1] Funding Source: researchfish; BBSRC [BB/I013695/1] Funding Source: UKRI	Cooley's Anemia Foundation; March of Dimes Foundation(March of Dimes); American Heart Association(American Heart Association); Dutch National Science Fund; Fondation Soldati pour la Recherche en Cancerologie; Burroughs Welcome Fund(Burroughs Wellcome Fund); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank members of our laboratory (M. Cassim, A. Kaplan, G. Hildick-Smith and H. Anderson) and colleagues (S. L. Alper, K. Pepper and N. S. Trede) for critical review of the manuscript, T. C. Law for pnt adult blood characterization, H. Mulhern for help with the electron microscopy, and Christopher Lawrence and his team for the zebrafish husbandry. This research was supported in part by the Cooley's Anemia Foundation (D.I.S. and C.C.), the March of Dimes Foundation (B.H.P.), the American Heart Association (J.D.C. and A.E.M.), the Dutch National Science Fund (I.J.S.), the Fondation Soldati pour la Recherche en Cancerologie (G.V.), the Burroughs Welcome Fund (N.N.D.), the NIDDK (D.I.S., B.H.P., A.N., J.K., H.A.D. and S.M.H.) and the NHLBI (D.I.S. and B.H.P).	Anderson K. E., 2011, ONLINE METABOLIC MOL, P1; Ando C, 2008, J BIOCHEM, V144, P547, DOI 10.1093/jb/mvn100; Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lanzilotta W.N., 2011, HDB METALLOPROTEINS, V4, P138; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Medlock AE, 2000, BIOCHEMISTRY-US, V39, P7461, DOI 10.1021/bi000134p; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Ransom DG, 1996, DEVELOPMENT, V123, P311; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sheftel AD, 2009, ACTA HAEMATOL-BASEL, V122, P120, DOI 10.1159/000243796; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110	30	67	74	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					608	612		10.1038/nature11536	http://dx.doi.org/10.1038/nature11536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135403	Green Accepted, Green Submitted			2022-12-24	WOS:000311339800055
J	Knight, ZA; Tan, K; Birsoy, K; Schmidt, S; Garrison, JL; Wysocki, RW; Emiliano, A; Ekstrand, MI; Friedman, JM				Knight, Zachary A.; Tan, Keith; Birsoy, Kivanc; Schmidt, Sarah; Garrison, Jennifer L.; Wysocki, Robert W.; Emiliano, Ana; Ekstrand, Mats I.; Friedman, Jeffrey M.			Molecular Profiling of Activated Neurons by Phosphorylated Ribosome Capture	CELL			English	Article							CELL-TYPES; GENE-EXPRESSION; NERVOUS-SYSTEM; GLUCOSE-HOMEOSTASIS; OSMOTIC STIMULATION; SIGNALING PATHWAY; ARCUATE NUCLEUS; NEUROPEPTIDE-Y; MESSENGER-RNA; BODY-WEIGHT	The mammalian brain is composed of thousands of interacting neural cell types. Systematic approaches to establish the molecular identity of functional populations of neurons would advance our understanding of neural mechanisms controlling behavior. Here, we show that ribosomal protein S6, a structural component of the ribosome, becomes phosphorylated in neurons activated by a wide range of stimuli. We show that these phosphorylated ribosomes can be captured from mouse brain homogenates, thereby enriching directly for the mRNAs expressed in discrete subpopulations of activated cells. We use this approach to identify neurons in the hypothalamus regulated by changes in salt balance or food availability. We show that galanin neurons are activated by fasting and that prodynorphin neurons restrain food intake during scheduled feeding. These studies identify elements of the neural circuit that controls food intake and illustrate how the activity-dependent capture of cell-type-specific transcripts can elucidate the functional organization of a complex tissue.	[Knight, Zachary A.; Tan, Keith; Birsoy, Kivanc; Schmidt, Sarah; Garrison, Jennifer L.; Wysocki, Robert W.; Emiliano, Ana; Ekstrand, Mats I.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Genet, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Knight, ZA (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Genet, 1230 York Ave, New York, NY 10021 USA.	zachary.knight@ucsf.edu; friedj@rockefeller.edu		Knight, Zachary/0000-0001-7621-1478; Ekstrand, Mats/0000-0003-0019-9462; Wysocki, Robert/0000-0001-9812-6071	JPB Foundation; NIH [DK083531]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK083531, R00DK083531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654] Funding Source: NIH RePORTER	JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by funding from the JPB Foundation (J.M.F.) and NIH grant DK083531 (Z.A.K.). The authors have filed a patent related to this work. Dr. Friedman is a Founder of Envoy Therapeutics and holds equity in it and receives a retainer from the company. Envoy holds an option to license this technology from the Rockefeller University.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; BROWN MR, 1988, BRAIN RES, V452, P212, DOI 10.1016/0006-8993(88)90025-X; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Carroll I, 2004, EUR J PHARMACOL, V501, P111, DOI 10.1016/j.ejphar.2004.08.028; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Mateos-Verchere JG, 2001, EUR J PHARMACOL, V414, P225; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; GAI WP, 1990, J COMP NEUROL, V298, P265, DOI 10.1002/cne.902980302; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hahm S, 2002, J NEUROSCI, V22, P6929; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Ivanova EA, 2008, AM J PHYSIOL-ENDOC M, V294, pE176, DOI 10.1152/ajpendo.00199.2007; Koch C., 2001, INT ENCY SOCIAL BEHA, P2600; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Koike K, 1997, MOL BRAIN RES, V52, P326, DOI 10.1016/S0169-328X(97)00300-8; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Porter JP, 2004, AM J PHYSIOL-REG I, V287, pR422, DOI 10.1152/ajpregu.00537.2003; Reaux-Le Goazigo A, 2011, AM J PHYSIOL-ENDOC M, V301, pE955, DOI 10.1152/ajpendo.00090.2011; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; SCHWARTZ MW, 1993, BRAIN RES BULL, V31, P361, DOI 10.1016/0361-9230(93)90228-4; SHERMAN TG, 1986, NEUROENDOCRINOLOGY, V44, P222, DOI 10.1159/000124649; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Sunn N, 2002, P NATL ACAD SCI USA, V99, P1701, DOI 10.1073/pnas.022647699; THORNTON SN, 1995, J NEUROENDOCRINOL, V7, P165, DOI 10.1111/j.1365-2826.1995.tb00743.x; Valjent E, 2011, NEUROPSYCHOPHARMACOL, V36, P2561, DOI 10.1038/npp.2011.144; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P384, DOI 10.1016/j.euroneuro.2010.06.005; Villanueva EC, 2009, ENDOCRINOLOGY, V150, P4541, DOI 10.1210/en.2009-0642; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhou D, 2005, REGUL PEPTIDES, V124, P53, DOI 10.1016/j.regpep.2004.06.026	49	187	190	0	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					1126	1137		10.1016/j.cell.2012.10.039	http://dx.doi.org/10.1016/j.cell.2012.10.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178128	Green Accepted, Bronze			2022-12-24	WOS:000311423500023
J	Soufi, A; Donahue, G; Zaret, KS				Soufi, Abdenour; Donahue, Greg; Zaret, Kenneth S.			Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the Genome	CELL			English	Article							EMBRYONIC STEM-CELLS; HUMAN SOMATIC-CELLS; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; HUMAN FIBROBLASTS; IN-VITRO; GENERATION; CHROMATIN; DNA; EXPRESSION	The ectopic expression of transcription factors can reprogram cell fate, yet it is unknown how the initial binding of factors to the genome relates functionally to the binding seen in the minority of cells that become reprogrammed. We report a map of Oct4, Sox2, Klf4, and c-Myc (O, S, K, and M) on the human genome during the first 48 hr of reprogramming fibroblasts to pluripotency. Three striking aspects of the initial chromatin binding events include an unexpected role for c-Myc in facilitating OSK chromatin engagement, the primacy of O, S, and K as pioneer factors at enhancers of genes that promote reprogramming, and megabase-scale chromatin domains spanned by H3K9me3, including many genes required for pluripotency, that prevent initial OSKM binding and impede the efficiency of reprogramming. We find diverse aspects of initial factor binding that must be overcome in the minority of cells that become reprogrammed.	[Soufi, Abdenour; Donahue, Greg; Zaret, Kenneth S.] Univ Penn, Dept Cell & Dev Biol, Smilow Ctr Translat Res, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Zaret, KS (corresponding author), Univ Penn, Dept Cell & Dev Biol, Smilow Ctr Translat Res, Perelman Sch Med, Bldg 421,Rooms 131-132,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zaret@upenn.edu		Soufi, Abdenour/0000-0002-3666-3266	NIH [R37GM36477, P01GM099134]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036477, P01GM099134, R01GM036477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kim for iPS reagents; G. Blobel, K. Blahnik, J. Caravaca, M. Iwafuchi-Doi, and J. Kim for comments on the manuscript; and K. Kaestner and J. Schug for sequencing by the UPenn Diabetes Research Center Functional Genomics Gore (P30-DK19525). The work was supported by NIH grants R37GM36477 and P01GM099134 to K.S.Z.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024351; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	567	584	5	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					994	1004		10.1016/j.cell.2012.09.045	http://dx.doi.org/10.1016/j.cell.2012.09.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23159369	Green Accepted, Bronze			2022-12-24	WOS:000311423500013
J	Rando, OJ				Rando, Oliver J.			Daddy Issues: Paternal Effects on Phenotype	CELL			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; MOUSE; TRANSMISSION; ARABIDOPSIS; METHYLATION; MECHANISMS; RESPONSES; DYNAMICS	The once popular and then heretical idea that ancestral environment can affect the phenotype of future generations is coming back into vogue due to advances in the field of epigenetic inheritance. How paternal environmental conditions influence the phenotype of progeny is now a tractable question, and researchers are exploring potential mechanisms underlying such effects.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu		Rando, Oliver/0000-0003-1516-9397	NIGMS; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033664] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Thanks to N. Francis, M. Walhout, J. Shea, M. Vallaster, M. Garber, H. Florman, and B. Carone for critical reading of early drafts of this manuscript. I apologize to the many authors of relevant work left uncited due to space constraints. This work was supported by NIGMS and by the G. Harold and Leila Y. Mathers Foundation.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Avital Eytan, 2000, ANIMAL TRADITIONS BE, DOI 10-1017/CBO9780511542251; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chason RJ, 2011, TRENDS ENDOCRIN MET, V22, P412, DOI 10.1016/j.tem.2011.05.005; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nelson VR, 2010, EPIGENOMICS-UK, V2, P513, DOI 10.2217/EPI.10.26; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ooi SL, 2007, CURR OPIN CELL BIOL, V19, P257, DOI 10.1016/j.ceb.2007.04.015; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rassoulzadegan M, 2010, ORGANOGENESIS, V6, P33, DOI 10.4161/org.6.1.11094; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; van Montfoort APA, 2012, HUM REPROD UPDATE, V18, P171, DOI 10.1093/humupd/dmr047; von Horsten HH, 2007, J BIOL CHEM, V282, P32912, DOI 10.1074/jbc.M703956200; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	48	192	198	1	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					702	708		10.1016/j.cell.2012.10.020	http://dx.doi.org/10.1016/j.cell.2012.10.020			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141533	Bronze, Green Accepted			2022-12-24	WOS:000310921200004
J	Upton, JP; Wang, LK; Han, D; Wang, ES; Huskey, NE; Lim, L; Truitt, M; McManus, MT; Ruggero, D; Goga, A; Papa, FR; Oakes, SA				Upton, John-Paul; Wang, Likun; Han, Dan; Wang, Eric S.; Huskey, Noelle E.; Lim, Lionel; Truitt, Morgan; McManus, Michael T.; Ruggero, Davide; Goga, Andrei; Papa, Feroz R.; Oakes, Scott A.			IRE1 alpha Cleaves Select microRNAs During ER Stress to Derepress Translation of Proapoptotic Caspase-2	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; CELL-DEATH; PROTEIN; APOPTOSIS; REQUIRES; PATHWAY	The endoplasmic reticulum (ER) is the primary organelle for folding and maturation of secretory and transmembrane proteins. Inability tomeet protein-folding demand leads to "ER stress," and activates IRE1 alpha, an ER transmembrane kinase-endoribonuclease (RNase). IRE1 alpha promotes adaptation through splicing Xbp1 mRNA or apoptosis through incompletely understood mechanisms. Here, we found that sustained IRE1 alpha RNase activation caused rapid decay of select microRNAs (miRs -17, -34a, -96, and -125b) that normally repress translation of Caspase-2 mRNA, and thus sharply elevates protein levels of this initiator protease of the mitochondrial apoptotic pathway. In cell-free systems, recombinant IRE1 alpha endonucleolytically cleaved microRNA precursors at sites distinct from DICER. Thus, IRE1 alpha regulates translation of a proapoptotic protein through terminating microRNA biogenesis, and noncoding RNAs are part of the ER stress response.	[Wang, Likun; Han, Dan; Huskey, Noelle E.; Lim, Lionel; Goga, Andrei; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Upton, John-Paul; Wang, Eric S.; Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Truitt, Morgan; Ruggero, Davide] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [McManus, Michael T.; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Wang, Likun; Han, Dan; McManus, Michael T.] Univ Calif San Francisco, Keck Ctr Noncoding RNAs, San Francisco, CA 94143 USA; [Upton, John-Paul; Huskey, Noelle E.; Lim, Lionel; Truitt, Morgan; Papa, Feroz R.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Wang, Likun; Han, Dan; Ruggero, Davide; Goga, Andrei; Oakes, Scott A.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu; scott.oakes@ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Papa, Feroz/0000-0002-3684-9108	NIH [DP2OD001925, R01CA136577, R01CA136717, R01DK080955, R01CA154916, GM080783, DK063720, R01CA140456]; Leukemia & Lymphoma Society Scholar Award; Howard Hughes Medical Institute Physician-Scientist Early Career Award; American Cancer Society Research Scholar Award; Burroughs Wellcome Foundation; Hillblom Foundation; Juvenile Diabetes Research Foundation; Partnership for Cures; National Science Foundation; Susan G. Komen Foundation; A*STAR Fellowship; NATIONAL CANCER INSTITUTE [R01CA154916, R01CA136717, R01CA136577, R01CA140456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080955, P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); American Cancer Society Research Scholar Award(American Cancer Society); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Hillblom Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Partnership for Cures; National Science Foundation(National Science Foundation (NSF)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); A*STAR Fellowship(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Kaufman for Atf6a<SUP>-/-</SUP> MEFs and D. Ron for Perk<SUP>-/-</SUP> and Ire1 alpha<SUP>-/-</SUP> MEFs. The work was supported by NIH: DP2OD001925 (F.R.P), R01CA136577 (S.A.O.), R01CA136717 (A.G.), R01DK080955 (F.R.P), R01CA154916 (D.R.), GM080783 (M.T.M.), DK063720 (M.T.M.), and R01CA140456 (D.R.); Leukemia & Lymphoma Society Scholar Award (D.R.); Howard Hughes Medical Institute Physician-Scientist Early Career Award (S.A.O.); American Cancer Society Research Scholar Award (S.A.O.); Burroughs Wellcome Foundation (F.R.P.); Hillblom Foundation (F.R.P.); Juvenile Diabetes Research Foundation (F.R.P); Partnership for Cures (F.R.P); National Science Foundation (E.S.W.); Susan G. Komen Foundation (A.G.); and an A*STAR Fellowship (L.L.). J-P.U., L.W., D.H., E.S.W., N.H., and M.T. designed and performed experiments and contributed to the manuscript. L.L., M.T.M., D.R., and A.G. contributed key ideas, reagents, and data interpretation. F.R.P. and S.A.O. designed the study and wrote the manuscript. There are no conflicts of interest.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reyes NA, 2010, J CLIN INVEST, V120, P3673, DOI 10.1172/JCI42986; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	24	445	461	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2012	338	6108					818	822		10.1126/science.1226191	http://dx.doi.org/10.1126/science.1226191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23042294	Green Accepted			2022-12-24	WOS:000310839500050
J	Breen, MS; Kemena, C; Vlasov, PK; Notredame, C; Kondrashov, FA				Breen, Michael S.; Kemena, Carsten; Vlasov, Peter K.; Notredame, Cedric; Kondrashov, Fyodor A.			Epistasis as the primary factor in molecular evolution	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPENSATORY EVOLUTION; ADAPTIVE EVOLUTION; PROTEIN EVOLUTION; NATURAL-SELECTION; GENETIC-VARIATION; PERSPECTIVE; DROSOPHILA; MUTATIONS; LANDSCAPE	The main forces directing long-term molecular evolution remain obscure. A sizable fraction of amino-acid substitutions seem to be fixed by positive selection(1-4), but it is unclear to what degree long-term protein evolution is constrained by epistasis, that is, instances when substitutions that are accepted in one genotype are deleterious in another. Here we obtain a quantitative estimate of the prevalence of epistasis in long-term protein evolution by relating data on amino-acid usage in 14 organelle proteins and 2 nuclear-encoded proteins to their rates of short-term evolution. We studied multiple alignments of at least 1,000 orthologues for each of these 16 proteins from species from a diverse phylogenetic background and found that an average site contained approximately eight different amino acids. Thus, without epistasis an average site should accept two-fifths of all possible amino acids, and the average rate of amino-acid substitutions should therefore be about three-fifths lower than the rate of neutral evolution. However, we found that the measured rate of amino-acid substitution in recent evolution is 20 times lower than the rate of neutral evolution and an order of magnitude lower than that expected in the absence of epistasis. These data indicate that epistasis is pervasive throughout protein evolution: about 90 per cent of all amino-acid substitutions have a neutral or beneficial impact only in the genetic backgrounds in which they occur, and must therefore be deleterious in a different background of other species. Our findings show that most amino-acid substitutions have different fitness effects in different species and that epistasis provides the primary conceptual framework to describe the tempo and mode of long-term protein evolution.	[Breen, Michael S.; Kemena, Carsten; Vlasov, Peter K.; Notredame, Cedric; Kondrashov, Fyodor A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain; [Breen, Michael S.; Kemena, Carsten; Vlasov, Peter K.; Notredame, Cedric; Kondrashov, Fyodor A.] Univ Pompeu Fabra, Barcelona 08003, Spain; [Kondrashov, Fyodor A.] 23 Passeig Lluis Co, ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Kondrashov, FA (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Programme, 88 Dr Aiguader, Barcelona 08003, Spain.	fyodor.kondrashov@crg.es	Vlasov, Peter/O-6392-2015; Kondrashov, Fyodor Alexeevich/H-6331-2015; notredame, cedric/G-3868-2010	Vlasov, Peter/0000-0003-0489-4200; Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Kemena, Carsten/0000-0002-2416-9842; notredame, cedric/0000-0003-1461-0988	Spanish Ministry of Science and Innovation; European Union [KBBE2A222664]; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); ICREA(ICREA)	The work was supported by Plan Nacional grants from the Spanish Ministry of Science and Innovation, to F.A.K. and C.N. C.K. was supported by the European Union FP7 project Quantomics (KBBE2A222664). F.A.K. is a European Molecular Biology Organization Young Investigator and Howard Hughes Medical Institute International Early Career Scientist. We thank B. Lehner and T. Warnecke for input and a critical reading of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Costanzo MS, 2011, J GENET, V90, P187, DOI 10.1007/s12041-011-0072-z; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Visser JAGM, 2011, P ROY SOC B-BIOL SCI, V278, P3617, DOI 10.1098/rspb.2011.1537; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; GILLESPIE JH, 1986, MOL BIOL EVOL, V3, P138; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Li W. H., 1997, MOL EVOLUTION, P419; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meer MV, 2010, NATURE, V464, P279, DOI 10.1038/nature08691; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Poelwijk FJ, 2011, CELL, V146, P462, DOI 10.1016/j.cell.2011.06.035; Poon AFY, 2006, EVOLUTION, V60, P2032, DOI 10.1111/j.0014-3820.2006.tb01841.x; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva RF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002181; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Weinreich DM, 2005, EVOLUTION, V59, P1165; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	237	244	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					535	+		10.1038/nature11510	http://dx.doi.org/10.1038/nature11510			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23064225				2022-12-24	WOS:000310196200041
J	Li, W; Shuai, L; Wan, HF; Dong, MZ; Wang, M; Sang, LS; Feng, CJ; Luo, GZ; Li, TD; Li, X; Wang, LB; Zheng, QY; Sheng, C; Wu, HJ; Liu, ZH; Liu, L; Wang, L; Wang, XJ; Zhao, XY; Zhou, Q				Li, Wei; Shuai, Ling; Wan, Haifeng; Dong, Mingzhu; Wang, Meng; Sang, Lisi; Feng, Chunjing; Luo, Guan-Zheng; Li, Tianda; Li, Xin; Wang, Libin; Zheng, Qin-Yuan; Sheng, Chao; Wu, Hua-Jun; Liu, Zhonghua; Liu, Lei; Wang, Liu; Wang, Xiu-Jie; Zhao, Xiao-Yang; Zhou, Qi			Androgenetic haploid embryonic stem cells produce live transgenic mice	NATURE			English	Article							MOUSE EMBRYOS; GENERATION; EMBRYOGENESIS; PLURIPOTENT; DERIVATION; OOCYTES; GENOME; EXPRESSION; INJECTION; DEVELOP	Haploids and double haploids are important resources for studying recessive traits and have large impacts on crop breeding(1), but natural haploids are rare in animals. Mammalian haploids are restricted to germline cells and are occasionally found in tumours with massive chromosome loss(2,3). Recent success in establishing haploid embryonic stem (ES) cells in medaka fish(4) and mice(5,6) raised the possibility of using engineered mammalian haploid cells in genetic studies. However, the availability and functional characterization of mammalian haploid ES cells are still limited. Here we show that mouse androgenetic haploid ES (ahES) cell lines can be established by transferring sperm into an enucleated oocyte. The ahES cells maintain haploidy and stable growth over 30 passages, express pluripotent markers, possess the ability to differentiate into all three germ layers in vitro and in vivo, and contribute to germlines of chimaeras when injected into blastocysts. Although epigenetically distinct from sperm cells, the ahES cells can produce viable and fertile progenies after intracytoplasmic injection into mature oocytes. The oocyte-injection procedure can also produce viable transgenic mice from genetically engineered ahES cells. Our findings show the developmental pluripotency of androgenentic haploids and provide a new tool to quickly produce genetic models for recessive traits. They may also shed new light on assisted reproduction.	[Li, Wei; Shuai, Ling; Wan, Haifeng; Dong, Mingzhu; Sang, Lisi; Feng, Chunjing; Li, Tianda; Li, Xin; Wang, Libin; Zheng, Qin-Yuan; Sheng, Chao; Liu, Lei; Wang, Liu; Zhao, Xiao-Yang; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Li, Wei; Wan, Haifeng; Dong, Mingzhu; Sang, Lisi; Feng, Chunjing; Wang, Libin; Zheng, Qin-Yuan; Wu, Hua-Jun] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Shuai, Ling; Li, Tianda; Li, Xin; Sheng, Chao; Liu, Zhonghua] NE Agr Univ China, Coll Life Sci, Harbin 150030, Peoples R China; [Wang, Meng; Luo, Guan-Zheng; Wu, Hua-Jun; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol Syst Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhou, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	xyzhao@ioz.ac.cn; qzhou@ioz.ac.cn	Liu, Zhunghua/F-2485-2010; Wang, Xiu-Jie/L-1312-2019	Liu, Zhunghua/0000-0002-9199-6493; Shuai, Ling/0000-0003-0671-7478; ZHAO, Xiao-Yang/0000-0003-2544-8293	National Science Foundation of China [90919060]; China National Basic Research Program [2012CBA01300]; Chinese Academy of Sciences [XDA01020100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank all members of the Group of Reproductive Engineering for discussion and help. This study was supported by a grant from the National Science Foundation of China 90919060 (to Q.Z.) and the China National Basic Research Program 2012CBA01300 (to Q.Z.), and a grant from the Strategic Priority Research Program of the Chinese Academy of Sciences XDA01020100 (to Q.Z.). We thank Fluidigm Corporation for their support in the utilization of BioMark HD system. We thank Eppendorf and Leica for supporting the facility.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Germana MA, 2011, PLANT CELL REP, V30, P839, DOI 10.1007/s00299-011-1061-7; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Loren J, 2006, REPRODUCTION, V131, P259, DOI 10.1530/rep.1.00894; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; Maruotti J, 2010, STEM CELLS, V28, P743, DOI 10.1002/stem.400; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; TARKOWSKI AK, 1977, J EMBRYOL EXP MORPH, V38, P187; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhao XY, 2010, STEM CELL REV REP, V6, P390, DOI 10.1007/s12015-010-9160-3; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	31	127	157	3	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					407	+		10.1038/nature11435	http://dx.doi.org/10.1038/nature11435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23023130				2022-12-24	WOS:000309918500047
J	Du, JM; Zhong, XH; Bernatavichute, YV; Stroud, H; Feng, SH; Caro, E; Vashisht, AA; Terragni, J; Chin, HG; Tu, A; Hetzel, J; Wohlschlegel, JA; Pradhan, S; Patel, DJ; Jacobsen, SE				Du, Jiamu; Zhong, Xuehua; Bernatavichute, Yana V.; Stroud, Hume; Feng, Suhua; Caro, Elena; Vashisht, Ajay A.; Terragni, Jolyon; Chin, Hang Gyeong; Tu, Andy; Hetzel, Jonathan; Wohlschlegel, James A.; Pradhan, Sriharsa; Patel, Dinshaw J.; Jacobsen, Steven E.			Dual Binding of Chromomethylase Domains to H3K9me2-Containing Nucleosomes Directs DNA Methylation in Plants	CELL			English	Article							HISTONE H3; STRUCTURAL BASIS; BAH DOMAIN; ARABIDOPSIS; RECOGNITION; MAINTENANCE; UHRF1; DIMETHYLATION; SPECIFICITY; MECHANISM	DNA methylation and histone modification exert epigenetic control over gene expression. CHG methylation by CHROMOMETHYLASE3 (CMT3) depends on histone H3K9 dimethylation (H3K9me2), but the mechanism underlying this relationship is poorly understood. Here, we report multiple lines of evidence that CMT3 interacts with H3K9me2-containing nucleosomes. CMT3 genome locations nearly perfectly correlated with H3K9me2, and CMT3 stably associated with H3K9me2-containing nucleosomes. Crystal structures of maize CMT3 homolog ZMET2, in complex with H3K9me2 peptides, showed that ZMET2 binds H3K9me2 via both bromo adjacent homology (BAH) and chromo domains. The structures reveal an aromatic cage within both BAH and chromo domains as interaction interfaces that capture H3K9me2. Mutations that abolish either interaction disrupt CMT3 binding to nucleosomes and show a complete loss of CMT3 activity in vivo. Our study establishes dual recognition of H3K9me2 marks by BAH and chromo domains and reveals a distinct mechanism of interplay between DNA methylation and histone modification.	[Du, Jiamu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Zhong, Xuehua; Bernatavichute, Yana V.; Stroud, Hume; Feng, Suhua; Caro, Elena; Tu, Andy; Hetzel, Jonathan; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Terragni, Jolyon; Chin, Hang Gyeong; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA	Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New England Biolabs	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; jacobsen@ucla.edu	Du, Jiamu/I-1334-2013; Stroud, Hume/ABF-1325-2021; Du, Jiamu/G-3308-2010; Caro, Elena/G-6352-2012; Caro, Elena/D-2611-2014	Du, Jiamu/0000-0002-1337-0786; Caro, Elena/0000-0002-1034-1621	Ruth L. Kirschstein National Research Service Award [F32GM096483-01]; Leukemia & Lymphoma Society; Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH [GM089778, GM60398]; UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096483, R37GM060398, R01GM060398, R01GM089778] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Jonsson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anders Lindroth and Debasis Patnak for initiating CMT3 in vitro activity assays, staff members at APS for support in diffraction data collection and at UCLA BSCRC BioSequencing core for high-throughput sequencing, and Nathan Springer and Shawn Kaeppler for providing ZMET2 gene. We are also grateful to Lianna Johnson for help with histone peptide array experiments, Greg Horwitz for help with baculoviral protein expression, and their critical reading of this manuscript. X.Z. is supported by Ruth L. Kirschstein National Research Service Award (F32GM096483-01). S.F. is supported by Leukemia & Lymphoma Society. This work was supported by the Abby Rockefeller Mauze Trust and the Maloris and STARR foundations to D.J.P., NIH grant GM089778 and the UCLA Jonsson Cancer Center to J.A.W., and NIH grant GM60398 to S.E.J. S.E.J. is an Investigator at the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Bartee L, 2001, NUCLEIC ACIDS RES, V29, P2127, DOI 10.1093/nar/29.10.2127; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chang YQ, 2011, J MOL BIOL, V408, P807, DOI 10.1016/j.jmb.2011.03.018; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Okada T, 2005, PLANT J, V44, P557, DOI 10.1111/j.1365-313X.2005.02554.x; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papa CM, 2001, PLANT CELL, V13, P1919, DOI 10.1105/tpc.13.8.1919; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rajakumara E, 2011, GENE DEV, V25, P137, DOI 10.1101/gad.1980311; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012	41	309	318	2	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					167	180		10.1016/j.cell.2012.07.034	http://dx.doi.org/10.1016/j.cell.2012.07.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021223	Bronze, Green Accepted			2022-12-24	WOS:000309544200018
J	Geu-Flores, F; Sherden, NH; Courdavault, V; Burlat, V; Glenn, WS; Wu, C; Nims, E; Cui, YH; O'Connor, SE				Geu-Flores, Fernando; Sherden, Nathaniel H.; Courdavault, Vincent; Burlat, Vincent; Glenn, Weslee S.; Wu, Cen; Nims, Ezekiel; Cui, Yuehua; O'Connor, Sarah E.			An alternative route to cyclic terpenes by reductive cyclization in iridoid biosynthesis	NATURE			English	Article							IRIDANE SKELETON FORMATION; PROGESTERONE 5-BETA-REDUCTASE; CATHARANTHUS-ROSEUS; ALKALOID BIOSYNTHESIS; METABOLISM; MECHANISM; GENES; SECOIRIDOIDS; VINDOLINE; P5-BETA-R	The iridoids comprise a large family of distinctive bicyclic monoterpenes that possess a wide range of pharmacological activities, including anticancer, anti-inflammatory, antifungal and antibacterial activities(1-4). Additionally, certain iridoids are used as sex pheromones in agriculturally important species of aphids, a fact that has underpinned innovative and integrated pest management strategies(5). To harness the biotechnological potential of this natural product class, the enzymes involved in the biosynthetic pathway must be elucidated. Here we report the discovery of iridoid synthase, a plant-derived enzyme that generates the iridoid ring scaffold, as evidenced by biochemical assays, gene silencing, co-expression analysis and localization studies. In contrast to all known monoterpene cyclases, which use geranyl diphosphate as substrate and invoke a cationic intermediate, iridoid synthase uses the linear monoterpene 10-oxogeranial as substrate and probably couples an initial NAD(P) H-dependent reduction step with a subsequent cyclization step via a Diels-Alder cycloaddition or a Michael addition. Our results illustrate how a short-chain reductase was recruited as cyclase for the production of iridoids in medicinal plants. Furthermore, we highlight the prospects of using unrelated reductases to generate artificial cyclic scaffolds. Beyond the recognition of an alternative biochemical mechanism for the biosynthesis of cyclic terpenes, we anticipate that our work will enable the large-scale heterologous production of iridoids in plants and microorganisms for agricultural(5-8) and pharmaceutical(1-4,9) applications.	[Geu-Flores, Fernando; Sherden, Nathaniel H.; Glenn, Weslee S.; O'Connor, Sarah E.] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Courdavault, Vincent] Univ Tours, Biomol & Biotechnol Vegetales EA2106, F-37200 Tours, France; [Burlat, Vincent] Univ Toulouse, UPS, UMR 5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Burlat, Vincent] CNRS, UMR 5546, F-31326 Castanet Tolosan, France; [Glenn, Weslee S.; Nims, Ezekiel] MIT, Dept Chem, Cambridge, MA 02139 USA; [Wu, Cen; Cui, Yuehua] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [O'Connor, Sarah E.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Massachusetts Institute of Technology (MIT); Michigan State University; University of East Anglia	O'Connor, SE (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	sarah.o'connor@jic.ac.uk	Cui, Yuehua/E-8004-2010; burlat, vincent/ABB-1802-2021; Courdavault, Vincent/AAK-1117-2020; O'Connor, Sarah Ellen/X-2893-2019; burlat, vincent/J-6831-2015; Cui, Yuehua/A-3529-2008; Geu-Flores, Fernando/B-2737-2015; O'Connor, Sarah/O-5850-2016	Cui, Yuehua/0000-0001-8099-1753; burlat, vincent/0000-0002-0897-6011; burlat, vincent/0000-0002-0897-6011; Cui, Yuehua/0000-0001-8099-1753; Geu-Flores, Fernando/0000-0002-5735-9810; O'Connor, Sarah/0000-0003-0356-6213; Courdavault, Vincent/0000-0001-8902-4532	Danish Council for Independent Research (Natural Sciences) [10-082858]; NIH [GM074820]; John Innes Foundation; National Science Foundation; NSF [DMS-1209112]; John Innes Centre; University of East Anglia;  [j004561SRC (BB/J004561/1)];  [BB/J009091/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074820] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J009091/1] Funding Source: researchfish; BBSRC [BB/J009091/1] Funding Source: UKRI	Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Innes Foundation; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); John Innes Centre; University of East Anglia; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The present study was funded by the Danish Council for Independent Research (Natural Sciences) through Postdoctoral Fellowship 10-082858 granted to F.G.-F. Additional funding was received from the NIH (GM074820), the j004561SRC (BB/J004561/1 and BB/J009091/1) and the John Innes Foundation. This work was conducted under Defra Plant Health Licence PHSI 449/6612(07/2011). W. S. G. gratefully acknowledges a National Science Foundation Predoctoral Fellowship. Y.C. would like to thank the NSF for grant DMS-1209112. K. R. Chauhan is acknowledged for providing initial nepetalactol samples. We thank S. Fairhurst, L. Hill and A. Jones for NMR, LC-MS and GC-MS assistance, respectively. J. Ward and N. Hawkins are acknowledged for the GC-MS-based high-resolution mass spectra (HRMS) of synthesized compounds. R. Buell and E. Gongora-Castillo provided many helpful discussions on the transcriptome data. The purified EasA protein was provided J. Z. Cheng, to whom we are deeply indebted. S.E.O. receives salary support through a synergy initiative between the John Innes Centre and the University of East Anglia.	Bauer P, 2010, PHYTOCHEMISTRY, V71, P1495, DOI 10.1016/j.phytochem.2010.06.004; Burlat V, 2004, PLANT J, V38, P131, DOI 10.1111/j.1365-313X.2004.02030.x; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cheng JZ, 2010, J AM CHEM SOC, V132, P1776, DOI 10.1021/ja910193p; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dewhirst SY, 2010, VITAM HORM, V83, P551, DOI 10.1016/S0083-6729(10)83022-5; Dinda B, 2007, CHEM PHARM BULL, V55, P689, DOI 10.1248/cpb.55.689; Dinda B, 2011, CHEM PHARM BULL, V59, P803, DOI 10.1248/cpb.59.803; Dinda B, 2009, CHEM PHARM BULL, V57, P765, DOI 10.1248/cpb.57.765; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Gavidia I, 2007, PHYTOCHEMISTRY, V68, P853, DOI 10.1016/j.phytochem.2006.11.019; Giddings LA, 2011, J BIOL CHEM, V286, P16751, DOI 10.1074/jbc.M111.225383; Gongora-Castillo E, 2012, METHOD ENZYMOL, V517, P139, DOI 10.1016/B978-0-12-404634-4.00007-3; Guirimand G, 2011, J PLANT PHYSIOL, V168, P549, DOI 10.1016/j.jplph.2010.08.018; Guirimand G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-182; Guirimand G, 2009, PLANT CELL REP, V28, P1215, DOI 10.1007/s00299-009-0722-2; INOUYE H, 1978, PLANTA MED, V33, P193, DOI 10.1055/s-0028-1097377; Kim HJ, 2012, CURR OPIN CHEM BIOL, V16, P124, DOI 10.1016/j.cbpa.2011.12.017; Liblikas I, 2005, J NAT PROD, V68, P886, DOI 10.1021/np049647d; Liscombe DK, 2011, PHYTOCHEMISTRY, V72, P1969, DOI 10.1016/j.phytochem.2011.07.001; Mahroug S, 2006, PLANTA, V223, P1191, DOI 10.1007/s00425-005-0167-y; McElvain SM, 1942, J AM CHEM SOC, V64, P1828, DOI 10.1021/ja01260a025; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; Oudin A, 2007, PLANT MOL BIOL, V65, P13, DOI 10.1007/s11103-007-9190-7; Soe ARB, 2004, ISOT ENVIRON HEALT S, V40, P175, DOI 10.1080/10256010410001674994; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Tundis R, 2008, MINI-REV MED CHEM, V8, P399, DOI 10.2174/138955708783955926; UESATO S, 1987, TETRAHEDRON LETT, V28, P4431, DOI 10.1016/S0040-4039(00)96530-4; UESATO S, 1984, CHEM PHARM BULL, V32, P3764, DOI 10.1248/cpb.32.3764; UESATO S, 1984, CHEM PHARM BULL, V32, P1671; UESATO S, 1983, CHEM PHARM BULL, V31, P4185; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	33	226	239	7	299	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					138	+		10.1038/nature11692	http://dx.doi.org/10.1038/nature11692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23172143				2022-12-24	WOS:000311893400061
J	Klein, F; Halper-Stromberg, A; Horwitz, JA; Gruell, H; Scheid, JF; Bournazos, S; Mouquet, H; Spatz, LA; Diskin, R; Abadir, A; Zang, T; Dorner, M; Billerbeck, E; Labitt, RN; Gaebler, C; Marcovecchio, PM; Incesu, RB; Eisenreich, TR; Bieniasz, PD; Seaman, MS; Bjorkman, PJ; Ravetch, JV; Ploss, A; Nussenzweig, MC				Klein, Florian; Halper-Stromberg, Ariel; Horwitz, Joshua A.; Gruell, Henning; Scheid, Johannes F.; Bournazos, Stylianos; Mouquet, Hugo; Spatz, Linda A.; Diskin, Ron; Abadir, Alexander; Zang, Trinity; Dorner, Marcus; Billerbeck, Eva; Labitt, Rachael N.; Gaebler, Christian; Marcovecchio, Paola M.; Incesu, Reha-Baris; Eisenreich, Thomas R.; Bieniasz, Paul D.; Seaman, Michael S.; Bjorkman, Pamela J.; Ravetch, Jeffrey V.; Ploss, Alexander; Nussenzweig, Michel C.			HIV therapy by a combination of broadly neutralizing antibodies in humanized mice	NATURE			English	Article							MONOCLONAL-ANTIBODIES; PASSIVE TRANSFER; B-CELLS; INFECTION; PROTECTION; GENERATION; VIREMIA; GENE; PCR	Human antibodies to human immunodeficiency virus-1 (HIV-1) can neutralize a broad range of viral isolates in vitro and protect non-human primates against infection(1,2). Previous work showed that antibodies exert selective pressure on the virus but escape variants emerge within a short period of time(3,4). However, these experiments were performed before the recent discovery of more potent anti-HIV-1 antibodies and their improvement by structure-based design(5-9). Here we re-examine passive antibody transfer as a therapeutic modality in HIV-1-infected humanized mice. Although HIV-1 can escape from antibody monotherapy, combinations of broadly neutralizing antibodies can effectively control HIV-1 infection and suppress viral load to levels below detection. Moreover, in contrast to antiretroviral therapy(10-12), the longer half-life of antibodies led to control of viraemia for an average of 60 days after cessation of therapy. Thus, combinations of potent monoclonal antibodies can effectively control HIV-1 replication in humanized mice, and should be re-examined as a therapeutic modality in HIV-1-infected individuals.	[Klein, Florian; Halper-Stromberg, Ariel; Horwitz, Joshua A.; Gruell, Henning; Scheid, Johannes F.; Mouquet, Hugo; Spatz, Linda A.; Abadir, Alexander; Gaebler, Christian; Incesu, Reha-Baris; Eisenreich, Thomas R.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Gruell, Henning] Univ Munster, Fak Med, D-48149 Munster, Germany; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Spatz, Linda A.] CUNY City Coll, Sophie Davis Sch Biomed Educ, Dept Microbiol & Immunol, New York, NY 10031 USA; [Diskin, Ron; Marcovecchio, Paola M.; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Zang, Trinity; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA; [Dorner, Marcus; Billerbeck, Eva; Labitt, Rachael N.; Ploss, Alexander] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Gaebler, Christian] Tech Univ Dresden, Fac Med Carl Gustav Carus, D-01307 Dresden, Germany; [Bieniasz, Paul D.; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Rockefeller University; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; California Institute of Technology; Rockefeller University; Rockefeller University; Technische Universitat Dresden; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; California Institute of Technology; Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Ploss, Alexander/ABG-2330-2020; Bournazos, Stylianos/ABH-1578-2021; Nussenzweig, Michel/AAE-7292-2019; Gaebler, Christian/GWZ-2628-2022; Ravetch, Jeffrey/Z-1596-2019; Mouquet, Hugo/M-2750-2014	Ploss, Alexander/0000-0001-9322-7252; Gaebler, Christian/0000-0001-7295-8128; Ravetch, Jeffrey/0000-0003-2024-9041; Mouquet, Hugo/0000-0002-4230-610X; Dorner, Marcus/0000-0003-0321-4226; Grull, Henning/0000-0002-0725-7138; Dorner, Marcus/0000-0001-7936-1527	German Research Foundation (DFG) [KL 2389/1-1, DO 1450/1-1, BI 1422/1-1]; German National Academic Foundation; Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium [1032144]; American Liver Foundation; CAVD from the Bill and Melinda Gates Foundation [OPP1033115]; NIAID [1UM1AI100663]; NIH [AI081677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI081677, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); German National Academic Foundation; Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium; American Liver Foundation; CAVD from the Bill and Melinda Gates Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Kaiser for analysing viral loads of reference HIV-1 samples and N. N. Freund for producing YU2 gp120. We thank B. Flatley, T. Friling, H. Gao, S. Sell and S. Hinklein for assistance and technical support, M. Suarez-Farinas for advice on statistical analysis, and M. Babayeva for helping with antibody t<INF>1/2</INF> estimation. M. C. N. and F. K. have a pending patent application for the antibody 3BC176 and M. C. N., P.J.B. and H. M. for the antibody 10-1074 with the United States Patent and Trademark Office. These reagents are available with a Material Transfer Agreement. F. K. (KL 2389/1-1), M. D. (DO 1450/1-1) and E. B. (BI 1422/1-1) were supported by the German Research Foundation (DFG). H. G., C. G. and R.-B.I. were supported by The German National Academic Foundation. M. S. S. was supported by the Bill and Melinda Gates Foundation's Comprehensive Antibody Vaccine Immune Monitoring Consortium, grant number 1032144. A. P. is a recipient of a Liver Scholar Award from the American Liver Foundation. This work was supported in part by CAVD grant OPP1033115 from the Bill and Melinda Gates Foundation to M. C. N., in part by NIAID 1UM1AI100663 to M. C. N. and NIH grant AI081677 to M. C. N. M. C. N., P.J.B. and P. D. B. are HHMI investigators.	Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Choudhary SK, 2009, J VIROL, V83, P8254, DOI 10.1128/JVI.00580-09; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Finzi D, 1998, CELL, V93, P665, DOI 10.1016/S0092-8674(00)81427-0; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Ince WL, 2010, J VIROL, V84, P2740, DOI 10.1128/JVI.02180-09; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Mouquet H., P NATL ACAD IN PRESS; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weiss RA, 2008, CLIN EXP IMMUNOL, V152, P201, DOI 10.1111/j.1365-2249.2008.03645.x; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002	36	393	406	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					118	+		10.1038/nature11604	http://dx.doi.org/10.1038/nature11604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23103874	Green Accepted			2022-12-24	WOS:000311893400057
J	Choy, A; Dancourt, J; Mugo, B; O'Connor, TJ; Isberg, RR; Melia, TJ; Roy, CR				Choy, Augustine; Dancourt, Julia; Mugo, Brian; O'Connor, Tamara J.; Isberg, Ralph R.; Melia, Thomas J.; Roy, Craig R.			The Legionella Effector RavZ Inhibits Host Autophagy Through Irreversible Atg8 Deconjugation	SCIENCE			English	Article							PNEUMOPHILA GENOME; SYSTEM; PATHWAY	Eukaryotic cells can use the autophagy pathway to defend against microbes that gain access to the cytosol or reside in pathogen-modified vacuoles. It remains unclear if pathogens have evolved specific mechanisms to manipulate autophagy. Here, we found that the intracellular pathogen Legionella pneumophila could interfere with autophagy by using the bacterial effector protein RavZ to directly uncouple Atg8 proteins attached to phosphatidylethanolamine on autophagosome membranes. RavZ hydrolyzed the amide bond between the carboxyl-terminal glycine residue and an adjacent aromatic residue in Atg8 proteins, producing an Atg8 protein that could not be reconjugated by Atg7 and Atg3. Thus, intracellular pathogens can inhibit autophagy by irreversibly inactivating Atg8 proteins during infection.	[Dancourt, Julia; Mugo, Brian; Melia, Thomas J.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Choy, Augustine; Roy, Craig R.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [O'Connor, Tamara J.; Isberg, Ralph R.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [O'Connor, Tamara J.; Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Yale University; Yale University; Howard Hughes Medical Institute; Tufts University; Tufts University	Melia, TJ (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	thomas.melia@yale.edu; craig.roy@yale.edu	Dancourt, Julia/U-1533-2017	Dancourt, Julia/0000-0002-6237-1566; Roy, Craig/0000-0003-4490-440X	Science, Technology and Research Scholars Program at Yale University; Howard Hughes Medical Institute; NIH [AI007019, NS063973, AI041699, AI048770]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019, R01AI048770, R01AI041699, R37AI041699, R29AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063973] Funding Source: NIH RePORTER	Science, Technology and Research Scholars Program at Yale University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Mizushima and A. Iwasaki for providing GFP-LC3 and Atg5-deficient mice and S. Shin for providing the plasmid encoding BlaM-RalF. Support for this research came from the Science, Technology and Research Scholars Program at Yale University (B. M.); the Howard Hughes Medical Institute (T.J.O. and R. R. I.); and NIH Awards AI007019 (A. C.), NS063973 (T.J.M.), AI041699, and AI048770 (C. R. R.). The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Hayward AP, 2011, ANNU REV PHYTOPATHOL, V49, P557, DOI 10.1146/annurev-phyto-072910-095333; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jotwani A, 2012, METHOD CELL BIOL, V108, P93, DOI 10.1016/B978-0-12-386487-1.00005-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	15	315	327	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1072	1076		10.1126/science.1227026	http://dx.doi.org/10.1126/science.1227026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23112293	Green Accepted			2022-12-24	WOS:000311390600042
J	Lichtenstein, P; Halldner, L; Zetterqvist, J; Sjolander, A; Serlachius, E; Fazel, S; Langstrom, N; Larsson, H				Lichtenstein, Paul; Halldner, Linda; Zetterqvist, Johan; Sjolander, Arvid; Serlachius, Eva; Fazel, Seena; Langstrom, Niklas; Larsson, Henrik			Medication for Attention Deficit-Hyperactivity Disorder and Criminality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RELEASE METHYLPHENIDATE TREATMENT; FOLLOW-UP; DEFICIT/HYPERACTIVITY DISORDER; ADHD; CHILDREN; SAFETY; MTA; PREVALENCE; EFFICACY; ADULTS	Background Attention deficit-hyperactivity disorder (ADHD) is a common disorder that has been associated with criminal behavior in some studies. Pharmacologic treatment is available for ADHD and may reduce the risk of criminality. Methods Using Swedish national registers, we gathered information on 25,656 patients with a diagnosis of ADHD, their pharmacologic treatment, and subsequent criminal convictions in Sweden from 2006 through 2009. We used stratified Cox regression analyses to compare the rate of criminality while the patients were receiving ADHD medication, as compared with the rate for the same patients while not receiving medication. Results As compared with nonmedication periods, among patients receiving ADHD medication, there was a significant reduction of 32% in the criminality rate for men (adjusted hazard ratio, 0.68; 95% confidence interval [CI], 0.63 to 0.73) and 41% for women (hazard ratio, 0.59; 95% CI, 0.50 to 0.70). The rate reduction remained between 17% and 46% in sensitivity analyses among men, with factors that included different types of drugs (e.g., stimulant vs. nonstimulant) and outcomes (e.g., type of crime). Conclusions Among patients with ADHD, rates of criminality were lower during periods when they were receiving ADHD medication. These findings raise the possibility that the use of medication reduces the risk of criminality among patients with ADHD. (Funded by the Swedish Research Council and others.)	[Lichtenstein, Paul; Halldner, Linda; Zetterqvist, Johan; Sjolander, Arvid; Langstrom, Niklas; Larsson, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Serlachius, Eva] Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Fazel, Seena] Univ Oxford, Dept Psychiat, Oxford, England	Karolinska Institutet; Karolinska Institutet; University of Oxford	Lichtenstein, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	paul.lichtenstein@ki.se	Sjölander, Arvid/AAR-2993-2021; Fazel, Seena/B-5307-2008; Larsson, Henrik/GYD-5161-2022; Langstrom, Niklas/C-5615-2009; Serlachius, Eva/E-8956-2013	Fazel, Seena/0000-0002-5383-5365; Langstrom, Niklas/0000-0002-2686-6799; Serlachius, Eva/0000-0001-7115-6422; Halldner Henriksson, Linda/0000-0003-0561-5998; Larsson, Henrik/0000-0002-6851-3297; lichtenstein, paul/0000-0003-3037-5287	Swedish Research Council; Swedish Council for Working Life and Social Research; Swedish Prison and Probation Services; National Institute of Child Health and Human Development [HD061817]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061817] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Prison and Probation Services; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Swedish Research Council and others.; Supported in part by grants from the Swedish Research Council, the Swedish Council for Working Life and Social Research, the Swedish Prison and Probation Services, the National Institute of Child Health and Human Development (HD061817), and the Wellcome Trust (to Dr. Fazel).	Adler LA, 2009, J CLIN PSYCHOPHARM, V29, P239, DOI 10.1097/JCP.0b013e3181a390ce; Adler LD, 2010, POSTGRAD MED, V122, P184, DOI 10.3810/pgm.2010.01.2112; Allison PD, 2009, FIXED EFFECTS REGRES; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; [Anonymous], 2011, KRIM 2010 CRIM STAT; Arnold LE, 2004, J ABNORM CHILD PSYCH, V32, P39, DOI 10.1023/B:JACP.0000007579.61289.31; Banaschewski T, 2006, EUR CHILD ADOLES PSY, V15, P476, DOI 10.1007/s00787-006-0549-0; Barkley RA, 2004, J CHILD PSYCHOL PSYC, V45, P195, DOI 10.1111/j.1469-7610.2004.00214.x; Biederman J, 2010, PSYCHIAT RES, V177, P299, DOI 10.1016/j.psychres.2009.12.010; Chamberlain SR, 2007, BIOL PSYCHIAT, V61, P1317, DOI 10.1016/j.biopsych.2007.04.009; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; DOLMEN L, 2001, BROTTSLIGHETEN OLIKA; FARRINGTON D, 2004, CROSS NATL STUDIES C; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Findling RL, 2008, CLIN THER, V30, P942, DOI 10.1016/j.clinthera.2008.05.006; Gibbons RD, 2010, ANNU REV PUBL HEALTH, V31, P419, DOI 10.1146/annurev.publhealth.012809.103649; Graham J, 2008, CNS DRUGS, V22, P213, DOI 10.2165/00023210-200822030-00003; Greenhill, 2007, J AM ACAD CHILD PSY, V46, P141; Greenhill L, 2006, J AM ACAD CHILD PSY, V45, P1284, DOI 10.1097/01.chi.0000235077.32661.61; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Koesters M, 2009, J PSYCHOPHARMACOL, V23, P733, DOI 10.1177/0269881108092338; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; Lindevall O., 2009, PASTILL COMPREHENSIV; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McCarthy S, 2009, BRIT J PSYCHIAT, V194, P273, DOI 10.1192/bjp.bp.107.045245; Molina BSG, 2007, J AM ACAD CHILD PSY, V46, P1028, DOI 10.1097/chi.0b013e3180686d96; Pastor Patricia N, 2008, Vital Health Stat 10, P1; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Satterfield JH, 2007, J AM ACAD CHILD PSY, V46, P601, DOI 10.1097/chi.0b013e318033ff59; Scheffler RM, 2007, HEALTH AFFAIR, V26, P450, DOI 10.1377/hlthaff.26.2.450; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; Swanson J, 2008, J ATTEN DISORD, V12, P4, DOI 10.1177/1087054708319345; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Winhusen TM, 2011, J CHILD ADOL PSYCHOP, V21, P455, DOI 10.1089/cap.2011.0014; Zetterqvist J, 2012, ACTA PSYCHIAT SCAND; Zoega H, 2011, ACTA PSYCHIAT SCAND, V123, P360, DOI 10.1111/j.1600-0447.2010.01607.x	40	318	326	1	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2012	367	21					2006	2014		10.1056/NEJMoa1203241	http://dx.doi.org/10.1056/NEJMoa1203241			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040RI	23171097	Green Accepted, Bronze			2022-12-24	WOS:000311340200008
J	Chaneton, B; Hillmann, P; Zheng, L; Martin, ACL; Maddocks, ODK; Chokkathukalam, A; Coyle, JE; Jankevics, A; Holding, FP; Vousden, KH; Frezza, C; O'Reilly, M; Gottlieb, E				Chaneton, Barbara; Hillmann, Petra; Zheng, Liang; Martin, Agnes C. L.; Maddocks, Oliver D. K.; Chokkathukalam, Achuthanunni; Coyle, Joseph E.; Jankevics, Andris; Holding, Finn P.; Vousden, Karen H.; Frezza, Christian; O'Reilly, Marc; Gottlieb, Eyal			Serine is a natural ligand and allosteric activator of pyruvate kinase M2	NATURE			English	Article							MASS-SPECTROMETRY DATA; X-RAY DATA; TUMOR-GROWTH; CANCER; CRYSTALLOGRAPHY; CONTRIBUTES; GLYCOLYSIS; METABOLISM; PATHWAY; QUALITY	Cancer cells exhibit several unique metabolic phenotypes that are critical for cell growth and proliferation(1). Specifically, they overexpress the M2 isoform of the tightly regulated enzyme pyruvate kinase (PKM2), which controls glycolytic flux, and are highly dependent on de novo biosynthesis of serine and glycine(2). Here we describe a new rheostat-like mechanistic relationship between PKM2 activity and serine biosynthesis. We show that serine can bind to and activate human PKM2, and that PKM2 activity in cells is reduced in response to serine deprivation. This reduction in PKM2 activity shifts cells to a fuel-efficient mode in which more pyruvate is diverted to the mitochondria and more glucose-derived carbon is channelled into serine biosynthesis to support cell proliferation.	[Chaneton, Barbara; Zheng, Liang; Maddocks, Oliver D. K.; Vousden, Karen H.; Frezza, Christian; Gottlieb, Eyal] Canc Res UK, Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Hillmann, Petra; Martin, Agnes C. L.; Coyle, Joseph E.; Holding, Finn P.; O'Reilly, Marc] Astex Pharmaceut, Cambridge CB4 0QA, England; [Chokkathukalam, Achuthanunni; Jankevics, Andris] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Jankevics, Andris] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen Bioinformat Ctr, NL-9747 AG Groningen, Netherlands	Beatson Institute; Cancer Research UK; Astex Pharmaceuticals; University of Glasgow; University of Groningen	Gottlieb, E (corresponding author), Canc Res UK, Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	marc.oreilly@astx.com; e.gottlieb@beatson.gla.ac.uk	Frezza, Christian/G-2174-2010; Maddocks, Oliver/K-5410-2012; Gottlieb, Eyal/G-6450-2010	Frezza, Christian/0000-0002-3293-7397; Maddocks, Oliver/0000-0002-5551-9091; Gottlieb, Eyal/0000-0002-9770-0956; Hillmann, Petra/0000-0001-8642-7109; Zheng, Liang/0000-0002-5346-4111; Jankevics, Andris/0000-0003-2095-6846	Cancer Research UK	Cancer Research UK(Cancer Research UK)	The work performed at the Beatson Institute for Cancer Research was supported by Cancer Research UK. We thank D. Sumpton for technical support with two-dimensional gel electrophoresis and N. Thompson, N. Wallis and M. Jones for comments provided during manuscript preparation. We would also like to thank D. M. Sabatini for the Scramble shRNA plasmid used as a control (shCntrla) and the Structural Genomics Consortium for providing us with the PKM2 expression plasmid from their collection. We thank A. King for editorial work and S. Tardito for graphical help.	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Davies TG, 2012, TOP CURR CHEM, V317, P33, DOI 10.1007/128_2011_179; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; EIGENBRODT E, 1983, BIOMED BIOCHIM ACTA, V42, pS278; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MARQUEZ J, 1989, ARCH BIOCHEM BIOPHYS, V268, P667, DOI 10.1016/0003-9861(89)90335-4; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MEDINA MA, 1992, BIOCHEM MED METAB B, V48, P1, DOI 10.1016/0885-4505(92)90041-V; Mooij WTM, 2006, CHEMMEDCHEM, V1, P827, DOI 10.1002/cmdc.200600074; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Salituro F. G., 2010, Preparation of Pyridinyl or Pyrimidinyl Imidazoles, Pyrroles and Pyrazoles as PKM2 Modulators Useful in Treating Cancer, Patent No. [2010118063 A2, 2010118063]; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SPELLMAN CM, 1973, FEBS LETT, V37, P281, DOI 10.1016/0014-5793(73)80478-8; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	39	396	415	8	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					458	+		10.1038/nature11540	http://dx.doi.org/10.1038/nature11540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23064226	Green Accepted			2022-12-24	WOS:000311031600049
J	Ackman, JB; Burbridge, TJ; Crair, MC				Ackman, James B.; Burbridge, Timothy J.; Crair, Michael C.			Retinal waves coordinate patterned activity throughout the developing visual system	NATURE			English	Article							RETINOTOPIC MAP REFINEMENT; LATERAL GENICULATE-NUCLEUS; MOUSE SUPERIOR COLLICULUS; EYE-SPECIFIC SEGREGATION; IMAGING IN-VIVO; GANGLION-CELLS; ACTIVITY TRANSIENTS; RETINOGENICULATE PROJECTIONS; DIRECTION SELECTIVITY; ACTION-POTENTIALS	The morphological and functional development of the vertebrate nervous system is initially governed by genetic factors and subsequently refined by neuronal activity. However, fundamental features of the nervous system emerge before sensory experience is possible. Thus, activity-dependent development occurring before the onset of experience must be driven by spontaneous activity, but the origin and nature of activity in vivo remains largely untested. Here we use optical methods to show in live neonatal mice that waves of spontaneous retinal activity are present and propagate throughout the entire visual system before eye opening. This patterned activity encompassed the visual field, relied on cholinergic neurotransmission, preferentially initiated in the binocular retina and exhibited spatiotemporal correlations between the two hemispheres. Retinal waves were the primary source of activity in the midbrain and primary visual cortex, but only modulated ongoing activity in secondary visual areas. Thus, spontaneous retinal activity is transmitted through the entire visual system and carries patterned information capable of guiding the activity-dependent development of complex intra-and inter-hemispheric circuits before the onset of vision.	[Ackman, James B.; Burbridge, Timothy J.; Crair, Michael C.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	Crair, MC (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	michael.crair@yale.edu		Ackman, James/0000-0003-0802-6080	US National Institutes of Health (NIH) [P30 EY000785, R01 EY015788, T32 NS007224, T15 LM070506, T32 EY017353]; family of William Ziegler III; NATIONAL EYE INSTITUTE [R01EY023105, P30EY000785, T32EY022312, R01EY015788, R01EY017353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); family of William Ziegler III; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Sachdev and D. McCormick for Emx1-Cre:Ai38 mice, C. Chen for helpful advice on ganglion cell loading with calcium indicators and Y. Zhang for technical support. We would like to thank M. Colonnese and members of the Crair laboratory for valuable comments on the manuscript. This work was supported by US National Institutes of Health (NIH) grants P30 EY000785 and R01 EY015788 (to M. C. C.), T32 NS007224 (to J.A.), and T15 LM070506 and T32 EY017353 (to T. B.). This work was also supported by the family of William Ziegler III.	Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Bansal A, 2000, J NEUROSCI, V20, P7672; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chalupa LM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-25; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Colonnese MT, 2010, J NEUROSCI, V30, P4325, DOI 10.1523/JNEUROSCI.4995-09.2010; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Dhande OS, 2011, JOVE-J VIS EXP, DOI 10.3791/2678; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Ford KJ, 2012, J NEUROSCI, V32, P850, DOI 10.1523/JNEUROSCI.5309-12.2012; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gastinger MJ, 2006, CURR EYE RES, V31, P655, DOI 10.1080/02713680600776119; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; LEWIS JW, 1995, J COMP NEUROL, V361, P119, DOI 10.1002/cne.903610110; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Marder E, 2005, CURR OPIN NEUROBIOL, V15, P86, DOI 10.1016/j.conb.2005.01.011; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; MULLER M, 1988, EXP BRAIN RES, V71, P611, DOI 10.1007/BF00248754; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Rebsam A, 2009, J NEUROSCI, V29, P14855, DOI 10.1523/JNEUROSCI.3462-09.2009; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Takahashi M, 2007, J NEUROPHYSIOL, V98, P2664, DOI 10.1152/jn.00696.2007; Tolonen M, 2007, NEUROSCIENCE, V145, P997, DOI 10.1016/j.neuroscience.2006.12.070; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Warland DK, 2006, J NEUROSCI, V26, P5190, DOI 10.1523/JNEUROSCI.0328-06.2006; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007	59	276	277	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					219	+		10.1038/nature11529	http://dx.doi.org/10.1038/nature11529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060192	Green Accepted			2022-12-24	WOS:000309733300041
J	Rowe, JH; Ertelt, JM; Xin, LJ; Way, SS				Rowe, Jared H.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing			Pregnancy imprints regulatory memory that sustains anergy to fetal antigen	NATURE			English	Article							T-CELLS; FOXP3(+); PREECLAMPSIA; EXPRESSION; TOLERANCE; EXPANSION; SELECTION; SYSTEM	Pregnancy is an intricately orchestrated process where immune effector cells with fetal specificity are selectively silenced. This requires the sustained expansion of immune-suppressive maternal FOXP3(+) regulatory T cells (T-reg cells), because even transient partial ablation triggers fetal-specific effector T-cell activation and pregnancy loss(1,2). In turn, many idiopathic pregnancy complications proposed to originate from disrupted fetal tolerance are associated with blunted maternal T-reg expansion(3-5). Importantly, however, the antigen specificity and cellular origin of maternal Treg cells that accumulate during gestation remain incompletely defined. Here we show that pregnancy selectively stimulates the accumulation of maternal FOXP3(+) CD4 cells with fetal specificity using tetramer-based enrichment that allows the identification of rare endogenous T cells(6). Interestingly, after delivery, fetal-specific T-reg cells persist at elevated levels, maintain tolerance to pre-existing fetal antigen, and rapidly re-accumulate during subsequent pregnancy. The accelerated expansion of T-reg cells during secondary pregnancy was driven almost exclusively by proliferation of fetal-specific FOXP3(+) cells retained from prior pregnancy, whereas induced FOXP3 expression and proliferation of pre-existing FOXP3(+) cells each contribute to T-reg expansion during primary pregnancy. Furthermore, fetal resorption in secondary compared with primary pregnancy becomes more resilient to partial maternal FOXP3(+) cell ablation. Thus, pregnancy imprints FOXP3(+) CD4 cells that sustain protective regulatory memory to fetal antigen. We anticipate that these findings will spark further investigation on maternal regulatory T-cell specificity that unlocks new strategies for improving pregnancy outcomes and novel approaches for therapeutically exploiting T-reg cell memory.	[Rowe, Jared H.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing] Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Ctr Immunol,Dept Pediat, Minneapolis, MN 55455 USA; [Rowe, Jared H.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing] Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Ctr Immunol,Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Way, SS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	singsing.way@cchmc.org		Way, Sing Sing/0000-0001-8948-1952	NIH-NIAID [R01AI087830, R01AI100934]; NIH-NIDDK [F30DK084674]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100934, R01AI087830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084674] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Jenkins for providing 2W1S-expressing mice, and A. Rudensky for providing Foxp3<SUP>DTR</SUP> mice. This research was supported by NIH-NIAID awards R01AI087830 and R01AI100934 (S.S.W.), and NIH-NIDDK award F30DK084674 (J.H.R.). S.S.W. holds an Investigator in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Erlebacher A, 2007, J CLIN INVEST, V117, P1399, DOI 10.1172/JCI28214; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kahn DA, 2010, P NATL ACAD SCI USA, V107, P9299, DOI 10.1073/pnas.1003909107; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Prins JR, 2009, HYPERTENS PREGNANCY, V28, P300, DOI 10.1080/10641950802601237; Robertson SA, 2010, J REPROD IMMUNOL, V85, P51, DOI 10.1016/j.jri.2010.01.008; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Rudd BD, 2011, P NATL ACAD SCI USA, V108, P13694, DOI 10.1073/pnas.1107594108; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; WIRTH R, 1986, J BACTERIOL, V165, P831, DOI 10.1128/jb.165.3.831-836.1986	34	340	349	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					102	U119		10.1038/nature11462	http://dx.doi.org/10.1038/nature11462			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23023128	Green Accepted			2022-12-24	WOS:000309446800041
J	Lin, CY; Loven, J; Rahl, PB; Paranal, RM; Burge, CB; Bradner, JE; Lee, TI; Young, RA				Lin, Charles Y.; Loven, Jakob; Rahl, Peter B.; Paranal, Ronald M.; Burge, Christopher B.; Bradner, James E.; Lee, Tong Ihn; Young, Richard A.			Transcriptional Amplification in Tumor Cells with Elevated c-Myc	CELL			English	Article							RECRUITS P-TEFB; GENE-EXPRESSION; NEOPLASTIC PHENOTYPE; RIBOSOMAL DNA; COPY-NUMBER; CANCER; MAX; BINDING; ACTIVATION; PROTEIN	Elevated expression of the c-Myc transcription factor occurs frequently in human cancers and is associated with tumor aggression and poor clinical outcome. The effect of high levels of c-Myc on global gene regulation is poorly understood but is widely thought to involve newly activated or repressed "Myc target genes." We report here that in tumor cells expressing high levels of c-Myc the transcription factor accumulates in the promoter regions of active genes and causes transcriptional amplification, producing increased levels of transcripts within the cell's gene expression program. Thus, rather than binding and regulating a new set of genes, c-Myc amplifies the output of the existing gene expression program. These results provide an explanation for the diverse effects of oncogenic c-Myc on gene expression in different tumor cells and suggest that transcriptional amplification reduces rate-limiting constraints for tumor cell growth and proliferation.	[Lin, Charles Y.; Loven, Jakob; Rahl, Peter B.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Burge, Christopher B.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Paranal, Ronald M.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Bradner, James E.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Burge, Christopher B./AAH-2177-2020; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	National Institutes of Health [HG002668, CA146445]; Swedish Research Council [VR-B0086301]; American Cancer Society [PF-11-042- 01-DMC]; Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA146445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Society(American Cancer Society); Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank John Minna and Chi Dang for cell lines; Ernest Martinez for constructs; David Orlando for bioinformatics support; Tom Volkert, Jennifer Love, Sumeet Gupta, and Vidya Dhanapal at the Whitehead Genome Technologies Core for Solexa sequencing; Nancy Hannett for cloning support; Jessica Reddy for assistance with FACS; Darin Fogg, Amins Corporation, and Nathan Elliott, NanoString, for excellent technical support; and Michael Cole and members of the Young, Burge and Bradner labs for helpful discussion. This work was supported by National Institutes of Health grants HG002668 (R.A.Y.) and CA146445 (R.A.Y., T.I.L.), Swedish Research Council Postdoctoral Fellowship VR-B0086301 (J.L.), American Cancer Society Postdoctoral Fellowship PF-11-042- 01-DMC (P.B.R.) and Damon-Runyon Cancer Research Foundation (J.E.B). J.E.B. and R.A.Y. are founders of Syros Pharmaceuticals.	Amati B, 2001, BBA-REV CANCER, V1471, pM135, DOI 10.1016/S0304-419X(01)00020-8; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BLACKWOOD EM, 1992, GENE DEV, V6, P71, DOI 10.1101/gad.6.1.71; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cowling Victoria H, 2010, Genes Cancer, V1, P576; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Farina A, 2004, PROTEIN EXPRES PURIF, V34, P215, DOI 10.1016/j.pep.2003.11.021; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; HIRVONEN HE, 1994, BRIT J CANCER, V69, P16, DOI 10.1038/bjc.1994.3; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hurlin PJ, 2004, INT REV CYTOL, V238, P183, DOI 10.1016/S0074-7696(04)38004-6; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; JOHNSON BE, 1987, J CLIN INVEST, V79, P1629, DOI 10.1172/JCI112999; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kuttler F, 2006, GENOME DYN, V1, P171, DOI 10.1159/000092507; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nieminen AI, 2007, CELL CYCLE, V6, P2464, DOI 10.4161/cc.6.20.4917; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Peterson CW, 2011, FRONT BIOSCI-LANDMRK, V16, P2206, DOI 10.2741/3848; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	78	991	1014	6	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					56	67		10.1016/j.cell.2012.08.026	http://dx.doi.org/10.1016/j.cell.2012.08.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021215	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000309544200010
J	Ellegren, H; Smeds, L; Burri, R; Olason, PI; Backstrom, N; Kawakami, T; Kunstner, A; Makinen, H; Nadachowska-Brzyska, K; Qvarnstrom, A; Uebbing, S; Wolf, JBW				Ellegren, Hans; Smeds, Linnea; Burri, Reto; Olason, Pall I.; Backstrom, Niclas; Kawakami, Takeshi; Kunstner, Axel; Makinen, Hannu; Nadachowska-Brzyska, Krystyna; Qvarnstrom, Anna; Uebbing, Severin; Wolf, Jochen B. W.			The genomic landscape of species divergence in Ficedula flycatchers	NATURE			English	Article							WILD BIRD POPULATION; FEMALE MEIOTIC DRIVE; REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; HYBRID STERILITY; EVOLUTION; CONSEQUENCES; HITCHHIKING; CHICKEN	Unravelling the genomic landscape of divergence between lineages is key to understanding speciation(1). The naturally hybridizing collared flycatcher and pied flycatcher are important avian speciation models(2-7) that show pre- as well as postzygotic isolation(8,9). We sequenced and assembled the 1.1-Gb flycatcher genome, physically mapped the assembly to chromosomes using a low-density linkage map(10) and re-sequenced population samples of each species. Here we show that the genomic landscape of species differentiation is highly heterogeneous with approximately 50 'divergence islands' showing up to 50-fold higher sequence divergence than the genomic background. These non-randomly distributed islands, with between one and three regions of elevated divergence per chromosome irrespective of chromosome size, are characterized by reduced levels of nucleotide diversity, skewed allele-frequency spectra, elevated levels of linkage disequilibrium and reduced proportions of shared polymorphisms in both species, indicative of parallel episodes of selection. Proximity of divergence peaks to genomic regions resistant to sequence assembly, potentially including centromeres and telomeres, indicate that complex repeat structures may drive species divergence. A much higher background level of species divergence of the Z chromosome, and a lower proportion of shared polymorphisms, indicate that sex chromosomes and autosomes are at different stages of speciation. This study provides a roadmap to the emerging field of speciation genomics.	[Ellegren, Hans; Smeds, Linnea; Burri, Reto; Olason, Pall I.; Backstrom, Niclas; Kawakami, Takeshi; Kunstner, Axel; Makinen, Hannu; Nadachowska-Brzyska, Krystyna; Uebbing, Severin; Wolf, Jochen B. W.] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Qvarnstrom, Anna] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, SE-75263 Uppsala, Sweden	Uppsala University; Uppsala University	Ellegren, H (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	Hans.Ellegren@ebc.uu.se	Kawakami, Takeshi/B-9060-2009; Nadachowska-Brzyska, Krystyna/ABB-7632-2020; Uebbing, Severin/K-5046-2012; Wolf, Jochen/U-2243-2017	Kawakami, Takeshi/0000-0002-9204-6852; Nadachowska-Brzyska, Krystyna/0000-0002-8457-310X; Uebbing, Severin/0000-0003-2439-6946; Wolf, Jochen/0000-0002-2958-5183; Smeds, Linnea/0000-0002-8415-9259; Qvarnstrom, Anna/0000-0002-1178-4053; Kunstner, Axel/0000-0003-0692-2105	European Research Council; Knut and Alice Wallenberg Scholar Grant; Swedish Research Council; Swiss National Science Foundation [PBLAB3-134299, PBLAB1-140171]; Knut and Alice Wallenberg Foundation; Swedish National Infrastructure for Computing (SNIC)	European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Scholar Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Infrastructure for Computing (SNIC)	Financial support was obtained from a European Research Council Advanced Investigator Grant (NEXTGENMOLECOL), a Knut and Alice Wallenberg Scholar Grant, and from the Swedish Research Council to H.E. R.B. was funded by the Swiss National Science Foundation (grants PBLAB3-134299 and PBLAB1-140171). We are grateful to M. Lascoux, M. Noor and T. Slotte for helpful discussion and comments. We thank the Uppsala University SNP and SEQ Technology Platform for help with DNA sequencing, and the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX), and the associated Next generation sequencing Cluster and Storage (UPPNEX) project, funded by the Knut and Alice Wallenberg Foundation and the Swedish National Infrastructure for Computing (SNIC), for computer resources.	Axelsson E, 2010, HEREDITY, V105, P290, DOI 10.1038/hdy.2009.193; Backstrom N, 2008, GENETICS, V179, P1479, DOI 10.1534/genetics.108.088195; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Borge T, 2005, J EVOLUTION BIOL, V18, P1416, DOI 10.1111/j.1420-9101.2005.00964.x; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Coyne JA, 2004, SPECIATION, V37; Darwin C., 1859, ORIGIN SPECIES MEANS; Delany ME, 2007, CYTOGENET GENOME RES, V117, P54, DOI 10.1159/000103165; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; Feder JL, 2010, EVOLUTION, V64, P1729, DOI [10.1111/j.1558-5646.2009.00943.x, 10.1111/j.1558-5646.2010.00943.x]; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; Henikoff S, 2002, NATURE, V417, P227, DOI 10.1038/417227a; Jiggins CD, 2001, EVOLUTION, V55, P1631, DOI 10.1111/j.0014-3820.2001.tb00682.x; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Saetre GP, 2003, P ROY SOC B-BIOL SCI, V270, P53, DOI 10.1098/rspb.2002.2204; Saetre GP, 1997, NATURE, V387, P589; SHIELDS GF, 1982, CONDOR, V84, P45, DOI 10.2307/1367820; Tsai JH, 2011, J CELL SCI, V124, P1955, DOI 10.1242/jcs.006387; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Wiley C, 2009, EVOLUTION, V63, P1731, DOI 10.1111/j.1558-5646.2009.00674.x; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	30	428	436	8	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					756	760		10.1038/nature11584	http://dx.doi.org/10.1038/nature11584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103876	hybrid			2022-12-24	WOS:000311606000045
J	Henne, WM; Buchkovich, NJ; Zhao, YY; Emr, SD				Henne, William Mike; Buchkovich, Nicholas J.; Zhao, Yingying; Emr, Scott D.			The Endosomal Sorting Complex ESCRT-II Mediates the Assembly and Architecture of ESCRT-III Helices	CELL			English	Article							STRUCTURAL BASIS; FTSZ; AUTOINHIBITION; ENDOCYTOSIS; CARGO	The endosomal sorting complexes required for transport (ESCRTs) constitute hetero-oligomeric machines that mediate topologically similar membrane-sculpting processes, including cytokinesis, retroviral egress, and multivesicular body (MVB) biogenesis. Although ESCRT-III drives membrane remodeling that creates MVBs, its structure and the mechanism of vesicle formation are unclear. Using electron microscopy, we visualize an ESCRT-II: ESCRT-III supercomplex and propose how it mediates vesicle formation. We define conformational changes that activate ESCRT-III subunit Snf7 and show that it assembles into spiraling similar to 9 nm protofilaments on lipid monolayers. A high-content flow cytometry assay further demonstrates that mutations halting ESCRT-III assembly block ESCRT function. Strikingly, the addition of Vps24 and Vps2 transforms flat Snf7 spirals into membrane-sculpting helices. Finally, we show that ESCRT-II and ESCRT-III coassemble into similar to 65 nm diameter rings indicative of a cargo-sequestering supercomplex. We propose that ESCRT-III has distinct architectural stages that are modulated by ESCRT-II to mediate cargo capture and vesicle formation by ordered assembly.	[Henne, William Mike; Buchkovich, Nicholas J.; Zhao, Yingying; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Henne, William Mike; Buchkovich, Nicholas J.; Zhao, Yingying; Emr, Scott D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University	Emr, SD (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	sde26@cornell.edu			Sam and Nancy Fleming Research Fellowship; American Cancer Society [PF-12-062-01-DMC]	Sam and Nancy Fleming Research Fellowship; American Cancer Society(American Cancer Society)	W. M. H. is supported by a Sam and Nancy Fleming Research Fellowship. N.J.B. is supported by an American Cancer Society Postdoctoral Fellowship (PF-12-062-01-DMC). We thank Beverly Wendland for the Mup1-pHluorin integration plasmid and Roger Williams for the ESCRT-II expression construct. The authors also thank Neil Adige and Bret Judson for all technical expertise. We also thank Chris Stefan, Jason MacGurn, Jeremy Thorner, Tony Bretscher, Chris Fromme, Gerald Feigenson, David Teis, Suraj Saksena, Jeanne Quirit, and Abbie Davies for helpful discussions.	Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Prosser DC, 2010, TRAFFIC, V11, P1141, DOI 10.1111/j.1600-0854.2010.01088.x; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	27	144	146	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					356	371		10.1016/j.cell.2012.08.039	http://dx.doi.org/10.1016/j.cell.2012.08.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063125	Bronze			2022-12-24	WOS:000309981000014
J	Wimmer, GE; Shohamy, D				Wimmer, G. Elliott; Shohamy, Daphna			Preference by Association: How Memory Mechanisms in the Hippocampus Bias Decisions	SCIENCE			English	Article							REACTIVATION; COMPETITION; CHOICE; MIND	Every day people make new choices between alternatives that they have never directly experienced. Yet, such decisions are often made rapidly and confidently. Here, we show that the hippocampus, traditionally known for its role in building long-term declarative memories, enables the spread of value across memories, thereby guiding decisions between new choice options. Using functional brain imaging in humans, we discovered that giving people monetary rewards led to activation of a preestablished network of memories, spreading the positive value of reward to nonrewarded items stored in memory. Later, people were biased to choose these nonrewarded items. This decision bias was predicted by activity in the hippocampus, reactivation of associated memories, and connectivity between memory and reward regions in the brain. These findings explain how choices among new alternatives emerge automatically from the associative mechanisms by which the brain builds memories. Further, our findings demonstrate a previously unknown role for the hippocampus in value-based decisions.	[Wimmer, G. Elliott; Shohamy, Daphna] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Columbia University	Shohamy, D (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	shohamy@psych.columbia.edu	Wimmer, G. Elliott/AAJ-8537-2020	Wimmer, G. Elliott/0000-0002-2227-119X; Shohamy, Daphna/0000-0003-4239-4960	NSF Career Development Award; National Institutes of Drug Abuse [R03-DA026957]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA026957] Funding Source: NIH RePORTER	NSF Career Development Award; National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by a NSF Career Development Award and National Institutes of Drug Abuse grant R03-DA026957 to D. S. We thank E. K. Braun, L. Davachi, R. Hassin, and E. Weber for helpful comments on an earlier draft of the manuscript; L. Atlas and T. Wager for guidance with the mediation analyses; and N. Daw and R. Hassin for insightful conversations.	Brogden WJ, 1939, J EXP PSYCHOL, V25, P323, DOI 10.1037/h0058944; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; De Houwer J., 2007, IMPLICIT MEASURES AT, P179; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; KIMMEL HD, 1977, AM J PSYCHOL, V90, P319, DOI 10.2307/1422055; Kuhl BA, 2011, P NATL ACAD SCI USA, V108, P5903, DOI 10.1073/pnas.1016939108; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Morewedge CK, 2010, TRENDS COGN SCI, V14, P435, DOI 10.1016/j.tics.2010.07.004; Pennartz CMA, 2011, TRENDS NEUROSCI, V34, P548, DOI 10.1016/j.tins.2011.08.001; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Preston AR, 2004, HIPPOCAMPUS, V14, P148, DOI 10.1002/hipo.20009; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Reddy L, 2006, CURR OPIN NEUROBIOL, V16, P408, DOI 10.1016/j.conb.2006.06.004; Rozin P., 2002, HEURISTICS BIASES PS, P201, DOI DOI 10.1017/CBO9780511808098; Schapiro AC, 2012, CURR BIOL, V22, P1622, DOI 10.1016/j.cub.2012.06.056; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Staresina BP, 2009, NEURON, V63, P267, DOI 10.1016/j.neuron.2009.06.024; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Turk-Browne NB, 2009, J COGNITIVE NEUROSCI, V21, P1934, DOI 10.1162/jocn.2009.21131; Walther E, 2002, J PERS SOC PSYCHOL, V82, P919, DOI 10.1037//0022-3514.82.6.919; Weber EU, 2007, PSYCHOL SCI, V18, P516, DOI 10.1111/j.1467-9280.2007.01932.x; Wimmer GE, 2011, DECISION MAKING AFFE, P281, DOI 10.1093/acprof:oso/9780199600434.003.0013	33	291	292	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					270	273		10.1126/science.1223252	http://dx.doi.org/10.1126/science.1223252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019BQ	23066083				2022-12-24	WOS:000309712300050
J	Voigt, P; LeRoy, G; Drury, WJ; Zee, BM; Son, J; Beck, DB; Young, NL; Garcia, BA; Reinberg, D				Voigt, Philipp; LeRoy, Gary; Drury, William J., III; Zee, Barry M.; Son, Jinsook; Beck, David B.; Young, Nicolas L.; Garcia, Benjamin A.; Reinberg, Danny			Asymmetrically Modified Nucleosomes	CELL			English	Article							HISTONE MODIFICATIONS; DNA-REPLICATION; CHROMATIN-STRUCTURE; BINDING MODULES; CELL-CYCLE; METHYLATION; GENOME; GENES; MARKS; INFORMATION	Mononucleosomes, the basic building blocks of chromatin, contain two copies of each core histone. The associated posttranslational modifications regulate essential chromatin-dependent processes, yet whether each histone copy is identically modified in vivo is unclear. We demonstrate that nucleosomes in embryonic stem cells, fibroblasts, and cancer cells exist in both symmetrically and asymmetrically modified populations for histone H3 lysine 27 di/trimethylation (H3K27me2/3) and H4K20me1. Further, we obtained direct physical evidence for bivalent nucleosomes carrying H3K4me3 or H3K36me3 along with H3K27me3, albeit on opposite H3 tails. Bivalency at target genes was resolved upon differentiation of ES cells. Polycomb repressive complex 2-mediated methylation of H3K27 was inhibited when nucleosomes contain symmetrically, but not asymmetrically, placed H3K4me3 or H3K36me3. These findings uncover a potential mechanism for the incorporation of bivalent features into nucleosomes and demonstrate how asymmetry might set the stage to diversify functional nucleosome states.	[Voigt, Philipp; Drury, William J., III; Son, Jinsook; Beck, David B.; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA; [LeRoy, Gary; Zee, Barry M.; Young, Nicolas L.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Schultz Lab 415, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; New York University; Princeton University	Reinberg, D (corresponding author), NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, 522 1st Ave, New York, NY 10016 USA.	danny.reinberg@nyumc.org		Voigt, Philipp/0000-0003-4366-0490; Young, Nicolas/0000-0002-3323-2815; Zee, Barry/0000-0002-3123-8375; Reinberg, Danny/0000-0003-4288-2016	Deutsche Akademie der Naturforscher Leopoldina [LPDS 2009-5]; Empire State Training Program in Stem Cell Research (NYSTEM) [C026880]; Howard Hughes Medical Institute; National Institute of Health [GM064844, R37GM037120]; NSF [CBET-0941143]; American Society for Mass Spectrometry; NIH Office of the Director [DP2OD007447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844, R37GM037120] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	Deutsche Akademie der Naturforscher Leopoldina; Empire State Training Program in Stem Cell Research (NYSTEM); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American Society for Mass Spectrometry; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Till Bartke and Tony Kouzarides for the H4 Delta(1-27)I28C construct. We are grateful to Dr. Inti De La Rosa Velazquez for advice on sequential ChIP experiments. We thank Drs. W.W. Tee and R. Bonasio for helpful discussions and Dr. L. Vales for critical reading of the manuscript. P.V. is supported by fellowships from the Deutsche Akademie der Naturforscher Leopoldina (LPDS 2009-5) and the Empire State Training Program in Stem Cell Research (NYSTEM, contract # C026880). Work in the Reinberg laboratory is funded by the Howard Hughes Medical Institute and the National Institute of Health (grants GM064844 and R37GM037120). The Garcia laboratory is supported by grants from the NSF (Early Faculty Career award and CBET-0941143), the American Society for Mass Spectrometry, and the NIH Office of the Director (DP2OD007447).	Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chen XZ, 2011, EMBO REP, V12, P244, DOI 10.1038/embor.2011.6; DiMaggio PA, 2009, MOL CELL PROTEOMICS, V8, P2527, DOI 10.1074/mcp.M900144-MCP200; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Voigt P, 2011, CHEMBIOCHEM, V12, P236, DOI 10.1002/cbic.201000493; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	36	281	285	1	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					181	193		10.1016/j.cell.2012.09.002	http://dx.doi.org/10.1016/j.cell.2012.09.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021224	Bronze, Green Accepted			2022-12-24	WOS:000309544200019
J	Burke, CJ; Huetteroth, W; Owald, D; Perisse, E; Krashes, MJ; Das, G; Gohl, D; Silies, M; Certel, S; Waddell, S				Burke, Christopher J.; Huetteroth, Wolf; Owald, David; Perisse, Emmanuel; Krashes, Michael J.; Das, Gaurav; Gohl, Daryl; Silies, Marion; Certel, Sarah; Waddell, Scott			Layered reward signalling through octopamine and dopamine in Drosophila	NATURE			English	Article							NEURONS; EXPRESSION; GENE; RECEPTOR; PROTEIN; MEMORY; MARKER; FAMILY; LIGHT; FLIES	Dopamine is synonymous with reward and motivation in mammals(1,2). However, only recently has dopamine been linked to motivated behaviour and rewarding reinforcement in fruitflies(3,4). Instead, octopamine has historically been considered to be the signal for reward in insects(5-7). Here we show, using temporal control of neural function in Drosophila, that only short-term appetitive memory is reinforced by octopamine. Moreover, octopamine-dependent memory formation requires signalling through dopamine neurons. Part of the octopamine signal requires the alpha-adrenergic-like OAMB receptor in an identified subset of mushroom-body-targeted dopamine neurons. Octopamine triggers an increase in intracellular calcium in these dopamine neurons, and their direct activation can substitute for sugar to form appetitive memory, even in flies lacking octopamine. Analysis of the beta-adrenergic-like OCT beta 2R receptor reveals that octopamine-dependent reinforcement also requires an interaction with dopamine neurons that control appetitive motivation. These data indicate that sweet taste engages a distributed octopamine signal that reinforces memory through discrete subsets of mushroom-body-targeted dopamine neurons. In addition, they reconcile previous findings with octopamine and dopamine and suggest that reinforcement systems in flies are more similar to mammals than previously thought.	[Burke, Christopher J.; Krashes, Michael J.; Waddell, Scott] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Huetteroth, Wolf; Owald, David; Perisse, Emmanuel; Das, Gaurav; Waddell, Scott] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3SR, England; [Gohl, Daryl; Silies, Marion] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Certel, Sarah] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Certel, Sarah] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Oxford; Stanford University; University of Montana System; University of Montana; University of Montana System; University of Montana	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	scott.waddell@cncb.ox.ac.uk	Krashes, Michael/P-7677-2019; Huetteroth, Wolf/L-5252-2019; Huetteroth, Wolf/I-6661-2015; Owald, David/ABB-5432-2020	Huetteroth, Wolf/0000-0003-3421-9935; Waddell, Scott/0000-0003-4503-6229; Perisse, Emmanuel/0000-0002-0830-0687; Gohl, Daryl/0000-0002-4434-2788; Owald, David/0000-0001-7747-7884; Das, Gaurav/0000-0002-3564-5621; Burke, Christopher/0000-0001-7609-1146	EMBO Long-Term Fellowship; Sir Henry Wellcome Postdoctoral Fellowship; Ruth L. Kirschstein NRSA Postdoctoral Fellowship [F32EY020040]; Jane Coffin Childs Postdoctoral Fellowship; Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences; National Institutes of Health [MH069883, MH081982]; Gatsby Charitable Foundation; Oxford Martin School; NATIONAL EYE INSTITUTE [F32EY020040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069883, R01MH081982] Funding Source: NIH RePORTER	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Sir Henry Wellcome Postdoctoral Fellowship; Ruth L. Kirschstein NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Postdoctoral Fellowship; Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; Oxford Martin School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to M. Yoshihara, S. DasGupta, V. Budnik and S. Goodwin for reagents. We thank T. Clandinin and E. Kravitz for collegial exchange. D.O. was supported by an EMBO Long-Term Fellowship and a Sir Henry Wellcome Postdoctoral Fellowship. D.G. was supported by a Ruth L. Kirschstein NRSA Postdoctoral Fellowship (F32EY020040). M.S. was supported by a Jane Coffin Childs Postdoctoral Fellowship. S.W. is funded by a Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences, by grants MH069883 and MH081982 from the National Institutes of Health and by funds from the Gatsby Charitable Foundation and Oxford Martin School.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fujita M, 2011, CURR BIOL, V21, P751, DOI 10.1016/j.cub.2011.03.058; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Han KA, 1998, J NEUROSCI, V18, P3650; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koon AC, 2011, NAT NEUROSCI, V14, P190, DOI 10.1038/nn.2716; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Pitman JL, 2011, CURR BIOL, V21, P855, DOI 10.1016/j.cub.2011.03.069; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yoshihara M, 2012, JOVE-J VIS EXP, DOI 10.3791/3625	37	329	337	6	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					433	+		10.1038/nature11614	http://dx.doi.org/10.1038/nature11614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23103875	Green Submitted, Green Accepted			2022-12-24	WOS:000312488200057
J	Lafaille, FG; Pessach, IM; Zhang, SY; Ciancanelli, MJ; Herman, M; Abhyankar, A; Ying, SW; Keros, S; Goldstein, PA; Mostoslavsky, G; Ordovas-Montanes, J; Jouanguy, E; Plancoulaine, S; Tu, E; Elkabetz, Y; Al-Muhsen, S; Tardieu, M; Schlaeger, TM; Daley, GQ; Abel, L; Casanova, JL; Studer, L; Notarangelo, LD				Lafaille, Fabien G.; Pessach, Itai M.; Zhang, Shen-Ying; Ciancanelli, Michael J.; Herman, Melina; Abhyankar, Avinash; Ying, Shui-Wang; Keros, Sotirios; Goldstein, Peter A.; Mostoslavsky, Gustavo; Ordovas-Montanes, Jose; Jouanguy, Emmanuelle; Plancoulaine, Sabine; Tu, Edmund; Elkabetz, Yechiel; Al-Muhsen, Saleh; Tardieu, Marc; Schlaeger, Thorsten M.; Daley, George Q.; Abel, Laurent; Casanova, Jean-Laurent; Studer, Lorenz; Notarangelo, Luigi D.			Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells	NATURE			English	Article							HERPES-SIMPLEX ENCEPHALITIS; EMBRYONIC STEM-CELLS; TOLL-LIKE RECEPTOR-3; RETICULAR THALAMIC NEURONS; CENTRAL-NERVOUS-SYSTEM; DOUBLE-STRANDED-RNA; TLR3 DEFICIENCY; HUMAN ES; PROTECTIVE IMMUNITY; VIRUS ENCEPHALITIS	In the course of primary infection with herpes simplex virus 1 (HSV-1), children with inborn errors of toll-like receptor 3 (TLR3) immunity are prone to HSV-1 encephalitis (HSE)(1-3). We tested the hypothesis that the pathogenesis of HSE involves non-haematopoietic CNS-resident cells. We derived induced pluripotent stem cells (iPSCs) from the dermal fibroblasts of TLR3- and UNC-93B-deficient patients and from controls. These iPSCs were differentiated into highly purified populations of neural stem cells (NSCs), neurons, astrocytes and oligodendrocytes. The induction of interferon-beta (IFN-beta) and/or IFN-lambda 1 in response to stimulation by the dsRNA analogue polyinosinic: polycytidylic acid (poly(I:C)) was dependent on TLR3 and UNC-93B in all cells tested. However, the induction of IFN-beta and IFN-lambda 1 in response to HSV-1 infection was impaired selectively in UNC-93B-deficient neurons and oligodendrocytes. These cells were also much more susceptible to HSV-1 infection than control cells, whereas UNC-93B-deficient NSCs and astrocytes were not. TLR3-deficient neurons were also found to be susceptible to HSV-1 infection. The rescue of UNC-93B- and TLR3-deficient cells with the corresponding wild-type allele showed that the genetic defect was the cause of the poly(I:C) and HSV-1 phenotypes. The viral infection phenotype was rescued further by treatment with exogenous IFN-alpha or IFN-beta (IFN-alpha/beta) but not IFN-lambda 1. Thus, impaired TLR3- and UNC-93B-dependent IFN-alpha/beta intrinsic immunity to HSV-1 in the CNS, in neurons and oligodendrocytes in particular, may underlie the pathogenesis of HSE in children with TLR3-pathway deficiencies.	[Zhang, Shen-Ying; Ciancanelli, Michael J.; Herman, Melina; Abhyankar, Avinash; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Lafaille, Fabien G.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA; [Lafaille, Fabien G.; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA; [Pessach, Itai M.; Ordovas-Montanes, Jose; Notarangelo, Luigi D.] Harvard Univ, Childrens Hosp, Div Immunol, Sch Med, Boston, MA 02115 USA; [Pessach, Itai M.] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Edmond & Lily Safra Childrens Hosp, IL-52621 Tel Hashomer, Israel; [Pessach, Itai M.] Tel Aviv Univ, Sackler Fac Med, IL-52621 Tel Aviv, Israel; [Zhang, Shen-Ying; Herman, Melina; Jouanguy, Emmanuelle; Abel, Laurent; Casanova, Jean-Laurent] Univ Paris 05, Lab Human Genet Infect Dis, Inst Natl Sante & Rech Med, Necker Med Sch,U980, F-75015 Paris, France; [Ying, Shui-Wang; Goldstein, Peter A.] Weill Cornell Med Coll, CV Starr Lab Mol Neuropharmacol, Dept Anesthesiol, New York, NY 10065 USA; [Keros, Sotirios] Weill Cornell Med Coll, Div Pediat Neurol, Dept Pediat, New York, NY 10065 USA; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Sect Gastroenterol, Dept Med, Boston, MA 02118 USA; [Elkabetz, Yechiel] Tel Aviv Univ, Lab Pluripotent & Neural Stem Cell Biol, Dept Cell & Dev Biol, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Al-Muhsen, Saleh] King Saud Univ, Prince Naif Ctr Immunol Res, Dept Pediat, Coll Med, Riyadh 11451, Saudi Arabia; [Tardieu, Marc] Hop Bicetre, Assistance Publ Hop Paris, Dept Pediat Neurol, F-94275 Le Kremlin Bicetre, France; [Schlaeger, Thorsten M.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Schlaeger, Thorsten M.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Notarangelo, Luigi D.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Harvard Medical School; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cornell University; Cornell University; Boston University; Tel Aviv University; Sackler Faculty of Medicine; King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital	Zhang, SY (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.	shzh289@rockefeller.edu; jean-laurent.casanova@rockefeller.edu	Jouanguy, Emmanuelle/H-7901-2017; PLANCOULAINE, Sabine/E-2824-2017; Al-muhsen, saleh/E-9315-2014; Studer, Lorenz/ABH-1491-2021; Zhang, Shen-Ying/I-2685-2017; Casanova, Jean-Laurent/I-3418-2017; Abel, Laurent/H-8888-2017; Notarangelo, Luigi D/F-9718-2016	Jouanguy, Emmanuelle/0000-0002-7358-9157; PLANCOULAINE, Sabine/0000-0003-0725-8306; Al-muhsen, saleh/0000-0003-3698-9968; Studer, Lorenz/0000-0003-0741-7987; Zhang, Shen-Ying/0000-0002-9449-3672; Abel, Laurent/0000-0001-7016-6493; Notarangelo, Luigi D/0000-0002-8335-0262; Goldstein, Peter/0000-0002-5973-9104; Casadio, Melina/0000-0003-2389-2243; Casanova, Jean-Laurent/0000-0002-7782-4169; Ciancanelli, Michael/0000-0002-4623-852X; Keros, Sotirios/0000-0001-9264-9824; Mostoslavsky, Gustavo/0000-0002-0784-2169; Schlaeger, Thorsten/0000-0002-1599-9908; Ordovas-Montanes, Jose/0000-0001-5444-5601	National Center for Translational Sciences (NCATS) [8UL1TR000043]; National Institutes of Health (NIH); Rockefeller University; St. Giles Foundation; ANR; INSERM; Paris Descartes University; March of Dimes; NIH [5R01NS072381-02, 1R03AI0883502-01, 1R01NS066390]; Manton Foundation; Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease [41/11]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI088352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066390, K12NS066274] Funding Source: NIH RePORTER	National Center for Translational Sciences (NCATS); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; St. Giles Foundation; ANR(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manton Foundation; Israeli Centers of Research Excellence (I-CORE); Gene Regulation in Complex Human Disease; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank our patients, their families and physicians; and the members of the three laboratories for helpful discussions and critical reading of this manuscript. The work was funded by grant number 8UL1TR000043 from the National Center for Translational Sciences (NCATS), the National Institutes of Health (NIH), the Rockefeller University, the St. Giles Foundation, the ANR, INSERM, Paris Descartes University, the March of Dimes, NIH grant 5R01NS072381-02 (to J.-L.C., L.S. and L.D.N.), NIH grant 1R03AI0883502-01 (to L.D.N.), NIH grant 1R01NS066390 and the Manton Foundation, the Israeli Centers of Research Excellence (I-CORE), and Gene Regulation in Complex Human Disease, Center No 41/11 (to I.M.P.). F.G.L. is supported by the New York Stem Cell Foundation.	Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bello-Morales R, 2005, J NEUROVIROL, V11, P190, DOI 10.1080/13550280590924179; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jackson AC, 2006, J NEUROVIROL, V12, P229, DOI 10.1080/13550280600848399; JACQUEMONT B, 1975, J VIROL, V15, P707, DOI 10.1128/JVI.15.4.707-713.1975; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lokensgard JR, 2001, J NEUROVIROL, V7, P208; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitchell BM, 2003, J NEUROVIROL, V9, P194, DOI 10.1080/13550280390194000; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pessach IM, 2011, J ALLERGY CLIN IMMUN, V127, P1400, DOI 10.1016/j.jaci.2010.11.008; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Ying SW, 2005, J NEUROPHYSIOL, V93, P1935, DOI 10.1152/jn.01058.2004; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhou L, 2009, NEUROSCIENCE, V159, P629, DOI 10.1016/j.neuroscience.2008.12.036	42	234	238	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					769	+		10.1038/nature11583	http://dx.doi.org/10.1038/nature11583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23103873	Green Submitted, Green Accepted			2022-12-24	WOS:000311606000048
J	Stern-Ginossar, N; Weisburd, B; Michalski, A; Vu, TKL; Hein, MY; Huang, SX; Ma, M; Shen, B; Qian, SB; Hengel, H; Mann, M; Ingolia, NT; Weissman, JS				Stern-Ginossar, Noam; Weisburd, Ben; Michalski, Annette; Vu Thuy Khanh Le; Hein, Marco Y.; Huang, Sheng-Xiong; Ma, Ming; Shen, Ben; Qian, Shu-Bing; Hengel, Hartmut; Mann, Matthias; Ingolia, Nicholas T.; Weissman, Jonathan S.			Decoding Human Cytomegalovirus	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; PROTEIN	The human cytomegalovirus (HCMV) genome was sequenced 20 years ago. However, like those of other complex viruses, our understanding of its protein coding potential is far from complete. We used ribosome profiling and transcript analysis to experimentally define the HCMV translation products and follow their temporal expression. We identified hundreds of previously unidentified open reading frames and confirmed a fraction by means of mass spectrometry. We found that regulated use of alternative transcript start sites plays a broad role in enabling tight temporal control of HCMV protein expression and allowing multiple distinct polypeptides to be generated from a single genomic locus. Our results reveal an unanticipated complexity to the HCMV coding capacity and illustrate the role of regulated changes in transcript start sites in generating this complexity.	[Michalski, Annette; Hein, Marco Y.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Stern-Ginossar, Noam; Weisburd, Ben; Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisico, CA 94158 USA; [Vu Thuy Khanh Le; Hengel, Hartmut] Univ Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; [Huang, Sheng-Xiong; Ma, Ming; Shen, Ben] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Shen, Ben] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Shen, Ben] Scripps Res Inst, Nat Prod Lib Initiat, Jupiter, FL 33458 USA; [Qian, Shu-Bing] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Max Planck Society; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Cornell University	Michalski, A (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany.	michalsk@biochem.mpg.de; weissman@cmp.ucsf.edu	Hein, Marco/C-2994-2014; Mann, Matthias/A-3454-2013; Le-Trilling, Vu Thuy Khanh/AAW-3600-2020	Hein, Marco/0000-0002-9490-2261; Mann, Matthias/0000-0003-1292-4799; Le-Trilling, Vu Thuy Khanh/0000-0002-2733-3732; Weisburd, Ben/0000-0001-9898-9109; Weissman, Jonathan/0000-0003-2445-670X; Huang, Sheng-Xiong/0000-0002-3616-8556; , Noam/0000-0003-3583-5932	human frontier science program postdoctoral fellowship; Howard Hughes Medical Institute; Max Planck Society; NATIONAL CANCER INSTITUTE [R01CA106150] Funding Source: NIH RePORTER	human frontier science program postdoctoral fellowship(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Max Planck Society(Max Planck Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank O. Mandelboim, D. Wolf, M. Trilling, A. Lauring, S. Karniely, and Weissman lab members for critical reading of the manuscript; C. Chu for assistance with sequencing; and J. Pelletier for providing Pateamine A. N.S.-G. is supported by a human frontier science program postdoctoral fellowship. This work was supported by the Howard Hughes Medical Institute (J. S. W.) and the Max Planck Society (M. M.). The Gene Expression Omnibus accession number for the data is GSE41605.	Biegalke BJ, 2004, J VIROL, V78, P9579, DOI 10.1128/JVI.78.17.9579-9583.2004; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; FIERS W, 1978, NATURE, V273, P113, DOI 10.1038/273113a0; Gatherer D, 2011, P NATL ACAD SCI USA, V108, P19755, DOI 10.1073/pnas.1115861108; Grainger L, 2010, J VIROL, V84, P9472, DOI 10.1128/JVI.00855-10; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Joachim T., 1998, MAKING LARGE SCALE S, P169, DOI DOI 10.17877/DE290R-5098; LEACH FS, 1989, J VIROL, V63, P1783, DOI 10.1128/JVI.63.4.1783-1791.1989; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; LORD PCW, 1989, J GEN VIROL, V70, P2383, DOI 10.1099/0022-1317-70-9-2383; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; Qian ZK, 2008, J VIROL, V82, P3452, DOI 10.1128/JVI.01964-07; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Robert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005428; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stamminger T, 2002, J VIROL, V76, P4836, DOI 10.1128/JVI.76.10.4836-4847.2002; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Zhang GJ, 2007, J VIROL, V81, P11267, DOI 10.1128/JVI.00007-07	24	409	417	5	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1088	1093		10.1126/science.1227919	http://dx.doi.org/10.1126/science.1227919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180859	Green Accepted			2022-12-24	WOS:000311390600046
J	Sienski, G; Donertas, D; Brennecke, J				Sienski, Grzegorz; Doenertas, Derya; Brennecke, Julius			Transcriptional Silencing of Transposons by Piwi and Maelstrom and Its Impact on Chromatin State and Gene Expression	CELL			English	Article							PRIMARY PIRNA BIOGENESIS; SMALL RNAS; EPIGENETIC MEMORY; DROSOPHILA; HETEROCHROMATIN; PROTEIN; METHYLATION; GERMLINE; PATHWAY; ROLES	Eukaryotic genomes are colonized by transposons whose uncontrolled activity causes genomic instability. The piRNA pathway silences transposons in animal gonads, yet how this is achieved molecularly remains controversial. Here, we show that the HMG protein Maelstrom is essential for Piwi-mediated silencing in Drosophila. Genome-wide assays revealed highly correlated changes in RNA polymerase II recruitment, nascent RNA output, and steady-state RNA levels of transposons upon loss of Piwi or Maelstrom. Our data demonstrate piRNA-mediated trans-silencing of hundreds of transposon copies at the transcriptional level. We show that Piwi is required to establish heterochromatic H3K9me3 marks on transposons and their genomic surroundings. In contrast, loss of Maelstrom affects transposon H3K9me3 patterns only mildly yet leads to increased heterochromatin spreading, suggesting that Maelstrom acts downstream of or in parallel to H3K9me3. Our work illustrates the widespread influence of transposons and the piRNA pathway on chromatin patterns and gene expression.	[Sienski, Grzegorz; Doenertas, Derya; Brennecke, Julius] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Brennecke, J (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	julius.brennecke@imba.oeaw.ac.at	Brennecke, Julius/C-1626-2015; Brennecke, Julius/T-5883-2019	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814	Austrian Academy of Sciences; European Community's 7th Framework Programme [FP7/2007-2013]; ERC grant [260711EU]; Austrian Science Fund (FWF) [Y 510-B12]; Boehringer Ingelheim Fonds; Austrian Science Fund (FWF) [Y 510] Funding Source: researchfish	Austrian Academy of Sciences; European Community's 7th Framework Programme; ERC grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank K. Adelman for alpha-Rbp3; M. Siomi for OSCs and alpha-Armi; M. Madalinski for antibody purifications; S. Lopez for fly injections; the VDRC; A. Pelisson and H. Ruohola-Baker for fly strains; D. Jurczak, A. Stark, D. Gerlach, R. Maier and R. Sachidanandam for help with bioinformatics; and the CSF NGS unit for deep sequencing. We thank S. Grewal and D. Moazed for inspiring discussions and comments on the manuscript. The Brennecke laboratory is supported by the Austrian Academy of Sciences, the European Community's 7th Framework Programme (FP7/2007-2013; ERC grant # 260711EU), and the Austrian Science Fund (FWF; Y 510-B12). G.S. is supported by the Boehringer Ingelheim Fonds. G.S., D.D., and J.B. designed the experiments. G.S. and D.D. performed the experiments. G.S. performed the computational analysis. G.S., D.D., and JB analyzed the data and wrote the paper.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dufourt J, 2011, DNA RES, V18, P451, DOI 10.1093/dnares/dsr031; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Luteijn MJ, 2012, EMBO J, V31, P3422, DOI 10.1038/emboj.2012.213; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Moshkovich N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000880; Niki Y, 2006, P NATL ACAD SCI USA, V103, P16325, DOI 10.1073/pnas.0607435103; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Patil VS, 2010, CURR BIOL, V20, P724, DOI 10.1016/j.cub.2010.02.046; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Shpiz S, 2011, NUCLEIC ACIDS RES, V39, P8703, DOI 10.1093/nar/gkr552; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Zhang DP, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-48; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	39	407	423	3	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					964	980		10.1016/j.cell.2012.10.040	http://dx.doi.org/10.1016/j.cell.2012.10.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23159368	Green Published, hybrid			2022-12-24	WOS:000311423500011
J	Bell, JC; Plank, JL; Dombrowski, CC; Kowalczykowski, SC				Bell, Jason C.; Plank, Jody L.; Dombrowski, Christopher C.; Kowalczykowski, Stephen C.			Direct imaging of RecA nucleation and growth on single molecules of SSB-coated ssDNA	NATURE			English	Article							DNA-BINDING-PROTEIN; STRANDED NUCLEIC-ACIDS; ESCHERICHIA-COLI; GENETIC-RECOMBINATION; E. COLI; FILAMENTS; EXCHANGE; MECHANISM; DYNAMICS; KINETICS	Escherichia coli RecA is the defining member of a ubiquitous class of DNA strand-exchange proteins that are essential for homologous recombination, a pathway that maintains genomic integrity by repairing broken DNA(1). To function, filaments of RecA must nucleate and grow on single-stranded DNA (ssDNA) in direct competition with ssDNA-binding protein (SSB), which rapidly binds and continuously sequesters ssDNA, kinetically blocking RecA assembly(2,3). This dynamic self-assembly on a DNA lattice, in competition with another protein, is unique for the RecA family compared to other filament-forming proteins such as actin and tubulin. The complexity of this process has hindered our understanding of RecA filament assembly because ensemble measurements cannot reliably distinguish between the nucleation and growth phases, despite extensive and diverse attempts(2-5). Previous single-molecule assays have measured the nucleation and growth of RecA-and its eukaryotic homologue RAD51-on naked double-stranded DNA and ssDNA(6-12); however, the template for RecA self-assembly in vivo is SSB-coated ssDNA(3). Using single-molecule microscopy, here we directly visualize RecA filament assembly on single molecules of SSB-coated ssDNA, simultaneously measuring nucleation and growth. We establish that a dimer of RecA is required for nucleation, followed by growth of the filament through monomer addition, consistent with the finding that nucleation, but not growth, is modulated by nucleotide and magnesium ion cofactors. Filament growth is bidirectional, albeit faster in the 5'-> 3' direction. Both nucleation and growth are repressed at physiological conditions, highlighting the essential role of recombination mediators in potentiating assembly in vivo. We define a two-step kinetic mechanism in which RecA nucleates on transiently exposed ssDNA during SSB sliding and/or partial dissociation (DNA unwrapping) and then the RecA filament grows. We further demonstrate that the recombination mediator protein pair, RecOR (RecO and RecR), accelerates both RecA nucleation and filament growth, and that the introduction of RecF further stimulates RecA nucleation.	[Bell, Jason C.; Plank, Jody L.; Dombrowski, Christopher C.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Bell, Jason C.; Plank, Jody L.; Dombrowski, Christopher C.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Bell, Jason C.; Kowalczykowski, Stephen C.] Univ Calif Davis, Biochem & Mol Biol Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Plank, Jody/0000-0002-8025-7935; Bell, Jason/0000-0001-5480-7975	National Institutes of Health (NIH) [T32 GM007377, CA10052159, CA136103, GM62653, GM64745]; NATIONAL CANCER INSTITUTE [F32CA136103, T32CA108459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064745, R01GM062653, R37GM062653, T32GM007377] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the laboratory for their comments on this work. J.C.B. was funded by a National Institutes of Health (NIH) Predoctoral Training Program in Molecular & Cellular Biology (T32 GM007377); C. C. D. and J.L.P. were funded by the NIH T32 Training Program in Oncogenic Signals and Chromosome Biology (CA10052159); J.L.P. was also funded by a NIH Postdoctoral Fellowship (CA136103); and S. C. K. was supported by the NIH (GM62653 and GM64745).	Bell J. C., 2011, THESIS U CALIFORNIA; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; CAZENAVE C, 1983, EMBO J, V2, P2247, DOI 10.1002/j.1460-2075.1983.tb01730.x; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Dillingham MS, 2008, BIOPHYS J, V95, P3330, DOI 10.1529/biophysj.108.133512; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Handa N, 2009, J BIOL CHEM, V284, P18664, DOI 10.1074/jbc.M109.004895; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; KOWALCZYKOWSKI S, 1977, J MOL BIOL, V115, P201, DOI 10.1016/0022-2836(77)90097-3; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; Kuznetsov SV, 2006, J MOL BIOL, V359, P55, DOI 10.1016/j.jmb.2006.02.070; LOHMAN TM, 1981, J MOL BIOL, V152, P67, DOI 10.1016/0022-2836(81)90096-6; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Napolitano MA, 2007, J CELL SCI, V120, P2904, DOI 10.1242/jcs.004002; Plank JL, 2006, J BIOL CHEM, V281, P17510, DOI 10.1074/jbc.M602933200; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Shivashankar GV, 1999, P NATL ACAD SCI USA, V96, P7916, DOI 10.1073/pnas.96.14.7916; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; THRESHER RJ, 1988, J MOL BIOL, V201, P101, DOI 10.1016/0022-2836(88)90442-1; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629	35	109	110	2	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					274	U144		10.1038/nature11598	http://dx.doi.org/10.1038/nature11598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23103864	Green Accepted, Green Submitted			2022-12-24	WOS:000310774300048
J	Santos, ME; Salzburger, W				Santos, M. Emilia; Salzburger, Walter			How Cichlids Diversify	SCIENCE			English	Editorial Material							ADAPTIVE RADIATION; EVOLUTION; SPECIATION; SELECTION; FISHES		[Santos, M. Emilia; Salzburger, Walter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland	University of Basel	Santos, ME (corresponding author), Univ Basel, Inst Zool, Vesalgasse 1, CH-4051 Basel, Switzerland.	emilia.santos@unibas.ch; walter.salzburger@unibas.ch	Salzburger, Walter/G-1598-2011	Salzburger, Walter/0000-0002-9988-1674; Santos, M. Emilia/0000-0003-3158-7935				Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; Barlow GW., 2000, CICHLID FISHES NATUR; Colombo M, 2013, MOL ECOL, V22, P670, DOI 10.1111/mec.12029; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; Fryer G., 1972, CICHLID FISHES GREAT; Fujimura K, 2011, AQUACULTURE, V319, P342, DOI 10.1016/j.aquaculture.2011.07.021; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Kidd MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031236; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Loh YHE, 2011, GENOME BIOL EVOL, V3, P55, DOI 10.1093/gbe/evq085; Manousaki T, 2013, MOL ECOL, V22, P650, DOI 10.1111/mec.12034; Miyagi R, 2012, MOL BIOL EVOL, V29, P3281, DOI 10.1093/molbev/mss139; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144	17	42	43	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					619	621		10.1126/science.1224818	http://dx.doi.org/10.1126/science.1224818			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118176				2022-12-24	WOS:000310516000037
J	Langecker, M; Arnaut, V; Martin, TG; List, J; Renner, S; Mayer, M; Dietz, H; Simmel, FC				Langecker, Martin; Arnaut, Vera; Martin, Thomas G.; List, Jonathan; Renner, Stephan; Mayer, Michael; Dietz, Hendrik; Simmel, Friedrich C.			Synthetic Lipid Membrane Channels Formed by Designed DNA Nanostructures	SCIENCE			English	Article							SOLID-STATE NANOPORES; SINGLE-NUCLEOTIDE RESOLUTION; HAIRPIN MOLECULES; NANOSCALE SHAPES; ALPHA-HEMOLYSIN; FOLDING DNA; ORIGAMI; PORE	We created nanometer-scale transmembrane channels in lipid bilayers by means of self-assembled DNA-based nanostructures. Scaffolded DNA origami was used to create a stem that penetrated and spanned a lipid membrane, as well as a barrel-shaped cap that adhered to the membrane, in part via 26 cholesterol moieties. In single-channel electrophysiological measurements, we found similarities to the response of natural ion channels, such as conductances on the order of 1 nanosiemens and channel gating. More pronounced gating was seen for mutations in which a single DNA strand of the stem protruded into the channel. Single-molecule translocation experiments show that the synthetic channels can be used to discriminate single DNA molecules.	[Martin, Thomas G.; Dietz, Hendrik] Tech Univ Munich, Dept Phys, Walter Schottky Inst, D-85748 Garching, Germany; [Langecker, Martin; Arnaut, Vera; List, Jonathan; Renner, Stephan; Simmel, Friedrich C.] Tech Univ Munich, Dept Phys, Lehrstuhl Bioelekt, D-85748 Garching, Germany; [Langecker, Martin; Arnaut, Vera; List, Jonathan; Renner, Stephan; Simmel, Friedrich C.] Tech Univ Munich, ZNN WSI, D-85748 Garching, Germany; [Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Michigan System; University of Michigan	Dietz, H (corresponding author), Tech Univ Munich, Dept Phys, Walter Schottky Inst, D-85748 Garching, Germany.	dietz@tum.de; simmel@tum.de	Simmel, Friedrich/G-3281-2010; Mayer, Michael/C-1299-2010; Mayer, Michael/AAS-1777-2020	Simmel, Friedrich/0000-0003-3829-3446; Mayer, Michael/0000-0002-6148-5756; Dietz, Hendrik/0000-0003-1270-3662; List, Jonathan/0000-0001-8408-0877	Deutsche Forschungsgemeinschaft [SFB 863]; Bundesministerium fur Bildung und Forschung [13N10970]; European Research Council [GA 256270]; Technische Universitat Munchen Institute for Advanced Study; NIH [1R01GM081705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081705] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission); Technische Universitat Munchen Institute for Advanced Study; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Deutsche Forschungsgemeinschaft [grant SFB 863 and Excellence Clusters NIM (Nanosystems Initiative Munich) and CIPSM (Center for Integrated Protein Science Munich)], the Bundesministerium fur Bildung und Forschung (grant 13N10970), the European Research Council (starting grant GA 256270, H. D.), the Technische Universitat Munchen Institute for Advanced Study, and NIH grant 1R01GM081705 (M. M.). We thank M. Hiller and A. Bessonov for preliminary work, G. Baaken and J. Behrends for kindly providing the MECA chips, and A. Seifert, M. Beckler, and N. Fertig for technical support with the Orbit setup. M. M., H. D., and F. C. S. designed the research; M. L., V. A., and S. R. performed electrophysiological experiments; T. G. M. prepared the synthetic DNA channels and performed TEM; J. L., V. A., and T. G. M. performed experiments with lipid vesicles; and H. D. and F. C. S. wrote the paper. All authors discussed the results and commented on the manuscript.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Baaken G, 2008, LAB CHIP, V8, P938, DOI 10.1039/b800431e; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bell NAW, 2012, NANO LETT, V12, P512, DOI 10.1021/nl204098n; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Danelon C, 2006, BIOPHYS J, V90, P1617, DOI 10.1529/biophysj.105.075192; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Hall AR, 2010, NAT NANOTECHNOL, V5, P874, DOI [10.1038/nnano.2010.237, 10.1038/NNANO.2010.237]; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Mathe J, 2004, BIOPHYS J, V87, P3205, DOI 10.1529/biophysj.104.047274; Renner S, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558902; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sakmann B., 1995, SINGLE CHANNEL RECOR; Sauer-Budge AF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238101; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Vercoutere W, 2001, NAT BIOTECHNOL, V19, P248, DOI 10.1038/85696; Wei RS, 2012, ANGEW CHEM INT EDIT, V51, P4864, DOI 10.1002/anie.201200688	27	508	572	26	465	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					932	936		10.1126/science.1225624	http://dx.doi.org/10.1126/science.1225624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161995	Green Accepted			2022-12-24	WOS:000311083600039
J	O'Roak, BJ; Vives, L; Fu, WQ; Egertson, JD; Stanaway, IB; Phelps, IG; Carvill, G; Kumar, A; Lee, C; Ankenman, K; Munson, J; Hiatt, JB; Turner, EH; Levy, R; O'Day, DR; Krumm, N; Coe, BP; Martin, BK; Borenstein, E; Nickerson, DA; Mefford, HC; Doherty, D; Akey, JM; Bernier, R; Eichler, EE; Shendure, J				O'Roak, Brian J.; Vives, Laura; Fu, Wenqing; Egertson, Jarrett D.; Stanaway, Ian B.; Phelps, Ian G.; Carvill, Gemma; Kumar, Akash; Lee, Choli; Ankenman, Katy; Munson, Jeff; Hiatt, Joseph B.; Turner, Emily H.; Levy, Roie; O'Day, Diana R.; Krumm, Niklas; Coe, Bradley P.; Martin, Beth K.; Borenstein, Elhanan; Nickerson, Deborah A.; Mefford, Heather C.; Doherty, Dan; Akey, Joshua M.; Bernier, Raphael; Eichler, Evan E.; Shendure, Jay			Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders	SCIENCE			English	Article							DE-NOVO MUTATIONS; DYRK1A; AMPLIFICATION; RISK	Exome sequencing studies of autism spectrum disorders (ASDs) have identified many de novo mutations but few recurrently disrupted genes. We therefore developed a modified molecular inversion probe method enabling ultra-low-cost candidate gene resequencing in very large cohorts. To demonstrate the power of this approach, we captured and sequenced 44 candidate genes in 2446 ASD probands. We discovered 27 de novo events in 16 genes, 59% of which are predicted to truncate proteins or disrupt splicing. We estimate that recurrent disruptive mutations in six genes-CHD8, DYRK1A, GRIN2B, TBR1, PTEN, and TBL1XR1-may contribute to 1% of sporadic ASDs. Our data support associations between specific genes and reciprocal subphenotypes (CHD8-macrocephaly and DYRK1A-microcephaly) and replicate the importance of a beta-catenin-chromatin-remodeling network to ASD etiology.	[O'Roak, Brian J.; Vives, Laura; Fu, Wenqing; Egertson, Jarrett D.; Stanaway, Ian B.; Kumar, Akash; Lee, Choli; Hiatt, Joseph B.; Turner, Emily H.; Levy, Roie; Krumm, Niklas; Coe, Bradley P.; Martin, Beth K.; Borenstein, Elhanan; Nickerson, Deborah A.; Akey, Joshua M.; Eichler, Evan E.; Shendure, Jay] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Phelps, Ian G.; Carvill, Gemma; O'Day, Diana R.; Mefford, Heather C.; Doherty, Dan] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Phelps, Ian G.; Carvill, Gemma; Mefford, Heather C.; Doherty, Dan] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Ankenman, Katy; Munson, Jeff; Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu; shendure@uw.edu	Shendure, Jay/AAU-3684-2021; Coe, Bradley/A-2878-2009	O'Roak, Brian/0000-0002-4141-0095; Martin, Beth/0000-0002-9661-014X; Akey, Joshua/0000-0002-4411-1330; Shendure, Jay/0000-0002-1516-1865; Coe, Bradley/0000-0001-8471-4016; Kumar, Akash/0000-0001-9442-3597; Turner, Emily/0000-0001-9040-9229	National Heart, Lung, and Blood Institute, NIH Grand Opportunity (GO) Exome Sequencing Project; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Simons Foundation [SFARI 137578, 191889]; NIH [HD065285, NS069605, R01 NS064077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102926, UC2HL103010, UC2HL102924, RC2HL102924, RC2HL102923, RC2HL102926, RC2HL103010, UC2HL102923, UC2HL102925, RC2HL102925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605, R56NS069605, R01NS064077] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, NIH Grand Opportunity (GO) Exome Sequencing Project; Lung GO Sequencing Project; Women's Health Initiative Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the National Heart, Lung, and Blood Institute, NIH Grand Opportunity (GO) Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010); we also thank B. Vernot, M. Dennis, T. Brown, and other members of the Eichler and Shendure labs for helpful discussions. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, E. Wijsman). We appreciate obtaining access to phenotypic data on the Simons Foundation Autism Research Initiative (SFARI) Base. Approved researchers can obtain the SSC population dataset described in this study (https://ordering.base.sfari.org/similar to browse_collection/archive[ssc_v13]/ui:view) by applying at https://base.sfari.org. This work was supported by grants from the Simons Foundation (SFARI 137578, 191889 to E. E. E., J.S., and R. B.), NIH HD065285 (E. E. E. and J.S.), NIH NS069605 (H. C. M.), and R01 NS064077 (D. D.). E. B. is an Alfred P. Sloan Research Fellow. E. E. E. is an Investigator of the Howard Hughes Medical Institute. Scientific advisory boards or consulting affiliations: Ariosa Diagnostics (J.S.), Stratos Genomics (J.S.), Good Start Genetics (J.S.), Adaptive Biotechnologies (J. S.), Pacific Biosciences (E. E. E.), SynapDx (E. E. E.), DNAnexus (E. E. E.), and SFARI GENE (H. C. M.). B.J.O. is an inventor on patent PCT/US2009/30620: Mutations in contactin associated protein 2 are associated with increased risk for idiopathic autism. Raw sequencing data available at the National Database for Autism Research, NDARCOL1878.	Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Guedj F, 2012, NEUROBIOL DIS, V46, P190, DOI 10.1016/j.nbd.2012.01.007; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; Williams CA, 2008, AM J MED GENET A, V146A, P2023, DOI 10.1002/ajmg.a.32434; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004	21	863	901	6	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1619	1622		10.1126/science.1227764	http://dx.doi.org/10.1126/science.1227764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23160955	Green Accepted			2022-12-24	WOS:000312533100053
J	Rincon-Arano, H; Halow, J; Delrow, JJ; Parkhurst, SM; Groudine, M				Rincon-Arano, Hector; Halow, Jessica; Delrow, Jeffrey J.; Parkhurst, Susan M.; Groudine, Mark			UpSET Recruits HDAC Complexes and Restricts Chromatin Accessibility and Acetylation at Promoter Regions	CELL			English	Article							SET-DOMAIN PROTEIN; RNA-POLYMERASE-II; NUCLEOSOME ORGANIZATION; DROSOPHILA GENOME; INACTIVE GENES; IN-VIVO; MLL5; METHYLTRANSFERASE; METHYLATION; H3K4	Developmental gene expression results from the orchestrated interplay between genetic and epigenetic mechanisms. Here, we describe upSET, a transcriptional regulator encoding a SET domain-containing protein recruited to active and inducible genes in Drosophila. However, unlike other Drosophila SET proteins associated with gene transcription, UpSET is part of an Rpd3/Sin3-containing complex that restricts chromatin accessibility and histone acetylation to promoter regions. In the absence of UpSET, active chromatin marks and chromatin accessibility increase and spread to genic and flanking regions due to destabilization of the histone deacetylase complex. Consistent with this, transcriptional noise increases, as manifest by activation of repetitive elements and off-target genes. Interestingly, upSET mutant flies are female sterile due to upregulation of key components of Notch signaling during oogenesis. Thus UpSET defines a class of metazoan transcriptional regulators required to fine tune transcription by preventing the spread of active chromatin.	[Rincon-Arano, Hector; Halow, Jessica; Parkhurst, Susan M.; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Groudine, Mark] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Groudine, M (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	markg@fhcrc.org	Halow, Jessica/GQO-7562-2022	Parkhurst, Susan/0000-0001-5806-9930	NIH [GM073021, GM097083, DK44746, HL65440]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044746, R37DK044746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097083, R01GM073021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jorja Henikoff, Steve Henikoff, and Galina Filippova for their interest, advice and comments on the manuscript. We thank Jorja Henikoff, Ryan Basom and Janet Young for bioinformatic help. We also thank Erika Bach, Al Courey, Barry Honda, Steven Hou, Lori Pile, Liz Wayner, the Harvard Exelixis Collection, the Bloomington/Kyoto Stock Centers, and the Developmental Studies Hybridoma Bank for antibodies, flies and other reagents used in this study. This work was supported by NIH grants GM073021 and GM097083 (to SMP) and DK44746 and HL65440 (to MG).	Abed M, 2009, METHODS MOL BIOL, V567, P155, DOI 10.1007/978-1-60327-414-2_11; Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Buratowski S, 2010, COLD SH Q B, V75, P95, DOI 10.1101/sqb.2010.75.036; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Castaneda J, 2011, MUTAT RES-FUND MOL M, V714, P95, DOI 10.1016/j.mrfmmm.2011.05.002; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Hallson G, 2012, GENETICS, V190, P91, DOI 10.1534/genetics.111.135863; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; KAMINKER JS, 2002, GENOME BIOL, V0003; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	46	38	40	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1214	1228		10.1016/j.cell.2012.11.009	http://dx.doi.org/10.1016/j.cell.2012.11.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23177352	Green Accepted, Bronze			2022-12-24	WOS:000311999900012
J	Dethoff, EA; Petzold, K; Chugh, J; Casiano-Negroni, A; Al-Hashimi, HM				Dethoff, Elizabeth A.; Petzold, Katja; Chugh, Jeetender; Casiano-Negroni, Anette; Al-Hashimi, Hashim M.			Visualizing transient low-populated structures of RNA	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 TAR RNA; RELAXATION DISPERSION NMR; LEAD-DEPENDENT RIBOZYME; 16S RIBOSOMAL-RNA; NUCLEOCAPSID PROTEIN; MOLECULAR-DYNAMICS; SPIN RELAXATION; INITIATION SITE; LOOP SEQUENCE	The visualization of RNA conformational changes has provided fundamental insights into how regulatory RNAs carry out their biological functions. The RNA structural transitions that have been characterized so far involve long-lived species that can be captured by structure characterization techniques. Here we report the nuclear magnetic resonance visualization of RNA transitions towards 'invisible' excited states (ESs), which exist in too little abundance (2-13%) and for too short a duration (45-250 ms) to allow structural characterization by conventional techniques. Transitions towards ESs result in localized rearrangements in base-pairing that alter building block elements of RNA architecture, including helix-junction-helix motifs and apical loops. The ES can inhibit function by sequestering residues involved in recognition and signalling or promote ATP-independent strand exchange. Thus, RNAs do not adopt a single conformation, but rather exist in rapid equilibrium with alternative ESs, which can be stabilized by cellular cues to affect functional outcomes.	[Dethoff, Elizabeth A.; Petzold, Katja; Chugh, Jeetender; Casiano-Negroni, Anette; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	hashimi@umich.edu	Petzold, Katja/E-9816-2011; Chugh, Jeetender/S-4436-2019; Petzold, Katja/M-7298-2015	Petzold, Katja/0000-0001-9470-0347; Chugh, Jeetender/0000-0002-9996-5202; Petzold, Katja/0000-0001-9470-0347	Michigan Economic Development Cooperation; Michigan Technology Tri-Corridor; Swedish Research Council [VR-K2011-78PK-21662-0-12]; US National Institutes of Health [R01 Al066975]; University of Michigan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066975] Funding Source: NIH RePORTER	Michigan Economic Development Cooperation; Michigan Technology Tri-Corridor; Swedish Research Council(Swedish Research CouncilEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E.A.D., K.P. and J.C contributed equally to this work. We thank members of the Al-Hashimi laboratory for input. We acknowledge the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for the support of the purchase of a 600 MHz spectrometer. K.P. is supported by a postdoctoral Fellowship from the Swedish Research Council (VR-K2011-78PK-21662-0-12). This work was supported by the US National Institutes of Health (R01 Al066975) and by a Rackham Graduate Student Research Grant awarded by the University of Michigan.	Baldwin AJ, 2009, J AM CHEM SOC, V131, P11939, DOI 10.1021/ja903896p; Bannwarth S, 2005, CURR HIV RES, V3, P61, DOI 10.2174/1570162052772924; BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Blad H, 2005, J MOL BIOL, V353, P540, DOI 10.1016/j.jmb.2005.08.030; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Dahlquist KD, 2000, J MOL BIOL, V299, P1, DOI 10.1006/jmbi.2000.3672; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dethoff EA, 2008, BIOPHYS J, V95, P3906, DOI 10.1529/biophysj.108.140285; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Fares C, 2007, J AM CHEM SOC, V129, P15814, DOI 10.1021/ja0727417; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; GHOSE R, 1994, J AM CHEM SOC, V116, P8827, DOI 10.1021/ja00098a060; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoogstraten CG, 2000, BIOCHEMISTRY-US, V39, P9951, DOI 10.1021/bi0007627; JAEGER JA, 1993, BIOCHEMISTRY-US, V32, P12522, DOI 10.1021/bi00097a032; Johnson JE, 2008, J AM CHEM SOC, V130, P16757, DOI 10.1021/ja805759z; Kipper K, 2009, J MOL BIOL, V385, P405, DOI 10.1016/j.jmb.2008.10.065; Korzhnev DM, 2005, J AM CHEM SOC, V127, P713, DOI 10.1021/ja0446855; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Kulinski T, 2003, J BIOL CHEM, V278, P38892, DOI 10.1074/jbc.M301939200; Lawrence DC, 2003, J MOL BIOL, V326, P529, DOI 10.1016/S0022-2836(02)01305-0; Legault P, 1997, J AM CHEM SOC, V119, P6621, DOI 10.1021/ja9640051; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Moore MD, 2009, AIDS REV, V11, P91; Mujeeb A, 2007, NUCLEIC ACIDS RES, V35, P2026, DOI 10.1093/nar/gkm097; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; OConnor M, 1997, NUCLEIC ACIDS RES, V25, P1185, DOI 10.1093/nar/25.6.1185; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Richter S, 2002, BIOCHEMISTRY-US, V41, P6391, DOI 10.1021/bi0159579; Rist MJ, 2002, BIOCHEMISTRY-US, V41, P14762, DOI 10.1021/bi0267240; Romanowska J, 2008, J PHYS CHEM B, V112, P15227, DOI 10.1021/jp806814s; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Shandrick S, 2004, ANGEW CHEM INT EDIT, V43, P3177, DOI 10.1002/anie.200454217; Snoussi K, 2001, BIOCHEMISTRY-US, V40, P8898, DOI 10.1021/bi010385d; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sun XY, 2007, NUCLEIC ACIDS RES, V35, P1698, DOI 10.1093/nar/gkm020; Takahashi KI, 2000, RNA, V6, P96, DOI 10.1017/S1355838200991635; Turner KB, 2007, J MOL BIOL, V369, P812, DOI 10.1016/j.jmb.2007.03.065; Ulyanov NB, 2006, J BIOL CHEM, V281, P16168, DOI 10.1074/jbc.M601711200; Vallurupalli P, 2011, J PHYS CHEM B, V115, P14891, DOI 10.1021/jp209610v; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722; Yuan YQ, 2003, BIOCHEMISTRY-US, V42, P5259, DOI 10.1021/bi034084a	53	143	143	1	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					724	+		10.1038/nature11498	http://dx.doi.org/10.1038/nature11498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23041928	Green Accepted			2022-12-24	WOS:000311606000037
J	LeGates, TA; Altimus, CM; Wang, H; Lee, HK; Yang, SG; Zhao, HQ; Kirkwood, A; Weber, ET; Hattar, S				LeGates, Tara A.; Altimus, Cara M.; Wang, Hui; Lee, Hey-Kyoung; Yang, Sunggu; Zhao, Haiqing; Kirkwood, Alfredo; Weber, E. Todd; Hattar, Samer			Aberrant light directly impairs mood and learning through melanopsin-expressing neurons	NATURE			English	Article							RETINAL GANGLION-CELLS; LONG-TERM DEPRESSION; MORRIS WATER MAZE; BEHAVIORAL DESPAIR; MEMORY; CLOCK; RATS; PROJECTIONS; FLUOXETINE; ANXIETY	The daily solar cycle allows organisms to synchronize their circadian rhythms and sleep-wake cycles to the correct temporal niche(1). Changes in day-length, shift-work, and transmeridian travel lead to mood alterations and cognitive function deficits(2). Sleep deprivation and circadian disruption underlie mood and cognitive disorders associated with irregular light schedules(2). Whether irregular light schedules directly affect mood and cognitive functions in the context of normal sleep and circadian rhythms remains unclear. Here we show, using an aberrant light cycle that neither changes the amount and architecture of sleep nor causes changes in the circadian timing system, that light directly regulates mood-related behaviours and cognitive functions in mice. Animals exposed to the aberrant light cycle maintain daily corticosterone rhythms, but the overall levels of corticosterone are increased. Despite normal circadian and sleep structures, these animals show increased depression-like behaviours and impaired hippocampal long-term potentiation and learning. Administration of the antidepressant drugs fluoxetine or desipramine restores learning in mice exposed to the aberrant light cycle, suggesting that the mood deficit precedes the learning impairments. To determine the retinal circuits underlying this impairment of mood and learning, we examined the behavioural consequences of this light cycle in animals that lack intrinsically photosensitive retinal ganglion cells. In these animals, the aberrant light cycle does not impair mood and learning, despite the presence of the conventional retinal ganglion cells and the ability of these animals to detect light for image formation. These findings demonstrate the ability of light to influence cognitive and mood functions directly through intrinsically photosensitive retinal ganglion cells.	[LeGates, Tara A.; Altimus, Cara M.; Zhao, Haiqing; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Wang, Hui; Lee, Hey-Kyoung; Yang, Sunggu; Kirkwood, Alfredo; Hattar, Samer] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; [Weber, E. Todd] Rider Univ, Dept Biol, Lawrenceville, NJ 08648 USA	Johns Hopkins University; Johns Hopkins University; Rider University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	shattar@jhu.edu	Hattar, Samer/W-6927-2019	Yang, Sunggu/0000-0002-7567-9949; LeGates, Tara/0000-0002-6005-4786; Lee, Hey-Kyoung/0000-0002-5554-983X	David and Lucile Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034606] Funding Source: NIH RePORTER	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank T. Gould, G. Ball and A. Sawa for their expert advice on the behavioural tests. We would like to thank R. Kuruvilla for her critical reading and advice on this manuscript. We would also like to thank the mouse tri-laboratory for suggestions and advice. This work was supported by the David and Lucile Packard Foundation grant to S.H.	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Baldi E, 2003, PHYSIOL BEHAV, V78, P785, DOI 10.1016/S0031-9384(03)00064-7; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Fonken LK, 2009, BEHAV BRAIN RES, V205, P349, DOI 10.1016/j.bbr.2009.07.001; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Honey RC, 1998, J NEUROSCI, V18, P2226; Iyilikci O, 2009, BEHAV BRAIN RES, V203, P65, DOI 10.1016/j.bbr.2009.04.013; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Lockley SW, 2006, SLEEP, V29, P161; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; McDermott CM, 2003, J NEUROSCI, V23, P9687; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sprouse J, 2006, BIOL PSYCHIAT, V60, P896, DOI 10.1016/j.biopsych.2006.03.003; Tataroglu O, 2004, BRAIN RES, V1001, P118, DOI 10.1016/j.brainres.2003.11.063; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Warthen DM, 2011, P NATL ACAD SCI USA, V108, P13788, DOI 10.1073/pnas.1103214108	27	316	327	8	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					594	+		10.1038/nature11673	http://dx.doi.org/10.1038/nature11673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23151476	Green Accepted			2022-12-24	WOS:000311339800052
J	Liu, GH; Qu, J; Suzuki, K; Nivet, E; Li, M; Montserrat, N; Yi, F; Xu, XL; Ruiz, S; Zhang, WQ; Wagner, U; Kim, A; Ren, B; Li, Y; Goebl, A; Kim, J; Soligalla, RD; Dubova, I; Thompson, J; Yates, J; Esteban, CR; Sancho-Martinez, I; Belmonte, JCI				Liu, Guang-Hui; Qu, Jing; Suzuki, Keiichiro; Nivet, Emmanuel; Li, Mo; Montserrat, Nuria; Yi, Fei; Xu, Xiuling; Ruiz, Sergio; Zhang, Weiqi; Wagner, Ulrich; Kim, Audrey; Ren, Bing; Li, Ying; Goebl, April; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Thompson, James; Yates, John, III; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos			Progressive degeneration of human neural stem cells caused by pathogenic LRRK2	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; KINASE-ACTIVITY; 14-3-3 BINDING; DISEASE; INHIBITION; MUTATIONS; EFFICIENT; EXPRESSION; NUCLEUS	Nuclear-architecture defects have been shown to correlate with the manifestation of a number of human diseases as well as ageing(1-4). It is therefore plausible that diseases whose manifestations correlate with ageing might be connected to the appearance of nuclear aberrations over time. We decided to evaluate nuclear organization in the context of ageing-associated disorders by focusing on a leucine-rich repeat kinase 2 (LRRK2) dominant mutation (G2019S; glycine-to-serine substitution at amino acid 2019), which is associated with familial and sporadic Parkinson's disease as well as impairment of adult neurogenesis in mice(5). Here we report on the generation of induced pluripotent stem cells (iPSCs) derived from Parkinson's disease patients and the implications of LRRK2 (G2019S) mutation in human neural-stem-cell (NSC) populations. Mutant NSCs showed increased susceptibility to proteasomal stress as well as passage-dependent deficiencies in nuclear-envelope organization, clonal expansion and neuronal differentiation. Disease phenotypes were rescued by targeted correction of the LRRK2 (G2019S) mutation with its wild-type counterpart in Parkinson's disease iPSCs and were recapitulated after targeted knock-in of the LRRK2(G2019S) mutation in human embryonic stem cells. Analysis of human brain tissue showed nuclear-envelope impairment in clinically diagnosed Parkinson's disease patients. Together, our results identify the nucleus as a previously unknown cellular organelle in Parkinson's disease pathology and may help to open new avenues for Parkinson's disease diagnoses as well as for the potential development of therapeutics targeting this fundamental cell structure.	[Liu, Guang-Hui; Qu, Jing; Suzuki, Keiichiro; Nivet, Emmanuel; Li, Mo; Yi, Fei; Ruiz, Sergio; Goebl, April; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Liu, Guang-Hui; Qu, Jing; Xu, Xiuling; Zhang, Weiqi; Li, Ying] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Montserrat, Nuria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Wagner, Ulrich; Kim, Audrey; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Thompson, James; Yates, John, III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Salk Institute; Chinese Academy of Sciences; Institute of Biophysics, CAS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghliu@ibp.ac.cn; belmonte@salk.edu	Li, Mo/J-2090-2014; Li, Mo/AAM-8266-2021; Qu, Jing/ABB-9088-2020; Ruiz, Sergio/G-1561-2016; Montserrat, Nuria/F-3136-2016; Nivet, Emmanuel/C-2729-2014	Li, Mo/0000-0003-0827-8907; Ruiz, Sergio/0000-0002-0177-6965; Montserrat, Nuria/0000-0002-1603-1755; Nivet, Emmanuel/0000-0001-7903-4059; Liu, Guang-Hui/0000-0001-9289-8177; Suzuki, Keiichiro/0000-0001-5603-9105; Zhang, Weiqi/0000-0002-8885-5104; qu, jing/0000-0002-3988-5067; Sancho-Martinez, Ignacio/0000-0003-4348-1038	Thousand Young Talents program of China; National Laboratory of Biomacromolecules; Chinese Academy of Sciences; National Natural Science Foundation of China (NSFC) [81271266, 31222039]; Beijing Municipal Natural Science Foundation; AFAR/Ellison Medical Foundation; Uehara Memorial Foundation; F.M. Kirby Foundation; NSFC [31201111]; US National Institute of Health (NIH) [ES017166]; Ludwig Institute for Cancer Research; NIH [P41 RR011823]; Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi; California Institute of Regenerative Medicine; Ellison Medical Foundation; Helmsley Charitable Trust; ERA-Net Neuron; MINECO; Fundacion Cellex; (G. Gaslini Institute)-Telethon Genetic Biobank Network [GTB07001]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Thousand Young Talents program of China(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); F.M. Kirby Foundation; NSFC(National Natural Science Foundation of China (NSFC)); US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Charitable Trust; ERA-Net Neuron; MINECO(Spanish Government); Fundacion Cellex(Foundation CELLEX); (G. Gaslini Institute)-Telethon Genetic Biobank Network(Fondazione Telethon); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to thank K. Mitani, P. Ng, A. Lieber, Y. Imai, M. A. Miyawaki, Filocamo, S. Goldwurm, Telethon Genetic Biobank Network for providing constructs and cells (the fibroblast samples were obtained from the "Cell Line and DNA Biobank from patients affected by Genetic Diseases" (G. Gaslini Institute)-Telethon Genetic Biobank Network (project no. GTB07001)); Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS for providing human brain tissue; F. Gage, M. Hetzer, J. Yao, Y. Mu, D. Yu, E. Gelpi, X. M. Wang, X. Wang, G. Bai and Z. J. Liu for helpful discussions; M. Joens and J. Fitzpatrick of the Waitt Advanced Biophotonics Core Facility for performing TEM analysis; M. Marti for imaging, teratoma and karyotyping analysis; F. Osakada for statistics analysis; and M. Schwarz, P. Schwarz and L. Laricchia-Robbio for administrative help. G.-H.L. is supported by the Thousand Young Talents program of China, the National Laboratory of Biomacromolecules, the Strategic Priority Research Program of the Chinese Academy of Sciences, the National Natural Science Foundation of China (NSFC) (81271266 and 31222039), and the Beijing Municipal Natural Science Foundation. J.Q. was partly supported by an AFAR/Ellison Medical Foundation postdoctoral fellowship. K.S. was partly supported by a Uehara Memorial Foundation research fellowship. E.N. was partly supported by an F.M. Kirby Foundation postdoctoral fellowship. X.X. is supported by NSFC (31201111). B.R. was supported by a US National Institute of Health (NIH) grant (ES017166) and the Ludwig Institute for Cancer Research. J.Y. was supported by an NIH grant (P41 RR011823). J.C.I.B. was supported by grants from the Glenn Foundation, G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi, the California Institute of Regenerative Medicine, the Ellison Medical Foundation, the Helmsley Charitable Trust, ERA-Net Neuron, MINECO and Fundacion Cellex.	Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Chang KH, 2011, MOL BIOL CELL, V22, P1452, DOI 10.1091/mbc.E10-07-0654; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Poulopoulos M, 2012, J MOL NEUROSCI, V47, P139, DOI 10.1007/s12031-011-9696-y; Rudenko IN, 2012, BMC MED, V10, DOI [10.1186/PREACCEPT-3356971966272323, 10.1186/1741-7015-10-20]; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Thaler A, 2012, NEUROLOGY, V79, P1027, DOI 10.1212/WNL.0b013e3182684646; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; Tran D, 2012, J CELL SCI, V125, P2831, DOI 10.1242/jcs.102111; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x; Xie WJ, 2010, J NEUROCHEM, V115, P188, DOI 10.1111/j.1471-4159.2010.06914.x	30	248	265	1	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					603	607		10.1038/nature11557	http://dx.doi.org/10.1038/nature11557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23075850	Green Accepted			2022-12-24	WOS:000311339800054
J	Milucka, J; Ferdelman, TG; Polerecky, L; Franzke, D; Wegener, G; Schmid, M; Lieberwirth, I; Wagner, M; Widdel, F; Kuypers, MMM				Milucka, Jana; Ferdelman, Timothy G.; Polerecky, Lubos; Franzke, Daniela; Wegener, Gunter; Schmid, Markus; Lieberwirth, Ingo; Wagner, Michael; Widdel, Friedrich; Kuypers, Marcel M. M.			Zero-valent sulphur is a key intermediate in marine methane oxidation	NATURE			English	Article							MEDIATING ANAEROBIC OXIDATION; IN-SITU HYBRIDIZATION; MOSBY MUD VOLCANO; SULFATE REDUCTION; ELEMENTAL SULFUR; EQUILIBRIUM DISTRIBUTION; OLIGONUCLEOTIDE PROBES; MICROBIAL COMMUNITIES; AQUEOUS-SOLUTIONS; POLYSULFIDE IONS	Emissions of methane, a potent greenhouse gas, from marine sediments are controlled by anaerobic oxidation of methane coupled primarily to sulphate reduction (AOM). Sulphate-coupled AOM is believed to be mediated by a consortium of methanotrophic archaea (ANME) and sulphate-reducing Deltaproteobacteria but the underlying mechanism has not yet been resolved. Here we show that zero-valent sulphur compounds (S-0) are formed during AOM through a new pathway for dissimilatory sulphate reduction performed by the methanotrophic archaea. Hence, AOM might not be an obligate syntrophic process but may be carried out by the ANME alone. Furthermore, we show that the produced S-0-in the form of disulphide-is disproportionated by the Deltaproteobacteria associated with the ANME. Our observations expand the diversity of known microbially mediated sulphur transformations and have significant implications for our understanding of the biogeochemical carbon and sulphur cycles.	[Milucka, Jana; Ferdelman, Timothy G.; Polerecky, Lubos; Franzke, Daniela; Wegener, Gunter; Widdel, Friedrich; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Wegener, Gunter] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Schmid, Markus; Wagner, Michael] Univ Vienna, A-1090 Vienna, Austria; [Lieberwirth, Ingo] Max Planck Inst Polymer Res, D-55128 Mainz, Germany	Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Vienna; Max Planck Society	Milucka, J (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	jmilucka@mpi-bremen.de	Lieberwirth, Ingo/Q-5862-2017; Schmid, Markus C/D-2669-2012; Ferdelman, Timothy G/A-3758-2013; Polerecky, Lubos/E-1134-2014; Wagner, Michael/A-7801-2011	Ferdelman, Timothy G/0000-0002-9701-3793; Polerecky, Lubos/0000-0003-4425-585X; Wagner, Michael/0000-0002-9778-7684; Wegener, Gunter/0000-0002-6819-373X	Max Planck Society; ERC [294343]	Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission)	We want to thank G. Klockgether, K. Imhoff, S. Littmann and T. Vagner for technical support, G. Lavik and M. Formolo for analytical support and discussions, M. Schuler and T. Keil for assistance with cryosectioning, A. Boetius for providing samples, and T. Holler for the initial enrichment and maintenance of the Isis culture. This work was financially supported by the Max Planck Society and the ERC Advanced Grant 294343 (to M.W.).	Alperin M, 2010, SCIENCE, V329, P288, DOI 10.1126/science.1189966; Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; Basen M, 2011, ENVIRON MICROBIOL, V13, P1370, DOI 10.1111/j.1462-2920.2011.02443.x; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; CORDRUWISCH R, 1985, J MICROBIOL METH, V4, P33, DOI 10.1016/0167-7012(85)90005-3; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; FUSELER K, 1995, ARCH MICROBIOL, V164, P104, DOI 10.1007/BF02525315; Hansen LB, 1998, AQUAT MICROB ECOL, V14, P195, DOI 10.3354/ame014195; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Holmkvist L, 2011, DEEP-SEA RES PT I, V58, P493, DOI 10.1016/j.dsr.2011.02.009; House Christopher H., 2011, Life-Basel, V1, P19, DOI 10.3390/life1010019; Huang WE, 2007, ENVIRON MICROBIOL, V9, P1878, DOI 10.1111/j.1462-2920.2007.01352.x; Johnson EF, 2008, MICROBIAL SULFUR METABOLISM, P202, DOI 10.1007/978-3-540-72682-1_16; JORGENSEN BB, 1974, MAR BIOL, V24, P189, DOI 10.1007/BF00391893; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kamyshny A, 2006, ANAL CHEM, V78, P2631, DOI 10.1021/ac051854a; Kamyshny A, 2004, ENVIRON SCI TECHNOL, V38, P6633, DOI 10.1021/es049514e; Kamyshny A, 2009, GEOCHIM COSMOCHIM AC, V73, P6022, DOI 10.1016/j.gca.2009.07.003; Kamyshny A, 2007, ENVIRON SCI TECHNOL, V41, P2395, DOI 10.1021/es062637+; Kamyshny A, 2009, GEOSTAND GEOANAL RES, V33, P415, DOI 10.1111/j.1751-908X.2009.00907.x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; KRAMER M, 1989, ARCH MICROBIOL, V151, P232, DOI 10.1007/BF00413135; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P2394, DOI 10.1128/AEM.60.7.2394-2399.1994; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Mastalerz V, 2007, CHEM GEOL, V246, P87, DOI 10.1016/j.chemgeo.2007.09.005; Meulepas RJW, 2010, APPL MICROBIOL BIOT, V87, P1499, DOI 10.1007/s00253-010-2597-0; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Meysman FJR, 2005, MAR CHEM, V97, P206, DOI 10.1016/j.marchem.2005.08.005; Milucka J., 2012, ENV MICROBIOL; Moran JJ, 2008, ENVIRON MICROBIOL, V10, P162, DOI 10.1111/j.1462-2920.2007.01441.x; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Pasteris JD, 2001, CHEM GEOL, V180, P3, DOI 10.1016/S0009-2541(01)00302-3; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Polerecky L, 2012, ENVIRON MICROBIOL, V14, P1009, DOI 10.1111/j.1462-2920.2011.02681.x; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; SALEH AM, 1964, J APPL BACTERIOL, V27, P281, DOI 10.1111/j.1365-2672.1964.tb04914.x; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Shima S, 2005, CURR OPIN MICROBIOL, V8, P643, DOI 10.1016/j.mib.2005.10.002; Sorensen KB, 2001, MICROBIAL ECOL, V42, P1; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; STEUDEL R, 1988, Z NATURFORSCH B, V43, P203; Stoecker K, 2010, APPL ENVIRON MICROB, V76, P922, DOI 10.1128/AEM.02456-09; Stumm W., 1996, AQUAT CHEM, P990; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003; THODE HG, 1961, GEOCHIM COSMOCHIM AC, V25, P159, DOI 10.1016/0016-7037(61)90074-6; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; Treude T, 2007, APPL ENVIRON MICROB, V73, P2271, DOI 10.1128/AEM.02685-06; Trofimov BA, 2009, J SULFUR CHEM, V30, P518, DOI 10.1080/17415990902998579; TRUPER HG, 1982, PHILOS T ROY SOC B, V298, P529, DOI 10.1098/rstb.1982.0095; Wegener G, 2008, ENVIRON MICROBIOL, V10, P2287, DOI 10.1111/j.1462-2920.2008.01653.x; Widdel F, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P265, DOI 10.1017/CBO9780511541490.010; Zopfi J, 2004, GEOLOGICAL SOC AM SP, V379, P97, DOI DOI 10.1130/0-8137-2379-5.97	73	375	398	15	476	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					541	+		10.1038/nature11656	http://dx.doi.org/10.1038/nature11656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135396				2022-12-24	WOS:000311339800041
J	Sheffield, J; Wood, EF; Roderick, ML				Sheffield, Justin; Wood, Eric F.; Roderick, Michael L.			Little change in global drought over the past 60 years	NATURE			English	Article							PAN EVAPORATION; SEVERITY INDEX; SOIL-MOISTURE; CLIMATE; PRECIPITATION; DATASET; WATER	Drought is expected to increase in frequency and severity in the future as a result of climate change, mainly as a consequence of decreases in regional precipitation but also because of increasing evaporation driven by global warming(1-3). Previous assessments of historic changes in drought over the late twentieth and early twenty-first centuries indicate that this may already be happening globally. In particular, calculations of the Palmer Drought Severity Index (PDSI) show a decrease in moisture globally since the 1970s with a commensurate increase in the area in drought that is attributed, in part, to global warming(4,5). The simplicity of the PDSI, which is calculated from a simple water-balance model forced by monthly precipitation and temperature data, makes it an attractive tool in large-scale drought assessments, but may give biased results in the context of climate change(6). Here we show that the previously reported increase in global drought is overestimated because the PDSI uses a simplified model of potential evaporation(7) that responds only to changes in temperature and thus responds incorrectly to global warming in recent decades. More realistic calculations, based on the underlying physical principles(8) that take into account changes in available energy, humidity and wind speed, suggest that there has been little change in drought over the past 60 years. The results have implications for how we interpret the impact of global warming on the hydrological cycle and its extremes, and may help to explain why palaeoclimate drought reconstructions based on tree-ring data diverge from the PDSI-based drought record in recent years(9,10).	[Sheffield, Justin; Wood, Eric F.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Roderick, Michael L.] Australian Natl Univ, Res Sch Earth Sci, Australian Res Council Ctr Excellence Climate Sys, Canberra, ACT 0200, Australia; [Roderick, Michael L.] Australian Natl Univ, Res Sch Biol, Australian Res Council Ctr Excellence Climate Sys, Canberra, ACT 0200, Australia	Princeton University; Australian National University; Australian National University	Sheffield, J (corresponding author), Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA.	justin@princeton.edu	Roderick, Michael/C-9621-2009	Roderick, Michael/0000-0002-3630-7739; Wood, Eric/0000-0001-7037-9675; Sheffield, Justin/0000-0003-2400-0630	US National Oceanic and Atmospheric Agency [NA10OAR4310130, NA11OAR4310097]; NASA [NNX08AN40A]; Australian Research Council [DP0879763, DP110105376, CE11E0098]	US National Oceanic and Atmospheric Agency; NASA(National Aeronautics & Space Administration (NASA)); Australian Research Council(Australian Research Council)	J.S. acknowledges support from the US National Oceanic and Atmospheric Agency (NA10OAR4310130, NA11OAR4310097) and NASA (NNX08AN40A). M.L.R. acknowledges the support of the Australian Research Council (DP0879763, DP110105376, CE11E0098).	ALLEY WM, 1984, J CLIM APPL METEOROL, V23, P1100, DOI 10.1175/1520-0450(1984)023<1100:TPDSIL>2.0.CO;2; [Anonymous], 1993, HDB HYDROLOGY; Briffa KR, 2009, INT J CLIMATOL, V29, P1894, DOI 10.1002/joc.1836; Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL037604, 10.1029/2009GL039902]; Chen MY, 2002, J HYDROMETEOROL, V3, P249, DOI 10.1175/1525-7541(2002)003<0249:GLPAYM>2.0.CO;2; Cleugh HA, 2007, REMOTE SENS ENVIRON, V106, P285, DOI 10.1016/j.rse.2006.07.007; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; DAI AG, 2011, WILEY INTERDISCIP RE, V2, P45, DOI [DOI 10.1002/WCC.81, 10.1002/wcc.81]; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; De Grandpre L, 2011, CAN J FOREST RES, V41, P1242, DOI [10.1139/x11-051, 10.1139/X11-051]; Donohue RJ, 2010, J HYDROL, V386, P186, DOI 10.1016/j.jhydrol.2010.03.020; Fang KY, 2009, CLIM RES, V38, P129, DOI 10.3354/cr00781; Gupta SK, 2006, GEWEX NEWS, V16, P12; Hirschi M, 2011, NAT GEOSCI, V4, P17, DOI 10.1038/NGEO1032; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Jensen M.E., 1973, CONSUMPTIVE USE WATE, P215; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lockart N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040598; McCabe GJ, 2006, INT J CLIMATOL, V26, P849, DOI 10.1002/joc.1289; Milly PCD, 2011, EARTH INTERACT, V15, DOI 10.1175/2010EI363.1; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Monteith J. L., 1964, S SOC EXP BIOL, V19, P205; Mu QZ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000179; Palmer W.C., 1965, 45 US DEP COMM WEATH, V30; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Roderick ML, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031166; Roderick ML, 2009, GEOGR COMPASS, V3, P761, DOI 10.1111/j.1749-8198.2008.00214.x; Roderick ML, 2004, INT J CLIMATOL, V24, P1077, DOI 10.1002/joc.1061; Schneider U., 2008, WEATHER CLIMATE DTSC; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Shaw SB, 2011, HYDROL PROCESS, V25, P1466, DOI 10.1002/hyp.7913; Sheffield J, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008288; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Sheffield J, 2010, J HYDROMETEOROL, V11, P253, DOI 10.1175/2009JHM1176.1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sternberg T, 2011, NATURE, V472, P169, DOI 10.1038/472169d; Svoboda M, 2002, B AM METEOROL SOC, V83, P1181, DOI 10.1175/1520-0477(2002)083&lt;1181:TDM&gt;2.3.CO;2; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; van der Schrier G, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006745; van der Schrier G, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015001; Wang JS, 2010, CLIM RES, V41, P51, DOI 10.3354/cr00837; Wells N, 2004, J CLIMATE, V17, P2335, DOI [10.1175/1520-0442(2004)017<2335:ASPDSI>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;2335:ASPDSI&gt;2.0.CO;2]; Willmott C. J., 2010, GLOBAL AIR TEMPERATU; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	47	1215	1268	66	777	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					435	+		10.1038/nature11575	http://dx.doi.org/10.1038/nature11575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151587				2022-12-24	WOS:000311031600044
J	Straub, AC; Lohman, AW; Billaud, M; Johnstone, SR; Dwyer, ST; Lee, MY; Bortz, PS; Best, AK; Columbus, L; Gaston, B; Isakson, BE				Straub, Adam C.; Lohman, Alexander W.; Billaud, Marie; Johnstone, Scott R.; Dwyer, Scott T.; Lee, Monica Y.; Bortz, Pamela Schoppee; Best, Angela K.; Columbus, Linda; Gaston, Benjamin; Isakson, Brant E.			Endothelial cell expression of haemoglobin alpha regulates nitric oxide signalling	NATURE			English	Article							RELAXING FACTOR; SMOOTH-MUSCLE; NO; PROPYLTHIOURACIL; NITROSYLATION; HEMOPROTEINS; MYOGLOBIN; OXIDATION; REDUCTASE; PROTEINS	Models of unregulated nitric oxide (NO) diffusion do not consistently account for the biochemistry of NO synthase (NOS)-dependent signalling in many cell systems(1-3). For example, endothelial NOS controls blood pressure, blood flow and oxygen delivery through its effect on vascular smooth muscle tone(4), but the regulation of these processes is not adequately explained by simple NO diffusion from endothelium to smooth muscle(3,5). Here we report a new model for the regulation of NO signalling by demonstrating that haemoglobin (Hb) alpha (encoded by the HBA1 and HBA2 genes in humans) is expressed in human and mouse arterial endothelial cells and enriched at the myoendothelial junction, where it regulates the effects of NO on vascular reactivity. Notably, this function is unique to Hb alpha and is abrogated by its genetic depletion. Mechanistically, endothelial Hb alpha haem iron in the Fe3+ state permits NO signalling, and this signalling is shut off when Hb alpha is reduced to the Fe2+ state by endothelial cytochrome b5 reductase 3 (CYB5R3, also known as diaphorase 1)(6). Genetic and pharmacological inhibition of CYB5R3 increases NO bioactivity in small arteries. These data reveal a new mechanism by which the regulation of the intracellular Hb alpha oxidation state controls NOS signalling in non-erythroid cells. This model may be relevant to haem-containing globins in a broad range of NOS-containing somatic cells(7-13).	[Straub, Adam C.; Lohman, Alexander W.; Billaud, Marie; Johnstone, Scott R.; Lee, Monica Y.; Bortz, Pamela Schoppee; Best, Angela K.; Isakson, Brant E.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Lohman, Alexander W.; Billaud, Marie; Isakson, Brant E.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Dwyer, Scott T.; Gaston, Benjamin] Univ Virginia, Dept Pediat, Charlottesville, VA 22908 USA; [Columbus, Linda] Univ Virginia, Dept Chem, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Isakson, BE (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	brant@virginia.edu	Billaud, Marie/N-7609-2017; Columbus, Linda/F-5877-2010; Johnstone, Scott R/E-5032-2013	Billaud, Marie/0000-0002-7591-0362; Columbus, Linda/0000-0002-2574-0561; Johnstone, Scott R/0000-0003-1920-5033; Straub, Adam/0000-0003-0542-9466	American Heart Association; National Institutes of Health [HL088554, HL107963, HL059337, HL101871, HL112904, HL007284]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL059337, R01HL088554, T32HL007284, K99HL112904, P01HL101871, R01HL059337, R00HL112904, R21HL107963] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Advanced Microscopy and Histology core at the University of Virginia and the Yale Proteomic Facility. We acknowledge V. Balasubramaniam, S. Lewis and D. Singel for discussions of the data and B. Duling for critical evaluation of experiments and the manuscript. We also thank M. Weiss for the Hb alpha-stabilizing protein antibody and for discussions. This work was supported by an American Heart Association Scientist Development Grant (B. E. I.), National Institutes of Health grants HL088554 (B. E. I.), HL107963 (B. E. I.) HL059337 (B. G.), HL101871 (B. G.), HL112904 (A. C. S.) and HL007284 (A. W. L. and A. C. S.). M. B. and S.R.J. were supported by American Heart Association postdoctoral fellowships, and A. W. L. and M.Y.L. were supported by American Heart Association predoctoral fellowships.	Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Angelo M, 2008, METHOD ENZYMOL, V436, P131, DOI 10.1016/S0076-6879(08)36008-X; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; Davalos A, 2010, MOL CELL PROTEOMICS, V9, P2109, DOI 10.1074/mcp.M110.001289; Dora KA, 1997, P NATL ACAD SCI USA, V94, P6529, DOI 10.1073/pnas.94.12.6529; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; FREGLY MJ, 1959, CIRC RES, V7, P486, DOI 10.1161/01.RES.7.3.486; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Heberlein KR, 2010, CIRC RES, V106, P1092, DOI 10.1161/CIRCRESAHA.109.215723; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; Lam YH, 2002, PRENATAL DIAG, V22, P56; LEE E, 1986, FEBS LETT, V209, P49, DOI 10.1016/0014-5793(86)81082-1; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927	30	206	212	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					473	477		10.1038/nature11626	http://dx.doi.org/10.1038/nature11626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23123858	Green Accepted			2022-12-24	WOS:000311031600052
J	Levin, GP; Robinson-Cohen, C; de Boer, IH; Houston, DK; Lohman, K; Liu, YM; Kritchevsky, SB; Cauley, JA; Tanaka, T; Ferrucci, L; Bandinelli, S; Patel, KV; Hagstrom, E; Michaelsson, K; Melhus, H; Wang, T; Wolf, M; Psaty, BM; Siscovick, D; Kestenbaum, B				Levin, Gregory P.; Robinson-Cohen, Cassianne; de Boer, Ian H.; Houston, Denise K.; Lohman, Kurt; Liu, Yongmei; Kritchevsky, Stephen B.; Cauley, Jane A.; Tanaka, Toshiko; Ferrucci, Luigi; Bandinelli, Stefania; Patel, Kushang V.; Hagstrom, Emil; Michaelsson, Karl; Melhus, Hakan; Wang, Thomas; Wolf, Myles; Psaty, Bruce M.; Siscovick, David; Kestenbaum, Bryan			Genetic Variants and Associations of 25-Hydroxyvitamin D Concentrations With Major Clinical Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							D-RECEPTOR GENE; VITAMIN-D; SERUM 25-HYDROXYVITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; SEASONAL-VARIATION; FRACTURE RISK; HIP FRACTURE; OLDER-ADULTS; POLYMORPHISMS; CANCER	Context Lower serum 25-hydroxyvitamin D concentrations are associated with greater risks of many chronic diseases across large, prospective community-based studies. Substrate 25-hydroxyvitamin D must be converted to 1,25-dihydroxyvitamin D for full biological activity, and complex metabolic pathways suggest that interindividual variability in vitamin D metabolism may alter the clinical consequences of measured serum 25-hydroxyvitamin D. Objective To investigate whether common variation within genes encoding the vitamin D-binding protein, megalin, cubilin, CYP27B1, CYP24A1, and the vitamin D receptor (VDR) modify associations of low 25-hydroxyvitamin D with major clinical outcomes. Design, Setting, and Participants Examination of 141 single-nucleotide polymorphisms in a discovery cohort of 1514 white participants (who were recruited from 4 US regions) from the community-based Cardiovascular Health Study. Participants had serum 25-hydroxyvitamin D measurements in 1992-1993 and were followed up for a median of 11 years (through 2006). Replication meta-analyses were conducted across the independent, community-based US Health, Aging, and Body Composition (n=922; follow-up: 1998-1999 through 2005), Italian Invecchiare in Chianti (n=835; follow-up: 1998-2000 through 2006), and Swedish Uppsala Longitudinal Study of Adult Men (n=970; follow-up: 1991-1995 through 2008) cohort studies. Main Outcome Measure Composite outcome of incident hip facture, myocardial infarction, cancer, and mortality over long-term follow-up. Results Interactions between 5 single-nucleotide polymorphisms and low 25-hydroxyvitamin D concentration were identified in the discovery phase and 1 involving a variant in the VDR gene replicated in independent meta-analysis. Among Cardiovascular Health Study participants, low 25-hydroxyvitamin D concentration was associated with hazard ratios for risk of the composite outcome of 1.40 (95% CI, 1.12-1.74) for those who had 1 minor allele at rs7968585 and 1.82 (95% CI, 1.31-2.54) for those with 2 minor alleles at rs7968585. In contrast, there was no evidence of an association (estimated hazard ratio, 0.93 [95% CI, 0.70-1.24]) among participants who had 0 minor alleles at this single-nucleotide polymorphism. Conclusion Known associations of low 25-hydroxyvitamin D with major health outcomes may vary according to common genetic differences in the vitamin D receptor. JAMA. 2012;308(18):1898-1905 www.jama.com	[Levin, Gregory P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Robinson-Cohen, Cassianne; de Boer, Ian H.; Psaty, Bruce M.; Siscovick, David; Kestenbaum, Bryan] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [de Boer, Ian H.; Psaty, Bruce M.; Siscovick, David; Kestenbaum, Bryan] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Patel, Kushang V.] Univ Washington, Dept Anasthesiol & Pain Med, Seattle, WA 98195 USA; [de Boer, Ian H.; Kestenbaum, Bryan] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [de Boer, Ian H.; Kestenbaum, Bryan] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Patel, Kushang V.] Univ Washington, Ctr Pain Res Impact Measurement & Effectiveness, Seattle, WA 98195 USA; [Psaty, Bruce M.; Siscovick, David] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Grp Hlth Res Inst & Cooperat, Seattle, WA 98195 USA; [Houston, Denise K.; Kritchevsky, Stephen B.] Wake Forest Univ, Dept Internal Med, Winston Salem, NC 27109 USA; [Lohman, Kurt] Wake Forest Univ, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Liu, Yongmei] Wake Forest Univ, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Lohman, Kurt; Liu, Yongmei] Wake Forest Univ, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [Houston, Denise K.; Lohman, Kurt; Kritchevsky, Stephen B.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Cauley, Jane A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy; [Hagstrom, Emil; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Wang, Thomas] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA USA; [Wolf, Myles] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Azienda Sanitaria di Firenze; Uppsala University; Uppsala University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Miami	Levin, GP (corresponding author), Univ Washington, Dept Biostat, Box 357232, Seattle, WA 98195 USA.	glevin11@uw.edu	Hagstrom, Emil/AAE-8361-2021; Michaelsson, Karl/AAM-9094-2021; bandinelli, stefania/AAL-4570-2020; de Boer, Ian/GYJ-3282-2022; Robinson-Cohen, Cassianne/ABB-4985-2021	Houston, Denise/0000-0002-3355-4304; Michaelsson, Karl/0000-0003-2815-1217; Cauley, Jane A/0000-0003-0752-4408; Kritchevsky, Stephen/0000-0003-3336-6781; Wang, Thomas/0000-0003-4063-6508; Robinson-Cohen, Cassianne/0000-0003-4783-7046	Abbott Laboratories; National Institute on Aging, National Institutes of Health; American Society for Nutrition; Department of Veteran Affairs; Abbott Nutrition Health Institute; National Institutes of Health; Shire; Amgen; Abbott; Genzyme; Medtronic; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055222, N01HC015103, N01HC085079, N01HC035129, N01HC045133, N01HC085086, N01HC075150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084443, U01HL080295, R01HL096875, R01HL087652, R01HL105756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062101, N01AG062106, R01AG027002, K01AG030506, N01AG062103, P30AG021332, R01AG032098, N01AG012111, R01AG029364] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Society for Nutrition; Department of Veteran Affairs(US Department of Veterans Affairs); Abbott Nutrition Health Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shire; Amgen(Amgen); Abbott(Abbott Laboratories); Genzyme(Sanofi-AventisGenzyme Corporation); Medtronic(Medtronic); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr de Boer reported receiving research grant funding from Abbott Laboratories. Dr Houston reported pending institutional grant support from the National Institute on Aging, National Institutes of Health; and receiving payment for lectures from the American Society for Nutrition, the Department of Veteran Affairs, and Abbott Nutrition Health Institute. Dr Wang reported serving as a consultant to Diasorin; receiving an investigatorinitiated grant from Diasorin; and receiving payment for lectures from Diasorin. Dr Wolf reported serving as a consultant to Abbott, Genzyme, Luitpold, Mitsubishi, Cytochroma, Astellas, and Kai; receiving institutional grants from the National Institutes of Health, Shire, and Amgen; receiving payment for lectures from Abbott, Genzyme, and Shire; and having a pending patent. Dr Psaty reported serving on a data and safety monitoring board for a clinical trial of a device funded by Zoll ZifeCor; and serving on a steering committee for the Yale Open Data Access Project funded by Medtronic. Dr Kestenbaum reported receiving institutional grant support from Amgen. No other authors reported disclosures.	Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; de Boer IH, 2012, ANN INTERN MED, V156, P627, DOI 10.7326/0003-4819-156-9-201205010-00004; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gong G, 1999, OSTEOPOROSIS INT, V9, P55, DOI 10.1007/s001980050116; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Ji GR, 2010, BONE, V47, P681, DOI 10.1016/j.bone.2010.06.024; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Karami S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007013; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Liu CK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S10; Looker AC, 2008, J BONE MINER RES, V23, P143, DOI 10.1359/JBMR.071003; Lurie G, 2007, CANCER EPIDEM BIOMAR, V16, P2566, DOI 10.1158/1055-9965.EPI-07-0753; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Melhus H, 2010, J CLIN ENDOCR METAB, V95, P2637, DOI 10.1210/jc.2009-2699; Morrison NA, 2005, PHARMACOGENET GENOM, V15, P127, DOI 10.1097/01213011-200502000-00008; Onen IH, 2008, EXP BIOL MED, V233, P1608, DOI 10.3181/0803-RM-110; Penna-Martinez M, 2009, THYROID, V19, P623, DOI 10.1089/thy.2008.0388; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Robinson-Cohen C, 2011, J CLIN ENDOCR METAB, V96, P2186, DOI 10.1210/jc.2010-2878; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; SHERMAN SS, 1990, J CLIN ENDOCR METAB, V71, P405, DOI 10.1210/jcem-71-2-405; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Smith NL, 2009, THROMB RES, V123, pS25, DOI 10.1016/S0049-3848(09)70139-2; Thakkinstian A, 2004, J BONE MINER RES, V19, P419, DOI 10.1359/JBMR.0301265; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398	46	132	139	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2012	308	18					1898	1905		10.1001/jama.2012.17304	http://dx.doi.org/10.1001/jama.2012.17304			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035NA	23150009	Green Accepted, Bronze			2022-12-24	WOS:000310952700026
J	Clement, JP; Aceti, M; Creson, TK; Ozkan, ED; Shi, YL; Reish, NJ; Almonte, AG; Miller, BH; Wiltgen, BJ; Miller, CA; Xu, XM; Rumbaugh, G				Clement, James P.; Aceti, Massimiliano; Creson, Thomas K.; Ozkan, Emin D.; Shi, Yulin; Reish, Nicholas J.; Almonte, Antoine G.; Miller, Brooke H.; Wiltgen, Brian J.; Miller, Courtney A.; Xu, Xiangmin; Rumbaugh, Gavin			Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; NMDA RECEPTOR; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; SILENT SYNAPSES; IN-VIVO; CRITICAL PERIOD; VISUAL-CORTEX; ANIMAL-MODEL; AUTISM	Mutations that cause intellectual disability (ID) and autism spectrum disorder (ASD) are commonly found in genes that encode for synaptic proteins. However, it remains unclear how mutations that disrupt synapse function impact intellectual ability. In the SYNGAP1 mouse model of ID/ASD, we found that dendritic spine synapses develop prematurely during the early postnatal period. Premature spine maturation dramatically enhanced excitability in the developing hippocampus, which corresponded with the emergence of behavioral abnormalities. Inducing SYNGAP1 mutations after critical developmental windows closed had minimal impact on spine synapse function, whereas repairing these pathogenic mutations in adulthood did not improve behavior and cognition. These data demonstrate that SynGAP protein acts as a critical developmental repressor of neural excitability that promotes the development of life-long cognitive abilities. We propose that the pace of dendritic spine synapse maturation in early life is a critical determinant of normal intellectual development.	[Clement, James P.; Aceti, Massimiliano; Creson, Thomas K.; Ozkan, Emin D.; Miller, Brooke H.; Miller, Courtney A.; Rumbaugh, Gavin] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Miller, Courtney A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Shi, Yulin; Xu, Xiangmin] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Reish, Nicholas J.; Almonte, Antoine G.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Wiltgen, Brian J.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Irvine; University of Alabama System; University of Alabama Birmingham; University of Virginia	Rumbaugh, G (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.	grumbaug@scripps.edu	Ozkan, Emin Deniz/A-5752-2009; Miller, Courtney A/E-8651-2010; Reish, Nicholas/ACC-7587-2022; Clement, James/Q-5628-2019; Wiltgen, Brian/D-2947-2013	Ozkan, Emin Deniz/0000-0002-1073-6703; Miller, Courtney A/0000-0001-8628-4902; Clement, James/0000-0001-7625-6430; Reish, Nicholas/0000-0001-5677-3895; Aceti, Massimiliano/0000-0002-6632-1398; Almonte, Antoine/0000-0002-8778-2724	National Institute for Neurological Disorders and Stroke [R01NS064079]; Eunice Kennedy Shriver National Institute for Child Health and Human Development [R03HD060672]; National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institute for Drug Abuse [DA023700-04S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA023700, R00DA023700] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Ronald Davis, Damon Page, and Fadi Hamdan, as well as members of the Rumbaugh Laboratory, for their helpful comments on this manuscript. We also thank Zachary Collier, Samuel Bacharach, Bryce Grier, and Gopi Patel for assistance in context discrimination studies. This work was supported by grants to G. R. from the National Institute for Neurological Disorders and Stroke (R01NS064079), The Eunice Kennedy Shriver National Institute for Child Health and Human Development (R03HD060672), and the National Alliance for Research on Schizophrenia and Depression (NARSAD). The laser photostimulation and voltage-sensitive dye imaging part of this work was performed in X.X.'s laboratory, supported by a grant from the National Institute for Drug Abuse (DA023700-04S1). J.P.C. and E.D.O. performed electrophysiological recordings; M. A. performed multiphoton imaging studies and spine analysis; T. K. C., N.J.R., A. G. A., and B.J.W. performed behavioral studies; Y.S. and X. X. performed laser photo-stimulation and imaging studies; G. R., C. A. M., T. K. C., J.P.C., M. A., B.J.W., X. X. designed experiments; B. M. and T. K. C. performed protein/mRNA studies; G. R. conceived the study and wrote the manuscript; G. R., C. A. M., J.P.C., and T. K. C. edited the manuscript.	Ashby MC, 2011, NEURON, V70, P510, DOI 10.1016/j.neuron.2011.02.057; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bender RA, 2004, ADV EXP MED BIOL, V548, P213; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Daenen EWPM, 2002, BEHAV BRAIN RES, V131, P67, DOI 10.1016/S0166-4328(01)00350-3; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Dvorkin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000027; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Guo XC, 2009, NEUROPSYCHOPHARMACOL, V34, P1659, DOI 10.1038/npp.2008.223; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Krepischi ACV, 2010, AM J MED GENET A, V152A, P2376, DOI 10.1002/ajmg.a.33554; Lau CG, 2012, J NEUROSCI, V32, P8521, DOI 10.1523/JNEUROSCI.1245-12.2012; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McMahon AC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1900; Muhia M, 2010, EUR J NEUROSCI, V31, P529, DOI 10.1111/j.1460-9568.2010.07079.x; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pilpel N, 2009, J NEUROSCI METH, V182, P55, DOI 10.1016/j.jneumeth.2009.05.020; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Porter K, 2005, EUR J NEUROSCI, V21, P351, DOI 10.1111/j.1460-9568.2005.03874.x; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saitoh O, 2001, BRAIN, V124, P1317, DOI 10.1093/brain/124.7.1317; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	56	216	223	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					709	723		10.1016/j.cell.2012.08.045	http://dx.doi.org/10.1016/j.cell.2012.08.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141534	Green Accepted, Bronze			2022-12-24	WOS:000310921200005
J	Wang, X; Zhang, XL; Dong, XP; Samie, M; Li, XR; Cheng, XP; Goschka, A; Shen, DB; Zhou, YD; Harlow, J; Zhu, MX; Clapham, DE; Ren, DJ; Xu, HX				Wang, Xiang; Zhang, Xiaoli; Dong, Xian-ping; Samie, Mohammad; Li, Xinran; Cheng, Xiping; Goschka, Andrew; Shen, Dongbiao; Zhou, Yandong; Harlow, Janice; Zhu, Michael X.; Clapham, David E.; Ren, Dejian; Xu, Haoxing			TPC Proteins Are Phosphoinositide-Activated Sodium-Selective Ion Channels in Endosomes and Lysosomes	CELL			English	Article							CA2+; NAADP; CALCIUM; IDENTIFICATION; RECEPTORS; CATIONS	Mammalian two-pore channel proteins (TPC1, TPC2; TPCN1, TPCN2) encode ion channels in intracellular endosomes and lysosomes and were proposed to mediate endolysosomal calcium release triggered by the second messenger, nicotinic acid adenine dinucleotide phosphate (NAADP). By directly recording TPCs in endolysosomes from wild-type and TPC double-knockout mice, here we show that, in contrast to previous conclusions, TPCs are in fact sodium-selective channels activated by PI(3,5)P-2 and are not activated by NAADP. Moreover, the primary endolysosomal ion is Na+, not K+, as had been previously assumed. These findings suggest that the organellar membrane potential may undergo large regulatory changes and may explain the specificity of PI(3,5)P-2 in regulating the fusogenic potential of intracellular organelles.	[Wang, Xiang; Zhang, Xiaoli; Dong, Xian-ping; Samie, Mohammad; Li, Xinran; Cheng, Xiping; Goschka, Andrew; Shen, Dongbiao; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Zhou, Yandong; Harlow, Janice; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Clapham, David E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 3089 Kraus Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	haoxingx@umich.edu	Clapham, David/S-1123-2019; xu, hao/GWQ-7394-2022; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Dong, Xianping/0000-0002-4496-7104	NIH [NS062792, NS055293, GM081658]; Sloan Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074257, R01NS062792, R01NS055293] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 grants (NS062792 to H. X., NS055293 to D. R., GM081658 to M.X.Z., and HHMI to D. E. C.) and a Sloan Research Fellowship (to H. X.). We thank the Gene Manipulation Facility of Children's Hospital Boston (TPC1) and the Transgenic and Chimera Mouse Facility at the University of Pennsylvania (TPC2) for embryonic stem cell injection. The authors are listed in the order of their institutions; X. W. initiated the project; X. W., X.Z., and X.-p. D. performed the electrophysiology experiments; X. W. also performed the Ca<SUP>2+</SUP> imaging experiments; M. S. and A. G. performed the ionic composition experiments; X. L., X. C., D. S., and M. X.Z. contributed the reagents; D. R. and J.H. developed the TPC1, TPC2 knockout mouse lines and the hTPC1, hTPC2, hTPC1 Delta N, and hTPC2 Delta N constructs; Y.Z. measured the glucose- and NAADP-induced Ca<SUP>2+</SUP> responses in the TPC mutant islets compared with wild-type; development of the TPC1 knockout was carried out by D. R. in the laboratory of D. E. C.; and H. X. and D. E. C. wrote the paper with input from all authors. We are grateful to Drs. Susan Slaugenhaupt and James Slama for sharing reagents; Drs. Ted Huston, Hollis Showalter, Yafei Jin, Leslie Satin, Jianhua Ren, Peter Arvan, and Gautam Rajpal for assistance; and Dr. Richard Hume for comments on an earlier version of the manuscript. We appreciate the encouragement and helpful comments from other members of the Xu, Ren, and Clapham laboratories.	ANZAI K, 1993, J BIOCHEM-TOKYO, V114, P487, DOI 10.1093/oxfordjournals.jbchem.a124204; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; COHN DV, 1968, J BIOL CHEM, V243, P1089; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Jain P, 2010, J MED CHEM, V53, P7599, DOI 10.1021/jm1007209; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kraayenhof R, 1996, BBA-BIOMEMBRANES, V1282, P293, DOI 10.1016/0005-2736(96)00069-7; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Parnas H, 2000, TRENDS NEUROSCI, V23, P60, DOI 10.1016/S0166-2236(99)01498-8; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; SCHMIDT R, 1980, NEUROSCIENCE, V5, P625, DOI 10.1016/0306-4522(80)90060-3; Seby F, 2003, ANAL BIOANAL CHEM, V377, P685, DOI 10.1007/s00216-003-2133-5; Shen DB, 2011, BIOESSAYS, V33, P448, DOI 10.1002/bies.201000152; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Toth B, 2010, J BIOL CHEM, V285, P30091, DOI 10.1074/jbc.M109.066464; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	40	349	354	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					372	383		10.1016/j.cell.2012.08.036	http://dx.doi.org/10.1016/j.cell.2012.08.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063126	Green Accepted, Bronze			2022-12-24	WOS:000309981000015
J	Adesnik, H; Bruns, W; Taniguchi, H; Huang, ZJ; Scanziani, M				Adesnik, Hillel; Bruns, William; Taniguchi, Hiroki; Huang, Z. Josh; Scanziani, Massimo			A neural circuit for spatial summation in visual cortex	NATURE			English	Article							CLASSICAL RECEPTIVE-FIELD; NEURONS; INHIBITION; CONTRAST; V1; CONNECTIONS; GENERATION; RESPONSES; DYNAMICS; SPARSE	The response of cortical neurons to a sensory stimulus is modulated by the context. In the visual cortex, for example, stimulation of a pyramidal cell's receptive-field surround can attenuate the cell's response to a stimulus in the centre of its receptive field, a phenomenon called surround suppression. Whether cortical circuits contribute to surround suppression or whether the phenomenon is entirely relayed from earlier stages of visual processing is debated. Here we show that, in contrast to pyramidal cells, the response of somatostatin-expressing inhibitory neurons (SOMs) in the superficial layers of the mouse visual cortex increases with stimulation of the receptive-field surround. This difference results from the preferential excitation of SOMs by horizontal cortical axons. By perturbing the activity of SOMs, we show that these neurons contribute to pyramidal cells' surround suppression. These results establish a cortical circuit for surround suppression and attribute a particular function to a genetically defined type of inhibitory neuron.	[Adesnik, Hillel; Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Adesnik, Hillel; Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.	massimo@ucsd.edu		Huang, Z. Josh/0000-0003-0592-028X	Helen Hay Whitney Foundation; Howard Hughes Medical Institute (HHMI); Gatsby charitable foundation; US National Institute of Health [NS069010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS069010] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Gatsby charitable foundation; US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to J. Evora for the reconstruction of SOMs and technical assistance. We thank C. Niell and M. Stryker for providing expertise and sharing code used at the initial stages of this project; S. Olsen for providing the firing rates of part of the units isolated under anaesthesia; P. Abelkop and A. Linder for technical assistance; and J. Isaacson and members of the Scanziani laboratory for helpful advice. H. A. was supported by the Helen Hay Whitney Foundation and the Howard Hughes Medical Institute (HHMI). W. B. and M. S. were supported by the HHMI, the Gatsby charitable foundation and US National Institute of Health grant NS069010.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Alitto HJ, 2008, NEURON, V57, P135, DOI 10.1016/j.neuron.2007.11.019; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Mareschal I, 2004, VISION RES, V44, P57, DOI 10.1016/j.visres.2003.07.009; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ozeki H, 2004, J NEUROSCI, V24, P1428, DOI 10.1523/JNEUROSCI.3852-03.2004; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Sceniak MP, 2006, J NEUROPHYSIOL, V96, P3474, DOI 10.1152/jn.00734.2006; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Solomon SG, 2006, J NEUROSCI, V26, P8715, DOI 10.1523/JNEUROSCI.0821-06.2006; Taniguchi H, 2011, NEURON, V72, P1091, DOI 10.1016/j.neuron.2011.12.010; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Van den Bergh G, 2010, J COMP NEUROL, V518, P2051, DOI 10.1002/cne.22321; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109	40	396	398	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					226	231		10.1038/nature11526	http://dx.doi.org/10.1038/nature11526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060193	Green Accepted			2022-12-24	WOS:000309733300042
J	Duch, A; Felipe-Abrio, I; Barroso, S; Yaakov, G; Garcia-Rubio, M; Aguilera, A; de Nadal, E; Posas, F				Duch, Alba; Felipe-Abrio, Irene; Barroso, Sonia; Yaakov, Gilad; Garcia-Rubio, Maria; Aguilera, Andres; de Nadal, Eulalia; Posas, Francesc			Coordinated control of replication and transcription by a SAPK protects genomic integrity	NATURE			English	Article							DOUBLE-STRAND BREAKS; GENE-EXPRESSION; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; FORK PROGRESSION; CELL-CYCLE; STRESS; MRC1; PHASE; KINASE	Upon environmental changes or extracellular signals, cells are subjected to marked changes in gene expression (1,2). Dealing with high levels of transcription during replication is critical to prevent collisions between the transcription and replication pathways and avoid recombination events(3-5). In response to osmostress, hundreds of stress-responsive genes are rapidly induced by the stress-activated protein kinase (SAPK) Hog1 (ref.6), even during S phase(7). Here we show in Saccharomyces cerevisae that a single signalling molecule, Hog1, coordinates both replication and transcription upon osmostress. Hog1 interacts with and phosphorylates Mrc1, a component of the replication complex(8-11). Phosphorylation occurs at different sites to those targeted by Mec1 upon DNA damage(8,9). Mrc1 phosphorylation by Hog1 delays early and late origin firing by preventing Cdc45 loading, as well as slowing down replication-complex progression. Regulation of Mrc1 by Hog1 is completely independent of Mec1 and Rad53. Cells carrying a non-phosphorylatable allele of MRC1 (mrc1(3A)) do not delay replication upon stress and show a marked increase in transcription-associated recombination, genomic instability and Rad52 foci. In contrast, mrc1(3A) induces Rad53 and survival in the presence of hydroxyurea or methyl methanesulphonate. Therefore, Hog1 and Mrc1 define a novel S-phase checkpoint independent of the DNA-damage checkpoint that permits eukaryotic cells to prevent conflicts between DNA replication and transcription, which would otherwise lead to genomic instability when both phenomena are temporally coincident.	[Duch, Alba; Yaakov, Gilad; de Nadal, Eulalia; Posas, Francesc] Univ Pompeu Fabra, Cell Signaling Unit, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain; [Felipe-Abrio, Irene; Barroso, Sonia; Garcia-Rubio, Maria; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Posas, F (corresponding author), Univ Pompeu Fabra, Cell Signaling Unit, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain.	francesc.posas@upf.edu	de Nadal, Eulàlia/J-8178-2014; Posas, Francesc/K-1364-2013; Garcia-Rubio, Maria/C-2061-2017; Duch, Alba/AGI-1035-2022; Aguilera, Andres/L-1825-2014; Barroso, Sonia/F-2288-2016; FELIPE, IRENE/ABF-9743-2021	de Nadal, Eulàlia/0000-0003-0039-5607; Posas, Francesc/0000-0002-4164-7076; Garcia-Rubio, Maria/0000-0003-0981-0555; Duch, Alba/0000-0001-6041-1360; Aguilera, Andres/0000-0003-4782-1714; Barroso, Sonia/0000-0002-0062-2016; FELIPE, IRENE/0000-0001-7781-1459	Spanish Government [BIO2009-07762, BFU2012-33503, BFU2011-26722, BFU2010-16372, CSD2007-0015]; FP7 UNICELLSYS grant [201142]; Fundacion Marcelino Botin; ICREA Academia (Generalitat de Catalunya)	Spanish Government(Spanish GovernmentEuropean Commission); FP7 UNICELLSYS grant; Fundacion Marcelino Botin; ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya)	We thank L. Subirana, S. Ovejas and A. Fernandez for technical support. This work was supported by grants from the Spanish Government (BIO2009-07762 and BFU2012-33503 to F. P., BFU2011-26722 to E.d.N., BFU2010-16372 to A. A., and Consolider Ingenio 2010 programme CSD2007-0015 to F. P. and A. A.) and FP7 UNICELLSYS grant (no. 201142) and the Fundacion Marcelino Botin to F. P. F. P. and E.d.N. are recipients of an ICREA Academia (Generalitat de Catalunya).	Aguilera A, 2005, NAT STRUCT MOL BIOL, V12, P737, DOI 10.1038/nsmb0905-737; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bianco JN, 2012, METHODS, V57, P149, DOI 10.1016/j.ymeth.2012.04.007; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Garcia-Rubio M, 2008, MOL GENET GENOMICS, V279, P123, DOI 10.1007/s00438-007-0301-6; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Moriel-Carretero M, 2010, MOL CELL, V37, P690, DOI 10.1016/j.molcel.2010.02.008; Muers M, 2011, NAT REV GENET, V12, P156, DOI 10.1038/nrg2960; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; SPENCER F, 1990, GENETICS, V124, P237; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129	32	61	62	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					116	+		10.1038/nature11675	http://dx.doi.org/10.1038/nature11675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23178807				2022-12-24	WOS:000312933800042
J	Ouyang, WM; Liao, W; Luo, CT; Yin, N; Huse, M; Kim, MV; Peng, M; Chan, P; Ma, Q; Mo, YF; Meijer, D; Zhao, KJ; Rudensky, AY; Atwal, G; Zhang, MQ; Li, MO				Ouyang, Weiming; Liao, Will; Luo, Chong T.; Yin, Na; Huse, Morgan; Kim, Myoungjoo V.; Peng, Min; Chan, Pamela; Ma, Qian; Mo, Yifan; Meijer, Dies; Zhao, Keji; Rudensky, Alexander Y.; Atwal, Gurinder; Zhang, Michael Q.; Li, Ming O.			Novel Foxo1-dependent transcriptional programs control T-reg cell function	NATURE			English	Article							FOXP3 EXPRESSION; GENE-EXPRESSION; TARGET GENES; DIFFERENTIATION; FOXO1; TOOL; AKT; MECHANISMS; INDUCTION; PROFILES	Regulatory T (T-reg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses(1-4). Foxp3 operates as a late-acting differentiation factor controlling T-reg cell homeostasis and function(5), whereas the early T-reg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors(6-10). However, whether Foxo proteins act beyond the T-reg-cell-commitment stage to control T-reg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of T-reg cell function. T-reg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with T-reg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of T-reg cells. Genome-wide analysis of Foxo1 binding sites reveals similar to 300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt-Foxo1 signalling module controls a novel genetic program indispensable for T-reg cell function.	[Ouyang, Weiming; Luo, Chong T.; Yin, Na; Huse, Morgan; Kim, Myoungjoo V.; Peng, Min; Chan, Pamela; Ma, Qian; Rudensky, Alexander Y.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Liao, Will; Mo, Yifan; Atwal, Gurinder] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Liao, Will; Mo, Yifan] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Luo, Chong T.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Meijer, Dies] Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; [Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Zhang, Michael Q.] Tsinghua Univ, TNLIST, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas; Tsinghua University	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	mzhang@cshl.edu; lim@mskcc.org	Meijer, Dies/C-7786-2012; Peng, Min/O-3770-2017	Meijer, Dies/0000-0002-8461-6341; Peng, Min/0000-0002-5885-0660; li, ming/0000-0002-1383-0535; Luo, Chong/0000-0002-3477-5969	Starr Cancer Consortium [13-A123]; Rita Allen Foundation; National Bio Resource Project (NBRPC) [2012CB316503]; National Institutes of Health [HG001696]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER	Starr Cancer Consortium; Rita Allen Foundation; National Bio Resource Project (NBRPC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank R. Flavell for the Foxp3-IRES-RFP mouse strain, K. Rajewsky and C. Xiao for the Rosa26 targeting vector and T. Unterman for the HA-hFoxo1(AAA) construct. This work was supported by the Starr Cancer Consortium (13-A123 to M.O.L., M.Q.Z. and G. A.), the Rita Allen Foundation (M.O.L.), National Bio Resource Project (NBRPC) (2012CB316503 to M.Q.Z.) and National Institutes of Health (HG001696 to M.Q.Z.).	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li LP, 2009, J COMPUT BIOL, V16, P317, DOI 10.1089/cmb.2008.16TT; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	44	278	286	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					554	+		10.1038/nature11581	http://dx.doi.org/10.1038/nature11581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23135404	Green Accepted			2022-12-24	WOS:000311339800043
J	Huang, JH; Ofek, G; Laub, L; Louder, MK; Doria-Rose, NA; Longo, NS; Imamichi, H; Bailer, RT; Chakrabarti, B; Sharma, SK; Alam, SM; Wang, T; Yang, YP; Zhang, BS; Migueles, SA; Wyatt, R; Haynes, BF; Kwong, PD; Mascola, JR; Connors, M				Huang, Jinghe; Ofek, Gilad; Laub, Leo; Louder, Mark K.; Doria-Rose, Nicole A.; Longo, Nancy S.; Imamichi, Hiromi; Bailer, Robert T.; Chakrabarti, Bimal; Sharma, Shailendra K.; Alam, S. Munir; Wang, Tao; Yang, Yongping; Zhang, Baoshan; Migueles, Stephen A.; Wyatt, Richard; Haynes, Barton F.; Kwong, Peter D.; Mascola, John R.; Connors, Mark			Broad and potent neutralization of HIV-1 by a gp41-specific human antibody	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN GP41; T-CELLS; EPITOPE; MEMBRANE; BINDING; 4E10; SPECIFICITIES	Characterization of human monoclonal antibodies is providing considerable insight into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-proximal external region (MPER)-specific antibody, named 10E8, which neutralizes similar to 98% of tested viruses. An analysis of sera from 78 healthy HIV-1-infected donors demonstrated that 27% contained MPER-specific antibodies and 8% contained 10E8-like specificities. In contrast to other neutralizing MPER antibodies, 10E8 did not bind phospholipids, was not autoreactive, and bound cell-surface envelope. The structure of 10E8 in complex with the complete MPER revealed a site of vulnerability comprising a narrow stretch of highly conserved gp41-hydrophobic residues and a critical arginine or lysine just before the transmembrane region. Analysis of resistant HIV-1 variants confirmed the importance of these residues for neutralization. The highly conserved MPER is a target of potent, non-self-reactive neutralizing antibodies, suggesting that HIV-1 vaccines should aim to induce antibodies to this region of HIV-1 envelope glycoprotein.	[Huang, Jinghe; Laub, Leo; Imamichi, Hiromi; Migueles, Stephen A.; Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Ofek, Gilad; Louder, Mark K.; Doria-Rose, Nicole A.; Longo, Nancy S.; Bailer, Robert T.; Wang, Tao; Yang, Yongping; Zhang, Baoshan; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Chakrabarti, Bimal; Sharma, Shailendra K.; Wyatt, Richard] Scripps Res Inst, Dept Immunol & Microbial Sci, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Alam, S. Munir; Haynes, Barton F.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); International AIDS Vaccine Initiative; Scripps Research Institute; Duke University	Connors, M (corresponding author), NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA.	mconnors@nih.gov	Mascola, John/AAI-7193-2021; Alam, S. Munir/AAC-6711-2019; Huang, Jinghe/P-8068-2019; Huang, Jinghe/O-1986-2015	Huang, Jinghe/0000-0002-1968-871X	NIAID; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, ZIAAI005095, ZIAAI005022, ZIAAI000855] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. W. Hallahan for statistical analyses. We thank K. Lloyd. R. Parks, J. Eudailey and J. Blinn for performing autoantibody assays. We also thank M. Zwick for providing us with the HIV-1 JR2 MPER alanine mutant pseudovirus plasmids. HIV-2/HIV-1 chimaeras were provided by G. Shaw and L. Morris. We thank J. Stuckey for assistance with figures, and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript. This project has been funded in part with federal funds from the Intramural Research Programs of NIAID and the National Cancer Institute, National Institutes of Health, under Contract no. HHSN261200800001E. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Binley J, 2009, CURR OPIN HIV AIDS, V4, P364, DOI 10.1097/COH.0b013e32832e06fe; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Imamichi H, 2001, J INFECT DIS, V183, P36, DOI 10.1086/317641; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kabat EA, 1991, SEQUENCES PROTEINS I; Kershaw MH, 2001, CANCER RES, V61, P7920; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Rathinakumar R, 2012, J VIROL, V86, P1820, DOI 10.1128/JVI.05489-11; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	56	610	653	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					406	+		10.1038/nature11544	http://dx.doi.org/10.1038/nature11544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23151583	Green Accepted			2022-12-24	WOS:000311031600038
J	Mathur, R; Oh, H; Zhang, DK; Park, SG; Seo, J; Koblansky, A; Hayden, MS; Ghosh, S				Mathur, Ramkumar; Oh, Hyunju; Zhang, Dekai; Park, Sung-Gyoo; Seo, Jin; Koblansky, Alicia; Hayden, Matthew S.; Ghosh, Sankar			A Mouse Model of Salmonella Typhi Infection	CELL			English	Article							TOLL-LIKE RECEPTOR-5; ENTERICA SEROVAR TYPHIMURIUM; BACTERIAL FLAGELLIN; DENDRITIC CELLS; GENE-EXPRESSION; HUMANIZED MICE; FEVER; VACCINE; TOLL-LIKE-RECEPTOR-5; PATHOGENESIS	Salmonella spp. are gram-negative flagellated bacteria that can cause food- and waterborne gastroenteritis and typhoid fever in humans. We now report that flagellin from Salmonella spp. is recognized in mouse intestine by Toll-like receptor 11 (TLR11). Absence of TLR11 renders mice more susceptible to infection by S. Typhimurium, with increased dissemination of the bacteria and enhanced lethality. Unlike S. Typhimurium, S. Typhi, a human obligatory pathogen that causes typhoid fever, is normally unable to infect mice. TLR11 is expressed in mice, but not in humans, and remarkably, we find that tlr11(-/-) mice are efficiently infected with orally administered S. Typhi. We also find that tlr11(-/-) mice can be immunized against S. Typhi. Therefore, tlr11(-/-) mice represent a small-animal model for the study of the immune response to S. Typhi and for the development of vaccines against this important human pathogen.	[Mathur, Ramkumar; Oh, Hyunju; Park, Sung-Gyoo; Seo, Jin; Koblansky, Alicia; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10032 USA; [Hayden, Matthew S.] Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10032 USA; [Zhang, Dekai] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA	Columbia University; Columbia University; Yale University	Ghosh, S (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10032 USA.	sg2715@columbia.edu	Park, Sung-Gyoo/H-8652-2019; Mathur, Ramkumar/AAZ-4314-2020	mathur, Ramkumar/0000-0002-9317-2631; Park, Sung-Gyoo/0000-0003-3702-5765; Hayden, Matthew/0000-0003-1670-6430	NIH [RO1-AI59440, R37-AI33443]; ARRA [P30 AR058886-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033443, R37AI033443, R01AI059440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work in this manuscript was supported by grants from NIH (RO1-AI59440 and R37-AI33443) and by institutional support from Columbia University. M. S. H. is supported by ARRA P30 AR058886-01. We would like to thank Ms. Crystal Bussey for help managing our animal colony and Dr. Suneeta Krishnareddy for help evaluating histology.	Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Carvalho FA, 2011, MUCOSAL IMMUNOL, V4, P102, DOI 10.1038/mi.2010.57; COLLINS FM, 1978, INFECT IMMUN, V21, P41, DOI 10.1128/IAI.21.1.41-47.1978; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Guzman CA, 2006, VACCINE, V24, P3804, DOI 10.1016/j.vaccine.2005.07.111; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Levine MM, 2007, CLIN INFECT DIS, V45, pS24, DOI 10.1086/518141; Libby SJ, 2010, P NATL ACAD SCI USA, V107, P15589, DOI 10.1073/pnas.1005566107; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; LIU SL, 1988, INFECT IMMUN, V56, P1967, DOI 10.1128/IAI.56.8.1967-1973.1988; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Mestecky J, 2008, CURR OPIN GASTROEN, V24, P713, DOI 10.1097/MOG.0b013e32830d58be; Mian MF, 2011, VIRULENCE, V2, P248, DOI 10.4161/viru.2.3.16133; Mian MF, 2011, CELL MOL IMMUNOL, V8, P83, DOI 10.1038/cmi.2010.52; Mohawk KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/258185; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Raffatellu M, 2008, J INFECT DEV COUNTR, V2, P260; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vijay-Kumar M, 2008, INFECT IMMUN, V76, P1276, DOI 10.1128/IAI.01491-07; West AP, 2005, J BIOL CHEM, V280, P9482, DOI 10.1074/jbc.M411875200; Winter SE, 2008, CELL MICROBIOL, V10, P247, DOI 10.1111/j.1462-5822.2007.01037.x; Woc-Colburn Laila, 2009, Curr Infect Dis Rep, V11, P120, DOI 10.1007/s11908-009-0018-2; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	38	134	141	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					590	602		10.1016/j.cell.2012.08.042	http://dx.doi.org/10.1016/j.cell.2012.08.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101627	Green Accepted, Bronze			2022-12-24	WOS:000310529300015
J	Nie, ZQ; Hu, GQ; Wei, G; Cui, KR; Yamane, A; Resch, W; Wang, RN; Green, DR; Tessarollo, L; Casellas, R; Zhao, KJ; Levens, D				Nie, Zuqin; Hu, Gangqing; Wei, Gang; Cui, Kairong; Yamane, Arito; Resch, Wolfgang; Wang, Ruoning; Green, Douglas R.; Tessarollo, Lino; Casellas, Rafael; Zhao, Keji; Levens, David			c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells	CELL			English	Article							GRAPHICAL USER-INTERFACE; TRANSCRIPTION FACTOR MYC; LYMPHOMA CELLS; RNA-POLYMERASE; ACTIVATION; MOUSE; FIBROBLASTS; ONCOGENES; REVEALS; GENOME	The c-Myc HLH-bZIP protein has been implicated in physiological or pathological growth, proliferation, apoptosis, metabolism, and differentiation at the cellular, tissue, or organismal levels via regulation of numerous target genes. No principle yet unifies Myc action due partly to an incomplete inventory and functional accounting of Myc's targets. To observe Myc target expression and function in a system where Myc is temporally and physiologically regulated, the transcriptomes and the genome-wide distributions of Myc, RNA polymerase II, and chromatin modifications were compared during lymphocyte activation and in ES cells as well. A remarkably simple rule emerged from this quantitative analysis: Myc is not an on-off specifier of gene activity, but is a nonlinear amplifier of expression, acting universally at active genes, except for immediate early genes that are strongly induced before Myc. This rule of Myc action explains the vast majority of Myc biology observed in literature.	[Hu, Gangqing; Wei, Gang; Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, Bethesda, MD 20892 USA; [Nie, Zuqin; Levens, David] NCI, Pathol Lab, Bethesda, MD 20892 USA; [Yamane, Arito; Resch, Wolfgang; Casellas, Rafael] NIAMS, Genom & Immun Sect, Bethesda, MD 20892 USA; [Wang, Ruoning; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Tessarollo, Lino] NCI, Neural Dev Sect, FNL, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov; levens@helix.nih.gov	Green, Douglas R/N-8083-2018; Levens, David/C-9216-2009; Hu, Gangqing/ABA-3507-2020; Wang, Ruoning/C-1683-2014; HU, GANGQING/K-5849-2012; Yamane, Arito/A-2959-2013	Green, Douglas R/0000-0002-7332-1417; Levens, David/0000-0002-7616-922X; HU, GANGQING/0000-0001-5453-6888; Resch, Wolfgang/0000-0001-7594-5963	NIH, National Cancer Institute, Center for Cancer Research; NHLBI; NIAMS; NATIONAL CANCER INSTITUTE [ZICBC011265, ZIABC011465] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank our colleagues, especially Eric Batchelor and Dan Larson for insight and valuable discussions. D.L. thanks Dirk Eick for insightful discussion. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, of NHLBI and of NIAMS. We thank the DNA Sequencing Core Facility of NHLBI for sequencing some of the ChIP-Seq libraries.	Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199; Alon U, 2007, INTRO SYSTEMS BIOL D; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Bui Thi V, 2010, Genes Cancer, V1, P568; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Chung HJ, 2005, MOL CELLS, V20, P157; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; James L, 2002, P NATL ACAD SCI USA, V99, P10429, DOI 10.1073/pnas.162369299; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Levens David, 2010, Genes Cancer, V1, P547; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu J, 2006, CURR TOP MICROBIOL, V302, P1; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Mehmet H, 1997, CELL GROWTH DIFFER, V8, P187; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Thomas LR, 2011, ADV CANCER RES, V110, P77, DOI 10.1016/B978-0-12-386469-7.00004-9; TONINI GP, 1987, CANCER RES, V47, P4544; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wasylishen Amanda R, 2010, Genes Cancer, V1, P532, DOI 10.1177/1947601910378024; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	58	721	739	4	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					68	79		10.1016/j.cell.2012.08.033	http://dx.doi.org/10.1016/j.cell.2012.08.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021216	Green Accepted, Bronze			2022-12-24	WOS:000309544200011
J	Shyh-Chang, N; Locasale, JW; Lyssiotis, CA; Zheng, YX; Teo, RY; Ratanasirintrawoot, S; Zhang, J; Onder, T; Unternaehrer, JJ; Zhu, H; Asara, JM; Daley, GQ; Cantley, LC				Ng Shyh-Chang; Locasale, Jason W.; Lyssiotis, Costas A.; Zheng, Yuxiang; Teo, Ren Yi; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Asara, John M.; Daley, George Q.; Cantley, Lewis C.			Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; MOUSE; GLYCINE; CANCER; CHROMATIN	Threonine is the only amino acid critically required for the pluripotency of mouse embryonic stem cells (mESCs), but the detailed mechanism remains unclear. We found that threonine and S-adenosylmethionine (SAM) metabolism are coupled in pluripotent stem cells, resulting in regulation of histone methylation. Isotope labeling of mESCs revealed that threonine provides a substantial fraction of both the cellular glycine and the acetyl-coenzyme A (CoA) needed for SAM synthesis. Depletion of threonine from the culture medium or threonine dehydrogenase (Tdh) from mESCs decreased accumulation of SAM and decreased trimethylation of histone H3 lysine 4 (H3K4me3), leading to slowed growth and increased differentiation. Thus, abundance of SAM appears to influence H3K4me3, providing a possible mechanism by which modulation of a metabolic pathway might influence stem cell fate.	[Ng Shyh-Chang; Teo, Ren Yi; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Ng Shyh-Chang; Teo, Ren Yi; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ng Shyh-Chang; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ng Shyh-Chang; Ratanasirintrawoot, Sutheera; Zhang, Jin; Onder, Tamer; Unternaehrer, Juli J.; Zhu, Hao; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ng Shyh-Chang; Daley, George Q.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Ng Shyh-Chang; Locasale, Jason W.; Lyssiotis, Costas A.; Zheng, Yuxiang; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02215 USA; [Ng Shyh-Chang; Locasale, Jason W.; Lyssiotis, Costas A.; Zheng, Yuxiang; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Daley, GQ (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; lewis_cantley@hms.harvard.edu	Lyssiotis, Costas A/AAI-1923-2019; Onder, Tamer T/H-3330-2013; ZHANG, JIN/D-1435-2013; Locasale, Jason W/ABE-6505-2020; Cantley, Lewis C/D-1800-2014; Zhu, Hao/L-5114-2013; Onder, Tamer/O-3669-2019	Lyssiotis, Costas A/0000-0001-9309-6141; Onder, Tamer T/0000-0002-2372-9158; Locasale, Jason W/0000-0002-7766-3502; Cantley, Lewis C/0000-0002-1298-7653; Zhu, Hao/0000-0002-8417-9698; Onder, Tamer/0000-0002-2372-9158; Shyh-Chang, Ng/0000-0003-3138-9525; Unternaehrer-Hamm, Julia/0000-0001-5864-4704; Ratanasirintrawoot, Sutheera/0000-0002-0641-5106	NSS Scholarship from the Agency for Science, Technology and Research, Singapore; American Cancer Society; NIH [4R00CA168997-02, RC2HL102815, U01 HL100001, R01 GM56203]; Damon Runyon Cancer Research Foundation Amgen fellowship; iPierian Inc.; NATIONAL CANCER INSTITUTE [R00CA168997, K08CA157727] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NSS Scholarship from the Agency for Science, Technology and Research, Singapore; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation Amgen fellowship; iPierian Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Daley and Cantley labs for helpful discussions. Supported by the NSS Scholarship from the Agency for Science, Technology and Research, Singapore (N.S.-C.), the American Cancer Society and NIH grant 4R00CA168997-02 (J.W.L.), a Damon Runyon Cancer Research Foundation Amgen fellowship (C. A. L.), NIH grants RC2HL102815 and U01 HL100001 (G. Q. D.), and NIH grant R01 GM56203 (L. C. C.). G. Q. D. is an investigator of the HHMI. G. Q. D., as a co-founder and scientific advisory board member, holds stock options and receives consulting fees from iPierian Inc., a biopharmaceutical company that uses iPS cells in drug discovery against neurologic disease. L. C. C. is the founder and a member of the board of directors of Agios Pharmaceuticals, a company that targets metabolic enzymes for cancer treatment.	Alexander PB, 2011, P NATL ACAD SCI USA, V108, P15828, DOI 10.1073/pnas.1111312108; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BACKLUND PS, 1986, EUR J BIOCHEM, V160, P245, DOI 10.1111/j.1432-1033.1986.tb09963.x; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; EAGLE H, 1961, J BIOL CHEM, V236, P2039; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Iwabata H, 2005, PROTEOMICS, V5, P4653, DOI 10.1002/pmic.200500042; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; McMillan JM, 2005, J PHARM PHARMACOL, V57, P599, DOI 10.1211/0022357056082; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; VALANCIUS V, 1991, MOL CELL BIOL, V11, P1402, DOI 10.1128/MCB.11.3.1402; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang DW, 2012, GENE DEV, V26, P461, DOI 10.1101/gad.182998.111; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	24	425	432	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					222	226		10.1126/science.1226603	http://dx.doi.org/10.1126/science.1226603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23118012	Green Accepted			2022-12-24	WOS:000313328200049
J	Clowney, EJ; LeGros, MA; Mosley, CP; Clowney, FG; Markenskoff-Papadimitriou, EC; Myllys, M; Barnea, G; Larabell, CA; Lomvardas, S				Clowney, E. Josephine; LeGros, Mark A.; Mosley, Colleen P.; Clowney, Fiona G.; Markenskoff-Papadimitriou, Eirene C.; Myllys, Markko; Barnea, Gilad; Larabell, Carolyn A.; Lomvardas, Stavros			Nuclear Aggregation of Olfactory Receptor Genes Governs Their Monogenic Expression	CELL			English	Article							ORGANIZATION; CHROMATIN; CHOICE; MORPHOLOGY; PROMOTER; LAMINA; GENOME; MICE	Gene positioning and regulation of nuclear architecture are thought to influence gene expression. Here, we show that, in mouse olfactory neurons, silent olfactory receptor (OR) genes from different chromosomes converge in a small number of heterochromatic foci. These foci are OR exclusive and form in a cell-type-specific and differentiation-dependent manner. The aggregation of OR genes is developmentally synchronous with the downregulation of lamin b receptor (LBR) and can be reversed by ectopic expression of LBR in mature olfactory neurons. LBR-induced reorganization of nuclear architecture and disruption of OR aggregates perturbs the singularity of OR transcription and disrupts the targeting specificity of the olfactory neurons. Our observations propose spatial sequestering of heterochromatinized OR family members as a basis of monogenic and monoallelic gene expression.	[Clowney, E. Josephine; Lomvardas, Stavros] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [LeGros, Mark A.; Mosley, Colleen P.; Clowney, Fiona G.; Larabell, Carolyn A.; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Markenskoff-Papadimitriou, Eirene C.; Lomvardas, Stavros] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [LeGros, Mark A.; Larabell, Carolyn A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Myllys, Markko] Univ Jyvaskyla, Dept Phys, FI-40014 Jyvaskyla, Finland; [Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Jyvaskyla; Brown University	Lomvardas, S (corresponding author), Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu		Clowney, Eleanor/0000-0002-9150-9464; Lomvardas, Stavros/0000-0002-7668-3026	National Science Foundation (NSF GRFP); Roadmap for Epigenomics grant [5R01DA030320-02]; McKnight Endowment for Neurosciences; National Center for Research Resources [5P41RR019664-08]; National Institute of General Medical Sciences from the National Institutes of Health [8 P41 GM103445-08]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-05CH11231]; NIH [5R01MH086920]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030320] Funding Source: NIH RePORTER	National Science Foundation (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Roadmap for Epigenomics grant; McKnight Endowment for Neurosciences; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Dr. Nicholas Ryba for the G gamma 8 tTA transgenic mice; Drs. Monica Zwerger and Harald Herrmann for the anti-LBR antibody; David Lyons and Drs. Richard Axel, Keith Yamamoto, and David Agard for input and suggestions; and Dr. Nirao Shah and the Lomvardas lab for critical reading of the manuscript. Also, we are grateful to Dr. Allan Basbaum for making the Shidduch between S.L. and C.A.L. E.J.C. and E.C.M.-P. are supported by fellowships from the National Science Foundation (NSF GRFP). This project was funded by the Roadmap for Epigenomics grant 5R01DA030320-02 and the McKnight Endowment for Neurosciences. National Center for X-Ray Tomography is funded by grants from the National Center for Research Resources (5P41RR019664-08) and the National Institute of General Medical Sciences (8 P41 GM103445-08) from the National Institutes of Health and US Department of Energy, Office of Biological and Environmental Research (DE-AC02-05CH11231). G.B. is a Pew scholar and is supported, in part, by NIH grant 5R01MH086920.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Eskiw CH, 2010, COLD SH Q B, V75, P501, DOI 10.1101/sqb.2010.75.046; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fuss SH, 2009, MOL CELL NEUROSCI, V41, P101, DOI 10.1016/j.mcn.2009.02.014; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; GOLDOWITZ D, 1982, DEV BIOL, V89, P261, DOI 10.1016/0012-1606(82)90313-X; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; McDermott G, 2009, TRENDS CELL BIOL, V19, P587, DOI 10.1016/j.tcb.2009.08.005; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Okada Y, 2005, EMBO REP, V6, P452, DOI 10.1038/sj.embor.7400406; Olins AL, 2009, EUR J CELL BIOL, V88, P203, DOI 10.1016/j.ejcb.2008.10.001; Peric-Hupkes D, 2010, COLD SH Q B, V75, P517, DOI 10.1101/sqb.2010.75.014; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pyrpasopoulou A, 1996, EMBO J, V15, P7108, DOI 10.1002/j.1460-2075.1996.tb01102.x; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; ZACHARIAS H, 1995, GENETICS, V141, P7; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	35	220	222	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					724	737		10.1016/j.cell.2012.09.043	http://dx.doi.org/10.1016/j.cell.2012.09.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141535	Bronze, Green Accepted			2022-12-24	WOS:000310921200006
J	Barry, ER; Morikawa, T; Butler, BL; Shrestha, K; de la Rosa, R; Yan, KS; Fuchs, CS; Magness, ST; Smits, R; Ogino, S; Kuo, CJ; Camargo, FD				Barry, Evan R.; Morikawa, Teppei; Butler, Brian L.; Shrestha, Kriti; de la Rosa, Rosemarie; Yan, Kelley S.; Fuchs, Charles S.; Magness, Scott T.; Smits, Ron; Ogino, Shuji; Kuo, Calvin J.; Camargo, Fernando D.			Restriction of intestinal stem cell expansion and the regenerative response by YAP	NATURE			English	Article							HIPPO SIGNALING PATHWAY; WNT/BETA-CATENIN; COLORECTAL-CANCER; IN-VITRO; MOUSE MODEL; EXPRESSION; HOMEOSTASIS; EPITHELIUM; CRYPT; LGR5	A remarkable feature of regenerative processes is their ability to halt proliferation once an organ's structure has been restored. The Wnt signalling pathway is the major driving force for homeostatic self-renewal and regeneration in the mammalian intestine. However, the mechanisms that counterbalance Wnt-driven proliferation are poorly understood. Here we demonstrate in mice and humans that yes-associated protein 1 (YAP; also known as YAP1)-a protein known for its powerful growth-inducing and oncogenic properties(1,2)-has an unexpected growth-suppressive function, restricting Wnt signals during intestinal regeneration. Transgenic expression of YAP reduces Wnt target gene expression and results in the rapid loss of intestinal crypts. In addition, loss of YAP results in Wnt hypersensitivity during regeneration, leading to hyperplasia, expansion of intestinal stem cells and niche cells, and formation of ectopic crypts and microadenomas. We find that cytoplasmic YAP restricts elevated Wnt signalling independently of the AXIN-APC-GSK-3 beta complex partly by limiting the activity of dishevelled (DVL). DVL signals in the nucleus of intestinal stem cells, and its forced expression leads to enhanced Wnt signalling in crypts. YAP dampens Wnt signals by restricting DVL nuclear translocation during regenerative growth. Finally, we provide evidence that YAP is silenced in a subset of highly aggressive and undifferentiated human colorectal carcinomas, and that its expression can restrict the growth of colorectal carcinoma xenografts. Collectively, our work describes a novel mechanistic paradigm for how proliferative signals are counterbalanced in regenerating tissues. Additionally, our findings have important implications for the targeting of YAP in human malignancies.	[Barry, Evan R.; Butler, Brian L.; Shrestha, Kriti; de la Rosa, Rosemarie; Camargo, Fernando D.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Barry, Evan R.; Butler, Brian L.; Shrestha, Kriti; de la Rosa, Rosemarie; Camargo, Fernando D.] Childrens Hosp, Dept Hematol Oncol, Boston, MA 02115 USA; [Barry, Evan R.; Butler, Brian L.; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Barry, Evan R.; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Morikawa, Teppei; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Morikawa, Teppei; Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Yan, Kelley S.; Kuo, Calvin J.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Magness, Scott T.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Magness, Scott T.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Smits, Ron] Erasmus MC, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital	Camargo, FD (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	Fernando.camargo@childrens.harvard.edu		camargo, fernando/0000-0002-5630-5909; Ogino, Shuji/0000-0002-3909-2323; Kuo, Calvin/0000-0002-7427-5985; Magness, Scott/0000-0002-2746-1224	Stand Up to Cancer-AACR initiative; National Institutes of Health [R01 CA131426, AR064036]; Harvard Stem Cell Institute; American Cancer Society Illinois Division [PF-12-245-01-CCG]; CIRM [1K08DK096048];  [1U01DK085527];  [R01 CA151993];  [R01 DK091427];  [P01CA87969];  [P50CA127003]; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA131426, R01CA151993, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527, P30DK049216, K08DK096048, R01DK091427] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; American Cancer Society Illinois Division(American Cancer Society); CIRM(California Institute for Regenerative Medicine); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Zon and Camargo laboratory members for critical review of this manuscript and X. He for Myc-DVL2 constructs. This work was supported by grants from the Stand Up to Cancer-AACR initiative (F. D. C.), National Institutes of Health R01 CA131426 and AR064036 (F. D. C.) and the Harvard Stem Cell Institute (F. D. C.). F. D. C. is a Pew Scholar in the Biomedical Sciences. E. R. B. is supported by a postdoctoral fellowship from the American Cancer Society Illinois Division (PF-12-245-01-CCG). This work has also benefited from support to K.S.Y. (CIRM, and 1K08DK096048), C.J.K. (1U01DK085527), S.O. (R01 CA151993 and R01 DK091427), S. T. M. (P01CA87969) and C. S. F. (P50CA127003).	Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Metcalfe C, 2010, CANCER RES, V70, P6629, DOI 10.1158/0008-5472.CAN-10-1616; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Roth S, 2009, GENESIS, V47, P7, DOI 10.1002/dvg.20446; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	39	388	399	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					106	+		10.1038/nature11693	http://dx.doi.org/10.1038/nature11693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23178811	Green Submitted, Green Accepted			2022-12-24	WOS:000312933800040
J	Clapier, CR; Cairns, BR				Clapier, Cedric R.; Cairns, Bradley R.			Regulation of ISWI involves inhibitory modules antagonized by nucleosomal epitopes	NATURE			English	Article							DNA TRANSLOCATION; CHROMATIN; MECHANISM; BINDING; RSC; IDENTIFICATION; RECOGNITION; DOMAIN	Chromatin-remodelling complexes (CRCs) mobilize nucleosomes to mediate the access of DNA-binding factors to their sites in vivo. These CRCs contain a catalytic subunit that bears an ATPase/DNA-translocase domain and flanking regions that bind nucleosomal epitopes(1). A central question is whether and how these flanking regions regulate ATP hydrolysis or the coupling of hydrolysis to DNA translocation, to affect nucleosome-sliding efficiency. ISWI-family CRCs contain the protein ISWI2, which uses its ATPase/DNA-translocase domain to pump DNA around the histone octamer to enable sliding(3-7). ISWI is positively regulated by two 'activating' nucleosomal epitopes: the 'basic patch' on the histone H4 tail, and extranucleosomal (linker) DNA(8-13). Previous work defined the HAND-SANT-SLIDE (HSS) domain at the ISWI carboxy terminus that binds linker DNA, needed for ISWI activity(14,15). Here we define two new, conserved and separate regulatory regions on Drosophila ISWI, termed AutoN and NegC, which negatively regulate ATP hydrolysis (AutoN) or the coupling of ATP hydrolysis to productive DNA translocation (NegC). The two aforementioned nucleosomal epitopes promote remodelling indirectly by preventing the negative regulation of AutoN and NegC. Notably, mutation or removal of AutoN and NegC enables marked nucleosome sliding without the H4 basic patch or extranucleosomal DNA, or the HSS domain, conferring on ISWI the biochemical attributes normally associated with SWI/SNF-family ATPases. Thus, the ISWI ATPase catalytic core is an intrinsically active DNA translocase that conducts nucleosome sliding, onto which selective 'inhibition-of-inhibition' modules are placed, to help ensure that remodelling occurs only in the presence of proper nucleosomal epitopes. This supports a general concept for the specialization of chromatin-remodelling ATPases, in which specific regulatory modules adapt an ancient active DNA translocase to conduct particular tasks only on the appropriate chromatin landscape.	[Clapier, Cedric R.; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Sch Med, Salt Lake City, UT 84112 USA; [Clapier, Cedric R.; Cairns, Bradley R.] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Howard Hughes Med Inst, Sch Med, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	cedric.clapier@hci.utah.edu; brad.cairns@hci.utah.edu			National Institutes of Health [GM60415, CA042014]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Tan for pST55-16 x NCP601a and G. Langst for pUC12 x 601. We thank C. Muller for experience gained by C. Clapier on structural aspects of ISWI protein. We thank T. Owen-Hughes for the S. cerevisiae strain TOH1358, T. Tsukiyama for the initial ISW1-containing plasmid, P. Gawu for technical assistance and B. Schackmann for DNA sequencing and peptide synthesis. This work was supported by National Institutes of Health grant GM60415 (supplies), Howard Hughes Medical Institute (support of C.R.C. and B.R.C.), and CA042014 (University of Utah core facilities).	Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Patel A, 2011, J BIOL CHEM, V286, P43984, DOI 10.1074/jbc.M111.282970; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schrodinger L. L. C., 2010, PYMOL MOL GRAPH SYST; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Sen P, 2011, NUCLEIC ACIDS RES, V39, P9155, DOI 10.1093/nar/gkr622; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sirinakis G, 2011, EMBO J, V30, P2364, DOI 10.1038/emboj.2011.141; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Wilson B, 2006, GENETICS, V172, P795, DOI 10.1534/genetics.105.047589; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	34	107	107	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					280	+		10.1038/nature11625	http://dx.doi.org/10.1038/nature11625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23143334	Green Accepted			2022-12-24	WOS:000312259300048
J	Pak, J; Maniar, JM; Mello, CC; Fire, A				Pak, Julia; Maniar, Jay Mahesh; Mello, Cecilia Cabral; Fire, Andrew			Protection from Feed-Forward Amplification in an Amplified RNAi Mechanism	CELL			English	Article							GERM-LINE DEVELOPMENT; C-ELEGANS; CAENORHABDITIS-ELEGANS; POLYMERASE-II; INTERFERENCE; SIRNAS; ARGONAUTE; ROLES; RDE-1; DCR-1	The effectiveness of RNA interference (RNAi) in many organisms is potentiated through the signal-amplifying activity of a targeted RNA-directed RNA polymerase (RdRP) system that can convert a small population of exogenously-encountered dsRNA fragments into an abundant internal pool of small interfering RNA (siRNA). As for any biological amplification system, we expect an underlying architecture that will limit the ability of a randomly encountered trigger to produce an uncontrolled and self-escalating response. Investigating such limits in Caenorhabditis elegans, we find that feed-forward amplification is limited by biosynthetic and structural distinctions at the RNA level between (1) triggers that can produce amplification and (2) siRNA products of the amplification reaction. By assuring that initial (primary) siRNAs can act as triggers but not templates for activation, and that the resulting (secondary) siRNAs can enforce gene silencing on additional targets without unbridled trigger amplification, the system achieves substantial but fundamentally limited signal amplification.	[Pak, Julia; Mello, Cecilia Cabral; Fire, Andrew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Maniar, Jay Mahesh; Fire, Andrew] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Fire, A (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	afire@stanford.edu		Fire, Andrew/0000-0001-6217-8312	NIGMS [R01GM37706]; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Liu, L. Zhang, M. Stadler, A. Lamm, H. Zhang, D. Wu, L. Gracey, R. Li, I. Gabdank, K. Artiles, S. Gu, J. Gent, C. Kumsta, M. Hansen, P. Parameswaran, C. Smith, Z. Weng, R. Alcazar, W. Lui, P. Lacroute, A. Sidow, A. Jheon, O. Klein, anonymous reviewers and NIGMS (R01GM37706) for help and support.	Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bergstrom CT, 2003, P NATL ACAD SCI USA, V100, P11511, DOI 10.1073/pnas.1931639100; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; Boisvert MEL, 2008, CURR TOP MICROBIOL, V320, P21; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; FILES JG, 1983, J MOL BIOL, V164, P355, DOI 10.1016/0022-2836(83)90056-6; Fischer SEJ, 2010, INT J BIOCHEM CELL B, V42, P1306, DOI 10.1016/j.biocel.2010.03.006; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gent JI, 2009, GENETICS, V183, P1297, DOI 10.1534/genetics.109.109686; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Habig JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004052; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kumsta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035428; LANDEL CP, 1984, J MOL BIOL, V180, P497, DOI 10.1016/0022-2836(84)90024-X; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; MacQueen AJ, 2005, MOL BIOL CELL, V16, P3247, DOI 10.1091/mbc.E04-12-1061; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nowotny M, 2009, CURR OPIN STRUC BIOL, V19, P286, DOI 10.1016/j.sbi.2009.04.006; Okamura K, 2011, MOL CELL BIOL, V31, P884, DOI 10.1128/MCB.01141-10; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parrish S, 2001, RNA, V7, P1397; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Willis JH, 2006, MOL BIOL CELL, V17, P1051, DOI 10.1091/mbc.E05-09-0886; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	55	53	55	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					885	899		10.1016/j.cell.2012.10.022	http://dx.doi.org/10.1016/j.cell.2012.10.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141544	Green Accepted, Bronze			2022-12-24	WOS:000310921200018
J	Psakhye, I; Jentsch, S				Psakhye, Ivan; Jentsch, Stefan			Protein Group Modification and Synergy in the SUMO Pathway as Exemplified in DNA Repair	CELL			English	Article							UBIQUITIN E3 LIGASE; HOMOLOGOUS RECOMBINATION; RAD52 SUMOYLATION; DAMAGE-TOLERANCE; S-PHASE; REPLICATION; CHECKPOINT; COMPLEX; PCNA; EXO1	Protein modification by SUMO affects a wide range of protein substrates. Surprisingly, although SUMO pathway mutants display strong phenotypes, the function of individual SUMO modifications is often enigmatic, and SUMOylation-defective mutants commonly lack notable phenotypes. Here, we use DNA double-strand break repair as an example and show that DNA damage triggers a SUMOylation wave, leading to simultaneous multisite modifications of several repair proteins of the same pathway. Catalyzed by a DNA-bound SUMO ligase and triggered by single-stranded DNA, SUMOylation stabilizes physical interactions between the proteins. Notably, only wholesale elimination of SUMOylation of several repair proteins significantly affects the homologous recombination pathway by considerably slowing down DNA repair. Thus, SUMO acts synergistically on several proteins, and individual modifications only add up to efficient repair. We propose that SUMOylation may thus often target a protein group rather than individual proteins, whereas localized modification enzymes and highly specific triggers ensure specificity.	[Psakhye, Ivan; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de		Psakhye, Ivan/0000-0003-3877-133X	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Louis-Jeantet Foundation; EU Marie Curie Training Network	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; Louis-Jeantet Foundation; EU Marie Curie Training Network(European Commission)	We thank S. Bergink, G. I. Karras, M. Kern, C. Lademann, B. Pfander, J. Renkawitz, and Z. Storchova for comments on the manuscript; C. Boulegue for mass spectrometry analysis; J. Rech for help with peptide array synthesis; K. Hofmann for help with bioinformatic analysis; and A. Strasser for technical assistance. I. P. was supported by a stipend from EU Marie Curie Training Network, and research by S. J. was supported by the Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, RUBICON EU Network of Excellence, and Louis-Jeantet Foundation.	Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; Davis AP, 2003, DNA REPAIR, V2, P1127, DOI 10.1016/S1568-7864(03)00121-6; Dou H, 2011, FEBS LETT, V585, P2891, DOI 10.1016/j.febslet.2011.04.002; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Maeda D, 2004, DNA REPAIR, V3, P335, DOI 10.1016/j.dnarep.2003.11.011; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Ohuchi T, 2008, DNA REPAIR, V7, P879, DOI 10.1016/j.dnarep.2008.02.005; Ohuchi T, 2009, DNA REPAIR, V8, P690, DOI 10.1016/j.dnarep.2009.01.018; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Panse VG, 2006, TRAFFIC, V7, P1311, DOI 10.1111/j.1600-0854.2006.00471.x; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Silver HR, 2011, DNA REPAIR, V10, P1243, DOI 10.1016/j.dnarep.2011.09.013; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Ullmann R, 2012, MOL CELL, V46, P759, DOI 10.1016/j.molcel.2012.04.006; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Westman BJ, 2011, NUCLEUS-AUSTIN, V2, P30, DOI 10.4161/nucl.2.1.14437; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	51	330	338	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					807	820		10.1016/j.cell.2012.10.021	http://dx.doi.org/10.1016/j.cell.2012.10.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23122649	Bronze			2022-12-24	WOS:000310921200012
J	Gill, RJ; Ramos-Rodriguez, O; Raine, NE				Gill, Richard J.; Ramos-Rodriguez, Oscar; Raine, Nigel E.			Combined pesticide exposure severely affects individual- and colony-level traits in bees	NATURE			English	Article							HONEY-BEES; RISK-ASSESSMENT; SYSTEMIC INSECTICIDES; HYMENOPTERA APIDAE; BOMBUS-TERRESTRIS; FORAGING SUCCESS; APIS-MELLIFERA; POLLINATORS; MITICIDES; TOXICITY	Reported widespread declines of wild and managed insect pollinators have serious consequences for global ecosystem services and agricultural production(1-3). Bees contribute approximately 80% of insect pollination, so it is important to understand and mitigate the causes of current declines in bee populations(4-6). Recent studies have implicated the role of pesticides in these declines, as exposure to these chemicals has been associated with changes in bee behaviour(7-11) and reductions in colony queen production(12). However, the key link between changes in individual behaviour and the consequent impact at the colony level has not been shown. Social bee colonies depend on the collective performance of many individual workers. Thus, although field-level pesticide concentrations can have subtle or sublethal effects at the individual level(8), it is not known whether bee societies can buffer such effects or whether it results in a severe cumulative effect at the colony level. Furthermore, widespread agricultural intensification means that bees are exposed to numerous pesticides when foraging(13-15), yet the possible combinatorial effects of pesticide exposure have rarely been investigated(16,17). Here we show that chronic exposure of bumblebees to two pesticides (neonicotinoid and pyrethroid) at concentrations that could approximate field-level exposure impairs natural foraging behaviour and increases worker mortality leading to significant reductions in brood development and colony success. We found that worker foraging performance, particularly pollen collecting efficiency, was significantly reduced with observed knock-on effects for forager recruitment, worker losses and overall worker productivity. Moreover, we provide evidence that combinatorial exposure to pesticides increases the propensity of colonies to fail.	[Gill, Richard J.; Ramos-Rodriguez, Oscar; Raine, Nigel E.] Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Gill, RJ (corresponding author), Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	richard.gill@rhul.ac.uk; nigel.raine@rhul.ac.uk	Raine, Nigel/AAK-6425-2020	Raine, Nigel/0000-0001-6343-2829; Gill, Richard/0000-0001-9389-1284	Insect Pollinator Initiative; Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; Scottish Government; Department for Environment, Food and Rural Affairs (DEFRA); Natural Environment Research Council (NERC) [BB/I000178/1]; Biotechnology and Biological Sciences Research Council [BB/I000178/1] Funding Source: researchfish; BBSRC [BB/I000178/1] Funding Source: UKRI	Insect Pollinator Initiative; Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Government; Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M.J.F. Brown, M. Clook, J. Culverhouse, A. Dixon, M. Furst, D. Garthwaite, A. Horsell, V. Jansen and I. Pedroso-Rovira for comments and technical assistance, and Syngenta Bioline Bees for supplying colonies. The study was supported by the Insect Pollinator Initiative (funded under the auspices of the Living with Environmental Change programme, Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust, Scottish Government, Department for Environment, Food and Rural Affairs (DEFRA) and Natural Environment Research Council (NERC): grant BB/I000178/1).	Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Garthwaite D., 2010, 235 FOOD ENV RES AG; Garthwaite DG, 2008, 224 FOOD ENV RES AG; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Krischik VA, 2007, ENVIRON ENTOMOL, V36, P1238, DOI 10.1603/0046-225X(2007)36[1238:SIITTN]2.0.CO;2; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Molet M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1919, DOI 10.1007/s00265-008-0623-3; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Thompson HM, 2001, APIDOLOGIE, V32, P305, DOI 10.1051/apido:2001131; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	40	595	625	26	1176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					105	U119		10.1038/nature11585	http://dx.doi.org/10.1038/nature11585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23086150	Green Accepted			2022-12-24	WOS:000310434500039
J	Pace, L; Tempez, A; Arnold-Schrauf, C; Lemaitre, F; Bousso, P; Fetler, L; Sparwasser, T; Amigorena, S				Pace, Luigia; Tempez, Andy; Arnold-Schrauf, Catharina; Lemaitre, Fabrice; Bousso, Philippe; Fetler, Luc; Sparwasser, Tim; Amigorena, Sebastian			Regulatory T Cells Increase the Avidity of Primary CD8(+) T Cell Responses and Promote Memory	SCIENCE			English	Article							DENDRITIC CELLS; IN-VIVO; PEPTIDE; REPERTOIRE; ANTIGEN; MHC; SELECTION; IMMUNITY; AUTOIMMUNITY; TOLERANCE	Although regulatory T cells (T-regs) are known to suppress self-reactive autoimmune responses, their role during T cell responses to nonself antigens is not well understood. We show that T-regs play a critical role during the priming of immune responses in mice. T-reg depletion induced the activation and expansion of a population of low-avidity CD8(+) T cells because of overproduction of CCL-3/4/5 chemokines, which stabilized the interactions between antigen-presenting dendritic cells and low-avidity T cells. In the absence of T-regs, the avidity of the primary immune response was impaired, which resulted in reduced memory to Listeria monocytogenes. These results suggest that T-regs are important regulators of the homeostasis of CD8(+) T cell priming and play a critical role in the induction of high-avidity primary responses and effective memory.	[Pace, Luigia; Tempez, Andy; Amigorena, Sebastian] Inst Curie, INSERM, U932, F-75248 Paris 05, France; [Arnold-Schrauf, Catharina; Sparwasser, Tim] TWINCORE, Ctr Expt & Clin Infect Res, Inst Infect Immunol, D-30625 Hannover, Germany; [Lemaitre, Fabrice; Bousso, Philippe] Inst Pasteur, INSERM, U668, Dept Immunol, F-75015 Paris, France; [Fetler, Luc] Inst Curie, CNRS, UMR 168, Lab Physicochim Curie, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Helmholtz-Center for Infection Research; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Amigorena, S (corresponding author), Inst Curie, INSERM, U932, F-75248 Paris 05, France.	sebastian.amigorena@curie.fr	Sparwasser, Tim/AAF-7085-2019; Fetler, luc/M-9034-2018; Sparwasser, Tim D/AAA-4306-2022; BOUSSO, Philippe/M-6547-2014	Sparwasser, Tim/0000-0001-5645-902X; BOUSSO, Philippe/0000-0002-6362-561X; Amigorena, Sebastian/0000-0001-8583-8416	Institut Curie; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; La Ligue Contre le Cancer; Association de Recherche Contre le Cancer (ARC); EC [ENCITE, Health-F5-2008-201842, SFB 900]; ARC; Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine	Institut Curie; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Association de Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); EC(European CommissionEuropean Commission Joint Research Centre); ARC(Australian Research Council); Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine	We thank all the U932 and TWINCORE Sparwasser members; D. Raulet, A. Dielmann, P. Paul-Gilloteaux, O. Lantz, and M. Albert; the Nikon Imaging Center and flow cytometry platform; and the animal facilities of Institut Curie and TWINCORE for help with the experiments and helpful discussions. rLM-OVA was kindly provided by H. Shen. This work was supported by funding from the Institut Curie; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; La Ligue Contre le Cancer; Association de Recherche Contre le Cancer (ARC); EC grant ENCITE, Health-F5-2008-201842, SFB 900. L.P. has been supported by ARC, A.T. was a fellow of Ministere de l'Education et de la Recherche. C.A.-S. was supported by the Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine. The authors have no conflicting financial interests. The data are tabulated in the main paper and in the supplementary materials.	Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Beltman JB, 2009, J IMMUNOL METHODS, V347, P54, DOI 10.1016/j.jim.2009.05.013; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Dal Secco V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007696; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gottschalk RA, 2012, P NATL ACAD SCI USA, V109, P881, DOI 10.1073/pnas.1119763109; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Moreau HD, 2012, IMMUNITY, V37, P351, DOI 10.1016/j.immuni.2012.05.014; Morlacchi S, 2011, J IMMUNOL, V186, P6807, DOI 10.4049/jimmunol.1003265; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	30	102	104	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					532	536		10.1126/science.1227049	http://dx.doi.org/10.1126/science.1227049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112334	Green Submitted			2022-12-24	WOS:000310195800059
J	Tritsch, NX; Ding, JB; Sabatini, BL				Tritsch, Nicolas X.; Ding, Jun B.; Sabatini, Bernardo L.			Dopaminergic neurons inhibit striatal output through non-canonical release of GABA	NATURE			English	Article							NUCLEUS-ACCUMBENS; DORSAL STRIATUM; GLUTAMATE; RAT; CORELEASE; NEUROTRANSMISSION; COLOCALIZATION; EXPRESSION; CIRCUITS; PATHWAY	The substantia nigra pars compacta and ventral tegmental area contain the two largest populations of dopamine-releasing neurons in the mammalian brain. These neurons extend elaborate projections in the striatum, a large subcortical structure implicated in motor planning and reward-based learning. Phasic activation of dopaminergic neurons in response to salient or reward-predicting stimuli is thought to modulate striatal output through the release of dopamine to promote and reinforce motor action(1-4). Here we show that activation of dopamine neurons in striatal slices rapidly inhibits action potential firing in both direct-and indirect-pathway striatal projection neurons through vesicular release of the inhibitory transmitter GABA (gamma-aminobutyric acid). GABA is released directly from dopaminergic axons but in a manner that is independent of the vesicular GABA transporter VGAT. Instead, GABA release requires activity of the vesicular monoamine transporter VMAT2, which is the vesicular transporter for dopamine. Furthermore, VMAT2 expression in GABAergic neurons lacking VGAT is sufficient to sustain GABA release. Thus, these findings expand the repertoire of synaptic mechanisms used by dopamine neurons to influence basal ganglia circuits, show a new substrate whose transport is dependent on VMAT2 and demonstrate that GABA can function as a bona fide co-transmitter in monoaminergic neurons.	[Tritsch, Nicolas X.; Ding, Jun B.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Tritsch, Nicolas/U-5266-2019; Ding, Jun/B-2513-2009	Ding, Jun/0000-0003-0690-1312; Tritsch, Nicolas/0000-0003-3181-7681	Nancy Lurie Marks Family Foundation; National Institutes of Health [NS046579, 4R00NS075136]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484, R00NS075136, R01NS046579] Funding Source: NIH RePORTER	Nancy Lurie Marks Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank A. Saunders and Y. Kozorovitskiy for generating and characterizing the AAV-DIO-EGFP and AAV-DIO-VGAT constructs, D. Sulzer and H. Zhang for assistance with amperometry, R. Shah and C. Johnson for technical support, and members of the laboratory for discussions. This work was supported by a Nancy Lurie Marks Family Foundation postdoctoral fellowship (N.X.T.) and by grants from the National Institutes of Health (NS046579 to B. L. S. and 4R00NS075136 to J.B.D.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bentivoglio M, 2005, HAND CHEM N, V21, P1; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broadbelt KG, 2010, AUTON NEUROSCI-BASIC, V154, P30, DOI 10.1016/j.autneu.2009.10.002; Chuhma N, 2004, J NEUROSCI, V24, P972, DOI 10.1523/JNEUROSCI.4317-03.2004; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gonzalez-Hernandez T, 2001, EUR J NEUROSCI, V13, P57, DOI 10.1046/j.1460-9568.2001.01371.x; Gonzalez-Hernandez T, 2004, MOVEMENT DISORD, V19, P1029, DOI 10.1002/mds.20206; Hirasawa H, 2009, J NEUROPHYSIOL, V102, P146, DOI 10.1152/jn.00130.2009; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; IIJIMA K, 1993, HISTOL HISTOPATHOL, V8, P581; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maher BJ, 2008, J NEUROPHYSIOL, V99, P1559, DOI 10.1152/jn.00636.2007; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ramirez M, 2001, BRAIN RES, V917, P139, DOI 10.1016/S0006-8993(01)02794-9; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Trottier S, 2002, BRAIN RES, V939, P52, DOI 10.1016/S0006-8993(02)02546-5; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yelin R, 1995, FEBS LETT, V377, P201, DOI 10.1016/0014-5793(95)01346-6	36	359	362	3	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					262	+		10.1038/nature11466	http://dx.doi.org/10.1038/nature11466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23034651	Green Submitted, Green Accepted			2022-12-24	WOS:000309733300050
J	Leathers, ML; Olson, CR				Leathers, Marvin L.; Olson, Carl R.			In Monkeys Making Value-Based Decisions, LIP Neurons Encode Cue Salience and Not Action Value	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; REWARD VALUE; ATTENTION; CHOICE; NEUROBIOLOGY; INFORMATION	In monkeys deciding between alternative saccadic eye movements, lateral intraparietal (LIP) neurons representing each saccade fire at a rate proportional to the value of the reward expected upon its completion. This observation has been interpreted as indicating that LIP neurons encode saccadic value and that they mediate value-based decisions between saccades. Here, we show that LIP neurons representing a given saccade fire strongly not only if it will yield a large reward but also if it will incur a large penalty. This finding indicates that LIP neurons are sensitive to the motivational salience of cues. It is compatible neither with the idea that LIP neurons represent action value nor with the idea that value-based decisions take place in LIP neurons.	[Leathers, Marvin L.; Olson, Carl R.] Carnegie Mellon Univ, Mellon Inst, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Leathers, Marvin L.; Olson, Carl R.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Leathers, ML (corresponding author), Carnegie Mellon Univ, Mellon Inst, Ctr Neural Basis Cognit, Room 115,4400 5th Ave, Pittsburgh, PA 15213 USA.	mleathers@cnbc.cmu.edu			NIH [RO1 EY018620, P50 MH45156, P30 EY08098, P41RR03631]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003631] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008098, R01EY018620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Ruff for comments and K. McCracken for technical assistance. Support: NIH RO1 EY018620 and NIH P50 MH45156. Technical support: NIH P30 EY08098 and P41RR03631.	Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Arcizet F, 2011, CEREB CORTEX, V21, P2498, DOI 10.1093/cercor/bhr035; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Berridge KC, 2003, WELL BEING FDN HEDON, P525; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Brosch T, 2011, NEUROPSYCHOLOGIA, V49, P1779, DOI 10.1016/j.neuropsychologia.2011.02.056; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cai X., 2010, NEUR M SOC NEUR SA D; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Lim SL, 2009, P NATL ACAD SCI USA, V106, P16841, DOI 10.1073/pnas.0904551106; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Mirpour K, 2012, P NATL ACAD SCI USA, V109, P10083, DOI 10.1073/pnas.1120763109; O'Brien JL, 2012, PSYCHOL SCI, V23, P359, DOI 10.1177/0956797611429800; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Platt ML, 2002, CURR OPIN NEUROBIOL, V12, P141, DOI 10.1016/S0959-4388(02)00302-1; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Wallis JD, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00124; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107	30	98	98	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					132	135		10.1126/science.1226405	http://dx.doi.org/10.1126/science.1226405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042897	Green Accepted			2022-12-24	WOS:000309457400070
J	Ding, SY; Liu, YS; Zeng, YN; Himmel, ME; Baker, JO; Bayer, EA				Ding, Shi-You; Liu, Yu-San; Zeng, Yining; Himmel, Michael E.; Baker, John O.; Bayer, Edward A.			How Does Plant Cell Wall Nanoscale Architecture Correlate with Enzymatic Digestibility?	SCIENCE			English	Article							TRICHODERMA-REESEI; CORN STOVER; CRYSTAL-STRUCTURE; BINDING MODULES; CELLULOSE; SYSTEM; RECALCITRANCE; CELLULASES; MICROSCOPY; BIOFUELS	Greater understanding of the mechanisms contributing to chemical and enzymatic solubilization of plant cell walls is critical for enabling cost-effective industrial conversion of cellulosic biomass to biofuels. Here, we report the use of correlative imaging in real time to assess the impact of pretreatment, as well as the resulting nanometer-scale changes in cell wall structure, upon subsequent digestion by two commercially relevant cellulase systems. We demonstrate that the small, noncomplexed fungal cellulases deconstruct cell walls using mechanisms that differ considerably from those of the larger, multienzyme complexes (cellulosomes). Furthermore, high-resolution measurement of the microfibrillar architecture of cell walls suggests that digestion is primarily facilitated by enabling enzyme access to the hydrophobic cellulose face. The data support the conclusion that ideal pretreatments should maximize lignin removal and minimize polysaccharide modification, thereby retaining the essentially native microfibrillar structure.	[Ding, Shi-You; Liu, Yu-San; Zeng, Yining; Himmel, Michael E.; Baker, John O.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Weizmann Institute of Science	Ding, SY (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.	shi.you.ding@nrel.gov	Ding, Shi-You/O-1209-2013; DING, SHIYOU/ABD-8519-2021	DING, SHIYOU/0000-0002-1102-1507; Zeng, Yining/0000-0002-0202-2479	U.S. Department of Energy (DOE) [DE-AC36-08-GO28308]; National Renewable Energy Laboratory; BioEnergy Science Center; DOE Bioenergy Research Center; Genomic Science Program [ER65258]; Office of Biological and Environmental Research in the DOE Office of Science	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); BioEnergy Science Center; DOE Bioenergy Research Center(United States Department of Energy (DOE)); Genomic Science Program; Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. P. Tucker for the fungal cellulases; S. Xie for guidance regarding SRS microscopy; K. Ruckman for manuscript editing; and A. J. Ragauskas, C. E. Wyman, M. F. Davis, D. J. Johnson, and R. H. Atalla for valuable discussion. This work was supported by the U.S. Department of Energy (DOE) under contract no. DE-AC36-08-GO28308 with the National Renewable Energy Laboratory. We acknowledge research support from the BioEnergy Science Center, a DOE Bioenergy Research Center, and the Genomic Science Program (ER65258), both supported by the Office of Biological and Environmental Research in the DOE Office of Science. S.-Y.D. conceptualized the project, conducted AFM, analyzed the data, and wrote the manuscript. Y.-S.L. conducted enzyme labeling, bright-field light microscopy, and CLSM. Y.Z. conducted SRS microscopy. E. A. B. purified the cellulosomes. S.-Y.D., M. E. H., J.O.B., and E. A. B. revised the manuscript. We declare no competing financial interests.	ATALLA RH, 1986, J RAMAN SPECTROSC, V17, P229, DOI 10.1002/jrs.1250170213; BERGHEM ER, 1973, EUR J BIOCHEM, V37, P21, DOI 10.1111/j.1432-1033.1973.tb02952.x; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2012, P NATL ACAD SCI USA, V109, P1772, DOI 10.1073/pnas.1120992109; Dagel DJ, 2011, J PHYS CHEM B, V115, P635, DOI 10.1021/jp109798p; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Donohoe BS, 2009, BIOTECHNOL BIOENG, V103, P480, DOI 10.1002/bit.22281; Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; GILKES NR, 1988, J BIOL CHEM, V263, P10401; Gritsch CS, 2005, ANN BOT-LONDON, V95, P619, DOI 10.1093/aob/mci068; Harris D, 2010, PLANT PHYSIOL, V153, P420, DOI 10.1104/pp.110.154203; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ishizawa CI, 2009, CELLULOSE, V16, P677, DOI 10.1007/s10570-009-9313-1; Jansen S, 1998, IAWA J, V19, P347, DOI 10.1163/22941932-90000658; JOHNSON EA, 1982, APPL ENVIRON MICROB, V43, P1125, DOI 10.1128/AEM.43.5.1125-1132.1982; Jung HG, 2006, CROP SCI, V46, P1801, DOI 10.2135/cropsci2006.02-0086; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kumar R, 2009, BIOTECHNOL BIOENG, V102, P1544, DOI 10.1002/bit.22203; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MORAG E, 1992, Enzyme and Microbial Technology, V14, P289, DOI 10.1016/0141-0229(92)90153-F; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; OOSHIMA H, 1990, BIOTECHNOL BIOENG, V36, P446, DOI 10.1002/bit.260360503; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Wise L. E., 1946, Paper Trade Journal, V122, P35; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Zeng YN, 2010, BIOENERG RES, V3, P272, DOI 10.1007/s12155-010-9079-1	35	550	577	16	563	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1055	1060		10.1126/science.1227491	http://dx.doi.org/10.1126/science.1227491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180856				2022-12-24	WOS:000311390600037
J	Wee, LM; Flores-Jasso, CF; Salomon, WE; Zamore, PD				Wee, Liang Meng; Flores-Jasso, C. Fabian; Salomon, William E.; Zamore, Phillip D.			Argonaute Divides Its RNA Guide into Domains with Distinct Functions and RNA-Binding Properties	CELL			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; CRYSTAL-STRUCTURE; GENETIC INTERFERENCE; SITE ACCESSIBILITY; CODING REGION; NUCLEIC-ACID; MICRO RNAS; TARGET; RISC	MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) guide Argonaute proteins to silence mRNA expression. Argonaute binding alters the properties of an RNA guide, creating functional domains. We show that the domains established by Argonaute-the anchor, seed, central, 30 supplementary, and tail regions-have distinct biochemical properties that explain the differences between how animal miRNAs and siRNAs bind their targets. Extensive complementarity between an siRNA and its target slows the rate at which fly Argonaute2 (Ago2) binds to and dissociates from the target. Highlighting its role in antiviral defense, fly Ago2 dissociates so slowly from extensively complementary target RNAs that essentially every fully paired target is cleaved. Conversely, mouse AGO2, which mainly mediates miRNA directed repression, dissociates rapidly and with similar rates for fully paired and seed-matched targets. Our data narrow the range of biochemically reasonable models for how Argonaute-bound siRNAs and miRNAs find, bind, and regulate their targets.	[Wee, Liang Meng; Flores-Jasso, C. Fabian; Salomon, William E.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Wee, Liang Meng; Flores-Jasso, C. Fabian; Salomon, William E.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Wee, Liang Meng/U-2188-2017; Zamore, Phillip D/A-8941-2013	Wee, Liang Meng/0000-0003-3870-8568; Flores-Jasso, C. Fabian/0000-0002-3745-495X; Flores-Jasso, Carlos Fabian/0000-0001-9096-0264; Zamore, Phillip/0000-0002-4505-9618	National Institutes of Health [GM62862, GM65236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM062862, R01GM065236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Turner, J. Chen, A. Carruthers, R. Gilmore, S. Ryder, B. Farley, O. Bilsel, S. Kathuria, and P. Gandhi for help and discussions; the Turner lab for use of equipment; A. Boucher, T. Covello, and G. Farley for technical support; and members of the Zamore lab for critical comments on the manuscript. This work was supported in part by National Institutes of Health grants GM62862 and GM65236. Phillip D. Zamore is a cofounder and scientific advisor to Alnylam Pharmaceuticals.	Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; COHEN LS, 1967, J CELL PHYSIOL, V69, P331, DOI 10.1002/jcp.1040690309; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; HALL KB, 1992, NUCLEIC ACIDS RES, V20, P4283, DOI 10.1093/nar/20.16.4283; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammes G.G., 1970, ENZYMES, V2, P67; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lai EC, 1998, CELL, V93, P1103, DOI 10.1016/S0092-8674(00)81454-3; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schroeder SJ, 2009, METHOD ENZYMOL, V468, P371, DOI 10.1016/S0076-6879(09)68017-4; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takeda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007513; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wright JE, 2011, EMBO J, V30, P533, DOI 10.1038/emboj.2010.334; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xie J, 2012, NAT METHODS, V9, P403, DOI [10.1038/NMETH.1903, 10.1038/nmeth.1903]; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	87	246	250	0	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1055	1067		10.1016/j.cell.2012.10.036	http://dx.doi.org/10.1016/j.cell.2012.10.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178124	Green Accepted, Bronze			2022-12-24	WOS:000311423500018
J	Mitra, D; Luo, X; Morgan, A; Wang, J; Hoang, MP; Lo, J; Guerrero, CR; Lennerz, JK; Mihm, MC; Wargo, JA; Robinson, KC; Devi, SP; Vanover, JC; D'Orazio, JA; McMahon, M; Bosenberg, MW; Haigis, KM; Haber, DA; Wang, YS; Fisher, DE				Mitra, Devarati; Luo, Xi; Morgan, Ann; Wang, Jin; Hoang, Mai P.; Lo, Jennifer; Guerrero, Candace R.; Lennerz, Jochen K.; Mihm, Martin C.; Wargo, Jennifer A.; Robinson, Kathleen C.; Devi, Suprabha P.; Vanover, Jillian C.; D'Orazio, John A.; McMahon, Martin; Bosenberg, Marcus W.; Haigis, Kevin M.; Haber, Daniel A.; Wang, Yinsheng; Fisher, David E.			An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background	NATURE			English	Article							STEM-CELL FACTOR; DNA LESIONS; MELANOCYTES; MICE; MUTATIONS; RISK; PIGMENTATION; SENESCENCE; EXPRESSION; DAMAGE	People with pale skin, red hair, freckles and an inability to tan-the 'red hair/fair skin' phenotype-are at highest risk of developing melanoma, compared to all other pigmentation types(1). Genetically, this phenotype is frequently the product of inactivating polymorphisms in the melanocortin 1 receptor (MC1R) gene. MC1R encodes a cyclic AMP-stimulating G-protein-coupled receptor that controls pigment production. Minimal receptor activity, as in red hair/fair skin polymorphisms, produces the red/yellow pheomelanin pigment, whereas increasing MC1R activity stimulates the production of black/brown eumelanin(2). Pheomelanin has weak shielding capacity against ultraviolet radiation relative to eumelanin, and has been shown to amplify ultraviolet-A-induced reactive oxygen species(3-5). Several observations, however, complicate the assumption that melanoma risk is completely ultraviolet-radiation-dependent. For example, unlike non-melanoma skin cancers, melanoma is not restricted to sun-exposed skin and ultraviolet radiation signature mutations are infrequently oncogenic drivers(6). Although linkage of melanoma risk to ultraviolet radiation exposure is beyond doubt, ultraviolet-radiation-independent events are likely to have a significant role(1,7). Here we introduce a conditional, melanocyte-targeted allele of the most common melanoma oncoprotein, BRAF(V600E), into mice carrying an inactivating mutation in the Mc1r gene (these mice have a phenotype analogous to red hair/fair skin humans). We observed a high incidence of invasive melanomas without providing additional gene aberrations or ultraviolet radiation exposure. To investigate the mechanism of ultraviolet-radiation-independent carcinogenesis, we introduced an albino allele, which ablates all pigment production on the Mc1r(e/e) background. Selective absence of pheomelanin synthesis was protective against melanoma development. In addition, normal Mc1r(e/e) mouse skin was found to have significantly greater oxidative DNA and lipid damage than albino Mc1r(e/e) mouse skin. These data suggest that the pheomelanin pigment pathway produces ultraviolet-radiation-independent carcinogenic contributions to melanomagenesis by a mechanism of oxidative damage. Although protection from ultraviolet radiation remains important, additional strategies may be required for optimal melanoma prevention.	[Mitra, Devarati; Morgan, Ann; Lo, Jennifer; Robinson, Kathleen C.; Devi, Suprabha P.; Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Luo, Xi; Haigis, Kevin M.; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Wang, Jin; Guerrero, Candace R.; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Hoang, Mai P.; Mihm, Martin C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lennerz, Jochen K.] Univ Ulm, Inst Pathol, D-89070 Ulm, Germany; [Wargo, Jennifer A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Vanover, Jillian C.; D'Orazio, John A.] Univ Kentucky, Sch Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of California System; University of California Riverside; Harvard University; Massachusetts General Hospital; Ulm University; Harvard University; Massachusetts General Hospital; University of Kentucky; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Yale University	Fisher, DE (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	dfisher3@partners.org	Wang, Jin/AAE-3809-2022; Fisher, David/AAH-2878-2019	Wang, Jin/0000-0001-5511-3983; Hoang, Mai/0000-0002-1406-7981; /0000-0002-9520-6874	National Institutes of Health [5R01 AR043369-16, R01-CA101864, F30 ES020663-01]; Dr Miriam and Sheldon G. Adelson Medical Research Foundation; US-Israel Binational Science Foundation; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [R01CA176839, R01CA131075, R01CA129933, R01CA101864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES020663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr Miriam and Sheldon G. Adelson Medical Research Foundation; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kunisada for generously sharing K14-SCF mice and C. L. Evans for help with mouse skin irradiation. We also thank A. P. Codgill for help with primary tumour cell culture and A. Piris for pathology consultation as well as M. Haigis and Z. Abdel-Malik for discussions. This work was supported by the following grants from the National Institutes of Health 5R01 AR043369-16 (D.E.F.), R01-CA101864 (Y.W.) and F30 ES020663-01 (D.M.), as well as support from the Dr Miriam and Sheldon G. Adelson Medical Research Foundation, the US-Israel Binational Science Foundation, and the Melanoma Research Alliance (D.E.F.).	Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; HALABAN R, 1988, P NATL ACAD SCI USA, V85, P7241, DOI 10.1073/pnas.85.19.7241; Hill HZ, 2000, PIGM CELL RES, V13, P140, DOI 10.1034/j.1600-0749.13.s8.25.x; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485; Kovacs D, 2012, J INVEST DERMATOL, V132, P1196, DOI 10.1038/jid.2011.457; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; NEUGUT AI, 1994, AM J PUBLIC HEALTH, V84, P1828, DOI 10.2105/AJPH.84.11.1828; Nofsinger JB, 2002, FREE RADICAL BIO MED, V32, P720, DOI 10.1016/S0891-5849(02)00763-3; Noonan FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1893; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Rae J, 2012, J INVEST DERMATOL, V132, P488, DOI 10.1038/jid.2011.341; RHODES AR, 1987, JAMA-J AM MED ASSOC, V258, P3146, DOI 10.1001/jama.258.21.3146; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rouzaud F, 2005, MUTAT RES-FUND MOL M, V571, P133, DOI 10.1016/j.mrfmmm.2004.09.014; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vanover JC, 2009, PIGM CELL MELANOMA R, V22, P827, DOI 10.1111/j.1755-148X.2009.00617.x; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Wang YS, 2008, CHEM RES TOXICOL, V21, P276, DOI 10.1021/tx700411g; Wenczl E, 1998, J INVEST DERMATOL, V111, P678, DOI 10.1046/j.1523-1747.1998.00357.x; Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159	30	310	316	3	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2012	491	7424					449	+		10.1038/nature11624	http://dx.doi.org/10.1038/nature11624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23123854	Green Accepted, Green Submitted			2022-12-24	WOS:000311031600047
J	Cho, J; Chang, H; Kwon, SC; Kim, B; Kim, Y; Choe, J; Ha, M; Kim, YK; Kim, VN				Cho, Jun; Chang, Hyeshik; Kwon, S. Chul; Kim, Baekgyu; Kim, Yoosik; Choe, Junho; Ha, Minju; Kim, Yoon Ki; Kim, V. Narry			LIN28A Is a Suppressor of ER-Associated Translation in Embryonic Stem Cells	CELL			English	Article							MESSENGER-RNA; NUCLEOTIDE RESOLUTION; MICRORNA BIOGENESIS; LET-7 MICRORNA; BINDING-SITES; CROSS-LINKING; IN-VIVO; CLIP; LIN-28; PROTEINS	LIN28 plays a critical role in developmental transition, glucose metabolism, and tumorigenesis. At the molecular level, LIN28 is known to repress maturation of let-7 microRNAs and enhance translation of certain mRNAs. In this study, we obtain a genome-wide view of the molecular function of LIN28A in mouse embryonic stem cells by carrying out RNA crosslinking-immunoprecipitation-sequencing (CLIP-seq) and ribosome footprinting. We find that, in addition to let-7 precursors, LIN28A binds to a large number of spliced mRNAs. LIN28A recognizes AAGNNG, AAGNG, and less frequently UGUG, which are located in the terminal loop of a small hairpin. LIN28A is localized to the periendo-plasmic reticulum (ER) area and inhibits translation of mRNAs that are destined for the ER, reducing the synthesis of transmembrane proteins, ER or Golgi lumen proteins, and secretory proteins. Our study suggests a selective regulatory mechanism for ER-associated translation and reveals an unexpected role of LIN28A as a global suppressor of genes in the secretory pathway.	[Cho, Jun; Chang, Hyeshik; Kwon, S. Chul; Kim, Baekgyu; Kim, Yoosik; Ha, Minju; Kim, V. Narry] Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea; [Cho, Jun; Chang, Hyeshik; Kwon, S. Chul; Kim, Baekgyu; Kim, Yoosik; Ha, Minju; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Choe, Junho; Kim, Yoon Ki] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Korea University	Kim, VN (corresponding author), Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kwon, S. Chul/ABG-9415-2020; Kim, Yoosik/B-9009-2016; Choe, Junho/E-3410-2019; Kwon, S. Chul/K-2515-2017; Ha, Minju/G-3559-2017	Kim, Yoosik/0000-0003-3064-4643; Choe, Junho/0000-0002-2365-3755; Kwon, S. Chul/0000-0002-9519-5132; Ha, Minju/0000-0003-2328-415X; Kim, Baekgyu/0000-0002-6681-6198; Kim, Yoon Ki/0000-0003-1303-072X; Chang, Hyeshik/0000-0002-9812-8015	Research Center Program of IBS (Institute for Basic Science) [EM1202]; BK21 Research Fellowships from the Ministry of Education, Science and Technology of Korea; TJ Park Postdoctoral Fellowship; National Honor Scientist Program through the National Research Foundation of Korea (NRF) [20100020415]	Research Center Program of IBS (Institute for Basic Science); BK21 Research Fellowships from the Ministry of Education, Science and Technology of Korea; TJ Park Postdoctoral Fellowship; National Honor Scientist Program through the National Research Foundation of Korea (NRF)	We are grateful to Huili Guo for advice on ribosome profiling and Daehyun Baek for critical comments on the manuscript. We also thank Ahyoung Cho and Yun Cheng Chang for technical help and members of our laboratory for discussion. This work was supported by the Research Center Program (EM1202) of IBS (Institute for Basic Science); the BK21 Research Fellowships (J.C., H. C., S. C. K., and B. K.) from the Ministry of Education, Science and Technology of Korea; the TJ Park Postdoctoral Fellowship (Y.K.); and the National Honor Scientist Program (20100020415) through the National Research Foundation of Korea (NRF).	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hamilton RL, 1999, J LIPID RES, V40, P1140; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Suzuki H, 1997, EXP ANIM TOKYO, V46, P17, DOI 10.1538/expanim.46.17; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; WAGENMAKERS AJM, 1980, EUR J BIOCHEM, V112, P323, DOI 10.1111/j.1432-1033.1980.tb07207.x; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	43	171	176	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					765	777		10.1016/j.cell.2012.10.019	http://dx.doi.org/10.1016/j.cell.2012.10.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23102813	Bronze			2022-12-24	WOS:000310921200009
J	Heo, I; Ha, M; Lim, J; Yoon, MJ; Park, JE; Kwon, SC; Chang, H; Kim, VN				Heo, Inha; Ha, Minju; Lim, Jaechul; Yoon, Mi-Jeong; Park, Jong-Eun; Kwon, S. Chul; Chang, Hyeshik; Kim, V. Narry			Mono-Uridylation of Pre-MicroRNA as a Key Step in the Biogenesis of Group II let-7 MicroRNAs	CELL			English	Article							RNA-INTERFERENCE; C-ELEGANS; POLY(A) POLYMERASES; NUCLEAR EXPORT; MICROPROCESSOR COMPLEX; CAENORHABDITIS-ELEGANS; DROSHA-DGCR8 COMPLEX; MOLECULAR-BASIS; 3' ADENYLATION; MESSENGER-RNA	RNase III Drosha initiates microRNA (miRNA) maturation by cleaving a primary miRNA transcript and releasing a pre-miRNA with a 2 nt 3' overhang. Dicer recognizes the 2 nt 3' overhang structure to selectively process pre-miRNAs. Here, we find that, unlike prototypic pre-miRNAs (group I), group II pre-miRNAs acquire a shorter (1 nt) 3' overhang from Drosha processing and therefore require a 3'-end mono-uridylation for Dicer processing. The majority of let-7 and miR-105 belong to group II. We identify TUT7/ZCCHC6, TUT4/ZCCHC11, and TUT2/PAPD4/GLD2 as the terminal uridylyl transferases responsible for pre-miRNA mono-uridylation. The TUTs act specifically on dsRNAs with a 1 nt 3' overhang, thereby creating a 2 nt 3' overhang. Depletion of TUTs reduces let-7 levels and disrupts let-7 function. Although the let-7 suppressor, Lin28, induces inhibitory oligo-uridylation in embryonic stem cells, mono-uridylation occurs in somatic cells lacking Lin28 to promote let-7 biogenesis. Our study reveals functional duality of uridylation and introduces TUT7/4/2 as components of the miRNA biogenesis pathway.	[Heo, Inha; Ha, Minju; Lim, Jaechul; Park, Jong-Eun; Kwon, S. Chul; Chang, Hyeshik; Kim, V. Narry] Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea; [Heo, Inha; Ha, Minju; Lim, Jaechul; Yoon, Mi-Jeong; Park, Jong-Eun; Kwon, S. Chul; Chang, Hyeshik; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU)	Kim, VN (corresponding author), Seoul Natl Univ, Inst Basic Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kwon, S. Chul/K-2515-2017; Kwon, S. Chul/ABG-9415-2020; Ha, Minju/G-3559-2017	Kwon, S. Chul/0000-0002-9519-5132; Chang, Hyeshik/0000-0002-9812-8015; Ha, Minju/0000-0003-2328-415X	Research Center Program of IBS (Institute for Basic Science) [EM1202]; Ministry of Education, Science and Technology of Korea; National Research Foundation of Korea (NRF) [20100020415]	Research Center Program of IBS (Institute for Basic Science); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	We are grateful to the members of our laboratory, particularly Joha Park, Hyerim Yi, Dr. Kyu-Hyeon Yeom, Dr. Yoosik Kim, Ahyoung Cho, and Yun Cheng Chang for discussion and technical help. We thank Dr. Yun-jeong Kim and Dr. Daehyun Baek for help in preparation of mRNA sequencing libraries. This work was supported by the Research Center Program (EM1202) of IBS (Institute for Basic Science); the BK21 Research Fellowships (J. L., J.-E. P., and H. C.) from the Ministry of Education, Science and Technology of Korea; and the National Honor Scientist Program (20100020415) through the National Research Foundation of Korea (NRF).	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bompfunewerer AF, 2005, THEOR BIOSCI, V123, P301, DOI 10.1016/j.thbio.2005.01.002; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MENEELY PM, 1979, GENETICS, V92, P99; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakanishi T, 2006, DEV BIOL, V289, P115, DOI 10.1016/j.ydbio.2005.10.017; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Ren GD, 2012, CURR BIOL, V22, P695, DOI 10.1016/j.cub.2012.02.052; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wickens M, 2008, SCIENCE, V319, P1344, DOI 10.1126/science.1154946; Wilusz CJ, 2008, GENE DEV, V22, P1, DOI 10.1101/gad.1634508; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	65	215	221	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					521	532		10.1016/j.cell.2012.09.022	http://dx.doi.org/10.1016/j.cell.2012.09.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23063654	Bronze			2022-12-24	WOS:000310529300010
J	Itsathitphaisarn, O; Wing, RA; Eliason, WK; Wang, JM; Steitz, TA				Itsathitphaisarn, Ornchuma; Wing, Richard A.; Eliason, William K.; Wang, Jimin; Steitz, Thomas A.			The Hexameric Helicase DnaB Adopts a Nonplanar Conformation during Translocation	CELL			English	Article							ESCHERICHIA-COLI; REPLICATIVE HELICASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MECHANISM; PROTEIN; COMPLEX; PRIMASE; DOMAIN; SITE	DNA polymerases can only synthesize nascent DNA from single-stranded DNA (ssDNA) templates. In bacteria, the unwinding of parental duplex DNA is carried out by the replicative DNA helicase (DnaB) that couples NTP hydrolysis to 5' to 3' translocation. The crystal structure of the DnaB hexamer in complex with GDP-AlF4 and ssDNA reported here reveals that DnaB adopts a closed spiral staircase quaternary structure around an A-form ssDNA with each C-terminal domain coordinating two nucleotides of ssDNA. The structure not only provides structural insights into the translocation mechanism of superfamily IV helicases but also suggests that members of this superfamily employ a translocation mechanismthat is distinct from other helicase super-families. We propose a hand-over-hand mechanism in which sequential hydrolysis of NTP causes a sequential 5' to 3' movement of the subunits along the helical axis of the staircase, resulting in the unwinding of two nucleotides per subunit.	[Itsathitphaisarn, Ornchuma; Wing, Richard A.; Eliason, William K.; Wang, Jimin; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Eliason, William K.; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu		Wing, Richard/0000-0001-5642-9349	NIH [RO1 GM057510]; Royal Thai Government Scholarship; Steitz Center for Structural Biology, Gwangju Institute of Science and Technology (SCSB-GIST), Republic of Korea; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510, P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government Scholarship; Steitz Center for Structural Biology, Gwangju Institute of Science and Technology (SCSB-GIST), Republic of Korea; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at APS beamline 24-ID and at NSLS beamlines X-25 and X-29. This work was supported by NIH RO1 GM057510 to T. A. S., the Royal Thai Government Scholarship to O.I., and by Steitz Center for Structural Biology, Gwangju Institute of Science and Technology (SCSB-GIST), Republic of Korea.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ayora S, 2002, NUCLEIC ACIDS RES, V30, P2280, DOI 10.1093/nar/30.11.2280; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Berger JM, 2008, CELL, V134, DOI 10.1016/j.cell.2008.08.027; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 1999, J BIOL CHEM, V274, P6889, DOI 10.1074/jbc.274.11.6889; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mesa P, 2006, J MOL BIOL, V357, P1077, DOI 10.1016/j.jmb.2005.12.027; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P4051, DOI 10.1093/nar/gkf527; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998a; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	48	158	159	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					267	277		10.1016/j.cell.2012.09.014	http://dx.doi.org/10.1016/j.cell.2012.09.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23022319	Green Accepted, Bronze			2022-12-24	WOS:000309981000007
J	Wesolowski, A; Eagle, N; Tatem, AJ; Smith, DL; Noor, AM; Snow, RW; Buckee, CO				Wesolowski, Amy; Eagle, Nathan; Tatem, Andrew J.; Smith, David L.; Noor, Abdisalan M.; Snow, Robert W.; Buckee, Caroline O.			Quantifying the Impact of Human Mobility on Malaria	SCIENCE			English	Article							ELIMINATION STRATEGIES; TRANSMISSION; KENYA; NAIROBI; SETTLEMENT; ZANZIBAR	Human movements contribute to the transmission of malaria on spatial scales that exceed the limits of mosquito dispersal. Identifying the sources and sinks of imported infections due to human travel and locating high-risk sites of parasite importation could greatly improve malaria control programs. Here, we use spatially explicit mobile phone data and malaria prevalence information from Kenya to identify the dynamics of human carriers that drive parasite importation between regions. Our analysis identifies importation routes that contribute to malaria epidemiology on regional spatial scales.	[Eagle, Nathan; Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wesolowski, Amy] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15221 USA; [Wesolowski, Amy] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15221 USA; [Eagle, Nathan] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA; [Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tatem, Andrew J.; Smith, David L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32610 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Collaborat Programme, KEMRI Wellcome Trust, Malaria Publ Hlth & Epidemiol Grp,Ctr Geog Med, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Carnegie Mellon University; Carnegie Mellon University; Northeastern University; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health	Buckee, CO (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	cbuckee@hsph.harvard.edu	Smith, David L/L-8850-2013; Snow, Robert William/AFR-1436-2022	Smith, David L/0000-0003-4367-3849; Snow, Robert William/0000-0003-3725-6088; Tatem, Andrew/0000-0002-7270-941X	National Science Foundation Graduate Research Fellowship program [0750271]; Bill & Melinda Gates Foundation [49446, OPP1032350]; National Institute of Allergy and Infectious Disease, NIH [U19AI089674]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH; Wellcome Trust [095127, 079080]; Wellcome Trust Major Overseas Programme grant [092654]; Models of Infectious Disease Agent Study program [1U54GM088558]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1005075] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1216345] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute of Allergy and Infectious Disease, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Major Overseas Programme grant(Wellcome Trust); Models of Infectious Disease Agent Study program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	A.W. was supported by the National Science Foundation Graduate Research Fellowship program (0750271). D. L. S. and A.J.T. acknowledge support from Bill & Melinda Gates Foundation grants (49446 and OPP1032350); National Institute of Allergy and Infectious Disease, NIH, grant (U19AI089674); and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; and the Fogarty International Center, NIH. A.M.N. is supported by the Wellcome Trust as an Intermediate Research Fellow (095127). R. W. S. is supported by the Wellcome Trust as Principal Research Fellow (079080). A.M.N. and R. W. S. also acknowledge programmatic support provided by the Wellcome Trust Major Overseas Programme grant to the Kenya Medical Research Institute-Wellcome Trust Programme (092654). C.O.B. was supported by the Models of Infectious Disease Agent Study program (cooperative agreement 1U54GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH. Mobile phone data were provided by an anonymous service provider in Kenya and are not available for distribution.	Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Dolgin E, 2010, NAT MED, V16, P1055, DOI 10.1038/nm1010-1055; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Kasili S, 2009, J VECTOR DIS, V46, P273; Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Lynch C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001040; Moonen B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-322; Mudhune SA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-138; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259; Rapuoda B., 1984, P KEMRI KETRI 5 ANN, P115; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Tatem AJ, 2004, REMOTE SENS ENVIRON, V93, P42, DOI 10.1016/j.rse.2004.06.014; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Wesolowski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035319; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160	20	539	549	11	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					267	270		10.1126/science.1223467	http://dx.doi.org/10.1126/science.1223467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066082	Green Accepted			2022-12-24	WOS:000309712300049
J	Karlsson, MP; Tervo, DGR; Karpova, AY				Karlsson, Mattias P.; Tervo, Dougal G. R.; Karpova, Alla Y.			Network Resets in Medial Prefrontal Cortex Mark the Onset of Behavioral Uncertainty	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; DECISION-MAKING; NEURAL ACTIVITY; NOREPINEPHRINE; INFORMATION; ENVIRONMENT; DYNAMICS; NEURONS; CONTEXT; REWARD	Regions within the prefrontal cortex are thought to process beliefs about the world, but little is known about the circuit dynamics underlying the formation and modification of these beliefs. Using a task that permits dissociation between the activity encoding an animal's internal state and that encoding aspects of behavior, we found that transient increases in the volatility of activity in the rat medial prefrontal cortex accompany periods when an animal's belief is modified after an environmental change. Activity across the majority of sampled neurons underwent marked, abrupt, and coordinated changes when prior belief was abandoned in favor of exploration of alternative strategies. These dynamics reflect network switches to a state of instability, which diminishes over the period of exploration as new stable representations are formed.	[Karlsson, Mattias P.; Tervo, Dougal G. R.; Karpova, Alla Y.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Karpova, AY (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	karpovaa@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank N. Ozel and B. Shields for technical help; K. Vicari for task illustration; and T. Jessell, W. Denk, V. Jayaraman, A. Leonardo, J. Dudman, E. Pastalkova, G. Murphy, K. Svoboda, R. Desimone, S. Druckmann, S. Eddy, and N. Spruston for comments on the manuscript. Supported by the Howard Hughes Medical Institute.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Dayan P, 2006, NETWORK-COMP NEURAL, V17, P335, DOI 10.1080/09548980601004024; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; EDWARDS W, 1961, ANNU REV PSYCHOL, V12, P473, DOI 10.1146/annurev.ps.12.020161.002353; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Holroyd CB, 2008, CORTEX, V44, P548, DOI 10.1016/j.cortex.2007.08.013; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pearce JM, 2001, ANNU REV PSYCHOL, V52, P111, DOI 10.1146/annurev.psych.52.1.111; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	28	129	131	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					135	139		10.1126/science.1226518	http://dx.doi.org/10.1126/science.1226518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042898				2022-12-24	WOS:000309457400071
J	Schlipalius, DI; Valmas, N; Tuck, AG; Jagadeesan, R; Ma, L; Kaur, R; Goldinger, A; Anderson, C; Kuang, JJ; Zuryn, S; Mau, YS; Cheng, Q; Collins, PJ; Nayak, MK; Schirra, HJ; Hilliard, MA; Ebert, PR				Schlipalius, David I.; Valmas, Nicholas; Tuck, Andrew G.; Jagadeesan, Rajeswaran; Ma, Li; Kaur, Ramandeep; Goldinger, Anita; Anderson, Cameron; Kuang, Jujiao; Zuryn, Steven; Mau, Yosep S.; Cheng, Qiang; Collins, Patrick J.; Nayak, Manoj K.; Schirra, Horst Joachim; Hilliard, Massimo A.; Ebert, Paul R.			A Core Metabolic Enzyme Mediates Resistance to Phosphine Gas	SCIENCE			English	Article							DOMINICA F COLEOPTERA; LESSER GRAIN BORER; RHYZOPERTHA-DOMINICA; CAENORHABDITIS-ELEGANS; COMPARATIVE TOXICITY; DEHYDROGENASE; BOSTRYCHIDAE; STRAINS	Phosphine is a small redox-active gas that is used to protect global grain reserves, which are threatened by the emergence of phosphine resistance in pest insects. We find that polymorphisms responsible for genetic resistance cluster around the redox-active catalytic disulfide or the dimerization interface of dihydrolipoamide dehydrogenase (DLD) in insects (Rhyzopertha dominica and Tribolium castaneum) and nematodes (Caenorhabditis elegans). DLD is a core metabolic enzyme representing a new class of resistance factor for a redox-active metabolic toxin. It participates in four key steps of core metabolism, and metabolite profiles indicate that phosphine exposure in mutant and wild-type animals affects these steps differently. Mutation of DLD in C. elegans increases arsenite sensitivity. This specific vulnerability may be exploited to control phosphine-resistant insects and safeguard food security.	[Valmas, Nicholas; Hilliard, Massimo A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Schlipalius, David I.; Tuck, Andrew G.; Kuang, Jujiao; Collins, Patrick J.; Nayak, Manoj K.] Agri Sci Queensland, Dept Agr Fisheries & Forestry, Ecosci Precinct, Brisbane, Qld 4001, Australia; [Schlipalius, David I.; Tuck, Andrew G.; Jagadeesan, Rajeswaran; Ma, Li; Kaur, Ramandeep; Ebert, Paul R.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Schlipalius, David I.; Tuck, Andrew G.; Collins, Patrick J.; Nayak, Manoj K.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT 2617, Australia; [Valmas, Nicholas; Goldinger, Anita; Anderson, Cameron; Zuryn, Steven; Mau, Yosep S.; Cheng, Qiang; Schirra, Horst Joachim; Ebert, Paul R.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Mau, Yosep S.] Univ Nusa Cendana, Fac Agr, Kupang 85001, NTT, Indonesia; [Schirra, Horst Joachim] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia	University of Queensland; Queensland Department of Agriculture & Fisheries; University of Queensland; University of Queensland; Nippon Telegraph & Telephone Corporation; Universitas Nusa Cendana; University of Queensland	Hilliard, MA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	m.hilliard@uq.edu.au; p.ebert@uq.edu.au	Jagadeesan, Rajeswaran/K-8804-2019; Schirra, Horst Joachim/B-4210-2009; Goldinger, Anita/K-9171-2018; Mau, Yosep Seran/AAC-4003-2021; Schlipalius, David/B-8155-2011; Mau, Yosep Seran/GNP-4795-2022; Zuryn, Steven/C-7967-2018	Schirra, Horst Joachim/0000-0002-7541-246X; Goldinger, Anita/0000-0002-7688-1823; Schlipalius, David/0000-0002-8102-7031; Mau, Yosep Seran/0000-0001-6654-5407; Zuryn, Steven/0000-0002-3551-6790; Valmas, Nicholas/0000-0002-6925-9673; Hilliard, Massimo A/0000-0001-7458-5812; Ebert, Paul/0000-0002-4435-0737; Jagadeesan, Rajeswaran/0000-0002-9890-5953; Kuang, Jujiao/0000-0002-1366-0089	Cooperative Research Centre for National Plant Biosecurity [CRC20080, CRC50150]; Australian Research Council (ARC) [DP0558507]; Grains Research and Development Corporation [UQ00010]; National Institutes of Health [R01NS060129]; National Health and Medical Research Council [569500]; ARC Future Fellowship; Queensland Smart State Fellowship; Australian Postgraduate Award scholarships; University of Queensland Research Scholarship; AusAid scholarship; NIH National Center for Research Resources; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060129] Funding Source: NIH RePORTER	Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Research Council (ARC)(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council); Queensland Smart State Fellowship; Australian Postgraduate Award scholarships; University of Queensland Research Scholarship(University of Queensland); AusAid scholarship; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Cooperative Research Centre for National Plant Biosecurity (CRC20080 and CRC50150) (D.I.S.); Australian Research Council (ARC) (DP0558507) and Grains Research and Development Corporation (UQ00010) (P.R.E.); National Institutes of Health (R01NS060129), National Health and Medical Research Council (PG# 569500), and ARC Future Fellowship (M.A.H.); Queensland Smart State Fellowship (H.J.S.); Australian Postgraduate Award scholarships (N.V., S.Z., and J.K.); University of Queensland Research Scholarship (Q.C., R.J., and R.K.); and AusAid scholarship (Y.S.M.). Sequence accession numbers (JX434596 to JX434608). We thank R. Tweedale, P. Bazzicalupo, and R. Tellam for comments and R. Barrero, H. Pavic, L. Bond, L. Kirszenblat, P. Mugno-Ramirez, A. Johnston, N. Mathew, and M. Mathew for technical assistance. Nematode strains provided by the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources. NMR data acquired at the Queensland NMR Network and University of Queensland-Institute of Molecular Bioscience NMR facilities. Author contribution statement: N.V., L.M., A.G.T., S.Z, J.K., Q.C., M.A.H., and P.R.E. provided data and analysis for C. elegans. R.J., R.K., A.G.T., and D.I.S. provided data and analysis for R. dominica and T. castaneum. H.J.S., A.G., and C.A. provided metabolomics data and analysis. H.J.S. performed homology modeling. P.J.C. and M.K.N. provided insect strains and phenotype data. D.I.S., N.V., H.J.S., M.A.H., and P.R.E. drafted the manuscript.	Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Bergquist ER, 2009, J ORGANOMET CHEM, V694, P973, DOI 10.1016/j.jorganchem.2008.12.028; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; CHAUDHRY MQ, 1991, COMP BIOCHEM PHYS C, V99, P41, DOI 10.1016/0742-8413(91)90072-2; Chen WH, 2010, PLANT PHYSIOL, V153, P1385, DOI 10.1104/pp.110.153452; Cheng Q, 2003, TOXICOL SCI, V73, P60, DOI 10.1093/toxsci/kfg049; Collins PJ, 2005, J STORED PROD RES, V41, P373, DOI 10.1016/j.jspr.2004.05.002; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Jagadeesan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031582; Lorini I, 2007, PEST MANAG SCI, V63, P358, DOI 10.1002/ps.1344; Mau YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034027; Mau YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031541; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROBINSON JR, 1970, J STORED PROD RES, V6, P133, DOI 10.1016/0022-474X(70)90002-0; Schlipalius DI, 2008, HEREDITY, V100, P506, DOI 10.1038/hdy.2008.4; Valmas N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000130; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Zuryn S, 2008, TOXICOL SCI, V102, P179, DOI 10.1093/toxsci/kfm278	18	102	110	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					807	810		10.1126/science.1224951	http://dx.doi.org/10.1126/science.1224951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139334				2022-12-24	WOS:000310839500047
J	Singh, G; Kucukural, A; Cenik, C; Leszyk, JD; Shaffer, SA; Weng, ZP; Moore, MJ				Singh, Guramrit; Kucukural, Alper; Cenik, Can; Leszyk, John D.; Shaffer, Scott A.; Weng, Zhiping; Moore, Melissa J.			The Cellular EJC Interactome Reveals Higher-Order mRNP Structure and an EJC-SR Protein Nexus	CELL			English	Article							EXON JUNCTION COMPLEX; RNA-BINDING PROTEINS; MESSENGER-RNA; NONSENSE; DECAY; TRANSLATION; CORE; EIF4AIII; SURVEILLANCE; ARCHITECTURE	In addition to sculpting eukaryotic transcripts by removing introns, pre-mRNA splicing greatly impacts protein composition of the emerging mRNP. The exon junction complex (EJC), deposited upstream of exon-exon junctions after splicing, is a major constituent of spliced mRNPs. Here, we report comprehensive analysis of the endogenous human EJC protein and RNA interactomes. We confirm that the major "canonical" EJC occupancy site in vivo lies 24 nucleotides upstream of exon junctions and that the majority of exon junctions carry an EJC. Unexpectedly, we find that endogenous EJCs multimerize with one another and with numerous SR proteins to form megadalton sized complexes in which SR proteins are super-stoichiometric to EJC core factors. This tight physical association may explain known functional parallels between EJCs and SR proteins. Further, their protection of long mRNA stretches from nuclease digestion suggests that endogenous EJCs and SR proteins cooperate to promote mRNA packaging and compaction.	[Singh, Guramrit; Kucukural, Alper; Cenik, Can; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Singh, Guramrit; Kucukural, Alper; Cenik, Can; Leszyk, John D.; Shaffer, Scott A.; Weng, Zhiping; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Moore, MJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	melissa.moore@umassmed.edu	Kucukural, Alper/T-3563-2018; Kucukural, Alper/AAJ-7758-2020	Kucukural, Alper/0000-0001-9983-394X; Kucukural, Alper/0000-0001-9983-394X; Cenik, Can/0000-0001-6370-0889; Singh, Guramrit/0000-0002-5283-9540	HHMI; NIH [RO1-GM53007]; Charles A. King trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053007] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For valuable antibodies, we thank Elisa Izaurralde (alpha-Magoh), Jens Lykke-Andersen (alpha-Upf1, -Upf2, -Upf3, -Y14, and -eIF4AIII), Akila Mayeda (alpha-RNPS1), and John Blenis (alpha-SKAR). Frederick Roth and Hon Nian Chua generously provided a modified AlignACE algorithm. Ellie Kittler and the deep sequencing core are thanked for generating the deep sequencing data. We thank members of the Moore lab for discussions and critiques and Herve Le Hir for communicating results prior to publication. This work was supported by funding from HHMI and NIH RO1-GM53007 (to M.J.M.). G. S. was partially supported by the Charles A. King trust postdoctoral fellowship program. M.J.M. is an HHMI Investigator. G. S. and M.J.M. originally conceived the project, and G. S. executed all wet bench experiments. A. K. implemented all computational analyses with input from C. C. and Z.W. on computational method design and statistical analysis. J.D.L and S. A. S. performed mass spec. All authors contributed to data analysis and interpretation. With input from all authors, G. S. and M.J.M. were primarily responsible for writing the paper.	Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Ashton-Beaucage D, 2010, CELL, V143, P251, DOI 10.1016/j.cell.2010.09.014; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barbosa I, 2012, NAT STRUCT MOL BIOL, V19, P983, DOI 10.1038/nsmb.2380; Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; Bjork P, 2009, J CELL BIOL, V184, P555, DOI 10.1083/jcb.200806156; Bono F, 2011, RNA BIOL, V8, P24, DOI 10.4161/rna.8.1.13618; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Dewey CN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-311; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hansen KD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000525; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Korneta I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002641; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P3340, DOI 10.1093/nar/gkq017; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Michelle L, 2012, MOL CELL BIOL, V32, P954, DOI 10.1128/MCB.06130-11; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mishler DM, 2008, RNA, V14, P2657, DOI 10.1261/rna.1312808; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sato H, 2008, MOL CELL, V29, P255, DOI 10.1016/j.molcel.2007.12.009; Sauliere J, 2010, NAT STRUCT MOL BIOL, V17, P1269, DOI 10.1038/nsmb.1890; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; SKOGLUND U, 1983, CELL, V34, P847, DOI 10.1016/0092-8674(83)90542-1; Steckelberg AL, 2012, CELL REP, V2, P454, DOI 10.1016/j.celrep.2012.08.017; Stroupe ME, 2006, J MOL BIOL, V360, P743, DOI 10.1016/j.jmb.2006.05.049; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	54	223	225	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 9	2012	151	4					750	764		10.1016/j.cell.2012.10.007	http://dx.doi.org/10.1016/j.cell.2012.10.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23084401	Bronze, Green Accepted			2022-12-24	WOS:000310921200008
J	Southwell, DG; Paredes, MF; Galvao, RP; Jones, DL; Froemke, RC; Sebe, JY; Alfaro-Cervello, C; Tang, YS; Garcia-Verdugo, JM; Rubenstein, JL; Baraban, SC; Alvarez-Buylla, A				Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Froemke, Robert C.; Sebe, Joy Y.; Alfaro-Cervello, Clara; Tang, Yunshuo; Garcia-Verdugo, Jose M.; Rubenstein, John L.; Baraban, Scott C.; Alvarez-Buylla, Arturo			Intrinsically determined cell death of developing cortical interneurons	NATURE			English	Article							FLUORESCENT PROTEIN EXPRESSION; GABAERGIC NEURONS; NERVOUS-SYSTEM; ES CELLS; MICE; ADULT; BRAIN; TRKC; NEUROGENESIS; RECEPTORS	Cortical inhibitory circuits are formed by gamma-aminobutyric acid (GABA)-secreting interneurons, a cell population that originates far from the cerebral cortex in the embryonic ventral forebrain. Given their distant developmental origins, it is intriguing how the number of cortical interneurons is ultimately determined. One possibility, suggested by the neurotrophic hypothesis(1-5), is that cortical interneurons are overproduced, and then after their migration into cortex the excess interneurons are eliminated through a competition for extrinsically derived trophic signals. Here we characterize the developmental cell death of mouse cortical interneurons in vivo, in vitro and after transplantation. We found that 40% of developing cortical interneurons were eliminated through Bax (Bcl-2-associated X)-dependent apoptosis during postnatal life. When cultured in vitro or transplanted into the cortex, interneuron precursors died at a cellular age similar to that at which endogenous interneurons died during normal development. Over transplant sizes that varied 200-fold, a constant fraction of the transplanted population underwent cell death. The death of transplanted neurons was not affected by the cell-autonomous disruption of TrkB (tropomyosin kinase receptor B), the main neurotrophin receptor expressed by neurons of the central nervous system(6-8). Transplantation expanded the cortical interneuron population by up to 35%, but the frequency of inhibitory synaptic events did not scale with the number of transplanted interneurons. Taken together, our findings indicate that interneuron cell death is determined intrinsically, either cell-autonomously or through a population-autonomous competition for survival signals derived from other interneurons.	[Southwell, Derek G.; Jones, Daniel L.; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Sebe, Joy Y.; Tang, Yunshuo; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosci, San Francisco, CA 94143 USA; [Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Sebe, Joy Y.; Tang, Yunshuo; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Southwell, Derek G.; Paredes, Mercedes F.; Galvao, Rui P.; Jones, Daniel L.; Sebe, Joy Y.; Tang, Yunshuo; Rubenstein, John L.; Baraban, Scott C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Southwell, Derek G.; Tang, Yunshuo] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Paredes, Mercedes F.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Froemke, Robert C.] Univ Calif San Francisco, Coleman Mem Lab, Dept Otolaryngol, San Francisco, CA 94143 USA; [Froemke, Robert C.] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Alfaro-Cervello, Clara; Garcia-Verdugo, Jose M.] Univ Valencia, CIBERNED, Inst Cavanilles, Valencia 46071, Spain; [Tang, Yunshuo] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBERNED; University of Valencia; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Southwell, DG (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.	dereksouthwell@gmail.com; abuylla@stemcell.ucsf.edu	Galvão, Rogério/AAD-9875-2019; Alfaro-Cervello, Clara/D-1900-2015; García-Verdugo, José Manuel/L-8421-2017	Galvão, Rogério/0000-0002-0819-7114; García-Verdugo, José Manuel/0000-0001-9872-6499; Alfaro-Cervello, Clara/0000-0002-3737-4028; Froemke, Robert/0000-0002-1230-6811; Southwell, Derek/0000-0001-6465-3869; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Baraban, Scott/0000-0003-1975-9781	California Institute for Regenerative Medicine [TR2-01749]; National Institute of Neurologic Disorders and Stroke [F32NS061497]; John G. Bowes Research Fund; Spanish Ministry of Science and Innovation [SAF-2008-01274]; National Institutes of Health [R01 NS071785, R01 NS048528]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071785, F32NS061497, R01NS048528] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John G. Bowes Research Fund; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Yanagawa for GAD67-GFP mice, L. Reichardt for TrkB mutant mice and R. Romero for technical contributions. D. G. S. and M. F. P. were supported by training grants from the California Institute for Regenerative Medicine. J.Y.S. was supported by a fellowship from the National Institute of Neurologic Disorders and Stroke (F32NS061497). This work was supported by the California Institute for Regenerative Medicine (A.A.-B., TR2-01749), the John G. Bowes Research Fund (A.A.-B.), the Spanish Ministry of Science and Innovation (J.M.G-V., SAF-2008-01274), and the National Institutes of Health (J. L. R., S. C. B. and A.A.-B., R01 NS071785; A.A.-B., R01 NS048528).	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Boya Patricia, 2005, Birth Defects Research, V75, P281, DOI 10.1002/bdrc.20054; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Gorba T, 1999, EUR J NEUROSCI, V11, P1179, DOI 10.1046/j.1460-9568.1999.00551.x; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; LEVIMONTALCINI R, 1949, J COMP NEUROL, V91, P209, DOI 10.1002/cne.900910204; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Polleux F, 2002, DEVELOPMENT, V129, P3147; Sahara S, 2012, J NEUROSCI, V32, P4755, DOI 10.1523/JNEUROSCI.6412-11.2012; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	24	204	206	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					109	U172		10.1038/nature11523	http://dx.doi.org/10.1038/nature11523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23041929	Green Accepted, Green Submitted			2022-12-24	WOS:000310434500040
J	Ma, XY; Hou, XG; Edgecombe, GD; Strausfeld, NJ				Ma, Xiaoya; Hou, Xianguang; Edgecombe, Gregory D.; Strausfeld, Nicholas J.			Complex brain and optic lobes in an early Cambrian arthropod	NATURE			English	Article							GROUND PATTERN; NERVOUS-SYSTEM; SISTER GROUP; EVOLUTION; CRUSTACEAN; INSECTS; HEAD; VIEW; ORGANIZATION; FUXIANHUIA	The nervous system provides a fundamental source of data for understanding the evolutionary relationships between major arthropod groups(1,2). Fossil arthropods rarely preserve neural tissue. As a result, inferring sensory and motor attributes of Cambrian taxa has been limited to interpreting external features, such as compound eyes(3) or sensilla decorating appendages(4), and early-diverging arthropods have scarcely been analysed in the context of nervous system evolution. Here we report exceptional preservation of the brain and optic lobes of a stem-group arthropod from 520 million years ago (Myr ago), Fuxianhuia protensa(5), exhibiting the most compelling neuroanatomy known from the Cambrian. The protocerebrum of Fuxianhuia is supplied by optic lobes evidencing traces of three nested optic centres serving forward-viewing eyes. Nerves from uniramous antennae define the deutocerebrum, and a stout pair of more caudal nerves indicates a contiguous tritocerebral component. Fuxianhuia shares a tripartite pre-stomodeal brain and nested optic neuropils with extant Malacostraca and Insecta(2,6), demonstrating that these characters were present in some of the earliest derived arthropods. The brain of Fuxianhuia impacts molecular analyses that advocate either a branchiopod-like ancestor of Hexapoda(7,8) or remipedes and possibly cephalocarids as sister groups of Hexapoda(9,10). Resolving arguments about whether the simple brain of a branchiopod approximates an ancestral insect brain or whether it is the result of secondary simplification has until now been hindered by lack of fossil evidence. The complex brain of Fuxianhuia accords with cladistic analyses on the basis of neural characters, suggesting that Branchiopoda derive from a malacostracan-like ancestor but underwent evolutionary reduction and character reversal of brain centres that are common to hexapods and malacostracans(2). The early origin of sophisticated brains provides a probable driver for versatile visual behaviours, a view that accords with compound eyes from the early Cambrian that were, in size and resolution, equal to those of modern insects and malacostracans(3).	[Ma, Xiaoya; Hou, Xianguang] Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China; [Ma, Xiaoya; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Strausfeld, Nicholas J.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Strausfeld, Nicholas J.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA	Yunnan University; Natural History Museum London; University of Arizona; University of Arizona	Ma, XY (corresponding author), Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China.	x.ma@nhm.ac.uk	Strausfeld, Nicholas James/AAF-4566-2021	Strausfeld, Nicholas James/0000-0002-1115-1774; Edgecombe, Gregory/0000-0002-9591-8011	National Natural Science Foundation of China [40730211]; Leverhulme Trust [F/00 696/T]; Center for Insect Science, University of Arizona	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leverhulme Trust(Leverhulme Trust); Center for Insect Science, University of Arizona	This account is dedicated to J. Bergstrom, who was first in suggesting a brain in YKLP 15006. The present work was supported by the National Natural Science Foundation of China (40730211), a Leverhulme Trust Research Project Grant (F/00 696/T), and the Center for Insect Science, University of Arizona. We thank A. Ball and J. Spratt for their assistance with scanning electron microscopy imagery and energy-dispersive X-ray spectroscopy, respectively.	Andrew DR, 2012, J COMP NEUROL, V520, P3446, DOI 10.1002/cne.23099; Bergstrom J, 2008, GFF, V130, P189; Boyan G. S., 2006, EVOLUTION NERVOUS SY, P249; Budd GE, 2008, PALAEONTOLOGY, V51, P561, DOI 10.1111/j.1475-4983.2008.00752.x; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; CHEN JY, 1995, SCIENCE, V268, P1339, DOI 10.1126/science.268.5215.1339; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; ELOFSSON R, 1970, Z ZELLFORSCH MIK ANA, V107, P343, DOI 10.1007/BF00336672; Fanenbruck M, 2005, ARTHROPOD STRUCT DEV, V34, P343, DOI 10.1016/j.asd.2005.01.007; Gaines RR, 2012, P NATL ACAD SCI USA, V109, P5180, DOI 10.1073/pnas.1111784109; Glenner H, 2006, SCIENCE, V314, P1883, DOI 10.1126/science.1129844; Hanstr_om B., 1926, K SVEN VETENSKAPSAKA, V4, P1; Harzsch S, 2006, INTEGR COMP BIOL, V46, P162, DOI 10.1093/icb/icj011; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2004, LETHAIA, V37, P235, DOI 10.1080/00241160410006555; Kirsch R, 2007, ARTHROPOD STRUCT DEV, V36, P143, DOI 10.1016/j.asd.2006.08.013; Land M.F., 1989, P90; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Sandeman D. C., 1995, NERVOUS SYSTEMS INVE, P329; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; Sombke A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-1; Stegner MEJ, 2011, ARTHROPOD STRUCT DEV, V40, P221, DOI 10.1016/j.asd.2011.04.001; Strausfeld N.J., 2012, ARTHROPOD BRAINS EVO; Strausfeld Nicholas J., 2011, Palaeontographica Canadiana, V31, P157; Strausfeld NJ, 2011, ARTHROPOD STRUCT DEV, V40, P276, DOI 10.1016/j.asd.2011.02.002; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Wolff G, 2012, J COMP NEUROL, V520, P2824, DOI 10.1002/cne.23059	30	139	143	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					258	+		10.1038/nature11495	http://dx.doi.org/10.1038/nature11495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23060195				2022-12-24	WOS:000309733300049
J	Koo, JW; Mazei-Robison, MS; Chaudhury, D; Juarez, B; LaPlant, Q; Ferguson, D; Feng, J; Sun, HS; Scobie, KN; Damez-Werno, D; Crumiller, M; Ohnishi, YN; Ohnishi, YH; Mouzon, E; Dietz, DM; Lobo, MK; Neve, RL; Russo, SJ; Han, MH; Nestler, EJ				Koo, Ja Wook; Mazei-Robison, Michelle S.; Chaudhury, Dipesh; Juarez, Barbara; LaPlant, Quincey; Ferguson, Deveroux; Feng, Jian; Sun, Haosheng; Scobie, Kimberly N.; Damez-Werno, Diane; Crumiller, Marshall; Ohnishi, Yoshinori N.; Ohnishi, Yoko H.; Mouzon, Ezekiell; Dietz, David M.; Lobo, Mary Kay; Neve, Rachael L.; Russo, Scott J.; Han, Ming-Hu; Nestler, Eric J.			BDNF Is a Negative Modulator of Morphine Action	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; MESOLIMBIC DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS; NEUROTROPHIC FACTOR; COCAINE REWARD; BEHAVIORAL-RESPONSES; GENE-EXPRESSION; DELTA-FOSB; NEURONS; BRAIN	Brain-derived neurotrophic factor (BDNF) is a key positive regulator of neural plasticity, promoting, for example, the actions of stimulant drugs of abuse such as cocaine. We discovered a surprising opposite role for BDNF in countering responses to chronic morphine exposure. The suppression of BDNF in the ventral tegmental area (VTA) enhanced the ability of morphine to increase dopamine (DA) neuron excitability and promote reward. In contrast, optical stimulation of VTA DA terminals in nucleus accumbens (NAc) completely reversed the suppressive effect of BDNF on morphine reward. Furthermore, we identified numerous genes in the NAc, a major target region of VTA DA neurons, whose regulation by BDNF in the context of chronic morphine exposure mediated this counteractive function. These findings provide insight into the molecular basis of morphine-induced neuroadaptations in the brain's reward circuitry.	[Koo, Ja Wook; Mazei-Robison, Michelle S.; LaPlant, Quincey; Ferguson, Deveroux; Feng, Jian; Sun, Haosheng; Scobie, Kimberly N.; Damez-Werno, Diane; Crumiller, Marshall; Mouzon, Ezekiell; Russo, Scott J.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Koo, Ja Wook; Mazei-Robison, Michelle S.; LaPlant, Quincey; Ferguson, Deveroux; Feng, Jian; Sun, Haosheng; Scobie, Kimberly N.; Damez-Werno, Diane; Crumiller, Marshall; Mouzon, Ezekiell; Russo, Scott J.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Chaudhury, Dipesh; Juarez, Barbara; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Ohnishi, Yoshinori N.] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 8300011, Japan; [Ohnishi, Yoko H.] Kyushu Univ, Dept Med Biophys & Radiat Biol, Higashi Ku, Fukuoka 8128582, Japan; [Dietz, David M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Lobo, Mary Kay] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Kurume University; Kyushu University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Maryland; University of Maryland Baltimore; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	Eric.Nestler@mssm.edu	Mazei-Robison, Michelle/I-4304-2017; Han, Ming-Hu/G-8836-2012; Lobo, Mary Kay/K-7734-2015; Dietz, David/J-9458-2015; Russo, Scott/R-7107-2019; Dietz, David/AAW-4574-2021	Mazei-Robison, Michelle/0000-0002-2372-1420; Lobo, Mary Kay/0000-0002-9419-2079; Dietz, David/0000-0002-6927-9236; Russo, Scott/0000-0002-6470-1805; Dietz, David/0000-0002-6927-9236; Ferguson, Deveroux/0000-0001-9302-5992; Juarez, Barbara/0000-0001-7897-8031; Sun, Haosheng/0000-0003-3919-559X	National Institute on Drug Abuse; Dutch Scientific Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092306, T32MH087004, K99MH094405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, R01DA014133] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Dutch Scientific Organization(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. E. Burger-Caplan and N. Mensah for excellent technical assistance. This work was supported by grants from the National Institute on Drug Abuse (E.J.N. and M.S.M.-R.) and a Rubicon Grant from the Dutch Scientific Organization (C.S.L.).	Abrahao KP, 2011, INT J NEUROPSYCHOPH, V14, P175, DOI 10.1017/S1461145710000441; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Badiani A, 2011, NAT REV NEUROSCI, V12, P685, DOI 10.1038/nrn3104; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Boye SM, 2001, NEUROPHARMACOLOGY, V40, P792, DOI 10.1016/S0028-3908(01)00003-X; Chu NN, 2008, ADDICT BIOL, V13, P47, DOI 10.1111/j.1369-1600.2007.00092.x; Desai NS, 1999, LEARN MEMORY, V6, P284; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Horger BA, 1999, J NEUROSCI, V19, P4110; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; KADDIS FG, 1995, BRAIN RES, V697, P76, DOI 10.1016/0006-8993(95)00786-P; Korostynski M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r128; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Krishnan V, 2008, BIOL PSYCHIAT, V64, P691, DOI 10.1016/j.biopsych.2008.06.003; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 1999, BIOL PSYCHIAT, V46, P1131, DOI 10.1016/S0006-3223(99)00158-4; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Numan S, 1998, J NEUROSCI, V18, P10700; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; SklairTavron L, 1996, P NATL ACAD SCI USA, V93, P11202, DOI 10.1073/pnas.93.20.11202; Spijker S, 2004, FASEB J, V18, P848, DOI 10.1096/fj.03-0612fje; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vargas-Perez H, 2009, SCIENCE, V324, P1732, DOI 10.1126/science.1168501; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267	40	129	139	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					124	128		10.1126/science.1222265	http://dx.doi.org/10.1126/science.1222265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042896	Green Accepted			2022-12-24	WOS:000309457400068
J	Sutton, MD; Briggs, DEG; Siveter, DJ; Siveter, DJ; Sigwart, JD				Sutton, Mark D.; Briggs, Derek E. G.; Siveter, David J.; Siveter, Derek J.; Sigwart, Julia D.			A Silurian armoured aplacophoran and implications for molluscan phylogeny	NATURE			English	Article							INVERTEBRATE EVOLUTION; VERMIFORM MOLLUSK; ACAENOPLAX; POLYCHAETE; FOSSILS; ORIGIN; CHITON	The Mollusca is one of the most diverse, important and well-studied invertebrate phyla; however, relationships among major molluscan taxa have long been a subject of controversy(1-9). In particular, the position of the shell-less vermiform Aplacophora and its relationship to the better-known Polyplacophora (chitons) have been problematic: Aplacophora has been treated as a paraphyletic or monophyletic group at the base of the Mollusca(3,6,8), proximate to other derived clades such as Cephalopoda(2,3,10), or as sister group to the Polyplacophora, forming the clade Aculifera(1,5,7,11,12). Resolution of this debate is required to allow the evolutionary origins of Mollusca to be reconstructed with confidence. Recent fossil finds(13-16) support the Aculifera hypothesis, demonstrating that the Palaeozoic-era palaeoloricate 'chitons' included taxa combining certain polyplacophoran and aplacophoran characteristics(5). However, fossils combining an unambiguously aplacophoran-like body with chiton-like valves have remained elusive. Here we describe such a fossil, Kulindroplax perissokomos gen. et sp. nov., from the Herefordshire Lagerstatte(17,18) (about 425 million years BP), a Silurian deposit preserving a marine biota(18) in unusual three-dimensional detail. The specimen is reconstructed three-dimensionally through physical-optical tomography(19). Phylogenetic analysis indicates that this and many other palaeoloricate chitons are crown-group aplacophorans.	[Sutton, Mark D.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2BP, England; [Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA; [Siveter, David J.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Siveter, Derek J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England; [Siveter, Derek J.] Univ Museum Nat Hist, Oxford OX1 3PW, England; [Sigwart, Julia D.] Queens Univ Belfast, Sch Biol Sci, Marine Lab, Portaferry BT22 1PF, North Ireland	Imperial College London; Yale University; Yale University; University of Leicester; University of Oxford; University of Oxford; Queens University Belfast	Sutton, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2BP, England.	m.sutton@imperial.ac.uk	Sigwart, Julia D/J-2928-2014	Sigwart, Julia D/0000-0002-3005-6246	Natural Environmental Research Council (NERC) [NE/F018037/1]; NERC [NE/F01693X/1, NE/F018037/1] Funding Source: UKRI; Natural Environment Research Council [NE/F01693X/1, NE/F018037/1] Funding Source: researchfish	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Natural Environmental Research Council (NERC Grant NE/F018037/1) supported this research. K. Saunders, K. Davies, C. Dean, D. Legg and C. Lewis provided technical assistance, and the staff of Tarmac Western and the late R. Fenn facilitated the fieldwork.	Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Briggs DEG, 2008, AM SCI, V96, P474, DOI 10.1511/2008.75.474; Cherns L, 1998, PALAEONTOLOGY, V41, P545; Donovan SK, 2010, GEOLOGY, V38, P935, DOI 10.1130/G31296.1; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; McAlester A. L., 1965, Palaeontology, V8, P231; Meyer A, 2011, METHODS ECOL EVOL, V2, P34, DOI 10.1111/j.2041-210X.2010.00052.x; Morris SC, 2007, SCIENCE, V315, P1255, DOI 10.1126/science.1137187; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Salvini-Plawen Luitfried v., 1996, P29; SCHELTEMA AH, 1993, BIOL BULL, V184, P57, DOI 10.2307/1542380; Scheltema AH, 2002, INVERTEBR BIOL, V121, P1; Sigwart JD, 2007, P R SOC B, V274, P2413, DOI 10.1098/rspb.2007.0701; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Steiner G, 2001, NATURE, V414, P601, DOI 10.1038/414601a; Sutton M, 2001, NATURE, V414, P602, DOI 10.1038/414602a; Sutton M. D., 2012, PALAEONTOLOGIA ELECT, V15, p5T; Sutton MD, 2008, P ROY SOC B-BIOL SCI, V275, P1587, DOI 10.1098/rspb.2008.0263; Sutton MD, 2012, PALAEONTOLOGY, V55, P401, DOI 10.1111/j.1475-4983.2011.01126.x; Sutton MD, 2004, PALAEONTOLOGY, V47, P293, DOI 10.1111/j.0031-0239.2004.00374.x; Sutton MD, 2001, NATURE, V410, P461, DOI 10.1038/35068549; Telford MJ, 2011, CURR BIOL, V21, pR964, DOI 10.1016/j.cub.2011.10.029; Vendrasco MJ, 2004, NATURE, V429, P288, DOI 10.1038/nature02548; Vinther J, 2012, P ROY SOC B-BIOL SCI, V279, P1259, DOI 10.1098/rspb.2011.1773; von Salvini-Plawen Luitfried, 2003, Iberus, V21, P67; Wilson NG, 2010, MOL PHYLOGENET EVOL, V54, P187, DOI 10.1016/j.ympev.2009.07.028	29	53	54	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					94	97		10.1038/nature11328	http://dx.doi.org/10.1038/nature11328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23038472				2022-12-24	WOS:000309446800039
J	Cook, DE; Lee, TG; Guo, XL; Melito, S; Wang, K; Bayless, AM; Wang, JP; Hughes, TJ; Willis, DK; Clemente, TE; Diers, BW; Jiang, JM; Hudson, ME; Bent, AF				Cook, David E.; Lee, Tong Geon; Guo, Xiaoli; Melito, Sara; Wang, Kai; Bayless, Adam M.; Wang, Jianping; Hughes, Teresa J.; Willis, David K.; Clemente, Thomas E.; Diers, Brian W.; Jiang, Jiming; Hudson, Matthew E.; Bent, Andrew F.			Copy Number Variation of Multiple Genes at Rhg1 Mediates Nematode Resistance in Soybean	SCIENCE			English	Article							PLANT-PATHOGEN; EXPRESSION; CLUSTERS; ROOTS	The rhg1-b allele of soybean is widely used for resistance against soybean cyst nematode (SCN), the most economically damaging pathogen of soybeans in the United States. Gene silencing showed that genes in a 31-kilobase segment at rhg1-b, encoding an amino acid transporter, an a-SNAP protein, and a WI12 (wound-inducible domain) protein, each contribute to resistance. There is one copy of the 31-kilobase segment per haploid genome in susceptible varieties, but 10 tandem copies are present in an rhg1-b haplotype. Overexpression of the individual genes in roots was ineffective, but overexpression of the genes together conferred enhanced SCN resistance. Hence, SCN resistance mediated by the soybean quantitative trait locus Rhg1 is conferred by copy number variation that increases the expression of a set of dissimilar genes in a repeated multigene segment.	[Cook, David E.; Guo, Xiaoli; Melito, Sara; Bayless, Adam M.; Hughes, Teresa J.; Bent, Andrew F.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Lee, Tong Geon; Wang, Jianping; Diers, Brian W.; Hudson, Matthew E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Wang, Kai; Jiang, Jiming] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Willis, David K.] Univ Wisconsin, USDA ARS, Madison, WI 53706 USA; [Willis, David K.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Clemente, Thomas E.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Hudson, Matthew E.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Nebraska System; University of Nebraska Lincoln; University of Illinois System; University of Illinois Urbana-Champaign	Bent, AF (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	afbent@wisc.edu	Bent, Andrew/E-5391-2016; Jiang, Jiming/V-6060-2019; Lee, Tong Geon/H-1812-2014; Cook, David E./AAM-9348-2021; Jiang, Jiming/A-9614-2009; Hudson, Matthew E/A-4438-2008; Wang, Kai/A-2143-2011	Bent, Andrew/0000-0001-6610-9525; Jiang, Jiming/0000-0002-6435-6140; Lee, Tong Geon/0000-0003-1672-4356; Cook, David E./0000-0002-2719-4701; Jiang, Jiming/0000-0002-6435-6140; Hudson, Matthew E/0000-0002-4737-0936; Wang, Kai/0000-0002-1074-0438; Guo, Xiaoli/0000-0002-5407-6911; Melito, Sara/0000-0002-4910-2353	United Soybean Board; USDA CSREES; Illinois Soybean Association; NSF [DBI-0922703]; Wisconsin Experiment Station Hatch Award; Pioneer Fellowship in Plant Pathology; American Phytopathological Society; Direct For Biological Sciences [0922703] Funding Source: National Science Foundation	United Soybean Board; USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Illinois Soybean Association; NSF(National Science Foundation (NSF)); Wisconsin Experiment Station Hatch Award; Pioneer Fellowship in Plant Pathology; American Phytopathological Society; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by the United Soybean Board (A.F.B.), USDA CSREES (M.E.H.), Illinois Soybean Association (M.E.H. and B.W.D.), NSF grant DBI-0922703 (J.J.), Wisconsin Experiment Station Hatch Award (A.F.B.), and the Pioneer Fellowship in Plant Pathology awarded to D.E.C. by the American Phytopathological Society through a gift from Pioneer Hi-Bred. We thank A. E. MacGuidwin for suggestions regarding SCN experiments and J. M. Palmer for assistance with RNA blots. DNA sequence data are available at NCBI GenBank under accession codes JX907804 to JX907808 and at the NCBI Short Read Archive, study no. SRA059285. A.F.B., M.E.H., B.W.D., D.E.C., T.G.L., X.G., S.M., T.J.H., and J.W. are listed as inventors on a provisional patent application filed by Wisconsin Alumni Research Foundation that covers the findings reported herein.	Cheng ZK, 2002, CHROMOSOME RES, V10, P379, DOI 10.1023/A:1016849618707; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; DellaPenna D, 2012, SCIENCE, V336, P1648, DOI 10.1126/science.1225473; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Frey NFD, 2009, CURR OPIN PLANT BIOL, V12, P437, DOI 10.1016/j.pbi.2009.06.002; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kim M, 2011, CROP SCI, V51, P934, DOI 10.2135/cropsci2010.08.0459; Kim M, 2010, PLANT GENOME-US, V3, P81, DOI 10.3835/plantgenome2010.02.0001; Matsye PD, 2012, PLANT MOL BIOL, V80, P131, DOI 10.1007/s11103-012-9932-z; McHale LK, 2012, PLANT PHYSIOL, V159, P1295, DOI 10.1104/pp.112.194605; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Narayanan RA, 1999, CROP SCI, V39, P1680, DOI 10.2135/cropsci1999.3961680x; Niblack TL, 2006, ANNU REV PHYTOPATHOL, V44, P283, DOI 10.1146/annurev.phyto.43.040204.140218; Okumoto S, 2011, MOL PLANT, V4, P453, DOI 10.1093/mp/ssr003; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Schmutz J, 2010, NATURE, V465, P120, DOI 10.1038/nature08957; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Wingen LU, 2012, P NATL ACAD SCI USA, V109, P7115, DOI 10.1073/pnas.1111670109; Yen ShyiKae, 1999, Plant Physiology, V119, P1147, DOI 10.1104/pp.119.3.1147; Yu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-372; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114	31	391	442	9	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1206	1209		10.1126/science.1228746	http://dx.doi.org/10.1126/science.1228746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23065905				2022-12-24	WOS:000311666200045
J	Gilliam, JC; Chang, JT; Sandoval, IM; Zhang, YW; Li, TS; Pittler, SJ; Chiu, W; Wensel, TG				Gilliam, Jared C.; Chang, Juan T.; Sandoval, Ivette M.; Zhang, Youwen; Li, Tiansen; Pittler, Steven J.; Chiu, Wah; Wensel, Theodore G.			Three-Dimensional Architecture of the Rod Sensory Cilium and Its Disruption in Retinal Neurodegeneration	CELL			English	Article							INTRAFLAGELLAR TRANSPORT PROTEIN; BARDET-BIEDL-SYNDROME; CGMP-GATED CHANNEL; ACID-RICH PROTEINS; CRYOELECTRON TOMOGRAPHY; CILIARY ROOTLET; BETA-SUBUNIT; BASAL BODY; DISK MORPHOGENESIS; OUTER SEGMENTS	Defects in primary cilia lead to devastating disease because of their roles in sensation and developmental signaling but much is unknown about ciliary structure and mechanisms of their formation and maintenance. We used cryo-electron tomography to obtain 3D maps of the connecting cilium and adjacent cellular structures of a modified primary cilium, the rod outer segment, from wild-type and genetically defective mice. The results reveal the molecular architecture of the cilium and provide insights into protein functions. They suggest that the ciliary rootlet is involved in cellular transport and stabilizes the axoneme. A defect in the BBSome membrane coat caused defects in vesicle targeting near the base of the cilium. Loss of the proteins encoded by the Cngb1 gene disrupted links between the disk and plasma membranes. The structures of the outer segment membranes support a model for disk morphogenesis in which basal disks are enveloped by the plasma membrane.	[Gilliam, Jared C.; Chang, Juan T.; Sandoval, Ivette M.; Chiu, Wah; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chang, Juan T.; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Zhang, Youwen; Pittler, Steven J.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35924 USA; [Li, Tiansen] NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA	Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Wensel, TG (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	twensel@bcm.edu	Pittler, Steven/J-7091-2013	Pittler, Steven/0000-0002-8464-9303; Wensel, Theodore/0000-0003-3518-9352	NIH [EY011900, EY07981, P41RR002250, EY018143, EY10309, EY10581, EY011731, T32EY007001, EY002520]; Robert Welch Foundation [Q-0035, Q1242]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009, P41RR002250] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007001, R01EY010309, P30EY003039, R01EY011731, P30EY002520, R29EY010581, R01EY007981, R01EY018143, R01EY010581, ZIAEY000490, R01EY011900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832, R25GM056929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the NIH (EY011900 and EY07981 to T.G.W., P41RR002250 to W. C., EY018143 to S.J.P., EY10309 and EY10581 to T.L., support for I.M.S. by EY011731, an NIH NRSA trainee appointment on grant T32EY007001 to J.C.G., and Vision Research Core Grant EY002520) and by the Robert Welch Foundation (Q-0035 to T.G.W. and Q1242 to W.C.). We thank Mr. Ralph Nichols for help with electron microscopy of fixed samples, Dr. Vera Moiseenkova-Bell for help in the early stages of the project, and Dr. Alecia Gross for helpful suggestions and pilot experiments.	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams NA, 2007, OPHTHALMIC GENET, V28, P113, DOI 10.1080/13816810701537424; ANDERSON RG, 1972, J CELL BIOL, V54, P246, DOI 10.1083/jcb.54.2.246; Ardell MD, 2000, GENE, V245, P311, DOI 10.1016/S0378-1119(00)00023-8; Batra-Safferling R, 2006, J BIOL CHEM, V281, P1449, DOI 10.1074/jbc.M505012200; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chaitin M H, 1989, Prog Clin Biol Res, V314, P265; CHAITIN MH, 1984, J CELL BIOL, V99, P239, DOI 10.1083/jcb.99.1.239; CHAITIN MH, 1986, INVEST OPHTH VIS SCI, V27, P1764; CHAITIN MH, 1992, EXP EYE RES, V54, P261, DOI 10.1016/S0014-4835(05)80216-7; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Clarke R.D., 1946, J I ACTUARIES, V72, P481, DOI [DOI 10.1017/S0020268100035435, 10.1017/S0020268100035435]; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; DELPRIORE LV, 1987, INVEST OPHTH VIS SCI, V28, P633; Eichers ER, 2006, HUM GENET, V120, P211, DOI 10.1007/s00439-006-0197-y; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Jin H, 2009, CURR BIOL, V19, pR472, DOI 10.1016/j.cub.2009.04.015; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Koyfman AY, 2011, P NATL ACAD SCI USA, V108, P11105, DOI 10.1073/pnas.1103634108; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Moser JJ, 2010, SEMIN CELL DEV BIOL, V21, P148, DOI 10.1016/j.semcdb.2009.06.006; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Nicastro D, 2005, P NATL ACAD SCI USA, V102, P15889, DOI 10.1073/pnas.0508274102; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Ozanics V., 1982, OCULAR ANATOMY EMBRY, P462; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; RENTHAL R, 1973, EXP EYE RES, V17, P511, DOI 10.1016/0014-4835(73)90081-X; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; SPIRA AW, 1979, AM J ANAT, V155, P319, DOI 10.1002/aja.1001550304; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Yahav T, 2011, CURR OPIN STRUC BIOL, V21, P670, DOI 10.1016/j.sbi.2011.07.004; Yang J, 2005, MOL CELL BIOL, V25, P4129, DOI 10.1128/MCB.25.10.4129-4137.2005; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang J, 2005, EXP CELL RES, V309, P379, DOI 10.1016/j.yexcr.2005.05.026; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531	53	106	110	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1029	1041		10.1016/j.cell.2012.10.038	http://dx.doi.org/10.1016/j.cell.2012.10.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178122	Bronze, Green Accepted			2022-12-24	WOS:000311423500016
J	Yang, YWJ; Baltus, AE; Mathew, RS; Murphy, EA; Evrony, GD; Gonzalez, DM; Wang, EP; Marshall-Walker, CA; Barry, BJ; Murn, J; Tatarakis, A; Mahajan, MA; Samuels, HH; Shi, Y; Golden, JA; Mahajnah, M; Shenhav, R; Walsh, CA				Yang, Yawei J.; Baltus, Andrew E.; Mathew, Rebecca S.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Murn, Jernej; Tatarakis, Antonis; Mahajan, Muktar A.; Samuels, Herbert H.; Shi, Yang; Golden, Jeffrey A.; Mahajnah, Muhammad; Shenhav, Ruthie; Walsh, Christopher A.			Microcephaly Gene Links Trithorax and REST/NRSF to Control Neural Stem Cell Proliferation and Differentiation	CELL			English	Article							HISTONE MODIFICATIONS; SELF-RENEWAL; CHROMATIN; NEUROGENESIS; REST; COMPLEX; TRANSCRIPTION; PROTEINS; NEURONS; STATES	Microcephaly is a neurodevelopmental disorder causing significantly reduced cerebral cortex size. Many known microcephaly gene products localize to centrosomes, regulating cell fate and proliferation. Here, we identify and characterize a nuclear zinc finger protein, ZNF335/NIF-1, as a causative gene for severe microcephaly, small somatic size, and neonatal death. Znf335 null mice are embryonically lethal, and conditional knockout leads to severely reduced cortical size. RNA-interference and postmortem human studies show that ZNF335 is essential for neural progenitor self-renewal, neurogenesis, and neuronal differentiation. ZNF335 is a component of a vertebrate-specific, trithorax H3K4-methylation complex, directly regulating REST/NRSF, a master regulator of neural gene expression and cell fate, as well as other essential neural-specific genes. Our results reveal ZNF335 as an essential link between H3K4 complexes and REST/NRSF and provide the first direct genetic evidence that this pathway regulates human neurogenesis and neuronal differentiation.	[Yang, Yawei J.; Baltus, Andrew E.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Yang, Yawei J.; Baltus, Andrew E.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Walsh, Christopher A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Murn, Jernej; Shi, Yang] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Yang, Yawei J.; Evrony, Gilad D.; Wang, Estee P.; Walsh, Christopher A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yang, Yawei J.; Evrony, Gilad D.; Walsh, Christopher A.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Yang, Yawei J.; Evrony, Gilad D.] Harvard Univ, Sch Med, Harvard MD PhD MSTP Program, Boston, MA 02115 USA; [Mathew, Rebecca S.; Murn, Jernej; Tatarakis, Antonis; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yang, Yawei J.; Baltus, Andrew E.; Mathew, Rebecca S.; Murphy, Elisabeth A.; Evrony, Gilad D.; Gonzalez, Dilenny M.; Wang, Estee P.; Marshall-Walker, Christine A.; Barry, Brenda J.; Tatarakis, Antonis; Walsh, Christopher A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Yang, Yawei J.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Murphy, Elisabeth A.] Northeastern Univ, Dept Neurosci, Boston, MA 02115 USA; [Wang, Estee P.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Mahajan, Muktar A.; Samuels, Herbert H.] NYU, Sch Med, Dept Pharmacol & Med, New York, NY 10016 USA; [Golden, Jeffrey A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mahajnah, Muhammad] Hillel Yaffe Med Ctr, IL-38100 Hadera, Israel; [Mahajnah, Muhammad] Technion Israel Inst Technol, IL-32000 Haifa, Israel; [Shenhav, Ruthie] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Northeastern University; Harvard University; Harvard School of Dental Medicine; New York University; Harvard University; Brigham & Women's Hospital; Technion Israel Institute of Technology; Rabin Medical Center	Walsh, CA (corresponding author), Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Murn, Jernej/ABD-3624-2020	Gonzalez, Dilenny/0000-0003-0661-5930; Golden, Jeffrey/0000-0001-9933-5502; Evrony, Gilad/0000-0001-7621-2630; Walsh, Christopher/0000-0002-0156-2238; Mahajan, Muktar/0000-0003-1024-6808	Stuart H.Q. and Victoria Quan Fellowship; NIH MSTP [T32GM007753]; NIH [T32 HD007466, GM058012, GM071004, CA118487]; Damon Runyon Cancer Research Foundation [DRG-2042-10]; HHMI Medical Research Fellows Program; NINDS [RO1 NS032457, R01 NS35129]; Manton Center for Orphan Disease Research;  [RO1 DK16636]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA118487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004, R01GM058012, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, R01NS032457] Funding Source: NIH RePORTER	Stuart H.Q. and Victoria Quan Fellowship; NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; HHMI Medical Research Fellows Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Manton Center for Orphan Disease Research; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Moazed, M.E. Hatten, B. Ren, D.M. Ferrero, and members of the Walsh laboratory for helpful discussions; L. Shechtman for tissue; N. Dwyer for early mapping; G. Mandel for DN-REST construct; E.E. Govek for help with cerebellar slices; K. S. Krishnamoorthy for control MRIs; and D.J. Tischfield, L.B. Hills, K.D. Atabay, P.P. Wang, J. Wortzel, D.G. Tierney, and J.M. Felie for technical assistance. This work was supported by a Stuart H.Q. and Victoria Quan Fellowship (Y.J.Y.); a NIH MSTP grant T32GM007753 (Y.J.Y. and G.D.E.); a NIH T32 HD007466 (A.E.B.); The Damon Runyon Cancer Research Foundation DRG-2042-10 (R.S.M.); HHMI Medical Research Fellows Program (E.P.W.); RO1 DK16636 (H.H.S.); NIH grants (GM058012, GM071004, and CA118487) (Y.S.); grants from the NINDS (RO1 NS032457 and R01 NS35129); and the Manton Center for Orphan Disease Research (C.A.W.). C.A.W. is an Investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the NIH.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BARKOVICH A, 2007, DIAGNOSTIC IMAGING P; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Dredge BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021585; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Garapaty S, 2009, J BIOL CHEM, V284, P7542, DOI 10.1074/jbc.M805872200; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Paro R, 1998, CIBA F SYMP, V214, P51; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Zheng JN, 2006, LIFE SCI, V78, P724, DOI 10.1016/j.lfs.2005.05.064	33	113	128	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 21	2012	151	5					1097	1112		10.1016/j.cell.2012.10.043	http://dx.doi.org/10.1016/j.cell.2012.10.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178126	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000311423500021
J	Ciofani, M; Madar, A; Galan, C; Sellars, M; Mace, K; Pauli, F; Agarwal, A; Huang, WD; Parkurst, CN; Muratet, M; Newberry, KM; Meadows, S; Greenfield, A; Yang, Y; Jain, P; Kirigin, FK; Birchmeier, C; Wagner, EF; Murphy, KM; Myers, RM; Bonneau, R; Littman, DR				Ciofani, Maria; Madar, Aviv; Galan, Carolina; Sellars, MacLean; Mace, Kieran; Pauli, Florencia; Agarwal, Ashish; Huang, Wendy; Parkurst, Christopher N.; Muratet, Michael; Newberry, Kim M.; Meadows, Sarah; Greenfield, Alex; Yang, Yi; Jain, Preti; Kirigin, Francis K.; Birchmeier, Carmen; Wagner, Erwin F.; Murphy, Kenneth M.; Myers, Richard M.; Bonneau, Richard; Littman, Dan R.			A Validated Regulatory Network for Th17 Cell Specification	CELL			English	Article							ROR-GAMMA-T; ARYL-HYDROCARBON RECEPTOR; FACTOR BATF CONTROLS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; HELPER-CELLS; T-H-17 CELLS; NUCLEAR RECEPTORS; C-MAF; DIFFERENTIATION	Th17 cells have critical roles in mucosal defense and are major contributors to inflammatory disease. Their differentiation requires the nuclear hormone receptor ROR gamma t working with multiple other essential transcription factors (TFs). We have used an iterative systems approach, combining genome-wide TF occupancy, expression profiling of TF mutants, and expression time series to delineate the Th17 global transcriptional regulatory network. We find that cooperatively bound BATF and IRF4 contribute to initial chromatin accessibility and, with STAT3, initiate a transcriptional program that is then globally tuned by the lineage-specifying TF ROR gamma t, which plays a focal deterministic role at key loci. Integration of multiple data sets allowed inference of an accurate predictive model that we computationally and experimentally validated, identifying multiple new Th17 regulators, including Fosl2, a key determinant of cellular plasticity. This interconnected network can be used to investigate new therapeutic approaches to manipulate Th17 functions in the setting of inflammatory disease.	[Madar, Aviv; Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10003 USA; [Ciofani, Maria; Galan, Carolina; Sellars, MacLean; Huang, Wendy; Parkurst, Christopher N.; Muratet, Michael; Yang, Yi; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol, New York, NY 10016 USA; [Ciofani, Maria; Galan, Carolina; Sellars, MacLean; Huang, Wendy; Parkurst, Christopher N.; Muratet, Michael; Yang, Yi; Littman, Dan R.] NYU, Sch Med, Med Skirball Inst, New York, NY 10016 USA; [Kirigin, Francis K.] NYU, Sch Med, Computat Biol Program, Sackler Inst, New York, NY 10016 USA; [Madar, Aviv; Mace, Kieran; Agarwal, Ashish; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Pauli, Florencia; Newberry, Kim M.; Meadows, Sarah; Greenfield, Alex; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Birchmeier, Carmen] Max Delbruck Mol Med, Dev Biol, D-13125 Berlin, Germany; [Wagner, Erwin F.] Spanish Natl Canc Res Ctr CNIO, Canc Cell Biol Programme, E-28029 Madrid, Spain; [Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA	New York University; New York University; New York University; New York University; New York University; HudsonAlpha Institute for Biotechnology; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centro Nacional de Investigaciones Oncologicas (CNIO); Washington University (WUSTL)	Bonneau, R (corresponding author), NYU, Courant Inst Math Sci, Dept Comp Sci, 251 Mercer St, New York, NY 10003 USA.	bonneau@nyu.edu; dan.littman@med.nyu.edu	Bonneau, Richard/ABD-6737-2021; Madar, Aviv/AAO-1540-2020; Bonneau, Richard/GZL-2900-2022; Madar, Aviv/D-1023-2013	Wagner, Erwin F/0000-0001-7872-0196; Mace, Kieran/0000-0002-8131-3118; Pauli Behn, Florencia/0000-0002-8984-4044; Ciofani, Maria/0000-0001-6472-5260	NIH [RC1 AI087266, RC4 AI092765, PN2 EY016586, IU54CA143907-01, EY016586-06]; NSF [IOS-1126971]; Leukemia and Lymphoma Society; Crohn's and Colitis Foundation of America; National Arthritis Research Foundation; Cancer Research Institute; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN1EY016586, PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI087266, RC4AI092765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Crohn's and Colitis Foundation of America; National Arthritis Research Foundation; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Andrew Sczesnak for generating TDF files and for multiple other contributions to data analysis during the course of the study. We thank R. Dalla Favera for providing IRF4 mutant mice; O. Uluckan and S. Wurm for coordinating shipping of AP-1 mutant mice; K. Ward for system administration; and K. Gunsalus and M. Dustin for helpful discussions. Support was provided by NIH grants RC1 AI087266 and RC4 AI092765 (A. A., D. R. L, R. B, and R. M. M.), PN2 EY016586 (A. G., A. M, and R. B.), and IU54CA143907-01 and EY016586-06 (A. G. and R. B.); NSF grant IOS-1126971 (R. B.); fellowships from the Leukemia and Lymphoma Society and Crohn's and Colitis Foundation of America (M. C.), the National Arthritis Research Foundation (Y.Y.); and Irvington Institute Fellowships from the Cancer Research Institute (M. S. and W. H.).	Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hindorff L, 2012, CATALOG PUBLISHED GE; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ho IC, 1999, COLD SPRING HARB SYM, V64, P573, DOI 10.1101/sqb.1999.64.573; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	46	753	780	1	89	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 12	2012	151	2					289	303		10.1016/j.cell.2012.09.016	http://dx.doi.org/10.1016/j.cell.2012.09.016			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23021777	Green Accepted, Bronze			2022-12-24	WOS:000309981000009
J	Jin, J; Sison, K; Li, CJ; Tian, RJ; Wnuk, M; Sung, HK; Jeansson, M; Zhang, CJ; Tucholska, M; Jones, N; Kerjaschki, D; Shibuya, M; Fantus, IG; Nagy, A; Gerber, HP; Ferrara, N; Pawson, T; Quaggin, SE				Jin, Jing; Sison, Karen; Li, Chengjin; Tian, Ruijun; Wnuk, Monika; Sung, Hoon-Ki; Jeansson, Marie; Zhang, Cunjie; Tucholska, Monika; Jones, Nina; Kerjaschki, Dontscho; Shibuya, Masabumi; Fantus, I. George; Nagy, Andras; Gerber, Hans-Peter; Ferrara, Napoleone; Pawson, Tony; Quaggin, Susan E.			Soluble FLT1 Binds Lipid Microdomains in Podocytes to Control Cell Morphology and Glomerular Barrier Function	CELL			English	Article							GROWTH-FACTOR RECEPTOR-1; TYROSINE KINASE; NEPHRIN PHOSPHORYLATION; MASS-SPECTROMETRY; HEPARIN-BINDING; VEGF RECEPTOR; RAFTS; LOCALIZATION; ANGIOGENESIS; GANGLIOSIDES	Vascular endothelial growth factor and its receptors, FLK1/KDR and FLT1, are key regulators of angiogenesis. Unlike FLK1/KDR, the role of FLT1 has remained elusive. FLT1 is produced as soluble (sFLT1) and full-length isoforms. Here, we show that pericytes from multiple tissues produce sFLT1. To define the biologic role of sFLT1, we chose the glomerular microvasculature as a model system. Deletion of Flt1 from specialized glomerular pericytes, known as podocytes, causes reorganization of their cytoskeleton with massive proteinuria and kidney failure, characteristic features of nephrotic syndrome in humans. The kinase-deficient allele of Flt1 rescues this phenotype, demonstrating dispensability of the full-length isoform. Using cell imaging, proteomics, and lipidomics, we show that sFLT1 binds to the glycosphingolipid GM3 in lipid rafts on the surface of podocytes, promoting adhesion and rapid actin reorganization. sFLT1 also regulates pericyte function in vessels outside of the kidney. Our findings demonstrate an autocrine function for sFLT1 to control pericyte behavior.	[Jin, Jing; Sison, Karen; Li, Chengjin; Tian, Ruijun; Wnuk, Monika; Sung, Hoon-Ki; Jeansson, Marie; Zhang, Cunjie; Tucholska, Monika; Nagy, Andras; Pawson, Tony; Quaggin, Susan E.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Fantus, I. George] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Kerjaschki, Dontscho] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Shibuya, Masabumi] Jobu Univ, Inst Physiol & Med, Takasaki, Gunma 3701393, Japan; [Fantus, I. George] Toronto Gen Res Hosp, Toronto, ON M5G 1L7, Canada; [Fantus, I. George] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Fantus, I. George] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5S 1A8, Canada; [Quaggin, Susan E.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON M5S 1A8, Canada; [Nagy, Andras] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5S 1A8, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Gerber, Hans-Peter] Pfizer Worldwide Res & Dev, BioConjugate Vasc Biol, Oncol Res Unit E, Pearl River, NY 10965 USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA; [Quaggin, Susan E.] St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Guelph; Medical University of Vienna; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Pfizer; Roche Holding; Genentech; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Quaggin, SE (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	quaggin@lunenfeld.ca	Sung, Hoon-Ki/G-3049-2013; Nagy, Andras/G-6465-2013; Tian, Ruijun/B-5629-2009; Pawson, Tony J/E-4578-2013; Sung, Hoon-Ki/A-1922-2016; Tian, Ruijun/J-3019-2014	Nagy, Andras/0000-0003-4311-0413; Tian, Ruijun/0000-0001-9521-5124; Sung, Hoon-Ki/0000-0001-6677-9385; Jeansson, Marie/0000-0003-1075-8563	CIHR [MOP62931]; TF grant [016002]; Gabor-Zellerman Chair [CIHR-MOP57793, HFSP-RGP0039/2009-C]; CCRI [2010-700465]; CIHR Postdoctoral Fellowship; KRES-CENT Award; Swiss NSF Postdoctoral Grant;  [CIHR- MOP-49409]	CIHR(Canadian Institutes of Health Research (CIHR)); TF grant; Gabor-Zellerman Chair; CCRI; CIHR Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); KRES-CENT Award; Swiss NSF Postdoctoral Grant; 	We thank Doug Holmyard and Ken Harpal for EM and histology; Sarang Kulkarni, Steffen Lawo, and Laurence Pelletier for microscopy and imaging; Gerry Gish for peptide synthesis and lipid assays; Rick Bagshaw for mass spec advice and providing Lys-N enzyme; Moin Saleem for human podocyte cells; Jim Dennis, Andras Kapus, Johan van der Vlag, Roy Zent, Jin Gyoon Park, and Sergio Grinstein for helpful discussions; and Vivian Nguyen, Bret Larsen, and Lorne Taylor for technical assistance. This work was funded by CIHR grant MOP62931, TF grant 016002 to S. E. Q., who holds the Gabor-Zellerman Chair, CIHR-MOP57793 and HFSP-RGP0039/2009-C grants to T. P., CIHR- MOP-49409 to I. G. F., and TF grant 016002, CCRI grant 2010-700465 to A.N. J.J. received a CIHR Postdoctoral Fellowship, N.J. received a KRES-CENT Award, and M.W. a Swiss NSF Postdoctoral Grant.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Balreira A, 2008, HUM MOL GENET, V17, P2238, DOI 10.1093/hmg/ddn124; Bass MD, 2011, DEV CELL, V21, P681, DOI 10.1016/j.devcel.2011.08.007; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Borza CM, 2008, J AM SOC NEPHROL, V19, P677, DOI 10.1681/ASN.2007070793; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kwak DH, 2003, LIFE SCI, V72, P1997, DOI 10.1016/S0024-3205(03)00090-0; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maezawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040547; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Rhainds D, 2004, J CELL SCI, V117, P3095, DOI 10.1242/jcs.01182; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665; Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Sundberg C, 2009, AM J PATHOL, V175, P171, DOI 10.2353/ajpath.2009.080769; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zobiack N, 2002, J CELL SCI, V115, P91	40	108	110	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					384	399		10.1016/j.cell.2012.08.037	http://dx.doi.org/10.1016/j.cell.2012.08.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063127	Bronze			2022-12-24	WOS:000309981000016
J	Xhemalce, B; Robson, SC; Kouzarides, T				Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony			Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing	CELL			English	Article							TARGETS; EXPRESSION; COMPLEX	MicroRNAs (miRNAs) regulate key biological processes and their aberrant expression may lead to cancer. The primary transcript of canonical miRNAs is sequentially cleaved by the RNase III enzymes, Drosha and Dicer, which generate 5' monophosphate ends that are important for subsequent miRNA functions. In particular, the recognition of the 5' monophosphate of pre-miRNAs by Dicer is important for precise and effective biogenesis of miRNAs. Here, we identify a RNA-methyltransferase, BCDIN3D, that O-methylates this 5' monophosphate and negatively regulates miRNA maturation. Specifically, we show that BCDIN3D phospho-dimethylates pre-miR-145 both in vitro and in vivo and that phospho-dimethylated pre-miR-145 displays reduced processing by Dicer in vitro. Consistently, BCDIN3D depletion leads to lower pre-miR-145 and concomitantly increased mature miR-145 levels in breast cancer cells, which suppresses their tumorigenic phenotypes. Together, our results uncover a miRNA methylation pathway potentially involved in cancer that antagonizes the Dicer-dependent processing of miR-145 as well as other miRNAs.	[Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Xhemalce, Blerta] Univ Texas Austin, Coll Nat Sci, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Cambridge; University of Texas System; University of Texas Austin	Kouzarides, T (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol,Tennis Court, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk		Kouzarides, Tony/0000-0002-8918-4162; Xhemalce, Blerta/0000-0002-0517-9607	ICMB at the University of Texas at Austin; Cancer Research UK; CRUK; European Union	ICMB at the University of Texas at Austin; Cancer Research UK(Cancer Research UK); CRUK(Cancer Research UK); European Union(European Commission)	We thank Dr. Till Bartke for the recombinant nucleosomes and the parental Hela-S3-FlpIn cell line, Dr. Kyle M. Miller for help with the xCELLigence system, the DNA core facility at the Institute of Cellular and Molecular Biology (ICMB) at the University of Texas at Austin for use of equipment, and Dr. Andrew J. Bannister for helpful discussions. B. X. was funded by a start-up grant from ICMB at the University of Texas at Austin and a Cancer Research UK project grant. The T. K. laboratory was funded by grants from CRUK and the 6th Research Framework Program of the European Union (Epitron, SMARTER and HEROIC). Tony Kouzarides is a director of Abcam.	Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gunther T, 2006, MAGNESIUM RES, V19, P225; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kawamata T, 2011, EMBO REP, V12, P944, DOI 10.1038/embor.2011.128; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sarnow P, 2006, NAT REV MICROBIOL, V4, P651, DOI 10.1038/nrmicro1473; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shuman S, 2007, MOL CELL, V27, P517, DOI 10.1016/j.molcel.2007.08.001; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Xhemalce B., 2011, HISTONE MODIFICATION; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	29	107	111	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					278	288		10.1016/j.cell.2012.08.041	http://dx.doi.org/10.1016/j.cell.2012.08.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23063121	Green Accepted, Bronze			2022-12-24	WOS:000309981000008
J	Samstein, RM; Arvey, A; Josefowicz, SZ; Peng, X; Reynolds, A; Sandstrom, R; Neph, S; Sabo, P; Kim, JM; Liao, W; Li, MO; Leslie, C; Stamatoyannopoulos, JA; Rudensky, AY				Samstein, Robert M.; Arvey, Aaron; Josefowicz, Steven Z.; Peng, Xiao; Reynolds, Alex; Sandstrom, Richard; Neph, Shane; Sabo, Peter; Kim, Jeong M.; Liao, Will; Li, Ming O.; Leslie, Christina; Stamatoyannopoulos, John A.; Rudensky, Alexander Y.			Foxp3 Exploits a Pre-Existent Enhancer Landscape for Regulatory T Cell Lineage Specification	CELL			English	Article							TRANSCRIPTION FACTOR FOXP3; GLUCOCORTICOID-RECEPTOR BINDING; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; RISK LOCI; CHROMATIN ACCESSIBILITY; DNA ELEMENTS; CBF-BETA; DIFFERENTIATION; DOMAIN	Regulatory T (Treg) cells, whose identity and function are defined by the transcription factor Foxp3, are indispensable for immune homeostasis. It is unclear whether Foxp3 exerts its Treg lineage specification function through active modification of the chromatin landscape and establishment of new enhancers or by exploiting a pre-existing enhancer landscape. Analysis of the chromatin accessibility of Foxp3-bound enhancers in Treg and Foxp3-negative T cells showed that Foxp3 was bound overwhelmingly to preaccessible enhancers occupied by its cofactors in precursor cells or a structurally related predecessor. Furthermore, the bulk of Foxp3-bound Treg cell enhancers lacking in Foxp3(-) CD4(+) cells became accessible upon T cell receptor activation prior to Foxp3 expression, and only a small subset associated with several functionally important genes were exclusively Treg cell specific. Thus, in a late cellular differentiation process, Foxp3 defines Treg cell functionality in an "opportunistic" manner by largely exploiting the preformed enhancer network instead of establishing a new enhancer landscape.	[Reynolds, Alex; Sandstrom, Richard; Neph, Shane; Sabo, Peter; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Samstein, Robert M.; Arvey, Aaron; Josefowicz, Steven Z.; Peng, Xiao; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Samstein, Robert M.; Josefowicz, Steven Z.; Peng, Xiao; Li, Ming O.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Leslie, Christina] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Kim, Jeong M.] Genentech Inc, San Francisco, CA 94080 USA; [Liao, Will] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	jstam@u.washington.edu; rudenska@mskcc.org		li, ming/0000-0002-1383-0535; Arvey, Aaron/0000-0002-8789-0290; josefowicz, steven/0000-0001-7453-779X; Sandstrom, Richard/0000-0002-3356-1547; Samstein, Robert/0000-0001-6860-2401	NIH [DK091968, 5R37AI034206]; MSTP [GM07739]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, R01AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Rudra and A. Chaudhry for helpful discussions. This work was supported by NIH DK091968 grant and MSTP grant GM07739 (both R.M.S.) and also by NIH 5R37AI034206 grant (A.Y.R.). A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	48	328	335	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					153	166		10.1016/j.cell.2012.06.053	http://dx.doi.org/10.1016/j.cell.2012.06.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021222	Green Accepted, Bronze			2022-12-24	WOS:000309544200017
J	Chistol, G; Liu, SX; Hetherington, CL; Moffitt, JR; Grimes, S; Jardine, PJ; Bustamante, C				Chistol, Gheorghe; Liu, Shixin; Hetherington, Craig L.; Moffitt, Jeffrey R.; Grimes, Shelley; Jardine, Paul J.; Bustamante, Carlos			High Degree of Coordination and Division of Labor among Subunits in a Homomeric Ring ATPase	CELL			English	Article							HEXAMERIC HELICASE; DNA TRANSLOCATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MECHANISM; HYDROLYSIS; MOTOR; TRANSPORT; MCM2-7; MODEL	Ring NTPases of the ASCE superfamily perform a variety of cellular functions. An important question about the operation of these molecular machines is how the ring subunits coordinate their chemical and mechanical transitions. Here, we present a comprehensive mechanochemical characterization of a homomeric ring ATPase-the bacteriophage phi 29 packaging motor-a homopentamer that translocates double-stranded DNA in cycles composed of alternating dwells and bursts. We use high-resolution optical tweezers to determine the effect of nucleotide analogs on the cycle. We find that ATP hydrolysis occurs sequentially during the burst and that ADP release is interlaced with ATP binding during the dwell, revealing a high degree of coordination among ring subunits. Moreover, we show that the motor displays an unexpected division of labor: although all subunits of the homopentamer bind and hydrolyze ATP during each cycle, only four participate in translocation, whereas the remaining subunit plays an ATP-dependent regulatory role.	[Chistol, Gheorghe; Liu, Shixin; Hetherington, Craig L.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Chistol, Gheorghe; Liu, Shixin; Hetherington, Craig L.; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Liu, Shixin; Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Moffitt, Jeffrey R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; Jardine, Paul/0000-0002-1090-0550; Chistol, Gheorghe/0000-0003-4868-3667	National Institutes of Health [GM071552, GM059604, DE003606]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003606, R37DE003606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059604, R01GM071552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Dangkulwanich, T. Ishibashi, C. Kaiser, N. Liu, R. Maillard, M. Morais, and M. Sen for critical discussions. This work was supported in part by grants from the National Institutes of Health (GM071552 to C.B., GM059604 and DE003606 to S.G.) and the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Contract No. DE-AC02-05CH11231 (single molecule force measurement) to C.B.	Aathavan K, 2009, NATURE, V461, P669, DOI 10.1038/nature08443; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C., 2008, SINGLE MOL TECHNIQUE, P297; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; Hetherington CL, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P420, DOI 10.1016/B978-0-12-374920-8.00431-8; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Kainov DE, 2008, J BIOL CHEM, V283, P3607, DOI 10.1074/jbc.M706366200; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Moffitt JR, 2010, METHOD ENZYMOL, V475, P221, DOI 10.1016/S0076-6879(10)75010-2; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Segel IH, 1975, ENZYME KINETICS BEHA; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Yang Q, 2004, BIOCHEMISTRY-US, V43, P289, DOI 10.1021/bi035532h; Yu J, 2010, J MOL BIOL, V400, P186, DOI 10.1016/j.jmb.2010.05.002	46	80	80	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1017	1028		10.1016/j.cell.2012.10.031	http://dx.doi.org/10.1016/j.cell.2012.10.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178121	Green Accepted, Bronze			2022-12-24	WOS:000311423500015
J	Miyamoto, T; Slone, J; Song, XY; Amrein, H				Miyamoto, Tetsuya; Slone, Jesse; Song, Xiangyu; Amrein, Hubert			A Fructose Receptor Functions as a Nutrient Sensor in the Drosophila Brain	CELL			English	Article							BITTER TASTE RECEPTORS; NEUROPEPTIDE Y-LIKE; EXPRESSION; SUGAR; GLUCOSE; FOOD; GENE; GUSTDUCIN; BEHAVIOR; NEURONS	Internal nutrient sensors play important roles in feeding behavior, yet their molecular structure and mechanism of action are poorly understood. Using Ca2+ imaging and behavioral assays, we show that the gustatory receptor 43a (Gr43a) functions as a narrowly tuned fructose receptor in taste neurons. Remarkably, Gr43a also functions as a fructose receptor in the brain. Interestingly, hemolymph fructose levels are tightly linked to feeding status: after nutritious carbohydrate consumption, fructose levels rise several fold and reach a concentration sufficient to activate Gr43a in the brain. By using different feeding paradigms and artificial activation of Gr43a-expressing brain neurons, we show that Gr43a is both necessary and sufficient to sense hemolymph fructose and promote feeding in hungry flies but suppress feeding in satiated flies. Thus, our studies indicate that the Gr43a-expressing brain neurons function as a nutrient sensor for hemolymph fructose and assign opposing valence to feeding experiences in a satiation-dependent manner.	[Miyamoto, Tetsuya; Slone, Jesse; Song, Xiangyu; Amrein, Hubert] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Amrein, H (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77845 USA.	amrein@tamhsc.edu	Amrein, Hubert/AAG-9480-2021	Amrein, Hubert/0000-0001-8799-7250; Slone, Jesse/0000-0002-2478-3295	National Institute of Health [RO1-DC009014, RO1-DC005606]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005606, R01DC009014] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank Drs. S. Fujii and Y. Chen for stimulating discussions while conducting these studies, and Drs. S. Waddell, R. Sitcheran, and two anonymous reviewers for comments and suggestions on the manuscript. We thank Drs. L. Looger, T. Lee, T. Kitamoto, and J. Carlson for Drosophila strains G-CaMP3.0, lexAop-rCD2GFP, Cha<SUP>7.4kb</SUP>-GAL80, and Delta Gr61a, respectively, and Dr. L.B. Vosshall for a LexA plasmid. This work was supported by grants from the National Institute of Health, RO1-DC009014 and RO1-DC005606, to H.A. T.M. conducted all experiments, except the PER analysis. J.S. and X.S. performed the PER analysis, and J.S. generated the Gr64f<SUP>GAL4</SUP> knock-in strain. T.M. and H.A. conceived the experiments and wrote the paper.	Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chapman R.F., 2012, INSECTS STRUCTURE FU; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Harvey RA., 2011, BIOCHEMISTRY-US; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Karnani M, 2011, AM J PHYSIOL-REG I, V300, pR47, DOI 10.1152/ajpregu.00527.2010; Kohyama-Koganeya A, 2008, P NATL ACAD SCI USA, V105, P15328, DOI 10.1073/pnas.0807833105; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kubli E, 2008, CURR BIOL, V18, pR210, DOI 10.1016/j.cub.2007.12.047; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nunes RD, 2008, J VECTOR ECOL, V33, P225, DOI 10.3376/1081-1710-33.2.225; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Suster ML, 2004, GENESIS, V39, P240, DOI 10.1002/gene.20051; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	58	275	282	6	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1113	1125		10.1016/j.cell.2012.10.024	http://dx.doi.org/10.1016/j.cell.2012.10.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178127	Green Accepted, Bronze			2022-12-24	WOS:000311423500022
J	Lima, MD; Li, N; de Andrade, MJ; Fang, SL; Oh, J; Spinks, GM; Kozlov, ME; Haines, CS; Suh, D; Foroughi, J; Kim, SJ; Chen, YS; Ware, T; Shin, MK; Machado, LD; Fonseca, AF; Madden, JDW; Voit, WE; Galvao, DS; Baughman, RH				Lima, Marcio D.; Li, Na; de Andrade, Monica Jung; Fang, Shaoli; Oh, Jiyoung; Spinks, Geoffrey M.; Kozlov, Mikhail E.; Haines, Carter S.; Suh, Dongseok; Foroughi, Javad; Kim, Seon Jeong; Chen, Yongsheng; Ware, Taylor; Shin, Min Kyoon; Machado, Leonardo D.; Fonseca, Alexandre F.; Madden, John D. W.; Voit, Walter E.; Galvao, Douglas S.; Baughman, Ray H.			Electrically, Chemically, and Photonically Powered Torsional and Tensile Actuation of Hybrid Carbon Nanotube Yarn Muscles	SCIENCE			English	Article							ARRAYS; DYNAMICS; SHEETS; FIBERS; SPUN	Artificial muscles are of practical interest, but few types have been commercially exploited. Typical problems include slow response, low strain and force generation, short cycle life, use of electrolytes, and low energy efficiency. We have designed guest-filled, twist-spun carbon nanotube yarns as electrolyte-free muscles that provide fast, high-force, large-stroke torsional and tensile actuation. More than a million torsional and tensile actuation cycles are demonstrated, wherein a muscle spins a rotor at an average 11,500 revolutions/minute or delivers 3% tensile contraction at 1200 cycles/minute. Electrical, chemical, or photonic excitation of hybrid yarns changes guest dimensions and generates torsional rotation and contraction of the yarn host. Demonstrations include torsional motors, contractile muscles, and sensors that capture the energy of the sensing process to mechanically actuate.	[Lima, Marcio D.; Li, Na; de Andrade, Monica Jung; Fang, Shaoli; Oh, Jiyoung; Kozlov, Mikhail E.; Haines, Carter S.; Suh, Dongseok; Ware, Taylor; Voit, Walter E.; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA; [Li, Na; Chen, Yongsheng] Nankai Univ, Coll Chem, Inst Polymer Chem, Ctr Nanoscale Sci & Technol, Tianjin 300071, Peoples R China; [Spinks, Geoffrey M.; Foroughi, Javad] Univ Wollongong, Intelligent Polymer Res Inst, Australian Res Council Ctr Excellence Electromat, Wollongong, NSW 2522, Australia; [Kim, Seon Jeong; Shin, Min Kyoon] Hanyang Univ, Ctr Bioartificial Muscle, Seoul 133791, South Korea; [Kim, Seon Jeong; Shin, Min Kyoon] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Machado, Leonardo D.; Galvao, Douglas S.] Univ Estadual Campinas, Dept Appl Phys, BR-13081970 Campinas, SP, Brazil; [Fonseca, Alexandre F.] Univ Estadual Paulista, Fac Ciencias, BR-17033360 Bauru, SP, Brazil; [Madden, John D. W.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada	University of Texas System; University of Texas Dallas; Nankai University; University of Wollongong; Hanyang University; Hanyang University; Universidade Estadual de Campinas; Universidade Estadual Paulista; University of British Columbia	Baughman, RH (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Kim, Seon Jeong/AAR-8127-2021; Li, Na/M-9852-2015; de Andrade, Monica Jung/N-3963-2019; Madden, John DW/B-8948-2009; Spinks, Geoffrey/E-5612-2011; Foroughi, Javad/A-1439-2012; Baughman, Ray/A-8628-2018; Spinks, Geoffrey/T-6363-2019; Chen, Yongsheng/D-3256-2011; Lima, Marcio/G-4634-2012; Machado, Leonardo D/E-2081-2017; Fonseca, Alexandre F./K-5477-2019; Suh, Dongseok/A-5447-2013; Voit, Walter/D-1185-2010; Fonseca, Alexandre/H-3105-2011; Ware, Taylor/I-2812-2013; Galvao, Douglas/J-6017-2013; Ware, Taylor/A-7130-2017	Kim, Seon Jeong/0000-0002-2867-6737; Li, Na/0000-0002-1909-6378; de Andrade, Monica Jung/0000-0003-0411-4008; Madden, John DW/0000-0002-0014-4712; Spinks, Geoffrey/0000-0003-4656-9473; Foroughi, Javad/0000-0003-1979-5213; Baughman, Ray/0000-0001-5845-5137; Spinks, Geoffrey/0000-0003-4656-9473; Chen, Yongsheng/0000-0003-1448-8177; Machado, Leonardo D/0000-0003-1221-4228; Voit, Walter/0000-0003-0135-0531; Fonseca, Alexandre/0000-0001-8413-9744; Galvao, Douglas/0000-0003-0145-8358; Suh, Dongseok/0000-0002-0392-3391; Ware, Taylor/0000-0001-7996-7393	Air Force Office of Scientific Research [FA9550-09-1-0537, FA9550-12-1-0211]; Office of Naval Research MURI [N00014-08-1-0654]; Robert A. Welch Foundation [AT-0029]; Creative Research Initiative Center for Bio-Artificial Muscle; Korea-U.S. Air Force Cooperation Program (Korea) [2012-00074]; Australian Research Council; MoST [2012CB933401]; National Natural Science Foundation of China [50933003]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research MURI(MURIOffice of Naval Research); Robert A. Welch Foundation(The Welch Foundation); Creative Research Initiative Center for Bio-Artificial Muscle; Korea-U.S. Air Force Cooperation Program (Korea); Australian Research Council(Australian Research Council); MoST; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank X. Lepro for scanning electron micrograph (SEM) images of yarn cross sections; B. J. Swedlove, D. B. Hagenasr, J. M. Cruciger, C. Mozayan, and S. Rudraraju for assistance with sample preparation and measurements; and F. Goktepe and O. Goktepe for valuable discussions. Support is largely from Air Force Office of Scientific Research grants FA9550-09-1-0537 and FA9550-12-1-0211, with additional support from Office of Naval Research MURI grant N00014-08-1-0654, Robert A. Welch Foundation grant AT-0029, the Creative Research Initiative Center for Bio-Artificial Muscle and the Korea-U.S. Air Force Cooperation Program grant-2012-00074 (Korea), and the Centre of Excellence funding from the Australian Research Council. N.L. and Y.C. acknowledge financial support from MoST (grant 2012CB933401) and National Natural Science Foundation of China (grant 50933003). D. S. G., L. D. M., and A. F. F. are research fellows of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo of Brazil. A provisional patent application on the topic of this manuscript has been filed by N. Li et al., "Coiled and non-coiled nanofiber yarn torsional and tensile actuators," U.S. Provisional Patent 61678340 (1 August 2012).	Carlen ET, 2002, J MICROELECTROMECH S, V11, P165, DOI 10.1109/JMEMS.2002.1007394; Chen LZ, 2011, ACS NANO, V5, P1588, DOI 10.1021/nn102251a; da Fonseca AF, 2006, J APPL PHYS, V99, DOI 10.1063/1.2194309; Foroughi J, 2011, SCIENCE, V334, P494, DOI 10.1126/science.1211220; FULLER FB, 1971, P NATL ACAD SCI USA, V68, P815, DOI 10.1073/pnas.68.4.815; Goriely A, 1997, PHYSICA D, V105, P20, DOI 10.1016/S0167-2789(96)00290-4; Hu Y, 2010, ACS NANO, V4, P3498, DOI 10.1021/nn1006013; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; Jakubinek MB, 2012, CARBON, V50, P244, DOI 10.1016/j.carbon.2011.08.041; JOSEPHSON RK, 1993, ANNU REV PHYSIOL, V55, P527, DOI 10.1146/annurev.ph.55.030193.002523; Li QW, 2006, ADV MATER, V18, P3160, DOI 10.1002/adma.200601344; Lima MD, 2011, SCIENCE, V331, P51, DOI 10.1126/science.1195912; Miaudet P, 2007, SCIENCE, V318, P1294, DOI 10.1126/science.1145593; Mirfakhrai T, 2007, SMART MATER STRUCT, V16, pS243, DOI 10.1088/0964-1726/16/2/S07; Mizumoto M, 2009, J ALLOY COMPD, V482, P416, DOI 10.1016/j.jallcom.2009.04.041; Peng HS, 2009, NAT NANOTECHNOL, V4, P738, DOI [10.1038/nnano.2009.264, 10.1038/NNANO.2009.264]; Peterson D. R., 2008, BIOMECHANICS PRINCIP; Potschke P, 2008, MACROMOL RAPID COMM, V29, P244, DOI 10.1002/marc.200700637; Sellinger AT, 2010, ADV MATER, V22, P3430, DOI 10.1002/adma.200904107; Shang YY, 2012, ADV MATER, V24, P2896, DOI 10.1002/adma.201200576; Xiao L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909593; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang XB, 2006, ADV MATER, V18, P1505, DOI 10.1002/adma.200502528; Zhang XF, 2007, SMALL, V3, P244, DOI 10.1002/smll.200600368; Zhou RF, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/34/345701	26	466	488	57	848	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					928	932		10.1126/science.1226762	http://dx.doi.org/10.1126/science.1226762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161994				2022-12-24	WOS:000311083600038
J	McGourty, K; Thurston, TL; Matthews, SA; Pinaud, L; Mota, LJ; Holden, DW				McGourty, Kieran; Thurston, Teresa L.; Matthews, Sophie A.; Pinaud, Laurie; Mota, Luis Jaime; Holden, David W.			Salmonella Inhibits Retrograde Trafficking of Mannose-6-Phosphate Receptors and Lysosome Function	SCIENCE			English	Article							TRANS-GOLGI; VIRULENCE PROTEIN; TYPHIMURIUM; ENDOSOMES; SIFA; PHAGOSOMES; MECHANISM	Salmonella enterica is an intracellular bacterial pathogen that replicates within membrane-bound vacuoles through the action of effector proteins translocated into host cells. Salmonella vacuoles have characteristics of lysosomes but are reduced in hydrolytic enzymes transported by mannose-6-phosphate receptors (MPRs). We found that the effector SifA subverted Rab9-dependent retrograde trafficking of MPRs, thereby attenuating lysosome function. This required binding of SifA to its host cell target SKIP/PLEKHM2. Furthermore, SKIP regulated retrograde trafficking of MPRs in noninfected cells. Translocated SifA formed a stable complex with SKIP and Rab9 in infected cells. Sequestration of Rab9 by SifA-SKIP accounted for the effect of SifA on MPR transport and lysosome function. Growth of Salmonella increased in cells with reduced lysosomal activity and decreased in cells with higher lysosomal activity. These results suggest that Salmonella vacuoles undergo fusion with lysosomes whose potency has been reduced by SifA.	[McGourty, Kieran; Thurston, Teresa L.; Matthews, Sophie A.; Pinaud, Laurie; Mota, Luis Jaime; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Holden, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, Armstrong Rd, London SW7 2AZ, England.	d.holden@imperial.ac.uk	Thurston, Teresa/AAZ-9938-2020; Mota, Luis/B-9497-2008	Thurston, Teresa/0000-0001-6139-3723; Mota, Luis/0000-0002-5592-8397	Wellcome Trust; Medical Research Council; Medical Research Council [G0800148] Funding Source: researchfish; MRC [G0800148] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Tang and members of the Holden laboratory for comments on the manuscript, S. Meresse for providing MEFs, S. Meresse and F. Randow for plasmids, and the European Conditional Mouse Mutagenesis Program Consortium for SkipPlekhm2<SUP>-/-</SUP> mice. We thank I. Dikic and D. McEwan for advice and discussions. This research was supported by a Wellcome Trust funded studentship to K. M. and grants to D. W. H. from the Medical Research Council and Wellcome Trust. The data are included in the main and the supplementary figures.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Deiwick J, 1998, J BACTERIOL, V180, P4775, DOI 10.1128/JB.180.18.4775-4780.1998; Diacovich L, 2009, J BIOL CHEM, V284, P33151, DOI 10.1074/jbc.M109.034975; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hang HC, 2006, ACS CHEM BIOL, V1, P713, DOI 10.1021/cb600431a; Ikeda K, 2008, BIOCHEM BIOPH RES CO, V377, P268, DOI 10.1016/j.bbrc.2008.09.121; Jackson LK, 2008, P NATL ACAD SCI USA, V105, P14141, DOI 10.1073/pnas.0801872105; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Rathman M, 1997, INFECT IMMUN, V65, P1475, DOI 10.1128/IAI.65.4.1475-1485.1997; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Schroeder N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001002; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; SHAPIRO AD, 1993, J BIOL CHEM, V268, P6925	24	120	123	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					963	967		10.1126/science.1227037	http://dx.doi.org/10.1126/science.1227037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23162002	Green Accepted			2022-12-24	WOS:000311083600048
J	Biankin, AV; Waddell, N; Kassahn, KS; Gingras, MC; Muthuswamy, LB; Johns, AL; Miller, DK; Wilson, PJ; Patch, AM; Wu, JM; Chang, DK; Cowley, MJ; Gardiner, BB; Song, S; Harliwong, I; Idrisoglu, S; Nourse, C; Nourbakhsh, E; Manning, S; Wani, S; Gongora, M; Pajic, M; Scarlett, CJ; Gill, AJ; Pinho, AV; Rooman, I; Anderson, M; Holmes, O; Leonard, C; Taylor, D; Wood, S; Xu, QY; Nones, K; Fink, JL; Christ, A; Bruxner, T; Cloonan, N; Kolle, G; Newell, F; Pinese, M; Mead, RS; Humphris, JL; Kaplan, W; Jones, MD; Colvin, EK; Nagrial, AM; Humphrey, ES; Chou, A; Chin, VT; Chantrill, LA; Mawson, A; Samra, JS; Kench, JG; Lovell, JA; Daly, RJ; Merrett, ND; Toon, C; Epari, K; Nguyen, NQ; Barbour, A; Zeps, N; Kakkar, N; Zhao, FM; Wu, YQ; Wang, M; Muzny, DM; Fisher, WE; Brunicardi, FC; Hodges, SE; Reid, JG; Drummond, J; Chang, K; Han, Y; Lewis, LR; Dinh, H; Buhay, CJ; Beck, T; Timms, L; Sam, M; Begley, K; Brown, A; Pai, D; Panchal, A; Buchner, N; De Borja, R; Denroche, RE; Yung, CK; Serra, S; Onetto, N; Mukhopadhyay, D; Tsao, MS; Shaw, PA; Petersen, GM; Gallinger, S; Hruban, RH; Maitra, A; Iacobuzio-Donahue, CA; Schulick, RD; Wolfgang, CL; Morgan, RA; Lawlor, RT; Capelli, P; Corbo, V; Scardoni, M; Tortora, G; Tempero, MA; Mann, KM; Jenkins, NA; Perez-Mancera, PA; Adams, DJ; Largaespada, DA; Wessels, LFA; Rust, AG; Stein, LD; Tuveson, DA; Copeland, NG; Musgrove, EA; Scarpa, A; Eshleman, JR; Hudson, TJ; Sutherland, RL; Wheeler, DA; Pearson, JV; McPherson, JD; Gibbs, RA; Grimmond, SM				Biankin, Andrew V.; Waddell, Nicola; Kassahn, Karin S.; Gingras, Marie-Claude; Muthuswamy, Lakshmi B.; Johns, Amber L.; Miller, David K.; Wilson, Peter J.; Patch, Ann-Marie; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Gardiner, Brooke B.; Song, Sarah; Harliwong, Ivon; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Gongora, Milena; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Nones, Katia; Fink, J. Lynn; Christ, Angelika; Bruxner, Tim; Cloonan, Nicole; Kolle, Gabriel; Newell, Felicity; Pinese, Mark; Mead, R. Scott; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Samra, Jaswinder S.; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Merrett, Neil D.; Toon, Christopher; Epari, Krishna; Nguyen, Nam Q.; Barbour, Andrew; Zeps, Nikolajs; Kakkar, Nipun; Zhao, Fengmei; Wu, Yuan Qing; Wang, Min; Muzny, Donna M.; Fisher, William E.; Brunicardi, F. Charles; Hodges, Sally E.; Reid, Jeffrey G.; Drummond, Jennifer; Chang, Kyle; Han, Yi; Lewis, Lora R.; Dinh, Huyen; Buhay, Christian J.; Beck, Timothy; Timms, Lee; Sam, Michelle; Begley, Kimberly; Brown, Andrew; Pai, Deepa; Panchal, Ami; Buchner, Nicholas; De Borja, Richard; Denroche, Robert E.; Yung, Christina K.; Serra, Stefano; Onetto, Nicole; Mukhopadhyay, Debabrata; Tsao, Ming-Sound; Shaw, Patricia A.; Petersen, Gloria M.; Gallinger, Steven; Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Schulick, Richard D.; Wolfgang, Christopher L.; Morgan, Richard A.; Lawlor, Rita T.; Capelli, Paola; Corbo, Vincenzo; Scardoni, Maria; Tortora, Giampaolo; Tempero, Margaret A.; Mann, Karen M.; Jenkins, Nancy A.; Perez-Mancera, Pedro A.; Adams, David J.; Largaespada, David A.; Wessels, Lodewyk F. A.; Rust, Alistair G.; Stein, Lincoln D.; Tuveson, David A.; Copeland, Neal G.; Musgrove, Elizabeth A.; Scarpa, Aldo; Eshleman, James R.; Hudson, Thomas J.; Sutherland, Robert L.; Wheeler, David A.; Pearson, John V.; McPherson, John D.; Gibbs, Richard A.; Grimmond, Sean M.		Australian Pancreatic Canc Genome	Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes	NATURE			English	Article							SOMATIC MUTATIONS; TUMOR; INSTABILITY; EXPRESSION; RESECTION; ROLES	Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed exome sequencing and copy number analysis to define genomic aberrations in a prospectively accrued clinical cohort (n=142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma. Detailed analysis of 99 informative tumours identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-number variations. We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including additional genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6). Integrative analysis with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis. Pathway-based analysis of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway. We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.	[Waddell, Nicola; Kassahn, Karin S.; Miller, David K.; Wilson, Peter J.; Patch, Ann-Marie; Gardiner, Brooke B.; Song, Sarah; Harliwong, Ivon; Idrisoglu, Senel; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Wani, Shivangi; Gongora, Milena; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Nones, Katia; Fink, J. Lynn; Christ, Angelika; Bruxner, Tim; Cloonan, Nicole; Newell, Felicity; Pearson, John V.; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia; [Biankin, Andrew V.; Johns, Amber L.; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Pinese, Mark; Mead, R. Scott; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Toon, Christopher; Musgrove, Elizabeth A.; Sutherland, Robert L.] Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Biankin, Andrew V.; Johns, Amber L.; Wu, Jianmin; Chang, David K.; Cowley, Mark J.; Pajic, Marina; Scarlett, Christopher J.; Gill, Anthony J.; Pinho, Andreia V.; Rooman, Ilse; Pinese, Mark; Mead, R. Scott; Humphris, Jeremy L.; Kaplan, Warren; Jones, Marc D.; Colvin, Emily K.; Nagrial, Adnan M.; Humphrey, Emily S.; Chou, Angela; Chin, Venessa T.; Chantrill, Lorraine A.; Mawson, Amanda; Kench, James G.; Lovell, Jessica A.; Daly, Roger J.; Toon, Christopher; Musgrove, Elizabeth A.; Sutherland, Robert L.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia; [Biankin, Andrew V.; Chang, David K.; Merrett, Neil D.] Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Biankin, Andrew V.; Chang, David K.] Univ New S Wales, Fac Med, S Western Sydney Clin Sch, Liverpool, NSW 2170, Australia; [Gingras, Marie-Claude; Kakkar, Nipun; Zhao, Fengmei; Wu, Yuan Qing; Wang, Min; Muzny, Donna M.; Reid, Jeffrey G.; Drummond, Jennifer; Chang, Kyle; Han, Yi; Lewis, Lora R.; Dinh, Huyen; Buhay, Christian J.; Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gingras, Marie-Claude; Fisher, William E.; Hodges, Sally E.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Muthuswamy, Lakshmi B.; Beck, Timothy; Timms, Lee; Sam, Michelle; Begley, Kimberly; Brown, Andrew; Pai, Deepa; Panchal, Ami; Buchner, Nicholas; De Borja, Richard; Denroche, Robert E.; Yung, Christina K.; Onetto, Nicole; Stein, Lincoln D.; Hudson, Thomas J.; McPherson, John D.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW 2258, Australia; [Gill, Anthony J.; Samra, Jaswinder S.] Royal N Shore Hosp, Dept Anat Pathol, Sydney, NSW 2065, Australia; [Gill, Anthony J.; Kench, James G.] Univ Sydney, Sydney, NSW 2006, Australia; [Kolle, Gabriel] Life Technol, Brisbane, Qld 4000, Australia; [Mead, R. Scott; Chou, Angela] St Vincents Hosp, Dept Anat Pathol, Sydney, NSW 2010, Australia; [Samra, Jaswinder S.] Royal N Shore Hosp, Dept Surg, Sydney, NSW 2065, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Merrett, Neil D.] Univ Western Sydney, Sch Med, Penrith, NSW 2175, Australia; [Epari, Krishna] Fremantle Hosp, Dept Surg, Fremantle, WA 6160, Australia; [Nguyen, Nam Q.] Royal Adelaide Hosp, Dept Gastroenterol, Adelaide, SA 5000, Australia; [Barbour, Andrew] Univ Queensland, Princess Alexandra Hosp, Dept Surg, Woollongabba, Qld 4102, Australia; [Zeps, Nikolajs] Univ Western Australia, Sch Surg M507, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] St John God Pathol, Subiaco, WA 6008, Australia; [Fisher, William E.; Hodges, Sally E.] Baylor Coll Med, Elkins Pancreas Ctr, Houston, TX 77030 USA; [Brunicardi, F. Charles] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Serra, Stefano; Tsao, Ming-Sound; Shaw, Patricia A.; Gallinger, Steven] Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Mukhopadhyay, Debabrata; Petersen, Gloria M.] Mayo Clin, Rochester, MN 55905 USA; [Gallinger, Steven] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Hruban, Ralph H.; Maitra, Anirban; Iacobuzio-Donahue, Christine A.; Morgan, Richard A.; Eshleman, James R.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [Schulick, Richard D.; Wolfgang, Christopher L.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA; [Lawlor, Rita T.; Corbo, Vincenzo; Scarpa, Aldo] Univ & Hosp Trust Verona, ARC NET Ctr Appl Res Canc, I-37134 Verona, Italy; [Capelli, Paola; Scardoni, Maria; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37134 Verona, Italy; [Tortora, Giampaolo] Univ & Hosp Trust Verona, Dept Surg & Oncol, I-37134 Verona, Italy; [Tempero, Margaret A.] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94115 USA; [Mann, Karen M.; Jenkins, Nancy A.; Copeland, Neal G.] Methodist Hosp, Res Inst, Canc Res Program, Houston, TX 77030 USA; [Perez-Mancera, Pedro A.; Tuveson, David A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Perez-Mancera, Pedro A.; Tuveson, David A.] Dept Oncol, Cambridge CB2 0RE, England; [Adams, David J.; Rust, Alistair G.] Wellcome Trust Sanger Inst, Hinxton CB10 1HH, England; [Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Wessels, Lodewyk F. A.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Musgrove, Elizabeth A.; Sutherland, Robert L.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2010, Australia	University of Queensland; Garvan Institute of Medical Research; University of New South Wales Sydney; Baylor College of Medicine; Baylor College of Medicine; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Newcastle; Royal North Shore Hospital; University of Sydney; University of Sydney; Thermo Fisher Scientific; St Vincents Hospital Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney; Western Sydney University; University of Western Australia; Royal Adelaide Hospital; University of Queensland; University of Western Australia; St John of God Health Care; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mayo Clinic; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Johns Hopkins University; Johns Hopkins University; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of California System; University of California San Francisco; The Methodist Hospital System; The Methodist Hospital - Houston; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Minnesota System; University of Minnesota Twin Cities; Netherlands Cancer Institute; University of New South Wales Sydney	Grimmond, SM (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia.	s.grimmond@imb.uq.edu.au	Tortora, Giampaolo/AAA-1252-2019; Wheeler, David A/M-9740-2018; Largaespada, David/C-9832-2014; Gallinger, Steven/E-4575-2013; Grimmond, Sean/K-3246-2019; Pearson, John V/F-2249-2011; Patch, Ann-Marie/C-4201-2018; Cowley, Mark/K-8731-2019; Gill, Anthony/D-4215-2015; Grimmond, Sean M/J-5304-2016; Merrett, Neil/H-8033-2019; Chantrill, Lorraine/GXF-5117-2022; Tsao, Ming-Sound/M-3503-2017; Barbour, Andrew/F-4717-2010; Newell, Felicity/AAN-1253-2020; Drummond, Jennifer/AAG-1654-2020; Nones, Katia/AAX-6453-2021; Gardiner, Brooke B/C-7773-2011; Zeps, Nikolajs/AAF-3186-2021; Zeps, Nikolajs/C-4180-2013; Iacobuzio-Donahue, Christine/ABF-1295-2020; scarpa, aldo/K-6832-2016; Waddell, Nicola/H-4929-2015; Merrett, Neil/ABB-4342-2021; Mann, Karen/AAW-8323-2020; Wolfgang, Christopher/HGD-0863-2022; Pearson, John/AAT-4211-2020; Leonard, Conrad/AAD-2587-2020; Fink, Lynn/C-2031-2008; McPherson, John D/D-2633-2017; Tsao, Ming Sound/AFQ-7332-2022; Corbo, Vincenzo/J-7754-2016; Cloonan, Nicole/B-5272-2008; Gill, Anthony J./M-5015-2019; Wu, Jianmin/G-3629-2010	Wheeler, David A/0000-0002-9056-6299; Grimmond, Sean/0000-0002-8102-7998; Pearson, John V/0000-0003-0904-4598; Patch, Ann-Marie/0000-0001-6121-4019; Cowley, Mark/0000-0002-9519-5714; Gill, Anthony/0000-0002-9447-1967; Grimmond, Sean M/0000-0002-8102-7998; Merrett, Neil/0000-0002-8370-0293; Drummond, Jennifer/0000-0002-2612-5958; Nones, Katia/0000-0003-1925-5196; Gardiner, Brooke B/0000-0003-3740-3244; Zeps, Nikolajs/0000-0002-6404-6839; Zeps, Nikolajs/0000-0002-6404-6839; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; scarpa, aldo/0000-0003-1678-739X; Waddell, Nicola/0000-0002-3950-2476; Merrett, Neil/0000-0002-8370-0293; Leonard, Conrad/0000-0002-4131-2065; Fink, Lynn/0000-0003-2912-6048; McPherson, John D/0000-0001-8049-9347; Tsao, Ming Sound/0000-0002-9160-5405; Corbo, Vincenzo/0000-0002-6340-8009; Cloonan, Nicole/0000-0001-7802-6647; Chang, Kyle/0000-0001-5295-9676; Jones, Marc/0000-0002-3078-8359; Christophi, Christopher/0000-0002-1349-0884; Rust, Alistair/0000-0001-7287-192X; Colvin, Emily/0000-0002-5435-5902; Pinese, Mark/0000-0001-5078-6687; serra, stefano/0000-0002-3258-2637; Christ, Angelika/0000-0002-8680-2367; Pajic, Marina/0000-0002-3871-3829; Bruxner, Timothy/0000-0002-8088-316X; Brancato, Mary-Anne/0000-0002-5439-4549; Yung, Christina/0000-0003-2958-150X; Barbour, Andrew/0000-0002-0991-7662; Wu, Jianmin/0000-0002-8876-128X; Chin, Venessa/0000-0002-4630-4451; Spry, Nigel/0000-0001-8659-5065; Chou, Angela/0000-0001-9212-6927; Daly, Roger/0000-0002-5739-8027; Adams, David/0000-0001-9490-0306; Wong, Rachel/0000-0001-6760-0463; Rooman, Ilse/0000-0001-7264-2246; Kassahn, Karin/0000-0002-1662-3355; Scarlett, Christopher/0000-0002-4140-7785; Nikfarjam, Mehrdad/0000-0003-4866-276X; Kench, James Geoffrey/0000-0001-8687-4988; Tortora, Giampaolo/0000-0002-1378-4962; Chang, David/0000-0002-4821-3078; Biankin, Andrew/0000-0002-0362-5597; Beck, Timothy/0000-0003-0145-3557; Pinho, Andreia V./0000-0003-0647-4015; Chantrill, Lorraine/0000-0002-5790-0208; lawlor, Rita/0000-0003-3160-0634	National Health and Medical Research Council of Australia (NHMRC) [631701, 535903, 427601, 535914]; Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); University of Queensland; Cancer Council NSW [SRP06-01, ICGC09-01, SRP11-01]; Cancer Institute NSW [06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26]; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); HGSC-BCM: NHGRI [U54 HG003273]; CPRIT [RP101353-P7]; Ontario Institute for Cancer Research; Ontario Ministry of Economic Development and Innovation; Canada Foundation for Innovation; Pancreatic Cancer Genetic Epidemiology Consortium, NIH [R01 CA97075]; Agency for Science, Technology, and Research (Singapore); University of Verona; Italian Ministry of University, Rome, Italy [FIRB RBAP10AHJB]; Cancer Research UK; Wellcome Trust; CPRIT (Cancer Prevention Research Institute of Texas); NIH [P50CA062924, P01CA134292]; Sol Goldman Pancreatic Cancer Research Center; NCI [R01 CA97075, P50 CA102701]; NIH SPORE grant [2P50CA101955]; AIRC (Associazione Italiana Ricerca sul Cancro), Italy [12182]; Cancer Research UK [13031] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA134292, R01CA097075, P50CA101955, R01CA113636, P50CA102701, P50CA062924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); University of Queensland(University of Queensland); Cancer Council NSW(Cancer Council New South Wales); Cancer Institute NSW; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); HGSC-BCM: NHGRI; CPRIT; Ontario Institute for Cancer Research; Ontario Ministry of Economic Development and Innovation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Pancreatic Cancer Genetic Epidemiology Consortium, NIH; Agency for Science, Technology, and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); University of Verona; Italian Ministry of University, Rome, Italy; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); CPRIT (Cancer Prevention Research Institute of Texas); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sol Goldman Pancreatic Cancer Research Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH SPORE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC (Associazione Italiana Ricerca sul Cancro), Italy(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This paper is dedicated to Robert L. Sutherland who died on 10 October 2012 of pancreatic cancer. We would like to thank C. Axford, D. Gwynne, M.-A. Brancato, S. Rowe, M. Thomas, S. Simpson and G. Hammond for central coordination of the Australian Pancreatic Cancer Genome Initiative, data management and quality control; M. Martyn-Smith, L. Braatvedt, H. Tang, V. Papangelis and M. Beilin for biospecimen acquisition; and W. Waterson, J. Shepperd, E. Campbell and E. Glasov for their efforts at the Queensland Centre for Medical Genomics. We also thank M. B. Hodgin, M. Debeljak and D. Trusty for technical assistance at Johns Hopkins University, and J. Lau, M. Karaus, K. Rabe, L. Zhang and T. Smyrk at the Mayo Clinic. We acknowledge the following funding support: National Health and Medical Research Council of Australia (NHMRC; 631701, 535903, 427601, 535914); Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education (DIISRTE); Australian Cancer Research Foundation (ACRF); Queensland Government (NIRAP); University of Queensland; Cancer Council NSW (SRP06-01; ICGC09-01; SRP11-01); Cancer Institute NSW (06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26); Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia (GESA); American Association for Cancer Research (AACR) Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons (RACS); Royal Australasian College of Physicians (RACP); Royal College of Pathologists of Australasia (RCPA); HGSC-BCM: NHGRI U54 HG003273; CPRIT grant RP101353-P7 (Tumor Banking for Genomic Research and Clinical Translation Site 1); The Ontario Institute for Cancer Research; The Ontario Ministry of Economic Development and Innovation; Canada Foundation for Innovation; Pancreatic Cancer Genetic Epidemiology Consortium, NIH grant R01 CA97075; The Agency for Science, Technology, and Research (Singapore); University of Verona and Italian Ministry of University (FIRB RBAP10AHJB), Rome, Italy; Cancer Research UK; Wellcome Trust; CPRIT (Cancer Prevention Research Institute of Texas); NIH P50CA062924 (SPORE) and P01CA134292 (PPG); The Sol Goldman Pancreatic Cancer Research Center; NCI grant P50 CA102701 (Mayo Clinic SPORE in Pancreatic Cancer) and NCI grant R01 CA97075 (Pancreatic Cancer Genetic Epidemiology Consortium); NIH SPORE grant 2P50CA101955 (UMN/UAB), and AIRC (Associazione Italiana Ricerca sul Cancro) 5xmille grant 12182, Italy.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Biankin AV, 2011, HUM GENET, V130, P79, DOI 10.1007/s00439-011-1010-0; Biankin AV, 2009, GASTROENTEROLOGY, V137, P558, DOI 10.1053/j.gastro.2009.04.009; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Butturini G, 2008, ARCH SURG-CHICAGO, V143, P75, DOI 10.1001/archsurg.2007.17; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cao Y, 2011, NAT REV CANCER, V11, P749, DOI 10.1038/nrc3138; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Chang DK, 2009, J CLIN ONCOL, V27, P2855, DOI 10.1200/JCO.2008.20.5104; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jamieson NB, 2011, ANN SURG ONCOL, V18, P2318, DOI 10.1245/s10434-011-1560-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kikuchi K, 2003, J BIOL CHEM, V278, P42985, DOI 10.1074/jbc.M302395200; Kris M. G., 2011, ACCELERATING PROGR C; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mueller MW, 2007, INT J CANCER, V121, P2421, DOI 10.1002/ijc.22949; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Pajic M, 2011, HUM GENET, V130, P93, DOI 10.1007/s00439-011-0990-0; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Roberts NJ, 2012, CANCER DISCOV, V2, P41, DOI 10.1158/2159-8290.CD-11-0194; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Samuel N, 2012, NAT REV GASTRO HEPAT, V9, P77, DOI 10.1038/nrgastro.2011.215; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111	38	1410	1452	8	270	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 15	2012	491	7424					399	405		10.1038/nature11547	http://dx.doi.org/10.1038/nature11547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036MY	23103869	Green Accepted			2022-12-24	WOS:000311031600037
J	Lammel, S; Lim, BK; Ran, C; Huang, KW; Betley, MJ; Tye, KM; Deisseroth, K; Malenka, RC				Lammel, Stephan; Lim, Byung Kook; Ran, Chen; Huang, Kee Wui; Betley, Michael J.; Tye, Kay M.; Deisseroth, Karl; Malenka, Robert C.			Input-specific control of reward and aversion in the ventral tegmental area	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; LATERAL HABENULA; GABA NEURONS; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; SUBSTANTIA-NIGRA; RABIES VIRUS; RAT; ACTIVATION; STIMULATION	Ventral tegmental area (VTA) dopamine neurons have important roles in adaptive and pathological brain functions related to reward and motivation. However, it is unknown whether subpopulations of VTA dopamine neurons participate in distinct circuits that encode different motivational signatures, and whether inputs to the VTA differentially modulate such circuits. Here we show that, because of differences in synaptic connectivity, activation of inputs to the VTA from the laterodorsal tegmentum and the lateral habenula elicit reward and aversion in mice, respectively. Laterodorsal tegmentum neurons preferentially synapse on dopamine neurons projecting to the nucleus accumbens lateral shell, whereas lateral habenula neurons synapse primarily on dopamine neurons projecting to the medial prefrontal cortex as well as on GABAergic (gamma-aminobutyric-acid-containing) neurons in the rostromedial tegmental nucleus. These results establish that distinct VTA circuits generate reward and aversion, and thereby provide a new framework for understanding the circuit basis of adaptive and pathological motivated behaviours.	[Lammel, Stephan; Lim, Byung Kook; Ran, Chen; Huang, Kee Wui; Betley, Michael J.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA	Stanford University; Massachusetts Institute of Technology (MIT); Northwell Health; Stanford University; Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Ran, Chen/N-3007-2017; Tye, Kay/J-6158-2013; Lammel, Stephan/O-8295-2018	Tye, Kay/0000-0002-2435-0182; Lammel, Stephan/0000-0002-3350-3208; Ran, Chen/0000-0002-6632-2366; Lim, Byungkook/0000-0002-3766-5415	National Institutes of Health [NIH NS069375]; Simons Foundation; DARPA REPAIR program; Wiegers Family Fund; German Academy of Sciences Leopoldina; Davis Foundation Postdoctoral Fellowship in Eating Disorders Research; JPB Foundation; NIMH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; DARPA REPAIR program; Wiegers Family Fund; German Academy of Sciences Leopoldina; Davis Foundation Postdoctoral Fellowship in Eating Disorders Research; JPB Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Stanford Neuroscience Imaging Core, the Stanford Neuroscience Behavior Phenotyping and Pharmacology Core and the Stanford Neuroscience Gene Vector and Virus Core (all supported by National Institutes of Health grant NIH NS069375). This work was supported by grants from the Simons Foundation and NIH (to R. C. M.). K. D. is supported by the NIH, the DARPA REPAIR program, and the Wiegers Family Fund. S. L. is supported by a fellowship from the German Academy of Sciences Leopoldina. B. K. L. is supported by a Davis Foundation Postdoctoral Fellowship in Eating Disorders Research. K. M. T. is supported by the JPB Foundation and NIMH.	ARAKI M, 1988, BRAIN RES, V441, P319, DOI 10.1016/0006-8993(88)91410-2; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; CORNWALL J, 1990, BRAIN RES BULL, V25, P271, DOI 10.1016/0361-9230(90)90072-8; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029766; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Sanchez CJ, 2003, NEUROSCIENCE, V119, P497, DOI 10.1016/S0306-4522(03)00078-2; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Vertes RP, 1999, J COMP NEUROL, V407, P555; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	42	854	904	5	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					212	+		10.1038/nature11527	http://dx.doi.org/10.1038/nature11527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23064228	Green Submitted, Green Accepted			2022-12-24	WOS:000310774300035
J	Tran, V; Lim, C; Xie, J; Chen, X				Vuong Tran; Lim, Cindy; Xie, Jing; Chen, Xin			Asymmetric Division of Drosophila Male Germline Stem Cell Shows Asymmetric Histone Distribution	SCIENCE			English	Article							SELF-RENEWAL; EPIGENETIC REGULATION; CHROMATIN; CENTROSOME; MEMORY; DNA; MECHANISMS; DEPOSITION; POLYCOMB	Stem cells can self-renew and generate differentiating daughter cells. It is not known whether these cells maintain their epigenetic information during asymmetric division. Using a dual-color method to differentially label "old" versus "new" histones in Drosophila male germline stem cells (GSCs), we show that preexisting canonical H3, but not variant H3.3, histones are selectively segregated to the GSC, whereas newly synthesized histones incorporated during DNA replication are enriched in the differentiating daughter cell. The asymmetric histone distribution occurs in GSCs but not in symmetrically dividing progenitor cells. Furthermore, if GSCs are genetically manipulated to divide symmetrically, this asymmetric mode is lost. This work suggests that stem cells retain preexisting canonical histones during asymmetric cell divisions, probably as a mechanism to maintain their unique molecular properties.	[Vuong Tran; Lim, Cindy; Xie, Jing; Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Chen, X (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	xchen32@jhu.edu	, jxie10@live.johnshopkins.edu/B-5028-2015	, jxie10@live.johnshopkins.edu/0000-0001-9715-3369	NICHD/NIH [R21HD065089, R01HD065816]; David & Lucile Packard Foundation; American Federation of Aging Research; JHU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231] Funding Source: NIH RePORTER	NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); American Federation of Aging Research; JHU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Prado for discussions to develop a controlled gene expression system and the FRT-MCS-SV40 Poly A-FRT plasmid; A. Talaga, A. Chin, A. Kim, and B. Weber for experimental assistance; K. Ahmad for plasmids containing H3, H2B, and H3.3 sequences; A. Nakamura for the UAS-mKO-vasa strain; S. DiNardo for the UAS-upd strain; Y. Yamashita for GSC cell cycle information and insightful suggestions; and R. Kuruvilla, K. Zhao, Y. Zheng, H. Zhao, M. Van Doren, D. Drummond-Barbosa, A. Hoyt, and Chen lab members for critical reading. Supported by NICHD/NIH grants R21HD065089 and R01HD065816, the David & Lucile Packard Foundation, American Federation of Aging Research, and JHU start-up (X.C.).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ANNUNZIATO AT, 1982, J BIOL CHEM, V257, P8507; Buszczak M, 2006, CELL, V125, P233, DOI 10.1016/j.cell.2006.04.004; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Eun SH, 2010, CURR OPIN CELL BIOL, V22, P737, DOI 10.1016/j.ceb.2010.09.004; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; JACKSON V, 1981, CELL, V23, P121, DOI 10.1016/0092-8674(81)90277-4; JACKSON V, 1981, J BIOL CHEM, V256, P5095; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; RUSSEV G, 1981, NUCLEIC ACIDS RES, V9, P4129, DOI 10.1093/nar/9.16.4129; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Yadlapalli S, 2011, J CELL SCI, V124, P933, DOI 10.1242/jcs.079798; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	25	112	117	7	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					679	682		10.1126/science.1226028	http://dx.doi.org/10.1126/science.1226028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23118191	Green Accepted			2022-12-24	WOS:000310516000056
J	Ell, B; Kang, YB				Ell, Brian; Kang, Yibin			SnapShot: Bone Metastasis	CELL			English	Editorial Material							BREAST-CANCER		[Ell, Brian; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Ell, B (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Kang, Yibin/0000-0002-1626-6730				Bidwell B. N., 2012, NAT MED; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Clezardin P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2835; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Schneider JG, 2011, BONE, V48, P54, DOI 10.1016/j.bone.2010.09.016; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055	10	81	83	2	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3							690.e1	10.1016/j.cell.2012.10.005	http://dx.doi.org/10.1016/j.cell.2012.10.005			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101634	Bronze			2022-12-24	WOS:000310529300024
J	Brennan, MD; Cheong, R; Levchenko, A				Brennan, Matthew D.; Cheong, Raymond; Levchenko, Andre			How Information Theory Handles Cell Signaling and Uncertainty	SCIENCE			English	Editorial Material							DYNAMICS; BIOLOGY; NOISE; FLOW		[Brennan, Matthew D.; Cheong, Raymond; Levchenko, Andre] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Brennan, MD (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	alev@jhu.edu		Brennan, Matthew/0000-0003-3992-713X	NCI NIH HHS [CA65145, R01 CA065145] Funding Source: Medline; NCRR NIH HHS [U54 RR020839] Funding Source: Medline; NIGMS NIH HHS [GM072024, U54 GM103520, R01 GM072024, GM084322] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065145] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103520, R01GM072024] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Alberts B, 2008, MOL BIOL CELL; Andrews BW, 2007, PLOS COMPUT BIOL, V3, P1489, DOI 10.1371/journal.pcbi.0030153; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BERGER T, 2003, IEEE INF THEORY SOC, V53, P1; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Bowsher CG, 2012, P NATL ACAD SCI USA, V109, pE1320, DOI 10.1073/pnas.1119407109; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; de Ronde W, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.048101; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Mian IS, 2011, INTEGR BIOL-UK, V3, P350, DOI 10.1039/c0ib00117a; Milenkovic O, 2010, IEEE T INFORM THEORY, V56, P649, DOI 10.1109/TIT.2009.2036971; Pandini A, 2012, FASEB J, V26, P868, DOI 10.1096/fj.11-190868; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Polani D, 2009, HFSP J, V3, P307, DOI 10.2976/1.3171566; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thomas MC, 2006, ELEMENTS INFORM THEO; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Waltermann C, 2011, BBA-GEN SUBJECTS, V1810, P924, DOI 10.1016/j.bbagen.2011.07.009; Ziv E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001077	25	50	51	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					334	335		10.1126/science.1227946	http://dx.doi.org/10.1126/science.1227946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022JS	23087235	Green Accepted			2022-12-24	WOS:000309955800026
J	Sun, LF; Zeng, X; Yan, CY; Sun, XY; Gong, XQ; Rao, Y; Yan, NE				Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Sun, Xiuyun; Gong, Xinqi; Rao, Yu; Yan, Nieng			Crystal structure of a bacterial homologue of glucose transporters GLUT1-4	NATURE			English	Article							DEFICIENCY SYNDROME GLUT1DS; MOLECULAR-BASIS; CLASSIFICATION DATABASE; SUBSTRATE RECOGNITION; LACTOSE PERMEASE; BINDING-SITE; MECHANISM; PROTEINS; GENE; SEQUENCE	Glucose transporters are essential for metabolism of glucose in cells of diverse organisms from microbes to humans, exemplified by the disease-related human proteins GLUT1, 2, 3 and 4. Despite rigorous efforts, the structural information for GLUT1-4 or their homologues remains largely unknown. Here we report three related crystal structures of XylE, an Escherichia coli homologue of GLUT1-4, in complex with D-xylose, D-glucose and 6-bromo-6-deoxy-D-glucose, at resolutions of 2.8, 2.9 and 2.6 angstrom, respectively. The structure consists of a typical major facilitator superfamily fold of 12 transmembrane segments and a unique intracellular four-helix domain. XylE was captured in an outward-facing, partly occluded conformation. Most of the important amino acids responsible for recognition of D-xylose or D-glucose are invariant in GLUT1-4, suggesting functional and mechanistic conservations. Structure-based modelling of GLUT1-4 allows mapping and interpretation of disease-related mutations. The structural and biochemical information reported here constitutes an important framework for mechanistic understanding of glucose transporters and sugar porters in general.	[Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Gong, Xinqi; Yan, Nieng] Tsinghua Univ, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Sun, Xiuyun; Gong, Xinqi; Rao, Yu; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Sun, Xiuyun; Gong, Xinqi; Rao, Yu; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Sun, Linfeng; Zeng, Xin; Yan, Chuangye; Gong, Xinqi; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Zeng, Xin/0000-0003-4207-2902	Ministry of Science and Technology [2009CB918802, 2011CB910501]; National Natural Science Foundation of China [31125009, 91017011]; Tsinghua University	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	We thank J. He, L. Tang, F. Yu and S. Huang at Shanghai Synchrotron Radiation Facility, and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU, for on-site assistance. This work was supported by funds from the Ministry of Science and Technology (grant numbers 2009CB918802 and 2011CB910501), projects 31125009 and 91017011 of the National Natural Science Foundation of China, and funds from Tsinghua University.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brockmann K, 2001, ANN NEUROL, V50, P476, DOI 10.1002/ana.1222; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DAVIS EO, 1984, J BIOL CHEM, V259, P1520; DAVIS EO, 1987, J BIOL CHEM, V262, P13928; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; HENDERSON PJF, 1990, J BIOENERG BIOMEMBR, V22, P525, DOI 10.1007/BF00762961; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Ho YY, 2001, PEDIATR RES, V50, P254, DOI 10.1203/00006450-200108000-00015; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Klepper J, 2008, EPILEPSIA, V49, P46, DOI 10.1111/j.1528-1167.2008.01833.x; LAM VMS, 1980, J BACTERIOL, V143, P396, DOI 10.1128/JB.143.1.396-402.1980; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Li FP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-168; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Mueckler Mike, 1993, Journal of Diabetes and its Complications, V7, P130, DOI 10.1016/1056-8727(93)90038-Z; Nelson D. L., 2008, LEHNINGER PRINCIPLES, P1158; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pascual JM, 2004, EUR J ENDOCRINOL, V150, P627, DOI 10.1530/eje.0.1500627; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Scheffer IE, 2012, NEUROLOGY, V78, P524, DOI 10.1212/WNL.0b013e318248a245; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Snider C., 2011, MEMBRANE PROTEINS KN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Veenhoff LM, 1999, J BIOL CHEM, V274, P33244, DOI 10.1074/jbc.274.47.33244; Wang D, 2005, ANN NEUROL, V57, P111, DOI 10.1002/ana.20331; Xiang ZX, 2007, PROTEINS, V66, P814, DOI 10.1002/prot.21099; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	62	327	350	29	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					361	+		10.1038/nature11524	http://dx.doi.org/10.1038/nature11524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23075985				2022-12-24	WOS:000309918500037
J	Agrawal, AA; Hastings, AP; Johnson, MTJ; Maron, JL; Salminen, JP				Agrawal, Anurag A.; Hastings, Amy P.; Johnson, Marc T. J.; Maron, John L.; Salminen, Juha-Pekka			Insect Herbivores Drive Real-Time Ecological and Evolutionary Change in Plant Populations	SCIENCE			English	Article							RESISTANCE; ELLAGITANNINS; COMMUNITIES; DEFENSE	Insect herbivores are hypothesized to be major factors affecting the ecology and evolution of plants. We tested this prediction by suppressing insects in replicated field populations of a native plant, Oenothera biennis, which reduced seed predation, altered interspecific competitive dynamics, and resulted in rapid evolutionary divergence. Comparative genotyping and phenotyping of nearly 12,000 O. biennis individuals revealed that in plots protected from insects, resistance to herbivores declined through time owing to changes in flowering time and lower defensive ellagitannins in fruits, whereas plant competitive ability increased. This independent real-time evolution of plant resistance and competitive ability in the field resulted from the relaxation of direct selective effects of insects on plant defense and through indirect effects due to reduced herbivory on plant competitors.	[Agrawal, Anurag A.; Hastings, Amy P.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Agrawal, Anurag A.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Johnson, Marc T. J.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Maron, John L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Salminen, Juha-Pekka] Univ Turku, Dept Chem, Lab Organ Chem & Chem Biol, FI-20014 Turku, Finland	Cornell University; Cornell University; University of Toronto; University Toronto Mississauga; University of Montana System; University of Montana; University of Turku	Agrawal, AA (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	agrawal@cornell.edu	Salminen, Juha-Pekka/N-3313-2017; Agrawal, Anurag A/Y-2497-2019	Salminen, Juha-Pekka/0000-0002-2912-7094; Agrawal, Anurag A/0000-0003-0095-1220	University of Turku; U.S. NSF [EAGER DEB-0950231]; Natural Sciences and Engineering Research Council of Canada; Government of Ontario; Connaught Early Researcher Award; NSF [DEB 0614406, DEB-0915409]; Academy of Finland [258992]; Direct For Biological Sciences [1118783] Funding Source: National Science Foundation	University of Turku; U.S. NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Government of Ontario; Connaught Early Researcher Award; NSF(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Alfano, F. Chen, S. Cook-Patton, P. Cooper, T. Dodge, N. Durfee, A. Erwin, M. Falise, J. Goldstein, E. Kearney, A. Knight, S. McArt, J. Peters, S. Rasmann, A. Smith, T. Ramsey, E. Reyes, M. Weber, and E. Woods for help with field work and discussion; T. Zhao, J. Yi, and A. Koivuniemi for assistance with chemical analyses; and J. Good, N. Hairston, S. McArt, T. Zust, and the Plant Interactions Group at Cornell University for comments. Molecular work for this study was conducted in the Evolutionary Genetics Core Facility at Cornell University with support from V. Askinazi, S. Bogdanowicz, R. Harrison, E. Larson, and E. Reyes. Chemical analyses on an ultraperformance liquid chromatography-mass spectrometry system were made possible by a Strategic Research Grant of University of Turku. This study was primarily supported by a U.S. NSF grant (EAGER DEB-0950231), and for this we thank L. Gough. M.T.J.J. was supported by the Natural Sciences and Engineering Research Council of Canada, the Government of Ontario, and a Connaught Early Researcher Award; J.L.M. was supported by NSF grants DEB 0614406 and DEB-0915409; J.-P.S was supported by the Academy of Finland (grant 258992). Data sets for genotype frequencies described in this paper are available in the DRYAD data repository under http://dx.doi.org/10.5061/dryad.6331s. This paper is dedicated to Paul Feeny and Dick Root.	Agrawal AA, 2004, ECOLOGY, V85, P2118, DOI 10.1890/03-4084; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Agrawal AA, 2013, AM NAT, V181, pS35, DOI 10.1086/666727; Barbehenn RV, 2006, J CHEM ECOL, V32, P2253, DOI 10.1007/s10886-006-9143-7; Bode RF, 2012, J ECOL, V100, P795, DOI 10.1111/j.1365-2745.2012.01958.x; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Desurmont GA, 2011, P NATL ACAD SCI USA, V108, P7070, DOI 10.1073/pnas.1102891108; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fornoni J, 2004, EVOLUTION, V58, P1696, DOI 10.1111/j.0014-3820.2004.tb00455.x; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Johnson MTJ, 2009, J EVOLUTION BIOL, V22, P1295, DOI 10.1111/j.1420-9101.2009.01747.x; Johnson MTJ, 2009, PHILOS T R SOC B, V364, P1593, DOI 10.1098/rstb.2008.0334; Karonen M, 2010, RAPID COMMUN MASS SP, V24, P3151, DOI 10.1002/rcm.4756; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Uriarte M, 2002, ECOLOGY, V83, P2649, DOI 10.1890/0012-9658(2002)083[2649:AMOSEO]2.0.CO;2; Zangerl AR, 2005, P NATL ACAD SCI USA, V102, P15529, DOI 10.1073/pnas.0507805102	24	293	298	11	520	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					113	116		10.1126/science.1225977	http://dx.doi.org/10.1126/science.1225977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	23042894				2022-12-24	WOS:000309457400065
J	Yamanaka, S; Mehta, S; Reyes-Turcu, FE; Zhuang, FL; Fuchs, RT; Rong, YK; Robb, GB; Grewal, SIS				Yamanaka, Soichiro; Mehta, Sameet; Reyes-Turcu, Francisca E.; Zhuang, Fanglei; Fuchs, Ryan T.; Rong, Yikang; Robb, Gregory B.; Grewal, Shiv I. S.			RNAi triggered by specialized machinery silences developmental genes and retrotransposons	NATURE			English	Article							MEIOTIC MESSENGER-RNAS; FISSION YEAST; ELIMINATION; PROMOTES; COMPLEX; TRANSCRIPTOME; SURVEILLANCE; MAINTENANCE; METHYLATION; NUCLEATION	RNA interference (RNAi) is a conserved mechanism in which small interfering RNAs (siRNAs) guide the degradation of cognate RNAs, but also promote heterochromatin assembly at repetitive DNA elements such as centromeric repeats(1,2). However, the full extent of RNAi functions and its endogenous targets have not been explored. Here we show that, in the fission yeast Schizosaccharomyces pombe, RNAi and heterochromatin factors cooperate to silence diverse loci, including sexual differentiation genes, genes encoding transmembrane proteins, and retrotransposons that are also targeted by the exosome RNA degradation machinery. In the absence of the exosome, transcripts are processed preferentially by the RNAi machinery, revealing siRNA clusters and a corresponding increase in heterochromatin modifications across large domains containing genes and retrotransposons. We show that the generation of siRNAs and heterochromatin assembly by RNAi is triggered by a mechanism involving the canonical poly(A) polymerase Pla1 and an associated RNA surveillance factor Red1, which also activate the exosome. Notably, siRNA production and heterochromatin modifications at these target loci are regulated by environmental growth conditions, and by developmental signals that induce gene expression during sexual differentiation. Our analyses uncover an interaction between RNAi and the exosome that is conserved in Drosophila, and show that differentiation signals modulate RNAi silencing to regulate developmental genes.	[Yamanaka, Soichiro; Mehta, Sameet; Reyes-Turcu, Francisca E.; Rong, Yikang; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhuang, Fanglei; Fuchs, Ryan T.; Robb, Gregory B.] New England Biolabs Inc, Ipswich, MA 01938 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New England Biolabs	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Mehta, Sameet/A-1936-2011	Mehta, Sameet/0000-0002-3029-3217; Grewal, Shiv/0000-0002-4552-9261; Robb, Gregory Brett/0000-0002-2382-2256	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523, ZIABC010446] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Zofall and K. Zhang for contributions, J. Barrowman for editing the manuscript, M. Yamamoto for the pla1-37 strain, E. Lei for the Drosophila rrp6 mutant, B. Walker and M. Pineda for their help in sequencing, and Grewal laboratory members for discussions. This study used the Helix Systems and the Biowulf Linux cluster at the National Institutes of Health. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bitton DA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.90; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Munafo DB, 2010, RNA, V16, P2537, DOI 10.1261/rna.2242610; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Reyes-Turcu FE, 2011, NAT STRUCT MOL BIOL, V18, P1132, DOI 10.1038/nsmb.2122; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	32	101	105	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					557	+		10.1038/nature11716	http://dx.doi.org/10.1038/nature11716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23151475	Green Accepted			2022-12-24	WOS:000313871400043
J	Bintu, L; Ishibashi, T; Dangkulwanich, M; Wu, YY; Lubkowska, L; Kashlev, M; Bustamante, C				Bintu, Lacramioara; Ishibashi, Toyotaka; Dangkulwanich, Manchuta; Wu, Yueh-Yi; Lubkowska, Lucyna; Kashlev, Mikhail; Bustamante, Carlos			Nucleosomal Elements that Control the Topography of the Barrier to Transcription	CELL			English	Article							RNA-POLYMERASE-II; HISTONE TAIL DOMAINS; DNA TRANSLOCATION; KINETIC-MODEL; ELONGATION; CHROMATIN; ACETYLATION; STABILITY; DYNAMICS; ARREST	The nucleosome represents a mechanical barrier to transcription that operates as a general regulator of gene expression. We investigate how each nucleosomal component-the histone tails, the specific histone-DNA contacts, and the DNA sequence-contributes to the strength of the barrier. Removal of the tails favors progression of RNA polymerase II into the entry region of the nucleosome by locally increasing the wrapping-unwrapping rates of the DNA around histones. In contrast, point mutations that affect histone-DNA contacts at the dyad abolish the barrier to transcription in the central region by decreasing the local wrapping rate. Moreover, we show that the nucleosome amplifies sequence-dependent transcriptional pausing, an effect mediated through the structure of the nascent RNA. Each of these nucleosomal elements controls transcription elongation by affecting distinctly the density and duration of polymerase pauses, thus providing multiple and alternative mechanisms for control of gene expression by chromatin remodeling and transcription factors.	[Bintu, Lacramioara; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Bintu, Lacramioara; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Ishibashi, Toyotaka; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Dangkulwanich, Manchuta; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wu, Yueh-Yi; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Lubkowska, Lucyna; Kashlev, Mikhail] NCI Ctr Canc Res, Frederick, MD 21702 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bustamante, C (corresponding author), Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Ishibashi, Toyotaka/AAW-2687-2020	Ishibashi, Toyotaka/0000-0001-8015-2319; Dangkulwanich, Manchuta/0000-0001-8927-0952; Bustamante, Carlos/0000-0002-2970-0073	NIH [R01-GM032543-31]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]; JSPS; NATIONAL CANCER INSTITUTE [ZIABC010795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Hodges, S. Kassube, S. Sternberg, B. Zamft, and members of the Bustamante laboratory for assistance and discussions. T. I. is supported by a fellowship from JSPS. This work was supported by NIH grant R01-GM032543-31 (C. B.) and by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Contract No. DE-AC02-05CH11231 (C.B.).	Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Angelov D, 2001, P NATL ACAD SCI USA, V98, P6599, DOI 10.1073/pnas.121171498; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Greive SJ, 2011, BIOPHYS J, V101, P1155, DOI 10.1016/j.bpj.2011.07.042; Greive SJ, 2011, BIOPHYS J, V101, P1166, DOI 10.1016/j.bpj.2011.07.043; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hsieh FK, 2010, EMBO REP, V11, P705, DOI 10.1038/embor.2010.113; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; KRUGER W, 1995, GENE DEV, V9, P2770, DOI 10.1101/gad.9.22.2770; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Muthurajan UM, 2004, EMBO J, V23, P260, DOI 10.1038/sj.emboj.7600046; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Protacio RU, 2000, MOL CELL BIOL, V20, P8866, DOI 10.1128/MCB.20.23.8866-8878.2000; Samkurashvili I, 1996, J BIOL CHEM, V271, P23495, DOI 10.1074/jbc.271.38.23495; SIMPSON RT, 1978, CELL, V13, P691, DOI 10.1016/0092-8674(78)90219-2; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Ujvari A, 2008, J BIOL CHEM, V283, P32236, DOI 10.1074/jbc.M806636200; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Widlund HR, 2000, BIOCHEMISTRY-US, V39, P3835, DOI 10.1021/bi991957l; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322; Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, pW605, DOI 10.1093/nar/gki447; Xu F, 2010, NUCLEIC ACIDS RES, V38, P6872, DOI 10.1093/nar/gkq506; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Zamft B, 2012, P NATL ACAD SCI USA, V109, P8948, DOI 10.1073/pnas.1205063109; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025	41	124	130	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					738	749		10.1016/j.cell.2012.10.009	http://dx.doi.org/10.1016/j.cell.2012.10.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141536	Green Accepted, Bronze			2022-12-24	WOS:000310921200007
J	Gire, SK; Stremlau, M; Andersen, KG; Schaffner, SF; Bjornson, Z; Rubins, K; Hensley, L; McCormick, JB; Lander, ES; Garry, RF; Happi, C; Sabeti, PC				Gire, Stephen K.; Stremlau, Matthew; Andersen, Kristian G.; Schaffner, Stephen F.; Bjornson, Zach; Rubins, Kathleen; Hensley, Lisa; McCormick, Joseph B.; Lander, Eric. S.; Garry, Robert F.; Happi, Christian; Sabeti, Pardis C.			Emerging Disease or Diagnosis?	SCIENCE			English	Editorial Material							LASSA FEVER; EBOLA-VIRUS; NIGERIA					sgire@oeb.harvard.edu; psabeti@oeb.harvard.edu	Schaffner, Stephen F/D-1189-2011; Sabeti, Pardis/GQH-8610-2022; Andersen, Kristian/D-5006-2009	Andersen, Kristian/0000-0001-6431-5982; Happi, Christian/0000-0002-3056-6705; Garry, Robert/0000-0002-5683-3250; McCormick, Joseph/0000-0002-5844-8102; Schaffner, Stephen/0000-0001-6699-3568; Hensley, Lisa/0000-0003-1188-4342	NIAID NIH HHS [AI2008031, AI2009061] Funding Source: Medline; NIH HHS [DP2 OD006514, 1DP2OD006514-01] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Asogun DA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001839; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bausch DG, 2001, VECTOR-BORNE ZOONOT, V1, P269, DOI 10.1089/15303660160025903; Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Ehichioya DU, 2011, J CLIN MICROBIOL, V49, P1157, DOI 10.1128/JCM.01891-10; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Lederberg J., 1992, I MED US COMMITTEE; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, J INFECT DIS, V190, P1895, DOI 10.1086/425421; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Suzuki Y, 1997, MOL BIOL EVOL, V14, P800, DOI 10.1093/oxfordjournals.molbev.a025820; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371	17	23	24	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					750	752		10.1126/science.1225893	http://dx.doi.org/10.1126/science.1225893			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	033ZI	23139320				2022-12-24	WOS:000310839500029
J	Rafelski, SM; Viana, MP; Zhang, Y; Chan, YHM; Thorn, KS; Yam, P; Fung, JC; Li, H; Costa, LD; Marshall, WF				Rafelski, Susanne M.; Viana, Matheus P.; Zhang, Yi; Chan, Yee-Hung M.; Thorn, Kurt S.; Yam, Phoebe; Fung, Jennifer C.; Li, Hao; Costa, Luciano da F.; Marshall, Wallace F.			Mitochondrial Network Size Scaling in Budding Yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; INHERITANCE; DAUGHTER; DIVISION; GROWTH	Mitochondria must grow with the growing cell to ensure proper cellular physiology and inheritance upon division. We measured the physical size of mitochondrial networks in budding yeast and found that mitochondrial network size increased with increasing cell size and that this scaling relation occurred primarily in the bud. The mitochondria-to-cell size ratio continually decreased in aging mothers over successive generations. However, regardless of the mother's age or mitochondrial content, all buds attained the same average ratio. Thus, yeast populations achieve a stable scaling relation between mitochondrial content and cell size despite asymmetry in inheritance.	[Rafelski, Susanne M.; Zhang, Yi; Chan, Yee-Hung M.; Thorn, Kurt S.; Li, Hao; Marshall, Wallace F.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Rafelski, Susanne M.; Chan, Yee-Hung M.; Li, Hao; Marshall, Wallace F.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94143 USA; [Viana, Matheus P.; Costa, Luciano da F.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Zhang, Yi] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Zhang, Yi] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Yam, Phoebe; Fung, Jennifer C.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Sao Paulo; Peking University; Peking University; University of California System; University of California San Francisco	Rafelski, SM (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92717 USA.	susanner@uci.edu; wallace.marshall@ucsf.edu	da F. Costa, Luciano/H-5475-2011; Viana, Matheus/A-7137-2012	da F. Costa, Luciano/0000-0001-5203-4366; Viana, Matheus/0000-0001-9288-2108; Zhang, Yi/0000-0001-6609-8635; Thorn, Kurt/0000-0001-9310-288X	Sandler Postdoctoral Fellowship; Herbert Boyer Junior Faculty Endowed Chair Award; NIH [R01GM097017, R01GM070808, R01GM026259, P50Gm081879, 5RO1GM097213-02]; NIH National Research Service Award fellowship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [05/00587-5, 07/50882-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301303/06-1]; Packard Fellowship; China Scholarship Council (CSC) scholarship; Boyer Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026259, R01GM097017, P50GM081879, R01GM097213, R01GM070808] Funding Source: NIH RePORTER	Sandler Postdoctoral Fellowship; Herbert Boyer Junior Faculty Endowed Chair Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Packard Fellowship(The David & Lucile Packard Foundation); China Scholarship Council (CSC) scholarship(China Scholarship Council); Boyer Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Nunnari, J. Shaw, and A. Lewandowska for plasmids, strains, and discussions; G. Pesce for sharing unpublished results and discussions; and A. Caudy, E. Hong, K. C. Huang, A. Rosebrock, and the Marshall laboratory for reading the manuscript. Microscopy was performed at the UCSF Nikon Imaging Center. This work was supported by Sandler and Boyer Postdoctoral Fellowships (S. M. R.); the Herbert Boyer Junior Faculty Endowed Chair Award and NIH grant R01GM097017 (W. F. M.); an NIH National Research Service Award fellowship (Y.-H.M.C.); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (05/00587-5, 07/50882-9) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (301303/06-1) grants (L.d.F.C. and M. P. V.); NIH grants R01GM070808, R01GM026259, P50Gm081879, and a Packard Fellowship (Y.Z. and H. L.); a China Scholarship Council (CSC) scholarship (Y.Z.); and NIH grant 5RO1GM097213-02 (P.Y. and J. C. F.). Image analysis algorithms are described in detail in methods (6). The data are included in the main and supplementary figures.	Devin A, 2004, TOXICOL MECH METHOD, V14, P271, DOI 10.1080/15376520490479620; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; TANAKA K, 1985, J CELL SCI, V73, P207; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834; WOLDRINGH CL, 1993, J BACTERIOL, V175, P3174, DOI 10.1128/JB.175.10.3174-3181.1993	11	112	114	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					822	824		10.1126/science.1225720	http://dx.doi.org/10.1126/science.1225720			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23139336	Green Accepted			2022-12-24	WOS:000310839500051
J	Evrony, GD; Cai, XY; Lee, E; Hills, LB; Elhosary, PC; Lehmann, HS; Parker, JJ; Atabay, KD; Gilmore, EC; Poduri, A; Park, PJ; Walsh, CA				Evrony, Gilad D.; Cai, Xuyu; Lee, Eunjung; Hills, L. Benjamin; Elhosary, Princess C.; Lehmann, Hillel S.; Parker, J. J.; Atabay, Kutay D.; Gilmore, Edward C.; Poduri, Annapurna; Park, Peter J.; Walsh, Christopher A.			Single-Neuron Sequencing Analysis of L1 Retrotransposition and Somatic Mutation in the Human Brain	CELL			English	Article							HUMAN GENOMES; EVOLUTION; CELLS; NEUN; GENERATION; LANDSCAPE; GERMLINE; TUMOR; GENE; AKT3	A major unanswered question in neuroscience is whether there exists genomic variability between individual neurons of the brain, contributing to functional diversity or to an unexplained burden of neurological disease. To address this question, we developed a method to amplify genomes of single neurons from human brains. Because recent reports suggest frequent LINE-1 (L1) retrotransposition in human brains, we performed genome-wide L1 insertion profiling of 300 single neurons from cerebral cortex and caudate nucleus of three normal individuals, recovering >80% of germline insertions from single neurons. While we find somatic L1 insertions, we estimate <0.6 unique somatic insertions per neuron, and most neurons lack detectable somatic insertions, suggesting that L1 is not a major generator of neuronal diversity in cortex and caudate. We then genotyped single cortical cells to characterize the mosaicism of a somatic AKT3 mutation identified in a child with hemimegalencephaly. Single-neuron sequencing allows systematic assessment of genomic diversity in the human brain.	[Evrony, Gilad D.; Cai, Xuyu; Walsh, Christopher A.] Harvard Univ, Program Biol & Biomed Sci, Sch Med, Boston, MA 02115 USA; [Lee, Eunjung; Park, Peter J.] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Poduri, Annapurna; Walsh, Christopher A.] Harvard Univ, Dept Neurol, Sch Med, Boston, MA 02115 USA; [Walsh, Christopher A.] Harvard Univ, Dept Pediat, Sch Med, Boston, MA 02115 USA; [Evrony, Gilad D.; Cai, Xuyu; Hills, L. Benjamin; Lehmann, Hillel S.; Parker, J. J.; Atabay, Kutay D.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Evrony, Gilad D.; Cai, Xuyu; Hills, L. Benjamin; Lehmann, Hillel S.; Parker, J. J.; Atabay, Kutay D.; Walsh, Christopher A.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Elhosary, Princess C.; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Park, Peter J.] Boston Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Lee, Eunjung; Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Gilmore, Edward C.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Case Western Reserve University	Walsh, CA (corresponding author), Harvard Univ, Program Biol & Biomed Sci, Sch Med, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu		Park, Peter/0000-0001-9378-960X; Parker, John James/0000-0002-6769-5922; Walsh, Christopher/0000-0002-0156-2238; Evrony, Gilad/0000-0001-7621-2630	NIH MSTP grant [T32GM007753]; NIH NIGMS grant [T32GM007726]; Manton Center for Orphan Disease Research; NINDS [R01 NS079277, R01 NS035129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079277, R01NS035129] Funding Source: NIH RePORTER	NIH MSTP grant; NIH NIGMS grant; Manton Center for Orphan Disease Research; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Peter V. Kharchenko, Tim W. Yu, Vijay S. Ganesh, and Nathan C. Silberman for helpful discussions; Hal Schneider, Richard Bennett, R. Sean Hill, and Christina Kourkoulis for technical assistance; Robert Johnson from the NICHD Brain and Tissue Bank; the Orchestra research computing support team (Harvard Medical School); and the Hematologic Neoplasia Flow Cytometry Core (Dana-Farber Cancer Institute). Brain image in Figure 1A adapted with permission from http://brainmuseum.org, supported by the US National Science Foundation. G. D. E. is supported, in part, by NIH MSTP grant T32GM007753. X. C. is supported, in part, by NIH NIGMS grant T32GM007726. C. A. W. is supported by the Manton Center for Orphan Disease Research and grants from the NINDS (R01 NS079277 and R01 NS035129). C. A. W. is an Investigator of the Howard Hughes Medical Institute.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Cantrell MA, 2008, GENETICS, V178, P393, DOI 10.1534/genetics.107.080275; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Flores-Sarnat L, 2003, J CHILD NEUROL, V18, P776, DOI 10.1177/08830738030180111101; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; Matevossian A., 2008, JOVE-J VIS EXP, V20, pe914, DOI DOI 10.3791/914; MIKI Y, 1992, CANCER RES, V52, P643; Mills SE, 2007, HISTOLOGY PATHOLOGIS; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ovchinnikov I, 2002, P NATL ACAD SCI USA, V99, P10522, DOI 10.1073/pnas.152346799; Parent A., 1996, CARPENTERS HUMAN NEU, V9th. Edn; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Salipante SJ, 2008, GENETICS, V178, P967, DOI 10.1534/genetics.107.081018; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	42	363	370	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					483	496		10.1016/j.cell.2012.09.035	http://dx.doi.org/10.1016/j.cell.2012.09.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101622	Green Accepted, Bronze			2022-12-24	WOS:000310529300007
J	Mallilankaraman, K; Doonan, P; Cardenas, C; Chandramoorthy, HC; Muller, M; Miller, R; Hoffman, NE; Gandhirajan, RK; Molgo, J; Birnbaum, MJ; Rothberg, BS; Mak, DOD; Foskett, JK; Madesh, M				Mallilankaraman, Karthik; Doonan, Patrick; Cardenas, Cesar; Chandramoorthy, Harish C.; Mueller, Marioly; Miller, Russell; Hoffman, Nicholas E.; Gandhirajan, Rajesh Kumar; Molgo, Jordi; Birnbaum, Morris J.; Rothberg, Brad S.; Mak, Don-On Daniel; Foskett, J. Kevin; Madesh, Muniswamy			MICU1 Is an Essential Gatekeeper for MCU-Mediated Mitochondrial Ca2+ Uptake that Regulates Cell Survival	CELL			English	Article							CALCIUM-UPTAKE; OXIDATIVE-PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; TRANSPORT; ACTIVATION; MECHANISMS; APOPTOSIS; SUPEROXIDE; UNIPORTER; MEMBRANE	Mitochondrial Ca2+ (Ca-m(2+)) uptake is mediated by an inner membrane Ca2+ channel called the uniporter. Ca2+ uptake is driven by the considerable voltage present across the inner membrane (Delta psi(m)) generated by proton pumping by the respiratory chain. Mitochondrial matrix Ca2+ concentration is maintained five to six orders of magnitude lower than its equilibrium level, but the molecular mechanisms for how this is achieved are not clear. Here, we demonstrate that the mitochondrial protein MICU1 is required to preserve normal [Ca2+](m) under basal conditions. In its absence, mitochondria become constitutively loaded with Ca2+, triggering excessive reactive oxygen species generation and sensitivity to apoptotic stress. MICU1 interacts with the uniporter pore-forming subunit MCU and sets a Ca2+ threshold for Ca-m(2+) uptake without affecting the kinetic properties of MCU-mediated Ca2+ uptake. Thus, MICU1 is a gatekeeper of MCU-mediated Ca-m(2+) uptake that is essential to prevent [Ca2+](m) overload and associated stress.	[Cardenas, Cesar; Mueller, Marioly; Mak, Don-On Daniel; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Miller, Russell; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Mallilankaraman, Karthik; Doonan, Patrick; Chandramoorthy, Harish C.; Hoffman, Nicholas E.; Gandhirajan, Rajesh Kumar; Rothberg, Brad S.; Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19140 USA; [Mallilankaraman, Karthik; Doonan, Patrick; Chandramoorthy, Harish C.; Hoffman, Nicholas E.; Gandhirajan, Rajesh Kumar; Madesh, Muniswamy] Temple Univ, Ctr Translat Med, Philadelphia, PA 19140 USA; [Cardenas, Cesar] Univ Chile, Anat & Dev Biol Program, Inst Biomed Sci, Santiago 8380453, Chile; [Molgo, Jordi] CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol & Dev,UPR 3294, F-91198 Gif Sur Yvette, France	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu; madeshm@temple.edu	Foskett, Kevin/R-2549-2019; Muller, Marioly/J-5420-2014; Rothberg, Brad/AAD-1260-2022	Gandhirajan, Rajesh/0000-0002-0039-771X; Foskett, J. Kevin/0000-0002-8854-0268; Birnbaum, Morris/0000-0001-9972-8680; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050; Chinna Konda Chandramoorthy, Harish/0000-0002-8780-8971; Rothberg, Brad/0000-0003-1982-2269	NIH [HL086699, HL086699-01A2S1, 1S10RR027327-01]; American Heart Association; NRSA Fellowship;  [GM56328];  [MH059937]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, R01DK056886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328, R37GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants HL086699, HL086699-01A2S1, and 1S10RR027327-01 to M. Madesh and by GM56328 and MH059937 to J. K. F. We thank Jun Yang for biochemistry assistance and the University of Pennsylvania IDOM (P30-DK19535) for assistance. C. C. was supported by the American Heart Association. R. M. was supported by an NRSA Fellowship.	Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; FELICEAZZONE G, 1977, BIOCHIM BIOPHYS ACTA, V459, P96, DOI 10.1016/0005-2728(77)90012-3; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; Jacobson J, 2002, J CELL SCI, V115, P1175; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Mallilankaraman K., 2011, J VIS EXP, V58, pe3511; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; NICHOLLS DG, 1978, BIOCHEM J, V176, P463, DOI 10.1042/bj1760463; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; ROTTENBERG H, 1974, BIOCHEMISTRY-US, V13, P4811, DOI 10.1021/bi00720a020; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Simpson PB, 1998, J PHYSIOL-LONDON, V508, P413, DOI 10.1111/j.1469-7793.1998.413bq.x; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200	54	435	446	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					630	644		10.1016/j.cell.2012.10.011	http://dx.doi.org/10.1016/j.cell.2012.10.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101630	Green Accepted, Bronze			2022-12-24	WOS:000310529300018
J	Behrndt, M; Salbreux, G; Campinho, P; Hauschild, R; Oswald, F; Roensch, J; Grill, SW; Heisenberg, CP				Behrndt, Martin; Salbreux, Guillaume; Campinho, Pedro; Hauschild, Robert; Oswald, Felix; Roensch, Julia; Grill, Stephan W.; Heisenberg, Carl-Philipp			Forces Driving Epithelial Spreading in Zebrafish Gastrulation	SCIENCE			English	Article							MORPHOGENESIS; DROSOPHILA; MOVEMENT	Contractile actomyosin rings drive various fundamental morphogenetic processes ranging from cytokinesis to wound healing. Actomyosin rings are generally thought to function by circumferential contraction. Here, we show that the spreading of the enveloping cell layer (EVL) over the yolk cell during zebrafish gastrulation is driven by a contractile actomyosin ring. In contrast to previous suggestions, we find that this ring functions not only by circumferential contraction but also by a flow-friction mechanism. This generates a pulling force through resistance against retrograde actomyosin flow. EVL spreading proceeds normally in situations where circumferential contraction is unproductive, indicating that the flow-friction mechanism is sufficient. Thus, actomyosin rings can function in epithelial morphogenesis through a combination of cable-constriction and flow-friction mechanisms.	[Salbreux, Guillaume; Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Behrndt, Martin; Oswald, Felix; Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Behrndt, Martin; Campinho, Pedro; Hauschild, Robert; Roensch, Julia; Heisenberg, Carl-Philipp] IST Austria, A-3400 Klosterneuburg, Austria	Max Planck Society; Max Planck Society; Institute of Science & Technology - Austria	Grill, SW (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.	grill@mpi-cbg.de; heisenberg@ist.ac.at	Grill, Stephan/D-9427-2012; Ladoux, Benoit/A-9879-2013	Heisenberg, Carl-Philipp/0000-0002-0912-4566; Campinho, Pedro/0000-0002-8526-5416; Salbreux, Guillaume/0000-0001-7041-1292	Fonds zur Forderung der wissenschaftlichen Forschung (FWF); Deutsche Forschungsgemeinschaft (DFG) [I930-B20]; Austrian Science Fund (FWF) [I 930] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to M. Sixt, T. Bollenbach, and E. Martin-Blanco for advice and the service facilities of the IST Austria and MPI-CBG for continuous help. M. B., G. S., S. W. G., and C.-P. H. synergistically and equally developed the presented ideas and the experimental and theoretical approaches. M. B. and P. C. performed the experiments; G. S. developed the theory; and R. H., F.O., and J.R. contributed to the experimental work. This work was supported by a grant from the Fonds zur Forderung der wissenschaftlichen Forschung (FWF) and the Deutsche Forschungsgemeinschaft (DFG) (I930-B20) to C.-P. H., S. W. G., and G.S.	Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Holloway BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000413; Howard J., 2001, MECH MOTOR PROTEINS; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Kane DA, 1996, DEVELOPMENT, V123, P47; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Salbreux G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058102; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Siddiqui M, 2010, DEV DYNAM, V239, P715, DOI 10.1002/dvdy.22172	18	266	268	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					257	260		10.1126/science.1224143	http://dx.doi.org/10.1126/science.1224143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066079				2022-12-24	WOS:000309712300046
J	Chau, AH; Walter, JM; Gerardin, J; Tang, C; Lim, WA				Chau, Angela H.; Walter, Jessica M.; Gerardin, Jaline; Tang, Chao; Lim, Wendell A.			Designing Synthetic Regulatory Networks Capable of Self-Organizing Cell Polarization	CELL			English	Article							SEGMENT POLARITY NETWORK; PAR PROTEINS; SYMMETRY-BREAKING; PATTERN-FORMATION; BUDDING YEAST; SMALL GTPASES; BIOLOGY; ESTABLISHMENT; ORGANIZATION; RECONSTITUTION	How cells form global, self-organized structures using genetically encoded molecular rules remains elusive. Here, we take a synthetic biology approach to investigate the design principles governing cell polarization. First, using a coarse-grained computational model, we searched for all possible simple networks that can achieve polarization. All solutions contained one of three minimal motifs: positive feedback, mutual inhibition, or inhibitor with positive feedback. These minimal motifs alone could achieve polarization under limited conditions; circuits that combined two or more of these motifs were significantly more robust. With these design principles as a blueprint, we experimentally constructed artificial polarization networks in yeast, using a toolkit of chimeric signaling proteins that spatially direct the synthesis and degradation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3). Circuits with combinatorial motifs yielded clear foci of synthetic PIP3 that can persist for nearly an hour. Thus, by harnessing localization-regulated signaling molecules, we can engineer simple molecular circuits that reliably execute spatial self-organized programs.	[Tang, Chao; Lim, Wendell A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Chau, Angela H.; Walter, Jessica M.; Gerardin, Jaline; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Chau, Angela H.; Walter, Jessica M.; Gerardin, Jaline; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Chau, Angela H.] Univ Calif San Francisco, UC Berkeley UCSF Grad Program Bioengn, San Francisco, CA 94158 USA; [Gerardin, Jaline] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Tang, Chao] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Tang, Chao] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Peking University; Peking University	Tang, C (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	tangc@pku.edu.cn; lim@cmp.ucsf.edu		Tang, Chao/0000-0003-1474-3705; Gerardin, Jaline/0000-0001-8071-9928	Achievement Rewards for College Scientists (ARCS) Foundation; NIH NRSA [5F32GM093475]; NSF [DMR-0804183, CMMI-0941355]; NIH [P50 GM081879, PN2 EY016546, RO1 GM062583]; National Natural Science Foundation of China [10721403]; NSF Synthetic Biology Engineering Research Center [EEC-0540879]; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093475, R01GM062583, P50GM081879, R01GM055040] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0804183] Funding Source: National Science Foundation	Achievement Rewards for College Scientists (ARCS) Foundation; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF Synthetic Biology Engineering Research Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Thanks to C. Baker, H. El-Samad, A. Houk, C. Lee, W. Ma, L. Maibaum, W. Marshall, K. Mostov, D. Mullins, C. Oguz, C. Voigt, O. Weiner, and the Lim lab for valuable comments and discussion. We thank M. Molina, V. Cid, L. Chan, E. Bi, and O. Weiner for strains and plasmids. Thanks to J. Baker-LePain and the QB3 shared computing cluster for technical support of the computational work and the Shokat lab for PI3K inhibitor. This work was supported by an Achievement Rewards for College Scientists (ARCS) Foundation scholarship (A. H. C.), NIH NRSA fellowship 5F32GM093475 (J. M. W.), an NSF Graduate Research Fellowship (J. G.), NIH grant P50 GM081879 (W. A. L. and C. T.), NIH grants PN2 EY016546 and RO1 GM062583 (W. A. L.), NSF grants DMR-0804183 and CMMI-0941355 (C. T.), National Natural Science Foundation of China grant 10721403 (C. T.), and the NSF Synthetic Biology Engineering Research Center EEC-0540879 (W. A. L.).	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Beatty A, 2010, DEVELOPMENT, V137, P3995, DOI 10.1242/dev.056028; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Doe CQ, 2001, NAT CELL BIOL, V3, pE7, DOI 10.1038/35050684; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hoege C, 2010, CURR BIOL, V20, P1296, DOI 10.1016/j.cub.2010.05.061; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inagaki N, 2011, DEV NEUROBIOL, V71, P584, DOI 10.1002/dneu.20837; Irazoqui JE, 2004, J CELL SCI, V117, P2169, DOI 10.1242/jcs.00953; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.0.CO;2-Z; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Mogilner A, 2012, SCIENCE, V336, P175, DOI 10.1126/science.1216380; Mogilner A, 2011, TRENDS CELL BIOL, V21, P692, DOI 10.1016/j.tcb.2011.09.007; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Narang A, 2006, J THEOR BIOL, V240, P538, DOI 10.1016/j.jtbi.2005.10.022; Onsum M, 2007, PLOS COMPUT BIOL, V3, P436, DOI 10.1371/journal.pcbi.0030036; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rafelski SM, 2008, NAT REV MOL CELL BIO, V9, P593, DOI 10.1038/nrm2460; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	53	116	117	1	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 12	2012	151	2					320	332		10.1016/j.cell.2012.08.040	http://dx.doi.org/10.1016/j.cell.2012.08.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	022RX	23039994	Bronze, Green Accepted			2022-12-24	WOS:000309981000011
J	Piel, FB; Patil, AP; Howes, RE; Nyangiri, OA; Gething, PW; Dewi, M; Temperley, WH; Williams, TN; Weatherall, DJ; Hay, SI				Piel, Frederic B.; Patil, Anand P.; Howes, Rosalind E.; Nyangiri, Oscar A.; Gething, Peter W.; Dewi, Mewahyu; Temperley, William H.; Williams, Thomas N.; Weatherall, David J.; Hay, Simon I.			Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates	LANCET			English	Article							CELL-DISEASE; MALARIA; DISORDERS; GENE; COUNTRIES; BURDEN	Background Reliable estimates of populations affected by diseases are necessary to guide efficient allocation of public health resources. Sickle haemoglobin (HbS) is the most common and clinically significant haemoglobin structural variant, but no contemporary estimates exist of the global populations affected. Moreover, the precision of available national estimates of heterozygous (AS) and homozygous (SS) neonates is unknown. We aimed to provide evidence-based estimates at various scales, with uncertainty measures. Methods Using a database of sickle haemoglobin surveys, we created a contemporary global map of HbS allele frequency distribution within a Bayesian geostatistical model. The pairing of this map with demographic data enabled calculation of global, regional, and national estimates of the annual number of AS and SS neonates. Subnational estimates were also calculated in data-rich areas. Findings Our map shows subnational spatial heterogeneities and high allele frequencies across most of sub-Saharan Africa, the Middle East, and India, as well as gene flow following migrations to western Europe and the eastern coast of the Americas. Accounting for local heterogeneities and demographic factors, we estimated that the global number of neonates affected by HbS in 2010 included 5 476 000 (IQR 5 291 000-5 679 000) AS neonates and 312 000 (294 000-330 000) SS neonates. These global estimates are higher than previous conservative estimates. Important differences predicted at the national level are discussed. Interpretation HbS will have an increasing effect on public health systems. Our estimates can help countries and the international community gauge the need for appropriate diagnoses and genetic counselling to reduce the number of neonates affected. Similar mapping and modelling methods could be used for other inherited disorders.	[Piel, Frederic B.; Patil, Anand P.; Howes, Rosalind E.; Gething, Peter W.; Temperley, William H.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Nyangiri, Oscar A.; Williams, Thomas N.] Kilifi Dist Hosp, Ctr Geog Med Res Coast, Kenya Med Res Inst, Wellcome Trust Programme, Kilifi, Kenya; [Dewi, Mewahyu] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Williams, Thomas N.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 3PS, England; [Weatherall, David J.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford; Kenya Medical Research Institute; Eijkman Institute; University of Oxford; University of Oxford	Piel, FB (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Tinbergen Bldg,S Parks Rd, Oxford OX1 3PS, England.	fred.piel@zoo.ox.ac.uk	Gething, Peter/GQR-1884-2022; Gething, Peter/ABD-2110-2020; Hay, Simon Iain/F-8967-2015	Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; Piel, Frederic B./0000-0001-8131-7728	Kenyan Medical Research Institute (KEMRI); Wellcome Trust [085406, 079091, 091758]; Li Ka Shing Foundation; Philippe Wiener-Maurice Anspach Foundation; European Research Council (ERC); MRC [MC_UU_12009/13] Funding Source: UKRI; Medical Research Council [MC_UU_12009/13] Funding Source: researchfish	Kenyan Medical Research Institute (KEMRI); Wellcome Trust(Wellcome TrustEuropean Commission); Li Ka Shing Foundation; Philippe Wiener-Maurice Anspach Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Kevin Baird and Sunetra Gupta for providing comments on the report. We also thank the following people for sharing unpublished data: Anabel Arends and Gilberto Gomez for Venezuela data; Marcelo Urbano Ferreira for Brazil data; Rick Fairhurst, Carole Long, and Mahamadou Diakite for Mali data; Rick Fairhurst and Duong Socheat for Cambodia data. Data from the MalariaGEN Consortium have been shared for inclusion in the database. We acknowledge all its contributing collaborators and members for collecting, preparing, and genotyping the samples. We thank Andy Tatem for providing modified Global Rural Urban Mapping Project data and members of the Malaria Atlas Project (MAP) including Katherine Battle, Catherine Moyes, and Marianne Sinka who have contributed their expertise and to Janey Messina and David Pigott for proofreading. We acknowledge the support of the Kenyan Medical Research Institute (KEMRI). FBP, REH, and OAN were funded by a Biomedical Resources Grant (#085406) from the Wellcome Trust (to SIH) and acknowledge contributions from their Technical Advisory Group: Kevin Baird, Suthat Fucharoen, Dominic Kwiatkowski, Kevin Marsh, Kirk Rockett, Graham Serjeant, David J Weatherall, Tom N Williams, and Bill Wood. SIH is supported by a Senior Research Fellowship from the Wellcome Trust (#079091), which also supported APP and PWG. TNW is supported by a Senior Fellowship from the Wellcome Trust (#091758). MD acknowledges the support of the Li Ka Shing Foundation. We are also grateful for support from the Philippe Wiener-Maurice Anspach Foundation and the European Research Council (ERC Advanced Grant-Diversity).	Akinyanju O, 2010, NATL BURDEN SICKLE C; Alexander N, 2004, BRIT J HAEMATOL, V126, P606, DOI 10.1111/j.1365-2141.2004.05025.x; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Balgir RS, 2000, CURR SCI INDIA, V79, P1536; Bittles AH, 2005, COMMUNITY GENET, V8, P17, DOI 10.1159/000083332; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Dyson S. M., 2012, GENETICS GLOBAL PUBL; Gething PW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000724; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Livingstone F. B., 1985, FREQUENCIES HEMOGLOB; LIVINGSTONE FB, 1964, AM J HUM GENET, V16, P435; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Panepinto JA, 2000, J PEDIATR-US, V136, P201, DOI 10.1016/S0022-3476(00)70102-8; Patil AP, 2011, TRENDS PARASITOL, V27, P245, DOI 10.1016/j.pt.2011.01.003; Penman BS, 2009, P NATL ACAD SCI USA, V106, P21242, DOI 10.1073/pnas.0910840106; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Streetly A, 2000, BRIT MED J, V320, P1353, DOI 10.1136/bmj.320.7246.1353; *UN, 2003, DEM YB; WEATHERALL D, 2006, INHERITED DISORDERS, P663; Weatherall DJ, 2011, BRIT J HAEMATOL, V154, P736, DOI 10.1111/j.1365-2141.2011.08742.x; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ, 2010, BRIT J HAEMATOL, V149, P635, DOI 10.1111/j.1365-2141.2010.08118.x; Weinberg W., 1908, JAHRESHEFTE VEREINS, V64, P369; Williams TN, 2011, TRENDS PARASITOL, V27, P315, DOI 10.1016/j.pt.2011.02.004; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; World Health Organization Regional Office for Africa, 2010, SICKL CELL DIS STRAT	35	567	572	2	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2013	381	9861					142	151		10.1016/S0140-6736(12)61229-X	http://dx.doi.org/10.1016/S0140-6736(12)61229-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23103089	Green Published			2022-12-24	WOS:000313420900030
J	Moeller, A; Kirchdoerfer, RN; Potter, CS; Carragher, B; Wilson, IA				Moeller, Arne; Kirchdoerfer, Robert N.; Potter, Clinton S.; Carragher, Bridget; Wilson, Ian A.			Organization of the Influenza Virus Replication Machinery	SCIENCE			English	Article							A VIRUS; ELECTRON-MICROSCOPY; RIBONUCLEOPROTEIN COMPLEXES; CRYSTAL-STRUCTURE; VIRAL POLYMERASE; HUMAN-CELLS; NUCLEOPROTEIN; RNA; GENERATION; BINDING	Influenza virus ribonucleoprotein complexes (RNPs) are central to the viral life cycle and in adaptation to new host species. RNPs are composed of the viral genome, viral polymerase, and many copies of the viral nucleoprotein. In vitro cell expression of all RNP protein components with four of the eight influenza virus gene segments enabled structural determination of native influenza virus RNPs by means of cryogenic electron microscopy (cryo-EM). The cryo-EM structure reveals the architecture and organization of the native RNP, defining the attributes of its largely helical structure and how polymerase interacts with nucleoprotein and the viral genome. Observations of branched-RNP structures in negative-stain electron microscopy and their putative identification as replication intermediates suggest a mechanism for viral replication by a second polymerase on the RNP template.	[Moeller, Arne; Potter, Clinton S.; Carragher, Bridget] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Kirchdoerfer, Robert N.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Carragher, B (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	bcarr@scripps.edu; wilson@scripps.edu		Carragher, Bridget/0000-0002-0624-5020; Moeller, Arne/0000-0003-1101-5366	National Institutes of Health [AI058113, GM095573]; National Center for Research Resources [2P41RR017573-11]; National Institute of General Medical Sciences Biomedical Technology Resource Centers [9 P41 GM103310-11]; Joint Center for Innovation in Membrane Protein Production for Structure Determination [P50GM073197]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, R01GM095573, P50GM073197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences Biomedical Technology Resource Centers; Joint Center for Innovation in Membrane Protein Production for Structure Determination; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Webster (St. Jude Children's Research Hospital) for providing the eight plasmid system (pHW2000, the cloning vector: pHW191-PB2, pHW192-PB1, pHW193-PA, and pHW195-NP, under a material transfer agreement from St. Jude) used for recombinant RNP expression; M. Brimble and P. Harris (Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland) for synthesizing the FLAG peptide; J. Quispe for help in EM grid specimen preparation; and A. Su for helpful advice on statistical analyses. We also thank J. Martin-Benito and J. Ortin (Consejo Superior de Investigaciones Cientificas, Spain) for sending us the previously reconstructed mini-RNP map. This project has been funded in part by the National Institutes of Health AI058113 to I. A. W. and GM095573 to C. S. P and B. C. The project was also supported by grants from the National Center for Research Resources (2P41RR017573-11) and the National Institute of General Medical Sciences Biomedical Technology Resource Centers (9 P41 GM103310-11) and by the Joint Center for Innovation in Membrane Protein Production for Structure Determination (P50GM073197). This is publication 21687 from The Scripps Research Institute. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Reconstructions of the free polymerase, RNP-bound polymerase, central filament, and loop regions have been deposited in the EM Data Bank (EMDB entry numbers 2209, 2211, 2212, and 2213). Coordinates of NP protomers docked into the central filament map have been deposited in the Protein Data Bank (PDB code 2YMN) The authors report no conflicts of interest.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Fields B. N., 2007, FIELDS VIROLOGY; Fournier E, 2012, NUCLEIC ACIDS RES, V40, P2197, DOI 10.1093/nar/gkr985; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; LUO GX, 1991, J VIROL, V65, P2861, DOI 10.1128/JVI.65.6.2861-2867.1991; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; NAEVE CW, 1980, J VIROL, V34, P764, DOI 10.1128/JVI.34.3.764-771.1980; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Noda T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1647; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Resa-Infante P, 2010, J VIROL, V84, P10477, DOI 10.1128/JVI.01115-10; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Shen YF, 2011, P NATL ACAD SCI USA, V108, P16515, DOI 10.1073/pnas.1113107108; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Wu WWH, 2007, J MOL BIOL, V374, P910, DOI 10.1016/j.jmb.2007.10.022; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	35	175	179	4	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1631	1634		10.1126/science.1227270	http://dx.doi.org/10.1126/science.1227270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23180774	Green Accepted			2022-12-24	WOS:000312533100056
J	Su, CY; Menuz, K; Reisert, J; Carlson, JR				Su, Chih-Ying; Menuz, Karen; Reisert, Johannes; Carlson, John R.			Non-synaptic inhibition between grouped neurons in an olfactory circuit	NATURE			English	Article							RECEPTOR NEURONS; DROSOPHILA-MELANOGASTER; CHEMOSENSORY RECEPTORS; BEHAVIORAL-RESPONSES; MOLECULAR-BASIS; PHEROMONE; SENSILLA; ORGANIZATION; MOTH; PERCEPTION	Diverse sensory organs, including mammalian taste buds and insect chemosensory sensilla, show a marked compartmentalization of receptor cells; however, the functional impact of this organization remains unclear. Here we show that compartmentalized Drosophila olfactory receptor neurons (ORNs) communicate with each other directly. The sustained response of one ORN is inhibited by the transient activation of a neighbouring ORN. Mechanistically, such lateral inhibition does not depend on synapses and is probably mediated by ephaptic coupling. Moreover, lateral inhibition in the periphery can modulate olfactory behaviour. Together, the results show that integration of olfactory information can occur via lateral interactions between ORNs. Inhibition of a sustained response by a transient response may provide a means of encoding salience. Finally, a CO2-sensitive ORN in the malaria mosquito Anopheles can also be inhibited by excitation of an adjacent ORN, suggesting a broad occurrence of lateral inhibition in insects and possible applications in insect control.	[Su, Chih-Ying; Menuz, Karen; Carlson, John R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Reisert, Johannes] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Yale University; Monell Chemical Senses Center	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Menuz, Karen/0000-0001-8163-0941	National Institutes of Health (NIH) [NIH DC009613]; Foundation for the NIH through the Grand Challenges in Global Health Initiative (GCGH) [121]; NRSA [NIH F32DC011242]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009613, R01DC011697, F32DC011242, R01DC004729] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH through the Grand Challenges in Global Health Initiative (GCGH); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Cardin for help with establishing the optogenetics system; Y. Zhao and E. Fikrig for providing mosquitoes; A. Tzingounis and G. Lowe for suggestions; Z. Berman and P. Graham for technical assistance; T. Koh for suggestions and for sharing reagents; and G. Thomas, F. Marion-Poll, R. Wyman and D. McCormick for comments on the manuscript. This work was funded by National Institutes of Health (NIH) grants to J. R. C. and by a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative (GCGH no. 121); an NRSA postdoctoral fellowship to K. M. (NIH F32DC011242); and an NIH grant to J. R. (NIH DC009613).	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; AKERS RP, 1988, J COMP PHYSIOL A, V163, P641, DOI 10.1007/BF00603848; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BERG BG, 1995, J COMP PHYSIOL A, V177, P683, DOI 10.1007/BF00187627; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DETHIER VG, 1989, PHYSIOL ENTOMOL, V14, P127, DOI 10.1111/j.1365-3032.1989.tb00944.x; FABER DS, 1989, PHYSIOL REV, V69, P821, DOI 10.1152/physrev.1989.69.3.821; Gaffin DD, 2002, MICROSC RES TECHNIQ, V58, P325, DOI 10.1002/jemt.10140; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jorgensen K, 2007, CHEM SENSES, V32, P863, DOI 10.1093/chemse/bjm057; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; KEIL TA, 1984, ZOOMORPHOLOGY, V104, P147, DOI 10.1007/BF00312133; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; MITCHELL BK, 1987, J CHEM ECOL, V13, P2009, DOI 10.1007/BF01041728; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; OCONNELL RJ, 1985, J COMP PHYSIOL A, V156, P747, DOI 10.1007/BF00610828; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Schoonhoven LM, 2002, ACTA ZOOL ACAD SCI H, V48, P215; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shanbhag SR, 2000, ARTHROPOD STRUCT DEV, V29, P211, DOI 10.1016/S1467-8039(00)00028-1; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Takanashi T, 2006, J EXP BIOL, V209, P4946, DOI 10.1242/jeb.02587; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vermeulen A, 2004, EUR BIOPHYS J BIOPHY, V33, P633, DOI 10.1007/s00249-004-0405-4; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	50	141	147	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					66	+		10.1038/nature11712	http://dx.doi.org/10.1038/nature11712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23172146	Green Accepted, Green Submitted			2022-12-24	WOS:000311893400046
J	Thomas, MK; Kremer, CT; Klausmeier, CA; Litchman, E				Thomas, Mridul K.; Kremer, Colin T.; Klausmeier, Christopher A.; Litchman, Elena			A Global Pattern of Thermal Adaptation in Marine Phytoplankton	SCIENCE			English	Article							CLIMATE-CHANGE; BIODIVERSITY LOSS; IMPACTS; PRODUCTIVITY; TERRESTRIAL	Rising ocean temperatures will alter the productivity and composition of marine phytoplankton communities, thereby affecting global biogeochemical cycles. Predicting the effects of future ocean warming on biogeochemical cycles depends critically on understanding how existing global temperature variation affects phytoplankton. Here we show that variation in phytoplankton temperature optima over 150 degrees of latitude is well explained by a gradient in mean ocean temperature. An eco-evolutionary model predicts a similar relationship, suggesting that this pattern is the result of evolutionary adaptation. Using mechanistic species distribution models, we find that rising temperatures this century will cause poleward shifts in species' thermal niches and a sharp decline in tropical phytoplankton diversity in the absence of an evolutionary response.	[Thomas, Mridul K.; Kremer, Colin T.; Klausmeier, Christopher A.; Litchman, Elena] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Thomas, Mridul K.; Litchman, Elena] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Kremer, Colin T.; Klausmeier, Christopher A.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Thomas, MK (corresponding author), Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA.	thomasmr@msu.edu	Klausmeier, Christopher A/J-9339-2012	Thomas, Mridul/0000-0002-5089-5610; Klausmeier, Christopher/0000-0002-6987-5871; Litchman, Elena/0000-0001-7736-6332	NSF [DEB-0845932, DEB-0845825, OCE-0928819]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; Graduate Research Fellowship; James S. McDonnell Foundation	NSF(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; Graduate Research Fellowship; James S. McDonnell Foundation	This research was supported by NSF (grants DEB-0845932, DEB-0845825, and OCE-0928819), including the BEACON Center for the Study of Evolution in Action (grant DBI-0939454) and a Graduate Research Fellowship to C. T. K., as well as a grant from the James S. McDonnell Foundation. K. Edwards and N. Swenson provided statistical advice, and J. Lennon, G. Mittelbach, and.. Miller provided comments on the manuscript. The trait data presented are shown in table S5, and the collated growth rate data are in table S6. Also thanks to NOAA/OAR/ESRL PSD, Boulder, CO, USA, for NOAA_OI_SST_V2 data provided at their Web site, www.esrl.noaa.gov/psd/. This is W. K. Kellogg Biological Station contribution number 1694. E. L. and M. K. T. conceived the original idea; M. K. T. collected the growth-temperature data; M. K. T. and C. T. K. analyzed the data; C. T. K. and C. A. K. developed and C. T. K. analyzed the eco-evolutionary model; M. K. T. and C. T. K. ran the mechanistic species distribution models; and M. K. T., C. T. K., and E. L. wrote and C. A. K. commented on the manuscript.	Abrams PA, 2001, ECOL LETT, V4, P166, DOI 10.1046/j.1461-0248.2001.00199.x; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bennett A. F., 2007, LIGHT EVOLUTION, V1, P225; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Huertas IE, 2011, P ROY SOC B-BIOL SCI, V278, P3534, DOI 10.1098/rspb.2011.0160; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Knies JL, 2006, PLOS BIOL, V4, P1257, DOI 10.1371/journal.pbio.0040201; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; REDFIELD AC, 1958, AM SCI, V46, P205; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Stegen JC, 2012, P ROY SOC B-BIOL SCI, V279, P1051, DOI 10.1098/rspb.2011.1733; Steinacher M, 2010, BIOGEOSCIENCES, V7, P979, DOI 10.5194/bg-7-979-2010; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0	33	444	451	46	502	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1085	1088		10.1126/science.1224836	http://dx.doi.org/10.1126/science.1224836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23112294				2022-12-24	WOS:000311390600045
J	Badrinarayanan, A; Reyes-Lamothe, R; Uphoff, S; Leake, MC; Sherratt, DJ				Badrinarayanan, Anjana; Reyes-Lamothe, Rodrigo; Uphoff, Stephan; Leake, Mark C.; Sherratt, David J.			In Vivo Architecture and Action of Bacterial Structural Maintenance of Chromosome Proteins	SCIENCE			English	Article							ESCHERICHIA-COLI; ATP HYDROLYSIS; CONDENSIN; DNA; COMPLEX; COHESIN; MUKB; SMC; STOICHIOMETRY; ORGANIZATION	SMC (structural maintenance of chromosome) proteins act ubiquitously in chromosome processing. In Escherichia coli, the SMC complex MukBEF plays roles in chromosome segregation and organization. We used single-molecule millisecond multicolor fluorescence microscopy of live bacteria to reveal that a dimer of dimeric fluorescent MukBEF molecules acts as the minimal functional unit. On average, 8 to 10 of these complexes accumulated as "spots" in one to three discrete chromosome-associated regions of the cell, where they formed higher-order structures. Functional MukBEF within spots exchanged with freely diffusing complexes at a rate of one complex about every 50 seconds in reactions requiring adenosine triphosphate (ATP) hydrolysis. Thus, by functioning in pairs, MukBEF complexes may undergo multiple cycles of ATP hydrolysis without being released from DNA, analogous to the behavior of well-characterized molecular motors.	[Uphoff, Stephan; Leake, Mark C.] Univ Oxford, Dept Phys, Oxford OX1 2JD, England; [Badrinarayanan, Anjana; Reyes-Lamothe, Rodrigo; Sherratt, David J.] Univ Oxford, Dept Biochem, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Leake, MC (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 2JD, England.	m.leake1@physics.ox.ac.uk; david.sherratt@bioch.ox.ac.uk	Leake, Mark/C-1245-2011	Leake, Mark/0000-0002-1715-1249; Sherratt, David/0000-0002-2104-5430; Uphoff, Stephan/0000-0002-3579-0888; Badrinarayanan, Anjana/0000-0001-5520-2134	New College (Oxford University); Mathworks scholarship; Royal Society; Engineering and Physical Sciences Research Council [EP/G061009]; Wellcome Trust [WT083469MA]	New College (Oxford University); Mathworks scholarship; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust)	R.R.-L. held the Todd-Bird Junior Research Fellowship of New College (Oxford University). S.U. was supported by a Mathworks scholarship. M.C.L. was supported by a Royal Society University Research Fellowship. We thank R. Oliveira for assistance with FRAP experiments and A. Kapanidis for discussions and provision of the PALM equipment. The experimental work was funded by an Engineering and Physical Sciences Research Council grant to M.C.L. (EP/G061009) and by a Wellcome Trust program grant to D.J.S. (WT083469MA). All data are presented in the supplementary materials, and bacterial strains are available on request. The authors declare that they have no competing financial interests. The project was conceived by all authors, each of whom contributed to writing the manuscript. A.B., R.R.-L., and S.U. performed the experiments, M.C.L. developed the millisecond microscopy and biophysical/analytical methods, and S.U. implemented live-cell PALM. M.C.L., A.B., and S.U. did the analysis. D.J.S. and M.C.L. contributed equally.	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Fennell-Fezzie R, 2005, EMBO J, V24, P1921, DOI 10.1038/sj.emboj.7600680; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Gloyd M, 2011, J MOL BIOL, V412, P578, DOI 10.1016/j.jmb.2011.08.009; Gruber S, 2011, MOL MICROBIOL, V81, P855, DOI 10.1111/j.1365-2958.2011.07764.x; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; HIRAGA S, 1991, RES MICROBIOL, V142, P189, DOI 10.1016/0923-2508(91)90029-A; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Mascarenhas J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-28; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Oliveira RA, 2007, CHROMOSOMA, V116, P259, DOI 10.1007/s00412-007-0097-5; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Yamanaka K, 1996, MOL GEN GENET, V250, P241	26	163	163	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					528	531		10.1126/science.1227126	http://dx.doi.org/10.1126/science.1227126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112333	Green Accepted			2022-12-24	WOS:000310195800058
J	Hyster, TK; Knorr, L; Ward, TR; Rovis, T				Hyster, Todd K.; Knoerr, Livia; Ward, Thomas R.; Rovis, Tomislav			Biotinylated Rh(III) Complexes in Engineered Streptavidin for Accelerated Asymmetric C-H Activation	SCIENCE			English	Article							ARTIFICIAL METALLOENZYMES; PROTEIN; HYDROGENATION; DESIGN; EVOLUTION; CATALYST; ENZYMES; ALKYNES	Enzymes provide an exquisitely tailored chiral environment to foster high catalytic activities and selectivities, but their native structures are optimized for very specific biochemical transformations. Designing a protein to accommodate a non-native transition metal complex can broaden the scope of enzymatic transformations while raising the activity and selectivity of small-molecule catalysis. Here, we report the creation of a bifunctional artificial metalloenzyme in which a glutamic acid or aspartic acid residue engineered into streptavidin acts in concert with a docked biotinylated rhodium(III) complex to enable catalytic asymmetric carbon-hydrogen (C-H) activation. The coupling of benzamides and alkenes to access dihydroisoquinolones proceeds with up to nearly a 100-fold rate acceleration compared with the activity of the isolated rhodium complex and enantiomeric ratios as high as 93:7.	[Hyster, Todd K.; Knoerr, Livia; Ward, Thomas R.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland; [Hyster, Todd K.; Rovis, Tomislav] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	University of Basel; Colorado State University	Ward, TR (corresponding author), Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.	thomas.ward@unibas.ch; rovis@lamar.colostate.edu	Ward, Thomas R/K-6419-2012	Ward, Thomas R/0000-0001-8602-5468	National Institute of General Medical Sciences [GM80442]; Swiss National Science Foundation [200020-126366]; National Center of Competence in Research Nanoscale Sciences; Marie Curie Training Network [FP7-ITN-238434]; Amgen; Roche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080442] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research Nanoscale Sciences; Marie Curie Training Network(European Commission); Amgen(Amgen); Roche(Roche Holding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institute of General Medical Sciences (GM80442), the Swiss National Science Foundation (grant 200020-126366), the National Center of Competence in Research Nanoscale Sciences, the Marie Curie Training Network (FP7-ITN-238434), Amgen, and Roche for support. We thank Johnson Matthey for a loan of rhodium salts and C. R. Cantor for the Sav gene. We thank M. J. Zimbron for providing an initial sample of [RhCp*<SUP>biotin</SUP>Cl<INF>2</INF>]<INF>2</INF> and for stimulating discussions.	Boersma AJ, 2010, CHEM SOC REV, V39, P2083, DOI 10.1039/b811349c; Collot J, 2004, J ORGANOMET CHEM, V689, P4868, DOI 10.1016/j.jorganchem.2004.09.032; Deuss PJ, 2011, CHEM-EUR J, V17, P4680, DOI 10.1002/chem.201003646; GREEN N. M., 1970, Methods in Enzymology, V18A, P418, DOI 10.1016/0076-6879(71)18342-5; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Heinisch T, 2010, CURR OPIN CHEM BIOL, V14, P184, DOI 10.1016/j.cbpa.2009.11.026; Hyster TK, 2010, J AM CHEM SOC, V132, P10565, DOI 10.1021/ja103776u; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Lapointe D, 2010, CHEM LETT, V39, P1119, DOI 10.1246/cl.2010.1118; Lin CC, 1999, TETRAHEDRON-ASYMMETR, V10, P1887, DOI 10.1016/S0957-4166(99)00193-7; Lin YW, 2010, J AM CHEM SOC, V132, P9970, DOI 10.1021/ja103516n; Lin YW, 2010, P NATL ACAD SCI USA, V107, P8581, DOI 10.1073/pnas.1000526107; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mugford PF, 2008, ANGEW CHEM INT EDIT, V47, P8782, DOI 10.1002/anie.200705159; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; Reetz MT, 2006, CHEM COMMUN, P4318, DOI 10.1039/b610461d; Reetz MT, 2011, ANGEW CHEM INT EDIT, V50, P138, DOI 10.1002/anie.201000826; Reiner T, 2009, J ORGANOMET CHEM, V694, P1934, DOI 10.1016/j.jorganchem.2009.01.056; Roelfes G, 2011, CHEMCATCHEM, V3, P647, DOI 10.1002/cctc.201000413; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Skander M, 2004, J AM CHEM SOC, V126, P14411, DOI 10.1021/ja0476718; Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u; WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064; Xu L, 2012, J ORG CHEM, V77, P3017, DOI 10.1021/jo202431q; Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620	30	561	573	9	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2012	338	6106					500	503		10.1126/science.1226132	http://dx.doi.org/10.1126/science.1226132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23112327	Green Accepted			2022-12-24	WOS:000310195800050
J	Sun, YD; Joachimski, MM; Wignall, PB; Yan, CB; Chen, YL; Jiang, HS; Wang, LN; Lai, XL				Sun, Yadong; Joachimski, Michael M.; Wignall, Paul B.; Yan, Chunbo; Chen, Yanlong; Jiang, Haishui; Wang, Lina; Lai, Xulong			Lethally Hot Temperatures During the Early Triassic Greenhouse	SCIENCE			English	Article							END-PERMIAN EXTINCTION; THERMAL TOLERANCE; DEPENDENT BIOGEOGRAPHY; OXYGEN LIMITATION; NANPANJIANG BASIN; CLIMATE-CHANGE; SOUTH CHINA; BOUNDARY; RECOVERY; PALEOENVIRONMENTS	Global warming is widely regarded to have played a contributing role in numerous past biotic crises. Here, we show that the end-Permian mass extinction coincided with a rapid temperature rise to exceptionally high values in the Early Triassic that were inimical to life in equatorial latitudes and suppressed ecosystem recovery. This was manifested in the loss of calcareous algae, the near-absence of fish in equatorial Tethys, and the dominance of small taxa of invertebrates during the thermal maxima. High temperatures drove most Early Triassic plants and animals out of equatorial terrestrial ecosystems and probably were a major cause of the end-Smithian crisis.	[Sun, Yadong; Yan, Chunbo; Jiang, Haishui; Wang, Lina; Lai, Xulong] China Univ Geosci, State Key Lab Geobiol & Environm Geol, Wuhan 430074, Peoples R China; [Sun, Yadong; Wignall, Paul B.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Joachimski, Michael M.] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Chen, Yanlong] Graz Univ, Inst Earth Sci Geol & Paleontol, A-8010 Graz, Austria	China University of Geosciences; University of Leeds; University of Erlangen Nuremberg; University of Graz	Sun, YD (corresponding author), China Univ Geosci, State Key Lab Geobiol & Environm Geol, Wuhan 430074, Peoples R China.	eeys@leeds.ac.uk	Joachimski, Michael M./B-9477-2011; Sun, Yadong/AAG-8781-2019; Sun, Yadong/N-6907-2013	Sun, Yadong/0000-0003-4032-2082; Sun, Yadong/0000-0003-4032-2082; Joachimski, Michael/0000-0001-6088-3261; Chen, Yanlong/0000-0003-1110-9020; Lai, Xulong/0000-0002-2837-0885	Chinese 973 Program [2011CB808800]; Natural Science Foundation of China [41172024, 40830212]	Chinese 973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	D. Lutz, F. Nenning, B. Yang, and X. Liu are acknowledged for lab and field assistance. This study was supported by Chinese 973 Program (2011CB808800) and the Natural Science Foundation of China (41172024 and 40830212). Y.S. acknowledges China University of Geosciences and China Scholarship Council for split-site Ph.D. at Wuhan, Leeds, and Erlangen.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Borsuk-Bialynicka M, 1999, ACTA PALAEONTOL POL, V44, P167; Broecker WS, 1999, GLOBAL BIOGEOCHEM CY, V13, P1167, DOI 10.1029/1999GB900066; CALLAWAY JM, 1989, CAN J EARTH SCI, V26, P1491, DOI 10.1139/e89-126; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chen J., 2004, MASS EXTINCTION RECO, VII, P647; CLARK DL, 1986, SCIENCE, V233, P984, DOI 10.1126/science.233.4767.984; COX CB, 1973, GEOL MAG, V110, P405, DOI 10.1017/S0016756800036190; Ellis RJ, 2010, NATURE, V463, P164, DOI 10.1038/463164a; Frank T. D., 2000, P ODP SCI RESULTS, V166, P137; Galfetti T, 2008, SEDIMENT GEOL, V204, P36, DOI 10.1016/j.sedgeo.2007.12.008; Galfetti T, 2007, GEOLOGY, V35, P291, DOI 10.1130/G23117A.1; Hallam A., 1997, MASS EXTINCTIONS THE; Huber M, 2008, SCIENCE, V321, P353, DOI 10.1126/science.1161170; Joachimski MM, 2012, GEOLOGY, V40, P195, DOI 10.1130/G32707.1; Kidder DL, 2004, PALAEOGEOGR PALAEOCL, V203, P207, DOI 10.1016/S0031-0182(03)00667-9; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Lehrmann DJ, 2003, PALAIOS, V18, P138, DOI 10.1669/0883-1351(2003)18<138:PBSFSC>2.0.CO;2; Locarnini R. A., 2010, WORLD OCEAN ATLAS 20, V1; Looy CV, 1999, P NATL ACAD SCI USA, V96, P13857, DOI 10.1073/pnas.96.24.13857; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; Muttoni G, 2009, GEOARABIA, V14, P17; O'Dogherty L, 2009, GEODIVERSITAS, V31, P213, DOI 10.5252/g2009n2a3; Orchard MJ, 2007, PALAEOGEOGR PALAEOCL, V252, P93, DOI 10.1016/j.palaeo.2006.11.037; Pan H., 1994, PALAEOWORLD, V4, P249; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Reichow MK, 2009, EARTH PLANET SC LETT, V277, P9, DOI 10.1016/j.epsl.2008.09.030; Retallack GJ, 1999, AUST J EARTH SCI, V46, P785, DOI 10.1046/j.1440-0952.1999.00745.x; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; Schneebeli-Hermann E, 2012, PALAEOGEOGR PALAEOCL, V339, P12, DOI 10.1016/j.palaeo.2012.04.010; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Sobolev SV, 2011, NATURE, V477, P312, DOI 10.1038/nature10385; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Song HJ, 2011, GEOLOGY, V39, P739, DOI 10.1130/G32191.1; Stanley SM, 2010, P NATL ACAD SCI USA, V107, P19185, DOI 10.1073/pnas.1012833107; Stanley SM, 2009, P NATL ACAD SCI USA, V106, P15264, DOI 10.1073/pnas.0907992106; Sues H.-D., 2010, TRIASSIC LIFE LAND; Sun D., 2004, MASS EXTINCTION RECO, VII, P543; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Twitchett RJ, 1999, PALAEOGEOGR PALAEOCL, V154, P27, DOI 10.1016/S0031-0182(99)00085-1; Wignall PB, 2002, GEOL SOC AM SPEC PAP, V356, P395, DOI 10.1130/0-8137-2356-6.395; Wignall PB, 1998, GEOL MAG, V135, P47, DOI 10.1017/S0016756897008121; Ziegler A.M., 1997, LATE GLACIAL POSTGLA, P111	51	700	767	36	470	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					366	370		10.1126/science.1224126	http://dx.doi.org/10.1126/science.1224126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	23087244				2022-12-24	WOS:000309955800037
J	Kyritsis, N; Kizil, C; Zocher, S; Kroehne, V; Kaslin, J; Freudenreich, D; Iltzsche, A; Brand, M				Kyritsis, Nikos; Kizil, Caghan; Zocher, Sara; Kroehne, Volker; Kaslin, Jan; Freudenreich, Dorian; Iltzsche, Anne; Brand, Michael			Acute Inflammation Initiates the Regenerative Response in the Adult Zebrafish Brain	SCIENCE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; IN-VIVO; INJURY; PROLIFERATION; TELENCEPHALON; ANTAGONIST; RECEPTOR-1; CELLS	The zebrafish regenerates its brain after injury and hence is a useful model organism to study the mechanisms enabling regenerative neurogenesis, which is poorly manifested in mammals. Yet the signaling mechanisms initiating such a regenerative response in fish are unknown. Using cerebroventricular microinjection of immunogenic particles and immunosuppression assays, we showed that inflammation is required and sufficient for enhancing the proliferation of neural progenitors and subsequent neurogenesis by activating injury-induced molecular programs that can be observed after traumatic brain injury. We also identified cysteinyl leukotriene signaling as an essential component of inflammation in the regenerative process of the adult zebrafish brain. Thus, our results demonstrate that in zebrafish, in contrast to mammals, inflammation is a positive regulator of neuronal regeneration in the central nervous system.	[Kyritsis, Nikos; Kizil, Caghan; Zocher, Sara; Kroehne, Volker; Kaslin, Jan; Freudenreich, Dorian; Iltzsche, Anne; Brand, Michael] Tech Univ Dresden, Deutsch Forshungsgemeinschaft Ctr Regenerat Thera, D-01307 Dresden, Germany; [Kaslin, Jan] Monash Univ, ARMI, Clayton, Vic 3800, Australia	Technische Universitat Dresden; Australian Regenerative Medicine Institute; Monash University	Brand, M (corresponding author), Tech Univ Dresden, Deutsch Forshungsgemeinschaft Ctr Regenerat Thera, Fetscherstasse 105, D-01307 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Kizil, Caghan/AFG-2073-2022; Kyritsis, Nikos/AAD-5187-2021; Kizil, Caghan/J-6923-2015; Brand, Michael/A-5509-2010	Kizil, Caghan/0000-0002-8164-9762; Kyritsis, Nikos/0000-0001-7801-5796; Kizil, Caghan/0000-0002-8164-9762; Brand, Michael/0000-0001-5711-6512; Zocher, Sara/0000-0001-8211-5490; Kroehne, Volker/0000-0002-5610-0866; Kaslin, Jan/0000-0002-6207-1889	Deutsche Forschungsgemeinschaft [SFB-655]; European Union (ZF Health, EC) [HEALTH-F4-2010-242048]; Technical University of Dresden	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (ZF Health, EC); Technical University of Dresden	We thank A. Menge for cryosections and paraffin sections, G. Kempermann and C. L. Antos for useful discussions, T. Chavakis for discussions and critical reading on the manuscript, N. Trede for discussion and assistance with the immunosuppression assay, and M. Redd for kindly providing us the L-plastin antibody. This work was supported by research grants from the Deutsche Forschungsgemeinschaft (SFB-655), European Union (ZF Health, EC Grant Agreement HEALTH-F4-2010-242048), and Technical University of Dresden.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Finsen B, 2011, FEBS LETT, V585, P3806, DOI 10.1016/j.febslet.2011.05.030; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Martin P, 2009, NATURE, V459, P921, DOI 10.1038/459921a; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Yu GL, 2005, BRAIN RES, V1053, P116, DOI 10.1016/j.brainres.2005.06.046; Zhang WP, 2002, ACTA PHARMACOL SIN, V23, P871	26	345	352	5	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1353	1356		10.1126/science.1228773	http://dx.doi.org/10.1126/science.1228773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23138980				2022-12-24	WOS:000311991200070
J	Hayashi, K; Ogushi, S; Kurimoto, K; Shimamoto, S; Ohta, H; Saitou, M				Hayashi, Katsuhiko; Ogushi, Sugako; Kurimoto, Kazuki; Shimamoto, So; Ohta, Hiroshi; Saitou, Mitinori			Offspring from Oocytes Derived from in Vitro Primordial Germ Cell-like Cells in Mice	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; MOUSE	Reconstitution of female germ cell development in vitro is a key challenge in reproductive biology and medicine. We show here that female (XX) embryonic stem cells and induced pluripotent stem cells in mice are induced into primordial germ cell-like cells (PGCLCs), which, when aggregated with female gonadal somatic cells as reconstituted ovaries, undergo X-reactivation, imprint erasure, and cyst formation, and exhibit meiotic potential. Upon transplantation under mouse ovarian bursa, PGCLCs in the reconstituted ovaries mature into germinal vesicle-stage oocytes, which then contribute to fertile offspring after in vitro maturation and fertilization. Our culture system serves as a robust foundation for the investigation of key properties of female germ cells, including the acquisition of totipotency, and for the reconstitution of whole female germ cell development in vitro.	[Hayashi, Katsuhiko; Ogushi, Sugako; Kurimoto, Kazuki; Shimamoto, So; Ohta, Hiroshi; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko; Saitou, Mitinori] Kyoto Univ, Ctr IPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Hayashi, Katsuhiko] Japan Sci & Technol Agcy CREST, Precursory Res Embryon Sci & Technol PRESTO, Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy JST,Sakyo Ku, Kyoto 6068501, Japan; [Ogushi, Sugako] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068302, Japan; [Kurimoto, Kazuki; Shimamoto, So; Ohta, Hiroshi] JST, CREST Exploratory Res Adv Technol ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Hayashi, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	khayashi@anat2.med.kyoto-u.ac.jp; saitou@anat2.med.kyoto-u.ac.jp		Ogushi, Sugako/0000-0001-8497-6972	Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-PRESTO/CREST/ERATO; Takeda Science Foundation; Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research [24681039, 19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-PRESTO/CREST/ERATO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Silva and A. Smith for the MS2 female iPSCs, K. Okita and S. Yamanaka for the female iPSCs, and Y. Matsui for the GOF18-ESCs. We also thank S. Matoba and A. Ogura for their advice on ovary reconstitution, S. Aramaki and Y. Ishikura for assistance, and T. Mori for encouragement. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by JST-PRESTO/CREST/ERATO; by the Takeda Science Foundation; and by the the Academia for Repro-regenerative Medicine. The accession number for the microarray data presented in this study is GSE40716 [Gene Expression Omnibus (GEO) database].	Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; HASHIMOTO K, 1992, DEV GROWTH DIFFER, V34, P233; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; KAUFMAN MH, 1987, DEVELOPMENT, V101, P383; Matoba S, 2011, BIOL REPROD, V84, P631, DOI 10.1095/biolreprod.110.087122; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	13	476	510	7	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					971	975		10.1126/science.1226889	http://dx.doi.org/10.1126/science.1226889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23042295				2022-12-24	WOS:000311083600050
J	Kosuri, P; Alegre-Cebollada, J; Feng, J; Kaplan, A; Ingles-Prieto, A; Badilla, CL; Stockwell, BR; Sanchez-Ruiz, JM; Holmgren, A; Fernandez, JM				Kosuri, Pallav; Alegre-Cebollada, Jorge; Feng, Jason; Kaplan, Anna; Ingles-Prieto, Alvaro; Badilla, Carmen L.; Stockwell, Brent R.; Sanchez-Ruiz, Jose M.; Holmgren, Arne; Fernandez, Julio M.			Protein Folding Drives Disulfide Formation	CELL			English	Article							THIOREDOXIN-LIKE DOMAINS; ACTIVE-SITE CYSTEINE; ENDOPLASMIC-RETICULUM; MOLTEN GLOBULE; SINGLE PROTEIN; NMR-SPECTROSCOPY; LIVING CELLS; ISOMERASE; FORCE; BOND	PDI catalyzes the oxidative folding of disulfide-containing proteins. However, the sequence of reactions leading to a natively folded and oxidized protein remains unknown. Here we demonstrate a technique that enables independent measurements of disulfide formation and protein folding. We find that non-native disulfides are formed early in the folding pathway and can trigger misfolding. In contrast, a PDI domain favors native disulfides by catalyzing oxidation at a late stage of folding. We propose a model for cotranslational oxidative folding wherein PDI acts as a placeholder that is relieved by the pairing of cysteines caused by substrate folding. This general mechanism can explain how PDI catalyzes oxidative folding in a variety of structurally unrelated substrates.	[Kosuri, Pallav] Columbia Univ, Grad Program Biochem & Mol Biophys, New York, NY 10027 USA; [Kosuri, Pallav; Alegre-Cebollada, Jorge; Feng, Jason; Kaplan, Anna; Badilla, Carmen L.; Stockwell, Brent R.; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA; [Ingles-Prieto, Alvaro; Sanchez-Ruiz, Jose M.] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; [Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, S-17177 Stockholm, Sweden	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; University of Granada; Karolinska Institutet	Kosuri, P (corresponding author), Columbia Univ, Grad Program Biochem & Mol Biophys, New York, NY 10027 USA.	pallav@caa.columbia.edu; jfernandez@columbia.edu	Stockwell, Brent R/AAE-7200-2019; Sanchez-Ruiz, Jose/H-2849-2015; Ingles-Prieto, Alvaro/A-4365-2017; Alegre-Cebollada, Jorge/I-4301-2014; Kosuri, Pallav/J-8279-2012	Stockwell, Brent R/0000-0002-3532-3868; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Ingles-Prieto, Alvaro/0000-0002-5409-8571; Alegre-Cebollada, Jorge/0000-0003-0542-0170; Kosuri, Pallav/0000-0002-7025-3543	NIH [HL066030, HL061228, CA097061, CA161061, GM085081]; HHMI; Arnold and Mabel Beckman Foundation; Spanish Ministry of Education; Spanish Ministry of Science and Innovation [BIO2009-09562, CSD2009-00088]; FEDER; Fundacion Ibercaja; Training Program in Molecular Biophysics [T32GM008281]; Fulbright scholarship; NATIONAL CANCER INSTITUTE [R01CA097061, R01CA161061] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061228, R01HL066030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081, T32GM008281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Arnold and Mabel Beckman Foundation; Spanish Ministry of Education(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Fundacion Ibercaja; Training Program in Molecular Biophysics; Fulbright scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (HL066030 and HL061228 to J.M.F.; CA097061, CA161061, and GM085081 to B. R. S.), HHMI (B. R. S.), the Arnold and Mabel Beckman Foundation (B. R. S.), the Spanish Ministry of Education (A. I.-P.), the Spanish Ministry of Science and Innovation (BIO2009-09562 and CSD2009-00088 to J.M.S.-R.), FEDER (J.M.S.-R.), Fundacion Ibercaja (J.A.-C.), and the Training Program in Molecular Biophysics (T32GM008281 to A. K.). P. K. was supported by a Fulbright scholarship. P. K., J.A.-C., and J.M.F. designed the experiments. P. K., J.A.-C., and J.F. performed the experiments and analyzed the data. A. K. and B. R. S. provided PDI A1. A. H. provided TRX. A. I.-P. and J.M.S.-R. provided TRX C35S. P. K., J.A.-C., and J.M.F. wrote the manuscript. We thank the members of the Fernandez lab for their illuminating feedback.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Baldwin RL, 2010, PROTEINS, V78, P2725, DOI 10.1002/prot.22803; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Berkovich R, 2010, BIOPHYS J, V98, P2692, DOI 10.1016/j.bpj.2010.02.053; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; Carvalho AP, 2006, PROG BIOPHYS MOL BIO, V91, P229, DOI 10.1016/j.pbiomolbio.2005.06.012; Chakravarthi Seema, 2009, P81; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Debarbieux L, 2000, J BACTERIOL, V182, P723, DOI 10.1128/JB.182.3.723-727.2000; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lappi AK, 2011, J MOL BIOL, V409, P238, DOI 10.1016/j.jmb.2011.03.024; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Walker KW, 1997, J BIOL CHEM, V272, P8845; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; WALKER KW, 1995, BIOCHEMISTRY-US, V34, P13642, DOI 10.1021/bi00041a045; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; ZAPUN A, 1992, PROTEINS, V14, P10, DOI 10.1002/prot.340140104	58	125	126	1	95	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					794	806		10.1016/j.cell.2012.09.036	http://dx.doi.org/10.1016/j.cell.2012.09.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141538	Green Accepted, Bronze			2022-12-24	WOS:000310921200011
J	Pfeffer, C; Larsen, S; Song, J; Dong, MD; Besenbacher, F; Meyer, RL; Kjeldsen, KU; Schreiber, L; Gorby, YA; El-Naggar, MY; Leung, KM; Schramm, A; Risgaard-Petersen, N; Nielsen, LP				Pfeffer, Christian; Larsen, Steffen; Song, Jie; Dong, Mingdong; Besenbacher, Flemming; Meyer, Rikke Louise; Kjeldsen, Kasper Urup; Schreiber, Lars; Gorby, Yuri A.; El-Naggar, Mohamed Y.; Leung, Kar Man; Schramm, Andreas; Risgaard-Petersen, Nils; Nielsen, Lars Peter			Filamentous bacteria transport electrons over centimetre distances	NATURE			English	Article							MICROSENSOR; REDUCTION; NANOWIRES; SEDIMENT	Oxygen consumption in marine sediments is often coupled to the oxidation of sulphide generated by degradation of organic matter in deeper, oxygen-free layers. Geochemical observations have shown that this coupling can be mediated by electric currents carried by unidentified electron transporters across centimetre-wide zones. Here we present evidence that the native conductors are long, filamentous bacteria. They abounded in sediment zones with electric currents and along their length they contained strings with distinct properties in accordance with a function as electron transporters. Living, electrical cables add a new dimension to the understanding of interactions in nature and may find use in technology development.	[Pfeffer, Christian; Kjeldsen, Kasper Urup; Schreiber, Lars; Schramm, Andreas; Risgaard-Petersen, Nils; Nielsen, Lars Peter] Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark; [Larsen, Steffen; Meyer, Rikke Louise; Schramm, Andreas; Nielsen, Lars Peter] Aarhus Univ, Dept Biosci, Microbiol Sect, DK-8000 Aarhus C, Denmark; [Song, Jie; Dong, Mingdong; Besenbacher, Flemming; Meyer, Rikke Louise] Aarhus Univ, Ctr DNA Nanotechnol CDNA, Interdisciplinary Nanosci Ctr INANO, DK-8000 Aarhus C, Denmark; [Gorby, Yuri A.; Leung, Kar Man] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [El-Naggar, Mohamed Y.; Leung, Kar Man] Univ So Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA	Aarhus University; Aarhus University; Aarhus University; University of Southern California; University of Southern California	Risgaard-Petersen, N (corresponding author), Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark.	nils.risgaard-petersen@biology.au.dk; biolpn@biology.au.dk	Schramm, Andreas/J-2655-2013; dong, mingdong/AAK-9315-2020; Schramm, Andreas/AAE-1616-2022; Dong, Mingdong/B-3341-2010; Risgaard-Petersen, Nils/J-2479-2013; Schreiber, Lars/J-5937-2013; Dong, Mingdong/AAC-3023-2020; Meyer, Rikke Louise/AAB-5377-2021; Nielsen, Lars Peter/AAL-6274-2021; Kjeldsen, Kasper U/A-4151-2011; Risgaard-Petersen, Nils/AAX-6747-2021; Nielsen, Lars Peter/J-7401-2013	Schramm, Andreas/0000-0002-7614-9616; Schramm, Andreas/0000-0002-7614-9616; Dong, Mingdong/0000-0002-2025-2171; Risgaard-Petersen, Nils/0000-0002-2767-2080; Schreiber, Lars/0000-0003-3411-0083; Dong, Mingdong/0000-0002-2025-2171; Meyer, Rikke Louise/0000-0002-6485-5134; Nielsen, Lars Peter/0000-0002-7269-4860; Kjeldsen, Kasper U/0000-0002-7805-5605; Risgaard-Petersen, Nils/0000-0002-2767-2080; Nielsen, Lars Peter/0000-0002-7269-4860	European Research Council; Danish National Research Foundation; Danish Council for Independent Research \ Natural Sciences (FNU); German Max Planck Society; Villum Foundation; Villum Fonden [00007194] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research \ Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); German Max Planck Society(Max Planck Society); Villum Foundation(Villum Fonden); Villum Fonden(Villum Fonden)	The authors thank P. G. Sorensen and L. B. Pedersen for construction of microsensors. Thanks to K. E. Thomsen for operating the TEM. B. B. Jorgensen is thanked for his general support. This research was financially supported by the European Research Council (L.P.N.), the Danish National Research Foundation (N.R.-P., C. P., K. U. K., L. S., M. D.), the Danish Council for Independent Research vertical bar Natural Sciences (FNU) (L.P.N.), the German Max Planck Society (N.R.-P., C. P., K. U. K., L. S.) and the Villum Foundation (M.D.).	CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; Cherniavskaya O, 2003, J PHYS CHEM B, V107, P1525, DOI 10.1021/jp0265438; Cologgi DL, 2011, P NATL ACAD SCI USA, V108, P15248, DOI 10.1073/pnas.1108616108; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P1234, DOI 10.1128/AEM.70.2.1234-1237.2004; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; Jorgensen B.B., 2006, MARINE GEOCHEMISTRY, P169, DOI DOI 10.1007/3-540-32144-6_5; Kato S, 2012, P NATL ACAD SCI USA, V109, P10042, DOI 10.1073/pnas.1117592109; Lu W, 2007, NANO LETT, V7, P2729, DOI 10.1021/nl071208m; Mariscal V, 2007, MOL MICROBIOL, V65, P1139, DOI 10.1111/j.1365-2958.2007.05856.x; Nielsen LP, 2010, NATURE, V463, P1071, DOI 10.1038/nature08790; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Risgaard-Petersen N, 2012, GEOCHIM COSMOCHIM AC, V92, P1, DOI 10.1016/j.gca.2012.05.036; Roden EE, 2010, NAT GEOSCI, V3, P417, DOI 10.1038/NGEO870; Sayama M, 2005, APPL ENVIRON MICROB, V71, P7575, DOI 10.1128/AEM.71.11.7575-7577.2005; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526	20	355	373	30	586	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2012	491	7423					218	221		10.1038/nature11586	http://dx.doi.org/10.1038/nature11586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033DP	23103872				2022-12-24	WOS:000310774300036
J	Barskey, AE; Schulte, C; Rosen, JB; Handschur, EF; Rausch-Phung, E; Doll, MK; Cummings, KP; Alleyne, EO; High, P; Lawler, J; Apostolou, A; Blog, D; Zimmerman, CM; Montana, B; Harpaz, R; Hickman, CJ; Rota, PA; Rota, JS; Bellini, WJ; Gallagher, KM				Barskey, Albert E.; Schulte, Cynthia; Rosen, Jennifer B.; Handschur, Elizabeth F.; Rausch-Phung, Elizabeth; Doll, Margaret K.; Cummings, Kisha P.; Alleyne, E. Oscar; High, Patricia; Lawler, Jacqueline; Apostolou, Andria; Blog, Debra; Zimmerman, Christopher M.; Montana, Barbara; Harpaz, Rafael; Hickman, Carole J.; Rota, Paul A.; Rota, Jennifer S.; Bellini, William J.; Gallagher, Kathleen M.			Mumps Outbreak in Orthodox Jewish Communities in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE EFFECTIVENESS; UNIVERSITY-STUDENTS; RECENT RESURGENCE; NETHERLANDS; INFECTION	Background By 2005, vaccination had reduced the annual incidence of mumps in the United States by more than 99%, with few outbreaks reported. However, in 2006, a large outbreak occurred among highly vaccinated populations in the United States, and similar outbreaks have been reported worldwide. The outbreak described in this report occurred among U. S. Orthodox Jewish communities during 2009 and 2010. Methods Cases of salivary-gland swelling and other symptoms clinically compatible with mumps were investigated, and demographic, clinical, laboratory, and vaccination data were evaluated. Results From June 28, 2009, through June 27, 2010, a total of 3502 outbreak-related cases of mumps were reported in New York City, two upstate New York counties, and one New Jersey county. Of the 1648 cases for which clinical specimens were available, 50% were laboratory-confirmed. Orthodox Jewish persons accounted for 97% of case patients. Adolescents 13 to 17 years of age (27% of all patients) and males (78% of patients in that age group) were disproportionately affected. Among case patients 13 to 17 years of age with documented vaccination status, 89% had previously received two doses of a mumps-containing vaccine, and 8% had received one dose. Transmission was focused within Jewish schools for boys, where students spend many hours daily in intense, face-to-face interaction. Orchitis was the most common complication (120 cases, 7% of male patients >= 12 years of age), with rates significantly higher among unvaccinated persons than among persons who had received two doses of vaccine. Conclusions The epidemiologic features of this outbreak suggest that intense exposures, particularly among boys in schools, facilitated transmission and overcame vaccine-induced protection in these patients. High rates of two-dose coverage reduced the severity of the disease and the transmission to persons in settings of less intense exposure.	[Barskey, Albert E.; Harpaz, Rafael; Hickman, Carole J.; Rota, Paul A.; Rota, Jennifer S.; Bellini, William J.; Gallagher, Kathleen M.] Ctr Res Dis Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Apostolou, Andria] Ctr Res Dis Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Schulte, Cynthia; Rausch-Phung, Elizabeth; Blog, Debra] New York State Dept Hlth, Albany, NY USA; [Rosen, Jennifer B.; Doll, Margaret K.; Cummings, Kisha P.; Zimmerman, Christopher M.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Alleyne, E. Oscar] Rockland Cty Dept Hlth, Pomona, NY USA; [Lawler, Jacqueline] Orange Cty Hlth Dept, Goshen, NY USA; [Handschur, Elizabeth F.; Montana, Barbara] New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA; [High, Patricia] Ocean Cty Hlth Dept, Toms River, NJ USA	Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; New York City Department of Health & Mental Hygiene; New Jersey Department of Health & Senior Services	Barskey, AE (corresponding author), Ctr Res Dis Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop A-34, Atlanta, GA 30333 USA.	abarskey@cdc.gov	Doll, Margaret K./AAR-3987-2021; Rausch-Phung, Elizabeth/AGL-7956-2022	Doll, Margaret K./0000-0002-2125-7820; 				AABY P, 1986, J INFECT DIS, V154, P858, DOI 10.1093/infdis/154.5.858; Anis E, 2012, EPIDEMIOL INFECT, V140, P439, DOI 10.1017/S095026881100063X; [Anonymous], 2010, MMWR-MORBID MORTAL W, V59, P594; [Anonymous], 2012, MMWR-MORBID MORTAL W, V60, P1762; [Anonymous], 1967, MMWR-MORBID MORTAL W, V16, P430; Bangor-Jones RD, 2009, MED J AUSTRALIA, V191, P398, DOI 10.5694/j.1326-5377.2009.tb02850.x; Barskey AE, 2009, VACCINE, V27, P6186, DOI 10.1016/j.vaccine.2009.06.109; Boddicker JD, 2007, J CLIN MICROBIOL, V45, P2902, DOI 10.1128/JCM.00614-07; Capua I, 2004, AVIAN PATHOL, V33, P158, DOI 10.1080/03079450310001652077; Carr MJ, 2010, J CLIN MICROBIOL, V48, P3288, DOI 10.1128/JCM.00434-10; Centers for Disease Control and Prevention, STAT SURV VACC COV U; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P629; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Cohen C, 2007, EMERG INFECT DIS, V13, P12; Cortese MM, 2008, CLIN INFECT DIS, V46, P1172, DOI 10.1086/529141; Cortese MM, 2011, J INFECT DIS, V204, P1413, DOI 10.1093/infdis/jir526; Council of State and Territorial Epidemiologists, CSTE POS STAT 09 ID; Davidkin I, 2010, EXPERT REV VACCINES, V9, P1045, DOI [10.1586/erv.10.99, 10.1586/ERV.10.99]; Dayan GH, 2008, NEW ENGL J MED, V358, P1580, DOI 10.1056/NEJMoa0706589; ENNIS FA, 1969, J INFECT DIS, V119, P654, DOI 10.1093/infdis/119.6.654; Greenland K, 2012, VACCINE, V30, P4676, DOI 10.1016/j.vaccine.2012.04.083; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Harling R, 2005, VACCINE, V23, P4070, DOI 10.1016/j.vaccine.2004.10.020; High P., 2010, Morbidity and Mortality Weekly Report, V59, P125; Jin L, 2005, ARCH VIROL, V150, P1903, DOI 10.1007/s00705-005-0563-4; Kutty P, 2011, 45 NAT IMM C WASH DC; LeBaron CW, 2009, J INFECT DIS, V199, P552, DOI 10.1086/596207; Livingston KA, 2011, 45 NAT IMM C WASH DC; Marin M, 2008, VACCINE, V26, P3601, DOI 10.1016/j.vaccine.2008.04.075; Paunio M, 1998, AM J EPIDEMIOL, V148, P1103, DOI 10.1093/oxfordjournals.aje.a009588; Plotkin S, 2008, VACCINES, P435; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Roberts C, 2009, EUROSURVEILLANCE, V14; Rota JS, 2009, J MED VIROL, V81, P1819, DOI 10.1002/jmv.21557; Rubin SA, 2008, J INFECT DIS, V198, P508, DOI 10.1086/590115; SIMPSON REH, 1952, LANCET, V263, P549; Snijders BEP, 2012, VACCINE, V30, P2999, DOI 10.1016/j.vaccine.2012.02.035; STOKES J, 1946, J EXP MED, V84, P407, DOI 10.1084/jem.84.5.407; 1977, MMWR MORB MORTAL WKL, V26, P393	39	109	111	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2012	367	18					1704	1713		10.1056/NEJMoa1202865	http://dx.doi.org/10.1056/NEJMoa1202865			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RS	23113481	Bronze			2022-12-24	WOS:000310440800007
J	Diochot, S; Baron, A; Salinas, M; Douguet, D; Scarzello, S; Dabert-Gay, AS; Debayle, D; Friend, V; Alloui, A; Lazdunski, M; Lingueglia, E				Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Douguet, Dominique; Scarzello, Sabine; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Friend, Valerie; Alloui, Abdelkrim; Lazdunski, Michel; Lingueglia, Eric			Black mamba venom peptides target acid-sensing ion channels to abolish pain	NATURE			English	Article							ACTIVATED CURRENTS; ASIC3; MECHANISMS; EVOLUTION; ALIGNMENT; TOXINS	Polypeptide toxins have played a central part in understanding physiological and physiopathological functions of ion channels(1,2). In the field of pain, they led to important advances in basic research(3-6) and even to clinical applications(7,8). Acid-sensing ion channels (ASICs) are generally considered principal players in the pain pathway(9), including in humans(10). A snake toxin activating peripheral ASICs in nociceptive neurons has been recently shown to evoke pain(11). Here we show that a new class of three-finger peptides from another snake, the black mamba, is able to abolish pain through inhibition of ASICs expressed either in central or peripheral neurons. These peptides, which we call mambalgins, are not toxic in mice but show a potent analgesic effect upon central and peripheral injection that can be as strong as morphine. This effect is, however, resistant to naloxone, and mambalgins cause much less tolerance than morphine and no respiratory distress. Pharmacological inhibition by mambalgins combined with the use of knockdown and knockout animals indicates that blockade of heteromeric channels made of ASIC1a and ASIC2a subunits in central neurons and of ASIC1b-containing channels in nociceptors is involved in the analgesic effect of mambalgins. These findings identify new potential therapeutic targets for pain and introduce natural peptides that block them to produce a potent analgesia.	[Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Douguet, Dominique; Scarzello, Sabine; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Friend, Valerie; Lazdunski, Michel; Lingueglia, Eric] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, F-06560 Valbonne, France; [Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Douguet, Dominique; Scarzello, Sabine; Dabert-Gay, Anne-Sophie; Debayle, Delphine; Friend, Valerie; Lazdunski, Michel; Lingueglia, Eric] Univ Nice Sophia Antipolis, F-06560 Valbonne, France; [Diochot, Sylvie; Baron, Anne; Salinas, Miguel; Friend, Valerie; Lingueglia, Eric] LabEx Ion Channel Sci & Therapeut, F-06560 Valbonne, France; [Alloui, Abdelkrim] Univ Auvergne, Clermont Univ, NEURO DOL, F-63000 Clermont Ferrand, France; [Alloui, Abdelkrim] INSERM, U1107, F-63001 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Baron, A (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, 660 Route Lucioles, F-06560 Valbonne, France.	baron@ipmc.cnrs.fr; lingueglia@ipmc.cnrs.fr	SALINAS, Miguel/N-6380-2016; Diochot, Sylvie/ABG-5495-2020; LINGUEGLIA, Eric/F-5509-2013; douguet, dominique/D-5644-2017; BARON, Anne/N-5691-2016	SALINAS, Miguel/0000-0002-7445-123X; LINGUEGLIA, Eric/0000-0003-3902-3405; BARON, Anne/0000-0002-8026-6380	Fondation pour la Recherche Medicale; Association Francaise contre les Myopathies; Agence Nationale de la Recherche; EMMAservice under European Union of the EC FP7 Capacities Specific Programme [227490]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); EMMAservice under European Union of the EC FP7 Capacities Specific Programme	We are grateful to M. P. Price and M. J. Welsh for their gift of the ASIC1a<SUP>-/-</SUP> mice, to A. Zimmer for providing the Penk1<SUP>-/-</SUP> mice, to H. Schweitz and L. Beress for their gift of pre-purified peptidic fractions of black mamba venom, to J. Noel for cultures of hippocampal neurons and comments, to E. Deval, P. Inquimbert, A. Delaunay and M. Christin for discussions, to C. Heurteaux and N. Blondeau for help with stereotaxic injections, to A. Lazzari for support with plethysmography, to V. Thieffin, N. Leroudier, S. Boulakirba, T. Lemaire, C. Karoutchi and G. Marrane for technical assistance, and to C. Chevance for secretarial assistance. We thank E. Bourinet, F. Rassendren and M. B. Emerit for providing the Cav3.2, P2X2 and 5-HT3A cDNAs, respectively. This work was supported by the Fondation pour la Recherche Medicale, the Association Francaise contre les Myopathies and the Agence Nationale de la Recherche. Part of this work has been supported by EMMAservice under European Union contract Grant Agreement number 227490 of the EC FP7 Capacities Specific Programme.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2008, J NEUROSCI, V28, P1498, DOI 10.1523/JNEUROSCI.4975-07.2008; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen TB, 2002, ANAL BIOCHEM, V311, P152, DOI 10.1016/S0003-2697(02)00404-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2011, J NEUROSCI, V31, P6059, DOI 10.1523/JNEUROSCI.5266-10.2011; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Douguet D, 2001, BIOINFORMATICS, V17, P752, DOI 10.1093/bioinformatics/17.8.752; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fitzjohn SM, 2001, NEUROPHARMACOLOGY, V41, P693, DOI 10.1016/S0028-3908(01)00128-9; Fromy B, 2012, NAT MED, V18, P1205, DOI 10.1038/nm.2844; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; Labesse G, 1998, BIOINFORMATICS, V14, P206, DOI 10.1093/bioinformatics/14.2.206; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; MALMBERG AB, 1995, PAIN, V60, P83, DOI 10.1016/0304-3959(94)00094-U; Mamet J, 2002, J NEUROSCI, V22, P10662; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; SCHWEITZ H, 1990, TOXICON, V28, P847, DOI 10.1016/S0041-0101(09)80007-X; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Vanegas H, 2000, PAIN, V85, P9, DOI 10.1016/S0304-3959(99)00241-9; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Zhou HY, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20732	43	276	288	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					552	+		10.1038/nature11494	http://dx.doi.org/10.1038/nature11494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23034652				2022-12-24	WOS:000310196200045
J	Landsberg, J; Kohlmeyer, J; Renn, M; Bald, T; Rogava, M; Cron, M; Fatho, M; Lennerz, V; Wolfel, T; Holzel, M; Tuting, T				Landsberg, Jennifer; Kohlmeyer, Judith; Renn, Marcel; Bald, Tobias; Rogava, Meri; Cron, Mira; Fatho, Martina; Lennerz, Volker; Woelfel, Thomas; Hoelzel, Michael; Tueting, Thomas			Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation	NATURE			English	Article							METASTATIC MELANOMA; CANCER REGRESSION; IN-VIVO; IMMUNOTHERAPY; ANTIGEN; LYMPHOCYTES; MICE; GROWTH; AUTOIMMUNITY; RESPONSES	Adoptive cell transfer therapies (ACTs) with cytotoxic T cells that target melanocytic antigens can achieve remissions in patients with metastatic melanomas, but tumours frequently relapse(1,2). Hypotheses explaining the acquired resistance to ACTs include the selection of antigen-deficient tumour cell variants(3-5) and the induction of T-cell tolerance(6). However, the lack of appropriate experimental melanoma models has so far impeded clear insights into the underlying mechanisms. Here we establish an effective ACT protocol in a genetically engineered mouse melanoma model that recapitulates tumour regression, remission and relapse as seen in patients. We report the unexpected observation that melanomas acquire ACT resistance through an inflammation-induced reversible loss of melanocytic antigens. In serial transplantation experiments, melanoma cells switch between a differentiated and a dedifferentiated phenotype in response to T-cell-driven inflammatory stimuli. We identified the proinflammatory cytokine tumour necrosis factor (TNF)-alpha as a crucial factor that directly caused reversible dedifferentiation of mouse and human melanoma cells. Tumour cells exposed to TNF-alpha were poorly recognized by T cells specific for melanocytic antigens, whereas recognition by T cells specific for non-melanocytic antigens was unaffected or even increased. Our results demonstrate that the phenotypic plasticity of melanoma cells in an inflammatory microenvironment contributes to tumour relapse after initially successful T-cell immunotherapy. On the basis of our work, we propose that future ACT protocols should simultaneously target melanocytic and non-melanocytic antigens to ensure broad recognition of both differentiated and dedifferentiated melanoma cells, and include strategies to sustain T-cell effector functions by blocking immune-inhibitory mechanisms in the tumour microenvironment.	[Landsberg, Jennifer; Kohlmeyer, Judith; Renn, Marcel; Bald, Tobias; Rogava, Meri; Cron, Mira; Tueting, Thomas] Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53105 Bonn, Germany; [Fatho, Martina; Lennerz, Volker; Woelfel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, D-55101 Mainz, Germany; [Hoelzel, Michael] Univ Bonn, Unit RNA Biol, Dept Clin Chem & Clin Pharmacol, D-53105 Bonn, Germany	University of Bonn; Johannes Gutenberg University of Mainz; University of Bonn	Tuting, T (corresponding author), Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53105 Bonn, Germany.	thomas.tueting@ukb.uni-bonn.de	Tüting, Thomas/AAJ-3610-2021; Landsberg, Jenny/AGI-0216-2022; Wölfel, Thomas/G-6519-2012; Bald, Tobias/H-9525-2018; Landsberg, Jennifer/AAF-5113-2019	Tüting, Thomas/0000-0001-7146-0934; Landsberg, Jenny/0000-0001-8029-3883; Bald, Tobias/0000-0003-0061-235X; Rogava, Meri/0000-0002-0314-5323; Renn, Marcel/0000-0002-0120-4035; Sirokay, Judith/0000-0003-3945-845X	DFG [SFB832, SFB704, SFB 432]; Deutsche Krebshilfe (P9 in the Melanoma Research Network); BONFOR	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe (P9 in the Melanoma Research Network); BONFOR	We would like to thank G. Merlino and M. Barbacid for providing genetically engineered mice; E. Endl for help with FACS sorting; S. Herms and P. Hoffmann for the cDNA microarrays; S. Mikus, A. Sporleder and C. Lemke for managing the mouse colony and performing histopathology, immunohistopatholgoy, immunoblotting and real-time PCR. This research was supported in part by grants from the DFG (A12 in the SFB832 and A22 in the SFB704) and the Deutsche Krebshilfe (P9 in the Melanoma Research Network) to T. T., by grants from BONFOR to J.L. and J.K., and by a DFG grant (A1 in the SFB 432) to T. W. T. T. and M. H. are members of the Excellence Cluster ImmunoSensation.	[Anonymous], 2010, R LANG ENV STAT COMP; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kanik AB, 1996, J CUTAN PATHOL, V23, P205, DOI 10.1111/j.1600-0560.1996.tb01468.x; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; Landsberg J, 2010, PIGM CELL MELANOMA R, V23, P649, DOI 10.1111/j.1755-148X.2010.00744.x; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; O'Rourke MGE, 2007, MELANOMA RES, V17, P316, DOI 10.1097/CMR.0b013e3282c3a73b; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Steitz J, 2000, INT J CANCER, V86, P89, DOI 10.1002/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tormo D, 2006, AM J PATHOL, V169, P665, DOI 10.2353/ajpath.2006.060017; Tormo D, 2006, CANCER RES, V66, P5427, DOI 10.1158/0008-5472.CAN-06-0399; van der Laan M. J., 2009, U C BERKELEY DIV BIO; Vatakis DN, 2011, P NATL ACAD SCI USA, V108, pE1408, DOI 10.1073/pnas.1115050108; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	43	377	387	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					412	+		10.1038/nature11538	http://dx.doi.org/10.1038/nature11538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23051752				2022-12-24	WOS:000309918500048
J	Huang, SD; Holzel, M; Knijnenburg, T; Schlicker, A; Roepman, P; McDermott, U; Garnett, M; Grernrum, W; Sun, C; Prahallad, A; Groenendijk, FH; Mittempergher, L; Nijkamp, W; Neefjes, J; Salazar, R; ten Dijke, P; Uramoto, H; Tanaka, F; Beijersbergen, RL; Wessels, LFA; Bernards, R				Huang, Sidong; Hoelzel, Michael; Knijnenburg, Theo; Schlicker, Andreas; Roepman, Paul; McDermott, Ultan; Garnett, Mathew; Grernrum, Wipawadee; Sun, Chong; Prahallad, Anirudh; Groenendijk, Floris H.; Mittempergher, Lorenza; Nijkamp, Wouter; Neefjes, Jacques; Salazar, Ramon; ten Dijke, Peter; Uramoto, Hidetaka; Tanaka, Fumihiro; Beijersbergen, Roderick L.; Wessels, Lodewyk F. A.; Bernards, Rene			MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-beta Receptor Signaling	CELL			English	Article							ANAPLASTIC LYMPHOMA KINASE; CELL LUNG-CANCER; COLORECTAL-CANCER; RESISTANCE; MUTATIONS; SENSITIVITY; INHIBITION; PATHWAY; THERAPY; SCREEN	Inhibitors of the ALK and EGF receptor tyrosine kinases provoke dramatic but short-lived responses in lung cancers harboring EML4-ALK translocations or activating mutations of EGFR, respectively. We used a large-scale RNAi screen to identify MED12, a component of the transcriptional MEDIATOR complex that is mutated in cancers, as a determinant of response to ALK and EGFR inhibitors. MED12 is in part cytoplasmic where it negatively regulates TGF-beta R2 through physical interaction. MED12 suppression therefore results in activation of TGF-beta R signaling, which is both necessary and sufficient for drug resistance. TGF-beta signaling causes MEK/ERK activation, and consequently MED12 suppression also confers resistance to MEK and BRAF inhibitors in other cancers. MED12 loss induces an EMT-like phenotype, which is associated with chemotherapy resistance in colon cancer patients and to gefitinib in lung cancer. Inhibition of TGF-beta R signaling restores drug responsiveness in MED12(KD) cells, suggesting a strategy to treat drug-resistant tumors that have lost MED12.	[Huang, Sidong; Hoelzel, Michael; Knijnenburg, Theo; Schlicker, Andreas; Grernrum, Wipawadee; Sun, Chong; Prahallad, Anirudh; Groenendijk, Floris H.; Mittempergher, Lorenza; Nijkamp, Wouter; Beijersbergen, Roderick L.; Wessels, Lodewyk F. A.; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Huang, Sidong; Hoelzel, Michael; Knijnenburg, Theo; Schlicker, Andreas; Grernrum, Wipawadee; Sun, Chong; Prahallad, Anirudh; Groenendijk, Floris H.; Mittempergher, Lorenza; Nijkamp, Wouter; Beijersbergen, Roderick L.; Wessels, Lodewyk F. A.; Bernards, Rene] Netherlands Canc Inst, Canc Syst Biol Ctr, NL-1066 CX Amsterdam, Netherlands; [Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Roepman, Paul; Bernards, Rene] Agendia Inc, Irvine, CA 92618 USA; [Roepman, Paul; Bernards, Rene] Agendia NV, NL-1098 XH Amsterdam, Netherlands; [McDermott, Ultan; Garnett, Mathew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Salazar, Ramon] Inst Catala Oncol IDIBELL, Lhospitalet De Llobregat 08908, Spain; [ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Uramoto, Hidetaka; Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Dept Surg 2, Sch Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Agendia; Agendia; Wellcome Trust Sanger Institute; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Occupational & Environmental Health - Japan	Bernards, R (corresponding author), Netherlands Canc Inst, Canc Genom Ctr, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Dijke, Peter ten/AAG-4660-2021; Sun, Chong/AAB-4859-2021; Neefjes, Jacques J.C./H-8780-2017	Dijke, Peter ten/0000-0002-7234-342X; Sun, Chong/0000-0001-9008-2158; Neefjes, Jacques J.C./0000-0001-6763-2211; Bernards, Rene/0000-0001-8677-3423; Mittempergher, Lorenza/0000-0003-3425-3965; Huang, Sidong/0000-0002-2838-4726; Beijersbergen, Roderick/0000-0003-0116-4130; McDermott, Ultan/0000-0001-9032-4700; Schlicker, Andreas/0000-0002-6588-7883	Dutch Cancer Society; European Research Council grant; Cancer Systems Biology Center grant by NWO; Netherlands Genomics Initiative (NGI); Spanish BAE FIS travel grant by Instituto Carlos III	Dutch Cancer Society(KWF Kankerbestrijding); European Research Council grant(European Research Council (ERC)); Cancer Systems Biology Center grant by NWO; Netherlands Genomics Initiative (NGI); Spanish BAE FIS travel grant by Instituto Carlos III	We thank the members of the NKI Genomics Core Facility, Maarten van Dinther, Jelle Wesseling, Ingrid Hofland, Ian Majewski, Kylie Greig, Johan Kuiken, and Erik Voets for technical support and discussion. We are grateful to Cinzia Pochet for support. This work was supported by grants from the Dutch Cancer Society, a European Research Council grant, The Cancer Systems Biology Center grant by NWO, The Netherlands Genomics Initiative (NGI), and a Spanish BAE FIS travel grant by Instituto Carlos III (to R.S.). P.R. and R.B. are employees and shareholders of Agendia Inc.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uramoto H, 2011, LUNG CANCER, V73, P361, DOI 10.1016/j.lungcan.2011.01.008; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	31	308	333	0	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					937	950		10.1016/j.cell.2012.10.035	http://dx.doi.org/10.1016/j.cell.2012.10.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178117	Bronze, Green Accepted			2022-12-24	WOS:000311423500009
J	Wu, BR; Zhang, Z; Lui, W; Chen, XJ; Wang, YD; Chamberlain, AA; Moreno-Rodriguez, RA; Markwald, RR; O'Rourke, BP; Sharp, DJ; Zheng, DY; Lenz, J; Baldwin, HS; Chang, CP; Zhou, B				Wu, Bingruo; Zhang, Zheng; Lui, Wendy; Chen, Xiangjian; Wang, Yidong; Chamberlain, Alyssa A.; Moreno-Rodriguez, Ricardo A.; Markwald, Roger R.; O'Rourke, Brian P.; Sharp, David J.; Zheng, Deyou; Lenz, Jack; Baldwin, H. Scott; Chang, Ching-Pin; Zhou, Bin			Endocardial Cells Form the Coronary Arteries by Angiogenesis through Myocardial-Endocardial VEGF Signaling	CELL			English	Article							SMOOTH-MUSCLE-CELLS; CARDIAC MORPHOGENESIS; TRANSCRIPTION FACTOR; VESSEL DEVELOPMENT; ENDOTHELIAL-CELLS; NF-ATC; MOUSE; EXPRESSION; LINEAGE; ORIGIN	The origins and developmental mechanisms of coronary arteries are incompletely understood. We show here by fate mapping, clonal analysis, and immunohistochemistry that endocardial cells generate the endothelium of coronary arteries. Dye tracking, live imaging, and tissue transplantation also revealed that ventricular endocardial cells are not terminally differentiated; instead, they are angiogenic and form coronary endothelial networks. Myocardial Vegf-a or endocardial Vegfr-2 deletion inhibited coronary angiogenesis and arterial formation by ventricular endocardial cells. In contrast, lineage and knockout studies showed that endocardial cells make a small contribution to the coronary veins, the formation of which is independent of myocardialto-endocardial Vegf signaling. Thus, contrary to the current view of a common source for the coronary vessels, our findings indicate that the coronary arteries and veins have distinct origins and are formed by different mechanisms. This information may help develop better cell therapies for coronary artery disease.	[Wu, Bingruo; Zhang, Zheng; Lui, Wendy; Chen, Xiangjian; Wang, Yidong; Chamberlain, Alyssa A.; Lenz, Jack; Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10461 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10461 USA; [O'Rourke, Brian P.; Sharp, David J.] Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Zheng, Deyou] Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Wu, Bingruo; Baldwin, H. Scott; Zhou, Bin] Vanderbilt Univ, Dept Pediat, Nashville, TN 37322 USA; [Zhang, Zheng; Wang, Yidong] Sichuan Univ, State Key Lab Biotherapy, W China Med Sch, Chengdu 610041, Sichuan, Peoples R China; [Chen, Xiangjian; Zhou, Bin] Jiangsu Prov Hosp, Dept Cardiol, Nanjing 210029, Jiangsu, Peoples R China; [Moreno-Rodriguez, Ricardo A.; Markwald, Roger R.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29403 USA; [Chang, Ching-Pin] Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University; Sichuan University; Nanjing Medical University; Medical University of South Carolina; Stanford University	Zhou, B (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	bin.zhou@einstein.yu.edu	Zhang, Zheng/G-7187-2016; moreno, ricardo/AAS-5868-2021; Moreno-Rodriguez, Ricardo/GPT-4006-2022	Zheng, Deyou/0000-0003-4354-5337; Moreno Rodriguez, Ricardo Alberto/0000-0002-5420-4231	NIH [HL078881, HL100398, HL85345]; AHA [0435128N]; Tuner-Hazinski Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100398, R01HL078881, R01HL085345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Tuner-Hazinski Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to Napoleone Ferrara, Janet Rossant, Kyunghee Choi, and Gordon Fishell for Vegf-a<SUP>f/f</SUP>, Vegfr-2<SUP>f/f</SUP>, RCE<SUP>fsEGFP</SUP> mice. We thank Drs. Bernice Morrow and Richard Kitsis for critical reading of the manuscript and Tatyana Harris for the illustration. B.Z. was supported by NIH (HL078881), AHA (0435128N) and Tuner-Hazinski Research Award. H.S.B. and C.-P.C. were supported by NIH (HL100398 and HL85345, respectively).	Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen JW, 2006, CIRC RES, V98, P923, DOI 10.1161/01.RES.0000218041.41932.e3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Gustafsson E, 2001, J CELL SCI, V114, P671; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; KOMIYAMA M, 1987, ANAT EMBRYOL, V176, P183, DOI 10.1007/BF00310051; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239; Luttun A, 2003, CARDIOVASC RES, V58, P378, DOI 10.1016/S0008-6363(03)00258-X; Majesky MW, 2004, CURR TOP DEV BIOL, V62, P225; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Perez-Pomares JM, 2002, INT J DEV BIOL, V46, P1005; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Sugi Y, 1996, DEV BIOL, V175, P66, DOI 10.1006/dbio.1996.0096; Tomanek RJ, 2006, CIRC RES, V98, P947, DOI 10.1161/01.RES.0000216974.75994.da; VIRAGH S, 1981, ANAT REC, V201, P157, DOI 10.1002/ar.1092010117; Wada AM, 2003, ARTERIOSCL THROM VAS, V23, P2138, DOI 10.1161/01.ATV.0000098645.38676.CC; Wikenheiser J, 2006, DEV DYNAM, V235, P115, DOI 10.1002/dvdy.20499; Wu BR, 2011, CIRC RES, V109, P183, DOI 10.1161/CIRCRESAHA.111.245035; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhou B, 2005, DEVELOPMENT, V132, P1137, DOI 10.1242/dev.01640; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	45	256	263	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2012	151	5					1083	1096		10.1016/j.cell.2012.10.023	http://dx.doi.org/10.1016/j.cell.2012.10.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	041TG	23178125	Green Accepted, Bronze			2022-12-24	WOS:000311423500020
J	Wang, RC; Wei, YJ; An, ZY; Zou, ZJ; Xiao, GH; Bhagat, G; White, M; Reichelt, J; Levine, B				Wang, Richard C.; Wei, Yongjie; An, Zhenyi; Zou, Zhongju; Xiao, Guanghua; Bhagat, Govind; White, Michael; Reichelt, Julia; Levine, Beth			Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation	SCIENCE			English	Article							MAMMALIAN AUTOPHAGY; INHIBITION; GROWTH; CANCER; TUMORS; CELLS	Aberrant signaling through the class I phosphatidylinositol 3-kinase (PI3K)-Akt axis is frequent in human cancer. Here, we show that Beclin 1, an essential autophagy and tumor suppressor protein, is a target of the protein kinase Akt. Expression of a Beclin 1 mutant resistant to Akt-mediated phosphorylation increased autophagy, reduced anchorage-independent growth, and inhibited Akt-driven tumorigenesis. Akt-mediated phosphorylation of Beclin 1 enhanced its interactions with 14-3-3 and vimentin intermediate filament proteins, and vimentin depletion increased autophagy and inhibited Akt-driven transformation. Thus, Akt-mediated phosphorylation of Beclin 1 functions in autophagy inhibition, oncogenesis, and the formation of an autophagy-inhibitory Beclin 1/14-3-3/vimentin intermediate filament complex. These findings have broad implications for understanding the role of Akt signaling and intermediate filament proteins in autophagy and cancer.	[Wang, Richard C.; Wei, Yongjie; An, Zhenyi; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Wang, Richard C.] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA; [Wei, Yongjie; An, Zhenyi; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Wei, Yongjie; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Bhagat, Govind] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bhagat, Govind] New York Presbyterian Hosp, New York, NY 10032 USA; [White, Michael] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Reichelt, Julia] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; NewYork-Presbyterian Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Newcastle University - UK; University of Texas System; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Wang, Richard/AAW-3066-2021; Bhagat, Govind/AAE-9493-2021; Reichelt, Julia/AAP-1842-2021; An, Zhenyi/H-9061-2016	Wang, Richard/0000-0003-4543-8295; Bhagat, Govind/0000-0001-6250-048X; Reichelt, Julia/0000-0002-4358-7011; 	NIH/National Cancer Institute [ROI CA84254-S1, RO1 CA109618, ROI CA129451, KO8 CA164047]; Dermatology Foundation Career Development Award; Burroughs Wellcome Fund Career Award for Medical Scientists; German Research Foundation [RE2673/1-1]; NATIONAL CANCER INSTITUTE [R01CA084254, R01CA129451, R01CA109618, R01CA071443, P30CA142543, K08CA164047] Funding Source: NIH RePORTER	NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dermatology Foundation Career Development Award; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. De Berardinis, W. Hahn, D. Lev, P. Mischel, N. Mizushima, B. Omary, G. Pearson, W. Sellers, R. Weinberg, and M. Yaffe for providing critical reagents and A. Diehl and H. Harrington for help with manuscript preparation. This work was supported by NIH/National Cancer Institute grants ROI CA84254-S1 and RO1 CA109618 to B. L., ROI CA129451 to M. W., KO8 CA164047 to R. W., a Dermatology Foundation Career Development Award, a Burroughs Wellcome Fund Career Award for Medical Scientists to R. W., and German Research Foundation grant RE2673/1-1 to J.R.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	21	511	549	10	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2012	338	6109					956	959		10.1126/science.1225967	http://dx.doi.org/10.1126/science.1225967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23112296	Green Accepted			2022-12-24	WOS:000311083600046
J	Allen, AS; Sequist, TD				Allen, Adrienne S.; Sequist, Thomas D.			Pharmacy Dispensing of Electronically Discontinued Medications	ANNALS OF INTERNAL MEDICINE			English	Article							ADVERSE DRUG EVENTS; HEALTH INFORMATION-TECHNOLOGY; CARE; PERFORMANCE; SAFETY	Background: Most physician offices do not transmit orders for medication discontinuation to the pharmacy, creating the potential for errors in dispensing of previously prescribed medications. Electronic health records offer the potential to assess this patient safety concern. Objective: To assess the frequency of and potential patient harm associated with pharmacy dispensing of discontinued medications in the ambulatory setting. Design: Retrospective cohort study. Setting: Multispecialty group practice in eastern Massachusetts using an electronic health record. Patients: 30 406 adult patients with an electronic discontinuation order for antihypertensive, antiplatelet, anticoagulant, oral hypoglycemic, and statin medications between November 2008 and October 2009. Measurements: Dispensing of discontinued medications within 12 months and associated potential patient harm. Results: Among 83 902 targeted medications that were electronically discontinued, 1218 (1.5% [95% CI, 1.4% to 1.5%]) were subsequently dispensed by the pharmacy a mean of 1.0 (SD, 0.3) time during the 12-month follow-up. Among the top 10 most frequently electronically discontinued medications, the rate of subsequent dispensing by a pharmacy ranged from 0.9% for metformin to 2.5% for metoprolol. Manual chart review of 416 medication-dispensing events that were predefined as high risk according to an automated algorithm identified potential harm in 50 (12%) cases, including clinical reactions (n = 18), laboratory abnormalities (n = 17), duplicated medication classes dispensed (n = 8), and potential allergic reactions (n = 7). Limitation: Information on pharmacy dispensing was available for only 52% of medication orders. Conclusion: The dispensing of discontinued medications represents an important ambulatory patient safety concern. Electronic health records should be used to facilitate better communication between providers and pharmacies and improve medication safety. Primary Funding Source: National Institutes of Health.	[Allen, Adrienne S.] N Shore Phys Grp, Danvers, MA 01923 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Vanguard Med Associates, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard Vanguard Medical Associates	Allen, AS (corresponding author), N Shore Phys Grp, 104 Endicott St,Suite 104, Danvers, MA 01923 USA.	aallen0@partners.org			National Institutes of Health [T32HP10251-02]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Allen was funded by a National Institutes of Health Institutional National Research Service Award (T32HP10251-02).	Allen AS, 2011, J PATIENT SAF, V7, P122, DOI 10.1097/PTS.0b013e318223cb41; Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Kaushal R, 2010, J GEN INTERN MED, V25, P530, DOI 10.1007/s11606-009-1238-8; Metzger J, 2010, HEALTH AFFAIR, V29, P655, DOI 10.1377/hlthaff.2010.0160; Nemeth Lynne S, 2010, J Patient Saf, V6, P238, DOI 10.1097/PTS.0b013e3181fe401f; Sequist TD, 2006, ARCH INTERN MED, V166, P2237, DOI 10.1001/archinte.166.20.2237; Sequist TD, 2011, MED CARE, V49, P126, DOI 10.1097/MLR.0b013e3181d5690f; Sequist TD, 2010, ANN INTERN MED, V152, P40, DOI 10.7326/0003-4819-152-1-201001050-00009	15	27	27	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2012	157	10					700	+		10.7326/0003-4819-157-10-201211200-00006	http://dx.doi.org/10.7326/0003-4819-157-10-201211200-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	043VZ	23165661				2022-12-24	WOS:000311580000015
J	Goetz, SC; Liem, KF; Anderson, KV				Goetz, Sarah C.; Liem, Karel F., Jr.; Anderson, Kathryn V.			The Spinocerebellar Ataxia-Associated Gene Tau Tubulin Kinase 2 Controls the Initiation of Ciliogenesis	CELL			English	Article							TAU-TUBULIN KINASE; INTRAFLAGELLAR TRANSPORT PROTEINS; HEDGEHOG SIGNAL-TRANSDUCTION; NEURAL STEM-CELLS; PRIMARY CILIA; REPRESSOR FUNCTIONS; MECKEL SYNDROME; SONIC HEDGEHOG; MOUSE; MEMBRANE	The primary cilium has critical roles in human development and disease, but the mechanisms that regulate ciliogenesis are not understood. Here, we show that Tau tubulin kinase 2 (TTBK2) is a dedicated regulator of the initiation of ciliogenesis in vivo. We identified a null allele of mouse Ttbk2 based on loss of Sonic hedgehog activity, a signaling pathway that requires the primary cilium. Despite a normal basal body template, Ttbk2 mutants lack cilia. TTBK2 acts at the distal end of the basal body, where it promotes the removal of CP110, which caps the mother centriole, and promotes recruitment of IFT proteins, which build the ciliary axoneme. Dominant truncating mutations in human TTBK2 cause spinocerebellar ataxia type 11 (SCA11); these mutant proteins do not promote ciliogenesis and inhibit ciliogenesis in wild-type cells. We propose that cell-cycle regulators target TTBK2 to the basal body, where it modifies specific targets to initiate ciliogenesis.	[Goetz, Sarah C.; Liem, Karel F., Jr.; Anderson, Kathryn V.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Anderson, KV (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	k-anderson@sloankettering.edu		Anderson, Kathryn/0000-0003-1657-2161	NIH [NS044385]; American Cancer Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to P. Jallepalli and B. Tsou and their laboratories for reagents and advice on retroviral transduction. We thank James Sillibourne and Michel Bornens (Institut Curie), Brian Dynlacht (NYU), and Greg Pazour (University of Massachusetts Medical School) for antibodies. We thank the MSKCC Molecular Cytology Core Facility and the Bio-Imaging Resource Center at Rockefeller University for help with imaging; the MSKCC Electron Microscopy Core Facility for SEM; and Peter Satir and Leslie Gunther at the Analytical Imaging Center of Albert Einstein College of Medicine for assistance with TEM. We thank A. Parrish, H. Bazzi, and F. Bangs for comments on the manuscript. This work was funded by NIH Grant NS044385 to K. V. A. and an American Cancer Society Postdoctoral Fellowship to S.C.G.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Aughsteen AA, 2001, EUR J MORPHOL, V39, P277, DOI 10.1076/ejom.39.5.277.7380; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bauer P, 2010, J NEUROL NEUROSUR PS, V81, P1229, DOI 10.1136/jnnp.2009.202150; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chakravarthy B, 2010, BIOCHEM BIOPH RES CO, V401, P458, DOI 10.1016/j.bbrc.2010.09.081; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Dowdle WE, 2011, AM J HUM GENET, V89, P94, DOI 10.1016/j.ajhg.2011.06.003; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; FONTE VG, 1971, J CELL BIOL, V49, P226, DOI 10.1083/jcb.49.1.226; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Ko HW, 2010, DEV CELL, V18, P237, DOI 10.1016/j.devcel.2009.12.014; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Matilla-Duenas A., 2012, CEREBELLUM; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qi HY, 2009, DEV DYNAM, V238, P3248, DOI 10.1002/dvdy.22150; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; TAKAHASHI M, 1995, FEBS LETT, V372, P59, DOI 10.1016/0014-5793(95)00955-9; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Tomizawa K, 2001, FEBS LETT, V492, P221, DOI 10.1016/S0014-5793(01)02256-6; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681	56	155	160	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					847	858		10.1016/j.cell.2012.10.010	http://dx.doi.org/10.1016/j.cell.2012.10.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	23141541	Green Accepted, Bronze			2022-12-24	WOS:000310921200015
J	Derr, ND; Goodman, BS; Jungmann, R; Leschziner, AE; Shih, WM; Reck-Peterson, SL				Derr, N. D.; Goodman, B. S.; Jungmann, R.; Leschziner, A. E.; Shih, W. M.; Reck-Peterson, S. L.			Tug-of-War in Motor Protein Ensembles Revealed with a Programmable DNA Origami Scaffold	SCIENCE			English	Article							CYTOPLASMIC DYNEIN; INTRACELLULAR-TRANSPORT; BIDIRECTIONAL TRANSPORT; ORGANELLE TRANSPORT; TRANSIENT BINDING; STEPPING BEHAVIOR; MOLECULAR MOTORS; CARGO TRANSPORT; KINESIN; MICROTUBULES	Cytoplasmic dynein and kinesin-1 are microtubule-based motors with opposite polarity that transport a wide variety of cargo in eukaryotic cells. Many cellular cargos demonstrate bidirectional movement due to the presence of ensembles of dynein and kinesin, but are ultimately sorted with spatial and temporal precision. To investigate the mechanisms that coordinate motor ensemble behavior, we built a programmable synthetic cargo using three-dimensional DNA origami to which varying numbers of DNA oligonucleotide-linked motors could be attached, allowing for control of motor type, number, spacing, and orientation in vitro. In ensembles of one to seven identical-polarity motors, motor number had minimal affect on directional velocity, whereas ensembles of opposite-polarity motors engaged in a tug-of-war resolvable by disengaging one motor species.	[Derr, N. D.; Goodman, B. S.; Reck-Peterson, S. L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Derr, N. D.; Shih, W. M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Derr, N. D.; Shih, W. M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jungmann, R.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Jungmann, R.; Shih, W. M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Leschziner, A. E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University	Reck-Peterson, SL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	reck-peterson@hms.harvard.edu	Jungmann, Ralf/A-6357-2015	Jungmann, Ralf/0000-0003-4607-3312; Leschziner, Andres/0000-0002-7732-7023; Reck-Peterson, Samara/0000-0002-1553-465X	Alexander von Humboldt Foundation; Rita Allen Foundation; Harvard Armenise Foundation; NIH [1 DP2 OD004268-1, 1U54GM094608, 1DP2OD004641]; ONR [N000014091118, N000141010241]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094608] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268, DP2OD004641] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Rita Allen Foundation; Harvard Armenise Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Lin for assistance with electron microscopy; F. Aguet for assistance with data analysis; J. Huang, W. Qiu, W. B. Redwine, and A. Roberts for helpful advice and critical reading of the manuscript; members of the Reck-Peterson and Shih labs for advice and helpful discussions; and J. Iwasa for illustrations. EM data were collected at the Center for Nanoscale Systems, Harvard University. DNA-PAINT data were collected at the Nikon Imaging Center, Harvard Medical School. R. J. is supported from the Alexander von Humboldt Foundation through a Feodor Lynen fellowship. S.L.R.-P. is funded by the Rita Allen Foundation, the Harvard Armenise Foundation, and a NIH New Innovator award (1 DP2 OD004268-1). W. M. S. is funded by NIH awards (1U54GM094608 and 1DP2OD004641) and ONR awards (N000014091118 and N000141010241).	Ali MY, 2011, P NATL ACAD SCI USA, V108, pE535, DOI 10.1073/pnas.1104298108; Amrute-Nayak M, 2012, NAT CELL BIOL, V14, P416, DOI 10.1038/ncb2446; Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; Bryantseva SA, 2012, CELL BIOL INT, V36, P1, DOI 10.1042/CBI20110413; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Constantinou PE, 2010, J BIOMECH, V43, P31, DOI 10.1016/j.jbiomech.2009.09.006; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Jamison DK, 2012, J BIOL CHEM, V287, P3357, DOI 10.1074/jbc.M111.296582; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Ke YG, 2012, J AM CHEM SOC, V134, P1770, DOI 10.1021/ja209719k; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Ko SH, 2012, ADV FUNCT MATER, V22, P1015, DOI 10.1002/adfm.201102077; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Leduc C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128103; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Lu HL, 2012, J BIOL CHEM, V287, P27753, DOI 10.1074/jbc.M112.371393; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1992, J CELL BIOL, V119, P1589, DOI 10.1083/jcb.119.6.1589; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Xu J, 2012, TRAFFIC, V13, P1198, DOI 10.1111/j.1600-0854.2012.01385.x; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	38	281	293	1	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					662	665		10.1126/science.1226734	http://dx.doi.org/10.1126/science.1226734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23065903	Green Submitted, Green Accepted			2022-12-24	WOS:000310516000052
J	Ginsberg, M; James, D; Ding, BS; Nolan, D; Geng, FQ; Butler, JM; Schachterle, W; Pulijaal, VR; Mathew, S; Chasen, ST; Xiang, J; Rosenwaks, Z; Shido, K; Elemento, O; Rabbany, SY; Rafii, S				Ginsberg, Michael; James, Daylon; Ding, Bi-Sen; Nolan, Daniel; Geng, Fuqiang; Butler, Jason M.; Schachterle, William; Pulijaal, Venkat R.; Mathew, Susan; Chasen, Stephen T.; Xiang, Jenny; Rosenwaks, Zev; Shido, Koji; Elemento, Olivier; Rabbany, Sina Y.; Rafii, Shahin			Efficient Direct Reprogramming of Mature Amniotic Cells into Endothelial Cells by ETS Factors and TGF beta Suppression	CELL			English	Article							TRANSCRIPTION FACTOR ERG; HEMATOPOIETIC STEM-CELLS; ANGIOCRINE SIGNALS; DIFFERENTIATION; ANGIOGENESIS; FAMILY; GROWTH; GENE; FLI1; ERYTHROLEUKEMIA	ETS transcription factors ETV2, FLI1, and ERG1 specify pluripotent stem cells into induced vascular endothelial cells (iVECs). However, iVECs are unstable and drift toward nonvascular cells. We show that human midgestation c-Kit(-) lineage-committed amniotic cells (ACs) can be reprogrammed into vascular endothelial cells (rAC-VECs) without transitioning through a pluripotent state. Transient ETV2 expression in ACs generates immature rAC-VECs, whereas coexpression with FLI1/ERG1 endows rAC-VECs with a vascular repertoire and morphology matching mature endothelial cells (ECs). Brief TGF beta-inhibition functionalizes VEGFR2 signaling, augmenting specification of ACs into rAC-VECs. Genome-wide transcriptional analyses showed that rAC-VECs are similar to adult ECs in which vascular-specific genes are expressed and nonvascular genes are silenced. Functionally, rAC-VECs form stable vasculature in Matrigel plugs and regenerating livers. Therefore, short-term ETV2 expression and TGF beta inhibition with constitutive ERG1/FLI1 coexpression reprogram mature ACs into durable rAC-VECs with clinical-scale expansion potential. Banking of HLA-typed rAC-VECs establishes a vascular inventory for treatment of diverse disorders.	[Ginsberg, Michael; James, Daylon; Ding, Bi-Sen; Nolan, Daniel; Geng, Fuqiang; Butler, Jason M.; Schachterle, William; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA; [Chasen, Stephen T.] Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY 10065 USA; [Xiang, Jenny] Weill Cornell Med Coll, Genom Resources Core Facil, New York, NY 10065 USA; [Pulijaal, Venkat R.; Mathew, Susan] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [James, Daylon; Rosenwaks, Zev] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11549 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; Cornell University; Hofstra University	Rafii, S (corresponding author), Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu			Howard Hughes Medical Institute; Ansary Stem Cell Institute; Empire State Stem Cell Board; NHLBI [R01s HL097797, DK095039]; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Qatar foundation BioMedical Research Program (BMRP); New York State Department of Health (NYSTEM) [C024180, C026438, C026878]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; Empire State Stem Cell Board; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Qatar National Priorities Research Foundation; Qatar foundation BioMedical Research Program (BMRP)(Qatar National Research Fund (QNRF)); New York State Department of Health (NYSTEM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	S.R. is supported by Howard Hughes Medical Institute; Ansary Stem Cell Institute; Empire State Stem Cell Board and New York State Department of Health grants (NYSTEM, C024180, C026438, C026878); NHLBI R01s HL097797 and DK095039; Qatar National Priorities Research Foundation NPRP08-663-3-140; and Qatar foundation BioMedical Research Program (BMRP). The authors acknowledge Agnes Stachnik and Pooja Rana for their technical contribution to this work.	Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Benavides OM, 2012, TISSUE ENG PT A, V18, P1123, DOI [10.1089/ten.tea.2011.0392, 10.1089/ten.TEA.2011.0392]; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cui JW, 2009, LEUKEMIA, V23, P1311, DOI 10.1038/leu.2009.20; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dryden NH, 2012, J BIOL CHEM, V287, P12331, DOI 10.1074/jbc.M112.346791; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Konig J, 2012, STEM CELLS DEV, V21, P1309, DOI 10.1089/scd.2011.0223; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Martens JHA, 2011, INT J BIOCHEM CELL B, V43, P1413, DOI 10.1016/j.biocel.2011.05.014; McLaughlin F, 2001, BLOOD, V98, P3332, DOI 10.1182/blood.V98.12.3332; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; RAFII S, 1994, BLOOD, V84, P10; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; ZHANG LQ, 1993, ONCOGENE, V8, P1621; Zhang P, 2009, STEM CELLS DEV, V18, P1299, DOI 10.1089/scd.2008.0331	39	153	158	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 26	2012	151	3					559	575		10.1016/j.cell.2012.09.032	http://dx.doi.org/10.1016/j.cell.2012.09.032			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23084400	Green Accepted, Bronze			2022-12-24	WOS:000310529300013
J	Morlot, S; Galli, V; Klein, M; Chiaruttini, N; Manzi, J; Humbert, F; Dinis, L; Lenz, M; Cappello, G; Roux, A				Morlot, Sandrine; Galli, Valentina; Klein, Marius; Chiaruttini, Nicolas; Manzi, John; Humbert, Frederic; Dinis, Luis; Lenz, Martin; Cappello, Giovanni; Roux, Aurelien			Membrane Shape at the Edge of the Dynamin Helix Sets Location and Duration of the Fission Reaction	CELL			English	Article							MEDIATED ENDOCYTOSIS; CRYSTAL-STRUCTURE; LIPID-BILAYERS; CURVATURE; MODEL; CONSTRICTION; TENSION; AMPHIPHYSIN; RINGS	The GTPase dynamin polymerizes into a helical coat that constricts membrane necks of endocytic pits to promote their fission. However, the dynamin mechanism is still debated because constriction is necessary but not sufficient for fission. Here, we show that fission occurs at the interface between the dynamin coat and the uncoated membrane. At this location, the considerable change in membrane curvature increases the local membrane elastic energy, reducing the energy barrier for fission. Fission kinetics depends on tension, bending rigidity, and the dynamin constriction torque. Indeed, we experimentally find that the fission rate depends on membrane tension in vitro and during endocytosis in vivo. By estimating the energy barrier from the increased elastic energy at the edge of dynamin and measuring the dynamin torque, we show that the mechanical energy spent on dynamin constriction can reduce the energy barrier for fission sufficiently to promote spontaneous fission.	[Morlot, Sandrine; Galli, Valentina; Chiaruttini, Nicolas; Humbert, Frederic; Roux, Aurelien] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Morlot, Sandrine; Klein, Marius; Manzi, John; Cappello, Giovanni] Univ Paris 06, Inst Curie, Ctr Rech, CNRS,UMR Physicochim Curie 168, F-75248 Paris, France; [Dinis, Luis] Univ Complutense Madrid, Dept Fis Atom Mol & Nucl, E-28040 Madrid, Spain; [Dinis, Luis] GISC, Madrid 28040, Spain; [Lenz, Martin] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Lenz, Martin] Univ Paris 11, CNRS, UMR LPTMS 8626, F-91405 Orsay, France; [Roux, Aurelien] Swiss Natl Ctr Competence Res, Programme Chem Biol, CH-1211 Geneva, Switzerland	University of Geneva; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Complutense University of Madrid; University of Chicago; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Roux, A (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	Aurelien.roux@unige.ch	Cappello, Giovanni/D-4876-2013; Manzi, John/AAI-8253-2021; Roux, Aurelien R/G-9541-2013; Roux, Aurelien/AAU-1262-2021; Dinis, Luis/B-8820-2011; Lenz, Martin/B-3329-2013; Dinis, Luis/AAN-6969-2021	Manzi, John/0000-0003-2574-4260; Roux, Aurelien R/0000-0002-6088-0711; Dinis, Luis/0000-0003-2064-2396; Lenz, Martin/0000-0002-2307-1106; Dinis, Luis/0000-0003-2064-2396; Morlot, Sandrine/0000-0002-0326-6694	Agence Nationale de la Recherche [JC08-317536, 0061/2008, RGY0076/2009-C, 31003A-130520/1]; Societe Academique de Geneve; Swiss National Centre for Competence in Research Programme Chemical Biology; Spanish Government [FIS2011-22644]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Societe Academique de Geneve; Swiss National Centre for Competence in Research Programme Chemical Biology; Spanish Government(Spanish GovernmentEuropean Commission)	We thank David Drubin for sharing with us the SKML-2 cells. We thank Marcos Gonzalez-Gaitan, for inspiring discussions and critical reading of the manuscript. We thank Pietro De Camilli, Jacques Prost, and Jean-Francois Joanny for thoughtful comments on this study. This work was supported by the Agence Nationale de la Recherche (Young Investigator Program Award No. JC08-317536 to A. R. and G. C.), Human Frontier Science Program Career Development Award No. 0061/2008 (to A. R.), Young Investigator Research Grant No. RGY0076/2009-C (to A. R.), Swiss National Fund for Research Grant No. 31003A-130520/1 (to A. R.), the Societe Academique de Geneve, and the Swiss National Centre for Competence in Research Programme Chemical Biology. L. D. acknowledges financial support from Grant ENFASIS (FIS2011-22644, from the Spanish Government).	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Happel, 2012, LOW REYNOLDS NUMBER; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Lenz M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011911; Lipfert J, 2010, NAT METHODS, V7, P977, DOI [10.1038/nmeth.1520, 10.1038/NMETH.1520]; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Morlot S, 2010, BIOPHYS J, V99, P3580, DOI 10.1016/j.bpj.2010.10.015; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Roux A, 2008, CELL, V135, P1163, DOI 10.1016/j.cell.2008.12.003; Shlomovitz R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/065008; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	41	118	119	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 26	2012	151	3					619	629		10.1016/j.cell.2012.09.017	http://dx.doi.org/10.1016/j.cell.2012.09.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	029WY	23101629	Green Accepted, Bronze			2022-12-24	WOS:000310529300017
J	Zhang, QC; Petrey, D; Deng, L; Qiang, L; Shi, Y; Thu, CA; Bisikirska, B; Lefebvre, C; Accili, D; Hunter, T; Maniatis, T; Califano, A; Honig, B				Zhang, Qiangfeng Cliff; Petrey, Donald; Deng, Lei; Qiang, Li; Shi, Yu; Thu, Chan Aye; Bisikirska, Brygida; Lefebvre, Celine; Accili, Domenico; Hunter, Tony; Maniatis, Tom; Califano, Andrea; Honig, Barry			Structure-based prediction of protein-protein interactions on a genome-wide scale	NATURE			English	Article							NETWORKS; DATABASE; SEQUENCES; CONTEXT	The genome-wide identification of pairs of interacting proteins is an important step in the elucidation of cell regulatory mechanisms(1,2). Much of our present knowledge derives from high-throughput techniques such as the yeast two-hybrid assay and affinity purification(3), as well as from manual curation of experiments on individual systems(4). A variety of computational approaches based, for example, on sequence homology, gene co-expression and phylogenetic profiles, have also been developed for the genome-wide inference of protein-protein interactions (PPIs)(5,6). Yet comparative studies suggest that the development of accurate and complete repertoires of PPIs is still in its early stages(7-9). Here we show that three-dimensional structural information can be used to predict PPIs with an accuracy and coverage that are superior to predictions based on non-structural evidence. Moreover, an algorithm, termed PrePPI, which combines structural information with other functional clues, is comparable in accuracy to high-throughput experiments, yielding over 30,000 high-confidence interactions for yeast and over 300,000 for human. Experimental tests of a number of predictions demonstrate the ability of the PrePPI algorithm to identify unexpected PPIs of considerable biological interest. The surprising effectiveness of three-dimensional structural information can be attributed to the use of homology models combined with the exploitation of both close and remote geometric relationships between proteins.	[Zhang, Qiangfeng Cliff; Petrey, Donald; Deng, Lei; Thu, Chan Aye; Maniatis, Tom; Califano, Andrea; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Zhang, Qiangfeng Cliff; Petrey, Donald; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Zhang, Qiangfeng Cliff; Petrey, Donald; Deng, Lei; Bisikirska, Brygida; Lefebvre, Celine; Califano, Andrea; Honig, Barry] Columbia Univ, Columbia Initiat Syst Biol, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Deng, Lei] Tongji Univ, Dept Comp Sci & Technol, Shanghai 201804, Peoples R China; [Qiang, Li; Accili, Domenico] Columbia Univ, Coll Phys & Surg, Dept Med, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Shi, Yu; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Lefebvre, Celine; Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Tongji University; Columbia University; Salk Institute; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	califano@c2b2.columbia.edu; bh6@columbia.edu	Zhang, Qiangfeng/C-2902-2011; Lefebvre, Celine/E-6290-2013; Califano, Andrea/F-7239-2012; Shi, Yu/N-4319-2019; dong, minghui/D-1806-2015	Shi, Yu/0000-0001-6742-9598; Califano, Andrea/0000-0003-4742-3679; Qiang, Li/0000-0001-8322-1797	National Institutes of Health [GM030518, GM094597, CA121852, DK057539, CA082683, R01NS043915]; China Scholarship Council [2010626059]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA082683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030518, R01GM030518, U54GM094597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health grants GM030518 and GM094597 (B.H.), CA121852 (A.C. and B.H.), DK057539 (D.A.), CA082683 (T.H.), R01NS043915 (T.M.). L.D. thanks the China Scholarship Council scholarship 2010626059. We thank U. Pieper from A. Sali's laboratory for help with ModBase, and H. Lee for help with SkyBase.	Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468851a, 10.1038/468854a, 10.1038/468852a]; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Davis FP, 2006, NUCLEIC ACIDS RES, V34, P2943, DOI 10.1093/nar/gkl353; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Enault F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-247; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Keskin O, 2008, METHODS MOL BIOL, V484, P505, DOI 10.1007/978-1-59745-398-1_30; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Mirkovic N, 2007, PROTEINS, V66, P766, DOI 10.1002/prot.21191; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Salwinski L, 2003, CURR OPIN STRUC BIOL, V13, P377, DOI 10.1016/S0959-440X(03)00070-8; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107	44	464	487	10	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					556	+		10.1038/nature11503	http://dx.doi.org/10.1038/nature11503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23023127	Green Accepted			2022-12-24	WOS:000310196200046
J	Zhang, Y; Feng, Y; Chatterjee, S; Tuske, S; Ho, MX; Arnold, E; Ebright, RH				Zhang, Yu; Feng, Yu; Chatterjee, Sujoy; Tuske, Steve; Ho, Mary X.; Arnold, Eddy; Ebright, Richard H.			Structural Basis of Transcription Initiation	SCIENCE			English	Article							RNA-POLYMERASE HOLOENZYME; PROMOTER OPEN COMPLEX; SIGMA-SUBUNIT; ANGSTROM RESOLUTION; RECOGNITION; ELEMENT; ORGANIZATION; ARCHITECTURE; ELONGATION; MECHANISM	During transcription initiation, RNA polymerase (RNAP) binds and unwinds promoter DNA to form an RNAP-promoter open complex. We have determined crystal structures at 2.9 and 3.0 angstrom resolution of functional transcription initiation complexes comprising Thermus thermophilus RNA polymerase, sigma(A), and a promoter DNA fragment corresponding to the transcription bubble and downstream double-stranded DNA of the RNAP-promoter open complex. The structures show that sigma recognizes the -10 element and discriminator element through interactions that include the unstacking and insertion into pockets of three DNA bases and that RNAP recognizes the -4/+2 region through interactions that include the unstacking and insertion into a pocket of the +2 base. The structures further show that interactions between sigma and template-strand single-stranded DNA (ssDNA) preorganize template-strand ssDNA to engage the RNAP active center.	[Zhang, Yu; Feng, Yu; Chatterjee, Sujoy; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Zhang, Yu; Feng, Yu; Chatterjee, Sujoy; Tuske, Steve; Ho, Mary X.; Arnold, Eddy; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Tuske, Steve; Ho, Mary X.; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu	Zhang, Yu/J-5225-2014; Ebright, Richard/O-3321-2019; Chatterjee, Sujoy/L-7325-2015; Zhang, Yu/AAV-5722-2021	Ebright, Richard/0000-0001-8915-7140; Zhang, Yu/0000-0002-1778-8389; Feng, Yu/0000-0003-4239-8320	NIH [GM41376, AI072766]; Howard Hughes Medical Institute Investigatorship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R37GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Brookhaven National Synchrotron Light Source and Cornell High Energy Synchrotron Source for beamline access; the Argonne Photon Source CCP4 School for training; and S. Borukhov, P. deHaseth, K. Kuznedelov, L. Minakhin, K. Severinov, and D. Temiakov for plasmids and discussion. This work was funded by NIH grants GM41376 and AI072766 and a Howard Hughes Medical Institute Investigatorship to R. H. E. PDB accession codes are 4G7H, 4G7Z, and 4G7O.	Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Hudson BP, 2009, P NATL ACAD SCI USA, V106, P19830, DOI 10.1073/pnas.0908782106; Kireeva ML, 2011, J BIOL CHEM, V286, P30898, DOI 10.1074/jbc.M111.260844; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Landick R, 2009, P NATL ACAD SCI USA, V106, P8797, DOI 10.1073/pnas.0904373106; Liu X, 2011, CELL, V147, P1218, DOI 10.1016/j.cell.2011.11.033; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mekler V, 2011, J BIOL CHEM, V286, P22600, DOI 10.1074/jbc.M111.247080; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Treutlein B, 2012, MOL CELL, V46, P136, DOI 10.1016/j.molcel.2012.02.008; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6	29	236	239	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1076	1080		10.1126/science.1227786	http://dx.doi.org/10.1126/science.1227786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23086998	Green Accepted			2022-12-24	WOS:000311390600043
J	Luk, KC; Kehm, V; Carroll, J; Zhang, B; O'Brien, P; Trojanowski, JQ; Lee, VMY				Luk, Kelvin C.; Kehm, Victoria; Carroll, Jenna; Zhang, Bin; O'Brien, Patrick; Trojanowski, John Q.; Lee, Virginia M. -Y.			Pathological alpha-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice	SCIENCE			English	Article							LEWY BODIES; DISEASE; BRAIN; DEATH	Parkinson's disease is characterized by abundant alpha-synuclein (alpha-Syn) neuronal inclusions, known as Lewy bodies and Lewy neurites, and the massive loss of midbrain dopamine neurons. However, a cause-and-effect relationship between Lewy inclusion formation and neurodegeneration remains unclear. Here, we found that in wild-type nontransgenic mice, a single intrastriatal inoculation of synthetic alpha-Syn fibrils led to the cell-to-cell transmission of pathologic alpha-Syn and Parkinson's-like Lewy pathology in anatomically interconnected regions. Lewy pathology accumulation resulted in progressive loss of dopamine neurons in the substantia nigra pars compacta, but not in the adjacent ventral tegmental area, and was accompanied by reduced dopamine levels culminating in motor deficits. This recapitulation of a neurodegenerative cascade thus establishes a mechanistic link between transmission of pathologic alpha-Syn and the cardinal features of Parkinson's disease.	[Lee, Virginia M. -Y.] Univ Penn, Dept Pathol & Lab Med, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Dept Pathol & Lab Med, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA.	vmylee@upenn.edu	Luk, Kelvin/AAZ-4202-2020	Luk, Kelvin/0000-0002-6591-6269	NIH [NS053488]; JPB Foundation; RJG Foundation; Parkinson Council; Jeff and Anne Keefer Fund; University of Pennsylvania Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; RJG Foundation; Parkinson Council; Jeff and Anne Keefer Fund; University of Pennsylvania Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Byrne, J. Levitan, I. Song, and J. Yeh for technical assistance, and L. Kwong, H. Tran, and K. Brunden for their comments. This work was funded by NIH NS053488, the JPB and RJG Foundations, the Parkinson Council, and the Jeff and Anne Keefer Fund. K. C. L. is supported in part by the University of Pennsylvania Institute for Translational Medicine and Therapeutics. The data reported in this paper are presented in the main text and supplementary materials. Materials and methods are available as supplementary materials on Science Online.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Baba M, 1998, AM J PATHOL, V152, P879; Bjorklund A, 2010, PROG BRAIN RES, V184, P17, DOI 10.1016/S0079-6123(10)84002-6; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033	24	1520	1556	12	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					949	953		10.1126/science.1227157	http://dx.doi.org/10.1126/science.1227157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	23161999	Green Accepted			2022-12-24	WOS:000311083600044
J	Ezenwa, VO; Gerardo, NM; Inouye, DW; Medina, M; Xavier, JB				Ezenwa, Vanessa O.; Gerardo, Nicole M.; Inouye, David W.; Medina, Monica; Xavier, Joao B.			Animal Behavior and the Microbiome	SCIENCE			English	Editorial Material							GUT MICROBIOTA; ACQUISITION; DIVERSITY		[Ezenwa, Vanessa O.] Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA; [Ezenwa, Vanessa O.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Gerardo, Nicole M.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Inouye, David W.] Rocky Mt Biol Labs, Crested Butte, CO 81224 USA; [Inouye, David W.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Xavier, Joao B.] Mem Sloan Kettering Canc Ctr, Program Computat Biol, New York, NY 10021 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Emory University; University System of Maryland; University of Maryland College Park; University of California System; University of California Merced; Memorial Sloan Kettering Cancer Center	Ezenwa, VO (corresponding author), Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA.	ngerard@emory.edu	Xavier, Joao/H-5471-2011; Inouye, David W./C-2997-2011	Xavier, Joao/0000-0003-3592-1689; Inouye, David W./0000-0003-2076-7834	Direct For Biological Sciences [1146880] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1229439] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Boettcher KJ, 1996, J COMP PHYSIOL A, V179, P65; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hosokawa T, 2008, BIOL LETTERS, V4, P45, DOI 10.1098/rsbl.2007.0510; Huang Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00228; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Lombardo MP, 2008, BEHAV ECOL SOCIOBIOL, V62, P479, DOI 10.1007/s00265-007-0428-9; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Theis KR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00615; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Verhulst NO, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020497, 10.1371/journal.pone.0028991]	16	300	314	11	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					198	199		10.1126/science.1227412	http://dx.doi.org/10.1126/science.1227412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	23066064				2022-12-24	WOS:000309712300024
J	Pass, HI; Levin, SM; Harbut, MR; Melamed, J; Chiriboga, L; Donington, J; Huflejt, M; Carbone, M; Chia, D; Goodglick, L; Goodman, GE; Thornquist, MD; Liu, G; de Perrot, M; Tsao, MS; Goparaju, C				Pass, Harvey I.; Levin, Stephen M.; Harbut, Michael R.; Melamed, Jonathan; Chiriboga, Luis; Donington, Jessica; Huflejt, Margaret; Carbone, Michele; Chia, David; Goodglick, Lee; Goodman, Gary E.; Thornquist, Mark D.; Liu, Geoffrey; de Perrot, Marc; Tsao, Ming-Sound; Goparaju, Chandra			Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROMOTER METHYLATION; LUNG-CANCER; ASBESTOS EXPOSURE; IN-VIVO; EXPRESSION; EFEMP1; PROTEIN; FAMILY; GENE; PROGRESSION	BACKGROUND New biomarkers are needed to detect pleural mesothelioma at an earlier stage and to individualize treatment strategies. We investigated whether fibulin-3 in plasma and pleural effusions could meet sensitivity and specificity criteria for a robust biomarker. METHODS We measured fibulin-3 levels in plasma (from 92 patients with mesothelioma, 136 asbestos-exposed persons without cancer, 93 patients with effusions not due to mesothelioma, and 43 healthy controls), effusions (from 74 patients with mesothelioma, 39 with benign effusions, and 54 with malignant effusions not due to mesothelioma), or both. A blinded validation was subsequently performed. Tumor tissue was examined for fibulin-3 by immunohistochemical analysis, and levels of fibulin-3 in plasma and effusions were measured with an enzyme-linked immunosorbent assay. RESULTS Plasma fibulin-3 levels did not vary according to age, sex, duration of asbestos exposure, or degree of radiographic changes and were significantly higher in patients with pleural mesothelioma (105 +/- 7 ng per milliliter in the Detroit cohort and 113 +/- 8 ng per milliliter in the New York cohort) than in asbestos-exposed persons without mesothelioma (14 +/- 1 ng per milliliter and 24 +/- 1 ng per milliliter, respectively; P<0.001). Effusion fibulin-3 levels were significantly higher in patients with pleural mesothelioma (694 +/- 37 ng per milliliter in the Detroit cohort and 636 +/- 92 ng per milliliter in the New York cohort) than in patients with effusions not due to mesothelioma (212 +/- 25 and 151 +/- 23 ng per milliliter, respectively; P<0.001). Fibulin-3 preferentially stained tumor cells in 26 of 26 samples. In an overall comparison of patients with and those without mesothelioma, the receiver-operating-characteristic curve for plasma fibulin-3 levels had a sensitivity of 96.7% and a specificity of 95.5% at a cutoff value of 52.8 ng of fibulin-3 per milliliter. In a comparison of patients with early-stage mesothelioma with asbestos-exposed persons, the sensitivity was 100% and the specificity was 94.1% at a cutoff value of 46.0 ng of fibulin-3 per milliliter. Blinded validation revealed an area under the curve of 0.87 for plasma specimens from 96 asbestos-exposed persons as compared with 48 patients with mesothelioma. CONCLUSIONS Plasma fibulin-3 levels can distinguish healthy persons with exposure to asbestos from patients with mesothelioma. In conjunction with effusion fibulin-3 levels, plasma fibulin-3 levels can further differentiate mesothelioma effusions from other malignant and benign effusions. (Funded by the Early Detection Research Network, National Institutes of Health, and others.)	[Pass, Harvey I.; Donington, Jessica; Huflejt, Margaret; Goparaju, Chandra] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Melamed, Jonathan; Chiriboga, Luis] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Levin, Stephen M.] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA; [Harbut, Michael R.] Karmanos Canc Inst, Natl Ctr Vermiculite & Asbestos Related Canc, Detroit, MI USA; [Carbone, Michele] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Chia, David; Goodglick, Lee] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Goodman, Gary E.] Swedish Canc Inst, Seattle, WA USA; [Thornquist, Mark D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Liu, Geoffrey; de Perrot, Marc; Tsao, Ming-Sound] Univ Toronto, Toronto, ON, Canada; [Liu, Geoffrey; de Perrot, Marc; Tsao, Ming-Sound] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Icahn School of Medicine at Mount Sinai; Barbara Ann Karmanos Cancer Institute; Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Los Angeles; Swedish Cancer Institute; Swedish Medical Center; Fred Hutchinson Cancer Center; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Pass, HI (corresponding author), NYU, Langone Med Ctr, Dept Cardiothorac Surg, 530 1st Ave,9V, New York, NY 10016 USA.	harvey.pass@med.nyu.edu	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017; Melamed, Jonathan/AAV-3769-2020	Tsao, Ming Sound/0000-0002-9160-5405; Melamed, Jonathan/0000-0003-2844-7990; Liu, Geoffrey/0000-0002-2603-7296; Huflejt, Malgorzata/0000-0002-2016-8367; Chiriboga, Luis/0000-0002-2028-6873; Pass, Harvey/0000-0003-3222-3471; de Perrot, Marc/0000-0003-2000-9427	Princess Margaret Hospital Foundation; Princess Margaret Hospital Mesothelioma Research Program; Masters Insulators Association of Ontario; International Association of Heat and Frost Insulators and Asbestos Workers [Local 793]; Imperial Oil Charitable Foundation; M. Qasim Choksi Chair in Lung Cancer Translational Research; Alan B. Brown Chair in Molecular Genetics; Ontario Ministry of Health and Long-Term Care; Early Detection Research Network, National Institutes of Health [U01 CA-111295, U01 CA-113913]; NATIONAL CANCER INSTITUTE [U01CA113913, U01CA111295] Funding Source: NIH RePORTER	Princess Margaret Hospital Foundation; Princess Margaret Hospital Mesothelioma Research Program; Masters Insulators Association of Ontario; International Association of Heat and Frost Insulators and Asbestos Workers; Imperial Oil Charitable Foundation; M. Qasim Choksi Chair in Lung Cancer Translational Research; Alan B. Brown Chair in Molecular Genetics; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Early Detection Research Network, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Princess Margaret Hospital Foundation and the Princess Margaret Hospital Mesothelioma Research Program (funded by the Masters Insulators Association of Ontario, International Association of Heat and Frost Insulators and Asbestos Workers, Local 793, and other unions, and the Imperial Oil Charitable Foundation) for plasma banking; by the M. Qasim Choksi Chair in Lung Cancer Translational Research (held by Dr. Tsao), the Alan B. Brown Chair in Molecular Genetics (held by Dr. Liu), and the Ontario Ministry of Health and Long-Term Care; and by donations from Belluck and Fox, the Simmons Foundation, Levi Phillips and Konigsberg, the Stephen E. Banner Fund for Lung Cancer Research, the Rosenwald Family, and the Anderson Family and grants from the Early Detection Research Network, National Institutes of Health, to the New York University Thoracic Oncology Research Laboratories (U01 CA-111295) and to Beth Israel Deaconess Medical Center (U01 CA-113913).	AISNER J, 1995, CHEST, V108, P1122; Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Barnhart S, 1997, AM J IND MED, V32, P573, DOI 10.1002/(SICI)1097-0274(199712)32:6<573::AID-AJIM1>3.0.CO;2-R; Davidson B, 2011, J CELL MOL MED, V15, P535, DOI [10.1111/j.1582-4934.2010.01019.x, 10.1111/j.1582-4934.2010.01023.x]; Fiorelli A, 2011, INTERACT CARDIOV TH, V12, P420, DOI 10.1510/icvts.2010.250357; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hirayama N, 2011, RESP MED, V105, P137, DOI 10.1016/j.rmed.2010.10.010; Hollevoet K, 2012, J CLIN ONCOL, V30, P1541, DOI 10.1200/JCO.2011.39.6671; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu YJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-123; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Kim YJ, 2011, CLIN CANCER RES, V17, P4523, DOI 10.1158/1078-0432.CCR-10-2817; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Michaelides M, 2006, INVEST OPHTH VIS SCI, V47, P3085, DOI 10.1167/iovs.05-1600; Moore RM, 2009, PLACENTA, V30, P335, DOI 10.1016/j.placenta.2009.01.007; Nomoto S, 2010, ANN SURG ONCOL, V17, P923, DOI 10.1245/s10434-009-0790-0; Pass HI, 2009, SEMIN THORAC CARDIOV, V21, P97, DOI 10.1053/j.semtcvs.2009.06.007; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; Roberts HC, 2009, J THORAC ONCOL, V4, P620, DOI 10.1097/JTO.0b013e31819f2e0e; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Sasaki T, 1996, EUR J BIOCHEM, V240, P427, DOI 10.1111/j.1432-1033.1996.0427h.x; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Segade F, 2010, GENE, V464, P17, DOI 10.1016/j.gene.2010.05.003; SELIKOFF IJ, 1992, AM J IND MED, V22, P481, DOI 10.1002/ajim.4700220403; Tong JD, 2011, NEOPLASMA, V58, P441, DOI 10.4149/neo_2011_05_441; Tran H, 1997, MATRIX BIOL, V15, P479, DOI 10.1016/S0945-053X(97)90021-4; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Yue W, 2007, CLIN CANCER RES, V13, P4336, DOI 10.1158/1078-0432.CCR-07-0015; Zhang YW, 2010, EXP EYE RES, V90, P374, DOI 10.1016/j.exer.2009.09.018; ZWEIG MH, 1993, CLIN CHEM, V39, P561	34	201	209	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1417	1427		10.1056/NEJMoa1115050	http://dx.doi.org/10.1056/NEJMoa1115050			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	23050525	Green Accepted			2022-12-24	WOS:000309652700008
J	Kaptoge, S; Di Angelantonio, E; Pennells, L; Wood, AM; White, IR; Gao, P; Walker, M; Thompson, A; Sarwar, N; Caslake, M; Butterworth, AS; Amouyel, P; Assmann, G; Bakker, SJL; Barr, ELM; Barrett-Connor, E; Benjamin, EJ; Bjorkelund, C; Brenner, H; Brunner, E; Clarke, R; Cooper, JA; Cremer, P; Cushman, M; Dagenais, GR; D'Agostino, RB; Dankner, R; Davey-Smith, G; Deeg, D; Dekker, JM; Engstrom, G; Folsom, AR; Fowkes, FGR; Gallacher, J; Gaziano, JM; Giampaoli, S; Gillum, RF; Hofman, A; Howard, BV; Ingelsson, E; Iso, H; Jorgensen, T; Kiechl, S; Kitamura, A; Kiyohara, Y; Koenig, W; Kromhout, D; Kuller, LH; Lawlor, DA; Meade, TW; Nissinen, A; Nordestgaard, BG; Onat, A; Panagiotakos, DB; Psaty, BM; Rodriguez, B; Rosengren, A; Salomaa, V; Kauhanen, J; Salonen, JT; Shaffer, JA; Shea, S; Ford, I; Stehouwer, CDA; Strandberg, TE; Tipping, RW; Tosetto, A; Wassertheil-Smoller, S; Wennberg, P; Westendorp, RG; Whincup, PH; Wilhelmsen, L; Woodward, M; Lowe, GDO; Wareham, NJ; Khaw, KT; Sattar, N; Packard, CJ; Gudnason, V; Ridker, PM; Pepys, MB; Thompson, SG; Danesh, J				Kaptoge, Stephen; Di Angelantonio, Emanuele; Pennells, Lisa; Wood, Angela M.; White, Ian R.; Gao, Pei; Walker, Matthew; Thompson, Alexander; Sarwar, Nadeem; Caslake, Muriel; Butterworth, Adam S.; Amouyel, Philippe; Assmann, Gerd; Bakker, Stephan J. L.; Barr, Elizabeth L. M.; Barrett-Connor, Elizabeth; Benjamin, Emelia J.; Bjorkelund, Cecilia; Brenner, Hermann; Brunner, Eric; Clarke, Robert; Cooper, Jackie A.; Cremer, Peter; Cushman, Mary; Dagenais, Gilles R.; D'Agostino, Ralph B., Sr.; Dankner, Rachel; Davey-Smith, George; Deeg, Dorly; Dekker, Jacqueline M.; Engstrom, Gunnar; Folsom, Aaron R.; Fowkes, F. Gerry R.; Gallacher, John; Gaziano, J. Michael; Giampaoli, Simona; Gillum, Richard F.; Hofman, Albert; Howard, Barbara V.; Ingelsson, Erik; Iso, Hiroyasu; Jorgensen, Torben; Kiechl, Stefan; Kitamura, Akihiko; Kiyohara, Yutaka; Koenig, Wolfgang; Kromhout, Daan; Kuller, Lewis H.; Lawlor, Debbie A.; Meade, Tom W.; Nissinen, Aulikki; Nordestgaard, Borge G.; Onat, Altan; Panagiotakos, Demosthenes B.; Psaty, Bruce M.; Rodriguez, Beatriz; Rosengren, Annika; Salomaa, Veikko; Kauhanen, Jussi; Salonen, Jukka T.; Shaffer, Jonathan A.; Shea, Steven; Ford, Ian; Stehouwer, Coen D. A.; Strandberg, Timo E.; Tipping, Robert W.; Tosetto, Alberto; Wassertheil-Smoller, Sylvia; Wennberg, Patrik; Westendorp, Rudi G.; Whincup, Peter H.; Wilhelmsen, Lars; Woodward, Mark; Lowe, Gordon D. O.; Wareham, Nicholas J.; Khaw, Kay-Tee; Sattar, Naveed; Packard, Chris J.; Gudnason, Vilmundur; Ridker, Paul M.; Pepys, Mark B.; Thompson, Simon G.; Danesh, John		Emerging Risk Factors	C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; PRIMARY PREVENTION; COST-EFFECTIVENESS; RISK PROFILE; GUIDELINES; INFLAMMATION; ASSOCIATION; CARE	Background There is debate about the value of assessing levels of C-reactive protein (CRP) and other biomarkers of inflammation for the prediction of first cardiovascular events. Methods We analyzed data from 52 prospective studies that included 246,669 participants without a history of cardiovascular disease to investigate the value of adding CRP or fibrinogen levels to conventional risk factors for the prediction of cardiovascular risk. We calculated measures of discrimination and reclassification during follow-up and modeled the clinical implications of initiation of statin therapy after the assessment of CRP or fibrinogen. Results The addition of information on high-density lipoprotein cholesterol to a prognostic model for cardiovascular disease that included age, sex, smoking status, blood pressure, history of diabetes, and total cholesterol level increased the C-index, a measure of risk discrimination, by 0.0050. The further addition to this model of information on CRP or fibrinogen increased the C-index by 0.0039 and 0.0027, respectively (P < 0.001), and yielded a net reclassification improvement of 1.52% and 0.83%, respectively, for the predicted 10-year risk categories of "low" (< 10%), " intermediate" (10% to < 20%), and "high" (>= 20%) (P < 0.02 for both comparisons). We estimated that among 100,000 adults 40 years of age or older, 15,025 persons would initially be classified as being at intermediate risk for a cardiovascular event if conventional risk factors alone were used to calculate risk. Assuming that statin therapy would be initiated in accordance with Adult Treatment Panel III guidelines (i.e., for persons with a predicted risk of >= 20% and for those with certain other risk factors, such as diabetes, irrespective of their 10-year predicted risk), additional targeted assessment of CRP or fibrinogen levels in the 13,199 remaining participants at intermediate risk could help prevent approximately 30 additional cardiovascular events over the course of 10 years. Conclusions In a study of people without known cardiovascular disease, we estimated that under current treatment guidelines, assessment of the CRP or fibrinogen level in people at intermediate risk for a cardiovascular event could help prevent one additional event over a period of 10 years for every 400 to 500 people screened. (Funded by the British Heart Foundation and others.)	[Kaptoge, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Emerging Risk Factors Collaborat Coordinating Ctr, Cambridge CB1 8RN, England; [White, Ian R.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Caslake, Muriel; Ford, Ian; Lowe, Gordon D. O.; Sattar, Naveed; Packard, Chris J.] Univ Glasgow, Glasgow, Lanark, Scotland; [Amouyel, Philippe] Inst Pasteur, Lille, France; [Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Bakker, Stephan J. L.] Univ Groningen, Groningen, Netherlands; [Barrett-Connor, Elizabeth] Univ Calif San Diego, San Diego, CA 92103 USA; [Benjamin, Emelia J.; D'Agostino, Ralph B., Sr.] Boston Univ, Boston, MA 02215 USA; [Bjorkelund, Cecilia; Wilhelmsen, Lars] Univ Gothenburg, Gothenburg, Sweden; [Brenner, Hermann] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Brunner, Eric; Cooper, Jackie A.; Pepys, Mark B.] UCL, London, England; [Clarke, Robert] Univ Oxford, Oxford, England; [Cremer, Peter] Klinikum Univ Munchen LMU, Munich, Germany; [Cushman, Mary] Univ Vermont, Burlington, ON, Canada; [Dagenais, Gilles R.] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Dankner, Rachel] Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel; [Davey-Smith, George; Lawlor, Debbie A.] Univ Bristol, Bristol, Avon, England; [Deeg, Dorly; Dekker, Jacqueline M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Engstrom, Gunnar] Lund Univ, Lund, Sweden; [Folsom, Aaron R.] Univ Minnesota, Minneapolis, MN USA; [Fowkes, F. Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Gallacher, John] Cardiff Univ, Cardiff, S Glam, Wales; [Gaziano, J. Michael] Harvard Univ, Sch Med, Boston, MA USA; [Giampaoli, Simona] Ist Super Sanita, I-00161 Rome, Italy; [Gillum, Richard F.] Ctr Dis Control & Prevent, Hyattsville, MD USA; [Hofman, Albert] Erasmus MC, Rotterdam, Netherlands; [Howard, Barbara V.] Medstar Hlth Res Inst, Hyattsville, MD USA; [Ingelsson, Erik] Karolinska Inst, Stockholm, Sweden; [Iso, Hiroyasu] Osaka Univ, Osaka, Japan; [Jorgensen, Torben] Glostrup Univ Hosp, Glostrup, Denmark; [Jorgensen, Torben; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen, Denmark; [Kiechl, Stefan] Med Univ Innsbruck, Innsbruck, Austria; [Kitamura, Akihiko] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Kiyohara, Yutaka] Kyushu Univ, Fukuoka 812, Japan; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Ulm, Germany; [Kromhout, Daan] Wageningen Univ, Wageningen, Netherlands; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA USA; [Meade, Tom W.] London Sch Hyg & Trop Med, London WC1, England; [Nissinen, Aulikki] Natl Inst Hlth & Welf, Helsinki, Finland; [Onat, Altan] Istanbul Univ, Istanbul, Turkey; [Panagiotakos, Demosthenes B.] Harokopio Univ, Athens, Greece; [Psaty, Bruce M.] Univ Washington, Seattle, WA 98195 USA; [Rodriguez, Beatriz] Univ Hawaii, Honolulu, HI 96822 USA; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Kauhanen, Jussi] Univ Eastern Finland, Kuopio, Finland; [Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Salonen, Jukka T.] Metab Analyt Serv, Helsinki, Finland; [Shaffer, Jonathan A.; Shea, Steven] Columbia Univ, Med Ctr, New York, NY USA; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Strandberg, Timo E.] Univ Helsinki, Oulu, Finland; [Strandberg, Timo E.] Univ Oulu, Oulu, Finland; [Tipping, Robert W.] Merck Res Labs, Philadelphia, PA USA; [Tosetto, Alberto] San Bortolo Hosp, Vicenza, Italy; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, New York, NY USA; [Wennberg, Patrik] Umea Univ, Umea, Sweden; [Westendorp, Rudi G.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Whincup, Peter H.] St Georges Univ London, London, England; [Woodward, Mark] Univ Sydney, Sydney, NSW 2006, Australia; [Wareham, Nicholas J.] MRC Epidemiol Unit, Cambridge, England; [Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Kopavogur, Iceland; [Ridker, Paul M.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Cambridge; MRC Biostatistics Unit; University of Glasgow; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Groningen; University of Groningen; University of California System; University of California San Diego; Boston University; University of Gothenburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of London; University College London; University of Oxford; University of Munich; University of Bristol; Vrije Universiteit Amsterdam; Lund University; University of Minnesota System; University of Minnesota Twin Cities; University of Edinburgh; Cardiff University; Harvard University; Harvard Medical School; Istituto Superiore di Sanita (ISS); Centers for Disease Control & Prevention - USA; Erasmus University Rotterdam; Erasmus MC; MedStar Health Research Institute; Karolinska Institutet; Osaka University; University of Copenhagen; University of Copenhagen; Medical University of Innsbruck; Kyushu University; Ulm University; Wageningen University & Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; London School of Hygiene & Tropical Medicine; Finland National Institute for Health & Welfare; Istanbul University; Harokopio University Athens; University of Washington; University of Washington Seattle; University of Hawaii System; University of Gothenburg; University of Eastern Finland; Finland National Institute for Health & Welfare; Columbia University; Maastricht University; University of Helsinki; University of Oulu; Merck & Company; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; Yeshiva University; Umea University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St Georges University London; University of Sydney; Icelandic Heart Association; University of Iceland; Harvard University; Brigham & Women's Hospital	Kaptoge, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Emerging Risk Factors Collaborat Coordinating Ctr, Worts Causeway, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	PALMIERI, LUIGI/O-1845-2017; Brunner, Eric/H-2114-2011; Woodward, Mark/L-6817-2017; Davey Smith, George/A-7407-2013; Brenner, Hermann/ABE-6383-2020; Khaw, Kay-Tee/AAZ-3209-2021; Gao, Pei/AAF-3065-2019; Meisinger, Christine/B-5358-2014; Tosetto, Alberto/AAB-9320-2022; Lamarche, Benoit/ABA-4785-2021; Panagiotakos, Demosthenes/M-9167-2019; Panagiotakos, Demosthenes/K-8294-2019; Kauhanen, Jussi/ABC-4064-2021; Gao, Pei/R-4794-2018; Gudnason, Vilmundur/K-6885-2015; Woodward, Mark/D-8492-2015; Gudnason, Vilmundur/AAE-7126-2019; Brenner, Hermann/B-4627-2017; Ford, Ian/ABE-6145-2020; Panagiotakos, Demosthenes/C-9776-2013; Kromhout, Daan/A-8566-2014; Shaffer, Jonathan A/B-2783-2013; Woo, Wai Lok/T-3662-2018; Dankner, Rachel/Q-5245-2019; Aspelund, Thor/C-5983-2008; Cushman, Mary/K-1157-2019; Jørgensen, Torben/Z-1335-2018; Tosetto, Alberto/AAM-3200-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; Stehouwer, Coen/AAB-3435-2021; Benn, Marianne/O-4164-2019; Schöttker, Ben/F-8183-2014; Stefanadis, Christodoulos/ABH-2232-2020; DiAngelantonio, Emanuele/ABE-6852-2020; Wood, Angela/GZA-5762-2022; Marmot, M G/Y-3920-2019; Bakker, Stephan J. L./J-4023-2015; donfrancesco, chiara/K-1460-2016; Benjamin, Emelia/E-7103-2011	PALMIERI, LUIGI/0000-0002-4298-2642; Brunner, Eric/0000-0002-0595-4474; Davey Smith, George/0000-0002-1407-8314; Brenner, Hermann/0000-0002-6129-1572; Gao, Pei/0000-0001-8649-1290; Lamarche, Benoit/0000-0002-4443-5378; Panagiotakos, Demosthenes/0000-0001-8583-153X; Gao, Pei/0000-0001-8649-1290; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Brenner, Hermann/0000-0002-6129-1572; Panagiotakos, Demosthenes/0000-0001-8583-153X; Woo, Wai Lok/0000-0002-8698-7605; Dankner, Rachel/0000-0001-6454-6000; Aspelund, Thor/0000-0002-7998-5433; Cushman, Mary/0000-0002-7871-6143; Tosetto, Alberto/0000-0002-0119-5204; Benn, Marianne/0000-0002-1701-595X; Schöttker, Ben/0000-0002-1217-4521; Stefanadis, Christodoulos/0000-0001-5974-6454; Wood, Angela/0000-0002-7937-304X; Marmot, M G/0000-0002-2431-6419; Bakker, Stephan J. L./0000-0003-3356-6791; Yamagishi, Kazumasa/0000-0003-3301-5519; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Rothenbacher, Dietrich/0000-0002-3563-2791; Alexander, Myriam/0000-0002-6848-9370; Ramachandran, Vasan/0000-0001-7357-5970; Lawlor, Debbie A/0000-0002-6793-2262; s, hema/0000-0002-3440-9475; Franco, Oscar/0000-0002-4606-4929; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Bremmer, Marijke/0000-0002-0415-1127; Butterworth, Adam/0000-0002-6915-9015; Whincup, Peter/0000-0002-5589-4107; Nordestgaard, Borge/0000-0002-1954-7220; Davidson, Karina/0000-0002-9162-477X; Nijpels, Giel/0000-0002-3679-9710; donfrancesco, chiara/0000-0002-8040-5571; Kirkland, Susan/0000-0002-8182-2369; Pennells, Lisa Anne/0000-0002-8594-3061; Lewington, Sarah/0000-0002-4496-4771; Koenig, Wolfgang/0000-0002-2064-9603; strandberg, timo/0000-0001-6299-925X; Jespersen, Jorgen/0000-0002-3059-2356; Stehouwer, Coen/0000-0001-8752-3223; Benjamin, Emelia/0000-0003-4076-2336; Woodward, Mark/0000-0001-9800-5296; Engstrom, Gunnar/0000-0002-8618-9152; Ballantyne, Christie/0000-0002-6432-1730; Amouyel, Philippe/0000-0001-9088-234X; Jorgensen, Torben/0000-0001-9453-2830; White, Ian/0000-0002-6718-7661; Di Angelantonio, Emanuele/0000-0001-8776-6719; Bladbjerg, Else Marie/0000-0003-0912-2437; Kivimaki, Mika/0000-0002-4699-5627; Haycock, Philip/0000-0001-5001-3350	British Heart Foundation; MRC [G0902037, G0701619, MC_U137686857, MC_U137686851, G0600705, G0701863, G7900510, MC_U105260558] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, PG/09/002/26056, RG/07/008/23674, RG/08/013/25942] Funding Source: researchfish; Medical Research Council [MC_U105260558, MC_U106179471, MC_U137686851, G0701619, G8802774, G7900510, G0600705, G19/35, MC_U137686857, G0902037, MC_U105260792, G0701863, G0100222, G1000143] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091099, K24HL084034, P01HL088117] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the British Heart Foundation and others.	[Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Blake GJ, 2003, AM J MED, V114, P485, DOI 10.1016/S0002-9343(03)00074-3; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper A, 2008, BRIT MED J, V336, P1246, DOI 10.1136/bmj.39554.624086.AD; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Godsland IF, 2011, QJM-INT J MED, V104, P387, DOI 10.1093/qjmed/hcq213; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Heart Protection Study, 2011, LANCET, V377, P469, DOI 10.1016/S0140-6736(10)62174-5; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Lee KK, 2010, CIRCULATION, V122, P1478, DOI 10.1161/CIRCULATIONAHA.110.947960; Lp-PLA2Studies Collaboration, 2010, J GERONTOL B-PSYCHOL, V375, P1536; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Myers GL, 2009, CLIN CHEM, V55, P378, DOI 10.1373/clinchem.2008.115899; National Heart Lung and Blood Institute, DET EV TREATM HIGH B; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2010, AM J CARDIOL, V106, P204, DOI 10.1016/j.amjcard.2010.03.018; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	30	747	767	2	117	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1310	1320		10.1056/NEJMoa1107477	http://dx.doi.org/10.1056/NEJMoa1107477			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23034020	Green Published, Green Accepted			2022-12-24	WOS:000309406100007
